PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nandakumar, J; Bell, CF; Weidenfeld, I; Zaug, AJ; Leinwand, LA; Cech, TR				Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.			The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity	NATURE			English	Article							SINGLE-STRANDED-DNA; FISSION YEAST; LENGTH REGULATOR; POT1; PROTECTION; GENE; LOCALIZATION; TEL1(ATM); INTERACTS; REQUIRES	Human chromosome ends are capped by shelterin, a protein complex that protects the natural ends from being recognized as sites of DNA damage and also regulates the telomere-replicating enzyme, telomerase(1-3). Shelterin includes the heterodimeric POT1-TPP1 protein, which binds the telomeric single-stranded DNA tail(4-9). TPP1 has been implicated both in recruiting telomerase to telomeres and in stimulating telomerase processivity (the addition of multiple DNA repeats after a single primer-binding event)(9-14). Determining the mechanisms of these activities has been difficult, especially because genetic perturbations also tend to affect the essential chromosome end-protection function of TPP1 (refs 15-17). Here we identify separation-of-function mutants of human TPP1 that retain full telomere-capping function in vitro and in vivo, yet are defective in binding human telomerase. The seven separation-of-function mutations map to a patch of amino acids on the surface of TPP1, the TEL patch, that both recruits telomerase to telomeres and promotes high-processivity DNA synthesis, indicating that these two activities are manifestations of the same molecular interaction. Given that the interaction between telomerase and TPP1 is required for telomerase function in vivo, the TEL patch of TPP1 provides a new target for anticancer drug development.	[Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Weidenfeld, Ina; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Nandakumar, Jayakrishnan/0000-0001-9146-2785; Bell, Caitlin/0000-0001-7352-142X; LEINWAND, LESLIE/0000-0003-1470-4810	National Cancer Institute of the National Institutes of Health [K99CA167644]; US National Institutes of Health [R01GM29090, R01GM099705]; NATIONAL CANCER INSTITUTE [K99CA167644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090, R01GM099705] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. de Lange, M. Terns and S. Langer for suggestions and sharing protocols; T. Nahreini for maintenance of the departmental tissue culture facility; J. Friedman and G. Voeltz for help with confocal microscopy; and A. Berman, S. Borah and M. Nakashima for critical reading of the manuscript. T.R.C. is an investigator of the Howard Hughes Medical Institute (HHMI). J.N. was an HHMI fellow of the Helen Hay Whitney Foundation during a major part of this study and is supported by the National Cancer Institute of the National Institutes of Health under award number K99CA167644. This work was supported in part by US National Institutes of Health grant R01GM29090 to L.A.L. and R01GM099705 to T.R.C.	Abell AN, 2004, J CELL SCI, V117, P243, DOI 10.1242/jcs.00853; Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Majerska J, 2011, MOL BIOSYST, V7, P1013, DOI 10.1039/c0mb00268b; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moser BA, 2011, NAT STRUCT MOL BIOL, V18, P1408, DOI 10.1038/nsmb.2187; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nandakumar J, 2010, P NATL ACAD SCI USA, V107, P651, DOI 10.1073/pnas.0911099107; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Sexton A. N, 2012, J BIOL CHEM; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devce1.2010.03.011, 10.1016/j.devcel.2010.03.011]; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Weidenfeld I, 2012, METHODS MOL BIOL, V815, P289, DOI 10.1007/978-1-61779-424-7_22; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	33	230	236	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					285	+		10.1038/nature11648	http://dx.doi.org/10.1038/nature11648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23103865	Green Accepted			2022-12-01	WOS:000312259300049
J	Rucklin, M; Donoghue, PCJ; Johanson, Z; Trinajstic, K; Marone, F; Stampanoni, M				Ruecklin, Martin; Donoghue, Philip C. J.; Johanson, Zerina; Trinajstic, Kate; Marone, Federica; Stampanoni, Marco			Development of teeth and jaws in the earliest jawed vertebrates	NATURE			English	Article							EVOLUTIONARY ORIGINS; PHARYNGEAL DENTICLES; PLACODERMS; DENTITION; SKELETON; GROWTH; FISH	Teeth and jaws constitute a model of the evolutionary developmental biology concept of modularity(1) and they have been considered the key innovations underpinning a classic example of adaptive radiation(2). However, their evolutionary origins are much debated. Placoderms comprise an extinct sister clade(3) or grade(4,5) to the clade containing chondrichthyans and osteichthyans, and although they clearly possess jaws, previous studies have suggested that they lack teeth(6-8), that they possess convergently evolved tooth-like structures(9-11) or that they possess true teeth(12). Here we use synchrotron radiation X-ray tomographic microscopy (SRXTM)(13) of a developmental series of Compagopiscis croucheri (Arthrodira) to show that placoderm jaws are composed of distinct cartilages and gnathal ossifications in both jaws, and a dermal element in the lower jaw. The gnathal ossification is a composite of distinct teeth that developed in succession, polarized along three distinct vectors, comparable to tooth families. The teeth are composed of dentine and bone, and show a distinct pulp cavity that is infilled centripetally as development proceeds. This pattern is repeated in other placoderms, but differs from the structure and development of tooth-like structures in the postbranchial lamina and dermal skeleton of Compagopiscis and other placoderms. We interpret this evidence to indicate that Compagopiscis and other arthrodires possessed teeth, but that tooth and jaw development was not developmentally or structurally integrated in placoderms. Teeth did not evolve convergently among the extant and extinct classes of early jawed vertebrates but, rather, successional teeth evolved within the gnathostome stem-lineage soon after the origin of jaws. The chimaeric developmental origin of this model of modularity reflects the distinct evolutionary origins of teeth and of component elements of the jaws.	[Ruecklin, Martin; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England; [Trinajstic, Kate] Curtin Univ Technol, Dept Chem, Bentley, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool 6106, Australia; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	University of Bristol; Natural History Museum London; Curtin University; Western Australian Museum; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rucklin, M (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	m.ruecklin@bristol.ac.uk; phil.donoghue@bristol.ac.uk	Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Rücklin, Martin/D-7948-2018; Stampanoni, Marco/J-4099-2013; Marone, Federica/J-4420-2013; Donoghue, Philip/A-3873-2008	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Rücklin, Martin/0000-0002-7254-837X; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Trinajstic, Kate/0000-0002-6519-6396; Johanson, Zerina/0000-0002-8444-6776	EU; Australian Research Council [DP 110101127]; Natural Environment Research Council [NE/G016623/1]; Paul Scherrer Institut; NERC [NE/G016623/1, NE/G020264/1] Funding Source: UKRI; Natural Environment Research Council [NE/G020264/1] Funding Source: researchfish	EU(European Commission); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Paul Scherrer Institut; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Bengtson, J. Cunningham, D. Murdock, S. Giles and A. Hetherington for help at the TOMCAT beamline; K. Robson-Brown for help at the Micro-CT, and H. Lelievre and G. Clement for loan of specimens. The study was funded by EU grant FP7 MC-IEF (to M.R. and P.C.J.D.), Australian Research Council Grant DP 110101127 (to Z.J. and K.T.), Natural Environment Research Council grant NE/G016623/1 (to P.C.J.D.) and the Paul Scherrer Institut (P.C.J.D.).	ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2003, SCIENCE, V300; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Downs JP, 2009, J MORPHOL, V270, P1364, DOI 10.1002/jmor.10765; Finarelli JA, 2012, P ROY SOC B-BIOL SCI, V279, P775, DOI 10.1098/rspb.2011.1107; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Huysseune A, 2008, DEV GENES EVOL, V218, P427, DOI 10.1007/s00427-008-0237-9; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Johanson Z, 2003, J MORPHOL, V257, P289, DOI 10.1002/jmor.10124; Lelievre Herve, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P163; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; Orvig T., 1973, Palaeontographica Abt A, V143, P119; REIF WE, 1982, EVOL BIOL, V15, P287; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; SMITH MM, 1985, J ANAT, V140, P627; Soukup V, 2008, NATURE, V455, P795, DOI 10.1038/nature07304; Stampanoni M, 2007, AIP CONF PROC, V879, P848; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; Young GC, 2003, J VERTEBR PALEONTOL, V23, P987, DOI 10.1671/31; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	29	77	82	5	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					748	+		10.1038/nature11555	http://dx.doi.org/10.1038/nature11555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23075852				2022-12-01	WOS:000311606000043
J	Elsasser, SJ; Huang, HD; Lewis, PW; Chin, JW; Allis, CD; Patel, DJ				Elsaesser, Simon J.; Huang, Hongda; Lewis, Peter W.; Chin, Jason W.; Allis, C. David; Patel, Dinshaw J.			DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition	NATURE			English	Article							STRUCTURAL BASIS; CHAPERONE; ATRX; H3; GENES	Histone chaperones represent a structurally and functionally diverse family of histone-binding proteins that prevent promiscuous interactions of histones before their assembly into chromatin. DAXX is a metazoan histone chaperone specific to the evolutionarily conserved histone variant H3.3. Here we report the crystal structures of the DAXX histone-binding domain with a histone H3.3-H4 dimer, including mutants within DAXX and H3.3, together with in vitro and in vivo functional studies that elucidate the principles underlying H3.3 recognition specificity. Occupying 40% of the histone surface-accessible area, DAXX wraps around the H3.3-H4 dimer, with complex formation accompanied by structural transitions in the H3.3-H4 histone fold. DAXX uses an extended a-helical conformation to compete with major inter-histone, DNA and ASF1 interaction sites. Our structural studies identify recognition elements that read out H3.3-specific residues, and functional studies address the contributions of Gly 90 in H3.3 and Glu 225 in DAXX to chaperone-mediated H3.3 variant recognition specificity.	[Elsaesser, Simon J.; Lewis, Peter W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Elsaesser, Simon J.; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Huang, Hongda; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Rockefeller University; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu; pated@mskcc.org	Elsässer, Simon/AAM-3986-2020; Huang, Hongda/G-8962-2015; Elsässer, Simon/B-8911-2014	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Lewis, Peter/0000-0002-9816-7823	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P30-EB-009998]; National Center for Research Resources of the NIH [1S10RR022321-01, 1S10RR027037-01]; Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC) [U105181009, UD99999908]; Boehringer Ingelheim Funds fellowship; David Rockefeller Graduate Program; MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321, S10RR027037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Funds fellowship(Boehringer Ingelheim); David Rockefeller Graduate Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the personnel of synchrotron beam lines 24-I/D-C/E at the Advanced Photon Source (Argonne National Laboratory) and beam line X29 at the Brookhaven National Laboratory for their assistance, and the Center for Synchrotron Biosciences grant, P30-EB-009998, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) for funding. The use of the Rigaku/MSC microMax 007HF and Formulator in the Rockefeller University Structural Biology Resource Center was made possible by grant numbers 1S10RR022321-01 and 1S10RR027037-01 from the National Center for Research Resources of the NIH. We thank B. Black for sharing data before publication, A. Ruthenburg, J. Song and Z. Cheng for advice and discussions, and E. Datan for help in expressing DAXX protein. D. J. P. was supported by funds from the Abby Rockefeller Mauze Trust, and the Maloris and STARR Foundations. C. D. A. also acknowledges support from the STARR Foundation and The Rockefeller University. J. W. C. acknowledges support from UK Medical Research Council (MRC) (grants U105181009 and UD99999908). S. J. E. was supported by a Boehringer Ingelheim Funds fellowship and the David Rockefeller Graduate Program and holds an EMBO ALTF 1232-2011.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hamiche A, 2012, BBA-GENE REGUL MECH, V1819, P230, DOI 10.1016/j.bbagrm.2011.08.009; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	29	165	168	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					560	+		10.1038/nature11608	http://dx.doi.org/10.1038/nature11608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075851	Green Accepted			2022-12-01	WOS:000311339800044
J	Paltiel, AD; Walensky, RP				Paltiel, A. David; Walensky, Rochelle P.			Home HIV Testing: Good News but Not a Game Changer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Management, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Paltiel, AD (corresponding author), Yale Univ, Sch Publ Hlth, 60 Coll St,Room 305, New Haven, CT 06520 USA.	david.paltiel@yale.edu		Walensky, Rochelle P./0000-0002-8795-379X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI42006, R37 AI042006, P30 AI060354] Funding Source: Medline; NIDA NIH HHS [R01 DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH65869, R01 MH065869] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; McNeil DG, 2012, NY TIMES, pA1; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Paltiel AD, 2010, MED DECIS MAKING, V30, P217, DOI 10.1177/0272989X09334420; Sax PE, J WATCH BLOGS HIV ID; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Food and Drug Administration, VACC BLOOD BIOL INF; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010	10	19	21	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					744	+		10.7326/0003-4819-157-10-201211200-00545	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23044643	Green Accepted			2022-12-01	WOS:000311580000020
J	Elias, M; Wellner, A; Goldin-Azulay, K; Chabriere, E; Vorholt, JA; Erb, TJ; Tawfik, DS				Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Chabriere, Eric; Vorholt, Julia A.; Erb, Tobias J.; Tawfik, Dan S.			The molecular basis of phosphate discrimination in arsenate-rich environments	NATURE			English	Article							BETA-SEMIALDEHYDE DEHYDROGENASE; HYDROGEN-BONDS; ESCHERICHIA-COLI; TRANSPORT-SYSTEMS; ACTIVE-TRANSPORT; PROTEIN; SPECIFICITY; BACTERIA; RECEPTOR; GFAJ-1	Arsenate and phosphate are abundant on Earth and have striking similarities: nearly identical pK(a) values(1,2), similarly charged oxygen atoms, and thermochemical radii that differ by only 4% (ref. 3). Phosphate is indispensable and arsenate is toxic, but this extensive similarity raises the question whether arsenate may substitute for phosphate in certain niches(4,5). However, whether it is used or excluded, discriminating phosphate from arsenate is a paramount challenge. Enzymes that utilize phosphate, for example, have the same binding mode and kinetic parameters as arsenate, and the latter's presence therefore decouples metabolism(6,7). Can proteins discriminate between these two anions, and how would they do so? In particular, cellular phosphate uptake systems face a challenge in arsenate-rich environments. Here we describe a molecular mechanism for this process. We examined the periplasmic phosphate-binding proteins (PBPs) of the ABC-type transport system that mediates phosphate uptake into bacterial cells, including two PBPs from the arsenate-rich Mono Lake Halomonas strain GFAJ-1. All PBPs tested are capable of discriminating phosphate over arsenate at least 500-fold. The exception is one of the PBPs of GFAJ-1 that shows roughly 4,500-fold discrimination and its gene is highly expressed under phosphate-limiting conditions. Sub-angstrom-resolution structures of Pseudomonas fluorescens PBP with both arsenate and phosphate show a unique mode of binding that mediates discrimination. An extensive network of dipole-anion interactions(8,9), and of repulsive interactions, results in the 4% larger arsenate distorting a unique low-barrier hydrogen bond. These features enable the phosphate transport system to bind phosphate selectively over arsenate (at least 10(3) excess) even in highly arsenate-rich environments.	[Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Chabriere, Eric] Univ Aix Marseille 2, CNRS, Fac Med & Pharm, Unite Rech Malad Infect & Trop Emergentes, F-13385 Marseille, France; [Vorholt, Julia A.; Erb, Tobias J.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mikael.elias@weizmann.ac.il; tawfik@weizmann.ac.il	Vorholt, Julia/K-3514-2016; Elias, Mikael/AAH-9385-2021; Erb, Tobias/J-5214-2013; Elias, Mikael/C-8484-2011	Vorholt, Julia/0000-0002-6011-4910; Elias, Mikael/0000-0003-0406-7539; Erb, Tobias/0000-0003-3685-0894; Elias, Mikael/0000-0003-0406-7539; WELLNER, ALON/0000-0001-5247-189X	Israel Science Foundation; Intra-European Fellowships Marie Curie program [252836]; Eidgenossische Technische Hochschule fellowship	Israel Science Foundation(Israel Science Foundation); Intra-European Fellowships Marie Curie program; Eidgenossische Technische Hochschule fellowship	We thank G. Gotthard for valuable inputs, C. Jelsch for help with the software Mopro, and A. Toth-Petroczy for help with the phylogenetic analysis. Financial support by the Israel Science Foundation is gratefully acknowledged. M. E. is a fellow supported by the Intra-European Fellowships Marie Curie program (grant No. 252836). D. S. T. is the Nella and Leon Benoziyo Professor of Biochemistry. T.J.E. was supported by an Eidgenossische Technische Hochschule fellowship.	Ahn S, 2007, FEBS LETT, V581, P3455, DOI 10.1016/j.febslet.2007.06.050; Butt AS, 2011, WORLD J MICROB BIOT, V27, P2435, DOI 10.1007/s11274-011-0716-4; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; Dixon HBF, 1997, ADV INORG CHEM, V44, P191; Erb TJ, 2012, SCIENCE, V337, P467, DOI 10.1126/science.1218455; Faehnle CR, 2004, ACTA CRYSTALLOGR D, V60, P2320, DOI 10.1107/S0907444904026411; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kish MM, 1999, INORG CHEM, V38, P818, DOI 10.1021/ic981082j; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Kohn RA, 1998, J ANIM SCI, V76, P1702; LARSEN EH, 1992, MIKROCHIM ACTA, V109, P47, DOI 10.1007/BF01243209; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.3.CO;2-X; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Reaves ML, 2012, SCIENCE, V337, P470, DOI 10.1126/science.1219861; STEINER T, 1994, ACTA CRYSTALLOGR B, V50, P348, DOI 10.1107/S0108768193011966; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Tawfik DS, 2011, BIOCHEMISTRY-US, V50, P1128, DOI 10.1021/bi200002a; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; WILLSKY GR, 1980, J BACTERIOL, V144, P366, DOI 10.1128/JB.144.1.366-374.1980; WILLSKY GR, 1980, J BACTERIOL, V144, P356, DOI 10.1128/JB.144.1.356-365.1980; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	30	144	149	4	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					134	137		10.1038/nature11517	http://dx.doi.org/10.1038/nature11517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23034649				2022-12-01	WOS:000310434500045
J	Okaz, E; Arguello-Miranda, O; Bogdanova, A; Vinod, PK; Lipp, JJ; Markova, Z; Zagoriy, I; Novak, B; Zachariae, W				Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Vinod, P. K.; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Novak, Bela; Zachariae, Wolfgang			Meiotic Prophase Requires Proteolysis of M Phase Regulators Mediated by the Meiosis-Specific APC/C-Ama1	CELL			English	Article							ANAPHASE PROMOTING COMPLEX/CYCLOSOME; SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BIOLOGY; YEAST MEIOSIS; BUDDING YEAST; FHA DOMAIN; PROTEIN; KINASE	Whereas proliferating cells enter M phase shortly after DNA replication, the first M phase of meiosis is preceded by an extended prophase in which homologous chromosomes undergo recombination. Exit from prophase I is controlled by the recombination checkpoint (RC), which, in yeast, represses the meiosis-specific transcription factor Ndt80 required for the expression of B-type cyclins and other M phase regulators. We show that an extended prophase I additionally requires the suppression of latent, mitotic cell-cycle controls by the anaphase-promoting complex (APC/C) and its meiosis-specific activator Ama1, which trigger the degradation of M phase regulators and Ndd1, a subunit of a mitotic transcription factor. ama1 Delta mutants exit from prophase I prematurely and independently of the RC, which results in recombination defects and chromosome missegregation. Thus, control of prophase I by meiotic mechanisms depends on the suppression of the alternative, mitotic mechanisms by a meiosis-specific form of the APC/C.	[Argueello-Miranda, Orlando; Bogdanova, Aliona; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Biochem, Lab Chromosome Biol, D-82152 Martinsried, Germany; [Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Okaz, Elwy; Vinod, P. K.; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	Max Planck Society; Max Planck Society; University of Oxford	Zachariae, W (corresponding author), Max Planck Inst Biochem, Lab Chromosome Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	zachar@biochem.mpg.de	Arguello-Miranda, Orlando/R-8552-2019; Novak, Bela/D-5365-2009; Arguello, Orlando/AAC-3445-2021; Argüello-Miranda, Orlando/AAU-6814-2020	Novak, Bela/0000-0002-6961-1366; Argüello-Miranda, Orlando/0000-0002-0579-4650; Zagoriy, Ievgeniia/0000-0003-2523-5132; Vinod, P K/0000-0003-2968-498X	Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1384, ZA519/1-1]; Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	We thank Angelika Amon, Kirsten Benjamin, Rita Cha, Franz Klein, Michael Knop, Shirleen Roeder, Karin Schmekel, and Wolfgang Seufert for strains and reagents. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SPP1384 grant ZA519/1-1 to W. Z.), a Boehringer Ingelheim Fonds scholarship to J. J. L., and European Commission FP7 (UniCellSys, MitoSys) and OCISB grants to B.N.	Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Dayani Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002083; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Johnson R, 2007, PLOS GENET, V3, P2338, DOI 10.1371/journal.pgen.0030223; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6	46	62	62	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					603	618		10.1016/j.cell.2012.08.044	http://dx.doi.org/10.1016/j.cell.2012.08.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101628	Bronze			2022-12-01	WOS:000310529300016
J	Schlebusch, CM; Skoglund, P; Sjodin, P; Gattepaille, LM; Hernandez, D; Jay, F; Li, S; De Jongh, M; Singleton, A; Blum, MGB; Soodyall, H; Jakobsson, M				Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Hernandez, Dena; Jay, Flora; Li, Sen; De Jongh, Michael; Singleton, Andrew; Blum, Michael G. B.; Soodyall, Himla; Jakobsson, Mattias			Genomic Variation in Seven Khoe-San Groups Reveals Adaptation and Complex African History	SCIENCE			English	Article							POPULATIONS; GENOTYPE	The history of click-speaking Khoe-San, and African populations in general, remains poorly understood. We genotyped similar to 2.3 million single-nucleotide polymorphisms in 220 southern Africans and found that the Khoe-San diverged from other populations >= 100,000 years ago, but population structure within the Khoe-San dated back to about 35,000 years ago. Genetic variation in various sub-Saharan populations did not localize the origin of modern humans to a single geographic region within Africa; instead, it indicated a history of admixture and stratification. We found evidence of adaptation targeting muscle function and immune response; potential adaptive introgression of protection from ultraviolet light; and selection predating modern human diversification, involving skeletal and neurological development. These new findings illustrate the importance of African genomic diversity in understanding human evolutionary history.	[Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Li, Sen; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Hernandez, Dena; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Jay, Flora] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [De Jongh, Michael] Univ S Africa, Dept Anthropol & Archaeol, ZA-0001 Pretoria, South Africa; [Blum, Michael G. B.] Univ Grenoble 1, Ctr Natl Rech Sci, Lab TIMC IMAG UMR 5525, Grenoble, France; [Soodyall, Himla] Univ Witwatersrand, Human Genom Divers & Dis Res Unit, Div Human Genet, Sch Pathol,Fac Hlth Sci, Johannesburg, South Africa; [Soodyall, Himla] Natl Hlth Lab Serv, Johannesburg, South Africa; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Berkeley; University of South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Witwatersrand; National Health Laboratory Service; Uppsala University	Schlebusch, CM (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Norbyvagen 18D, S-75236 Uppsala, Sweden.	carina.schlebusch@ebc.uu.se; mattias.jakobsson@ebc.uu.se	Schlebusch, Carina/B-3411-2010; Singleton, Andrew B/C-3010-2009; Gattepaille, Lucie/V-3229-2019; Jakobsson, Mattias/A-6116-2011; Blum, Michael/F-9978-2010	Schlebusch, Carina/0000-0002-8160-9621; Jakobsson, Mattias/0000-0001-7840-7853; Blum, Michael/0000-0003-4174-7373; Skoglund, Pontus/0000-0002-3021-5913; jay, flora/0000-0001-5884-4730	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging; NIH; U.S. Department of Health and Human Services [Z01 AG000932-04]; Medical Research Council of South Africa; National Health Laboratory Service; STINT; Swedish Research Council; Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000932] Funding Source: NIH RePORTER	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; Medical Research Council of South Africa(South African Medical Research Council); National Health Laboratory Service; STINT; Swedish Research Council(Swedish Research CouncilEuropean Commission); Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank participants who donated blood samples, T. Jenkins, and B. Henn. Approved by the Working Group of Indigenous Minorities in Southern Africa (WIMSA) and the South African San Council; we thank them for facilitating sampling trips. Computations were performed at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) in Uppsala, Sweden (project number p2011187). This work was supported by the Wenner-Gren Foundation (C. S.); the Intramural Research Program of the National Institute on Aging, NIH, U.S. Department of Health and Human Services, grant Z01 AG000932-04 (A. S.); the Medical Research Council of South Africa and National Health Laboratory Service (H. S.); STINT (M. B. and M.J.); the Swedish Research Council (M.J.); and the Erik Philip Sorensen Foundation (M.J.). H. S. retains governance of the DNA samples. Author contributions were as follows: conception and design of study: C. M. S., P.Sk., and M.J.; sample collection, preparation, and description: C. M. S., M.D.J., and H. S.; genotyping: D. H. and A. S.; data preparation: C. M. S., P.Sk., D. H., and M.J.; population structure analysis: C. M. S., P.Sk., L. M. G., S. L., F.J., M. B., and M.J.; model-based inference: P.Sk. and M.J.; language/geography comparisons: F.J., C. M. S., and M. B.; diversity statistics: C. M. S., P.Sk., L. M. G., P.Sj., and M.J.; Selection scans: P.Sj., P.Sk., C. M. S., and M.J.. The paper was written by C. M. S., P.Sk., and M.J. with contributions from all authors. Genotype data are available at the Arrayexpress database (www.ebi.ac.uk/arrayexpress/, accession no. E-MTAB-1259) and at www.ebc.uu.se/Research/IEG/evbiol/research/Jakobsson/data/.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barham L., 2008, 1 AFRICANS; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Falk D, 2012, P NATL ACAD SCI USA, V109, P8467, DOI 10.1073/pnas.1119752109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hill AD, 2007, AM J MED GENET A, V143A, P1692, DOI 10.1002/ajmg.a.31776; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nurse GT., 1985, PEOPLES SO AFRICA TH; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	29	245	250	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					374	379		10.1126/science.1227721	http://dx.doi.org/10.1126/science.1227721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22997136	Green Published, Green Accepted			2022-12-01	WOS:000309955800039
J	Blackburn, EH; Epel, ES				Blackburn, Elizabeth H.; Epel, Elissa S.			Too toxic to ignore	NATURE			English	Editorial Material							TELOMERE LENGTH; LIFE STRESS; CANCER		[Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu						Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Commission on Social Determinants of Health, 2008, CLOS GAP GEN; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Honig LS, 2012, ARCH NEUROL; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Shalev I, 2012, MOL PSYCHIAT; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901	10	101	102	0	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					169	171		10.1038/490169a	http://dx.doi.org/10.1038/490169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060172	Bronze			2022-12-01	WOS:000309733300023
J	Mets, OM; de Jong, PA; Prokop, M				Mets, Onno M.; de Jong, Pim A.; Prokop, Mathias			Computed Tomographic Screening for Lung Cancer An Opportunity to Evaluate Other Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-ARTERY CALCIUM; POPULATION; MORTALITY; TRIAL		[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100,Postbus 85500, NL-3508 GA Utrecht, Netherlands.	pimdejong@gmail.com	Prokop, W.M./H-8081-2014; de Jong, Pim A/G-7220-2014	de Jong, Pim A/0000-0003-4840-6854; Prokop, Mathias/0000-0001-8157-8055				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Budoff MJ, 2010, RADIOLOGY, V257, P434, DOI 10.1148/radiol.10100132; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Sverzellati N, 2012, RADIOLOGY, V262, P460, DOI 10.1148/radiol.11110364; van Ginneken B, 2011, RADIOLOGY, V261, P719, DOI 10.1148/radiol.11091710; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	8	60	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1433	1434		10.1001/jama.2012.12656	http://dx.doi.org/10.1001/jama.2012.12656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047354				2022-12-01	WOS:000309579300018
J	Costentin, C; Drouet, S; Robert, M; Saveant, JM				Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel			A Local Proton Source Enhances CO2 Electroreduction to CO by a Molecular Fe Catalyst	SCIENCE			English	Article							ELECTROCHEMICAL REDUCTION; CARBON-DIOXIDE; ELECTROCATALYTIC REDUCTION; PALLADIUM COMPLEX; PORPHYRINS; CONVERSION	Electrochemical conversion of carbon dioxide (CO2) to carbon monoxide (CO) is a potentially useful step in the desirable transformation of the greenhouse gas to fuels and commodity chemicals. We have found that modification of iron tetraphenylporphyrin through the introduction of phenolic groups in all ortho and ortho' positions of the phenyl groups considerably speeds up catalysis of this reaction by the electrogenerated iron(0) complex. The catalyst, which uses one of the most earth-abundant metals, manifests a CO faradaic yield above 90% through 50 million turnovers over 4 hours of electrolysis at low overpotential (0.465 volt), with no observed degradation. The basis for the enhanced activity appears to be the high local concentration of protons associated with the phenolic hydroxyl substituents.	[Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel] Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, F-75205 Paris 13, France	UDICE-French Research Universities; Universite Paris Cite	Costentin, C (corresponding author), Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, Batiment Lavoisier,15 Rue Jean de Baif, F-75205 Paris 13, France.	cyrille.costentin@univ-paris-diderot.fr; saveant@univ-paris-diderot.fr			Agence Nationale de la Recherche [ANR 2010 BLAN 0808]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Partial financial support from the Agence Nationale de la Recherche (ANR 2010 BLAN 0808) is gratefully acknowledged.	Bard A. J., 1995, STANDARD POTENTIALS; BELEY M, 1986, J AM CHEM SOC, V108, P7461, DOI 10.1021/ja00284a003; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Bhugun I, 1996, J PHYS CHEM-US, V100, P19981, DOI 10.1021/jp9618486; BHUGUN I, 1994, J AM CHEM SOC, V116, P5015, DOI 10.1021/ja00090a068; Bhugun I, 1996, J AM CHEM SOC, V118, P1769, DOI 10.1021/ja9534462; Bourrez M, 2011, ANGEW CHEM INT EDIT, V50, P9903, DOI 10.1002/anie.201103616; Carver CT, 2012, J AM CHEM SOC, V134, P5444, DOI 10.1021/ja211987f; Chen ZF, 2011, CHEM COMMUN, V47, P12607, DOI 10.1039/c1cc15071e; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; Costentin C, 2012, J AM CHEM SOC, V134, P11235, DOI 10.1021/ja303560c; Costentin C, 2011, P NATL ACAD SCI USA, V108, P8559, DOI 10.1073/pnas.1104952108; DuBois DL, 2011, EUR J INORG CHEM, P1017, DOI 10.1002/ejic.201001081; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Froehlich JD, 2012, INORG CHEM, V51, P3932, DOI 10.1021/ic3001619; HAMMOUCHE M, 1988, J ELECTROANAL CHEM, V249, P347, DOI 10.1016/0022-0728(88)80372-3; HAWECKER J, 1984, J CHEM SOC CHEM COMM, P328, DOI 10.1039/c39840000328; LAMY E, 1977, J ELECTROANAL CHEM, V78, P403, DOI 10.1016/0368-1874(77)80196-2; Raebiger JW, 2006, ORGANOMETALLICS, V25, P3345, DOI 10.1021/om060228g; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Saveant JM, 2008, CHEM REV, V108, P2348, DOI 10.1021/cr068079z; STEFFEY BD, 1995, ORGANOMETALLICS, V14, P4937, DOI 10.1021/om00010a066	22	852	865	39	1199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					90	94		10.1126/science.1224581	http://dx.doi.org/10.1126/science.1224581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042890				2022-12-01	WOS:000309457400059
J	McCartney, M				McCartney, Margaret			Taking ecstasy on television: a show trial	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Channel 4, DRUGS LIV ECST TRIAL; Laughland O., 2012, GUARDIAN	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 1	2012	345								e6621	10.1136/bmj.e6621	http://dx.doi.org/10.1136/bmj.e6621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028102				2022-12-01	WOS:000309657900003
J	Senovilla, L; Vitale, I; Martins, I; Tailler, M; Pailleret, C; Michaud, M; Galluzzi, L; Adjemian, S; Kepp, O; Niso-Santano, M; Shen, SS; Marino, G; Criollo, A; Boileve, A; Job, B; Ladoire, S; Ghiringhelli, F; Sistigu, A; Yamazaki, T; Rello-Varona, S; Locher, C; Poirier-Colame, V; Talbot, M; Valent, A; Berardinelli, F; Antoccia, A; Ciccosanti, F; Fimia, GM; Piacentini, M; Fueyo, A; Messina, NL; Li, M; Chan, CJ; Sigl, V; Pourcher, G; Ruckenstuhl, C; Carmona-Gutierrez, D; Lazar, V; Penninger, JM; Madeo, F; Lopez-Otin, C; Smyth, MJ; Zitvogel, L; Castedo, M; Kroemer, G				Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Ladoire, Sylvain; Ghiringhelli, Francois; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Valent, Alexander; Berardinelli, Francesco; Antoccia, Antonio; Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro; Fueyo, Antonio; Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Sigl, Verena; Pourcher, Guillaume; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Lazar, Vladimir; Penninger, Josef M.; Madeo, Frank; Lopez-Otin, Carlos; Smyth, Mark J.; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido			An Immunosurveillance Mechanism Controls Cancer Cell Ploidy	SCIENCE			English	Article							CALRETICULIN EXPOSURE; ADAPTIVE IMMUNITY; IMMUNOGENICITY; TETRAPLOIDY; CLEARANCE; MITOSIS; DEATH; P53	Cancer cells accommodate multiple genetic and epigenetic alterations that initially activate intrinsic (cell-autonomous) and extrinsic (immune-mediated) oncosuppressive mechanisms. Only once these barriers to oncogenesis have been overcome can malignant growth proceed unrestrained. Tetraploidization can contribute to oncogenesis because hyperploid cells are genomically unstable. We report that hyperploid cancer cells become immunogenic because of a constitutive endoplasmic reticulum stress response resulting in the aberrant cell surface exposure of calreticulin. Hyperploid, calreticulin-exposing cancer cells readily proliferated in immunodeficient mice and conserved their increased DNA content. In contrast, hyperploid cells injected into immunocompetent mice generated tumors only after a delay, and such tumors exhibited reduced DNA content, endoplasmic reticulum stress, and calreticulin exposure. Our results unveil an immunosurveillance system that imposes immunoselection against hyperploidy in carcinogen-and oncogene-induced cancers.	[Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Lazar, Vladimir; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Rello-Varona, Santiago; Castedo, Maria; Kroemer, Guido] INSERM, U848, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Pourcher, Guillaume; Zitvogel, Laurence; Castedo, Maria] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Job, Bastien; Lazar, Vladimir] Unite Genom Fonct & Bioinformat, Villejuif, France; [Job, Bastien; Lazar, Vladimir] Genom Platform, Villejuif, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Univ Burgundy, CRI 866, Avenir Team, INSERM, Dijon, France; [Sistigu, Antonella; Yamazaki, Takahiro; Locher, Clara; Poirier-Colame, Vichnou; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Valent, Alexander] Dept Biol & Pathol Med, Villejuif, France; [Berardinelli, Francesco; Antoccia, Antonio] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Fueyo, Antonio] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Biol Func, Oviedo, Spain; [Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Messina, Nicole L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Chan, Christopher J.] Monash Univ, Dept Immunol, Prahran, Vic, Australia; [Sigl, Verena; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Pourcher, Guillaume] Antoine Beclere Hosp, AP HP, Dept Minimal Invas Surg, Clamart, France; [Pourcher, Guillaume] INSERM, U972, F-94275 Le Kremlin Bicetre, France; [Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Madeo, Frank] Inst Mol Biosci, Graz, Austria; [Lopez-Otin, Carlos] Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Roma Tre University; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oviedo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Villejuif, France.	zitvogel@igr.fr; castedo@igr.fr; kroemer@orange.fr	GARCÍA, GUILLERMO MARIÑO/AAI-8015-2020; Vitale, Ilio/M-3960-2017; Ciccosanti, Fabiola/B-5284-2017; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAH-3286-2021; SHEN, Shensi/AAW-2735-2020; Penninger, Josef M/I-6860-2013; Senovilla, Laura/AAX-5599-2021; Smyth, Mark J/H-8709-2014; Fimia, Gian Maria/K-3232-2016; Niso-Santano, Mireia/AAO-1285-2021; Lazar, Vladimir/AAQ-2086-2020; GARCÍA, GUILLERMO MARIÑO/J-1726-2012; Kepp, Oliver/GPX-8627-2022; Sistigu, Antonella/J-8934-2018; Kroemer, Guido/AAY-9859-2020; Berardinelli, Francesco/AAP-2355-2021; Lazar, Vladimir/AAV-2087-2020; Rello-Varona, Santi/A-4882-2009; Piacentini, Mauro/I-2411-2016; Kepp, Oliver/N-2763-2017; KROEMER, Guido/B-4263-2013; López-Otín, Carlos/AAB-2106-2020; ADJEMIAN, Sandy/K-7632-2012; Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAG-6294-2019; Fueyo, Antonio/ABH-3243-2020; Locher, Clara/ABF-3635-2020	Vitale, Ilio/0000-0002-5918-1841; Ciccosanti, Fabiola/0000-0003-0481-6878; SHEN, Shensi/0000-0002-5087-8220; Penninger, Josef M/0000-0002-8194-3777; Smyth, Mark J/0000-0001-7098-7240; Fimia, Gian Maria/0000-0003-4438-3325; GARCÍA, GUILLERMO MARIÑO/0000-0003-1960-1677; Sistigu, Antonella/0000-0002-2528-1238; Berardinelli, Francesco/0000-0002-3094-4139; Rello-Varona, Santi/0000-0002-7500-5522; Piacentini, Mauro/0000-0003-2919-1296; Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; López-Otín, Carlos/0000-0001-6964-1904; ADJEMIAN, Sandy/0000-0001-5594-5499; Galluzzi, Lorenzo/0000-0003-2257-8500; Fueyo, Antonio/0000-0002-7121-9398; Locher, Clara/0000-0002-8212-4351; Messina, Nicole/0000-0001-8404-4462; ZITVOGEL, laurence/0000-0003-1596-0998; Madeo, Frank/0000-0002-5070-1329; LADOIRE, Sylvain/0000-0002-0331-9194; Pourcher, Guillaume/0000-0001-9788-628X; Ruckenstuhl, Christoph/0000-0002-4338-4679; ghiringhelli, francois/0000-0002-5465-8305; Criollo, Alfredo/0000-0002-2737-7751; Senovilla, Laura/0000-0001-6887-2436; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Niso-Santano, Mireia/0000-0002-6506-422X	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF) [LIPOTOX, P23490-B12, P24381-B20, W 1226-B18]; FRM; LNC; Junta de Extremadura (Spain); European Molecular Biology Organization; National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council; European Union INFLA-CARE network; Austrian Science Fund (FWF) [P 23490] Funding Source: researchfish	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); FRM(Fondation pour la Recherche Medicale); LNC; Junta de Extremadura (Spain); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council(European Research Council (ERC)); European Union INFLA-CARE network; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. L. Albert (Institut Pasteur, Paris) for Ifnar1<SUP>-/-</SUP> and Ifng<SUP>-/-</SUP> mice, M. Colonna (Washington University School of Medicine, St. Louis, MO) for Cd226<SUP>-/-</SUP> mice (Dnam-1<SUP>-/-</SUP> mice), S. B. Horwitz (Albert Einstein College of Medicine, New York) for epothilone B-resistant A549 cells, R. Prywes (Columbia University, New York) for the GFP-ATF6-encoding plasmid, J. Yuan (Massachusetts Institute of Technology, Boston) for the XBP1-DBD-Venus-encoding construct, T. Reid (NIH, Bethesda, MD) for DLD-1 and DLD1+7 cell lines, and D. Metivier for assistance with fluorescence-activated cell sorting (FACS) experiments. G. K. is supported by the Ligue Nationale contre le Cancer (LNC, Equipe labelisee), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Canceropole Ile-de-France, Fondation Bettencourt-Schueller, and the LabEx Immuno-Oncology. F. M. is grateful to the Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF, grants LIPOTOX, P23490-B12, P24381-B20, and W 1226-B18). L. S. and M. M. are supported by FRM. I. V., I. M., M. T., and S. A. are supported by LNC. M. N.-S. is supported by a postdoctoral contract of Junta de Extremadura (Spain) and G. M. by European Molecular Biology Organization. M. J. S. was supported by National Health and Medical Research Council (NH and MRC) Australia and the Victorian Cancer Agency. C. J. C. was supported by Leukemia Foundation of Australia, Monash University. N. M. was supported by Cancer Research Institute. J. M. P. and V. S. are supported by the Austrian Academy of Sciences, an Advanced European Research Council grant, and the European Union INFLA-CARE network. L. S., I. V., I. M., M. T., C. P., M. M., S. A., O.K., M. N.-S., S. S., G. M., A. C., A. B., B.J., S. L., F. G., A. S., T.Y., S.R.-V., C. L., V.P.-C., M. T., A. V., F. B., A. A., F. C., G. M. F., M. P., A. F., N.L.M., M. L., C.J.C., V. S., G. P., V. L., J.M.P., C.L.-O., M.J.S., and M. C. performed experiments. L. S., C. R., D. C.-G., F. M., L.Z., M. C., and G. K. designed the study. L. S., L.Z., M. C., and G. K. analyzed results. L. S., L. G., and G. K. assembled the figures and wrote the paper. The authors declare no conflicts of interest.	Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Ladoire S, 2011, CLIN BREAST CANCER, V11, P235, DOI 10.1016/j.clbc.2011.06.002; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wakita D, 2009, CARCINOGENESIS, V30, P1408, DOI 10.1093/carcin/bgp144; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	34	295	301	4	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1678	1684		10.1126/science.1224922	http://dx.doi.org/10.1126/science.1224922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019653				2022-12-01	WOS:000309215400052
J	Hoofnagle, JH; Nelson, KE; Purcell, RH				Hoofnagle, Jay H.; Nelson, Kenrad E.; Purcell, Robert H.			CURRENT CONCEPTS Hepatitis E	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NON-B HEPATITIS; E VIRUS-INFECTION; UNITED-STATES; NON-A; IGG SEROPREVALENCE; RISK-FACTORS; PATIENT; DISEASE; FOOD; EPIDEMIOLOGY		[Hoofnagle, Jay H.] NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; [Purcell, Robert H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hoofnagle, JH (corresponding author), NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Rm 9A27,31 Ctr Dr, Bethesda, MD 20892 USA.	hoofnaglej@extra.niddk.nih.gov						Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Feagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068; Fontana RJ, HEPATITIS E CAUSE AC; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Holmberg SD, HEPATITIS E US; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kase JA, 2009, J WATER HEALTH, V7, P344, DOI 10.2166/wh.2009.137; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2011, EMERG INFECT DIS, V17, P2216, DOI 10.3201/eid1712.110482; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Sainokami S, 2004, J GASTROENTEROL, V39, P640, DOI 10.1007/s00535-003-1359-5; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Takahashi H, 2012, ARCH VIROL, V157, P235, DOI 10.1007/s00705-011-1153-2; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; WONG DC, 1980, LANCET, V2, P876; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Xu C, ASSESSMENT HEV PREVA; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	55	361	377	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1237	1244		10.1056/NEJMra1204512	http://dx.doi.org/10.1056/NEJMra1204512			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013075				2022-12-01	WOS:000309161100010
J	Papadopoulos, F; Kitsak, M; Serrano, MA; Boguna, M; Krioukov, D				Papadopoulos, Fragkiskos; Kitsak, Maksim; Angeles Serrano, M.; Boguna, Marian; Krioukov, Dmitri			Popularity versus similarity in growing networks	NATURE			English	Article							PREFERENTIAL ATTACHMENT; EMERGENCE; EVOLUTION; PAPER	The principle(1) that 'popularity is attractive' underlies preferential attachment(2), which is a common explanation for the emergence of scaling in growing networks. If new connections are made preferentially to more popular nodes, then the resulting distribution of the number of connections possessed by nodes follows power laws(3,4), as observed in many real networks(5,6). Preferential attachment has been directly validated for some real networks (including the Internet(7,8)), and can be a consequence of different underlying processes based on node fitness, ranking, optimization, random walks or duplication(9-16). Here we show that popularity is just one dimension of attractiveness; another dimension is similarity(17-24). We develop a framework in which new connections optimize certain trade-offs between popularity and similarity, instead of simply preferring popular nodes. The framework has a geometric interpretation in which popularity preference emerges from local optimization. As opposed to preferential attachment, our optimization framework accurately describes the large-scale evolution of technological (the Internet), social (trust relationships between people) and biological (Escherichia coli metabolic) networks, predicting the probability of new links with high precision. The framework that we have developed can thus be used for predicting new links in evolving networks, and provides a different perspective on preferential attachment as an emergent phenomenon.	[Papadopoulos, Fragkiskos] Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, CY-3036 Limassol, Cyprus; [Kitsak, Maksim; Krioukov, Dmitri] Univ Calif San Diego, CAIDA, La Jolla, CA 92093 USA; [Angeles Serrano, M.; Boguna, Marian] Univ Barcelona, Dept Fis Fonamental, E-08028 Barcelona, Spain	Cyprus University of Technology; University of California System; University of California San Diego; University of Barcelona	Papadopoulos, F (corresponding author), Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, 33 Saripolou St, CY-3036 Limassol, Cyprus.	f.papadopoulos@cut.ac.cy; dima@ucsd.edu	Serrano, M. Ángeles/AAS-8246-2020; Krioukov, Dmitri/K-7035-2017; Papadopoulos, Fragkiskos/B-6391-2014; Serrano, M. Angeles/A-4198-2013; Boguna, Marian/B-7795-2011	Krioukov, Dmitri/0000-0001-9478-8182; Papadopoulos, Fragkiskos/0000-0002-4072-5781; Serrano, M. Angeles/0000-0001-8779-5931; Boguna, Marian/0000-0001-7833-3487; Kitsak, Maksim/0000-0002-6862-6021	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN [FIS2010-21781-C02-02, BFU2010-21847-C02-02]; Generalitat de Catalunya [2009SGR838]; Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia; Generalitat de Catalunya; NSF [CNS-0964236, CNS-1039646, CNS-0722070]; DHS [N66001-08-C-2029]; DARPA [HR0011-12-1-0012]; Cisco Systems; Direct For Computer & Info Scie & Enginr [1039646, 0964236] Funding Source: National Science Foundation	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia(ICREA); Generalitat de Catalunya(Generalitat de Catalunya); NSF(National Science Foundation (NSF)); DHS(United States Department of Homeland Security (DHS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Cisco Systems; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank C. Elkan, G. Bianconi, P. Krapivsky, S. Redner, S. Havlin, E. Stanley and A.-L. Barabasi for discussions and suggestions. This work was supported by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN Projects FIS2010-21781-C02-02 and BFU2010-21847-C02-02; Generalitat de Catalunya grant 2009SGR838; the Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia prize 2010, funded by the Generalitat de Catalunya; NSF grants CNS-0964236, CNS-1039646, CNS-0722070; DHS grant N66001-08-C-2029; DARPA grant HR0011-12-1-0012; and Cisco Systems.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; [Anonymous], WWW INTERNET MODELS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1; Bonahon F., 2009, LOW DIMENSIONAL GEOM; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Crandall D, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; Dorogovtsev S., 2010, COMPLEX NETWORKS; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.062101; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Menczer F, 2004, P NATL ACAD SCI USA, V101, P5261, DOI 10.1073/pnas.0307554100; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; Menon AK, 2011, LECT NOTES ARTIF INT, V6912, P437, DOI 10.1007/978-3-642-23783-6_28; Motter AE, 2007, CHAOS, V17, DOI 10.1063/1.2751266; Newman M, 2018, NETWORKS INTRO, DOI [DOI 10.1093/ACPROF:OSO/9780199206650.001.0001, 10.1162/artl_r_00062]; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Simsek O, 2008, P NATL ACAD SCI USA, V105, P12758, DOI 10.1073/pnas.0800497105; van Raan AFJ, 2000, SCIENTOMETRICS, V47, P347, DOI 10.1023/A:1005647328460; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	30	335	353	11	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					537	540		10.1038/nature11459	http://dx.doi.org/10.1038/nature11459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22972194	Green Submitted			2022-12-01	WOS:000309167100044
J	Selkoe, DJ				Selkoe, Dennis J.			Preventing Alzheimer's Disease	SCIENCE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; LEISURE ACTIVITIES; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK; MODEL; THERAPEUTICS; BIOMARKERS; OLIGOMERS	Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not at hand. Recent clinical trial failures suggest that we must treat the disease earlier than in its mild to moderate stages, and major progress in validating presymptomatic biomarkers now makes secondary prevention trials possible. We will learn more about the natural history of the disease and any partial therapeutic responses from detailed analyses of recent trial results. This process will likely position the field for success, but only with much greater investment in all aspects of Alzheimer research and with careful design of future trials.	Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu						Alzheimer Research Forum, 2012, ALZHEIMER RES F 0515; Alzheimer Research Forum, 2011, ALZHEIMER RES F 1227; Bateman R. J., 2012, NEW ENGL J MED; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Blennow K., ARCH NEUROL; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Intlekofer K. A., NEUROBIOL DIS; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; LANDAU SM, 2012, ARCH NEUROL; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; Morris J. C., 2011, NEUROBIOL AGING S1, V32, pS1; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Muller U. C., 2012, BIOL ALZHEIMERS DIS, P231; NIH Fogarty International Center, 2012, 1 EV ALZH PREV TRIAL; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Pankevich D. E., 2012, ALZHEIMERS DIAGNOSTI; RINNE JO, 2010, OPTN SRTR ANN REP, V9, P363, DOI DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wimo A., 2010, WORLD ALZHEIMER REPO; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004	44	293	303	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1488	1492		10.1126/science.1228541	http://dx.doi.org/10.1126/science.1228541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997326	Green Published			2022-12-01	WOS:000308912900038
J	Ryan, O; Shapiro, RS; Kurat, CF; Mayhew, D; Baryshnikova, A; Chin, B; Lin, ZY; Cox, MJ; Vizeacoumar, F; Cheung, D; Bahr, S; Tsui, K; Tebbji, F; Sellam, A; Istel, F; Schwarzmuller, T; Reynolds, TB; Kuchler, K; Gifford, DK; Whiteway, M; Giaever, G; Nislow, C; Costanzo, M; Gingras, AC; Mitra, RD; Andrews, B; Fink, GR; Cowen, LE; Boone, C				Ryan, Owen; Shapiro, Rebecca S.; Kurat, Christoph F.; Mayhew, David; Baryshnikova, Anastasia; Chin, Brian; Lin, Zhen-Yuan; Cox, Michael J.; Vizeacoumar, Frederick; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Tebbji, Faiza; Sellam, Adnane; Istel, Fabian; Schwarzmueller, Tobias; Reynolds, Todd B.; Kuchler, Karl; Gifford, David K.; Whiteway, Malcolm; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Gingras, Anne-Claude; Mitra, Robi David; Andrews, Brenda; Fink, Gerald R.; Cowen, Leah E.; Boone, Charles			Global Gene Deletion Analysis Exploring Yeast Filamentous Growth	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; HYPHAL DEVELOPMENT; FUNGAL DEVELOPMENT; KINASE; FLO11; SPECIFICITY; PATHWAY	The dimorphic switch from a single-cell budding yeast to a filamentous form enables Saccharomyces cerevisiae to forage for nutrients and the opportunistic pathogen Candida albicans to invade human tissues and evade the immune system. We constructed a genome-wide set of targeted deletion alleles and introduced them into a filamentous S. cerevisiae strain, Sigma 1278b. We identified genes involved in morphologically distinct forms of filamentation: haploid invasive growth, biofilm formation, and diploid pseudohyphal growth. Unique genes appear to underlie each program, but we also found core genes with general roles in filamentous growth, including MFG1 (YDL233w), whose product binds two morphogenetic transcription factors, Flo8 and Mss11, and functions as a critical transcriptional regulator of filamentous growth in both S. cerevisiae and C. albicans.	[Chin, Brian; Gifford, David K.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Shapiro, Rebecca S.; Baryshnikova, Anastasia; Cox, Michael J.; Giaever, Guri; Nislow, Corey; Gingras, Anne-Claude; Andrews, Brenda; Cowen, Leah E.; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Mayhew, David; Mitra, Robi David] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Mayhew, David; Mitra, Robi David] Washington Univ, Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63108 USA; [Lin, Zhen-Yuan; Vizeacoumar, Frederick; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tsui, Kyle; Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Tebbji, Faiza; Sellam, Adnane; Whiteway, Malcolm] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Tebbji, Faiza; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Sellam, Adnane] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1B1, Canada; [Istel, Fabian; Schwarzmueller, Tobias; Kuchler, Karl] Med Univ Vienna, Christian Doppler Lab Infect Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Reynolds, Todd B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gifford, David K.; Fink, Gerald R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Gifford, David K.; Fink, Gerald R.] Harvard Univ, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Toronto; University of Toronto; Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Research Council Canada; McGill University; McGill University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Tennessee System; University of Tennessee Knoxville; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; leah.cowen@utoronto.ca; charlie.boone@utoronto.ca	Young, Richard A/F-6495-2012; Gingras, Anne-Claude/ABA-8341-2020; Sellam, Adnane/H-9765-2013; kuchler, karl/AAL-6937-2020; Gingras, Anne-Claude/E-9982-2010; Shapiro, Rebecca/I-9247-2019	Young, Richard A/0000-0001-8855-8647; Gingras, Anne-Claude/0000-0002-6090-4437; kuchler, karl/0000-0003-2719-5955; Gingras, Anne-Claude/0000-0002-6090-4437; Shapiro, Rebecca/0000-0002-7119-8865; Mitra, Robi/0000-0002-2680-4264; Sellam, Adnane/0000-0002-0506-7752; Vizeacoumar, Frederick/0000-0002-4676-2911; Tebbji, Faiza/0000-0002-7359-727X; Kurat, Christoph/0000-0003-0962-3258; Cowen, Leah/0000-0001-5797-0110; Reynolds, Todd/0000-0002-2867-7182	Canadian Institutes of Heath Research [MOP-97939]; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 204899-05]; Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund; Canada Research Chair in Microbial Genomics and Infectious Disease; NSERC [355965-2009]; NIH [GM40266, GM035010]; National Human Genome Research Institute; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R37GM035010, R01GM035010] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 746] Funding Source: researchfish	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Johnston for inspiring the calling-card analysis and M. Usaj for assistance with image and data processing. Supported by the Canadian Institutes of Heath Research (MOP-97939) (C. B. and B. A.), Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 204899-05) (C. B.), Howard Hughes Medical Institute Research Scholar (C. B.), Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (L. E. C.), Canada Research Chair in Microbial Genomics and Infectious Disease (L. E. C.), NSERC Discovery Grant (355965-2009) (L. E. C.), and NIH (GM40266 and GM035010) (G. R. F.). C.N. and G. G. are supported by a grant from the National Human Genome Research Institute. R. S. S. is supported by an NSERC Canada Graduate Scholarship. C. F. K. is supported by a European Molecular Biology Organization long-term fellowship Raw images and data derived from haploid invasive growth, pseudohyphal growth and biofilm formation assays can be downloaded from http://spidey.ccbr.utoronto.ca/data/ryan_et_al/.	Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bastidas RJ, 2009, P NATL ACAD SCI USA, V106, P351, DOI 10.1073/pnas.0811994106; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; van Dyk D, 2005, GENETICS, V169, P91, DOI 10.1534/genetics.104.033704; Wang HY, 2011, GENOME RES, V21, P748, DOI 10.1101/gr.114850.110; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	23	136	141	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1353	1356		10.1126/science.1224339	http://dx.doi.org/10.1126/science.1224339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984072				2022-12-01	WOS:000308705000045
J	van Werven, FJ; Neuert, G; Hendrick, N; Lardenois, A; Buratowski, S; van Oudenaarden, A; Primig, M; Amon, A				van Werven, Folkert J.; Neuert, Gregor; Hendrick, Natalie; Lardenois, Aurelie; Buratowski, Stephen; van Oudenaarden, Alexander; Primig, Michael; Amon, Angelika			Transcription of Two Long Noncoding RNAs Mediates Mating-Type Control of Gametogenesis in Budding Yeast	CELL			English	Article							ZINC-FINGER PROTEIN; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; INTERGENIC TRANSCRIPTION; GENE-EXPRESSION; REPRESSION; MEIOSIS; METHYLATION; SPORULATION; ACTIVATOR	The cell-fate decision leading to gametogenesis is essential for sexual reproduction. In S. cerevisiae, only diploid MATa/alpha but not haploid MATa or MAT alpha cells undergo gametogenesis, known as sporulation. We find that transcription of two long noncoding RNAs (lncRNAs) mediates mating-type control of sporulation. In MATa or MAT alpha haploids, expression of IME1, the central inducer of gametogenesis, is inhibited in cis by transcription of the lncRNA IRT1, located in the IME1 promoter. IRT1 transcription recruits the Set2 histone methyltransferase and the Set3 histone deacetylase complex to establish repressive chromatin at the IME1 promoter. Inhibiting expression of IRT1 and an antisense transcript that antagonizes the expression of the meiotic regulator IME4 allows cells expressing the haploid mating type to sporulate with kinetics that are indistinguishable from that of MATa/alpha diploids. Conversely, expression of the two lncRNAs abolishes sporulation in MATa/alpha diploids. Thus, transcription of two lncRNAs governs mating-type control of gametogenesis in yeast.	[van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Neuert, Gregor; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lardenois, Aurelie; Primig, Michael] Univ Rennes 1, Inst Natl Sante & Rech Med, Irset U1085, F-35042 Rennes, France; [Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes 1; Harvard University; Harvard Medical School	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Primig, Michael/G-3175-2013; Lardenois, Aurélie/AAA-8961-2020; van Oudenaarden, Alexander/AAA-1705-2019	Primig, Michael/0000-0002-2061-0119; Amon, Angelika/0000-0001-9837-0314; van Werven, Folkert/0000-0002-6685-2084	Netherlands Organization for Scientific Research [GM62207, 825.09.004]; National Science Foundation [ECCS-0835623]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; Inserm Avenir [R07216NS]; CREATE [NR11016NN]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663, R01GM046498, R01GM062207] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inserm Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); CREATE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Sudeep Agarwala, Gerald Fink, and Vincent Guacci for reagents, Stacie Bumgardner for suggestions, and Stephen Bell, Frank Solomon, Gerald Fink, and members of the Amon lab for their critical reading of this manuscript. This work was supported by a grant GM62207 to A.A., by a Rubicon-grant (825.09.004) from the Netherlands Organization for Scientific Research to F.W., by grants from the National Science Foundation (ECCS-0835623) and NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) to A.v.O. and G.N., and by the grants Inserm Avenir (R07216NS) and CREATE (NR11016NN) to M.P. A.A. is also an Investigator of the Howard Hughes Medical Institute.	Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Blumental-Perry A, 2002, MOL BIOL CELL, V13, P1709, DOI 10.1091/mbc.01-09-0468; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; COVITZ PA, 1994, GENETICS, V138, P577; Deng C, 2001, MOL GENET GENOMICS, V266, P497, DOI 10.1007/s004380100571; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Leza MA, 1999, GENETICS, V151, P531; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MITCHELL AP, 1992, GENETICS, V131, P65; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Shimizu M, 1998, NUCLEIC ACIDS RES, V26, P2329, DOI 10.1093/nar/26.10.2329; Shimizu M, 1997, P NATL ACAD SCI USA, V94, P790, DOI 10.1073/pnas.94.3.790; Thebault P, 2011, MOL CELL BIOL, V31, P1288, DOI 10.1128/MCB.01083-10; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	51	183	185	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1170	1181		10.1016/j.cell.2012.06.049	http://dx.doi.org/10.1016/j.cell.2012.06.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959267	Green Accepted, Bronze			2022-12-01	WOS:000308928100011
J	Cloud, V; Chan, YL; Grubb, J; Budke, B; Bishop, DK				Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.			Rad51 Is an Accessory Factor for Dmc1-Mediated Joint Molecule Formation During Meiosis	SCIENCE			English	Article							MEIOTIC RECOMBINATION; PROTEIN COMPLEX; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; DMC1; HOMOLOG; ROLES	Meiotic recombination in budding yeast requires two RecA-related proteins, Rad51 and Dmc1, both of which form filaments on DNA capable of directing homology search and catalyzing formation of homologous joint molecules (JMs) and strand exchange. With use of a separation-of-function mutant form of Rad51 that retains filament-forming but not JM-forming activity, we show that the JM activity of Rad51 is fully dispensable for meiotic recombination. The corresponding mutation in Dmc1 causes a profound recombination defect, demonstrating Dmc1's JM activity alone is responsible for meiotic recombination. We further provide biochemical evidence that Rad51 acts with Mei5-Sae3 as a Dmc1 accessory factor. Thus, Rad51 is a multifunctional protein that catalyzes recombination directly in mitosis and indirectly, via Dmc1, during meiosis.	[Cloud, Veronica; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Comm Genet, Chicago, IL 60637 USA; [Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Genet, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@uchicago.edu		Budke, Brian/0000-0001-6051-8416	National Institute for General Medical Sciences [GM50936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050936] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Zhang and P. Rice for structural alignments, N. Hunter for critical reading of the manuscript and strains, P. Sung for plasmid pET11d-ScRad52, and W. Heyer for Rad54 protein. This work was supported by National Institute for General Medical Sciences grant GM50936.	BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Kokabu Y, 2011, J BIOL CHEM, V286, P43569, DOI 10.1074/jbc.M111.303339; Kurumizaka H, 1999, ARCH BIOCHEM BIOPHYS, V365, P83, DOI 10.1006/abbi.1999.1166; MULLER B, 1990, J MOL BIOL, V212, P97, DOI 10.1016/0022-2836(90)90307-8; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Say AF, 2011, DNA REPAIR, V10, P586, DOI 10.1016/j.dnarep.2011.03.006; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506	18	183	187	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1222	1225		10.1126/science.1219379	http://dx.doi.org/10.1126/science.1219379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955832	Green Accepted			2022-12-01	WOS:000308414000037
J	Blair, AC; Fisher, ER; Rickey, D				Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn			Discovering Nanoscience	SCIENCE			English	Editorial Material							GOLD NANOPARTICLE; ALTERNATIVE TOOL		[Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Blair, AC (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	dawn.rickey@colostate.edu						Mattox AC, 2006, J CHEM EDUC, V83, P622, DOI 10.1021/ed083p622; McFarland A.D., 2004, J CHEM EDUC, V81, P544, DOI DOI 10.1021/ED081P544A; President's Council of Advisors on Science and Technology, 2012, ENGAGE EXCEL PRODUCI; Rickey D., 1999, THESIS U CALIFORNIA; Rojanathanes R, 2008, TAIWAN J OBSTET GYNE, V47, P296, DOI 10.1016/S1028-4559(08)60127-8; Schwartz DL, 2011, J EDUC PSYCHOL, V103, P759, DOI 10.1037/a0025140; Tien L. T., 1998, THESIS U CALIFORNIA; Tien L. T., 1999, J COLL SCI TEACH, V28, P318; Wiwanitkit V, 2007, RENAL FAILURE, V29, P1047, DOI 10.1080/08860220701643575	9	3	4	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1056	1057		10.1126/science.1215151	http://dx.doi.org/10.1126/science.1215151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936769				2022-12-01	WOS:000308125800036
J	Towbin, BD; Gonzalez-Aguilera, C; Sack, R; Gaidatzis, D; Kalck, V; Meister, P; Askjaer, P; Gasser, SM				Towbin, Benjamin D.; Gonzalez-Aguilera, Cristina; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Askjaer, Peter; Gasser, Susan M.			Step-Wise Methylation of Histone H3K9 Positions Heterochromatin at the Nuclear Periphery	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; LAMINA INTERACTIONS; LYSINE 9; HP1 PROTEINS; GERM-LINE; GENOME; CHROMATIN; COMPLEX; METHYLTRANSFERASES	The factors that sequester transcriptionally repressed heterochromatin at the nuclear periphery are currently unknown. In a genome-wide RNAi screen, we found that depletion of S-adenosylmethionine (SAM) synthetase reduces histone methylation globally and causes derepression and release of heterochromatin from the nuclear periphery in Caenorhabditis elegans embryos. Analysis of histone methyltransferases (HMTs) showed that elimination of two HMTs, MET-2 and SET-25, mimics the loss of SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes and of native chromosomal arms rich in histone H3 lysine 9 methylation. The two HMTs target H3K9 in a consecutive fashion: MET-2, a SETDB1 homolog, mediates mono-and dimethylation, and SET-25, a previously uncharacterized HMT, deposits H3K9me3. SET-25 colocalizes with its own product in perinuclear foci, in a manner dependent on H3K9me3, but not on its catalytic domain. This colocalization suggests an autonomous, self-reinforcing mechanism for the establishment and propagation of repeat-rich heterochromatin.	[Towbin, Benjamin D.; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Towbin, Benjamin D.; Gasser, Susan M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Gonzalez-Aguilera, Cristina; Askjaer, Peter] Univ Pablo de Olavide, CABD, CSIC, Seville 41013, Spain	Friedrich Miescher Institute for Biomedical Research; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Towbin, Benjamin D/AAO-8064-2021; Towbin, Benjamin D/C-8545-2018; Meister, Peter/B-4770-2010; Askjaer, Peter/I-3316-2012	Towbin, Benjamin D/0000-0001-7046-1257; Meister, Peter/0000-0002-6230-4216; Askjaer, Peter/0000-0003-3192-4428; Gasser, Susan/0000-0003-3610-9123; Gonzalez- Aguilera, Cristina/0000-0003-4845-5744	European Union Network of Excellence "Epigenome"; Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation [BFU2010-15478]; EMBO [ASTF 478-2011]	European Union Network of Excellence "Epigenome"(European Commission); Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO))	We thank Y. Gruenbaum and T. Jenuwein for antibodies; M. Thomas, R. Arpagaus, R. Son, and T. Sakuragi for excellent technical assistance; I. Katic for help with injections; the Caenorhabditis Genetics Center; R. Horvitz, M. Tijsterman and F. Palladino for strains; D. Schubeler, A. Peters, and H. Ferreira for critical reading of the manuscript; and L. Hoerner for help with array hybridization. This work was supported by the European Union Network of Excellence "Epigenome", the Novartis Research Foundation, the "Fondation Suisse de recherche sur les maladies musculaires", the Spanish Ministry of Science and Innovation (BFU2010-15478 to P.A.), and EMBO (ASTF 478-2011 to C.G.A.).	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Koester-Eiserfunke N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehner B, 2006, NAT PROTOC, V1, P1617, DOI 10.1038/nprot.2006.245; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sassi HE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni164; Schott S, 2006, DEV BIOL, V298, P176, DOI 10.1016/j.ydbio.2006.06.039; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	44	376	385	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					934	947		10.1016/j.cell.2012.06.051	http://dx.doi.org/10.1016/j.cell.2012.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939621	Bronze, Green Submitted			2022-12-01	WOS:000308500200009
J	Eisenstein, M				Eisenstein, Michael			PUBLIC HEALTH Prevention comes of age	NATURE			English	Editorial Material																		LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.08986, 10.2471/BLT.11.089862]; Ovedraogo N, 2011, LANCET, V378, P315, DOI 10.1016/S0140-6736(11)61164-1; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S11	S13		10.1038/488S11a	http://dx.doi.org/10.1038/488S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932434				2022-12-01	WOS:000308095100009
J	Johnson, JE; Reyes, FE; Polaski, JT; Batey, RT				Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.			B-12 cofactors directly stabilize an mRNA regulatory switch	NATURE			English	Article							VITAMIN-B-12 METABOLISM; COMPARATIVE GENOMICS; GENETIC-CONTROL; FOLDING MOTIF; RIBOSWITCHES; RECOGNITION; MECHANISMS; EXPRESSION; BACTERIA; ELEMENTS	Structures of riboswitch receptor domains bound to their effector have shown how messenger RNAs recognize diverse small molecules, but mechanistic details linking the structures to the regulation of gene expression remain elusive(1,2). To address this, here we solve crystal structures of two different classes of cobalamin (vitamin B-12)-binding riboswitches that include the structural switch of the downstream regulatory domain. These classes share a common cobalamin-binding core, but use distinct peripheral extensions to recognize different B12 derivatives. In each case, recognition is accomplished through shape complementarity between the RNA and cobalamin, with relatively few hydrogen bonding interactions that typically govern RNA-small molecule recognition. We show that a composite cobalamin-RNA scaffold stabilizes an unusual long-range intramolecular kissing-loop interaction that controls mRNA expression. This is the first, to our knowledge, riboswitch crystal structure detailing how the receptor and regulatory domains communicate in a ligand-dependent fashion to regulate mRNA expression.	[Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 596, Boulder, CO 80309 USA.	francis.reyes@colorado.edu; robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625; Polaski, Jacob/0000-0001-6570-1789	National Institutes of Health [GM073850, 1S10RR026516]; Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship [F32GM095121]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850, F32GM095121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM073850 and 1S10RR026516) to R. T. B. and by a Colorado Diversity Initiative Fellowship and NIH Ruth L. Kirschstein fellowship (F32GM095121) to J.E.J. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare AR, 2010, METHODS, V52, P159, DOI 10.1016/j.ymeth.2010.06.008; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Franklund CV, 1997, J BACTERIOL, V179, P4039, DOI 10.1128/jb.179.12.4039-4042.1997; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Gilbert Sunny D., 2009, V540, P97, DOI 10.1007/978-1-59745-558-9_8; GREGORIAN RS, 1995, J MOL BIOL, V248, P968, DOI 10.1006/jmbi.1995.0275; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; LUNDRIGAN MD, 1991, P NATL ACAD SCI USA, V88, P1479, DOI 10.1073/pnas.88.4.1479; LUNDRIGAN MD, 1989, J BACTERIOL, V171, P154, DOI 10.1128/jb.171.1.154-161.1989; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Pyle AM, 2002, J BIOL INORG CHEM, V7, P679, DOI 10.1007/s00775-002-0387-6; Reyes FE, 2009, METHOD ENZYMOL, V469, P119, DOI 10.1016/S0076-6879(09)69006-6; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Sussman D, 2000, NAT STRUCT BIOL, V7, P53, DOI 10.1038/71253; TAYLOR RT, 1973, ARCH BIOCHEM BIOPHYS, V156, P521, DOI 10.1016/0003-9861(73)90301-9; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208	40	114	114	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					133	+		10.1038/nature11607	http://dx.doi.org/10.1038/nature11607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23064232	Green Accepted			2022-12-01	WOS:000311893400060
J	Hayashi, K; Ogushi, S; Kurimoto, K; Shimamoto, S; Ohta, H; Saitou, M				Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori			Offspring from Oocytes Derived from in Vitro Primordial Germ Cell-like Cells in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; MOUSE	Reconstitution of female germ cell development in vitro is a key challenge in reproductive biology and medicine. We show here that female (XX) embryonic stem cells and induced pluripotent stem cells in mice are induced into primordial germ cell-like cells (PGCLCs), which, when aggregated with female gonadal somatic cells as reconstituted ovaries, undergo X-reactivation, imprint erasure, and cyst formation, and exhibit meiotic potential. Upon transplantation under mouse ovarian bursa, PGCLCs in the reconstituted ovaries mature into germinal vesicle-stage oocytes, which then contribute to fertile offspring after in vitro maturation and fertilization. Our culture system serves as a robust foundation for the investigation of key properties of female germ cells, including the acquisition of totipotency, and for the reconstitution of whole female germ cell development in vitro.	[Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Saitou, Mitinori] Kyoto Univ, Ctr IPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Katsuhiko] Japan Sci & Technol Agcy CREST, Precursory Res Embryon Sci & Technol PRESTO, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy JST,Sakyo Ku, Kyoto 6068501, Japan; [Ogushi, Sugako] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068302, Japan; [Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi] JST, CREST Exploratory Res Adv Technol ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Hayashi, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	khayashi@anat2.med.kyoto-u.ac.jp; saitou@anat2.med.kyoto-u.ac.jp		Ogushi, Sugako/0000-0001-8497-6972	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-PRESTO/CREST/ERATO; Takeda Science Foundation; Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research [24681039, 19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-PRESTO/CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Silva and A. Smith for the MS2 female iPSCs, K. Okita and S. Yamanaka for the female iPSCs, and Y. Matsui for the GOF18-ESCs. We also thank S. Matoba and A. Ogura for their advice on ovary reconstitution, S. Aramaki and Y. Ishikura for assistance, and T. Mori for encouragement. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-PRESTO/CREST/ERATO; by the Takeda Science Foundation; and by the the Academia for Repro-regenerative Medicine. The accession number for the microarray data presented in this study is GSE40716 [Gene Expression Omnibus (GEO) database].	Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; HASHIMOTO K, 1992, DEV GROWTH DIFFER, V34, P233; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KAUFMAN MH, 1987, DEVELOPMENT, V101, P383; Matoba S, 2011, BIOL REPROD, V84, P631, DOI 10.1095/biolreprod.110.087122; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	13	474	508	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					971	975		10.1126/science.1226889	http://dx.doi.org/10.1126/science.1226889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23042295				2022-12-01	WOS:000311083600050
J	Feng, Y; Li, WF; Li, J; Wang, JW; Ge, JP; Xu, D; Liu, YJ; Wu, KQ; Zeng, QY; Wu, JW; Tian, CL; Zhou, B; Yang, MJ				Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Liu, Yanjing; Wu, Kaiqi; Zeng, Qingyin; Wu, Jia-Wei; Tian, Changlin; Zhou, Bing; Yang, Maojun			Structural insight into the type-II mitochondrial NADH dehydrogenases	NATURE			English	Article							QUINONE OXIDOREDUCTASE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; PROTON; NDI1; IDENTIFICATION; SOFTWARE; OXIDASE	The single-component type-II NADH dehydrogenases (NDH-2s) serve as alternatives to the multisubunit respiratory complex I (type-I NADH dehydrogenase (NDH-1), also called NADH: ubiquinone oxidoreductase; EC 1.6.5.3) in catalysing electron transfer from NADH to ubiquinone in the mitochondrial respiratory chain(1). The yeast NDH-2 (Ndi1) oxidizes NADH on the matrix side and reduces ubiquinone to maintain mitochondrial NADH/NAD(+) homeostasis. Ndi1 is a potential therapeutic agent for human diseases caused by complex I defects(2-9), particularly Parkinson's disease, because its expression restores the mitochondrial activity in animals with complex I deficiency. NDH-2s in pathogenic microorganisms are viable targets for new antibiotics(10,11). Here we solve the crystal structures of Ndi1 in its substrate-free, NADH-, ubiquinone-and NADH-ubiquinone-bound states, to help understand the catalytic mechanism of NDH-2s. We find that Ndi1 homodimerization through its carboxy-terminal domain is critical for its catalytic activity and membrane targeting. The structures reveal two ubiquinone-binding sites (UQ(I) and UQ(II)) in Ndi1. NADH and UQ(I) can bind to Ndi1 simultaneously to form a substrate-protein complex. We propose that UQ(I) interacts with FAD to act as an intermediate for electron transfer, and that NADH transfers electrons through this FAD-UQ(I) complex to UQ(II). Together our data reveal the regulatory and catalytic mechanisms of Ndi1 and may facilitate the development or targeting of NDH-2s for potential therapeutic applications.	[Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Wu, Jia-Wei; Zhou, Bing; Yang, Maojun] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Yanjing; Zeng, Qingyin] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wu, Kaiqi; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Yang, MJ (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	刘, 妍婧/HCI-6701-2022; Tian, Changlin/P-1469-2014; Ge, Jingpeng/AGG-3471-2022; Wang, Jiawei/D-1144-2010; Gai, Jingpeng/AAT-9369-2021; Xu, Duo/M-9378-2019	Wang, Jiawei/0000-0001-9893-8539; Gai, Jingpeng/0000-0001-6164-1221; Xu, Duo/0000-0003-0483-8719; Yang, Maojun/0000-0002-6798-3094; Feng, Yue/0000-0002-1576-1385; Zeng, Qing-Yin/0000-0002-5730-3016	Ministry of Science and Technology of China [2011CB910502, 2011CB910900, 2012CB911101]; National Natural Science Foundation of China [31030020, 31170679]; Chinese Key Research Plan-Protein Sciences [2011CB911104]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Research Plan-Protein Sciences	We would like to thank the staff at beamline BL17U of the Shanghai Synchrotron Radiation Facility for their assistance with data collection. We thank W. Tong for maintenance and support of the EPR facility at the High Magnetic Field Laboratory, Chinese Academy of Sciences. This work was supported by the Ministry of Science and Technology of China (2011CB910502, 2011CB910900 and 2012CB911101), the National Natural Science Foundation of China (31030020 and 31170679) and Chinese Key Research Plan-Protein Sciences (2011CB911104).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adelroth P, 2000, P NATL ACAD SCI USA, V97, P13086, DOI 10.1073/pnas.230439597; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barber-Singh J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/438370; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Biagini GA, 2012, P NATL ACAD SCI USA, V109, P8298, DOI 10.1073/pnas.1205651109; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T., 1999, NUCL ACIDS S SERIES, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Maas MFPM, 2010, J MOL BIOL, V399, P31, DOI 10.1016/j.jmb.2010.04.015; Marella M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025910; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; OHNISHI T, 1966, B SOC CHIM BIOL, V48, P1189; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Ohnishi T, 2012, BBA-BIOENERGETICS, V1817, P1803, DOI 10.1016/j.bbabio.2012.03.032; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Teh J. S., 2007, Infectious Disorders - Drug Targets, V7, P169; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P2213, DOI 10.1107/S0907444902016384; Villegas JM, 2011, ARCH BIOCHEM BIOPHYS, V505, P155, DOI 10.1016/j.abb.2010.10.001; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yang Y, 2011, J BIOL CHEM, V286, P9287, DOI 10.1074/jbc.M110.175547	42	82	84	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					478	+		10.1038/nature11541	http://dx.doi.org/10.1038/nature11541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086143				2022-12-01	WOS:000311031600053
J	Pfeffer, C; Larsen, S; Song, J; Dong, MD; Besenbacher, F; Meyer, RL; Kjeldsen, KU; Schreiber, L; Gorby, YA; El-Naggar, MY; Leung, KM; Schramm, A; Risgaard-Petersen, N; Nielsen, LP				Pfeffer, Christian; Larsen, Steffen; Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise; Kjeldsen, Kasper Urup; Schreiber, Lars; Gorby, Yuri A.; El-Naggar, Mohamed Y.; Leung, Kar Man; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter			Filamentous bacteria transport electrons over centimetre distances	NATURE			English	Article							MICROSENSOR; REDUCTION; NANOWIRES; SEDIMENT	Oxygen consumption in marine sediments is often coupled to the oxidation of sulphide generated by degradation of organic matter in deeper, oxygen-free layers. Geochemical observations have shown that this coupling can be mediated by electric currents carried by unidentified electron transporters across centimetre-wide zones. Here we present evidence that the native conductors are long, filamentous bacteria. They abounded in sediment zones with electric currents and along their length they contained strings with distinct properties in accordance with a function as electron transporters. Living, electrical cables add a new dimension to the understanding of interactions in nature and may find use in technology development.	[Pfeffer, Christian; Kjeldsen, Kasper Urup; Schreiber, Lars; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Larsen, Steffen; Meyer, Rikke Louise; Schramm, Andreas; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise] Aarhus Univ, Ctr DNA Nanotechnol CDNA, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark; [Gorby, Yuri A.; Leung, Kar Man] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [El-Naggar, Mohamed Y.; Leung, Kar Man] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA	Aarhus University; Aarhus University; Aarhus University; University of Southern California; University of Southern California	Risgaard-Petersen, N (corresponding author), Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark.	nils.risgaard-petersen@biology.au.dk; biolpn@biology.au.dk	Dong, Mingdong/AAC-3023-2020; Nielsen, Lars Peter/AAL-6274-2021; Meyer, Rikke Louise/AAB-5377-2021; dong, mingdong/AAK-9315-2020; Nielsen, Lars Peter/J-7401-2013; Risgaard-Petersen, Nils/J-2479-2013; Schramm, Andreas/AAE-1616-2022; Risgaard-Petersen, Nils/AAX-6747-2021; Schreiber, Lars/J-5937-2013; Schramm, Andreas/J-2655-2013; Dong, Mingdong/B-3341-2010; Kjeldsen, Kasper U/A-4151-2011	Dong, Mingdong/0000-0002-2025-2171; Nielsen, Lars Peter/0000-0002-7269-4860; Meyer, Rikke Louise/0000-0002-6485-5134; Nielsen, Lars Peter/0000-0002-7269-4860; Risgaard-Petersen, Nils/0000-0002-2767-2080; Schramm, Andreas/0000-0002-7614-9616; Risgaard-Petersen, Nils/0000-0002-2767-2080; Schreiber, Lars/0000-0003-3411-0083; Schramm, Andreas/0000-0002-7614-9616; Dong, Mingdong/0000-0002-2025-2171; Kjeldsen, Kasper U/0000-0002-7805-5605	European Research Council; Danish National Research Foundation; Danish Council for Independent Research \ Natural Sciences (FNU); German Max Planck Society; Villum Foundation; Villum Fonden [00007194] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research \ Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); German Max Planck Society(Max Planck Society); Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	The authors thank P. G. Sorensen and L. B. Pedersen for construction of microsensors. Thanks to K. E. Thomsen for operating the TEM. B. B. Jorgensen is thanked for his general support. This research was financially supported by the European Research Council (L.P.N.), the Danish National Research Foundation (N.R.-P., C. P., K. U. K., L. S., M. D.), the Danish Council for Independent Research vertical bar Natural Sciences (FNU) (L.P.N.), the German Max Planck Society (N.R.-P., C. P., K. U. K., L. S.) and the Villum Foundation (M.D.).	CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Cherniavskaya O, 2003, J PHYS CHEM B, V107, P1525, DOI 10.1021/jp0265438; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Lu W, 2007, NANO LETT, V7, P2729, DOI 10.1021/nl071208m; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; Nielsen LP, 2010, NATURE, V463, P1071, DOI 10.1038/nature08790; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Risgaard-Petersen N, 2012, GEOCHIM COSMOCHIM AC, V92, P1, DOI 10.1016/j.gca.2012.05.036; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526	20	354	372	21	577	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					218	221		10.1038/nature11586	http://dx.doi.org/10.1038/nature11586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103872				2022-12-01	WOS:000310774300036
J	Diochot, S; Baron, A; Salinas, M; Douguet, D; Scarzello, S; Dabert-Gay, AS; Debayle, D; Friend, V; Alloui, A; Lazdunski, M; Lingueglia, E				Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Alloui, Abdelkrim; Lazdunski, Michel; Lingueglia, Eric			Black mamba venom peptides target acid-sensing ion channels to abolish pain	NATURE			English	Article							ACTIVATED CURRENTS; ASIC3; MECHANISMS; EVOLUTION; ALIGNMENT; TOXINS	Polypeptide toxins have played a central part in understanding physiological and physiopathological functions of ion channels(1,2). In the field of pain, they led to important advances in basic research(3-6) and even to clinical applications(7,8). Acid-sensing ion channels (ASICs) are generally considered principal players in the pain pathway(9), including in humans(10). A snake toxin activating peripheral ASICs in nociceptive neurons has been recently shown to evoke pain(11). Here we show that a new class of three-finger peptides from another snake, the black mamba, is able to abolish pain through inhibition of ASICs expressed either in central or peripheral neurons. These peptides, which we call mambalgins, are not toxic in mice but show a potent analgesic effect upon central and peripheral injection that can be as strong as morphine. This effect is, however, resistant to naloxone, and mambalgins cause much less tolerance than morphine and no respiratory distress. Pharmacological inhibition by mambalgins combined with the use of knockdown and knockout animals indicates that blockade of heteromeric channels made of ASIC1a and ASIC2a subunits in central neurons and of ASIC1b-containing channels in nociceptors is involved in the analgesic effect of mambalgins. These findings identify new potential therapeutic targets for pain and introduce natural peptides that block them to produce a potent analgesia.	[Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Friend, Valerie; Lingueglia, Eric] LabEx Ion Channel Sci & Therapeut, F-06560 Valbonne, France; [Alloui, Abdelkrim] Univ Auvergne, Clermont Univ, NEURO DOL, F-63000 Clermont Ferrand, France; [Alloui, Abdelkrim] INSERM, U1107, F-63001 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Baron, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	baron@ipmc.cnrs.fr; lingueglia@ipmc.cnrs.fr	Diochot, Sylvie/ABG-5495-2020; LINGUEGLIA, Eric/F-5509-2013; SALINAS, Miguel/N-6380-2016; BARON, Anne/N-5691-2016; douguet, dominique/D-5644-2017	LINGUEGLIA, Eric/0000-0003-3902-3405; SALINAS, Miguel/0000-0002-7445-123X; BARON, Anne/0000-0002-8026-6380; 	Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; Agence Nationale de la Recherche; EMMAservice under European Union of the EC FP7 Capacities Specific Programme [227490]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); EMMAservice under European Union of the EC FP7 Capacities Specific Programme	We are grateful to M. P. Price and M. J. Welsh for their gift of the ASIC1a<SUP>-/-</SUP> mice, to A. Zimmer for providing the Penk1<SUP>-/-</SUP> mice, to H. Schweitz and L. Beress for their gift of pre-purified peptidic fractions of black mamba venom, to J. Noel for cultures of hippocampal neurons and comments, to E. Deval, P. Inquimbert, A. Delaunay and M. Christin for discussions, to C. Heurteaux and N. Blondeau for help with stereotaxic injections, to A. Lazzari for support with plethysmography, to V. Thieffin, N. Leroudier, S. Boulakirba, T. Lemaire, C. Karoutchi and G. Marrane for technical assistance, and to C. Chevance for secretarial assistance. We thank E. Bourinet, F. Rassendren and M. B. Emerit for providing the Cav3.2, P2X2 and 5-HT3A cDNAs, respectively. This work was supported by the Fondation pour la Recherche Medicale, the Association Francaise contre les Myopathies and the Agence Nationale de la Recherche. Part of this work has been supported by EMMAservice under European Union contract Grant Agreement number 227490 of the EC FP7 Capacities Specific Programme.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; Fromy B, 2012, NAT MED, V18, P1205, DOI 10.1038/nm.2844; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Mamet J, 2002, J NEUROSCI, V22, P10662; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SCHWEITZ H, 1990, TOXICON, V28, P847, DOI 10.1016/S0041-0101(09)80007-X; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	43	275	286	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					552	+		10.1038/nature11494	http://dx.doi.org/10.1038/nature11494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23034652				2022-12-01	WOS:000310196200045
J	Morf, J; Rey, G; Schneider, K; Stratmann, M; Fujita, J; Naef, F; Schibler, U				Morf, Joerg; Rey, Guillaume; Schneider, Kim; Stratmann, Markus; Fujita, Jun; Naef, Felix; Schibler, Ueli			Cold-Inducible RNA-Binding Protein Modulates Circadian Gene Expression Posttranscriptionally	SCIENCE			English	Article							BODY-TEMPERATURE; TRANSCRIPTION; CELLS; ENTRAINMENT; INSIGHTS; RHYTHMS; CLOCK	In mammalian tissues, circadian gene expression can be driven by local oscillators or systemic signals controlled by the master pacemaker in the suprachiasmatic nucleus. We show that simulated body temperature cycles, but not peripheral oscillators, controlled the rhythmic expression of cold-inducible RNA-binding protein (CIRP) in cultured fibroblasts. In turn, loss-of-function experiments indicated that CIRP was required for high-amplitude circadian gene expression. The transcriptome-wide identification of CIRP-bound RNAs by a biotin-streptavidin-based cross-linking and immunoprecipitation (CLIP) procedure revealed several transcripts encoding circadian oscillator proteins, including CLOCK. Moreover, CLOCK accumulation was strongly reduced in CIRP-depleted fibroblasts. Because ectopic expression of CLOCK improved circadian gene expression in these cells, we surmise that CIRP confers robustness to circadian oscillators through regulation of CLOCK expression.	[Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; [Rey, Guillaume; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Rey, Guillaume; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Fujita, Jun] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Sakyo Ku, Kyoto 6058507, Japan	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Kyoto University	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch	Rey, Guillaume/F-5303-2012; Morf, Jorg/AAH-4825-2020	Rey, Guillaume/0000-0001-7664-7052; Morf, Jorg/0000-0002-0485-3380; Naef, Felix/0000-0001-9786-3037	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC-2009-AdG 20090506, ERC-2010-StG-260667]; State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF) [31-130714]; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for constructing the bioluminescence recording device; J. Strouboulis (Vari, Greece) for the IRES-BirA vector plasmid (pTRIP-IRES-EGFP-BirA); P. Gos, F. Fleury-Olela, K. Harshman and the Lausanne Genomic Technologies Facility, as well as P. Descombes and the National Center of Competence in Research (NCCR) Genomics Platform, Geneva, for technical help; and N. Roggli for the artwork. The computations were performed at the Vital-IT (www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics. The work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1 and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. The work in the laboratory of J. F. was supported by the Smoking Research Foundation of Japan. The work in the laboratory of F. N. was supported by the Swiss National Science Foundation (SNF grant 31-130714), the European Research Council (ERC-2010-StG-260667), and the Ecole Polytechnique Federale de Lausanne (EPFL). CLIP-seq and RNA-seq data have been deposited in the Gene Expression Omnibus database (accession no. GSE37685).	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Guo X, 2010, MOL CARCINOGEN, V49, P130, DOI 10.1002/mc.20582; Kornmann B, 2007, COLD SH Q B, V72, P319; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	21	176	184	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					379	383		10.1126/science.1217726	http://dx.doi.org/10.1126/science.1217726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22923437				2022-12-01	WOS:000309955800040
J	Landsberg, J; Kohlmeyer, J; Renn, M; Bald, T; Rogava, M; Cron, M; Fatho, M; Lennerz, V; Wolfel, T; Holzel, M; Tuting, T				Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Fatho, Martina; Lennerz, Volker; Woelfel, Thomas; Hoelzel, Michael; Tueting, Thomas			Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation	NATURE			English	Article							METASTATIC MELANOMA; CANCER REGRESSION; IN-VIVO; IMMUNOTHERAPY; ANTIGEN; LYMPHOCYTES; MICE; GROWTH; AUTOIMMUNITY; RESPONSES	Adoptive cell transfer therapies (ACTs) with cytotoxic T cells that target melanocytic antigens can achieve remissions in patients with metastatic melanomas, but tumours frequently relapse(1,2). Hypotheses explaining the acquired resistance to ACTs include the selection of antigen-deficient tumour cell variants(3-5) and the induction of T-cell tolerance(6). However, the lack of appropriate experimental melanoma models has so far impeded clear insights into the underlying mechanisms. Here we establish an effective ACT protocol in a genetically engineered mouse melanoma model that recapitulates tumour regression, remission and relapse as seen in patients. We report the unexpected observation that melanomas acquire ACT resistance through an inflammation-induced reversible loss of melanocytic antigens. In serial transplantation experiments, melanoma cells switch between a differentiated and a dedifferentiated phenotype in response to T-cell-driven inflammatory stimuli. We identified the proinflammatory cytokine tumour necrosis factor (TNF)-alpha as a crucial factor that directly caused reversible dedifferentiation of mouse and human melanoma cells. Tumour cells exposed to TNF-alpha were poorly recognized by T cells specific for melanocytic antigens, whereas recognition by T cells specific for non-melanocytic antigens was unaffected or even increased. Our results demonstrate that the phenotypic plasticity of melanoma cells in an inflammatory microenvironment contributes to tumour relapse after initially successful T-cell immunotherapy. On the basis of our work, we propose that future ACT protocols should simultaneously target melanocytic and non-melanocytic antigens to ensure broad recognition of both differentiated and dedifferentiated melanoma cells, and include strategies to sustain T-cell effector functions by blocking immune-inhibitory mechanisms in the tumour microenvironment.	[Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany; [Fatho, Martina; Lennerz, Volker; Woelfel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55101 Mainz, Germany; [Hoelzel, Michael] Univ Bonn, Unit RNA Biol, Dept Clin Chem & Clin Pharmacol, D-53105 Bonn, Germany	University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn	Tuting, T (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de	Landsberg, Jennifer/AAF-5113-2019; Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022; Bald, Tobias/H-9525-2018; Wölfel, Thomas/G-6519-2012	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Bald, Tobias/0000-0003-0061-235X; Rogava, Meri/0000-0002-0314-5323; Sirokay, Judith/0000-0003-3945-845X; Renn, Marcel/0000-0002-0120-4035	DFG [SFB832, SFB704, SFB 432]; Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	We would like to thank G. Merlino and M. Barbacid for providing genetically engineered mice; E. Endl for help with FACS sorting; S. Herms and P. Hoffmann for the cDNA microarrays; S. Mikus, A. Sporleder and C. Lemke for managing the mouse colony and performing histopathology, immunohistopatholgoy, immunoblotting and real-time PCR. This research was supported in part by grants from the DFG (A12 in the SFB832 and A22 in the SFB704) and the Deutsche Krebshilfe (P9 in the Melanoma Research Network) to T. T., by grants from BONFOR to J.L. and J.K., and by a DFG grant (A1 in the SFB 432) to T. W. T. T. and M. H. are members of the Excellence Cluster ImmunoSensation.	[Anonymous], 2010, R LANG ENV STAT COMP; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kanik AB, 1996, J CUTAN PATHOL, V23, P205, DOI 10.1111/j.1600-0560.1996.tb01468.x; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Rourke MGE, 2007, MELANOMA RES, V17, P316, DOI 10.1097/CMR.0b013e3282c3a73b; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tormo D, 2006, AM J PATHOL, V169, P665, DOI 10.2353/ajpath.2006.060017; Tormo D, 2006, CANCER RES, V66, P5427, DOI 10.1158/0008-5472.CAN-06-0399; van der Laan M. J., 2009, U C BERKELEY DIV BIO; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	43	375	385	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					412	+		10.1038/nature11538	http://dx.doi.org/10.1038/nature11538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23051752				2022-12-01	WOS:000309918500048
J	Chen, XF; Cui, DD; Papusha, A; Zhang, XT; Chu, CD; Tang, JW; Chen, KF; Pan, XW; Ira, G				Chen, Xuefeng; Cui, Dandan; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen; Ira, Grzegorz			The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; H2A PHOSPHORYLATION; BUDDING YEAST; REPAIR; CHROMATIN; HELICASE; SGS1; MRE11-RAD50-XRS2	Chromosomal double-strand breaks (DSBs) are resected by 5' nucleases to form 3' single-stranded DNA substrates for binding by homologous recombination and DNA damage checkpoint proteins. Two redundant pathways of extensive resection have been described both in cells(1-3) and in vitro(4-6), one relying on Exo1 exonuclease and the other on Sgs1 helicase and Dna2 nuclease. However, it remains unknown how resection proceeds within the context of chromatin, where histones and histone-bound proteins represent barriers for resection enzymes. Here we identify the yeast nucleosome-remodelling enzyme Fun30 as a factor promoting DSB end resection. Fun30 is the major nucleosome remodeller promoting extensive Exo1- and Sgs1-dependent resection of DSBs. The RSC and INO80 chromatin-remodelling complexes and Fun30 have redundant roles in resection adjacent to DSB ends. ATPase and helicase domains of Fun30, which are needed for nucleosome remodelling(7), are also required for resection. Fun30 is robustly recruited to DNA breaks and spreads along the DSB coincident with resection. Fun30 becomes less important for resection in the absence of the histone-bound Rad9 checkpoint adaptor protein known to block 5' strand processing(8) and in the absence of either histone H3 K79 methylation or gamma-H2A, which mediate recruitment of Rad9 (refs 9, 10). Together these data suggest that Fun30 helps to overcome the inhibitory effect of Rad9 on DNA resection.	[Cui, Dandan; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Xuefeng; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Pan, XW (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	xuewenp@bcm.edu; gira@bcm.edu	Chen, Xuefeng/C-3410-2013	Zhang, Xiaotian/0000-0002-9533-4761	National Institutes of Health [GM080600, HG004840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Sung, W.-D. Heyer and A. Pellicioli for antibodies; S.-E. Lee, S. Kron and M. Osley for strains; B. Llorente for sharing unpublished data; and J. Tyler, P. Sung and S. E. Lee for comments on the manuscript. This work was supported by the National Institutes of Health grants GM080600 (to G. I.) and HG004840 (to X.P.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	34	173	179	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					576	+		10.1038/nature11355	http://dx.doi.org/10.1038/nature11355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960743	Green Accepted			2022-12-01	WOS:000311781500006
J	Costelloe, T; Louge, R; Tomimatsu, N; Mukherjee, B; Martini, E; Khadaroo, B; Dubois, K; Wiegant, WW; Thierry, A; Burma, S; van Attikum, H; Llorente, B				Costelloe, Thomas; Louge, Raphael; Tomimatsu, Nozomi; Mukherjee, Bipasha; Martini, Emmanuelle; Khadaroo, Basheer; Dubois, Kenny; Wiegant, Wouter W.; Thierry, Agnes; Burma, Sandeep; van Attikum, Haico; Llorente, Bertrand			The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DISTINCT ROLES; DAMAGE; EXO1; REPAIR; RECOMBINATION; MUTANTS; GENES; SGS1	Several homology-dependent pathways can repair potentially lethal DNA double-strand breaks (DSBs). The first step common to all homologous recombination reactions is the 5'-3' degradation of DSB ends that yields the 39 single-stranded DNA required for the loading of checkpoint and recombination proteins. In yeast, the Mre11-Rad50-Xrs2 complex (Xrs2 is known as NBN or NBS1 in humans) and Sae2 (known as RBBP8 or CTIP in humans) initiate end resection, whereas long-range resection depends on the exonuclease Exo1, or the helicase-topoisomerase complex Sgs1-Top3-Rmi1 together with the endonuclease Dna2 (refs 1-6). DSBs occur in the context of chromatin, but how the resection machinery navigates through nucleosomal DNA is a process that is not well understood(7). Here we show that the yeast Saccharomyces cerevisiae Fun30 protein and its human counterpart SMARCAD1 (ref. 8), two poorly characterized ATP-dependent chromatin remodellers of the Snf2 ATPase family, are directly involved in the DSB response. Fun30 physically associates with DSB ends and directly promotes both Exo1- and Sgs1-dependent end resection through a mechanism involving its ATPase activity. The function of Fun30 in resection facilitates the repair of camptothecin-induced DNA lesions, although it becomes dispensable when Exo1 is ectopically overexpressed. Interestingly, SMARCAD1 is also recruited to DSBs, and the kinetics of recruitment is similar to that of EXO1. The loss of SMARCAD1 impairs end resection and recombinational DNA repair, and renders cells hypersensitive to DNA damage resulting from camptothecin or poly(ADP-ribose) polymerase inhibitor treatments. These findings unveil an evolutionarily conserved role for the Fun30 and SMARCAD1 chromatin remodellers in controlling end resection, homologous recombination and genome stability in the context of chromatin.	[Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France; [Costelloe, Thomas; Wiegant, Wouter W.; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 ZC Leiden, Netherlands; [Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Aix Marseille Univ, Unite Mixte Rech 7258, F-13284 Marseille, France; [Tomimatsu, Nozomi; Mukherjee, Bipasha; Burma, Sandeep] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Martini, Emmanuelle] CEA DSV Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Thierry, Agnes] Inst Pasteur, CNRS, Unite Genet Mol Levures, F-75724 Paris 15, France; [Thierry, Agnes] Univ Paris 06, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Llorente, B (corresponding author), Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France.	h.van.attikum@lumc.nl; bllorente@ifr88.cnrs-mrs.fr	van Attikum, Haico/A-4596-2010; llorente, bertrand/M-3501-2016	Van Attikum, Haico/0000-0001-8590-0240; martini, emmanuelle/0000-0003-2005-0796; Llorente, Bertrand/0000-0002-6291-5797	National Institutes of Health [RO1 CA149461]; National Aeronautics and Space Administration [NNX10AE08G]; Cancer Prevention and Research Institute of Texas [RP100644]; Netherlands Organization for Scientific Research (NWO-VIDI grant); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP); Agence Nationale de la Recherche [ANR-10-BLAN-1606-03]; NATIONAL CANCER INSTITUTE [R01CA149461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; Netherlands Organization for Scientific Research (NWO-VIDI grant)(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Ira for sharing unpublished data and S. Janicki, R. Greenberg, L. Symington and all the laboratories from the Centre National de la Recherche Scientifique (CNRS) UPR3081 for providing reagents. We thank S. Coulon for help in the analysis of the fun30 repressible allele, I. Lafontaine for support in statistical analyses, C. V. Camacho for generating the V5-EXO1 constructs and A. Guenole, R. Srivas, T. Ideker, K. Vreeken and M. Vermeulen for help in searching for Fun30 interactors. B. L. is grateful to B. Dujon for hosting him and providing the opportunity to perform the BIR screen. S. B. is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX10AE08G) and the Cancer Prevention and Research Institute of Texas (RP100644). H.v.A. receives funding from the Netherlands Organization for Scientific Research (NWO-VIDI grant) and Human Frontiers Science Program(HFSP-CDA grant). B. L. is supported by grants from the CNRS (ATIP) and the Agence Nationale de la Recherche (ANR-10-BLAN-1606-03).	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Burke D., 2005, METHODS YEAST GENETI; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2007, NUCLEIC ACIDS RES, V35, P822, DOI 10.1093/nar/gkl1081; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Martini EMD, 2002, GENETICS, V160, P1375; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 2001, GENETICS, V159, P1423; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pardo B, 2006, GENETICS, V172, P2689, DOI 10.1534/genetics.105.053512; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	38	184	188	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					581	+		10.1038/nature11353	http://dx.doi.org/10.1038/nature11353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960744	Green Accepted			2022-12-01	WOS:000311781500007
J	Smith, R				Smith, Richard			Why a Macroeconomic Perspective Is Critical to the Prevention of Noncommunicable Disease	SCIENCE			English	Editorial Material							PANDEMIC INFLUENZA; HEALTH; EQUILIBRIUM; IMPACT; UK	Effective prevention of noncommunicable diseases will require changes in how we live, and thereby effect important economic changes across populations, sectors, and countries. What we do not know is which populations, sectors, or countries will be positively or negatively affected by such changes, nor by how much. Without this information we cannot know which policies will produce effects that are beneficial both for economies and for health.	Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Smith, R (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	richard.smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2001, MACR HLTH INV HLTH E; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Bloom D., 2011, GLOBAL EC BURDEN NON; BLOUIN C, 2009, J GERONTOL B-PSYCHOL, V373, P502, DOI DOI 10.1016/S0140-6736(08)61777-8; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Smith R. D., 2011, INTRO HLTH EC, P21; Smith R. D., 2010, J PUBLIC HLTH BANGKO, V32, P2; Smith RD, 2011, SOC SCI MED, V73, P235, DOI 10.1016/j.socscimed.2011.05.025; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; World Health Organization, 2008, COM SOC DET HLTH, V89	18	17	19	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1501	1503		10.1126/science.1222569	http://dx.doi.org/10.1126/science.1222569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997330	Green Published			2022-12-01	WOS:000308912900042
J	Glover, JD; Reganold, JP; Cox, CM				Glover, Jerry D.; Reganold, John P.; Cox, Cindy M.			Plant perennials to save Africa's soils	NATURE			English	Editorial Material							MANAGEMENT; SECURITY; FOOD		[Glover, Jerry D.] USAID Bur Food Secur, Washington, DC 20523 USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Cox, Cindy M.] Int Food Policy Res Inst, Washington, DC 20006 USA	United States Agency for International Development (USAID); Washington State University; CGIAR; International Food Policy Research Institute (IFPRI)	Glover, JD (corresponding author), USAID Bur Food Secur, Washington, DC 20523 USA.	jglover@usaid.gov						Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Betru S, 2010, AFR J AGR RES, V5, P2757; Committee on a Study of Technologies to Benefit Farmers in Africa and South Asia National Research Council, 2008, EM TECHN BEN FARM SU; Eswaran H, 1997, GEODERMA, V77, P1, DOI 10.1016/S0016-7061(97)00007-4; Garrity DP, 2010, FOOD SECUR, V2, P197, DOI 10.1007/s12571-010-0070-7; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Hassanali A, 2008, PHILOS T R SOC B, V363, P611, DOI 10.1098/rstb.2007.2173; Henao J., 2006, AGR PRODUCTION SOIL; Snapp SS, 2010, P NATL ACAD SCI USA, V107, P20840, DOI 10.1073/pnas.1007199107	10	64	67	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					359	361		10.1038/489359a	http://dx.doi.org/10.1038/489359a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996532	Bronze			2022-12-01	WOS:000308860900017
J	Dunham, I; Kundaje, A; Aldred, SF; Collins, PJ; Davis, C; Doyle, F; Epstein, CB; Frietze, S; Harrow, J; Kaul, R; Khatun, J; Lajoie, BR; Landt, SG; Lee, BK; Pauli, F; Rosenbloom, KR; Sabo, P; Safi, A; Sanyal, A; Shoresh, N; Simon, JM; Song, L; Trinklein, ND; Altshuler, RC; Birney, E; Brown, JB; Cheng, C; Djebali, S; Dong, XJ; Dunham, I; Ernst, J; Furey, TS; Gerstein, M; Giardine, B; Greven, M; Hardison, RC; Harris, RS; Herrero, J; Hoffman, MM; Iyer, S; Kellis, M; Khatun, J; Kheradpour, P; Kundaje, A; Lassmann, T; Li, QH; Lin, X; Marinov, GK; Merkel, A; Mortazavi, A; Parker, SCJ; Reddy, TE; Rozowsky, J; Schlesinger, F; Thurman, RE; Wang, J; Ward, LD; Whitfield, TW; Wilder, SP; Wu, W; Xi, HLS; Yip, KY; Zhuang, JL; Bernstein, BE; Birney, E; Dunham, I; Green, ED; Gunter, C; Snyder, M; Pazin, MJ; Lowdon, RF; Dillon, LAL; Adams, LB; Kelly, CJ; Zhang, J; Wexler, JR; Green, ED; Good, PJ; Feingold, EA; Bernstein, BE; Birney, E; Crawford, GE; Dekker, J; Elnitski, L; Farnham, PJ; Gerstein, M; Giddings, MC; Gingeras, TR; Green, ED; Guigo, R; Hardison, RC; Hubbard, TJ; Kellis, M; Kent, WJ; Lieb, JD; Margulies, EH; Myers, RM; Snyder, M; Stamatoyannopoulos, JA; Tenenbaum, SA; Weng, ZP; White, KP; Wold, B; Khatun, J; Yu, Y; Wrobel, J; Risk, BA; Gunawardena, HP; Kuiper, HC; Maier, CW; Xie, L; Chen, X; Giddings, MC; Bernstein, BE; Epstein, CB; Shoresh, N; Ernst, J; Kheradpour, P; Mikkelsen, TS; Gillespie, S; Goren, A; Ram, O; Zhang, XL; Wang, L; Issner, R; Coyne, MJ; Durham, T; Ku, M; Truong, T; Ward, LD; Altshuler, RC; Eaton, ML; Kellis, M; Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roeder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Batut, P; Bell, I; Bell, K; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, HP; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Li, GL; Luo, OJ; Park, E; Preall, JB; Presaud, K; Ribeca, P; Risk, BA; Robyr, D; Ruan, XA; Sammeth, M; Sandhu, KS; Schaeffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, HE; Wrobel, J; Yu, YB; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, TJ; Reymond, A; Antonarakis, SE; Hannon, GJ; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR; Rosenbloom, KR; Sloan, CA; Learned, K; Malladi, VS; Wong, MC; Barber, G; Cline, MS; Dreszer, TR; Heitner, SG; Karolchik, D; Kent, WJ; Kirkup, VM; Meyer, LR; Long, JC; Maddren, M; Raney, BJ; Furey, TS; Song, LY; Grasfeder, LL; Giresi, PG; Lee, BK; Battenhouse, A; Sheffield, NC; Simon, JM; Showers, KA; Safi, A; London, D; Bhinge, AA; Shestak, C; Schaner, MR; Kim, SK; Zhang, ZZZ; Mieczkowski, PA; Mieczkowska, JO; Liu, Z; McDaniell, RM; Ni, YY; Rashid, NU; Kim, MJ; Adar, S; Zhang, ZC; Wang, TY; Winter, D; Keefe, D; Birney, E; Iyer, VR; Lieb, JD; Crawford, GE; Li, GL; Sandhu, KS; Zheng, MZ; Wang, P; Luo, OJ; Shahab, A; Fullwood, MJ; Ruan, XA; Ruan, YJ; Myers, RM; Pauli, F; Williams, BA; Gertz, J; Marinov, GK; Reddy, TE; Vielmetter, J; Partridge, EC; Trout, D; Varley, KE; Gasper, C; Bansal, A; Pepke, S; Jain, P; Amrhein, H; Bowling, KM; Anaya, M; Cross, MK; King, B; Muratet, MA; Antoshechkin, I; Newberry, KM; Mccue, K; Nesmith, AS; Fisher-Aylor, KI; Pusey, B; DeSalvo, G; Parker, SL; Balasubramanian, S; Davis, NS; Meadows, SK; Eggleston, T; Gunter, C; Newberry, JS; Levy, SE; Absher, DM; Mortazavi, A; Wong, WH; Wold, B; Blow, MJ; Visel, A; Pennachio, LA; Elnitski, L; Margulies, EH; Parker, SCJ; Petrykowska, HM; Abyzov, A; Aken, B; Barrell, D; Barson, G; Berry, A; Bignell, A; Boychenko, V; Bussotti, G; Chrast, J; Davidson, C; Derrien, T; Despacio-Reyes, G; Diekhans, M; Ezkurdia, I; Frankish, A; Gilbert, J; Gonzalez, JM; Griffiths, E; Harte, R; Hendrix, DA; Howald, C; Hunt, T; Jungreis, I; Kay, M; Khurana, E; Kokocinski, F; Leng, J; Lin, MF; Loveland, J; Lu, Z; Manthravadi, D; Mariotti, M; Mudge, J; Mukherjee, G; Notredame, C; Pei, BK; Rodriguez, JM; Saunders, G; Sboner, A; Searle, S; Sisu, C; Snow, C; Steward, C; Tanzer, A; Tapanari, E; Tress, ML; van Baren, MJ; Walters, N; Washietl, S; Wilming, L; Zadissa, A; Zhang, ZD; Brent, M; Haussler, D; Kellis, M; Valencia, A; Gerstein, M; Reymond, A; Guigo, R; Harrow, J; Hubbard, TJ; Landt, SG; Frietze, S; Abyzov, A; Addleman, N; Alexander, RP; Auerbach, RK; Balasubramanian, S; Bettinger, K; Bhardwaj, N; Boyle, AP; Cao, AR; Cayting, P; Charos, A; Cheng, Y; Cheng, C; Eastman, C; Euskirchen, G; Fleming, JD; Grubert, F; Habegger, L; Hariharan, M; Harmanci, A; Iyengar, S; Jin, VX; Karczewski, KJ; Kasowski, M; Lacroute, P; Lam, H; Lamarre-Vincent, N; Leng, J; Lian, J; Lindahl-Allen, M; Min, RQ; Miotto, B; Monahan, H; Moqtaderi, Z; Mu, XMJ; O'Geen, H; Ouyang, ZQ; Patacsil, D; Pei, BK; Raha, D; Ramirez, L; Reed, B; Rozowsky, J; Sboner, A; Shi, MY; Sisu, C; Slifer, T; Witt, H; Wu, LF; Xu, XQ; Yan, KK; Yang, XQ; Yip, KY; Zhang, ZD; Struhl, K; Weissman, SM; Gerstein, M; Farnham, PJ; Snyder, M; Tenenbaum, SA; Penalva, LO; Doyle, F; Karmakar, S; Landt, SG; Bhanvadia, RR; Choudhury, A; Domanus, M; Ma, LJ; Moran, J; Patacsil, D; Slifer, T; Victorsen, A; Yang, XQ; Snyder, M; White, KP; Auer, T; Centanin, L; Eichenlaub, M; Gruhl, F; Heermann, S; Hoeckendorf, B; Inoue, D; Kellner, T; Kirchmaier, S; Mueller, C; Reinhardt, R; Schertel, L; Schneider, S; Sinn, R; Wittbrodt, B; Wittbrodt, J; Weng, ZP; Whitfield, TW; Wang, J; Collins, PJ; Aldred, SF; Trinklein, ND; Partridge, EC; Myers, RM; Dekker, J; Jain, G; Lajoie, BR; Sanyal, A; Balasundaram, G; Bates, DL; Byron, R; Canfield, TK; Diegel, MJ; Dunn, D; Ebersol, AK; Frum, T; Garg, K; Gist, E; Hansen, RS; Boatman, L; Haugen, E; Humbert, R; Jain, G; Johnson, AK; Johnson, EM; Kutyavin, TV; Lajoie, BR; Lee, K; Lotakis, D; Maurano, MT; Neph, SJ; Neri, FV; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Rynes, E; Sabo, P; Sanchez, ME; Sandstrom, RS; Sanyal, A; Shafer, AO; Stergachis, AB; Thomas, S; Thurman, RE; Vernot, B; Vierstra, J; Vong, S; Wang, H; Weaver, MA; Yan, YQ; Zhang, MH; Akey, JM; Bender, M; Dorschner, MO; Groudine, M; MacCoss, MJ; Navas, P; Stamatoyannopoulos, G; Kaul, R; Dekker, J; Stamatoyannopoulos, JA; Dunham, I; Beal, K; Brazma, A; Flicek, P; Herrero, J; Johnson, N; Keefe, D; Lukk, M; Luscombe, NM; Sobral, D; Vaquerizas, JM; Wilder, SP; Batzoglou, S; Sidow, A; Hussami, N; Kyriazopoulou-Panagiotopoulou, S; Libbrecht, MW; Schaub, MA; Kundaje, A; Hardison, RC; Miller, W; Giardine, B; Harris, RS; Wu, W; Bickel, PJ; Banfai, B; Boley, NP; Brown, JB; Huang, HY; Li, QH; Li, JJ; Noble, WS; Bilmes, JA; Buske, OJ; Hoffman, MM; Sahu, AD; Kharchenko, PV; Park, PJ; Baker, D; Taylor, J; Weng, ZP; Iyer, S; Dong, XJ; Greven, M; Lin, XY; Wang, J; Xi, HLS; Zhuang, JL; Gerstein, M; Alexander, RP; Balasubramanian, S; Cheng, C; Harmanci, A; Lochovsky, L; Min, R; Mu, XMJ; Rozowsky, J; Yan, KK; Yip, KY; Birney, E				Dunham, Ian; Kundaje, Anshul; Aldred, Shelley F.; Collins, Patrick J.; Davis, CarrieA.; Doyle, Francis; Epstein, Charles B.; Frietze, Seth; Harrow, Jennifer; Kaul, Rajinder; Khatun, Jainab; Lajoie, Bryan R.; Landt, Stephen G.; Lee, Bum-Kyu; Pauli, Florencia; Rosenbloom, Kate R.; Sabo, Peter; Safi, Alexias; Sanyal, Amartya; Shoresh, Noam; Simon, Jeremy M.; Song, Lingyun; Trinklein, Nathan D.; Altshuler, Robert C.; Birney, Ewan; Brown, James B.; Cheng, Chao; Djebali, Sarah; Dong, Xianjun; Dunham, Ian; Ernst, Jason; Furey, Terrence S.; Gerstein, Mark; Giardine, Belinda; Greven, Melissa; Hardison, Ross C.; Harris, Robert S.; Herrero, Javier; Hoffman, Michael M.; Iyer, Sowmya; Kellis, Manolis; Khatun, Jainab; Kheradpour, Pouya; Kundaje, Anshul; Lassmann, Timo; Li, Qunhua; Lin, Xinying; Marinov, Georgi K.; Merkel, Angelika; Mortazavi, Ali; Parker, Stephen C. J.; Reddy, Timothy E.; Rozowsky, Joel; Schlesinger, Felix; Thurman, Robert E.; Wang, Jie; Ward, Lucas D.; Whitfield, Troy W.; Wilder, Steven P.; Wu, Weisheng; Xi, Hualin S.; Yip, Kevin Y.; Zhuang, Jiali; Bernstein, Bradley E.; Birney, Ewan; Dunham, Ian; Green, Eric D.; Gunter, Chris; Snyder, Michael; Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Green, Eric D.; Good, Peter J.; Feingold, Elise A.; Bernstein, Bradley E.; Birney, Ewan; Crawford, Gregory E.; Dekker, Job; Elnitski, Laura; Farnham, Peggy J.; Gerstein, Mark; Giddings, Morgan C.; Gingeras, Thomas R.; Green, Eric D.; Guigo, Roderic; Hardison, Ross C.; Hubbard, Timothy J.; Kellis, Manolis; Kent, W. James; Lieb, Jason D.; Margulies, Elliott H.; Myers, Richard M.; Snyder, Michael; Stamatoyannopoulos, John A.; Tenenbaum, Scott A.; Weng, Zhiping; White, Kevin P.; Wold, Barbara; Khatun, Jainab; Yu, Yanbao; Wrobel, John; Risk, Brian A.; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian; Giddings, Morgan C.; Bernstein, Bradley E.; Epstein, Charles B.; Shoresh, Noam; Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Ku, Manching; Truong, Thanh; Ward, Lucas D.; Altshuler, Robert C.; Eaton, Matthew L.; Kellis, Manolis; Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Batut, Philippe; Bell, Ian; Bell, Kimberly; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Fastuca, Megan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha P.; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Li, Guoliang; Luo, Oscar J.; Park, Eddie; Preall, Jonathan B.; Presaud, Kimberly; Ribeca, Paolo; Risk, Brian A.; Robyr, Daniel; Ruan, Xiaoan; Sammeth, Michael; Sandhu, Kuljeet Singh; Schaeffer, Lorain; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Timothy J.; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory J.; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.; Rosenbloom, Kate R.; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kent, W. James; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Furey, Terrence S.; Song, Lingyun; Grasfeder, Linda L.; Giresi, Paul G.; Lee, Bum-Kyu; Battenhouse, Anna; Sheffield, Nathan C.; Simon, Jeremy M.; Showers, Kimberly A.; Safi, Alexias; London, Darin; Bhinge, Akshay A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowski, Piotr A.; Mieczkowska, Joanna O.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Rashid, Naim U.; Kim, Min Jae; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Winter, Deborah; Keefe, Damian; Birney, Ewan; Iyer, Vishwanath R.; Lieb, Jason D.; Crawford, Gregory E.; Li, Guoliang; Sandhu, Kuljeet Singh; Zheng, Meizhen; Wang, Ping; Luo, Oscar J.; Shahab, Atif; Fullwood, Melissa J.; Ruan, Xiaoan; Ruan, Yijun; Myers, Richard M.; Pauli, Florencia; Williams, Brian A.; Gertz, Jason; Marinov, Georgi K.; Reddy, Timothy E.; Vielmetter, Jost; Partridge, E. Christopher; Trout, Diane; Varley, Katherine E.; Gasper, Clarke; Bansal, Anita; Pepke, Shirley; Jain, Preti; Amrhein, Henry; Bowling, Kevin M.; Anaya, Michael; Cross, Marie K.; King, Brandon; Muratet, Michael A.; Antoshechkin, Igor; Newberry, Kimberly M.; Mccue, Kenneth; Nesmith, Amy S.; Fisher-Aylor, Katherine I.; Pusey, Barbara; DeSalvo, Gilberto; Parker, Stephanie L.; Balasubramanian, Sreeram; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Gunter, Chris; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.; Mortazavi, Ali; Wong, Wing H.; Wold, Barbara; Blow, Matthew J.; Visel, Axel; Pennachio, Len A.; Elnitski, Laura; Margulies, Elliott H.; Parker, Stephen C. J.; Petrykowska, Hanna M.; Abyzov, Alexej; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Bussotti, Giovanni; Chrast, Jacqueline; Davidson, Claire; Derrien, Thomas; Despacio-Reyes, Gloria; Diekhans, Mark; Ezkurdia, Iakes; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Harte, Rachel; Hendrix, David A.; Howald, Cedric; Hunt, Toby; Jungreis, Irwin; Kay, Mike; Khurana, Ekta; Kokocinski, Felix; Leng, Jing; Lin, Michael F.; Loveland, Jane; Lu, Zhi; Manthravadi, Deepa; Mariotti, Marco; Mudge, Jonathan; Mukherjee, Gaurab; Notredame, Cedric; Pei, Baikang; Rodriguez, Jose Manuel; Saunders, Gary; Sboner, Andrea; Searle, Stephen; Sisu, Cristina; Snow, Catherine; Steward, Charlie; Tanzer, Andrea; Tapanari, Electra; Tress, Michael L.; van Baren, Marijke J.; Walters, Nathalie; Washietl, Stefan; Wilming, Laurens; Zadissa, Amonida; Zhang, Zhengdong; Brent, Michael; Haussler, David; Kellis, Manolis; Valencia, Alfonso; Gerstein, Mark; Reymond, Alexandre; Guigo, Roderic; Harrow, Jennifer; Hubbard, Timothy J.; Landt, Stephen G.; Frietze, Seth; Abyzov, Alexej; Addleman, Nick; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bettinger, Keith; Bhardwaj, Nitin; Boyle, Alan P.; Cao, Alina R.; Cayting, Philip; Charos, Alexandra; Cheng, Yong; Cheng, Chao; Eastman, Catharine; Euskirchen, Ghia; Fleming, Joseph D.; Grubert, Fabian; Habegger, Lukas; Hariharan, Manoj; Harmanci, Arif; Iyengar, Sushma; Jin, Victor X.; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Lamarre-Vincent, Nathan; Leng, Jing; Lian, Jin; Lindahl-Allen, Marianne; Min, Renqiang; Miotto, Benoit; Monahan, Hannah; Moqtaderi, Zarmik; Mu, Xinmeng J.; O'Geen, Henriette; Ouyang, Zhengqing; Patacsil, Dorrelyn; Pei, Baikang; Raha, Debasish; Ramirez, Lucia; Reed, Brian; Rozowsky, Joel; Sboner, Andrea; Shi, Minyi; Sisu, Cristina; Slifer, Teri; Witt, Heather; Wu, Linfeng; Xu, Xiaoqin; Yan, Koon-Kiu; Yang, Xinqiong; Yip, Kevin Y.; Zhang, Zhengdong; Struhl, Kevin; Weissman, Sherman M.; Gerstein, Mark; Farnham, Peggy J.; Snyder, Michael; Tenenbaum, Scott A.; Penalva, Luiz O.; Doyle, Francis; Karmakar, Subhradip; Landt, Stephen G.; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Patacsil, Dorrelyn; Slifer, Teri; Victorsen, Alec; Yang, Xinqiong; Snyder, Michael; White, Kevin P.; Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen; Weng, Zhiping; Whitfield, Troy W.; Wang, Jie; Collins, Patrick J.; Aldred, Shelley F.; Trinklein, Nathan D.; Partridge, E. Christopher; Myers, Richard M.; Dekker, Job; Jain, Gaurav; Lajoie, Bryan R.; Sanyal, Amartya; Balasundaram, Gayathri; Bates, Daniel L.; Byron, Rachel; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Garg, Kavita; Gist, Erica; Hansen, R. Scott; Boatman, Lisa; Haugen, Eric; Humbert, Richard; Jain, Gaurav; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tattyana V.; Lajoie, Bryan R.; Lee, Kristen; Lotakis, Dimitra; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sabo, Peter; Sanchez, Minerva E.; Sandstrom, Richard S.; Sanyal, Amartya; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Thurman, Robert E.; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Yan, Yongqi; Zhang, Miaohua; Akey, Joshua M.; Bender, Michael; Dorschner, Michael O.; Groudine, Mark; MacCoss, Michael J.; Navas, Patrick; Stamatoyannopoulos, George; Kaul, Rajinder; Dekker, Job; Stamatoyannopoulos, John A.; Dunham, Ian; Beal, Kathryn; Brazma, Alvis; Flicek, Paul; Herrero, Javier; Johnson, Nathan; Keefe, Damian; Lukk, Margus; Luscombe, Nicholas M.; Sobral, Daniel; Vaquerizas, Juan M.; Wilder, Steven P.; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.; Kundaje, Anshul; Hardison, Ross C.; Miller, Webb; Giardine, Belinda; Harris, Robert S.; Wu, Weisheng; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Brown, James B.; Huang, Haiyan; Li, Qunhua; Li, Jingyi Jessica; Noble, William Stafford; Bilmes, Jeffrey A.; Buske, Orion J.; Hoffman, Michael M.; Sahu, Avinash D.; Kharchenko, Peter V.; Park, Peter J.; Baker, Dannon; Taylor, James; Weng, Zhiping; Iyer, Sowmya; Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Xi, Hualin S.; Zhuang, Jiali; Gerstein, Mark; Alexander, Roger P.; Balasubramanian, Suganthi; Cheng, Chao; Harmanci, Arif; Lochovsky, Lucas; Min, Renqiang; Mu, Xinmeng J.; Rozowsky, Joel; Yan, Koon-Kiu; Yip, Kevin Y.; Birney, Ewan		ENCODE Project Consortium	An integrated encyclopedia of DNA elements in the human genome	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMOSOME CONFORMATION CAPTURE; HUMAN-CELLS; IN-VIVO; CHROMATIN; REGIONS; MOUSE; MAPS; WIDE; DETERMINANTS	The human genome encodes the blueprint of life, but the function of the vast majority of its nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) project has systematically mapped regions of transcription, transcription factor association, chromatin structure and histone modification. These data enabled us to assign biochemical functions for 80% of the genome, in particular outside of the well-studied protein-coding regions. Many discovered candidate regulatory elements are physically associated with one another and with expressed genes, providing new insights into the mechanisms of gene regulation. The newly identified elements also show a statistical correspondence to sequence variants linked to human disease, and can thereby guide interpretation of this variation. Overall, the project provides new insights into the organization and regulation of our genes and genome, and is an expansive resource of functional annotations for biomedical research.	[Dunham, Ian; Birney, Ewan; Herrero, Javier; Wilder, Steven P.; Keefe, Damian; Brazma, Alvis; Flicek, Paul; Lukk, Margus; Sobral, Daniel] European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England; [Kundaje, Anshul; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Aldred, Shelley F.; Collins, Patrick J.; Trinklein, Nathan D.] SwitchGear Genom, Menlo Pk, CA 94025 USA; [Davis, CarrieA.; Schlesinger, Felix; Gingeras, Thomas R.; Davis, Carrie A.; Dobin, Alex; Lin, Wei; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Megan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Preall, Jonathan B.; Presaud, Kimberly; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory J.; Frankish, Adam; Ebersol, Abigail K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Doyle, Francis; Bernstein, Bradley E.; Tenenbaum, Scott A.] SUNY Albany, Albany, NY 12203 USA; [Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.; Mikkelsen, Tarjei S.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Truong, Thanh; Loveland, Jane] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Frietze, Seth; Farnham, Peggy J.; Witt, Heather] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Harrow, Jennifer; Hubbard, Timothy J.; Kokocinski, Felix; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Davidson, Claire; Despacio-Reyes, Gloria; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Hunt, Toby; Kay, Mike; Manthravadi, Deepa; Mudge, Jonathan; Mukherjee, Gaurab; Saunders, Gary; Searle, Stephen; Snow, Catherine; Steward, Charlie; Tapanari, Electra; Wilming, Laurens; Zadissa, Amonida] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Khatun, Jainab; Giddings, Morgan C.; Wrobel, John; Risk, Brian A.] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Lajoie, Bryan R.; Sanyal, Amartya; Dekker, Job; Jain, Gaurav] Univ Massachusetts, Sch Med, Program Syst Biol, Program Gene Funct & Express,Dept Biochem & Mol P, Worcester, MA 01605 USA; [Landt, Stephen G.; Snyder, Michael; Addleman, Nick; Bettinger, Keith; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Hariharan, Manoj; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Ebersol, Abigail K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lee, Bum-Kyu; Battenhouse, Anna; Bhinge, Akshay A.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Pauli, Florencia; Reddy, Timothy E.; Gunter, Chris; Myers, Richard M.; Gertz, Jason; Partridge, E. Christopher; Varley, Katherine E.; Bansal, Anita; Bowling, Kevin M.; Cross, Marie K.; Muratet, Michael A.; Newberry, Kimberly M.; Nesmith, Amy S.; Pusey, Barbara; Parker, Stephanie L.; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Rosenbloom, Kate R.; Kent, W. James; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Diekhans, Mark; Harte, Rachel] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Sabo, Peter; Hoffman, Michael M.; Thurman, Robert E.; Bates, Daniel L.; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Gist, Erica; Haugen, Eric; Humbert, Richard; Johnson, Audra K.; Kutyavin, Tattyana V.; Lee, Kristen; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sandstrom, Richard S.; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Akey, Joshua M.; MacCoss, Michael J.; Buske, Orion J.; Sahu, Avinash D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Safi, Alexias; Song, Lingyun; Crawford, Gregory E.; Sheffield, Nathan C.; London, Darin] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Simon, Jeremy M.; Lieb, Jason D.; Grasfeder, Linda L.; Giresi, Paul G.; Showers, Kimberly A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowska, Joanna O.; Kim, Min Jae] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Altshuler, Robert C.; Ernst, Jason; Kellis, Manolis; Kheradpour, Pouya; Ward, Lucas D.; Eaton, Matthew L.; Hendrix, David A.; Jungreis, Irwin; Lin, Michael F.; Washietl, Stefan] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Brown, James B.; Li, Qunhua; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Huang, Haiyan; Li, Jingyi Jessica] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cheng, Chao; Gerstein, Mark; Rozowsky, Joel; Yip, Kevin Y.; Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Pei, Baikang; Sisu, Cristina; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bhardwaj, Nitin; Harmanci, Arif; Min, Renqiang; Mu, Xinmeng J.; Yan, Koon-Kiu; Lochovsky, Lucas] Yale Univ, Computat Biol & Bioinformat Program, New Haven, CT 06520 USA; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; Kingswood, Colin; Skancke, Jorgen; Tilgner, Hagen; Bussotti, Giovanni; Mariotti, Marco; Notredame, Cedric] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Whitfield, Troy W.; Zhuang, Jiali; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Furey, Terrence S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Giardine, Belinda; Hardison, Ross C.; Harris, Robert S.; Wu, Weisheng; Miller, Webb] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Hardison, Ross C.; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Iyer, Sowmya] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Omics Sci Ctr, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaeffer, Lorain; Trout, Diane; Vielmetter, Jost; Amrhein, Henry; Mccue, Kenneth] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Margulies, Elliott H.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Xi, Hualin S.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Good, Peter J.; Feingold, Elise A.] NHGRI, NIH, Bethesda, MD 20892 USA; Duke Univ, Dept Pediat, Div Med Genet, Sch Med, Durham, NC 27710 USA; [Elnitski, Laura; Petrykowska, Hanna M.] NHGRI, NIH, Rockville, MD 20892 USA; [Gingeras, Thomas R.; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona 08002, Catalonia, Spain; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [White, Kevin P.; Karmakar, Subhradip; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Victorsen, Alec; Ebersol, Abigail K.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Wold, Barbara; Gasper, Clarke; Anaya, Michael; Fisher-Aylor, Katherine I.; DeSalvo, Gilberto; Balasubramanian, Sreeram] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Yu, Yanbao; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Alioto, Tyler; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bell, Ian; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Reymond, Alexandre] Affymetrix Inc, Genom, Santa Clara, CA 95051 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Ruan, Xiaoan; Sandhu, Kuljeet Singh; Shahab, Atif; Ruan, Yijun; Zheng, Meizhen; Wang, Ping] Genome Inst Singapore, Singapore 138672, Singapore; [Li, Guoliang; Reymond, Alexandre] Genome Inst Singapore, Singapore 138672, Singapore; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Sch Med, CH-1211 Geneva 4, Switzerland; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; [Mieczkowski, Piotr A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rashid, Naim U.; Winter, Deborah] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Pepke, Shirley] CALTECH, Ctr Adv Comp Res, Pasadena, CA 91125 USA; [Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Blow, Matthew J.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Visel, Axel; Pennachio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Ezkurdia, Iakes; Rodriguez, Jose Manuel; Tress, Michael L.; Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Lu, Zhi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sboner, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, Inst Computat Biomed, New York, NY 10065 USA; [van Baren, Marijke J.; Brent, Michael] Washington Univ, St Louis, MO 63130 USA; [Zhang, Zhengdong] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Cao, Alina R.; O'Geen, Henriette; Xu, Xiaoqin] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Fleming, Joseph D.; Lamarre-Vincent, Nathan; Lindahl-Allen, Marianne; Miotto, Benoit; Moqtaderi, Zarmik; Struhl, Kevin] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Iyengar, Sushma] Univ So Calif, Los Angeles, CA 90089 USA; [Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Penalva, Luiz O.] Childrens Canc Res Inst UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Balasundaram, Gayathri; Byron, Rachel; Zhang, Miaohua; Bender, Michael; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Ebersol, Abigail K.; Frum, Tristan; Hansen, R. Scott; Boatman, Lisa; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Navas, Patrick; Stamatoyannopoulos, George] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Garg, Kavita] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Beal, Kathryn; Johnson, Nathan] European Bioinformat Inst EMBL EBI, Microarray Informat Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian; Luscombe, Nicholas M.; Vaquerizas, Juan M.] European Bioinformat Inst EMBL EBI, Genom & Regulatory Syst Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian] Stanford Univ, Dept Genet, Dept Pathol, Stanford, CA 94305 USA; [Noble, William Stafford] Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Bilmes, Jeffrey A.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA	European Molecular Biology Laboratory (EMBL); Stanford University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Idaho; Boise State University; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of Texas System; University of Texas Austin; HudsonAlpha Institute for Biotechnology; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; Yale University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University; RIKEN; California Institute of Technology; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Affymetrix; University of Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Geneva; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; California Institute of Technology; Stanford University; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Tsinghua University; Cornell University; Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Davis; Yale University; Harvard University; Harvard Medical School; University of Southern California; University System of Ohio; Ohio State University; Yale University; University of Texas System; University of Texas Health San Antonio; Ruprecht Karls University Heidelberg; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Stanford University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Emory University; Emory University	Dunham, I (corresponding author), European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England.		Fullwood, Melissa/G-5713-2011; Hariharan, Manoj/N-2855-2015; Miotto, Benoit/CAF-2937-2022; Rodriguez, Jose josemrc/R-4018-2018; wang, baocheng/B-7805-2008; Vernot, Benjamin/ABH-1495-2021; Ezkurdia, Iakes/H-9334-2015; Herrero, Javier/H-6971-2019; Yu, Yanbao/G-3035-2010; Hardison, Ross C/G-1142-2010; Visel, Axel/A-9398-2009; Alexander, Roger/A-8643-2008; Antonarakis, Stylianos E/N-8866-2014; Li, Jingyi Jessica/K-2037-2012; Kundaje, Anshul/Y-2598-2019; Yip, Kevin/AAT-4771-2020; Sboner, Andrea/C-6487-2008; Abyzov, Alexej/AAT-4615-2020; Hoffman, Michael M./I-1924-2012; Gao, Hui/AAF-9770-2019; Boyle, Alan/I-1848-2014; Sobral, Daniel/K-3097-2019; Raney, Brian/ABE-6267-2020; Lagarde, Julien/AAI-1686-2020; Parker, Stephen/ABF-1063-2021; Lassmann, Timo/A-8271-2008; Sammeth, Michael/C-1157-2014; Luo, Oscar Junhong/G-3293-2018; Elnitski, Laura/AAD-3595-2021; Takahashi, Hazuki/F-9007-2017; Karmakar, Subhradip/AAP-6043-2020; Wittbrodt, Joachim/D-4735-2014; Yan, Koon-Kiu/A-5940-2009; Sobral, Daniel/B-4786-2014; SANYAL, AMARTYA/D-7240-2015; Abyzov, Alexej/M-4284-2013; Ganesh, Dunna Sai/AGX-5170-2022; Winter, Deborah R./AAQ-9253-2020; Kundaje, Anshul/Y-2739-2019; Adams, Leslie/AAZ-9323-2020; Taylor, James/F-1026-2011; Li, Guoliang/D-8014-2012; Hannon, Gregory/AAB-3568-2019; Brown, James/H-2971-2015; Rodriguez, Jose/AAS-4147-2021; Johnson, Rory/H-2961-2015; Blow, Matthew/G-6369-2012; Hubbard, Tim J/C-2567-2008; Ferreira, Pedro G/J-6379-2013; Sheffield, Nathan/ABG-8124-2020; zhang, zheng/HCH-9684-2022; Lin, Wei/AAH-9924-2019; Dong, Xianjun/N-3867-2014; Mariotti, Marco/AAB-7136-2019; Khurana, Ekta/C-4933-2013; Kellis, Manolis/ABE-7385-2020; Mikkelsen, Tarjei S/A-1306-2007; Heermann, Stephan/J-8586-2015; Brent, Michael/AAK-3702-2020; Ferreira, Pedro/HDO-1346-2022; Carninci, Piero/K-1568-2014; Johnson, Rory/ABE-2503-2021; Miotto, Benoit/I-6040-2018; Vaquerizas, Juan M/F-2676-2011; Mu, Xinmeng/P-2562-2016; Guigo, Roderic/D-1303-2010; Derrien, Thomas/ABD-6197-2020; Sisu, Cristina/K-8994-2019; Tenenbaum, Scott A/H-4744-2019; Karmakar, Subhradip/AAF-7678-2021; Vaquerizas, Juan M/AAY-2339-2020; Alioto, Tyler/AAF-6342-2020; Tanzer, Andrea/L-3147-2015; Djebali, Sarah/O-9817-2014; Lassmann, Timo/HCH-4313-2022; Alioto, Tyler/K-7267-2015; Tanzer, Andrea/AAY-5431-2021; Luo, Junhong/N-8583-2019; Hubbard, Tim J.P./AAT-4571-2020; Li, Jingyi Jessica/I-2779-2019; Gunter, Chris/AHA-7271-2022; cheng, yong/I-4270-2012; Valencia, Alfonso/I-3127-2015; notredame, cedric/G-3868-2010; Karczewski, Jakub/L-7326-2018; Bussotti, Giovanni/C-3082-2019	Fullwood, Melissa/0000-0003-0321-7865; Hariharan, Manoj/0000-0002-1006-5372; Miotto, Benoit/0000-0003-2857-2126; Rodriguez, Jose josemrc/0000-0002-9948-5073; wang, baocheng/0000-0002-8236-8014; Vernot, Benjamin/0000-0002-6820-2181; Ezkurdia, Iakes/0000-0001-9074-5302; Herrero, Javier/0000-0001-7313-717X; Yu, Yanbao/0000-0003-2994-1974; Hardison, Ross C/0000-0003-4084-7516; Visel, Axel/0000-0002-4130-7784; Alexander, Roger/0000-0002-2967-7395; Antonarakis, Stylianos E/0000-0001-8907-5823; Li, Jingyi Jessica/0000-0002-9288-5648; Kundaje, Anshul/0000-0003-3084-2287; Yip, Kevin/0000-0001-5516-9944; Sboner, Andrea/0000-0001-6915-3070; Hoffman, Michael M./0000-0002-4517-1562; Boyle, Alan/0000-0002-2081-1105; Sobral, Daniel/0000-0003-3955-0117; Lagarde, Julien/0000-0002-0290-7445; Lassmann, Timo/0000-0002-0138-2691; Sammeth, Michael/0000-0002-6528-9883; Takahashi, Hazuki/0000-0001-7315-7349; Karmakar, Subhradip/0000-0002-4757-8729; Wittbrodt, Joachim/0000-0001-8550-7377; Sobral, Daniel/0000-0003-3955-0117; SANYAL, AMARTYA/0000-0002-2109-4478; Winter, Deborah R./0000-0003-1806-673X; Kundaje, Anshul/0000-0003-3084-2287; Adams, Leslie/0000-0003-4956-271X; Taylor, James/0000-0001-5079-840X; Li, Guoliang/0000-0003-1601-6640; Rodriguez, Jose/0000-0002-9948-5073; Johnson, Rory/0000-0003-4607-2782; Blow, Matthew/0000-0002-8844-9149; Hubbard, Tim J/0000-0002-1767-9318; Ferreira, Pedro G/0000-0003-3838-8664; Sheffield, Nathan/0000-0001-5643-4068; Lin, Wei/0000-0002-7506-3466; Dong, Xianjun/0000-0002-8052-9320; Mariotti, Marco/0000-0002-7411-4161; Kellis, Manolis/0000-0001-7113-9630; Mikkelsen, Tarjei S/0000-0002-8133-3135; Brent, Michael/0000-0002-8689-0299; Carninci, Piero/0000-0001-7202-7243; Johnson, Rory/0000-0003-4607-2782; Miotto, Benoit/0000-0003-2857-2126; Vaquerizas, Juan M/0000-0002-6583-6541; Mu, Xinmeng/0000-0002-8079-0828; Guigo, Roderic/0000-0002-5738-4477; Sisu, Cristina/0000-0001-9371-0797; Vaquerizas, Juan M/0000-0002-6583-6541; Alioto, Tyler/0000-0002-2960-5420; Tanzer, Andrea/0000-0003-2873-4236; Djebali, Sarah/0000-0002-0599-1267; Lassmann, Timo/0000-0002-0138-2691; Alioto, Tyler/0000-0002-2960-5420; Tanzer, Andrea/0000-0003-2873-4236; Hubbard, Tim J.P./0000-0002-1767-9318; Li, Jingyi Jessica/0000-0002-9288-5648; Valencia, Alfonso/0000-0002-8937-6789; Moran, Jennifer/0000-0002-5664-4716; Bignell, alexandra/0000-0002-5926-7020; Whitfield, Troy/0000-0002-2026-4201; Snyder, Michael/0000-0003-0784-7987; Centanin, Lazaro/0000-0003-3889-4524; Batut, Philippe/0000-0003-4250-0663; Gingeras, Thomas/0000-0001-9106-3573; Pazin, Michael/0000-0002-7561-3640; Gonzalez, Jose M/0000-0001-5569-0705; Flicek, Paul/0000-0002-3897-7955; Despacio-Reyes, Gloria/0000-0001-5906-8999; Levy, Shawn/0000-0002-1369-5740; Epstein, Charles B./0000-0001-8358-8345; Haugen, Eric/0000-0001-7444-8981; Wilder, Steven/0000-0001-8049-2559; Johnson, Nathan/0000-0002-2783-9047; Dobin, Alexander/0000-0002-4115-9128; Gertz, Jason/0000-0001-7568-6789; Elnitski, Laura/0000-0003-1065-019X; Steward, Charles/0000-0001-8829-5349; Harrow, Jennifer/0000-0003-0338-3070; notredame, cedric/0000-0003-1461-0988; Saunders, Gary/0000-0002-7468-0008; Dreszer, Timothy/0000-0002-7328-1283; Anaya, Michael/0000-0002-6944-3614; Loveland, Jane/0000-0002-7669-2934; Bell, Kimberly/0000-0003-2204-8569; Wilming, Laurens/0000-0002-4154-7358; Victorsen, Alec/0000-0003-2326-0916; Lukk, Margus/0000-0002-0701-5358; Fisher-Aylor, Katherine/0000-0003-3371-2947; Zadissa, Amonida/0000-0001-5310-8830; Karczewski, Jakub/0000-0001-9322-7842; Kirchmaier, Stephan/0000-0002-3870-8624; Foss, Kimberly/0000-0003-3996-7895; Vierstra, Jeff/0000-0001-6406-8563; Akey, Joshua/0000-0002-4411-1330; Mudge, Jonathan/0000-0003-4789-7495; Gilbert, James/0000-0001-8079-3159; Penalva, Luiz/0000-0003-4491-6769; Aken, Bronwen/0000-0002-3032-4095; Kokocinski, Felix/0000-0002-8472-9207; Bussotti, Giovanni/0000-0002-4078-7413; FRUM, Tristan/0000-0003-3452-8762; Brazma, Alvis/0000-0001-5988-7409; Dunham, Ian/0000-0003-2525-5598; Varley, Katherine/0000-0003-1622-5290; zheng, meizhen/0000-0001-5569-1812; Pauli Behn, Florencia/0000-0002-8984-4044; Gunter, Chris/0000-0001-9369-7537; Meyer, Laurence/0000-0003-1430-7225; Snow, Catherine/0000-0002-1672-3532; Balasubramanian, Suganthi/0000-0003-2243-5948; Ward, Lucas/0000-0002-8017-809X; Altshuler, Robert/0000-0001-5096-1932; Sandstrom, Richard/0000-0002-3356-1547; Gillespie, Shawn/0000-0003-1913-0860; Foissac, Sylvain/0000-0002-2631-5356; Lee, Bum Kyu/0000-0001-7835-419X; Merkel, Angelika/0000-0001-5164-6803; Birney, Ewan/0000-0001-8314-8497; Banfai, Balazs/0000-0003-0422-7977; Luo, Oscar Junhong/0000-0002-1266-3069; Sandhu, Kuljeet/0000-0001-7632-6339; Marinov, Georgi/0000-0003-1822-7273; Collins, Patrick/0000-0002-7141-7503; Abyzov, Alexej/0000-0001-5405-6729; Hunt, Toby/0000-0001-8377-0841; Berry, Andrew/0000-0001-5096-7701; Kay, Mike/0000-0002-3282-0834; Farnham, Peggy/0000-0003-4469-7914; Reymond, Alexandre/0000-0003-1030-8327; Barrell, Daniel/0000-0002-0977-0963; Tress, Michael/0000-0001-9046-6370; Auer, Thomas Oliver/0000-0003-3442-0567; Kapranov, Philipp/0000-0003-2647-4856; Rozowsky, Joel/0000-0002-3565-0762; Mieczkowska, Joanna/0000-0002-6482-336X; Furey, Terry/0000-0001-5546-9672; Karczewski, Konrad/0000-0003-2878-4671; park, eddie/0000-0001-5651-1481; Park, Peter/0000-0001-9378-960X; Mieczkowski, Piotr/0000-0003-2418-0096; Curado, Joao/0000-0003-3916-0936; Derrien, Thomas/0000-0002-8211-5789; Sahu, Avinash/0000-0002-2193-6276; Nguyen, Eric/0000-0002-0516-2434; Kaul, Rajinder/0000-0002-7895-9284; Tapanari, Electra/0000-0002-9329-0996; Davidson, Claire/0000-0002-4910-8202; Frankish, Adam/0000-0002-4333-628X; Bhinge, Akshay/0000-0003-2939-099X; Buske, Orion/0000-0002-9064-092X	NHGRI [U54HG004570, U01HG004695, U54HG004563, U54HG004557, U54HG004555, U41HG004568, U54HG004576, U54HG004558, U54HG004592]; American Recovery and Reinvestment Act (ARRA) funds from the NHGRI [U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, U01HG004561, RC2HG005679, R01HG003541, R01HG003988]; Intramural Research Program of the NHGRI [ZIAHG200323, ZIAHG200341]; United States Department of Energy Joint Genome Institute, Department of Energy, University of California [DE-AC02-05CH11231];  [R01HG003700];  [R01HG004456-03];  [U01HG004571]; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323, U41HG004568, U01HG004561, U54HG004555, R01HG004456, RC2HG005679, RC2HG005573, U54HG004570, R01HG003541, U54HG004563, U01HG004571, RC2HG005591, U54HG004558, R01HG003988, R01HG003143, U01HG004695, U54HG004576, R01HG005085, U54HG004592, K99HG006698, U54HG004557, R01HG003700, ZIAHG200341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, R01DK054369, R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Recovery and Reinvestment Act (ARRA) funds from the NHGRI; Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); United States Department of Energy Joint Genome Institute, Department of Energy, University of California; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank additional members of our laboratories and institutions who have contributed to the experimental and analytical components of this project. We thank D. Leja for assistance with production of the figures. The Consortium is funded by grants from the NHGRI as follows: production grants: U54HG004570 (B. E. Bernstein); U01HG004695 (E. Birney); U54HG004563 (G. E. Crawford); U54HG004557 (T. R. Gingeras); U54HG004555 (T. J. Hubbard); U41HG004568 (W. J. Kent); U54HG004576 (R. M. Myers); U54HG004558 (M. Snyder); U54HG004592 (J. A. Stamatoyannopoulos). Pilot grants: R01HG003143 (J. Dekker); RC2HG005591 and R01HG003700 (M. C. Giddings); R01HG004456-03 (Y. Ruan); U01HG004571 (S. A. Tenenbaum); U01HG004561 (Z. Weng); RC2HG005679 (K. P. White). This project was supported in part by American Recovery and Reinvestment Act (ARRA) funds from the NHGRI through grants U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, R01HG003541, U01HG004561, RC2HG005679 and R01HG003988(L. Pennacchio). In addition, work from NHGRI Groups was supported by the Intramural Research Program of the NHGRI (L. Elnitski, ZIAHG200323; E. H. Margulies, ZIAHG200341). Research in the Pennachio laboratory was performed at Lawrence Berkeley National Laboratory and at the United States Department of Energy Joint Genome Institute, Department of Energy Contract DE-AC02-05CH11231, University of California.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle A. P., 2012, GENOME RES; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cheng C., 2012, GENOME RES; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Derrien T, 2012, GENOME RES; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harrow J, 2012, GENOME RES; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Howald C., 2012, GENOME RES; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundaje A., 2012, GENOME RES; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Landt S. G., 2012, GENOME RES; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Sandelin A, 2007, NAT REV GENET, V8, P424, DOI 10.1038/nrg2026; Schaub M. A., 2012, GENOME RES; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Tilgner H., 2012, GENOME RES; Urnov FD, 2003, J CELL BIOCHEM, V88, P684, DOI 10.1002/jcb.10397; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vernot B., 2012, GENOME RES; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P7024, DOI 10.1093/nar/gkp747; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	75	10089	10323	65	1633	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					57	74		10.1038/nature11247	http://dx.doi.org/10.1038/nature11247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955616	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-01	WOS:000308347000039
J	Neph, S; Vierstra, J; Stergachis, AB; Reynolds, AP; Haugen, E; Vernot, B; Thurman, RE; John, S; Sandstrom, R; Johnson, AK; Maurano, MT; Humbert, R; Rynes, E; Wang, H; Vong, S; Lee, K; Bates, D; Diegel, M; Roach, V; Dunn, D; Neri, J; Schafer, A; Hansen, RS; Kutyavin, T; Giste, E; Weaver, M; Canfield, T; Sabo, P; Zhang, MH; Balasundaram, G; Byron, R; MacCoss, MJ; Akey, JM; Bender, MA; Groudine, M; Kaul, R; Stamatoyannopoulos, JA				Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; MacCoss, Michael J.; Akey, Joshua M.; Bender, M. A.; Groudine, Mark; Kaul, Rajinder; Stamatoyannopoulos, John A.			An expansive human regulatory lexicon encoded in transcription factor footprints	NATURE			English	Article							IN-VIVO; DNA; PROTEIN; GENE; EXPRESSION; CHROMATIN; DIFFERENTIATION; ERYTHROPOIESIS; INDUCTION; REQUIRES	Regulatory factor binding to genomic DNA protects the underlying sequence from cleavage by DNase I, leaving nucleotide-resolution 'footprints'. Using genomic DNase I footprinting across 41 diverse cell and tissue types, we detected 45 million transcription factor occupancy events within regulatory regions, representing differential binding to 8.4 million distinct short sequence elements. Here we show that this small genomic sequence compartment, roughly twice the size of the exome, encodes an expansive repertoire of conserved recognition sequences for DNA-binding proteins that nearly doubles the size of the human cis-regulatory lexicon. We find that genetic variants affecting allelic chromatin states are concentrated in footprints, and that these elements are preferentially sheltered from DNA methylation. High-resolution DNase I cleavage patterns mirror nucleotide-level evolutionary conservation and track the crystallographic topography of protein-DNA interfaces, indicating that transcription factor structure has been evolutionarily imprinted on the human genome sequence. We identify a stereotyped 50-base-pair footprint that precisely defines the site of transcript origination within thousands of human promoters. Finally, we describe a large collection of novel regulatory factor recognition motifs that are highly conserved in both sequence and function, and exhibit cell-selective occupancy patterns that closely parallel major regulators of development, differentiation and pluripotency.	[Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; MacCoss, Michael J.; Akey, Joshua M.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; Bender, M. A.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Groudine, Mark] Univ Washington, Dept Med, Dept Radiat Oncol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Sandstrom, Richard/0000-0002-3356-1547; Vierstra, Jeff/0000-0001-6406-8563; Kaul, Rajinder/0000-0002-7895-9284; Akey, Joshua/0000-0002-4411-1330; Haugen, Eric/0000-0001-7444-8981	National Institutes of Health (NIH) [HG004592, RC2HG005654]; National Science Foundation [DGE-071824]; University of Washington Proteomics Resource [UWPR95794]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, RC2HG005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, F30DK095678] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Washington Proteomics Resource(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants HG004592 (J.A.S.) and RC2HG005654 (J.A.S. and M. G.). J.V. is supported by a National Science Foundation Graduate Research Fellowship under grant no. DGE-071824. Additional support was provided in part by the University of Washington Proteomics Resource (UWPR95794). We thank F. Urnov for critical reading of the manuscript and many discussions, and S. Thomas for insights.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Treisman R., 1985, DNA CELL BIOL, V315, P73; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	42	527	546	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					83	90		10.1038/nature11212	http://dx.doi.org/10.1038/nature11212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955618	hybrid, Green Accepted			2022-12-01	WOS:000308347000041
J	Gornall, J				Gornall, Jonathan			Proton beam therapy: more than a leap of faith?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; NEUTRON TREATMENT; ADVANCED TUMORS; GAMMA-RAYS; NECK; HEAD; CANCER; RADIOTHERAPY; RADIATION					jgornall@mac.com						Agency for Healthcare Research and Quality, 2012, PROT BEAM RAD US MED; [Anonymous], 2012, BMJ; CATTERALL M, 1975, BMJ-BRIT MED J, V2, P653, DOI 10.1136/bmj.2.5972.653; CATTERALL M, 1977, BRIT MED J, V1, P1642, DOI 10.1136/bmj.1.6077.1642; Chung CS, 2008, INT J RADIAT ONCOL, V72, pS8, DOI 10.1016/j.ijrobp.2008.06.785; De Ruysscher D, 2012, RADIOTHER ONCOL, V103, P5, DOI 10.1016/j.radonc.2012.01.003; Department of Health, 2007, CANC REF STRAT; Emanuel E, 2012, NY TIMES        1121; Epstein K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2488; ERRINGTON RD, 1991, BRIT MED J, V302, P1045, DOI 10.1136/bmj.302.6784.1045; Goitein M, 2008, J CLIN ONCOL, V26, P175, DOI 10.1200/JCO.2007.14.4329; Kunkler IH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3193; Lundkvist J, 2005, CANCER-AM CANCER SOC, V103, P793, DOI 10.1002/cncr.20844; MACDOUGALL RH, 1990, BRIT MED J, V301, P1241, DOI 10.1136/bmj.301.6763.1241; MAOR MH, 1995, INT J RADIAT ONCOL, V32, P599, DOI 10.1016/0360-3016(94)00595-C; Miralbell R, 2002, INT J RADIAT ONCOL, V54, P824, DOI 10.1016/S0360-3016(02)02982-6; National Radiotherapy Advisory Group, 2007, RAD DEV WORLD CLASS; National Radiotherapy Advisory Group, 2006, PROT TREATM CANC; National Specialised Commissioning Team, 2011, GUID REF PAT ABR NHS; WILSON RR, 1946, RADIOLOGY, V47, P487, DOI 10.1148/47.5.487	20	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 5	2012	345								e4917	10.1136/bmj.e4917	http://dx.doi.org/10.1136/bmj.e4917			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TK	22951923				2022-12-01	WOS:000308634000001
J	Vafabakhsh, R; Ha, T				Vafabakhsh, Reza; Ha, Taekjip			Extreme Bendability of DNA Less than 100 Base Pairs Long Revealed by Single-Molecule Cyclization	SCIENCE			English	Article							DOUBLE HELIX; DYNAMICS SIMULATIONS; IN-VIVO; FLEXIBILITY; ELASTICITY; FRAGMENTS; CLOSURE; LOOPS	The classical view of DNA posits that DNA must be stiff below the persistence length [<150 base pairs (bp)], but recent studies addressing this have yielded contradictory results. We developed a fluorescence-based, protein-free assay for studying the cyclization of single DNA molecules in real time. The assay samples the equilibrium population of a sharply bent, transient species that is entirely suppressed in single-molecule mechanical measurements and is biologically more relevant than the annealed species sampled in the traditional ligase-based assay. The looping rate has a weak length dependence between 67 and 106 bp that cannot be described by the worm-like chain model. Many biologically important protein-DNA interactions that involve looping and bending of DNA below 100 bp likely use this intrinsic bendability of DNA.	[Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	U.S. National Science Foundation [0646550, 0822613]; U.S. National Institutes of Health [GM065367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Phillips, H. Garcia, K. Rangunathan, R. Zhou, S. Doganay, A. Jain, K. Lee, G. Lee, and S. Arslan for helpful discussions. We are grateful to the late J. Widom for generous comments on an earlier version of this paper. This work was supported by U.S. National Science Foundation grants 0646550 and 0822613 and U.S. National Institutes of Health grant GM065367 to T. H. T. H. is an employee of the Howard Hughes Medical Institute.	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NB, 2009, SCIENCE, V325, DOI 10.1126/science.1168786; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Curuksu J, 2009, NUCLEIC ACIDS RES, V37, P3766, DOI 10.1093/nar/gkp234; Douarche N, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061902; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Lankas F, 2006, STRUCTURE, V14, P1527, DOI 10.1016/j.str.2006.08.004; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Mastroianni AJ, 2009, BIOPHYS J, V97, P1408, DOI 10.1016/j.bpj.2009.06.031; Mathew-Fenn RS, 2009, SCIENCE, V325, P538, DOI 10.1126/science.1168876; Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yuan CL, 2007, NUCLEIC ACIDS RES, V35, P5294, DOI 10.1093/nar/gkm582	34	224	225	0	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1097	1101		10.1126/science.1224139	http://dx.doi.org/10.1126/science.1224139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936778	Green Accepted			2022-12-01	WOS:000308125800048
J	Alexander, RT; Hemmelgarn, BR; Wiebe, N; Bello, A; Morgan, C; Samuel, S; Klarenbach, SW; Curhan, GC; Tonelli, M				Alexander, R. Todd; Hemmelgarn, Brenda R.; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Samuel, Susan; Klarenbach, Scott W.; Curhan, Gary C.; Tonelli, Marcello		Alberta Kidney Dis Network	Kidney stones and kidney function loss: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENETIC-HETEROGENEITY; UNITED-STATES; DISEASE; PREVALENCE; RISK; RECURRENCE	Objective To investigate whether the presence of kidney stones increase the risk of end stage renal disease (ESRD) or other adverse renal outcomes. Design A registry cohort study using validated algorithms based on claims and facility utilisation data. Median follow-up of 11 years. Setting Alberta, Canada, between 1997 and 2009. Participants 3 089 194 adult patients without ESRD at baseline or a history of pyelonephritis. Of these, 1 954 836 had outpatient serum creatinine measurements and were included in analyses of chronic kidney disease and doubling of serum creatinine level. Exposure One or more kidney stones during follow-up. Main outcome measures Incident ESRD, development of stage 3b-5 chronic kidney disease (estimated glomerular filtration rate <45 mL/min/1.73 m(2)), and sustained doubling of serum creatinine concentration from baseline. Results 23 706 (0.8%) patients had at least one kidney stone, 5333 (0.2%) developed ESRD, 68 525 (4%) developed stage 3b-5 chronic kidney disease, and 6581 (0.3%) experienced sustained doubling of serum creatinine. Overall, one or more stone episodes during follow-up was associated with increased risk of ESRD (adjusted hazard ratio 2.16 (95% CI 1.79 to 2.62)), new stage 3b-5 chronic kidney disease (hazard ratio 1.74 (1.61 to 1.88)), and doubling of serum creatinine (hazard ratio 1.94 (1.56 to 2.43)), all compared with those without kidney stones during follow-up. The excess risk of adverse outcomes associated with at least one episode of stones seemed greater in women than in men, and in people aged <50 years than in those aged >= 50. However, the risks of all three adverse outcomes in those with at least one episode of stones were significantly higher than in those without stones in both sexes and age strata. The absolute increase in the rate of adverse renal outcomes associated with stones was small: the unadjusted rate of ESRD was 2.48 per million person days in people with one or more episodes of stones versus 0.52 per million person days in people without stones. Conclusion Even a single kidney stone episode during follow-up was associated with a significant increase in the likelihood of adverse renal outcomes including ESRD. However, the increases were small in absolute terms.	[Alexander, R. Todd; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Edmonton, AB T6B 2G3, Canada; [Hemmelgarn, Brenda R.; Samuel, Susan] Univ Calgary, Calgary, AB, Canada; [Curhan, Gary C.] Harvard Univ, Channing Lab, Boston, MA 02115 USA	University of Alberta; University of Calgary; Harvard University	Tonelli, M (corresponding author), Univ Alberta, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Wiebe, Natasha/V-7803-2019; Klarenbach, Scott/E-7731-2013; Alexander, R. Todd/G-1373-2012; Hemmelgarn, Brenda R./I-6894-2012; Tonelli, Marcello/B-3028-2009; Bello, Aminu K/D-2213-2013	Wiebe, Natasha/0000-0002-5613-1582; Klarenbach, Scott/0000-0002-8611-1056; Tonelli, Marcello/0000-0002-0846-3187; Bello, Aminu K/0000-0002-6905-5937	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research; KRESCENT New Investigator award; Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health [DK070756]; AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); KRESCENT New Investigator award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a team grant to the Interdisciplinary Chronic Disease Collaboration from the Alberta Heritage Foundation for Medical Research (AHFMR), the Kidney Foundation of Canada, and by the University Hospital Foundation. RTA is supported by a Clinician-Scientist award from the Canadian Institute of Health Research, a KRESCENT New Investigator award, and an Alberta Innovates Health Solutions Clinical Investigator Award. SS is supported by a KRESCENT New Investigator award and a Canadian Child Health Clinician Scientist Program Career Development award. GCC is supported by grant DK070756 from the National Institutes of Health. MT is supported by an AHFMR Population Health Scholar award and a Government of Canada Research Chair in the optimal care of people with chronic kidney disease.	Assimos DG, 2002, J UROLOGY, V168, P27, DOI 10.1016/S0022-5347(05)64824-0; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; Collins AJ, 2010, AM J KIDNEY DIS, V55, pVI, DOI 10.1053/j.ajkd.2009.10.009; Edvardsson V, 2001, AM J KIDNEY DIS, V38, P473, DOI 10.1053/ajkd.2001.26826; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lieske JC, 2005, AM J NEPHROL, V25, P290, DOI 10.1159/000086360; Ludwig M, 2006, NEPHROL DIAL TRANSPL, V21, P2708, DOI 10.1093/ndt/gfl346; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stankus N, 2007, UROL RES, V35, P83, DOI 10.1007/s00240-007-0079-3; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Tosetto E, 2006, NEPHROL DIAL TRANSPL, V21, P2452, DOI 10.1093/ndt/gfl274; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; United States Renal Data System II, 1997, AM J KIDNEY DIS, V30, pS40	24	171	176	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5287	10.1136/bmj.e5287	http://dx.doi.org/10.1136/bmj.e5287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936784	Green Published, hybrid			2022-12-01	WOS:000311050800001
J	Clayton, J				Clayton, Julie			CLINICAL APPROVAL Trials of an anticancer jab	NATURE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; VACCINATION PROGRAM; EFFICACY											Australia Dept. Health and Aging, 2011, NAT HPV VACC DAT GIR; Brotherton J. M. L., LANCET INFE IN PRESS; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Department of Health, ANN HPV VACC COV ENG; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Shearer B., 2011, HPV VACCINATION UNDE; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Widgren K, 2011, VACCINE, V29, P9663, DOI 10.1016/j.vaccine.2011.10.021	15	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S4	S6		10.1038/488S4a	http://dx.doi.org/10.1038/488S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932438				2022-12-01	WOS:000308095100005
J	McCartney, M				McCartney, Margaret			The V word: selling genital hygiene products to women	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				ADAMS R, 2010, GUARDIAN; Advertising Standards Bureau, 2012, ADV STAND BOARD DET; Brown L, 2012, CNN             0621; NHS Choices, VAG HLTH; YouTube, 2012, CAR ACT AD 2012 AU	5	1	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 24	2012	345								e5732	10.1136/bmj.e5732	http://dx.doi.org/10.1136/bmj.e5732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923540				2022-12-01	WOS:000308074500004
J	Moon, TS; Lou, CB; Tamsir, A; Stanton, BC; Voigt, CA				Moon, Tae Seok; Lou, Chunbo; Tamsir, Alvin; Stanton, Brynne C.; Voigt, Christopher A.			Genetic programs constructed from layered logic gates in single cells	NATURE			English	Article							III SECRETION SYSTEM; SYNTHETIC BIOLOGY; ACTIVATION	Genetic programs function to integrate environmental sensors, implement signal processing algorithms and control expression dynamics(1). These programs consist of integrated genetic circuits that individually implement operations ranging from digital logic to dynamic circuits(2-6), and they have been used in various cellular engineering applications, including the implementation of process control in metabolic networks and the coordination of spatial differentiation in artificial tissues. A key limitation is that the circuits are based on biochemical interactions occurring in the confined volume of the cell, so the size of programs has been limited to a few circuits(1,7). Here we apply part mining and directed evolution to build a set of transcriptional AND gates in Escherichia coli. Each AND gate integrates two promoter inputs and controls one promoter output. This allows the gates to be layered by having the output promoter of an upstream circuit serve as the input promoter for a downstream circuit. Each gate consists of a transcription factor that requires a second chaperone protein to activate the output promoter. Multiple activator-chaperone pairs are identified from type III secretion pathways in different strains of bacteria. Directed evolution is applied to increase the dynamic range and orthogonality of the circuits. These gates are connected in different permutations to form programs, the largest of which is a 4-input AND gate that consists of 3 circuits that integrate 4 inducible systems, thus requiring 11 regulatory proteins. Measuring the performance of individual gates is sufficient to capture the behaviour of the complete program. Errors in the output due to delays (faults), a common problem for layered circuits, are not observed. This work demonstrates the successful layering of orthogonal logic gates, a design strategy that could enable the construction of large, integrated circuits in single cells.	[Moon, Tae Seok; Lou, Chunbo; Stanton, Brynne C.; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Tamsir, Alvin] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com		hong, xizhi/0000-0001-6029-6761; Moon, Tae Seok/0000-0001-8373-9051; Lou, Chunbo/0000-0002-7941-6038	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA) [CLIO N66001-12-C-4018]; Office of Naval Research [N00014-10-1-0245]; National Science Foundation (NSF) [CCF-0943385]; National Institutes of Health [AI067699]; NSF Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067699, R01AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA; CLIO N66001-12-C-4018), the Office of Naval Research (N00014-10-1-0245), the National Science Foundation (NSF; CCF-0943385), the National Institutes of Health (AI067699) and the NSF Synthetic Biology Engineering Research Center (SynBERC; SA5284-11210). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Katz R. H., 1994, CONT LOGIC DESIGN; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516	28	361	378	2	295	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					249	253		10.1038/nature11516	http://dx.doi.org/10.1038/nature11516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23041931	Green Submitted, Green Accepted			2022-12-01	WOS:000310774300043
J	Bernards, R				Bernards, Rene			A Missing Link in Genotype-Directed Cancer Therapy	CELL			English	Editorial Material							INHIBITION; VEMURAFENIB; EGFR	Genotype-directed therapy holds great promise for the treatment of cancer, but crosstalk between signaling pathways often confounds simple genotype-drug response relationships. To deliver on the promise of precision medicine, a coordinated effort is needed to make a comprehensive inventory of the many signaling feedback circuits that exist in cancer cells.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	9	76	79	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					465	468		10.1016/j.cell.2012.10.014	http://dx.doi.org/10.1016/j.cell.2012.10.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101617	Bronze			2022-12-01	WOS:000310529300002
J	Tussiwand, R; Lee, WL; Murphy, TL; Mashayekhi, M; Wumesh, KC; Albring, JC; Satpathy, AT; Rotondo, JA; Edelson, BT; Kretzer, NM; Wu, XD; Weiss, LA; Glasmacher, E; Li, P; Liao, W; Behnke, M; Lam, SSK; Aurthur, CT; Leonard, WJ; Singh, H; Stallings, CL; Sibley, LD; Schreiber, RD; Murphy, KM				Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Weiss, Leslie A.; Glasmacher, Elke; Li, Peng; Liao, Wei; Behnke, Michael; Lam, Samuel S. K.; Aurthur, Cora T.; Leonard, Warren J.; Singh, Harinder; Stallings, Christina L.; Sibley, L. David; Schreiber, Robert D.; Murphy, Kenneth M.			Compensatory dendritic cell development mediated by BATF-IRF interactions	NATURE			English	Article							NEGATIVE REGULATOR; B-ATF; CD8-ALPHA(+); TRANSCRIPTION; EXPRESSION; INFECTION; AP-1; REVEALS; MICE; ACTIVATION	The AP1 transcription factor Batf3 is required for homeostatic development of CD8 alpha(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for CD8 alpha(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-gamma. This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection. Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4. Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation. Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.	[Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Lam, Samuel S. K.; Aurthur, Cora T.; Schreiber, Robert D.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Weiss, Leslie A.; Behnke, Michael; Stallings, Christina L.; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Glasmacher, Elke; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Schreiber, Robert/Q-7550-2019; Glasmacher, Elke/B-8939-2015; Behnke, Michael S/R-8839-2016; Leonard, Warren/AAA-1397-2022; Schreiber, Robert D/A-1276-2013	Glasmacher, Elke/0000-0003-1265-2543; Behnke, Michael S/0000-0002-4668-8109; Schreiber, Robert D/0000-0001-6311-0432; Satpathy, Ansuman/0000-0002-5167-537X; Edelson, Brian/0000-0003-2856-7650; Tussiwand, Roxane/0000-0002-1712-868X; Mashayekhi, Mona/0000-0003-0331-2395; Albring, Jorn/0000-0002-5534-7250; Schreiber, Robert/0000-0003-1590-2341; Lam, Siu Kit/0000-0003-1671-3999	Howard Hughes Medical Institute; National Institutes of Health [AI076427-02]; Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005]; German Research Foundation [AL 1038/1-1]; American Society of Hematology; Cancer Research Institute; NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [R01CA043059, P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, R01AI036629, R01AI076427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); American Society of Hematology; Cancer Research Institute; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (AI076427-02) and Department of Defense (W81XWH-09-1-0185) (K.M.M.), the American Heart Association (12PRE8610005) (A.T.S.), German Research Foundation (AL 1038/1-1) (J.C.A), American Society of Hematology Scholar Award and Burroughs Welcome Fund Career Award for Medical Scientists (B.T.E.), and Cancer Research Institute predoctoral fellowship (W.-L.L.). We thank the ImmGen consortium<SUP>34</SUP>, M. White for blastocyst injections and generation of mouse chimaeras, the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. The Siteman Cancer Center is supported in part by the NCI Cancer Center Support Grant P30 CA91842. IL-12 was a gift from Pfizer.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E., SCIENCE IN PRESS; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kanbe E, 2004, BLOOD CELL MOL DIS, V33, P64, DOI 10.1016/j.bcmd.2004.04.001; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li P., 2012, NATURE; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Modlin RL, 1995, RES IMMUNOL, V146, P526, DOI 10.1016/0923-2494(96)83027-6; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; SZABO SJ, 1993, MOL CELL BIOL, V13, P5928; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300	46	280	288	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					502	+		10.1038/nature11531	http://dx.doi.org/10.1038/nature11531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992524	Green Accepted			2022-12-01	WOS:000310196200034
J	Frieda, KL; Block, SM				Frieda, Kirsten L.; Block, Steven M.			Direct Observation of Cotranscriptional Folding in an Adenine Riboswitch	SCIENCE			English	Article							RNA-POLYMERASE; NASCENT RNA; TRANSCRIPTION; ELONGATION; KINETICS; BINDING; RIBOZYME	Growing RNA chains fold cotranscriptionally as they are synthesized by RNA polymerase. Riboswitches, which regulate gene expression by adopting alternative RNA folds, are sensitive to cotranscriptional events. We developed an optical-trapping assay to follow the cotranscriptional folding of a nascent RNA and used it to monitor individual transcripts of the pbuE adenine riboswitch, visualizing distinct folding transitions. We report a particular folding signature for the riboswitch aptamer whose presence directs the gene-regulatory transcription outcome, and we measured the termination frequency as a function of adenine level and tension applied to the RNA. Our results demonstrate that the outcome is kinetically controlled. These experiments furnish a means to observe conformational switching in real time and enable the precise mapping of events during cotranscriptional folding.	[Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu			National Institute of General Medical Services, NIH; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057035] Funding Source: NIH RePORTER	National Institute of General Medical Services, NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Landick for providing purified RNAP and C. Garcia-Garcia, V. Schweikhard, W. Greenleaf, P. Anthony, and other members of the Block lab for useful discussions. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by a grant from the National Institute of General Medical Services, NIH (S. M. B.), and an NSF Graduate Research Fellowship and Stanford Graduate Fellowship (K.L.F.).	Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pan T, 1999, J MOL BIOL, V286, P721, DOI 10.1006/jmbi.1998.2516; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Xayaphoummine A, 2007, NUCLEIC ACIDS RES, V35, P614, DOI 10.1093/nar/gkl1036	26	126	129	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					397	400		10.1126/science.1225722	http://dx.doi.org/10.1126/science.1225722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087247	Green Accepted			2022-12-01	WOS:000309955800045
J	Keller, R				Keller, Ray			Physical Biology Returns to Morphogenesis	SCIENCE			English	Editorial Material							GASTRULATION; MECHANICS; SHAPE; ADHESION; CELLS		Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Keller, R (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	rek3k@virginia.edu						Bellairs R., 1982, CELL BEHAV; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; GUSTAFSON T, 1963, INT REV CYTOL, V15, P139, DOI 10.1016/S0074-7696(08)61117-1; HARDIN JD, 1986, DEV BIOL, V115, P490, DOI 10.1016/0012-1606(86)90269-1; Holtfreter J, 1944, J EXP ZOOL, V95, P171, DOI 10.1002/jez.1400950203; Holtfreter J, 1943, J EXP ZOOL, V94, P261, DOI 10.1002/jez.1400940302; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; Holtreter J, 1939, ARCH EXP ZELLFORSCH, V23, P169; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; Koehl M.A.R., 1990, Seminars in Developmental Biology, V1, P367; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; STEINBERG M S, 1978, P25; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Trinkaus JP, 1984, CELLS ORGANS FORCES; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667	18	58	59	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					201	203		10.1126/science.1230718	http://dx.doi.org/10.1126/science.1230718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066066				2022-12-01	WOS:000309712300026
J	Chalmers, M				Chalmers, Matthew			COSMOLOGY Out of the darkness	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S2	S4		10.1038/490S2a	http://dx.doi.org/10.1038/490S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051769	Bronze			2022-12-01	WOS:000309733300002
J	Roehr, B				Roehr, Bob			Why the NFL is investing in health research	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Lehman EJ, 2012, NEUROLOGY; NFL, WE CAN MAK GAM SAF; NFL. Mangini Lt. Co, 2012, KYL DISC HEAD INJ NF; Roehr B, AAAS BRIEFING RES DE; US Army, TBI MIL GRID PAN DIS	5	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 5	2012	345								e6626	10.1136/bmj.e6626	http://dx.doi.org/10.1136/bmj.e6626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LO	23043091				2022-12-01	WOS:000309662300010
J	Koboldt, DC; Fulton, RS; McLellan, MD; Schmidt, H; Kalicki-Veizer, J; McMichael, JF; Fulton, LL; Dooling, DJ; Ding, L; Mardis, ER; Wilson, RK; Ally, A; Balasundaram, M; Butterfield, YSN; Carlsen, R; Carter, C; Chu, A; Chuah, E; Chun, HJE; Coope, RJN; Dhalla, N; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lee, D; Li, HYI; Mayo, M; Moore, RA; Mungall, AJ; Pleasance, E; Robertson, AG; Schein, JE; Shafiei, A; Sipahimalani, P; Slobodan, JR; Stoll, D; Tam, A; Thiessen, N; Varhol, RJ; Wye, N; Zeng, T; Zhao, YJ; Birol, I; Jones, SJM; Marra, MA; Cherniack, AD; Saksena, G; Onofrio, RC; Pho, NH; Carter, SL; Schumacher, SE; Tabak, B; Hernandez, B; Gentry, J; Nguyen, H; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Getz, G; Gabriel, SB; Meyerson, M; Chin, L; Park, PJ; Kucherlapati, R; Hoadley, KA; Auman, JT; Fan, C; Turman, YJ; Shi, Y; Li, L; Topal, MD; He, XP; Chao, HH; Prat, A; Silva, GO; Iglesia, MD; Zhao, W; Usary, J; Berg, JS; Adams, M; Booker, J; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Parker, JS; Hayes, DN; Perou, CM; Malik, S; Mahurkar, S; Shen, H; Weisenberger, DJ; Triche, T; Lai, PH; Bootwalla, MS; Maglinte, DT; Berman, BP; Van den Berg, DJ; Baylin, SB; Laird, PW; Creighton, CJ; Donehower, LA; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Sinha, R; Park, RW; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Reynolds, S; Kreisberg, RB; Bernard, B; Bressler, R; Erkkila, T; Lin, J; Thorsson, V; Zhang, W; Shmulevich, I; Ciriello, G; Weinhold, N; Schultz, N; Gao, JJ; Cerami, E; Gross, B; Jacobsen, A; Sinha, R; Aksoy, BA; Antipin, Y; Reva, B; Shen, RL; Taylor, BS; Ladanyi, M; Sander, C; Anur, P; Spellman, PT; Lu, YL; Liu, WB; Verhaak, RRG; Mills, GB; Akbani, R; Zhang, NX; Broom, BM; Casasent, TD; Wakefield, C; Unruh, AK; Baggerly, K; Coombes, K; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Benz, SC; Zhu, JC; Szeto, CC; Scott, GK; Yau, C; Paul, EO; Carlin, D; Wong, C; Sokolov, A; Thusberg, J; Mooney, S; Ng, S; Goldstein, TC; Ellrott, K; Grifford, M; Wilks, C; Ma, S; Craft, B; Yan, CH; Hu, Y; Meerzaman, D; Gastier-Foster, JM; Bowen, J; Ramirez, NC; Black, AD; Pyatt, RE; White, P; Zmuda, EJ; Frick, J; Lichtenberg, T; Brookens, R; George, MM; Gerken, MA; Harper, HA; Leraas, KM; Wise, LJ; Tabler, TR; McAllister, C; Barr, T; Hart-Kothari, M; Tarvin, K; Saller, C; Sandusky, G; Mitchell, C; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Dolzhansky, O; Abramov, M; Voronina, O; Potapova, O; Marks, JR; Suchorska, WM; Murawa, D; Kycler, W; Ibbs, M; Korski, K; Spychala, A; Murawa, P; Brzezinski, JJ; Perz, H; Lazniak, R; Teresiak, M; Tatka, H; Leporowska, E; Bogusz-Czerniewicz, M; Malicki, J; Mackiewicz, A; Wiznerowicz, M; Le, XV; Kohl, B; Tien, NV; Thorp, R; Bang, NV; Sussman, H; Phu, BD; Hajek, R; Hung, NP; Tran, VTP; Thang, HQ; Khan, KZ; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Ingle, JN; Couch, FJ; Lingle, WL; King, TA; Gonzalez-Angulo, AM; Mills, GB; Dyer, MD; Liu, SY; Meng, XL; Patangan, M; Waldman, F; Stoppler, H; Rathmell, WK; Thorne, L; Huang, M; Boice, L; Hill, A; Morrison, C; Gaudioso, C; Bshara, W; Daily, K; Egea, SC; Pegram, MD; Gomez-Fernandez, C; Dhir, R; Bhargava, R; Brufsky, A; Shriver, CD; Hooke, JA; Campbell, JL; Mural, RJ; Hu, H; Somiari, S; Larson, C; Deyarmin, B; Kvecher, L; Kovatich, AJ; Ellis, MJ; King, TA; Hu, H; Couch, FJ; Mural, RJ; Stricker, T; White, K; Olopade, O; Ingle, JN; Luo, CQ; Chen, YQ; Marks, JR; Waldman, F; Wiznerowicz, M; Bose, R; Chang, LW; Beck, AH; Gonzalez-Angulo, AM; Pihl, T; Jensen, M; Sfeir, R; Kahn, A; Chu, A; Kothiyal, P; Wang, ZN; Snyder, E; Pontius, J; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, D; Nicholls, M; Srinivasan, D; Raman, R; Girshik, S; Kigonya, P; Alonso, S; Sanbhadti, R; Barletta, S; Pot, D; Sheth, M; Demchok, JA; Shaw, KRM; Yang, LM; Eley, G; Ferguson, ML; Tarnuzzer, RW; Zhang, JS; Dillon, LAL; Buetow, K; Fielding, P; Ozenberger, BA; Guyer, MS; Sofia, HJ; Palchik, JD				Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.; Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Hoadley, Katherine A.; Auman, J. Todd; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Adams, Michael; Booker, Jessica; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Baylin, Stephen B.; Laird, Peter W.; Creighton, Chad J.; Donehower, Lawrence A.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Erkkila, Timo; Lin, Jake; Thorsson, Vesteinn; Zhang, Wei; Shmulevich, Ilya; Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Ladanyi, Marc; Sander, Chris; Anur, Pavana; Spellman, Paul T.; Lu, Yiling; Liu, Wenbin; Verhaak, Roel R. G.; Mills, Gordon B.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Scott, Gary K.; Yau, Christina; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Thusberg, Janita; Mooney, Sean; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian; Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa; Tarvin, Katie; Saller, Charles; Sandusky, George; Mitchell, Colleen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Dolzhansky, Oleg; Abramov, Mikhail; Voronina, Olga; Potapova, Olga; Marks, Jeffrey R.; Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej; Xuan Van Le; Kohl, Bernard; Nguyen Viet Tien; Thorp, Richard; Nguyen Van Bang; Sussman, Howard; Bui Duc Phu; Hajek, Richard; Nguyen Phi Hung; Tran Viet The Phuong; Huynh Quyet Thang; Khan, Khurram Zaki; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.; King, Tari A.; Gonzalez-Angulo, Ana Maria; Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto; Waldman, Frederic; Stoeppler, Hubert; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley; Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam; Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen; Dhir, Rajiv; Bhargava, Rohit; Brufsky, Adam; Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh; Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Kovatich, Albert J.; Ellis, Matthew J.; King, Tari A.; Hu, Hai; Couch, Fergus J.; Mural, Richard J.; Stricker, Thomas; White, Kevin; Olopade, Olufunmilayo; Ingle, James N.; Luo, Chunqing; Chen, Yaqin; Marks, Jeffrey R.; Waldman, Frederic; Wiznerowicz, Maciej; Bose, Ron; Chang, Li-Wei; Beck, Andrew H.; Gonzalez-Angulo, Ana Maria; Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David; Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Eley, Greg; Ferguson, Martin L.; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Buetow, Kenneth; Fielding, Peter; Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.		Canc Genome Atlas Network	Comprehensive molecular portraits of human breast tumours	NATURE			English	Article							BASAL-LIKE; MUTATIONAL EVOLUTION; HIGH-FREQUENCY; PIK3CA GENE; LUMINAL-B; CANCER; SUPPRESSOR; SUBTYPES; PATHWAYS; TARGET	We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays. Our ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers; however, there were numerous subtype-associated and novel gene mutations including the enrichment of specific mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype. We identified two novel protein-expression-defined subgroups, possibly produced by stromal/microenvironmental elements, and integrated analyses identified specific signalling pathways dominant in each molecular subtype including a HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature within the HER2-enriched expression subtype. Comparison of basal-like breast tumours with high-grade serous ovarian tumours showed many molecular commonalities, indicating a related aetiology and similar therapeutic opportunities. The biological finding of the four main breast cancer subtypes caused by different subsets of genetic and epigenetic abnormalities raises the hypothesis that much of the clinically observable plasticity and heterogeneity occurs within, and not across, these major biological subtypes of breast cancer.	[Hoadley, Katherine A.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Berg, Jonathan S.; Adams, Michael; Weisenberger, Daniel J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Mardis, Elaine R.; Wilson, Richard K.; Ellis, Matthew J.; Bose, Ron] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Schumacher, Steven E.; Tabak, Barbara; Beroukhim, Rameen; Nguyen Phi Hung] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Meyerson, Matthew; Beck, Andrew H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Park, Peter J.; Gehlenborg, Nils; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hoadley, Katherine A.; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Topal, Michael D.; Booker, Jessica; Weisenberger, Daniel J.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Shen, Hui] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC 27599 USA; [Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Laird, Peter W.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Hailei; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Chin, Lynda] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Zhang, Juinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77054 USA; [Wu, Chang-Jiun] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Lin, Jake; Thorsson, Vesteinn; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Erkkila, Timo] Tampere Univ Technol, FIN-33101 Tampere, Finland; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Canc Genom Core Lab, Houston, TX 77030 USA; [Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Anur, Pavana; Spellman, Paul T.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Lu, Yiling; Mills, Gordon B.; Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Kleberg Ctr Mol Markers, Houston, TX 77030 USA; [Liu, Wenbin; Verhaak, Roel R. G.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina; Thusberg, Janita; Mooney, Sean] Buck Inst Res Aging, Novato, CA 94945 USA; [Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Bioinformat & Informat Technol, Rockville, MD 20852 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Pyatt, Robert E.; White, Peter] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Tarvin, Katie] ABS Inc, Indianapolis, IN 46204 USA; [Saller, Charles] ABS Inc, Wilmington, DE 19801 USA; [Sandusky, George; Mitchell, Colleen] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Christiana Care, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Dolzhansky, Oleg] Moscow Hlth Dept, Moscow City Clin Oncol Dispensary 1, Moscow 105005, Russia; [Dolzhansky, Oleg] Moscow Hlth Dept, Cent IHC Lab, Moscow 105005, Russia; [Abramov, Mikhail] Russian Canc Res Ctr, Moscow 115478, Russia; [Voronina, Olga; Potapova, Olga] Cureline Inc, San Francisco, CA 94080 USA; [Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej] Poznan Univ Med Sci, PL-61701 Poznan, Poland; [Xuan Van Le; Kohl, Bernard] ILSBio LLC, Chestertown, MD 21620 USA; [Nguyen Viet Tien] Minist Hlth, Hanoi, Vietnam; [Thorp, Richard; Khan, Khurram Zaki] ILSBio LLC, Karachi, Pakistan; [Nguyen Van Bang; Bui Duc Phu] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Nguyen Phi Hung] Natl Canc Inst, Hanoi, Vietnam; [Tran Viet The Phuong] Ho Chi Minh City Canc Ctr, Ho Chi Minh City, Vietnam; [Huynh Quyet Thang] Can Tho Canc Ctr, Can Tho, Vietnam; [Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy] Int Genom Consortium, Phoenix, AZ 85004 USA; [Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.] Mayo Clin, Rochester, MN 55905 USA; [King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA; [Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Waldman, Frederic] Univ Calif San Francisco, San Francisco, CA 94143 USA; Canc Diagnost, San Juan Capistrano, CA 92675 USA; Quest Diagnost, Nichols Inst, San Juan Capistrano, CA 92675 USA; [Stoeppler, Hubert] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Thorne, Leigh; Huang, Mei; Boice, Lori] UNC Lineberger Canc Ctr, Dept Pathol, UNC Tissue Procurement Facil, Chapel Hill, NC 27599 USA; [Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Pathol, Miami, FL 33136 USA; [Dhir, Rajiv] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Bhargava, Rohit; Brufsky, Adam] Univ Pittsburgh Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20899 USA; [Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Luo, Chunqing; Chen, Yaqin] Windber Res Inst, Windber, PA 15963 USA; [Kovatich, Albert J.] MDR Global LLC, Windber, PA 15963 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Breast Canc Program, St Louis, MO 63110 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Stricker, Thomas; White, Kevin] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Olopade, Olufunmilayo] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David] SRA Int, Fairfax, VA 22033 USA; [Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Fielding, Peter] NCI, Canc Genome Atlas Program Off, Ctr Canc Genom, Bethesda, MD 20892 USA; [Eley, Greg] Scimentis LLC, TCGA, Statham, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.] NHGRI, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Institute for Systems Biology (ISB); Tampere University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Indiana University System; Indiana University Bloomington; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Duke University; Wielkopolskie Centrum Onkologii; Poznan University of Medical Sciences; Stanford University; University of Texas System; UTMD Anderson Cancer Center; International Genomics Consortium; Mayo Clinic; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Nichols Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Roswell Park Cancer Institute; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Walter Reed National Military Medical Center; Windber Research Institute; Washington University (WUSTL); Washington University (WUSTL); University of Chicago; University of Chicago; Washington University (WUSTL); SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Perou, CM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Verhaak, Roel/ABE-7058-2020; Wilson, Richard K./AAF-4139-2019; Schultz, Nikolaus/ABE-6347-2020; Schumacher, Steven/E-9821-2013; Suchorska, Wiktoria/CAG-0479-2022; Parker, Joel/AAG-1108-2019; White, Peter/E-4301-2011; Berman, Benjamin P/D-5942-2014; Schein, Jacquie E/G-3674-2015; Weisenberger, Daniel/AAA-8314-2020; Kucherlapati, Raju/ABC-8807-2021; Stojanov, Petar/GQI-4462-2022; Brufsky, Adam/AAE-7470-2020; Perou, Charles M/H-9934-2014; Birol, Inanc/G-5440-2011; Laird, Peter W/G-8683-2012; Prat, Aleix/P-8561-2014; Van Den Berg, David J/G-8598-2017; Gastier-Foster, Julie/E-3105-2011; Ganesh, Dunna Sai/AGX-5170-2022; Cherniack, Andrew D./AAY-8132-2020; wang, edwin/G-5372-2010; , Pathology Services Core/CEZ-2246-2022; BERMAN, BENJAMIN/AAT-3720-2021; Akbani, Rehan/AAG-1490-2019; Ibbs, Matthew/AAU-1511-2021; Gao, JianJiong/B-5673-2016; Reva, Boris A./B-6436-2014; Hirst, Martin/B-7684-2016; Reva, Boris/AAB-8932-2022; Cherniack, Andrew/AAC-5310-2019; Mardis, Elaine/W-2202-2019; Ladanyi, Marc/AAG-8585-2019; Auman, James/AAY-7748-2020; Jones, Steven J/C-3621-2009; Lawrence, Michael/AAC-8202-2020; Skanderup, Anders Jacobsen/K-1081-2013; Marra, Marco A/B-5987-2008; Holt, Robert A/C-3303-2009; Mungall, Andrew J./U-7067-2018; Shen, Hui/AAO-4387-2020; Mesirov, Jill/AGF-7626-2022	Wilson, Richard K./0000-0002-1992-1358; Schumacher, Steven/0000-0002-6819-5647; White, Peter/0000-0002-5218-5903; Berman, Benjamin P/0000-0002-2099-9005; Weisenberger, Daniel/0000-0001-8303-2603; Stojanov, Petar/0000-0001-7815-776X; Perou, Charles M/0000-0001-9827-2247; Birol, Inanc/0000-0003-0950-7839; Laird, Peter W/0000-0001-9117-3641; Prat, Aleix/0000-0003-2377-540X; Van Den Berg, David J/0000-0002-5404-5218; Cherniack, Andrew D./0000-0003-0470-0111; BERMAN, BENJAMIN/0000-0002-2099-9005; Ibbs, Matthew/0000-0003-2510-3447; Gao, JianJiong/0000-0002-5739-1781; Reva, Boris A./0000-0002-8805-389X; Jones, Steven J/0000-0003-3394-2208; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Marra, Marco A/0000-0001-7146-7175; Holt, Robert A/0000-0002-7259-1247; Mungall, Andrew J./0000-0002-0905-2742; MOONEY, SEAN D/0000-0003-2654-0833; Shen, Hui/0000-0001-9767-4084; MCLELLAN, MICHAEL/0000-0002-2703-8784; Kovatich, Albert/0000-0002-5169-4087; Park, Peter/0000-0001-9378-960X; Mahurkar-Joshi, Swapna/0000-0001-9591-4590; Jensen, Mark/0000-0001-5215-101X; Hayes, D. Neil/0000-0001-6203-7771; Coombes, Kevin/0000-0002-7630-2123; Benz, Stephen/0000-0002-4067-0602; Bowen, Jay/0000-0001-6861-9043; Suchorska, Wiktoria/0000-0003-4742-2465; Berg, Jonathan/0000-0003-2360-2664; Schultz, Nikolaus/0000-0002-0131-4904; Brufsky, Adam/0000-0001-8080-7960; Weinstein, John/0000-0001-9401-6908; Casasent, Anna/0000-0002-7857-179X; Stuart, Joshua/0000-0002-2171-565X; Stoll, Dominik/0000-0003-0701-4301; Quyet Thang, Huynh/0000-0002-0788-6380; Tarnuzzer, Roy/0000-0002-3725-4173; Ciriello, Giovanni/0000-0003-2021-8683; Meyerson, Matthew/0000-0002-9133-8108; Sinha, Rileen/0000-0001-5497-5055; Gehlenborg, Nils/0000-0003-0327-8297; Triche, Tim/0000-0001-5665-946X; Hu, Hai/0000-0001-5345-8371; Hoadley, Katherine/0000-0002-1216-477X; Malicki, Julian/0000-0002-5558-5558; Pot, David/0000-0002-1480-9826	USA National Institutes of Health [U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201, P50CA58223]; Susan G. Komen for the Cure; US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U24CA143840, K08CA148912, P30CA016672, U24CA144025, R01CA094143, U01CA084955, U24CA143845, P30CA016058, P50CA116201, U24CA143858, U24CA143835, U24CA143867, U24CA143882, U24CA143799, U24CA143883, P30CA016086, U24CA143848, P50CA058223, U24CA143866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003079, U54HG004028] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Sheth and S. Lucas for administrative coordination of TCGA activities, and C. Gunter for critical reading of the manuscript. This work was supported by the following grants from the USA National Institutes of Health: U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201 and P50CA58223. Additional support was provided by the Susan G. Komen for the Cure, the US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine, and the Breast Cancer Research Foundation. The views expressed in this paper are those of the authors and do not reflect the official policy of the Department of Defense, or US Government.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Li QY, 1997, NAT GENET, V15, P21; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y	56	7878	8025	66	1455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					61	70		10.1038/nature11412	http://dx.doi.org/10.1038/nature11412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23000897	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-01	WOS:000309446800032
J	Lyle, M; Heusser, L; Ravelo, C; Yamamoto, M; Barron, J; Diffenbaugh, NS; Herbert, T; Andreasen, D				Lyle, Mitchell; Heusser, Linda; Ravelo, Christina; Yamamoto, Masanobu; Barron, John; Diffenbaugh, Noah S.; Herbert, Timothy; Andreasen, Dyke			Out of the Tropics: The Pacific, Great Basin Lakes, and Late Pleistocene Water Cycle in the Western United States	SCIENCE			English	Article							CALIFORNIA CURRENT SYSTEM; NORTH-AMERICA; SURFACE WATERS; CLIMATE-CHANGE; LAHONTAN; RECORD; OCEAN; OSCILLATIONS; TEMPERATURE; EVAPORATION	The water cycle in the western United States changed dramatically over glacial cycles. In the past 20,000 years, higher precipitation caused desert lakes to form which have since dried out. Higher glacial precipitation has been hypothesized to result from a southward shift of Pacific winter storm tracks. We compared Pacific Ocean data to lake levels from the interior west and found that Great Basin lake high stands are older than coastal wet periods at the same latitude. Westerly storms were not the source of high precipitation. Instead, air masses from the tropical Pacific were transported northward, bringing more precipitation into the Great Basin when coastal California was still dry. The changing climate during the deglaciation altered precipitation source regions and strongly affected the regional water cycle.	[Lyle, Mitchell] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Heusser, Linda] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ravelo, Christina; Andreasen, Dyke] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Yamamoto, Masanobu] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Barron, John] US Geol Survey, Menlo Pk, CA 94025 USA; [Diffenbaugh, Noah S.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Herbert, Timothy] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Texas A&M University System; Texas A&M University College Station; Columbia University; University of California System; University of California Santa Cruz; Hokkaido University; United States Department of the Interior; United States Geological Survey; Stanford University; Stanford University; Brown University	Lyle, M (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	mlyle@ocean.tamu.edu	Diffenbaugh, Noah S/I-5920-2014; Yamamoto, Masanobu/A-6990-2012	Diffenbaugh, Noah S/0000-0002-8856-4964; Yamamoto, Masanobu/0000-0003-1312-825X; Barron, John/0000-0002-9309-1145	U.S. National Science Foundation [EAR-0450211, OCE-9809438]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank the Ocean Drilling Program and its successor program, IODP, for collecting and archiving the drill cores used. We also thank M. Reheis for her insights in a thorough internal U.S. Geological Surbey review. The U.S. National Science Foundation supported this research through grants EAR-0450211 and OCE-9809438.	Anderson RY, 2002, QUATERNARY RES, V57, P371, DOI 10.1006/qres.2002.2323; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; BENSON L V, 1991, Journal of Paleolimnology, V5, P115; Bradbury JP, 2004, J PALEOLIMNOL, V31, P167; Briggs RW, 2005, QUATERNARY RES, V64, P257, DOI 10.1016/j.yqres.2005.02.011; Broecker WS, 2009, QUATERNARY SCI REV, V28, P2557, DOI 10.1016/j.quascirev.2009.07.007; BROECKER WS, 1958, GEOL SOC AM BULL, V69, P1009, DOI 10.1130/0016-7606(1958)69[1009:RCOLLA]2.0.CO;2; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; Freidel D. E., 1993, THESIS U OREGON; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Heusser L. E., 2000, P OC DRILL PROGR SCI, V167, P239; Heusser L.E., 1995, PROC OCEAN DRILL SCI, V146, P265; HEUSSER LE, 1979, SCIENCE, V204, P837, DOI 10.1126/science.204.4395.837; Heusser LE, 2000, PALAEOGEOGR PALAEOCL, V161, P407, DOI 10.1016/S0031-0182(00)00096-1; Hostetler S., 1990, CLIM DYNAM, V4, P207, DOI DOI 10.1007/BF00209522; Hostetler S.W., 1991, CLIM DYNAM, V6, P43, DOI DOI 10.1007/BF00210581; HOSTETLER SW, 1994, SCIENCE, V263, P665, DOI 10.1126/science.263.5147.665; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Kennett J. P., 1995, P OCEAN DRILLING P 2, V146; Kim SJ, 2008, CLIM DYNAM, V31, P1, DOI 10.1007/s00382-007-0332-z; Kreitz S.F, 2000, PROC OCEAN DRILL SCI, V167, P153; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lyle M, 2001, GEOLOGY, V29, P1115, DOI 10.1130/0091-7613(2001)029<1115:ITAVKY>2.0.CO;2; Lyle M., 2000, P OCEAN DRILL PROGRA, V167, P163, DOI DOI 10.2973/ODP.PROC.SR.167.214.2000; Lyle M., 2000, P OCEAN DRILLING PRO, V167; Lyle M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001836; McClymont EL, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002226; McIntyre A., 1976, Science, V191, P1131, DOI 10.1126/science.191.4232.1131; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Oster JL, 2009, EARTH PLANET SC LETT, V288, P434, DOI 10.1016/j.epsl.2009.10.003; Pisias NG, 2001, QUATERNARY SCI REV, V20, P1561, DOI 10.1016/S0277-3791(01)00018-X; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; REA DK, 1988, PALAEOGEOGR PALAEOCL, V66, P1, DOI 10.1016/0031-0182(88)90076-4; SANCETTA C, 1992, QUATERNARY RES, V38, P359, DOI 10.1016/0033-5894(92)90044-J; Seki O, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015200; Toracinta ER, 2004, J CLIMATE, V17, P504, DOI 10.1175/1520-0442(2004)017<0504:ARTMCO>2.0.CO;2; Unterman MB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049599; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Whitlock C, 2000, PALAEOGEOGR PALAEOCL, V155, P7, DOI 10.1016/S0031-0182(99)00092-9; Winograd IJ, 2006, QUATERNARY RES, V66, P202, DOI 10.1016/j.yqres.2006.06.003; Yamamato M, 2007, QUATERNARY SCI REV, V26, P405, DOI 10.1016/j.quascirev.2006.07.014; Yamamoto M., 2005, GEOPHYS RES LETT, V32	43	99	100	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1629	1633		10.1126/science.1218390	http://dx.doi.org/10.1126/science.1218390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019644				2022-12-01	WOS:000309215400038
J	Zenon, A; Krauzlis, RJ				Zenon, Alexandre; Krauzlis, Richard J.			Attention deficits without cortical neuronal deficits	NATURE			English	Article							AREAS MT; MODULATION; MICROSTIMULATION; INACTIVATION; SELECTION; SIGNALS	The ability to process relevant stimuli selectively is a fundamental function of the primate visual system. The best-understood correlate of this function is the enhanced response of neurons in the visual cortex to attended stimuli(1,2). However, recent results show that the superior colliculus (SC), a midbrain structure, also has a crucial role in visual attention(3-5). It has been assumed that the SC acts through the same well-known mechanisms in the visual cortex(3,5). Here we tested this hypothesis by transiently inactivating the SC during a motion-change-detection task and measuring responses in two visual cortical areas. We found that despite large deficits in visual attention, the enhanced responses of neurons in the visual cortex to attended stimuli were unchanged. These results show that the SC contributes to visual attention through mechanisms that are independent of the classic effects in the visual cortex, demonstrating that other processes must have key roles in visual attention.	[Zenon, Alexandre; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Zenon, Alexandre] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Krauzlis, Richard J.] NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA	Salk Institute; Universite Catholique Louvain; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	richard.krauzlis@nih.gov	Zénon, Alexandre/AGN-7203-2022	Zénon, Alexandre/0000-0001-7989-1261; Richard, Krauzlis/0000-0002-1826-0447	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000511] Funding Source: NIH RePORTER	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Boehle, N. Dill and A. Karnik for technical assistance, and R. Wurtz for discussions and reading of the manuscript. This work was supported by the F.M. Kirby Foundation and the National Eye Institute Intramural Research Program at the National Institutes of Health.	Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; BERGER J, 2001, MODEL SELECTION, P135; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Palmer J, 2009, VISION RES, V49, P1045, DOI 10.1016/j.visres.2008.02.022; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Ross TD, 2003, COMPUT BIOL MED, V33, P509, DOI 10.1016/S0010-4825(03)00019-2; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wetzels R, 2009, PSYCHON B REV, V16, P752, DOI 10.3758/PBR.16.4.752	37	145	146	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					434	U124		10.1038/nature11497	http://dx.doi.org/10.1038/nature11497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972195	Green Accepted			2022-12-01	WOS:000308860900046
J	Ibarra, CA; Feng, XQ; Schoft, VK; Hsieh, TF; Uzawa, R; Rodrigues, JA; Zemach, A; Chumak, N; Machlicova, A; Nishimura, T; Rojas, D; Fischer, RL; Tamaru, H; Zilberman, D				Ibarra, Christian A.; Feng, Xiaoqi; Schoft, Vera K.; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Chumak, Nina; Machlicova, Adriana; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Tamaru, Hisashi; Zilberman, Daniel			Active DNA Demethylation in Plant Companion Cells Reinforces Transposon Methylation in Gametes	SCIENCE			English	Article							ARABIDOPSIS ENDOSPERM; GENOME; GLYCOSYLASE; CHROMATIN; STATES	The Arabidopsis thaliana central cell, the companion cell of the egg, undergoes DNA demethylation before fertilization, but the targeting preferences, mechanism, and biological significance of this process remain unclear. Here, we show that active DNA demethylation mediated by the DEMETER DNA glycosylase accounts for all of the demethylation in the central cell and preferentially targets small, AT-rich, and nucleosome-depleted euchromatic transposable elements. The vegetative cell, the companion cell of sperm, also undergoes DEMETER-dependent demethylation of similar sequences, and lack of DEMETER in vegetative cells causes reduced small RNA-directed DNA methylation of transposons in sperm. Our results demonstrate that demethylation in companion cells reinforces transposon methylation in plant gametes and likely contributes to stable silencing of transposable elements across generations.	[Ibarra, Christian A.; Feng, Xiaoqi; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Schoft, Vera K.; Chumak, Nina; Machlicova, Adriana; Tamaru, Hisashi] Austrian Acad Sci, Gregor Mendel Inst, A-1030 Vienna, Austria	University of California System; University of California Berkeley; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu; hisashi.tamaru@gmi.oeaw.ac.at; danielz@berkeley.edu		Zemach, Assaf/0000-0003-3282-4445; Zilberman, Daniel/0000-0002-0123-8649; Rodrigues, Jessica/0000-0002-1562-2211; Hsieh, Tzung-Fu/0000-0001-7584-3721; Schoft, Vera/0000-0003-4857-3804; Feng, Xiaoqi/0000-0002-4008-1234	NIH [GM69415]; NSF [MCB-0918821, IOS-1025890]; Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF) [P21389-B03]; Ruth L. Kirschstein NIH Predoctoral Fellowship [GM093633]; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF) [P 24918] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM093633, R01GM069415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ruth L. Kirschstein NIH Predoctoral Fellowship; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harmer for assistance with the analysis of histone modifications, the BioOptics team at the Vienna Biocenter Campus for sorting sperm and vegetative cell nuclei, K. Slotkin for the LAT52p-amiRNA=GFP plasmid, and G. Drews for the DD45p-GFP transgenic line. This work was partially funded by an NIH grant (GM69415) to R. L. F., NSF grants (MCB-0918821 and IOS-1025890) to R. L. F. and D.Z., a Young Investigator Grant from the Arnold and Mabel Beckman Foundation to D.Z., an Austrian Science Fund (FWF) grant P21389-B03 to H. T., a Ruth L. Kirschstein NIH Predoctoral Fellowship (GM093633) to C. A. I., a Fulbright Scholarship to J.A.R., a fellowship from the Jane Coffin Childs Memorial Fund to A.Z., and a Robert and Colleen Haas Scholarship to D. R. Sequencing data are deposited in GEO (GSE38935).	Bauer MJ, 2011, CURR OPIN PLANT BIOL, V14, P162, DOI 10.1016/j.pbi.2011.02.006; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	14	321	328	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1360	1364		10.1126/science.1224839	http://dx.doi.org/10.1126/science.1224839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984074	Green Accepted			2022-12-01	WOS:000308705000047
J	Liu, W; Huang, XY; Cheng, MJ; Nielsen, RJ; Goddard, WA; Groves, JT				Liu, Wei; Huang, Xiongyi; Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III; Groves, John T.			Oxidative Aliphatic C-H Fluorination with Fluoride Ion Catalyzed by a Manganese Porphyrin	SCIENCE			English	Article							ELEMENTAL FLUORINE; MECHANISM; PHARMACEUTICALS; REACTIVITY; REAGENT; ACIDS	Despite the growing importance of fluorinated organic compounds in drug development, there are no direct protocols for the fluorination of aliphatic C-H bonds using conveniently handled fluoride salts. We have discovered that a manganese porphyrin complex catalyzes alkyl fluorination by fluoride ion under mild conditions in conjunction with stoichiometric oxidation by iodosylbenzene. Simple alkanes, terpenoids, and even steroids were selectively fluorinated at otherwise inaccessible sites in 50 to 60% yield. Decalin was fluorinated predominantly at the C2 and C3 methylene positions. Bornyl acetate was converted to exo-5-fluoro-bornyl acetate, and 5a-androstan-17-one was fluorinated selectively in the A ring. Mechanistic analysis suggests that the regioselectivity for C-H bond cleavage is directed by an oxomanganese(V) catalytic intermediate followed by F delivery via an unusual manganese(IV) fluoride that has been isolated and structurally characterized.	[Liu, Wei; Huang, Xiongyi; Groves, John T.] Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA; [Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III] CALTECH, Dept Chem, Mat & Proc Simulat Ctr MC 139 74, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	Groves, JT (corresponding author), Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA.	jtgroves@princeton.edu	Huang, Xiongyi/H-3079-2013; Groves, John T./GPP-7588-2022; Cheng, Mu-Jeng/I-7316-2012	Groves, John T./0000-0002-9944-5899; Huang, Xiongyi/0000-0001-7156-8881	NSF [CHE-0616633, CHE-1148597]; Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001298]; Division Of Chemistry [1148597] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to NSF (grants CHE-0616633 and CHE-1148597 to J.T.G.) for support of this research. DFT calculations, hydrocarbon C-H activation, and the CalTech-Princeton collaboration were supported by the Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences, under award no. DE-SC0001298 to W. A. G. and J.T.G. A patent application has been filed through Princeton University on methods and catalysts presented in this paper. We thank S. Semproni for assistance with the x-ray crystal structure of Mn<SUP>IV</SUP>(TMP)F<INF>2</INF>, data for which are available free of charge from the Cambridge Crystallographic Data Centre under reference no. CCDC 893742.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Auclair K, 2002, J AM CHEM SOC, V124, P6020, DOI 10.1021/ja025608h; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Chambers RD, 2002, J CHEM SOC PERK T 1, P2190, DOI 10.1039/b204776b; Chen K, 2009, ANGEW CHEM INT EDIT, V48, P9705, DOI 10.1002/anie.200904474; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Eustaquio AS, 2010, J NAT PROD, V73, P378, DOI 10.1021/np900719u; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GROVES JT, 1988, J AM CHEM SOC, V110, P8628, DOI 10.1021/ja00234a009; Harki DA, 2008, P NATL ACAD SCI USA, V105, P13039, DOI 10.1073/pnas.0806308105; Herrmann P, 2008, COLLECT CZECH CHEM C, V73, P1825, DOI 10.1135/cccc20081825; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Jin N, 2007, J AM CHEM SOC, V129, P12416, DOI 10.1021/ja0761737; Jin N, 2010, INORG CHEM, V49, P11516, DOI 10.1021/ic1015274; Kalow JA, 2010, J AM CHEM SOC, V132, P3268, DOI 10.1021/ja100161d; Kaskel S, 1997, Z ANORG ALLG CHEM, V623, P1259, DOI 10.1002/zaac.19976230813; Kaustov L, 1997, INORG CHEM, V36, P3503, DOI 10.1021/ic961207p; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Liu W, 2010, J AM CHEM SOC, V132, P12847, DOI 10.1021/ja105548x; Lourie LF, 2006, J FLUORINE CHEM, V127, P377, DOI 10.1016/j.jfluchem.2005.12.027; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; Rentmeister A, 2009, NAT CHEM BIOL, V5, P26, DOI 10.1038/nchembio.128; Rozen S, 2005, EUR J ORG CHEM, V2005, P2433, DOI 10.1002/ejoc.200400876; ROZEN S, 1987, J ORG CHEM, V52, P2769, DOI 10.1021/jo00389a024; Rueda-Becerril M, 2012, J AM CHEM SOC, V134, P4026, DOI 10.1021/ja211679v; Sandford G, 2007, J FLUORINE CHEM, V128, P90, DOI 10.1016/j.jfluchem.2006.10.019; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; STAVBER S, 1989, TETRAHEDRON, V45, P2737, DOI 10.1016/S0040-4020(01)80103-4; Tang PP, 2010, J AM CHEM SOC, V132, P12150, DOI 10.1021/ja105834t; Umile TP, 2011, INORG CHEM, V50, P10353, DOI 10.1021/ic201430v; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin F, 2012, J AM CHEM SOC, V134, P10401, DOI 10.1021/ja3048255; Zanzonico PB, 2004, J NUCL MED, V45, P1966; Zhao YJ, 2012, ORG BIOMOL CHEM, V10, P479, DOI 10.1039/c1ob05840a	41	214	221	7	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1322	1325		10.1126/science.1222327	http://dx.doi.org/10.1126/science.1222327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984066				2022-12-01	WOS:000308705000037
J	Greene, JA; Choudhry, NK; Kesselheim, AS; Brennan, TA; Shrank, W				Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Brennan, Troyen A.; Shrank, William			Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DRUGS		[Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Shrank, William] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Greene, JA (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	greene@jhmi.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Faerber AE, 2012, HEALTH COMMUN, V27, P66, DOI 10.1080/10410236.2011.569001; *IMS HLTH, TOT US PROM SPEND TY; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; VMS, 2010, ADS PROD SHEET; World Health Organization, ETH CRIT MED DRUG PR	6	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					973	975		10.1001/2012.jama.10647	http://dx.doi.org/10.1001/2012.jama.10647			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968881				2022-12-01	WOS:000308579300015
J	Maurano, MT; Humbert, R; Rynes, E; Thurman, RE; Haugen, E; Wang, H; Reynolds, AP; Sandstrom, R; Qu, HZ; Brody, J; Shafer, A; Neri, F; Lee, K; Kutyavin, T; Stehling-Sun, S; Johnson, AK; Canfield, TK; Giste, E; Diegel, M; Bates, D; Hansen, RS; Neph, S; Sabo, PJ; Heimfeld, S; Raubitschek, A; Ziegler, S; Cotsapas, C; Sotoodehnia, N; Glass, I; Sunyaev, SR; Kaul, R; Stamatoyannopoulos, JA				Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Brody, Jennifer; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Hansen, R. Scott; Neph, Shane; Sabo, Peter J.; Heimfeld, Shelly; Raubitschek, Antony; Ziegler, Steven; Cotsapas, Chris; Sotoodehnia, Nona; Glass, Ian; Sunyaev, Shamil R.; Kaul, Rajinder; Stamatoyannopoulos, John A.			Systematic Localization of Common Disease-Associated Variation in Regulatory DNA	SCIENCE			English	Article							CROHNS-DISEASE; 22 LOCI; VARIANTS; EVOLUTION; PROMOTER; CELLS	Genome-wide association studies have identified many noncoding variants associated with common diseases and traits. We show that these variants are concentrated in regulatory DNA marked by deoxyribonuclease I (DNase I) hypersensitive sites (DHSs). Eighty-eight percent of such DHSs are active during fetal development and are enriched in variants associated with gestational exposure-related phenotypes. We identified distant gene targets for hundreds of variant-containing DHSs that may explain phenotype associations. Disease-associated variants systematically perturb transcription factor recognition sequences, frequently alter allelic chromatin states, and form regulatory networks. We also demonstrated tissue-selective enrichment of more weakly disease-associated variants within DHSs and the de novo identification of pathogenic cell types for Crohn's disease, multiple sclerosis, and an electrocardiogram trait, without prior knowledge of physiological mechanisms. Our results suggest pervasive involvement of regulatory DNA variation in common human disease and provide pathogenic insights into diverse disorders.	[Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Neph, Shane; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qu, Hongzhu] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing 100029, Peoples R China; [Brody, Jennifer; Sotoodehnia, Nona] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Raubitschek, Antony; Ziegler, Steven] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Glass, Ian] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Benaroya Research Institute; Yale University; Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu		Sandstrom, Richard/0000-0002-3356-1547; Kaul, Rajinder/0000-0002-7895-9284; Haugen, Eric/0000-0001-7444-8981; Cotsapas, Chris/0000-0002-7772-5910	NIH [U54HG004592, U01ES01156, P30 DK056465, R01HL088456, R24HD000836-47]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088456] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank many colleagues for their insightful comments and critical readings of the manuscript. We also thank many colleagues who provided individual cell samples for DNase I analysis. This work was supported by NIH grants U54HG004592 and U01ES01156 (J.A.S.), P30 DK056465 (S. H.), R01HL088456 (N.S.), and R24HD000836-47 (I. G.). We acknowledge the generous sharing of results from the International MS Genetics, International IBD Genetics, and CHARGE QRS Consortia. DNase I data have been deposited in Gene Expression Omnibus (GEO) under accession nos. GSE29692 and GSE18927 and can be viewed and downloaded at genome.ucsc.edu, www.uwencode.org/data, and www.epigenomebrowser.org.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Booth DR, 2010, NAT GENET, V42, P469, DOI 10.1038/ng0610-469; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, CATALOG PUBLISHED GE; International Multiple Sclerosis Genetics Consortium (IMSGC), 2010, NAT GENET       0527, V42, P470; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003	36	2093	2147	11	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1190	1195		10.1126/science.1222794	http://dx.doi.org/10.1126/science.1222794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955828	Green Accepted			2022-12-01	WOS:000308414000028
J	Yoshizaki, A; Miyagaki, T; DiLillo, DJ; Matsushita, T; Horikawa, M; Kountikov, EI; Spolski, R; Poe, JC; Leonard, WJ; Tedder, TF				Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Spolski, Rosanne; Poe, Jonathan C.; Leonard, Warren J.; Tedder, Thomas F.			Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions	NATURE			English	Article							B10 CELLS; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; CUTTING EDGE; PLASMA-CELLS; HUMAN CD19; MEMORY B; IN-VIVO; IL-21; IL-10	B cells regulate immune responses by producing antigen-specific antibodies(1). However, specific B-cell subsets can also negatively regulate T-cell immune responses, and have been termed regulatory B cells(2-4). Human and mouse regulatory B cells (B10 cells) with the ability to express the inhibitory cytokine interleukin-10 (IL-10) have been identified(2-5). Although rare, B10 cells are potent negative regulators of antigen-specific inflammation and T-cell-dependent autoimmune diseases in mice(5-7). How B10-cell IL-10 production and regulation of antigen-specific immune responses are controlled in vivo without inducing systemic immunosuppression is unknown. Using a mouse model for multiple sclerosis, here we show that B10-cell maturation into functional IL-10-secreting effector cells that inhibit in vivo autoimmune disease requires IL-21 and CD40-dependent cognate interactions with T cells. Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease. The ex vivo expansion and reinfusion of autologous B10 cells may provide a novel and effective in vivo treatment for severe autoimmune diseases that are resistant to current therapies.	[Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Poe, Jonathan C.; Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	thomas.tedder@duke.edu	Yoshizaki, Ayumi/AAN-1548-2021; Miyagaki, Tomomitsu/AFP-0003-2022; Matsushita, Takashi/C-4750-2015; Leonard, Warren/AAA-1397-2022	Yoshizaki, Ayumi/0000-0002-8194-9140; Matsushita, Takashi/0000-0002-1617-086X; Poe, Jonathan/0000-0002-7789-1564	National Institutes of Health (NIH) [AI56363, AI057157]; Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363, U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Maseda, E. Weimer, J. Bryant, K. Candando and G. Venturi for help and comments. These studies were supported by grants from the National Institutes of Health (NIH; AI56363 and AI057157), the Lymphoma Research Foundation, and the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH.	Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2011, IMMUNOL REV, V240, P52, DOI 10.1111/j.1600-065X.2010.00991.x; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Tedder T. F., 1995, LEUCOCYTE TYPING 5, V1, P483; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	37	463	490	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					264	+		10.1038/nature11501	http://dx.doi.org/10.1038/nature11501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064231	Green Accepted			2022-12-01	WOS:000310774300046
J	Gill, RJ; Ramos-Rodriguez, O; Raine, NE				Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.			Combined pesticide exposure severely affects individual- and colony-level traits in bees	NATURE			English	Article							HONEY-BEES; RISK-ASSESSMENT; SYSTEMIC INSECTICIDES; HYMENOPTERA APIDAE; BOMBUS-TERRESTRIS; FORAGING SUCCESS; APIS-MELLIFERA; POLLINATORS; MITICIDES; TOXICITY	Reported widespread declines of wild and managed insect pollinators have serious consequences for global ecosystem services and agricultural production(1-3). Bees contribute approximately 80% of insect pollination, so it is important to understand and mitigate the causes of current declines in bee populations(4-6). Recent studies have implicated the role of pesticides in these declines, as exposure to these chemicals has been associated with changes in bee behaviour(7-11) and reductions in colony queen production(12). However, the key link between changes in individual behaviour and the consequent impact at the colony level has not been shown. Social bee colonies depend on the collective performance of many individual workers. Thus, although field-level pesticide concentrations can have subtle or sublethal effects at the individual level(8), it is not known whether bee societies can buffer such effects or whether it results in a severe cumulative effect at the colony level. Furthermore, widespread agricultural intensification means that bees are exposed to numerous pesticides when foraging(13-15), yet the possible combinatorial effects of pesticide exposure have rarely been investigated(16,17). Here we show that chronic exposure of bumblebees to two pesticides (neonicotinoid and pyrethroid) at concentrations that could approximate field-level exposure impairs natural foraging behaviour and increases worker mortality leading to significant reductions in brood development and colony success. We found that worker foraging performance, particularly pollen collecting efficiency, was significantly reduced with observed knock-on effects for forager recruitment, worker losses and overall worker productivity. Moreover, we provide evidence that combinatorial exposure to pesticides increases the propensity of colonies to fail.	[Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Gill, RJ (corresponding author), Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	richard.gill@rhul.ac.uk; nigel.raine@rhul.ac.uk	Raine, Nigel/AAK-6425-2020	Raine, Nigel/0000-0001-6343-2829; Gill, Richard/0000-0001-9389-1284	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA); Natural Environment Research Council (NERC) [BB/I000178/1]; BBSRC [BB/I000178/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000178/1] Funding Source: researchfish	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M.J.F. Brown, M. Clook, J. Culverhouse, A. Dixon, M. Furst, D. Garthwaite, A. Horsell, V. Jansen and I. Pedroso-Rovira for comments and technical assistance, and Syngenta Bioline Bees for supplying colonies. The study was supported by the Insect Pollinator Initiative (funded under the auspices of the Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Scottish Government, Department for Environment, Food and Rural Affairs (DEFRA) and Natural Environment Research Council (NERC): grant BB/I000178/1).	Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Garthwaite D., 2010, 235 FOOD ENV RES AG; Garthwaite DG, 2008, 224 FOOD ENV RES AG; Goulson D., 2010, BUMBLEBEES BEHAV ECO; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	40	592	621	22	1171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					105	U119		10.1038/nature11585	http://dx.doi.org/10.1038/nature11585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23086150	Green Accepted			2022-12-01	WOS:000310434500039
J	Koike, N; Yoo, SH; Huang, HC; Kumar, V; Lee, C; Kim, TK; Takahashi, JS				Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Lee, Choogon; Kim, Tae-Kyung; Takahashi, Joseph S.			Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals	SCIENCE			English	Article							RNA-POLYMERASE-II; REV-ERB-ALPHA; GENE-EXPRESSION; HUMAN GENOME; PROTEIN DBP; METABOLISM; PROMOTERS; DEGRADATION; MECHANISMS; REPRESSION	The mammalian circadian clock involves a transcriptional feedback loop in which CLOCK and BMAL1 activate the Period and Cryptochrome genes, which then feed back and repress their own transcription. We have interrogated the transcriptional architecture of the circadian transcriptional regulatory loop on a genome scale in mouse liver and find a stereotyped, time-dependent pattern of transcription factor binding, RNA polymerase II (RNAPII) recruitment, RNA expression, and chromatin states. We find that the circadian transcriptional cycle of the clock consists of three distinct phases: a poised state, a coordinated de novo transcriptional activation state, and a repressed state. Only 22% of messenger RNA (mRNA) cycling genes are driven by de novo transcription, suggesting that both transcriptional and posttranscriptional mechanisms underlie the mammalian circadian clock. We also find that circadian modulation of RNAPII recruitment and chromatin remodeling occurs on a genome-wide scale far greater than that seen previously by gene expression profiling.	[Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Kim, Tae-Kyung; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Kim, Tae-Kyung/AAX-4230-2020; Koike, Nobuya/G-1116-2016; Takahashi, Joseph S./Y-2781-2019; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Kim, Tae-Kyung/0000-0001-5161-9864; Takahashi, Joseph S./0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465	Howard Hughes Medical Institute; Whitehall Foundation grant; NIH [R01 NS053616, F32 DA024556]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Whitehall Foundation grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute (J.S.T.), Whitehall Foundation grant (T.-K.K.), and NIH grants R01 NS053616 (C. L.) and F32 DA024556 (V. K.). We thank H. Hobbs and D. Mangelsdorf for helpful discussions and support; B. Crider, V. Schmid, A. Guillory, S. Hildebrand, J. Knepper, J. Denton, S. Niu, and the McDermott Next Generation Sequencing Facility for outstanding technical and computational support; and S. L. McKnight for NPAS2 antibody. J. S. T. is an Investigator and S.-H.Y. and V. K. were Associates in the Howard Hughes Medical Institute. J. S. T. is a cofounder of, a Scientific Advisory Board member of, and a paid consultant for Reset Therapeutics, Incorporated, a biotechnology company aimed at discovering small-molecule therapies that modulate circadian activity for a variety of disease indications. ChIP-seq and RNA-seq data sets have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through GEO Series accession number GSE39860 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39860).	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka S. M., 2007, CELL, V129, P1011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WUARIN J, 1992, J CELL SCI, P123; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	876	902	5	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					349	354		10.1126/science.1226339	http://dx.doi.org/10.1126/science.1226339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936566	Green Accepted			2022-12-01	WOS:000309955800033
J	Tritsch, NX; Ding, JB; Sabatini, BL				Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.			Dopaminergic neurons inhibit striatal output through non-canonical release of GABA	NATURE			English	Article							NUCLEUS-ACCUMBENS; DORSAL STRIATUM; GLUTAMATE; RAT; CORELEASE; NEUROTRANSMISSION; COLOCALIZATION; EXPRESSION; CIRCUITS; PATHWAY	The substantia nigra pars compacta and ventral tegmental area contain the two largest populations of dopamine-releasing neurons in the mammalian brain. These neurons extend elaborate projections in the striatum, a large subcortical structure implicated in motor planning and reward-based learning. Phasic activation of dopaminergic neurons in response to salient or reward-predicting stimuli is thought to modulate striatal output through the release of dopamine to promote and reinforce motor action(1-4). Here we show that activation of dopamine neurons in striatal slices rapidly inhibits action potential firing in both direct-and indirect-pathway striatal projection neurons through vesicular release of the inhibitory transmitter GABA (gamma-aminobutyric acid). GABA is released directly from dopaminergic axons but in a manner that is independent of the vesicular GABA transporter VGAT. Instead, GABA release requires activity of the vesicular monoamine transporter VMAT2, which is the vesicular transporter for dopamine. Furthermore, VMAT2 expression in GABAergic neurons lacking VGAT is sufficient to sustain GABA release. Thus, these findings expand the repertoire of synaptic mechanisms used by dopamine neurons to influence basal ganglia circuits, show a new substrate whose transport is dependent on VMAT2 and demonstrate that GABA can function as a bona fide co-transmitter in monoaminergic neurons.	[Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Ding, Jun/B-2513-2009; Tritsch, Nicolas/U-5266-2019	Ding, Jun/0000-0003-0690-1312; Tritsch, Nicolas/0000-0003-3181-7681	Nancy Lurie Marks Family Foundation; National Institutes of Health [NS046579, 4R00NS075136]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R00NS075136, R01NS046579] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Saunders and Y. Kozorovitskiy for generating and characterizing the AAV-DIO-EGFP and AAV-DIO-VGAT constructs, D. Sulzer and H. Zhang for assistance with amperometry, R. Shah and C. Johnson for technical support, and members of the laboratory for discussions. This work was supported by a Nancy Lurie Marks Family Foundation postdoctoral fellowship (N.X.T.) and by grants from the National Institutes of Health (NS046579 to B. L. S. and 4R00NS075136 to J.B.D.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broadbelt KG, 2010, AUTON NEUROSCI-BASIC, V154, P30, DOI 10.1016/j.autneu.2009.10.002; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Gonzalez-Hernandez T, 2004, MOVEMENT DISORD, V19, P1029, DOI 10.1002/mds.20206; Hirasawa H, 2009, J NEUROPHYSIOL, V102, P146, DOI 10.1152/jn.00130.2009; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; IIJIMA K, 1993, HISTOL HISTOPATHOL, V8, P581; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ramirez M, 2001, BRAIN RES, V917, P139, DOI 10.1016/S0006-8993(01)02794-9; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Trottier S, 2002, BRAIN RES, V939, P52, DOI 10.1016/S0006-8993(02)02546-5; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6	36	359	362	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					262	+		10.1038/nature11466	http://dx.doi.org/10.1038/nature11466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23034651	Green Submitted, Green Accepted			2022-12-01	WOS:000309733300050
J	Leathers, ML; Olson, CR				Leathers, Marvin L.; Olson, Carl R.			In Monkeys Making Value-Based Decisions, LIP Neurons Encode Cue Salience and Not Action Value	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; REWARD VALUE; ATTENTION; CHOICE; NEUROBIOLOGY; INFORMATION	In monkeys deciding between alternative saccadic eye movements, lateral intraparietal (LIP) neurons representing each saccade fire at a rate proportional to the value of the reward expected upon its completion. This observation has been interpreted as indicating that LIP neurons encode saccadic value and that they mediate value-based decisions between saccades. Here, we show that LIP neurons representing a given saccade fire strongly not only if it will yield a large reward but also if it will incur a large penalty. This finding indicates that LIP neurons are sensitive to the motivational salience of cues. It is compatible neither with the idea that LIP neurons represent action value nor with the idea that value-based decisions take place in LIP neurons.	[Leathers, Marvin L.; Olson, Carl R.] Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Leathers, Marvin L.; Olson, Carl R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leathers, ML (corresponding author), Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	mleathers@cnbc.cmu.edu			NIH [RO1 EY018620, P50 MH45156, P30 EY08098, P41RR03631]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018620, P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Ruff for comments and K. McCracken for technical assistance. Support: NIH RO1 EY018620 and NIH P50 MH45156. Technical support: NIH P30 EY08098 and P41RR03631.	Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Berridge KC, 2003, WELL BEING FDN HEDON, P525; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brosch T, 2011, NEUROPSYCHOLOGIA, V49, P1779, DOI 10.1016/j.neuropsychologia.2011.02.056; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cai X., 2010, NEUR M SOC NEUR SA D; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Mirpour K, 2012, P NATL ACAD SCI USA, V109, P10083, DOI 10.1073/pnas.1120763109; O'Brien JL, 2012, PSYCHOL SCI, V23, P359, DOI 10.1177/0956797611429800; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	30	98	98	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					132	135		10.1126/science.1226405	http://dx.doi.org/10.1126/science.1226405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042897	Green Accepted			2022-12-01	WOS:000309457400070
J	Patel, K				Patel, Kinesh			Tax calories to end the buffet syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 3	2012	345								e6674	10.1136/bmj.e6674	http://dx.doi.org/10.1136/bmj.e6674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KZ	23034861				2022-12-01	WOS:000309660600002
J	Seifert, AW; Kiama, SG; Seifert, MG; Goheen, JR; Palmer, TM; Maden, M				Seifert, Ashley W.; Kiama, Stephen G.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.; Maden, Malcolm			Skin shedding and tissue regeneration in African spiny mice (Acomys)	NATURE			English	Article							HAIR FOLLICLE DEVELOPMENT; LIMB REGENERATION; WOUND REPAIR; DIFFERENTIATION; EXPRESSION; AUTOTOMY; NEWT	Evolutionary modification has produced a spectrum of animal defence traits to escape predation, including the ability to autotomize body parts to elude capture(1,2). After autotomy, the missing part is either replaced through regeneration (for example, in urodeles, lizards, arthropods and crustaceans) or permanently lost (such as in mammals). Although most autotomy involves the loss of appendages (legs, chelipeds, antennae or tails, for example), skin autotomy can occur in certain taxa of scincid and gekkonid lizards(3). Here we report the first demonstration of skin autotomy in Mammalia (African spiny mice, Acomys). Mechanical testing showed a propensity for skin to tear under very low tension and the absence of a fracture plane. After skin loss, rapid wound contraction was followed by hair follicle regeneration in dorsal skin wounds. Notably, we found that regenerative capacity in Acomys was extended to ear holes, where the mice exhibited complete regeneration of hair follicles, sebaceous glands, dermis and cartilage. Salamanders capable of limb regeneration form a blastema (a mass of lineage-restricted progenitor cells(4)) after limb loss, and our findings suggest that ear tissue regeneration in Acomys may proceed through the assembly of a similar structure. This study underscores the importance of investigating regenerative phenomena outside of conventional model organisms, and suggests that mammals may retain a higher capacity for regeneration than was previously believed. As re-emergent interest in regenerative medicine seeks to isolate molecular pathways controlling tissue regeneration in mammals, Acomys may prove useful in identifying mechanisms to promote regeneration in lieu of fibrosis and scarring.	[Seifert, Ashley W.; Seifert, Megan G.; Palmer, Todd M.; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Seifert, Ashley W.; Kiama, Stephen G.] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi 00010, Kenya; [Seifert, Ashley W.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA	State University System of Florida; University of Florida; University of Nairobi; University of Wyoming; University of Wyoming	Seifert, AW (corresponding author), Univ Florida, Dept Biol, 223 Bartram Hall,POB 118525, Gainesville, FL 32610 USA.	seifert@ufl.edu	Palmer, Todd/GRS-0639-2022; Kiama, Stephen Gitahi/C-9595-2016	Kiama, Stephen Gitahi/0000-0002-0217-6283; Seifert, Ashley/0000-0001-6576-3664; Palmer, Todd/0000-0001-5710-9750	NIDDK NIH HHS [T32 DK074367] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; [Anonymous], 1979, STEREOLOGICAL METHOD; BAUER AM, 1989, J EXP BIOL, V145, P79; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; BREEDIS C, 1954, CANCER RES, V14, P575; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; DUBOST G, 1987, J ZOOL, V212, P563, DOI 10.1111/j.1469-7998.1987.tb02924.x; GLOBUS M, 1980, DEV BIOL, V75, P358, DOI 10.1016/0012-1606(80)90169-4; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kiama SG, 2001, J ZOOL, V254, P521, DOI 10.1017/S0952836901001029; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; Neufeld DA, 1996, ANAT RECORD, V246, P155; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Shargal E, 1999, J ZOOL, V249, P187, DOI 10.1111/j.1469-7998.1999.tb00757.x; Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024; VOGEL HG, 1974, CONNECT TISSUE RES, V2, P177, DOI 10.3109/03008207409152242; Vorontsova M. A., 1960, ASEXUAL PROPAGATION, P377; Yannas I.V., 2001, REGENERATION SKIN	31	321	327	4	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					561	+		10.1038/nature11499	http://dx.doi.org/10.1038/nature11499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	23018966	Green Accepted			2022-12-01	WOS:000311781500003
J	Thompson, AW; Foster, RA; Krupke, A; Carter, BJ; Musat, N; Vaulot, D; Kuypers, MMM; Zehr, JP				Thompson, Anne W.; Foster, Rachel A.; Krupke, Andreas; Carter, Brandon J.; Musat, Niculina; Vaulot, Daniel; Kuypers, Marcel M. M.; Zehr, Jonathan P.			Unicellular Cyanobacterium Symbiotic with a Single-Celled Eukaryotic Alga	SCIENCE			English	Article							PHYTOPLANKTON; FIXATION	Symbioses between nitrogen (N)(2)-fixing prokaryotes and photosynthetic eukaryotes are important for nitrogen acquisition in N-limited environments. Recently, a widely distributed planktonic uncultured nitrogen-fixing cyanobacterium (UCYN-A) was found to have unprecedented genome reduction, including the lack of oxygen-evolving photosystem II and the tricarboxylic acid cycle, which suggested partnership in a symbiosis. We showed that UCYN-A has a symbiotic association with a unicellular prymnesiophyte, closely related to calcifying taxa present in the fossil record. The partnership is mutualistic, because the prymnesiophyte receives fixed N in exchange for transferring fixed carbon to UCYN-A. This unusual partnership between a cyanobacterium and a unicellular alga is a model for symbiosis and is analogous to plastid and organismal evolution, and if calcifying, may have important implications for past and present oceanic N-2 fixation.	[Thompson, Anne W.; Carter, Brandon J.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Foster, Rachel A.; Krupke, Andreas; Musat, Niculina; Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Vaulot, Daniel] Univ Paris 06, F-29680 Roscoff, France; [Vaulot, Daniel] CNRS, UMR 7144, Biol Stn, F-29680 Roscoff, France	University of California System; University of California Santa Cruz; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Zehr, Jonathan P/B-3513-2014; Musat, Niculina/ABA-2180-2021; Vaulot, Daniel/T-6649-2019	Zehr, Jonathan P/0000-0002-5691-5408; Musat, Niculina/0000-0001-9539-189X; Vaulot, Daniel/0000-0002-0717-5685; Thompson, Anne/0000-0002-2022-9553; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation; NSF Center for Microbial Oceanography: Research and Education (C-MORE); Max Planck Society; PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union [287589]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union(European Commission)	D. Bottjer and M. Hogan provided advice for <SUP>15</SUP>N<INF>2</INF> additions. Water samples were collected with the help of S. Curless, M. Church, S. Wilson, S. Tozzi, and the captain and crew of the research vessel Kilo Moana. On-board flow cytometry was made possible by K. Doggett and D. Karl. Funding was provided by the Gordon and Betty Moore Foundation (J.P.Z.) and the NSF Center for Microbial Oceanography: Research and Education (C-MORE). The Max Planck Society sponsored the HISH-SIMS analysis. We thank G. Lavik (Max Planck Institute, Bremen) for advice and suggestions for data analysis. J. Waterbury provided the scientific name for UCYN-A. D. V. was supported by PHYTOMETAGENE (JST-CNRS), METAPICO (Genoscope), and Micro B3 (funded by the European Union, contract 287589). BIOSOPE metagenome sequencing was performed at Genoscope (French National Sequencing Center) by J. Poulain. We thank H. Claustre, A. Sciandra, D. Marie, and all other BIOSOPE cruise participants. GenBank accession nos.: JX291679 to JX291804 and JX291547 to JX291678 (see table S4 for details).	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Bothe H, 2010, ARCH MICROBIOL, V192, P783, DOI 10.1007/s00203-010-0621-5; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Carpenter EJ, 2002, CYANOBACTERIA IN SYMBIOSIS, P11; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DEFLANDRE G, 1947, CR HEBD ACAD SCI, V225, P439; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Foster RA, 2006, J PHYCOL, V42, P453, DOI 10.1111/j.1529-8817.2006.00206.x; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; GRAN H. H., 1935, JOUR BIOL BD CANADA, V1, P279; GREEN JC, 1972, J MAR BIOL ASSOC UK, V52, P469, DOI 10.1017/S002531540001883X; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hagino K, 2009, MAR MICROPALEONTOL, V72, P210, DOI 10.1016/j.marmicro.2009.06.001; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Saez AG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P251; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Siesser W.G., 1992, Proceedings of the Ocean Drilling Program Scientific Results, V122, P653, DOI 10.2973/odp.proc.sr.122.163.1992; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; TAYLOR FJR, 1982, ANN I OCEANOGR PARIS, V58, P61; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	32	315	328	8	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1546	1550		10.1126/science.1222700	http://dx.doi.org/10.1126/science.1222700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997339				2022-12-01	WOS:000308912900053
J	Roland, M; Abel, G				Roland, Martin; Abel, Gary			Reducing emergency admissions: are we on the right track?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL; HOSPITALIZATIONS; IMPACT; CARE		[Roland, Martin; Abel, Gary] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England.	mr108@cam.ac.uk	Abel, Gary/ABE-1765-2021	Abel, Gary/0000-0003-2231-5161; Roland, Martin/0000-0002-8533-3060				Blunt I, 2010, TRENDS EMERGENCY ADM; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Department of Health, 2010, PAYM RES BACKGR; Evidence Adoption Centre, 2011, EFF PRED MOD TOOLS I; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; King's Health Partners, INT CAR PROGR; Munro J, 2005, BRIT J GEN PRACT, V55, P790; NHS Information Centre, 2011, HOSP EP STAT HEADL F; Northamptonshire Observatory, JOINT STRAT NEEDS AS; Nuffield Trust, 2011, PRED RISK HLTH CAR O; Ovretveit J., 2009, DOES IMPROVING QUALI; Powell Davies G, 2006, COORDINATION CARE PR; Purdy S, 2012, INTERVENTIONS REDUCE; Purdy S., 2010, AVOIDING HOSP ADMISS; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; Roland M., 2012, INT J INTEGRATED CAR, V12; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sargent P, 2008, J NURS MANAGE, V16, P38, DOI 10.1111/j.1365-2934.2007.00785.x; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256; Wennberg D, 2006, COMBINED PREDICTIVE	21	78	78	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 18	2012	345								e6017	10.1136/bmj.e6017	http://dx.doi.org/10.1136/bmj.e6017			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JH	22990102				2022-12-01	WOS:000309160400006
J	Pal, A; Barber, TM; Van de Bunt, M; Rudge, SA; Zhang, QF; Lachlan, KL; Cooper, NS; Linden, H; Levy, JC; Wakelam, MJO; Walker, L; Karpe, F; Gloyn, AL				Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Rudge, Simon A.; Zhang, Qifeng; Lachlan, Katherine L.; Cooper, Nicola S.; Linden, Helen; Levy, Jonathan C.; Wakelam, Michael J. O.; Walker, Lisa; Karpe, Fredrik; Gloyn, Anna L.			PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL GLUCOSE-TOLERANCE; PROSTATE-CANCER RISK; PLASMA ADIPONECTIN; TUMOR-SUPPRESSOR; RESISTANCE; HOMEOSTASIS; DELETION; PTEN/MMAC1; PROTECTS; MODEL	Background Epidemiologic and genetic evidence links type 2 diabetes, obesity, and cancer. The tumor-suppressor phosphatase and tensin homologue (PTEN) has roles in both cellular growth and metabolic signaling. Germline PTEN mutations cause a cancer-predisposition syndrome, providing an opportunity to study the effect of PTEN haploinsufficiency in humans. Methods We measured insulin sensitivity and beta-cell function in 15 PTEN mutation carriers and 15 matched controls. Insulin signaling was measured in muscle and adipose-tissue biopsy specimens from 5 mutation carriers and 5 well-matched controls. We also assessed the effect of PTEN haploinsufficiency on obesity by comparing anthropometric indexes between the 15 patients and 2097 controls from a population-based study of healthy adults. Body composition was evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness. Results Measures of insulin resistance were lower in the patients with a PTEN mutation than in controls (e.g., mean fasting plasma insulin level, 29 pmol per liter [range, 9 to 99] vs. 74 pmol per liter [range, 22 to 185]; P = 0.001). This finding was confirmed with the use of hyperinsulinemic euglycemic clamping, showing a glucose infusion rate among carriers 2 times that among controls (P = 0.009). The patients' insulin sensitivity could be explained by the presence of enhanced insulin signaling through the PI3K-AKT pathway, as evidenced by increased AKT phosphorylation. The PTEN mutation carriers were obese as compared with population-based controls (mean body-mass index [the weight in kilograms divided by the square of the height in meters], 32 [range, 23 to 42] vs. 26 [range, 15 to 48]; P<0.001). This increased body mass in the patients was due to augmented adiposity without corresponding changes in fat distribution. Conclusions PTEN haploinsufficiency is a monogenic cause of profound constitutive insulin sensitization that is apparently obesogenic. We demonstrate an apparently divergent effect of PTEN mutations: increased risks of obesity and cancer but a decreased risk of type 2 diabetes owing to enhanced insulin sensitivity. (Funded by the Wellcome Trust and others.)	[Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England; [Pal, Aparna; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Linden, Helen; Walker, Lisa] Churchill Hosp, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Inositide Lab, Cambridge, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Lachlan, Katherine L.] Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Lachlan, Katherine L.] Univ Southampton, Fac Med, Dept Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Cooper, Nicola S.] Birmingham Womens Hosp, W Midlands Reg Clin Genet Serv, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Southampton; University of Southampton; Birmingham Women's Hospital	Gloyn, AL (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.	anna.gloyn@drl.ox.ac.uk	LACHLAN, KATHERINE/ABH-6991-2020	LACHLAN, KATHERINE/0000-0002-3816-7346; Wakelam, Michael/0000-0003-4059-9276; Karpe, Fredrik/0000-0002-2751-1770; Levy, Jonathan/0000-0002-9486-1885; van de Bunt, Martijn/0000-0002-6744-6125; Gloyn, Anna/0000-0003-1205-1844	Wellcome Trust [095101/Z/10Z]; Medical Research Council [G0700222, G0800467]; National Institute for Health Research Oxford Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; European Union Seventh Framework Program LipodomicNet [202272]; BBSRC [BBS/E/B/0000C227, BBS/E/B/000C0415, BBS/E/B/000C0413] Funding Source: UKRI; MRC [G0700222, G0800467] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C227, BBS/E/B/000C0413, BBS/E/B/000C0415] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Seventh Framework Program LipodomicNet; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the Wellcome Trust and others.; Supported by grants from the Wellcome Trust (095101/Z/10Z, to Dr. Gloyn), the Medical Research Council (G0700222, to Dr. Gloyn; and G0800467, to Drs. Pal and Gloyn), the National Institute for Health Research Oxford Biomedical Research Centre (to Drs. Pal, Karpe, and Gloyn), the Biotechnology and Biological Sciences Research Council (to Drs. Rudge, Zhang, and Wakelam), and the European Union Seventh Framework Program LipodomicNet (202272, for adipocyte signaling work, to Drs. Wakelam and Karpe).	Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Goberdhan DCI, 2003, HUM MOL GENET, V12, pR239, DOI 10.1093/hmg/ddg288; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Holly JMP, 2008, BEST PRACT RES CL EN, V22, P539, DOI 10.1016/j.beem.2008.07.007; Iida S, 2000, ANTICANCER RES, V20, P1901; Karpe F, 2005, BIOCHEM SOC T, V33, P1045, DOI 10.1042/BST0331045; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Semple RK, 2006, J CLIN ENDOCR METAB, V91, P3219, DOI 10.1210/jc.2006-0166; Smith U, 2010, DIABETOLOGIA, V53, P1541, DOI 10.1007/s00125-010-1815-8; Stiles B, 2004, P NATL ACAD SCI USA, V101, P5180, DOI 10.1073/pnas.0401220101; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x	32	164	168	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1002	1011		10.1056/NEJMoa1113966	http://dx.doi.org/10.1056/NEJMoa1113966			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970944	Green Accepted			2022-12-01	WOS:000308649100006
J	Pohlker, C; Wiedemann, KT; Sinha, B; Shiraiwa, M; Gunthe, SS; Smith, M; Su, H; Artaxo, P; Chen, Q; Cheng, YF; Elbert, W; Gilles, MK; Kilcoyne, ALD; Moffet, RC; Weigand, M; Martin, ST; Poeschl, U; Andreae, MO				Poehlker, Christopher; Wiedemann, Kenia T.; Sinha, Baerbel; Shiraiwa, Manabu; Gunthe, Sachin S.; Smith, Mackenzie; Su, Hang; Artaxo, Paulo; Chen, Qi; Cheng, Yafang; Elbert, Wolfgang; Gilles, Mary K.; Kilcoyne, Arthur L. D.; Moffet, Ryan C.; Weigand, Markus; Martin, Scot T.; Poeschl, Ulrich; Andreae, Meinrat O.			Biogenic Potassium Salt Particles as Seeds for Secondary Organic Aerosol in the Amazon	SCIENCE			English	Article							LIQUID PHASE-SEPARATION; ATMOSPHERE; FOREST; BASIN; RELEASE; NUCLEI; SULFUR; CLOUDS; CARBON; WET	The fine particles serving as cloud condensation nuclei in pristine Amazonian rainforest air consist mostly of secondary organic aerosol. Their origin is enigmatic, however, because new particle formation in the atmosphere is not observed. Here, we show that the growth of organic aerosol particles can be initiated by potassium-salt-rich particles emitted by biota in the rainforest. These particles act as seeds for the condensation of low- or semi-volatile organic compounds from the atmospheric gas phase or multiphase oxidation of isoprene and terpenes. Our findings suggest that the primary emission of biogenic salt particles directly influences the number concentration of cloud condensation nuclei and affects the microphysics of cloud formation and precipitation over the rainforest.	[Poehlker, Christopher; Shiraiwa, Manabu; Gunthe, Sachin S.; Su, Hang; Cheng, Yafang; Elbert, Wolfgang; Poeschl, Ulrich; Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Wiedemann, Kenia T.; Artaxo, Paulo] Univ Sao Paulo, Inst Phys, BR-05508900 Sao Paulo, Brazil; [Wiedemann, Kenia T.; Smith, Mackenzie; Chen, Qi; Martin, Scot T.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wiedemann, Kenia T.] Univ Arizona, Ecol & Evolutionary Biol Dept, Tucson, AZ 85721 USA; [Sinha, Baerbel] Max Planck Inst Chem, Particle Chem Dept, D-55020 Mainz, Germany; [Sinha, Baerbel] Indian Inst Sci Educ & Res Mohali, Dept Earth & Environm Sci, Sas Nagar, Manauli PO, India; [Shiraiwa, Manabu] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Gunthe, Sachin S.; Moffet, Ryan C.] Indian Inst Technol, Environm & Water Resources Engn Div, Dept Civil Engn, Madras 600036, Tamil Nadu, India; [Gilles, Mary K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Kilcoyne, Arthur L. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Moffet, Ryan C.] Univ Pacific, Dept Chem, Stockton, CA 95211 USA; [Weigand, Markus] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	Max Planck Society; Universidade de Sao Paulo; Harvard University; University of Arizona; Max Planck Society; Indian Institute of Science Education & Research (IISER) - Mohali; California Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of the Pacific; Max Planck Society	Pohlker, C (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	c.pohlker@mpic.de; u.poschl@mpic.de; u.poschl@mpic.de	Martin, Scot/G-1094-2015; Artaxo, Paulo/E-8874-2010; Pöschl, Ulrich/A-6263-2010; Shiraiwa, Manabu/A-6246-2010; Sinha, Baerbel/H-1250-2012; Gunthe, Sachin/A-1970-2010; Pöhlker, Christopher/S-5207-2016; Su, Hang/A-6226-2010; Andreae, Meinrat O./B-1068-2008; Cheng, Yafang/F-9362-2010; Gunthe, Sachin/E-4934-2016; Kilcoyne, Arthur A L/I-1465-2013	Martin, Scot/0000-0002-8996-7554; Artaxo, Paulo/0000-0001-7754-3036; Pöschl, Ulrich/0000-0003-1412-3557; Shiraiwa, Manabu/0000-0003-2532-5373; Sinha, Baerbel/0000-0001-8614-7473; Pöhlker, Christopher/0000-0001-6958-425X; Su, Hang/0000-0003-4889-1669; Andreae, Meinrat O./0000-0003-1968-7925; Cheng, Yafang/0000-0003-4912-9879; Gunthe, Sachin/0000-0002-7903-7783; Kilcoyne, Arthur A L/0000-0002-8805-8690; Moffet, Ryan/0000-0002-2352-5454	Max Planck Society; Max Planck Graduate Center; Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS) [FP7-265148]; Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE) [DE-FG02-08ER6452]; U.S. NSF [0925467]; Office of Science, BES, of the U.S. DOE [DE-AC02-05CH11231]	Max Planck Society(Max Planck Society); Max Planck Graduate Center(Max Planck Society); Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS); Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE); U.S. NSF(National Science Foundation (NSF)); Office of Science, BES, of the U.S. DOE(United States Department of Energy (DOE))	This work has been supported by the Max Planck Society, the Max Planck Graduate Center, the Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz), and the European Community (PEGASOS, FP7-265148). The Harvard Environmental Chamber was supported by the Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE), grant no. DE-FG02-08ER6452, and the U.S. NSF under grant no. 0925467. The Advanced Light Source is supported by the Director, Office of Science, BES, of the U.S. DOE under contract no. DE-AC02-05CH11231. We thank the Helmholtz-Zentrum Berlin for the allocation of synchrotron radiation beamtime at BESSY II. We thank the Instituto Nacional de Pesquisas da Amazonia (INPA), Manaus, and the ATTO team under the Brazilian coordinator, A. O. Manzi, for their collaboration and field support. We also thank G. R. Carmichael and the Center for Global and Regional Environmental Research at the University of Iowa for support in the Weather Research and Forecasting (WRF) model simulations. We gratefully acknowledge R. Ditz, I. Trebs, X. Chi, J. A. Huffman, J. Kesselmeier, J. Schongart, M. Kuwata, T. Tyliszczak, J. Huth, G. Schutz, E. Goering, M. Bechtel, J.-D. Forster, and T. Behrendt for support and helpful discussions.	Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; ANDREAE MO, 1983, SCIENCE, V220, P1148, DOI 10.1126/science.220.4602.1148; ARTAXO P, 1990, J GEOPHYS RES-ATMOS, V95, P16971, DOI 10.1029/JD095iD10p16971; ARTAXO P, 1995, ATMOS ENVIRON, V29, P393, DOI 10.1016/1352-2310(94)00178-N; BEAUFORD W, 1975, NATURE, V256, P35, DOI 10.1038/256035a0; BEAUFORD W, 1977, SCIENCE, V195, P571, DOI 10.1126/science.195.4278.571; Bertram AK, 2011, ATMOS CHEM PHYS, V11, P10995, DOI 10.5194/acp-11-10995-2011; Chen Q, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039880; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; CROZAT G, 1979, TELLUS, V31, P52, DOI 10.1111/j.2153-3490.1979.tb00881.x; Ekman AML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034970; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; GOATLEY JL, 1966, PLANT PHYSIOL, V41, P373, DOI 10.1104/pp.41.3.373; Gunthe SS, 2009, ATMOS CHEM PHYS, V9, P7551, DOI 10.5194/acp-9-7551-2009; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; LAWSON DR, 1978, GEOPHYS RES LETT, V5, P195, DOI 10.1029/GL005i003p00195; LAWSON DR, 1979, J GEOPHYS RES-OC ATM, V84, P3723, DOI 10.1029/JC084iC07p03723; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002310; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Martin ST, 2010, REV GEOPHYS, V48, DOI 10.1029/2008RG000280; NEMERYUK G E, 1970, Soviet Plant Physiology, V17, P560; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Solomon S., 2007, 4 IPCC; Song M, 2012, ATMOS CHEM PHYS, V12, P2691, DOI 10.5194/acp-12-2691-2012; Spracklen DV, 2006, ATMOS CHEM PHYS, V6, P5631, DOI 10.5194/acp-6-5631-2006; Tivanski AV, 2007, J PHYS CHEM A, V111, P5448, DOI 10.1021/jp070155u; Weigel R, 2011, ATMOS CHEM PHYS, V11, P9983, DOI 10.5194/acp-11-9983-2011; Worobiec A, 2007, ATMOS ENVIRON, V41, P9217, DOI 10.1016/j.atmosenv.2007.07.056; Zuend A, 2012, ATMOS CHEM PHYS, V12, P3857, DOI 10.5194/acp-12-3857-2012	31	133	135	13	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1075	1078		10.1126/science.1223264	http://dx.doi.org/10.1126/science.1223264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936773				2022-12-01	WOS:000308125800041
J	Sutcliffe, AG; Barnes, J; Belsky, J; Gardiner, J; Melhuish, E				Sutcliffe, Alastair G.; Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward			The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data	BRITISH MEDICAL JOURNAL			English	Article							YOUNG MATERNAL AGE; PATERNAL AGE; RISK; SCHIZOPHRENIA; OUTCOMES; AUTISM	Objective To assess relations between children's health and development and maternal age. Design Observational study of longitudinal cohorts. Setting Millennium Cohort Study (a random sample of UK children) and the National Evaluation of Sure Start study (a random sample of children in deprived areas in England), 2001 to 2007. Participants 31 257 children at age 9 months, 24 781 children at age 3 years, and 22 504 at age 5 years. Main outcome measures Childhood unintentional injuries and hospital admissions (aged 9 months, 3 years, and 5 years), immunisations (aged 9 months and 3 years), body mass index, language development, and difficulties with social development (aged 3 and 5 years). Results Associations were independent of personal and family characteristics and parity. The risk of children having unintentional injuries requiring medical attention or being admitted to hospital both declined with increasing maternal age. For example, at three years the risk of unintentional injuries declined from 36.6% for mothers aged 20 to 28.6% for mothers aged 40 and hospital admissions declined, respectively, from 27.1% to 21.6%. Immunisation rates at nine months increased with maternal age from 94.6% for mothers aged 20 to 98.1% for mothers aged 40. At three years, immunisation rates reached a maximum, at 81.3% for mothers aged 27, being lower for younger and older mothers. This was linked to rates for the combined measles, mumps, and rubella immunisation because excluding these resulted in no significant relation with maternal age. An increase in overweight children at ages 3 and 5 years associated with increasing maternal age was eliminated once maternal body mass index was included as a covariate. Language development was associated with improvements with increasing maternal age, with scores for children of mothers aged 20 being lower than those of children of mothers aged 40 by 0.21 to 0.22 standard deviations at ages 3 and 4 years. There were fewer social and emotional difficulties associated with increasing maternal age. Children of teenage mothers had more difficulties than children of mothers aged 40 (difference 0.28 SD at age 3 and 0.16 SD at age 5). Conclusion Increasing maternal age was associated with improved health and development for children up to 5 years of age.	[Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward] Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England; [Sutcliffe, Alastair G.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Belsky, Jay] Univ Calif Davis, Davis, CA 95616 USA	University of London; Birkbeck University London; University of London; University College London; University of California System; University of California Davis	Melhuish, E (corresponding author), Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England.	e.melhuish@bbk.ac.uk	Gardiner, Julian/AAO-2583-2020	Belsky, Jay/0000-0003-2191-2503; Gardiner, Julian/0000-0001-8988-3812; Sutcliffe, Alastair/0000-0001-8542-6155	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust through a grant entitled "Health of children born to older mothers"; the funding body had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors are independent of the funding agency.	Berryman J., 1995, OLDER MOTHERS CONCEP; Botting B, 1998, Popul Trends, P19; Centers for Disease Control and Prevention, 2010, PERC DAT FIL LMS VAL; Centers for Disease Control and Prevention, 2007, MEASL MUMPS RUB MMR; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dex S, 2004, MILLENNIUM COHORT ST; Eisenberg DTA, 2012, P NATL ACAD SCI US; Elliott C., 1996, BRIT ABILITY SCALES; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hesterberg T, 1998, 75 MATHSOFT; Honaker J, 2010, AMELIA 2 R PACKAGE; Irwin LG, 2007, EARLY CHILD DEV POWE; Kiernan KE, 2009, MATERNAL INDICATORS; Martin JA, 2004, NATL VITAL STAT REPO, V55; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Noble M, 2000, MEASURING MULTIPLE D; Office for National Statistics, 2007, SER FM1, V35; Phipps MG, 2002, OBSTET GYNECOL, V100, P481, DOI 10.1016/S0029-7844(02)02172-5; Plewis I., 2007, MILLENNIUM COHORT ST; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Statistics New Zealand, 2012, BIRTHS DEATHS YEAR E; Sutcliffe A, 2009, REPROD AGEING, P173; Venables WN, MASS R PACKAGE; Vohr BR, 2009, J PEDIATR-US, V154, P498, DOI 10.1016/j.jpeds.2008.10.044; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Zammit S, 2003, BRIT J PSYCHIAT, V183, P405, DOI 10.1192/bjp.183.5.405	31	75	76	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 21	2012	345								e5116	10.1136/bmj.e5116	http://dx.doi.org/10.1136/bmj.e5116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915663	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-01	WOS:000308073200001
J	Friedmann-Morvinski, D; Bushong, EA; Ke, E; Soda, Y; Marumoto, T; Singer, O; Ellisman, MH; Verma, IM				Friedmann-Morvinski, Dinorah; Bushong, Eric A.; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Ellisman, Mark H.; Verma, Inder M.			Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice	SCIENCE			English	Article							NEURAL STEM-CELLS; MOUSE MODELS; BRAIN; GLIOBLASTOMA; ORIGIN; NF1; NEUROGENESIS; PROGRESSION; EXPRESSION; DISEASE	Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here we show that gliomas can originate from differentiated cells in the central nervous system (CNS), including cortical neurons. Transduction by oncogenic lentiviral vectors of neural stem cells (NSCs), astrocytes, or even mature neurons in the brains of mice can give rise to malignant gliomas. All the tumors, irrespective of the site of lentiviral vector injection (the initiating population), shared common features of high expression of stem or progenitor markers and low expression of differentiation markers. Microarray analysis revealed that tumors of astrocytic and neuronal origin match the mesenchymal GBM subtype. We propose that most differentiated cells in the CNS upon defined genetic alterations undergo dedifferentiation to generate a NSC or progenitor state to initiate and maintain the tumor progression, as well as to give rise to the heterogeneous populations observed in malignant gliomas.	[Friedmann-Morvinski, Dinorah; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ke, Eugene] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Marumoto, Tomotoshi] Kyushu Univ, Dept Mol Genet, Div Mol & Clin Genet, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyushu University	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH) [HL053670]; Cancer Center Core Grant [P30 CA014195-38]; Ipsen/Biomeasure; Sanofi Aventis; H. N. and Frances C. Berger Foundation; National Center for Research Resources [5P41RR004050]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; Ipsen/Biomeasure; Sanofi Aventis(Sanofi-Aventis); H. N. and Frances C. Berger Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Estepa for her technical help, F. H. Gage and S. Subramaniam for useful discussions, and N. Varki and S. Kesari for pathological analysis. I. M. V. is an American Cancer Society Professor of Molecular Biology and holds the Irwin and Joan Jacobs Chair in Exemplary Life Sciences. D. F.-M. was supported by a fellowship from the European Molecular Biology Organization. This work was supported in part by grants from the National Institutes of Health (NIH) (HL053670), a Cancer Center Core Grant (P30 CA014195-38), Ipsen/Biomeasure, Sanofi Aventis, the H. N. and Frances C. Berger Foundation, and National Center for Research Resources grant 5P41RR004050 to M. H. E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or NIH. Microarray data have been deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE35917). The authors (T. M., I. M. V., and Y.S.) and the Salk Institute have filed a patent application relating to mouse tumor models created with lentiviral vectors.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hide T, 2011, STEM CELLS, V29, P590, DOI 10.1002/stem.618; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Price DL, 2006, NEUROINFORMATICS, V4, P65, DOI 10.1385/NI:4:1:65; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	23	367	380	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1080	1084		10.1126/science.1226929	http://dx.doi.org/10.1126/science.1226929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23087000	Green Accepted			2022-12-01	WOS:000311390600044
J	Litvak, V; Ratushny, AV; Lampano, AE; Schmitz, F; Huang, AC; Raman, A; Rust, AG; Bergthaler, A; Aitchison, JD; Aderem, A				Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Huang, Albert C.; Raman, Ayush; Rust, Alistair G.; Bergthaler, Andreas; Aitchison, John D.; Aderem, Alan			A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; HISTONE ACETYLATION; EXPRESSION; ACTIVATION; DATABASE; CELLS	Antiviral responses must be tightly regulated to defend rapidly against infection while minimizing inflammatory damage. Type 1 interferons (IFN-I) are crucial mediators of antiviral responses(1) and their transcription is regulated by a variety of transcription factors(2); principal among these is the family of interferon regulatory factors (IRFs)(3). The IRF gene regulatory networks are complex and contain multiple feedback loops. The tools of systems biology are well suited to elucidate the complex interactions that give rise to precise coordination of the interferon response. Here we have used an unbiased systems approach to predict that a member of the forkhead family of transcription factors, FOXO3, is a negative regulator of a subset of antiviral genes. This prediction was validated using macrophages isolated from Foxo3-null mice. Genome-wide location analysis combined with gene deletion studies identified the Irf7 gene as a critical target of FOXO3. FOXO3 was identified as a negative regulator of Irf7 transcription and we have further demonstrated that FOXO3, IRF7 and IFN-I forma coherent feed-forward regulatory circuit. Our data suggest that the FOXO3-IRF7 regulatory circuit represents a novel mechanism for establishing the requisite set points in the interferon pathway that balances the beneficial effects and deleterious sequelae of the antiviral response.	[Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Aitchison, John D.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ratushny, Alexander V.; Huang, Albert C.; Raman, Ayush; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Rust, Alistair G.] Welcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Bergthaler, Andreas] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Center for Infectious Disease Research; Institute for Systems Biology (ISB); Wellcome Trust Sanger Institute; Austrian Academy of Sciences	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Raman, Ayush/AAR-6165-2021; Bergthaler, Andreas/ABG-5047-2020	Raman, Ayush/0000-0003-2872-2307; Bergthaler, Andreas/0000-0003-0597-1976; Rust, Alistair/0000-0001-7287-192X	National Institutes of Health [R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C, U54GM103511]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025032, R01AI032972, U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. A. Kennedy and J. J. Peschon for discussions and critical reading of the manuscript; and S. A. Danziger, T. Stolyar and E. van Gaver for technical assistance. This work was supported by grants and contracts from the National Institutes of Health (R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C and U54GM103511).	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Biobase, TRANSFAC PROF V9 3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dollar P., 2006, P DOLLARS IMAGE VIDE; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; MCLAREN LC, 1959, J EXP MED, V109, P475, DOI 10.1084/jem.109.5.475; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith K, 2003, POETRY REV, V93, P5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Wang ST, 2011, GENE THER, V18, P372, DOI 10.1038/gt.2010.146	37	112	114	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					421	+		10.1038/nature11428	http://dx.doi.org/10.1038/nature11428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22982991	Green Accepted			2022-12-01	WOS:000309918500050
J	Messerli, FH				Messerli, Franz H.			Chocolate Consumption, Cognitive Function, and Nobel Laureates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COCOA		[Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Messerli, Franz H.] Columbia Univ, New York, NY USA	Mount Sinai St. Luke's; Mount Sinai West; Columbia University	Messerli, FH (corresponding author), St Lukes Roosevelt Hosp, New York, NY 10025 USA.		Messerli, Franz/AAR-4783-2021					Bisson JF, 2008, BRIT J NUTR, V100, P94, DOI 10.1017/S0007114507886375; Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022; Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060; Nurk E, 2009, J NUTR, V139, P120, DOI 10.3945/jn.108.095182; Sorond Farzaneh A, 2008, Neuropsychiatr Dis Treat, V4, P433	5	95	96	35	273	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1562	1564		10.1056/NEJMon1211064	http://dx.doi.org/10.1056/NEJMon1211064			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23050509				2022-12-01	WOS:000309904500016
J	Guthrie, B; Payne, K; Alderson, P; McMurdo, MET; Mercer, SW				Guthrie, Bruce; Payne, Katherine; Alderson, Phil; McMurdo, Marion E. T.; Mercer, Stewart W.			Adapting clinical guidelines to take account of multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; QUALITY; TRIALS		[Guthrie, Bruce; McMurdo, Marion E. T.] Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland; [Payne, Katherine] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Alderson, Phil] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice, Manchester, Lancs, England; [Mercer, Stewart W.] Univ Glasgow, Glasgow, Lanark, Scotland	University of Dundee; University of Manchester; National Institute for Health & Care Excellence; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Payne, Katherine/AAJ-3728-2020	Payne, Katherine/0000-0002-3938-4350; Mercer, Stewart William/0000-0002-1703-3664; Guthrie, Bruce/0000-0003-4191-4880	National Institute for Health Research [11/2003/27] Funding Source: researchfish; Chief Scientist Office [ARPG/07/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office		Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braithwaite RS, 2011, MED DECIS MAKING, V31, P582, DOI 10.1177/0272989X10386117; Braithwaite R Scott, 2009, Med Care, V47, P610, DOI 10.1097/MLR.0b013e31819748d5; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Grimshaw J M, 2004, Health Technol Assess, V8, piii; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; McMurdo MET, 2005, BMJ-BRIT MED J, V331, P1036, DOI 10.1136/bmj.331.7524.1036; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; National Institute for Health and Clinical Excellence, 2006, ATR FIBR NAT CLIN GU; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	286	290	3	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2012	345								e6341	10.1136/bmj.e6341	http://dx.doi.org/10.1136/bmj.e6341			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LH	23036829	Green Accepted			2022-12-01	WOS:000309661500009
J	Haley, RW				Haley, Robert W.			Controlling Urban Epidemics of West Nile Virus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COUNTY		Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Haley, RW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Robert.Haley@UTSouthwestern.edu	Haley, Robert/P-9026-2014	Haley, Robert/0000-0001-8849-9579				Centers for Disease Control and Prevention, 2012, W NIL VIR INF GUID C; Centers for Disease Control and Prevention, 2012, MOSQ STUD; Chung W, 2012, W NILE VIRUS OUTBREA; Dallas County Medical Society, 2012, DCMS PHYS D MCCOY MD; Goodman Denise M, 2012, JAMA, V308, P1052, DOI 10.1001/2012.jama.11678; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; National Pesticide Telecommunications Network, 1998, PYR PYR; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2	9	9	10	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1325	1326		10.1001/2012.jama.11930	http://dx.doi.org/10.1001/2012.jama.11930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	22922679	Bronze			2022-12-01	WOS:000309369300023
J	Ball, LT; Lloyd-Jones, GC; Russell, CA				Ball, Liam T.; Lloyd-Jones, Guy C.; Russell, Christopher A.			Gold-Catalyzed Direct Arylation	SCIENCE			English	Article							(HETERO)ARENES; OXYARYLATION	Biaryls (two directly connected aromatic rings, Ar-1-Ar-2) are common motifs in pharmaceuticals, agrochemicals, and organic materials. Current methods for establishing the Ar-1-Ar-2 bond are dominated by the cross-coupling of aryl halides (Ar-1-X) with aryl metallics (Ar-2-M). We report that, in the presence of 1 to 2 mole percent of a gold catalyst and a mild oxidant, a wide range of arenes (Ar-1-H) undergo site-selective arylation by arylsilanes (Ar-2-SiMe3) to generate biaryls (Ar-1-Ar-2), with little or no homocoupling (Ar-1-Ar-1/Ar-2-Ar-2). Catalysis proceeds at room temperature and tolerates a broad range of functional groups, including those incompatible with cross-coupling. These features expedite biaryl preparation, as demonstrated by synthesis of the nonsteroidal anti-inflammatory diflunisal.					Lloyd-Jones, Guy/A-3417-2009	Ball, Liam/0000-0003-3849-9006; Russell, Christopher/0000-0003-2921-5278; Lloyd-Jones, Guy/0000-0003-2128-6864	Engineering and Physical Sciences Research Council [EP/G036764/1]; AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; University of Bristol; Royal Society	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Syngenta(Syngenta); University of Bristol; Royal Society(Royal Society of London)	Experimental procedures and compound characterization data are both presented in the supplementary materials. L. T. B., G.C.L.-J., and C. A. R contributed equally to the conception and direction of this work and to the preparation of the manuscript. L. T. B. conducted all of the experimental work. We thank Umicore AG & Co. KG for the generous donation of HAuCl<INF>4</INF>. L. T. B. thanks the Bristol Chemical Synthesis Doctoral Training Centre, funded by the Engineering and Physical Sciences Research Council (grant EP/G036764/1); AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; and the University of Bristol, for the provision of a Ph.D. studentship. G.C.L.-J. is a Royal Society Wolfson Research Merit Award holder.	Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Ball LT, 2012, CHEM-EUR J, V18, P2931, DOI 10.1002/chem.201103061; Ball LT, 2010, ORG LETT, V12, P4724, DOI 10.1021/ol1019162; Ciana CL, 2011, ANGEW CHEM INT EDIT, V50, P458, DOI 10.1002/anie.201004703; Funaki K, 2011, CHEM LETT, V40, P1050, DOI 10.1246/cl.2011.1050; Hachiya H, 2010, ANGEW CHEM INT EDIT, V49, P2202, DOI 10.1002/anie.200906996; HANNAH J, 1978, J MED CHEM, V21, P1093, DOI 10.1021/jm00209a001; Kar A, 2008, CHEM COMMUN, P386, DOI 10.1039/b714928j; Kar A, 2009, J ORGANOMET CHEM, V694, P524, DOI 10.1016/j.jorganchem.2008.11.016; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; McGlacken GP, 2009, CHEM SOC REV, V38, P2447, DOI 10.1039/b805701j; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f; NORMAN ROC, 1976, J CHEM SOC PERK T 1, P1983, DOI 10.1039/p19760001983; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rombke P, 2001, J CHEM SOC DALTON, P2482, DOI 10.1039/b104001b; Ruyle W. V., 1973, U. S. Patent, Patent No. [3,714,226, 3714226]; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Taylor R., 1990, ELECTROPHILIC AROMAT; Tsuji J., 2004, PALLADIUM REAGENTS C; Wen J, 2008, ANGEW CHEM INT EDIT, V47, P8897, DOI 10.1002/anie.200802526; Yang SD, 2008, ANGEW CHEM INT EDIT, V47, P1473, DOI 10.1002/anie.200704619	24	264	272	2	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1644	1648		10.1126/science.1225709	http://dx.doi.org/10.1126/science.1225709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019647	Green Accepted			2022-12-01	WOS:000309215400042
J	Blount, ZD; Barrick, JE; Davidson, CJ; Lenski, RE				Blount, Zachary D.; Barrick, Jeffrey E.; Davidson, Carla J.; Lenski, Richard E.			Genomic analysis of a key innovation in an experimental Escherichia coli population	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; CITRATE UTILIZATION; GENE; SEQUENCES; PROMOTER; DUPLICATION; ADAPTATION; AMPLIFICATION; SUPPRESSION; CONTINGENCY	Evolutionary novelties have been important in the history of life, but their origins are usually difficult to examine in detail. We previously described the evolution of a novel trait, aerobic citrate utilization (Cit(+)), in an experimental population of Escherichia coli. Here we analyse genome sequences to investigate the history and genetic basis of this trait. At least three distinct clades coexisted for more than 10,000 generations before its emergence. The Cit(+) trait originated in one clade by a tandem duplication that captured an aerobically expressed promoter for the expression of a previously silent citrate transporter. The clades varied in their propensity to evolve this novel trait, although genotypes able to do so existed in all three clades, implying that multiple potentiating mutations arose during the population's history. Our findings illustrate the importance of promoter capture and altered gene regulation in mediating the exaptation events that often underlie evolutionary innovations.	[Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blount, Zachary D.; Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Davidson, Carla J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada	Michigan State University; Michigan State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Calgary	Blount, ZD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	blountza@msu.edu; lenski@msu.edu	Blount, Zachary/L-3130-2019; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375; Blount, Zachary/0000-0001-5153-0034	US National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; US National Institutes of Health [K99-GM087550]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550, K99GM087550] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Hajela, M. Kauth and S. Sleight for assistance, J. Meyer and J. Plucain for discussion, and C. Turner for comments on the paper. Sequencing services were provided by the MSU Research Technology Support Facility. We acknowledge support from the US National Science Foundation (DEB-1019989 to R. E. L.) including the BEACON Center for the Study of Evolution in Action (DBI-0939454), the US National Institutes of Health (K99-GM087550 to J. E. B.), the Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L.), a Rudolf Hugh Fellowship (to Z.D.B.), a DuVall Family Award (to Z.D.B.), a Ronald M. and Sharon Rogowski Fellowship (to Z.D.B.) and a Barnett Rosenberg Fellowship (to Z.D.B).	ADAM D, 1993, SCIENCE, V259, P816, DOI 10.1126/science.8430335; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick J. E., 2010, BRESEQ; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CHARLIER D, 1982, NUCLEIC ACIDS RES, V10, P5935, DOI 10.1093/nar/10.19.5935; Christensen W. B., 1949, RES B WELD COUNTY HL, V1, P3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; HALL BG, 1982, J BACTERIOL, V151, P269, DOI 10.1128/JB.151.1.269-273.1982; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jacob F., 1982, POSSIBLE ACTUAL; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Koser SA, 1924, J BACTERIOL, V9, P59, DOI 10.1128/JB.9.1.59-77.1924; LARA FJS, 1952, J BACTERIOL, V63, P415, DOI 10.1128/JB.63.3.415-420.1952; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LUTGENS M, 1980, J GEN MICROBIOL, V119, P63; Mayr E., 1960, EVOLUTION DARWIN, P349; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nizam SA, 2009, BIOCHEM ENG J, V44, P240, DOI 10.1016/j.bej.2008.12.017; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Pigliucci M, 2008, PHILOS SCI, V75, P887, DOI 10.1086/594532; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Rozen DE, 2005, J MOL EVOL, V61, P171, DOI 10.1007/s00239-004-0322-2; Scheutz F., 2005, BERGEYS MANUAL SYSTE, VTwo Part B, P607, DOI [10.1002/9781118960608.gbm01147, DOI 10.1002/9781118960608.GBM01147]; SHANKAR S, 1995, MOL MICROBIOL, V17, P935, DOI 10.1111/j.1365-2958.1995.mmi_17050935.x; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Usakin LA, 2005, MOL BIOL EVOL, V22, P1555, DOI 10.1093/molbev/msi147; WHORISKEY SK, 1987, GENE DEV, V1, P227, DOI 10.1101/gad.1.3.227; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZHU LQ, 1992, GENE, V119, P101, DOI 10.1016/0378-1119(92)90072-W	52	369	372	2	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					513	+		10.1038/nature11514	http://dx.doi.org/10.1038/nature11514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22992527	Green Accepted			2022-12-01	WOS:000309167100040
J	Hand, TW; Dos Santos, LM; Bouladoux, N; Molloy, MJ; Pagan, AJ; Pepper, M; Maynard, CL; Elson, CO; Belkaid, Y				Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Pagan, Antonio J.; Pepper, Marion; Maynard, Craig L.; Elson, Charles O., III; Belkaid, Yasmine			Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses	SCIENCE			English	Article							GUT COMMENSAL BACTERIA; TOXOPLASMA-GONDII; CROHNS-DISEASE; INDUCTION; DOMINANT; EFFECTOR; IMMUNITY; NAIVE; IGA	The mammalian gastrointestinal tract contains a large and diverse population of commensal bacteria and is also one of the primary sites of exposure to pathogens. How the immune system perceives commensals in the context of mucosal infection is unclear. Here, we show that during a gastrointestinal infection, tolerance to commensals is lost, and microbiota-specific T cells are activated and differentiate to inflammatory effector cells. Furthermore, these T cells go on to form memory cells that are phenotypically and functionally consistent with pathogen-specific T cells. Our results suggest that during a gastrointestinal infection, the immune response to commensals parallels the immune response against pathogenic microbes and that adaptive responses against commensals are an integral component of mucosal immunity.	[Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Dos Santos, Liliane M.] Univ Fed Minas Gerais, Lab Gnotobiol & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Pagan, Antonio J.; Pepper, Marion] Univ Minnesota, Microbiol Immunol & Canc Biol Program, Minneapolis, MN 55455 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Maynard, Craig L.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Elson, Charles O., III] Univ Alabama Birmingham, Mucosal HIV & Immunobiol Ctr, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Pagan, Antonio/AAB-1604-2019; Hand, Timothy W/AAH-1216-2021; Santos, Liliane Martins dos/AAR-9220-2020	Hand, Timothy W/0000-0002-2684-9462; Santos, Liliane Martins dos/0000-0002-4466-8868; Bouladoux, Nicolas/0000-0003-1593-671X; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); CNPq-Brazil; NIH [DK071176, DK64400]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176, R24DK064400] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) (T. W. H., L. M. D., N.B., M.J.M., and Y.B.), CNPq-Brazil (L. M. D.), NIH grants DK071176 and DK64400 (C.O.E.) and The Crohn's and Colitis Foundation of America Career Development Award (C. L. M.). The authors thank M. Jenkins, A. Poholek, S. Kaech, N. Peters, J. Monteiro and the members of the Belkaid Lab for critical discussion and reading of the manuscript; the NIH Tetramer Core Facility for the T. gondii Me49 hypothetical protein tetramers; C. Eigsti, T. Moyer, E. Stregevsky, K. Holmes, and the NIAID Flow Cytometry Core for assistance with sorting; L. Koo and the NIAID Microscopy Core for assistance with 16S fluorescence in situ hybridization (FISH) images; and the NIAID Protein Biochemistry Core for CBir1 peptide. We thank the University of Alabama-Birmingham for sharing the CBir1 Tg mice by material transfer agreement. The data reported in this paper are tabulated in the main text and in the supplementary materials. The authors declare that they have no conflict of interest.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87	31	263	272	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1553	1556		10.1126/science.1220961	http://dx.doi.org/10.1126/science.1220961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22923434	Green Accepted			2022-12-01	WOS:000308912900055
J	Weber, T; Deutsch, C				Weber, Thomas; Deutsch, Curtis			Oceanic nitrogen reservoir regulated by plankton diversity and ocean circulation	NATURE			English	Article							TO-PHOSPHORUS STOICHIOMETRY; MARINE PROCHLOROCOCCUS; ELEMENTAL COMPOSITION; COMMUNITY STRUCTURE; NUTRIENT RATIOS; SOUTHERN-OCEAN; PHYTOPLANKTON; FIXATION; DENITRIFICATION; IRON	The average nitrogen-to-phosphorus ratio of marine phytoplankton (16N:1P) is closely matched to the nutrient content of mean ocean waters (14.3N:1P). This condition is thought to arise from biological control over the ocean's nitrogen budget, in which removal of bioavailable nitrogen by denitrifying bacteria ensures widespread selection for diazotrophic phytoplankton that replenish this essential nutrient when it limits the growth of other species(1-3). Here we show that in the context of a realistic ocean circulation model, and a uniform N:P ratio of plankton biomass, this feedback mechanism yields an oceanic nitrate deficit more than double its observed value. The critical missing phenomenon is diversity in the metabolic N: P requirement of phytoplankton, which has recently been shown to exhibit large-scale patterns associated with species composition(4). When we model these variations, such that diazotrophs compete with high N: P communities in subtropical regions, the ocean nitrogen inventory rises and may even exceed the average N: P ratio of plankton. The latter condition, previously considered impossible, is prevented in the modern ocean by shallow circulations that communicate stoichiometric signals from remote biomes dominated by diatoms with low N: P ratios. Large-scale patterns of plankton diversity and the circulation pathways connecting them are thus key factors determining the availability of fixed nitrogen in the ocean.	[Weber, Thomas; Deutsch, Curtis] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Weber, T (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	tweber@atmos.ucla.edu			NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation	NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank T. DeVries for providing the ocean circulation model. This work was funded by a NASA Earth Systems Science Fellowship (T. W.) and a grant from the Gordon and Betty Moore Foundation (C.D.).	Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Deutsch C, 2012, ANNU REV MAR SCI, V4, P113, DOI 10.1146/annurev-marine-120709-142821; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Khatiwala S, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002923; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kwon EY, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002631; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lenton TM, 2007, BIOGEOSCIENCES, V4, P353, DOI 10.5194/bg-4-353-2007; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Redfield AC., 1963, SEA, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Sarmiento J.L., 2006, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1017/S0016756807003755, DOI 10.1017/S0016756807003755]; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403	38	75	77	6	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					419	U105		10.1038/nature11357	http://dx.doi.org/10.1038/nature11357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996557				2022-12-01	WOS:000308860900042
J	Morrato, EH; Allison, DB				Morrato, Elaine H.; Allison, David B.			FDA Approval of Obesity Drugs A Difference in Risk-Benefit Perceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROFECOXIB		[Morrato, Elaine H.] Univ Colorado Denver, Dept Hlth Syst Management & Policy, Aurora, CO 80045 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Nutr & Obes Res Ctr, Birmingham, AL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Morrato, EH (corresponding author), Univ Colorado Denver, Dept Hlth Syst Management & Policy, 13199 E Montview Blvd,Ste 300,Mail Stop F443, Aurora, CO 80045 USA.	elaine.morrato@ucdenver.edu		Allison, David/0000-0003-3566-9399	AHRQ HHS [K12 HS019464, K12HS019464] Funding Source: Medline; NIDDK NIH HHS [P30 DK056336, P30DK056336] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERLIN SB, 1990, SOC SERV REV, V64, P46, DOI 10.1086/603741; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, 2012, ETH SCI ISS STUD SAF; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; US Department of Health and Human Services Food and Drug Administration (FDA), 2012 M END MET DRUGS; [US Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER)], 2007, GUID IND DEV PROD WE	7	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1097	1098		10.1001/jama.2012.10007	http://dx.doi.org/10.1001/jama.2012.10007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AL	22990266	Green Accepted			2022-12-01	WOS:000308861000023
J	Andreux, PA; Williams, EG; Koutnikova, H; Houtkooper, RH; Champy, MF; Henry, H; Schoonjans, K; Williams, RW; Auwerx, J				Andreux, Penelope A.; Williams, Evan G.; Koutnikova, Hana; Houtkooper, Riekelt H.; Champy, Marie-France; Henry, Hugues; Schoonjans, Kristina; Williams, Robert W.; Auwerx, Johan			Systems Genetics of Metabolism: The Use of the BXD Murine Reference Panel for Multiscalar Integration of Traits	CELL			English	Article							INNATE IMMUNITY; COMPLEX TRAITS; DISSECTION; SUBSTITUTION; ASSOCIATION; REGULATOR; GENOMICS; VARIANT; LOCI; MASS	Metabolic homeostasis is achieved by complex molecular and cellular networks that differ significantly among individuals and are difficult to model with genetically engineered lines of mice optimized to study single gene function. Here, we systematically acquired metabolic phenotypes by using the EUMODIC EMPReSS protocols across a large panel of isogenic but diverse strains of mice (BXD type) to study the genetic control of metabolism. We generated and analyzed 140 classical phenotypes and deposited these in an open-access web service for systems genetics (www.genenetwork.org). Heritability, influence of sex, and genetic modifiers of traits were examined singly and jointly by using quantitative-trait locus (QTL) and expression QTL-mapping methods. Traits and networks were linked to loci encompassing both known variants and novel candidate genes, including alkaline phosphatase (ALPL), here linked to hypophosphatasia. The assembled and curated phenotypes provide key resources and exemplars that can be used to dissect complex metabolic traits and disorders.	[Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Andreux, Penelope A.; Williams, Evan G.; Houtkooper, Riekelt H.; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Koutnikova, Hana; Champy, Marie-France; Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [Henry, Hugues] CHU Vaudois, CH-1011 Lausanne, Switzerland	University of Tennessee System; University of Tennessee Health Science Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Williams, RW (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	rwilliams@uthsc.edu; admin.auwerx@epfl.ch	Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Auwerx, Johan/ABE-9307-2021; Koutnikova, Hana/I-7758-2017; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Auwerx, Johan/0000-0002-5065-5393; Williams, Robert W./0000-0001-8924-4447; Schoonjans, Kristina/0000-0003-1247-4265; Williams, Evan/0000-0002-9746-376X	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program [ERC-2008-AdG-23118]; Velux Stiftung; Swiss National Science Foundation [31003A-124713, 31003A-125487, CSRII3-136201]; NIH [P20-DA 21131, UO1AA13499, U01AA14425]; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499, U01AA017590, U01AA016662, U01AA014425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program; Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Laurent Pouilly, Tania Sorg, Hongbo Zhang, and Ulrike Kettenberger for technical assistance with various aspects of mouse phenotyping. Discussions with Thomas Vogt (Merck Research Laboratories), Carmen Argmann and Sander Houten (University of Amsterdam), Vincent Mooser (CHUV), Stephan Morgenthaler (EPFL), Dominique Pioletti (EPFL), Bernard Thorens (UNIL), Paul Franken (UNIL), and Ioannis Xenarios (UNIL) and the team members of the Auwerx lab are acknowledged. R.H.H. is supported by a Rubicon fellowship of the NWO. J.A. is the Nestle Chair in Energy Metabolism and the J.A./K.S. laboratory is supported by grants of the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (ERC-2008-AdG-23118), the Velux Stiftung, the Swiss National Science Foundation (31003A-124713, 31003A-125487, and the Sinergia grant CSRII3-136201). R.W.W. and GeneNetwork are supported by NIH (P20-DA 21131 UO1AA13499 and U01AA14425) and the UT Center for Integrative and Translational Genomics.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Champy MF, 2008, MAMM GENOME, V19, P318, DOI 10.1007/s00335-008-9107-z; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Fossey SC, 2001, GENOMICS, V76, P45, DOI 10.1006/geno.2001.6584; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Laughlin RE, 2011, BIOL PSYCHIAT, V69, P1109, DOI 10.1016/j.biopsych.2011.01.014; Lehninger A.L., 2008, LEHNINGER PRINCIPLES, V5th ed.; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Lynch M., 1998, AM J HUM GENET; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nielson CM, 2012, J BONE MINER RES, V27, P93, DOI 10.1002/jbmr.527; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; POPP RA, 1962, J HERED, V53, P73, DOI 10.1093/oxfordjournals.jhered.a107127; Riu E, 1996, P NATL ACAD SCI USA, V93, P2198, DOI 10.1073/pnas.93.5.2198; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/nmeth.1806, 10.1038/NMETH.1806]; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Whyte M., 2000, METABOLIC MOL BASES, P5313; Williams RW, 2001, GENOME BIOL, V2; Windahl SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021402; Wolford JK, 2003, MOL GENET METAB, V79, P61, DOI 10.1016/S1096-7192(03)00051-9; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	62	144	147	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1287	1299		10.1016/j.cell.2012.08.012	http://dx.doi.org/10.1016/j.cell.2012.08.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22939713	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000308928100020
J	Ecker, JR				Ecker, Joseph R.			FORUM: Genomics ENCODE explained	NATURE			English	Editorial Material									[Ecker, Joseph R.] Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Bickmore, Wendy A/C-7314-2013	Ecker, Joseph R/0000-0001-5799-5895; Bickmore, Wendy A/0000-0001-6660-7735; Segal, Eran/0000-0002-6859-1164; Barroso, Ines/0000-0001-5800-4520	MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)			0	162	174	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					52	53		10.1038/489052a	http://dx.doi.org/10.1038/489052a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955614	Bronze			2022-12-01	WOS:000308347000034
J	Rizzuto, D; Orsini, N; Qiu, CX; Wang, HX; Fratiglioni, L				Rizzuto, Debora; Orsini, Nicola; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura			Lifestyle, social factors, and survival after age 75: population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; KUNGSHOLMEN-PROJECT; ALZHEIMERS-DISEASE; MULTIPLE IMPUTATION; ALCOHOL-CONSUMPTION; 5-YEAR MORTALITY; OLDER-ADULTS; RISK-FACTORS; DEMENTIA; LONGEVITY	Objective To identify modifiable factors associated with longevity among adults aged 75 and older. Design Population based cohort study. Setting Kungsholmen, Stockholm, Sweden. Participants 1810 adults aged 75 or more participating in the Kungsholmen Project, with follow-up for 18 years. Main outcome measure Median age at death. Vital status from 1987 to 2005. Results During follow-up 1661 (91.8%) participants died. Half of the participants lived longer than 90 years. Half of the current smokers died 1.0 year (95% confidence interval 0.0 to 1.9 years) earlier than non-smokers. Of the leisure activities, physical activity was most strongly associated with survival; the median age at death of participants who regularly swam, walked, or did gymnastics was 2.0 years (0.7 to 3.3 years) greater than those who did not. The median survival of people with a low risk profile (healthy lifestyle behaviours, participation in at least one leisure activity, and a rich or moderate social network) was 5.4 years longer than those with a high risk profile (unhealthy lifestyle behaviours, no participation in leisure activities, and a limited or poor social network). Even among the oldest old (85 years or older) and people with chronic conditions, the median age at death was four years higher for those with a low risk profile compared with those with a high risk profile. Conclusion Even after age 75 lifestyle behaviours such as not smoking and physical activity are associated with longer survival. A low risk profile can add five years to women's lives and six years to men's. These associations, although attenuated, were also present among the oldest old (>= 85 years) and in people with chronic conditions.	[Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden; [Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Stockholm Univ, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Unit Nutr Epidemiol, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Biostat Unit, S-11330 Stockholm, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Rizzuto, D (corresponding author), Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden.	debora.rizzuto@ki.se	Orsini, Nicola/A-3602-2012; Rizzuto, Debora/V-1890-2018; Rizzuto, Debora/X-7065-2019	Orsini, Nicola/0000-0002-2210-5634; Rizzuto, Debora/0000-0001-6199-9629; Qiu, Chengxuan/0000-0003-1922-4912; Wang, Hui-Xin/0000-0002-5051-4929	Swedish Council for Working Life and Social Research; Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	This study was funded by the Swedish Council for Working Life and Social Research, Swedish Research Council for Medicine, Swedish Brain Power, Karolinska Institutet's Faculty funding for postgraduate students, and the Stiftelsen Ragnhild och Einar Lundstroms Minne. The sponsor had no role in study design, data collection, data analysis, data interpretation, the writing of the report, or in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Benetos A, 2005, J HYPERTENS, V23, P1803, DOI 10.1097/01.hjh.0000179512.71018.40; Bottai M, BIOM J, V52, P487; Candore G, 2006, ANN NY ACAD SCI, V1089, P516, DOI 10.1196/annals.1386.051; de Groot LCPMG, 2004, J GERONTOL A-BIOL, V59, P1277, DOI 10.1093/gerona/59.12.1277; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Diehr P, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-1; Dupre ME, 2008, AM J PUBLIC HEALTH, V98, P1203, DOI 10.2105/AJPH.2007.113886; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Hagberg B, 2008, J GERONTOL A-BIOL, V63, P1219, DOI 10.1093/gerona/63.11.1219; Halme JT, 2010, DRUG ALCOHOL DEPEN, V106, P212, DOI 10.1016/j.drugalcdep.2009.08.017; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 1996, PREV MED, V25, P319, DOI 10.1006/pmed.1996.0062; Newson RS, 2010, AGE, V32, P521, DOI 10.1007/s11357-010-9154-8; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Orsini N, 2012, EPIDEMIOLOGY, V23, P770, DOI 10.1097/EDE.0b013e3182625eff; Rodriguez-Laso A., 2007, BMC GERIATR, V1, P7; Rousson V, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-18; RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225; RUIGOMEZ A, 1995, AGE AGEING, V24, P113, DOI 10.1093/ageing/24.2.113; Spencer CA, 2005, PREV MED, V40, P712, DOI 10.1016/j.ypmed.2004.09.012; Timmreck T C, 1987, Health Educ, V18, P23; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	34	89	91	3	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 30	2012	345								e5568	10.1136/bmj.e5568	http://dx.doi.org/10.1136/bmj.e5568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SM	22936786	hybrid, Green Published			2022-12-01	WOS:000311050800003
J	Kjer-Nielsen, L; Patel, O; Corbett, AJ; Le Nours, J; Meehan, B; Liu, LG; Bhati, M; Chen, ZJ; Kostenko, L; Reantragoon, R; Williamson, NA; Purcell, AW; Dudek, NL; McConville, MJ; O'Hair, RAJ; Khairallah, GN; Godfrey, DI; Fairlie, DP; Rossjohn, J; McCluskey, J				Kjer-Nielsen, Lars; Patel, Onisha; Corbett, Alexandra J.; Le Nours, Jerome; Meehan, Bronwyn; Liu, Ligong; Bhati, Mugdha; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.; O'Hair, Richard A. J.; Khairallah, George N.; Godfrey, Dale I.; Fairlie, David P.; Rossjohn, Jamie; McCluskey, James			MR1 presents microbial vitamin B metabolites to MAIT cells	NATURE			English	Article							INVARIANT T-CELLS; CRYSTAL-STRUCTURE; ANTIGEN PRESENTATION; SELECTION	Antigen-presenting molecules, encoded by the major histocompatibility complex (MHC) and CD1 family, bind peptide- and lipid-based antigens, respectively, for recognition by T cells. Mucosal-associated invariant T (MAIT) cells are an abundant population of innate-like T cells in humans that are activated by an antigen(s) bound to the MHC class I-like molecule MR1. Although the identity of MR1-restricted antigen(s) is unknown, it is present in numerous bacteria and yeast. Here we show that the structure and chemistry within the antigen-binding cleft of MR1 is distinct from the MHC and CD1 families. MR1 is ideally suited to bind ligands originating from vitamin metabolites. The structure of MR1 in complex with 6-formyl pterin, a folic acid (vitamin B9) metabolite, shows the pterin ring sequestered within MR1. Furthermore, we characterize related MR1-restricted vitamin derivatives, originating from the bacterial riboflavin (vitamin B2) biosynthetic pathway, which specifically and potently activate MAIT cells. Accordingly, we show that metabolites of vitamin B represent a class of antigen that are presented by MR1 for MAIT-cell immunosurveillance. As many vitamin biosynthetic pathways are unique to bacteria and yeast, our data suggest that MAIT cells use these metabolites to detect microbial infection.	[Kjer-Nielsen, Lars; Corbett, Alexandra J.; Meehan, Bronwyn; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Patel, Onisha; Le Nours, Jerome; Bhati, Mugdha; Purcell, Anthony W.; Dudek, Nadine L.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Metabol Australia, Parkville, Vic 3010, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Metabol Australia, Parkville, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, ARC Ctr Excellence Free Radical Chem & Biotechnol, Melbourne, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; Monash University; University of Queensland; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Cardiff University	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Fairlie, David P/F-8865-2014; Corbett, Alexandra/A-1225-2019; Rossjohn, Jamie/F-9032-2013; liu, ligong/B-1690-2010; Williamson, Nicholas A/O-9812-2016; McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019	Fairlie, David P/0000-0002-7856-8566; Corbett, Alexandra/0000-0003-1618-4337; Rossjohn, Jamie/0000-0002-2020-7522; liu, ligong/0000-0002-2693-1896; Williamson, Nicholas A/0000-0002-2173-3452; McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Patel, Onisha/0000-0001-6701-7139; Khairallah, George/0000-0002-3359-8358; Le Nours, Jerome/0000-0002-2221-7636; Godfrey, Dale/0000-0002-3009-5472; Kostenko, Lyudmila/0000-0002-8466-7966; Meehan, Bronwyn/0000-0001-7368-2979; O'Hair, Richard/0000-0002-8044-0502	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank R. Strugnell, T. Stinear, T. Mulhern, P. O'Donnell, J. Pyke, T. Rupasinghe, D. L. Tull, J. Ralton, L. Foster, S. H. Ramarathinam, M. Bharadwaj, D. Pellicci and K. Wun for discussions and technical advice, T. Hansen for the anti-MR1 monoclonal antibody and the staff of the Australian Synchrotron for assistance with data collection. This research was supported by the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council. O.P. was supported by an ARC Future Fellowship; A.W.P. by an NHMRC Senior Research Fellowship; M.J.M. by a NHMRC Principal Research Fellowship; D.I.G. and D.P.F. were supported by NHMRC Senior Principal Research Fellowships; J. R. was supported by an NHMRC Australia Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bricogne G., 2011, AUTOBUSTER V 1 6 0; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, NAT IMMUNOL, V11, P693, DOI 10.1038/ni0810-693; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goldfinch N, 2010, VET RES, V41, DOI 10.1051/vetres/2010034; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hee CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000557; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LESLIE AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Off MK, 2005, J PHOTOCH PHOTOBIO B, V80, P47, DOI 10.1016/j.jphotobiol.2005.03.001; PLAUT GWE, 1974, ANNU REV BIOCHEM, V43, P899, DOI 10.1146/annurev.bi.43.070174.004343; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Shimamura M, 2007, EUR J IMMUNOL, V37, P1836, DOI 10.1002/eji.200636689; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432	42	825	862	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					717	+		10.1038/nature11605	http://dx.doi.org/10.1038/nature11605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23051753				2022-12-01	WOS:000311606000036
J	Mathew, R; Seiler, MP; Scanlon, ST; Mao, AP; Constantinides, MG; Bertozzi-Villa, C; Singer, JD; Bendelac, A				Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Singer, Jeffrey D.; Bendelac, Albert			BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs	NATURE			English	Article							UBIQUITIN LIGASE; PROMYELOCYTIC LEUKEMIA; NUCLEAR LAMINA; CHROMATIN; PROTEINS; GENES; MECHANISMS; REPRESSION; ADAPTERS; COMPLEX	The differentiation of several T- and B-cell effector programs in the immune system is directed by signature transcription factors that induce rapid epigenetic remodelling. Here we report that promyelocytic leukaemia zinc finger (PLZF), the BTB-zinc finger (BTB-ZF) transcription factor directing the innate-like effector program of natural killer T-cell thymocytes(1,2), is prominently associated with cullin 3 (CUL3), an E3 ubiquitin ligase previously shown to use BTB domain-containing proteins as adaptors for substrate binding(3-7). PLZF transports CUL3 to the nucleus, where the two proteins are associated within a chromatin-modifying complex. Furthermore, PLZF expression results in selective ubiquitination changes of several components of this complex. CUL3 was also found associated with the BTB-ZF transcription factor BCL6, which directs the germinal-centre B cell and follicular T-helper cell programs. Conditional CUL3 deletion in mice demonstrated an essential role for CUL3 in the development of PLZF- and BCL6-dependent lineages. We conclude that distinct lineage-specific BTB-ZF transcription factors recruit CUL3 to alter the ubiquitination pattern of their associated chromatin-modifying complex. We propose that this new function is essential to direct the differentiation of several T- and B-cell effector programs, and may also be involved in the oncogenic role of PLZF and BCL6 in leukaemias and lymphomas(8,9).	[Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Singer, Jeffrey D.] Portland State Univ, Dept Biol, Portland, OR 97207 USA	Howard Hughes Medical Institute; University of Chicago; Portland State University	Bendelac, A (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Mathew, Rebecca/H-7154-2013	Scanlon, Seth Thomas/0000-0002-1792-6382; Constantinides, Michael/0000-0003-4770-7751	National Institute of Health (NIH) [5RO1GM082940, RO1AI038339]; Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082940] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dinner, J. Licht, G. Prive, A. Ruthenburg, R. Sciammas, H. Singh and P. Wilson for discussions, J. C. Silva and M. Stokes for UbiScan analysis, C. Labno and V. Bindokas for help with confocal microscopy, and K. Block, L. Roach, D. Zabner, F. Meng and L. Bai for help with experiments. This work was supported by National Institute of Health (NIH) grants 5RO1GM082940 (J.D.S.) and RO1AI038339 (A.B.), and an Irvington Institute postdoctoral fellowship from the Cancer Research Institute (R.M.). A.B. is a Howard Hughes Medical Institute Investigator.	Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hyjek E, 2001, BLOOD, V97, P270, DOI 10.1182/blood.V97.1.270; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	33	76	82	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					619	+		10.1038/nature11548	http://dx.doi.org/10.1038/nature11548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086144	Green Accepted			2022-12-01	WOS:000311339800057
J	Aoudjehane, HC; Avice, G; Barrat, JA; Boudouma, O; Chen, G; Duke, MJM; Franchi, IA; Gattacceca, J; Grady, MM; Greenwood, RC; Herd, CDK; Hewins, R; Jambon, A; Marty, B; Rochette, P; Smith, CL; Sautter, V; Verchovsky, A; Weber, P; Zanda, B				Aoudjehane, H. Chennaoui; Avice, G.; Barrat, J. -A.; Boudouma, O.; Chen, G.; Duke, M. J. M.; Franchi, I. A.; Gattacceca, J.; Grady, M. M.; Greenwood, R. C.; Herd, C. D. K.; Hewins, R.; Jambon, A.; Marty, B.; Rochette, P.; Smith, C. L.; Sautter, V.; Verchovsky, A.; Weber, P.; Zanda, B.			Tissint Martian Meteorite: A Fresh Look at the Interior, Surface, and Atmosphere of Mars	SCIENCE			English	Article							SHERGOTTITES; GEOCHEMISTRY; CHEMISTRY; DAR-AL-GANI-476; NITROGEN; SYSTEM; GASES; HF	Tissint (Morocco) is the fifth martian meteorite collected after it was witnessed falling to Earth. Our integrated mineralogical, petrological, and geochemical study shows that it is a depleted picritic shergottite similar to EETA79001A. Highly magnesian olivine and abundant glass containing martian atmosphere are present in Tissint. Refractory trace element, sulfur, and fluorine data for the matrix and glass veins in the meteorite indicate the presence of a martian surface component. Thus, the influence of in situ martian weathering can be unambiguously distinguished from terrestrial contamination in this meteorite. Martian weathering features in Tissint are compatible with the results of spacecraft observations of Mars. Tissint has a cosmic-ray exposure age of 0.7 +/- 0.3 million years, consistent with those of many other shergottites, notably EETA79001, suggesting that they were ejected from Mars during the same event.	[Aoudjehane, H. Chennaoui] Hassan II Univ Casablanca, GAIA Lab, Fac Sci, Casablanca, Morocco; [Aoudjehane, H. Chennaoui; Boudouma, O.; Jambon, A.] Univ Paris 06, Inst Terre Paris, UMR 7193, F-75005 Paris, France; [Avice, G.; Marty, B.] Univ Lorraine, Ctr Rech Petrograph & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Barrat, J. -A.] Univ Bretagne Occidentale, Inst Univ Europeen Mer, UMR 6538, F-29280 Plouzane, France; [Chen, G.; Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Duke, M. J. M.] Univ Alberta, SLOWPOKE Nucl Reactor Facil, Edmonton, AB T6G 2J9, Canada; [Grady, M. M.; Greenwood, R. C.; Verchovsky, A.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Rochette, P.] Aix Marseille Univ, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence 4, France; [Grady, M. M.; Smith, C. L.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Hewins, R.; Sautter, V.; Zanda, B.] Museum Natl Hist Nat, Lab Etud Mat Extraterrestre, F-75005 Paris, France; [Hewins, R.; Sautter, V.; Zanda, B.] CNRS, UMS2679, F-75005 Paris, France; [Smith, C. L.] ESA European Space Agcy, European Space Res & Technol Ctr, NL-2200 AG Noordwijk, Netherlands; [Smith, C. L.] UK Space Agcy, ESA Harwell Ctr, Didcot OX11 0QX, Oxon, England; [Weber, P.] Univ Bern, Albert Einstein Ctr Fundamental Phys, CH-3012 Bern, Switzerland	Hassan II University of Casablanca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Alberta; University of Alberta; Open University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; European Space Agency; University of Bern	Aoudjehane, HC (corresponding author), Hassan II Univ Casablanca, GAIA Lab, Fac Sci, BP 5366 Maarif, Casablanca, Morocco.	chennaoui_h@yahoo.fr	Barrat, Jean-Alix/C-8416-2017; IMPMC, ROCKS @/U-8478-2017; Zanda, Brigitte M/D-6787-2015; Rochette, Pierre/O-4612-2019; Gattacceca, Jerome/AAG-5651-2019; Smith, Caroline/AAO-3652-2020	Barrat, Jean-Alix/0000-0003-3158-3109; Zanda, Brigitte M/0000-0002-4210-7151; Rochette, Pierre/0000-0002-7362-0660; Gattacceca, Jerome/0000-0002-1639-7140; Smith, Caroline/0000-0001-7005-6470; Avice, Guillaume/0000-0003-0962-0049; Herd, Christopher/0000-0001-5210-4002; Greenwood, Richard/0000-0002-5544-8027; Grady, Monica/0000-0002-4055-533X; Chennaoui, Hasnaa/0000-0001-8792-246X	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France [01/10]; Comite Mixte Inter Universitaire Franco-Marocain Volubilis [MA/11/252]; CRPG Nancy, France; CNES; CNRS; European Research Council under the European Community's Seventh Framework Programme [267255]; Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council; University of Alberta; Natural Sciences and Engineering Research Council of Canada [261740-03]; STFC [ST/I001964/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001964/1, ST/I002820/1] Funding Source: researchfish	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France(Centre National de la Recherche Scientifique (CNRS)); Comite Mixte Inter Universitaire Franco-Marocain Volubilis; CRPG Nancy, France; CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council under the European Community's Seventh Framework Programme(European Commission); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); University of Alberta(University of Alberta); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge D. N. Menegas and family for their generous donation enabling the acquisition of Tissint (BM.2012,M1), M. Aoudjehane for fieldwork, A. Aaranson for field information, J. Gibson for assistance with oxygen isotope analysis, L. Labenne for loan of a sample, and A. Irving for 400 mg of powdered sample. This study was funded at Hassan II University Casablanca, Faculte des Sciences Ain Chock, by Centre de Recherches Scientifiques et Techniques Morocco and CNRS France (Projet International de Cooperation Scientifique, Sciences de l'Univers 01/10), and by Comite Mixte Inter Universitaire Franco-Marocain Volubilis (MA/11/252); CRPG Nancy, France, by the CNES, CNRS, and European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 no. 267255); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France, by the Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University, by Science and Technology Facilities Council grant to the Planetary and Space Sciences Discipline; and University of Alberta, by the Natural Sciences and Engineering Research Council of Canada (grant 261740-03).	ARVIDSON RE, 1989, REV GEOPHYS, V27, P39, DOI 10.1029/RG027i001p00039; Barrat JA, 2012, GEOCHIM COSMOCHIM AC, V83, P79, DOI 10.1016/j.gca.2011.12.011; Barrat JA, 2002, GEOCHIM COSMOCHIM AC, V66, P3505, DOI 10.1016/S0016-7037(02)00934-1; Barrat JA, 2001, METEORIT PLANET SCI, V36, P23, DOI 10.1111/j.1945-5100.2001.tb01807.x; Beck P, 2006, GEOCHIM COSMOCHIM AC, V70, P2127, DOI 10.1016/j.gca.2006.01.016; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Crozaz G, 2001, GEOCHIM COSMOCHIM AC, V65, P971, DOI 10.1016/S0016-7037(00)00586-X; Dreibus G, 2000, METEORIT PLANET SCI, V35, pA49; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; MARTI K, 1995, SCIENCE, V267, P1981, DOI 10.1126/science.7701319; Marty B, 2003, SPACE SCI REV, V106, P175, DOI 10.1023/A:1024689721371; Mittlefehldt DW, 2003, GEOCHIM COSMOCHIM AC, V67, P1911, DOI 10.1016/S0016-7037(02)01411-4; Neal C. R., 2001, LUNAR PLANET SCI, V32, P1671; Nier A. O., 1977, Journal of Geophysical Research, V82, P4341, DOI 10.1126/science.194.4271.1298; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Rao MN, 1999, GEOPHYS RES LETT, V26, P3265, DOI 10.1029/1999GL005388; Rochette P, 2005, METEORIT PLANET SCI, V40, P529, DOI 10.1111/j.1945-5100.2005.tb00961.x; Sautter V, 2002, EARTH PLANET SC LETT, V195, P223, DOI 10.1016/S0012-821X(01)00591-X; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Walton EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4829, DOI 10.1016/j.gca.2010.04.065	24	103	103	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					785	788		10.1126/science.1224514	http://dx.doi.org/10.1126/science.1224514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23065902				2022-12-01	WOS:000310839500040
J	Trivedi, TK; DeSalvo, T; Lee, L; Palumbo, A; Moll, M; Curns, A; Hall, AJ; Patel, M; Parashar, UD; Lopman, BA				Trivedi, Tarak K.; DeSalvo, Traci; Lee, Lore; Palumbo, Aimee; Moll, Maria; Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.			Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM-CARE FACILITIES; MINIMUM DATA SET; GASTROENTERITIS OUTBREAKS; RESIDENT ASSESSMENT; NORWALK VIRUS; UNITED-STATES; ENGLAND; SURVEILLANCE; OUTCOMES; DEATHS	Context Norovirus outbreaks are common among vulnerable, elderly populations in US nursing homes. Objectives To assess whether all-cause hospitalization and mortality rates are increased during norovirus outbreak vs nonoutbreak periods in nursing homes, and to identify factors associated with increased risk. Design, Setting, and Participants A retrospective cohort study of Medicare-certified nursing homes in Oregon, Wisconsin, and Pennsylvania that reported at least 1 confirmed or suspected norovirus outbreak to the Centers for Disease Control and Prevention's National Outbreak Reporting System (NORS), January 2009 to December 2010. Deaths and hospitalizations occurring among residents of these nursing homes were identified through the Medicare Minimum Data Set (MDS). Main Outcome Measures Rates of all-cause hospitalization and mortality during outbreak compared with nonoutbreak periods were estimated using a random-effects Poisson regression model controlling for background seasonality in both outcomes. Results The cohort consisted of 308 nursing homes that reported 407 norovirus outbreaks to NORS. Per MDS, 67 730 hospitalizations and 26 055 deaths occurred in these homes during the 2-year study. Hospitalization rates were 124.0 (95% CI, 119.4-129.1) vs 109.5 (95% CI, 108.6-110.3) hospitalizations per nursing home-year during outbreak vs nonoutbreak periods, yielding a seasonally adjusted rate ratio (RR) of 1.09 (95% CI, 1.05-1.14). Similarly, mortality rates were 53.7 (95% CI, 50.6-57.0) vs 41.9 (95% CI, 41.4-42.4) deaths per nursing home-year in outbreak vs nonoutbreak periods (seasonally adjusted RR, 1.11; 95% CI, 1.05-1.18). The increases in hospitalizations and mortality were concentrated in the first 2 weeks (week 0 and 1) and the initial week (week 0) of the outbreak, respectively. Homes with lower daily registered nurse (RN) hours per resident (<0.75) had increased mortality rates during norovirus outbreaks compared with baseline (RR, 1.26; 95% CI, 1.14-1.40), while no increased risk (RR, 1.03; 95% CI, 0.96-1.12) was observed in homes with higher daily RN hours per resident (P=.007 by likelihood ratio test); the increase in hospitalization rates did not show a similar pattern. Conclusion Norovirus outbreaks were associated with significant concurrent increases in all-cause hospitalization and mortality in nursing homes. JAMA. 2012;308(16):1668-1675 Published online October 18, 2012. doi:10.1001/jama.2012.14023 www.jama.com	[Trivedi, Tarak K.] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [DeSalvo, Traci] Wisconsin Dept Hlth Serv, Div Publ Hlth, Madison, WI USA; [Lee, Lore] Oregon Publ Hlth Div, Portland, OR USA; [Palumbo, Aimee; Moll, Maria] Div Infect Dis Epidemiol, Harrisburg, PA USA; [Palumbo, Aimee; Moll, Maria] Penn Dept Hlth, Harrisburg, PA 17108 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Trivedi, TK (corresponding author), Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, 1600 Clifton Rd NE,MS A34, Atlanta, GA 30333 USA.	ttrivedi@uchicago.edu	Trivedi, Tarak/S-9107-2019; Palumbo, Aimee/AAE-1762-2022	Trivedi, Tarak/0000-0003-3357-9525; Palumbo, Aimee/0000-0003-0769-6015	Centers for Disease Control and Prevention (CDC); Pfizer Inc.; CDC	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer Inc.(Pfizer); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Trivedi reports being a fellow of The CDC Experience, a 1-year fellowship for medical students in applied epidemiology at the Centers for Disease Control and Prevention (CDC) and made possible by a public/private partnership supported by a grant to the CDC Foundation from external medical affairs, Pfizer Inc. Ms DeSalvo reports receipt of a grant to the institution and travel support to the institution from the CDC; and travel/accommodations/meeting expenses unrelated to activities listed from the Association of Public Health Laboratories and the Council of State and Territorial Epidemiologists. The other authors report no disclosures.	[Anonymous], 2011, HLTH US 2010 SPEC FE; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Blaney DD, 2011, AM J INFECT CONTROL, V39, P296, DOI 10.1016/j.ajic.2010.10.010; Centers for Disease Control and Prevention, FLUV WEEKL INFL SURV; Centers for Medicare and Medicaid Services, NURS HOM DAT COMP; Centers for Medicare and Medicaid Services, NURS HOM COMP; Centers for Medicare & Medicaid Services, IMPR NURS HOM COMP C; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2000, GERONTOLOGIST, V40, P5; Harris JP, 2010, J HOSP INFECT, V74, P1, DOI 10.1016/j.jhin.2009.07.025; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Horn SD, 2005, AM J NURS, V105, P58, DOI 10.1097/00000446-200511000-00028; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; MacCannell T, 2011, INFECT CONT HOSP EP, V32, P939, DOI 10.1086/662025; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; Rosenthal NA, 2011, EPIDEMIOL INFECT, V139, P286, DOI 10.1017/S095026881000083X; Turcios RM, 2006, CLIN INFECT DIS, V42, P964, DOI 10.1086/500940; US Social Security Administration, COMP SOC SEC LAWS RE; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Wikswo M, 2012, INT C EM INF DIS ICE; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478	31	67	68	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1668	1675		10.1001/jama.2012.14023	http://dx.doi.org/10.1001/jama.2012.14023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028PI	23079758	Bronze			2022-12-01	WOS:000310434100021
J	Howan, K; Smith, AJ; Westblade, LF; Joly, N; Grange, W; Zorman, S; Darst, SA; Savery, NJ; Strick, TR				Howan, Kevin; Smith, Abigail J.; Westblade, Lars F.; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Darst, Seth A.; Savery, Nigel J.; Strick, Terence R.			Initiation of transcription-coupled repair characterized at single-molecule resolution	NATURE			English	Article							RNA-POLYMERASE; DNA-REPAIR; STRUCTURAL BASIS; MECHANISM; MFD; NANOMANIPULATION; TRANSLOCATION; TERMINATION; MUTATION; STRAND	Transcription-coupled DNA repair uses components of the transcription machinery to identify DNA lesions and initiate their repair. These repair pathways are complex, so their mechanistic features remain poorly understood. Bacterial transcription-coupled repair is initiated when RNA polymerase stalled at a DNA lesion is removed by Mfd, an ATP-dependent DNA translocase(1-3). Here we use single-molecule DNA nanomanipulation to observe the dynamic interactions of Escherichia coli Mfd with RNA polymerase elongation complexes stalled by a cyclopyrimidine dimer or by nucleotide starvation. We show that Mfd acts by catalysing two irreversible, ATP-dependent transitions with different structural, kinetic and mechanistic features. Mfd remains bound to the DNA in a long-lived complex that could act as a marker for sites of DNA damage, directing assembly of subsequent DNA repair factors. These results provide a framework for considering the kinetics of transcription-coupled repair in vivo, and open the way to reconstruction of complete DNA repair pathways at single-molecule resolution.	[Howan, Kevin; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Strick, Terence R.] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France; [Smith, Abigail J.; Savery, Nigel J.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Rockefeller University	Strick, TR (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France.	strick.terence@ijm.univ-paris-diderot.fr	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827; Strick, Terence/0000-0003-1744-3679; Savery, Nigel/0000-0002-0803-4075	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale; BBSRC [BB/I003142/1]; National Institutes of Health [GM073829]; EURYI grant; CNRS; University of Paris Diderot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073829] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I001859/1, BB/I003142/1] Funding Source: researchfish; BBSRC [BB/I001859/1] Funding Source: UKRI	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EURYI grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris Diderot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Neumann for showing us how to perform global fitting with the Igor software package. K.H. was supported by a PhD scholarship from the Frontieres Interdisciplinaires du Vivant Doctoral Program and the Fondation pour la Recherche Medicale. Work in the laboratory of N.J.S. was supported by BBSRC grant BB/I003142/1, and work in the laboratory of S.A.D. was supported by National Institutes of Health grant GM073829. This work was also made possible by a EURYI grant, in addition to CNRS and University of Paris Diderot core funding, to T.R.S.	Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deaconescu AM, 2012, P NATL ACAD SCI USA, V109, P3353, DOI 10.1073/pnas.1115105109; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Deaconescu AM, 2005, ACTA CRYSTALLOGR F, V61, P1062, DOI 10.1107/S1744309105035876; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; SELBY CP, 1993, J BACTERIOL, V175, P7509, DOI 10.1128/JB.175.23.7509-7514.1993; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Smith AJ, 2008, DNA REPAIR, V7, P1670, DOI 10.1016/j.dnarep.2008.06.020; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2011, J MOL BIOL, V406, P275, DOI 10.1016/j.jmb.2010.12.004; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; WITKIN EM, 1956, COLD SPRING HARB SYM, V21, P123, DOI 10.1101/SQB.1956.021.01.011	28	66	66	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					431	434		10.1038/nature11430	http://dx.doi.org/10.1038/nature11430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960746	Green Accepted			2022-12-01	WOS:000309918500052
J	Kocabas, A; Shen, CH; Guo, ZCV; Ramanathan, S				Kocabas, Askin; Shen, Ching-Han; Guo, Zengcai V.; Ramanathan, Sharad			Controlling interneuron activity in Caenorhabditis elegans to evoke chemotactic behaviour	NATURE			English	Article							LIM HOMEOBOX GENE; C-ELEGANS; NEURAL ACTIVITY; NERVOUS-SYSTEM; OPTICAL CONTROL; NEURONS; WORM; EXPRESSION; CIRCUITS; PROTEIN	Animals locate and track chemoattractive gradients in the environment to find food. With its small nervous system, Caenorhabditis elegans is a good model system(1,2) in which to understand how the dynamics of neural activity control this search behaviour. Extensive work on the nematode has identified the neurons that are necessary for the different locomotory behaviours underlying chemotaxis through the use of laser ablation(3-7), activity recording in immobilized animals and the study of mutants(4,5). However, we do not know the neural activity patterns in C. elegans that are sufficient to control its complex chemotactic behaviour. To understand how the activity in its interneurons coordinate different motor programs to lead the animal to food, here we used optogenetics and new optical tools to manipulate neural activity directly in freely moving animals to evoke chemotactic behaviour. By deducing the classes of activity patterns triggered during chemotaxis and exciting individual neurons with these patterns, we identified interneurons that control the essential locomotory programs for this behaviour. Notably, we discovered that controlling the dynamics of activity in just one interneuron pair (AIY) was sufficient to force the animal to locate, turn towards and track virtual light gradients. Two distinct activity patterns triggered in AIY as the animal moved through the gradient controlled reversals and gradual turns to drive chemotactic behaviour. Because AIY neurons are post-synaptic to most chemosensory and thermosensory neurons(8), it is probable that these activity patterns in AIY have an important role in controlling and coordinating different taxis behaviours of the animal.	[Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Guo, Zengcai V.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramanathan, Sharad] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Allen Institute for Brain Science; Harvard University; Harvard University	Kocabas, A (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	akocabas@cgr.harvard.edu; sharad@post.harvard.edu		Kocabas, Askin/0000-0002-6930-1202	Human Frontier Science Program (HFSP) Postdoctoral Fellowship; National Science Foundation (NSF) Graduate Fellowship; NSF Career Award; Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) Postdoctoral Fellowship(Human Frontier Science Program); National Science Foundation (NSF) Graduate Fellowship(National Science Foundation (NSF)); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Dowling, S. Lockery, J. Lichtman, K. McCormick, A. Murray, E. O'Shea, A. Schier, B. Stern and members of the Ramanathan laboratory for discussions and comments, the Human Frontier Science Program (HFSP) Postdoctoral Fellowship (A. K.), National Science Foundation (NSF) Graduate Fellowship (C.-H.S.), NSF Career Award, Pew Scholar, Klingenstein Fellowship Award and the National Institutes of Health (NIH) Pioneer Awards (S. R.) for support.	Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; BOULIN T, 2006, WORMBOOK; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chou JH, 2001, GENETICS, V157, P211; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Stirman JN, 2011, NAT METHODS, V8, P153, DOI [10.1038/nmeth.1555, 10.1038/NMETH.1555]; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	33	83	86	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					273	+		10.1038/nature11431	http://dx.doi.org/10.1038/nature11431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23000898	Green Accepted, Green Submitted			2022-12-01	WOS:000309733300052
J	Wootton, DM; Alevriadou, BR				Wootton, David M.; Alevriadou, B. Rita			The Shear Stress of Busting Blood Clots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FLOW		[Wootton, David M.] Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA; [Wootton, David M.] Cooper Union Adv Sci & Art, Maurice Kanbar Ctr Biomed Engn, New York, NY 10003 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Internal Med Cardiovasc Med, Columbus, OH USA; [Alevriadou, B. Rita] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA	Ohio State University; Ohio State University; Ohio State University	Wootton, DM (corresponding author), Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA.		Alevriadou, Barbara R/E-2628-2011	Alevriadou, Barbara/0000-0003-1897-755X				Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Ruggeri ZM, 2009, MICROCIRCULATION, V16, P58, DOI 10.1080/10739680802651477; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; TILLES AW, 1987, MICROVASC RES, V33, P211, DOI 10.1016/0026-2862(87)90018-5; Wootton DM, 2002, BIOTECHNOL BIOENG, V77, P405, DOI 10.1002/bit.10127	5	10	10	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1361	1363		10.1056/NEJMcibr1207994	http://dx.doi.org/10.1056/NEJMcibr1207994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034026				2022-12-01	WOS:000309406100017
J	Arshad, A; Powell, C; Tighe, MP				Arshad, A.; Powell, C.; Tighe, M. P.			Hirschsprung's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; 1ST STOOL; DIAGNOSIS; ENTEROCOLITIS; CONSTIPATION; BIOPSY; JAPAN		[Arshad, A.; Tighe, M. P.] Poole Hosp NHS Trust, Dept Paediat, Poole BH15 2JB, Dorset, England; [Powell, C.] Upton Surg, Poole BH16 5PW, Dorset, England		Tighe, MP (corresponding author), Poole Hosp NHS Fdn Trust, Poole Hosp, Longfleet Rd, Poole BH21 2HJ, Dorset, England.	mpt195@hotmail.com						Afzal NA, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-28; Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Beaudet A.R., 2001, METABOLIC MOL BASES, V8th; Blake NS, 2010, HIRSCHSPRUNGS DIS AL, P223; CLARK DA, 1977, PEDIATRICS, V60, P457; de Lorijn F, 2005, J PEDIATR-US, V146, P787, DOI 10.1016/j.jpeds.2005.01.044; Doodnath R, 2010, PEDIATR SURG INT, V26, P1107, DOI 10.1007/s00383-010-2694-2; Ghosh A, 1998, ARCH DIS CHILD, V79, P266, DOI 10.1136/adc.79.3.266; Hackam DJ, 1998, J PEDIATR SURG, V33, P830, DOI 10.1016/S0022-3468(98)90652-2; Haricharan RN, 2008, J PEDIATR SURG, V43, P1115, DOI 10.1016/j.jpedsurg.2008.02.039; IKEDA K, 1984, ANN SURG, V199, P400, DOI 10.1097/00000658-198404000-00005; KLEINHAUS S, 1979, J PEDIATR SURG, V14, P588, DOI 10.1016/S0022-3468(79)80145-1; Liem NT, 2008, ASIAN J SURG, V31, P216, DOI 10.1016/S1015-9584(08)60090-1; National Institute for Health and Clinical Excellence, 2010, DIAGN MAN ID CHILDH; Nofech-Mozes Y, 2004, J PAEDIATR CHILD H, V40, P716, DOI 10.1111/j.1440-1754.2004.00519.x; Pini-Prato A, 2007, PEDIATR SURG INT, V23, P117, DOI 10.1007/s00383-006-1845-y; RESCORLA FJ, 1992, ARCH SURG-CHICAGO, V127, P934; SHERRY SN, 1955, J PEDIATR-US, V46, P158, DOI 10.1016/S0022-3476(55)80205-3; Singh SJ, 2003, PEDIATR SURG INT, V19, P247, DOI 10.1007/s00383-002-0842-z; Suita S, 2005, J PEDIATR SURG, V40, P197, DOI 10.1016/j.jpedsurg.2004.09.052; SWENSON O, 1973, J PEDIATR SURG, V8, P587, DOI 10.1016/0022-3468(73)90395-3; TEITELBAUM DH, 1988, ANN SURG, V207, P240, DOI 10.1097/00000658-198803000-00003; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Ziad F, 2006, ANN SAUDI MED, V26, P200, DOI 10.5144/0256-4947.2006.200	24	20	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2012	345								e5521	10.1136/bmj.e5521	http://dx.doi.org/10.1136/bmj.e5521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028095				2022-12-01	WOS:000309657900005
J	Leppik, IE; Walczak, TS; Birnbaum, AK				Leppik, Ilo E.; Walczak, Thaddeus S.; Birnbaum, Angela K.			Challenges of epilepsy in elderly people	LANCET			English	Editorial Material							NURSING-HOME RESIDENTS; ANTIEPILEPTIC DRUG-USE; VARIABILITY; THERAPY		[Leppik, Ilo E.; Birnbaum, Angela K.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] MINCEP Epilepsy Care, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Leppik, IE (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	leppi001@umn.edu			NIA NIH HHS [R01 AG026390] Funding Source: Medline; NINDS NIH HHS [P50 NS016308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026390] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahn JE, 2008, NEUROLOGY, V71, P38, DOI 10.1212/01.wnl.0000316392.55784.57; Birnbaum A, 2003, NEUROLOGY, V60, P555, DOI 10.1212/01.WNL.0000052997.43492.E0; Birnbaum AK, 2012, EPILEPSY RES, V101, P22, DOI 10.1016/j.eplepsyres.2012.02.014; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; COLD JA, 1990, DICP ANN PHARMAC, V24, P601, DOI 10.1177/106002809002400610; Eberly LE, 2010, NEUROLOGY, V74, pA42; Ensrud KE, 2008, NEUROLOGY, V71, P723, DOI 10.1212/01.wnl.0000324919.86696.a9; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Fisher RS, 2008, EPILEPSIA, V49, P7, DOI 10.1111/j.1528-1167.2008.01921.x; Garrard J, 2000, J GERONTOL A-BIOL, V55, pM384, DOI 10.1093/gerona/55.7.M384; Garrard J, 2007, INT REV NEUROBIOL, V81, P165, DOI 10.1016/S0074-7742(06)81010-X; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Leppik IE, 2006, EPILEPSY RES, V68, pS1; LEPPIK IE, 1979, THER DRUG MONIT, V1, P475, DOI 10.1097/00007691-197910000-00004	14	9	9	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1128	1130		10.1016/S0140-6736(12)61517-7	http://dx.doi.org/10.1016/S0140-6736(12)61517-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021270				2022-12-01	WOS:000309255900007
J	Van den Bruel, A; Thompson, M; Buntinx, F; Mant, D				Van den Bruel, Ann; Thompson, Matthew; Buntinx, Frank; Mant, David			Clinicians' gut feeling about serious infections in children: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; YOUNG-CHILDREN; MODEL; RECOGNITION; BACTEREMIA; DIAGNOSIS; SIGNS	Objective To investigate the basis and added value of clinicians' "gut feeling" that infections in children are more serious than suggested by clinical assessment. Design Observational study. Setting Primary care setting, Flanders, Belgium. Participants Consecutive series of 3890 children and young people aged 0-16 years presenting in primary care. Main outcome measures Presenting features, clinical assessment, doctors' intuitive response at first contact with children in primary care, and any subsequent diagnosis of serious infection determined from hospital records. Results Of the 3369 children and young people assessed clinically as having a non-severe illness, six (0.2%) were subsequently admitted to hospital with a serious infection. Intuition that something was wrong despite the clinical assessment of non-severe illness substantially increased the risk of serious illness (likelihood ratio 25.5, 95% confidence interval 7.9 to 82.0) and acting on this gut feeling had the potential to prevent two of the six cases being missed (33%, 95% confidence interval 4.0% to 100%) at a cost of 44 false alarms (1.3%, 95% confidence interval 0.95% to 1.75%). The clinical features most strongly associated with gut feeling were the children's overall response (drowsiness, no laughing), abnormal breathing, weight loss, and convulsions. The strongest contextual factor was the parents' concern that the illness was different from their previous experience (odds ratio 36.3, 95% confidence interval 12.3 to 107). Conclusions A gut feeling about the seriousness of illness in children is an instinctive response by clinicians to the concerns of the parents and the appearance of the children. It should trigger action such as seeking a second opinion or further investigations. The observed association between intuition and clinical markers of serious infection means that by reflecting on the genesis of their gut feeling, clinicians should be able to hone their clinical skills.	[Van den Bruel, Ann; Thompson, Matthew; Mant, David] Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium	Universite Catholique Louvain	Van den Bruel, A (corresponding author), Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	ann.vandenbruel@phc.ox.ac.uk	Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009	Research Foundation-Flanders (FWO); Eurogenerics; National Institute for Health Research [RP-PG-0407-10347]; National Institute for Health Research [CL-2009-13-007, NF-SI-0507-10198, CDF-2011-04-052] Funding Source: researchfish	Research Foundation-Flanders (FWO)(FWO); Eurogenerics; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The original study was funded by a grant of the Research Foundation-Flanders (FWO) and an unconditional grant from Eurogenerics. None of the funders had any role in the design or analysis of the original study nor of the current analyses. The present analyses were done as part of the MaDOx programme, which presents independent research commissioned by the National Institute for Health Research under its programme grants for applied research funding scheme (RP-PG-0407-10347). MT is funded by a career development fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Balla JI, 2009, J EVAL CLIN PRACT, V15, P964, DOI 10.1111/j.1365-2753.2009.01243.x; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Grant CC, 2012, ARCH DIS CHILD, V97, P21, DOI 10.1136/archdischild-2011-300604; Greenhalgh R, 2002, BRIT J GEN PRACT, V52, P395; Haddon RA, 1999, MED J AUSTRALIA, V170, P475, DOI 10.5694/j.1326-5377.1999.tb127847.x; Harnden A, 2007, BRIT MED J, V335, P409, DOI 10.1136/bmj.39295.383843.AD; Lykke K, 2008, FAM PRACT, V25, P146, DOI 10.1093/fampra/cmn021; MCCARTHY PL, 1987, J PEDIATR-US, V110, P26, DOI 10.1016/S0022-3476(87)80282-2; Pearson GA, 2008, CONFIDENTIAL ENQUIRY; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Stolper E, 2011, J GEN INTERN MED, V26, P197, DOI 10.1007/s11606-010-1524-5; Stolper E, 2010, EUR J GEN PRACT, V16, P72, DOI 10.3109/13814781003653424; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; WASKERWITZ S, 1981, J PEDIATR-US, V99, P231, DOI 10.1016/S0022-3476(81)80458-1; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218	26	105	106	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e6144	10.1136/bmj.e6144	http://dx.doi.org/10.1136/bmj.e6144			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014ON	23015034	hybrid, Green Published			2022-12-01	WOS:000309385500004
J	Makinodan, M; Rosen, KM; Ito, S; Corfas, G				Makinodan, Manabu; Rosen, Kenneth M.; Ito, Susumu; Corfas, Gabriel			A Critical Period for Social Experience-Dependent Oligodendrocyte Maturation and Myelination	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; EARLY DEPRIVATION; WORKING-MEMORY; IN-VIVO; CHILDREN; SCHIZOPHRENIA; DISORDERS; ALTERS; CELLS; ERBB3	Early social isolation results in adult behavioral and cognitive dysfunction that correlates with white matter alterations. However, how social deprivation influences myelination and the significance of these myelin defects in the adult remained undefined. We show that mice isolated for 2 weeks immediately after weaning have alterations in prefrontal cortex function and myelination that do not recover with reintroduction into a social environment. These alterations, which occur only during this critical period, are phenocopied by loss of oligodendrocyte ErbB3 receptors, and social isolation leads to reduced expression of the ErbB3 ligand neuregulin-1. These findings indicate that social experience regulates prefrontal cortex myelination through neuregulin-1/ErbB3 signaling and that this is essential for normal cognitive function, thus providing a cellular and molecular context to understand the consequences of social isolation.	[Makinodan, Manabu; Rosen, Kenneth M.; Corfas, Gabriel] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Makinodan, Manabu; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rosen, Kenneth M.; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Ito, Susumu] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Corfas, G (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institute of Neurological Disorders and Stroke, NIH [R01 NS35884]; Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center [P30-HD 18655]; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Schwarz, C. J. Woolf, R. A. Corfas, M. Rao, F. Sher and M. Lozada for critical reading of the manuscript; C. Hart for help with the mouse colony; G. Gorski for help with electron microscopy; C. Arteaga for the generous gift of the ErbB3 floxed mouse line; J. C. Dodart for advice on behavioral tests; M. Fagiolini for allowing us to use behavioral equipment. This research was supported in part by the National Institute of Neurological Disorders and Stroke, NIH, grant R01 NS35884 (to G. C.), by Lori and Joel Freedman (to G. C.), an NIH Intellectual and Developmental Disabilities Research Center grant P30-HD 18655, and Nara Medical University (M.M.).	Bos K, 2011, HARVARD REV PSYCHIAT, V19, P15, DOI 10.3109/10673229.2011.549773; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Egeland B, 1983, Child Abuse Negl, V7, P459, DOI 10.1016/0145-2134(83)90053-4; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; GARIEPY JL, 1995, PHARMACOL BIOCHEM BE, V51, P767, DOI 10.1016/0091-3057(95)00028-U; Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8; Kim JY, 2003, J NEUROSCI, V23, P5561; Li CR, 2010, BRAIN RES, V1346, P183, DOI 10.1016/j.brainres.2010.05.064; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murtie JC, 2007, J NEUROSCI RES, V85, P2080, DOI 10.1002/jnr.21339; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Prevot V, 2003, J NEUROSCI, V23, P230; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Rico B, 2011, CURR OPIN GENET DEV, V21, P262, DOI 10.1016/j.gde.2010.12.010; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Sanchez MM, 1998, BRAIN RES, V812, P38, DOI 10.1016/S0006-8993(98)00857-9; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Winterfeld KT, 1998, J NEUROSCI RES, V52, P201, DOI 10.1002/(SICI)1097-4547(19980415)52:2<201::AID-JNR8>3.0.CO;2-E; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	37	534	540	6	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1357	1360		10.1126/science.1220845	http://dx.doi.org/10.1126/science.1220845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984073	Green Accepted			2022-12-01	WOS:000308705000046
J	Sherratt, TN; Roberts, G				Sherratt, Thomas N.; Roberts, Gilbert			When Paths to Cooperation Converge	SCIENCE			English	Editorial Material							RECIPROCAL ALTRUISM; EVOLUTION		[Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Roberts, Gilbert] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Carleton University; Newcastle University - UK	Sherratt, TN (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	tom_sherratt@carleton.ca	Roberts, Gilbert/K-5449-2019					Akcay E, 2011, P ROY SOC B-BIOL SCI, V278, P2198, DOI 10.1098/rspb.2010.2105; Andre JB, 2011, EVOLUTION, V65, P1447, DOI 10.1111/j.1558-5646.2011.01232.x; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Backwell PRY, 2004, NATURE, V430, P417, DOI 10.1038/430417a; BENDOR J, 1995, P NATL ACAD SCI USA, V92, P3596, DOI 10.1073/pnas.92.8.3596; Binmore K., 2007, PLAYING REAL; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001	15	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1304	1305		10.1126/science.1226328	http://dx.doi.org/10.1126/science.1226328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	004TW	22984060				2022-12-01	WOS:000308705000030
J	State, MW; Sestan, N				State, Matthew W.; Sestan, Nenad			The Emerging Biology of Autism Spectrum Disorders	SCIENCE			English	Editorial Material							DE-NOVO MUTATIONS; BRAIN; CHILDREN		[State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	State, MW (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 333 Cedar St, New Haven, CT 06510 USA.	matthew.state@yale.edu; nenad.sestan@yale.edu	State, Matthew/W-2256-2019	Candy, Cotton/0000-0002-3032-5872; State, Matthew/0000-0003-1624-8302	NIMH NIH HHS [P50MH081756, P50 MH081756, U01MH081896, R01MH081754, RC2 MH089956, R01 MH081754, RC2MH089956, U01 MH081896] Funding Source: Medline; NINDS NIH HHS [R01 NS054273, R01NS054273] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081756, R01MH081754, RC2MH089956, U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	14	112	120	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1301	1303		10.1126/science.1224989	http://dx.doi.org/10.1126/science.1224989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984058	Green Accepted			2022-12-01	WOS:000308705000028
J	Sung, JH; Zhang, H; Moseman, EA; Alvarez, D; Iannacone, M; Henrickson, SE; de la Torre, JC; Groom, JR; Luster, AD; von Andrian, UH				Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; de la Torre, Juan C.; Groom, Joanna R.; Luster, Andrew D.; von Andrian, Ulrich H.			Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes	CELL			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SUBCAPSULAR SINUS MACROPHAGES; HIGH ENDOTHELIAL VENULES; DENDRITIC CELLS; NONLYMPHOID TISSUE; RECEPTOR CXCR3; IN-VIVO; B-CELLS; EFFECTOR; IMMUNITY	A defining feature of vertebrate immunity is the acquisition of immunological memory, which confers enhanced protection against pathogens by mechanisms that are incompletely understood. Here, we compared responses by virus-specific naive T cells (T-N) and central memory T cells (T-CM) to viral antigen challenge in lymph nodes (LNs). In steady-state LNs, both T cell subsets localized in the deep T cell area and interacted similarly with antigen-presenting dendritic cells. However, upon entry of lymph-borne virus, only T-CM relocalized rapidly and efficiently toward the outermost LN regions in the medullary, interfollicular, and subcapsular areas where viral infection was initially confined. This rapid peripheralization was coordinated by a cascade of cytokines and chemokines, particularly ligands for T-CM-expressed CXCR3. Consequently, in vivo recall responses to viral infection by CXCR3-deficient T-CM were markedly compromised, indicating that early antigen detection afforded by intranodal chemokine guidance of T-CM is essential for efficient antiviral memory.	[Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Groom, Joanna R.; Luster, Andrew D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Iannacone, Matteo/I-8507-2018; von Andrian, Ulrich H/A-5775-2008; Luster, Andrew/ABE-6504-2020	Iannacone, Matteo/0000-0002-9370-2671; Luster, Andrew/0000-0001-9679-7912; Henrickson, Sarah/0000-0001-5569-4132; Groom, Joanna/0000-0001-5251-7835	NIH [AI078897, AI069259, 5T32-HL07623-20, CA069212]; Samsung Scholarship; Armenise-Harvard Foundation; Canadian Institutes of Health Research; Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI069259, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholarship(Samsung); Armenise-Harvard Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Flynn and Dr. G. Cheng for technical support, M. Perdue for secretarial assistance, and the members of the von Andrian laboratory for helpful discussion. This work was supported by NIH grants AI078897, AI069259 (to U.H.v.A.), 5T32-HL07623-20 (to E.A.M.), and CA069212 (to A.D.L.); a Samsung Scholarship (to J.H.S.); the Armenise-Harvard Foundation (to M.I.); the Canadian Institutes of Health Research (to D.A.); and an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia (to J.R.G.).	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; BYRNE JA, 1984, J VIROL, V51, P682, DOI 10.1128/JVI.51.3.682-686.1984; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medoff BD, 2006, J IMMUNOL, V176, P7087, DOI 10.4049/jimmunol.176.11.7087; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; von Herrath M, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1910s36; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	54	153	154	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1249	1263		10.1016/j.cell.2012.08.015	http://dx.doi.org/10.1016/j.cell.2012.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980984	Bronze, Green Accepted			2022-12-01	WOS:000308928100017
J	Mascre, G; Dekoninck, S; Drogat, B; Youssef, KK; Brohee, S; Sotiropoulou, PA; Simons, BD; Blanpain, C				Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Simons, Benjamin D.; Blanpain, Cedric			Distinct contribution of stem and progenitor cells to epidermal maintenance	NATURE			English	Article							HAIR FOLLICLE; MOUSE SKIN; IN-VIVO; LINEAGE; PROLIFERATION; HOMEOSTASIS; POPULATIONS; EXPRESSION; MODEL; UNITS	The skin interfollicular epidermis (IFE) is the first barrier against the external environment and its maintenance is critical for survival. Two seemingly opposite theories have been proposed to explain IFE homeostasis. One posits that IFE is maintained by long-lived slow-cycling stem cells that give rise to transit-amplifying cell progeny, whereas the other suggests that homeostasis is achieved by a single committed progenitor population that balances stochastic fate. Here we probe the cellular heterogeneity within the IFE using two different inducible Cre recombinase-oestrogen receptor constructs targeting IFE progenitors in mice. Quantitative analysis of clonal fate data and proliferation dynamics demonstrate the existence of two distinct proliferative cell compartments arranged in a hierarchy involving slow-cycling stem cells and committed progenitor cells. After wounding, only stem cells contribute substantially to the repair and long-term regeneration of the tissue, whereas committed progenitor cells make a limited contribution.	[Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Brussels, Machine Learning Grp, B-1050 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] Univ Libre Brussels, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Cambridge; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium.	bds10@cam.ac.uk; cedric.blanpain@ulb.ac.be	Simons, Benjamin/AAY-8920-2020; Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021	Simons, Benjamin/0000-0002-3875-7071; Youssef, Khalil Kass/0000-0002-4572-3160; benjamin, Drogat/0000-0002-0020-4826	FRS/FNRS; TELEVIE; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program; EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging. C. B. and P. A. S. are chercheur qualifie, G. M. and S. B. are supported by fellowship of the FRS/FNRS. B. D. is supported by TELEVIE. C. B. is an investigator of WELBIO. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, the European Research Council (ERC) and the EMBO Young Investigator Program.	Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI [10.1038/nrm2292, 10.1038/nrm2292x]; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; LOEFFLER M, 1987, VIRCHOWS ARCH B, V53, P286, DOI 10.1007/BF02890255; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MORRIS RJ, 1985, J INVEST DERMATOL, V84, P277, DOI 10.1111/1523-1747.ep12265358; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2010, CELL CYCLE, V9, P1504, DOI 10.4161/cc.9.8.11252; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	51	376	384	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					257	+		10.1038/nature11393	http://dx.doi.org/10.1038/nature11393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22940863				2022-12-01	WOS:000308635900034
J	Yang, LC; Rieves, D; Ganley, C				Yang, Lucie; Rieves, Dwaine; Ganley, Charles			Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Lucie; Rieves, Dwaine] Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off New Drugs, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off Drug Evaluat 4, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Yang, LC (corresponding author), Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA.							[Anonymous], 2011, PROM BRAIN HLTH; [Anonymous], HIGHL PRESCR INF AM; Department of Energy National Energy Technology Laboratory, 2004, GUID US ANT AG HIV 1, P2; Lister-James J, 2011, SEMIN NUCL MED, V41, P300, DOI 10.1053/j.semnuclmed.2011.03.001; Okie S, 2011, NEW ENGL J MED, V365, P1069, DOI 10.1056/NEJMp1107288	5	125	127	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					885	887		10.1056/NEJMp1208061	http://dx.doi.org/10.1056/NEJMp1208061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931256	Bronze			2022-12-01	WOS:000308343300002
J	Althoff, KN; Buchacz, K; Hall, HI; Zhang, JB; Hanna, DB; Rebeiro, P; Gange, SJ; Moore, RD; Kitahata, MM; Gebo, KA; Martin, J; Justice, AC; Horberg, MA; Hogg, RS; Sterling, TR; Cescon, A; Klein, MB; Thorne, JE; Crane, HM; Mugavero, MJ; Napravnik, S; Kirk, GD; Jacobson, LP; Brooks, JT				Althoff, Keri N.; Buchacz, Kate; Hall, H. Irene; Zhang, Jinbing; Hanna, David B.; Rebeiro, Peter; Gange, Stephen J.; Moore, Richard D.; Kitahata, Mari M.; Gebo, Kelly A.; Martin, Jeffrey; Justice, Amy C.; Horberg, Michael A.; Hogg, Robert S.; Sterling, Timothy R.; Cescon, Angela; Klein, Marina B.; Thorne, Jennifer E.; Crane, Heidi M.; Mugavero, Michael J.; Napravnik, Sonia; Kirk, Gregory D.; Jacobson, Lisa P.; Brooks, John T.		N Amer AIDS Cohort Collaboration	US Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; VIROLOGICAL RESPONSES; CLINICAL COHORT; MEDICAL-CARE; AIDS; ADULTS; IMMUNODEFICIENCY; MORTALITY; HAART; DEATH	Background: The U.S. National HIV/AIDS Strategy targets for 2015 include "increasing access to care and improving health outcomes for persons living with HIV in the United States" (PLWH-US). Objective: To demonstrate the utility of the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) for monitoring trends in the HIV epidemic in the United States and to present trends in HIV treatment and related health outcomes. Design: Trends from annual cross-sectional analyses comparing patients from pooled, multicenter, prospective, clinical HIV cohort studies with PLWH-US, as reported to national surveillance systems in 40 states. Setting: U.S. HIV outpatient clinics. Patients: HIV-infected adults with 1 or more HIV RNA plasma viral load (HIV VL) or CD4 T-lymphocyte (CD4) cell count measured in any calendar year from 1 January 2000 to 31 December 2008. Measurements: Annual rates of antiretroviral therapy use, HIV VL, and CD4 cell count at death. Results: 45 529 HIV-infected persons received care in an NA-ACCORD-participating U.S. clinical cohort from 2000 to 2008. In 2008, the 26 030 NA-ACCORD participants in care and the 655 966 PLWH-US had qualitatively similar demographic characteristics. From 2000 to 2008, the proportion of participants prescribed highly active antiretroviral therapy increased by 9 percentage points to 83% (P < 0.001), whereas the proportion with suppressed HIV VL (<= 2.7 log(10) copies/mL) increased by 26 percentage points to 72% (P < 0.001). Median CD4 cell count at death more than tripled to 0.209 x 10(9) cells/L (P < 0.001). Limitation: The usual limitations of observational data apply. Conclusion: The NA-ACCORD is the largest cohort of HIV-infected adults in clinical care in the United States that is demographically similar to PLWH-US in 2008. From 2000 to 2008, increases were observed in the percentage of prescribed HAART, the percentage who achieved a suppressed HIV VL, and the median CD4 cell count at death. Primary Funding Source: National Institutes of Health; Centers for Disease Control and Prevention; Canadian Institutes of Health Research; Canadian HIV Trials Network; and the government of British Columbia, Canada.	Johns Hopkins Univ, Baltimore, MD USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Univ Washington, Seattle, WA 98104 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Yale Univ, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Mid Atlantic Permanente Res Inst, Rockville, MD 20852 USA; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Simon Fraser Univ, Vancouver, BC, Canada; Vanderbilt Univ, Nashville, TN 37232 USA; McGill Univ, Montreal, PQ H2X 2P4, Canada; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Univ N Carolina, Chapel Hill, NC 27599 USA	Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Vanderbilt University; McGill University; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Althoff, KN (corresponding author), 615 N Wolfe St,Room E-7142, Baltimore, MD 21231 USA.	kalthoff@jhsph.edu	Gange, Stephen/AGY-5004-2022; Gebo, Kelly/AHA-7533-2022	Gange, Stephen/0000-0001-7842-512X; Gebo, Kelly/0000-0003-4010-398X; Althoff, Keri/0000-0002-5068-6595; Rebeiro, Peter/0000-0003-1951-9104; Jacobson, Lisa P./0000-0003-1722-6826; Hogg, Robert/0000-0003-3463-5488; Klein, Marina/0000-0002-3063-8430	National Institutes of Health [M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725]; CDC [CDC200-2006-18797]; Canadian Institutes of Health Research [TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, 169621]; Canadian HIV Trials Network [24]; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, M01RR000079, M01RR000722, M01RR000071, UL1RR024131, M01RR000083, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY013707, U10EY008057, U10EY008052, U10EY008067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI035004, U01AI034994, P30AI054999, U01AI035043, P30AI027767, R24AI067039, U01AI069434, U01AI037613, U01AI035041, U01AI069432, U01AI035042, U01AI037984, U01AI069918, U01AI042590, U01AI034993, P30AI027757, K01AI093197, UM1AI069434, K01AI071725, UM1AI069432, P30AI050410, U01AI035040, U01AI038855, U01AI035039, U01AI034989, U01AI031834, U01AI068636, U01AI068634, P30AI094189, U01AI038858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015032, U10AA013566, R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, R01DA004334, K24DA000432, F31DA030254, R01DA011602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grants U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K01-AI093197 (Dr. Althoff) and F31-DA30254 (Mr. Hanna) from the National Institutes of Health; contract CDC200-2006-18797 from the CDC; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, and 169621 from the Canadian Institutes of Health Research; the Canadian HIV Trials Network, project 24; and the government of British Columbia. The CDC funds all U.S. states and the District of Columbia to conduct HIV surveillance and provides technical assistance to all funded areas. Participating investigators and contributors are CDC employees. Employees of the CDC conducted the surveillance data analyses, and the report was reviewed and approved by the CDC.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2010, NAT HIV AIDS STRAT U; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Belperio PS, 2010, HIV MED, V11, P209, DOI 10.1111/j.1468-1293.2009.00764.x; Blair Janet M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; *CDCP, 2005, HIV AIDS SURVEILLA S, V11, P1; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cole SR, 2010, AM J EPIDEMIOL, V172, P107, DOI 10.1093/aje/kwq084; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Gandhi NR, 2007, MED CARE, V45, P1105, DOI 10.1097/MLR.0b013e3181271476; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gay CL, 2006, AIDS, V20, P775, DOI 10.1097/01.aids.0000216380.30055.4a; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Henrich TJ, 2008, J COMMUN HEALTH, V33, P69, DOI 10.1007/s10900-007-9069-1; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; Hughes JP, 1999, BIOMETRICS, V55, P625, DOI 10.1111/j.0006-341X.1999.00625.x; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Leone S, 2011, INFECTION, V39, P13, DOI 10.1007/s15010-010-0079-z; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mehta SH, 2007, AIDS CARE, V19, P637, DOI 10.1080/09540120701235644; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Seal PS, 2011, J GEN INTERN MED, V26, P745, DOI 10.1007/s11606-011-1693-x; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Silverberg MJ, 2009, J GEN INTERN MED, V24, P1065, DOI 10.1007/s11606-009-1049-y; Thiebaut R, 2004, COMPUT METH PROG BIO, V74, P255, DOI 10.1016/j.cmpb.2003.08.004; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Wood E, 2003, CAN MED ASSOC J, V169, P656; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	47	91	91	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					325	U63		10.7326/0003-4819-157-5-201209040-00005	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944874	Green Accepted, Green Submitted			2022-12-01	WOS:000308361500003
J	Einstein, DJ				Einstein, David J.			ON BEING A DOCTOR Knot	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Einstein, DJ (corresponding author), Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	deinstein@tuftsmedicalcenter.org	Einstein, David/ABB-3748-2020						0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					381	382		10.7326/0003-4819-157-5-201209040-00012	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944877				2022-12-01	WOS:000308361500009
J	Cheng, L; Booker, FL; Tu, C; Burkey, KO; Zhou, LS; Shew, HD; Rufty, TW; Hu, SJ				Cheng, Lei; Booker, Fitzgerald L.; Tu, Cong; Burkey, Kent O.; Zhou, Lishi; Shew, H. David; Rufty, Thomas W.; Hu, Shuijin			Arbuscular Mycorrhizal Fungi Increase Organic Carbon Decomposition Under Elevated CO2	SCIENCE			English	Article							SOIL MICROBIAL COMMUNITY; RESIDUE DECOMPOSITION; NITROGEN LIMITATION; EXTERNAL HYPHAE; ASSIMILATION; AGGREGATION; ACQUISITION; GRASSLAND; FEEDBACKS; BACTERIA	The extent to which terrestrial ecosystems can sequester carbon to mitigate climate change is a matter of debate. The stimulation of arbuscular mycorrhizal fungi (AMF) by elevated atmospheric carbon dioxide (CO2) has been assumed to be a major mechanism facilitating soil carbon sequestration by increasing carbon inputs to soil and by protecting organic carbon from decomposition via aggregation. We present evidence from four independent microcosm and field experiments demonstrating that CO2 enhancement of AMF results in considerable soil carbon losses. Our findings challenge the assumption that AMF protect against degradation of organic carbon in soil and raise questions about the current prediction of terrestrial ecosystem carbon balance under future climate-change scenarios.	[Cheng, Lei; Tu, Cong; Zhou, Lishi; Shew, H. David; Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Booker, Fitzgerald L.; Burkey, Kent O.] ARS, USDA, Plant Sci Res Unit, Raleigh, NC 27607 USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Rufty, Thomas W.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Zhou, Lishi] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Chinese Academy of Sciences; Institute of Botany, CAS	Hu, SJ (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.	shuijin_hu@ncsu.edu	Cheng, lei/E-6307-2013; Tu, Cong/H-9750-2013	Cheng, Lei/0000-0002-5486-3632; Hu, Shuijin/0000-0002-3225-5126	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA [2009-35101-05351]	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA(United States Department of Agriculture (USDA))	We thank F. Chapin III, D. Coleman, Y. Luo, R. Miller, and M. Rillig for valuable comments; M. Gumpertz for advice on statistical analyses; J. Barton, W. Pursley, and E. Silva for technical assistance; and D. Watson and J. Morton for providing mycorrhizal inoculum. L. C. was primarily supported by a fellowship from U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC) and in part by a USDA grant to S. H. (2009-35101-05351). S. H., L. C. and C. T. conceived experiments 1 to 4. K.O.B. and F. L. B. designed and maintained the long-term CO<INF>2</INF> and O<INF>3</INF> study. H. D. S and T. W. R. contributed to design of experiments 1 and 2. L. C. performed experiments 1 to 3 and the meta-analysis study; and C. T., F. L. B., and L.Z. performed experiment 4. L. C. and S. H. analyzed the data and mainly wrote the manuscript with inputs from all coauthors. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.b7f53).	Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021377; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Orwin KH, 2011, ECOL LETT, V14, P493, DOI 10.1111/j.1461-0248.2011.01611.x; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Sanders IR, 1998, OECOLOGIA, V117, P496, DOI 10.1007/s004420050685; Smith SE., 2008, MYCORRHIZAL SYMBIOSI; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tisdall JM, 1997, AUST J SOIL RES, V35, P55, DOI 10.1071/S96065; Treseder KK, 2000, NEW PHYTOL, V147, P189, DOI 10.1046/j.1469-8137.2000.00690.x; Tu C, 2006, GLOBAL CHANGE BIOL, V12, P793, DOI 10.1111/j.1365-2486.2006.01149.x; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x	30	311	361	46	963	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1084	1087		10.1126/science.1224304	http://dx.doi.org/10.1126/science.1224304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936776				2022-12-01	WOS:000308125800044
J	Dong, N; Zhu, YQ; Lu, QH; Hu, LY; Zheng, YQ; Shao, F				Dong, Na; Zhu, Yongqun; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng			Structurally Distinct Bacterial TBC-like GAPs Link Arf GTPase to Rab1 Inactivation to Counteract Host Defenses	CELL			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; MATRIX PROTEIN GM130; ENDOPLASMIC-RETICULUM; ACTIVATING PROTEIN; EFFECTOR PROTEIN; SHIGELLA; VIRA; COMPLEX; DOMAIN; IDENTIFICATION	Rab GTPases are frequent targets of vacuole-living bacterial pathogens for appropriate trafficking of the vacuole. Here we discover that bacterial effectors including VirA from nonvacuole Shigella flexneri and EspG from extracellular Enteropathogenic Escherichia coli (EPEC) harbor TBC-like dual-finger motifs and exhibits potent RabGAP activities. Specific inactivation of Rab1 by VirA/EspG disrupts ER-to-Golgi trafficking. S. flexneri intracellular persistence requires VirA TBC-like GAP activity that mediates bacterial escape from autophagy-mediated host defense. Rab1 inactivation by EspG severely blocks host secretory pathway, resulting in inhibited interleukin-8 secretion from infected cells. Crystal structures of VirA/EspG-Rab1-GDP-aluminum fluoride complexes highlight TBC-like catalytic role for the arginine and glutamine finger residues and reveal a 3D architecture distinct from that of the TBC domain. Structure of Arf6-EspG-Rab1 ternary complex illustrates a pathogenic signaling complex that rewires host Arf signaling to Rab1 inactivation. Structural distinctions of VirA/EspG further predict a possible extensive presence of TBC-like RabGAP effectors in counteracting various host defenses.	[Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dong, Na; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Zhejiang University; National Institute of Biological Sciences, Beijing	Zhu, YQ (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zhuyongqun@zju.edu.cn; shaofeng@nibs.ac.cn	Zheng, Yuqing/AAO-6891-2020	Lu, Qiuhe/0000-0002-0202-7448	Howard Hughes Medical Institute; Zhejiang University; National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Zhejiang University; National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank Dr. David G. Lambright for kindly providing bacterial expression constructs for 30 Rabs. We thank the staff at the KEK Synchrotron Facility (Tsukuba, Japan) and Argonne Advanced Photon Source (Chicago, IL) for assistances with data collection. We also thank Yan Zhou, Jieling Yang, Yin Xu, and Jianjin Shi for technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. Y.Z. was supported by new faculty start-up funds from Zhejiang University. This work was also supported by the National Basic Research Program of China (973 Programs 2010CB835400 and 2012CB518700) to F.S.	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clements A, 2011, CELL MICROBIOL, V13, P1429, DOI 10.1111/j.1462-5822.2011.01631.x; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Elliott SJ, 2001, INFECT IMMUN, V69, P4027, DOI 10.1128/IAI.69.6.4027-4033.2001; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Germane KL, 2011, BIOCHEMISTRY-US, V50, P917, DOI 10.1021/bi1020138; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	39	157	162	6	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1029	1041		10.1016/j.cell.2012.06.050	http://dx.doi.org/10.1016/j.cell.2012.06.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939626	Bronze			2022-12-01	WOS:000308500200016
J	Vargas-Parada, L				Vargas-Parada, Laura			PATHOLOGY Three questions	NATURE			English	Editorial Material							CANCER											Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	5	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S14	S15		10.1038/488S14a	http://dx.doi.org/10.1038/488S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932435				2022-12-01	WOS:000308095100010
J	Button, B; Cai, LH; Ehre, C; Kesimer, M; Hill, DB; Sheehan, JK; Boucher, RC; Rubinstein, M				Button, Brian; Cai, Li-Heng; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Sheehan, John K.; Boucher, Richard C.; Rubinstein, Michael			A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia	SCIENCE			English	Article							CYSTIC-FIBROSIS; SURFACE LIQUID; PSEUDOMONAS-AERUGINOSA; MUCOCILIARY CLEARANCE; RESPIRATORY-TRACT; IN-VIVO; MUCIN; TRANSPORT; DISEASE; IDENTIFICATION	Mucus clearance is the primary defense mechanism that protects airways from inhaled infectious and toxic agents. In the current gel-on-liquid mucus clearance model, a mucus gel is propelled on top of a "watery" periciliary layer surrounding the cilia. However, this model fails to explain the formation of a distinct mucus layer in health or why mucus clearance fails in disease. We propose a gel-on-brush model in which the periciliary layer is occupied by membrane-spanning mucins and mucopolysaccharides densely tethered to the airway surface. This brush prevents mucus penetration into the periciliary space and causes mucus to form a distinct layer. The relative osmotic moduli of the mucus and periciliary brush layers explain both the stability of mucus clearance in health and its failure in airway disease.	[Cai, Li-Heng; Rubinstein, Michael] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [Button, Brian; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Kesimer, Mehmet; Sheehan, John K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Rubinstein, Michael] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rubinstein, M (corresponding author), Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA.	mr@unc.edu	Cai, Li-Heng/A-1602-2009; , Mehmet Kesimer/AHB-9223-2022; Cai, Liheng/O-2834-2013	Cai, Liheng/0000-0002-6806-0566	Cystic Fibrosis Foundation [BUTTON07XX0, BUTTON11G0, RUBIN09XX0, R026-CRII]; NSF [CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915, CBET-0609087]; NIH [K01DK080847, R01HL077546, P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, UL1-RR025747, R01HL103940]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873, P50HL107168, P01HL034322, R01HL077546, R01HL103940, P01HL108808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080847, P30DK065988] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0911588] Funding Source: National Science Foundation; Division Of Materials Research [0907515] Funding Source: National Science Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding for this work was provided by Cystic Fibrosis Foundation grants BUTTON07XX0 (to B. B.), BUTTON11G0 (to B. B.), RUBIN09XX0 (to M. R.), and R026-CRII (to R. C. B.); NSF grants CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915 (in part), and CBET-0609087 (to M. R.); and NIH grants K01DK080847 (to B. B.), R01HL077546 (in part to M. R.), P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, and UL1-RR025747 (to R. C. B.), and R01HL103940 (to M. K.). We thank S. Panyukov and E. B. Zhulina for illuminating discussions, L. Brown for graphical and editorial assistance, S. Randell for the human airway epithelial cells, K. Burns for histology assistance, and R. Tarran for use of the Leica SP5 confocal microscope. M. R. conceived the study, and B. B., L.-H. C., R. C. B., and M. R. designed the experiments. B. B. developed experimental approaches for the osmotic pressure measurements and the PCL permeability and osmotic compression experiments. L.-H. C. prepared regents and, along with B. B., performed the PCL permeability and osmotic compression experiments. C. E. conducted the transmission electron microscopy and immunological experiments. M. K., D. B. H., and J.K.S. provided technical assistance in preparing reagents. M. R., L.-H. C., B. B., and R. C. B. discussed and analyzed the results. M. R. and R. C. B. supervised the whole study. B. B., L.-H. C., R. C. B., and M. R. wrote the paper. The authors declare that they have no competing financial interests.	Arfken G.B., 2005, MATH METHODS PHYS; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finkbeiner WE, 2011, AM J PHYSIOL-LUNG C, V301, pL402, DOI 10.1152/ajplung.00210.2010; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hilding A C, 1967, Minn Med, V50, P915; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; IRAVANI J, 1972, J PATHOL, V106, P81, DOI 10.1002/path.1711060204; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; KALINER M, 1984, J ALLERGY CLIN IMMUN, V73, P318, DOI 10.1016/0091-6749(84)90403-2; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kinsky MP, 2000, J TRAUMA, V49, P844, DOI 10.1097/00005373-200011000-00009; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lucas AM, 1934, ARCHIV OTOLARYNGOL, V20, P518; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Pattison J.R., 2000, PRINCIPLES PRACTICE, P645; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Raphael JH, 1996, BRIT J ANAESTH, V76, P116, DOI 10.1093/bja/76.1.116; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/bj3620289; ROSE MC, 1992, AM J PHYSIOL, V263, pL413, DOI 10.1152/ajplung.1992.263.4.L413; Rubinstein M., 2003, POLYM PHYS, DOI DOI 10.1002/PI.1472; Schwab U, 2002, INFECT IMMUN, V70, P4547, DOI 10.1128/IAI.70.8.4547-4555.2002; Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037; Smith DJ, 2007, B MATH BIOL, V69, P817, DOI 10.1007/s11538-006-9163-z; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	44	512	518	13	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					937	941		10.1126/science.1223012	http://dx.doi.org/10.1126/science.1223012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923574	Green Accepted, Green Submitted			2022-12-01	WOS:000307807600037
J	Cho, J; Chang, H; Kwon, SC; Kim, B; Kim, Y; Choe, J; Ha, M; Kim, YK; Kim, VN				Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Choe, Junho; Ha, Minju; Kim, Yoon Ki; Kim, V. Narry			LIN28A Is a Suppressor of ER-Associated Translation in Embryonic Stem Cells	CELL			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; MICRORNA BIOGENESIS; LET-7 MICRORNA; BINDING-SITES; CROSS-LINKING; IN-VIVO; CLIP; LIN-28; PROTEINS	LIN28 plays a critical role in developmental transition, glucose metabolism, and tumorigenesis. At the molecular level, LIN28 is known to repress maturation of let-7 microRNAs and enhance translation of certain mRNAs. In this study, we obtain a genome-wide view of the molecular function of LIN28A in mouse embryonic stem cells by carrying out RNA crosslinking-immunoprecipitation-sequencing (CLIP-seq) and ribosome footprinting. We find that, in addition to let-7 precursors, LIN28A binds to a large number of spliced mRNAs. LIN28A recognizes AAGNNG, AAGNG, and less frequently UGUG, which are located in the terminal loop of a small hairpin. LIN28A is localized to the periendo-plasmic reticulum (ER) area and inhibits translation of mRNAs that are destined for the ER, reducing the synthesis of transmembrane proteins, ER or Golgi lumen proteins, and secretory proteins. Our study suggests a selective regulatory mechanism for ER-associated translation and reveals an unexpected role of LIN28A as a global suppressor of genes in the secretory pathway.	[Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Choe, Junho; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Korea University	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Choe, Junho/E-3410-2019; Kwon, S. Chul/ABG-9415-2020; Kim, Yoosik/B-9009-2016; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Choe, Junho/0000-0002-2365-3755; Kim, Yoosik/0000-0003-3064-4643; Kim, Yoon Ki/0000-0003-1303-072X; Kim, Baekgyu/0000-0002-6681-6198; Chang, Hyeshik/0000-0002-9812-8015; Ha, Minju/0000-0003-2328-415X	Research Center Program of IBS (Institute for Basic Science) [EM1202]; BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF)	We are grateful to Huili Guo for advice on ribosome profiling and Daehyun Baek for critical comments on the manuscript. We also thank Ahyoung Cho and Yun Cheng Chang for technical help and members of our laboratory for discussion. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J.C., H. C., S. C. K., and B. K.) from the Ministry of Education, Science and Technology of Korea; the TJ Park Postdoctoral Fellowship (Y.K.); and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hamilton RL, 1999, J LIPID RES, V40, P1140; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	43	171	176	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					765	777		10.1016/j.cell.2012.10.019	http://dx.doi.org/10.1016/j.cell.2012.10.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23102813	Bronze			2022-12-01	WOS:000310921200009
J	Heo, I; Ha, M; Lim, J; Yoon, MJ; Park, JE; Kwon, SC; Chang, H; Kim, VN				Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry			Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-7 MicroRNAs	CELL			English	Article							RNA-INTERFERENCE; C-ELEGANS; POLY(A) POLYMERASES; NUCLEAR EXPORT; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; DROSHA-DGCR8 COMPLEX; MOLECULAR-BASIS; 3' ADENYLATION; MESSENGER-RNA	RNase III Drosha initiates microRNA (miRNA) maturation by cleaving a primary miRNA transcript and releasing a pre-miRNA with a 2 nt 3' overhang. Dicer recognizes the 2 nt 3' overhang structure to selectively process pre-miRNAs. Here, we find that, unlike prototypic pre-miRNAs (group I), group II pre-miRNAs acquire a shorter (1 nt) 3' overhang from Drosha processing and therefore require a 3'-end mono-uridylation for Dicer processing. The majority of let-7 and miR-105 belong to group II. We identify TUT7/ZCCHC6, TUT4/ZCCHC11, and TUT2/PAPD4/GLD2 as the terminal uridylyl transferases responsible for pre-miRNA mono-uridylation. The TUTs act specifically on dsRNAs with a 1 nt 3' overhang, thereby creating a 2 nt 3' overhang. Depletion of TUTs reduces let-7 levels and disrupts let-7 function. Although the let-7 suppressor, Lin28, induces inhibitory oligo-uridylation in embryonic stem cells, mono-uridylation occurs in somatic cells lacking Lin28 to promote let-7 biogenesis. Our study reveals functional duality of uridylation and introduces TUT7/4/2 as components of the miRNA biogenesis pathway.	[Heo, Inha; Ha, Minju; Lim, Jaechul; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Ha, Minju/0000-0003-2328-415X; Chang, Hyeshik/0000-0002-9812-8015	Research Center Program of IBS (Institute for Basic Science) [EM1202]; Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	We are grateful to the members of our laboratory, particularly Joha Park, Hyerim Yi, Dr. Kyu-Hyeon Yeom, Dr. Yoosik Kim, Ahyoung Cho, and Yun Cheng Chang for discussion and technical help. We thank Dr. Yun-jeong Kim and Dr. Daehyun Baek for help in preparation of mRNA sequencing libraries. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J. L., J.-E. P., and H. C.) from the Ministry of Education, Science and Technology of Korea; and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MENEELY PM, 1979, GENETICS, V92, P99; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	65	213	219	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					521	532		10.1016/j.cell.2012.09.022	http://dx.doi.org/10.1016/j.cell.2012.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063654	Bronze			2022-12-01	WOS:000310529300010
J	Itsathitphaisarn, O; Wing, RA; Eliason, WK; Wang, JM; Steitz, TA				Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.			The Hexameric Helicase DnaB Adopts a Nonplanar Conformation during Translocation	CELL			English	Article							ESCHERICHIA-COLI; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; PROTEIN; COMPLEX; PRIMASE; DOMAIN; SITE	DNA polymerases can only synthesize nascent DNA from single-stranded DNA (ssDNA) templates. In bacteria, the unwinding of parental duplex DNA is carried out by the replicative DNA helicase (DnaB) that couples NTP hydrolysis to 5' to 3' translocation. The crystal structure of the DnaB hexamer in complex with GDP-AlF4 and ssDNA reported here reveals that DnaB adopts a closed spiral staircase quaternary structure around an A-form ssDNA with each C-terminal domain coordinating two nucleotides of ssDNA. The structure not only provides structural insights into the translocation mechanism of superfamily IV helicases but also suggests that members of this superfamily employ a translocation mechanismthat is distinct from other helicase super-families. We propose a hand-over-hand mechanism in which sequential hydrolysis of NTP causes a sequential 5' to 3' movement of the subunits along the helical axis of the staircase, resulting in the unwinding of two nucleotides per subunit.	[Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Eliason, William K.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu		Wing, Richard/0000-0001-5642-9349	NIH [RO1 GM057510]; Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778, R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at APS beamline 24-ID and at NSLS beamlines X-25 and X-29. This work was supported by NIH RO1 GM057510 to T. A. S., the Royal Thai Government Scholarship to O.I., and by Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998a; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	48	154	155	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					267	277		10.1016/j.cell.2012.09.014	http://dx.doi.org/10.1016/j.cell.2012.09.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23022319	Bronze, Green Accepted			2022-12-01	WOS:000309981000007
J	Wesolowski, A; Eagle, N; Tatem, AJ; Smith, DL; Noor, AM; Snow, RW; Buckee, CO				Wesolowski, Amy; Eagle, Nathan; Tatem, Andrew J.; Smith, David L.; Noor, Abdisalan M.; Snow, Robert W.; Buckee, Caroline O.			Quantifying the Impact of Human Mobility on Malaria	SCIENCE			English	Article							ELIMINATION STRATEGIES; TRANSMISSION; KENYA; NAIROBI; SETTLEMENT; ZANZIBAR	Human movements contribute to the transmission of malaria on spatial scales that exceed the limits of mosquito dispersal. Identifying the sources and sinks of imported infections due to human travel and locating high-risk sites of parasite importation could greatly improve malaria control programs. Here, we use spatially explicit mobile phone data and malaria prevalence information from Kenya to identify the dynamics of human carriers that drive parasite importation between regions. Our analysis identifies importation routes that contribute to malaria epidemiology on regional spatial scales.	[Eagle, Nathan; Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15221 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15221 USA; [Eagle, Nathan] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.; Smith, David L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Collaborat Programme, KEMRI Wellcome Trust, Malaria Publ Hlth & Epidemiol Grp,Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Carnegie Mellon University; Carnegie Mellon University; Northeastern University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Buckee, CO (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	cbuckee@hsph.harvard.edu	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X	National Science Foundation Graduate Research Fellowship program [0750271]; Bill & Melinda Gates Foundation [49446, OPP1032350]; National Institute of Allergy and Infectious Disease, NIH [U19AI089674]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH; Wellcome Trust [095127, 079080]; Wellcome Trust Major Overseas Programme grant [092654]; Models of Infectious Disease Agent Study program [1U54GM088558]; Direct For Social, Behav & Economic Scie [1005075] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1216345] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Disease, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Major Overseas Programme grant(Wellcome Trust); Models of Infectious Disease Agent Study program; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.W. was supported by the National Science Foundation Graduate Research Fellowship program (0750271). D. L. S. and A.J.T. acknowledge support from Bill & Melinda Gates Foundation grants (49446 and OPP1032350); National Institute of Allergy and Infectious Disease, NIH, grant (U19AI089674); and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; and the Fogarty International Center, NIH. A.M.N. is supported by the Wellcome Trust as an Intermediate Research Fellow (095127). R. W. S. is supported by the Wellcome Trust as Principal Research Fellow (079080). A.M.N. and R. W. S. also acknowledge programmatic support provided by the Wellcome Trust Major Overseas Programme grant to the Kenya Medical Research Institute-Wellcome Trust Programme (092654). C.O.B. was supported by the Models of Infectious Disease Agent Study program (cooperative agreement 1U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. Mobile phone data were provided by an anonymous service provider in Kenya and are not available for distribution.	Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Dolgin E, 2010, NAT MED, V16, P1055, DOI 10.1038/nm1010-1055; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Kasili S, 2009, J VECTOR DIS, V46, P273; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; Moonen B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-322; Mudhune SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-138; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Rapuoda B., 1984, P KEMRI KETRI 5 ANN, P115; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	20	535	544	11	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					267	270		10.1126/science.1223467	http://dx.doi.org/10.1126/science.1223467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066082	Green Accepted			2022-12-01	WOS:000309712300049
J	Lee, GM; Kleinman, K; Soumerai, SB; Tse, A; Cole, D; Fridkin, SK; Horan, T; Platt, R; Gay, C; Kassler, W; Goldmann, DA; Jernigan, J; Jha, AK				Lee, Grace M.; Kleinman, Ken; Soumerai, Stephen B.; Tse, Alison; Cole, David; Fridkin, Scott K.; Horan, Teresa; Platt, Richard; Gay, Charlene; Kassler, William; Goldmann, Donald A.; Jernigan, John; Jha, Ashish K.			Effect of Nonpayment for Preventable Infections in US Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-ASSOCIATED INFECTIONS; PAY-FOR-PERFORMANCE; URINARY-TRACT-INFECTIONS; QUALITY-OF-CARE; SAFETY-NET HOSPITALS; HEALTH-CARE; MEDICARE POLICY; PAYMENT POLICY; UNINTENDED CONSEQUENCES; ACQUIRED CONDITIONS	Background In October 2008, the Centers for Medicare and Medicaid Services (CMS) discontinued additional payments for certain hospital-acquired conditions that were deemed preventable. The effect of this policy on rates of health care-associated infections is unknown. Methods Using a quasi-experimental design with interrupted time series with comparison series, we examined changes in trends of two health care-associated infections that were targeted by the CMS policy (central catheter-associated bloodstream infections and catheter-associated urinary tract infections) as compared with an outcome that was not targeted by the policy (ventilator-associated pneumonia). Hospitals participating in the National Healthcare Safety Network and reporting data on at least one health care-associated infection before the onset of the policy were eligible to participate. Data from January 2006 through March 2011 were included. We used regression models to measure the effect of the policy on changes in infection rates, adjusting for base-line trends. Results A total of 398 hospitals or health systems contributed 14,817 to 28,339 hospital unit-months, depending on the type of infection. We observed decreasing secular trends for both targeted and nontargeted infections long before the policy was implemented. There were no significant changes in quarterly rates of central catheter-associated bloodstream infections (incidence-rate ratio in the postimplementation vs. preimplementation period, 1.00; P = 0.97), catheter-associated urinary tract infections (incidence-rate ratio, 1.03; P = 0.08), or ventilator-associated pneumonia (incidence-rate ratio, 0.99; P = 0.52) after the policy implementation. Our findings did not differ for hospitals in states without mandatory reporting, nor did it differ according to the quartile of percentage of Medicare admissions or hospital size, type of ownership, or teaching status. Conclusions We found no evidence that the 2008 CMS policy to reduce payments for central catheter-associated bloodstream infections and catheter-associated urinary tract infections had any measurable effect on infection rates in U.S. hospitals. (Funded by the Agency for Healthcare Research and Quality.)	[Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, Boston, MA 02215 USA; [Lee, Grace M.] Harvard Univ, Sch Med, Div Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicare Serv, Boston, MA 02115 USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicaid Serv, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Inst Healthcare Improvement, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fridkin, Scott K.; Horan, Teresa; Jernigan, John] Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA	Lee, GM (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.	grace.lee@childrens.harvard.edu		Jernigan, John/0000-0001-8163-925X; Kawai, Alison/0000-0002-2923-2169; Kleinman, Ken/0000-0002-5600-5834	Agency for Healthcare Research and Quality [5R01HS018414-03]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018414] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant from the Agency for Healthcare Research and Quality (5R01HS018414-03, to Dr. Lee).	Agency for Healthcare Research and Quality, HEALTHC ASS INF; American Hospital Association, 2011, MED NONP HEALTHC ASS; [Anonymous], STAT BAS HAI PREV; [Anonymous], RED HEALTHC INF; [Anonymous], 2011, HOSP ACQ COND PRES A; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Department of Health and Human Services, 2011, COMMUNICATION    071; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Emmert M, 2011, EUR J HLTH EC; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Hartmann CW, 2012, MED CARE RES REV, V69, P45, DOI 10.1177/1077558711413606; Health Forum LLC, 2010, AM HOSP ASS ANN SURV; Healthcare-associated infections (HAI), HEALTHC ASS INF HAI; Hoff T, 2011, J HEALTHC MANAG, V56, P319, DOI 10.1097/00115514-201109000-00007; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Karve AM, 2008, AM HEART J, V155, P571, DOI 10.1016/j.ahj.2007.10.043; Krein SL, 2012, J GEN INTERN MED, V27, P773, DOI 10.1007/s11606-011-1935-y; Lee GM, 2012, AM J INFECT CONTROL, V40, P314, DOI 10.1016/j.ajic.2011.11.003; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McClellan M., 2009, MOVING ACCOUNT ABLE; McHugh M, 2011, MED CARE RES REV, V68, P667, DOI 10.1177/1077558711408326; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; McNutt Robert, 2010, Qual Manag Health Care, V19, P17, DOI 10.1097/QMH.0b013e3181ccbd07; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections, METH RES STAPH AURC; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Shadish W.R., 2002, EXPT QUASIEXPERIMENT; Sherman ER, 2006, INFECT CONT HOSP EP, V27, P332, DOI 10.1086/502684; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f; Teufack SG, 2010, J NEUROSURG, V112, P249, DOI 10.3171/2009.7.JNS09753; The Joint Commission, INF CONTR; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700; Zhan CL, 2009, MED CARE, V47, P364, DOI 10.1097/MLR.0b013e31818af83d; Zrelak Patricia A, 2011, J Healthc Qual, V33, P29, DOI 10.1111/j.1945-1474.2010.00114.x	53	161	166	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1428	1437		10.1056/NEJMsa1202419	http://dx.doi.org/10.1056/NEJMsa1202419			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050526	Green Published, Green Submitted			2022-12-01	WOS:000309652700009
J	Karlsson, MP; Tervo, DGR; Karpova, AY				Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.			Network Resets in Medial Prefrontal Cortex Mark the Onset of Behavioral Uncertainty	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DECISION-MAKING; NEURAL ACTIVITY; NOREPINEPHRINE; INFORMATION; ENVIRONMENT; DYNAMICS; NEURONS; CONTEXT; REWARD	Regions within the prefrontal cortex are thought to process beliefs about the world, but little is known about the circuit dynamics underlying the formation and modification of these beliefs. Using a task that permits dissociation between the activity encoding an animal's internal state and that encoding aspects of behavior, we found that transient increases in the volatility of activity in the rat medial prefrontal cortex accompany periods when an animal's belief is modified after an environmental change. Activity across the majority of sampled neurons underwent marked, abrupt, and coordinated changes when prior belief was abandoned in favor of exploration of alternative strategies. These dynamics reflect network switches to a state of instability, which diminishes over the period of exploration as new stable representations are formed.	[Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Karpova, AY (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	karpovaa@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank N. Ozel and B. Shields for technical help; K. Vicari for task illustration; and T. Jessell, W. Denk, V. Jayaraman, A. Leonardo, J. Dudman, E. Pastalkova, G. Murphy, K. Svoboda, R. Desimone, S. Druckmann, S. Eddy, and N. Spruston for comments on the manuscript. Supported by the Howard Hughes Medical Institute.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; EDWARDS W, 1961, ANNU REV PSYCHOL, V12, P473, DOI 10.1146/annurev.ps.12.020161.002353; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	28	128	130	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					135	139		10.1126/science.1226518	http://dx.doi.org/10.1126/science.1226518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042898				2022-12-01	WOS:000309457400071
J	Vohra, P				Vohra, Pankaj			Why this love for antibiotics in India?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Healthcare, New Delhi, India		Vohra, P (corresponding author), Max Healthcare, New Delhi, India.	pankajvohramd@yahoo.com						Bate R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006003; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6209	10.1136/bmj.e6209	http://dx.doi.org/10.1136/bmj.e6209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033364				2022-12-01	WOS:000309659300006
J	Foster, EA; Franks, DW; Mazzi, S; Darden, SK; Balcomb, KC; Ford, JKB; Croft, DP				Foster, Emma A.; Franks, Daniel W.; Mazzi, Sonia; Darden, Safi K.; Balcomb, Ken C.; Ford, John K. B.; Croft, Darren P.			Adaptive Prolonged Postreproductive Life Span in Killer Whales	SCIENCE			English	Article							MENOPAUSE; HUMANS		[Foster, Emma A.; Darden, Safi K.; Croft, Darren P.] Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England; [Foster, Emma A.; Balcomb, Ken C.] Ctr Whale Res, Friday Harbor, WA 98250 USA; [Franks, Daniel W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Mazzi, Sonia] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England; [Ford, John K. B.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	University of Exeter; University of York - UK; University of York - UK; Fisheries & Oceans Canada	Croft, DP (corresponding author), Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England.	d.p.croft@exeter.ac.uk	Croft, Darren P/B-5503-2009; Darden, Safi/C-5940-2016	Croft, Darren P/0000-0001-6869-5097; Darden, Safi/0000-0002-2567-7902; Franks, Daniel Wayne/0000-0002-4832-7470	Biotechnology and Biological Sciences Research Council; Leverhulme Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust)	We thank our colleagues for their important roles in data collection over the past 35 years, particularly M. Bigg, D. Ellifrit, G. Ellis, E. Heydenrich, and A. van Ginneken and the Biotechnology and Biological Sciences Research Council and the Leverhulme Trust for funding. Data are available in the supplementary materials.	Baird RW, 2000, CETACEAN SOCIETIES, P127; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hill K, 2012, NATURE, V483, P160, DOI 10.1038/483160a; Johnstone RA, 2010, P ROY SOC B-BIOL SCI, V277, P3765, DOI 10.1098/rspb.2010.0988; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Ward EJ, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-4	9	114	117	3	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1313	1313		10.1126/science.1224198	http://dx.doi.org/10.1126/science.1224198			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984064	Green Submitted			2022-12-01	WOS:000308705000034
J	Gozem, S; Schapiro, I; Ferre, N; Olivucci, M				Gozem, Samer; Schapiro, Igor; Ferre, Nicolas; Olivucci, Massimo			The Molecular Mechanism of Thermal Noise in Rod Photoreceptors	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; VISUAL PIGMENTS; CONICAL INTERSECTION; RHODOPSIN; ISOMERIZATION; VISION; ACTIVATION; DARK; PHOTOISOMERIZATION; PHOTOACTIVATION	Spontaneous electrical signals in the retina's photoreceptors impose a limit on visual sensitivity. Their origin is attributed to a thermal, rather than photochemical, activation of the transduction cascade. Although the mechanism of such a process is under debate, the observation of a relationship between the maximum absorption wavelength (lambda(max)) and the thermal activation kinetic constant (k) of different visual pigments (the Barlow correlation) indicates that the thermal and photochemical activations are related. Here we show that a quantum chemical model of the bovine rod pigment provides a molecular-level understanding of the Barlow correlation. The transition state mediating thermal activation has the same electronic structure as the photoreceptor excited state, thus creating a direct link between lambda(max) and k. Such a link appears to be the manifestation of intrinsic chromophore features associated with the existence of a conical intersection between its ground and excited states.	[Gozem, Samer; Schapiro, Igor; Olivucci, Massimo] Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA; [Ferre, Nicolas] Univ Aix Marseille, Inst Chim Radicalaire, UMR 7273, F-13397 Marseille 20, France; [Olivucci, Massimo] Univ Siena, Dipartimento Chim, I-53100 Siena, Italy	University System of Ohio; Bowling Green State University; UDICE-French Research Universities; Aix-Marseille Universite; University of Siena	Olivucci, M (corresponding author), Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA.	molivuc@bgsu.edu	OLIVUCCI, MASSIMO/O-2588-2019; Ferré, Nicolas/K-8228-2012; Schapiro, Igor/C-7335-2014	OLIVUCCI, MASSIMO/0000-0002-8247-209X; Ferré, Nicolas/0000-0002-5583-8834; Gozem, Samer/0000-0002-6429-2853; Schapiro, Igor/0000-0001-8536-6869	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	We are grateful to M. A. Robb for a critical reading of the manuscript. This work was supported by the Bowling Green State University. M.O. is grateful to the Center for Photochemical Sciences and the School of Arts and Sciences of Bowling Green State University for startup funds. We are grateful to the Ohio Supercomputer Center for granted computer time.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Andruniow T, 2004, P NATL ACAD SCI USA, V101, P17908, DOI 10.1073/pnas.0407997101; ATCHITY GJ, 1991, J CHEM PHYS, V95, P1862, DOI 10.1063/1.461036; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bokkon I, 2009, J PHOTOCH PHOTOBIO B, V96, P255, DOI 10.1016/j.jphotobiol.2009.07.002; Coto PB, 2006, MOL PHYS, V104, P983, DOI 10.1080/00268970500415865; De Vico L, 2005, J CHEM THEORY COMPUT, V1, P1029, DOI 10.1021/ct0500949; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; HERZBERG G, 1963, DISCUSS FARADAY SOC, P77, DOI 10.1039/df9633500077; Kaila VRI, 2012, J PHYS CHEM B, V116, P2249, DOI 10.1021/jp205918m; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Khrenova MG, 2010, PROTEINS, V78, P614, DOI 10.1002/prot.22590; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MILDER SJ, 1991, BIOPHYS J, V60, P440, DOI 10.1016/S0006-3495(91)82070-7; Polli D, 2010, NATURE, V467, P440, DOI 10.1038/nature09346; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P2558, DOI 10.1073/pnas.75.6.2558; Zilberg S, 2003, PHOTOCH PHOTOBIO SCI, V2, P1256, DOI 10.1039/b306137j	30	82	83	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1225	1228		10.1126/science.1220461	http://dx.doi.org/10.1126/science.1220461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955833				2022-12-01	WOS:000308414000038
J	Gerstein, MB; Kundaje, A; Hariharan, M; Landt, SG; Yan, KK; Cheng, C; Mu, XJ; Khurana, E; Rozowsky, J; Alexander, R; Min, RQ; Alves, P; Abyzov, A; Addleman, N; Bhardwaj, N; Boyle, AP; Cayting, P; Charos, A; Chen, DZ; Cheng, Y; Clarke, D; Eastman, C; Euskirchen, G; Frietze, S; Fu, Y; Gertz, J; Grubert, F; Harmanci, A; Jain, P; Kasowski, M; Lacroute, P; Leng, J; Lian, J; Monahan, H; O'Geen, H; Ouyang, ZQ; Partridge, EC; Patacsil, D; Pauli, F; Raha, D; Ramirez, L; Reddy, TE; Reed, B; Shi, MY; Slifer, T; Wang, J; Wu, LF; Yang, XQ; Yip, KY; Zilberman-Schapira, G; Batzoglou, S; Sidow, A; Farnham, PJ; Myers, RM; Weissman, SM; Snyder, M				Gerstein, Mark B.; Kundaje, Anshul; Hariharan, Manoj; Landt, Stephen G.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Addleman, Nick; Bhardwaj, Nitin; Boyle, Alan P.; Cayting, Philip; Charos, Alexandra; Chen, David Z.; Cheng, Yong; Clarke, Declan; Eastman, Catharine; Euskirchen, Ghia; Frietze, Seth; Fu, Yao; Gertz, Jason; Grubert, Fabian; Harmanci, Arif; Jain, Preti; Kasowski, Maya; Lacroute, Phil; Leng, Jing; Lian, Jin; Monahan, Hannah; O'Geen, Henriette; Ouyang, Zhengqing; Partridge, E. Christopher; Patacsil, Dorrelyn; Pauli, Florencia; Raha, Debasish; Ramirez, Lucia; Reddy, Timothy E.; Reed, Brian; Shi, Minyi; Slifer, Teri; Wang, Jing; Wu, Linfeng; Yang, Xinqiong; Yip, Kevin Y.; Zilberman-Schapira, Gili; Batzoglou, Serafim; Sidow, Arend; Farnham, Peggy J.; Myers, Richard M.; Weissman, Sherman M.; Snyder, Michael			Architecture of the human regulatory network derived from ENCODE data	NATURE			English	Article							EMBRYONIC STEM-CELLS; HIERARCHICAL STRUCTURE; TRANSCRIPTION FACTORS; ESCHERICHIA-COLI; GENOMIC ANALYSIS; MOTIFS; CHROMATIN; BINDING; SPECIFICITY; EXPRESSION	Transcription factors bind in a combinatorial fashion to specify the on-and-off states of genes; the ensemble of these binding events forms a regulatory network, constituting the wiring diagram for a cell. To examine the principles of the human transcriptional regulatory network, we determined the genomic binding information of 119 transcription-related factors in over 450 distinct experiments. We found the combinatorial, co-association of transcription factors to be highly context specific: distinct combinations of factors bind at specific genomic locations. In particular, there are significant differences in the binding proximal and distal to genes. We organized all the transcription factor binding into a hierarchy and integrated it with other genomic information (for example, microRNA regulation), forming a dense meta-network. Factors at different levels have different properties; for instance, top-level transcription factors more strongly influence expression and middle-level ones co-regulate targets to mitigate information-flow bottlenecks. Moreover, these co-regulations give rise to many enriched network motifs (for example, noise-buffering feed-forward loops). Finally, more connected network components are under stronger selection and exhibit a greater degree of allele-specific activity (that is, differential binding to the two parental alleles). The regulatory information obtained in this study will be crucial for interpreting personal genome sequences and understanding basic principles of human biology and disease.	[Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Bhardwaj, Nitin; Fu, Yao; Harmanci, Arif; Leng, Jing; Wang, Jing; Yip, Kevin Y.; Zilberman-Schapira, Gili] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Abyzov, Alexej; Bhardwaj, Nitin; Harmanci, Arif; Yip, Kevin Y.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Chen, David Z.] Yale Univ, Dept Commun Sci, New Haven, CT 06511 USA; [Kundaje, Anshul; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Hariharan, Manoj; Landt, Stephen G.; Addleman, Nick; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Kasowski, Maya; Lacroute, Phil; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Min, Renqiang] NEC Labs Amer, Dept Machine Learning, Princeton, NJ 08540 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Frietze, Seth; Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Gertz, Jason; Jain, Preti; Partridge, E. Christopher; Pauli, Florencia; Reddy, Timothy E.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [O'Geen, Henriette] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Yip, Kevin Y.] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Sidow, Arend] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Yale University; Yale University; Yale University; Stanford University; Stanford University; NEC Corporation; Yale University; Yale University; University of Southern California; HudsonAlpha Institute for Biotechnology; Yale University; University of California System; University of California Davis; Chinese University of Hong Kong; Stanford University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	Mark.gerstein@yale.edu; mpsnyder@stanford.edu	Abyzov, Alexej/AAT-4615-2020; Kundaje, Anshul/Y-2598-2019; Yip, Kevin/AAT-4771-2020; cheng, yong/I-4270-2012; Kundaje, Anshul/Y-2739-2019; Hariharan, Manoj/N-2855-2015; Mu, Xinmeng/P-2562-2016; Yan, Koon-Kiu/A-5940-2009; Khurana, Ekta/C-4933-2013; Abyzov, Alexej/M-4284-2013; Boyle, Alan/I-1848-2014	Kundaje, Anshul/0000-0003-3084-2287; Yip, Kevin/0000-0001-5516-9944; Kundaje, Anshul/0000-0003-3084-2287; Hariharan, Manoj/0000-0002-1006-5372; Mu, Xinmeng/0000-0002-8079-0828; Boyle, Alan/0000-0002-2081-1105; Farnham, Peggy/0000-0003-4469-7914; Snyder, Michael/0000-0003-0784-7987; Abyzov, Alexej/0000-0001-5405-6729; Pauli Behn, Florencia/0000-0002-8984-4044; Rozowsky, Joel/0000-0002-3565-0762; Alexander, Roger/0000-0002-2967-7395; Reddy, Timothy/0000-0002-7629-061X; Gertz, Jason/0000-0001-7568-6789	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics [T32 GM008283-24]; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558, U01HG004695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008283, T32GM007205] Funding Source: NIH RePORTER	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)) for funding. We thank P. Bickel and B. Brown for conversations. Funding has also been provided by the NIH Predoctoral Training Program in Biophysics (D. C.; T32 GM008283-24) and the Sackler institute (G.Z.-S.). M. H. thanks G. Nair for designing database operations.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Balaji S, 2006, J MOL BIOL, V360, P204, DOI 10.1016/j.jmb.2006.04.026; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARON MH, 1994, MOL CELL BIOL, V14, P3108, DOI 10.1128/MCB.14.5.3108; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng C., 2012, GENOME RES; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Yu HY, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r55; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	47	1014	1035	2	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					91	100		10.1038/nature11245	http://dx.doi.org/10.1038/nature11245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955619	hybrid, Green Accepted			2022-12-01	WOS:000308347000042
J	Havugimana, PC; Hart, GT; Nepusz, T; Yang, HX; Turinsky, AL; Li, ZH; Wang, PI; Boutz, DR; Fong, V; Phanse, S; Babu, M; Craig, SA; Hu, PZ; Wan, CH; Vlasblom, J; Dar, VUN; Bezginov, A; Clark, GW; Wu, GC; Wodak, SJ; Tillier, ERM; Paccanaro, A; Marcotte, EM; Emili, A				Havugimana, Pierre C.; Hart, G. Traver; Nepusz, Tamas; Yang, Haixuan; Turinsky, Andrei L.; Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Craig, Stephanie A.; Hu, Pingzhao; Wan, Cuihong; Vlasblom, James; Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Wu, Gabriel C.; Wodak, Shoshana J.; Tillier, Elisabeth R. M.; Paccanaro, Alberto; Marcotte, Edward M.; Emili, Andrew			A Census of Human Soluble Protein Complexes	CELL			English	Article							SYSTEMATIC ANALYSIS; INTERACTION NETWORK; CELL; ORGANIZATION; GENES; SCALE; MUTATIONS; DISCOVERY; 8Q24; MAP	Cellular processes often depend on stable physical associations between proteins. Despite recent progress, knowledge of the composition of human protein complexes remains limited. To close this gap, we applied an integrative global proteomic profiling approach, based on chromatographic separation of cultured human cell extracts into more than one thousand biochemical fractions that were subsequently analyzed by quantitative tandem mass spectrometry, to systematically identify a network of 13,993 high-confidence physical interactions among 3,006 stably associated soluble human proteins. Most of the 622 putative protein complexes we report are linked to core biological processes and encompass both candidate disease genes and unannotated proteins to inform on mechanism. Strikingly, whereas larger multiprotein assemblies tend to be more extensively annotated and evolutionarily conserved, human protein complexes with five or fewer subunits are far more likely to be functionally unannotated or restricted to vertebrates, suggesting more recent functional innovations.	[Nepusz, Tamas; Yang, Haixuan; Paccanaro, Alberto] Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England; [Havugimana, Pierre C.; Hart, G. Traver; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Hu, Pingzhao; Wan, Cuihong; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Havugimana, Pierre C.; Hart, G. Traver; Vlasblom, James; Wodak, Shoshana J.; Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Turinsky, Andrei L.; Vlasblom, James; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Craig, Stephanie A.; Wu, Gabriel C.; Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Tillier, Elisabeth R. M.] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of London; Royal Holloway University London; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Austin; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Paccanaro, A (corresponding author), Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England.	alberto.paccanaro@cs.rhul.ac.uk; marcotte@icmb.utexas.edu; andrew.emili@utoronto.ca	Nepusz, Tamás/E-2832-2016; Mohan, Babu P./I-7362-2019; Paccanaro, Alberto/AAW-5625-2020; Boutz, Daniel/M-4872-2013	Nepusz, Tamás/0000-0002-1451-338X; Boutz, Daniel/0000-0001-7462-4105; wodak, shoshana/0000-0002-0701-6545; Marcotte, Edward/0000-0001-8808-180X; Phanse, Sadhna/0000-0001-6306-0551; Hart, Traver/0000-0002-1880-3341; Clark, Greg/0000-0002-9805-4300; Hu, Pingzhao/0000-0002-9546-2245; Tillier, Elisabeth/0000-0003-2194-9058	University of Toronto; Royal Society [NF080750]; Biotechnology and Biological Sciences Research Council [BB/F00964X/1, BB/K004131/1]; Canada Institutes of Health Research [MOP 82940]; SickKids Foundation; National Institutes of Health; National Science Foundation; Cancer Prevention Research Institute of Texas; Welch Foundation [F1515]; Packard Foundation; Ontario Ministry of Research and Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106408, R01GM088624, R01GM076536, R01GM067779] Funding Source: NIH RePORTER; BBSRC [BB/K004131/1, BB/F00964X/1] Funding Source: UKRI	University of Toronto(University of Toronto); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canada Institutes of Health Research; SickKids Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. Isserlin, Z. Ni, H. Guo, D. Merico and A. Alpert for technical assistance and J. Parkinson, G. Bader, A. Wilde, and J. Greenblatt for critical suggestions. P.C.H. was a recipient of a University of Toronto Open Fellowship, T.N. was supported by the Newton International Fellowship Scheme of the Royal Society, A.E. is an Ontario Research Chair, and S.J.W. is a Canada Research Chair Tier 1. This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/F00964X/1 and BB/K004131/1) and the Royal Society (NF080750) to A.P., the Canada Institutes of Health Research (MOP 82940) and the SickKids Foundation to S.J.W., the National Institutes of Health, National Science Foundation, Cancer Prevention Research Institute of Texas, and Welch (F1515) and Packard Foundations to E.M.M., and the Ontario Ministry of Research and Innovation to A.E.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Babu M., 2012, NATURE; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; DeScipio C, 2005, AM J MED GENET A, V137A, P276, DOI 10.1002/ajmg.a.30857; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Havugimana PC, 2007, J CHROMATOGR B, V847, P54, DOI 10.1016/j.jchromb.2006.10.075; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McBrien J, 2008, AM J MED GENET A, V146A, P1587, DOI 10.1002/ajmg.a.32347; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pie J, 2010, AM J MED GENET A, V152A, P924, DOI 10.1002/ajmg.a.33348; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wessels HJCT, 2009, PROTEOMICS, V9, P4221, DOI 10.1002/pmic.200900157; Wuyts W, 2002, AM J MED GENET, V113, P326, DOI 10.1002/ajmg.10845; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129	51	559	569	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1068	1081		10.1016/j.cell.2012.08.011	http://dx.doi.org/10.1016/j.cell.2012.08.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939629	Bronze, Green Accepted			2022-12-01	WOS:000308500200019
J	Sanderson, K				Sanderson, Katharine			VACCINATION A durable design	NATURE			English	Editorial Material																		Wick DA, 2011, VACCINE, V29, P7857, DOI 10.1016/j.vaccine.2011.07.090	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S7	S7		10.1038/488S7a	http://dx.doi.org/10.1038/488S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932439	Bronze			2022-12-01	WOS:000308095100006
J	Soerjomataram, I; Lortet-Tieulent, J; Parkin, DM; Ferlay, J; Mathers, C; Forman, D; Bray, F				Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Parkin, D. Maxwell; Ferlay, Jacques; Mathers, Colin; Forman, David; Bray, Freddie			Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions	LANCET			English	Article							MORTALITY; SURVIVAL; OVERDIAGNOSIS; OUTCOMES; DISEASE; EUROPE; TRENDS	Background Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008. Methods We used population-based data, mostly from cancer registries, for incidence, mortality, life expectancy, disease duration, and age at onset and death, alongside proportions of patients who were treated and living with sequelae or regarded as cured, to calculate years of life lost (YLLs) and years lived with disability (YLDs). We used YLLs and YLDs to derive DALYs for 27 sites of cancers in 184 countries in 12 world regions. Estimates were grouped into four categories based on a country's human development index (HDI). We applied zero discounting and uniform age weighting, and age-standardised rates to enable cross-country and regional comparisons. Findings Worldwide, an estimated 169.3 million years of healthy life were lost because of cancer in 2008. Colorectal, lung, breast, and prostate cancers were the main contributors to total DALYs in most world regions and caused 18-50% of the total cancer burden. We estimated an additional burden of 25% from infection-related cancers (liver, stomach, and cervical) in sub-Saharan Africa, and 27% in eastern Asia. We noted substantial global differences in the cancer profile of DALYs by country and region; however, YLLs were the most important component of DALYs in all countries and for all cancers, and contributed to more than 90% of the total burden. Nonetheless, low-resource settings had consistently higher YLLs (as a proportion of total DALYs) than did high-resource settings. Interpretation Age-adjusted DALYs lost from cancer are substantial, irrespective of world region. The consistently larger proportions of YLLs in low HDI than in high HDI countries indicate substantial inequalities in prognosis after diagnosis, related to degree of human development. Therefore, radical improvement in cancer care is needed in low-resource countries.	[Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Ferlay, Jacques; Forman, David; Bray, Freddie] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Parkin, D. Maxwell] Univ Oxford, Dept Med, Clin Trial Serv Unit, Oxford, England; [Mathers, Colin] WHO, Dept Evidence & Policy Cluster, CH-1211 Geneva, Switzerland	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; World Health Organization	Soerjomataram, I (corresponding author), Int Agcy Res Canc, Sect Canc Informat, 150 Cours Albert Thomas, F-69372 Lyon, France.	soerjomatarami@iarc.fr	Lortet-Tieulent, Joannie/AAE-9099-2019; Ferlay, Jacques/ABD-5058-2021	Lortet-Tieulent, Joannie/0000-0002-8816-7475; Bray, Freddie/0000-0002-3248-7787; Mathers, Colin/0000-0002-0617-6731	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society, Erasmus University Rotterdam, and International Agency for research on Cancer.	Albreht T, 2008, EUR J CANCER, V44, P1451, DOI 10.1016/j.ejca.2008.02.015; [Anonymous], 2004, LANCET, V364, P2153; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Cvancarova M, 2012, INT J CANC, DOI 10.1002/ijc.27802; de Larrea-Baz NF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-42; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francisci S, 2009, EUR J CANCER, V45, P1067, DOI 10.1016/j.ejca.2008.11.034; International Agency for Research on Cancer WHO, 2010, GLOBOCAN 2008 CANC I; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kerr DJ, 2010, NEW ENGL J MED, V363, P801, DOI 10.1056/NEJMp1002812; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murthy NS, 2010, ASIAN PAC J CANCER P, V11, P633; National Cancer Institute, SURV EP END RES; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Public Health Group of the Department of Human Services, 2005, VICT BURD DIS STUD M; Sankaranarayanan R, 2011, IARC Sci Publ, P257; Sankaranarayanan R, 2011, IARC Sci Publ, P1; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Sankaranarayanan R, 1998, IARC SCI PUBL, V145, P1; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Soerjomataram I, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-125; Stouthard MEA, 1997, DISABILITY WEIGHTS D; United Nations, 2009, WORLD POP PROSP 2008; United Nations Development Programme, 2009, HUM DEV REP 2009 OV; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; Verhoeven RHA, 2007, EUR J CANCER, V43, P2553, DOI 10.1016/j.ejca.2007.08.022; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; World Health Organization, 2020, GLOBAL REPORT EPIDEM	44	407	445	2	111	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1840	1850		10.1016/S0140-6736(12)60919-2	http://dx.doi.org/10.1016/S0140-6736(12)60919-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23079588				2022-12-01	WOS:000311435000029
J	Adashi, EY; Lee, E				Adashi, Eli Y.; Lee, Eric			The President's Global Health Initiative at Midterm Progress in the Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Lee, Eric] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu		Lee, Eric/0000-0002-1347-2635				Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Romney M., 2011, MY PROL PLEDG; The Henry J. Kaiser Family Foundation Kaiser Family Foundation, 2012, BUDG TRACK STAT US F; The United States government Global Health Initiative: strategy document, 2011, STRAT DOC PRES EM PL; The US Global Health Initiative (GHI), 2012, FACT SHEET; US Department of State, 2010, 1 QUADR DIPL DEV QDD; US Global Health Initiative, 2011, LEADERSHIP; US Global Health Initiative, 2012, GLOB HLTH IN NEXT ST; *WHIT HOUS, 2009, STAT PRES GLOB HLTH	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1977	1978		10.1001/jama.2012.14287	http://dx.doi.org/10.1001/jama.2012.14287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23060258				2022-12-01	WOS:000311291400018
J	Ipsaro, JJ; Haase, AD; Knott, SR; Joshua-Tor, L; Hannon, GJ				Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.			The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis	NATURE			English	Article							SMALL RNAS; NUAGE FORMATION; MESSENGER-RNA; PROTEIN; RECOGNITION; MECHANISM; ELEMENTS; MITOPLD; PATHWAY	PIWI-family proteins and their associated small RNAs (piRNAs) act in an evolutionarily conserved innate immune mechanism to provide essential protection for germ-cell genomes against the activity of mobile genetic elements(1). piRNA populations comprise a molecular definition of transposons, which permits them to distinguish transposons from host genes and selectively silence them. piRNAs can be generated in two distinct ways, forming either primary or secondary piRNAs. Primary piRNAs come from discrete genomic loci, termed piRNA clusters, and seem to be derived from long, single-stranded precursors(2). The biogenesis of primary piRNAs involves at least two nucleolytic steps. An unknown enzyme cleaves piRNA cluster transcripts to generate monophosphorylated piRNA 5' ends. piRNA 3' ends are probably formed by exonucleolytic trimming, after a piRNA precursor is loaded into its PIWI partner(1,3). Secondary piRNAs arise during the adaptive 'ping-pong' cycle, with their 5' termini being formed by the activity of PIWIs themselves(2,4). A number of proteins have been implicated genetically in primary piRNA biogenesis. One of these, Drosophila melanogaster Zucchini, is a member of the phospholipase-D family of phosphodiesterases, which includes both phospholipases and nucleases(5-7). Here we produced a dimeric, soluble fragment of the mouse Zucchini homologue (mZuc; also known as PLD6) and show that it possesses single-strand-specific nuclease activity. A crystal structure of mZuc at 1.75 angstrom resolution indicates greater architectural similarity to phospholipase-D family nucleases than to phospholipases. Together, our data suggest that the Zucchini proteins act in primary piRNA biogenesis as nucleases, perhaps generating the 5' ends of primary piRNAs.	[Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Ipsaro, Jonathan J.; Joshua-Tor, Leemor] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu; hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019	Joshua-Tor, Leemor/0000-0001-8185-8049; Ipsaro, Jonathan/0000-0002-2743-3776	National Cancer Institute Cancer Center Support Grant [CA045508]; Department of Energy, Office of Basic Energy Sciences; Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) [F32GM97888]; NIH [R01GM062534]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097888, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Filipowicz, R. MacDonald and members of the G.J.H. and L.J. laboratories for discussions; G. Bencze, K. Rivera and D. Pappin of the Cold Spring Harbor Laboratory proteomics facility, which is funded in part by an National Cancer Institute Cancer Center Support Grant (CA045508), for support with mass spectrometry; and H. Robinson for help at the National Synchrotron Light Source, which is supported by the Department of Energy, Office of Basic Energy Sciences. J.J.I. was supported by the Harvey L. Karp award and by a Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) fellowship F32GM97888. This work was supported by NIH grant R01GM062534. G.J.H. and L.J. are Howard Hughes Medical Institute Investigators.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Pozharski EV, 2001, ANAL BIOCHEM, V291, P158, DOI 10.1006/abio.2001.5012; SCHUPBACH T, 1991, GENETICS, V129, P1119; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005	44	216	227	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					279	U151		10.1038/nature11502	http://dx.doi.org/10.1038/nature11502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064227	Green Accepted			2022-12-01	WOS:000310774300049
J	Mathur, R; Oh, H; Zhang, DK; Park, SG; Seo, J; Koblansky, A; Hayden, MS; Ghosh, S				Mathur, Ramkumar; Oh, Hyunju; Zhang, Dekai; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar			A Mouse Model of Salmonella Typhi Infection	CELL			English	Article							TOLL-LIKE RECEPTOR-5; ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL FLAGELLIN; DENDRITIC CELLS; GENE-EXPRESSION; HUMANIZED MICE; FEVER; VACCINE; TOLL-LIKE-RECEPTOR-5; PATHOGENESIS	Salmonella spp. are gram-negative flagellated bacteria that can cause food- and waterborne gastroenteritis and typhoid fever in humans. We now report that flagellin from Salmonella spp. is recognized in mouse intestine by Toll-like receptor 11 (TLR11). Absence of TLR11 renders mice more susceptible to infection by S. Typhimurium, with increased dissemination of the bacteria and enhanced lethality. Unlike S. Typhimurium, S. Typhi, a human obligatory pathogen that causes typhoid fever, is normally unable to infect mice. TLR11 is expressed in mice, but not in humans, and remarkably, we find that tlr11(-/-) mice are efficiently infected with orally administered S. Typhi. We also find that tlr11(-/-) mice can be immunized against S. Typhi. Therefore, tlr11(-/-) mice represent a small-animal model for the study of the immune response to S. Typhi and for the development of vaccines against this important human pathogen.	[Mathur, Ramkumar; Oh, Hyunju; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA; [Hayden, Matthew S.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Dekai] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA	Columbia University; Columbia University; Yale University	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA.	sg2715@columbia.edu	Park, Sung-Gyoo/H-8652-2019; Mathur, Ramkumar/AAZ-4314-2020	Hayden, Matthew/0000-0003-1670-6430; Park, Sung-Gyoo/0000-0003-3702-5765; mathur, Ramkumar/0000-0002-9317-2631	NIH [RO1-AI59440, R37-AI33443]; ARRA [P30 AR058886-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI033443, R01AI059440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this manuscript was supported by grants from NIH (RO1-AI59440 and R37-AI33443) and by institutional support from Columbia University. M. S. H. is supported by ARRA P30 AR058886-01. We would like to thank Ms. Crystal Bussey for help managing our animal colony and Dr. Suneeta Krishnareddy for help evaluating histology.	Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; COLLINS FM, 1978, INFECT IMMUN, V21, P41, DOI 10.1128/IAI.21.1.41-47.1978; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Levine MM, 2007, CLIN INFECT DIS, V45, pS24, DOI 10.1086/518141; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Mestecky J, 2008, CURR OPIN GASTROEN, V24, P713, DOI 10.1097/MOG.0b013e32830d58be; Mian MF, 2011, VIRULENCE, V2, P248, DOI 10.4161/viru.2.3.16133; Mian MF, 2011, CELL MOL IMMUNOL, V8, P83, DOI 10.1038/cmi.2010.52; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; West AP, 2005, J BIOL CHEM, V280, P9482, DOI 10.1074/jbc.M411875200; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Woc-Colburn Laila, 2009, Curr Infect Dis Rep, V11, P120, DOI 10.1007/s11908-009-0018-2; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	38	134	141	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					590	602		10.1016/j.cell.2012.08.042	http://dx.doi.org/10.1016/j.cell.2012.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101627	Bronze, Green Accepted			2022-12-01	WOS:000310529300015
J	Roskar, R; Debattista, VP				Roskar, Rok; Debattista, Victor P.			Galactic Archaeology	SCIENCE			English	Editorial Material									[Roskar, Rok] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Debattista, Victor P.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England	University of Zurich; University of Central Lancashire	Roskar, R (corresponding author), Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland.	roskar@physik.uzh.ch; vpdebattista@uclan.ac.uk		Roskar, Rok/0000-0001-9962-0389	STFC [ST/J001341/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001341/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		[Anonymous], 2012, STARS BORDERS RADIAL; Bland-Hawthorn J, 2010, ASTROPHYS J, V713, P166, DOI 10.1088/0004-637X/713/1/166; Gilmore G., 2012, MESSENGER, V147, P25; Meidt SE, 2009, ASTROPHYS J, V702, P277, DOI 10.1088/0004-637X/702/1/277; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Sellwood JA, 2011, MON NOT R ASTRON SOC, V410, P1637, DOI 10.1111/j.1365-2966.2010.17545.x; Sellwood JA, 2002, MON NOT R ASTRON SOC, V336, P785, DOI 10.1046/j.1365-8711.2002.05806.x; Wielen R, 1996, ASTRON ASTROPHYS, V314, P438	8	0	0	3	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					333	334		10.1126/science.1227302	http://dx.doi.org/10.1126/science.1227302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087234				2022-12-01	WOS:000309955800025
J	Lavzin, M; Rapoport, S; Polsky, A; Garion, L; Schiller, J				Lavzin, Maria; Rapoport, Sophia; Polsky, Alon; Garion, Liora; Schiller, Jackie			Nonlinear dendritic processing determines angular tuning of barrel cortex neurons in vivo	NATURE			English	Article							PRIMARY VISUAL-CORTEX; 5 PYRAMIDAL NEURONS; BASAL DENDRITES; THALAMOCORTICAL SYNAPSES; DIRECTION SELECTIVITY; SOMATOSENSORY CORTEX; NMDA SPIKES; LAYER-IV; CELLS; ORGANIZATION	Layer 4 neurons in primary sensory cortices receive direct sensory information from the external world(1,2). A general feature of these neurons is their selectivity to specific features of the sensory stimulation(3-5). Various theories try to explain the manner in which these neurons are driven by their incoming sensory information(6-11). In all of these theories neurons are regarded as simple elements summing small biased inputs to create tuned output through the axosomatic amplification mechanism(12). However, the possible role of active dendritic integration(13-15) in further amplifying the sensory responses and sharpening the tuning curves of neurons(16-19) is disregarded. Our findings show that dendrites of layer 4 spiny stellate neurons in the barrel cortex can generate local and global multi-branch N-methyl-D-aspartate (NMDA) spikes, which are the main regenerative events in these dendrites. In turn, these NMDA receptor (NMDAR) regenerative mechanisms can sum supralinearly the coactivated thalamocortical and corticocortical inputs. Using in vivo whole-cell recordings combined with an intracellular NMDAR blocker and membrane hyperpolarization, we show that dendritic NMDAR-dependent regenerative responses contribute substantially to the angular tuning of layer 4 neurons by preferentially amplifying the preferred angular directions over non-preferred angles. Taken together, these findings indicate that dendritic NMDAR regenerative amplification mechanisms contribute markedly to sensory responses and critically determine the tuning of cortical neurons.	[Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel; [Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Polsky, Alon] NINDS, Synapt Physiol Sect, NIH, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schiller, J (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel.	Jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129	Israel Science Foundation (ISF); Rappaport Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); Rappaport Foundation	We thank Y. Schiller and G. Major for their helpful comments and discussions on the manuscript. We thank A. Korngreen and C. de Kock for help with Neurolucida reconstructions, U. Dubin for help in programming the stimulus and analysis programs, O. Schiff for help with Igor software and R. Azouz for help with the passive stimulus. We thank I. Reiter for her technical help, particularly with histology. We also thank R. Bruno for sharing his knowledge of in vivo patch clamp recordings. This study was supported by the Israel Science Foundation (ISF) and the Rappaport Foundation (J.S.).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2003, J NEUROSCI, V23, P9565; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; WHITE EL, 1980, J NEUROCYTOL, V9, P615, DOI 10.1007/BF01205029; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	29	165	170	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					397	401		10.1038/nature11451	http://dx.doi.org/10.1038/nature11451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22940864				2022-12-01	WOS:000309918500045
J	Rolland, M; Edlefsen, PT; Larsen, BB; Tovanabutra, S; Sanders-Buell, E; Hertz, T; deCamp, AC; Carrico, C; Menis, S; Magaret, CA; Ahmed, H; Juraska, M; Chen, L; Konopa, P; Nariya, S; Stoddard, JN; Wong, K; Zhao, H; Deng, WJ; Maust, BS; Bose, M; Howell, S; Bates, A; Lazzaro, M; O'Sullivan, A; Lei, E; Bradfield, A; Ibitamuno, G; Assawadarachai, V; O'Connell, RJ; deSouza, MS; Nitayaphan, S; Rerks-Ngarm, S; Robb, ML; McLellan, JS; Georgiev, I; Kwong, PD; Carlson, JM; Michael, NL; Schief, WR; Gilbert, PB; Mullins, JI; Kim, JH				Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.; Tovanabutra, Sodsai; Sanders-Buell, Eric; Hertz, Tomer; deCamp, Allan C.; Carrico, Chris; Menis, Sergey; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; Assawadarachai, Vatcharain; O'Connell, Robert J.; deSouza, Mark S.; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Robb, Merlin L.; McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.; Carlson, Jonathan M.; Michael, Nelson L.; Schief, William R.; Gilbert, Peter B.; Mullins, James I.; Kim, Jerome H.			Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2	NATURE			English	Article							COMPETING RISKS; SUBTYPE-C; TRIAL; NEUTRALIZATION; PROTECTION; INFECTION; SEQUENCES; EPITOPES; THAILAND; AIDSVAX	The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection(1). Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env V1 and V2) correlated inversely with infection risk(2). We proposed that vaccine-induced immune responses against V1/V2 would have a selective effect against, or sieve, HIV-1 breakthrough viruses. A total of 936 HIV-1 genome sequences from 44 vaccine and 66 placebo recipients were examined. We show that vaccine-induced immune responses were associated with two signatures in V2 at amino acid positions 169 and 181. Vaccine efficacy against viruses matching the vaccine at position 169 was 48% (confidence interval 18% to 66%; P = 0.0036), whereas vaccine efficacy against viruses mismatching the vaccine at position 181 was 78% (confidence interval 35% to 93%; P = 0.0028). Residue 169 is in a cationic glycosylated region recognized by broadly neutralizing and RV144-derived antibodies. The predicted distance between the two signature sites (21 +/- 7 angstrom) and their match/mismatch dichotomy indicate that multiple factors may be involved in the protection observed in RV144. Genetic signatures of RV144 vaccination in V2 complement the finding of an association between high V1/V2-binding antibodies and reduced risk of HIV-1 acquisition, and provide evidence that vaccine-induced V2 responses plausibly had a role in the partial protection conferred by the RV144 regimen.	[Rolland, Morgane; Tovanabutra, Sodsai; Sanders-Buell, Eric; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Edlefsen, Paul T.; Hertz, Tomer; deCamp, Allan C.; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Larsen, Brendan B.; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Assawadarachai, Vatcharain; deSouza, Mark S.; Nitayaphan, Sorachai] Royal Thai Army Component, AFRIMS, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Thai Minist Publ Hlth, Nonthaburi 11000, Thailand; [McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98052 USA	Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Microsoft	Rolland, M (corresponding author), US Mil HIV Res Program, Silver Spring, MD 20910 USA.	mrolland@hivresearch.org	Schief, William/ABF-3645-2020; Hertz, Tomer/S-5744-2016	Schief, William/0000-0002-1120-0150; Hertz, Tomer/0000-0002-0561-1578; McLellan, Jason/0000-0003-3991-542X; Carrico, Chris/0000-0003-0939-9006	US Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense (DOD) [W81XWH-07-2-0067]; NIH [2R37AI05465-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642, U01AI068635, ZIAAI005023, UM1AI068635, R01AI054165, R37AI054165, K25AI087397] Funding Source: NIH RePORTER	US Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. F. Haynes and F. A. Matsen for advice and comments, and I. A. Wilson and R. L. Stanfield for assistance. This study was supported in part by an Interagency Agreement Y1-AI-2642-12 between US Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense (DOD). Additional support was provided to P.B.G. through the NIH grant 2R37AI05465-10. The opinions herein are those of the authors and should not be construed as official or representing the views of the US Department of Defense or the Department of the Army.	Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edlefsen P. T., 2012, MODEL BASED SIEVE AN; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; Gilbert PB, 2000, STAT MED, V19, P3065; Gilbert PB, 1998, BIOMETRICS, V54, P799, DOI 10.2307/2533835; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rolland M, 2012, AIDS RES HUM RETROV, V28, P400, DOI [10.1089/aid.2011.0240, 10.1089/AID.2011.0240]; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	30	323	331	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					417	+		10.1038/nature11519	http://dx.doi.org/10.1038/nature11519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960785	Green Accepted			2022-12-01	WOS:000309918500049
J	Moreira, L; Balaguer, F; Lindor, N; de la Chapelle, A; Hampel, H; Aaltonen, LA; Hopper, JL; Le Marchand, L; Gallinger, S; Newcomb, PA; Haile, R; Thibodeau, SN; Gunawardena, S; Jenkins, MA; Buchanan, DD; Potter, JD; Baron, JA; Ahnen, DJ; Moreno, V; Andreu, M; de Leon, MP; Rustgi, AK; Castells, A				Moreira, Leticia; Balaguer, Francesc; Lindor, Noralane; de la Chapelle, Albert; Hampel, Heather; Aaltonen, Lauri A.; Hopper, John L.; Le Marchand, Loic; Gallinger, Steven; Newcomb, Polly A.; Haile, Robert; Thibodeau, Stephen N.; Gunawardena, Shanaka; Jenkins, Mark A.; Buchanan, Daniel D.; Potter, John D.; Baron, John A.; Ahnen, Dennis J.; Moreno, Victor; Andreu, Montserrat; de Leon, Maurizio Ponz; Rustgi, Anil K.; Castells, Antoni		EPICOLON Consortium	Identification of Lynch Syndrome Among Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REVISED BETHESDA GUIDELINES; POPULATION-BASED COHORT; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; COST-EFFECTIVENESS; CLINICAL-CRITERIA; COLON-CANCER; RISK; MLH1; PREDICTION	Context Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of gene carriers currently relies on germline analysis in patients with MMR-deficient tumors, but criteria to select individuals in whom tumor MMR testing should be performed are unclear. Objective To establish a highly sensitive and efficient strategy for the identification of MMR gene mutation carriers among CRC probands. Design, Setting, and Patients Pooled-data analysis of 4 large cohorts of newly diagnosed CRC probands recruited between 1994 and 2010 (n=10 206) from the Colon Cancer Family Registry, the EPICOLON project, the Ohio State University, and the University of Helsinki examining personal, tumor-related, and family characteristics, as well as microsatellite instability, tumor MMR immunostaining, and germline MMR mutational status data. Main Outcome Measures Performance characteristics of selected strategies (Bethesda guidelines, Jerusalem recommendations, and those derived from a bivariate/multivariate analysis of variables associated with Lynch syndrome) were compared with tumor MMR testing of all CRC patients (universal screening). Results Of 10 206 informative, unrelated CRC probands, 312 (3.1%) were MMR gene mutation carriers. In the population-based cohorts (n=3671 probands), the universal screening approach (sensitivity, 100%; 95% CI, 99.3%-100%; specificity, 93.0%; 95% CI, 92.0%-93.7%; diagnostic yield, 2.2%; 95% CI, 1.7%-2.7%) was superior to the use of Bethesda guidelines (sensitivity, 87.8%; 95% CI, 78.9%-93.2%; specificity, 97.5%; 95% CI, 96.9%-98.0%; diagnostic yield, 2.0%; 95% CI, 1.5%-2.4%; P<.001), Jerusalem recommendations (sensitivity, 85.4%; 95% CI, 77.1%-93.6%; specificity, 96.7%; 95% CI, 96.0%-97.2%; diagnostic yield, 1.9%; 95% CI, 1.4%-2.3%; P<.001), and a selective strategy based on tumor MMR testing of cases with CRC diagnosed at age 70 years or younger and in older patients fulfilling the Bethesda guidelines (sensitivity, 95.1%; 95% CI, 89.8%-99.0%; specificity, 95.5%; 95% CI, 94.7%-96.1%; diagnostic yield, 2.1%; 95% CI, 1.6%-2.6%; P<.001). This selective strategy missed 4.9% of Lynch syndrome cases but resulted in 34.8% fewer cases requiring tumor MMR testing and 28.6% fewer cases undergoing germline mutational analysis than the universal approach. Conclusion Universal tumor MMR testing among CRC probands had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the increase in the diagnostic yield was modest. JAMA. 2012;308(15):1555-1565 www.jama.com	[Moreira, Leticia; Balaguer, Francesc; Castells, Antoni] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, E-08036 Barcelona, Catalonia, Spain; [Lindor, Noralane; Thibodeau, Stephen N.; Gunawardena, Shanaka] Mayo Clin, Mayo Colorectal Canc Family Registry, Rochester, MN USA; [de la Chapelle, Albert; Hampel, Heather] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Le Marchand, Loic] Univ Hawaii, Hawaii Family Registry Colon Canc, Honolulu, HI 96822 USA; [Gallinger, Steven] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Newcomb, Polly A.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle Familial Colorectal Canc Registry, Seattle, WA 98104 USA; [Haile, Robert] Univ So Calif Consortium, Los Angeles, CA USA; [Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Ahnen, Dennis J.] Vet Affairs Med Ctr, Denver Dept, Dept Med, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Moreno, Victor] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Unit Biomarkers & Susceptibil,Catalan Inst Oncol, E-08036 Barcelona, Catalonia, Spain; [Andreu, Montserrat] Pompeu Fabra Univ, IMIM, Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [de Leon, Maurizio Ponz] Univ Modena, Dept Med Genet, I-41100 Modena, Italy; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Genet, Philadelphia, PA 19104 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Mayo Clinic; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Helsinki; University of Helsinki; University of Melbourne; University of Hawaii System; Cancer Care Ontario; Fred Hutchinson Cancer Center; QIMR Berghofer Medical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universita di Modena e Reggio Emilia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Castells, A (corresponding author), Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, Villarroel 170, E-08036 Barcelona, Catalonia, Spain.	castells@clinic.ub.es	de Leon, Maurizio Ponz/A-9356-2015; Andreu, Montserrat/D-9911-2015; Moreira, Leticia/AAN-9863-2021; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Gallinger, Steven/E-4575-2013; Moreno, Victor/A-1697-2010; Jenkins, Mark/P-7803-2015; Aaltonen, Lauri/A-5375-2010; Hampel, Heather/AAV-4041-2020; BALAGUER, FRANCESC/G-2389-2016	de Leon, Maurizio Ponz/0000-0003-4465-1043; Andreu, Montserrat/0000-0003-4286-1098; Moreira, Leticia/0000-0002-4518-8591; Castells, Antoni/0000-0001-8431-2033; Moreno, Victor/0000-0002-2818-5487; Jenkins, Mark/0000-0002-8964-6160; Aaltonen, Lauri/0000-0001-6839-4286; Hampel, Heather/0000-0001-7558-9794; Potter, John/0000-0001-5439-1500; Buchanan, Daniel/0000-0003-2225-6675; Balaguer, Francesc/0000-0002-0206-0539	Ministerio de Economia y Competividad [SAF2010-19273]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 849]; Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III [PI10/00384]; National Cancer Institute [CA67941, CA16058]; National Institutes of Health [5R01DK056645, RFA CA-95-011]; National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE [U01CA074800, P30CA016058, U01CA074799, U01CA074783, U01CA097735, U01CA074794, K22CA095011, R01CA067941, U01CA074806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056645] Funding Source: NIH RePORTER	Ministerio de Economia y Competividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Ministerio de Economia y Competividad (SAF2010-19273), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 849), Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona), Hospital Clinic of Barcelona (Josep Font grant), and Instituto de Salud Carlos III (PI10/00384). CIBEREHD and CIBERESP are funded by the Instituto de Salud Carlos III. The research at the Ohio State University Comprehensive Cancer Center was supported by National Cancer Institute grants CA67941 and CA16058. The research at the University of Pennsylvania was supported by the National Institutes of Health under 5R01DK056645, the National Colon Cancer Research Alliance, and the Hansen Foundation. This work was also supported by the National Cancer Institute, by the National Institutes of Health under RFA CA-95-011, and through cooperative agreements with members of the Colon Cancer Family Registry and Principal Investigators. Collaborating centers include Australasian Colorectal Cancer Family Registry (U01 CA097735), Familial Colorectal Neoplasia Collaborative Group (U01 CA074799) (University of Southern California), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), Seattle Colorectal Cancer Family Registry (U01 CA074794), and University of Hawaii Colorectal Cancer Family Registry (U01 CA074806). The work was carried out in part at the Esther Koplowitz Center, Barcelona.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; [Anonymous], BREAST COL CANC FAM; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balmana J, 2008, J MED GENET, V45, P557, DOI 10.1136/jmg.2008.059311; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Boland C. R., 2010, GASTROENTEROLOGY, V138, P2197, DOI [DOI 10.1053/J.GASTRO.2010.04.024, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Boland CR, 2010, GASTROENTEROLOGY, V138, pe1; Chen SN, 2006, JAMA-J AM MED ASSOC, V296, P1479, DOI 10.1001/jama.296.12.1479; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Cicek MS, 2011, J MOL DIAGN, V13, P271, DOI 10.1016/j.jmoldx.2010.12.004; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kastrinos F, 2011, CANCER J, V17, P405, DOI 10.1097/PPO.0b013e318237e408; Kastrinos F, 2011, GASTROENTEROLOGY, V140, P73, DOI 10.1053/j.gastro.2010.08.021; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Loughrey MB, 2007, FAM CANCER, V6, P301, DOI 10.1007/s10689-007-9124-1; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Paya A, 2009, CLIN CANCER RES, V15, P3156, DOI 10.1158/1078-0432.CCR-08-3116; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; Rodriguez-Moranta F, 2006, AM J GASTROENTEROL, V101, P1104, DOI 10.1111/j.1572-0241.2006.00522.x; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Stoffel EM, 2010, GASTROENTEROLOGY, V139, P1436, DOI 10.1053/j.gastro.2010.09.018; Therneau TM, R PORT; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2005, JAMA-J AM MED ASSOC, V293, P2028, DOI 10.1001/jama.293.16.2028; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	40	346	361	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1555	1565		10.1001/jama.2012.13088	http://dx.doi.org/10.1001/jama.2012.13088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073952	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000309858100022
J	Grosse-Sundrup, M; Henneman, JP; Sandberg, WS; Bateman, BT; Uribe, JV; Nguyen, NT; Ehrenfeld, JM; Martinez, EA; Kurth, T; Eikermann, M				Grosse-Sundrup, Martina; Henneman, Justin P.; Sandberg, Warren S.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Ehrenfeld, Jesse M.; Martinez, Elizabeth A.; Kurth, Tobias; Eikermann, Matthias			Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHEAL INTUBATION; MUSCLE-ACTIVITY; CARE-UNIT; ANESTHESIA; MORBIDITY; BLOCKADE; REVERSAL; NEOSTIGMINE; PREDICTORS; SURGERY	Objective To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design Prospective, propensity score matched cohort study. Setting General teaching hospital in Boston, Massachusetts, United States, 2006-10. Participants 18 579 surgical patients who received intermediate acting neuromuscular blocking agents during surgery were matched by propensity score to 18 579 reference patients who did not receive such agents. Main outcome measures The main outcome measures were oxygen desaturation after extubation (hemoglobin oxygen saturation <90% with a decrease in oxygen saturation after extubation of >3%) and reintubations requiring unplanned admission to an intensive care unit within seven days of surgery. We also evaluated effects on these outcome variables of qualitative monitoring of neuromuscular transmission (train-of-four ratio) and reversal of neuromuscular blockade with neostigmine to prevent residual postoperative neuromuscular blockade. Results The use of intermediate acting neuromuscular blocking agents was associated with an increased risk of postoperative desaturation less than 90% after extubation (odds ratio 1.36, 95% confidence interval 1.23 to 1.51) and reintubation requiring unplanned admission to an intensive care unit (1.40, 1.09 to 1.80). Qualitative monitoring of neuromuscular transmission did not decrease this risk and neostigmine reversal increased the risk of postoperative desaturation less than 90% (1.32, 1.20 to 1.46) and reintubation (1.76, 1.38 to 2.26). Conclusion The use of intermediate acting neuromuscular blocking agents during anesthesia was associated with an increased risk of clinically meaningful respiratory complications. Our data suggest that the strategies used in our trial to prevent residual postoperative neuromuscular blockade should be revisited.	[Grosse-Sundrup, Martina; Henneman, Justin P.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Martinez, Elizabeth A.; Eikermann, Matthias] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Sandberg, Warren S.; Ehrenfeld, Jesse M.] Vanderbilt Univ, Sch Med, Dept Anaesthesiol, Nashville, TN 37212 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA; [Kurth, Tobias] INSERM, Unit Neuroepidemio 708, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France; [Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02114 USA; [Eikermann, Matthias] Univ Klinikum Essen, Klin Anaesthesie & Intens Med, Essen, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen	Eikermann, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	meikermann@partners.org	Ehrenfeld, Jesse/AAI-2951-2020; Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Ehrenfeld, Jesse/0000-0003-3427-0140	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency; US National Institutes of Health; Migraine Research Foundation; Parkinson's Disease Foundation; Merck; Pfizer; ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Migraine Research Foundation; Parkinson's Disease Foundation; Merck(Merck & Company); Pfizer(Pfizer); ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	This study was funded by the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that this study has been funded only by academic research funds; TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, the Migraine Research Foundation, and the Parkinson's Disease Foundation. He has received honorariums from Allergan, the American Academy of Neurology, and Merck for educational lectures, from the BMJ for editorial services, and from MAP Pharmaceutical for contributing to a scientific advisory panel. ME has received investigator initiated research funding from Merck, Pfizer, and the ResMed Foundation, as well as the Department of Anesthesia and Critical Care and Pain Medicine of the Massachusetts General Hospital. He has received honorariums from Hill-Rom for giving advise, and from the American Thoracic Society, Brown University, Michigan University, and Vanderbilt University for educational lectures, and from the Journal Anesthesiology for editorial services; the authors have no financial relationships with any organisation or company that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	ABAJIAN J, 1955, ANN SURG, V142, P138; Alfille PH, 2009, CURR OPIN ANESTHESIO, V22, P730, DOI 10.1097/ACO.0b013e328331d545; Arbous MS, 2005, ANESTHESIOLOGY, V102, P257, DOI 10.1097/00000542-200502000-00005; BEECHER HK, 1954, ANN SURG, V140, P2, DOI 10.1097/00000658-195407000-00001; BEEMER GH, 1991, BRIT J ANAESTH, V66, P469, DOI 10.1093/bja/66.4.469; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Butterly A, 2010, BRIT J ANAESTH, V105, P304, DOI 10.1093/bja/aeq157; CALDWELL JE, 1995, ANESTH ANALG, V80, P1168, DOI 10.1097/00000539-199506000-00018; Chan KS, 2009, SURG TODAY, V39, P295, DOI 10.1007/s00595-008-3876-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claudius C, 2008, ANESTHESIOLOGY, V108, P1117, DOI 10.1097/ALN.0b013e318173f62f; Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004; Eikermann M, 2008, BRIT J ANAESTH, V101, P344, DOI 10.1093/bja/aen176; Eikermann M, 2005, CHEST, V127, P1703, DOI 10.1378/chest.127.5.1703; Eikermann M, 2002, BRIT J ANAESTH, V89, P277, DOI 10.1093/bja/aef177; Eikermann M, 2007, ANESTHESIOLOGY, V107, P621, DOI 10.1097/01.anes.0000281928.88997.95; Eikermann M, 2007, AM J RESP CRIT CARE, V175, P9, DOI 10.1164/rccm.200512-1862OC; Evers AS, 2005, CLIN ANESTH, P111; HARRISON GG, 1978, BRIT J ANAESTH, V50, P1041, DOI 10.1093/bja/50.10.1041; Hayes AH, 2001, ANAESTHESIA, V56, P312, DOI 10.1046/j.1365-2044.2001.01921.x; Herbstreit F, 2010, ANESTHESIOLOGY, V113, P1280, DOI 10.1097/ALN.0b013e3181f70f3d; Johnson RG, 2007, J AM COLL SURGEONS, V204, P1188, DOI 10.1016/j.jamcollsurg.2007.02.070; Kopman AF, 2009, ANAESTHESIA, V64, P22, DOI 10.1111/j.1365-2044.2008.05867.x; Krodel DJ, 2010, ANESTHESIOLOGY, V113, P200, DOI 10.1097/ALN.0b013e3181e32e68; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; LUNN JN, 1983, ANAESTHESIA, V38, P1090, DOI 10.1111/j.1365-2044.1983.tb12486.x; Mencke T, 2003, ANESTHESIOLOGY, V98, P1049, DOI 10.1097/00000542-200305000-00005; Mencke T, 2006, ANESTH ANALG, V102, P306, DOI 10.1213/01.ANE.0000181290.37527.CE; Murphy GS, 2006, MINERVA ANESTESIOL, V72, P97; Murphy GS, 2008, ANESTHESIOLOGY, V109, P389, DOI 10.1097/ALN.0b013e318182af3b; Murphy GS, 2008, ANESTH ANALG, V107, P130, DOI 10.1213/ane.0b013e31816d1268; Murphy GS, 2010, ANESTH ANALG, V111, P120, DOI 10.1213/ANE.0b013e3181da832d; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Parsons L., SAS I P 26 ANN SAS U; Paton F, 2010, BRIT J ANAESTH, V105, P558, DOI 10.1093/bja/aeq269; PAYNE JP, 1980, BRIT J ANAESTH, V52, P69, DOI 10.1093/bja/52.1.69; PEDERSEN T, 1992, ACTA ANAESTH SCAND, V36, P812, DOI 10.1111/j.1399-6576.1992.tb03570.x; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; ROSE DK, 1994, ANESTHESIOLOGY, V81, P410, DOI 10.1097/00000542-199408000-00020; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; Sprung J, 2003, ANESTHESIOLOGY, V99, P259, DOI 10.1097/00000542-200308000-00006; Srivastava A, 2009, BRIT J ANAESTH, V103, P115, DOI 10.1093/bja/aep093; Sundman E, 2000, ANESTHESIOLOGY, V92, P977, DOI 10.1097/00000542-200004000-00014; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67; Williams MT, 2003, ANAESTHESIA, V58, P574, DOI 10.1046/j.1365-2044.2003.03150.x	46	164	169	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2012	345								e6329	10.1136/bmj.e6329	http://dx.doi.org/10.1136/bmj.e6329			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WG	23077290	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000310140600001
J	Imlach, WL; Beck, ES; Choi, BJ; Lotti, F; Pellizzoni, L; McCabe, BD				Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.			SMN Is Required for Sensory-Motor Circuit Function in Drosophila	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; NEUROMUSCULAR-JUNCTIONS; ELECTRICAL-PROPERTIES; SINGLE NUCLEOTIDE; NEURON PROTEIN; MOUSE MODEL; GENE; SURVIVAL; MICE; MUSCLE	Spinal muscular atrophy (SMA) is a lethal human disease characterized by motor neuron dysfunction and muscle deterioration due to depletion of the ubiquitous survival motor neuron (SMN) protein. Drosophila SMN mutants have reduced muscle size and defective locomotion, motor rhythm, and motor neuron neurotransmission. Unexpectedly, restoration of SMN in either muscles or motor neurons did not alter these phenotypes. Instead, SMN must be expressed in proprioceptive neurons and interneurons in the motor circuit to nonautonomously correct defects in motor neurons and muscles. SMN depletion disrupts the motor system subsequent to circuit development and can be mimicked by the inhibition of motor network function. Furthermore, increasing motor circuit excitability by genetic or pharmacological inhibition of K+ channels can correct SMN-dependent phenotypes. These results establish sensory-motor circuit dysfunction as the origin of motor system deficits in this SMA model and suggest that enhancement of motor neural network activity could ameliorate the disease.	[Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA; [Imlach, Wendy L.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Beck, Erin S.; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	McCabe, BD (corresponding author), Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA.	brian@mccabelab.org	Lotti, Francesco/AAC-3186-2019; Beck, Erin/AAA-8399-2022; Imlach, Wendy/G-7609-2011	Imlach, Wendy/0000-0002-7521-9969; McCabe, Brian/0000-0003-1620-0501; Pellizzoni, Livio/0000-0002-9168-5628; Choi, Ben Jiwon/0000-0001-9155-8445	NIH-NINDS [R01NS069601]; Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry;  [DoD-W81XWH-08-1-0009];  [DoD-W81XWH-11-1-0753]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069601, R21NS075572] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are very grateful to Spyros Artavanis-Tsakonas and Greg Matera for smn stocks and reagents. We also thank Haig Keshishian, James Hodge, Cynthia Hughes, John Thomas, Michael Nitabach, Andrea Pizzo, Jonathan Javitch, Graeme Davis, Julie Simpson, and Wesley Grueber for additional stocks and advice. We thank George Mentis and especially Chris Henderson for critical reading of this manuscript. L. P. was supported by NIH-NINDS R01NS069601 and with B. D. M. by the Columbia University Motor Neuron Center. B. D. M. was supported by DoD-W81XWH-08-1-0009, DoD-W81XWH-11-1-0753, and the Gatsby Initiative in Brain Circuitry.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baines RA, 2006, INT REV NEUROBIOL, V75, P91, DOI 10.1016/S0074-7742(06)75005-X; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chwieduk CM, 2010, CNS DRUGS, V24, P883, DOI 10.2165/11205910-000000000-00000; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hayes Keith C, 2007, Expert Rev Neurother, V7, P453, DOI 10.1586/14737175.7.5.453; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imlach Wendy, 2009, J Vis Exp, DOI 10.3791/1109; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pinter MJ, 1997, J NEUROSCI, V17, P4500; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Renault F, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P301, DOI 10.1016/S0370-4475(83)80042-2; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	57	139	140	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					427	439		10.1016/j.cell.2012.09.011	http://dx.doi.org/10.1016/j.cell.2012.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063130	Green Accepted, Bronze			2022-12-01	WOS:000309981000019
J	Zaratiegui, M; Martienssen, RA				Zaratiegui, Mikel; Martienssen, Robert A.			SnapShot: Small RNA-Mediated Epigenetic Modifications	CELL			English	Editorial Material							GERMLINE; PIRNAS; MEMORY		[Zaratiegui, Mikel] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zaratiegui, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.			Zaratiegui, Mikel/0000-0002-0342-0268	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076396, R01GM076396-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	10	4	4	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					456	+		10.1016/j.cell.2012.10.001	http://dx.doi.org/10.1016/j.cell.2012.10.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063132	Green Accepted, Bronze			2022-12-01	WOS:000309981000022
J	Qi, QB; Chu, AY; Kang, JH; Jensen, MK; Curhan, GC; Pasquale, LR; Ridker, PM; Hunter, DJ; Willett, WC; Rimm, EB; Chasman, DI; Hu, FB; Qi, L				Qi, Qibin; Chu, Audrey Y.; Kang, Jae H.; Jensen, Majken K.; Curhan, Gary C.; Pasquale, Louis R.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu			Sugar-Sweetened Beverages and Genetic Risk of Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; WEIGHT-GAIN; FOOD-INTAKE; VARIANTS; HEALTH; REPRODUCIBILITY; VALIDITY; DISEASE	BACKGROUND Temporal increases in the consumption of sugar-sweetened beverages have paralleled the rise in obesity prevalence, but whether the intake of such beverages interacts with the genetic predisposition to adiposity is unknown. METHODS We analyzed the interaction between genetic predisposition and the intake of sugar-sweetened beverages in relation to body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) and obesity risk in 6934 women from the Nurses' Health Study (NHS) and in 4423 men from the Health Professionals Follow-up Study (HPFS) and also in a replication cohort of 21,740 women from the Women's Genome Health Study (WGHS). The genetic-predisposition score was calculated on the basis of 32 BMI-associated loci. The intake of sugar-sweetened beverages was examined prospectively in relation to BMI. RESULTS In the NHS and HPFS cohorts, the genetic association with BMI was stronger among participants with higher intake of sugar-sweetened beverages than among those with lower intake. In the combined cohorts, the increases in BMI per increment of 10 risk alleles were 1.00 for an intake of less than one serving per month, 1.12 for one to four servings per month, 1.38 for two to six servings per week, and 1.78 for one or more servings per day (P < 0.001 for interaction). For the same categories of intake, the relative risks of incident obesity per increment of 10 risk alleles were 1.19 (95% confidence interval [CI], 0.90 to 1.59), 1.67 (95% CI, 1.28 to 2.16), 1.58 (95% CI, 1.01 to 2.47), and 5.06 (95% CI, 1.66 to 15.5) (P = 0.02 for interaction). In the WGHS cohort, the increases in BMI per increment of 10 risk alleles were 1.39, 1.64, 1.90, and 2.53 across the four categories of intake (P = 0.001 for interaction); the relative risks for incident obesity were 1.40 (95% CI, 1.19 to 1.64), 1.50 (95% CI, 1.16 to 1.93), 1.54 (95% CI, 1.21 to 1.94), and 3.16 (95% CI, 2.03 to 4.92), respectively (P = 0.007 for interaction). CONCLUSIONS The genetic association with adiposity appeared to be more pronounced with greater intake of sugar-sweetened beverages. (Funded by the National Institutes of Health and others.)	[Qi, Qibin; Jensen, Majken K.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Curhan, Gary C.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chu, Audrey Y.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kang, Jae H.; Curhan, Gary C.; Pasquale, Louis R.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Qi, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Qi, Qibin/H-9055-2012	Venkatasubramanian, Siddharth/0000-0002-5860-0768; Jensen, Majken Karoline/0000-0003-4729-7545	National Institutes of Health; National Institutes of Health [DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, DK46200, HL043851, HL69757, CA047988]; Merck Research Laboratories; American Heart Association Scientist Development Award [0730094N]; Research to Prevent Blindness award; Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen; Genzyme; Isis Pharmaceuticals; Vascular Biogenics; Merck; Abbott; Novartis; AstraZeneca; Novo Nordisk; California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE [U54CA155626, R01CA049449, P01CA087969, P01CA055075, R01CA047988, U01CA049449] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL069757, R01HL073168, R01HL034594, R01HL071981, R01HL043851, R01HL088521, T32HL007575, U01HL069757] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, U01HG004728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, K24DK080140, P01DK070756, R01DK058845, R01DK091718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); American Heart Association Scientist Development Award(American Heart Association); Research to Prevent Blindness award(Research to Prevent Blindness (RPB)); Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen(Amgen); Genzyme(Sanofi-AventisGenzyme Corporation); Isis Pharmaceuticals; Vascular Biogenics; Merck(Merck & Company); Abbott(Abbott Laboratories); Novartis(Novartis); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants (DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, and DK46200) from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories; an American Heart Association Scientist Development Award (0730094N, to Dr. L. Qi); and a Research to Prevent Blindness award and a Harvard Ophthalmology Scholar Award (both to Dr. Pasquale) from the Harvard Glaucoma Center of Excellence. The WGHS is supported by grants (HL043851, HL69757, and CA047988) from the National Institutes of Health, with collaborative scientific support and funding for genotyping provided by Amgen.; Dr. Ridker reports receiving consulting fees from Genzyme, Isis Pharmaceuticals, Vascular Biogenics, Merck, and Abbott and grant support to his institution from Novartis and AstraZeneca and being listed as a co-inventor on patents held by his institution that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes (patent and royalty payments are received by Brigham and Women's Hospital); Dr. Hu, receiving consulting fees from Novo Nordisk and grant support to his institution from Merck and the California Walnut Commission; and Dr. L. Qi, receiving lecture fees from Kellogg. No other potential conflict of interest relevant to this article was reported.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jonsson A, 2010, DIABETOLOGIA, V53, P1244, DOI 10.1007/s00125-010-1709-9; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rampersaud E, 2009, ARCH INTERN MED, V169, P453; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	44	366	379	2	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1387	1396		10.1056/NEJMoa1203039	http://dx.doi.org/10.1056/NEJMoa1203039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	22998338	Green Accepted			2022-12-01	WOS:000309652700005
J	Emmerich, J; Dumarcet, N; Lorence, A				Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie			France's New Framework for Regulating Off-Label Drug Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie] Agence Natl Securite Med & Prod Sante, St Denis, France		Emmerich, J (corresponding author), Agence Natl Securite Med & Prod Sante, St Denis, France.							Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; FERNER RE, 1996, PRESCRIBERS J, V36, P73; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107	5	43	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1279	1281		10.1056/NEJMp1208347	http://dx.doi.org/10.1056/NEJMp1208347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014WJ	23034018				2022-12-01	WOS:000309406100002
J	Nie, ZQ; Hu, GQ; Wei, G; Cui, KR; Yamane, A; Resch, W; Wang, RN; Green, DR; Tessarollo, L; Casellas, R; Zhao, KJ; Levens, D				Nie, Zuqin; Hu, Gangqing; Wei, Gang; Cui, Kairong; Yamane, Arito; Resch, Wolfgang; Wang, Ruoning; Green, Douglas R.; Tessarollo, Lino; Casellas, Rafael; Zhao, Keji; Levens, David			c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells	CELL			English	Article							GRAPHICAL USER-INTERFACE; TRANSCRIPTION FACTOR MYC; LYMPHOMA CELLS; RNA-POLYMERASE; ACTIVATION; MOUSE; FIBROBLASTS; ONCOGENES; REVEALS; GENOME	The c-Myc HLH-bZIP protein has been implicated in physiological or pathological growth, proliferation, apoptosis, metabolism, and differentiation at the cellular, tissue, or organismal levels via regulation of numerous target genes. No principle yet unifies Myc action due partly to an incomplete inventory and functional accounting of Myc's targets. To observe Myc target expression and function in a system where Myc is temporally and physiologically regulated, the transcriptomes and the genome-wide distributions of Myc, RNA polymerase II, and chromatin modifications were compared during lymphocyte activation and in ES cells as well. A remarkably simple rule emerged from this quantitative analysis: Myc is not an on-off specifier of gene activity, but is a nonlinear amplifier of expression, acting universally at active genes, except for immediate early genes that are strongly induced before Myc. This rule of Myc action explains the vast majority of Myc biology observed in literature.	[Hu, Gangqing; Wei, Gang; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Nie, Zuqin; Levens, David] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NIAMS, Genom & Immun Sect, Bethesda, MD 20892 USA; [Wang, Ruoning; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tessarollo, Lino] NCI, Neural Dev Sect, FNL, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; levens@helix.nih.gov	Yamane, Arito/A-2959-2013; HU, GANGQING/K-5849-2012; Green, Douglas R/N-8083-2018; Hu, Gangqing/ABA-3507-2020; Wang, Ruoning/C-1683-2014; Levens, David/C-9216-2009	HU, GANGQING/0000-0001-5453-6888; Green, Douglas R/0000-0002-7332-1417; Levens, David/0000-0002-7616-922X; Resch, Wolfgang/0000-0001-7594-5963	NIH, National Cancer Institute, Center for Cancer Research; NHLBI; NIAMS; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC011465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank our colleagues, especially Eric Batchelor and Dan Larson for insight and valuable discussions. D.L. thanks Dirk Eick for insightful discussion. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, of NHLBI and of NIAMS. We thank the DNA Sequencing Core Facility of NHLBI for sequencing some of the ChIP-Seq libraries.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Alon U., 2020, An introduction to systems biology: design principles of biological circuits ed., V2nd edn, P249; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bui Thi V, 2010, Genes Cancer, V1, P568; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Chung HJ, 2005, MOL CELLS, V20, P157; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Levens David, 2010, Genes Cancer, V1, P547; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mehmet H, 1997, CELL GROWTH DIFFER, V8, P187; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; TONINI GP, 1987, CANCER RES, V47, P4544; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	719	737	3	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					68	79		10.1016/j.cell.2012.08.033	http://dx.doi.org/10.1016/j.cell.2012.08.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021216	Green Accepted, Bronze			2022-12-01	WOS:000309544200011
J	Woo, DH; Han, KS; Shim, JW; Yoon, BE; Kim, E; Bae, JY; Oh, SJ; Hwang, EM; Marmorstein, AD; Bae, YC; Park, JY; Lee, CJ				Woo, Dong Ho; Han, Kyung-Seok; Shim, Jae Wan; Yoon, Bo-Eun; Kim, Eunju; Bae, Jin Young; Oh, Soo-Jin; Hwang, Eun Mi; Marmorstein, Alan D.; Bae, Yong Chul; Park, Jae-Yong; Lee, C. Justin			TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in Astrocytes upon GPCR Activation	CELL			English	Article							RAT HIPPOCAMPAL SLICES; K+ CHANNELS; SYNAPTIC-TRANSMISSION; ANION CHANNEL; RECEPTORS; EXOCYTOSIS; INHIBITION; NEURONS; CA2+; FREQUENCY	Astrocytes release glutamate upon activation of various GPCRs to exert important roles in synaptic functions. However, the molecular mechanism of release has been controversial. Here, we report two kinetically distinct modes of nonvesicular, channel-mediated glutamate release. The fast mode requires activation of G(alpha i), dissociation of G(beta gamma), and subsequent opening of glutamate-permeable, two-pore domain potassium channel TREK-1 through direct interaction between G(beta gamma) and N terminus of TREK-1. The slow mode is Ca2+ dependent and requires G(alpha q) activation and opening of glutamate-permeable, Ca2+-activated anion channel Best1. Ultrastructural analyses demonstrate that TREK-1 is preferentially localized at cell body and processes, whereas Best1 is mostly found in microdomains of astrocytes near synapses. Diffusion modeling predicts that the fast mode can target neuronal mGluR with peak glutamate concentration of 100 mu M, whereas slow mode targets neuronal NMDA receptors at around 1 mu M. Our results reveal two distinct sources of astrocytic glutamate that can differentially influence neighboring neurons.	[Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, WCI Ctr Funct Connect, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol UST, Neurosci Program, Taejon 305350, South Korea; [Shim, Jae Wan] Korea Inst Sci & Technol, Future Convergence Res Div, Seoul 136791, South Korea; [Shim, Jae Wan] Univ Sci & Technol, Seoul 136791, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Med Res Ctr Neural Dysfunct, Inst Hlth Sci, Dept Physiol,Sch Med, Jinju 660751, South Korea; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, BK21, Taegu 700412, South Korea; [Oh, Soo-Jin] Seoul Natl Univ, Dent Res Inst, Sch Dent, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Marmorstein, Alan D.] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85711 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Korea Institute of Science & Technology (KIST); Gyeongsang National University; Kyungpook National University; Seoul National University (SNU); University of Arizona; University of Arizona	Park, JY (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea.	jaeyong@gnu.ac.kr; cjl@kist.re.kr	Lee, C. Justin/AAC-1663-2019	Park, Jae-Yong/0000-0001-7698-7890; Lee, C Justin/0000-0002-3555-0980	World Class Institute [WCI 2009-003]; MRC [2012-0000305]; NRF [2010-0029460]; MEST of Korea; NIH [R01-EY013160]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013160] Funding Source: NIH RePORTER	World Class Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF; MEST of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the World Class Institute (WCI 2009-003), MRC (2012-0000305), and Basic Science Research (2010-0029460) Programs of the NRF funded by the MEST of Korea and also by NIH (R01-EY013160) and a grant from Research to Prevent Blindness to the Department of Ophthalmology and Vision Science at the University of Arizona. We thank George Augustine, Larry Cohen, and Keiko Tanaka for careful editing of the manuscript. We thank Taekeun Kim for technical support for immunocytochemistry, Nammi Park for technical support for Y2H, Lucie Langevin for providing clone of pRK-beta-Ark-C terminus, and Nevin A. Lambert for pCDNA3.1-SS-ECFP-TM-Gi1-CG(GiCG) and pCDNA3.1-SS-ECFP-TM-Gs.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; FARINELLI SE, 1992, J NEUROCHEM, V58, P1905, DOI 10.1111/j.1471-4159.1992.tb10068.x; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Greenwood IA, 2007, TRENDS PHARMACOL SCI, V28, P1, DOI 10.1016/j.tips.2006.11.004; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kim E, 2010, BIOCHEM BIOPH RES CO, V395, P244, DOI 10.1016/j.bbrc.2010.03.171; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li DD, 2012, J PHYSIOL-LONDON, V590, P855, DOI 10.1113/jphysiol.2011.219345; Li X, 2005, J BIOL CHEM, V280, P23945, DOI 10.1074/jbc.M414078200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Obrenovitch TP, 2001, METHODS, V23, P63, DOI 10.1006/meth.2000.1106; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wang HS, 1997, CIRC RES, V81, P711; WEST RE, 1985, J BIOL CHEM, V260, P4428; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	51	215	217	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					25	40		10.1016/j.cell.2012.09.005	http://dx.doi.org/10.1016/j.cell.2012.09.005			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021213	Bronze			2022-12-01	WOS:000309544200008
J	Trasande, L; Attina, TM; Blustein, J				Trasande, Leonardo; Attina, Teresa M.; Blustein, Jan			Association Between Urinary Bisphenol A Concentration and Obesity Prevalence in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; TEMPORAL VARIABILITY; PRESCHOOL-CHILDREN; ADIPOSE-TISSUE; TOBACCO-SMOKE; UNITED-STATES; EXPOSURE; WOMEN; ADIPOCYTES; DISEASE	Context Bisphenol A (BPA), a manufactured chemical, is found in canned food, polycarbonate-bottled liquids, and other consumer products. In adults, elevated urinary BPA concentrations are associated with obesity and incident coronary artery disease. BPA exposure is plausibly linked to childhood obesity, but evidence is lacking to date. Objective To examine associations between urinary BPA concentration and body mass outcomes in children. Design, Setting, and Participants Cross-sectional analysis of a nationally representative subsample of 2838 participants aged 6 through 19 years randomly selected for measurement of urinary BPA concentration in the 2003-2008 National Health and Nutrition Examination Surveys. Main Outcome Measures Body mass index (BMI), converted to sex-and age-standardized z scores and used to classify participants as overweight (BMI >= 85th percentile for age/sex) or obese (BMI >= 95th percentile). Results Median urinary BPA concentration was 2.8 ng/mL (interquartile range, 1.5-5.6). Of the participants, 1047 (34.1% [SE, 1.5%]) were overweight and 590 (17.8% [SE, 1.3%]) were obese. Controlling for race/ethnicity, age, caregiver education, poverty to income ratio, sex, serum cotinine level, caloric intake, television watching, and urinary creatinine level, children in the lowest urinary BPA quartile had a lower estimated prevalence of obesity (10.3% [95% CI, 7.5%-13.1%]) than those in quartiles 2 (20.1% [95% CI, 14.5%-25.6%]), 3 (19.0% [95% CI, 13.7%-24.2%]), and 4 (22.3% [95% CI, 16.6%-27.9%]). Similar patterns of association were found in multivariable analyses examining the association between quartiled urinary BPA concentration and BMI z score and in analyses that examined the logarithm of urinary BPA concentration and the prevalence of obesity. Obesity was not associated with exposure to other environmental phenols commonly used in other consumer products, such as sunscreens and soaps. In stratified analysis, significant associations between urinary BPA concentrations and obesity were found among whites (P < .001) but not among blacks or Hispanics. Conclusions Urinary BPA concentration was significantly associated with obesity in this cross-sectional study of children and adolescents. Explanations of the association cannot rule out the possibility that obese children ingest food with higher BPA content or have greater adipose stores of BPA. JAMA. 2012;308(11):1113-1121 www.jama.com	[Trasande, Leonardo; Attina, Teresa M.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Blustein, Jan] NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo; Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Trasande, L (corresponding author), NYU, Dept Pediat, Sch Med, 227 E 30th St,Room 711, New York, NY 10016 USA.	leonardo.trasande@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X				[Anonymous], NHANES 2003 2004 ENV; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, pA143, DOI 10.1289/ehp.1205179; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Centers for Disease Control and Prevention, 2012, OV NHANES SURV DES W; Centers for Disease Control and Prevention, MEAS GUID DIET REC I; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Elobeid MA, 2008, CURR OPIN ENDOCRINOL, V15, P403, DOI 10.1097/MED.0b013e32830ce95c; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FLEISS JL, 1977, AM J PUBLIC HEALTH, V67, P1188, DOI 10.2105/AJPH.67.12.1188; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lim DS, 2009, J TOXICOL ENV HEAL A, V72, P1327; Lohman T.G., 1998, ANTHROPOMETRIC STAND; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Masuno H, 2002, J LIPID RES, V43, P676; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Mendoza JA, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-44; Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Sakurai K, 2004, BRIT J PHARMACOL, V141, P209, DOI 10.1038/sj.bjp.0705520; Schecter A, 2010, ENVIRON SCI TECHNOL, V44, P9425, DOI 10.1021/es102785d; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Tavernise S., 2012, NY TIMES        1121; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Thomson BM, 2005, FOOD ADDIT CONTAM, V22, P65, DOI 10.1080/02652030400027920; Trasande L, 2009, ENVIRON HEALTH PERSP, V117, P159, DOI 10.1289/ehp.11839; United States Department of Agriculture (USDA), 2010, DIET GUID AM; Update on Bisphenol A for Use in Food Contact Applications, 2012, UPD BISPH US FOOD CO; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; White House Task Force on Childhood Obesity, 2010, SOLV PROBL CHILDH OB; Wilson KM, 2011, NICOTINE TOB RES, V13, P800, DOI 10.1093/ntr/ntr076; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014	47	326	344	3	139	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1113	1121		10.1001/2012.jama.11461	http://dx.doi.org/10.1001/2012.jama.11461			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990270	Bronze			2022-12-01	WOS:000308861000027
J	Puymirat, E; Simon, T; Steg, PG; Schiele, F; Gueret, P; Blanchard, D; Khalife, K; Goldstein, P; Cattan, S; Vaur, L; Cambou, JP; Ferrieres, J; Danchin, N				Puymirat, Etienne; Simon, Tabassome; Steg, Philippe Gabriel; Schiele, Francois; Gueret, Pascal; Blanchard, Didier; Khalife, Khalife; Goldstein, Patrick; Cattan, Simon; Vaur, Laurent; Cambou, Jean-Pierre; Ferrieres, Jean; Danchin, Nicolas		USIK USIC 2000 Investigator; FAST MI Investigator	Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; FAST-MI; TRENDS; REGISTRY; DECREASE; DECLINE; DISEASE	Context The contemporary decline in mortality reported in patients with ST-segment elevation myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion therapy. Objective To determine potential factors-beyond reperfusion therapy-associated with improved survival in patients with STEMI over a 15-year period. Design, Setting, and Patients Four 1-month French nationwide registries, conducted 5 years apart (between 1995, 2000, 2005, 2010), including a total of 6707 STEMI patients admitted to intensive care or coronary care units. Main Outcome Measures Changes over time in crude 30-day mortality, and mortality standardized to the 2010 population characteristics. Results Mean(SD) age decreased from 66.2 (14.0) to 63.3 (14.5) years, with a concomitant decline in history of cardiovascular events and comorbidities. The proportion of younger patients increased, particularly in women younger than 60 years (from 11.8% to 25.5%), in whom prevalence of current smoking (37.3% to 73.1%) and obesity (17.6% to 27.1%) increased. Time from symptom onset to hospital admission decreased, with a shorter time from onset to first call, and broader use of mobile intensive care units. Reperfusion therapy increased from 49.4% to 74.7%, driven by primary percutaneous coronary intervention (11.9% to 60.8%). Early use of recommended medications increased, particularly low-molecular-weight heparins and statins. Crude 30-day mortality decreased from 13.7% (95% CI, 12.0-15.4) to 4.4% (95% CI, 3.5-5.4), whereas standardized mortality decreased from 11.3% (95% CI, 9.5-13.2) to 4.4% (95% CI, 3.5-5.4). Multivariable analysis showed a consistent reduction in mortality from 1995 to 2010 after controlling for clinical characteristics in addition to the initial population risk score and use of reperfusion therapy, with odds mortality ratios of 0.39 (95%, 0.29-0.53, P < .001) in 2010 compared with 1995. Conclusion In France, the overall rate of cardiovascular mortality among patients with STEMI decreased from 1995 to 2010, accompanied by an increase in the proportion of women younger than 60 years with STEMI, changes in other population characteristics, and greater use of reperfusion therapy and recommended medications. JAMA. 2012;308(10):998-1006 Published online August 27, 2012. doi:10.1001/jama.2012.11348 www.jama.com	[Puymirat, Etienne; Danchin, Nicolas] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France; [Puymirat, Etienne] INSERM, U970, Paris, France; [Simon, Tabassome] Hop St Antoine, AP HP, Dept Clin Pharmacol, F-75571 Paris, France; [Simon, Tabassome] Unite Rech Clin URCEST, Paris, France; [Simon, Tabassome] Univ Paris 06, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Paris, France; [Steg, Philippe Gabriel] INSERM, U698, Paris, France; [Schiele, Francois] Univ Hosp Jean Minjoz, Dept Cardiol, Besancon, France; [Gueret, Pascal] Univ Hosp Henri Mondor, Dept Cardiol, Creteil, France; [Blanchard, Didier] Clin St Gatien, Tours, France; [Khalife, Khalife] Metz Reg Hosp, Dept Cardiol, Metz, France; [Goldstein, Patrick] Lille Reg Univ Hosp, Emergency Dept, Lille, France; [Vaur, Laurent] Novo Nordisk, Paris, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Toulouse Rangueil Univ Hosp, Dept Cardiol, Toulouse, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHR Metz-Thionville; Universite de Lille - ISITE; CHU Lille; Novo Nordisk; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Danchin, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	nicolas.danchin@egp.aphp.fr	Puymirat, Etienne/AAP-8895-2021; STEG, Philippe Gabriel/Z-1567-2019; Danchin, Nicolas/AAN-8291-2020; Ferrieres, Jean/S-7993-2016	STEG, Philippe Gabriel/0000-0001-6896-2941; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450; Puymirat, Etienne/0000-0002-0533-9682	Astra-Zeneca; Daiichi-Sankyo; Eli-Lilly; Glaxo-Smith-Kline; MSD; Novartis; Pfizer; sanofi-aventis; Servier; AstraZeneca; Bayer-Schering; NYU School of Medicine; Ablynx; Amarin; Astellas; Bayer; Boehringer-Ingelheim; BMS; Daiichi-Sankyo-Lilly; GSK; Medtronic; Otsuka; Roche; Medicines Company; Lilly; Takeda; Toshiba; General Electric Systems; Ipsen; Lilly Daiichi Sankyo; Boehringer Ingelheim; Boston Scientific; Genzyme; Merck; Bristol-Myers Squibb; Menarini; Merck-Serono; Novo-Nordisk; Laboratoire Roussel; Aventis-France; Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance; GlaxoSmithKline; French Society of Cardiology	Astra-Zeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eli-Lilly(Eli Lilly); Glaxo-Smith-Kline(GlaxoSmithKline); MSD; Novartis(Novartis); Pfizer(Pfizer); sanofi-aventis(Sanofi-Aventis); Servier(Servier); AstraZeneca(AstraZeneca); Bayer-Schering(Bayer AG); NYU School of Medicine; Ablynx(Ablynx); Amarin; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Boehringer-Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); Daiichi-Sankyo-Lilly(Daiichi Sankyo Company LimitedEli Lilly); GSK(GlaxoSmithKline); Medtronic(Medtronic); Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding); Medicines Company; Lilly(Eli Lilly); Takeda(Takeda Pharmaceutical Company Ltd); Toshiba; General Electric Systems(General Electric); Ipsen(Ipsen); Lilly Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Boston Scientific(Boston Scientific); Genzyme(Sanofi-AventisGenzyme Corporation); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Menarini(Menarini Group); Merck-Serono(Merck & Company); Novo-Nordisk(Novo Nordisk); Laboratoire Roussel; Aventis-France(Sanofi-Aventis); Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); French Society of Cardiology	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simon reported receiving research grants: Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, and Servier and speaker and consulting fees: AstraZeneca, Bayer-Schering, Eli-Lilly, and sanofi-aventis. Dr Steg reported receiving institutional research grant support: NYU School of Medicine, sanofi-aventis, and Servier; Consulting/advisory board fees: Ablynx, Amarin, Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Daiichi-Sankyo-Lilly, GSK, Medtronic, MSD, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, and The Medicines Company; and being a stockholder and co-founder: Aterovax. Dr Schiele reported receiving grant support to his institution and travel support for scientific meetings: AstraZeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Lilly, Medtronic, Pfizer; sanofi-aventis, Servier, and Takeda. Dr Gueret reported receiving research grants: Toshiba and General Electric Systems and consulting and speaker's fees: Boehringer-Ingelheim, Daiichi-Sankyo, Eli-Lilly, General Electric Systems, Ipsen, Pfizer, sanofi-aventis, and Servier. Dr Goldstein reported speaker, board membership, and consulting fees: Boeringer-Ingelheim, The Medicines Company, sanofi-aventis, BMS, AstraZeneca, Bayer, and Lilly Daiichi Sankyo. Dr Cattan reported receiving grants: AstraZeneca, Boehringer Ingelheim, Boston Scientific, Medtronic, and Servier. Dr Vaur reported being a former full-time employee of Roussel and Aventis-France and being currently employed at Novo-Nordisk. Dr Ferrieres reported receiving grants and speaker fees: AstraZeneca, Genzyme, Merck, Novartis, and Servier. Dr Danchin reported receiving research grants: AstraZeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, Servier, and The Medicines Company and advisory panels or lecture fees: AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Menarini, Merck-Serono, Novo-Nordisk, Servier, and sanofi-aventis. Drs Puymirat, Blanchard, Khalife, and Cambou reported no conflicts of interest.; USIK 1995 was funded by Laboratoire Roussel, which was involved in the design and conduct of the study, as well as data collection and management. USIC 2000 was funded by Aventis-France, which was involved in the design and conduct of the study, as well as data collection and management. FAST-MI 2005 and FAST-MI 2010 are registries of the French Society of Cardiology. FAST-MI 2005 was supported by unrestricted grants from Pfizer and Servier, and an additional grant from the Caisse Nationale d'Assurance Maladie-Travailleurs Salaries. FAST-MI 2010 was supported by unrestricted grants from AstraZeneca, the Daiichi-Sankyo-Eli-Lilly alliance, GlaxoSmithKline, Merck, Novartis, and sanofi-aventis. Sophie Rushton-Smith provided editorial assistance on the first submitted version of the manuscript and was funded by the French Society of Cardiology.	Beck F., 2011, Bulletin Epidemiologique Hebdomadaire, P230; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Danchin N, 1997, J AM COLL CARDIOL, V30, P1598, DOI 10.1016/S0735-1097(97)00371-9; Danchin N, 1999, CIRCULATION, V99, P2639, DOI 10.1161/01.CIR.99.20.2639; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gale CP, 2009, HEART, V95, P221, DOI 10.1136/hrt.2008.144022; Hanania G, 2004, HEART, V90, P1404, DOI 10.1136/hrt.2003.025460; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Movahed MR, 2009, AM J CARDIOL, V104, P1030, DOI 10.1016/j.amjcard.2009.05.051; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Schiele F, 2010, EUR HEART J, V31, P2614, DOI 10.1093/eurheartj/ehq305; Steiger VS, 2009, SWISS MED WKLY, V139, P453; Wagner A., 2011, BEH, V40-41, P414; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	21	317	332	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					998	1006		10.1001/2012.jama.11348	http://dx.doi.org/10.1001/2012.jama.11348			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22928184	Bronze			2022-12-01	WOS:000308579300023
J	Wadham, JL; Arndt, S; Tulaczyk, S; Stibal, M; Tranter, M; Telling, J; Lis, GP; Lawson, E; Ridgwell, A; Dubnick, A; Sharp, MJ; Anesio, AM; Butler, CEH				Wadham, J. L.; Arndt, S.; Tulaczyk, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Dubnick, A.; Sharp, M. J.; Anesio, A. M.; Butler, C. E. H.			Potential methane reservoirs beneath Antarctica	NATURE			English	Article							GAS-HYDRATE; PRODUCTION-RATES; CASCADIA MARGIN; ICE-SHEET; SEDIMENTS; DEEP; LAKE; GEOCHEMISTRY; POPULATIONS; DIAGENESIS	Once thought to be devoid of life, the ice-covered parts of Antarctica are now known to be a reservoir of metabolically active microbial cells and organic carbon(1). The potential for methanogenic archaea to support the degradation of organic carbon to methane beneath the ice, however, has not yet been evaluated. Large sedimentary basins containing marine sequences up to 14 kilometres thick(2) and an estimated 21,000 petagrams (1 Pg equals 10(15) g) of organic carbon are buried beneath the Antarctic Ice Sheet. No data exist for rates of methanogenesis in sub-Antarctic marine sediments. Here we present experimental data from other subglacial environments that demonstrate the potential for overridden organic matter beneath glacial systems to produce methane. We also numerically simulate the accumulation of methane in Antarctic sedimentary basins using an established one-dimensional hydrate model(3) and show that pressure/temperature conditions favour methane hydrate formation down to sediment depths of about 300 metres in West Antarctica and 700 metres in East Antarctica. Our results demonstrate the potential for methane hydrate accumulation in Antarctic sedimentary basins, where the total inventory depends on rates of organic carbon degradation and conditions at the ice-sheet bed. We calculate that the sub-Antarctic hydrate inventory could be of the same order of magnitude as that of recent estimates made for Arctic permafrost. Our findings suggest that the Antarctic Ice Sheet may be a neglected but important component of the global methane budget, with the potential to act as a positive feedback on climate warming during ice-sheet wastage.	[Wadham, J. L.; Arndt, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Anesio, A. M.; Butler, C. E. H.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Arndt, S.] Univ Utrecht, Dept Earth Sci Geochem, NL-3508 Utrecht, Netherlands; [Tulaczyk, S.; Sharp, M. J.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Dubnick, A.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of Bristol; Utrecht University; University of California System; University of California Santa Cruz; University of Alberta	Wadham, JL (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	j.l.wadham@bris.ac.uk	Wadham, Jemma L/A-8352-2012; Ridgwell, Andy/AAD-9487-2021; Tulaczyk, Slawek/O-7375-2018; Tranter, Martyn/E-3722-2010; Wadham, Jemma L/G-3138-2014; Telling, Jon/M-7643-2013; Stibal, Marek/I-3852-2016; Anesio, Alexandre/A-7597-2008; Arndt, Sandra/E-7639-2017	Ridgwell, Andy/0000-0003-2333-0128; Tulaczyk, Slawek/0000-0002-9711-4332; Tranter, Martyn/0000-0003-2071-3094; Stibal, Marek/0000-0002-9998-5086; Anesio, Alexandre/0000-0003-2990-4014; Arndt, Sandra/0000-0002-0235-8124; Lis, Grzegorz/0000-0001-5796-7798; O'Donnell, Emily/0000-0003-4303-4705; Telling, Jon/0000-0002-8180-0979	Natural Environment Research Council (UK-NERC) [NE/E004016/1]; National Science Foundation WISSARD project [NSF-AISS 0839142]; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO); NSERC; Antarctica New Zealand; Polar Continental Shelf Project; NSERC Undergraduate Student Research Award; US National Science Foundation; Natural Environment Research Council [NE/E004016/1, NE/I021322/1] Funding Source: researchfish; NERC [NE/E004016/1, NE/I021322/1] Funding Source: UKRI; Directorate For Geosciences [0839142, 0838947] Funding Source: National Science Foundation	Natural Environment Research Council (UK-NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation WISSARD project; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Antarctica New Zealand; Polar Continental Shelf Project(Natural Resources Canada); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the Natural Environment Research Council (UK-NERC grant NE/E004016/1) and the National Science Foundation WISSARD project (NSF-AISS 0839142). Support to J.L.W. was also provided by the Leverhulme Trust via a Phillip Leverhulme award and to S. A. by the Netherlands Organisation for Scientific Research (NWO). We acknowledge NSERC and Antarctica New Zealand for financial and logistic support for sampling in Antarctica and the Polar Continental Shelf Project for financial and logistic support for sampling in Arctic Canada. We thank S. Fitzsimons for assistance with sampling in Antarctica. A. D. was funded by an NSERC Undergraduate Student Research Award. This research used data provided by the Ocean Drilling Program. The Ocean Drilling Program is sponsored by the US National Science Foundation and participating countries under the management of the Joint Oceanographic Institutions, Inc. We thank C. Ruppel for comments on this manuscript.	Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Barker P. F., 1999, P ODP INIT REP, V178, P60; Boswell R, 2011, ENERG ENVIRON SCI, V4, P1206, DOI 10.1039/c0ee00203h; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Boyd ES, 2010, ENV MICROBIOL REP, V2, P685, DOI 10.1111/j.1758-2229.2010.00162.x; Claypool G., 2004, PROC OCEAN DRILL SCI, V188, P1, DOI DOI 10.2973/0DP.PR0C.SR.188.004.2003; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; Cragg BA, 1996, EARTH PLANET SC LETT, V139, P497, DOI 10.1016/0012-821X(95)00246-9; Davie MK, 2001, J GEOPHYS RES-SOL EA, V106, P497, DOI 10.1029/2000JB900363; Dickens GR, 1997, NATURE, V385, P426, DOI 10.1038/385426a0; Dyke A. S., 1987, MAP GEOLOGICAL SURVE; ELLISEVANS JC, 1984, POLAR BIOL, V3, P63, DOI 10.1007/BF00258149; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Ferraccioli F, 2009, TECTONOPHYSICS, V478, P62, DOI 10.1016/j.tecto.2009.03.013; FRANZMANN PD, 1991, HYDROBIOLOGIA, V210, P191, DOI 10.1007/BF00034677; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Maule CF, 2005, SCIENCE, V309, P464, DOI 10.1126/science.1106888; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; PARKES RJ, 1990, PHILOS T R SOC A, V331, P139, DOI 10.1098/rsta.1990.0061; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Priscu J, 2009, POLAR LAKES RIVERS, P320; Reeburgh W. S., 1993, P1; SMITH RL, 1993, BIOGEOCHEMISTRY, V21, P95, DOI 10.1007/BF00000873; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Torres ME, 2002, EARTH PLANET SC LETT, V201, P525, DOI 10.1016/S0012-821X(02)00733-1; Wadham JL, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002951; Wallmann K, 2006, EARTH PLANET SC LETT, V248, P545, DOI 10.1016/j.epsl.2006.06.026; Wellsbury P, 2002, FEMS MICROBIOL ECOL, V42, P59, DOI 10.1111/j.1574-6941.2002.tb00995.x; Yoshioka H, 2009, GEOCHEM J, V43, P315, DOI 10.2343/geochemj.1.0028	32	113	121	7	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					633	637		10.1038/nature11374	http://dx.doi.org/10.1038/nature11374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932387				2022-12-01	WOS:000308095100051
J	Tayi, AS; Shveyd, AK; Sue, ACH; Szarko, JM; Rolczynski, BS; Cao, D; Kennedy, TJ; Sarjeant, AA; Stern, CL; Paxton, WF; Wu, W; Dey, SK; Fahrenbach, AC; Guest, JR; Mohseni, H; Chen, LX; Wang, KL; Stoddart, JF; Stupp, SI				Tayi, Alok S.; Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Kennedy, T. Jackson; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Wu, Wei; Dey, Sanjeev K.; Fahrenbach, Albert C.; Guest, Jeffrey R.; Mohseni, Hooman; Chen, Lin X.; Wang, Kang L.; Stoddart, J. Fraser; Stupp, Samuel I.			Room-temperature ferroelectricity in supramolecular networks of charge-transfer complexes	NATURE			English	Article							IONIC PHASE-TRANSITION; TETRATHIAFULVALENE-CHLORANIL; MOLECULAR-CRYSTAL; STACK	Materials exhibiting a spontaneous electrical polarization(1,2) that can be switched easily between antiparallel orientations are of potential value for sensors, photonics and energy-efficient memories. In this context, organic ferroelectrics(3,4) are of particular interest because they promise to be lightweight, inexpensive and easily processed into devices. A recently identified family of organic ferroelectric structures is based on intermolecular charge transfer, where donor and acceptor molecules co-crystallize in an alternating fashion known as a mixed stack(5-8): in the crystalline lattice, a collective transfer of electrons from donor to acceptor molecules results in the formation of dipoles that can be realigned by an external field as molecules switch partners in the mixed stack. Although mixed stacks have been investigated extensively, only three systems are known(9,10) to show ferroelectric switching, all below 71 kelvin. Here we describe supramolecular charge-transfer networks that undergo ferroelectric polarization switching with a ferroelectric Curie temperature above room temperature. These polar and switchable systems utilize a structural synergy between a hydrogen-bonded network and charge-transfer complexation of donor and acceptor molecules in a mixed stack. This supramolecular motif could help guide the development of other functional organic systems that can switch polarization under the influence of electric fields at ambient temperatures.	[Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Dey, Sanjeev K.; Fahrenbach, Albert C.; Chen, Lin X.; Stoddart, J. Fraser; Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Tayi, Alok S.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sue, Andrew C-H; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Northwestern Univ, ANSER Ctr, Evanston, IL 60208 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Cao, Dennis; Fahrenbach, Albert C.; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Taejon 305701, South Korea; [Kennedy, T. Jackson] Northwestern Univ, Dept Phys, Evanston, IL 60208 USA; [Wu, Wei; Mohseni, Hooman] Northwestern Univ, Dept Elect Engn, Evanston, IL 60208 USA; [Guest, Jeffrey R.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; University of California System; University of California Los Angeles; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Stoddart, JF (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stoddart@northwestern.edu; s-stupp@northwestern.edu	Mohseni, Hooman/AAZ-5878-2020; Sue, Andrew C.-H./K-1641-2015; Cao, Dennis/C-2240-2013; Mohseni, Hooman/AAX-7824-2021; Paxton, Walter/AAP-8682-2021; Guest, Jeffrey R/B-2715-2009; Stoddart, James Fraser/H-1518-2011; Mohseni, Hooman/B-7253-2009; Fahrenbach, Albert/B-3042-2014; Stupp, Samuel/B-6737-2009; Stupp, Samuel/AGV-1942-2022; Masino, Matteo/O-5429-2015; Szarko, Jodi/L-1497-2015	Mohseni, Hooman/0000-0002-0183-4213; Sue, Andrew C.-H./0000-0001-9557-2658; Cao, Dennis/0000-0002-0315-1619; Paxton, Walter/0000-0002-2438-4542; Guest, Jeffrey R/0000-0002-9756-8801; Stoddart, James Fraser/0000-0003-3161-3697; Masino, Matteo/0000-0002-5869-6800; Szarko, Jodi/0000-0002-2181-9408	Non-equilibrium Energy Research Center (NERC) at Northwestern University; US Department of Energy (DOE), Office of Basic Energy Sciences [DE-SC0000989]; Materials Research Science and Engineering Centre (MRSEC) at Northwestern University; National Science Foundation (NSF); WCU program at KAIST in Korea [R-31-2008-000-10055-0]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NERC; Initiative for Sustainability and Energy at Northwestern (ISEN)	Non-equilibrium Energy Research Center (NERC) at Northwestern University(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); Materials Research Science and Engineering Centre (MRSEC) at Northwestern University(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF)); WCU program at KAIST in Korea; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Initiative for Sustainability and Energy at Northwestern (ISEN)	This work was supported by the Non-equilibrium Energy Research Center (NERC) at Northwestern University, funded by the US Department of Energy (DOE), Office of Basic Energy Sciences under award number DE-SC0000989. A.K.S. received support from the Materials Research Science and Engineering Centre (MRSEC) at Northwestern University, funded by the National Science Foundation (NSF). D.C., A.C.F. and J.F.S. were supported by the WCU program (R-31-2008-000-10055-0) at KAIST in Korea. Use of the Center for Nanoscale Materials was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. D.C. and A.C.F. were supported by NSF Graduate Research Fellowships. A.K.S. and A.C.-H.S. were supported by a fellowship from the NERC. A.S.T. was supported by a fellowship from the Initiative for Sustainability and Energy at Northwestern (ISEN) and NERC. We thank J.B. Ketterson and O. Chernyashevskyy (Northwestern University) for discussions and advice, Y.D. Shah (Northwestern University) for assistance with ferroelectricity measurements, A.M.Z. Slawin (University of St Andrews) for initial help with crystallographic data collection and refinement, M. Mara (Northwestern University) for assistance with spectroscopy, Y. Liu (The Molecular Foundry, Lawrence Berkeley National Laboratory) for discussions, and the Integrated Molecular Structure Education and Research Centre (IMSERC) and the Magnet and Low Temperature Facility at Northwestern University for providing access to equipment for the relevant experiments. Molecular crystal images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualisation and Informatics at the University of California, San Francisco.	[Anonymous], 2007, CRYST EXPL V 2 1; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; GIRLANDO A, 1985, SOLID STATE COMMUN, V54, P753, DOI 10.1016/0038-1098(85)90279-0; GIRLANDO A, 1983, J CHEM PHYS, V79, P1075, DOI 10.1063/1.445833; Hamilton DG, 1997, AUST J CHEM, V50, P439, DOI 10.1071/C97033; Horiuchi S, 2003, SCIENCE, V299, P229, DOI 10.1126/science.1076129; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Kagawa F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.227602; Kobayashi K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237601; KUWATA-GONOKAMI M, 1994, NATURE, V367, P47, DOI 10.1038/367047a0; McKinnon JJ, 2004, ACTA CRYSTALLOGR B, V60, P627, DOI 10.1107/S0108768104020300; Meneghetti M, 1996, J CHEM PHYS, V105, P397, DOI 10.1063/1.471916; Miyajima D, 2012, SCIENCE, V336, P209, DOI 10.1126/science.1217954; Nielsen MB, 1999, EUR J ORG CHEM, V1999, P2807; OKAMOTO H, 1991, PHYS REV B, V43, P8224, DOI 10.1103/PhysRevB.43.8224; Saha S, 2005, CHEM-EUR J, V11, P6846, DOI 10.1002/chem.200500371; Soos ZG, 2007, CHEM PHYS LETT, V440, P87, DOI 10.1016/j.cplett.2007.04.024; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; TOKURA Y, 1989, PHYS REV LETT, V63, P2405, DOI 10.1103/PhysRevLett.63.2405; TORRANCE JB, 1979, ACCOUNTS CHEM RES, V12, P79, DOI 10.1021/ar50135a001; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253; TORRANCE JB, 1981, PHYS REV LETT, V47, P1747, DOI 10.1103/PhysRevLett.47.1747; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	24	364	372	14	569	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					485	489		10.1038/nature11395	http://dx.doi.org/10.1038/nature11395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914165				2022-12-01	WOS:000307761600031
J	Singh, G; Kucukural, A; Cenik, C; Leszyk, JD; Shaffer, SA; Weng, ZP; Moore, MJ				Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.			The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus	CELL			English	Article							EXON JUNCTION COMPLEX; RNA-BINDING PROTEINS; MESSENGER-RNA; NONSENSE; DECAY; TRANSLATION; CORE; EIF4AIII; SURVEILLANCE; ARCHITECTURE	In addition to sculpting eukaryotic transcripts by removing introns, pre-mRNA splicing greatly impacts protein composition of the emerging mRNP. The exon junction complex (EJC), deposited upstream of exon-exon junctions after splicing, is a major constituent of spliced mRNPs. Here, we report comprehensive analysis of the endogenous human EJC protein and RNA interactomes. We confirm that the major "canonical" EJC occupancy site in vivo lies 24 nucleotides upstream of exon junctions and that the majority of exon junctions carry an EJC. Unexpectedly, we find that endogenous EJCs multimerize with one another and with numerous SR proteins to form megadalton sized complexes in which SR proteins are super-stoichiometric to EJC core factors. This tight physical association may explain known functional parallels between EJCs and SR proteins. Further, their protection of long mRNA stretches from nuclease digestion suggests that endogenous EJCs and SR proteins cooperate to promote mRNA packaging and compaction.	[Singh, Guramrit; Kucukural, Alper; Cenik, Can; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu	Kucukural, Alper/AAJ-7758-2020; Kucukural, Alper/T-3563-2018	Kucukural, Alper/0000-0001-9983-394X; Kucukural, Alper/0000-0001-9983-394X; Cenik, Can/0000-0001-6370-0889; Singh, Guramrit/0000-0002-5283-9540	HHMI; NIH [RO1-GM53007]; Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053007] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For valuable antibodies, we thank Elisa Izaurralde (alpha-Magoh), Jens Lykke-Andersen (alpha-Upf1, -Upf2, -Upf3, -Y14, and -eIF4AIII), Akila Mayeda (alpha-RNPS1), and John Blenis (alpha-SKAR). Frederick Roth and Hon Nian Chua generously provided a modified AlignACE algorithm. Ellie Kittler and the deep sequencing core are thanked for generating the deep sequencing data. We thank members of the Moore lab for discussions and critiques and Herve Le Hir for communicating results prior to publication. This work was supported by funding from HHMI and NIH RO1-GM53007 (to M.J.M.). G. S. was partially supported by the Charles A. King trust postdoctoral fellowship program. M.J.M. is an HHMI Investigator. G. S. and M.J.M. originally conceived the project, and G. S. executed all wet bench experiments. A. K. implemented all computational analyses with input from C. C. and Z.W. on computational method design and statistical analysis. J.D.L and S. A. S. performed mass spec. All authors contributed to data analysis and interpretation. With input from all authors, G. S. and M.J.M. were primarily responsible for writing the paper.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barbosa I, 2012, NAT STRUCT MOL BIOL, V19, P983, DOI 10.1038/nsmb.2380; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Bjork P, 2009, J CELL BIOL, V184, P555, DOI 10.1083/jcb.200806156; Bono F, 2011, RNA BIOL, V8, P24, DOI 10.4161/rna.8.1.13618; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Michelle L, 2012, MOL CELL BIOL, V32, P954, DOI 10.1128/MCB.06130-11; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mishler DM, 2008, RNA, V14, P2657, DOI 10.1261/rna.1312808; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sauliere J, 2010, NAT STRUCT MOL BIOL, V17, P1269, DOI 10.1038/nsmb.1890; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; SKOGLUND U, 1983, CELL, V34, P847, DOI 10.1016/0092-8674(83)90542-1; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Stroupe ME, 2006, J MOL BIOL, V360, P743, DOI 10.1016/j.jmb.2006.05.049; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	54	223	225	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					750	764		10.1016/j.cell.2012.10.007	http://dx.doi.org/10.1016/j.cell.2012.10.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23084401	Green Accepted, Bronze			2022-12-01	WOS:000310921200008
J	Southwell, DG; Paredes, MF; Galvao, RP; Jones, DL; Froemke, RC; Sebe, JY; Alfaro-Cervello, C; Tang, YS; Garcia-Verdugo, JM; Rubenstein, JL; Baraban, SC; Alvarez-Buylla, A				Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Froemke, Robert C.; Sebe, Joy Y.; Alfaro-Cervello, Clara; Tang, Yunshuo; Garcia-Verdugo, Jose M.; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo			Intrinsically determined cell death of developing cortical interneurons	NATURE			English	Article							FLUORESCENT PROTEIN EXPRESSION; GABAERGIC NEURONS; NERVOUS-SYSTEM; ES CELLS; MICE; ADULT; BRAIN; TRKC; NEUROGENESIS; RECEPTORS	Cortical inhibitory circuits are formed by gamma-aminobutyric acid (GABA)-secreting interneurons, a cell population that originates far from the cerebral cortex in the embryonic ventral forebrain. Given their distant developmental origins, it is intriguing how the number of cortical interneurons is ultimately determined. One possibility, suggested by the neurotrophic hypothesis(1-5), is that cortical interneurons are overproduced, and then after their migration into cortex the excess interneurons are eliminated through a competition for extrinsically derived trophic signals. Here we characterize the developmental cell death of mouse cortical interneurons in vivo, in vitro and after transplantation. We found that 40% of developing cortical interneurons were eliminated through Bax (Bcl-2-associated X)-dependent apoptosis during postnatal life. When cultured in vitro or transplanted into the cortex, interneuron precursors died at a cellular age similar to that at which endogenous interneurons died during normal development. Over transplant sizes that varied 200-fold, a constant fraction of the transplanted population underwent cell death. The death of transplanted neurons was not affected by the cell-autonomous disruption of TrkB (tropomyosin kinase receptor B), the main neurotrophin receptor expressed by neurons of the central nervous system(6-8). Transplantation expanded the cortical interneuron population by up to 35%, but the frequency of inhibitory synaptic events did not scale with the number of transplanted interneurons. Taken together, our findings indicate that interneuron cell death is determined intrinsically, either cell-autonomously or through a population-autonomous competition for survival signals derived from other interneurons.	[Southwell, Derek G.; Jones, Daniel L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Southwell, Derek G.; Tang, Yunshuo] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Paredes, Mercedes F.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, Dept Otolaryngol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Alfaro-Cervello, Clara; Garcia-Verdugo, Jose M.] Univ Valencia, CIBERNED, Inst Cavanilles, Valencia 46071, Spain; [Tang, Yunshuo] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; University of Valencia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Southwell, DG (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	dereksouthwell@gmail.com; abuylla@stemcell.ucsf.edu	Alfaro-Cervello, Clara/D-1900-2015; Galvão, Rogério/AAD-9875-2019; García-Verdugo, José Manuel/L-8421-2017	Galvão, Rogério/0000-0002-0819-7114; García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Froemke, Robert/0000-0002-1230-6811; Southwell, Derek/0000-0001-6465-3869; Baraban, Scott/0000-0003-1975-9781; Alfaro-Cervello, Clara/0000-0002-3737-4028	California Institute for Regenerative Medicine [TR2-01749]; National Institute of Neurologic Disorders and Stroke [F32NS061497]; John G. Bowes Research Fund; Spanish Ministry of Science and Innovation [SAF-2008-01274]; National Institutes of Health [R01 NS071785, R01 NS048528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071785, F32NS061497, R01NS048528] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John G. Bowes Research Fund; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Yanagawa for GAD67-GFP mice, L. Reichardt for TrkB mutant mice and R. Romero for technical contributions. D. G. S. and M. F. P. were supported by training grants from the California Institute for Regenerative Medicine. J.Y.S. was supported by a fellowship from the National Institute of Neurologic Disorders and Stroke (F32NS061497). This work was supported by the California Institute for Regenerative Medicine (A.A.-B., TR2-01749), the John G. Bowes Research Fund (A.A.-B.), the Spanish Ministry of Science and Innovation (J.M.G-V., SAF-2008-01274), and the National Institutes of Health (J. L. R., S. C. B. and A.A.-B., R01 NS071785; A.A.-B., R01 NS048528).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Boya Patricia, 2005, Birth Defects Research, V75, P281, DOI 10.1002/bdrc.20054; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Polleux F, 2002, DEVELOPMENT, V129, P3147; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	24	204	206	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					109	U172		10.1038/nature11523	http://dx.doi.org/10.1038/nature11523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041929	Green Submitted, Green Accepted			2022-12-01	WOS:000310434500040
J	Brayne, C; Davis, D				Brayne, Carol; Davis, Daniel			Making Alzheimer's and dementia research fit for populations	LANCET			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; DISEASE; PREVALENCE; DIAGNOSIS; CRITERIA		[Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Robinson Way, Cambridge CB2 0SR, England.	cb105@medschl.cam.ac.uk	Davis, Daniel/F-9995-2012; Brayne, Carol/AAA-4285-2020	Davis, Daniel/0000-0002-1560-1955; Brayne, Carol/0000-0001-5307-663X	Wellcome Trust [090661] Funding Source: Medline; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Ablin R, 2010, NY TIMES; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; BRAYNE C, 1993, PSYCHOL MED, V23, P287, DOI 10.1017/S003329170002835X; BRAYNE C, 1993, BRIT J PSYCHIAT, V162, P439, DOI 10.1192/bjp.162.4.439; BRAYNE C, 1988, LANCET, V2, P514, DOI 10.1016/S0140-6736(88)90166-3; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Muniz-Terrera G, 2011, INT J GERIATR PSYCH, V26, P584, DOI 10.1002/gps.2566; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Yip AG, 2006, AGE AGEING, V35, P154, DOI 10.1093/ageing/afj030; Zimmern RL, 2009, CLIN MED, V9, P68, DOI 10.7861/clinmedicine.9-1-68	22	68	68	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1441	1443		10.1016/S0140-6736(12)61803-0	http://dx.doi.org/10.1016/S0140-6736(12)61803-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084456	Green Accepted			2022-12-01	WOS:000310196500034
J	Arie, S				Arie, Sophie			Ending the French love affair with drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						Benkimoun P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6882; Debre B, 2012, GUIDE 4000 MED UTILE; OECD, 2012, HLTH KEY TABL PHARM; OECD, 2011, HLTH GLANC 2011 PHAR	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 17	2012	345								e6996	10.1136/bmj.e6996	http://dx.doi.org/10.1136/bmj.e6996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077372				2022-12-01	WOS:000310141900016
J	Hinrichs, KU; Inagaki, F				Hinrichs, Kai-Uwe; Inagaki, Fumio			Downsizing the Deep Biosphere	SCIENCE			English	Editorial Material							SUBSURFACE SEDIMENTS		[Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Hinrichs, Kai-Uwe] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Kochi 7838502, Japan	University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hinrichs, KU (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	khinrichs@uni-bremen.de; inagaki@jamstec.go.jp	Hinrichs, Kai-Uwe/C-7675-2009; Inagaki, Fumio/AAI-1156-2019	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Inagaki, Fumio/0000-0003-2887-6525				D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Hoehler TM, 2004, GEOBIOLOGY, V2, P205, DOI 10.1111/j.1472-4677.2004.00033.x; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Kallmeyer J, 2008, LIMNOL OCEANOGR-METH, V6, P236, DOI 10.4319/lom.2008.6.236; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lipp JS, 2009, GEOCHIM COSMOCHIM AC, V73, P6816, DOI 10.1016/j.gca.2009.08.003; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Rebata-Landa V, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001355; Schouten S, 2010, GEOCHIM COSMOCHIM AC, V74, P3806, DOI 10.1016/j.gca.2010.03.029; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	12	28	29	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					204	205		10.1126/science.1229296	http://dx.doi.org/10.1126/science.1229296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066067				2022-12-01	WOS:000309712300028
J	Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Complex brain and optic lobes in an early Cambrian arthropod	NATURE			English	Article							GROUND PATTERN; NERVOUS-SYSTEM; SISTER GROUP; EVOLUTION; CRUSTACEAN; INSECTS; HEAD; VIEW; ORGANIZATION; FUXIANHUIA	The nervous system provides a fundamental source of data for understanding the evolutionary relationships between major arthropod groups(1,2). Fossil arthropods rarely preserve neural tissue. As a result, inferring sensory and motor attributes of Cambrian taxa has been limited to interpreting external features, such as compound eyes(3) or sensilla decorating appendages(4), and early-diverging arthropods have scarcely been analysed in the context of nervous system evolution. Here we report exceptional preservation of the brain and optic lobes of a stem-group arthropod from 520 million years ago (Myr ago), Fuxianhuia protensa(5), exhibiting the most compelling neuroanatomy known from the Cambrian. The protocerebrum of Fuxianhuia is supplied by optic lobes evidencing traces of three nested optic centres serving forward-viewing eyes. Nerves from uniramous antennae define the deutocerebrum, and a stout pair of more caudal nerves indicates a contiguous tritocerebral component. Fuxianhuia shares a tripartite pre-stomodeal brain and nested optic neuropils with extant Malacostraca and Insecta(2,6), demonstrating that these characters were present in some of the earliest derived arthropods. The brain of Fuxianhuia impacts molecular analyses that advocate either a branchiopod-like ancestor of Hexapoda(7,8) or remipedes and possibly cephalocarids as sister groups of Hexapoda(9,10). Resolving arguments about whether the simple brain of a branchiopod approximates an ancestral insect brain or whether it is the result of secondary simplification has until now been hindered by lack of fossil evidence. The complex brain of Fuxianhuia accords with cladistic analyses on the basis of neural characters, suggesting that Branchiopoda derive from a malacostracan-like ancestor but underwent evolutionary reduction and character reversal of brain centres that are common to hexapods and malacostracans(2). The early origin of sophisticated brains provides a probable driver for versatile visual behaviours, a view that accords with compound eyes from the early Cambrian that were, in size and resolution, equal to those of modern insects and malacostracans(3).	[Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Ma, XY (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	x.ma@nhm.ac.uk	Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [40730211]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona	This account is dedicated to J. Bergstrom, who was first in suggesting a brain in YKLP 15006. The present work was supported by the National Natural Science Foundation of China (40730211), a Leverhulme Trust Research Project Grant (F/00 696/T), and the Center for Insect Science, University of Arizona. We thank A. Ball and J. Spratt for their assistance with scanning electron microscopy imagery and energy-dispersive X-ray spectroscopy, respectively.	Andrew DR, 2012, J COMP NEUROL, V520, P3446, DOI 10.1002/cne.23099; Bergstrom J, 2008, GFF, V130, P189; Boyan G. S., 2006, EVOLUTION NERVOUS SY, P249; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; ELOFSSON R, 1970, Z ZELLFORSCH MIK ANA, V107, P343, DOI 10.1007/BF00336672; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Hanstr_om B., 1926, K SVEN VETENSKAPSAKA, V4, P1; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2004, LETHAIA, V37, P235, DOI 10.1080/00241160410006555; Kirsch R, 2007, ARTHROPOD STRUCT DEV, V36, P143, DOI 10.1016/j.asd.2006.08.013; Land M.F., 1989, P90; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Sandeman D. C., 1995, NERVOUS SYSTEMS INVE, P329; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Sombke A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-1; Stegner MEJ, 2011, ARTHROPOD STRUCT DEV, V40, P221, DOI 10.1016/j.asd.2011.04.001; Strausfeld Nicholas J., 2011, Palaeontographica Canadiana, V31, P157; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; Strausfeld NJ, 2012, ARTHROPOD BRAINS EVO; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wolff G, 2012, J COMP NEUROL, V520, P2824, DOI 10.1002/cne.23059	30	137	141	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					258	+		10.1038/nature11495	http://dx.doi.org/10.1038/nature11495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060195				2022-12-01	WOS:000309733300049
J	Erickson, GM; Krick, BA; Hamilton, M; Bourne, GR; Norell, MA; Lilleodden, E; Sawyer, WG				Erickson, Gregory M.; Krick, Brandon A.; Hamilton, Matthew; Bourne, Gerald R.; Norell, Mark A.; Lilleodden, Erica; Sawyer, W. Gregory			Complex Dental Structure and Wear Biomechanics in Hadrosaurid Dinosaurs	SCIENCE			English	Article							CONTACT; SURFACE	Mammalian grinding dentitions are composed of four major tissues that wear differentially, creating coarse surfaces for pulverizing tough plants and liberating nutrients. Although such dentition evolved repeatedly in mammals (such as horses, bison, and elephants), a similar innovation occurred much earlier (similar to 85 million years ago) within the duck-billed dinosaur group Hadrosauridae, fueling their 35-million-year occupation of Laurasian megaherbivorous niches. How this complexity was achieved is unknown, as reptilian teeth are generally two-tissue structures presumably lacking biomechanical attributes for grinding. Here we show that hadrosaurids broke from the primitive reptilian archetype and evolved a six-tissue dental composition that is among the most sophisticated known. Three-dimensional wear models incorporating fossilized wear properties reveal how these tissues interacted for grinding and ecological specialization.	[Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Krick, Brandon A.; Hamilton, Matthew; Sawyer, W. Gregory] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Bourne, Gerald R.] Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lilleodden, Erica] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany	State University System of Florida; Florida State University; State University System of Florida; University of Florida; Colorado School of Mines; American Museum of Natural History (AMNH); Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Bourne, Gerald/B-7219-2008; Sawyer, W Gregory/A-7983-2008	Bourne, Gerald/0000-0001-6977-2138; Sawyer, W Gregory/0000-0002-4461-7227; Lilleodden, Erica/0000-0002-4014-0986; Krick, Brandon/0000-0003-3191-5433	NSF [EAR 0959029]; Directorate For Geosciences [1226730] Funding Source: National Science Foundation; Division Of Earth Sciences [1226704] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank W. Nix, A. Prieto-Marquez, P. Lee, P. Druckenmiller, C. Taylor, and E. McCumiskey for their assistance and NSF (grant EAR 0959029 to G.M.E. and M.A.N.) for research funding. Data described in the paper are archived by the Computer Support Group of the Department of Biological Science at Florida State University as databases S1 to S19.	ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448; ARCHARD JF, 1956, PROC R SOC LON SER-A, V236, P397, DOI 10.1098/rspa.1956.0144; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Currey JD, 2003, ARCH ORAL BIOL, V48, P439, DOI 10.1016/S0003-9969(03)00037-2; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Evans DC, 2005, LIFE O PAST, P349; Hillson S., 1986, TEETH; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Johnson WM, 2007, J MATER SCI-MATER M, V18, P591, DOI 10.1007/s10856-007-2306-4; KHRUSCHOV MM, 1974, WEAR, V28, P69, DOI 10.1016/0043-1648(74)90102-1; Leidy J., 1865, SMITHSONIAN CONTRIBU, V14, P1; Lucas P.W., 2004, DENT FUNCTIONAL MORP; Lull R.S., 1942, SPEC PAP GEOL SOC AM, V40; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P1; Peyer B, 1968, COMP ODONTOLOGY; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; Sawyer WG, 2004, TRIBOL LETT, V17, P139, DOI 10.1023/B:TRIL.0000032438.56992.be; Schmidt W.J., 1971, POLARIZING MICROSCOP; Schwenk K., 2000, FEEDING FUNCTION EVO; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106	24	85	85	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					98	101		10.1126/science.1224495	http://dx.doi.org/10.1126/science.1224495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042891	Green Submitted			2022-12-01	WOS:000309457400061
J	Koo, JW; Mazei-Robison, MS; Chaudhury, D; Juarez, B; LaPlant, Q; Ferguson, D; Feng, J; Sun, HS; Scobie, KN; Damez-Werno, D; Crumiller, M; Ohnishi, YN; Ohnishi, YH; Mouzon, E; Dietz, DM; Lobo, MK; Neve, RL; Russo, SJ; Han, MH; Nestler, EJ				Koo, Ja Wook; Mazei-Robison, Michelle S.; Chaudhury, Dipesh; Juarez, Barbara; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Ohnishi, Yoshinori N.; Ohnishi, Yoko H.; Mouzon, Ezekiell; Dietz, David M.; Lobo, Mary Kay; Neve, Rachael L.; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.			BDNF Is a Negative Modulator of Morphine Action	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; NEUROTROPHIC FACTOR; COCAINE REWARD; BEHAVIORAL-RESPONSES; GENE-EXPRESSION; DELTA-FOSB; NEURONS; BRAIN	Brain-derived neurotrophic factor (BDNF) is a key positive regulator of neural plasticity, promoting, for example, the actions of stimulant drugs of abuse such as cocaine. We discovered a surprising opposite role for BDNF in countering responses to chronic morphine exposure. The suppression of BDNF in the ventral tegmental area (VTA) enhanced the ability of morphine to increase dopamine (DA) neuron excitability and promote reward. In contrast, optical stimulation of VTA DA terminals in nucleus accumbens (NAc) completely reversed the suppressive effect of BDNF on morphine reward. Furthermore, we identified numerous genes in the NAc, a major target region of VTA DA neurons, whose regulation by BDNF in the context of chronic morphine exposure mediated this counteractive function. These findings provide insight into the molecular basis of morphine-induced neuroadaptations in the brain's reward circuitry.	[Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Chaudhury, Dipesh; Juarez, Barbara; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Ohnishi, Yoshinori N.] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 8300011, Japan; [Ohnishi, Yoko H.] Kyushu Univ, Dept Med Biophys & Radiat Biol, Higashi Ku, Fukuoka 8128582, Japan; [Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Lobo, Mary Kay] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Kurume University; Kyushu University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Maryland; University of Maryland Baltimore; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	Eric.Nestler@mssm.edu	Han, Ming-Hu/G-8836-2012; Mazei-Robison, Michelle/I-4304-2017; Russo, Scott/R-7107-2019; Dietz, David/AAW-4574-2021; Lobo, Mary Kay/K-7734-2015; Dietz, David/J-9458-2015	Mazei-Robison, Michelle/0000-0002-2372-1420; Russo, Scott/0000-0002-6470-1805; Dietz, David/0000-0002-6927-9236; Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Juarez, Barbara/0000-0001-7897-8031; Sun, Haosheng/0000-0003-3919-559X; Ferguson, Deveroux/0000-0001-9302-5992	National Institute on Drug Abuse; Dutch Scientific Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH094405, T32MH087004, R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. E. Burger-Caplan and N. Mensah for excellent technical assistance. This work was supported by grants from the National Institute on Drug Abuse (E.J.N. and M.S.M.-R.) and a Rubicon Grant from the Dutch Scientific Organization (C.S.L.).	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Boye SM, 2001, NEUROPHARMACOLOGY, V40, P792, DOI 10.1016/S0028-3908(01)00003-X; Chu NN, 2008, ADDICT BIOL, V13, P47, DOI 10.1111/j.1369-1600.2007.00092.x; Desai NS, 1999, LEARN MEMORY, V6, P284; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; KADDIS FG, 1995, BRAIN RES, V697, P76, DOI 10.1016/0006-8993(95)00786-P; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Numan S, 1998, J NEUROSCI, V18, P10700; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267	40	128	139	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					124	128		10.1126/science.1222265	http://dx.doi.org/10.1126/science.1222265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042896	Green Accepted			2022-12-01	WOS:000309457400068
J	Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ; Sigwart, JD				Sutton, Mark D.; Briggs, Derek E. G.; Siveter, David J.; Siveter, Derek J.; Sigwart, Julia D.			A Silurian armoured aplacophoran and implications for molluscan phylogeny	NATURE			English	Article							INVERTEBRATE EVOLUTION; VERMIFORM MOLLUSK; ACAENOPLAX; POLYCHAETE; FOSSILS; ORIGIN; CHITON	The Mollusca is one of the most diverse, important and well-studied invertebrate phyla; however, relationships among major molluscan taxa have long been a subject of controversy(1-9). In particular, the position of the shell-less vermiform Aplacophora and its relationship to the better-known Polyplacophora (chitons) have been problematic: Aplacophora has been treated as a paraphyletic or monophyletic group at the base of the Mollusca(3,6,8), proximate to other derived clades such as Cephalopoda(2,3,10), or as sister group to the Polyplacophora, forming the clade Aculifera(1,5,7,11,12). Resolution of this debate is required to allow the evolutionary origins of Mollusca to be reconstructed with confidence. Recent fossil finds(13-16) support the Aculifera hypothesis, demonstrating that the Palaeozoic-era palaeoloricate 'chitons' included taxa combining certain polyplacophoran and aplacophoran characteristics(5). However, fossils combining an unambiguously aplacophoran-like body with chiton-like valves have remained elusive. Here we describe such a fossil, Kulindroplax perissokomos gen. et sp. nov., from the Herefordshire Lagerstatte(17,18) (about 425 million years BP), a Silurian deposit preserving a marine biota(18) in unusual three-dimensional detail. The specimen is reconstructed three-dimensionally through physical-optical tomography(19). Phylogenetic analysis indicates that this and many other palaeoloricate chitons are crown-group aplacophorans.	[Sutton, Mark D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Siveter, Derek J.] Univ Museum Nat Hist, Oxford OX1 3PW, England; [Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Marine Lab, Portaferry BT22 1PF, North Ireland	Imperial College London; Yale University; Yale University; University of Leicester; University of Oxford; University of Oxford; Queens University Belfast	Sutton, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England.	m.sutton@imperial.ac.uk	Sigwart, Julia D/J-2928-2014	Sigwart, Julia D/0000-0002-3005-6246	Natural Environmental Research Council (NERC) [NE/F018037/1]; NERC [NE/F018037/1, NE/F01693X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F018037/1, NE/F01693X/1] Funding Source: researchfish	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environmental Research Council (NERC Grant NE/F018037/1) supported this research. K. Saunders, K. Davies, C. Dean, D. Legg and C. Lewis provided technical assistance, and the staff of Tarmac Western and the late R. Fenn facilitated the fieldwork.	Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Briggs DEG, 2008, AM SCI, V96, P474, DOI 10.1511/2008.75.474; Cherns L, 1998, PALAEONTOLOGY, V41, P545; Donovan SK, 2010, GEOLOGY, V38, P935, DOI 10.1130/G31296.1; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; McAlester A. L., 1965, Palaeontology, V8, P231; Meyer A, 2011, METHODS ECOL EVOL, V2, P34, DOI 10.1111/j.2041-210X.2010.00052.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Salvini-Plawen Luitfried v., 1996, P29; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Steiner G, 2001, NATURE, V414, P601, DOI 10.1038/414601a; Sutton M, 2001, NATURE, V414, P602, DOI 10.1038/414602a; Sutton M. D., 2012, PALAEONTOLOGIA ELECT, V15, p5T; Sutton MD, 2008, P ROY SOC B-BIOL SCI, V275, P1587, DOI 10.1098/rspb.2008.0263; Sutton MD, 2012, PALAEONTOLOGY, V55, P401, DOI 10.1111/j.1475-4983.2011.01126.x; Sutton MD, 2004, PALAEONTOLOGY, V47, P293, DOI 10.1111/j.0031-0239.2004.00374.x; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; Telford MJ, 2011, CURR BIOL, V21, pR964, DOI 10.1016/j.cub.2011.10.029; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2012, P ROY SOC B-BIOL SCI, V279, P1259, DOI 10.1098/rspb.2011.1773; von Salvini-Plawen Luitfried, 2003, Iberus, V21, P67; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028	29	53	54	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					94	97		10.1038/nature11328	http://dx.doi.org/10.1038/nature11328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038472				2022-12-01	WOS:000309446800039
J	Baker, CR; Booth, LN; Sorrells, TR; Johnson, AD				Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.			Protein Modularity, Cooperative Binding, and Hybrid Regulatory States Underlie Transcriptional Network Diversification	CELL			English	Article							HOMEO DOMAIN PROTEIN; CELL-TYPE; SACCHAROMYCES-CEREVISIAE; REPRESSOR ALPHA-2; YEAST ALPHA-2; EVOLUTION; HOMEODOMAIN; CIRCUIT; LOCUS; GENE	We examine how different transcriptional network structures can evolve from an ancestral network. By characterizing how the ancestral mode of gene regulation for genes specific to a-type cells in yeast species evolved from an activating paradigm to a repressing one, we show that regulatory protein modularity, conversion of one cis-regulatory sequence to another, distribution of binding energy among protein-protein and protein-DNA interactions, and exploitation of ancestral network features all contribute to the evolution of a novel regulatory mode. The formation of this derived mode of regulation did not disrupt the ancestral mode and thereby created a hybrid regulatory state where both means of transcription regulation (ancestral and derived) contribute to the conserved expression pattern of the network. Finally, we show how this hybrid regulatory state has resolved in different ways in different lineages to generate the diversity of regulatory network structures observed in modern species.	[Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA; [Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94102 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA.	ajohnson@cgl.ucsf.edu		Sorrells, Trevor/0000-0002-3527-8622	National Institute of Health [RO1 GM057049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM057049] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Chiraj Dalal, Clarissa Nobile, and Brian Tuch for critically reading the manuscript and Jennifer Garcia, Victor Hanson-Smith, Oliver Homann, Quinn Mitrovich, and Brian Tuch for their generous and helpful advice concerning experimental and computational procedures. We thank Peter Philippsen for kindly sharing genomic DNA and sequences from Ashbya gossypii. This work was supported by RO1 GM057049 from the National Institute of Health. The authors declare no conflict of interest. C.R.B. performed reporter assays and the Mcm1 ancestral gene reconstruction. L.N.B. performed experiments in L. kluyveri and K. wickerhamii. L.N.B. and T.R.S. performed K. lactis experiments. Data were analyzed and computation experiments performed by C.R.B., L.N.B., and T.R.S. All authors contributed to the design of the study and wrote the article.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MADHANI HD, 2007, A ALPHA YEAST MODEL; MAK A, 1993, GENE DEV, V7, P1862, DOI 10.1101/gad.7.10.1862; Mead J, 1996, MOL CELL BIOL, V16, P2135; SMITH DL, 1994, EMBO J, V13, P2378, DOI 10.1002/j.1460-2075.1994.tb06521.x; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; Wohlbach DJ, 2009, CURR OPIN GENET DEV, V19, P571, DOI 10.1016/j.gde.2009.09.007; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	38	70	70	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					80	95		10.1016/j.cell.2012.08.018	http://dx.doi.org/10.1016/j.cell.2012.08.018			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021217	Green Accepted, Bronze			2022-12-01	WOS:000309544200012
J	Ward, LD; Kellis, M				Ward, Lucas D.; Kellis, Manolis			Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions	SCIENCE			English	Article							HUMAN GENOME; NONCODING SEQUENCES; ELEMENTS; EVOLUTION; INNOVATION; DYNAMICS; REVEALS; PROJECT; GENES; MAP	Although only 5% of the human genome is conserved across mammals, a substantially larger portion is biochemically active, raising the question of whether the additional elements evolve neutrally or confer a lineage-specific fitness advantage. To address this question, we integrate human variation information from the 1000 Genomes Project and activity data from the ENCODE Project. A broad range of transcribed and regulatory nonconserved elements show decreased human diversity, suggesting lineage-specific purifying selection. Conversely, conserved elements lacking activity show increased human diversity, suggesting that some recently became nonfunctional. Regulatory elements under human constraint in nonconserved regions were found near color vision and nerve-growth genes, consistent with purifying selection for recently evolved functions. Our results suggest continued turnover in regulatory regions, with at least an additional 4% of the human genome subject to lineage-specific constraint.	[Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Ward, Lucas/0000-0002-8017-809X	NIH [R01HG004037, RC1HG005334]; NSF CAREER [0644282]; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, RC1HG005334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the ENCODE Project Consortium data producers and the ENCODE Data Analysis Center for coordinating access and performing quality control and peak-calling analysis; the Analysis Working Group of the ENCODE Project Consortium for feedback throughout this project, especially E. Birney, I. Dunham, M. Gerstein, R. Hardison, J. Stamatoyannopoulos, J. Herrero, S. Parker, P. Sabeti, S. Sunyaev, R. Altshuler, P. Kheradpour, and J. Ernst; and other members of the Kellis laboratory for discussions. L. D. W. and M. K. were funded by NIH grants R01HG004037 and RC1HG005334 and NSF CAREER grant 0644282. Data from the ENCODE consortium are available from the UCSC Genome Browser at http://genome.ucsc.edu/ENCODE, and data from the 1000 Genomes Project is available at www.1000genomes.org/data. ENCODE annotations, mammalian constraint, human diversity, background selection, and filtering information for every SNP and every human nucleotide are available at http://compbio.mit.edu/human-constraint. L. D. W. and M. K. designed the study, analyzed data, and wrote the paper.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jacobs GH, 2012, ADV EXP MED BIOL, V739, P156, DOI 10.1007/978-1-4614-1704-0_10; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lomelin D, 2010, GENOME RES, V20, P311, DOI 10.1101/gr.094151.109; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592	29	136	140	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1675	1678		10.1126/science.1225057	http://dx.doi.org/10.1126/science.1225057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22956687	Green Accepted, Green Submitted			2022-12-01	WOS:000309215400051
J	de Gage, SB; Begaud, B; Bazin, F; Verdoux, H; Dartigues, JF; Peres, K; Kurth, T; Pariente, A				de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine			Benzodiazepine use and risk of dementia: prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NESTED CASE-CONTROL; MINI-MENTAL-STATE; COGNITIVE DECLINE; ALZHEIMER-DISEASE; ELDERLY-PEOPLE; PSYCHOTROPIC MEDICATION; HUMAN-MEMORY; COMMUNITY; EPIDEMIOLOGY; IMPAIRMENT	Objective To evaluate the association between use of benzodiazepines and incident dementia. Design Prospective, population based study. Setting PAQUID study, France. Participants 1063 men and women (mean age 78.2 years) who were free of dementia and did not start taking benzodiazepines until at least the third year of follow-up. Main outcome measures Incident dementia, confirmed by a neurologist. Results During a 15 year follow-up, 253 incident cases of dementia were confirmed. New use of benzodiazepines was associated with an increased risk of dementia (multivariable adjusted hazard ratio 1.60, 95% confidence interval 1.08 to 2.38). Sensitivity analysis considering the existence of depressive symptoms showed a similar association (hazard ratio 1.62, 1.08 to 2.43). A secondary analysis pooled cohorts of participants who started benzodiazepines during follow-up and evaluated the association with incident dementia. The pooled hazard ratio across the five cohorts of new benzodiazepine users was 1.46 (1.10 to 1.94). Results of a complementary nested case-control study showed that ever use of benzodiazepines was associated with an approximately 50% increase in the risk of dementia (adjusted odds ratio 1.55, 1.24 to 1.95) compared with never users. The results were similar in past users (odds ratio 1.56, 1.23 to 1.98) and recent users (1.48, 0.83 to 2.63) but reached significance only for past users. Conclusions In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzodiazepines throughout the study and in a complementary case-control study. Considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects of this drug class in the general population, indiscriminate widespread use should be cautioned against.	[de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine] Univ Bordeaux Segalen, F-33000 Bordeaux, France; [de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Pariente, Antoine] INSERM, U657, F-33000 Bordeaux, France; [Begaud, Bernard; Dartigues, Jean-Francois; Pariente, Antoine] CHU Bordeaux, F-33000 Bordeaux, France; [Verdoux, Helene] Ctr Hosp Charles Perrens, F-33000 Bordeaux, France; [Dartigues, Jean-Francois; Peres, Karine] INSERM, U897, F-33000 Bordeaux, France; [Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, F-33000 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Gage, SB (corresponding author), Univ Bordeaux Segalen, INSERM, U657, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	sophie.billiotidegage@u-bordeaux2.fr; bernard.begaud@u-bordeaux2.fr	Kurth, Tobias/A-9243-2012; DARTIGUES, Jean François/T-4513-2019; Pariente, Antoine/S-9231-2019; PERES, Karine/T-4128-2019; Verdoux, Helene/T-1996-2019	Kurth, Tobias/0000-0001-7169-2620; Pariente, Antoine/0000-0002-7873-5483; PERES, Karine/0000-0002-0720-0684; Verdoux, Helene/0000-0003-2948-3782	INSERM (Institut National de la Sante et de la Recherche Medicale); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	This research was conducted by the INSERM U657 research team co-funded by INSERM (Institut National de la Sante et de la Recherche Medicale) and Universite Bordeaux Segalen. Additional support was provided by a 2010 grant from IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); by a 2011 grant from the French Ministry of Health (Direction Generale de la Sante); and by Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie, and Institut National de Prevention et d'Education pour la Sante.	Allard J, 2003, INT J GERIATR PSYCH, V18, P874, DOI 10.1002/gps.891; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BENTON AL, 1972, J PSYCHOL, V80, P189, DOI 10.1080/00223980.1972.9924794; Boeuf-Cazou O, 2011, EUR J CLIN PHARMACOL, V67, P1045, DOI 10.1007/s00228-011-1047-y; Briot M, 2006, BON USAGE MEDICAMENT; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; CURRAN HV, 1986, BIOL PSYCHOL, V23, P179, DOI 10.1016/0301-0511(86)90081-5; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; Dealberto MJ, 1997, INT J GERIATR PSYCH, V12, P567, DOI 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V; Dell'osso B, 2012, EUR PSYCHIAT; Egan M, 2000, J AM GERIATR SOC, V48, P811, DOI 10.1111/j.1532-5415.2000.tb04758.x; European Medicines Agency, 2012, SUMM PROD CHAR BENZ; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hanlon JT, 1998, CLIN PHARMACOL THER, V64, P684, DOI 10.1016/S0009-9236(98)90059-5; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hogan David B, 2003, Can J Clin Pharmacol, V10, P72; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Jorm AF, 2000, AUST NZ J PUBL HEAL, V24, P7, DOI 10.1111/j.1467-842X.2000.tb00715.x; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lagnaoui R, 2009, AGE AGEING, V38, P226, DOI 10.1093/ageing/afn277; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Pariente A, 2008, DRUG AGING, V25, P61, DOI 10.2165/00002512-200825010-00007; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sonnenberg CM, 2012, SOC PSYCH PSYCH EPID, V47, P293, DOI 10.1007/s00127-011-0344-1; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Verdoux H, 2005, PSYCHOL MED, V35, P307, DOI 10.1017/S0033291704003897; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Windle A, 2007, AUST NZ J PUBL HEAL, V31, P379, DOI 10.1111/j.1753-6405.2007.00091.x; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	50	178	184	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2012	345								e6231	10.1136/bmj.e6231	http://dx.doi.org/10.1136/bmj.e6231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23045258	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000309386700007
J	Babu, MM; Kriwacki, RW; Pappu, RV				Babu, M. Madan; Kriwacki, Richard W.; Pappu, Rohit V.			Versatility from Protein Disorder	SCIENCE			English	Editorial Material							INTRINSICALLY UNSTRUCTURED PROTEINS; RECOGNITION; CHARGE; MOTIFS		[Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	MRC Laboratory Molecular Biology; St Jude Children's Research Hospital; Washington University (WUSTL)	Babu, MM (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	madanm@mrc-lmb.cam.ac.uk; richard.kriwacki@stjude.org; pappu@wustl.edu	Kriwacki, Richard/N-8154-2018; Mohan, Babu P./I-7362-2019	Kriwacki, Richard/0000-0002-9798-6018; 	Div Of Molecular and Cellular Bioscience [1121867] Funding Source: National Science Foundation; MRC [MC_U105185859] Funding Source: UKRI; Medical Research Council [MC_U105185859] Funding Source: Medline	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Mitrea D. M., 2012, PAC S BIOCOMPUT, V17, P152; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Pajkos M, 2012, MOL BIOSYST, V8, P296, DOI 10.1039/c1mb05246b; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747	16	157	158	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1460	1461		10.1126/science.1228775	http://dx.doi.org/10.1126/science.1228775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997313				2022-12-01	WOS:000308912900027
J	Cordero, OX; Wildschutte, H; Kirkup, B; Proehl, S; Ngo, L; Hussain, F; Le Roux, F; Mincer, T; Polz, MF				Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Le Roux, Frederique; Mincer, Tracy; Polz, Martin F.			Ecological Populations of Bacteria Act as Socially Cohesive Units of Antibiotic Production and Resistance	SCIENCE			English	Article							ANTAGONISTIC INTERACTIONS; MARINE; DIFFERENTIATION; DIVERSITY	In animals and plants, social structure can reduce conflict within populations and bias aggression toward competing populations; however, for bacteria in the wild it remains unknown whether such population-level organization exists. Here, we show that environmental bacteria are organized into socially cohesive units in which antagonism occurs between rather than within ecologically defined populations. By screening approximately 35,000 possible mutual interactions among Vibrionaceae isolates from the ocean, we show that genotypic clusters known to have cohesive habitat association also act as units in terms of antibiotic production and resistance. Genetic analyses show that within populations, broad-range antibiotics are produced by few genotypes, whereas all others are resistant, suggesting cooperation between conspecifics. Natural antibiotics may thus mediate competition between populations rather than solely increase the success of individuals.	[Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Polz, Martin F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Le Roux, Frederique] IFREMER, Lab Genet & Pathol BP 133, F-17390 La Tremblade, France; [Mincer, Tracy] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Ifremer; Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Kirkup, Benjamin/C-3610-2009; Polz, Martin/ABE-7199-2020	Kirkup, Benjamin/0000-0002-8722-6218; Polz, Martin/0000-0002-4975-2946; /0000-0001-9296-3733; Le Roux, Frederique/0000-0002-9112-6199; Mincer, Tracy/0000-0002-4644-5609	Gordon and Betty Moore Foundation; Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF [DEB 0821391]; Netherlands Organisation for Scientific Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank W. Hanage and E. Alm for valuable suggestions. Funding was provided by the Gordon and Betty Moore Foundation, the Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC) program, NSF grant DEB 0821391, and the NSF-sponsored Woods Hole Center for Oceans and Human Health. Support for O.X.C. was provided by the Netherlands Organisation for Scientific Research. Whole Genome Shotgun projects have been deposited at DDBJ/EMBL/GenBank under the accessions AJWN00000000, AJYD00000000 to AJYZ00000000, and AJZA00000000 to AJZQ00000000 (table S4).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BURKHOLDER PR, 1966, APPL MICROBIOL, V14, P649, DOI 10.1128/AEM.14.4.649-653.1966; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Doolittle WF, 2009, COLD SH Q B, V74, P197, DOI 10.1101/sqb.2009.74.002; Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Long RA, 2005, APPL ENVIRON MICROB, V71, P8531, DOI 10.1128/AEM.71.12.8531-8536.2005; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184	17	197	201	7	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1228	1231		10.1126/science.1219385	http://dx.doi.org/10.1126/science.1219385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955834	Green Submitted			2022-12-01	WOS:000308414000039
J	Hyman, AA; Simons, K				Hyman, Anthony A.; Simons, Kai			Beyond Oil and Water-Phase Transitions in Cells	SCIENCE			English	Editorial Material							PROTEINS; GRANULES; RNA; ASSEMBLIES		[Hyman, Anthony A.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany	Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany.	hyman@mpi-cbg.de; simons@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Simons, Kai/0000-0002-9231-9996				Ball P., 2004, CRITICAL MASS ONE TH; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Choi YH, 2011, PLANT PHYSIOL, V156, P1701, DOI 10.1104/pp.111.178426; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Oparin, 1936, ORIGINS LIFE EVOL B; Sear RP, 2008, FARADAY DISCUSS, V139, P21, DOI 10.1039/b713076g; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wilson E. B., 1899, Science, Vx, P33	16	170	171	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1047	1049		10.1126/science.1223728	http://dx.doi.org/10.1126/science.1223728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936764				2022-12-01	WOS:000308125800031
J	Yuan, W; Wu, T; Fu, H; Dai, C; Wu, H; Liu, N; Li, X; Xu, M; Zhang, ZQ; Niu, TH; Han, ZF; Chai, JJ; Zhou, XJ; Gao, SR; Zhu, B				Yuan, Wen; Wu, Tong; Fu, Hang; Dai, Chao; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Zhou, Xianghong Jasmine; Gao, Shaorong; Zhu, Bing			Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN SUZ12; HUMAN GENOME; MARKS; GENE; ENHANCER; CELLS	Polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) methylation is vital for Polycomb gene silencing, a classic epigenetic phenomenon that maintains transcriptional silencing throughout cell divisions. We report that PRC2 activity is regulated by the density of its substrate nucleosome arrays. Neighboring nucleosomes activate the PRC2 complex with a fragment of their H3 histones (Ala(31) to Arg(42)). We also identified mutations on PRC2 subunit Su(z)12, which impair its binding and response to the activating peptide and its ability in establishing H3K27 trimethylation levels in vivo. In mouse embryonic stem cells, local chromatin compaction occurs before the formation of trimethylated H3K27 upon transcription cessation of the retinoic acid-regulated gene CYP26a1. We propose that PRC2 can sense the chromatin environment to exert its role in the maintenance of transcriptional states.	[Yuan, Wen; Wu, Tong; Fu, Hang; Niu, Tianhui] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Yuan, Wen; Wu, Tong; Fu, Hang; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Gao, Shaorong; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Dai, Chao; Zhou, Xianghong Jasmine] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wu, Hui; Li, Xiang; Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wu, Hui; Li, Xiang; Xu, Mo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Nan] Beijing Normal Univ, Beijing 100875, Peoples R China; [Chai, Jijie] Tsinghua Univ, Beijing 10084, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Tsinghua University	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn; zhubing@nibs.ac.cn	Zhang, Zhuqiang/P-7329-2019; li, ran/K-1896-2012	Zhang, Zhuqiang/0000-0001-6513-2854; Chai, Jijie/0000-0001-7591-3873; yuan, wen/0000-0003-0029-2544	Chinese Ministry of Science and Technology [2011CB812700, 2011CB965300, 2010CB944900, 2011CB964800, 2010CB835300]; Howard Hughes Medical Institute International Early Career Scientist Program; NSF [0747475]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Howard Hughes Medical Institute International Early Career Scientist Program; NSF(National Science Foundation (NSF))	We appreciate K. Helin and Y. Shinkai for providing the Su(z)12 null and TT2 ES cells. This work was supported by the Chinese Ministry of Science and Technology (grants 2011CB812700 and 2011CB965300 to B.Z.; 2010CB944900 and 2011CB964800 to S. G.; and 2010CB835300 to J.C.), the Howard Hughes Medical Institute International Early Career Scientist Program (to B.Z.), and NSF Career award 0747475 (to X.J.Z.).	Allis C. D., 2006, EPIGENETICS; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birve A, 2001, DEVELOPMENT, V128, P3371; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	26	191	196	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					971	975		10.1126/science.1225237	http://dx.doi.org/10.1126/science.1225237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923582				2022-12-01	WOS:000307807600047
J	Cook, DE; Lee, TG; Guo, XL; Melito, S; Wang, K; Bayless, AM; Wang, JP; Hughes, TJ; Willis, DK; Clemente, TE; Diers, BW; Jiang, JM; Hudson, ME; Bent, AF				Cook, David E.; Lee, Tong Geon; Guo, Xiaoli; Melito, Sara; Wang, Kai; Bayless, Adam M.; Wang, Jianping; Hughes, Teresa J.; Willis, David K.; Clemente, Thomas E.; Diers, Brian W.; Jiang, Jiming; Hudson, Matthew E.; Bent, Andrew F.			Copy Number Variation of Multiple Genes at Rhg1 Mediates Nematode Resistance in Soybean	SCIENCE			English	Article							PLANT-PATHOGEN; EXPRESSION; CLUSTERS; ROOTS	The rhg1-b allele of soybean is widely used for resistance against soybean cyst nematode (SCN), the most economically damaging pathogen of soybeans in the United States. Gene silencing showed that genes in a 31-kilobase segment at rhg1-b, encoding an amino acid transporter, an a-SNAP protein, and a WI12 (wound-inducible domain) protein, each contribute to resistance. There is one copy of the 31-kilobase segment per haploid genome in susceptible varieties, but 10 tandem copies are present in an rhg1-b haplotype. Overexpression of the individual genes in roots was ineffective, but overexpression of the genes together conferred enhanced SCN resistance. Hence, SCN resistance mediated by the soybean quantitative trait locus Rhg1 is conferred by copy number variation that increases the expression of a set of dissimilar genes in a repeated multigene segment.	[Cook, David E.; Guo, Xiaoli; Melito, Sara; Bayless, Adam M.; Hughes, Teresa J.; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lee, Tong Geon; Wang, Jianping; Diers, Brian W.; Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wang, Kai; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, USDA ARS, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Clemente, Thomas E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Hudson, Matthew E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln; University of Illinois System; University of Illinois Urbana-Champaign	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Hudson, Matthew E/A-4438-2008; Bent, Andrew/E-5391-2016; Wang, Kai/A-2143-2011; Jiang, Jiming/V-6060-2019; Lee, Tong Geon/H-1812-2014; Jiang, Jiming/A-9614-2009; Cook, David E./AAM-9348-2021	Hudson, Matthew E/0000-0002-4737-0936; Bent, Andrew/0000-0001-6610-9525; Wang, Kai/0000-0002-1074-0438; Jiang, Jiming/0000-0002-6435-6140; Lee, Tong Geon/0000-0003-1672-4356; Jiang, Jiming/0000-0002-6435-6140; Cook, David E./0000-0002-2719-4701; Melito, Sara/0000-0002-4910-2353	United Soybean Board; USDA CSREES; Illinois Soybean Association; NSF [DBI-0922703]; Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation	United Soybean Board; USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Illinois Soybean Association; NSF(National Science Foundation (NSF)); Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by the United Soybean Board (A.F.B.), USDA CSREES (M.E.H.), Illinois Soybean Association (M.E.H. and B.W.D.), NSF grant DBI-0922703 (J.J.), Wisconsin Experiment Station Hatch Award (A.F.B.), and the Pioneer Fellowship in Plant Pathology awarded to D.E.C. by the American Phytopathological Society through a gift from Pioneer Hi-Bred. We thank A. E. MacGuidwin for suggestions regarding SCN experiments and J. M. Palmer for assistance with RNA blots. DNA sequence data are available at NCBI GenBank under accession codes JX907804 to JX907808 and at the NCBI Short Read Archive, study no. SRA059285. A.F.B., M.E.H., B.W.D., D.E.C., T.G.L., X.G., S.M., T.J.H., and J.W. are listed as inventors on a provisional patent application filed by Wisconsin Alumni Research Foundation that covers the findings reported herein.	Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Frey NFD, 2009, CURR OPIN PLANT BIOL, V12, P437, DOI 10.1016/j.pbi.2009.06.002; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim M, 2011, CROP SCI, V51, P934, DOI 10.2135/cropsci2010.08.0459; Kim M, 2010, PLANT GENOME-US, V3, P81, DOI 10.3835/plantgenome2010.02.0001; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Narayanan RA, 1999, CROP SCI, V39, P1680, DOI 10.2135/cropsci1999.3961680x; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Okumoto S, 2011, MOL PLANT, V4, P453, DOI 10.1093/mp/ssr003; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schmutz J, 2010, NATURE, V465, P120, DOI 10.1038/nature08957; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wingen LU, 2012, P NATL ACAD SCI USA, V109, P7115, DOI 10.1073/pnas.1111670109; Yen ShyiKae, 1999, Plant Physiology, V119, P1147, DOI 10.1104/pp.119.3.1147; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	31	390	441	6	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1206	1209		10.1126/science.1228746	http://dx.doi.org/10.1126/science.1228746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23065905				2022-12-01	WOS:000311666200045
J	Shin, HN; Iwasaki, A				Shin, Haina; Iwasaki, Akiko			A vaccine strategy that protects against genital herpes by establishing local memory T cells	NATURE			English	Article							REPLICATION-DEFECTIVE MUTANT; SIMPLEX-VIRUS TYPE-2; IMMUNE-RESPONSES; DENDRITIC CELLS; VIRAL-INFECTION; RESIDENT MEMORY; RM CELLS; MIGRATION; MUCOSAL; HSV-2	Most successful existing vaccines rely on neutralizing antibodies, which may not require specific anatomical localization of B cells. However, efficacious vaccines that rely on T cells for protection have been difficult to develop, as robust systemic memory T-cell responses do not necessarily correlate with host protection(1). In peripheral sites, tissue-resident memory T cells provide superior protection compared to circulating memory T cells(2,3). Here we describe a simple and non-inflammatory vaccine strategy that enables the establishment of a protective memory T-cell pool within peripheral tissue. The female genital tract, which is a portal of entry for sexually transmitted infections, is an immunologically restrictive tissue that prevents entry of activated T cells in the absence of inflammation or infection(4). To overcome this obstacle, we developed a vaccine strategy that we term 'prime and pull' to establish local tissue-resident memory T cells at a site of potential viral exposure. This approach relies on two steps: conventional parenteral vaccination to elicit systemic T-cell responses (prime), followed by recruitment of activated T cells by means of topical chemokine application to the restrictive genital tract (pull), where such T cells establish a long-term niche and mediate protective immunity. In mice, prime and pull protocol reduces the spread of infectious herpes simplex virus 2 into the sensory neurons and prevents development of clinical disease. These results reveal a promising vaccination strategy against herpes simplex virus 2, and potentially against other sexually transmitted infections such as human immunodeficiency virus.	[Shin, Haina; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Shin, Haina/0000-0002-1014-1451	NIAID [F32AI091024]; NIH [AI054359, AI062428]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062428, R01AI054359, R01AI062428, F32AI091024] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Foxman and R. Medzhitov for critical reading of the manuscript, and N. Iijima, H. Dong and B. Yordy for technical support. H. S. is supported by NIAID grant F32AI091024. This work is supported by NIH grants AI054359 and AI062428 to A.I.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gill N, 2008, AM J REPROD IMMUNOL, V59, P35, DOI 10.1111/j.1600-0897.2007.00558.x; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Parr MB, 2003, J NEUROVIROL, V9, P594, DOI 10.1080/714044481; PARR MB, 1994, LAB INVEST, V70, P369; Perkins N, 2011, SEX TRANSM INFECT, V87, P292, DOI 10.1136/sti.2010.047431; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soderberg KA, 2004, J IMMUNOL, V173, P1908, DOI 10.4049/jimmunol.173.3.1908; SPANG AE, 1983, J VIROL, V45, P332, DOI 10.1128/JVI.45.1.332-342.1983; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	30	412	425	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					463	+		10.1038/nature11522	http://dx.doi.org/10.1038/nature11522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23075848	Green Accepted			2022-12-01	WOS:000311031600050
J	Marcia, M; Pyle, AM				Marcia, Marco; Pyle, Anna Marie			Visualizing Group II Intron Catalysis through the Stages of Splicing	CELL			English	Article							SMALL NUCLEAR-RNA; METAL-ION COORDINATION; STRUCTURE VALIDATION; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; 2ND STEP; IN-VIVO; SPLICEOSOME; NUCLEOTIDES	Group II introns are self-splicing ribozymes that share a reaction mechanism and a common ancestor with the eukaryotic spliceosome, thereby providing a model system for understanding the chemistry of pre-mRNA splicing. Here we report 14 crystal structures of a group II intron at different stages of catalysis. We provide a detailed mechanism for the first step of splicing, we describe a reversible conformational change between the first and the second steps of splicing, and we present the ligand-free intron structure after splicing in an active state that corresponds to the retrotransposable form of the intron. During each reaction, the reactants are aligned and activated by a heteronuclear four-metal-ion center that contains a metal cluster and obligate monovalent cations, and they adopt a structural arrangement similar to that of protein endonucleases. Based on our data, we propose a model for the splicing cycle and show that it is applicable to the eukaryotic spliceosome.	[Marcia, Marco; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	anna.pyle@yale.edu	Marcia, Marco/M-2887-2014	Marcia, Marco/0000-0003-2430-0713	National Institute of Health [RO1GM50313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline scientists at 24-ID-C and E, NE-CAT, APS, Argonne (IL), USA for their thorough support during data collection. We acknowledge all members of the Pyle lab, and in particular Dr. Olga Fedorova for synthesizing the oligonucleotide fragment, Dr. Maximilian Bailor for cloning the OiD1-5 construct, Gabriele Drews for cloning the Oi5eD1-5 construct, Dr. Kevin Keating for the analysis of the backbone kink at the 50 splice junction (Table S2), Dr. Srinivas Somarowthu for calculating the model of intron domain 6 in the silent conformation (Figure S4), Dr. Laura Murray for sharing preliminary unpublished results, Dr. Dahai Luo and Dr. Patrick Lombardi for valuable discussion, and Dr. Isabel Chillon Gazquez for constructive criticism and help preparing the figures. Additionally, we acknowledge Dr. John Abelson, Dr. John Stahley, Dr. Magda Konarska, Dr. Patrick Cramer, Dr. Giovanni Capranico, Dr. Ulrich Ermler, and Tanja Hedderich for insightful discussion. This project was supported by the National Institute of Health (RO1GM50313). Prof. Pyle is a Howard Hughes Medical Institute Investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BOULANGER SC, 1995, MOL CELL BIOL, V15, P4479; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; CHANFREAU G, 1993, EMBO J, V12, P5173, DOI 10.1002/j.1460-2075.1993.tb06212.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn GL, 2002, J MOL BIOL, V318, P963, DOI 10.1016/S0022-2836(02)00147-X; Cotton AF, 1980, ADV ORGANIC CHEM COM, P58; Dai LX, 2002, RNA, V8, P1294, DOI 10.1017/S1355838202023014; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; De Lencastre A, 2008, RNA, V14, P11, DOI 10.1261/rna.774008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erat MC, 2008, J BIOL INORG CHEM, V13, P1025, DOI 10.1007/s00775-008-0390-7; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; HARDY SF, 1984, NATURE, V308, P375, DOI 10.1038/308375a0; Ho Faix P., 1998, THESIS U PITTSBURGH; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Lambert D, 2009, J MOL BIOL, V390, P791, DOI 10.1016/j.jmb.2009.04.083; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; Messerschmidt A., 2001, HDB METALLOPROTEINS; Mikheeva S, 2000, RNA, V6, P1509, DOI 10.1017/S1355838200000972; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PADGETT RA, 1994, SCIENCE, V266, P1685, DOI 10.1126/science.7527587; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Podar M, 1998, RNA, V4, P890, DOI 10.1017/S1355838298971643; PODAR M, 1995, MOL CELL BIOL, V15, P4466; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Schmidt U, 1996, RNA, V2, P1161; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2010, RNA, V16, P57, DOI 10.1261/rna.1844010; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617	57	123	123	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					497	507		10.1016/j.cell.2012.09.033	http://dx.doi.org/10.1016/j.cell.2012.09.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101623	Green Accepted, Bronze			2022-12-01	WOS:000310529300008
J	Joosten, MM; Pai, JK; Bertoia, ML; Rimm, EB; Spiegelman, D; Mittleman, MA; Mukamal, KJ				Joosten, Michel M.; Pai, Jennifer K.; Bertoia, Monica L.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.; Mukamal, Kenneth J.			Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANKLE-BRACHIAL INDEX; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; INTERMITTENT CLAUDICATION; NUTRITION EXAMINATION; ALCOHOL-CONSUMPTION; FUNCTIONAL DECLINE; SMOKING-CESSATION; PHYSICAL-ACTIVITY; NATIONAL-HEALTH	Context Previous studies have examined the associations of individual clinical risk factors with risk of peripheral artery disease (PAD), but the combined effects of these risk factors are largely unknown. Objective To estimate the degree to which the 4 conventional cardiovascular risk factors of smoking, hypertension, hypercholesterolemia, and type 2 diabetes are associated with the risk of PAD among men. Design, Setting, and Participants Prospective study of 44 985 men in the United States without a history of cardiovascular disease at baseline in 1986; participants in the Health Professionals Follow-up Study were followed up for 25 years until January 2011. The presence of risk factors was updated biennially during follow-up. Main Outcome Measure Clinically significant PAD defined as limb amputation or revascularization, angiogram reporting vascular obstruction of 50% or greater, ankle-brachial index of less than 0.90, or physician-diagnosed PAD. Results During a median follow-up of 24.2 years (interquartile range, 20.8-24.7 years), there were 537 cases of incident PAD. Each risk factor was significantly and independently associated with a higher risk of PAD after adjustment for the other 3 risk factors and confounders. The age-adjusted incidence rates were 9 (95% CI, 6-14) cases/100 000 person-years (n=19 incident cases) for 0 risk factors, 23 (95% CI, 18-28) cases/100 000 person-years (n=99 incident cases) for 1 risk factor, 47 (95% CI, 39-56) cases/100 000 person-years (n=176 incident cases) for 2 risk factors, 92(95% CI, 76-111) cases/100 000 person-years (n=180 incident cases) for 3 risk factors, and 186(95% CI, 141-246) cases/100 000 person-years (n=63 incident cases) for 4 risk factors. The multivariable-adjusted hazard ratio for each additional risk factor was 2.06 (95% CI, 1.88-2.26). Men without any of the 4 risk factors had a hazard ratio of PAD of 0.23 (95% CI, 0.14-0.36) compared with all other men in the cohort. In 96% of PAD cases (95% CI, 94%-98%), at least 1 of the 4 risk factors was present at the time of PAD diagnosis. The population-attributable risk associated with these 4 risk factors was 75% (95% CI, 64%-87%). The absolute incidence of PAD among men with all 4 risk factors was 3.5/1000 person-years. Conclusion Among men in this cohort, smoking, hypertension, hypercholesterolemia, and type 2 diabetes account for the majority of risk associated with development of clinically significant PAD. JAMA. 2012;308(16):1660-1667 www.jama.com	[Joosten, Michel M.; Bertoia, Monica L.; Mukamal, Kenneth J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Cardiovasc Epidemiol Res Unit, Sch Med,Dept Med, Boston, MA 02215 USA; [Joosten, Michel M.; Bertoia, Monica L.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joosten, Michel M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Joosten, Michel M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna] Harvard Univ, Channing Div Network Med, Brigham & Womens Hosp, Sch Med,Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Top Institute Food & Nutrition; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Joosten, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,Bldg 2, Boston, MA 02115 USA.	hpmmj@channing.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274; Joosten, Michel Marinus/0000-0002-0039-6629	National Institutes of Health [R01 HL091874, HL35464, CA55075]; National Heart, Lung, and Blood Institute; Environmental Protection Agency; Health Effects Institute; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091874, R01HL035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Environmental Protection Agency(United States Environmental Protection Agency); Health Effects Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mittleman reported institutional grant support from the National Heart, Lung, and Blood Institute; and receiving or having institutional grants pending from the National Institutes of Health, the Environmental Protection Agency, and Health Effects Institute. Dr Mukamal reported institutional grant support from the National Heart, Lung, and Blood Institute and the National Institutes of Health; and institutional support in the form of active and placebo capsules provided from the Martek Corporation to Harvard Medical School for a trial of docosahexaenoic acid for periodontitis. No other author reported disclosures.; This work was supported by National Institutes of Health grants R01 HL091874, HL35464, and CA55075.	Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Al-Delaimy WK, 2004, AM J MED, V116, P236, DOI 10.1016/j.amjmed.2003.09.038; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Bonow RO, 2011, BRAUNWALDS HEART DIS, P1338; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Dhaliwal G, 2007, INT J ANGIOL, V16, P36, DOI 10.1055/s-0031-1278244; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gentil A, 2009, J NEUROL NEUROSUR PS, V80, P1006, DOI 10.1136/jnnp.2009.172551; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hussein AA, 2011, J AM COLL CARDIOL, V57, P1220, DOI 10.1016/j.jacc.2010.10.034; JONASON T, 1987, ACTA MED SCAND, V221, P253; Joosten MM, 2011, DIABETES, V60, P74, DOI 10.2337/db10-1052; KANNEL WB, 1985, J AM GERIATR SOC, V33, P13, DOI 10.1111/j.1532-5415.1985.tb02853.x; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kennedy M, 2005, ARCH INTERN MED, V165, P1896, DOI 10.1001/archinte.165.16.1896; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mehler PS, 2003, CIRCULATION, V107, P753, DOI 10.1161/01.CIR.0000049640.46039.52; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; West AM, 2011, J AM COLL CARDIOL, V58, P1068, DOI 10.1016/j.jacc.2011.04.034	46	176	186	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1660	1667		10.1001/jama.2012.13415	http://dx.doi.org/10.1001/jama.2012.13415			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093164	Bronze, Green Accepted			2022-12-01	WOS:000310434100020
J	Lemos, JC; Wanat, MJ; Smith, JS; Reyes, BAS; Hollon, NG; Van Bockstaele, EJ; Chavkin, C; Phillips, PEM				Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Reyes, Beverly A. S.; Hollon, Nick G.; Van Bockstaele, Elisabeth J.; Chavkin, Charles; Phillips, Paul E. M.			Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive	NATURE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DOPAMINERGIC-NEURONS; FACTOR RECEPTORS; BEHAVIOR; ANXIETY; ACTIVATION; DEPRESSION; MOUSE	Stressors motivate an array of adaptive responses ranging from 'fight or flight' to an internal urgency signal facilitating long-term goals(1). However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments(2). Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal(3). An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry(4). Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors(5) and other arousing environmental stimuli(6), acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF's capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.	[Lemos, Julia C.; Wanat, Matthew J.; Hollon, Nick G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Lemos, Julia C.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Reyes, Beverly A. S.; Van Bockstaele, Elisabeth J.] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jefferson University	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026; Lemos, Julia/0000-0002-5442-8876; Hollon, Nick/0000-0003-4827-1582; Smith, Jeffrey/0000-0003-2840-2899; Wanat, Matthew/0000-0003-1643-6557	National Institutes of Health [F31-MH086269, F32-DA026273, R01-DA009082, R01-DA030074, R01-MH079292, R01-DA016782]; National Science Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292, F31MH086269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016782, R01DA030074, R01DA009082, K05DA020570, F32DA026273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants F31-MH086269 (J.C.L.), F32-DA026273 (M.J.W.), R01-DA009082 (E.J.V.B.), R01-DA030074 (C. C.), R01-MH079292 and R01-DA016782 (P. E. M. P.), the National Science Foundation (N.G.H.) and NARSAD (P. E. M. P.). We thank C. Zietz, M. Miyatake and P. Groblewski for assisting with histological verification of cannula placement, H. Gill for help with data analysis, D. Messinger for breeding and genotyping mice and N. Stella for use of a microscope. We thank M. Darvas and R. Palmiter for providing Th<SUP>fs/fs</SUP>; Dbh<SUP>Th/+</SUP> mice. We thank R. Sapolsky, J. Day, S. Sesack, M. Soden, C. Walker and E. Horne for useful suggestions and insights.	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; CADOR M, 1992, BRAIN RES, V597, P304, DOI 10.1016/0006-8993(92)91487-Y; Chaki S, 2004, EUR J PHARMACOL, V485, P145, DOI 10.1016/j.ejphar.2003.11.032; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; CORYELL W, 1994, ARCH GEN PSYCHIAT, V51, P405; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; FINK JS, 1980, NEUROSCI LETT, V17, P61, DOI 10.1016/0304-3940(80)90062-2; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; Gelenberg Alan J, 2010, J Clin Psychiatry, V71, pe02, DOI 10.4088/JCP.8001tx16c; Iredale PA, 1997, MOL PHARMACOL, V51, P794, DOI 10.1124/mol.51.5.794; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Merali Z, 2004, NEUROPSYCHOPHARMACOL, V29, P1409, DOI 10.1038/sj.npp.1300441; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OLDFIELD EH, 1985, NEUROENDOCRINOLOGY, V40, P84, DOI 10.1159/000124056; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Peters A., 1978, FINE STRUCTURE NERVO, V4, P588; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reyes BAS, 2008, ENDOCRINOLOGY, V149, P122, DOI 10.1210/en.2007-0705; Reyes BAS, 2006, EUR J NEUROSCI, V23, P2991, DOI 10.1111/j.1460-9568.2006.04820.x; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Torres G, 1998, NEUROSCIENCE, V87, P463, DOI 10.1016/S0306-4522(98)00147-X; VANBOCKSTAELE EJ, 1994, J COMP NEUROL, V341, P1, DOI 10.1002/cne.903410102; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014	35	183	187	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					402	+		10.1038/nature11436	http://dx.doi.org/10.1038/nature11436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22992525	Green Accepted, Green Published			2022-12-01	WOS:000309918500046
J	Ciofani, M; Madar, A; Galan, C; Sellars, M; Mace, K; Pauli, F; Agarwal, A; Huang, WD; Parkurst, CN; Muratet, M; Newberry, KM; Meadows, S; Greenfield, A; Yang, Y; Jain, P; Kirigin, FK; Birchmeier, C; Wagner, EF; Murphy, KM; Myers, RM; Bonneau, R; Littman, DR				Ciofani, Maria; Madar, Aviv; Galan, Carolina; Sellars, MacLean; Mace, Kieran; Pauli, Florencia; Agarwal, Ashish; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Yang, Yi; Jain, Preti; Kirigin, Francis K.; Birchmeier, Carmen; Wagner, Erwin F.; Murphy, Kenneth M.; Myers, Richard M.; Bonneau, Richard; Littman, Dan R.			A Validated Regulatory Network for Th17 Cell Specification	CELL			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; FACTOR BATF CONTROLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HELPER-CELLS; T-H-17 CELLS; NUCLEAR RECEPTORS; C-MAF; DIFFERENTIATION	Th17 cells have critical roles in mucosal defense and are major contributors to inflammatory disease. Their differentiation requires the nuclear hormone receptor ROR gamma t working with multiple other essential transcription factors (TFs). We have used an iterative systems approach, combining genome-wide TF occupancy, expression profiling of TF mutants, and expression time series to delineate the Th17 global transcriptional regulatory network. We find that cooperatively bound BATF and IRF4 contribute to initial chromatin accessibility and, with STAT3, initiate a transcriptional program that is then globally tuned by the lineage-specifying TF ROR gamma t, which plays a focal deterministic role at key loci. Integration of multiple data sets allowed inference of an accurate predictive model that we computationally and experimentally validated, identifying multiple new Th17 regulators, including Fosl2, a key determinant of cellular plasticity. This interconnected network can be used to investigate new therapeutic approaches to manipulate Th17 functions in the setting of inflammatory disease.	[Madar, Aviv; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10003 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Kirigin, Francis K.] NYU, Sch Med, Computat Biol Program, Sackler Inst, New York, NY 10016 USA; [Madar, Aviv; Mace, Kieran; Agarwal, Ashish; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Pauli, Florencia; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Birchmeier, Carmen] Max Delbruck Mol Med, Dev Biol, D-13125 Berlin, Germany; [Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, Canc Cell Biol Programme, E-28029 Madrid, Spain; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA	New York University; New York University; New York University; New York University; New York University; HudsonAlpha Institute for Biotechnology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centro Nacional de Investigaciones Oncologicas (CNIO); Washington University (WUSTL)	Bonneau, R (corresponding author), NYU, Courant Inst Math Sci, Dept Comp Sci, 251 Mercer St, New York, NY 10003 USA.	bonneau@nyu.edu; dan.littman@med.nyu.edu	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/AAO-1540-2020	Pauli Behn, Florencia/0000-0002-8984-4044; Ciofani, Maria/0000-0001-6472-5260; Mace, Kieran/0000-0002-8131-3118; Wagner, Erwin F/0000-0001-7872-0196	NIH [RC1 AI087266, RC4 AI092765, PN2 EY016586, IU54CA143907-01, EY016586-06]; NSF [IOS-1126971]; Leukemia and Lymphoma Society; Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586, PN1EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI087266, RC4AI092765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Andrew Sczesnak for generating TDF files and for multiple other contributions to data analysis during the course of the study. We thank R. Dalla Favera for providing IRF4 mutant mice; O. Uluckan and S. Wurm for coordinating shipping of AP-1 mutant mice; K. Ward for system administration; and K. Gunsalus and M. Dustin for helpful discussions. Support was provided by NIH grants RC1 AI087266 and RC4 AI092765 (A. A., D. R. L, R. B, and R. M. M.), PN2 EY016586 (A. G., A. M, and R. B.), and IU54CA143907-01 and EY016586-06 (A. G. and R. B.); NSF grant IOS-1126971 (R. B.); fellowships from the Leukemia and Lymphoma Society and Crohn's and Colitis Foundation of America (M. C.), the National Arthritis Research Foundation (Y.Y.); and Irvington Institute Fellowships from the Cancer Research Institute (M. S. and W. H.).	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hindorff L, 2012, CATALOG PUBLISHED GE; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho IC, 1999, COLD SPRING HARB SYM, V64, P573, DOI 10.1101/sqb.1999.64.573; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	750	777	2	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					289	303		10.1016/j.cell.2012.09.016	http://dx.doi.org/10.1016/j.cell.2012.09.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23021777	Green Accepted, Bronze			2022-12-01	WOS:000309981000009
J	Jin, J; Sison, K; Li, CJ; Tian, RJ; Wnuk, M; Sung, HK; Jeansson, M; Zhang, CJ; Tucholska, M; Jones, N; Kerjaschki, D; Shibuya, M; Fantus, IG; Nagy, A; Gerber, HP; Ferrara, N; Pawson, T; Quaggin, SE				Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Jones, Nina; Kerjaschki, Dontscho; Shibuya, Masabumi; Fantus, I. George; Nagy, Andras; Gerber, Hans-Peter; Ferrara, Napoleone; Pawson, Tony; Quaggin, Susan E.			Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function	CELL			English	Article							GROWTH-FACTOR RECEPTOR-1; TYROSINE KINASE; NEPHRIN PHOSPHORYLATION; MASS-SPECTROMETRY; HEPARIN-BINDING; VEGF RECEPTOR; RAFTS; LOCALIZATION; ANGIOGENESIS; GANGLIOSIDES	Vascular endothelial growth factor and its receptors, FLK1/KDR and FLT1, are key regulators of angiogenesis. Unlike FLK1/KDR, the role of FLT1 has remained elusive. FLT1 is produced as soluble (sFLT1) and full-length isoforms. Here, we show that pericytes from multiple tissues produce sFLT1. To define the biologic role of sFLT1, we chose the glomerular microvasculature as a model system. Deletion of Flt1 from specialized glomerular pericytes, known as podocytes, causes reorganization of their cytoskeleton with massive proteinuria and kidney failure, characteristic features of nephrotic syndrome in humans. The kinase-deficient allele of Flt1 rescues this phenotype, demonstrating dispensability of the full-length isoform. Using cell imaging, proteomics, and lipidomics, we show that sFLT1 binds to the glycosphingolipid GM3 in lipid rafts on the surface of podocytes, promoting adhesion and rapid actin reorganization. sFLT1 also regulates pericyte function in vessels outside of the kidney. Our findings demonstrate an autocrine function for sFLT1 to control pericyte behavior.	[Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Nagy, Andras; Pawson, Tony; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Shibuya, Masabumi] Jobu Univ, Inst Physiol & Med, Takasaki, Gunma 3701393, Japan; [Fantus, I. George] Toronto Gen Res Hosp, Toronto, ON M5G 1L7, Canada; [Fantus, I. George] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fantus, I. George] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5S 1A8, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON M5S 1A8, Canada; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5S 1A8, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gerber, Hans-Peter] Pfizer Worldwide Res & Dev, BioConjugate Vasc Biol, Oncol Res Unit E, Pearl River, NY 10965 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Quaggin, Susan E.] St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Guelph; Medical University of Vienna; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Pfizer; Roche Holding; Genentech; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Quaggin, SE (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@lunenfeld.ca	Tian, Ruijun/B-5629-2009; Tian, Ruijun/J-3019-2014; Nagy, Andras/G-6465-2013; Sung, Hoon-Ki/A-1922-2016; Sung, Hoon-Ki/G-3049-2013; Pawson, Tony J/E-4578-2013	Tian, Ruijun/0000-0001-9521-5124; Nagy, Andras/0000-0003-4311-0413; Sung, Hoon-Ki/0000-0001-6677-9385; Jeansson, Marie/0000-0003-1075-8563	CIHR [MOP62931]; TF grant [016002]; Gabor-Zellerman Chair [CIHR-MOP57793, HFSP-RGP0039/2009-C]; CCRI [2010-700465]; CIHR Postdoctoral Fellowship; KRES-CENT Award; Swiss NSF Postdoctoral Grant;  [CIHR- MOP-49409]	CIHR(Canadian Institutes of Health Research (CIHR)); TF grant; Gabor-Zellerman Chair; CCRI; CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); KRES-CENT Award; Swiss NSF Postdoctoral Grant; 	We thank Doug Holmyard and Ken Harpal for EM and histology; Sarang Kulkarni, Steffen Lawo, and Laurence Pelletier for microscopy and imaging; Gerry Gish for peptide synthesis and lipid assays; Rick Bagshaw for mass spec advice and providing Lys-N enzyme; Moin Saleem for human podocyte cells; Jim Dennis, Andras Kapus, Johan van der Vlag, Roy Zent, Jin Gyoon Park, and Sergio Grinstein for helpful discussions; and Vivian Nguyen, Bret Larsen, and Lorne Taylor for technical assistance. This work was funded by CIHR grant MOP62931, TF grant 016002 to S. E. Q., who holds the Gabor-Zellerman Chair, CIHR-MOP57793 and HFSP-RGP0039/2009-C grants to T. P., CIHR- MOP-49409 to I. G. F., and TF grant 016002, CCRI grant 2010-700465 to A.N. J.J. received a CIHR Postdoctoral Fellowship, N.J. received a KRES-CENT Award, and M.W. a Swiss NSF Postdoctoral Grant.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Balreira A, 2008, HUM MOL GENET, V17, P2238, DOI 10.1093/hmg/ddn124; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kwak DH, 2003, LIFE SCI, V72, P1997, DOI 10.1016/S0024-3205(03)00090-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maezawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040547; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rhainds D, 2004, J CELL SCI, V117, P3095, DOI 10.1242/jcs.01182; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zobiack N, 2002, J CELL SCI, V115, P91	40	107	109	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					384	399		10.1016/j.cell.2012.08.037	http://dx.doi.org/10.1016/j.cell.2012.08.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063127	Bronze			2022-12-01	WOS:000309981000016
J	Xhemalce, B; Robson, SC; Kouzarides, T				Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony			Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing	CELL			English	Article							TARGETS; EXPRESSION; COMPLEX	MicroRNAs (miRNAs) regulate key biological processes and their aberrant expression may lead to cancer. The primary transcript of canonical miRNAs is sequentially cleaved by the RNase III enzymes, Drosha and Dicer, which generate 5' monophosphate ends that are important for subsequent miRNA functions. In particular, the recognition of the 5' monophosphate of pre-miRNAs by Dicer is important for precise and effective biogenesis of miRNAs. Here, we identify a RNA-methyltransferase, BCDIN3D, that O-methylates this 5' monophosphate and negatively regulates miRNA maturation. Specifically, we show that BCDIN3D phospho-dimethylates pre-miR-145 both in vitro and in vivo and that phospho-dimethylated pre-miR-145 displays reduced processing by Dicer in vitro. Consistently, BCDIN3D depletion leads to lower pre-miR-145 and concomitantly increased mature miR-145 levels in breast cancer cells, which suppresses their tumorigenic phenotypes. Together, our results uncover a miRNA methylation pathway potentially involved in cancer that antagonizes the Dicer-dependent processing of miR-145 as well as other miRNAs.	[Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Xhemalce, Blerta] Univ Texas Austin, Coll Nat Sci, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Cambridge; University of Texas System; University of Texas Austin	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Xhemalce, Blerta/0000-0002-0517-9607	ICMB at the University of Texas at Austin; Cancer Research UK; CRUK; European Union	ICMB at the University of Texas at Austin; Cancer Research UK(Cancer Research UK); CRUK(Cancer Research UK); European Union(European Commission)	We thank Dr. Till Bartke for the recombinant nucleosomes and the parental Hela-S3-FlpIn cell line, Dr. Kyle M. Miller for help with the xCELLigence system, the DNA core facility at the Institute of Cellular and Molecular Biology (ICMB) at the University of Texas at Austin for use of equipment, and Dr. Andrew J. Bannister for helpful discussions. B. X. was funded by a start-up grant from ICMB at the University of Texas at Austin and a Cancer Research UK project grant. The T. K. laboratory was funded by grants from CRUK and the 6th Research Framework Program of the European Union (Epitron, SMARTER and HEROIC). Tony Kouzarides is a director of Abcam.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gunther T, 2006, MAGNESIUM RES, V19, P225; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawamata T, 2011, EMBO REP, V12, P944, DOI 10.1038/embor.2011.128; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Xhemalce B., 2011, HISTONE MODIFICATION; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	29	107	111	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					278	288		10.1016/j.cell.2012.08.041	http://dx.doi.org/10.1016/j.cell.2012.08.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063121	Green Accepted, Bronze			2022-12-01	WOS:000309981000008
J	Cohen, DA; Babey, SH				Cohen, Deborah A.; Babey, Susan H.			Candy at the Cash Register - A Risk Factor for Obesity and Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, Deborah A.] RAND Hlth, Santa Clara, CA USA; [Babey, Susan H.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles	Cohen, DA (corresponding author), RAND Hlth, Santa Clara, CA USA.			Babey, Susan/0000-0001-8113-1739				CURHAN RC, 1974, J MARKETING RES, V11, P286, DOI 10.2307/3151144; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Sorenson H., 2009, INSIDE MIND SHOPPER; Thomas M, 2011, J CONSUM RES, V38, P126, DOI 10.1086/657331; Wedel Michel., 2008, VISUAL MARKETING ATT	5	37	36	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1381	1383		10.1056/NEJMp1209443	http://dx.doi.org/10.1056/NEJMp1209443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050524				2022-12-01	WOS:000309652700003
J	Mather, J; Mao, M				Mather, John; Mao, Minnie			ASTRONOMY A conversation about observation	NATURE			English	Editorial Material									[Mao, Minnie] Natl Radio Astron Observ, Socorro, NM 87801 USA	National Radio Astronomy Observatory (NRAO)	Mather, J (corresponding author), NASA, Washington, DC 20546 USA.								0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S5	S7		10.1038/490S5a	http://dx.doi.org/10.1038/490S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051770	Bronze			2022-12-01	WOS:000309733300003
J	Grynbaum, MM				Grynbaum, Michael M.			Will soda restrictions help New York win the war on obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									New York Times Co, New York, NY 10036 USA	New York Times	Grynbaum, MM (corresponding author), New York Times Co, New York, NY 10036 USA.	grynbaum@nytimes.com						City of New York, 2012, REV EP NEW YORK CIT; de Ruyter JC, 2012, N ENGL J MED; Ebbeling CB, 2012, N ENGL J MED; KATAN M, NEW ENG J MEDI; Nestle M, FIGHTING FOOD GIANTS; Rabin Roni Caryn, 2012, NY TIMES; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	7	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6768	10.1136/bmj.e6768	http://dx.doi.org/10.1136/bmj.e6768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054050				2022-12-01	WOS:000309907400019
J	Mallam, AL; Del Campo, M; Gilman, B; Sidote, DJ; Lambowitz, AM				Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.			Structural basis for RNA-duplex recognition and unwinding by the DEAD-box helicase Mss116p	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN MSS116P; ATP HYDROLYSIS; GROUP-I; ACTIVATION; MECHANISM; RIBOSE; ROLES	DEAD-box proteins are the largest family of nucleic acid helicases, and are crucial to RNA metabolism throughout all domains of life(1,2). They contain a conserved 'helicase core' of two RecA-like domains (domains (D)1 and D2), which uses ATP to catalyse the unwinding of short RNA duplexes by non-processive, local strand separation(3). This mode of action differs from that of translocating helicases and allows DEAD-box proteins to remodel large RNAs and RNA-protein complexes without globally disrupting RNA structure(4). However, the structural basis for this distinctive mode of RNA unwinding remains unclear. Here, structural, biochemical and genetic analyses of the yeast DEAD-box protein Mss116p indicate that the helicase core domains have modular functions that enable a novel mechanism for RNA-duplex recognition and unwinding. By investigating D1 and D2 individually and together, we find that D1 acts as an ATP-binding domain and D2 functions as an RNA-duplex recognition domain. D2 contains a nucleic-acid-binding pocket that is formed by conserved DEAD-box protein sequence motifs and accommodates A-form but not B-form duplexes, providing a basis for RNA substrate specificity. Upon a conformational change in which the two core domains join to form a 'closed state' with an ATPase active site, conserved motifs in D1 promote the unwinding of duplex substrates bound to D2 by excluding one RNA strand and bending the other. Our results provide a comprehensive structural model for how DEAD-box proteins recognize and unwind RNA duplexes. This model explains key features of DEAD-box protein function and affords a new perspective on how the evolutionarily related cores of other RNA and DNA helicases diverged to use different mechanisms.	[Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			National Institutes of Health (NIH), National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; EMBO [ALTF 389-2010]; NIH [GM037951]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037951, R01GM037951] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Monzingo (University of Texas at Austin Macromolecular Crystallography Facility) for help with X-ray diffraction data collection, and R. Russell (University of Texas at Austin) and E. Jankowsky (Case Western Reserve University) for comments on the manuscript. X-ray diffraction data were collected at the Berkeley Center for Structural Biology, which is supported in part by the National Institutes of Health (NIH), National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. A.L.M. is the recipient of an EMBO long-term fellowship (ALTF 389-2010). This work was supported by NIH grant GM037951.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Cao WX, 2011, J MOL BIOL, V409, P399, DOI 10.1016/j.jmb.2011.04.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mallam AL, 2011, P NATL ACAD SCI USA, V108, P12254, DOI 10.1073/pnas.1109566108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr G, 2011, J MOL BIOL, V413, P952, DOI 10.1016/j.jmb.2011.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potratz JP, 2011, J MOL BIOL, V411, P661, DOI 10.1016/j.jmb.2011.05.047; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709; Wilkins MR, 1999, METH MOL B, V112, P531; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016	41	79	85	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					121	+		10.1038/nature11402	http://dx.doi.org/10.1038/nature11402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940866	Green Accepted			2022-12-01	WOS:000309446800045
J	Chng, SS; Xue, MY; Garner, RA; Kadokura, H; Boyd, D; Beckwith, J; Kahne, D				Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan; Kahne, Daniel			Disulfide Rearrangement Triggered by Translocon Assembly Controls Lipopolysaccharide Export	SCIENCE			English	Article							OUTER-MEMBRANE; PROTEIN COMPLEX; IDENTIFICATION; BIOGENESIS	The presence of lipopolysaccharide (LPS) on the cell surface of Gram-negative bacteria is critical for viability. A conserved beta-barrel membrane protein LptD (lipopolysaccharide transport protein D) translocates LPS from the periplasm across the outer membrane (OM). In Escherichia coli, this protein contains two disulfide bonds and forms the OM LPS translocon with the lipoprotein LptE. Here, we identified seven in vivo states on the oxidative-folding pathway of LptD. Proper assembly involved a nonfunctional intermediate containing non-native disulfides. Intermediate formation required the oxidase DsbA, and subsequent maturation to the active form with native disulfides was triggered by LptE. Thus, disulfide bond-dependent protein folding of LptD requires the proper assembly of a two-protein complex to promote disulfide bond rearrangement.	[Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chng, Shu-Sin; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA; [Kadokura, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Nara Institute of Science & Technology; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Chng, Shu Sin/B-1759-2018; Kadokura, Hiroshi/AAE-1645-2019	Chng, Shu Sin/0000-0001-5466-7183; Kadokura, Hiroshi/0000-0001-7308-7141	NIH [AI081059]; NIGMS [41883]; Japan Society for the Promotion of Science [21580092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Freinkman for pET23/42lptD-FLAG<INF>3</INF>. J.B. is an American Cancer Society Professor. This work is supported by NIH grants AI081059 (to D. K.) and NIGMS 41883 (to J.B.) and in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) 21580092 (to H.K.).	Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; SAMPSON BA, 1989, GENETICS, V122, P491; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	19	76	79	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1665	1668		10.1126/science.1227215	http://dx.doi.org/10.1126/science.1227215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22936569	Green Accepted			2022-12-01	WOS:000309215400048
J	Samstein, RM; Arvey, A; Josefowicz, SZ; Peng, X; Reynolds, A; Sandstrom, R; Neph, S; Sabo, P; Kim, JM; Liao, W; Li, MO; Leslie, C; Stamatoyannopoulos, JA; Rudensky, AY				Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Kim, Jeong M.; Liao, Will; Li, Ming O.; Leslie, Christina; Stamatoyannopoulos, John A.; Rudensky, Alexander Y.			Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; GLUCOCORTICOID-RECEPTOR BINDING; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; RISK LOCI; CHROMATIN ACCESSIBILITY; DNA ELEMENTS; CBF-BETA; DIFFERENTIATION; DOMAIN	Regulatory T (Treg) cells, whose identity and function are defined by the transcription factor Foxp3, are indispensable for immune homeostasis. It is unclear whether Foxp3 exerts its Treg lineage specification function through active modification of the chromatin landscape and establishment of new enhancers or by exploiting a pre-existing enhancer landscape. Analysis of the chromatin accessibility of Foxp3-bound enhancers in Treg and Foxp3-negative T cells showed that Foxp3 was bound overwhelmingly to preaccessible enhancers occupied by its cofactors in precursor cells or a structurally related predecessor. Furthermore, the bulk of Foxp3-bound Treg cell enhancers lacking in Foxp3(-) CD4(+) cells became accessible upon T cell receptor activation prior to Foxp3 expression, and only a small subset associated with several functionally important genes were exclusively Treg cell specific. Thus, in a late cellular differentiation process, Foxp3 defines Treg cell functionality in an "opportunistic" manner by largely exploiting the preformed enhancer network instead of establishing a new enhancer landscape.	[Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Samstein, Robert M.; Josefowicz, Steven Z.; Peng, Xiao; Li, Ming O.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Kim, Jeong M.] Genentech Inc, San Francisco, CA 94080 USA; [Liao, Will] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	jstam@u.washington.edu; rudenska@mskcc.org		Arvey, Aaron/0000-0002-8789-0290; Sandstrom, Richard/0000-0002-3356-1547; Samstein, Robert/0000-0001-6860-2401; josefowicz, steven/0000-0001-7453-779X; li, ming/0000-0002-1383-0535	NIH [DK091968, 5R37AI034206]; MSTP [GM07739]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Rudra and A. Chaudhry for helpful discussions. This work was supported by NIH DK091968 grant and MSTP grant GM07739 (both R.M.S.) and also by NIH 5R37AI034206 grant (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	48	327	334	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					153	166		10.1016/j.cell.2012.06.053	http://dx.doi.org/10.1016/j.cell.2012.06.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021222	Bronze, Green Accepted			2022-12-01	WOS:000309544200017
J	Ye, L; Kleiner, S; Wu, J; Sah, R; Gupta, RK; Banks, AS; Cohen, P; Khandekar, MJ; Bostrom, P; Mepani, RJ; Laznik, D; Kamenecka, TM; Song, XY; Liedtke, W; Mootha, VK; Puigserver, P; Griffin, PR; Clapham, DE; Spiegelman, BM				Ye, Li; Kleiner, Sandra; Wu, Jun; Sah, Rajan; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Kamenecka, Theodore M.; Song, Xinyi; Liedtke, Wolfgang; Mootha, Vamsi K.; Puigserver, Pere; Griffin, Patrick R.; Clapham, David E.; Spiegelman, Bruce M.			TRPV4 Is a Regulator of Adipose Oxidative Metabolism, Inflammation, and Energy Homeostasis	CELL			English	Article							DIET-INDUCED OBESITY; WHITE FAT DEPOTS; BROWN ADIPOCYTES; INSULIN-RESISTANCE; CATION CHANNEL; GENE-EXPRESSION; PROTEIN-KINASE; TISSUE; ACTIVATION; MICE	PGC1 alpha is a key transcriptional coregulator of oxidative metabolism and thermogenesis. Through a high-throughput chemical screen, we found that molecules antagonizing the TRPVs (transient receptor potential vanilloid), a family of ion channels, induced PGC1 alpha expression in adipocytes. In particular, TRPV4 negatively regulated the expression of PGC1 alpha, UCP1, and cellular respiration. Additionally, it potently controlled the expression of multiple proinflammatory genes involved in the development of insulin resistance. Mice with a null mutation for TRPV4 or wild-type mice treated with a TRPV4 antagonist showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance. This role of TRPV4 as a cell-autonomous mediator for both the thermogenic and proinflammatory programs in adipocytes could offer a target for treating obesity and related metabolic diseases.	[Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cardiol,Boston Childrens Hosp, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Song, Xinyi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liedtke, Wolfgang] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Scripps Research Institute; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Clapham, David/R-5974-2019; Gupta, Rana/R-3051-2019; Banks, Alexander/B-4832-2012; Clapham, David/S-1123-2019; Liedtke, Wolfgang/GNH-1878-2022	Banks, Alexander/0000-0003-1787-6925; Clapham, David/0000-0002-4459-9428; Gupta, Rana/0000-0002-9001-4531	NIH [DK031405, DK080261];  [5R90DK071507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094824, R90DK071507, R01DK031405, R24DK080261, R37DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Zoltan Arany (Beth Israel Deaconess Medical Center) and Bridget Wagner (The Broad Institute) for help with screen setup and Dr. Kai Cui (Duke University) for assistance with statistical analysis. We are grateful to Drs. Patrick Seale and Chih-Hao Lee for useful discussion. We also thank Yingying Zhang, Diti Bhowmick, and Lingling Dai for technical assistance. L.Y. was supported by the Interdisciplinary Training grant 5R90DK071507. This work was supported by NIH grants DK031405 and DK080261 (B.M.S.). B.M.S., V.K.M., and P.R.G. are consultants and shareholders in Ember Therapeutics, Inc.	Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jia L, 2010, J LIPID RES, V51, P3024, DOI 10.1194/jlr.M008599; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Li JJ, 2009, ENVIRON HEALTH PERSP, V117, P400, DOI 10.1289/ehp.0800311; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/nmeth.1806, 10.1038/NMETH.1806]; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	56	236	245	10	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					96	110		10.1016/j.cell.2012.08.034	http://dx.doi.org/10.1016/j.cell.2012.08.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021218	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000309544200013
J	Spence, D				Spence, Des			Good medicine: homeopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2010, NHS NEWS        0727; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2011, PRESCR COST AN ENGL; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483	4	4	4	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6184	10.1136/bmj.e6184	http://dx.doi.org/10.1136/bmj.e6184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983533				2022-12-01	WOS:000308865100004
J	Young, NE; Briner, JP; Rood, DH; Finkel, RC				Young, Nicolas E.; Briner, Jason P.; Rood, Dylan H.; Finkel, Robert C.			Glacier Extent During the Younger Dryas and 8.2-ka Event on Baffin Island, Arctic Canada	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; LAURENTIDE; GREENLAND; SEASONALITY; LANDSCAPES; INTERVAL; RETREAT; HISTORY; END	Greenland ice cores reveal that mean annual temperatures during the Younger Dryas (YD) cold interval-about 12.9 to 11.7 thousand years ago (ka)-and the similar to 150-year-long cold reversal that occurred 8.2 thousand years ago were similar to 15 degrees and 3 degrees to 4 degrees C colder than today, respectively. Reconstructing ice-sheet response to these climate perturbations can help evaluate ice-sheet sensitivity to climate change. Here, we report the widespread advance of Laurentide Ice Sheet outlet glaciers and independent mountain glaciers on Baffin Island, Arctic Canada, in response to the 8.2-ka event and show that mountain glaciers during the 8.2-ka event were larger than their YD predecessors. In contrast to the wintertime bias of YD cooling, we suggest that cooling during the 8.2-ka event was more evenly distributed across the seasons.	[Young, Nicolas E.; Briner, Jason P.] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Rood, Dylan H.] SUERC, Accelerator Mass Spectrometry Lab, E Kilbride, Lanark, Scotland; [Rood, Dylan H.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Finkel, Robert C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Scottish Universities Research & Reactor Center; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Young, NE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA.	nicolasy@ldeo.columbia.edu			U.S. National Science Foundation [ARC-909334, BCS-1002597, BCS-752848]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank M. Badding, D. Bedard, S. McGrane, N. Michelutti, and E. Thomas, who aided in sample collection. We also thank G. Miller for insightful discussions and the helpful comments from two anonymous reviewers. This work was funded in part by U.S. National Science Foundation awards ARC-909334, BCS-1002597, and BCS-752848 to J.P.B.	Alley R., 2003, EOS T AM GEOPHYS UN, V84; Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; ANDREWS JT, 1978, ARCTIC ALPINE RES, V10, P617, DOI 10.2307/1550683; ANDREWS JT, 1995, PALEOCEANOGRAPHY, V10, P943, DOI 10.1029/95PA01426; Axford Y, 2009, QUATERNARY RES, V71, P142, DOI 10.1016/j.yqres.2008.09.006; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bjorck S, 2002, GEOLOGY, V30, P427, DOI 10.1130/0091-7613(2002)030<0427:AMYDSC>2.0.CO;2; Born A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC003024; Briner JP, 2007, J QUATERNARY SCI, V22, P223, DOI 10.1002/jqs.1057; Briner JP, 2009, NAT GEOSCI, V2, P496, DOI 10.1038/ngeo556; Briner JP, 2006, GEOL SOC AM BULL, V118, P406, DOI 10.1130/B25716.1; Briner JP, 2005, CAN J EARTH SCI, V42, P67, DOI 10.1139/E04-102; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; FALCONER G, 1965, SCIENCE, V147, P608, DOI 10.1126/science.147.3658.608; Hillaire-Marcel C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030396; Kaplan MR, 2010, NATURE, V467, P194, DOI 10.1038/nature09313; KAPSNER WR, 1995, NATURE, V373, P52, DOI 10.1038/373052a0; Kelly MA, 2008, QUATERNARY SCI REV, V27, P2273, DOI 10.1016/j.quascirev.2008.08.004; Kobashi T, 2007, QUATERNARY SCI REV, V26, P1212, DOI 10.1016/j.quascirev.2007.01.009; Koerner RM, 2005, ANN GLACIOL-SER, V42, P417, DOI 10.3189/172756405781813122; Lohne OS, 2012, J QUATERNARY SCI, V27, P81, DOI 10.1002/jqs.1516; LOWELL TV, 2005, EOS, V86, P365, DOI DOI 10.1029/2005EO400001; Miller G. H., 1974, GEOLOGY, V2, P125; Oerlemans J., 2001, GLACIERS CLIMATE CHA; Putnam AE, 2010, NAT GEOSCI, V3, P700, DOI 10.1038/NGEO962; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Smith J. E., 1966, THESIS MCGILL U MONT; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Young NE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049639	35	42	42	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1330	1333		10.1126/science.1222759	http://dx.doi.org/10.1126/science.1222759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984068				2022-12-01	WOS:000308705000039
J	Sun, JY; Zhao, XH; Illeperuma, WRK; Chaudhuri, O; Oh, KH; Mooney, DJ; Vlassak, JJ; Suo, ZG				Sun, Jeong-Yun; Zhao, Xuanhe; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Oh, Kyu Hwan; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang			Highly stretchable and tough hydrogels	NATURE			English	Article							DOUBLE-NETWORK GELS; HIGH MECHANICAL STRENGTH; LARGE-STRAIN; FRACTURE; HYSTERESIS; FATIGUE; MODEL	Hydrogels are used as scaffolds for tissue engineering(1), vehicles for drug delivery(2), actuators for optics and fluidics(3), and model extracellular matrices for biological studies(4). The scope of hydrogel applications, however, is often severely limited by their mechanical behaviour(5). Most hydrogels do not exhibit high stretchability; for example, an alginate hydrogel ruptures when stretched to about 1.2 times its original length. Some synthetic elastic hydrogels(6,7) have achieved stretches in the range 10-20, but these values are markedly reduced in samples containing notches. Most hydrogels are brittle, with fracture energies of about 10 J m(-2) (ref. 8), as compared with similar to 1,000 J m(-2) for cartilage(9) and similar to 10,000 J m(-2) for natural rubbers(10). Intense efforts are devoted to synthesizing hydrogels with improved mechanical properties(11-18); certain synthetic gels have reached fracture energies of 100-1,000 J m(-2) (refs 11, 14, 17). Here we report the synthesis of hydrogels from polymers forming ionically and covalently crosslinked networks. Although such gels contain similar to 90% water, they can be stretched beyond 20 times their initial length, and have fracture energies of similar to 9,000 J m(-2). Even for samples containing notches, a stretch of 17 is demonstrated. We attribute the gels' toughness to the synergy of two mechanisms: crack bridging by the network of covalent crosslinks, and hysteresis by unzipping the network of ionic crosslinks. Furthermore, the network of covalent crosslinks preserves the memory of the initial state, so that much of the large deformation is removed on unloading. The unzipped ionic crosslinks cause internal damage, which heals by re-zipping. These gels may serve as model systems to explore mechanisms of deformation and energy dissipation, and expand the scope of hydrogel applications.	[Sun, Jeong-Yun; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sun, Jeong-Yun; Oh, Kyu Hwan] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea; [Zhao, Xuanhe] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Mooney, David J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Suo, Zhigang] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Seoul National University (SNU); Duke University; Harvard University; Harvard University	Suo, ZG (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	suo@seas.harvard.edu	Zhao, Xuanhe/B-1532-2008; oh, kyuhwan/H-5265-2018; Suo, Zhigang/B-1067-2008; Sun, Jeong-Yun/AAR-4630-2020; Sun, Jeong-Yun/F-5662-2012	Zhao, Xuanhe/0000-0001-5387-6186; Suo, Zhigang/0000-0002-4068-4844; Chaudhuri, Ovijit/0000-0002-9287-3401; Mooney, David/0000-0001-6299-1194	ARO [W911NF-09-1-0476]; NSF [CMMI-0800161]; DARPA [W911NF-10-1-0113]; NIH [R37 DE013033]; MRSEC [DMR-0820484]; NSF Research Triangle MRSEC [DMR-1121107]; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R11-2005-065]; Alexander von Humboldt Award; Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033, R01DE013033] Funding Source: NIH RePORTER	ARO; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRSEC(National Science Foundation (NSF)); NSF Research Triangle MRSEC; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Alexander von Humboldt Award(Alexander von Humboldt Foundation); Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work at Harvard was supported by ARO (W911NF-09-1-0476), NSF (CMMI-0800161), DARPA (W911NF-10-1-0113), NIH (R37 DE013033) and MRSEC (DMR-0820484). X.Z. acknowledges the support of the NSF Research Triangle MRSEC (DMR-1121107) and Haythornthwaite Research Initiation grants. K.H.O. is supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (R11-2005-065). Z.S. acknowledges a sabbatical leave at the Karlsruhe Institute of Technology funded by the Alexander von Humboldt Award and by Harvard University.	Baumberger T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078267; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haque MA, 2011, MACROMOLECULES, V44, P8916, DOI 10.1021/ma201653t; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Huang T, 2007, ADV MATER, V19, P1622, DOI 10.1002/adma.200602533; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; JACKSON AP, 1990, BIOMATERIALS, V11, P403, DOI 10.1016/0142-9612(90)90095-8; Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; LAKE GJ, 1995, RUBBER CHEM TECHNOL, V68, P435, DOI 10.5254/1.3538750; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r; Maldonado-Codina C, 2004, OPHTHAL PHYSL OPT, V24, P551, DOI 10.1111/j.1475-1313.2004.00236.x; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x; Seitz ME, 2009, SOFT MATTER, V5, P447, DOI 10.1039/b810041a; Simha N. K., 2003, J MATER SCI-MATER M, V14, P631; Tanaka Y, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/56005; Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y; Yu QM, 2009, MACROMOLECULES, V42, P3852, DOI 10.1021/ma900622s	30	3227	3343	433	6291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					133	136		10.1038/nature11409	http://dx.doi.org/10.1038/nature11409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955625	Green Accepted			2022-12-01	WOS:000308347000049
J	Thurman, RE; Rynes, E; Humbert, R; Vierstra, J; Maurano, MT; Haugen, E; Sheffield, NC; Stergachis, AB; Wang, H; Vernot, B; Garg, K; John, S; Sandstrom, R; Bates, D; Boatman, L; Canfield, TK; Diegel, M; Dunn, D; Ebersol, AK; Frum, T; Giste, E; Johnson, AK; Johnson, EM; Kutyavin, T; Lajoie, B; Lee, BK; Lee, K; London, D; Lotakis, D; Neph, S; Neri, F; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Safi, A; Sanchez, ME; Sanyal, A; Shafer, A; Simon, JM; Song, LY; Vong, S; Weaver, M; Yan, YQ; Zhang, ZC; Zhang, ZZ; Lenhard, B; Tewari, M; Dorschner, MO; Hansen, RS; Navas, PA; Stamatoyannopoulos, G; Iyer, VR; Lieb, JD; Sunyaev, SR; Akey, JM; Sabo, PJ; Kaul, R; Furey, TS; Dekker, J; Crawford, GE; Stamatoyannopoulos, JA				Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Sheffield, Nathan C.; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; Garg, Kavita; John, Sam; Sandstrom, Richard; Bates, Daniel; Boatman, Lisa; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Giste, Erika; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tanya; Lajoie, Bryan; Lee, Bum-Kyu; Lee, Kristen; London, Darin; Lotakis, Dimitra; Neph, Shane; Neri, Fidencio; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Safi, Alexias; Sanchez, Minerva E.; Sanyal, Amartya; Shafer, Anthony; Simon, Jeremy M.; Song, Lingyun; Vong, Shinny; Weaver, Molly; Yan, Yongqi; Zhang, Zhancheng; Zhang, Zhuzhu; Lenhard, Boris; Tewari, Muneesh; Dorschner, Michael O.; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Iyer, Vishwanath R.; Lieb, Jason D.; Sunyaev, Shamil R.; Akey, Joshua M.; Sabo, Peter J.; Kaul, Rajinder; Furey, Terrence S.; Dekker, Job; Crawford, Gregory E.; Stamatoyannopoulos, John A.			The accessible chromatin landscape of the human genome	NATURE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; TRANSCRIPTION; BINDING; DISTINCT; PROTEIN; NF-E2	DNase I hypersensitive sites (DHSs) are markers of regulatory DNA and have underpinned the discovery of all classes of cis-regulatory elements including enhancers, promoters, insulators, silencers and locus control regions. Here we present the first extensive map of human DHSs identified through genome-wide profiling in 125 diverse cell and tissue types. We identify similar to 2.9 million DHSs that encompass virtually all known experimentally validated cis-regulatory sequences and expose a vast trove of novel elements, most with highly cell-selective regulation. Annotating these elements using ENCODE data reveals novel relationships between chromatin accessibility, transcription, DNA methylation and regulatory factor occupancy patterns. We connect similar to 580,000 distal DHSs with their target promoters, revealing systematic pairing of different classes of distal DHSs and specific promoter types. Patterning of chromatin accessibility at many regulatory regions is organized with dozens to hundreds of co-activated elements, and the transcellular DNase I sensitivity pattern at a given region can predict cell-type-specific functional behaviours. The DHS landscape shows signatures of recent functional evolutionary constraint. However, the DHS compartment in pluripotent and immortalized cells exhibits higher mutation rates than that in highly differentiated cells, exposing an unexpected link between chromatin accessibility, proliferative potential and patterns of human variation.	[Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; John, Sam; Sandstrom, Richard; Bates, Daniel; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Giste, Erika; Johnson, Audra K.; Kutyavin, Tanya; Lee, Kristen; Neph, Shane; Neri, Fidencio; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Shafer, Anthony; Vong, Shinny; Weaver, Molly; Akey, Joshua M.; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sheffield, Nathan C.; London, Darin; Safi, Alexias; Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Garg, Kavita; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Boatman, Lisa; Ebersol, Abigail K.; Frum, Tristan; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Lajoie, Bryan; Sanyal, Amartya; Dekker, Job] Univ Massachusetts, Program Syst Biol, Sch Med, Worcester, MA 01605 USA; [Lee, Bum-Kyu; Iyer, Vishwanath R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Qu, Hongzhu] Chinese Acad Sci, Lab Dis Genom & Individualized Med, Beijing Inst Genom, Beijing 100029, Peoples R China; [Simon, Jeremy M.; Zhang, Zhancheng; Zhang, Zhuzhu; Lieb, Jason D.; Furey, Terrence S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lenhard, Boris] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of Bergen; University of Bergen; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021; Sheffield, Nathan/ABG-8124-2020; SANYAL, AMARTYA/D-7240-2015	Vernot, Benjamin/0000-0002-6820-2181; Sheffield, Nathan/0000-0001-5643-4068; SANYAL, AMARTYA/0000-0002-2109-4478; FRUM, Tristan/0000-0003-3452-8762; Furey, Terry/0000-0001-5546-9672; Akey, Joshua/0000-0002-4411-1330; Haugen, Eric/0000-0001-7444-8981; Kaul, Rajinder/0000-0002-7895-9284; Lenhard, Boris/0000-0002-1114-1509; Sandstrom, Richard/0000-0002-3356-1547; Lee, Bum Kyu/0000-0001-7835-419X; Nguyen, Eric/0000-0002-0516-2434; Lieb, Jason/0000-0001-7601-8061; Vierstra, Jeff/0000-0001-6406-8563	National Institutes of Health [HG004592, HG004563, GM076036, R01MH084676]; National Science Foundation Graduate Research Fellowship [DGE-0718124]; National Science Foundation; Research Council of Norway; caBIG In Silico Center of Excellence, NCI/NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004563, R01HG003143, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER; MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Research Council of Norway(Research Council of Norway); caBIG In Silico Center of Excellence, NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank our ENCODE colleagues for many insights into the data types generated by different centres and for help with coordinated analyses. We thank I. Stanaway for assistance with the variation analysis, and many colleagues, particularly F. Urnov, for helpful critiques of the manuscript and figures. This work was funded by National Institutes of Health grants HG004592 (J.A.S.), HG004563 (G. E. C.), GM076036 (J.M.A.) and R01MH084676 (S. R. S), and J.V. is supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-0718124. N.C.S. is supported by a National Science Foundation Graduate Research Fellowship and the Research Council of Norway. M. T. and K. G. acknowledge funding support from the caBIG In Silico Center of Excellence, NCI/NIH contract no. HHSN261200800001E.	Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harrow J., GENOME RES IN PRESS; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; REDDY PMS, 1994, J BIOL CHEM, V269, P8287; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/NMETH.1770, 10.1038/nmeth.1770]; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Vernot B., GENOME RES IN PRESS; WEISBROD S, 1979, P NATL ACAD SCI USA, V76, P630, DOI 10.1073/pnas.76.2.630	32	1712	1765	9	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					75	82		10.1038/nature11232	http://dx.doi.org/10.1038/nature11232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955617	Green Submitted, hybrid, Green Accepted			2022-12-01	WOS:000308347000040
J	Guermazi, A; Niu, JB; Hayashi, D; Roemer, FW; Englund, M; Neogi, T; Aliabadi, P; McLennan, CE; Felson, DT				Guermazi, Ali; Niu, Jingbo; Hayashi, Daichi; Roemer, Frank W.; Englund, Martin; Neogi, Tuhina; Aliabadi, Piran; McLennan, Christine E.; Felson, David T.			Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study)	BRITISH MEDICAL JOURNAL			English	Article							BONE-MARROW LESIONS; JOINT SPACE WIDTH; BODY-MASS INDEX; CARTILAGE LOSS; RADIOGRAPHIC FEATURES; RHEUMATIC CONDITIONS; UNITED-STATES; RISK-FACTORS; PAIN; ASSOCIATION	Objective To examine use of magnetic resonance imaging (MRI) of knees with no radiographic evidence of osteoarthritis to determine the prevalence of structural lesions associated with osteoarthritis and their relation to age, sex, and obesity. Design Population based observational study. Setting Community cohort in Framingham, MA, United States (Framingham osteoarthritis study). Participants 710 people aged >50 who had no radiographic evidence of knee osteoarthritis (Kellgren-Lawrence grade 0) and who underwent MRI of the knee. Main outcome measures Prevalence of MRI findings that are suggestive of knee osteoarthritis (osteophytes, cartilage damage, bone marrow lesions, subchondral cysts, meniscal lesions, synovitis, attrition, and ligamentous lesions) in all participants and after stratification by age, sex, body mass index (BMI), and the presence or absence of knee pain. Pain was assessed by three different questions and also by WOMAC questionnaire. Results Of the 710 participants, 393 (55%) were women, 660 (93%) were white, and 206 (29%) had knee pain in the past month. The mean age was 62.3 years and mean BMI was 27.9. Prevalence of "any abnormality" was 89% (631/710) overall. Osteophytes were the most common abnormality among all participants (74%, 524/710), followed by cartilage damage (69%, 492/710) and bone marrow lesions (52%, 371/710). The higher the age, the higher the prevalence of all types of abnormalities detectable by MRI. There were no significant differences in the prevalence of any of the features between BMI groups. The prevalence of at least one type of pathology ("any abnormality") was high in both painful (90-97%, depending on pain definition) and painless (86-88%) knees. Conclusions MRI shows lesions in the tibiofemoral joint in most middle aged and elderly people in whom knee radiographs do not show any features of osteoarthritis, regardless of pain.	[Guermazi, Ali; Hayashi, Daichi; Roemer, Frank W.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Niu, Jingbo; Englund, Martin; Neogi, Tuhina; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Roemer, Frank W.] Klinikum Augsburg, Dept Radiol, Augsburg, Germany; [Englund, Martin] Lund Univ, Dept Orthopaed, Lund, Sweden; [Aliabadi, Piran] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [McLennan, Christine E.] OptumInsight Life Sci, Waltham, MA 02451 USA	Boston University; Boston University; Klinikum Augsburg; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Optum	Guermazi, A (corresponding author), Boston Univ, Sch Med, Dept Radiol, FGH Bldg,820 Harrison Ave, Boston, MA 02118 USA.	guermazi@bu.edu	Englund, Martin/J-7245-2012; Hayashi, Daichi/J-9875-2012; Roemer, Frank/AAS-6317-2020; Neogi, Tuhina/AAM-1110-2020	Englund, Martin/0000-0003-3320-2437; Felson, David/0000-0002-2668-2447; Neogi, Tuhina/0000-0002-9515-1711; Niu, Jingbo/0000-0002-6170-1965	National Institutes of Health [AG18393, AR47785]; Arthritis Foundation; Swedish Research Council; Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS [AR055127]; Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055127, P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health (AG18393 and AR47785) and the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers work independently of their funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: AG is the president of Boston Imaging Core Lab (BICL), LLC, and a consultant to Merck Serono, Stryker, Genzyme, AstraZeneca, and Novartis; FWR a vice president and shareholder of BICL and is a consultant to Merck Serono and National Institute of Health; ME is funded by the Swedish Research Council, the Greta and Johan Kock Foundation, King Gustaf V 80-year Birthday Foundation, and the Faculty of Medicine, Lund University, Sweden; TN is supported by NIAMS AR055127 and the Arthritis Foundation Arthritis Investigator Award.	Amin S, 2005, ARTHRITIS RHEUM, V52, P3152, DOI 10.1002/art.21296; Avasthi S, 2009, INT J ORTHOPED SURG, V13, P1; Bedson J, 2005, FAM PRACT, V22, P103, DOI 10.1093/fampra/cmh700; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA87, DOI 10.1016/j.joca.2006.02.028; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Guermazi A, 2012, SKELETAL RADIOL, V41, P179, DOI 10.1007/s00256-011-1142-2; Guermazi A, 2011, CURR OPIN RHEUMATOL, V23, P484, DOI 10.1097/BOR.0b013e328349c2d2; Hill CL, 2001, J RHEUMATOL, V28, P1330; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Neogi T, 2011, CURR OPIN RHEUMATOL, V23, P185, DOI 10.1097/BOR.0b013e32834307eb; Neogi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2844; Peterfy CG, 2006, OSTEOARTHR CARTILAGE, V14, pA95, DOI 10.1016/j.joca.2006.02.029; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Roemer FW, 2009, OSTEOARTHR CARTILAGE, V17, P1115, DOI 10.1016/j.joca.2009.03.012; Roemer FW, 2009, ANN RHEUM DIS, V68, P1461, DOI 10.1136/ard.2008.096834; Roemer FW, 2009, RADIOLOGY, V252, P772, DOI 10.1148/radiol.2523082197; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sanghi D, 2011, J ORTHOP SCI, V16, P719, DOI 10.1007/s00776-011-0147-y; Szebenyi B, 2006, ARTHRITIS RHEUM-US, V54, P230, DOI 10.1002/art.21534; Theiler R, 1999, OSTEOARTHR CARTILAGE, V7, P515, DOI 10.1053/joca.1999.0262; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wills AK, 2012, ANN RHEUM DIS, V71, P655, DOI 10.1136/ard.2011.154021; Yusuf E, 2011, OSTEOARTHR CARTILAGE, V19, P1117, DOI 10.1016/j.joca.2011.06.001; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	35	273	278	8	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 29	2012	345								e5339	10.1136/bmj.e5339	http://dx.doi.org/10.1136/bmj.e5339			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SK	22932918	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000311050600002
J	McCabe, MT; Ott, HM; Ganji, G; Korenchuk, S; Thompson, C; Van Aller, GS; Liu, Y; Graves, AP; Della Pietra, A; Diaz, E; LaFrance, LV; Mellinger, M; Duquenne, C; Tian, XR; Kruger, RG; McHugh, CF; Brandt, M; Miller, WH; Dhanak, D; Verma, SK; Tummino, PJ; Creasy, CL				McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Graves, Alan P.; Della Pietra, Anthony, III; Diaz, Elsie; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Brandt, Martin; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.			EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations	NATURE			English	Article							HISTONE METHYLTRANSFERASE EZH2; LYSINE 27; SOMATIC MUTATIONS; GENES; H3; HYPERTRIMETHYLATION; METHYLATION; SUBSTRATE; CANCER; H3K27	In eukaryotes, post-translational modification of histones is critical for regulation of chromatin structure and gene expression. EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and is involved in repressing gene expression through methylation of histone H3 on lysine 27 (H3K27). EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumour types(1-5). Additionally, somatic heterozygous mutations of Y641 and A677 residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma(6-10). The Y641 residue is the most frequently mutated residue, with up to 22% of germinal centre B-cell DLBCL and follicular lymphoma harbouring mutations at this site. These lymphomas have increased H3K27 tri-methylation (H3K27me3) owing to altered substrate preferences of the mutant enzymes(9,11-13). However, it is unknown whether specific, direct inhibition of EZH2 methyltransferase activity will be effective in treating EZH2 mutant lymphomas. Here we demonstrate that GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes. GSK126 effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice. Together, these data demonstrate that pharmacological inhibition of EZH2 activity may provide a promising treatment for EZH2 mutant lymphoma.	[McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Della Pietra, Anthony, III; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, Collegeville, PA 19426 USA; [Graves, Alan P.; Diaz, Elsie; Brandt, Martin] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Creasy, CL (corresponding author), GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	caretha.l.creasy@gsk.com	Thompson, Christine/GWV-6539-2022	Graves, Alan/0000-0002-8949-4961				Al-Katib AM, 1998, CLIN CANCER RES, V4, P1305; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chou RH, 2011, AM J TRANSL RES, V3, P243; Diaz E., 2012, J BIOMOL SCREEN; DYER MJS, 1990, BLOOD, V75, P709; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; TORNHEIM K, 1994, ANAL BIOCHEM, V221, P53, DOI 10.1006/abio.1994.1377; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	30	1273	1345	6	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					108	+		10.1038/nature11606	http://dx.doi.org/10.1038/nature11606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23051747				2022-12-01	WOS:000311893400055
J	Tidow, H; Poulsen, LR; Andreeva, A; Knudsen, M; Hein, KL; Wiuf, C; Palmgren, MG; Nissen, P				Tidow, Henning; Poulsen, Lisbeth R.; Andreeva, Antonina; Knudsen, Michael; Hein, Kim L.; Wiuf, Carsten; Palmgren, Michael G.; Nissen, Poul			A bimodular mechanism of calcium control in eukaryotes	NATURE			English	Article							MEMBRANE CA2+ PUMP; STRUCTURE VALIDATION; REGULATORY DOMAIN; BINDING DOMAIN; CALMODULIN; PLANT; CA2+-ATPASE; ACTIVATION; DIVERSITY; PROTEINS	Calcium ions (Ca2+) have an important role as secondary messengers in numerous signal transduction processes(1-4), and cells invest much energy in controlling and maintaining a steep gradient between intracellular (similar to 0.1-micromolar) and extracellular (similar to 2-millimolar) Ca2+ concentrations(1). Calmodulin-stimulated calcium pumps, which include the plasma-membrane Ca2+-ATPases (PMCAs), are key regulators of intracellular Ca2+ in eukaryotes(5-8). They contain a unique amino- or carboxy-terminal regulatory domain responsible for autoinhibition, and binding of calcium-loaded calmodulin to this domain releases autoinhibition and activates the pump. However, the structural basis for the activation mechanism is unknown and a key remaining question is how calmodulin-mediated PMCA regulation can cover both basal Ca2+ levels in the nanomolar range as well as micromolar-range Ca2+ transients generated by cell stimulation(7). Here we present an integrated study combining the determination of the high-resolution crystal structure of a PMCA regulatory-domain/calmodulin complex with in vivo characterization and biochemical, biophysical and bioinformatics data that provide mechanistic insights into a two-step PMCA activation mechanism mediated by calcium-loaded calmodulin. The structure shows the entire PMCA regulatory domain and reveals an unexpected 2: 1 stoichiometry with two calcium-loaded calmodulin molecules binding to different sites on a long helix. A multifaceted characterization of the role of both sites leads to a general structural-model for calmodulin-mediated regulation of PMCAs that allows stringent, highly responsive control of intracellular calcium in eukaryotes, making it possible to maintain a stable, basal level at a threshold Ca2+ concentration, where steep activation occurs.	[Tidow, Henning; Poulsen, Lisbeth R.; Knudsen, Michael; Hein, Kim L.; Palmgren, Michael G.; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Tidow, Henning; Hein, Kim L.; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Andreeva, Antonina] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Knudsen, Michael] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Wiuf, Carsten] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; MRC Laboratory Molecular Biology; Aarhus University; University of Copenhagen	Palmgren, MG (corresponding author), Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	palmgren@life.ku.dk; pn@mb.au.dk	Poulsen, Lisbeth Rosager/AAP-1301-2020; Nissen, Poul/D-5774-2014; Palmgren, Michael/A-9808-2013; Poulsen, Lisbeth R/I-1843-2014; Wiuf, Carsten/H-6320-2011; Tidow, Henning/K-3420-2015	Palmgren, Michael/0000-0002-9982-6114; Poulsen, Lisbeth R/0000-0002-9133-3358; Wiuf, Carsten/0000-0002-1302-4445; Knudsen, Michael/0000-0002-6294-2517; Tidow, Henning/0000-0002-4702-9332; Nissen, Poul/0000-0003-0948-6628; Andreeva, Antonina/0000-0002-0450-0091	EMBO Long-Term Fellowship; Marie-Curie Intra-European Fellowship; HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); Medical Research Council [MC_U105192716] Funding Source: researchfish; MRC [MC_U105192716] Funding Source: UKRI	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission); HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Nissen and Palmgren labs for discussions, and P. Gourdon for help with data collection. We thank the staff at beamlines ID23-2 at the European Radiation Synchrotron Facility, France; PX3 at the Swiss Light Source, Paul Scherrer Institute, Switzerland; and X33 at EMBL/DESY, Germany. We are grateful to K. Nagai for a plasmid expressing mammalian CaM. Support from the European Community-Research Infrastructure Action under the FP7 is acknowledged for access to EMBL/DESY. H. T. is a Junior Research Fellow at Trinity College, Cambridge, and was supported by an EMBO Long-Term Fellowship, a Marie-Curie Intra-European Fellowship and an HFSP Long-Term Fellowship. P.N. was supported by an ERC advanced grant (BIOMEMOS).	Afonine PV, 2005, CCP4 NEWSL, V42, P8; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; Brini M, 2011, COLD SPRING HARB PER, V3, DOI [DOI 10.1101/CSHPERSPECT.A004168, 10.1101/cshperspect.a004168]; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Malmstrom S, 1997, FEBS LETT, V400, P324, DOI 10.1016/S0014-5793(96)01448-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tidow H, 2010, ACTA CRYSTALLOGR F, V66, P361, DOI 10.1107/S1744309110003805	48	83	84	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					468	+		10.1038/nature11539	http://dx.doi.org/10.1038/nature11539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086147				2022-12-01	WOS:000311031600051
J	Joiner, MLA; Koval, OM; Li, JD; He, BJ; Allamargot, C; Gao, Z; Luczak, ED; Hall, DD; Fink, BD; Chen, BY; Yang, JY; Moore, SA; Scholz, TD; Strack, S; Mohler, PJ; Sivitz, WI; Song, LS; Anderson, ME				Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Allamargot, Chantal; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Fink, Brian D.; Chen, Biyi; Yang, Jinying; Moore, Steven A.; Scholz, Thomas D.; Strack, Stefan; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.			CaMKII determines mitochondrial stress responses in heart	NATURE			English	Article							II INHIBITION PROTECTS; KINASE-II; CALMODULIN KINASE; CALCIUM UNIPORTER; IN-VIVO; INNER MEMBRANE; FAILURE; HYPERTROPHY; APOPTOSIS; OXIDATION	Myocardial cell death is initiated by excessive mitochondrial Ca2+ entry causing Ca2+ overload, mitochondrial permeability transition pore (mPTP) opening and dissipation of the mitochondrial inner membrane potential (Delta Psi m)(1,2). However, the signalling pathways that control mitochondrial Ca2+ entry through the inner membrane mitochondrial Ca2+ uniporter (MCU)(3-5) are not known. The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated in ischaemia reperfusion, myocardial infarction and neurohumoral injury, common causes of myocardial death and heart failure; these findings suggest that CaMKII could couple disease stress to mitochondrial injury. Here we show that CaMKII promotes mPTP opening and myocardial death by increasing MCU current (I-MCU). Mitochondrial-targeted CaMKII inhibitory protein or cyclosporin A, an mPTP antagonist with clinical efficacy in ischaemia reperfusion injury(6), equivalently prevent mPTP opening, Delta Psi m deterioration and diminish mitochondrial disruption and programmed cell death in response to ischaemia reperfusion injury. Mice with myocardial and mitochondrial-targeted CaMKII inhibition have reduced I-MCU and are resistant to ischaemia reperfusion injury, myocardial infarction and neurohumoral injury, suggesting that pathological actions of CaMKII are substantially mediated by increasing I-MCU. Our findings identify CaMKII activity as a central mechanism for mitochondrial Ca2+ entry in myocardial cell death, and indicate that mitochondrial-targeted CaMKII inhibition could prevent or reduce myocardial death and heart failure in response to common experimental forms of pathophysiological stress.	[Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Ctr Cardiovasc, Carver Coll Med, Iowa City, IA 52242 USA; [He, B. Julie; Moore, Steven A.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Carver Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Fink, Brian D.; Sivitz, William I.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Scholz, Thomas D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Joiner, MLA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	mei-ling-joiner@uiowa.edu; mark-e-anderson@uiowa.edu	Hall, Duane/ACD-6815-2022; Chen, Biyi/AAF-3077-2021	Hall, Duane/0000-0003-2228-0966; Strack, Stefan/0000-0002-6175-7280; Song, Long-Sheng/0000-0002-6035-8106; Scholz, Thomas/0000-0003-0759-2486; Koval, Olha/0000-0003-1644-0046; Sivitz, William/0000-0002-7829-0189; Joiner, Mei-ling/0000-0002-7775-7349; Fink, Brian/0000-0002-1149-7935; Moore, Steven/0000-0002-6353-7900	AHA [0635357N]; NIH [R01 HL090905, R01 HL079031, R01 HL62494, R01 HL70250, R01 HL113001, R01 HL084583, R01 HL083422]; Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL084583, R01HL062494, R01HL079031, R01HL083422, R01HL070250, R01HL113001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge discussions with A. Lee, B. Davidson, K. Campbell and C. Sigmund. This work was funded by: AHA 0635357N (M.A.J.); (NIH R01 HL090905 (L.-S.S.); NIH R01 HL079031, R01 HL62494, R01 HL70250 and R01 HL113001 and supported by a grant from the Fondation Leducq for the Alliance for CaMKII Signaling (M. E. A.); NIH R01 HL084583, R01 HL083422 and Pew Scholars Trust (P.J.M.).	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Feldman DS, 2005, NAT CLIN PRACT CARD, V2, P475, DOI 10.1038/ncpcardio0309; FONG YL, 1989, J BIOL CHEM, V264, P16759; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Saotome M, 2005, AM J PHYSIOL-HEART C, V288, pH1820, DOI 10.1152/ajpheart.00589.2004; Sharma V, 2010, MOL CELL BIOCHEM, V337, P223, DOI 10.1007/s11010-009-0303-2; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	31	292	308	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					269	+		10.1038/nature11444	http://dx.doi.org/10.1038/nature11444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23051746	Green Accepted			2022-12-01	WOS:000310774300047
J	Camm, AJ				Camm, A. John			Cardiac arrhythmias-trials and tribulations	LANCET			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ATRIAL-FIBRILLATION; ANTIARRHYTHMIC-DRUGS; PROPHYLACTIC IMPLANTATION; VENTRICULAR-ARRHYTHMIAS; CATHETER ABLATION; RHYTHM CONTROL; HIGH-RISK; PREVENTION; THERAPY		St Georges Univ London, Dept Clin Sci, London SW17 0RE, England	St Georges University London	Camm, AJ (corresponding author), St Georges Univ London, Dept Clin Sci, London SW17 0RE, England.	jcamm@sgul.ac.uk						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Brignole M, 2012, CIRCULATION, V125, P2566, DOI 10.1161/CIRCULATIONAHA.111.082313; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2007, EUROPACE, V9, P1110, DOI 10.1093/europace/eum253; Camm A J, 2012, J R Coll Physicians Edinb, V42 Suppl 18, P23, DOI 10.4997/JRCPE.2012.S03; Camm AJ, 2010, EUROPACE, V12, P1356, DOI 10.1093/europace/euq183; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Einthoven W., 1906, ARCH INT PHYSIOL, V4, P132; Gold MR, 2009, HEART RHYTHM, V6, P295, DOI 10.1016/j.hrthm.2008.11.033; Grace AA, 2012, LANCET, V380, P1498, DOI 10.1016/S0140-6736(12)61462-7; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Healey JS, 2006, CIRCULATION, V114, P11, DOI 10.1161/CIRCULATIONAHA.105.610303; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Morillo C, 2012, LAT BREAK TRIALS HEA, P9; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; Romme JJ, 2011, COCHRANE DB SYST REV, V10; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Savelieva I, 2008, EUROPACE, V10, P647, DOI 10.1093/europace/eun130; Savelieva I, 2011, EUROPACE, V13, P1063, DOI 10.1093/europace/eur181; Theuns DAMJ, 2010, EUROPACE, V12, P1564, DOI 10.1093/europace/euq329; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; Wells G, 2011, CAN MED ASSOC J, V183, P421, DOI 10.1503/cmaj.101685; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	32	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1448	1451		10.1016/S0140-6736(12)61773-5	http://dx.doi.org/10.1016/S0140-6736(12)61773-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101702				2022-12-01	WOS:000310272000005
J	Grace, AA; Roden, DM				Grace, Andrew A.; Roden, Dan M.			Systems biology and cardiac arrhythmias	LANCET			English	Article							GENOME-WIDE ASSOCIATION; LONG-QT SYNDROME; ATRIAL-FIBRILLATION; COMMON VARIANTS; ION-CHANNEL; VENTRICULAR-ARRHYTHMIAS; SUDDEN-DEATH; RISK-FACTORS; PR INTERVAL; CELL MODEL	During the past few years, the development of effective, empirical technologies for treatment of cardiac arrhythmias has exceeded the pace at which detailed knowledge of the underlying biology has accumulated. As a result, although some clinical arrhythmias can be cured with techniques such as catheter ablation, drug treatment and prediction of the risk of sudden death remain fairly primitive. The identification of key candidate genes for monogenic arrhythmia syndromes shows that to bring basic biology to the clinic is a powerful approach. Increasingly sophisticated experimental models and methods of measurement, including stem cell-based models of human cardiac arrhythmias, are being deployed to study how perturbations in several biologic pathways can result in an arrhythmia-prone heart. The biology of arrhythmia is largely quantifiable, which allows for systematic analysis that could transform treatment strategies that are often still empirical into management based on molecular evidence.	[Grace, Andrew A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Grace, Andrew A.] Papworth Hosp, Cambridge CB3 8RE, England; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	University of Cambridge; Papworth Hospital; Vanderbilt University	Grace, AA (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	aag1000@cam.ac.uk	Roden, Dan/ABD-5412-2021		Clinical Data (Forest Laboratories); British Heart Foundation; UK Medical Research Council; Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; US Public Health Service [HL49989, HL65962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL065962, U01HL065962, R01HL049989] Funding Source: NIH RePORTER	Clinical Data (Forest Laboratories); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AAG is a consultant for Xention. DMR has received patent royalties from Clinical Data (Forest Laboratories).; AAG is supported by the British Heart Foundation, the UK Medical Research Council, the Wellcome Trust, and the UK Biotechnology and Biological Sciences Research Council. DMR is supported by grants from the US Public Health Service, including grant numbers HL49989 and HL65962.	Ackerman MJ, 2010, CIRC RES, V107, P457, DOI 10.1161/CIRCRESAHA.110.224592; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Barsheshet A, 2012, CIRCULATION, V125, P1988, DOI 10.1161/CIRCULATIONAHA.111.048041; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Cerrone M, 2009, HEART RHYTHM, V6, P1652, DOI 10.1016/j.hrthm.2009.06.033; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2010, NAT REV CARDIOL, V7, P318, DOI 10.1038/nrcardio.2010.52; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Dewey FE, 2012, CIRCULATION, V125, P931, DOI 10.1161/CIRCULATIONAHA.110.972828; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Jons C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001551; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; Lalani GG, 2012, J AM COLL CARDIOL, V59, P595, DOI 10.1016/j.jacc.2011.10.879; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Magnani JW, 2011, CIRCULATION, V124, P1982, DOI 10.1161/CIRCULATIONAHA.111.039677; Mann SA, 2012, J AM COLL CARDIOL, V59, P1017, DOI 10.1016/j.jacc.2011.11.039; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Murray SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025387; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Rienstra M, 2012, CIRCULATION, V125, P2933, DOI 10.1161/CIRCULATIONAHA.111.069450; Ritchie MD, 2012, J AM COLL CARDIOL, V60, P1173, DOI 10.1016/j.jacc.2012.04.030; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Thomsen PEB, 2010, CIRCULATION, V122, P1258, DOI 10.1161/CIRCULATIONAHA.109.902148; Thul R, 2012, P NATL ACAD SCI USA, V109, P2150, DOI 10.1073/pnas.1115855109; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2011, CIRCULATION, V124, P1001, DOI 10.1161/CIRCULATIONAHA.110.987248; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	100	23	25	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1498	1508		10.1016/S0140-6736(12)61462-7	http://dx.doi.org/10.1016/S0140-6736(12)61462-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101717	Green Accepted			2022-12-01	WOS:000310272000030
J	Kong, D; Tong, QC; Ye, CP; Koda, S; Fuller, PM; Krashes, MJ; Vong, L; Ray, RS; Olson, DP; Lowell, BB				Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Fuller, Patrick M.; Krashes, Michael J.; Vong, Linh; Ray, Russell S.; Olson, David P.; Lowell, Bradford B.			GABAergic RIP-Cre Neurons in the Arcuate Nucleus Selectively Regulate Energy Expenditure	CELL			English	Article							BROWN ADIPOSE-TISSUE; INSULIN-RECEPTOR SUBSTRATE-2; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PANCREATIC BETA-CELL; GLUCOSE-HOMEOSTASIS; AGRP NEURONS; VENTROLATERAL MEDULLA; SYMPATHETIC OUTFLOW; TRACTUS-SOLITARIUS; LEPTIN RESISTANCE	Neural regulation of energy expenditure is incompletely understood. By genetically disrupting GABAergic transmission in a cell-specific fashion, and by combining this with selective pharmacogenetic activation and optogenetic mapping techniques, we have uncovered an arcuate-based circuit that selectively drives energy expenditure. Specifically, mice lacking synaptic GABA release from RIP-Cre neurons have reduced energy expenditure, become obese and are extremely sensitive to high-fat diet-induced obesity, the latter due to defective diet-induced thermogenesis. Leptin's ability to stimulate thermogenesis, but not to reduce feeding, is markedly attenuated. Acute, selective activation of arcuate GABAergic RIP-Cre neurons, which monosynaptically innervate PVH neurons projecting to the NTS, rapidly stimulates brown fat and increases energy expenditure but does not affect feeding. Importantly, this response is dependent upon GABA release from RIP-Cre neurons. Thus, GABAergic RIP-Cre neurons in the arcuate selectively drive energy expenditure, contribute to leptin's stimulatory effect on thermogenesis, and protect against diet-induced obesity.	[Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Krashes, Michael J.; Vong, Linh; Olson, David P.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Fuller, Patrick M.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Ray, Russell S.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Tong, Qingchun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA; [Koda, Shuichi] Asubio Pharma, Kobe, Hyogo 6500047, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; Asubio Pharma Co., Ltd.	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu	Krashes, Michael/P-7677-2019	Tong, Qingchun/0000-0002-4561-2540; Olson, David/0000-0001-9249-7760	BNORC & BADERC Transgenic Core Grant [P30DK046200, P30DK057521]; P&F from BADERC BNORC Grant [P30DK057521, P30DK0460200, R01 DK092605, AHA SDG3280017, NS0736313];  [R01 DK089044];  [R01 DK071051];  [R01 DK075632];  [R37 DK053477]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R37DK053477, R01DK089044, R01DK075632, K08DK071561, R01DK071051, P30DK046200, R01DK096010, R01DK092605, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073613] Funding Source: NIH RePORTER	BNORC & BADERC Transgenic Core Grant; P&F from BADERC BNORC Grant; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge J. Lu, J. B. Ding, and members of the B. B. L. lab for helpful discussion; Z. Yang, J. Yu, B. Choi, X. Hu, S. Ma, and D. Cusher for technical support; C. B. Saper for insightful suggestions and reading the manuscript; K. Deisseroth for AAV-Flex-ChR2(H134R)-mCherry; and B. L. Roth for AAV-FLEX-hM3Dq-mCherry. This work was supported by Grants R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, and BNORC & BADERC Transgenic Core Grants P30DK046200 and P30DK057521 (to B. B. L.), P&F from BADERC & BNORC Grants P30DK057521 and P30DK0460200 (to D. K.), R01 DK092605 and AHA SDG3280017 (to Q. T.), and NS0736313 (to P. M. F.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Cao WH, 2010, AM J PHYSIOL-REG I, V299, pR277, DOI 10.1152/ajpregu.00039.2010; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fuller PM, 2002, P NATL ACAD SCI USA, V99, P15723, DOI 10.1073/pnas.242251499; Geerling JC, 2006, J COMP NEUROL, V497, P646, DOI 10.1002/cne.21019; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; GOLD RM, 1977, PHYSIOL BEHAV, V18, P1111, DOI 10.1016/0031-9384(77)90019-1; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; LEIBOWITZ SF, 1978, PHARMACOL BIOCHEM BE, V8, P163, DOI 10.1016/0091-3057(78)90333-7; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Madden CJ, 2012, AM J PHYSIOL-REG I, V302, pR224, DOI 10.1152/ajpregu.00449.2011; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	59	153	155	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					645	657		10.1016/j.cell.2012.09.020	http://dx.doi.org/10.1016/j.cell.2012.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101631	Bronze, Green Accepted			2022-12-01	WOS:000310529300019
J	Nasvall, J; Sun, L; Roth, JR; Andersson, DI				Nasvall, Joakim; Sun, Lei; Roth, John R.; Andersson, Dan I.			Real-Time Evolution of New Genes by Innovation, Amplification, and Divergence	SCIENCE			English	Article							DUPLICATION	Gene duplications allow evolution of genes with new functions. Here, we describe the innovation-amplification-divergence (IAD) model in which the new function appears before duplication and functionally distinct new genes evolve under continuous selection. One example fitting this model is a preexisting parental gene in Salmonella enterica that has low levels of two distinct activities. This gene is amplified to a high copy number, and the amplified gene copies accumulate mutations that provide enzymatic specialization of different copies and faster growth. Selection maintains the initial amplification and beneficial mutant alleles but is relaxed for other less improved gene copies, allowing their loss. This rapid process, completed in fewer than 3000 generations, shows the efficacy of the IAD model and allows the study of gene evolution in real time.	[Nasvall, Joakim; Sun, Lei; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Roth, John R.] Univ Calif Davis, Dept Biol, Davis, CA 95616 USA	Uppsala University; University of California System; University of California Davis	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se	Näsvall, Joakim/F-8750-2018; zhou, hua/A-6862-2017; Sun, Lei/C-3687-2014	Näsvall, Joakim/0000-0002-6831-3105; Andersson, Dan/0000-0001-6640-2174; Sun, Lei/0000-0002-7222-3137	Swedish Research Council; NIH [GM27068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027068] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Swedish Research Council to D. I. A. and from the NIH (grant GM27068) to J.R.R. The raw Illumina sequencing data sets have been deposited in the National Center for Biotechnology Information Sequence Read Archive (www.ncbi.nlm.nih.gov/Traces/sra/) with accession numbers SRX180378, SRX180382, SRX180383, SRX180384, SRX180385, SRX180387, SRX180388, SRX180390, SRX180391, and SRX180392.	ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hooper SD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r48; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Pettersson ME, 2009, GENETICA, V135, P309, DOI 10.1007/s10709-008-9289-z; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100	20	148	150	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					384	387		10.1126/science.1226521	http://dx.doi.org/10.1126/science.1226521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087246	Green Accepted			2022-12-01	WOS:000309955800041
J	Handley, SA; Thackray, LB; Zhao, G; Presti, R; Miller, AD; Droit, L; Abbink, P; Maxfield, LF; Kambal, A; Duan, E; Stanley, K; Kramer, J; Macri, SC; Permar, SR; Schmitz, JE; Mansfield, K; Brenchley, JM; Veazey, RS; Stappenbeck, TS; Wang, D; Barouch, DH; Virgin, HW				Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Presti, Rachel; Miller, Andrew D.; Droit, Lindsay; Abbink, Peter; Maxfield, Lori F.; Kambal, Amal; Duan, Erning; Stanley, Kelly; Kramer, Joshua; Macri, Sheila C.; Permar, Sallie R.; Schmitz, Joern E.; Mansfield, Keith; Brenchley, Jason M.; Veazey, Ronald S.; Stappenbeck, Thaddeus S.; Wang, David; Barouch, Dan H.; Virgin, Herbert W.			Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome	CELL			English	Article							GUT MICROBIOME; IMMUNE ACTIVATION; HIV-INFECTION; GENE ATG16L1; METAGENOMICS; DISEASE; MOUSE; TRANSLOCATION; SEQUENCES; COLITIS	Pathogenic simian immunodeficiency virus (SIV) infection is associated with enteropathy, which likely contributes to AIDS progression. To identify candidate etiologies for AIDS enteropathy, we used next-generation sequencing to define the enteric virome during SIV infection in nonhuman primates. Pathogenic, but not nonpathogenic, SIV infection was associated with significant expansion of the enteric virome. We identified at least 32 previously undescribed enteric viruses during pathogenic SIV infection and confirmed their presence by using viral culture and PCR testing. We detected unsuspected mucosal adenovirus infection associated with enteritis as well as parvovirus viremia in animals with advanced AIDS, indicating the pathogenic potential of SIV-associated expansion of the enteric virome. No association between pathogenic SIV infection and the family-level taxonomy of enteric bacteria was detected. Thus, enteric viral infections may contribute to AIDS enteropathy and disease progression. These findings underline the importance of metagenomic analysis of the virome for understanding AIDS pathogenesis.	[Abbink, Peter; Maxfield, Lori F.; Stanley, Kelly; Schmitz, Joern E.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Droit, Lindsay; Kambal, Amal; Duan, Erning; Stappenbeck, Thaddeus S.; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhao, Guoyan; Droit, Lindsay; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Presti, Rachel] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Comparat Pathol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Vet Resources, New England Primate Res Ctr, Southborough, MA 01772 USA; [Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [Brenchley, Jason M.] NIAID, Program Barrier Immun, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Repair & Immunopathogenesis Unit, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Veazey, Ronald S.] Tulane Univ, Tulane Natl Primate Res Ctr, Sch Med, Covington, LA 70433 USA; [Barouch, Dan H.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Barouch, Dan H.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; virgin@wustl.edu	Duan, Erning/H-4608-2014; Schmitz, Joern/A-4929-2018; Brenchley, Jason/AAC-5085-2019; Barouch, Dan/Y-3918-2019	Schmitz, Joern/0000-0001-8803-0922; Virgin, Herbert/0000-0001-8580-7628; Brenchley, Jason/0000-0001-8357-2984; Presti, Rachel/0000-0002-5469-0727	Project 10 [U54 AI057160-08]; National Center for Research Resources [1R01 RR032309]; Office of Research Infrastructure Programs [OD11170-02]; Crohn's and Colitis Foundation [3132];  [AI066305];  [AI066924];  [AI078526];  [AI095985];  [AI65335];  [8P51OD011103-5]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR032309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065335, K08AI087992, U54AI057160, R01AI066924, U19AI095985, P30AI060354, U19AI066305, U19AI078526, ZIAAI001029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103, R01OD011170] Funding Source: NIH RePORTER	Project 10; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; Crohn's and Colitis Foundation; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Project 10 of U54 AI057160-08 to D. W. for development of VirusHunter software, was initially funded by the National Center for Research Resources 1R01 RR032309, and is currently supported by the Office of Research Infrastructure Programs OD11170-02 to H. W. V. and D. H. B.; Crohn's and Colitis Foundation Grant 3132 to H. W. V. and T. S. S.; grants AI066305, AI066924, AI078526, and AI095985 to D. H. B.; AI65335 to J.E.S.; and grant 8P51OD011103-5 to A. D. M. and J.K. We would like to thank Angela Carville, Elizabeth Curran, and Vanessa Hirsch for assistance with these experiments.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey C, 2010, VET PATHOL, V47, P462, DOI 10.1177/0300985810363719; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Oberste MS, 2007, J GEN VIROL, V88, P3360, DOI 10.1099/vir.0.83124-0; Oberste MS, 2002, J VIROL, V76, P1244, DOI 10.1128/JVI.76.3.1244-1251.2002; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sasseville VG, 2010, J IMMUNOTOXICOL, V7, P79, DOI 10.3109/15476910903213521; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao GY, 2011, J VIROL, V85, P10230, DOI 10.1128/JVI.00637-11	38	210	218	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					253	266		10.1016/j.cell.2012.09.024	http://dx.doi.org/10.1016/j.cell.2012.09.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063120	Bronze, Green Accepted			2022-12-01	WOS:000309981000006
J	Hardie, RC; Franze, K				Hardie, Roger C.; Franze, Kristian			Photomechanical Responses in Drosophila Photoreceptors	SCIENCE			English	Article							LIGHT-SENSITIVE CHANNELS; MEMBRANE-PROTEIN FUNCTION; PHOSPHOLIPASE-C; ION CHANNELS; TRP; ACTIVATION	Phototransduction in Drosophila microvillar photoreceptor cells is mediated by a G protein-activated phospholipase C (PLC). PLC hydrolyzes the minor membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), leading by an unknown mechanism to activation of the prototypical transient receptor potential (TRP) and TRP-like (TRPL) channels. We found that light exposure evoked rapid PLC-mediated contractions of the photoreceptor cells and modulated the activity of mechanosensitive channels introduced into photoreceptor cells. Furthermore, photoreceptor light responses were facilitated by membrane stretch and were inhibited by amphipaths, which alter lipid bilayer properties. These results indicate that, by cleaving PIP2, PLC generates rapid physical changes in the lipid bilayer that lead to contractions of the microvilli, and suggest that the resultant mechanical forces contribute to gating the light-sensitive channels.	[Hardie, Roger C.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	rch14@cam.ac.uk		Franze, Kristian/0000-0002-8425-7297; Hardie, Roger/0000-0001-5531-3264	UK Biotechnology and Biological Sciences Research Council [BB/G0068651]; UK Medical Research Council Career Development Award; BBSRC [BB/J009253/1] Funding Source: UKRI; MRC [G1100312] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009253/1] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. G. Stavenga, S. B. Laughlin, and M. Postma for comments on the manuscript; O. Andersen for advice on the use of gramicidin; and J. Grosche (Effigos AG) for artwork for Fig. 1A. Supported by UK Biotechnology and Biological Sciences Research Council grant BB/G0068651 (R. C. H.) and a UK Medical Research Council Career Development Award (K. F.). Author contributions: project initiation, R. C. H.; whole-cell electrophysiology experiments, R. C. H.; AFM measurements, K. F., R. C. H.; paper written by R. C. H. with contribution from K.F.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Franze K, 2011, CURR OPIN GENET DEV, V21, P530, DOI 10.1016/j.gde.2011.07.001; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2012, WIRES MEMBR TRANSP S, V1, P162, DOI [10.1002/wmts.20, DOI 10.1002/WMTS.20]; Holopainen JM, 2002, BIOPHYS J, V83, P932, DOI 10.1016/S0006-3495(02)75219-3; HUANG JH, 2010, FASD, V20, P189, DOI DOI 10.1016/J.CUB.2009.12.019; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Patel A., 2010, FADS, V460, P571; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3	21	135	136	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					260	263		10.1126/science.1222376	http://dx.doi.org/10.1126/science.1222376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066080				2022-12-01	WOS:000309712300047
J	Broderick, CR; Herbert, RD; Latimer, J; Barnes, C; Curtin, JA; Mathieu, E; Monagle, P; Brown, SA				Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane; Barnes, Chris; Curtin, Julie A.; Mathieu, Erin; Monagle, Paul; Brown, Simon A.			Association Between Physical Activity and Risk of Bleeding in Children With Hemophilia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT FACTOR-VIII; FACTOR-IX; PROPHYLACTIC TREATMENT; PHARMACOKINETICS; PARTICIPATION; OUTCOMES; PATIENT; DISEASE; SAFETY	Context Vigorous physical activity is thought to increase risk of bleeds in children with hemophilia, but the magnitude of the risk is unknown. Objective To quantify the transient increase in risk of bleeds associated with physical activity in children with hemophilia. Design, Setting, and Participants A case-crossover study nested within a prospective cohort study was conducted at 3 pediatric hemophilia centers in Australia between July 2008 and October 2010. A total of 104 children and adolescent boys aged 4 through 18 years with moderate or severe hemophilia A or B were monitored for bleeds for up to 1 year. Following each bleed, the child or parent was interviewed to ascertain exposures to physical activity preceding the bleed. Physical activity was categorized according to expected frequency and severity of collisions. The risk of bleeds associated with physical activity was estimated by contrasting exposure to physical activity in the 8 hours before the bleed with exposures in two 8-hour control windows, controlling for levels of clotting factor in the blood. Main Outcome Measures Association of physical activity and factor level with risk of bleeding. Results The participants were observed for 4839 person-weeks during which time 436 bleeds occurred. Of these, 336 bleeds occurred more than 2 weeks after the preceding bleed and were used in the primary analysis of risk. Compared with inactivity and category 1 activities (eg, swimming), category 2 activities (eg, basketball) were associated with a transient increase in the risk of bleeding (30.6% of bleed windows vs 24.8% of first control windows; odds ratio, 2.7; 95% CI, 1.7-4.8, P < .001). Category 3 activities (eg, wrestling) were associated with a greater transient increase in risk (7.0% of bleed windows vs 3.4% of first control windows; odds ratio, 3.7; 95% CI, 2.3-7.3, P < .001). To illustrate absolute risk increase, for a child who bleeds 5 times annually and is exposed on average to category 2 activities twice weekly and to category 3 activities once weekly, exposure to these activities was associated with only 1 of the 5 annual bleeds. For every 1% increase in clotting factor level, bleeding incidence was lower by 2% (95% CI, 1%-3%; P=.004). Conclusions In children and adolescents with hemophilia, vigorous physical activity was transiently associated with a moderate relative increase in risk of bleeding. Because the increased relative risk is transient, the absolute increase in risk of bleeds associated with physical activity is likely to be small. JAMA. 2012;308(14):1452-1459 www.jama.com	[Broderick, Carolyn R.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia; [Broderick, Carolyn R.; Latimer, Jane; Mathieu, Erin] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Broderick, Carolyn R.] Childrens Hosp Westmead, Childrens Hosp Inst Sports Med, Westmead, NSW, Australia; [Curtin, Julie A.] Childrens Hosp Westmead, Dept Haematol, Westmead, NSW, Australia; [Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane] George Inst Global Hlth, Musculoskeletal Div, Sydney, NSW, Australia; [Herbert, Robert D.] Neurosci Res Australia, Randwick, NSW, Australia; [Barnes, Chris; Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Monagle, Paul] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Brown, Simon A.] Royal Childrens Hosp, Dept Haematol & Oncol, Herston, Qld, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; Neuroscience Research Australia; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Brisbane	Broderick, CR (corresponding author), Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia.	c.broderick@unsw.edu.au	Herbert, Rob/E-9442-2012	Herbert, Rob/0000-0003-4188-9195; Monagle, Paul/0000-0002-3970-8984; Mathieu, Erin/0000-0002-5209-7989; Broderick, Carolyn/0000-0003-0096-796X	Bayer Hemophilia Awards Program; NovoNordisk; Bayer; Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer; National Health and Medical Research Council (NHMRC); Australian NHMRC; Australian Research Council	Bayer Hemophilia Awards Program; NovoNordisk(Novo Nordisk); Bayer(Bayer AG); Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer(Pfizer); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Broderick, Herbert, Latimer, and Curtin reported that they have previously received a competitive research grant from the Bayer Hemophilia Awards Program. Dr Barnes reported receiving speaker fees from NovoNordisk, Bayer, Baxter Health Care, and CSL-Behring. He has also received consultant fees from NovoNordisk and BaxterHealthCare. Dr Curtin reported that she is a paid consultant of the Novo Nordisk Hemophilia Advisory Board and has received research support from CSL. She has also received conference travel support from Baxter and Pfizer. Dr Brown has previously received an honorarium from Novo Nordisk.; This study was supported by a project grant from the National Health and Medical Research Council (NHMRC). Dr Herbert is supported by a research fellowship from the Australian NHMRC, and Dr Latimer is supported by a Future Fellowship from the Australian Research Council.	ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Anderson A, 2005, PLAYING IT SAFE BLEE; Barnes C, 2006, HAEMOPHILIA, V12, P40, DOI 10.1111/j.1365-2516.2006.01333.x; Bjorkman S, 1997, HAEMOPHILIA, V3, P1, DOI 10.1046/j.1365-2516.1997.00074.x; Bjorkman S, 2001, HAEMOPHILIA, V7, P133, DOI 10.1046/j.1365-2516.2001.00465.x; Blanchette VS, 2008, J THROMB HAEMOST, V6, P1319, DOI 10.1111/j.1538-7836.2008.03032.x; Broderick CR, 2013, HAEMOPHILIA, V19, P59, DOI 10.1111/j.1365-2516.2012.02904.x; Broderick Carolyn R, 2008, BMC Blood Disord, V8, P2, DOI 10.1186/1471-2326-8-2; CARLSSON N, 1993, EUR J HAEMATOL, V51, P247; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fischer K, 2002, HAEMOPHILIA, V8, P753, DOI 10.1046/j.1365-2516.2002.00694.x; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Karafoulidou A, 2009, EUR J CLIN PHARMACOL, V65, P1121, DOI 10.1007/s00228-009-0699-3; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Poon MC, 2002, THROMB HAEMOSTASIS, V87, P431; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Ross C, 2009, PEDIATRICS, V124, P1267, DOI 10.1542/peds.2009-0072; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Srivastava A, 2003, HAEMOPHILIA, V9, P391, DOI 10.1046/j.1365-2516.2003.00766.x; Tiktinsky R, 2009, HAEMOPHILIA, V15, P695, DOI 10.1111/j.1365-2516.2009.01990.x; Twisk JWR., 2003, APPL LONGITUDINAL DA; Van den Berg HM, 2007, J THROMB HAEMOST, V5, P151, DOI 10.1111/j.1538-7836.2007.02503.x; Weigel N, 1975, Am Correct Ther J, V29, P197	25	91	93	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1452	1459		10.1001/jama.2012.12727	http://dx.doi.org/10.1001/jama.2012.12727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047359	Bronze			2022-12-01	WOS:000309579300024
J	Qin, JJ; Li, YR; Cai, ZM; Li, SH; Zhu, JF; Zhang, F; Liang, SS; Zhang, WW; Guan, YL; Shen, DQ; Peng, YQ; Zhang, DY; Jie, ZY; Wu, WX; Qin, YW; Xue, WB; Li, JH; Han, LC; Lu, DH; Wu, PX; Dai, YL; Sun, XJ; Li, ZS; Tang, AF; Zhong, SL; Li, XP; Chen, WN; Xu, R; Wang, MB; Feng, Q; Gong, MH; Yu, J; Zhang, YY; Zhang, M; Hansen, T; Sanchez, G; Raes, J; Falony, G; Okuda, S; Almeida, M; LeChatelier, E; Renault, P; Pons, N; Batto, JM; Zhang, ZX; Chen, H; Yang, RF; Zheng, WM; Li, SG; Yang, HM; Wang, J; Ehrlich, SD; Nielsen, R; Pedersen, O; Kristiansen, K; Wang, J				Qin, Junjie; Li, Yingrui; Cai, Zhiming; Li, Shenghui; Zhu, Jianfeng; Zhang, Fan; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Zhong, Shilong; Li, Xiaoping; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Hansen, Torben; Sanchez, Gaston; Raes, Jeroen; Falony, Gwen; Okuda, Shujiro; Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Ehrlich, S. Dusko; Nielsen, Rasmus; Pedersen, Oluf; Kristiansen, Karsten; Wang, Jun			A metagenome-wide association study of gut microbiota in type 2 diabetes	NATURE			English	Article							OBESITY; DIVERSITY; BACTEREMIA; INFECTION; STRESS	Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabetes, the most prevalent endocrine disease worldwide. To carry out analysis on gut microbial content in patients with type 2 diabetes, we developed a protocol for a metagenome-wide association study (MGWAS) and undertook a two-stage MGWAS based on deep shotgun sequencing of the gut microbial DNA from 345 Chinese individuals. We identified and validated approximately 60,000 type-2-diabetes-associated markers and established the concept of a metagenomic linkage group, enabling taxonomic species-level analyses. MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance. An analysis of 23 additional individuals demonstrated that these gut microbial markers might be useful for classifying type 2 diabetes.	[Qin, Junjie; Li, Yingrui; Li, Shenghui; Zhu, Jianfeng; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cai, Zhiming; Li, Zesong; Tang, Aifa; Zhong, Shilong] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen 518035, Peoples R China; [Zhang, Fan; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan] Peking Univ, Shenzhen Hosp, Shenzhen 518036, Peoples R China; [Li, Xiaoping] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou 510080, Peoples R China; [Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] Vrije Univ Brussel, Dept Appl Biol Sci DBIT, B-1050 Brussels, Belgium; [Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Shenzhen University; Peking University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Beijing Institute of Microbiology & Epidemiology; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn	Pedersen, Oluf/Z-1731-2019; Nielsen, Rasmus/D-4405-2009; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; raes, jeroen/D-7835-2018; Yang, Ruifu/A-2273-2011; Wang, Mingbang/F-4457-2018; Pedersen, Oluf/AAG-8015-2020; Okuda, Shujiro/D-1700-2016; Qin, Youwen/AAY-1194-2021; LE CHATELIER, Emmanuelle/O-1243-2017; Ehrlich, S./Y-2423-2019; Falony, Gwen/AAN-5011-2020; Li, Junhua/AAG-3919-2019; Kristiansen, Karsten/J-5148-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Pedersen, Oluf/0000-0002-3321-3972; Nielsen, Rasmus/0000-0003-0513-6591; raes, jeroen/0000-0002-1337-041X; Yang, Ruifu/0000-0003-3219-7269; Wang, Mingbang/0000-0002-5989-5377; Okuda, Shujiro/0000-0002-7704-8104; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Ehrlich, S./0000-0002-7563-4046; Falony, Gwen/0000-0003-2450-0782; Li, Junhua/0000-0001-6784-1873; Kristiansen, Karsten/0000-0002-6024-0917; Hansen, Torben/0000-0001-8748-3831; Wang, Jun/0000-0002-2113-5874; Qin, Youwen/0000-0003-3956-4711; guan, yuanlin/0000-0002-4839-0146; Liang, Suisha/0000-0003-0426-9827; Wang, Jun/0000-0002-8540-8931; Li, Shenghui/0000-0003-1071-8510	Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation; Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank L. Goodman for editing the manuscript and providing comments. This research was supported by the Ministry of Science and Technology of China, 863 program (2012AA02A201), the National Natural Science Foundation of China (30890032, 30725008, 30811130531, 31161130357), the Shenzhen Municipal Government of China (ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A), the Danish Strategic Research Council grant (2106-07-0021), the Ole Romer grant from Danish Natural Science Research Council, the Solexa project (272-07-0196), and the European Commission FP7 grant HEALTH-F4-2007-201052. The Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp, www.lucamp.org). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this work.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BROOK I, 1995, J MED MICROBIOL, V42, P78, DOI 10.1099/00222615-42-2-78; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elsayed S, 2004, J CLIN MICROBIOL, V42, P4390, DOI 10.1128/JCM.42.9.4390-4392.2004; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P111, DOI 10.1111/j.1365-2982.2010.01659.x; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li S., 2012, GIGASCIENCE; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Woo PCY, 2004, J CLIN MICROBIOL, V42, P5947, DOI 10.1128/JCM.42.12.5947-5949.2004; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	3718	4116	76	1471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					55	60		10.1038/nature11450	http://dx.doi.org/10.1038/nature11450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023125				2022-12-01	WOS:000309446800031
J	Garber, K				Garber, Ken			BIOCHEMISTRY A radical treatment	NATURE			English	Editorial Material																		Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278	9	18	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S4	S6		10.1038/489S4a	http://dx.doi.org/10.1038/489S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013714				2022-12-01	WOS:000309167100003
J	Bygbjerg, IC				Bygbjerg, I. C.			Double Burden of Noncommunicable and Infectious Diseases in Developing Countries	SCIENCE			English	Editorial Material							LOW-BIRTH-WEIGHT; FETAL; POPULATION; TUBERCULOSIS; PREVENTION; MALARIA	On top of the unfinished agenda of infectious diseases in low- and middle-income countries, development, industrialization, urbanization, investment, and aging are drivers of an epidemic of noncommunicable diseases (NCDs). Malnutrition and infection in early life increase the risk of chronic NCDs in later life, and in adult life, combinations of major NCDs and infections, such as diabetes and tuberculosis, can interact adversely. Because intervention against either health problem will affect the other, intervening jointly against noncommunicable and infectious diseases, rather than competing for limited funds, is an important policy consideration requiring new thinking and approaches.	Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, DK-1014 Copenhagen K, Denmark	University of Copenhagen	Bygbjerg, IC (corresponding author), Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, 5 Oster Farimagsgade, DK-1014 Copenhagen K, Denmark.	iby@sund.ku.dk		Bygbjerg, Ib/0000-0001-9100-2754				Agrasada GV, 2011, ASIA PAC J CLIN NUTR, V20, P62; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; [Anonymous], WHOHTMTB201115; Barker D. J., 1986, J GERONTOL B-PSYCHOL, V327, P1077, DOI 10.1016/S0140-6736(86)91340-1; Bygbjerg Ib Christian, 2012, Ugeskr Laeger, V174, P1516; C. Y, 2008, PLOS MED, V15, pe152; Christensen DL, 2011, INT J GYNECOL OBSTET, V115, pS16, DOI 10.1016/S0020-7292(11)60006-4; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harries AD, 2011, INT J TUBERC LUNG D, V15, pi; Lau C, 2011, OBSTET GYNECOL, V117, P978, DOI 10.1097/AOG.0b013e318212140e; LEIKIN EL, 1987, OBSTET GYNECOL, V69, P570; Li L., 2012, TROP MED INT HEALTH, DOI [10.1111/j.13652012.03068.x, DOI 10.1111/J.13652012.03068.X]; Lutter CK, 2012, SCIENCE, V337, P1495, DOI 10.1126/science.1224616; Mathers C.D., 2005, UPDATED PROJECTIONS; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Murray CJL, 1996, GLOBAL BURDEN DIS, V1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Philips I., 1968, BRIT MED J, V5589, P407; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; WHO, 2003, WHOCDSTB2003319, P319; WHO, MAL HIV AIDS INT IMP; WHO UNAIDS, 2001, WHOCDSCPESMT200113 U, P13; World Bank, 2007, PUBL POL CHALL CHRON; World Health Organization, 1999, WORLD HLTH REP, P13; World Health Organization, 2005, PREVENTING CHRONIC D; World Health Organization, 2011, UN HIGH LEV M NONC D; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	34	185	188	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1499	1501		10.1126/science.1223466	http://dx.doi.org/10.1126/science.1223466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997329	Green Submitted			2022-12-01	WOS:000308912900041
J	Williams, Z				Williams, Zev			Inducing Tolerance to Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA	Montefiore Medical Center; Yeshiva University	Williams, Z (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA.				NICHD NIH HHS [K08 HD068546] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	4	74	86	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1159	1161		10.1056/NEJMcibr1207279	http://dx.doi.org/10.1056/NEJMcibr1207279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22992082	Green Accepted			2022-12-01	WOS:000308861800016
J	Wilding, J				Wilding, John			Are the causes of obesity primarily environmental? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BODY-MASS INDEX; CHILDHOOD OBESITY		Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England	University of Liverpool	Wilding, J (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England.	j.p.h.wilding@liv.ac.uk	Wilding, John PH/A-7106-2008; Wilding, John/ABB-6443-2020	Wilding, John PH/0000-0003-2839-8404; Wilding, John/0000-0003-2839-8404				Allison DB, 1996, INT J OBESITY, V20, P501; Borys JM, 2012, OBES REV, V13, P299, DOI 10.1111/j.1467-789X.2011.00950.x; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Foresight, 2007, TACKL OB FUT CHOIC P; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gilmore AB, 2011, J PUBLIC HEALTH-UK, V33, P2, DOI 10.1093/pubmed/fdr008; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mayor S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6688; Romon M, 2009, PUBLIC HEALTH NUTR, V12, P1735, DOI 10.1017/S1368980008004278; ROTHWELL NJ, 1982, BRIT J NUTR, V47, P461, DOI 10.1079/BJN19820058; World Health Organization, 2009, GLOB HLTH RISKS MORT	12	17	17	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5843	10.1136/bmj.e5843	http://dx.doi.org/10.1136/bmj.e5843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BG	22968528				2022-12-01	WOS:000308863200005
J	Lima, WF; Prakash, TP; Murray, HM; Kinberger, GA; Li, WY; Chappell, AE; Li, CS; Murray, SF; Gaus, H; Seth, PP; Swayze, EE; Crooke, ST				Lima, Walt F.; Prakash, Thazha P.; Murray, Heather M.; Kinberger, Garth A.; Li, Wenyu; Chappell, Alfred E.; Li, Cheryl S.; Murray, Susan F.; Gaus, Hans; Seth, Punit P.; Swayze, Eric E.; Crooke, Stanley T.			Single-Stranded siRNAs Activate RNAi in Animals	CELL			English	Article							SMALL INTERFERING RNA; MAMMALIAN-CELLS; CHEMICAL-MODIFICATIONS; HUMAN DICER; OLIGONUCLEOTIDE; IDENTIFICATION; ARGONAUTE2; STABILITY; CLEAVAGE; DUPLEXES	The therapeutic utility of siRNAs is limited by the requirement for complex formulations to deliver them to tissues. If potent single-stranded RNAs could be identified, they would provide a simpler path to pharmacological agents. Here, we describe single-stranded siRNAs (ss-siRNAs) that silence gene expression in animals absent lipid formulation. Effective ss-siRNAs were identified by iterative design by determining structure-activity relationships correlating chemically modified single strands and Argonaute 2 (AGO2) activities, potency in cells, nuclease stability, and pharmacokinetics. We find that the passenger strand is not necessary for potent gene silencing. The guide-strand activity requires AGO2, demonstrating action through the RNAi pathway. ss-siRNA action requires a 5' phosphate to achieve activity in vivo, and we developed a metabolically stable 5'-(E)-vinylphosphonate (5'-VP) with conformation and sterioelectronic properties similar to the natural phosphate. Identification of potent ss-siRNAs offers an additional option for RNAi therapeutics and an alternate perspective on RNAi mechanism.	[Lima, Walt F.; Murray, Heather M.; Li, Cheryl S.; Crooke, Stanley T.] Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA; [Prakash, Thazha P.; Kinberger, Garth A.; Li, Wenyu; Seth, Punit P.; Swayze, Eric E.] Isis Pharmaceut Inc, Med Chem, Carlsbad, CA 92010 USA; [Chappell, Alfred E.; Gaus, Hans] Isis Pharmaceut Inc, Struct Biol, Carlsbad, CA 92010 USA; [Murray, Susan F.] Isis Pharmaceut Inc, Mol Pharmacol, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA.	wlima@isisph.com	Seth, Punit/M-2205-2019; Murray, Heather/GQY-8016-2022	Seth, Punit/0000-0002-1783-7806; Gaus, Hans/0000-0002-7471-8619; Swayze, Eric/0000-0001-6430-6576				Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Caplen NJ, 2003, EXPERT OPIN BIOL TH, V3, P575, DOI 10.1517/14712598.3.4.575; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Crooke S. T., 2008, ANTISENSE DRUG TECHN; Dande P, 2006, J MED CHEM, V49, P1624, DOI 10.1021/jm050822c; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Graham MJ, 1998, J PHARMACOL EXP THER, V286, P447; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Guzaev AP, 2003, J AM CHEM SOC, V125, P2380, DOI 10.1021/ja0284613; Hall AHS, 2004, NUCLEIC ACIDS RES, V32, P5991, DOI 10.1093/nar/gkh936; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Kini HK, 2007, FEBS LETT, V581, P5611, DOI 10.1016/j.febslet.2007.11.010; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tao WK, 2011, MOL THER, V19, P567, DOI 10.1038/mt.2010.282; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wu HJ, 1998, J BIOL CHEM, V273, P2532, DOI 10.1074/jbc.273.5.2532; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	34	184	245	2	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					883	894		10.1016/j.cell.2012.08.014	http://dx.doi.org/10.1016/j.cell.2012.08.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939618	Bronze			2022-12-01	WOS:000308500200005
J	Rapley, C				Rapley, Chris			Time to raft up	NATURE			English	Editorial Material							CLIMATE		UCL, Dept Earth Sci, London WC1E 6BT, England	University of London; University College London	Rapley, C (corresponding author), UCL, Dept Earth Sci, London WC1E 6BT, England.	christopher.rapley@ucl.ac.uk						Ding D, 2011, NAT CLIM CHANGE, V1, P462, DOI 10.1038/NCLIMATE1295; Festinger L, 1964, CONFLICT DECIS DISSO; Grundmann R., 2012, SCI TECHNOL HUM VALU; International Council for Science, 2012, FUT EARTH RES GLOB S; Kahan D, 2012, NATURE CLIM CHANGE; McCallie E, 2007, MUS SOC ISS, V2, P165, DOI 10.1179/msi.2007.2.2.165; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Sarewitz D., 2012, WORKSH AAAS SCI RESP; Shuckburgh E., CLIMATE SCI IN PRESS; Weintrobe S., ENGAGING CL IN PRESS	10	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					583	585		10.1038/488583a	http://dx.doi.org/10.1038/488583a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932363				2022-12-01	WOS:000308095100025
J	Yi, W; Clark, PM; Mason, DE; Keenan, MC; Hill, C; Goddard, WA; Peters, EC; Driggers, EM; Hsieh-Wilson, LC				Yi, Wen; Clark, Peter M.; Mason, Daniel E.; Keenan, Marie C.; Hill, Collin; Goddard, William A., III; Peters, Eric C.; Driggers, Edward M.; Hsieh-Wilson, Linda C.			Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism	SCIENCE			English	Article							O-GLCNAC MODIFICATION; BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; GLUCOSE-METABOLISM; BREAST-CANCER; TRANSFERASE; INHIBITION; PATHWAY; STRESS	Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing microenvironment. We demonstrated that the dynamic posttranslational modification of proteins by O-linked beta-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells. Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired tumor formation in vivo. These studies reveal a previously uncharacterized mechanism for the regulation of metabolic pathways in cancer and a possible target for therapeutic intervention.	[Goddard, William A., III; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Yi, Wen; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mason, Daniel E.; Peters, Eric C.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Keenan, Marie C.; Hill, Collin; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; Agios Pharmaceuticals	Hsieh-Wilson, LC (corresponding author), CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	lhw@caltech.edu	Peters, Eric/W-2739-2019; Yi, Wen/M-5905-2014		National Institutes of Health [R01 GM084724]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0988]; Tobacco-Related Disease Research Program Postdoctoral Fellowship [19FT-0078]; Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Tobacco-Related Disease Research Program Postdoctoral Fellowship(University of California System); Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Qasba for the Y289L GalT construct, R. Abrol for computational modeling advice, R. Diamond for cell cycle analysis, and L. Cantley and M. Vander Heiden for useful discussions. This work was supported by the National Institutes of Health (grant R01 GM084724 to L. C. H-W), the Department of Defense Breast Cancer Research Program (grant W81XWH-10-1-0988 to W.Y), and a Tobacco-Related Disease Research Program Postdoctoral Fellowship (19FT-0078 to W.Y). We also thank Agios Pharmaceuticals for financial support in providing patient tumor and matched tissue samples.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lu XH, 2000, CLIN CANCER RES, V6, P271; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Moseley HNB, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-37; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/nchembio.770, 10.1038/NCHEMBIO.770]; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Sidorenko Y, 2008, BIOTECHNOL PROGR, V24, P311, DOI 10.1021/bp0702673; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	29	390	420	10	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					975	980		10.1126/science.1222278	http://dx.doi.org/10.1126/science.1222278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923583	Green Accepted			2022-12-01	WOS:000307807600048
J	Zhang, Y; Feng, Y; Chatterjee, S; Tuske, S; Ho, MX; Arnold, E; Ebright, RH				Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.			Structural Basis of Transcription Initiation	SCIENCE			English	Article							RNA-POLYMERASE HOLOENZYME; PROMOTER OPEN COMPLEX; SIGMA-SUBUNIT; ANGSTROM RESOLUTION; RECOGNITION; ELEMENT; ORGANIZATION; ARCHITECTURE; ELONGATION; MECHANISM	During transcription initiation, RNA polymerase (RNAP) binds and unwinds promoter DNA to form an RNAP-promoter open complex. We have determined crystal structures at 2.9 and 3.0 angstrom resolution of functional transcription initiation complexes comprising Thermus thermophilus RNA polymerase, sigma(A), and a promoter DNA fragment corresponding to the transcription bubble and downstream double-stranded DNA of the RNAP-promoter open complex. The structures show that sigma recognizes the -10 element and discriminator element through interactions that include the unstacking and insertion into pockets of three DNA bases and that RNAP recognizes the -4/+2 region through interactions that include the unstacking and insertion into a pocket of the +2 base. The structures further show that interactions between sigma and template-strand single-stranded DNA (ssDNA) preorganize template-strand ssDNA to engage the RNAP active center.	[Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tuske, Steve; Ho, Mary X.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	Ebright, Richard/O-3321-2019; Chatterjee, Sujoy/L-7325-2015; Zhang, Yu/AAV-5722-2021; Zhang, Yu/J-5225-2014	Ebright, Richard/0000-0001-8915-7140; Zhang, Yu/0000-0002-1778-8389; Feng, Yu/0000-0003-4239-8320	NIH [GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Brookhaven National Synchrotron Light Source and Cornell High Energy Synchrotron Source for beamline access; the Argonne Photon Source CCP4 School for training; and S. Borukhov, P. deHaseth, K. Kuznedelov, L. Minakhin, K. Severinov, and D. Temiakov for plasmids and discussion. This work was funded by NIH grants GM41376 and AI072766 and a Howard Hughes Medical Institute Investigatorship to R. H. E. PDB accession codes are 4G7H, 4G7Z, and 4G7O.	Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Kireeva ML, 2011, J BIOL CHEM, V286, P30898, DOI 10.1074/jbc.M111.260844; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Liu X, 2011, CELL, V147, P1218, DOI 10.1016/j.cell.2011.11.033; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P22600, DOI 10.1074/jbc.M111.247080; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6	29	236	239	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1076	1080		10.1126/science.1227786	http://dx.doi.org/10.1126/science.1227786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086998	Green Accepted			2022-12-01	WOS:000311390600043
J	Tischer, T; Hormanseder, E; Mayer, TU				Tischer, Thomas; Hoermanseder, Eva; Mayer, Thomas U.			The APC/C Inhibitor XErp1/Emi2 Is Essential for Xenopus Early Embryonic Divisions	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYTOSTATIC FACTOR ARREST; MEIOTIC ARREST; CELL-CYCLE; GREATWALL KINASE; PHOSPHATASE 2A; LAEVIS EGGS; PHOSPHORYLATION; EMI2; MITOSIS	Mitotic divisions result from the oscillating activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 activity is terminated by the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets cyclin B for destruction. In somatic divisions, the early mitotic inhibitor 1 (Emi1) and the spindle assembly checkpoint (SAC) regulate cell cycle progression by inhibiting the APC/C. Early embryonic divisions lack these APC/C-inhibitory components, which raises the question of how those cycles are controlled. We found that the APC/C-inhibitory activity of XErp1 (also known as Emi2) was essential for early divisions in Xenopus embryos. Loss of XErp1 resulted in untimely destruction of APC/C substrates and embryonic lethality. XErp1's APC/C-inhibitory function was negatively regulated by Cdk1 and positively by protein phosphatase 2A (PP2A). Thus, Cdk1 and PP2A operate at the core of early mitotic cell cycles by antagonistically controlling XErp1 activity, which results in oscillating APC/C activity.	[Mayer, Thomas U.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Mayer, TU (corresponding author), Univ Konstanz, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	thomas.u.mayer@uni-konstanz.de		Tischer, Thomas/0000-0002-6845-2762; Mayer, Thomas/0000-0001-6954-2287; Hormanseder, Eva/0000-0003-0340-6340	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	We thank D. Bertinetti, A. Burkle, J. Gannon, T. Hunt, F. W. Herberg, T. Lorca, S. Mochida, and N. Sagata for reagents; the team of D. Schopper and G. Mende for excellent animal care; and the Mayer group and B. Novak for discussions. The authors declare no competing financial interests. Supported by the Doc-fForte program of the Austrian Academy of Science and by the Collaborative Research Center 969 of the German Research Foundation (DFG).	ASHBY CD, 1973, J BIOL CHEM, V248, P1255; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CLUTE P, 1992, DEV GROWTH DIFFER, V34, P27; Duncan T, 2004, CURR BIOL, V14, pR305, DOI 10.1016/j.cub.2004.03.050; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Isoda M, 2011, DEV CELL, V21, P506, DOI 10.1016/j.devcel.2011.06.029; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Maller JL, 2001, NOVART FDN SYMP, V237, P58, DOI 10.1002/0470846666.ch6; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	22	33	33	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					520	524		10.1126/science.1228394	http://dx.doi.org/10.1126/science.1228394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23019610	Green Submitted			2022-12-01	WOS:000310195800056
J	Farago, M; Rosenbluh, C; Tevlin, M; Fraenkel, S; Schlesinger, S; Masika, H; Gouzman, M; Teng, G; Schatz, D; Rais, Y; Hanna, JH; Mildner, A; Jung, S; Mostoslavsky, G; Cedar, H; Bergman, Y				Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Teng, Grace; Schatz, David; Rais, Yoach; Hanna, Jacob H.; Mildner, Alexander; Jung, Steffen; Mostoslavsky, Gustavo; Cedar, Howard; Bergman, Yehudit			Clonal allelic predetermination of immunoglobulin-kappa rearrangement	NATURE			English	Article							B-CELL DEVELOPMENT; ASYNCHRONOUS REPLICATION; IN-VITRO; MATURE B; GENES; EXPRESSION; TRANSCRIPTION; INACTIVATION; LYSINE-4; MICE	Although most genes are expressed biallelically, a number of key genomic sites-including immune and olfactory receptor regions-are controlled monoallelically in a stochastic manner, with some cells expressing the maternal allele and others the paternal allele in the target tissue(1,2). Very little is known about how this phenomenon is regulated and programmed during development. Here, using mouse immunoglobulin-kappa (Ig kappa) as a model system, we demonstrate that although individual haematopoietic stem cells are characterized by allelic plasticity, early lymphoid lineage cells become committed to the choice of a single allele, and this decision is then stably maintained in a clonal manner that predetermines monoallelic rearrangement in B cells. This is accompanied at the molecular level by underlying allelic changes in asynchronous replication timing patterns at the kappa locus. These experiments may serve to define a new concept of stem cell plasticity.	[Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Cedar, Howard; Bergman, Yehudit] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Teng, Grace; Schatz, David] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Schatz, David] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Rais, Yoach; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Dept Med, Boston, MA 02118 USA	Hebrew University of Jerusalem; Yale University; Howard Hughes Medical Institute; Yale University; Weizmann Institute of Science; Weizmann Institute of Science; Boston University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	cedar@mail.huji.ac.il; Yehudit.Bergman@huji.ac.il	mildner, alexander/GQA-3761-2022; Schatz, David/A-6748-2013; Hanna, Jacob/K-1339-2012; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AAF-9451-2022; Schlesinger, Sharon/A-5283-2016; mildner, alexander/AFK-2161-2022; Jung, Steffen/K-1409-2012	mildner, alexander/0000-0002-2019-8427; Schatz, David/0000-0002-5669-1176; Hanna, Jacob/0000-0003-2042-9974; mildner, alexander/0000-0002-2019-8427; Schlesinger, Sharon/0000-0001-9549-2383; mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; Mostoslavsky, Gustavo/0000-0002-0784-2169	Israel Academy of Sciences; National Institutes of Health; Israel Cancer Research Foundation; European Community	Israel Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Cancer Research Foundation; European Community(European Commission)	We thank M. Nussenzweig for providing the Ig kappa<SUP>m/h</SUP> mice, A. Waisman for providing the IiMOG-marked ES cells, A. G. Fisher and V. Azuara for guiding us through the replication timing analysis by S-phase fractionation assay, M. Inlay for coaching us on the purification and culturing of MPPs and CLPs, A. Wutz for providing some of the single-cell clones, Y. Smith for image analysis and L. Dempsey for sharing ideas. This work was supported by research grants from the Israel Academy of Sciences (H.C., Y.B.), National Institutes of Health (Y.B.), the Israel Cancer Research Foundation (H.C., Y.B.), the European Community 5th Framework Quality of Life Program (Y.B.), Lew Sanders (H.C.) and Norton Herrick (H.C.).	Alexander MK, 2007, J CELL BIOL, V179, P269, DOI 10.1083/jcb.200706053; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gribnau J, 2005, J CELL BIOL, V168, P365, DOI 10.1083/jcb.200405117; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Ikawa M, 1999, CURR TOP DEV BIOL, V44, P1; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Liu XD, 1999, MOL IMMUNOL, V36, P461, DOI 10.1016/S0161-5890(99)00065-6; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150	36	34	34	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					561	+		10.1038/nature11496	http://dx.doi.org/10.1038/nature11496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023124				2022-12-01	WOS:000310196200047
J	Beaglehole, R; Bonita, R; Horton, R; Ezzati, M; Bhala, N; Amuyunzu-Nyamongo, M; Mwatsama, M; Reddy, KS				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Ezzati, Majid; Bhala, Neeraj; Amuyunzu-Nyamongo, Mary; Mwatsama, Modi; Reddy, K. Srinath			Measuring progress on NCDs: one goal and five targets	LANCET			English	Editorial Material							CHRONIC DISEASES; CARDIOVASCULAR-DISEASE; INCOME COUNTRIES; MIDDLE-INCOME; PREVENTION; HEALTH; PROGRAMS; POLICIES; ALCOHOL; REDUCE		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1142, New Zealand; [Horton, Richard] The Lancet, London NW1 7BY, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Bhala, Neeraj] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Amuyunzu-Nyamongo, Mary] Consortium NCD Prevent & Control Sub Saharan Afri, Nairobi, Kenya; [Mwatsama, Modi] Natl Heart Forum, London, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of Auckland; Imperial College London; University of Birmingham; Public Health Foundation of India	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1142, New Zealand.			Reddy, K Srinath/0000-0003-3416-3548; Bhala, Neeraj/0000-0003-2502-1177	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abascal W, 2012, LANCET; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], SMOKEFREE 2025; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Joint WHO/FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases, 2002, DIET NUTRITION AND T; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacMahon S, 2005, LANCET, V365, P1108; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; Mehta S, 2014, EUR J PREV CARDIOL, V21, P192, DOI 10.1177/2047487312462150; Mendez D, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050147, DOI 10.1136/T0BACCOCONTROL-2011-050147]; Sadler K, 2011, NATIONAL DIET AND NU; UN General Assembly, 2011, UNITED NATIONS A 66; WHO, 2012, 65TH WORLD HEALTH AS; WHO, 2012, MONITORING FRAMEWORK; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	20	65	70	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1283	1285		10.1016/S0140-6736(12)61692-4	http://dx.doi.org/10.1016/S0140-6736(12)61692-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	23063272				2022-12-01	WOS:000309931400004
J	Ezenwa, VO; Gerardo, NM; Inouye, DW; Medina, M; Xavier, JB				Ezenwa, Vanessa O.; Gerardo, Nicole M.; Inouye, David W.; Medina, Monica; Xavier, Joao B.			Animal Behavior and the Microbiome	SCIENCE			English	Editorial Material							GUT MICROBIOTA; ACQUISITION; DIVERSITY		[Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA; [Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Inouye, David W.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Inouye, David W.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Xavier, Joao B.] Mem Sloan Kettering Canc Ctr, Program Computat Biol, New York, NY 10021 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University; University System of Maryland; University of Maryland College Park; University of California System; University of California Merced; Memorial Sloan Kettering Cancer Center	Ezenwa, VO (corresponding author), Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA.	ngerard@emory.edu	Inouye, David W./C-2997-2011; Xavier, Joao/H-5471-2011	Inouye, David W./0000-0003-2076-7834; Xavier, Joao/0000-0003-3592-1689	Direct For Biological Sciences [1146880] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1229439] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Boettcher KJ, 1996, J COMP PHYSIOL A, V179, P65; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]	16	299	313	11	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					198	199		10.1126/science.1227412	http://dx.doi.org/10.1126/science.1227412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066064				2022-12-01	WOS:000309712300024
J	Yoshiba, S; Shiratori, H; Kuo, IY; Kawasumi, A; Shinohara, K; Nonaka, S; Asai, Y; Sasaki, G; Belo, JA; Sasaki, H; Nakai, J; Dworniczak, B; Ehrlich, BE; Pennekamp, P; Hamada, H				Yoshiba, Satoko; Shiratori, Hidetaka; Kuo, Ivana Y.; Kawasumi, Aiko; Shinohara, Kyosuke; Nonaka, Shigenori; Asai, Yasuko; Sasaki, Genta; Belo, Jose Antonio; Sasaki, Hiroshi; Nakai, Junichi; Dworniczak, Bernd; Ehrlich, Barbara E.; Pennekamp, Petra; Hamada, Hiroshi			Cilia at the Node of Mouse Embryos Sense Fluid Flow for Left-Right Determination via Pkd2	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; POLYCYSTIN-2; MICE; EXPRESSION; RELEASE; LACKING; KIF3A	Unidirectional fluid flow plays an essential role in the breaking of left-right (L-R) symmetry in mouse embryos, but it has remained unclear how the flow is sensed by the embryo. We report that the Ca2+ channel Polycystin-2 (Pkd2) is required specifically in the perinodal crown cells for sensing the nodal flow. Examination of mutant forms of Pkd2 shows that the ciliary localization of Pkd2 is essential for correct L-R patterning. Whereas Kif3a mutant embryos, which lack all cilia, failed to respond to an artificial flow, restoration of primary cilia in crown cells rescued the response to the flow. Our results thus suggest that nodal flow is sensed in a manner dependent on Pkd2 by the cilia of crown cells located at the edge of the node.	[Dworniczak, Bernd; Pennekamp, Petra] Univ Klinikum Munster, Inst Humangenet, D-48149 Munster, Germany; [Pennekamp, Petra] Univ Klinikum Muenster, Klin Kinder & Jugendmed, D-48149 Munster, Germany; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Japan Sci & Technol Corp JST, Japan Sci & Technol Agcy CREST, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 4448585, Japan; [Belo, Jose Antonio] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, P-8005135 Faro, Portugal; [Belo, Jose Antonio] Univ Algarve, IBB Inst Biotechnol & Bioengn, P-8005135 Faro, Portugal; [Sasaki, Hiroshi] RIKEN Ctr Dev Biol, Lab Embryon Induct, Kobe, Hyogo 6500047, Japan; [Nakai, Junichi] Saitama Univ, Brain Sci Inst, Sakura Ku, Saitama 3388570, Japan	University of Munster; University of Munster; Osaka University; Japan Science & Technology Agency (JST); Yale University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Universidade do Algarve; Universidade do Algarve; RIKEN; Saitama University	Pennekamp, P (corresponding author), Univ Klinikum Munster, Inst Humangenet, Vesaliusweg 12-14, D-48149 Munster, Germany.	petra.pennekamp@uni-muenster.de; hamada@fbs.osaka-u.ac.jp	Belo, José A. A/F-4444-2012; Nonaka, Shigenori/I-2132-2013; Kawasumi, Aiko/D-1324-2017; Hamada, Hiroshi/N-6374-2015; Yoshiba, Satoko/AAD-1546-2019; Shinohara, Kyosuke/AAU-2471-2020; Sasaki, Hiroshi/AAY-5939-2020; /AAX-8408-2021; Nakai, Junichi/GQZ-6415-2022; Shinohara, Kyosuke/I-1470-2016	Belo, José A. A/0000-0001-7384-0949; Nonaka, Shigenori/0000-0002-8093-0325; Kawasumi, Aiko/0000-0002-8118-8548; Hamada, Hiroshi/0000-0002-7196-5948; Shinohara, Kyosuke/0000-0002-6350-1684; Sasaki, Hiroshi/0000-0001-8752-6846; /0000-0001-9657-9704; Yoshiba, Satoko/0000-0002-9415-3619; Kuo, Ivana/0000-0002-9867-2408	CREST of the Japan Science and Technology Corporation; NIH [P30 DK090744]; Human Frontier Science Program [ST00246/2003C]; Deutsche Forschungsgemeinschaft [PE 853/2]; Japan Society for the Promotion of Science; American Heart Association [R10682]; Grants-in-Aid for Scientific Research [24113004, 22770215] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, P30DK090744, R01DK087844] Funding Source: NIH RePORTER	CREST of the Japan Science and Technology Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Cai for YCB9 antibodies to Pkd2; S. Somlo for very helpful comments on Pkd2 function; D. P. Norris for Pkd1l1-CC-GFP plasmid; and A. Fukumoto, Y. Ikawa, K. Miyama, K. Mochida, H. Nishimura, and S. Ohishi for technical assistance. This work was supported by a grant from CREST of the Japan Science and Technology Corporation to H. H., an NIH grant P30 DK090744 to B. E. E., and Human Frontier Science Program grant ST00246/2003C and the Deutsche Forschungsgemeinschaft grant PE 853/2 to P. P. S. Y. was supported by a fellowship from the Japan Society for the Promotion of Science for Japanese Junior Scientists. I. Y. K. was supported by the American Heart Association Postdoctoral Fellowship R10682.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hirokawa N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000802; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494	27	198	208	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					226	231		10.1126/science.1222538	http://dx.doi.org/10.1126/science.1222538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22983710	Green Submitted, Green Accepted			2022-12-01	WOS:000309712300038
J	Pass, HI; Levin, SM; Harbut, MR; Melamed, J; Chiriboga, L; Donington, J; Huflejt, M; Carbone, M; Chia, D; Goodglick, L; Goodman, GE; Thornquist, MD; Liu, G; de Perrot, M; Tsao, MS; Goparaju, C				Pass, Harvey I.; Levin, Stephen M.; Harbut, Michael R.; Melamed, Jonathan; Chiriboga, Luis; Donington, Jessica; Huflejt, Margaret; Carbone, Michele; Chia, David; Goodglick, Lee; Goodman, Gary E.; Thornquist, Mark D.; Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound; Goparaju, Chandra			Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTER METHYLATION; LUNG-CANCER; ASBESTOS EXPOSURE; IN-VIVO; EXPRESSION; EFEMP1; PROTEIN; FAMILY; GENE; PROGRESSION	BACKGROUND New biomarkers are needed to detect pleural mesothelioma at an earlier stage and to individualize treatment strategies. We investigated whether fibulin-3 in plasma and pleural effusions could meet sensitivity and specificity criteria for a robust biomarker. METHODS We measured fibulin-3 levels in plasma (from 92 patients with mesothelioma, 136 asbestos-exposed persons without cancer, 93 patients with effusions not due to mesothelioma, and 43 healthy controls), effusions (from 74 patients with mesothelioma, 39 with benign effusions, and 54 with malignant effusions not due to mesothelioma), or both. A blinded validation was subsequently performed. Tumor tissue was examined for fibulin-3 by immunohistochemical analysis, and levels of fibulin-3 in plasma and effusions were measured with an enzyme-linked immunosorbent assay. RESULTS Plasma fibulin-3 levels did not vary according to age, sex, duration of asbestos exposure, or degree of radiographic changes and were significantly higher in patients with pleural mesothelioma (105 +/- 7 ng per milliliter in the Detroit cohort and 113 +/- 8 ng per milliliter in the New York cohort) than in asbestos-exposed persons without mesothelioma (14 +/- 1 ng per milliliter and 24 +/- 1 ng per milliliter, respectively; P<0.001). Effusion fibulin-3 levels were significantly higher in patients with pleural mesothelioma (694 +/- 37 ng per milliliter in the Detroit cohort and 636 +/- 92 ng per milliliter in the New York cohort) than in patients with effusions not due to mesothelioma (212 +/- 25 and 151 +/- 23 ng per milliliter, respectively; P<0.001). Fibulin-3 preferentially stained tumor cells in 26 of 26 samples. In an overall comparison of patients with and those without mesothelioma, the receiver-operating-characteristic curve for plasma fibulin-3 levels had a sensitivity of 96.7% and a specificity of 95.5% at a cutoff value of 52.8 ng of fibulin-3 per milliliter. In a comparison of patients with early-stage mesothelioma with asbestos-exposed persons, the sensitivity was 100% and the specificity was 94.1% at a cutoff value of 46.0 ng of fibulin-3 per milliliter. Blinded validation revealed an area under the curve of 0.87 for plasma specimens from 96 asbestos-exposed persons as compared with 48 patients with mesothelioma. CONCLUSIONS Plasma fibulin-3 levels can distinguish healthy persons with exposure to asbestos from patients with mesothelioma. In conjunction with effusion fibulin-3 levels, plasma fibulin-3 levels can further differentiate mesothelioma effusions from other malignant and benign effusions. (Funded by the Early Detection Research Network, National Institutes of Health, and others.)	[Pass, Harvey I.; Donington, Jessica; Huflejt, Margaret; Goparaju, Chandra] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Melamed, Jonathan; Chiriboga, Luis] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Levin, Stephen M.] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [Harbut, Michael R.] Karmanos Canc Inst, Natl Ctr Vermiculite & Asbestos Related Canc, Detroit, MI USA; [Carbone, Michele] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Chia, David; Goodglick, Lee] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Goodman, Gary E.] Swedish Canc Inst, Seattle, WA USA; [Thornquist, Mark D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Univ Toronto, Toronto, ON, Canada; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Barbara Ann Karmanos Cancer Institute; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; Swedish Cancer Institute; Swedish Medical Center; Fred Hutchinson Cancer Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Pass, HI (corresponding author), NYU, Langone Med Ctr, Dept Cardiothorac Surg, 530 1st Ave,9V, New York, NY 10016 USA.	harvey.pass@med.nyu.edu	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Melamed, Jonathan/AAV-3769-2020	Tsao, Ming Sound/0000-0002-9160-5405; Melamed, Jonathan/0000-0003-2844-7990; Huflejt, Malgorzata/0000-0002-2016-8367; Liu, Geoffrey/0000-0002-2603-7296; de Perrot, Marc/0000-0003-2000-9427; Pass, Harvey/0000-0003-3222-3471; Chiriboga, Luis/0000-0002-2028-6873	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers [Local 793]; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care; Early Detection Research Network, National Institutes of Health [U01 CA-111295, U01 CA-113913]; NATIONAL CANCER INSTITUTE [U01CA111295, U01CA113913] Funding Source: NIH RePORTER	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Early Detection Research Network, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Princess Margaret Hospital Foundation and the Princess Margaret Hospital Mesothelioma Research Program (funded by the Masters Insulators Association of Ontario, International Association of Heat and Frost Insulators and Asbestos Workers, Local 793, and other unions, and the Imperial Oil Charitable Foundation) for plasma banking; by the M. Qasim Choksi Chair in Lung Cancer Translational Research (held by Dr. Tsao), the Alan B. Brown Chair in Molecular Genetics (held by Dr. Liu), and the Ontario Ministry of Health and Long-Term Care; and by donations from Belluck and Fox, the Simmons Foundation, Levi Phillips and Konigsberg, the Stephen E. Banner Fund for Lung Cancer Research, the Rosenwald Family, and the Anderson Family and grants from the Early Detection Research Network, National Institutes of Health, to the New York University Thoracic Oncology Research Laboratories (U01 CA-111295) and to Beth Israel Deaconess Medical Center (U01 CA-113913).	AISNER J, 1995, CHEST, V108, P1122; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Barnhart S, 1997, AM J IND MED, V32, P573, DOI 10.1002/(SICI)1097-0274(199712)32:6<573::AID-AJIM1>3.0.CO;2-R; Davidson B, 2011, J CELL MOL MED, V15, P535, DOI [10.1111/j.1582-4934.2010.01019.x, 10.1111/j.1582-4934.2010.01023.x]; Fiorelli A, 2011, INTERACT CARDIOV TH, V12, P420, DOI 10.1510/icvts.2010.250357; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hirayama N, 2011, RESP MED, V105, P137, DOI 10.1016/j.rmed.2010.10.010; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michaelides M, 2006, INVEST OPHTH VIS SCI, V47, P3085, DOI 10.1167/iovs.05-1600; Moore RM, 2009, PLACENTA, V30, P335, DOI 10.1016/j.placenta.2009.01.007; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Roberts HC, 2009, J THORAC ONCOL, V4, P620, DOI 10.1097/JTO.0b013e31819f2e0e; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Sasaki T, 1996, EUR J BIOCHEM, V240, P427, DOI 10.1111/j.1432-1033.1996.0427h.x; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Segade F, 2010, GENE, V464, P17, DOI 10.1016/j.gene.2010.05.003; SELIKOFF IJ, 1992, AM J IND MED, V22, P481, DOI 10.1002/ajim.4700220403; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	201	209	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1417	1427		10.1056/NEJMoa1115050	http://dx.doi.org/10.1056/NEJMoa1115050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050525	Green Accepted			2022-12-01	WOS:000309652700008
J	Tornqvist, B; Stromberg, C; Persson, G; Nilsson, M				Tornqvist, Bjorn; Stromberg, Cecilia; Persson, Gunnar; Nilsson, Magnus			Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEPATIC-ARTERY INJURY; LAPAROSCOPIC CHOLECYSTECTOMY; VOLUME; STRICTURES; LESIONS; LEAKS; RISK	Objectives To determine whether the routine use of intraoperative cholangiography can improve survival from complications related to bile duct injuries. Design Population based cohort study. Setting Prospectively collected data from the Swedish national registry of gallstone surgery and endoscopic retrograde cholangiopancreatography, GallRiks. Multivariate analysis done by Cox regression. Population All cholecystectomies recorded in GallRiks between 1 May 2005 and 31 December 2010. Main outcome measures Evidence of bile duct injury, rate of intended use of intraoperative cholangiography, and rate of survival after cholecytectomy. Results During the study, 51 041 cholecystectomies were registered in GallRiks and 747 (1.5%) iatrogenic bile duct injuries identified. Patients with bile duct injuries had an impaired survival compared with those without injury (mortality at one year 3.9% v 1.1%). Kaplan-Meier analysis showed that early detection of a bile duct injury, during the primary operation, improved survival. The intention to use intraoperative cholangiography reduced the risk of death after cholecystectomy by 62% (hazard ratio 0.38 (95% confidence interval 0.31 to 0.46)). Conclusions The high incidence of bile duct injury recorded is probably from GallRiks' ability to detect the entire range of injury severities, from minor ductal lesions to complete transections of major ducts. Patients with bile duct injury during cholecystectomy had impaired survival, and early detection of the injury improved survival. The intention to perform an intraoperative cholangiography reduced the risk of death after cholecystectomy.	[Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden; [Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Karolinska Inst, CLINTEC, Div Surg, SE-14186 Stockholm, Sweden; [Persson, Gunnar] Ryhov Hosp, Dept Surg, Jonkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tornqvist, B (corresponding author), Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden.	bjorn.tornqvist@karolinska.se		Nilsson, Magnus/0000-0002-6215-8132; Stromberg, Cecilia/0000-0003-0843-7920				Alves A, 2003, ANN SURG, V238, P93, DOI 10.1097/01.sla.0000074983.39297.c5; Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; Bektas H, 2007, BRIT J SURG, V94, P1119, DOI 10.1002/bjs.5752; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; Bismuth H, 2001, WORLD J SURG, V25, P1241, DOI 10.1007/s00268-001-0102-8; Connor S, 2006, BRIT J SURG, V93, P158, DOI 10.1002/bjs.5266; Dolan JP, 2005, SURG ENDOSC, V19, P967, DOI 10.1007/s00464-004-8942-6; Eisenstein S, 2008, ARCH SURG-CHICAGO, V143, P1178, DOI 10.1001/archsurg.143.12.1178; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; GOUMA DJ, 1994, J AM COLL SURGEONS, V178, P229; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lillemoe KD, 1997, ANN SURG, V225, P459, DOI 10.1097/00000658-199705000-00003; Murphy MM, 2010, J AM COLL SURGEONS, V211, P73, DOI 10.1016/j.jamcollsurg.2010.02.050; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Persson G, 2011, GALLRIKS ANN REPORT; Persson G, 2010, GALLRIKS ANN REPORT; Pinkas H, 2008, HEPATOB PANCREAT DIS, V7, P628; Richardson MC, 1996, BRIT J SURG, V83, P1356, DOI 10.1002/bjs.1800831009; Savader SJ, 1997, ANN SURG, V225, P268, DOI 10.1097/00000658-199703000-00005; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIEWERT JR, 1994, CHIRURG, V65, P748; Stewart L, 2004, J GASTROINTEST SURG, V8, P523, DOI 10.1016/j.gassur.2004.02.010; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Tornqvist B, 2009, CLIN GASTROENTEROL H, V7, P1013, DOI 10.1016/j.cgh.2009.05.014; Tzovaras G, 2001, HPB (Oxford), V3, P165, DOI 10.1080/136518201317077189; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207	29	131	134	3	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 11	2012	345								e6457	10.1136/bmj.e6457	http://dx.doi.org/10.1136/bmj.e6457			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TI	23060654	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000309907900001
J	van Loenhout, MTJ; de Grunt, MV; Dekker, C				van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.			Dynamics of DNA Supercoils	SCIENCE			English	Article							DOUBLE-STRANDED DNA; FLUCTUATIONS; RESOLVASE; MOLECULES; SYNAPSIS; FORCE	DNA in cells exhibits a supercoiled state in which the double helix is additionally twisted to form extended intertwined loops called plectonemes. Although supercoiling is vital to many cellular processes, its dynamics remain elusive. In this work, we directly visualize the dynamics of individual plectonemes. We observe that multiple plectonemes can be present and that their number depends on applied stretching force and ionic strength. Plectonemes moved along DNA by diffusion or, unexpectedly, by a fast hopping process that facilitated very rapid (<20 milliseconds) long-range plectoneme displacement by nucleating a new plectoneme at a distant position. These observations directly reveal the dynamics of plectonemes and identify a mode of movement that allows long-distance reorganization of the conformation of the genome on a millisecond time scale.	[van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.dekker@tudelft.nl		Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]	European Research Council(European Research Council (ERC)European Commission)	We thank M. Emanuel and H. Schiessel for discussions on plectoneme energetics, I. De Vlaminck for discussions, D. van der Vlies for experimental assistance, S. Hage and B. Cross for DNA constructs, and J. van der Does for mechanical modifications to the magnetic tweezers. This work has been supported in part by the European Research Council research grant NanoforBio (no. 247072).	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; LAUNDON CH, 1988, CELL, V52, P545, DOI 10.1016/0092-8674(88)90467-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MARKO JF, 1994, SCIENCE, V265, P506, DOI 10.1126/science.8036491; Marko JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011908; Neukirch S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.138104; Oram M, 1997, J MOL BIOL, V270, P396, DOI 10.1006/jmbi.1997.1109; PARKER CN, 1991, CELL, V66, P781, DOI 10.1016/0092-8674(91)90121-E; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Zuccheri G, 1998, APPL PHYS A-MATER, V66, pS585, DOI 10.1007/s003390051206; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	23	131	132	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					94	97		10.1126/science.1225810	http://dx.doi.org/10.1126/science.1225810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983709				2022-12-01	WOS:000309457400060
J	Kaptoge, S; Di Angelantonio, E; Pennells, L; Wood, AM; White, IR; Gao, P; Walker, M; Thompson, A; Sarwar, N; Caslake, M; Butterworth, AS; Amouyel, P; Assmann, G; Bakker, SJL; Barr, ELM; Barrett-Connor, E; Benjamin, EJ; Bjorkelund, C; Brenner, H; Brunner, E; Clarke, R; Cooper, JA; Cremer, P; Cushman, M; Dagenais, GR; D'Agostino, RB; Dankner, R; Davey-Smith, G; Deeg, D; Dekker, JM; Engstrom, G; Folsom, AR; Fowkes, FGR; Gallacher, J; Gaziano, JM; Giampaoli, S; Gillum, RF; Hofman, A; Howard, BV; Ingelsson, E; Iso, H; Jorgensen, T; Kiechl, S; Kitamura, A; Kiyohara, Y; Koenig, W; Kromhout, D; Kuller, LH; Lawlor, DA; Meade, TW; Nissinen, A; Nordestgaard, BG; Onat, A; Panagiotakos, DB; Psaty, BM; Rodriguez, B; Rosengren, A; Salomaa, V; Kauhanen, J; Salonen, JT; Shaffer, JA; Shea, S; Ford, I; Stehouwer, CDA; Strandberg, TE; Tipping, RW; Tosetto, A; Wassertheil-Smoller, S; Wennberg, P; Westendorp, RG; Whincup, PH; Wilhelmsen, L; Woodward, M; Lowe, GDO; Wareham, NJ; Khaw, KT; Sattar, N; Packard, CJ; Gudnason, V; Ridker, PM; Pepys, MB; Thompson, SG; Danesh, J				Kaptoge, Stephen; Di Angelantonio, Emanuele; Pennells, Lisa; Wood, Angela M.; White, Ian R.; Gao, Pei; Walker, Matthew; Thompson, Alexander; Sarwar, Nadeem; Caslake, Muriel; Butterworth, Adam S.; Amouyel, Philippe; Assmann, Gerd; Bakker, Stephan J. L.; Barr, Elizabeth L. M.; Barrett-Connor, Elizabeth; Benjamin, Emelia J.; Bjorkelund, Cecilia; Brenner, Hermann; Brunner, Eric; Clarke, Robert; Cooper, Jackie A.; Cremer, Peter; Cushman, Mary; Dagenais, Gilles R.; D'Agostino, Ralph B., Sr.; Dankner, Rachel; Davey-Smith, George; Deeg, Dorly; Dekker, Jacqueline M.; Engstrom, Gunnar; Folsom, Aaron R.; Fowkes, F. Gerry R.; Gallacher, John; Gaziano, J. Michael; Giampaoli, Simona; Gillum, Richard F.; Hofman, Albert; Howard, Barbara V.; Ingelsson, Erik; Iso, Hiroyasu; Jorgensen, Torben; Kiechl, Stefan; Kitamura, Akihiko; Kiyohara, Yutaka; Koenig, Wolfgang; Kromhout, Daan; Kuller, Lewis H.; Lawlor, Debbie A.; Meade, Tom W.; Nissinen, Aulikki; Nordestgaard, Borge G.; Onat, Altan; Panagiotakos, Demosthenes B.; Psaty, Bruce M.; Rodriguez, Beatriz; Rosengren, Annika; Salomaa, Veikko; Kauhanen, Jussi; Salonen, Jukka T.; Shaffer, Jonathan A.; Shea, Steven; Ford, Ian; Stehouwer, Coen D. A.; Strandberg, Timo E.; Tipping, Robert W.; Tosetto, Alberto; Wassertheil-Smoller, Sylvia; Wennberg, Patrik; Westendorp, Rudi G.; Whincup, Peter H.; Wilhelmsen, Lars; Woodward, Mark; Lowe, Gordon D. O.; Wareham, Nicholas J.; Khaw, Kay-Tee; Sattar, Naveed; Packard, Chris J.; Gudnason, Vilmundur; Ridker, Paul M.; Pepys, Mark B.; Thompson, Simon G.; Danesh, John		Emerging Risk Factors	C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; COST-EFFECTIVENESS; RISK PROFILE; GUIDELINES; INFLAMMATION; ASSOCIATION; CARE	Background There is debate about the value of assessing levels of C-reactive protein (CRP) and other biomarkers of inflammation for the prediction of first cardiovascular events. Methods We analyzed data from 52 prospective studies that included 246,669 participants without a history of cardiovascular disease to investigate the value of adding CRP or fibrinogen levels to conventional risk factors for the prediction of cardiovascular risk. We calculated measures of discrimination and reclassification during follow-up and modeled the clinical implications of initiation of statin therapy after the assessment of CRP or fibrinogen. Results The addition of information on high-density lipoprotein cholesterol to a prognostic model for cardiovascular disease that included age, sex, smoking status, blood pressure, history of diabetes, and total cholesterol level increased the C-index, a measure of risk discrimination, by 0.0050. The further addition to this model of information on CRP or fibrinogen increased the C-index by 0.0039 and 0.0027, respectively (P < 0.001), and yielded a net reclassification improvement of 1.52% and 0.83%, respectively, for the predicted 10-year risk categories of "low" (< 10%), " intermediate" (10% to < 20%), and "high" (>= 20%) (P < 0.02 for both comparisons). We estimated that among 100,000 adults 40 years of age or older, 15,025 persons would initially be classified as being at intermediate risk for a cardiovascular event if conventional risk factors alone were used to calculate risk. Assuming that statin therapy would be initiated in accordance with Adult Treatment Panel III guidelines (i.e., for persons with a predicted risk of >= 20% and for those with certain other risk factors, such as diabetes, irrespective of their 10-year predicted risk), additional targeted assessment of CRP or fibrinogen levels in the 13,199 remaining participants at intermediate risk could help prevent approximately 30 additional cardiovascular events over the course of 10 years. Conclusions In a study of people without known cardiovascular disease, we estimated that under current treatment guidelines, assessment of the CRP or fibrinogen level in people at intermediate risk for a cardiovascular event could help prevent one additional event over a period of 10 years for every 400 to 500 people screened. (Funded by the British Heart Foundation and others.)	[Kaptoge, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England; [White, Ian R.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Caslake, Muriel; Ford, Ian; Lowe, Gordon D. O.; Sattar, Naveed; Packard, Chris J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Amouyel, Philippe] Inst Pasteur, Lille, France; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Bakker, Stephan J. L.] Univ Groningen, Groningen, Netherlands; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Benjamin, Emelia J.; D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Bjorkelund, Cecilia; Wilhelmsen, Lars] Univ Gothenburg, Gothenburg, Sweden; [Brenner, Hermann] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Brunner, Eric; Cooper, Jackie A.; Pepys, Mark B.] UCL, London, England; [Clarke, Robert] Univ Oxford, Oxford, England; [Cremer, Peter] Klinikum Univ Munchen LMU, Munich, Germany; [Cushman, Mary] Univ Vermont, Burlington, ON, Canada; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Davey-Smith, George; Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Deeg, Dorly; Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Engstrom, Gunnar] Lund Univ, Lund, Sweden; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gallacher, John] Cardiff Univ, Cardiff, S Glam, Wales; [Gaziano, J. Michael] Harvard Univ, Sch Med, Boston, MA USA; [Giampaoli, Simona] Ist Super Sanita, I-00161 Rome, Italy; [Gillum, Richard F.] Ctr Dis Control & Prevent, Hyattsville, MD USA; [Hofman, Albert] Erasmus MC, Rotterdam, Netherlands; [Howard, Barbara V.] Medstar Hlth Res Inst, Hyattsville, MD USA; [Ingelsson, Erik] Karolinska Inst, Stockholm, Sweden; [Iso, Hiroyasu] Osaka Univ, Osaka, Japan; [Jorgensen, Torben] Glostrup Univ Hosp, Glostrup, Denmark; [Jorgensen, Torben; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen, Denmark; [Kiechl, Stefan] Med Univ Innsbruck, Innsbruck, Austria; [Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kiyohara, Yutaka] Kyushu Univ, Fukuoka 812, Japan; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Kromhout, Daan] Wageningen Univ, Wageningen, Netherlands; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Meade, Tom W.] London Sch Hyg & Trop Med, London WC1, England; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Panagiotakos, Demosthenes B.] Harokopio Univ, Athens, Greece; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Rodriguez, Beatriz] Univ Hawaii, Honolulu, HI 96822 USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Salonen, Jukka T.] Metab Analyt Serv, Helsinki, Finland; [Shaffer, Jonathan A.; Shea, Steven] Columbia Univ, Med Ctr, New York, NY USA; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Strandberg, Timo E.] Univ Helsinki, Oulu, Finland; [Strandberg, Timo E.] Univ Oulu, Oulu, Finland; [Tipping, Robert W.] Merck Res Labs, Philadelphia, PA USA; [Tosetto, Alberto] San Bortolo Hosp, Vicenza, Italy; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Wennberg, Patrik] Umea Univ, Umea, Sweden; [Westendorp, Rudi G.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Whincup, Peter H.] St Georges Univ London, London, England; [Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Kopavogur, Iceland; [Ridker, Paul M.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Cambridge; MRC Biostatistics Unit; University of Glasgow; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Groningen; University of Groningen; University of California System; University of California San Diego; Boston University; University of Gothenburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; University College London; University of Oxford; University of Munich; University of Bristol; Vrije Universiteit Amsterdam; Lund University; University of Minnesota System; University of Minnesota Twin Cities; University of Edinburgh; Cardiff University; Harvard University; Harvard Medical School; Istituto Superiore di Sanita (ISS); Centers for Disease Control & Prevention - USA; Erasmus University Rotterdam; Erasmus MC; MedStar Health Research Institute; Karolinska Institutet; Osaka University; University of Copenhagen; University of Copenhagen; Medical University of Innsbruck; Kyushu University; Ulm University; Wageningen University & Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; London School of Hygiene & Tropical Medicine; Finland National Institute for Health & Welfare; Istanbul University; Harokopio University Athens; University of Washington; University of Washington Seattle; University of Hawaii System; University of Gothenburg; University of Eastern Finland; Finland National Institute for Health & Welfare; Columbia University; Maastricht University; University of Helsinki; University of Oulu; Merck & Company; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Yeshiva University; Umea University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St Georges University London; University of Sydney; Icelandic Heart Association; University of Iceland; Harvard University; Brigham & Women's Hospital	Kaptoge, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Worts Causeway, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Woodward, Mark/D-8492-2015; Kromhout, Daan/A-8566-2014; Schöttker, Ben/F-8183-2014; Panagiotakos, Demosthenes/C-9776-2013; PALMIERI, LUIGI/O-1845-2017; Kauhanen, Jussi/ABC-4064-2021; Stefanadis, Christodoulos/ABH-2232-2020; Gudnason, Vilmundur/K-6885-2015; Gao, Pei/AAF-3065-2019; Marmot, M G/Y-3920-2019; Jørgensen, Torben/Z-1335-2018; Shaffer, Jonathan A/B-2783-2013; Gao, Pei/R-4794-2018; Brenner, Hermann/B-4627-2017; Meisinger, Christine/B-5358-2014; Cushman, Mary/K-1157-2019; Benn, Marianne/O-4164-2019; Bakker, Stephan J. L./J-4023-2015; Lamarche, Benoit/ABA-4785-2021; Stehouwer, Coen/AAB-3435-2021; Tosetto, Alberto/AAM-3200-2020; Gudnason, Vilmundur/AAE-7126-2019; Brunner, Eric/H-2114-2011; Panagiotakos, Demosthenes/M-9167-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Woodward, Mark/L-6817-2017; DiAngelantonio, Emanuele/ABE-6852-2020; Wood, Angela/GZA-5762-2022; Davey Smith, George/A-7407-2013; Tosetto, Alberto/AAB-9320-2022; Aspelund, Thor/C-5983-2008; Brenner, Hermann/ABE-6383-2020; Ford, Ian/ABE-6145-2020; Dankner, Rachel/Q-5245-2019; Woo, Wai Lok/T-3662-2018; Panagiotakos, Demosthenes/K-8294-2019; donfrancesco, chiara/K-1460-2016; Benjamin, Emelia/E-7103-2011	Schöttker, Ben/0000-0002-1217-4521; Panagiotakos, Demosthenes/0000-0001-8583-153X; PALMIERI, LUIGI/0000-0002-4298-2642; Stefanadis, Christodoulos/0000-0001-5974-6454; Gudnason, Vilmundur/0000-0001-5696-0084; Gao, Pei/0000-0001-8649-1290; Marmot, M G/0000-0002-2431-6419; Gao, Pei/0000-0001-8649-1290; Brenner, Hermann/0000-0002-6129-1572; Cushman, Mary/0000-0002-7871-6143; Benn, Marianne/0000-0002-1701-595X; Bakker, Stephan J. L./0000-0003-3356-6791; Lamarche, Benoit/0000-0002-4443-5378; Tosetto, Alberto/0000-0002-0119-5204; Gudnason, Vilmundur/0000-0001-5696-0084; Brunner, Eric/0000-0002-0595-4474; Panagiotakos, Demosthenes/0000-0001-8583-153X; Wood, Angela/0000-0002-7937-304X; Davey Smith, George/0000-0002-1407-8314; Aspelund, Thor/0000-0002-7998-5433; Brenner, Hermann/0000-0002-6129-1572; Dankner, Rachel/0000-0001-6454-6000; Woo, Wai Lok/0000-0002-8698-7605; Yamagishi, Kazumasa/0000-0003-3301-5519; strandberg, timo/0000-0001-6299-925X; Nijpels, Giel/0000-0002-3679-9710; Jorgensen, Torben/0000-0001-9453-2830; Butterworth, Adam/0000-0002-6915-9015; Alexander, Myriam/0000-0002-6848-9370; Haycock, Philip/0000-0001-5001-3350; Pennells, Lisa Anne/0000-0002-8594-3061; Jespersen, Jorgen/0000-0002-3059-2356; Engstrom, Gunnar/0000-0002-8618-9152; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kirkland, Susan/0000-0002-8182-2369; Nordestgaard, Borge/0000-0002-1954-7220; Kivimaki, Mika/0000-0002-4699-5627; Lawlor, Debbie A/0000-0002-6793-2262; Amouyel, Philippe/0000-0001-9088-234X; Woodward, Mark/0000-0001-9800-5296; Davidson, Karina/0000-0002-9162-477X; donfrancesco, chiara/0000-0002-8040-5571; Bremmer, Marijke/0000-0002-0415-1127; Koenig, Wolfgang/0000-0002-2064-9603; Stehouwer, Coen/0000-0001-8752-3223; Whincup, Peter/0000-0002-5589-4107; Lewington, Sarah/0000-0002-4496-4771; Franco, Oscar/0000-0002-4606-4929; Benjamin, Emelia/0000-0003-4076-2336; Di Angelantonio, Emanuele/0000-0001-8776-6719; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Ballantyne, Christie/0000-0002-6432-1730; White, Ian/0000-0002-6718-7661; Ramachandran, Vasan/0000-0001-7357-5970; Rothenbacher, Dietrich/0000-0002-3563-2791; s, hema/0000-0002-3440-9475; Bladbjerg, Else Marie/0000-0003-0912-2437	British Heart Foundation; MRC [G0701619, MC_U105260558, G0902037, G0701863, MC_U137686851, G7900510, G0600705, MC_U137686857] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/08/013/25942, PG/09/002/26056, RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U105260558, MC_U105260792, MC_U137686857, G19/35, G7900510, MC_U137686851, MC_U106179471, G0100222, G0902037, G0600705, G0701619, G1000143, G8802774, G0701863] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL084034, R01HL091099, P01HL088117] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the British Heart Foundation and others.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Blake GJ, 2003, AM J MED, V114, P485, DOI 10.1016/S0002-9343(03)00074-3; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Godsland IF, 2011, QJM-INT J MED, V104, P387, DOI 10.1093/qjmed/hcq213; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Heart Protection Study, 2011, LANCET, V377, P469, DOI 10.1016/S0140-6736(10)62174-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Lp-PLA2Studies Collaboration, 2010, J GERONTOL B-PSYCHOL, V375, P1536; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; National Heart Lung and Blood Institute, DET EV TREATM HIGH B; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	30	748	768	2	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1310	1320		10.1056/NEJMoa1107477	http://dx.doi.org/10.1056/NEJMoa1107477			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034020	Green Published, Green Accepted			2022-12-01	WOS:000309406100007
J	Calarco, JP; Borges, F; Donoghue, MTA; Van Ex, F; Jullien, PE; Lopes, T; Gardner, R; Berger, F; Feijo, JA; Becker, JD; Martienssen, RA				Calarco, Joseph P.; Borges, Filipe; Donoghue, Mark T. A.; Van Ex, Frederic; Jullien, Pauline E.; Lopes, Telma; Gardner, Rui; Berger, Frederic; Feijo, Jose A.; Becker, Joerg D.; Martienssen, Robert A.			Reprogramming of DNA Methylation in Pollen Guides Epigenetic Inheritance via Small RNA	CELL			English	Article							TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; ARABIDOPSIS; PLANT; DEMETHYLATION; REVEALS; HETEROCHROMATIN; MAINTENANCE; INVOLVEMENT; ENDOSPERM	Epigenetic inheritance is more widespread in plants than in mammals, in part because mammals erase epigenetic information by germline reprogramming. We sequenced the methylome of three haploid cell types from developing pollen: the sperm cell, the vegetative cell, and their precursor, the postmeiotic microspore, and found that unlike in mammals the plant germline retains CG and CHG DNA methylation. However, CHH methylation is lost from retrotransposons in microspores and sperm cells and restored by de novo DNA methyltransferase guided by 24 nt small interfering RNA, both in the vegetative nucleus and in the embryo after fertilization. In the vegetative nucleus, CG methylation is lost from targets of DEMETER (DME), REPRESSOR OF SILENCING 1 (ROS1), and their homologs, which include imprinted loci and recurrent epialleles that accumulate corresponding small RNA and are premethylated in sperm. Thus genome reprogramming in pollen contributes to epigenetic inheritance, transposon silencing, and imprinting, guided by small RNA.	[Calarco, Joseph P.; Donoghue, Mark T. A.; Van Ex, Frederic; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Lopes, Telma; Gardner, Rui; Feijo, Jose A.; Becker, Joerg D.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Jullien, Pauline E.; Berger, Frederic] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Instituto Gulbenkian de Ciencia; National University of Singapore; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Becker, Jorg/A-5930-2011; Feijo, Jose A./ADM-0262-2022; jullien, pauline emilie/AAN-6932-2021; Jullien, Pauline/B-7271-2009; Lopes, Telma/Q-9767-2016	Becker, Jorg/0000-0002-6845-6122; Feijo, Jose A./0000-0002-1100-5478; jullien, pauline emilie/0000-0003-1212-3246; Jullien, Pauline/0000-0003-1212-3246; Lopes, Telma/0000-0003-3816-4708; Van Ex, Frederic/0000-0003-2481-0115; Borges, Filipe/0000-0002-7388-2118; Berger, Frederic/0000-0002-3609-8260	NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/103787/2008, PTDC/BIA-BCM/108044/2008, SFRH/BD/48761/2008]; Temasek Lifescience Laboratory; NSERC; Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/103787/2008, PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/108044/2008] Funding Source: FCT	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Temasek Lifescience Laboratory; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Fundação para a Ciência e a Tecnologia	We thank Michael Regulski, Jude Kendall, Evan Ernst, Emily Hodges, and Antoine Molaro for advice with bisulfite sequencing and analysis; Vincent Colot, Arp Schnittger, and Daniel Bouyer for helpful discussions; and Shiran Pasternak for help with graphic presentation. This work was supported by NIH grant R01 GM067014 to R.A.M., grants PTDC/AGR-GPL/103778/2008 and PTDC/BIA-BCM/103787/2008 from Fundacao para a Ciencia e a Tecnologia (FCT) to J.D.B. and FCT grant PTDC/BIA-BCM/108044/2008 to J.A.F. F. Berger and P.E.J. were supported by Temasek Lifescience Laboratory. J.P.C. was supported by a graduate student fellowship from NSERC and by a grant from the Fred C. Gloeckner Foundation, F. Borges was supported by a FCT PhD fellowship SFRH/BD/48761/2008, and F.V.E. was funded by a Herbert Hoover postdoctoral fellowship from the Belgian American Educational Foundation.	Bartolomei Marisa S, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a002592; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grant-Downton R, 2009, MOL PLANT, V2, P500, DOI 10.1093/mp/ssp003; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Lu J, 2012, P NATL ACAD SCI USA, V109, P5529, DOI 10.1073/pnas.1203094109; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCCLINTOCK B, 1965, BROOKHAVEN SYM BIOL, P162; McKeown PC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-113; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Salvaing J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038156; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Zhang P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096073	56	369	386	5	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					194	205		10.1016/j.cell.2012.09.001	http://dx.doi.org/10.1016/j.cell.2012.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23000270	Green Accepted, Bronze			2022-12-01	WOS:000309544200020
J	Wiig, JA; Hu, YL; Lee, CC; Ribbe, MW				Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.			Radical SAM-Dependent Carbon Insertion into the Nitrogenase M-Cluster	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; FEMO-COFACTOR; PROTEIN; NIFEN; MECHANISM; PRECURSOR; ENZYMES; LIGAND; HYDROGENASE; SUPERFAMILY	The active site of nitrogenase, the M-cluster, is a metal-sulfur cluster containing a carbide at its core. Using radiolabeling experiments, we show that this carbide originates from the methyl group of S-adenosylmethionine (SAM) and that it is inserted into the M-cluster by the assembly protein NifB. Our SAM cleavage and deuterium substitution analyses suggest a similarity between the mechanism of carbon insertion by NifB and the proposed mechanism of RNA methylation by the radical SAM enzymes RlmN and Cfr, which involves methyl transfer from one SAM equivalent, followed by hydrogen atom abstraction from the methyl group by a 5'-deoxyadenosyl radical generated from a second SAM equivalent. This work is an initial step toward unraveling the importance of the interstitial carbide and providing insights into the nitrogenase mechanism.	[Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			National Institutes of Health [GM 67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM 67626 (M.W.R.).	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; DUKES GR, 1975, J AM CHEM SOC, V97, P528, DOI 10.1021/ja00836a011; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fay AW, 2011, ANGEW CHEM INT EDIT, V50, P7787, DOI 10.1002/anie.201102724; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HANCOCK RD, 1989, CHEM REV, V89, P1875, DOI 10.1021/cr00098a011; Hartman F. C., 1989, J BIOL CHEM, V246, P11784; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; JOB RC, 1975, P NATL ACAD SCI USA, V72, P2478, DOI 10.1073/pnas.72.7.2478; Kaiser JT, 2011, SCIENCE, V331, P91, DOI 10.1126/science.1196954; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Pavlov M, 1998, J AM CHEM SOC, V120, P548, DOI 10.1021/ja971681+; Reed GH, 2004, CURR OPIN CHEM BIOL, V8, P477, DOI 10.1016/j.cbpa.2004.08.008; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yang XZ, 2009, J AM CHEM SOC, V131, P10901, DOI 10.1021/ja902689n	27	177	179	5	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1672	1675		10.1126/science.1224603	http://dx.doi.org/10.1126/science.1224603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019652	Green Accepted			2022-12-01	WOS:000309215400050
J	Rodgers, GP; Collins, FS				Rodgers, Griffin P.; Collins, Francis S.			The Next Generation of Obesity Research No Time to Waste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFE-STYLE INTERVENTION; TRIAL; RISK		[Rodgers, Griffin P.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Rodgers, GP (corresponding author), NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	griffin.rodgers@nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Spring B, 2012, ARCH INTERN MED, V172, P789, DOI 10.1001/archinternmed.2012.1044; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	7	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1095	1096		10.1001/2012.jama.11853	http://dx.doi.org/10.1001/2012.jama.11853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990265	Bronze, Green Published			2022-12-01	WOS:000308861000022
J	Talchai, C; Xuan, SH; Lin, HV; Sussel, L; Accili, D				Talchai, Chutima; Xuan, Shouhong; Lin, Hua V.; Sussel, Lori; Accili, Domenico			Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure	CELL			English	Article							INSULIN-RECEPTOR; ALPHA-CELL; ISLET CELLS; STEM-CELLS; FOXO1; ENDOCRINE; DIFFERENTIATION; MICE; PROGENITORS; RESISTANCE	Diabetes is associated with beta cell failure. But it remains unclear whether the latter results from reduced beta cell number or function. FoxO1 integrates beta cell proliferation with adaptive beta cell function. We interrogated the contribution of these two processes to b cell dysfunction, using mice lacking FoxO1 in b cells. FoxO1 ablation caused hyperglycemia with reduced beta cell mass following physiologic stress, such as multiparity and aging. Surprisingly, lineage-tracing experiments demonstrated that loss of beta cell mass was due to beta cell dedifferentiation, not death. Dedifferentiated beta cells reverted to progenitor-like cells expressing Neurogenin3, Oct4, Nanog, and L-Myc. A subset of FoxO1-deficient beta cells adopted the alpha cell fate, resulting in hyperglucagonemia. Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes. We propose that dedifferentiation trumps endocrine cell death in the natural history of beta cell failure and suggest that treatment of beta cell dysfunction should restore differentiation, rather than promoting beta cell replication.	[Talchai, Chutima; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Xuan, Shouhong; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Talchai, Chutima] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Bangkok 10330, Thailand; [Lin, Hua V.] Lilly China Res & Dev Ctr, Shanghai 201203, Peoples R China	Columbia University; Columbia University; Chulalongkorn University	Accili, D (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	da230@columbia.edu		Lin, Hua/0000-0001-5001-5567	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH [DK64819, DK58282, DK63608]; Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064819, R37DK058282, R01DK058282, R01DK082590, P30DK063608, R01DK057539] Funding Source: NIH RePORTER	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Druckenmiller Fellowship of the New York Stem Cell Foundation to C.T., by NIH Grants DK64819, DK58282, and DK63608 (Columbia University Diabetes Research Center), the Brehm Coalition, and the Russell Berrie Foundation. We thank Drs. J.Y. Kim-Muller, T. Mastracci, H. Hua (Columbia University Medical Center), and S. Cinti (Universita Politecnica delle Marche) for advice and reagents and Q. Xu for excellent technical support. We thank members of the Accili laboratory for insightful discussion and critical reading of the manuscript.	Accili D, 2010, DIABETES OBES METAB, V12, P1, DOI 10.1111/j.1463-1326.2010.01296.x; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Lin HV, 2011, DIABETES, V60, P700, DOI 10.2337/db10-1056; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Movassat J, 1997, DIABETES, V46, P1445, DOI 10.2337/diabetes.46.9.1445; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Weinberg N, 2007, FORBES, V179, P56; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002666; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	57	901	945	13	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1223	1234		10.1016/j.cell.2012.07.029	http://dx.doi.org/10.1016/j.cell.2012.07.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980982	Bronze, Green Accepted			2022-12-01	WOS:000308928100015
J	Nielsen, SF; Bojesen, SE; Schnohr, P; Nordestgaard, BG				Nielsen, Sune F.; Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.			Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLIC CITRULLINATED PEPTIDE; HEART-DISEASE; FOLLOW-UP; ANTIBODIES; PREDICTS; REMISSION; CLASSIFICATION; AUTOANTIBODIES; DIAGNOSIS; CRITERIA	Objective To test whether elevated concentration of rheumatoid factor is associated with long term development of rheumatoid arthritis. Design A prospective cohort study, the Copenhagen City Heart Study. Blood was drawn in 1981-83, and participants were followed until 10 August 2010. Setting Copenhagen general population. Participants 9712 white Danish individuals from the general population aged 20-100 years without rheumatoid arthritis at study entry. Main outcome measures Rheumatoid arthritis according to baseline plasma IgM rheumatoid factor level categories of 25-50, 50.1-100, and >100, versus <25 IU/mL. Results Rheumatoid factor levels were similar from age 20 to 100 years. During 187 659 person years, 183 individuals developed rheumatoid arthritis. In healthy individuals, a doubling in levels of rheumatoid factor was associated with a 3.3-fold (95% confidence interval 2.7 to 4.0) increased risk of developing rheumatoid arthritis, with a similar trend for most other autoimmune rheumatic diseases. The cumulative incidence of rheumatoid arthritis increased with increasing rheumatoid factor category (P-trend<0.0001). Multivariable adjusted hazard ratios for rheumatoid arthritis were 3.6 (95% confidence interval 1.7 to 7.3) for rheumatoid factor levels of 25-50 IU/mL, 6.0 (3.4 to 10) for 50.1-100 IU/mL, and 26 (15 to 46) for >100 IU/mL, compared with <25 IU/mL (P-trend<0.0001). The highest absolute 10 year risk of rheumatoid arthritis of 32% was observed in 50-69 years old women who smoked with rheumatoid factor levels >100 IU/mL. Conclusion Individuals in the general population with elevated rheumatoid factor have up to 26-fold greater long term risk of rheumatoid arthritis, and up to 32% 10 year absolute risk of rheumatoid arthritis. These novel findings may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on rheumatoid factor testing.	[Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, DK-2730 Herlev, Denmark; [Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen City Heart Study, Bispebjerg Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	This study was funded by Herlev Hospital, Copenhagen University Hospital and the Danish Heart Foundation. The sponsors had no role in the design of the study; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication. The views expressed in this paper are those of the authors and not those of any funding body or others whose support is acknowledged.	AHO K, 1991, J RHEUMATOL, V18, P1282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Andersen TF, 1999, DAN MED BULL, V46, P263; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Balsa A, 2010, RHEUMATOLOGY, V49, P458, DOI 10.1093/rheumatology/kep380; Bas S, 2003, RHEUMATOLOGY, V42, P677, DOI 10.1093/rheumatology/keg184; Boutry N, 2009, EUR J RADIOL, V71, P217, DOI 10.1016/j.ejrad.2009.02.013; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Cohen SB, 2010, BEST PRACT RES CL RH, V24, P553, DOI 10.1016/j.berh.2009.11.006; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Don BR, 2010, CLIN NEPHROL, V73, P431; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FISCHER KM, 1991, MED HYPOTHESES, V34, P116, DOI 10.1016/0306-9877(91)90177-Z; Gaston J. S. H, 1999, RHEUMATIC DIS IMMUNO; Hutchinson D, 2001, ANN RHEUM DIS, V60, P223, DOI 10.1136/ard.60.3.223; Innala L, 2008, J RHEUMATOL, V35, P1002; Johansson M, 2006, SCAND J RHEUMATOL, V35, P29; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kuriya B, 2009, ANN RHEUM DIS, V68, P1482, DOI 10.1136/ard.2008.092676; Machold KP, 2002, J RHEUMATOL, V29, P2278; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Orsted D, 2011, EUR J CANCER, V47, pS504, DOI 10.1016/S0959-8049(11)72015-9; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Tamai M, 2010, SCAND J RHEUMATOL, V39, P287, DOI 10.3109/03009741003604534; Turesson C, 2007, ANN RHEUM DIS, V66, P59, DOI 10.1136/ard.2006.054445; Ursum J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2907; Verschueren P, 2009, SCAND J RHEUMATOL, V38, P166, DOI 10.1080/03009740802484846; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P38, DOI 10.1136/ard.2003.014928; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160	38	85	87	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5244	10.1136/bmj.e5244	http://dx.doi.org/10.1136/bmj.e5244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956589	Green Published, hybrid			2022-12-01	WOS:000308634100001
J	Sanyal, A; Lajoie, BR; Jain, G; Dekker, J				Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job			The long-range interaction landscape of gene promoters	NATURE			English	Article							CHROMOSOMAL INTERACTIONS; CHROMATIN CONFORMATION; ELEMENTS; BINDING; DOMAIN; 5C	The vast non-coding portion of the human genome is full of functional elements and disease-causing regulatory variants. The principles defining the relationships between these elements and distal target genes remain unknown. Promoters and distal elements can engage in looping interactions that have been implicated in gene regulation(1). Here we have applied chromosome conformation capture carbon copy (5C(2)) to interrogate comprehensively interactions between transcription start sites (TSSs) and distal elements in 1% of the human genome representing the ENCODE pilot project regions(3). 5C maps were generated for GM12878, K562 and HeLa-S3 cells and results were integrated with data from the ENCODE consortium(4). In each cell line we discovered >1,000 long-range interactions between promoters and distal sites that include elements resembling enhancers, promoters and CTCF-bound sites. We observed significant correlations between gene expression, promoter-enhancer interactions and the presence of enhancer RNAs. Long-range interactions show marked asymmetry with a bias for interactions with elements located similar to 120 kilobases upstream of the TSS. Long-range interactions are often not blocked by sites bound by CTCF and cohesin, indicating that many of these sites do not demarcate physically insulated gene domains. Furthermore, only similar to 7% of looping interactions are with the nearest gene, indicating that genomic proximity is not a simple predictor for long-range interactions. Finally, promoters and distal elements are engaged in multiple long-range interactions to form complex networks. Our results start to place genes and regulatory elements in three-dimensional context, revealing their functional relationships.	[Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	job.dekker@umassmed.edu	SANYAL, AMARTYA/D-7240-2015; Peng, Bo/A-6920-2009	SANYAL, AMARTYA/0000-0002-2109-4478; Peng, Bo/0000-0001-8225-2284	National Institutes of Health, National Human Genome Research Institute [HG003143, HG003143-06S1]; W.M Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); W.M Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the University of Massachusetts Medical School Deep Sequencing core for sequencing 5C libraries, and R. Thurman and J. Stamatoyannopoulos for discussion and help with peak calling analysis. We thank M. Walhout and members of the Dekker laboratory for discussions. This work was supported by grants from the National Institutes of Health, National Human Genome Research Institute (HG003143 and HG003143-06S1) and a W.M Keck Foundation Distinguished Young scholar in Medical Research award to J.D.	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dong X., GENOME BIOL IN PRESS; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Harrow J, 2012, GENOME RES; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	26	984	1021	7	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					109	U127		10.1038/nature11279	http://dx.doi.org/10.1038/nature11279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955621	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000308347000044
J	Kong, A; Frigge, ML; Masson, G; Besenbacher, S; Sulem, P; Magnusson, G; Gudjonsson, SA; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Wong, WSW; Sigurdsson, G; Walters, GB; Steinberg, S; Helgason, H; Thorleifsson, G; Gudbjartsson, DF; Helgason, A; Magnusson, OT; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Wong, Wendy S. W.; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari			Rate of de novo mutations and the importance of father's age to disease risk	NATURE			English	Article							AUTISM SPECTRUM DISORDERS; SCHIZOPHRENIA; HUMANS; CONSEQUENCES; NUCLEOTIDE; PATTERNS; NRXN1	Mutations generate sequence diversity and provide a substrate for selection. The rate of de novo mutations is therefore of major importance to evolution. Here we conduct a study of genome-wide mutation rates by sequencing the entire genomes of 78 Icelandic parent-offspring trios at high coverage. We show that in our samples, with an average father's age of 29.7, the average de novo mutation rate is 1.20 x 10(-8) per nucleotide per generation. Most notably, the diversity in mutation rate of single nucleotide polymorphisms is dominated by the age of the father at conception of the child. The effect is an increase of about two mutations per year. An exponential model estimates paternal mutations doubling every 16.5 years. After accounting for random Poisson variation, father's age is estimated to explain nearly all of the remaining variation in the de novo mutation counts. These observations shed light on the importance of the father's age on the risk of diseases such as schizophrenia and autism.	[Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Wong, Wendy S. W.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Aarhus University; Illumina; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Walters, G. Bragi/L-4215-2013	Walters, G. Bragi/0000-0002-5415-6487; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Besenbacher, Soren/0000-0003-1455-1738; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgason, Agnar/0000-0002-8545-3767	National Institutes of Health [MH071425]; European Community [HEALTH-F2-2009-223423, IAPP-MC-251592]; European Community IMI grant EU-AIMS [115300]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); European Community IMI grant EU-AIMS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was partly funded by The National Institutes of Health grant MH071425 (K.S.); the European Community's Seventh Framework Programme, PsychCNVs project, grant agreement HEALTH-F2-2009-223423, and NextGene project, grant agreement IAPP-MC-251592; The European Community IMI grant EU-AIMS, grant agreement 115300.	Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Duong L, 2012, AM J MED GENET B, V159B, P354, DOI 10.1002/ajmg.b.32036; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	27	1248	1278	2	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					471	475		10.1038/nature11396	http://dx.doi.org/10.1038/nature11396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914163	Green Accepted			2022-12-01	WOS:000307761600028
J	Park, SH; Das, BB; Casagrande, F; Tian, Y; Nothnagel, HJ; Chu, MN; Kiefer, H; Maier, K; De Angelis, AA; Marassi, FM; Opella, SJ				Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Kiefer, Hans; Maier, Klaus; De Angelis, Anna A.; Marassi, Francesca M.; Opella, Stanley J.			Structure of the chemokine receptor CXCR1 in phospholipid bilayers	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN INTERLEUKIN-8 RECEPTOR; NMR CHEMICAL-SHIFTS; SOLID-STATE NMR; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SPECTROSCOPY; GPCR; PROTEOLIPOSOMES; REFINEMENT	CXCR1 is one of two high-affinity receptors for the CXC chemokine interleukin-8 (IL-8), a major mediator of immune and inflammatory responses implicated in many disorders, including tumour growth(1-3). IL-8, released in response to inflammatory stimuli, binds to the extracellular side of CXCR1. The ligand-activated intracellular signalling pathways result in neutrophil migration to the site of inflammation(2). CXCR1 is a class A, rhodopsin-like G-protein-coupled receptor (GPCR), the largest class of integral membrane proteins responsible for cellular signal transduction and targeted as drug receptors(4-7). Despite its importance, the molecular mechanism of CXCR1 signal transduction is poorly understood owing to the limited structural information available. Recent structural determination of GPCRs has advanced by modifying the receptors with stabilizing mutations, insertion of the protein T4 lysozyme and truncations of their amino acid sequences(8), as well as addition of stabilizing antibodies and small molecules(9) that facilitate crystallization in cubic phase monoolein mixtures(10). The intracellular loops of GPCRs are crucial for G-protein interactions(11), and activation of CXCR1 involves both amino-terminal residues and extracellular loops(2,12,13). Our previous nuclear magnetic resonance studies indicate that IL-8 binding to the N-terminal residues is mediated by the membrane, underscoring the importance of the phospholipid bilayer for physiological activity(14). Here we report the three-dimensional structure of human CXCR1 determined by NMR spectroscopy. The receptor is in liquid crystalline phospholipid bilayers, without modification of its amino acid sequence and under physiological conditions. Features important for intracellular G-protein activation and signal transduction are revealed. The structure of human CXCR1 in a lipid bilayer should help to facilitate the discovery of new compounds that interact with GPCRs and combat diseases such as breast cancer.	[Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Tian, Ye; Marassi, Francesca M.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Kiefer, Hans] HBC Hsch Biberach, D-88400 Biberach, Germany; [Maier, Klaus; De Angelis, Anna A.] Membrane Receptor Technol, San Diego, CA 92121 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Opella, SJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sopella@ucsd.edu	Das, Bibhuti B./ABC-9067-2021; Park, Sang Ho/AAK-3432-2020	Das, Bibhuti B./0000-0001-9530-8785; Kiefer, Hans/0000-0002-8574-9867	National Institutes of Health (NIH) [R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805, P41EB002031]; Swiss National Science Foundation [PBBSP3-123151]; Novartis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005161, P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075877, R01GM099986, R21GM075917, R21GM094727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805 and P41EB002031 from the National Institutes of Health (NIH). Further support came from Cambridge Isotope Laboratories. F.C. was supported by fellowships from the Swiss National Science Foundation (PBBSP3-123151) and the Novartis Foundation.	Casagrande F, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P297; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das BB, 2012, J AM CHEM SOC, V134, P2047, DOI 10.1021/ja209464f; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano WL, 2005, PYMOL; Denny JK, 2001, J MAGN RESON, V152, P217, DOI 10.1006/jmre.2001.2405; EDIDIN M, 1974, ANNU REV BIOPHYS BIO, V3, P179, DOI 10.1146/annurev.bb.03.060174.001143; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goncalves JA, 2010, PROG NUCL MAG RES SP, V57, P159, DOI 10.1016/j.pnmrs.2010.04.004; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; Mesleh MF, 2003, J AM CHEM SOC, V125, P8928, DOI 10.1021/ja034211q; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park SH, 2006, J AM CHEM SOC, V128, P7402, DOI 10.1021/ja0606632; Park SH, 2012, BBA-BIOMEMBRANES, V1818, P584, DOI 10.1016/j.bbamem.2011.10.008; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Park SH, 2011, BIOCHEMISTRY-US, V50, P2371, DOI 10.1021/bi101568j; Park SH, 2010, J PHYS CHEM B, V114, P13995, DOI 10.1021/jp106043w; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817	46	356	359	4	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					779	+		10.1038/nature11580	http://dx.doi.org/10.1038/nature11580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23086146	Green Accepted, Green Submitted			2022-12-01	WOS:000311606000050
J	Young, GR; Eksmond, U; Salcedo, R; Alexopoulou, L; Stoye, JP; Kassiotis, G				Young, George R.; Eksmond, Urszula; Salcedo, Rosalba; Alexopoulou, Lena; Stoye, Jonathan P.; Kassiotis, George			Resurrection of endogenous retroviruses in antibody-deficient mice	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; B-CELL RESPONSES; TARGETED DISRUPTION; RECEPTOR; LYMPHOCYTES; MOUSE; RETROELEMENTS; EXPRESSION; INDUCTION; LIPOPOLYSACCHARIDE	The mammalian host has developed a long-standing symbiotic relationship with a considerable number of microbial species. These include the microbiota on environmental surfaces, such as the respiratory and gastrointestinal tracts(1), and also endogenous retroviruses (ERVs), comprising a substantial fraction of the mammalian genome(2,3). The long-term consequences for the host of interactions with these microbial species can range from mutualism to parasitism and are not always completely understood. The potential effect of one microbial symbiont on another is even less clear. Here we study the control of ERVs in the commonly used C57BL/6 (B6) mouse strain, which lacks endogenous murine leukaemia viruses (MLVs) able to replicate in murine cells. We demonstrate the spontaneous emergence of fully infectious ecotropic(4) MLV in B6 mice with a range of distinct immune deficiencies affecting antibody production. These recombinant retroviruses establish infection of immunodeficient mouse colonies, and ultimately result in retrovirus-induced lymphomas. Notably, ERV activation in immunodeficient mice is prevented in husbandry conditions associated with reduced or absent intestinal microbiota. Our results shed light onto a previously unappreciated role for immunity in the control of ERVs and provide a potential mechanistic link between immune activation by microbial triggers and a range of pathologies associated with ERVs, including cancer.	[Young, George R.; Eksmond, Urszula; Kassiotis, George] MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; [Salcedo, Rosalba] SAIC Frederick Inc, Basic Sci Program, NIH, Frederick, MD 21701 USA; [Salcedo, Rosalba] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Alexopoulou, Lena] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy CIML,INSERM, U1104,CNRS UMR7280, Marseille, France; [Stoye, Jonathan P.] MRC Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; MRC National Institute for Medical Research	Kassiotis, G (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England.	gkassio@nimr.mrc.ac.uk	Young, George/C-6733-2009; Alexopoulou, Lena/A-5041-2017	Young, George/0000-0002-1203-588X; Alexopoulou, Lena/0000-0003-4619-697X; Stoye, Jonathan/0000-0003-3377-323X; Kassiotis, George/0000-0002-8457-2633	UK Medical Research Council [U117581330, U117512710]; Medical Research Council [MC_U117512710, MC_U117581330] Funding Source: researchfish; MRC [MC_U117581330, MC_U117512710] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank W.-D. Hardt for mouse samples and discussion, L. Selles Vidal for technical assistance, and colleagues for critical reading of the manuscript. We also wish to thank the staff of the Unit for Laboratory Animal Medicine, University of Michigan, for the provision of germ-free mice. We are grateful for assistance from the Division of Biological Services, the Flow Cytometry, Electron Microscopy and Microarray facilities at NIMR. This work was supported by the UK Medical Research Council (U117581330 and U117512710).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bromham L, 2001, J VIROL, V75, P3053, DOI 10.1128/JVI.75.6.3053-3057.2001; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING SR, 1988, VIROLOGY, V162, P1, DOI 10.1016/0042-6822(88)90388-1; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOZAK CA, 1980, J EXP MED, V152, P219, DOI 10.1084/jem.152.1.219; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Li MF, 1999, J VIROL, V73, P9178, DOI 10.1128/JVI.73.11.9178-9186.1999; Lim A, 2011, AIDS, V25, P1379, DOI 10.1097/QAD.0b013e328348a789; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MCCUBREY J, 1982, CELL, V28, P881, DOI 10.1016/0092-8674(82)90067-8; MELAMEDOFF M, 1983, J EXP MED, V158, P506, DOI 10.1084/jem.158.2.506; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORONI C, 1975, NATURE, V254, P60, DOI 10.1038/254060a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Reid RR, 1997, J IMMUNOL, V159, P970; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; STOYE JP, 1983, J EXP MED, V157, P1660, DOI 10.1084/jem.157.5.1660; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wu Licheng, 2006, Current Issues in Intestinal Microbiology, V7, P19; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshinobu K, 2009, J IMMUNOL, V182, P8094, DOI 10.4049/jimmunol.0900263; Young GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002709	59	151	157	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					774	+		10.1038/nature11599	http://dx.doi.org/10.1038/nature11599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103862	Green Accepted			2022-12-01	WOS:000311606000049
J	Harnett, MT; Makara, JK; Spruston, N; Kath, WL; Magee, JC				Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Kath, William L.; Magee, Jeffrey C.			Synaptic amplification by dendritic spines enhances input cooperativity	NATURE			English	Article							PYRAMIDAL NEURON DENDRITES; ELECTRICAL COMPARTMENTALIZATION; LEARNING RULES; PLASTICITY; COMPUTATION; INTEGRATION; MEMBRANE; SIGNALS; MODEL; NECK	Dendritic spines are the nearly ubiquitous site of excitatory synaptic input onto neurons(1,2) and as such are critically positioned to influence diverse aspects of neuronal signalling. Decades of theoretical studies have proposed that spines may function as highly effective and modifiable chemical and electrical compartments that regulate synaptic efficacy, integration and plasticity(3-8). Experimental studies have confirmed activity-dependent structural dynamics and biochemical compartmentalization by spines(9-12). However, there is a longstanding debate over the influence of spines on the electrical aspects of synaptic transmission and dendritic operation(3-8,13-18). Here we measure the amplitude ratio of spine head to parent dendrite voltage across a range of dendritic compartments and calculate the associated spine neck resistance (R-neck) for spines at apical trunk dendrites in rat hippocampal CA1 pyramidal neurons. We find that R-neck is large enough (similar to 500M Omega) to amplify substantially the spine head depolarization associated with a unitary synaptic input by similar to 1.5- to similar to 45-fold, depending on parent dendritic impedance. A morphologically realistic compartmental model capable of reproducing the observed spatial profile of the amplitude ratio indicates that spines provide a consistently high-impedance input structure throughout the dendritic arborization. Finally, we demonstrate that the amplification produced by spines encourages electrical interaction among coactive inputs through an R-neck-dependent increase in spine head voltage-gated conductance activation. We conclude that the electrical properties of spines promote nonlinear dendritic processing and associated forms of plasticity and storage, thus fundamentally enhancing the computational capabilities of neurons(19-21).	[Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Magee, Jeffrey C.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Makara, Judit K.] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Kath, William L.] Northwestern Univ, Dept Appl Math, Evanston, IL 60208 USA; [Kath, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Northwestern University; Northwestern University	Magee, JC (corresponding author), HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Kath, William/B-6771-2009	Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783	Howard Hughes Medical Institute; National Institutes of Health [NS-046064, NS-077601]; Wellcome Trust [090915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077601, R01NS046064] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Milstein, S. Gale and R. Chitwood for help in creating analysis tools and G. Murphy, S. Williams and D. Johnston for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health (NS-046064, NS-077601) and the Wellcome Trust (International Senior Research Fellowship to J.K.M., grant number 090915).	Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Chen Y, 2012, CURR OPIN NEUROBIOL, V22, P389, DOI 10.1016/j.conb.2012.03.003; Dowell M., 1971, BIT (Nordisk Tidskrift for Informationsbehandling), V11, P168, DOI 10.1007/BF01934364; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036007; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hao J, 2012, CURR OPIN NEUROBIOL, V22, P509, DOI 10.1016/j.conb.2011.10.004; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Johnston D., 1995, FDN CELLULAR NEUROPH, P400; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; KOCH C, 1993, J NEUROSCI, V13, P413; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; MILLER JP, 1985, BRAIN RES, V325, P325, DOI 10.1016/0006-8993(85)90333-6; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rall W., 1974, CELLULAR MECH SUBSER; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; Yasuda R, 2011, CURR OPIN NEUROBIOL, V21, P313, DOI 10.1016/j.conb.2011.02.008; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	39	171	173	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					599	+		10.1038/nature11554	http://dx.doi.org/10.1038/nature11554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103868	Green Accepted			2022-12-01	WOS:000311339800053
J	Mancusso, R; Gregorio, GG; Liu, Q; Wang, DN				Mancusso, Romina; Gregorio, G. Glenn; Liu, Qun; Wang, Da-Neng			Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter	NATURE			English	Article							COUPLED CITRATE TRANSPORTER; CRYSTAL-STRUCTURE; NA+/DICARBOXYLATE COTRANSPORTER; ANOMALOUS DIFFRACTION; CARRIER PROTEIN; MEMBRANE; EXPRESSION; SYSTEM; RESIDUES; INSIGHTS	In human cells, cytosolic citrate is a chief precursor for the synthesis of fatty acids, triacylglycerols, cholesterol and low-density lipoprotein. Cytosolic citrate further regulates the energy balance of the cell by activating the fatty-acid-synthesis pathway while downregulating both the glycolysis and fatty-acid beta-oxidation pathways(1-4). The rate of fatty-acid synthesis in liver and adipose cells, the two main tissue types for such synthesis, correlates directly with the concentration of citrate in the cytosol(2-5), with the cytosolic citrate concentration partially depending on direct import across the plasma membrane through the Na+-dependent citrate transporter (NaCT)(6,7). Mutations of the homologous fly gene (Indy; I'm not dead yet) result in reduced fat storage through calorie restriction(8). More recently, Nact (also known as Slc13a5)-knockout mice have been found to have increased hepatic mitochondrial biogenesis, higher lipid oxidation and energy expenditure, and reduced lipogenesis, which taken together protect the mice from obesity and insulin resistance(9). To understand the transport mechanism of NaCT and INDY proteins, here we report the 3.2 angstrom crystal structure of a bacterial INDY homologue. One citrate molecule and one sodium ion are bound per protein, and their binding sites are defined by conserved amino acid motifs, forming the structural basis for understanding the specificity of the transporter. Comparison of the structures of the two symmetrical halves of the transporter suggests conformational changes that propel substrate translocation.	[Mancusso, Romina; Gregorio, G. Glenn; Wang, Da-Neng] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Mancusso, Romina] NYU, Sch Med, Mol Biophys Grad Program, New York, NY 10016 USA; [Liu, Qun] Brookhaven Natl Lab, NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; United States Department of Energy (DOE); Brookhaven National Laboratory; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10016 USA.	wang@saturn.med.nyu.edu	Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Wang, Da-Neng/0000-0002-6496-4699; Gregorio, Gabriel Glenn/0000-0001-8677-133X	National Institutes of Health [U54-GM075026, R01-DK073973, R01-GM093825, R01-MH083840]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053973, R01DK073973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093825, U54GM075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Punta and B. Rost for bioinformatics analysis of membrane transporters, to J. Love and B. Kloss for assistance in cloning, and to the staff at beamlines X4, X25 and X29 of the National Synchrotron Light Source in the Brookhaven National Laboratory and at the 23ID at the Advanced Photon Source at the Argonne National Laboratory for assistance in X-ray diffraction experiments, and to J. Llodra for help with artwork. We thank B. K. Czyzewski, W. A. Hendrickson, N. K. Karpowich, F. Mancia and J. J. Marden for discussions and for participating in synchrotron trips. This work was financially supported by National Institutes of Health grants U54-GM075026, R01-DK073973, R01-GM093825 and R01-MH083840.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; BLOCH K, 1977, ANNU REV BIOCHEM, V46, P263, DOI 10.1146/annurev.bi.46.070177.001403; Boulter JM, 2001, PROTEIN EXPRES PURIF, V22, P337, DOI 10.1006/prep.2001.1440; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano WL., 2002, PYMOL USERS MANUAL D; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Hall JA, 2005, J BACTERIOL, V187, P5189, DOI 10.1128/JB.187.15.5189-5194.2005; Hall JA, 2007, J BACTERIOL, V189, P880, DOI 10.1128/JB.01452-06; HIRATO T, 1984, J BACTERIOL, V160, P421, DOI 10.1128/JB.160.1.421-426.1984; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Joshi A. D., 1945, BIOCHEMISTRY-US, V45, P4231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Li XD, 2001, FEBS LETT, V494, P165, DOI 10.1016/S0014-5793(01)02334-1; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; NISHIKOR.K, 1973, FEBS LETT, V32, P19, DOI 10.1016/0014-5793(73)80725-2; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; Pajor AM, 2010, AM J PHYSIOL-RENAL, V299, pF704, DOI 10.1152/ajprenal.00213.2010; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPENCER AF, 1962, J BIOL CHEM, V237, P3640; Strickler MA, 2009, BBA-BIOMEMBRANES, V1788, P2489, DOI 10.1016/j.bbamem.2009.10.008; Sul HS, 2008, N COMP BIOC, P155, DOI 10.1016/B978-044453219-0.50008-8; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; WRIGHT SH, 1980, J MEMBRANE BIOL, V57, P73, DOI 10.1007/BF01868987; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Zhang FF, 2001, BBA-BIOMEMBRANES, V1511, P80, DOI 10.1016/S0005-2736(00)00385-0	49	124	125	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					622	+		10.1038/nature11542	http://dx.doi.org/10.1038/nature11542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086149	Green Accepted			2022-12-01	WOS:000311339800058
J	Smith, BE; Braun, RE				Smith, Benjamin E.; Braun, Robert E.			Germ Cell Migration Across Sertoli Cell Tight Junctions	SCIENCE			English	Article							INTERCELLULAR BRIDGES; BARRIER; TESTIS; RAT; SPERMATOGENESIS	The blood-testis barrier includes strands of tight junctions between somatic Sertoli cells that restricts solutes from crossing the paracellular space, creating a microenvironment within seminiferous tubules and providing immune privilege to meiotic and postmeiotic cells. Large cysts of germ cells transit the Sertoli cell tight junctions (SCTJs) without compromising their integrity. We used confocal microscopy to visualize SCTJ components during germ cell cyst migration across the SCTJs. Cysts become enclosed within a network of transient compartments fully bounded by old and new tight junctions. Dissolution of the old tight junctions releases the germ cells into the adluminal compartment, thus completing transit across the blood-testis barrier. Claudin 3, a tight junction protein, is transiently incorporated into new tight junctions and then replaced by claudin 11.	[Smith, Benjamin E.; Braun, Robert E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Washington; University of Washington Seattle; Jackson Laboratory	Braun, RE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	bob.braun@jax.org			National Institute of Child Health and Human Development/NIH [HD12629]; National Cancer Institute [CA34196]; Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD012629] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Lessard and J. Denegre for ssistance with confocal imaging and S. Leighton for artistic rendering of the images. This research was supported by a grant to R.E.B. from the National Institute of Child Health and Human Development/NIH (HD12629) as part of the Specialized Cooperative Centers Program in Reproduction Research and from the National Cancer Institute (CA34196) in support of The Jackson Laboratories shared services.	DYM M, 1977, BIOL REPROD, V17, P390, DOI 10.1095/biolreprod17.3.390; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102	12	122	130	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					798	802		10.1126/science.1219969	http://dx.doi.org/10.1126/science.1219969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	22997133	Green Accepted			2022-12-01	WOS:000310839500044
J	Lorang, J; Kidarsa, T; Bradford, CS; Gilbert, B; Curtis, M; Tzeng, SC; Maier, CS; Wolpert, TJ				Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Tzeng, S. -C.; Maier, C. S.; Wolpert, T. J.			Tricking the Guard: Exploiting Plant Defense for Disease Susceptibility	SCIENCE			English	Article							HOST-SELECTIVE TOXINS; VICTORIN SENSITIVITY; RESISTANCE GENE; THIOREDOXIN H5; LRR GENE; ARABIDOPSIS; PROTEINS; FEATURES	Typically, pathogens deploy virulence effectors to disable defense. Plants defeat effectors with resistance proteins that guard effector targets. We found that a pathogen exploits a resistance protein by activating it to confer susceptibility in Arabidopsis. The guard mechanism of plant defense is recapitulated by interactions among victorin (an effector produced by the necrotrophic fungus Cochliobolus victoriae), TRX-h5 (a defense-associated thioredoxin), and LOV1 (an Arabidopsis susceptibility protein). In LOV1's absence, victorin inhibits TRX-h5, resulting in compromised defense but not disease by C. victoriae. In LOV1's presence, victorin binding to TRX-h5 activates LOV1 and elicits a resistance-like response that confers disease susceptibility. We propose that victorin is, or mimics, a conventional pathogen virulence effector that was defeated by LOV1 and confers virulence to C. victoriae solely because it incites defense.	[Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Tzeng, S. -C.; Maier, C. S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Wolpert, TJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	wolpertt@science.oregonstate.edu		Maier, Claudia S./0000-0003-0743-8956	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society; BBSRC [BB/D016541/1, BB/H008039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Lorang J, 2010, MOL BREEDING, V26, P545, DOI 10.1007/s11032-010-9458-5; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mundt CC, 2009, PHYTOPATHOLOGY, V99, P1116, DOI 10.1094/PHYTO-99-10-1116; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Sweat TA, 2008, MOL PLANT MICROBE IN, V21, P7, DOI 10.1094/MPMI-21-1-0007; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; WOLPERT TJ, 1988, PLANT PHYSIOL, V88, P37, DOI 10.1104/pp.88.1.37; Wroblewski T, 2009, PLANT PHYSIOL, V150, P1733, DOI 10.1104/pp.109.140251	16	129	130	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					659	662		10.1126/science.1226743	http://dx.doi.org/10.1126/science.1226743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23087001	Green Accepted			2022-12-01	WOS:000310516000051
J	Lee, J; Sayed, N; Hunter, A; Au, KF; Wong, WH; Mocarski, ES; Pera, RR; Yakubov, E; Cooke, JP				Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Au, Kin Fai; Wong, Wing H.; Mocarski, Edward S.; Pera, Renee Reijo; Yakubov, Eduard; Cooke, John P.			Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; NF-KAPPA-B; MURINE LEUKEMIA-VIRUS; TOLL-LIKE RECEPTOR-3; HISTONE H3; GENE-EXPRESSION; SOMATIC-CELLS; BINDING-SITE; LYSINE 9; FIBROBLASTS	Retroviral overexpression of reprogramming factors (Oct4, Sox2, Klf4, c-Myc) generates induced pluripotent stem cells (iPSCs). However, the integration of foreign DNA could induce genomic dysregulation. Cell-permeant proteins (CPPs) could overcome this limitation. To date, this approach has proved exceedingly inefficient. We discovered a striking difference in the pattern of gene expression induced by viral versus CPP-based delivery of the reprogramming factors, suggesting that a signaling pathway required for efficient nuclear reprogramming was activated by the retroviral, but not CPP approach. In gain-and loss-of-function studies, we find that the toll-like receptor 3 (TLR3) pathway enables efficient induction of pluripotency by viral or mmRNA approaches. Stimulation of TLR3 causes rapid and global changes in the expression of epigenetic modifiers to enhance chromatin remodeling and nuclear reprogramming. Activation of inflammatory pathways are required for efficient nuclear reprogramming in the induction of pluripotency.	[Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Yakubov, Eduard; Cooke, John P.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Au, Kin Fai; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mocarski, Edward S.] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA	Stanford University; Stanford University; Stanford University; Emory University	Cooke, JP (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	john.cooke@stanford.edu	Mocarski, Edward/ABC-2893-2020	Sayed, Nazish/0000-0002-8229-721X; Reijo Pera, Renee/0000-0002-6487-1329; Cooke, John/0000-0003-0033-9138	National Institutes of Health [U01HL100397, RC2HL103400]; University of California; NRSA grant [HL098049-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049, RC2HL103400, U01HL100397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NRSA grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs. Joanna Wysocka, Karla Kirkegaard, and Vittorio Sebastiano for their guidance; Mr. Liqun Zhu for technical assistance; and Dr. Yaso Natkunam for histological studies. This work was supported by grants to J. P. C from National Institutes of Health (U01HL100397 and RC2HL103400). J. L. was supported by grant from the Tobacco Related Disease Research Program of the University of California. N. S was supported by NRSA grant (HL098049-01A1). J. P. C., N. S., and J. L. are inventors of the intellectual property, assigned to Stanford University, which was generated by this research.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; HAGINOYAMAGISHI K, 1987, J VIROL, V61, P1964, DOI 10.1128/JVI.61.6.1964-1971.1987; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang WC, 2009, BIOTECHNOL BIOENG, V104, P1047, DOI 10.1002/bit.22517; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	42	240	261	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					547	558		10.1016/j.cell.2012.09.034	http://dx.doi.org/10.1016/j.cell.2012.09.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101625	Bronze, Green Accepted			2022-12-01	WOS:000310529300012
J	White, JF; Noinaj, N; Shibata, Y; Love, J; Kloss, B; Xu, F; Gvozdenovic-Jeremic, J; Shah, P; Shiloach, J; Tate, CG; Grisshammer, R				White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard			Structure of the agonist-bound neurotensin receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; OPIOID RECEPTOR; BINDING-SITE; ACTIVE STATE; PEPTIDE; GPCR; ACTIVATION; INSIGHTS	Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR). In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes. Here we present the structure at 2.8 angstrom resolution of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor. The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core. Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurological disorders, cancer and obesity.	[White, Jim F.; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Grisshammer, Reinhard] Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA; [Noinaj, Nicholas] NIDDKD, Mol Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Shibata, Yoko; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Love, James; Kloss, Brian] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, Prot Prod Facil, New York, NY 10027 USA; [Shiloach, Joseph] NIDDKD, Biotechnol Core Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Grisshammer, R (corresponding author), Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA.	rkgriss@helix.nih.gov	Grisshammer, Reinhard/C-3089-2015	Tate, Christopher/0000-0002-2008-9183; Kloss, Brian/0000-0003-0130-8739	National Institutes of Health (National Institute of Neurological Disorders and Stroke); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases); Pfizer Global Research and Development; MRCT Development Gap Fund; UK Medical Research Council [MRC U105197215]; National Institutes of Health [U54GM075026]; NIH Roadmap grant [P50 GM073197]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, P50GM073197] Funding Source: NIH RePORTER; Medical Research Council [MC_U105197215] Funding Source: researchfish; MRC [MC_U105197215] Funding Source: UKRI	National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pfizer Global Research and Development(Pfizer); MRCT Development Gap Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Intramural Research Program of the National Institutes of Health (J.F.W., J.G.-J., P.S. and R.G.: National Institute of Neurological Disorders and Stroke; N.N. and J.S.: National Institute of Diabetes and Digestive and Kidney Diseases) and a joint grant from Pfizer Global Research and Development and the MRCT Development Gap Fund in addition to core funding from the UK Medical Research Council MRC U105197215 (Y.S., C.G.T.). The Protein Production Facility of the New York Consortium on Membrane Protein Structure was supported by the National Institutes of Health grant U54GM075026 (J.L., B.K.). We acknowledge the NIH Roadmap grant P50 GM073197 for technology development (to R. C. Stevens) for visitor support at The Scripps Research Institute. We thank the staff at the General Medicine and Cancer Institute's Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source, Argonne National Laboratory for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Barroso S, 2002, BRIT J PHARMACOL, V135, P997, DOI 10.1038/sj.bjp.0704546; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Harterich S, 2008, BIOORGAN MED CHEM, V16, P9359, DOI 10.1016/j.bmc.2008.08.051; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; HENRY JA, 1993, BIOORG MED CHEM LETT, V3, P949, DOI 10.1016/S0960-894X(00)80698-8; Hilgart MC, 2011, J SYNCHROTRON RADIAT, V18, P717, DOI 10.1107/S0909049511029918; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lebon G., 2012, CURR OPIN STRUC BIOL, V22, P1; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Luca S, 2003, P NATL ACAD SCI USA, V100, P10706, DOI 10.1073/pnas.1834523100; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	59	373	383	6	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					508	+		10.1038/nature11558	http://dx.doi.org/10.1038/nature11558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23051748	Green Accepted			2022-12-01	WOS:000310196200035
J	Teperino, R; Amann, S; Bayer, M; Mcgee, SL; Loipetzberger, A; Connor, T; Jaeger, C; Kammerer, B; Winter, L; Wiche, G; Dalgaard, K; Selvaraj, M; Gaster, M; Lee-Young, RS; Febbraio, MA; Knauf, C; Cani, PD; Aberger, F; Penninger, JM; Pospisilik, JA; Esterbauer, H				Teperino, Raffaele; Amann, Sabine; Bayer, Martina; Mcgee, Sean L.; Loipetzberger, Andrea; Connor, Timothy; Jaeger, Carsten; Kammerer, Bernd; Winter, Lilli; Wiche, Gerhard; Dalgaard, Kevin; Selvaraj, Madhan; Gaster, Michael; Lee-Young, Robert S.; Febbraio, Mark A.; Knauf, Claude; Cani, Patrice D.; Aberger, Fritz; Penninger, Josef M.; Pospisilik, J. Andrew; Esterbauer, Harald			Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat	CELL			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PRIMARY CILIA; PATHWAY; PROMOTE; OBESITY; REQUIREMENT; INHIBITION; OXYSTEROLS; MECHANISMS	Diabetes, obesity, and cancer affect upward of 15% of the world's population. Interestingly, all three diseases juxtapose dysregulated intracellular signaling with altered metabolic state. Exactly which genetic factors define stable metabolic set points in vivo remains poorly understood. Here, we show that hedgehog signaling rewires cellular metabolism. We identify a cilium-dependent Smo-Ca2+-Ampk axis that triggers rapid Warburg-like metabolic reprogramming within minutes of activation and is required for proper metabolic selectivity and flexibility. We show that Smo modulators can uncouple the Smo-Ampk axis from canonical signaling and identify cyclopamine as one of a new class of "selective partial agonists," capable of concomitant inhibition of canonical and activation of noncanonical hedgehog signaling. Intriguingly, activation of the Smo-Ampk axis in vivo drives robust insulin-independent glucose uptake in muscle and brown adipose tissue. These data identify multiple noncanonical endpoints that are pivotal for rational design of hedgehog modulators and provide a new therapeutic avenue for obesity and diabetes.	[Teperino, Raffaele; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Amann, Sabine; Bayer, Martina; Dalgaard, Kevin; Selvaraj, Madhan; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Mcgee, Sean L.; Connor, Timothy] Deakin Univ, Metabol Remodeling Lab, Metab Res Unit, Sch Med, Geelong, Vic 3220, Australia; [Loipetzberger, Andrea; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Jaeger, Carsten; Kammerer, Bernd] Ctr Biol Syst Anal ZBSA, Metabol Core, D-79104 Freiburg, Germany; [Winter, Lilli; Wiche, Gerhard] Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria; [Gaster, Michael] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Lee-Young, Robert S.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; [Knauf, Claude] Univ Toulouse 3, Inst Med Mol Rangueil, Team 3, CHU Rangueil,INSERM,U1048, F-31432 Toulouse 4, France; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Max Planck Society; Medical University of Vienna; Deakin University; Salzburg University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Baker Heart and Diabetes Institute; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	Winter, Lilli/ABB-3043-2021; Aberger, Fritz/B-6357-2012; Penninger, Josef M/I-6860-2013; Febbraio, Mark/AAE-9632-2019; Winter, Lilli/R-5949-2017; WICHE, Gerhard/AAA-3227-2021; D., Cani Patrice/M-8055-2016	Winter, Lilli/0000-0002-6368-1160; Aberger, Fritz/0000-0003-2009-6305; Penninger, Josef M/0000-0002-8194-3777; Winter, Lilli/0000-0002-6368-1160; D., Cani Patrice/0000-0003-2040-2448; Lee, Robert/0000-0002-8166-142X; Knauf, Claude/0000-0001-5213-5378; Teperino, Raffaele/0000-0001-8815-1409; Jaeger, Carsten/0000-0003-2192-1792; Esterbauer, Harald/0000-0001-7343-7455; Febbraio, Mark/0000-0002-9296-4418; Wiche, Gerhard/0000-0001-9550-5463; McGee, Sean/0000-0001-6953-106X	DART; AIRC; Marie-Curie; JDRF; WWTF; MPG; FWF; FFG; OeAW; Austrian Science Fund (FWF) [I 413, P 23729, I 1207] Funding Source: researchfish	DART; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie-Curie(European Commission); JDRF(Juvenile Diabetes Research Foundation); WWTF; MPG(Max Planck Society); FWF(Austrian Science Fund (FWF)); FFG; OeAW; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are indebted to the DART, AIRC, Marie-Curie, and JDRF for fellowships and WWTF, MPG, FWF, FFG (GenAU-program), and OeAW for funding. S. L. M. is a Career Development Fellow and M. A. F. a Senior Research Fellow of the National Health and Medical Research Council of Australia. The authors are grateful to E. Hobeika, M. Bilban, E. Einwallner, A. Jais, I. Lynfort, and B. Vind for critical technical and theoretical help. The authors are also grateful to M. Scott for providing Smoothened expression constructs, to J. Reiter for Smo-CLD and providing Kif3a<SUP>-/-</SUP> and Ift88<SUP>-/-</SUP> cells, to J. Taipale for providing Smo<SUP>-/-</SUP> cells, and to L. Cantley for the AMPKAR vector.	Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Li YW, 2012, EXPERT OPIN THER TAR, V16, P49, DOI 10.1517/14728222.2011.617367; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Roudaut H, 2011, MOL PHARMACOL, V79, P453, DOI 10.1124/mol.110.069708; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	56	188	190	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					414	426		10.1016/j.cell.2012.09.021	http://dx.doi.org/10.1016/j.cell.2012.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063129	Green Published, Bronze			2022-12-01	WOS:000309981000018
J	Yang, HH; Kim, A; David, T; Palmer, D; Jin, TH; Tien, J; Huang, F; Cheng, T; Coughlin, SR; Jan, YN; Jan, LY				Yang, Huanghe; Kim, Andrew; David, Tovo; Palmer, Daniel; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Coughlin, Shaun R.; Jan, Yuh Nung; Jan, Lily Yeh			TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation	CELL			English	Article							ACTIVATED CHLORIDE CHANNELS; SCOTT-SYNDROME; EXPRESSION; TRPM5; MEMBRANES; CELLS	Collapse of membrane lipid asymmetry is a hallmark of blood coagulation. TMEM16F of the TMEM16 family that includes TMEM16A/B Ca2+-activated Cl- channels (CaCCs) is linked to Scott syndrome with deficient Ca2+-dependent lipid scrambling. We generated TMEM16F knockout mice that exhibit bleeding defects and protection in an arterial thrombosis model associated with platelet deficiency in Ca2+-dependent phosphatidylserine exposure and procoagulant activity and lack a Ca2+-activated cation current in the platelet precursor megakaryocytes. Heterologous expression of TMEM16F generates a small-conductance Ca2+-activated nonselective cation (SCAN) current with subpicosiemens single-channel conductance rather than a CaCC. TMEM16F-SCAN channels permeate both monovalent and divalent cations, including Ca2+, and exhibit synergistic gating by Ca2+ and voltage. We further pinpointed a residue in the putative pore region important for the cation versus anion selectivity of TMEM16F-SCAN and TMEM16A-CaCC channels. This study thus identifies a Ca2+-activated channel permeable to Ca2+ and critical for Ca2+-dependent scramblase activity during blood coagulation.	[Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA; [David, Tovo; Palmer, Daniel; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	DAVID, Tovo/B-5573-2013; Palmer, Daniel/Q-7595-2016; Palmer, Daniel/J-2967-2014	Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Jan, Yuh Nung/0000-0003-1367-6299; Yang, Huanghe/0000-0001-9521-9328; Tien, Jason/0000-0003-3853-0827; Jan, Lily/0000-0003-3938-8498	NIH [HL65185, MH65334]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334, R01MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank David Gorczyca for help with confocal imaging; Xiuming Wong for help with cell culture; and Jianmin Cui, Ehud Isacoff, Min Li, Shi-Bing Yang, James Berg, and Christian Peters for suggestions and comments on the manuscript. We also thank Kevin Shannon and Ethan Weiss for sharing their CBC machine, Thrombinoscope, and other equipment. This study was supported by the NIH grant HL65185 to S.R.C. and MH65334 to L.Y.J. Y.N.J. and L.Y.J. are Howard Hughes Medical Institute investigators.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gurtovenko AA, 2010, CHEM REV, V110, P6077, DOI 10.1021/cr1000783; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mahaut-Smith Martyn P, 2004, Methods Mol Biol, V273, P277; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; ROSING J, 1985, BLOOD, V65, P319; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Teulon J, 2000, HANDB EXP PHARM, V147, P625; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; Varga-Szabo D, 2011, CELL CALCIUM, V50, P270, DOI 10.1016/j.ceca.2011.04.002; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	38	280	284	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					111	122		10.1016/j.cell.2012.07.036	http://dx.doi.org/10.1016/j.cell.2012.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021219	Bronze, Green Accepted			2022-12-01	WOS:000309544200014
J	Banerjee, S; Narayanan, M; Gould, K				Banerjee, Suryabrata; Narayanan, Manjusha; Gould, Kate			Monitoring aminoglycoside level	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; ADULTS		[Banerjee, Suryabrata] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [Narayanan, Manjusha] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gould, Kate] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	Banerjee, S (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	drsuryabrata@yahoo.co.uk	Banerjee, Suryabrata/AAY-7602-2021	Banerjee, Suryabrata/0000-0001-8200-4432				American Speech-Language-Hearing Association, 1994, AUD MAN IND REC COCH; Anaizi N, 1997, INT J CLIN PHARM TH, V35, P223; [Anonymous], 2010, GOODMAN GILLMAN PHAR; Begg EJ, 1999, BRIT J CLIN PHARMACO, V47, P23, DOI 10.1046/j.1365-2125.1999.00850.x; Edson RS, 1999, MAYO CLIN PROC, V74, P519, DOI 10.4065/74.5.519; Gilbert DN, 2010, MANDELL DOUGLAS BENN; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Naughton CA, 2008, AM FAM PHYSICIAN, V78, P743; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Ramakrishnan K, 2005, AM FAM PHYSICIAN, V71, P933; Scottish Medicines Consortium Scottish Antimicrobial Prescribing Group, 2009, GUID US GENT VANC AD; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; Urban A W, 1997, Curr Clin Top Infect Dis, V17, P236	13	7	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6354	10.1136/bmj.e6354	http://dx.doi.org/10.1136/bmj.e6354			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044986				2022-12-01	WOS:000309386700009
J	Garaycoechea, JI; Crossan, GP; Langevin, F; Daly, M; Arends, MJ; Patel, KJ				Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Arends, Mark J.; Patel, Ketan J.			Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function	NATURE			English	Article							FANCONI-ANEMIA; DEHYDROGENASE-ACTIVITY; PROGENITOR CELLS; DNA-REPAIR; MARROW-CELLS; MICE; TRANSPLANTATION; SUPPRESSION; PATHWAY; ASSAYS	Haematopoietic stem cells (HSCs) regenerate blood cells throughout the lifespan of an organism. With age, the functional quality of HSCs declines, partly owing to the accumulation of damaged DNA(1-3). However, the factors that damage DNA and the protective mechanisms that operate in these cells are poorly understood. We have recently shown that the Fanconi anaemia DNA-repair pathway counteracts the genotoxic effects of reactive aldehydes(4,5). Mice with combined inactivation of aldehyde catabolism (through Aldh2 knockout) and the Fanconi anaemia DNA-repair pathway (Fancd2 knockout) display developmental defects, a predisposition to leukaemia, and are susceptible to the toxic effects of ethanol-an exogenous source of acetaldehyde(4). Here we report that aged Aldh2(-/-) Fancd2(-/-) mutant mice that do not develop leukaemia spontaneously develop aplastic anaemia, with the concomitant accumulation of damaged DNA within the haematopoietic stem and progenitor cell (HSPC) pool. Unexpectedly, we find that only HSPCs, and not more mature blood precursors, require Aldh2 for protection against acetaldehyde toxicity. Additionally, the aldehyde-oxidizing activity of HSPCs, as measured by Aldefluor stain, is due to Aldh2 and correlates with this protection. Finally, there is more than a 600-fold reduction in the HSC pool of mice deficient in both Fanconi anaemia pathway-mediated DNA repair and acetaldehyde detoxification. Therefore, the emergence of bone marrow failure in Fanconi anaemia is probably due to aldehyde-mediated genotoxicity restricted to the HSPC pool. These findings identify a new link between endogenous reactive metabolites and DNA damage in HSCs, and define the protective mechanisms that counteract this threat.	[Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk		Crossan, Gerry/0000-0002-7974-009X	CRUK; Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation; Cancer Research UK [13647] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	CRUK(Cancer Research UK); Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation(March of Dimes); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Grompe for Fancd2-deficient mice and M. Milsom and D. Walter for technical advice. We are grateful to T. Langford, R. Berks, A. Middleton, C. Knox and J. Wiles for their help with mouse experimental work. We would also like to thank the Biomed services and ARES staff for animal husbandry and assistance. We thank N. Grant for photography. We thank the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. We also thank F. Zhang for help with FACS. G. P. C. is supported by CRUK and Homerton College, Cambridge. J. I. G. is supported by the Milstein Fund and the Darwin Trust of Edinburgh. F. L. is supported by the March of Dimes Foundation.	Amrani YM, 2011, J EXP MED, V208, P1757, DOI 10.1084/jem.20102170; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Levi BP, 2009, BLOOD, V113, P1670, DOI 10.1182/blood-2008-05-156752; Lo Celso C, 2007, CURR PROTOC STEM CEL; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Wang LJ, 2002, LIVER TRANSPLANT, V8, P822, DOI 10.1053/jlts.2002.34891; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang QS, 2010, BLOOD, V116, P5140, DOI 10.1182/blood-2010-04-278226	34	264	270	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					571	+		10.1038/nature11368	http://dx.doi.org/10.1038/nature11368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22922648				2022-12-01	WOS:000311781500005
J	Graham-Rowe, D				Graham-Rowe, Duncan			THERAPEUTICS Strength in numbers	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S16	S17		10.1038/489S16a	http://dx.doi.org/10.1038/489S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013711	Bronze			2022-12-01	WOS:000309167100009
J	Cheng, JK				Cheng, Jennifer K.			Food for Thought	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.	jennifer.cheng@childrens.harvard.edu						American Academy of Pediatrics, PED GUID CHILDR OR H; Le Billon K, 2012, FRENCH KIDS EAT EVER, P320; Maier A, 2007, APPETITE, V49, P429, DOI 10.1016/j.appet.2007.02.007	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1101	1102		10.1001/jama.2012.7198	http://dx.doi.org/10.1001/jama.2012.7198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990268				2022-12-01	WOS:000308861000025
J	Govindan, R; Ding, L; Griffith, M; Subramanian, J; Dees, ND; Kanchi, KL; Maher, CA; Fulton, R; Fulton, L; Wallis, J; Chen, K; Walker, J; McDonald, S; Bose, R; Ornitz, D; Xiong, DH; You, M; Dooling, DJ; Watson, M; Mardis, ER; Wilson, RK				Govindan, Ramaswamy; Ding, Li; Griffith, Malachi; Subramanian, Janakiraman; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Chen, Ken; Walker, Jason; McDonald, Sandra; Bose, Ron; Ornitz, David; Xiong, Donghai; You, Ming; Dooling, David J.; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.			Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers	CELL			English	Article							MUTATIONAL SIGNIFICANCE; SOMATIC MUTATIONS; GENE FUSIONS; IDENTIFICATION; REARRANGEMENTS; HETEROGENEITY; TRANSCRIPTION; EXPRESSION; EVOLUTION; ARID1A	We report the results of whole-genome and transcriptome sequencing of tumor and adjacent normal tissue samples from 17 patients with non-small cell lung carcinoma (NSCLC). We identified 3,726 point mutations and more than 90 indels in the coding sequence, with an average mutation frequency more than 10-fold higher in smokers than in never-smokers. Novel alterations in genes involved in chromatin modification and DNA repair pathways were identified, along with DACH1, CFTR, RELN, ABCB5, and HGF. Deep digital sequencing revealed diverse clonality patterns in both never-smokers and smokers. All validated EFGR and KRAS mutations were present in the founder clones, suggesting possible roles in cancer initiation. Analysis revealed 14 fusions, including ROS1 and ALK, as well as novel metabolic enzymes. Cell-cycle and JAK-STAT pathways are significantly altered in lung cancer, along with perturbations in 54 genes that are potentially targetable with currently available drugs.	[Govindan, Ramaswamy; Subramanian, Janakiraman; Maher, Christopher A.; McDonald, Sandra; Bose, Ron; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Govindan, Ramaswamy; Ding, Li; Subramanian, Janakiraman; Maher, Christopher A.; Bose, Ron] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Walker, Jason; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Fulton, Robert; Fulton, Lucinda; Wallis, John; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ornitz, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [McDonald, Sandra; Watson, Mark] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Xiong, Donghai; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Chen, Ken] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical College of Wisconsin; University of Texas System; UTMD Anderson Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.	rwilson@wustl.edu	Walker, Jason/A-9702-2013; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019; Griffith, Malachi/P-1285-2014; Chen, Ken/AAU-1432-2021	Walker, Jason/0000-0001-7547-5789; Wilson, Richard K./0000-0002-1992-1358; Griffith, Malachi/0000-0002-6388-446X; Chen, Ken/0000-0003-4013-5279; Ornitz, David/0000-0003-1592-7629	Washington University in St. Louis; National Human Genome Research Institute [NHGRI U54 HG003079]; Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE [R00CA149182, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University in St. Louis; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following groups at The Genome Institute for their dedicated efforts in this work: the Production group for sequence data production and processing, the Technology Development group for formulation of methods and troubleshooting, the Analysis Pipeline group for developing the automated sequence analysis pipelines, the LIMS group for developing tools and software to manage samples and sequencing, and the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis. We thank Daniel C. Koboldt for his help on tumor clonality analysis, Mike Wendl for help with pathway analysis, Josh Peck for help with manuscript preparation, and Joshua McMichael for help with figure preparation. We also thank the Washington University Cancer Genome Initiative and Siteman Cancer Center for their support. This work was funded by grants to R.K.W. from Washington University in St. Louis and the National Human Genome Research Institute (NHGRI U54 HG003079).	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chen K, 2012, BIOINFORMATICS, V28, P1923, DOI 10.1093/bioinformatics/bts272; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koukourakis MI, 2003, CANCER RES, V63, P5376; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Ng Tze Pin, 1994, Annals Academy of Medicine Singapore, V23, P752; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.3.CO;2-B; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	831	871	20	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1121	1134		10.1016/j.cell.2012.08.024	http://dx.doi.org/10.1016/j.cell.2012.08.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980976	Green Accepted, Bronze			2022-12-01	WOS:000308928100007
J	Imielinski, M; Berger, AH; Hammerman, PS; Hernandez, B; Pugh, TJ; Hodis, E; Cho, J; Suh, J; Capelletti, M; Sivachenko, A; Sougnez, C; Auclair, D; Lawrence, MS; Stojanov, P; Cibulskis, K; Choi, K; de Waal, L; Sharifnia, T; Brooks, A; Greulich, H; Banerji, S; Zander, T; Seidel, D; Leenders, F; Ansen, S; Ludwig, C; Engel-Riedel, W; Stoelben, E; Wolf, J; Goparju, C; Thompson, K; Winckler, W; Kwiatkowski, D; Johnson, BE; Janne, PA; Miller, VA; Pao, W; Travis, WD; Pass, HI; Gabriel, SB; Lander, ES; Thomas, RK; Garraway, LA; Getz, G; Meyerson, M				Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Cho, Jeonghee; Suh, James; Capelletti, Marzia; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; Choi, Kyusam; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Goparju, Chandra; Thompson, Kristin; Winckler, Wendy; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Miller, Vincent A.; Pao, William; Travis, William D.; Pass, Harvey I.; Gabriel, Stacey B.; Lander, Eric S.; Thomas, Roman K.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew			Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing	CELL			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; GENE-MUTATIONS; CANCER; GENOME; EGFR; LANDSCAPE; GEFITINIB; PATTERNS; REVEALS	Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, is responsible for more than 500,000 deaths per year worldwide. Here, we report exome and genome sequences of 183 lung adenocarcinoma tumor/normal DNA pairs. These analyses revealed a mean exonic somatic mutation rate of 12.0 events/megabase and identified the majority of genes previously reported as significantly mutated in lung adenocarcinoma. In addition, we identified statistically recurrent somatic mutations in the splicing factor gene U2AF1 and truncating mutations affecting RBM10 and ARID1A. Analysis of nucleotide context-specific mutation signatures grouped the sample set into distinct clusters that correlated with smoking history and alterations of reported lung adenocarcinoma genes. Whole-genome sequence analysis revealed frequent structural rearrangements, including in-frame exonic alterations within EGFR and SIK2 kinases. The candidate genes identified in this study are attractive targets for biological characterization and therapeutic targeting of lung adenocarcinoma.	[Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Thompson, Kristin; Winckler, Wendy; Gabriel, Stacey B.; Lander, Eric S.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Imielinski, Marcin] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Imielinski, Marcin; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Pugh, Trevor J.; Capelletti, Marzia; Stojanov, Petar; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cho, Jeonghee; Choi, Kyusam] Samsung Med Ctr, Samsung Res Inst, Seoul 135967, South Korea; [Suh, James] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Goparju, Chandra; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Dept Internal Med, D-50924 Cologne, Germany; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Lab Translat Canc Genom Koln Bonn, D-50924 Cologne, Germany; [Zander, Thomas; Thomas, Roman K.] Max Planck Inst Neurol Res, D-50924 Cologne, Germany; [Miller, Vincent A.] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Div Hematol Oncol, Nashville, TN 37232 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Pathol, D-50937 Cologne, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Sungkyunkwan University (SKKU); Samsung Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Massachusetts Institute of Technology (MIT); University of Cologne; University of Cologne	Meyerson, M (corresponding author), Broad Inst Harvard & MIT, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Stojanov, Petar/GQI-4462-2022; Pugh, Trevor/Y-2535-2019; Seidel, Danila/Y-6795-2018; Capelletti, Marzia/L-6317-2016	Stojanov, Petar/0000-0001-7815-776X; Pugh, Trevor/0000-0002-8073-5888; Seidel, Danila/0000-0003-4388-3117; Capelletti, Marzia/0000-0001-5095-7060; Meyerson, Matthew/0000-0002-9133-8108; Pass, Harvey/0000-0003-3222-3471; Cibulskis, Kristian/0000-0003-1343-1582	NCI [T32 CA9216]; Canadian Institutes of Health; American Cancer Society; National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE [P50 CA090578]; NIGMS [T32GM07753]; German Ministry of Science and Education (BMBF) [01GS08100]; Max Planck Society [M.I.F.A.NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) [SFB832 (TP6), TH1386/3-1]; EU-Framework Programme CURELUNG [HEALTH-F2-2010-258677]; American Association for Cancer Research [SU2C-AACR-IR60109]; Behrens-Weise Foundation; National Human Genome Research Institute; National Cancer Institute; Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE [R01CA109038, P50CA090578, R01CA116020, T32CA009216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU-Framework Programme CURELUNG; American Association for Cancer Research; Behrens-Weise Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Biological Samples Platform, DNA Sequencing Platform, and Genetic Analysis Platforms of the Broad Institute, without whose work this sequencing project could not have occurred. M.I. is supported by NCI Training Grant T32 CA9216. T.J.P. is supported by a Canadian Institutes of Health Research Fellowship. A.H.B. is supported by a postdoctoral fellowship from the American Cancer Society. P.S.H. is supported by a Young Investigator Award from the National Lung Cancer Partnership and a Career Development Award from the Dana-Farber/Harvard Cancer Center Lung Cancer SPORE P50 CA090578. E.H. is supported by NIGMS training grant T32GM07753. R.K.T. is supported by the German Ministry of Science and Education (BMBF) as a member of the NGFN-Plus program (grant 01GS08100), by the Max Planck Society (M.I.F.A.NEUR8061), by the Deutsche Forschungsgemeinschaft (DFG) through SFB832 (TP6) and grant TH1386/3-1, by the EU-Framework Programme CURELUNG (HEALTH-F2-2010-258677), by Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2C-AACR-IR60109), by the Behrens-Weise Foundation, and by an anonymous foundation. This work was supported by the National Human Genome Research Institute (E.S.L.) and by the National Cancer Institute, Uniting Against Lung Cancer, the Lung Cancer Research Foundation, and the American Lung Association (M.M.). M.M., E.L., and L.A.G. are founders and equity holders of Foundation Medicine, a for-profit company that provides next-generation sequencing diagnostic services. V.A.M. is an employee of Foundation Medicine.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Cancer Genome Atlas Research Network, 2012, NATURE; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/nmeth.1374, 10.1038/NMETH.1374]; Minna J, 2008, HARRISONS PRINCIPLES, P551; MITSUDOMI T, 1993, JNCI-J NATL CANCER I, V85, P2018, DOI 10.1093/jnci/85.24.2018; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; SLEBOS RJC, 1991, J NATL CANCER I, V83, P1024, DOI 10.1093/jnci/83.14.1024; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wheeler M, 2001, MOL CELL BIOL, V21, P6660, DOI 10.1128/MCB.21.19.6660-6667.2001; WHO, 2012, CANCER; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	56	1291	1335	4	149	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1107	1120		10.1016/j.cell.2012.08.029	http://dx.doi.org/10.1016/j.cell.2012.08.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980975	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000308928100006
J	Birney, E				Birney, Ewan			Lessons for big-data projects	NATURE			English	Editorial Material									European Bioinformat Inst, European Mol Biol Labs, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Labs, Hinxton, England.	birney@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497					0	66	71	0	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					49	51		10.1038/489049a	http://dx.doi.org/10.1038/489049a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955613	Bronze			2022-12-01	WOS:000308347000033
J	Meddings, JA; Reichert, H; Rogers, MAM; Saint, S; Stephansky, J; McMahon, LF				Meddings, Jennifer A.; Reichert, Heidi; Rogers, Mary A. M.; Saint, Sanjay; Stephansky, Joe; McMahon, Laurence F., Jr.			Effect of Nonpayment for Hospital-Acquired, Catheter-Associated Urinary Tract Infection	ANNALS OF INTERNAL MEDICINE			English	Article							SAFETY-NET; MEDICARE POLICY; CARE; PREVENTION; PAYMENT; IMPACT; RISK	Background: Most (59% to 86%) hospital-acquired urinary tract infections (UTIs) are catheter-associated urinary tract infections (CAUTIs). As of 2008, claims data are used to deny payment for certain hospital-acquired conditions, including CAUTIs, and publicly report hospital performance. Objective: To examine rates of UTIs in adults that are coded in claims data as hospital-acquired and catheter-associated events and evaluate how often nonpayment for CAUTI lowers hospital payment. Design: Before-and-after study of all-payer cross-sectional claims data. Setting: 96 nonfederal acute care Michigan hospitals. Patients: Nonobstetric adults discharged in 2007 (n = 767 531) and 2009 (n = 781 343). Measurements: Hospital rates of UTIs (categorized as catheter-associated or hospital-acquired) and frequency of reduced payment for hospital-acquired CAUTIs. Results: Hospitals frequently requested payment for non-CAUTIs as secondary diagnoses: 10.0% (95% CI, 9.5% to 10.5%) of discharges in 2007 and 10.3% (CI, 9.8% to 10.9%) in 2009. Hospital rates of CAUTI were very low: 0.09% (CI, 0.06% to 0.12%) in 2007 and 0.14% (CI, 0.11% to 0.17%) in 2009. In 2009, 2.6% (CI, 1.6% to 3.6%) of hospital-acquired UTIs were described as CAUTIs. Nonpayment for hospital-acquired CAUTIs reduced payment for 25 of 781 343 (0.003%) hospitalizations in 2009. Limitations: Data are from only 1 state and involved only 1 year before and after nonpayment for complications. Hospital prevention practices were not examined. Conclusion: Catheter-associated UTI rates determined by claims data seem to be inaccurate and are much lower than expected from epidemiologic surveillance data. The financial impact of current nonpayment policy for hospital-acquired CAUTI is low. Claims data are currently not valid data sets for comparing hospital-acquired CAUTI rates for the purpose of public reporting or imposing financial incentives or penalties. Primary Funding Source: Blue Cross Blue Shield of Michigan Foundation.	Univ Michigan, Sch Med, Hosp Outcomes Program Excellence, Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Michigan Hlth & Hosp Assoc, Lansing, MI 48933 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Meddings, JA (corresponding author), Div Gen Med, N Campus Res Complex,2800 Plymouth Rd,Bldg 16,Roo, Ann Arbor, MI 48109 USA.	meddings@umich.edu	Saint, Sanjay/AAF-5126-2019	Rogers, Mary/0000-0001-5519-3223; Meddings, Jennifer/0000-0001-9503-0293	Blue Cross Blue Shield of Michigan Foundation [1452.11]; Agency for Healthcare Research and Quality [1R010HS018344-01A1, 1K08-HS019767- 01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK078717]; National Institute of Nursing Research [R01-NR010700]; National Institutes of Health Clinical Loan Repayment Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010700] Funding Source: NIH RePORTER	Blue Cross Blue Shield of Michigan Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health Clinical Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The study was funded by grant 1452.11 from the Blue Cross Blue Shield of Michigan Foundation. The authors were also supported by awards 1R010HS018344-01A1 (Dr. McMahon) and 1K08-HS019767- 01 (Dr. Meddings) from the Agency for Healthcare Research and Quality; award R21-DK078717 (Dr. Saint) from the National Institute of Diabetes and Digestive and Kidney Diseases; and award R01-NR010700 (Dr. Saint) from the National Institute of Nursing Research. Dr. Meddings is also a recipient of the National Institutes of Health Clinical Loan Repayment Program for 2009 to 2012.	[Anonymous], 2010, BLUE CROSS BLUE SHIE; [Anonymous], 2008, FED REGISTER, V73; Centers for Medicare and Medicaid Services (CMS) HHS, 2007, Fed Regist, V72, P47129; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Centers for Medicare & Medicaid Services (CMS) National Center for Health Statistics (NCHS), 2009, ICD 9 CM OFF GUID CO; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Foxman B, 2002, AM J MED, V113, p5S; GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599; Gaskin DJ, 2001, HEALTH SERV RES, V36, P25; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; Healthcare Cost and Utilization Project, 2012, OV STAT INP DAT SID; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KRIEGER JN, 1983, J INFECT DIS, V148, P57, DOI 10.1093/infdis/148.1.57; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; McHugh M, 2011, J HEALTH CARE POOR U, V22, P638, DOI 10.1353/hpu.2011.0058; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Pennsylvania Health Care Cost Containment Council, 2012, IMP HEALTHC ASS INF; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; 2008, FED REG, V73, P23547	27	53	52	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					305	U33		10.7326/0003-4819-157-5-201209040-00003	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000BM	22944872	Green Accepted			2022-12-01	WOS:000308361500001
J	Senthilan, PR; Piepenbrock, D; Ovezmyradov, G; Nadrowski, B; Bechstedt, S; Pauls, S; Winkler, M; Mobius, W; Howard, J; Gopfert, MC				Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Bechstedt, Susanne; Pauls, Stephanie; Winkler, Margret; Moebius, Wiebke; Howard, Jonathon; Goepfert, Martin C.			Drosophila Auditory Organ Genes and Genetic Hearing Defects	CELL			English	Article							NOMPC TRP CHANNEL; OUTER HAIR-CELLS; PRONEURAL GENE; MECHANOSENSORY TRANSDUCTION; PHOTORECEPTOR CELLS; SIGNALING COMPLEX; COMPOUND EYE; PROTEIN; MELANOGASTER; EXPRESSION	The Drosophila auditory organ shares equivalent transduction mechanisms with vertebrate hair cells, and both are specified by atonal family genes. Using a whole-organ knockout strategy based on atonal, we have identified 274 Drosophila auditory organ genes. Only four of these genes had previously been associated with fly hearing, yet one in five of the genes that we identified has a human cognate that is implicated in hearing disorders. Mutant analysis of 42 genes shows that more than half of them contribute to auditory organ function, with phenotypes including hearing loss, auditory hypersusceptibility, and ringing ears. We not only discover ion channels and motors important for hearing, but also show that auditory stimulus processing involves chemoreceptor proteins as well as phototransducer components. Our findings demonstrate mechanosensory roles for ionotropic receptors and visual rhodopsins and indicate that different sensory modalities utilize common signaling cascades.	[Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Pauls, Stephanie; Winkler, Margret; Goepfert, Martin C.] Univ Gottingen, Dept Cellular Neurobiol, D-37077 Gottingen, Germany; [Bechstedt, Susanne; Howard, Jonathon] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Moebius, Wiebke] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society	Gopfert, MC (corresponding author), Univ Gottingen, Dept Cellular Neurobiol, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany.	mgoepfe@gwdg.de	Senthilan, Pingkalai R/A-3466-2013; Senthilan, Pingkalai/A-9387-2019; Howard, Jonathon/J-7492-2016; 889, CRC/L-1607-2018; Howard, Jonathon/D-4229-2011	Senthilan, Pingkalai R/0000-0003-3921-8886; Senthilan, Pingkalai/0000-0003-3921-8886; Howard, Jonathon/0000-0003-0086-1196; 889, CRC/0000-0002-6678-3138; Howard, Jonathon/0000-0003-0086-1196; /0000-0002-2902-7165; Kok, Kivanc/0000-0002-1502-1600; Gopfert, Martin/0000-0001-8201-5334	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation; DFG [Go1092/1-1];  [SFB 889]	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); 	We thank Claude Desplan, Roger Hardy, Charlotte Helfrich-Forster, Andrew Jarman, Bloomington Stock Centre, Exelixis Collection at Harvard Medical School, the Nippon Consortium, and Fly-Till for fly lines; BestGene, Inc. for fly injections; Steve Britt for antibodies; Thomas Effertz and Swantje Gratsch for help with physiology; and Matthias Schink and Torben Ruhwedel for technical support. This work was supported by the International Graduate School in Genetics and Functional Genomics (to P.R.S. and G.O.), the German National Academic Foundation (to D.P.), the Volkswagen Foundation (to B.N. and M.C.G.), the SFB 889 (A1 to M.C.G.) and a research grant from the DFG (Go1092/1-1, to M.C.G.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Bechstedt S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1007; Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cachero S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000568; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Herrero J, 2003, NUCLEIC ACIDS RES, V31, P3461, DOI 10.1093/nar/gkg591; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QH, 2009, INTEGR COMP BIOL, V49, P674, DOI 10.1093/icb/icp072; Ma L, 2011, J CELL SCI, V124, P2622, DOI 10.1242/jcs.084798; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Nelson HB, 1997, GENETICS, V147, P1783; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Niwa N, 2004, NAT GENET, V36, P293, DOI 10.1038/ng1308; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Raybould NP, 2007, J PHYSIOL-LONDON, V579, P101, DOI 10.1113/jphysiol.2006.122929; Roche JP, 2005, AUDIOL NEURO-OTOL, V10, P310, DOI 10.1159/000087348; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	83	130	133	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1042	1054		10.1016/j.cell.2012.06.043	http://dx.doi.org/10.1016/j.cell.2012.06.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939627	Bronze			2022-12-01	WOS:000308500200017
J	Stanley, M				Stanley, Margaret			PERSPECTIVE Vaccinate boys too	NATURE			English	Editorial Material									Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England	University of Cambridge	Stanley, M (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England.	mas1001@cam.ac.uk						Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Frisch M, 2002, DAN MED BULL, V49, P194; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; Kim JJ, 2011, NEW ENGL J MED, V364, P393, DOI 10.1056/NEJMp1012246	6	34	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S10	S10		10.1038/488S10a	http://dx.doi.org/10.1038/488S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932433	Bronze			2022-12-01	WOS:000308095100008
J	McLaughlin, RN; Poelwijk, FJ; Raman, A; Gosal, WS; Ranganathan, R				McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama			The spatial architecture of protein function and adaptation	NATURE			English	Article							PDZ DOMAIN; ACTIVATION; TRANSCRIPTION; DETERMINANTS; INFORMATION; ROBUSTNESS; MECHANISM; NETWORK; FITNESS; UNITS	Statistical analysis of protein evolution suggests a design for natural proteins in which sparse networks of coevolving amino acids (termed sectors) comprise the essence of three-dimensional structure and function(1-5). However, proteins are also subject to pressures deriving from the dynamics of the evolutionary process itself-the ability to tolerate mutation and to be adaptive to changing selection pressures(6-10). To understand the relationship of the sector architecture to these properties, we developed a high-throughput quantitative method for a comprehensive single-mutation study in which every position is substituted individually to every other amino acid. Using a PDZ domain (PSD95(pdz3)) model system, we show that sector positions are functionally sensitive to mutation, whereas non-sector positions are more tolerant to substitution. In addition, we find that adaptation to a new binding specificity initiates exclusively through variation within sector residues. A combination of just two sector mutations located near and away from the ligand-binding site suffices to switch the binding specificity of PSD95(pdz3) quantitatively towards a class-switching ligand. The localization of functional constraint and adaptive variation within the sector has important implications for understanding and engineering proteins.	[McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Gosal, Walraj/J-5260-2012	Gosal, Walraj/0000-0003-3396-1505; Poelwijk, Frank/0000-0002-5696-4357; McLaughlin, Richard/0000-0003-0950-2253	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health [R01EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank W. Russ, P. Mishra and other members of the Ranganathan laboratory for contributions to this work, W. Wakeland and C. Liang for assistance with Solexa sequencing, E. Curry and A. Mobley for assistance with flow cytometry, and M. Elowitz for providing the pZ plasmids. We acknowledge support from the University of Texas Southwestern Graduate School and Pharmacology Training Grant (R. N. M.), the Helen Hay Whitney Fellowship program (F.J.P.) and support from the National Institutes of Health (R01EY018720-05, R. R.), The Robert A. Welch Foundation (I-1366, R. R.) and the Green Center for Systems Biology (R.R.).	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BUSHMAN FD, 1989, CELL, V58, P1163, DOI 10.1016/0092-8674(89)90514-X; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tiana G, 2004, P NATL ACAD SCI USA, V101, P2846, DOI 10.1073/pnas.0306638101; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Whipple FW, 1997, J MOL BIOL, V265, P261, DOI 10.1006/jmbi.1996.0735	35	297	298	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					138	U163		10.1038/nature11500	http://dx.doi.org/10.1038/nature11500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041932	Green Accepted			2022-12-01	WOS:000310434500046
J	Marguerat, S; Schmidt, A; Codlin, S; Chen, W; Aebersold, R; Bahler, J				Marguerat, Samuel; Schmidt, Alexander; Codlin, Sandra; Chen, Wei; Aebersold, Ruedi; Baehler, Juerg			Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in Proliferating and Quiescent Cells	CELL			English	Article							GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; ABSOLUTE QUANTIFICATION; SEXUAL-DIFFERENTIATION; PROTEIN; HETEROCHROMATIN; RESOLUTION; RESPONSES; DIVISION	Data on absolute molecule numbers will empower the modeling, understanding, and comparison of cellular functions and biological systems. We quantified transcriptomes and proteomes in fission yeast during cellular proliferation and quiescence. This rich resource provides the first comprehensive reference for all RNA and most protein concentrations in a eukaryote under two key physiological conditions. The integrated data set supports quantitative biology and affords unique insights into cell regulation. Although mRNAs are typically expressed in a narrow range above 1 copy/cell, most long, noncoding RNAs, except for a distinct subset, are tightly repressed below 1 copy/cell. Cell-cycle-regulated transcription tunes mRNA numbers to phase-specific requirements but can also bring about more switch-like expression. Proteins greatly exceed mRNAs in abundance and dynamic range, and concentrations are regulated to functional demands. Upon transition to quiescence, the proteome changes substantially, but, in stark contrast to mRNAs, proteins do not uniformly decrease but scale with cell volume.	[Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Schmidt, Alexander] Univ Basel, Proteom Core Facil, Biozentrum, CH-4056 Basel, Switzerland; [Chen, Wei] Max Delbruck Ctr Mol Med MDC, Berlin Inst Med Syst Biol, D-13092 Berlin, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; University of London; University College London; University of Basel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch; j.bahler@ucl.ac.uk	Chen, Wei/C-1273-2011; Marguerat, Samuel/AAY-3792-2020; Bahler, Jurg/B-4572-2009	Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532; Chen, Wei/0000-0003-3263-1627	PhenOxiGEn (an EU FP7 research project); BBSRC [BB/I012451/1]; Wellcome Trust; SystemsX.ch; ERC; Biotechnology and Biological Sciences Research Council [BB/I012451/1] Funding Source: researchfish; Wellcome Trust [095598/Z/11/Z] Funding Source: researchfish	PhenOxiGEn (an EU FP7 research project); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SystemsX.ch; ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Bachand, D. Bitton, L. Foukas, A. Lock, D. Lovell, J. Mata, and V. Wood for comments on the manuscript, P. Gardner for advice on lncRNA sequences, and P. Oliveri for help with nCounter. This research was funded by PhenOxiGEn (an EU FP7 research project), a BBSRC Research Grant BB/I012451/1, and a Wellcome Trust Senior Investigator Award to J. B., and by SystemsX.ch and an ERC Advanced Grant to R.A.	Atkinson SR, 2012, SEMIN CELL DEV BIOL, V23, P200, DOI 10.1016/j.semcdb.2011.12.003; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Coller HA, 2011, SCIENCE, V334, P1074, DOI 10.1126/science.1216242; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovell D, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P193; MACLEAN N, 1965, NATURE, V207, P322, DOI 10.1038/207322a0; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	52	357	361	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					671	683		10.1016/j.cell.2012.09.019	http://dx.doi.org/10.1016/j.cell.2012.09.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101633	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000310529300021
J	Sylwestrak, EL; Ghosh, A				Sylwestrak, Emily L.; Ghosh, Anirvan			Elfn1 Regulates Target-Specific Release Probability at CA1-Interneuron Synapses	SCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; SCHAFFER COLLATERAL SYNAPSES; EXCITATORY SYNAPSES; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; INTERNEURONS; FACILITATION; EXPRESSION; CIRCUITS; RAT	Although synaptic transmission may be unidirectional, the establishment of synaptic connections with specific properties can involve bidirectional signaling. Pyramidal neurons in the hippocampus form functionally distinct synapses onto two types of interneurons. Excitatory synapses onto oriens-lacunosum moleculare (O-LM) interneurons are facilitating and have a low release probability, whereas synapses onto parvalbumin interneurons are depressing and have a high release probability. Here, we show that the extracellular leucine-rich repeat fibronectin containing 1 (Elfn1) protein is selectively expressed by O-LM interneurons and regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses. Thus, postsynaptic expression of Elfn1 in O-LM interneurons regulates presynaptic release probability, which confers target-specific synaptic properties to pyramidal cell axons.	[Sylwestrak, Emily L.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Sylwestrak, Emily L.; Ghosh, Anirvan] F Hoffmann La Roche, CNS Discovery, CH-4070 Basel, Switzerland; [Sylwestrak, Emily L.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of California System; University of California San Diego; Roche Holding; University of Basel	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	anirvan.ghosh@roche.com	Sylwestrak, Emily/GSE-3871-2022	Sylwestrak, Emily/0000-0002-1172-6523	NIH [R01NS067216]; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Scanziani, P. Scheiffele, and members of the Ghosh lab for suggestions and comments on the manuscript; J. de Wit for generating the Elfn1-GFP construct; and M. Macias, C. Sanchez, and E. Kang for help with virus and protein production. This work was supported by NIH grant R01NS067216 and the Gatsby Charitable Foundation.	Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Sun HY, 2006, J NEUROSCI, V26, P10796, DOI 10.1523/JNEUROSCI.2746-06.2006; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	30	91	94	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					536	540		10.1126/science.1222482	http://dx.doi.org/10.1126/science.1222482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23042292	Green Accepted			2022-12-01	WOS:000310195800060
J	Sasson, C; Magid, DJ; Chan, P; Root, ED; McNally, BF; Kellermann, AL; Haukoos, JS				Sasson, Comilla; Magid, David J.; Chan, Paul; Root, Elisabeth D.; McNally, Bryan F.; Kellermann, Arthur L.; Haukoos, Jason S.		CARES Surveillance Grp	Association of Neighborhood Characteristics with Bystander-Initiated CPR	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; CARDIOPULMONARY-RESUSCITATION; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; RACIAL-DIFFERENCES; STROKE-FOUNDATION; TASK-FORCE; SURVIVAL	BACKGROUND For persons who have an out-of-hospital cardiac arrest, the probability of receiving bystander-initiated cardiopulmonary resuscitation (CPR) may be influenced by neighborhood characteristics. METHODS We analyzed surveillance data prospectively submitted from 29 U. S. sites to the Cardiac Arrest Registry to Enhance Survival between October 1, 2005, and December 31, 2009. The neighborhood in which each cardiac arrest occurred was determined from census-tract data. We classified neighborhoods as high-income or low-income on the basis of a median household income threshold of $40,000 and as white or black if more than 80% of the census tract was predominantly of one race. Neighborhoods without a predominant racial composition were classified as integrated. We analyzed the relationship between the median income and racial composition of a neighborhood and the performance of bystander-initiated CPR. RESULTS Among 14,225 patients with cardiac arrest, bystander-initiated CPR was provided to 4068 (28.6%). As compared with patients who had a cardiac arrest in high-income white neighborhoods, those in low-income black neighborhoods were less likely to receive bystander-initiated CPR (odds ratio, 0.49; 95% confidence interval [CI], 0.41 to 0.58). The same was true of patients with cardiac arrest in neighborhoods characterized as low-income white (odds ratio, 0.65; 95% CI, 0.51 to 0.82), low-income integrated (odds ratio, 0.62; 95% CI, 0.56 to 0.70), and high-income black (odds ratio, 0.77; 95% CI, 0.68 to 0.86). The odds ratio for bystander-initiated CPR in high-income integrated neighborhoods (1.03; 95% CI, 0.64 to 1.65) was similar to that for high-income white neighborhoods. CONCLUSIONS In a large cohort study, we found that patients who had an out-of-hospital cardiac arrest in low-income black neighborhoods were less likely to receive bystander-initiated CPR than those in high-income white neighborhoods. (Funded by the Centers for Disease Control and Prevention and others.)	[Sasson, Comilla; Haukoos, Jason S.] Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA; [Magid, David J.] Kaiser Permanente, Inst Healthcare Res, Denver, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO USA; [Chan, Paul] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Root, Elisabeth D.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [McNally, Bryan F.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Kellermann, Arthur L.] RAND Corp, Washington, DC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Colorado School of Public Health; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Colorado System; University of Colorado Boulder; Emory University; RAND Corporation	Sasson, C (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA.	comilla.sasson@ucdenver.edu	Root, Elisabeth/A-7429-2016; McNally, Bryan/AAE-9332-2020	Root, Elisabeth/0000-0002-9566-4031; McMullan, Jason/0000-0002-7656-7447	Cardiac Arrest Registry to Enhance Survival [U18 PS000314]; Centers for Disease Control and Prevention [U18 PS000314]; Emergency Medicine Foundation; American Heart Association; Agency for Healthcare Research and Quality [K02 HS017526]; National Heart, Lung, and Blood Institute [K23HL102224]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	Cardiac Arrest Registry to Enhance Survival; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Emergency Medicine Foundation; American Heart Association(American Heart Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a cooperative agreement between the Cardiac Arrest Registry to Enhance Survival and the Centers for Disease Control and Prevention (U18 PS000314); grants from the Emergency Medicine Foundation and the American Heart Association (to Dr. Sasson); an Independent Scientist Award from the Agency for Healthcare Research and Quality (K02 HS017526, to Dr. Haukoos); and a grant from the National Heart, Lung, and Blood Institute (K23HL102224, to Dr. Chan).	Abella BS, 2008, CIRCULATION, V117, P704, DOI 10.1161/CIRCULATIONAHA.107.188486; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BROOKOFF D, 1994, ANN EMERG MED, V24, P1147, DOI 10.1016/S0196-0644(94)70246-2; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1993, ANNU REV PUBL HEALTH, V14, P313; Diez-Roux AV, 2000, SOC SCI MED, V50, P673, DOI 10.1016/S0277-9536(99)00320-2; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan P, 2012, RESUSCITATION, V83, P76, DOI 10.1016/j.resuscitation.2011.06.026; Grenvik ASP., 1981, BRAIN FAILURE RESUSC, P155; Iwashyna TJ, 1999, ANN EMERG MED, V34, P459, DOI 10.1016/S0196-0644(99)80047-X; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lisabeth LD, 2007, AM J EPIDEMIOL, V165, P279, DOI 10.1093/aje/kwk005; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Petersen LA, 2002, MED CARE, V40, P86; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, ANN INTERN MED, V153, P19, DOI 10.7326/0003-4819-153-1-201007060-00255; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; U.S. Census Bureau, TOP INT GEOGR ENC RE; Vadeboncoeur TF, 2008, AM J EMERG MED, V26, P655, DOI 10.1016/j.ajem.2007.10.002; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012	32	183	189	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1607	1615		10.1056/NEJMoa1110700	http://dx.doi.org/10.1056/NEJMoa1110700			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094722	Green Accepted			2022-12-01	WOS:000310131700007
J	Chopra, V; Flanders, SA; Saint, S				Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay			The Problem With Peripherally Inserted Central Catheters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETER; CENTERS		[Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, Hosp Outcomes Program Excellence, Patient Safety Enhancement Program, Ann Arbor, MI USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Chopra, V (corresponding author), 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	vineetc@med.umich.edu	Kokot, Antonio/O-3111-2019; Kokot, Antonio/B-3276-2017; Saint, Sanjay/AAF-5126-2019	Kokot, Antonio/0000-0002-4836-7536; Chopra, Vineet/0000-0001-8670-9376				Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Climo M, 2003, INFECT CONT HOSP EP, V24, P942, DOI 10.1086/502163; Ajenjo MC, 2011, INFECT CONT HOSP EP, V32, P125, DOI 10.1086/657942; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; El Ters M, 2012, AM J KIDNEY DIS, V60, P601, DOI 10.1053/j.ajkd.2012.05.007; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Tsan L, 2010, AM J INFECT CONTROL, V38, P461, DOI 10.1016/j.ajic.2009.12.009; Woller SC, 2011, AM J MED, V124, P947, DOI 10.1016/j.amjmed.2011.06.004	9	76	78	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1527	1528		10.1001/jama.2012.12704	http://dx.doi.org/10.1001/jama.2012.12704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073947				2022-12-01	WOS:000309858100016
J	Spence, D				Spence, Des			Bad medicine: clinical breast examination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						American Cancer Society, BREAST CANC EARL DET; [Anonymous], 2012, BBC NEWS; Fenton Joshua J, 2005, J Natl Cancer Inst Monogr, P67, DOI 10.1093/jncimonographs/lgi040; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC C; US Preventive Services Task Force, 2009, SCREEN BREAST CANC	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2012	345								e6789	10.1136/bmj.e6789	http://dx.doi.org/10.1136/bmj.e6789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TI	23060657				2022-12-01	WOS:000309907900006
J	Fried, TR; Fragoso, CAV; Rabow, MW				Fried, Terri R.; Fragoso, Carlos A. Vaz; Rabow, Michael W.			Caring for the Older Person With Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE CHRONIC CONDITIONS; SERIOUSLY ILL PATIENTS; CHRONIC LUNG-DISEASE; QUALITY-OF-LIFE; PALLIATIVE CARE; REFRACTORY DYSPNEA; COPD PATIENTS; INHALED ANTICHOLINERGICS	Chronic obstructive pulmonary disease (COPD), a common disease in elderly patients, is characterized by high symptom burden, health care utilization, mortality, and unmet needs of patients and caregivers. Respiratory failure and dyspnea maybe exacerbated by heart failure, pulmonary embolism, and anxiety; by medication effects; and by other conditions, including deconditioning and malnutrition. Randomized controlled trials, which provide the strongest evidence for guideline recommendations, may underestimate the risk of adverse effects of interventions for older patients with COPD. The focus of guidelines on disease-modifying therapies may not address the full spectrum of patient and caregiver needs, particularly the high rates of bothersome symptoms, risk of functional and cognitive decline, and need for end-of-life care planning. Meeting the many needs of older patients with COPD and their families requires that clinicians supplement guideline-recommended care with treatment decision making that takes into account older persons' comorbid conditions, recognizes the trade-offs engendered by the increased risk of adverse events, focuses on symptom relief and function, and prepares patients and their loved ones for further declines in the patient's health and their end-of-life care. A case of COPD in an 81-year-old man hospitalized with severe dyspnea and respiratory failure highlights both the challenges in managing COPD in the elderly and the limitations in applying guidelines to geriatric patients. JAMA. 2012;308(12):1254-1263 www.jama.com	[Fried, Terri R.; Fragoso, Carlos A. Vaz] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fried, Terri R.; Fragoso, Carlos A. Vaz] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, Washington, DC USA; [Rabow, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Yale University; University of California System; University of California San Francisco	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr 151B, 950 Campbell Ave, West Haven, CT 06516 USA.	terri.fried@yale.edu		Vaz Fragoso, Carlos/0000-0002-7045-3334	National Institute on Aging [K24AG028443, R03AG037051]; Department of Veterans Affairs; SCAN Foundation; NATIONAL INSTITUTE ON AGING [P30AG021342, R03AG037051, K24AG028443] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Fried is the recipient of amid-career development award from the National Institute on Aging (K24AG028443). Dr Vaz Fragoso is a recipient of a Career Development Award from the Department of Veterans Affairs and an R03 award from the National Institute on Aging (R03AG037051). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2009, WIEN MED WOCHENSCHR, V159, P583, DOI 10.1007/s10354-009-0727-z; Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; Allen SC, 2003, AGE AGEING, V32, P299, DOI 10.1093/ageing/32.3.299; Allen SC, 1997, AGE AGEING, V26, P83, DOI 10.1093/ageing/26.2.83; Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; *AM THOR SOC, STAND DIAGN MAN PAT; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Baltzan Marcel A, 2004, Can Respir J, V11, P407; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Beauchamp MK, 2009, RESP MED, V103, P1885, DOI 10.1016/j.rmed.2009.06.008; Berger RL, 2010, CHEST, V138, P407, DOI 10.1378/chest.09-1822; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; BORSON S, 1992, PSYCHOSOMATICS, V33, P190, DOI 10.1016/S0033-3182(92)71995-1; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; Chatham K, 2009, PHYS THER, V89, P257, DOI 10.2522/ptj.20080155; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Clemens KE, 2012, CURR OPIN SUPPORT PA, V6, P163, DOI 10.1097/SPC.0b013e3283530fee; Clini EM, 2008, EUR RESPIR J, V32, P218, DOI 10.1183/09031936.00134007; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Curtis JR, 2008, EUR RESPIR J, V32, P796, DOI 10.1183/09031936.00126107; Curtis JR, 1997, AM J RESP CRIT CARE, V156, P1032, DOI 10.1164/ajrccm.156.4.97-02011; Di Meo F, 2008, AGE AGEING, V37, P530, DOI 10.1093/ageing/afn126; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Elliott MW, 2011, CLIN MED, V11, P150, DOI 10.7861/clinmedicine.11-2-150; Emery CF, 2008, RESP CARE, V53, P1208; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fragoso CAV, 2011, J AM GERIATR SOC, V59, P1847, DOI 10.1111/j.1532-5415.2011.03596.x; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Harrison RA, 2007, J BONE MINER RES, V22, P447, DOI 10.1359/jbmr.061202; HEATON RK, 1983, ARCH INTERN MED, V143, P1941, DOI 10.1001/archinte.143.10.1941; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Horton Robert, 2010, Curr Opin Support Palliat Care, V4, P56, DOI 10.1097/SPC.0b013e328338c1c6; Howard C, 2010, PSYCHOL HEALTH MED, V15, P371, DOI 10.1080/13548506.2010.482142; Hunt T, 2010, EUR RESPIR REV, V19, P30, DOI 10.1183/09059180.00006009; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Johnson MJ, 2012, J PAIN SYMPTOM MANAG, V43, P614, DOI 10.1016/j.jpainsymman.2011.04.024; Kallet RH, 2007, RESP CARE, V52, P900; Kamal AH, 2012, J PALLIAT MED, V15, P106, DOI 10.1089/jpm.2011.0110; Karapolat H, 2008, CHINESE MED J-PEKING, V121, P592; Katsura H, 2004, RESPIROLOGY, V9, P230, DOI 10.1111/j.1440-1843.2004.00561.x; Kunik ME, 2008, PSYCHOL MED, V38, P385, DOI 10.1017/S0033291707001687; Kunik ME, 2007, PSYCHOSOMATICS, V48, P16, DOI 10.1176/appi.psy.48.1.16; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Luce JM, 2001, JAMA-J AM MED ASSOC, V285, P1331, DOI 10.1001/jama.285.10.1331; Mahler Donald A, 2011, Curr Opin Support Palliat Care, V5, P71, DOI 10.1097/SPC.0b013e328345bc84; Marciniuk DD, 2011, CAN RESPIR J, V18, P69, DOI 10.1155/2011/745047; Maurer J, 2008, CHEST, V134, p43S, DOI 10.1378/chest.08-0342; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MORRISON NJ, 1989, CHEST, V95, P90, DOI 10.1378/chest.95.1.90; ODONNELL DE, 1994, CHEST, V106, P904, DOI 10.1378/chest.106.3.904; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Rafii R, 2011, PULM MED, V2011, DOI 10.1155/2011/257496; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Reuben DB, 2009, HAZZARDS GERIATRIC M; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rocker G, 2012, CAN MED ASSOC J, V184, pE497, DOI 10.1503/cmaj.111758; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; SCHWARTZSTEIN RM, 1987, AM REV RESPIR DIS, V136, P58, DOI 10.1164/ajrccm/136.1.58; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Singh S, 2011, ARCH INTERN MED, V171, P920, DOI 10.1001/archinternmed.2011.171; Smith TA, 2012, RESPIROLOGY, V17, P300, DOI 10.1111/j.1440-1843.2011.02085.x; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stephenson A, 2011, ARCH INTERN MED, V171, P914, DOI 10.1001/archinternmed.2011.170; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Suzuki M, 2012, ARCH INTERN MED, V172, P878, DOI 10.1001/archinternmed.2012.1233; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thakur Neeta, 2010, Int J Chron Obstruct Pulmon Dis, V5, P263; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Varkey B, 2010, CURR OPIN PULM MED, V16, P150, DOI 10.1097/MCP.0b013e3283364378; Vaz Fragoso CA, 2012, J GERONTOL A-BIOL, V67, P264, DOI 10.1093/gerona/glr198; White P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578043; WILLIAMS SJ, 1989, SOC SCI MED, V29, P609, DOI 10.1016/0277-9536(89)90180-9; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; ZuWallack R, 2008, AM J MED, V121, pS25, DOI 10.1016/j.amjmed.2008.04.004; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	103	41	44	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1254	1263		10.1001/jama.2012.12422	http://dx.doi.org/10.1001/jama.2012.12422			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011715	Green Accepted			2022-12-01	WOS:000309103600029
J	Lutter, CK; Lutter, R				Lutter, Chessa K.; Lutter, Randall			Fetal and Early Childhood Undernutrition, Mortality, and Lifelong Health	SCIENCE			English	Editorial Material							FEEDING PATTERNS; WEIGHT-GAIN; BIRTH; NUTRITION; INFANT; RISK; ORIGINS; COHORTS; BURDEN; IMPACT	Child undernutrition is a major public health challenge, estimated to be responsible for 2.2 million annual deaths. Implementation of available interventions could prevent one-third of these deaths. Emerging evidence suggests that breast-feeding can lead to improvements in intelligence quotient in children and lower risks of noncommunicable diseases in mothers and children decades later. Nonetheless, breast-feeding and complementary feeding practices differ greatly from global recommendations. Although the World Health Organization recommends that infants receive solely breast milk for the first 6 months of life, only about one-third of infants in low-income countries meet this goal, just one-third of children 6 to 24 months old in low-income countries meet the minimum criteria for dietary diversity, and only one in five who are breast-fed receive a minimum acceptable diet. Although the potential effects of improved breast-feeding and complementary feeding appear large, funding for research and greater use of existing effective interventions seems low compared with other life-saving child health interventions.	[Lutter, Chessa K.] PAHO WHO, Washington, DC 20037 USA; [Lutter, Randall] Resources Future Inc, Washington, DC 20036 USA	Resources for the Future	Lutter, CK (corresponding author), PAHO WHO, 525 23rd St NW, Washington, DC 20037 USA.	lutterch@paho.org		Lutter, Chessa/0000-0003-1601-4645				Adair LS, 2012, NUTR METAB CARDIOVAS, V22, P765, DOI 10.1016/j.numecd.2012.03.011; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Archer C., 2012, IMPACT BREASTFEEDING; Arimond M., 2010, COMBATING MICRONUTRI; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2009, LANCET, V373, P1584, DOI 10.1016/S0140-6736(09)60886-2; Bloom D., 2011, GLOBAL EC BURDEN NON; Brady JP, 2012, ARCH DIS CHILD, V97, P529, DOI 10.1136/archdischild-2011-301299; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Clinton H. Rodham, 2010, 1000 DAYS CHANGE LIF; Edmond K., 2006, OPTIMAL FEEDING LOW; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Field E, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.1.1; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gribble JN, 2009, MATERN CHILD NUTR, V5, P49, DOI 10.1111/j.1740-8709.2008.00158.x; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Horta BL, 2007, EVIDENCE LONG TERM E; Horton S, 1996, HEALTH POLICY PLANN, V11, P156, DOI 10.1093/heapol/11.2.156; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jelliffe D B, 1972, Nutr Rev, V30, P199; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; LESTER RT, 2010, J GERONTOL B-PSYCHOL, V376, P1838, DOI DOI 10.1016/S0140-6736(10)61997-6; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Lutter CK, 2011, AM J PUBLIC HEALTH, V101, P2130, DOI 10.2105/AJPH.2011.300244; Lutter Chessa K., 1992, Food and Nutrition Bulletin, V14, P36; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Poskitt EME, 2012, NUTR METAB CARDIOVAS, V22, P819, DOI 10.1016/j.numecd.2012.08.005; Rea M. F., 2003, CAUDE SALUD PUB, V19, P119; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SHORT RV, 1991, LANCET, V337, P715, DOI 10.1016/0140-6736(91)90288-Z; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P787, DOI 10.1016/j.numecd.2012.04.003; Stuebe AM, 2011, AM J EPIDEMIOL, V174, P1147, DOI 10.1093/aje/kwr227; U.S. EPA, 2008, REG IMP AN PROP REV; U. S. EPA (U. S. Environmental Protection Agency), 1997, BEN COSTS CLEAN AIR; [UN UNGA], 2011, PREV CONTR NONC DIS; United States Office of Management and Budget (OMB), 2003, A4 US OMB; WHO and partners, 2010, IND ASS INF YOUNG 3; WHO UNICEF, 2008, AFR HLTH 2010 LEARN; Woo JG, 2012, J PEDIATR GASTR NUTR, V54, P532, DOI 10.1097/MPG.0b013e31823fde04; World Health Organization, 1981, INT COD MARK BREAST	52	27	32	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1495	1499		10.1126/science.1224616	http://dx.doi.org/10.1126/science.1224616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997328	Green Published			2022-12-01	WOS:000308912900040
J	Herzog, F; Kahraman, A; Boehringer, D; Mak, R; Bracher, A; Walzthoeni, T; Leitner, A; Beck, M; Hartl, FU; Ban, N; Malmstrom, L; Aebersold, R				Herzog, Franz; Kahraman, Abdullah; Boehringer, Daniel; Mak, Raymond; Bracher, Andreas; Walzthoeni, Thomas; Leitner, Alexander; Beck, Martin; Hartl, Franz-Ulrich; Ban, Nenad; Malmstroem, Lars; Aebersold, Ruedi			Structural Probing of a Protein Phosphatase 2A Network by Chemical Cross-Linking and Mass Spectrometry	SCIENCE			English	Article							MOLECULAR ARCHITECTURE; CRYSTAL-STRUCTURE; CHAPERONIN; COMPLEX; IDENTIFICATION; OPTIMIZATION; ALPHA-4; BINDING	The identification of proximate amino acids by chemical cross-linking and mass spectrometry (XL-MS) facilitates the structural analysis of homogeneous protein complexes. We gained distance restraints on a modular interaction network of protein complexes affinity-purified from human cells by applying an adapted XL-MS protocol. Systematic analysis of human protein phosphatase 2A (PP2A) complexes identified 176 interprotein and 570 intraprotein cross-links that link specific trimeric PP2A complexes to a multitude of adaptor proteins that control their cellular functions. Spatial restraints guided molecular modeling of the binding interface between immunoglobulin binding protein 1 (IGBP1) and PP2A and revealed the topology of TCP1 ring complex (TRiC) chaperonin interacting with the PP2A regulatory subunit 2ABG. This study establishes XL-MS as an integral part of hybrid structural biology approaches for the analysis of endogenous protein complexes.	[Herzog, Franz; Kahraman, Abdullah; Mak, Raymond; Walzthoeni, Thomas; Leitner, Alexander; Malmstroem, Lars; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Boehringer, Daniel; Ban, Nenad] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Beck, Martin] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bracher, Andreas; Hartl, Franz-Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); Max Planck Society	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch	Malmström, Lars/R-4991-2019; Leitner, Alexander/U-1601-2019; Hartl, F. Ulrich/Y-8206-2019; Beck, Martin/B-5589-2011; Herzog, Franz/G-4832-2012	Malmström, Lars/0000-0001-9885-9312; Leitner, Alexander/0000-0003-4126-0725; Beck, Martin/0000-0002-7397-1321; Herzog, Franz/0000-0001-8270-1449; Mak, Raymond/0000-0002-7081-8671; Kahraman, Abdullah/0000-0003-3523-4467	EU; European Molecular Biology Organization; European Commission [FP7-PEOPLE-IEF]; European Research Council [Proteomics v.3.0.]	EU(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	We thank S. Hauri, A. Frei, and M. Gstaiger for support. Primary mass spectrometry data are available as mzXML files at www.peptideatlas.org/PASS/PASS00053. This work was supported by the EU FP7 project PROSPECTS. F. H. was supported by the European Molecular Biology Organization and by the European Commission (FP7-PEOPLE-IEF). R. A. was supported by the European Research Council advanced grant Proteomics v.3.0.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lauber MA, 2010, ANAL CHEM, V82, P7736, DOI 10.1021/ac101586z; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Zhang HZ, 2009, MOL CELL PROTEOMICS, V8, P409, DOI 10.1074/mcp.M800232-MCP200	37	303	308	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1348	1352		10.1126/science.1221483	http://dx.doi.org/10.1126/science.1221483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984071				2022-12-01	WOS:000308705000044
J	Aldy, JE; Stavins, RN				Aldy, Joseph E.; Stavins, Robert N.			Climate Negotiators Create an Opportunity for Scholars	SCIENCE			English	Editorial Material									[Stavins, Robert N.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Resources Future Inc, Washington, DC 20036 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Resources for the Future; National Bureau of Economic Research	Stavins, RN (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	robert_stavins@harvard.edu						Aldy J. E., 2012, DESIGNING BRETTON WO; Bosetti V., 2011, 201146 HARV KENN SCH; Jaffe J, 2009, ECOL LAW QUART, V36, P789; Newell R. G., 2010, POSTKYOTO INT CLIMAT; Nordhaus WD., 2008, QUESTION BALANCE; United States Energy Information Administration, 2012, INT EN STAT; World Resources Institute, 2012, CLIM AN IND TOOL	7	28	28	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1043	1044		10.1126/science.1223836	http://dx.doi.org/10.1126/science.1223836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996WP	22936761				2022-12-01	WOS:000308125800028
J	Spence, D				Spence, Des			Methadone is no panacea	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, BBC NEWS	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 22	2012	345								e5670	10.1136/bmj.e5670	http://dx.doi.org/10.1136/bmj.e5670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GV	22915733				2022-12-01	WOS:000308073800004
J	Tachibana, M; Amato, P; Sparman, M; Woodward, J; Sanchis, DM; Ma, H; Gutierrez, NM; Tippner-Hedges, R; Kang, E; Lee, HS; Ramsey, C; Masterson, K; Battaglia, D; Lee, D; Wu, D; Jensen, J; Patton, P; Gokhale, S; Stouffer, R; Mitalipov, S				Tachibana, Masahito; Amato, Paula; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Jensen, Jeffrey; Patton, Phillip; Gokhale, Sumita; Stouffer, Richard; Mitalipov, Shoukhrat			Towards germline gene therapy of inherited mitochondrial diseases	NATURE			English	Article							OOCYTE VITRIFICATION; ACTIVATION; COMMON	Mutations in mitochondrial DNA (mtDNA) are associated with severe human diseases and are maternally inherited through the egg's cytoplasm. Here we investigated the feasibility of mtDNA replacement in human oocytes by spindle transfer (ST; also called spindle-chromosomal complex transfer). Of 106 human oocytes donated for research, 65 were subjected to reciprocal ST and 33 served as controls. Fertilization rate in ST oocytes (73%) was similar to controls (75%); however, a significant portion of ST zygotes (52%) showed abnormal fertilization as determined by an irregular number of pronuclei. Among normally fertilized ST zygotes, blastocyst development (62%) and embryonic stem cell isolation (38%) rates were comparable to controls. All embryonic stem cell lines derived from ST zygotes had normal euploid karyotypes and contained exclusively donor mtDNA. The mtDNA can be efficiently replaced in human oocytes. Although some ST oocytes displayed abnormal fertilization, remaining embryos were capable of developing to blastocysts and producing embryonic stem cells similar to controls.	[Tachibana, Masahito; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Jensen, Jeffrey; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Amato, Paula; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Patton, Phillip; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, Portland, OR 97239 USA; [Jensen, Jeffrey] Oregon Hlth & Sci Univ, Ctr Womens Hlth, Portland, OR 97239 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Univ Pathologists LLC, Providence, RI 02908 USA; [Gokhale, Sumita] Roger Williams Med Ctr, Providence, RI 02908 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Boston University; Roger Williams Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224; Melguizo Sanchis, Dario/0000-0002-5728-4345	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation; National Institutes of Health [HD063276, HD057121, HD059946, EY021214, 8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059946, R01HD063276, R01HD057121] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Oregon Health & Science University (OHSU) Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and staff at the Women's Health Research Unit at the Center for Women's Health, University Fertility Consultants and Reproductive Endocrinology & Infertility Division at the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of human gametes. The Division of Animal Resources, Surgery Team, Assisted Reproductive Technology & Embryonic Stem Cell Core, Endocrine Technology Core, Imaging & Morphology Core, Flow Cytometry Core and Molecular & Cellular Biology Core at the Oregon National Primate Research Center provided expertise and services for the nonhuman primate research. Hamilton Thorne Inc., donated an XYClone laser system for this study. We are grateful to W. Sanger and D. Zaleski for karyotyping services, C. Penedo for microsatellite analysis and J. Hennebold for consulting on metabolic assays. We are also indebted to A. Steele, R. Cervera Juanes and E. Wolff for their technical support. The human oocyte/embryo research was supported by grants from the OHSU Center for Women's Health Circle of Giving and other OHSU institutional funds, as well as the Leducq Foundation. The nonhuman primate study was supported by grants from the National Institutes of Health HD063276, HD057121, HD059946, EY021214 and 8P51OD011092.	Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Gao SR, 2005, TRENDS BIOTECHNOL, V23, P66, DOI 10.1016/j.tibtech.2004.12.007; Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Smith DG, 2005, COMPARATIVE MED, V55, P227; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100	24	264	282	5	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					627	631		10.1038/nature11647	http://dx.doi.org/10.1038/nature11647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23103867	Green Accepted			2022-12-01	WOS:000314219600047
J	Burke, CJ; Huetteroth, W; Owald, D; Perisse, E; Krashes, MJ; Das, G; Gohl, D; Silies, M; Certel, S; Waddell, S				Burke, Christopher J.; Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Krashes, Michael J.; Das, Gaurav; Gohl, Daryl; Silies, Marion; Certel, Sarah; Waddell, Scott			Layered reward signalling through octopamine and dopamine in Drosophila	NATURE			English	Article							NEURONS; EXPRESSION; GENE; RECEPTOR; PROTEIN; MEMORY; MARKER; FAMILY; LIGHT; FLIES	Dopamine is synonymous with reward and motivation in mammals(1,2). However, only recently has dopamine been linked to motivated behaviour and rewarding reinforcement in fruitflies(3,4). Instead, octopamine has historically been considered to be the signal for reward in insects(5-7). Here we show, using temporal control of neural function in Drosophila, that only short-term appetitive memory is reinforced by octopamine. Moreover, octopamine-dependent memory formation requires signalling through dopamine neurons. Part of the octopamine signal requires the alpha-adrenergic-like OAMB receptor in an identified subset of mushroom-body-targeted dopamine neurons. Octopamine triggers an increase in intracellular calcium in these dopamine neurons, and their direct activation can substitute for sugar to form appetitive memory, even in flies lacking octopamine. Analysis of the beta-adrenergic-like OCT beta 2R receptor reveals that octopamine-dependent reinforcement also requires an interaction with dopamine neurons that control appetitive motivation. These data indicate that sweet taste engages a distributed octopamine signal that reinforces memory through discrete subsets of mushroom-body-targeted dopamine neurons. In addition, they reconcile previous findings with octopamine and dopamine and suggest that reinforcement systems in flies are more similar to mammals than previously thought.	[Burke, Christopher J.; Krashes, Michael J.; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Das, Gaurav; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England; [Gohl, Daryl; Silies, Marion] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Certel, Sarah] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Certel, Sarah] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford; Stanford University; University of Montana System; University of Montana; University of Montana System; University of Montana	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@cncb.ox.ac.uk	Owald, David/ABB-5432-2020; Krashes, Michael/P-7677-2019; Huetteroth, Wolf/L-5252-2019; Huetteroth, Wolf/I-6661-2015	Huetteroth, Wolf/0000-0003-3421-9935; Gohl, Daryl/0000-0002-4434-2788; Burke, Christopher/0000-0001-7609-1146; Perisse, Emmanuel/0000-0002-0830-0687; Owald, David/0000-0001-7747-7884; Waddell, Scott/0000-0003-4503-6229; Das, Gaurav/0000-0002-3564-5621	EMBO Long-Term Fellowship; Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship [F32EY020040]; Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences; National Institutes of Health [MH069883, MH081982]; Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE [F32EY020040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883, R01MH081982] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Yoshihara, S. DasGupta, V. Budnik and S. Goodwin for reagents. We thank T. Clandinin and E. Kravitz for collegial exchange. D.O. was supported by an EMBO Long-Term Fellowship and a Sir Henry Wellcome Postdoctoral Fellowship. D.G. was supported by a Ruth L. Kirschstein NRSA Postdoctoral Fellowship (F32EY020040). M.S. was supported by a Jane Coffin Childs Postdoctoral Fellowship. S.W. is funded by a Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences, by grants MH069883 and MH081982 from the National Institutes of Health and by funds from the Gatsby Charitable Foundation and Oxford Martin School.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Han KA, 1998, J NEUROSCI, V18, P3650; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yoshihara M, 2012, JOVE-J VIS EXP, DOI 10.3791/3625	37	327	335	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					433	+		10.1038/nature11614	http://dx.doi.org/10.1038/nature11614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23103875	Green Submitted, Green Accepted			2022-12-01	WOS:000312488200057
J	Lafaille, FG; Pessach, IM; Zhang, SY; Ciancanelli, MJ; Herman, M; Abhyankar, A; Ying, SW; Keros, S; Goldstein, PA; Mostoslavsky, G; Ordovas-Montanes, J; Jouanguy, E; Plancoulaine, S; Tu, E; Elkabetz, Y; Al-Muhsen, S; Tardieu, M; Schlaeger, TM; Daley, GQ; Abel, L; Casanova, JL; Studer, L; Notarangelo, LD				Lafaille, Fabien G.; Pessach, Itai M.; Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Ying, Shui-Wang; Keros, Sotirios; Goldstein, Peter A.; Mostoslavsky, Gustavo; Ordovas-Montanes, Jose; Jouanguy, Emmanuelle; Plancoulaine, Sabine; Tu, Edmund; Elkabetz, Yechiel; Al-Muhsen, Saleh; Tardieu, Marc; Schlaeger, Thorsten M.; Daley, George Q.; Abel, Laurent; Casanova, Jean-Laurent; Studer, Lorenz; Notarangelo, Luigi D.			Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells	NATURE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; EMBRYONIC STEM-CELLS; TOLL-LIKE RECEPTOR-3; RETICULAR THALAMIC NEURONS; CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRANDED-RNA; TLR3 DEFICIENCY; HUMAN ES; PROTECTIVE IMMUNITY; VIRUS ENCEPHALITIS	In the course of primary infection with herpes simplex virus 1 (HSV-1), children with inborn errors of toll-like receptor 3 (TLR3) immunity are prone to HSV-1 encephalitis (HSE)(1-3). We tested the hypothesis that the pathogenesis of HSE involves non-haematopoietic CNS-resident cells. We derived induced pluripotent stem cells (iPSCs) from the dermal fibroblasts of TLR3- and UNC-93B-deficient patients and from controls. These iPSCs were differentiated into highly purified populations of neural stem cells (NSCs), neurons, astrocytes and oligodendrocytes. The induction of interferon-beta (IFN-beta) and/or IFN-lambda 1 in response to stimulation by the dsRNA analogue polyinosinic: polycytidylic acid (poly(I:C)) was dependent on TLR3 and UNC-93B in all cells tested. However, the induction of IFN-beta and IFN-lambda 1 in response to HSV-1 infection was impaired selectively in UNC-93B-deficient neurons and oligodendrocytes. These cells were also much more susceptible to HSV-1 infection than control cells, whereas UNC-93B-deficient NSCs and astrocytes were not. TLR3-deficient neurons were also found to be susceptible to HSV-1 infection. The rescue of UNC-93B- and TLR3-deficient cells with the corresponding wild-type allele showed that the genetic defect was the cause of the poly(I:C) and HSV-1 phenotypes. The viral infection phenotype was rescued further by treatment with exogenous IFN-alpha or IFN-beta (IFN-alpha/beta) but not IFN-lambda 1. Thus, impaired TLR3- and UNC-93B-dependent IFN-alpha/beta intrinsic immunity to HSV-1 in the CNS, in neurons and oligodendrocytes in particular, may underlie the pathogenesis of HSE in children with TLR3-pathway deficiencies.	[Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Pessach, Itai M.; Ordovas-Montanes, Jose; Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Div Immunol, Sch Med, Boston, MA 02115 USA; [Pessach, Itai M.] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Hashomer, Israel; [Pessach, Itai M.] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Aviv, Israel; [Zhang, Shen-Ying; Herman, Melina; Jouanguy, Emmanuelle; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Lab Human Genet Infect Dis, Inst Natl Sante & Rech Med, Necker Med Sch,U980, F-75015 Paris, France; [Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, CV Starr Lab Mol Neuropharmacol, Dept Anesthesiol, New York, NY 10065 USA; [Keros, Sotirios] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY 10065 USA; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Sect Gastroenterol, Dept Med, Boston, MA 02118 USA; [Elkabetz, Yechiel] Tel Aviv Univ, Lab Pluripotent & Neural Stem Cell Biol, Dept Cell & Dev Biol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Al-Muhsen, Saleh] King Saud Univ, Prince Naif Ctr Immunol Res, Dept Pediat, Coll Med, Riyadh 11451, Saudi Arabia; [Tardieu, Marc] Hop Bicetre, Assistance Publ Hop Paris, Dept Pediat Neurol, F-94275 Le Kremlin Bicetre, France; [Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Schlaeger, Thorsten M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Cornell University; Boston University; Tel Aviv University; Sackler Faculty of Medicine; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital	Zhang, SY (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	shzh289@rockefeller.edu; jean-laurent.casanova@rockefeller.edu	Notarangelo, Luigi D/F-9718-2016; PLANCOULAINE, Sabine/E-2824-2017; Al-muhsen, saleh/E-9315-2014; Abel, Laurent/H-8888-2017; Jouanguy, Emmanuelle/H-7901-2017; Studer, Lorenz/ABH-1491-2021; Casanova, Jean-Laurent/I-3418-2017; Zhang, Shen-Ying/I-2685-2017	Notarangelo, Luigi D/0000-0002-8335-0262; PLANCOULAINE, Sabine/0000-0003-0725-8306; Al-muhsen, saleh/0000-0003-3698-9968; Abel, Laurent/0000-0001-7016-6493; Jouanguy, Emmanuelle/0000-0002-7358-9157; Studer, Lorenz/0000-0003-0741-7987; Zhang, Shen-Ying/0000-0002-9449-3672; Schlaeger, Thorsten/0000-0002-1599-9908; Ciancanelli, Michael/0000-0002-4623-852X; Ordovas-Montanes, Jose/0000-0001-5444-5601; Goldstein, Peter/0000-0002-5973-9104; Keros, Sotirios/0000-0001-9264-9824; Casadio, Melina/0000-0003-2389-2243; Mostoslavsky, Gustavo/0000-0002-0784-2169; Casanova, Jean-Laurent/0000-0002-7782-4169	National Center for Translational Sciences (NCATS) [8UL1TR000043]; National Institutes of Health (NIH); Rockefeller University; St. Giles Foundation; ANR; INSERM; Paris Descartes University; March of Dimes; NIH [5R01NS072381-02, 1R03AI0883502-01, 1R01NS066390]; Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease [41/11]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI088352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS066274, R01NS066390] Funding Source: NIH RePORTER	National Center for Translational Sciences (NCATS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; St. Giles Foundation; ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank our patients, their families and physicians; and the members of the three laboratories for helpful discussions and critical reading of this manuscript. The work was funded by grant number 8UL1TR000043 from the National Center for Translational Sciences (NCATS), the National Institutes of Health (NIH), the Rockefeller University, the St. Giles Foundation, the ANR, INSERM, Paris Descartes University, the March of Dimes, NIH grant 5R01NS072381-02 (to J.-L.C., L.S. and L.D.N.), NIH grant 1R03AI0883502-01 (to L.D.N.), NIH grant 1R01NS066390 and the Manton Foundation, the Israeli Centers of Research Excellence (I-CORE), and Gene Regulation in Complex Human Disease, Center No 41/11 (to I.M.P.). F.G.L. is supported by the New York Stem Cell Foundation.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jackson AC, 2006, J NEUROVIROL, V12, P229, DOI 10.1080/13550280600848399; JACQUEMONT B, 1975, J VIROL, V15, P707, DOI 10.1128/JVI.15.4.707-713.1975; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1400, DOI 10.1016/j.jaci.2010.11.008; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036	42	231	235	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					769	+		10.1038/nature11583	http://dx.doi.org/10.1038/nature11583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103873	Green Accepted, Green Submitted			2022-12-01	WOS:000311606000048
J	Bell, JC; Plank, JL; Dombrowski, CC; Kowalczykowski, SC				Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.			Direct imaging of RecA nucleation and growth on single molecules of SSB-coated ssDNA	NATURE			English	Article							DNA-BINDING-PROTEIN; STRANDED NUCLEIC-ACIDS; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; E. COLI; FILAMENTS; EXCHANGE; MECHANISM; DYNAMICS; KINETICS	Escherichia coli RecA is the defining member of a ubiquitous class of DNA strand-exchange proteins that are essential for homologous recombination, a pathway that maintains genomic integrity by repairing broken DNA(1). To function, filaments of RecA must nucleate and grow on single-stranded DNA (ssDNA) in direct competition with ssDNA-binding protein (SSB), which rapidly binds and continuously sequesters ssDNA, kinetically blocking RecA assembly(2,3). This dynamic self-assembly on a DNA lattice, in competition with another protein, is unique for the RecA family compared to other filament-forming proteins such as actin and tubulin. The complexity of this process has hindered our understanding of RecA filament assembly because ensemble measurements cannot reliably distinguish between the nucleation and growth phases, despite extensive and diverse attempts(2-5). Previous single-molecule assays have measured the nucleation and growth of RecA-and its eukaryotic homologue RAD51-on naked double-stranded DNA and ssDNA(6-12); however, the template for RecA self-assembly in vivo is SSB-coated ssDNA(3). Using single-molecule microscopy, here we directly visualize RecA filament assembly on single molecules of SSB-coated ssDNA, simultaneously measuring nucleation and growth. We establish that a dimer of RecA is required for nucleation, followed by growth of the filament through monomer addition, consistent with the finding that nucleation, but not growth, is modulated by nucleotide and magnesium ion cofactors. Filament growth is bidirectional, albeit faster in the 5'-> 3' direction. Both nucleation and growth are repressed at physiological conditions, highlighting the essential role of recombination mediators in potentiating assembly in vivo. We define a two-step kinetic mechanism in which RecA nucleates on transiently exposed ssDNA during SSB sliding and/or partial dissociation (DNA unwrapping) and then the RecA filament grows. We further demonstrate that the recombination mediator protein pair, RecOR (RecO and RecR), accelerates both RecA nucleation and filament growth, and that the introduction of RecF further stimulates RecA nucleation.	[Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Bell, Jason C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Biochem & Mol Biol Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Plank, Jody/0000-0002-8025-7935; Bell, Jason/0000-0001-5480-7975	National Institutes of Health (NIH) [T32 GM007377, CA10052159, CA136103, GM62653, GM64745]; NATIONAL CANCER INSTITUTE [F32CA136103, T32CA108459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, T32GM007377, R01GM062653, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. J.C.B. was funded by a National Institutes of Health (NIH) Predoctoral Training Program in Molecular & Cellular Biology (T32 GM007377); C. C. D. and J.L.P. were funded by the NIH T32 Training Program in Oncogenic Signals and Chromosome Biology (CA10052159); J.L.P. was also funded by a NIH Postdoctoral Fellowship (CA136103); and S. C. K. was supported by the NIH (GM62653 and GM64745).	Bell J. C., 2011, THESIS U CALIFORNIA; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Dillingham MS, 2008, BIOPHYS J, V95, P3330, DOI 10.1529/biophysj.108.133512; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Handa N, 2009, J BIOL CHEM, V284, P18664, DOI 10.1074/jbc.M109.004895; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.bi.63.070194.005015; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.biophys.20.1.539; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629	35	105	106	5	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					274	U144		10.1038/nature11598	http://dx.doi.org/10.1038/nature11598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103864	Green Accepted, Green Submitted			2022-12-01	WOS:000310774300048
J	Phrampus, BJ; Hornbach, MJ				Phrampus, Benjamin J.; Hornbach, Matthew J.			Recent changes to the Gulf Stream causing widespread gas hydrate destabilization	NATURE			English	Article							OCEAN; FLOW	The Gulf Stream is an ocean current that modulates climate in the Northern Hemisphere by transporting warm waters from the Gulf of Mexico into the North Atlantic and Arctic oceans(1,2). A changing Gulf Stream has the potential to thaw and convert hundreds of gigatonnes of frozen methane hydrate trapped below the sea floor into methane gas, increasing the risk of slope failure and methane release(3-9). How the Gulf Stream changes with time and what effect these changes have on methane hydrate stability is unclear. Here, using seismic data combined with thermal models, we show that recent changes in intermediate-depth ocean temperature associated with the Gulf Stream are rapidly destabilizing methane hydrate along a broad swathe of the North American margin. The area of active hydrate destabilization covers at least 10,000 square kilometres of the United States eastern margin, and occurs in a region prone to kilometre-scale slope failures. Previous hypothetical studies(3,5) postulated that an increase of five degrees Celsius in intermediate-depth ocean temperatures could release enough methane to explain extreme global warming events like the Palaeocene-Eocene thermal maximum (PETM) and trigger widespread ocean acidification(7). Our analysis suggests that changes in Gulf Stream flow or temperature within the past 5,000 years or so are warming the western North Atlantic margin by up to eight degrees Celsius and are now triggering the destabilization of 2.5 gigatonnes of methane hydrate (about 0.2 per cent of that required to cause the PETM). This destabilization extends along hundreds of kilometres of the margin and may continue for centuries. It is unlikely that the western North Atlantic margin is the only area experiencing changing ocean currents(10-12); our estimate of 2.5 gigatonnes of destabilizing methane hydrate may therefore represent only a fraction of the methane hydrate currently destabilizing globally. The transport from ocean to atmosphere of any methane released-and thus its impact on climate-remains uncertain.	[Phrampus, Benjamin J.; Hornbach, Matthew J.] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA	Southern Methodist University	Phrampus, BJ (corresponding author), So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA.	bphrampus@mail.smu.edu		Phrampus, Benjamin/0000-0002-6405-3625				Archer D, 2004, EARTH PLANET SC LETT, V222, P333, DOI 10.1016/j.epsl.2004.03.011; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; BRYAN GM, 1980, MAR GEOL, V35, P43, DOI 10.1016/0025-3227(80)90021-3; Carpenter G., 1981, GEO-MAR LETT, V1, P29, DOI [10.1007/BF02463298, DOI 10.1007/BF02463298]; DESER C, 1993, J CLIMATE, V6, P1743, DOI 10.1175/1520-0442(1993)006<1743:SCVOTN>2.0.CO;2; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dillon W. P., 1993, US GEOL SURV PROF PA, V1570, P313; Dugan B, 2000, SCIENCE, V289, P288, DOI 10.1126/science.289.5477.288; Evans HK, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001409; Flemings PB, 2003, GEOLOGY, V31, P1057, DOI 10.1130/G19863.1; Holbrook WS, 1996, SCIENCE, V273, P1840, DOI 10.1126/science.273.5283.1840; Hornbach MJ, 2004, NATURE, V427, P142, DOI 10.1038/nature02172; HUTCHISON I, 1985, GEOPHYS J ROY ASTR S, V82, P439, DOI 10.1111/j.1365-246X.1985.tb05145.x; Kennett JP, 2003, SPEC PUBL SER, V54; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Lynch-Stieglitz J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002032; MACKENZIE KV, 1981, J ACOUST SOC AM, V70, P801, DOI 10.1121/1.386919; Milton D. J., 1976, FUTURE SUPPLY NATURE, P927; Paull C. K., 1996, P OCEAN DRILLING PRO, V164, P5; Rajan A, 2012, MAR PETROL GEOL, V32, P36, DOI 10.1016/j.marpetgeo.2011.12.008; Ruppel C, 1997, GEOLOGY, V25, P699, DOI 10.1130/0091-7613(1997)025<0699:ACTOAT>2.3.CO;2; RUPPEL C, 1995, J GEOPHYS RES-SOL EA, V100, P20037, DOI 10.1029/95JB01860; SHIPLEY TH, 1979, AAPG BULL, V63, P2204; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Westbrook CD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038186; Winguth A, 2010, J CLIMATE, V23, P2562, DOI 10.1175/2009JCLI3113.1; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; YAMANO M, 1982, GEOLOGY, V10, P339, DOI 10.1130/0091-7613(1982)10<339:EOHFDF>2.0.CO;2	30	110	114	6	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					527	+		10.1038/nature11528	http://dx.doi.org/10.1038/nature11528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099408				2022-12-01	WOS:000310196200039
J	Lake, A				Lake, Anthony			A tipping point for child survival, health, and nutrition	LANCET			English	Editorial Material									UNICEF, New York, NY 10017 USA	UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Amouzou A, 2012, LANCET; [Anonymous], LEV TRENDS CHILD MOR; Carrera C, 2012, LANCET; Chopra M, 2012, LANCET; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Victora CG, 2012, LANCET; World Health Organization, 2012, TRENDS MAT MORT 1990	7	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1286	1287		10.1016/S0140-6736(12)61539-6	http://dx.doi.org/10.1016/S0140-6736(12)61539-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	22999429				2022-12-01	WOS:000309931400005
J	Chen, W; Jongkamonwiwat, N; Abbas, L; Eshtan, SJ; Johnson, SL; Kuhn, S; Milo, M; Thurlow, JK; Andrews, PW; Marcotti, W; Moore, HD; Rivolta, MN				Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.			Restoration of auditory evoked responses by human ES-cell-derived otic progenitors	NATURE			English	Article							EMBRYONIC STEM-CELLS; INNER-EAR; SPIRAL GANGLION; IN-VITRO; PLACODE INDUCTION; HAIR-CELLS; DIFFERENTIATION; NEURONS; NERVE; TRANSPLANTATION	Deafness is a condition with a high prevalence worldwide, produced primarily by the loss of the sensory hair cells and their associated spiral ganglion neurons (SGNs). Of all the forms of deafness, auditory neuropathy is of particular concern. This condition, defined primarily by damage to the SGNs with relative preservation of the hair cells(1), is responsible for a substantial proportion of patients with hearing impairment(2). Although the loss of hair cells can be circumvented partially by a cochlear implant, no routine treatment is available for sensory neuron loss, as poor innervation limits the prospective performance of an implant(3). Using stem cells to recover the damaged sensory circuitry is a potential therapeutic strategy. Here we present a protocol to induce differentiation from human embryonic stem cells (hESCs) using signals involved in the initial specification of the otic placode. We obtained two types of otic progenitors able to differentiate in vitro into hair-cell-like cells and auditory neurons that display expected electrophysiological properties. Moreover, when transplanted into an auditory neuropathy model, otic neuroprogenitors engraft, differentiate and significantly improve auditory-evoked response thresholds. These results should stimulate further research into the development of a cell-based therapy for deafness.	[Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Thurlow, Johanna K.; Andrews, Peter W.; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Jongkamonwiwat, Nopporn] Srinakharinwirot Univ, Fac Hlth Sci, Ongkharak 26120, Nakhonnayok, Thailand	University of Sheffield; University of Sheffield; Srinakharinwirot University	Rivolta, MN (corresponding author), Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	m.n.rivolta@sheffield.ac.uk		Jongkamonwiwat, Nopporn/0000-0002-3592-8787; , Stephanie/0000-0001-6633-9478; Andrews, Peter/0000-0001-7215-4410	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust [088719]; Medical Research Council; ESTOOLS; Wellcome Trust VIP award; RNID; Medical Research Council [G0700785, G0801059, G0900919] Funding Source: researchfish; RNID [515:SHE:MR, G44] Funding Source: researchfish; MRC [G0900919, G0700785, G0801059] Funding Source: UKRI	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESTOOLS(European Commission); Wellcome Trust VIP award(Wellcome Trust); RNID; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported primarily by grants from Action on Hearing Loss (RNID) to M.N.R. Other support included Deafness Research UK (M.N.R and W. M.), the Wellcome Trust (088719, W. M.), Medical Research Council (P. W. A, H. D. M. and M.N.R) and ESTOOLS (P. W. A). S.L.J. was supported by a Wellcome Trust VIP award and the RNID. W. M. and S.L.J. are Royal Society university research fellows. Confocal images were taken at the Light Microscopy Facility of the Department of Biomedical Sciences, University of Sheffield. We are grateful for the advice of M. Mulheran and I. Russell on the tests of auditory function, provided at the earlier stages of this project, and to the assistance of P. Gokhale on the use of the InCell Analyzer. M.N.R. acknowledges the support and encouragement of his late parents, Noemi Lujan-Ceballos and Juan Carlos Rivolta.	Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; BOETTCHER FA, 1993, HEARING RES, V71, P137, DOI 10.1016/0378-5955(93)90029-Z; Bradley Jane, 2008, Cochlear Implants Int, V9, P34, DOI 10.1179/cim.2008.9.1.34; BURKARD R, 1993, J ACOUST SOC AM, V94, P2441, DOI 10.1121/1.407465; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Coleman B, 2007, EXP CELL RES, V313, P232, DOI 10.1016/j.yexcr.2006.10.010; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Hildebrand MS, 2005, JARO-J ASSOC RES OTO, V6, P341, DOI 10.1007/s10162-005-0012-9; Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Lang H, 2005, JARO-J ASSOC RES OTO, V6, P63, DOI 10.1007/s10162-004-5021-6; Lang HN, 2008, JARO-J ASSOC RES OTO, V9, P225, DOI 10.1007/s10162-008-0119-x; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Sekiya T, 2007, EUR J NEUROSCI, V25, P2307, DOI 10.1111/j.1460-9568.2007.05478.x; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uus K, 2006, PEDIATRICS, V117, pE887, DOI 10.1542/peds.2005-1064; Vlastarakos PV, 2008, INT J PEDIATR OTORHI, V72, P1135, DOI 10.1016/j.ijporl.2008.04.004; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555	29	238	253	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					278	+		10.1038/nature11415	http://dx.doi.org/10.1038/nature11415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972191	Green Accepted			2022-12-01	WOS:000309733300053
J	Machin, JT; Wordsworth, DR; Raja, S; Burtt, S				Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon			Hip pain in an adolescent after injury while playing football	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFERIOR ILIAC SPINE; AVULSION FRACTURES; PELVIS; ATHLETE		[Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon] Luton & Dunstable Hosp NHS Fdn Trust, Dept Trauma & Orthopaed, Luton, Beds, England		Machin, JT (corresponding author), 15 Denholme Rd, London W9 3HU, England.	johnmachin@doctors.org.uk						Clancy W G Jr, 1976, Am J Sports Med, V4, P214, DOI 10.1177/036354657600400504; FERNBACH SK, 1981, AM J ROENTGENOL, V137, P581, DOI 10.2214/ajr.137.3.581; Kocher MS, 2006, CLIN SPORT MED, V25, P241, DOI 10.1016/j.csm.2006.01.001; METZMAKER JN, 1985, AM J SPORT MED, V13, P349, DOI 10.1177/036354658501300510; Miller MD, 2008, REV ORTHOPEDICS, P509; Moeller James L, 2003, Curr Sports Med Rep, V2, P110; Perry DC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3565; Rajasekhar C, 2001, INT ORTHOP, V24, P364, DOI 10.1007/s002640000184; Rossi F, 2001, SKELETAL RADIOL, V30, P127, DOI 10.1007/s002560000319; Saluan PM, 1997, ORTHOPEDICS, V20, P558; Sanders TG, 2008, SEMIN MUSCULOSKEL R, V12, P42, DOI 10.1055/s-2008-1067936; SUNDAR M, 1994, SKELETAL RADIOL, V23, P85, DOI 10.1007/BF00563198; VESELKO M, 1994, J TRAUMA, V36, P444, DOI 10.1097/00005373-199403000-00039; WATERS PM, 1988, CLIN SPORT MED, V7, P513; Weinstein SL, 1984, AAOS INSTRUCTIONAL C, V33	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 26	2012	345								e6265	10.1136/bmj.e6265	http://dx.doi.org/10.1136/bmj.e6265			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OV	23015300				2022-12-01	WOS:000309386300005
J	Neeland, IJ; Turer, AT; Ayers, CR; Powell-Wiley, TM; Vega, GL; Farzaneh-Far, R; Grundy, SM; Khera, A; McGuire, DK; de Lemos, JA				Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Powell-Wiley, Tiffany M.; Vega, Gloria L.; Farzaneh-Far, Ramin; Grundy, Scott M.; Khera, Amit; McGuire, Darren K.; de Lemos, James A.			Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; SEX-DIFFERENCES; PLASMA-LEVELS; ASSOCIATION; TISSUE; POPULATION; PREVALENCE; PREDICTION; MORTALITY	Context The risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized. A dysfunctional adiposity phenotype, characterized by excess visceral fat and insulin resistance, may contribute to diabetes development in those with obesity. Objective To investigate associations between adiposity phenotypes and risk for incident prediabetes and diabetes in a multiethnic, population-based cohort of obese adults. Design, Setting, and Participants Among 732 obese participants (body mass index >= 30) aged 30 to 65 years without diabetes or cardiovascular disease enrolled between 2000 and 2002 in the Dallas Heart Study, we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); circulating adipokines and biomarkers of insulin resistance, dyslipidemia, and inflammation; and subclinical atherosclerosis and cardiac structure and function by computed tomography and MRI. Main Outcome Measures Incidence of diabetes through a median 7.0 years (interquartile range, 6.6-7.6) of follow-up. In a subgroup of 512 participants with normal fasting glucose values at baseline, incidence of the composite of prediabetes or diabetes was determined. Results Of the 732 participants (mean age, 43 years; 65% women; 71% non-white), 84 (11.5%) developed diabetes. In multivariable analysis, higher baseline visceral fat mass (odds ratio [OR] per 1 SD [1.4 kg], 2.4; 95% CI, 1.6-3.7), fructosamine level (OR per 1 SD [1.1 mu mol/L], 2.0; 95% CI, 1.4-2.7), fasting glucose level (OR per 1 SD [1.1 mu mol/L], 1.9; 95% CI, 1.4-2.6), family history of diabetes (OR, 2.3; 95% CI, 1.3-4.3), systolic blood pressure (OR per 10 mm Hg, 1.3; 95% CI, 1.1-1.5), and weight gain over follow-up (OR per 1 kg, 1.06; 95% CI, 1.02-1.10) were independently associated with diabetes, with no associations observed for body mass index, total body fat, or abdominal subcutaneous fat. Among the 512 participants with normal baseline glucose values, the composite outcome of prediabetes or diabetes occurred in 39.1% and was independently associated with baseline measurements of visceral fat mass; levels of fasting glucose, insulin, and fructosamine; older age; non-white race; family history of diabetes; and weight gain over follow-up (P < .05 for each) but not with measurements of general adiposity. Conclusion Excess visceral fat and insulin resistance, but not general adiposity, were independently associated with incident prediabetes and type 2 diabetes mellitus in obese adults. JAMA. 2012;308(11):1150-1159 www.jama.com	[Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Farzaneh-Far, Ramin; Khera, Amit; McGuire, Darren K.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Ayers, Colby R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Vega, Gloria L.; Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; mcguire, darren keith/AAL-4172-2021		F. Hoffmann LaRoche; Genentech; sanofi-aventis; Daiichi Sankyo; Novo Nordisk; Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics; Alere; AstraZeneca; Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center [M01-RR00633]; National Institutes of Health (NIH) [UL1DE019584, PL1DK081182]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007360]; Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	F. Hoffmann LaRoche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); sanofi-aventis(Sanofi-Aventis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Novo Nordisk(Novo Nordisk); Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics(Abbott Laboratories); Alere; AstraZeneca(AstraZeneca); Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McGuire reported having received consulting income from F. Hoffmann LaRoche, Genentech, sanofi-aventis, Daiichi Sankyo, Novo Nordisk, and Tethys Bioscience. Dr de Lemos reported having received grant support from Roche Diagnostics, Abbott Diagnostics, and Alere; consulting income from Tethys Bioscience, AstraZeneca, and Daiichi Sankyo; and lecture honoraria from Bristol-Myers Squibb/sanofi-aventis. No other disclosures were reported.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633, with additional support for the present study provided by grants UL1DE019584 and PL1DK081182 from the National Institutes of Health (NIH). Dr Neeland is supported by award T32HL007360 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Powell-Wiley is funded by the Division of Intramural Research of the NHLBI of the NIH. Biomarker measurements were supported by investigator-initiated grants from Alere and Roche Diagnostics.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc11-S011, 10.2337/dc12-S064, 10.2337/dc09-S062]; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Garber Alan J, 2008, Endocr Pract, V14, P933; Genuth S, 2003, DIABETES CARE, V26, P3160; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Rohatgi A, 2009, ATHEROSCLEROSIS, V203, P569, DOI 10.1016/j.atherosclerosis.2008.07.015; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tikuisis P, 2001, EUR J APPL PHYSIOL, V85, P264, DOI 10.1007/s004210100484; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Turer AT, 2011, DIABETOLOGIA, V54, P2515, DOI 10.1007/s00125-011-2252-z; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	40	408	428	5	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1150	1159		10.1001/2012.jama.11132	http://dx.doi.org/10.1001/2012.jama.11132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990274	Green Accepted, Bronze			2022-12-01	WOS:000308861000031
J	Haskel-Ittah, M; Ben-Zvi, D; Branski-Arieli, M; Schejter, ED; Shilo, BZ; Barkai, N				Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama			Self-Organized Shuttling: Generating Sharp Dorsoventral Polarity in the Early Drosophila Embryo	CELL			English	Article							DORSAL-VENTRAL POLARITY; MORPHOGEN GRADIENT; SPATZLE PROTEIN; POSITIONAL INFORMATION; BLASTODERM EMBRYO; NUCLEAR GRADIENT; GENE-EXPRESSION; NERVOUS-SYSTEM; AXIS FORMATION; TRANSPORT	Morphogen gradients pattern tissues and organs during development. When morphogen production is spatially restricted, diffusion and degradation are sufficient to generate sharp concentration gradients. It is less clear how sharp gradients can arise within the source of a broadly expressed morphogen. A recent solution relies on localized production of an inhibitor outside the domain of morphogen production, which effectively redistributes (shuttles) and concentrates the morphogen within its expression domain. Here, we study how a sharp gradient is established without a localized inhibitor, focusing on early dorsoventral patterning of the Drosophila embryo, where an active ligand and its inhibitor are concomitantly generated in a broad ventral domain. Using theory and experiments, we show that a sharp Toll activation gradient is produced through "self-organized shuttling," which dynamically relocalizes inhibitor production to lateral regions, followed by inhibitor-dependent ventral shuttling of the activating ligand Spatzle. Shuttling may represent a general paradigm for patterning early embryos.	[Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shilo, BZ (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	benny.shilo@weizmann.ac.il; naama.barkai@weizmann.ac.il		Haskel-Ittah, Michal/0000-0003-2626-5835; Ben-Zvi, Danny/0000-0002-8697-9744	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council; Israel Science Foundation; Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	We thank R. DeLotto, T. Ip, Z. Paroush, and D. Stein for reagents; Y. Gilad, A. Rubinstein, and I. Koren for technical help; T. Volk for insightful suggestions; and Orit Bechar, Tali Wiesel, and Itzchak Reuven for their dedicated graphic design and animation work. We thank members of our groups for fruitful discussions. D.B.-Z. is supported by the Adams Fellowship Program of the Israeli Academy of Sciences and Humanities. This work was supported by the European Research Council, Israel Science Foundation, Minerva, and the Helen and Martin Kimmel Award for Innovative Investigations to N.B., who is the incumbent of the Lorna Greenberg Scherzer Professorial Chair, and the Minerva Foundation to B.-Z.S., who is an incumbent of the Hilda and Cecil Lewis Professorial Chair in Molecular Genetics.	Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Cho YS, 2012, CURR BIOL, V22, P1013, DOI 10.1016/j.cub.2012.03.065; Cho YS, 2010, CURR BIOL, V20, P1133, DOI 10.1016/j.cub.2010.04.056; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; James KE, 2002, DEVELOPMENT, V129, P2209; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Morisato D, 2001, DEVELOPMENT, V128, P2309; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Peri F, 2002, DEVELOPMENT, V129, P2965; Plouhinec JL, 2011, CURR OPIN GENET DEV, V21, P696, DOI 10.1016/j.gde.2011.09.001; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; ROTH S, 1994, DEVELOPMENT, V120, P2245; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stein D, 1995, CURR BIOL, V5, P1360, DOI 10.1016/S0960-9822(95)00270-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOLPERT L, 1989, DEVELOPMENT, V107, P3; Zhang ZY, 2009, CURR BIOL, V19, P1200, DOI 10.1016/j.cub.2009.05.050; Zhao GY, 2007, INT J DEV BIOL, V51, P107, DOI 10.1387/ijdb.062188gz; Zhu XJ, 2007, DEVELOPMENT, V134, P1465, DOI 10.1242/dev.003426	56	35	35	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1016	1028		10.1016/j.cell.2012.06.044	http://dx.doi.org/10.1016/j.cell.2012.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939625	Bronze			2022-12-01	WOS:000308500200015
J	Dethoff, EA; Petzold, K; Chugh, J; Casiano-Negroni, A; Al-Hashimi, HM				Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.			Visualizing transient low-populated structures of RNA	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 TAR RNA; RELAXATION DISPERSION NMR; LEAD-DEPENDENT RIBOZYME; 16S RIBOSOMAL-RNA; NUCLEOCAPSID PROTEIN; MOLECULAR-DYNAMICS; SPIN RELAXATION; INITIATION SITE; LOOP SEQUENCE	The visualization of RNA conformational changes has provided fundamental insights into how regulatory RNAs carry out their biological functions. The RNA structural transitions that have been characterized so far involve long-lived species that can be captured by structure characterization techniques. Here we report the nuclear magnetic resonance visualization of RNA transitions towards 'invisible' excited states (ESs), which exist in too little abundance (2-13%) and for too short a duration (45-250 ms) to allow structural characterization by conventional techniques. Transitions towards ESs result in localized rearrangements in base-pairing that alter building block elements of RNA architecture, including helix-junction-helix motifs and apical loops. The ES can inhibit function by sequestering residues involved in recognition and signalling or promote ATP-independent strand exchange. Thus, RNAs do not adopt a single conformation, but rather exist in rapid equilibrium with alternative ESs, which can be stabilized by cellular cues to affect functional outcomes.	[Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Chugh, Jeetender/S-4436-2019; Petzold, Katja/E-9816-2011; Petzold, Katja/M-7298-2015	Chugh, Jeetender/0000-0002-9996-5202; Petzold, Katja/0000-0001-9470-0347; Petzold, Katja/0000-0001-9470-0347	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council [VR-K2011-78PK-21662-0-12]; US National Institutes of Health [R01 Al066975]; University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.A.D., K.P. and J.C contributed equally to this work. We thank members of the Al-Hashimi laboratory for input. We acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for the support of the purchase of a 600 MHz spectrometer. K.P. is supported by a postdoctoral Fellowship from the Swedish Research Council (VR-K2011-78PK-21662-0-12). This work was supported by the US National Institutes of Health (R01 Al066975) and by a Rackham Graduate Student Research Grant awarded by the University of Michigan.	Baldwin AJ, 2009, J AM CHEM SOC, V131, P11939, DOI 10.1021/ja903896p; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Blad H, 2005, J MOL BIOL, V353, P540, DOI 10.1016/j.jmb.2005.08.030; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Dahlquist KD, 2000, J MOL BIOL, V299, P1, DOI 10.1006/jmbi.2000.3672; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dethoff EA, 2008, BIOPHYS J, V95, P3906, DOI 10.1529/biophysj.108.140285; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Fares C, 2007, J AM CHEM SOC, V129, P15814, DOI 10.1021/ja0727417; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; GHOSE R, 1994, J AM CHEM SOC, V116, P8827, DOI 10.1021/ja00098a060; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; JAEGER JA, 1993, BIOCHEMISTRY-US, V32, P12522, DOI 10.1021/bi00097a032; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kipper K, 2009, J MOL BIOL, V385, P405, DOI 10.1016/j.jmb.2008.10.065; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kulinski T, 2003, J BIOL CHEM, V278, P38892, DOI 10.1074/jbc.M301939200; Lawrence DC, 2003, J MOL BIOL, V326, P529, DOI 10.1016/S0022-2836(02)01305-0; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Moore MD, 2009, AIDS REV, V11, P91; Mujeeb A, 2007, NUCLEIC ACIDS RES, V35, P2026, DOI 10.1093/nar/gkm097; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Nozinovic S, 2010, NUCLEIC ACIDS RES, V38, P683, DOI 10.1093/nar/gkp956; OConnor M, 1997, NUCLEIC ACIDS RES, V25, P1185, DOI 10.1093/nar/25.6.1185; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; Rist MJ, 2002, BIOCHEMISTRY-US, V41, P14762, DOI 10.1021/bi0267240; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Shandrick S, 2004, ANGEW CHEM INT EDIT, V43, P3177, DOI 10.1002/anie.200454217; Snoussi K, 2001, BIOCHEMISTRY-US, V40, P8898, DOI 10.1021/bi010385d; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XY, 2007, NUCLEIC ACIDS RES, V35, P1698, DOI 10.1093/nar/gkm020; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Turner KB, 2007, J MOL BIOL, V369, P812, DOI 10.1016/j.jmb.2007.03.065; Ulyanov NB, 2006, J BIOL CHEM, V281, P16168, DOI 10.1074/jbc.M601711200; Vallurupalli P, 2011, J PHYS CHEM B, V115, P14891, DOI 10.1021/jp209610v; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Yuan YQ, 2003, BIOCHEMISTRY-US, V42, P5259, DOI 10.1021/bi034084a	53	146	145	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					724	+		10.1038/nature11498	http://dx.doi.org/10.1038/nature11498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041928	Green Accepted			2022-12-01	WOS:000311606000037
J	Liu, GH; Qu, J; Suzuki, K; Nivet, E; Li, M; Montserrat, N; Yi, F; Xu, XL; Ruiz, S; Zhang, WQ; Wagner, U; Kim, A; Ren, B; Li, Y; Goebl, A; Kim, J; Soligalla, RD; Dubova, I; Thompson, J; Yates, J; Esteban, CR; Sancho-Martinez, I; Belmonte, JCI				Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Montserrat, Nuria; Yi, Fei; Xu, Xiuling; Ruiz, Sergio; Zhang, Weiqi; Wagner, Ulrich; Kim, Audrey; Ren, Bing; Li, Ying; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Thompson, James; Yates, John, III; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos			Progressive degeneration of human neural stem cells caused by pathogenic LRRK2	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; KINASE-ACTIVITY; 14-3-3 BINDING; DISEASE; INHIBITION; MUTATIONS; EFFICIENT; EXPRESSION; NUCLEUS	Nuclear-architecture defects have been shown to correlate with the manifestation of a number of human diseases as well as ageing(1-4). It is therefore plausible that diseases whose manifestations correlate with ageing might be connected to the appearance of nuclear aberrations over time. We decided to evaluate nuclear organization in the context of ageing-associated disorders by focusing on a leucine-rich repeat kinase 2 (LRRK2) dominant mutation (G2019S; glycine-to-serine substitution at amino acid 2019), which is associated with familial and sporadic Parkinson's disease as well as impairment of adult neurogenesis in mice(5). Here we report on the generation of induced pluripotent stem cells (iPSCs) derived from Parkinson's disease patients and the implications of LRRK2 (G2019S) mutation in human neural-stem-cell (NSC) populations. Mutant NSCs showed increased susceptibility to proteasomal stress as well as passage-dependent deficiencies in nuclear-envelope organization, clonal expansion and neuronal differentiation. Disease phenotypes were rescued by targeted correction of the LRRK2 (G2019S) mutation with its wild-type counterpart in Parkinson's disease iPSCs and were recapitulated after targeted knock-in of the LRRK2(G2019S) mutation in human embryonic stem cells. Analysis of human brain tissue showed nuclear-envelope impairment in clinically diagnosed Parkinson's disease patients. Together, our results identify the nucleus as a previously unknown cellular organelle in Parkinson's disease pathology and may help to open new avenues for Parkinson's disease diagnoses as well as for the potential development of therapeutics targeting this fundamental cell structure.	[Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Yi, Fei; Ruiz, Sergio; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Guang-Hui; Qu, Jing; Xu, Xiuling; Zhang, Weiqi; Li, Ying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Wagner, Ulrich; Kim, Audrey; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Salk Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghliu@ibp.ac.cn; belmonte@salk.edu	Qu, Jing/ABB-9088-2020; Li, Mo/J-2090-2014; Li, Mo/AAM-8266-2021; Montserrat, Nuria/F-3136-2016; Ruiz, Sergio/G-1561-2016; Nivet, Emmanuel/C-2729-2014	Li, Mo/0000-0003-0827-8907; Montserrat, Nuria/0000-0002-1603-1755; Ruiz, Sergio/0000-0002-0177-6965; Nivet, Emmanuel/0000-0001-7903-4059; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Suzuki, Keiichiro/0000-0001-5603-9105; Zhang, Weiqi/0000-0002-8885-5104; Liu, Guang-Hui/0000-0001-9289-8177	Thousand Young Talents program of China; National Laboratory of Biomacromolecules; Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC) [81271266, 31222039]; Beijing Municipal Natural Science Foundation; AFAR/Ellison Medical Foundation; Uehara Memorial Foundation; F.M. Kirby Foundation; NSFC [31201111]; US National Institute of Health (NIH) [ES017166]; Ludwig Institute for Cancer Research; NIH [P41 RR011823]; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine; Ellison Medical Foundation; Helmsley Charitable Trust; ERA-Net Neuron; MINECO; Fundacion Cellex; (G. Gaslini Institute)-Telethon Genetic Biobank Network [GTB07001]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); F.M. Kirby Foundation; NSFC(National Natural Science Foundation of China (NSFC)); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ERA-Net Neuron; MINECO(Spanish Government); Fundacion Cellex(Foundation CELLEX); (G. Gaslini Institute)-Telethon Genetic Biobank Network(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank K. Mitani, P. Ng, A. Lieber, Y. Imai, M. A. Miyawaki, Filocamo, S. Goldwurm, Telethon Genetic Biobank Network for providing constructs and cells (the fibroblast samples were obtained from the "Cell Line and DNA Biobank from patients affected by Genetic Diseases" (G. Gaslini Institute)-Telethon Genetic Biobank Network (project no. GTB07001)); Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS for providing human brain tissue; F. Gage, M. Hetzer, J. Yao, Y. Mu, D. Yu, E. Gelpi, X. M. Wang, X. Wang, G. Bai and Z. J. Liu for helpful discussions; M. Joens and J. Fitzpatrick of the Waitt Advanced Biophotonics Core Facility for performing TEM analysis; M. Marti for imaging, teratoma and karyotyping analysis; F. Osakada for statistics analysis; and M. Schwarz, P. Schwarz and L. Laricchia-Robbio for administrative help. G.-H.L. is supported by the Thousand Young Talents program of China, the National Laboratory of Biomacromolecules, the Strategic Priority Research Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (NSFC) (81271266 and 31222039), and the Beijing Municipal Natural Science Foundation. J.Q. was partly supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship. K.S. was partly supported by a Uehara Memorial Foundation research fellowship. E.N. was partly supported by an F.M. Kirby Foundation postdoctoral fellowship. X.X. is supported by NSFC (31201111). B.R. was supported by a US National Institute of Health (NIH) grant (ES017166) and the Ludwig Institute for Cancer Research. J.Y. was supported by an NIH grant (P41 RR011823). J.C.I.B. was supported by grants from the Glenn Foundation, G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi, the California Institute of Regenerative Medicine, the Ellison Medical Foundation, the Helmsley Charitable Trust, ERA-Net Neuron, MINECO and Fundacion Cellex.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Chang KH, 2011, MOL BIOL CELL, V22, P1452, DOI 10.1091/mbc.E10-07-0654; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x	30	247	264	1	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					603	607		10.1038/nature11557	http://dx.doi.org/10.1038/nature11557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075850	Green Accepted			2022-12-01	WOS:000311339800054
J	Kaufman, F				Kaufman, Frederick			Wall Street's thirst for water	NATURE			English	Editorial Material									CUNY, Grad Sch Journalism, New York, NY 10018 USA	City University of New York (CUNY) System	Kaufman, F (corresponding author), CUNY, Grad Sch Journalism, New York, NY 10018 USA.							Brookshire D. S., 2011, RFF PRESS WATER POLI; Ghosh N, 2010, COMMODITY VISION, V4, P8; Global Water Partnership and International Network of Basin Organizations, 2009, HDB INT WAT RES MAN; Kaufman F., 2011, FOREIGN POLICY; Keim B., 2012, WIRED SCI       0306; Lagi M, 2011, PREPRINT; Moya E., 2010, GUARDIAN; Nguyen A., 2011, BLOOMBERG       1214	8	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					469	471		10.1038/490469a	http://dx.doi.org/10.1038/490469a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NK	23099383	Bronze			2022-12-01	WOS:000310196200012
J	Newman, SA				Newman, Stuart A.			Physico-Genetic Determinants in the Evolution of Development	SCIENCE			English	Editorial Material							BIOLOGICAL PATTERN-FORMATION; AMPHIMEDON-QUEENSLANDICA; SEGMENTATION CLOCK; GENOME; ORIGIN; COMPLEXITY; DROSOPHILA; EXPLOSION; MODEL; WNT	Animal bodies and the embryos that generate them exhibit an assortment of stereotypic morphological motifs that first appeared more than half a billion years ago. During development, cells arrange themselves into tissues with interior cavities and multiple layers with immiscible boundaries, containing patterned arrangements of cell types. These tissues go on to elongate, fold, segment, and form appendages. Their motifs are similar to the outcomes of physical processes generic to condensed, chemically excitable, viscoelastic materials, although the embryonic mechanisms that generate them are typically much more complex. I propose that the origins of animal development lay in the mobilization of physical organizational effects that resulted when certain gene products of single-celled ancestors came to operate on the spatial scale of multicellular aggregates.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College	Newman, SA (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	newman@nymc.edu	Newman, Stuart/W-1617-2019					Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Harrington MJ, 2009, MOL REPROD DEV, V76, P954, DOI 10.1002/mrd.21085; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Newman SA, 2006, INT J DEV BIOL, V50, P289, DOI 10.1387/ijdb.052049sn; Newman SA, 2011, J EXP ZOOL PART B, V316B, P467, DOI 10.1002/jez.b.21417; Newman SA, 2009, INT J DEV BIOL, V53, P693, DOI 10.1387/ijdb.072481sn; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Reinke H, 2006, TRENDS BIOCHEM SCI, V31, P189, DOI 10.1016/j.tibs.2006.02.001; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shen B, 2008, SCIENCE, V319, P81, DOI 10.1126/science.1150279; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Strogatz S., 2003, SYNC THE EMERGING SC; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Tyson JJ, 2011, CURR BIOL, V21, pR185, DOI 10.1016/j.cub.2011.01.042; Wilkins A., 2002, THE EVOLUTION OF DEV	30	61	66	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					217	219		10.1126/science.1222003	http://dx.doi.org/10.1126/science.1222003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066074	Green Submitted			2022-12-01	WOS:000309712300035
J	Wang, X; Zhang, XL; Dong, XP; Samie, M; Li, XR; Cheng, XP; Goschka, A; Shen, DB; Zhou, YD; Harlow, J; Zhu, MX; Clapham, DE; Ren, DJ; Xu, HX				Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Zhou, Yandong; Harlow, Janice; Zhu, Michael X.; Clapham, David E.; Ren, Dejian; Xu, Haoxing			TPC Proteins Are Phosphoinositide-Activated Sodium-Selective Ion Channels in Endosomes and Lysosomes	CELL			English	Article							CA2+; NAADP; CALCIUM; IDENTIFICATION; RECEPTORS; CATIONS	Mammalian two-pore channel proteins (TPC1, TPC2; TPCN1, TPCN2) encode ion channels in intracellular endosomes and lysosomes and were proposed to mediate endolysosomal calcium release triggered by the second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). By directly recording TPCs in endolysosomes from wild-type and TPC double-knockout mice, here we show that, in contrast to previous conclusions, TPCs are in fact sodium-selective channels activated by PI(3,5)P-2 and are not activated by NAADP. Moreover, the primary endolysosomal ion is Na+, not K+, as had been previously assumed. These findings suggest that the organellar membrane potential may undergo large regulatory changes and may explain the specificity of PI(3,5)P-2 in regulating the fusogenic potential of intracellular organelles.	[Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zhou, Yandong; Harlow, Janice; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Clapham, David E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	Clapham, David/S-1123-2019; xu, hao/GWQ-7394-2022; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Dong, Xianping/0000-0002-4496-7104	NIH [NS062792, NS055293, GM081658]; Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792, R01NS055293, R01NS074257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 grants (NS062792 to H. X., NS055293 to D. R., GM081658 to M.X.Z., and HHMI to D. E. C.) and a Sloan Research Fellowship (to H. X.). We thank the Gene Manipulation Facility of Children's Hospital Boston (TPC1) and the Transgenic and Chimera Mouse Facility at the University of Pennsylvania (TPC2) for embryonic stem cell injection. The authors are listed in the order of their institutions; X. W. initiated the project; X. W., X.Z., and X.-p. D. performed the electrophysiology experiments; X. W. also performed the Ca<SUP>2+</SUP> imaging experiments; M. S. and A. G. performed the ionic composition experiments; X. L., X. C., D. S., and M. X.Z. contributed the reagents; D. R. and J.H. developed the TPC1, TPC2 knockout mouse lines and the hTPC1, hTPC2, hTPC1 Delta N, and hTPC2 Delta N constructs; Y.Z. measured the glucose- and NAADP-induced Ca<SUP>2+</SUP> responses in the TPC mutant islets compared with wild-type; development of the TPC1 knockout was carried out by D. R. in the laboratory of D. E. C.; and H. X. and D. E. C. wrote the paper with input from all authors. We are grateful to Drs. Susan Slaugenhaupt and James Slama for sharing reagents; Drs. Ted Huston, Hollis Showalter, Yafei Jin, Leslie Satin, Jianhua Ren, Peter Arvan, and Gautam Rajpal for assistance; and Dr. Richard Hume for comments on an earlier version of the manuscript. We appreciate the encouragement and helpful comments from other members of the Xu, Ren, and Clapham laboratories.	ANZAI K, 1993, J BIOCHEM-TOKYO, V114, P487, DOI 10.1093/oxfordjournals.jbchem.a124204; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; COHN DV, 1968, J BIOL CHEM, V243, P1089; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kraayenhof R, 1996, BBA-BIOMEMBRANES, V1282, P293, DOI 10.1016/0005-2736(96)00069-7; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; SCHMIDT R, 1980, NEUROSCIENCE, V5, P625, DOI 10.1016/0306-4522(80)90060-3; Seby F, 2003, ANAL BIOANAL CHEM, V377, P685, DOI 10.1007/s00216-003-2133-5; Shen DB, 2011, BIOESSAYS, V33, P448, DOI 10.1002/bies.201000152; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	348	353	3	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					372	383		10.1016/j.cell.2012.08.036	http://dx.doi.org/10.1016/j.cell.2012.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063126	Green Accepted, Bronze			2022-12-01	WOS:000309981000015
J	Adesnik, H; Bruns, W; Taniguchi, H; Huang, ZJ; Scanziani, M				Adesnik, Hillel; Bruns, William; Taniguchi, Hiroki; Huang, Z. Josh; Scanziani, Massimo			A neural circuit for spatial summation in visual cortex	NATURE			English	Article							CLASSICAL RECEPTIVE-FIELD; NEURONS; INHIBITION; CONTRAST; V1; CONNECTIONS; GENERATION; RESPONSES; DYNAMICS; SPARSE	The response of cortical neurons to a sensory stimulus is modulated by the context. In the visual cortex, for example, stimulation of a pyramidal cell's receptive-field surround can attenuate the cell's response to a stimulus in the centre of its receptive field, a phenomenon called surround suppression. Whether cortical circuits contribute to surround suppression or whether the phenomenon is entirely relayed from earlier stages of visual processing is debated. Here we show that, in contrast to pyramidal cells, the response of somatostatin-expressing inhibitory neurons (SOMs) in the superficial layers of the mouse visual cortex increases with stimulation of the receptive-field surround. This difference results from the preferential excitation of SOMs by horizontal cortical axons. By perturbing the activity of SOMs, we show that these neurons contribute to pyramidal cells' surround suppression. These results establish a cortical circuit for surround suppression and attribute a particular function to a genetically defined type of inhibitory neuron.	[Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Huang, Z. Josh/0000-0003-0592-028X	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI); Gatsby charitable foundation; US National Institute of Health [NS069010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS069010] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Gatsby charitable foundation; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. Evora for the reconstruction of SOMs and technical assistance. We thank C. Niell and M. Stryker for providing expertise and sharing code used at the initial stages of this project; S. Olsen for providing the firing rates of part of the units isolated under anaesthesia; P. Abelkop and A. Linder for technical assistance; and J. Isaacson and members of the Scanziani laboratory for helpful advice. H. A. was supported by the Helen Hay Whitney Foundation and the Howard Hughes Medical Institute (HHMI). W. B. and M. S. were supported by the HHMI, the Gatsby charitable foundation and US National Institute of Health grant NS069010.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Mareschal I, 2004, VISION RES, V44, P57, DOI 10.1016/j.visres.2003.07.009; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Sceniak MP, 2006, J NEUROPHYSIOL, V96, P3474, DOI 10.1152/jn.00734.2006; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Taniguchi H, 2011, NEURON, V72, P1091, DOI 10.1016/j.neuron.2011.12.010; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	40	394	396	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					226	231		10.1038/nature11526	http://dx.doi.org/10.1038/nature11526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060193	Green Accepted			2022-12-01	WOS:000309733300042
J	Steinbrook, R; Sharfstein, JM				Steinbrook, Robert; Sharfstein, Joshua M.			The FDA Safety and Innovation Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinbrook, Robert] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Yale University; Maryland Department of Health & Mental Hygiene	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	2	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1437	1438		10.1001/jama.2012.12829	http://dx.doi.org/10.1001/jama.2012.12829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047356				2022-12-01	WOS:000309579300020
J	Chen, SX; Cherry, A; Tari, PK; Podgorski, K; Kwong, YKK; Haas, K				Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt			The Transcription Factor MEF2 Directs Developmental Visually Driven Functional and Structural Metaplasticity	CELL			English	Article							LONG-TERM DEPRESSION; DENDRITIC ARBOR GROWTH; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; EMBRYONIC BRAIN; NERVOUS-SYSTEM; NMDA RECEPTOR; CORTEX; DIFFERENTIATION	Natural sensory input shapes both structure and function of developing neurons, but how early experience-driven morphological and physiological plasticity are interrelated remains unclear. Using rapid time-lapse two-photon calcium imaging of network activity and single-neuron growth within the unanesthetized developing brain, we demonstrate that visual stimulation induces coordinated changes to neuronal responses and dendritogenesis. Further, we identify the transcription factor MEF2A/2D as a major regulator of neuronal response to plasticity-inducing stimuli directing both structural and functional changes. Unpatterned sensory stimuli that change plasticity thresholds induce rapid degradation of MEF2A/2D through a classical apoptotic pathway requiring NMDA receptors and caspases-9 and -3/7. Knockdown of MEF2A/2D alone is sufficient to induce a metaplastic shift in threshold of both functional and morphological plasticity. These findings demonstrate how sensory experience acting through altered levels of the transcription factor MEF2 fine-tunes the plasticity thresholds of brain neurons during neural circuit formation.	[Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada; [Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Chen, Simon/0000-0002-7595-7443; Podgorski, Kaspar/0000-0002-0374-2005	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Tula Foundation; EJLB Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Tula Foundation; EJLB Foundation	This work was funded by grants from the Canadian Institutes of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), the Tula Foundation, and the EJLB Foundation.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; COLEMAN PD, 1968, J ANAT, V102, P363; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Dunfield D, 2010, NAT PROTOC, V5, P841, DOI 10.1038/nprot.2010.10; Dunfield D, 2009, NEURON, V64, P240, DOI 10.1016/j.neuron.2009.08.034; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Hossain S, 2012, DEV NEUROBIOL, V72, P615, DOI 10.1002/dneu.20959; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Philpot BD, 2003, J NEUROSCI, V23, P5583; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	46	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					41	55		10.1016/j.cell.2012.08.028	http://dx.doi.org/10.1016/j.cell.2012.08.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021214	Bronze			2022-12-01	WOS:000309544200009
J	Lang, M; Murat, S; Clark, AG; Gouppil, G; Blais, C; Matzkin, LM; Guittard, E; Yoshiyama-Yanagawa, T; Kataoka, H; Niwa, R; Lafont, R; Dauphin-Villemant, C; Orgogozo, V				Lang, Michael; Murat, Sophie; Clark, Andrew G.; Gouppil, Geraldine; Blais, Catherine; Matzkin, Luciano M.; Guittard, Emilie; Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi; Niwa, Ryusuke; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie			Mutations in the neverland Gene Turned Drosophila pachea into an Obligate Specialist Species	SCIENCE			English	Article							CACTUS; OXYGENASE; PATHWAYS; STEROL	Most living species exploit a limited range of resources. However, little is known about how tight associations build up during evolution between such specialist species and the hosts they use. We examined the dependence of Drosophila pachea on its single host, the senita cactus. Several amino acid changes in the Neverland oxygenase rendered D. pachea unable to transform cholesterol into 7-dehydrocholesterol (the first reaction in the steroid hormone biosynthetic pathway in insects) and thus made D. pachea dependent on the uncommon sterols of its host plant. The neverland mutations increase survival on the cactus's unusual sterols and are in a genomic region that faced recent positive selection. This study illustrates how relatively few genetic changes in a single gene may restrict the ecological niche of a species.	[Lang, Michael; Murat, Sophie; Gouppil, Geraldine; Orgogozo, Virginie] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, F-75205 Paris 13, France; [Murat, Sophie; Blais, Catherine; Guittard, Emilie; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie] Univ Paris 06, CNRS, F-75005 Paris, France; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Matzkin, Luciano M.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Yoshiyama-Yanagawa, Takuji; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Cornell University; University of Alabama System; University of Alabama Huntsville; University of Tsukuba; University of Tokyo	Orgogozo, V (corresponding author), Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France.	virginie.orgogozo@normalesup.org	Matzkin, Luciano/B-3168-2013; Matzkin, Luciano/AAI-2913-2020; LAFONT, Rene/GYA-4891-2022	Matzkin, Luciano/0000-0002-3580-9171; Lang, Michael/0000-0002-2297-5680; Crilat, Emilie/0000-0001-8796-5582; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH [AI064950]; Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF [DEB-1020009]; JSPS; Ministry of Education, Culture, Sports, Science and Technology in Japan; Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Joron for the linkage disequilibrium heat map; M.-A. Felix, N. Gompel, and C. Desplan for comments on the manuscript; C. Parada for help with field work; T. A. Markow for D. pachea samples; C. S. Thummel and the San Diego Drosophila Species Stock Center for flies; Y. Hiromi for reagents; T. Blasco for liquid chromatography tandem mass spectrometry analyses; and M. Gho for hosting V.O. in 2009-2010. Supported by CNRS ATIP-AVENIR (to V.O.), French Foreign Ministry postdoctoral fellowship (to M. L.), NIH grant AI064950 (to A. G. C.), Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS) (to H. K. and C. D.-V.), NSF award DEB-1020009 (to L. M. M.), JSPS postdoctoral fellowship (to T.Y.-Y.), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to R. N.), and Amylin Endowment (to T. A. Markow). The nvd sequences were deposited in GenBank under accession nos. JF764559 to JF764595 and JX066807 to JX067384. The authors declare no conflict of interest. V.O. conceived the study and wrote the paper. M. L., C. B., R. L., C. D.-V., L. M. M., H. K., and R. N. provided technical support and conceptual advice for designing the experiments. V.O., M. L., G. G., S. M., L. M. M., C. B., E. G., T.Y.-Y., C. D.-V., and R. N. performed the experiments. A. G. C. did the population genetics analysis.	Blais C, 2010, J CHROMATOGR B, V878, P925, DOI 10.1016/j.jchromb.2010.02.018; CAMPBELL CE, 1980, PHYTOCHEMISTRY, V19, P2777, DOI 10.1016/S0031-9422(00)83969-2; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; GOODNIGHT KC, 1971, LIPIDS, V6, P166, DOI 10.1007/BF02533031; HEED WB, 1965, SCIENCE, V149, P758, DOI 10.1126/science.149.3685.758; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Lwoff A, 1944, EVOLUTION PHYSL ETUD; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; PITNICK S, 1994, ANN ENTOMOL SOC AM, V87, P307, DOI 10.1093/aesa/87.3.307; Romero P, 2005, GENOME BIOL, V6; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Voet D., 2004, BIOCHEMISTRY-US; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	16	63	63	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1658	1661		10.1126/science.1224829	http://dx.doi.org/10.1126/science.1224829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019649	Green Accepted			2022-12-01	WOS:000309215400046
J	Paige, SL; Thomas, S; Stoick-Cooper, CL; Wang, H; Maves, L; Sandstrom, R; Pabon, L; Reinecke, H; Pratt, G; Keller, G; Moon, RT; Stamatoyannopoulos, J; Murry, CE				Paige, Sharon L.; Thomas, Sean; Stoick-Cooper, Cristi L.; Wang, Hao; Maves, Lisa; Sandstrom, Richard; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Keller, Gordon; Moon, Randall T.; Stamatoyannopoulos, John; Murry, Charles E.			A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development	CELL			English	Article							CARDIOVASCULAR PROGENITOR CELLS; DIRECTED DIFFERENTIATION; PLURIPOTENT; METHYLATION; ZEBRAFISH; POLYCOMB; GENES; EXPRESSION; PROMOTERS; MOUSE	Directed differentiation of human embryonic stem cells(ESCs) into cardiovascular cells provides a model for studying molecular mechanisms of human cardiovascular development. Although it is known that chromatin modification patterns in ESCs differ markedly from those in lineage-committed progenitors and differentiated cells, the temporal dynamics of chromatin alterations during differentiation along a defined lineage have not been studied. We show that differentiation of human ESCs into cardiovascular cells is accompanied by programmed temporal alterations in chromatin structure that distinguish key regulators of cardiovascular development from other genes. We used this temporal chromatin signature to identify regulators of cardiac development, including the homeobox gene MEIS2. Using the zebrafish model, we demonstrate that MEIS2 is critical for proper heart tube formation and subsequent cardiac looping. Temporal chromatin signatures should be broadly applicable to other models of stem cell differentiation to identify regulators and provide key insights into major developmental decisions.	[Wang, Hao; Sandstrom, Richard; Moon, Randall T.; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Paige, Sharon L.; Stoick-Cooper, Cristi L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Moon, Randall T.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Stamatoyannopoulos, John] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98109 USA; [Thomas, Sean] Gladstone Inst, San Francisco, CA 94158 USA; [Maves, Lisa] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Keller, Gordon] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON M5G 2C4, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes; Fred Hutchinson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA.	jstam@u.washington.edu; murry@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Pratt, Gabriel/0000-0003-1670-4507; Sandstrom, Richard/0000-0002-3356-1547; Keller, Gordon/0000-0001-9309-9297	NIH [P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, F30 HL095343]; UW ENCODE Center [U54HG004592];  [R90HG004152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094374, U01HL100405, R01HL064387, R01HL084642, F30HL095343] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004152, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW ENCODE Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Nina Tan, Mark Saiget, James Fugate, Kristen Lee, Rajinder Kaul, and Stanley Kim for technical expertise. This work was supported by NIH grants P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, and UW ENCODE Center (U54HG004592). S.P. was supported through NIH F30 HL095343. H.W. was supported by R90HG004152. R.T.M. is an investigator of the HHMI.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Collas P, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12517; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Maves L, 2009, DEV BIOL, V333, P409, DOI 10.1016/j.ydbio.2009.07.004; Mazzarella L, 2011, BLOOD, V117, P83, DOI 10.1182/blood-2010-03-273128; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minehata K, 2008, BIOCHEM BIOPH RES CO, V374, P647, DOI 10.1016/j.bbrc.2008.07.075; Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zerucha T, 2001, MECH DEVELOP, V102, P247, DOI 10.1016/S0925-4773(01)00299-4	42	239	248	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					221	232		10.1016/j.cell.2012.08.027	http://dx.doi.org/10.1016/j.cell.2012.08.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981225	Green Accepted, Bronze			2022-12-01	WOS:000309544200022
J	Duncan, SR				Duncan, Steven R.			PERSPECTIVE Clues, not conclusions	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Duncan, SR (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu						Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935	5	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S15	S15		10.1038/489S15a	http://dx.doi.org/10.1038/489S15a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013710	Bronze			2022-12-01	WOS:000309167100008
J	Kaelin, CB; Xu, X; Hong, LZ; David, VA; McGowan, KA; Schmidt-Kuntzel, A; Roelke, ME; Pino, J; Pontius, J; Cooper, GM; Manuel, H; Swanson, WF; Marker, L; Harper, CK; van Dyk, A; Yue, BS; Mullikin, JC; Warren, WC; Eizirik, E; Kos, L; O'Brien, SJ; Barsh, GS; Menotti-Raymond, M				Kaelin, Christopher B.; Xu, Xiao; Hong, Lewis Z.; David, Victor A.; McGowan, Kelly A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; Pontius, Joan; Cooper, Gregory M.; Manuel, Hermogenes; Swanson, William F.; Marker, Laurie; Harper, Cindy K.; van Dyk, Ann; Yue, Bisong; Mullikin, James C.; Warren, Wesley C.; Eizirik, Eduardo; Kos, Lidia; O'Brien, Stephen J.; Barsh, Gregory S.; Menotti-Raymond, Marilyn			Specifying and Sustaining Pigmentation Patterns in Domestic and Wild Cats	SCIENCE			English	Article							COAT COLOR; SKIN COLOR; EXPRESSION; GENETICS; FAMILY; MODEL	Color markings among felid species display both a remarkable diversity and a common underlying periodicity. A similar range of patterns in domestic cats suggests a conserved mechanism whose appearance can be altered by selection. We identified the gene responsible for tabby pattern variation in domestic cats as Transmembrane aminopeptidase Q (Taqpep), which encodes a membrane-bound metalloprotease. Analyzing 31 other felid species, we identified Taqpep as the cause of the rare king cheetah phenotype, in which spots coalesce into blotches and stripes. Histologic, genomic expression, and transgenic mouse studies indicate that paracrine expression of Endothelin3 (Edn3) coordinates localized color differences. We propose a two-stage model in which Taqpep helps to establish a periodic pre-pattern during skin development that is later implemented by differential expression of Edn3.	[Kaelin, Christopher B.; Cooper, Gregory M.; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Kaelin, Christopher B.; Hong, Lewis Z.; McGowan, Kelly A.; Manuel, Hermogenes; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Xu, Xiao; David, Victor A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; O'Brien, Stephen J.; Menotti-Raymond, Marilyn] Frederick Natl Lab Canc Res, Lab Genom Divers, Frederick, MD 21702 USA; [Xu, Xiao; Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Sichuan, Peoples R China; [Schmidt-Kuentzel, Anne; Marker, Laurie] Cheetah Conservat Fund, Otjiwarongo, Namibia; [Roelke, Melody E.; Pontius, Joan] Frederick Natl Lab Canc Res, SAIC Frederick, Frederick, MD 21702 USA; [Pino, Javier; Kos, Lidia] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Swanson, William F.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH 45220 USA; [Harper, Cindy K.] Univ Pretoria, Fac Vet Sci Onderstepoort, Vet Genet Lab, ZA-0002 Pretoria, South Africa; [van Dyk, Ann] Ann van Dyk Cheetah Ctr, De Wildt, South Africa; [Mullikin, James C.] NHGRI, Comparat Genom Unit, NIH, Rockville, MD 20892 USA; [Warren, Wesley C.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil; [Eizirik, Eduardo] Inst Pro Carnivoros, Atibaia, Brazil	HudsonAlpha Institute for Biotechnology; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sichuan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; State University System of Florida; Florida International University; University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Pontificia Universidade Catolica Do Rio Grande Do Sul	O'Brien, SJ (corresponding author), St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Informat, St Petersburg, Russia.	lgdchief@gmail.com; gbarsh@hudsonalpha.org	OBRIEN, STEPHEN/ABD-1346-2020; David, Victor A/I-9330-2012; Eizirik, Eduardo/K-8034-2012	Eizirik, Eduardo/0000-0002-9658-0999; Yue, Bisong/0000-0001-6731-538X; O'Brien, Stephen J./0000-0001-7353-8301; OBRIEN, STEPHEN/0000-0001-7857-0757	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; federal funds [N01-CO-12400]; Genentech; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, ZIAHG200330] Funding Source: NIH RePORTER	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal funds; Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank San Jose Animal Care and Services, Fix Our Ferals, the Berkeley East-Bay Humane Society, Pets In Need, the Monterey Animal Hospital, and the City of Huntsville Animal Shelter for assistance with sample collection; the Wild Cat Education and Conservation Fund for contributing king cheetah samples; R. Finn for assistance with Norwegian Forest Cat samples and phenotypes; H. Flick for domestic cat photographs; and J. C. Kaelin for help with feral cat sample collection. We thank the Production Sequencing Group of the Washington University School of Medicine Genome Center for cDNA sequencing. Namibian samples were collected with the approval of the Ministry of Environment and Tourism (permit 1532). Supported in part by the HudsonAlpha Institute for Biotechnology and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, using federal funds under contract N01-CO-12400. L.Z.H. and J.P. were supported by fellowships from Genentech and the National Institutes of Health, respectively. A.vD. is the founder and director of the Ann van Dyk Cheetah Centre, a nonprofit conservation organization. DNA sequence data for this study are available at http://genome.wustl.edu/genomes/view/felis_catus/ and the NIH Short Read Archive (SRA056885).	April CS, 2006, PIGM CELL RES, V19, P194, DOI 10.1111/j.1600-0749.2006.00305.x; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik E, 2010, GENETICS, V184, P267, DOI 10.1534/genetics.109.109629; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; LOMAX TD, 1988, J HERED, V79, P21, DOI 10.1093/oxfordjournals.jhered.a110438; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Peterschmitt M, 2009, ANIM GENET, V40, P547, DOI 10.1111/j.1365-2052.2009.01864.x; Pocock R. I., 1927, P ZOOL SOC LOND, V97, P245; Searle A.G., 1968, COMP GENETICS COAT C; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Van Raamsdonk CD, 2009, PIGM CELL MELANOMA R, V22, P819, DOI 10.1111/j.1755-148X.2009.00609.x; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VANAARDE RJ, 1986, J ZOOL, V209, P573, DOI 10.1111/j.1469-7998.1986.tb03612.x; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757	21	81	95	8	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1536	1541		10.1126/science.1220893	http://dx.doi.org/10.1126/science.1220893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997338	Green Accepted, Green Submitted			2022-12-01	WOS:000308912900051
J	McCartney, M				McCartney, Margaret			Cosmetic approval	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], OFFICIAL J L, V342, P59; Aveda, FAQ; Church and Dwight, FEMFRESH DAILY INTIM; Johnson and Johnson, JOHNS BAB OIL; Unilever, PERSL NONB	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6046	10.1136/bmj.e6046	http://dx.doi.org/10.1136/bmj.e6046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BZ	22983532				2022-12-01	WOS:000308865100002
J	Spracklen, DV; Arnold, SR; Taylor, CM				Spracklen, D. V.; Arnold, S. R.; Taylor, C. M.			Observations of increased tropical rainfall preceded by air passage over forests	NATURE			English	Article							AMAZON DEFORESTATION; CLIMATE-CHANGE; LEAF-AREA; IMPACT; CLOUDS; BASIN	Vegetation affects precipitation patterns by mediating moisture, energy and trace-gas fluxes between the surface and atmosphere(1). When forests are replaced by pasture or crops, evapotranspiration of moisture from soil and vegetation is often diminished, leading to reduced atmospheric humidity and potentially suppressing precipitation(2,3). Climate models predict that large-scale tropical deforestation causes reduced regional precipitation(4-10), although the magnitude of the effect is model(9,11) and resolution(8) dependent. In contrast, observational studies have linked deforestation to increased precipitation locally(12-14) but have been unable to explore the impact of large-scale deforestation. Here we use satellite remote-sensing data of tropical precipitation and vegetation, combined with simulated atmospheric transport patterns, to assess the pan-tropical effect of forests on tropical rainfall. We find that for more than 60 per cent of the tropical land surface (latitudes 30 degrees south to 30 degrees north), air that has passed over extensive vegetation in the preceding few days produces at least twice as much rain as air that has passed over little vegetation. We demonstrate that this empirical correlation is consistent with evapotranspiration maintaining atmospheric moisture in air that passes over extensive vegetation. We combine these empirical relationships with current trends of Amazonian deforestation to estimate reductions of 12 and 21 per cent in wet-season and dry-season precipitation respectively across the Amazon basin by 2050, due to less-efficient moisture recycling. Our observation-based results complement similar estimates from climate models(4-10), in which the physical mechanisms and feedbacks at work could be explored in more detail.	[Spracklen, D. V.; Arnold, S. R.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Taylor, C. M.] Ctr Ecol & Hydrol, Oxford OX10 8BB, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH)	Spracklen, DV (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	d.v.spracklen@leeds.ac.uk	Spracklen, Dominick/AAA-6257-2019; Spracklen, Dominick V/B-4890-2014; Taylor, Chris/K-2319-2012; Arnold, Steve/B-8856-2014; Taylor, Christopher/Y-7529-2019	Taylor, Chris/0000-0002-0120-3198; Arnold, Steve/0000-0002-4881-5685	Natural Environment Research Council [NE/G015015/1]; NERC [earth010002, NE/F00060X/1, NE/G018499/1] Funding Source: UKRI; Natural Environment Research Council [earth010002, NE/B505538/1, NE/F00060X/1, ceh010023, NE/G018499/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.V.S. acknowledges a Natural Environment Research Council grant (NE/G015015/1). The GLDAS data used in this study were acquired as part of the mission of NASA's Earth Science Division and were archived and distributed by the Goddard Earth Sciences Data and Information Services Center.	Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; [Anonymous], TECH REP; Aragao LEOC, 2005, IEEE T GEOSCI REMOTE, V43, P2526, DOI 10.1109/TGRS.2005.856632; Aragao LEOC, 2005, FOREST ECOL MANAG, V211, P240, DOI 10.1016/j.foreco.2005.02.062; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946, 10.1029/2006GL028946.]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Butt N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015174; Chagnon FJF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022722; Da Silva RR, 2008, J CLIMATE, V21, P1153, DOI 10.1175/2007JCLI1304.1; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; Garcia-Carreras L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049099; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Hasler N, 2009, J CLIMATE, V22, P1124, DOI 10.1175/2008JCLI2157.1; HENDERSON-SELLERS A, 1984, CLIMATIC CHANGE, V6, P231, DOI 10.1007/BF00142475; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 1997, J APPL METEOROL, V36, P1191, DOI 10.1175/1520-0450(1997)036<1191:EORMSR>2.0.CO;2; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/NGEO1364, 10.1038/ngeo1364]; LEAN J, 1989, NATURE, V342, P411, DOI 10.1038/342411a0; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Negri AJ, 2004, J CLIMATE, V17, P1306, DOI 10.1175/1520-0442(2004)017&lt;1306:TIOADO&gt;2.0.CO;2; Nobre P, 2009, J CLIMATE, V22, P5686, DOI 10.1175/2009JCLI2757.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Smith TM, 2006, J HYDROMETEOROL, V7, P841, DOI 10.1175/JHM524.1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2000, J HYDROMETEOROL, V1, P267, DOI 10.1175/1525-7541(2000)001<0267:TIOODO>2.0.CO;2; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	32	361	367	12	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					282	U127		10.1038/nature11390	http://dx.doi.org/10.1038/nature11390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951966				2022-12-01	WOS:000308635900039
J	Vilchez, D; Boyer, L; Morantte, I; Lutz, M; Merkwirth, C; Joyce, D; Spencer, B; Page, L; Masliah, E; Berggren, WT; Gage, FH; Dillin, A				Vilchez, David; Boyer, Leah; Morantte, Ianessa; Lutz, Margaret; Merkwirth, Carsten; Joyce, Derek; Spencer, Brian; Page, Lesley; Masliah, Eliezer; Berggren, W. Travis; Gage, Fred H.; Dillin, Andrew			Increased proteasome activity in human embryonic stem cells is regulated by PSMD11	NATURE			English	Article							DIFFERENTIATION; PROTEOSTASIS; SUBUNIT; MUTANT; RPN6P; CORE	Embryonic stem cells can replicate continuously in the absence of senescence and, therefore, are immortal in culture(1,2). Although genome stability is essential for the survival of stem cells, proteome stability may have an equally important role in stem-cell identity and function. Furthermore, with the asymmetric divisions invoked by stem cells, the passage of damaged proteins to daughter cells could potentially destroy the resulting lineage of cells. Therefore, a firm understanding of how stem cells maintain their proteome is of central importance. Here we show that human embryonic stem cells (hESCs) exhibit high proteasome activity that is correlated with increased levels of the 19S proteasome subunit PSMD11 (known as RPN-6 in Caenorhabditis elegans)(3-5) and a corresponding increased assembly of the 26S/30S proteasome. Ectopic expression of PSMD11 is sufficient to increase proteasome assembly and activity. FOXO4, an insulin/insulin-like growth factor-I (IGF-I) responsive transcription factor associated with long lifespan in invertebrates(6,7), regulates proteasome activity by modulating the expression of PSMD11 in hESCs. Proteasome inhibition in hESCs affects the expression of pluripotency markers and the levels of specific markers of the distinct germ layers. Our results suggest a new regulation of proteostasis in hESCs that links longevity and stress resistance in invertebrates to hESC function and identity.	[Vilchez, David; Morantte, Ianessa; Merkwirth, Carsten; Joyce, Derek; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Lutz, Margaret; Berggren, W. Travis] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA; [Spencer, Brian; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Page, Lesley] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Vilchez, David/A-8446-2008	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Boyer, Leah/0000-0002-0546-4344	Howard Hughes Medical Institute; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG031097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W. E. Balch for critical comments on this work. We thank A. Stauffer and V. Modesto for their help with BrdU assays and cell culture, respectively. We thank S. Ruiz for advice on hESC culture and lentiviral infection. This work was supported by the Howard Hughes Medical Institute. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship. F. H. G. acknowledges the Helmsley Foundation, JPB Foundation, Mathers Foundation, Lookout Fund and California Institute for Regenerative Medicine.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Isono E, 2005, J BIOL CHEM, V280, P6537, DOI 10.1074/jbc.M409364200; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	269	276	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					304	+		10.1038/nature11468	http://dx.doi.org/10.1038/nature11468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972301	Green Accepted			2022-12-01	WOS:000308635900044
J	Previs, MJ; Previs, SB; Gulick, J; Robbins, J; Warshaw, DM				Previs, M. J.; Previs, S. Beck; Gulick, J.; Robbins, J.; Warshaw, D. M.			Molecular Mechanics of Cardiac Myosin-Binding Protein C in Native Thick Filaments	SCIENCE			English	Article							KINASE-A PHOSPHORYLATION; CMYBP-C; MUSCLE; ACTIN; ACCELERATION; ACTIVATION; MICROSCOPY; KNOCKOUT; DOMAIN	The heart's pumping capacity results from highly regulated interactions of actomyosin molecular motors. Mutations in the gene for a potential regulator of these motors, cardiac myosin-binding protein C (cMyBP-C), cause hypertrophic cardiomyopathy. However, cMyBP-C's ability to modulate cardiac contractility is not well understood. Using single-particle fluorescence imaging techniques, transgenic protein expression, proteomics, and modeling, we found that cMyBP-C slowed actomyosin motion generation in native cardiac thick filaments. This mechanical effect was localized to where cMyBP-C resides within the thick filament (i.e., the C-zones) and was modulated by phosphorylation and site-specific proteolytic degradation. These results provide molecular insight into why cMyBP-C should be considered a member of a tripartite complex with actin and myosin that allows fine tuning of cardiac muscle contraction.	[Previs, M. J.; Previs, S. Beck; Warshaw, D. M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA	University of Vermont; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@uvm.edu			NIH [HL007647, HL059408]; Vermont Genetics Network [8P20GM103449]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086728, P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vermont Genetics Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH funds supported M. P. (HL007647); J.G., J.R., and D. W. (HL059408); and the Vermont Genetics Network for the LC-MS instrumentation (8P20GM103449). We thank B. Palmer and Y. Wang for mouse colony management; S. Tremble for technical assistance; M. Jennings for LC-MS expertise; M. Von Turkovich and the University of Vermont Microscopy Imaging Center for electron microscopy assistance; and G. Kennedy, from the Instrumentation and Modeling Facility, for imaging expertise. Data described in the paper are presented in the supplementary materials.	Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MOL CELL CARDIOL, V52, P154, DOI 10.1016/j.yjmcc.2011.09.011; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	22	119	121	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1215	1218		10.1126/science.1223602	http://dx.doi.org/10.1126/science.1223602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22923435	Green Accepted			2022-12-01	WOS:000308414000035
J	Rodwin, MA; Abramson, JD				Rodwin, Marc A.; Abramson, John D.			Clinical Trial Data as a Public Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodwin, Marc A.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Rodwin, Marc A.] Suffolk Univ, Sch Law, Boston, MA 02114 USA; [Abramson, John D.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Suffolk University; Harvard University; Harvard Medical School	Rodwin, MA (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, 124 Mt Auburn St,Ste 520N, Cambridge, MA 02138 USA.	mrodwin@ethics.harvard.edu						Department of Health and Human Services, 1996, FED REGISTER, V61, P37320; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Graham DY, 2011, AM J MED SCI, V342, P356, DOI 10.1097/MAJ.0b013e3182113658; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126	9	37	37	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					871	872		10.1001/jama.2012.9661	http://dx.doi.org/10.1001/jama.2012.9661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948695				2022-12-01	WOS:000308292900015
J	Andersson, LS; Larhammar, M; Memic, F; Wootz, H; Schwochow, D; Rubin, CJ; Patra, K; Arnason, T; Wellbring, L; Hjalm, G; Imsland, F; Petersen, JL; McCue, ME; Mickelson, JR; Cothran, G; Ahituv, N; Roepstorff, L; Mikko, S; Vallstedt, A; Lindgren, G; Andersson, L; Kullander, K				Andersson, Lisa S.; Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Schwochow, Doreen; Rubin, Carl-Johan; Patra, Kalicharan; Arnason, Thorvaldur; Wellbring, Lisbeth; Hjalm, Goran; Imsland, Freyja; Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.; Cothran, Gus; Ahituv, Nadav; Roepstorff, Lars; Mikko, Sofia; Vallstedt, Anna; Lindgren, Gabriella; Andersson, Leif; Kullander, Klas			Mutations in DMRT3 affect locomotion in horses and spinal circuit function in mice	NATURE			English	Article							LAMINA-VIII INTERNEURONS; PATTERN GENERATION; CORD; NETWORKS; DIFFERENTIATION; PATHWAYS; WALKING; GENES; CAT	Locomotion in mammals relies on a central pattern-generating circuitry of spinal interneurons established during development that coordinates limb movement(1). These networks produce left-right alternation of limbs as well as coordinated activation of flexor and extensor muscles(2). Here we show that a premature stop codon in the DMRT3 gene has a major effect on the pattern of locomotion in horses. The mutation is permissive for the ability to perform alternate gaits and has a favourable effect on harness racing performance. Examination of wild-type and Dmrt3-null mice demonstrates that Dmrt3 is expressed in the dI6 subdivision of spinal cord neurons, takes part in neuronal specification within this subdivision, and is critical for the normal development of a coordinated locomotor network controlling limb movements. Our discovery positions Dmrt3 in a pivotal role for configuring the spinal circuits controlling stride in vertebrates. The DMRT3 mutation has had a major effect on the diversification of the domestic horse, as the altered gait characteristics of a number of breeds apparently require this mutation.	[Andersson, Lisa S.; Schwochow, Doreen; Wellbring, Lisbeth; Mikko, Sofia; Lindgren, Gabriella; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Patra, Kalicharan; Vallstedt, Anna; Kullander, Klas] Uppsala Univ, Dept Neurosci, SE-75124 Uppsala, Sweden; [Rubin, Carl-Johan; Hjalm, Goran; Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Arnason, Thorvaldur] Agr Univ Iceland, Fac Land & Anim Resources, IS-311 Borgarnes, Iceland; [Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77483 USA; [Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Roepstorff, Lars] Swedish Univ Agr Sci, Unit Equine Studies, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swedish University of Agricultural Sciences	Andersson, LS (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Petersen, Jessica/ABF-2462-2020; Mikko, Sofia/F-1347-2017	Mikko, Sofia/0000-0002-6375-1376; Ahituv, Nadav/0000-0002-7434-8144; Roepstorff, Lars/0000-0002-4109-9284; Kullander, Klas/0000-0001-6418-5460; McCue, Molly/0000-0002-6807-0318; Rubin, Carl-Johan/0000-0001-8238-5052; Imsland, Freyja/0000-0002-9452-5566; Lindgren, Gabriella/0000-0001-6046-9669; Petersen, Jessica/0000-0001-5438-8555; Mickelson, James/0000-0001-6951-0234	Swedish Foundation for Strategic Research; Swedish Research Council Formas [221-2009-1631]; Swedish Research Council Medicine and Health [2007-3630/4479, 2010-4394]; Swedish Society for Medical Research; National Institute of Child Health & Human Development [R01HD059862]; Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council [80576801, 70374401]; Knut and Alice Wallenberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council Medicine and Health; Swedish Society for Medical Research; National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to S. Mikulovic and E. Restrepo for valuable input, C. Birchmeier for Lbx1 antibody, L. Enquist and J. Martin for PRV152, S. Ewart for horse samples, and B. Agerup for access to race horses. The work was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council Formas (221-2009-1631), Swedish Research Council Medicine and Health (2007-3630/4479, 2010-4394), Swedish Society for Medical Research (H. W.), National Institute of Child Health & Human Development R01HD059862 (N.A.), and the Swedish Brain Foundation. Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX. K. K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Albertsdottir E, 2011, J ANIM BREED GENET, V128, P124, DOI 10.1111/j.1439-0388.2010.00902.x; Burrill JD, 1997, DEVELOPMENT, V124, P4493; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Gallarda BW, 2010, ANN NY ACAD SCI, V1198, P133, DOI 10.1111/j.1749-6632.2010.05437.x; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Jovanovic K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011743; Kullander K, 2005, TRENDS NEUROSCI, V28, P239, DOI 10.1016/j.tins.2005.03.001; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rabe N, 2009, J NEUROSCI, V29, P15642, DOI 10.1523/JNEUROSCI.5096-09.2009; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3	27	255	269	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					642	646		10.1038/nature11399	http://dx.doi.org/10.1038/nature11399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932389	Green Accepted, hybrid, Green Published			2022-12-01	WOS:000308095100053
J	Levendorf, MP; Kim, CJ; Brown, L; Huang, PY; Havener, RW; Muller, DA; Park, J				Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.; Park, Jiwoong			Graphene and boron nitride lateral heterostructures for atomically thin circuitry	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; MONOLAYER GRAPHENE; GRAIN-BOUNDARIES; HIGH-QUALITY; TRANSISTORS; GROWTH; FILMS	Precise spatial control over the electrical properties of thin films is the key capability enabling the production of modern integrated circuitry. Although recent advances in chemical vapour deposition methods have enabled the large-scale production of both intrinsic and doped graphene(1-6), as well as hexagonal boron nitride (h-BN)(7-10), controlled fabrication of lateral heterostructures in these truly atomically thin systems has not been achieved. Graphene/h-BN interfaces are of particular interest, because it is known that areas of different atomic compositions may coexist within continuous atomically thin films(5,10) and that, with proper control, the bandgap and magnetic properties can be precisely engineered(11-13). However, previously reported approaches for controlling these interfaces have fundamental limitations and cannot be easily integrated with conventional lithography(14-16). Here we report a versatile and scalable process, which we call 'patterned regrowth', that allows for the spatially controlled synthesis of lateral junctions between electrically conductive graphene and insulating h-BN, as well as between intrinsic and substitutionally doped graphene. We demonstrate that the resulting films form mechanically continuous sheets across these heterojunctions. Conductance measurements confirm laterally insulating behaviour for h-BN regions, while the electrical behaviour of both doped and undoped graphene sheets maintain excellent properties, with low sheet resistances and high carrier mobilities. Our results represent an important step towards developing atomically thin integrated circuitry and enable the fabrication of electrically isolated active and passive elements embedded in continuous, one-atom-thick sheets, which could be manipulated and stacked to form complex devices at the ultimate thickness limit.	[Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David A.; Park, Jiwoong] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University	Park, J (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jpark@cornell.edu	Park, Jiwoong/C-2327-2013; Muller, David/A-7745-2010; Kim, Cheol-Joo/A-2217-2010	Muller, David/0000-0003-4129-0473; Huang, Pinshane/0000-0002-1095-1833; Kim, Cheol-Joo/0000-0002-4312-3866	AFOSR [FA9550-09-1-0691, FA9550-10-1-0410]; NSF through the Cornell Centers for Materials Research [NSF DMR-1120296]; Alfred P. Sloan Foundation; Fullbright scholarship; NSF Graduate Research Fellowship; National Science Foundation [ECS-0335765]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the Cornell Centers for Materials Research; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Fullbright scholarship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	We thank P. McEuen and M. Spencer for discussions. This work was mainly supported by AFOSR grants (FA9550-09-1-0691 and FA9550-10-1-0410) and the NSF through the Cornell Centers for Materials Research (NSF DMR-1120296), which also provided the electron microscopy facilities. Additional funding was provided by the Alfred P. Sloan Foundation. L. B. was partially supported by a Fullbright scholarship; R. W. H. and P.Y.H. were supported by an NSF Graduate Research Fellowship. Device fabrication was performed at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (grant ECS-0335765).	Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Chen SS, 2011, ACS NANO, V5, P1321, DOI 10.1021/nn103028d; Ci L, 2010, NAT MATER, V9, P430, DOI [10.1038/nmat2711, 10.1038/NMAT2711]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Kim YJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3266836; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liang XL, 2011, ACS NANO, V5, P9144, DOI 10.1021/nn203377t; Liu YY, 2011, NANO LETT, V11, P3113, DOI 10.1021/nl2011142; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; MIYAMOTO Y, 1994, PHYS REV B, V50, P4976, DOI 10.1103/PhysRevB.50.4976; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pruneda JM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161409; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI 10.1038/NNANO.2010.279; Sanchez-Yamagishi JD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.076601; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; Wehling TO, 2008, NANO LETT, V8, P173, DOI 10.1021/nL072364w; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759	31	665	681	18	877	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					627	632		10.1038/nature11408	http://dx.doi.org/10.1038/nature11408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932386				2022-12-01	WOS:000308095100050
J	Sedrakyan, A				Sedrakyan, Art			Hip resurfacing: a complex challenge for device regulation	LANCET			English	Editorial Material							NATIONAL JOINT REGISTRY; METAL; IMPLANTS; ENGLAND; WALES; RATES		[Sedrakyan, Art] Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA; [Sedrakyan, Art] Weill Cornell Med Coll, Med Device Epidemiol Sci & Infrastruct Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Sedrakyan, A (corresponding author), Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu						Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Food and Drug Administration, PREM APPR PMA; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Makela T, 2012, BRIT MED J, V345, pe4646; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; McMinn DJW, 2011, INT ORTHOP, V35, P231, DOI 10.1007/s00264-010-1148-8; Meier B, 2012, NY TIMES; MHRA, 2012, MDA2012036 MHRA; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Smith AJ, 2012, LANCET; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430	15	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1720	1722		10.1016/S0140-6736(12)61270-7	http://dx.doi.org/10.1016/S0140-6736(12)61270-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23036898				2022-12-01	WOS:000311153700008
J	Bedell, VM; Wang, Y; Campbell, JM; Poshusta, TL; Starker, CG; Krug, RG; Tan, WF; Penheiter, SG; Ma, AC; Leung, AYH; Fahrenkrug, SC; Carlson, DF; Voytas, DF; Clark, KJ; Essner, JJ; Ekker, SC				Bedell, Victoria M.; Wang, Ying; Campbell, Jarryd M.; Poshusta, Tanya L.; Starker, Colby G.; Krug, Randall G., II; Tan, Wenfang; Penheiter, Sumedha G.; Ma, Alvin C.; Leung, Anskar Y. H.; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.; Clark, Karl J.; Essner, Jeffrey J.; Ekker, Stephen C.			In vivo genome editing using a high-efficiency TALEN system	NATURE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; DNA-BINDING SPECIFICITY; ZEBRAFISH; EFFECTORS; CELLS	The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human disease with a rich array of in vivo genetic and molecular tools. However, the inability to readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for targeted zebrafish genome editing and functional genomic applications(1-5). Using the GoldyTALEN modified scaffold and zebrafish delivery system, we show that this enhanced TALEN toolkit has a high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino-based targeted gene knockdowns(6). With this updated TALEN system, we successfully used single-stranded DNA oligonucleotides to precisely modify sequences at predefined locations in the zebrafish genome through homology-directed repair, including the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered chromosomes. This combined approach offers the potential to model genetic variation as well as to generate targeted conditional alleles.	[Bedell, Victoria M.; Campbell, Jarryd M.; Poshusta, Tanya L.; Krug, Randall G., II; Penheiter, Sumedha G.; Ma, Alvin C.; Clark, Karl J.; Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, Ying; Essner, Jeffrey J.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Dept Anim Sci, Minneapolis, MN 55455 USA; [Ma, Alvin C.; Leung, Anskar Y. H.] Univ Hong Kong, LKS Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fahrenkrug, Scott C.; Carlson, Daniel F.] Recombinetics Inc, St Paul, MN 55114 USA	Mayo Clinic; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong	Ekker, SC (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ekker.stephen@mayo.edu	Ma, Alvin/AAM-5951-2021; Leung, Andrew Yee Tak/X-4743-2019	Clark, Karl/0000-0002-9637-0967; Essner, Jeffrey/0000-0001-8816-3848; Voytas, Daniel/0000-0002-4944-1224; /0000-0002-4800-2844; Fahrenkrug, Scott/0000-0002-7176-6551; Ekker, Stephen/0000-0003-0726-4212; Starker, Colby/0000-0002-6774-7227; Bedell, Victoria/0000-0002-8959-6431	State of Minnesota [H001274506]; NIH [GM63904, P30DK084567, DK083219, DA032194, R41HL108440, GM088424]; Mayo Foundation; NSF [DBI0923827]; Research Grant Council, The University of Hong Kong [HKU771611, HKU771110, HKU769809M]; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL108440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, F30DK083219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088424, R01GM063904, R56GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032194] Funding Source: NIH RePORTER	State of Minnesota(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NSF(National Science Foundation (NSF)); Research Grant Council, The University of Hong Kong; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	State of Minnesota grant H001274506 to S. C. E. and D. F. V.; NIH GM63904 to S. C. E.; NIH grant P30DK084567 to S. C. E. and K.J.C.; NIH grant DK083219 to V. M. B.; Mayo Foundation; NIH DA032194 to K.J.C.; NIH grant R41HL108440 to D. F. C. and S. C. F.; NIH grant GM088424 to J.J.E.; NSF grant DBI0923827 to D. F. V.; General Research Fund (HKU771611, HKU771110, HKU769809M) from the Research Grant Council, The University of Hong Kong and the Tang King Yin Research Fund to A. C. M. and A.Y.H.L. We thank G. Davis for discussion on ssDNA use with custom restriction enzymes, H. J. Fadel for in vitro RNA synthesis, and S. Westcot for comments on this manuscript. We thank G. Moulder for help in DNA analyses and members of the Mayo Clinic Zebrafish Core Facility for excellent animal care.	Bedell VM, 2012, DEVELOPMENT, V139, P793, DOI 10.1242/dev.071720; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785	27	694	822	13	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					114	U133		10.1038/nature11537	http://dx.doi.org/10.1038/nature11537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000899	Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000310434500041
J	Evrony, GD; Cai, XY; Lee, E; Hills, LB; Elhosary, PC; Lehmann, HS; Parker, JJ; Atabay, KD; Gilmore, EC; Poduri, A; Park, PJ; Walsh, CA				Evrony, Gilad D.; Cai, Xuyu; Lee, Eunjung; Hills, L. Benjamin; Elhosary, Princess C.; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Gilmore, Edward C.; Poduri, Annapurna; Park, Peter J.; Walsh, Christopher A.			Single-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain	CELL			English	Article							HUMAN GENOMES; EVOLUTION; CELLS; NEUN; GENERATION; LANDSCAPE; GERMLINE; TUMOR; GENE; AKT3	A major unanswered question in neuroscience is whether there exists genomic variability between individual neurons of the brain, contributing to functional diversity or to an unexplained burden of neurological disease. To address this question, we developed a method to amplify genomes of single neurons from human brains. Because recent reports suggest frequent LINE-1 (L1) retrotransposition in human brains, we performed genome-wide L1 insertion profiling of 300 single neurons from cerebral cortex and caudate nucleus of three normal individuals, recovering >80% of germline insertions from single neurons. While we find somatic L1 insertions, we estimate <0.6 unique somatic insertions per neuron, and most neurons lack detectable somatic insertions, suggesting that L1 is not a major generator of neuronal diversity in cortex and caudate. We then genotyped single cortical cells to characterize the mosaicism of a somatic AKT3 mutation identified in a child with hemimegalencephaly. Single-neuron sequencing allows systematic assessment of genomic diversity in the human brain.	[Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Poduri, Annapurna; Walsh, Christopher A.] Harvard Univ, Dept Neurol, Sch Med, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Elhosary, Princess C.; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Park, Peter J.] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gilmore, Edward C.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Case Western Reserve University	Walsh, CA (corresponding author), Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		Evrony, Gilad/0000-0001-7621-2630; Walsh, Christopher/0000-0002-0156-2238; Parker, John James/0000-0002-6769-5922; Park, Peter/0000-0001-9378-960X	NIH MSTP grant [T32GM007753]; NIH NIGMS grant [T32GM007726]; Manton Center for Orphan Disease Research; NINDS [R01 NS079277, R01 NS035129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS079277] Funding Source: NIH RePORTER	NIH MSTP grant; NIH NIGMS grant; Manton Center for Orphan Disease Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Peter V. Kharchenko, Tim W. Yu, Vijay S. Ganesh, and Nathan C. Silberman for helpful discussions; Hal Schneider, Richard Bennett, R. Sean Hill, and Christina Kourkoulis for technical assistance; Robert Johnson from the NICHD Brain and Tissue Bank; the Orchestra research computing support team (Harvard Medical School); and the Hematologic Neoplasia Flow Cytometry Core (Dana-Farber Cancer Institute). Brain image in Figure 1A adapted with permission from http://brainmuseum.org, supported by the US National Science Foundation. G. D. E. is supported, in part, by NIH MSTP grant T32GM007753. X. C. is supported, in part, by NIH NIGMS grant T32GM007726. C. A. W. is supported by the Manton Center for Orphan Disease Research and grants from the NINDS (R01 NS079277 and R01 NS035129). C. A. W. is an Investigator of the Howard Hughes Medical Institute.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Flores-Sarnat L, 2003, J CHILD NEUROL, V18, P776, DOI 10.1177/08830738030180111101; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Matevossian A., 2008, JOVE-J VIS EXP, V20, pe914, DOI DOI 10.3791/914; MIKI Y, 1992, CANCER RES, V52, P643; Mills SE, 2007, HISTOLOGY PATHOLOGIS; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Parent A, 1996, CARPENTERS HUMAN NEU; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	42	362	369	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					483	496		10.1016/j.cell.2012.09.035	http://dx.doi.org/10.1016/j.cell.2012.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101622	Green Accepted, Bronze			2022-12-01	WOS:000310529300007
J	Mallilankaraman, K; Doonan, P; Cardenas, C; Chandramoorthy, HC; Muller, M; Miller, R; Hoffman, NE; Gandhirajan, RK; Molgo, J; Birnbaum, MJ; Rothberg, BS; Mak, DOD; Foskett, JK; Madesh, M				Mallilankaraman, Karthik; Doonan, Patrick; Cardenas, Cesar; Chandramoorthy, Harish C.; Mueller, Marioly; Miller, Russell; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Molgo, Jordi; Birnbaum, Morris J.; Rothberg, Brad S.; Mak, Don-On Daniel; Foskett, J. Kevin; Madesh, Muniswamy			MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival	CELL			English	Article							CALCIUM-UPTAKE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; TRANSPORT; ACTIVATION; MECHANISMS; APOPTOSIS; SUPEROXIDE; UNIPORTER; MEMBRANE	Mitochondrial Ca2+ (Ca-m(2+)) uptake is mediated by an inner membrane Ca2+ channel called the uniporter. Ca2+ uptake is driven by the considerable voltage present across the inner membrane (Delta psi(m)) generated by proton pumping by the respiratory chain. Mitochondrial matrix Ca2+ concentration is maintained five to six orders of magnitude lower than its equilibrium level, but the molecular mechanisms for how this is achieved are not clear. Here, we demonstrate that the mitochondrial protein MICU1 is required to preserve normal [Ca2+](m) under basal conditions. In its absence, mitochondria become constitutively loaded with Ca2+, triggering excessive reactive oxygen species generation and sensitivity to apoptotic stress. MICU1 interacts with the uniporter pore-forming subunit MCU and sets a Ca2+ threshold for Ca-m(2+) uptake without affecting the kinetic properties of MCU-mediated Ca2+ uptake. Thus, MICU1 is a gatekeeper of MCU-mediated Ca-m(2+) uptake that is essential to prevent [Ca2+](m) overload and associated stress.	[Cardenas, Cesar; Mueller, Marioly; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Miller, Russell; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Rothberg, Brad S.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Cardenas, Cesar] Univ Chile, Anat & Dev Biol Program, Inst Biomed Sci, Santiago 8380453, Chile; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol & Dev,UPR 3294, F-91198 Gif Sur Yvette, France	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu; madeshm@temple.edu	Muller, Marioly/J-5420-2014; Rothberg, Brad/AAD-1260-2022; Foskett, Kevin/R-2549-2019	Chinna Konda Chandramoorthy, Harish/0000-0002-8780-8971; Gandhirajan, Rajesh/0000-0002-0039-771X; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050; Birnbaum, Morris/0000-0001-9972-8680; Foskett, J. Kevin/0000-0002-8854-0268; Rothberg, Brad/0000-0003-1982-2269	NIH [HL086699, HL086699-01A2S1, 1S10RR027327-01]; American Heart Association; NRSA Fellowship;  [GM56328];  [MH059937]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, P01DK049210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants HL086699, HL086699-01A2S1, and 1S10RR027327-01 to M. Madesh and by GM56328 and MH059937 to J. K. F. We thank Jun Yang for biochemistry assistance and the University of Pennsylvania IDOM (P30-DK19535) for assistance. C. C. was supported by the American Heart Association. R. M. was supported by an NRSA Fellowship.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; FELICEAZZONE G, 1977, BIOCHIM BIOPHYS ACTA, V459, P96, DOI 10.1016/0005-2728(77)90012-3; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jacobson J, 2002, J CELL SCI, V115, P1175; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mallilankaraman K., 2011, J VIS EXP, V58, pe3511; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; ROTTENBERG H, 1974, BIOCHEMISTRY-US, V13, P4811, DOI 10.1021/bi00720a020; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200	54	431	442	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					630	644		10.1016/j.cell.2012.10.011	http://dx.doi.org/10.1016/j.cell.2012.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101630	Bronze, Green Accepted			2022-12-01	WOS:000310529300018
J	Ohsawa, S; Sato, Y; Enomoto, M; Nakamura, M; Betsumiya, A; Igaki, T				Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi			Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila	NATURE			English	Article							STEM-CELL PROLIFERATION; TISSUE OVERGROWTH; OXIDATIVE STRESS; PATHWAY; CANCER; REGENERATION; GROWTH; COOPERATION; INVASION; MIDGUT	Mitochondrial respiratory function is frequently impaired in human cancers(1-4). However, the mechanisms by which mitochondrial dysfunction contributes to tumour progression remain elusive. Here we show in Drosophila imaginal epithelium that defects in mitochondrial function potently induce tumour progression of surrounding tissue in conjunction with oncogenic Ras. Our data show that Ras activation and mitochondrial dysfunction cooperatively stimulate production of reactive oxygen species, which causes activation of c-Jun amino (N)-terminal kinase (JNK) signalling. JNK cooperates with oncogenic Ras to inactivate the Hippo pathway, leading to upregulation of its targets Unpaired (an interleukin-6 homologue) and Wingless (a Wnt homologue). Mitochondrial dysfunction in Ras-activated cells further cooperates with Ras signalling in neighbouring cells with normal mitochondrial function, causing benign tumours to exhibit metastatic behaviour. Our findings provide a mechanistic basis for interclonal tumour progression driven by mitochondrial dysfunction and oncogenic Ras.	[Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi] Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Igaki, Tatsushi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kobe University; Japan Science & Technology Agency (JST)	Igaki, T (corresponding author), Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	igaki@med.kobe-u.ac.jp	Sato, Yoshitaka/P-9728-2015	Sato, Yoshitaka/0000-0002-8541-6413; Igaki, Tatsushi/0000-0001-5839-9526	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Society for the Promotion of Science for Young Scientists; Japan Science and Technology Agency; G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	We thank J. Pastor-Pareja and M. Miura for comments on the manuscript; T. Sawada and K. Takino for technical support; D. Harrison, T. Orr-Weaver and H. Richardson for antibodies; T. Adachi-Yamada, U. Banerjee, D. Bohmann, F. Missirlis, M. Miura, H. Sun, T. Xu, Y. Hiromi, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the National Institute of Genetics Stock Center and the Drosophila Genetic Resource Center for fly stocks. We also thank T. Xu for encouragement. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S.O., M.E. and T.I, a Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT to S.O. and T.I., the Japan Society for the Promotion of Science for Young Scientists to S.O. and M. E., the Japan Science and Technology Agency to T.I., the G-COE program for Global Center for Education and Research in Integrative Membrane Biology to S.O. and T.I., the Fumi Yamamura Memorial Foundation for Female Natural Scientists to S.O, the Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists to S.O., the Takeda Science Foundation to S.O. and T.I., the Astellas Foundation for Research on Metabolic Disorders to T.I., the Kanae Foundation for the Promotion of Medical Science to T.I., the Senri Life Science Foundation to T.I. and a Human Frontier Science Program Career Development Award to T.I.	Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	29	139	140	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					547	+		10.1038/nature11452	http://dx.doi.org/10.1038/nature11452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023132				2022-12-01	WOS:000310196200044
J	Behrndt, M; Salbreux, G; Campinho, P; Hauschild, R; Oswald, F; Roensch, J; Grill, SW; Heisenberg, CP				Behrndt, Martin; Salbreux, Guillaume; Campinho, Pedro; Hauschild, Robert; Oswald, Felix; Roensch, Julia; Grill, Stephan W.; Heisenberg, Carl-Philipp			Forces Driving Epithelial Spreading in Zebrafish Gastrulation	SCIENCE			English	Article							MORPHOGENESIS; DROSOPHILA; MOVEMENT	Contractile actomyosin rings drive various fundamental morphogenetic processes ranging from cytokinesis to wound healing. Actomyosin rings are generally thought to function by circumferential contraction. Here, we show that the spreading of the enveloping cell layer (EVL) over the yolk cell during zebrafish gastrulation is driven by a contractile actomyosin ring. In contrast to previous suggestions, we find that this ring functions not only by circumferential contraction but also by a flow-friction mechanism. This generates a pulling force through resistance against retrograde actomyosin flow. EVL spreading proceeds normally in situations where circumferential contraction is unproductive, indicating that the flow-friction mechanism is sufficient. Thus, actomyosin rings can function in epithelial morphogenesis through a combination of cable-constriction and flow-friction mechanisms.	[Salbreux, Guillaume; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Behrndt, Martin; Oswald, Felix; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Behrndt, Martin; Campinho, Pedro; Hauschild, Robert; Roensch, Julia; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria	Max Planck Society; Max Planck Society; Institute of Science & Technology - Austria	Grill, SW (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	grill@mpi-cbg.de; heisenberg@ist.ac.at	Grill, Stephan/D-9427-2012; Ladoux, Benoit/A-9879-2013	Heisenberg, Carl-Philipp/0000-0002-0912-4566; Campinho, Pedro/0000-0002-8526-5416; Salbreux, Guillaume/0000-0001-7041-1292	Fonds zur Forderung der wissenschaftlichen Forschung (FWF); Deutsche Forschungsgemeinschaft (DFG) [I930-B20]; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. Sixt, T. Bollenbach, and E. Martin-Blanco for advice and the service facilities of the IST Austria and MPI-CBG for continuous help. M. B., G. S., S. W. G., and C.-P. H. synergistically and equally developed the presented ideas and the experimental and theoretical approaches. M. B. and P. C. performed the experiments; G. S. developed the theory; and R. H., F.O., and J.R. contributed to the experimental work. This work was supported by a grant from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) and the Deutsche Forschungsgemeinschaft (DFG) (I930-B20) to C.-P. H., S. W. G., and G.S.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Holloway BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000413; Howard J., 2001, MECH MOTOR PROTEINS; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Kane DA, 1996, DEVELOPMENT, V123, P47; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Siddiqui M, 2010, DEV DYNAM, V239, P715, DOI 10.1002/dvdy.22172	18	265	267	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					257	260		10.1126/science.1224143	http://dx.doi.org/10.1126/science.1224143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066079				2022-12-01	WOS:000309712300046
J	Chau, AH; Walter, JM; Gerardin, J; Tang, C; Lim, WA				Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Tang, Chao; Lim, Wendell A.			Designing Synthetic Regulatory Networks Capable of Self-Organizing Cell Polarization	CELL			English	Article							SEGMENT POLARITY NETWORK; PAR PROTEINS; SYMMETRY-BREAKING; PATTERN-FORMATION; BUDDING YEAST; SMALL GTPASES; BIOLOGY; ESTABLISHMENT; ORGANIZATION; RECONSTITUTION	How cells form global, self-organized structures using genetically encoded molecular rules remains elusive. Here, we take a synthetic biology approach to investigate the design principles governing cell polarization. First, using a coarse-grained computational model, we searched for all possible simple networks that can achieve polarization. All solutions contained one of three minimal motifs: positive feedback, mutual inhibition, or inhibitor with positive feedback. These minimal motifs alone could achieve polarization under limited conditions; circuits that combined two or more of these motifs were significantly more robust. With these design principles as a blueprint, we experimentally constructed artificial polarization networks in yeast, using a toolkit of chimeric signaling proteins that spatially direct the synthesis and degradation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Circuits with combinatorial motifs yielded clear foci of synthetic PIP3 that can persist for nearly an hour. Thus, by harnessing localization-regulated signaling molecules, we can engineer simple molecular circuits that reliably execute spatial self-organized programs.	[Tang, Chao; Lim, Wendell A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chau, Angela H.] Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94158 USA; [Gerardin, Jaline] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Tang, Chao] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Peking University; Peking University	Tang, C (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	tangc@pku.edu.cn; lim@cmp.ucsf.edu		Gerardin, Jaline/0000-0001-8071-9928; Tang, Chao/0000-0003-1474-3705	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA [5F32GM093475]; NSF [DMR-0804183, CMMI-0941355]; NIH [P50 GM081879, PN2 EY016546, RO1 GM062583]; National Natural Science Foundation of China [10721403]; NSF Synthetic Biology Engineering Research Center [EEC-0540879]; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, F32GM093475, P50GM081879, R01GM055040] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0804183] Funding Source: National Science Foundation	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF Synthetic Biology Engineering Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Thanks to C. Baker, H. El-Samad, A. Houk, C. Lee, W. Ma, L. Maibaum, W. Marshall, K. Mostov, D. Mullins, C. Oguz, C. Voigt, O. Weiner, and the Lim lab for valuable comments and discussion. We thank M. Molina, V. Cid, L. Chan, E. Bi, and O. Weiner for strains and plasmids. Thanks to J. Baker-LePain and the QB3 shared computing cluster for technical support of the computational work and the Shokat lab for PI3K inhibitor. This work was supported by an Achievement Rewards for College Scientists (ARCS) Foundation scholarship (A. H. C.), NIH NRSA fellowship 5F32GM093475 (J. M. W.), an NSF Graduate Research Fellowship (J. G.), NIH grant P50 GM081879 (W. A. L. and C. T.), NIH grants PN2 EY016546 and RO1 GM062583 (W. A. L.), NSF grants DMR-0804183 and CMMI-0941355 (C. T.), National Natural Science Foundation of China grant 10721403 (C. T.), and the NSF Synthetic Biology Engineering Research Center EEC-0540879 (W. A. L.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inagaki N, 2011, DEV NEUROBIOL, V71, P584, DOI 10.1002/dneu.20837; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2012, SCIENCE, V336, P175, DOI 10.1126/science.1216380; Mogilner A, 2011, TRENDS CELL BIOL, V21, P692, DOI 10.1016/j.tcb.2011.09.007; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rafelski SM, 2008, NAT REV MOL CELL BIO, V9, P593, DOI 10.1038/nrm2460; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	53	115	116	1	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					320	332		10.1016/j.cell.2012.08.040	http://dx.doi.org/10.1016/j.cell.2012.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23039994	Green Accepted, Bronze			2022-12-01	WOS:000309981000011
J	Farley, T				Farley, Thomas			Support Regulation of Sugar-Sweetened Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Farley, T (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.								0	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1464	1465						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	22998342				2022-12-01	WOS:000309652700015
J	Kourtis, N; Nikoletopoulou, V; Tavernarakis, N				Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios			Small heat-shock proteins protect from heat-stroke-associated neurodegeneration	NATURE			English	Article							NECROTIC CELL-DEATH; CAENORHABDITIS-ELEGANS; C-ELEGANS; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; LIFE-SPAN; MOLECULAR CHAPERONES; STRESS-RESPONSE; NEURONS; GENE	Heat stroke is a life-threatening condition, characterized by catastrophic collapse of thermoregulation and extreme hyperthermia. In recent years, intensification of heat waves has caused a surge of heat-stroke fatalities. The mechanisms underlying heat-related pathology are poorly understood. Here we show that heat stroke triggers pervasive necrotic cell death and neurodegeneration in Caenorhabditis elegans. Preconditioning of animals at a mildly elevated temperature strongly protects from heat-induced necrosis. The heat-shock transcription factor HSF-1 and the small heat-shock protein HSP-16.1 mediate cytoprotection by preconditioning. HSP-16.1 localizes to the Golgi, where it functions with the Ca2+- and Mn2+-transporting ATPase PMR-1 to maintain Ca2+ homeostasis under heat stroke. Preconditioning also suppresses cell death inflicted by diverse insults, and protects mammalian neurons from heat cytotoxicity. These findings reveal an evolutionarily conserved mechanism that defends against diverse necrotic stimuli, and may be relevant to heat stroke and other pathological conditions involving necrosis in humans.	[Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece		Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; Nikoletopoulou, Vassiliki/0000-0003-3646-992X	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH); National Bioresource Project in Japan; European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC); European Commission 7th Framework Programme	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission 7th Framework Programme(European Commission)	We thank K. Georgila, K. Palikaras and E. Bessa for help with cell-death assays, A. Pasparaki for technical support with experiments and C. Olendrowitz for help with electron microscopy. We thank S. Eimer for providing the Golgi and endosomal reporter constructs and for support with the electron microscopy, N. Chronis for providing the pN1-GCaMP2.0 plasmid, G. Caldwell for the alpha-synuclein-expressing C. elegans strain and K. Palikaras for the skn-1 RNAi plasmid. We thank J. Vanoevelen and F. Wuytack for the antibody against PMR-1, S. Mitrovic for the antibody against mannosidase II, G. Sourvinos for lentiviral plasmids, and S. Gascon for the pLV plasmid. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources (NCRR) of the National Institutes of Health (NIH), and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors. V. N. is supported by an European Molecular Biology Organization (EMBO) Long Term Fellowship. This work was funded by grants from the European Research Council (ERC) and the European Commission 7th Framework Programme.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2004, EMBO REP, V5, pS37, DOI 10.1038/sj.embor.7400222; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; DHOPESH VP, 1976, NEW ENGL J MED, V294, P557; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lehotsky J, 2002, GEN PHYSIOL BIOPHYS, V21, P31; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Michelangeli F, 2005, CURR OPIN CELL BIOL, V17, P135, DOI 10.1016/j.ceb.2005.01.005; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pavlikova M, 2009, CELL MOL NEUROBIOL, V29, P909, DOI 10.1007/s10571-009-9374-6; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	56	108	127	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					213	+		10.1038/nature11417	http://dx.doi.org/10.1038/nature11417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972192				2022-12-01	WOS:000309733300040
J	Zust, T; Heichinger, C; Grossniklaus, U; Harrington, R; Kliebenstein, DJ; Turnbull, LA				Zuest, Tobias; Heichinger, Christian; Grossniklaus, Ueli; Harrington, Richard; Kliebenstein, Daniel J.; Turnbull, Lindsay A.			Natural Enemies Drive Geographic Variation in Plant Defenses	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; EVOLUTIONARY DYNAMICS; GENETIC DIVERSITY; LOCAL ADAPTATION; GREEN PEACH; GLUCOSINOLATE; POPULATIONS; POLYMORPHISM; RESISTANCE; HERBIVORY	Plants defend themselves against attack by natural enemies, and these defenses vary widely across populations. However, whether communities of natural enemies are a sufficiently potent force to maintain polymorphisms in defensive traits is largely unknown. Here, we exploit the genetic resources of Arabidopsis thaliana, coupled with 39 years of field data on aphid abundance, to (i) demonstrate that geographic patterns in a polymorphic defense locus (GS-ELONG) are strongly correlated with changes in the relative abundance of two specialist aphids; and (ii) demonstrate differential selection by the two aphids on GS-ELONG, using a multigeneration selection experiment. We thereby show a causal link between variation in abundance of the two specialist aphids and the geographic pattern at GS-ELONG, which highlights the potency of natural enemies as selective forces.	[Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Harrington, Richard] Rothamsted Res, Rothamsted Insect Survey, AgroEcol Dept, Harpenden AL5 2JQ, Herts, England; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DynaMo Ctr Excellence, DK-1871 Copenhagen, Denmark	University of Zurich; University of Zurich; University of Zurich; University of Zurich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Davis; University of Copenhagen	Zust, T (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	tobias.zuest@cornell.edu	Turnbull, Lindsay A./A-2680-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Zust, Tobias/0000-0001-7142-8731; Kliebenstein, Daniel/0000-0001-5759-3175	Forschungskredit of the University of Zurich; Swiss National Science Foundation [31-107531]; U.S. NSF [DBI0820580]; European Research Council; University of Zurich; Biotechnology and Biological Sciences Research Council; Lawes Agricultural Trust; EU EXAMINE Project [EVK2-1999-00151]; BBSRC [BBS/E/C/00004957, BBS/E/C/00005191] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00005191, BBS/E/C/00004957] Funding Source: researchfish	Forschungskredit of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); University of Zurich; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; EU EXAMINE Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Forschungskredit of the University of Zurich (T.Z.) and by Swiss National Science Foundation grant 31-107531 (L.A.T.), by U.S. NSF grant DBI0820580 (D.J.K.), an Advanced Grant of the European Research Council (U.G.), and a special grant of the University of Zurich in commemoration of Prof. Christine B. Muller. The Rothamsted Insect Survey is supported by a Biotechnology and Biological Sciences Research Council National Capability Grant and the Lawes Agricultural Trust. We thank members of the EU EXAMINE Project (EVK2-1999-00151) for use of data and A. A. Agrawal, S. West, J. Levine, and two anonymous reviewers for comments that improved the manuscript. All data presented in this paper and R code of all analyses are provided in the supplementary materials.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DELOACH CJ, 1974, ANN ENTOMOL SOC AM, V67, P332, DOI 10.1093/aesa/67.3.332; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7	24	196	197	7	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					116	119		10.1126/science.1226397	http://dx.doi.org/10.1126/science.1226397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042895	Green Accepted			2022-12-01	WOS:000309457400066
J	Quint, M; Drost, HG; Gabel, A; Ullrich, KK; Bonn, M; Grosse, I				Quint, Marcel; Drost, Hajk-Georg; Gabel, Alexander; Ullrich, Kristian Karsten; Boenn, Markus; Grosse, Ivo			A transcriptomic hourglass in plant embryogenesis	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; BEGINNINGS; EVOLUTION	Animal and plant development starts with a constituting phase called embryogenesis, which evolved independently in both lineages(1). Comparative anatomy of vertebrate development-based on the Meckel-Serres law(2) and von Baer's laws of embryology(3) from the early nineteenth century-shows that embryos from various taxa appear different in early stages, converge to a similar form during mid-embryogenesis, and again diverge in later stages. This morphogenetic series is known as the embryonic 'hourglass'(4,5), and its bottleneck of high conservation in mid-embryogenesis is referred to as the phylotypic stage(6). Recent analyses in zebrafish and Drosophila embryos provided convincing molecular support for the hourglass model, because during the phylotypic stage the transcriptome was dominated by ancient genes(7) and global gene expression profiles were reported to be most conserved(8). Although extensively explored in animals, an embryonic hourglass has not been reported in plants, which represent the second major kingdom in the tree of life that evolved embryogenesis. Here we provide phylotranscriptomic evidence for a molecular embryonic hourglass in Arabidopsis thaliana, using two complementary approaches. This is particularly significant because the possible absence of an hourglass based on morphological features in plants suggests that morphological and molecular patterns might be uncoupled. Together with the reported developmental hourglass patterns in animals, these findings indicate convergent evolution of the molecular hourglass and a conserved logic of embryogenesis across kingdoms.	[Quint, Marcel; Ullrich, Kristian Karsten] Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, D-06120 Halle, Saale, Germany; [Drost, Hajk-Georg; Gabel, Alexander; Boenn, Markus; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Saale, Germany; [Boenn, Markus] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Quint, M (corresponding author), Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, Weinberg 3, D-06120 Halle, Saale, Germany.	mquint@ipb-halle.de	Ullrich, Kristian/AAP-6724-2021; Drost, Hajk-Georg/G-2632-2015; quint, marcel/J-8483-2012	Ullrich, Kristian/0000-0003-4308-9626; Drost, Hajk-Georg/0000-0002-1567-306X; Quint, Marcel/0000-0003-2935-4083	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	We are grateful to S. Abel, L. I. A. Calderon Villalobos, C. Delker, T. Greb, D. Grubb, J. J. Harada, D. Jackson, R. Paxton, A. Soro and C. Wasternack for discussions, to S. Neumann for support with the IPB-cluster, and the 'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany, for financial support of M.Q.	Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Baer v., 1828, ENTWICKLUNGSGESCHICH; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Meckel JF, 1811, BEYTRAGE VERGLEICHEN; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Oh DH, 2010, PLANT PHYSIOL, V154, P1040, DOI 10.1104/pp.110.163923; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peris CIL, 2010, CURR TOP DEV BIOL, V91, P1, DOI 10.1016/S0070-2153(10)91001-6; Raff R.A., 1996, SHAPE LIFE GENES DEV; Sander K., 1983, DEV EVOLUTION, P137; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Zuber H, 2010, PLANT PHYSIOL, V154, P913, DOI 10.1104/pp.110.162123	31	123	126	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					98	+		10.1038/nature11394	http://dx.doi.org/10.1038/nature11394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22951968				2022-12-01	WOS:000309446800040
J	Galvez, T; Gilleron, J; Zerial, M; O'Sullivan, GA				Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.			SnapShot: Mammalian Rab Proteins in Endocytic Trafficking	CELL			English	Editorial Material									[Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Galvez, T (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Gilleron, Jerome/GRX-8574-2022; O'Sullivan, Gregory A/F-8355-2011	Gilleron, Jerome/0000-0002-6389-8685; O'Sullivan, Gregory A/0000-0003-0428-041X; galvez, thierry/0000-0003-2800-3732				Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Pfeffer SR, 2011, COLD SPRING HARB PER, V3; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	4	46	47	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					234	U244	234.e2	10.1016/j.cell.2012.09.013	http://dx.doi.org/10.1016/j.cell.2012.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021225	Bronze			2022-12-01	WOS:000309544200023
J	Zhen, Y; Aardema, ML; Medina, EM; Schumer, M; Andolfatto, P				Zhen, Ying; Aardema, Matthew L.; Medina, Edgar M.; Schumer, Molly; Andolfatto, Peter			Parallel Molecular Evolution in an Herbivore Community	SCIENCE			English	Article							OUABAIN-BINDING-SITE; CARDIAC-GLYCOSIDES; MORPHOLOGICAL EVOLUTION; GASTRIC H,K-ATPASE; DANAUS-PLEXIPPUS; K+-ATPASE; EVO-DEVO; INSENSITIVITY; NA+,K+-ATPASE; NA,K-ATPASE	Numerous insects have independently evolved the ability to feed on plants that produce toxic secondary compounds called cardenolides and can sequester these compounds for use in their defense. We surveyed the protein target for cardenolides, the alpha subunit of the sodium pump, Na+, K+-ATPase (ATP alpha), in 14 species that feed on cardenolide-producing plants and 15 outgroups spanning three insect orders. Despite the large number of potential targets for modulating cardenolide sensitivity, amino acid substitutions associated with host-plant specialization are highly clustered, with many parallel substitutions. Additionally, we document four independent duplications of ATPa with convergent tissue-specific expression patterns. We find that unique substitutions are disproportionately associated with recent duplications relative to parallel substitutions. Together, these findings support the hypothesis that adaptation tends to take evolutionary paths that minimize negative pleiotropy.	[Zhen, Ying; Aardema, Matthew L.; Schumer, Molly; Andolfatto, Peter] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Zhen, Ying; Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Medina, Edgar M.] Univ Los Andes, Dept Ciencias Biol, Bogota 11001, Colombia	Princeton University; Princeton University; Universidad de los Andes (Colombia)	Andolfatto, P (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pandolfa@princeton.edu	Zhen, Ying/M-4705-2016	Schumer, Molly/0000-0002-2075-5668; Andolfatto, Peter/0000-0003-3393-4574; Medina, Edgar M./0000-0002-5518-5933	International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/COL09-01]; NSF [DEB-0946398]; NIH [R01-GM083228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083228] Funding Source: NIH RePORTER	International Centre for Genetic Engineering and Biotechnology (ICGEB); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to M. and K. Kardestuncer for collecting the hickory tussock moths; A. Briscoe for providing queen, solider, and tiger-mimic queen butterfly tissue samples; D. Stern for the suggestion of trying de novo assembly of RNA-seq data; and M. Przeworski for helpful discussions and comments on the manuscript. Funded in part by an International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant (No. CRP/COL09-01) to E. M. M. and NSF grant DEB-0946398 and NIH grant R01-GM083228 to P. A. All raw sequence data generated in this study can be downloaded at http://genomics-pubs. princeton.edu/insect_genomics/data.shtml, and assemblies of ATP alpha have been submitted to GenBank under accession nos. JQ771496 to 527.	Aardema ML, 2012, MOL ECOL, V21, P340, DOI 10.1111/j.1365-294X.2011.05379.x; Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; ALROBAI AA, 1993, COMP BIOCHEM PHYS B, V106, P805, DOI 10.1016/0305-0491(93)90034-3; CANFIELD VA, 1992, NEW BIOL, V4, P339; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; De Pont JJHHM, 2009, PFLUG ARCH EUR J PHY, V457, P623, DOI 10.1007/s00424-008-0467-8; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Kimura M., 1983, NEUTRAL THEORY MOL E; Labeyrie E, 2004, MOL BIOL EVOL, V21, P218, DOI 10.1093/molbev/msg240; Lynch M., 2007, ORIGINS GENOME ARCHI; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Moore DJ, 2009, BIOL LETTERS, V5, P513, DOI 10.1098/rsbl.2009.0281; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Stern DL, 2011, EVOLUTION DEV PREDIC; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VAUGHAN GL, 1977, J INSECT PHYSIOL, V23, P585, DOI 10.1016/0022-1910(77)90052-X; Wright S., 1968, EVOLUTION GENETICS P, V1; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	34	171	173	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1634	1637		10.1126/science.1226630	http://dx.doi.org/10.1126/science.1226630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019645	Green Accepted			2022-12-01	WOS:000309215400039
J	Carville, S; Padhi, S; Reason, T; Underwood, M				Carville, Serena; Padhi, Smita; Reason, Tim; Underwood, Martin		Guideline Dev Grp	Diagnosis and management of headaches in young people and adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Underwood, Martin] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Carville, Serena; Padhi, Smita; Reason, Tim] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Warwick; Royal College of Physicians	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Whitehouse, William P/F-9065-2017; Underwood, Martin/D-6364-2015	Whitehouse, William P/0000-0001-5207-5731; Underwood, Martin/0000-0002-0309-1708				Dias S, 2011, 2 NICE DSU; Faculty of Sexual and Reproductive Healthcare clinical guidance, 2011, DRUG INT HORM CONTR; International Headache Society, IHS CLASS ICHD 2; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; National Institute for Health and Clinical Excellence, 2012, HEAD DIAGN MAN HEAD; National Institute for Health and Clinical Excellence, 2012, BOT TOX TYP A PREV H; Weatherall MW, 2006, J ROY COLL PHYS EDIN, V36, P196	7	41	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2012	345								e5765	10.1136/bmj.e5765	http://dx.doi.org/10.1136/bmj.e5765			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JI	22993393				2022-12-01	WOS:000309160500002
J	Bar-Peled, L; Schweitzer, LD; Zoncu, R; Sabatini, DM				Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.			Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; CENTROSOME DYNAMICS; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; CELLULAR TARGET; LATE ENDOSOMES; COMPLEX	The mTOR Complex 1 (mTORC1) pathway regulates cell growth in response to numerous cues, including amino acids, which promote mTORC1 translocation to the lysosomal surface, its site of activation. The heterodimeric RagA/B-RagC/D GTPases, the Ragulator complex that tethers the Rags to the lysosome, and the v-ATPase form a signaling system that is necessary for amino acid sensing by mTORC1. Amino acids stimulate the binding of guanosine triphosphate to RagA and RagB but the factors that regulate Rag nucleotide loading are unknown. Here, we identify HBXIP and C7orf59 as two additional Ragulator components that are required for mTORC1 activation by amino acids. The expanded Ragulator has nucleotide exchange activity toward RagA and RagB and interacts with the Rag heterodimers in an amino acid-and v-ATPase-dependent fashion. Thus, we provide mechanistic insight into how mTORC1 senses amino acids by identifying Ragulator as a guanine nucleotide exchange factor (GEF) for the Rag GTPases.	[Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; LAM Foundation; NCI [F31CA167872]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE [R01CA129105, F31CA167872, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); LAM Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini Lab for helpful suggestions, John Doench for technical assistance, and Eric Spooner for mass spectrometric analyses of samples. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S., awards from the LAM Foundation to D.M.S., and fellowship support from the NCI (F31CA167872) to L.D.S. and from the LAM Foundation and the Jane Coffin Childs Memorial Fund for Medical Research to R.Z.D. M.S. is an investigator of the Howard Hughes Medical Institute.	Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bowman AB, 1999, J CELL BIOL, V146, P165; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiegen D., 2006, PROTEINS CELL REGUL, V4, P45; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirose E, 1998, J CELL SCI, V111, P11; HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; JOHN J, 1993, J BIOL CHEM, V268, P923; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt G, 1996, ONCOGENE, V12, P87; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	607	639	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1196	1208		10.1016/j.cell.2012.07.032	http://dx.doi.org/10.1016/j.cell.2012.07.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980980	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000308928100013
J	Kim, T; Sandra, ZYX; Clauder-Munster, S; Steinmetz, LM; Buratowski, S				Kim, TaeSoo; Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.; Buratowski, Stephen			Set3 HDAC Mediates Effects of Overlapping Noncoding Transcription on Gene Induction Kinetics	CELL			English	Article							HISTONE H3; SACCHAROMYCES-CEREVISIAE; METHYLATION; RNA; PHD; ACETYLATION; DEACETYLASE; EXPRESSION; CHROMATIN; LYSINE-4	The Set3 histone deacetylase complex (Set3C) binds histone H3 dimethylated at lysine 4 (H3K4me2) to mediate deacetylation of histones in 50-transcribed regions. To discern how Set3C affects gene expression, genome-wide transcription was analyzed in yeast undergoing a series of carbon source shifts. Deleting SET3 primarily caused changes during transition periods, as genes were induced or repressed. Surprisingly, a majority of Set3-affected genes are overlapped by noncoding RNA (ncRNA) transcription. Many Set3-repressed genes have H3K4me2 instead of me3 over promoter regions, due to either reduced H3K4me3 or ncRNA transcription from distal or antisense promoters. Set3C also represses internal cryptic promoters, but in different regions of genes than the Set2/Rpd3S pathway. Finally, Set3C stimulates some genes by repressing an overlapping antagonistic antisense transcript. These results show that overlapping noncoding transcription can fine-tune gene expression, not via the ncRNA but by depositing H3K4me2 to recruit the Set3C deacetylase.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Buratowski, S (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Clauder-Muenster, Sandra/0000-0002-9530-2938; Steinmetz, Lars/0000-0002-3962-2865; Kim, TaeSoo/0000-0002-3902-1058	US National Institutes of Health [GM068717, GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717, R01GM056663, R29GM046498, R01GM046498] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Angelika Amon (MIT) for sharing unpublished work, Sebastian Marquardt for the northern blot analysis protocol, and Ollie Rando (University of Massachusetts, Worcester) and all members of the Buratowski lab for helpful advice and discussions. T.K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grants GM068717 to L.M.S. and GM46498 and GM56663 to S.B. from the US National Institutes of Health.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S., 2011, COLD SPRING HARB SYM, V75, P95; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hang MD, 2011, GENETICS, V187, P1053, DOI 10.1534/genetics.110.125419; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	50	139	140	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1158	1169		10.1016/j.cell.2012.08.016	http://dx.doi.org/10.1016/j.cell.2012.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959268	Green Accepted, Bronze			2022-12-01	WOS:000308928100010
J	Ludwig, DS; Ebbeling, CB; Livingston, EH				Ludwig, David S.; Ebbeling, Cara B.; Livingston, Edward H.			Surgical vs Lifestyle Treatment for Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; RISK-FACTORS; WEIGHT		[Ludwig, David S.; Ebbeling, Cara B.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1990, METABOLISM, V39, P905, DOI 10.1016/0026-0495(90)90299-R; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	9	9	10	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					981	982		10.1001/2012.jama.10156	http://dx.doi.org/10.1001/2012.jama.10156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968885				2022-12-01	WOS:000308579300019
J	Cals, JWL; de Bont, EGPM				Cals, Jochen W. L.; de Bont, Eefje G. P. M.			10-MINUTE CONSULTATION Minor incised traumatic laceration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cals, Jochen W. L.; de Bont, Eefje G. P. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands	Maastricht University	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@maastrichtuniversity.nl	Cals, Jochen WL/A-1262-2007	Cals, Jochen WL/0000-0001-9550-5674; de Bont, Eefje/0000-0002-2700-4752					0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 23	2012	345								e6824	10.1136/bmj.e6824	http://dx.doi.org/10.1136/bmj.e6824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MT	23092899				2022-12-01	WOS:000310427100017
J	Clevers, H				Clevers, Hans			The Paneth Cell, Caloric Restriction, and Intestinal Integrity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.							CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	4	5	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1560	1561		10.1056/NEJMcibr1208353	http://dx.doi.org/10.1056/NEJMcibr1208353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075184				2022-12-01	WOS:000309904500015
J	Milstein, A; Shortell, S				Milstein, Arnold; Shortell, Stephen			Innovations in Care Delivery to Slow Growth of US Health Spending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL		[Milstein, Arnold] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Shortell, Stephen] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Milstein, A (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, 366 Galvez St,334, Stanford, CA 94305 USA.	amilstein@stanford.edu						[Anonymous], IMPR PAT FLOW THROUG; [Anonymous], HLTH AFFAIRS; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Orszag P, FOREIGN AFFAIRS; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Zuvekas SH, 2007, HEALTH AFFAIR, V26, P249, DOI 10.1377/hlthaff.26.1.249	10	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1439	1440		10.1001/jama.2012.12659	http://dx.doi.org/10.1001/jama.2012.12659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	017GY	23047357				2022-12-01	WOS:000309579300021
J	Tren, R; Nchabi, R; Attaran, A				Tren, Richard; Nchabi, Richard; Attaran, Amir			The UN is premature in trying to ban DDT for malaria control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Tren, Richard] Africa Fighting Malaria, Washington, DC USA	University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						African Leaders Malaria Alliance, 2010, 2010 REP ALMA HEADS; Attaran A, 2000, BRIT MED J, V321, P1403, DOI 10.1136/bmj.321.7273.1403; Mckay B, 2006, WALL STREET J; Office of Senator Tom Coburn US Senate, 2012, OV ACT MULT BIL MAL; PATH Malaria Vaccine Initiative, 2011, STAY COURS MAL RES D; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Southern African Development Community Secretariat, NOT SADC COUNTR RESP; Stockholm Convention on Persistent Organic Pollutants, 2010, 2 M INT STEER COMM; Stockholm Convention on Persistent Organic Pollutants, 2010, 3 EXP GROUP M DDT; Stockholm Convention on Persistent Organic Pollutants, PRINC ORG; Stockholm Convention on Persistent Organic Pollutants, 2009, CONV TEXT; Stockholm Convention on Persistent Organic Pollutants, 2011, 1 ASS GLOB ALL ALT D; Stockholm Convention on Persistent Organic Pollutants, 2007, FUT PLANS WORK DDT E; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, DDT IND RES SPRAY HU; World Health Organization, 2011, US DDT MAL VECT CONT	18	1	1	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6801	10.1136/bmj.e6801	http://dx.doi.org/10.1136/bmj.e6801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054354				2022-12-01	WOS:000309907400009
J	Gittis, A				Gittis, Aryn			Striatal Interneurons: Causes of or Cures for Movement Disorders?	SCIENCE			English	Editorial Material							BASAL GANGLIA; INHIBITION; DOPAMINE		[Gittis, Aryn] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Gittis, Aryn] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittis, A (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.		Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775	NINDS NIH HHS [R00 NS076524] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365	10	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229852	http://dx.doi.org/10.1126/science.1229852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042880				2022-12-01	WOS:000309457400049
J	Girirajan, S; Rosenfeld, JA; Coe, BP; Parikh, S; Friedman, N; Goldstein, A; Filipink, RA; McConnell, JS; Angle, B; Meschino, WS; Nezarati, MM; Asamoah, A; Jackson, KE; Gowans, GC; Martin, JA; Carmany, EP; Stockton, DW; Schnur, RE; Penney, LS; Martin, DM; Raskin, S; Leppig, K; Thiese, H; Smith, R; Aberg, E; Niyazov, DM; Escobar, LF; El-Khechen, D; Johnson, KD; Lebel, RR; Siefkas, K; Ball, S; Shur, N; McGuire, M; Brasington, CK; Spence, JE; Martin, LS; Clericuzio, C; Ballif, BC; Shaffer, LG; Eichler, EE				Girirajan, Santhosh; Rosenfeld, Jill A.; Coe, Bradley P.; Parikh, Sumit; Friedman, Neil; Goldstein, Amy; Filipink, Robyn A.; McConnell, Juliann S.; Angle, Brad; Meschino, Wendy S.; Nezarati, Marjan M.; Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.; Martin, Judith A.; Carmany, Erin P.; Stockton, David W.; Schnur, Rhonda E.; Penney, Lynette S.; Martin, Donna M.; Raskin, Salmo; Leppig, Kathleen; Thiese, Heidi; Smith, Rosemarie; Aberg, Erika; Niyazov, Dmitriy M.; Escobar, Luis F.; El-Khechen, Dima; Johnson, Kisha D.; Lebel, Robert R.; Siefkas, Kiana; Ball, Susie; Shur, Natasha; McGuire, Marianne; Brasington, Campbell K.; Spence, J. Edward; Martin, Laura S.; Clericuzio, Carol; Ballif, Blake C.; Shaffer, Lisa G.; Eichler, Evan E.			Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMITH-MAGENIS-SYNDROME; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; MENTAL-RETARDATION; MULTIPLE GENES; AUTISM; SCHIZOPHRENIA; 16P11.2; MICRODUPLICATIONS; REARRANGEMENTS	Background Some copy-number variants are associated with genomic disorders with extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents challenges in genetic diagnosis, counseling, and management. Methods We analyzed the genomes of 2312 children known to carry a copy- number variant associated with intellectual disability and congenital abnormalities, using array comparative genomic hybridization. Results Among the affected children, 10.1% carried a second large copy-number variant in addition to the primary genetic lesion. We identified seven genomic disorders, each defined by a specific copy-number variant, in which the affected children were more likely to carry multiple copy-number variants than were controls. We found that syndromic disorders could be distinguished from those with extreme phenotypic heterogeneity on the basis of the total number of copy-number variants and whether the variants are inherited or de novo. Children who carried two large copy-number variants of unknown clinical significance were eight times as likely to have developmental delay as were controls (odds ratio, 8.16; 95% confidence interval, 5.33 to 13.07; P = 2.11x10(-38)). Among affected children, inherited copy-number variants tended to co-occur with a second-site large copy-number variant (Spearman correlation coefficient, 0.66; P < 0.001). Boys were more likely than girls to have disorders of phenotypic heterogeneity (P < 0.001), and mothers were more likely than fathers to transmit second-site copy-number variants to their offspring (P = 0.02). Conclusions Multiple, large copy-number variants, including those of unknown pathogenic significance, compound to result in a severe clinical presentation, and secondary copy-number variants are preferentially transmitted from maternal carriers. (Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.)	[Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] PerkinElmer, Signature Genom Labs, Spokane, WA USA; [Martin, Judith A.] Providence Sacred Heart Hosp, Spokane, WA USA; [Leppig, Kathleen; Thiese, Heidi] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Siefkas, Kiana; Ball, Susie] Yakima Valley Mem Hosp, Yakima, WA USA; [Parikh, Sumit; Friedman, Neil] Cleveland Clin, Cleveland, OH USA; [Goldstein, Amy; Filipink, Robyn A.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Child Neurol, Med Ctr, Pittsburgh, PA 15213 USA; [McConnell, Juliann S.; McGuire, Marianne] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [McGuire, Marianne] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Angle, Brad] Rush Univ, Med Ctr, Ann & Robert H Lurie Childrens Hosp, Chicago, IL 60612 USA; [Johnson, Kisha D.] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Meschino, Wendy S.; Nezarati, Marjan M.] N York Gen Hosp, Toronto, ON, Canada; [Penney, Lynette S.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Aberg, Erika] Izaak Walton Killam Hlth Ctr, Halifax, NS, Canada; [Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Carmany, Erin P.; Stockton, David W.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; [Schnur, Rhonda E.] Rowan Univ, Cooper Med Sch, Dept Pediat, Div Genet, Camden, NJ USA; [Raskin, Salmo] Pontificia Univ Catolica Parana, Ctr Biol & Hlth Sci, Grad Program Hlth Sci, Grp Adv Mol Invest, Curitiba, Parana, Brazil; [Raskin, Salmo] Ctr Aconselhamento & Lab Genet, Curitiba, Parana, Brazil; [Niyazov, Dmitriy M.] Ochsner Clin Fdn, Dept Pediat, New Orleans, LA USA; [Escobar, Luis F.; El-Khechen, Dima] Peyton Manning Childrens Hosp St Vincent, Indianapolis, IN USA; [Lebel, Robert R.] SUNY Upstate Med Univ, Syracuse, NY USA; [Shur, Natasha] Rhode Isl Hosp, Hasbro Childrens Hosp, Providence, RI USA; [Brasington, Campbell K.; Spence, J. Edward] Carolinas Med Ctr, Levine Childrens Hosp, Dept Pediat, Charlotte, NC 28203 USA; [Martin, Laura S.] Nemours Childrens Clin, Jacksonville, FL USA; [Clericuzio, Carol] Univ New Mexico, Div Pediat Genet, Hlth Sci Ctr, Div Clin Genet Dysmorphol, Albuquerque, NM 87131 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Group Health Cooperative; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ann & Robert H. Lurie Children's Hospital of Chicago; Rush University; Rush University; University of Toronto; University Toronto Affiliates; North York General Hospital; Dalhousie University; Dalhousie University; University of Louisville; Children's Hospital of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rowan University; Cooper Medical School of Rowan University; Pontificia Universidade Catolica do Parana; Ochsner Health System; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Hasbro Children's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Carolinas Medical Center; University of New Mexico; University of New Mexico's Health Sciences Center	Eichler, EE (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Foege S-413A,Box 355065,3720 15th Ave NE, Seattle, WA 98195 USA.	eee@gs.washington.edu	Girirajan, Santhosh/AAR-3659-2020; Coe, Bradley/A-2878-2009; Raskin, Salmo/C-4155-2013	Coe, Bradley/0000-0001-8471-4016; Friedman, Neil/0000-0002-7349-7981; Martin, Donna/0000-0002-8070-2007	Simons Foundation Autism Research Initiative; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.	Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bruno DL, 2010, J MED GENET, V47, P299, DOI 10.1136/jmg.2009.069906; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Feenstra I, 2011, EUR J HUM GENET, V19, P1152, DOI 10.1038/ejhg.2011.120; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rosenfeld JA, 2011, EUR J HUM GENET, V19, P547, DOI 10.1038/ejhg.2010.237; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarasua SM, 2011, J MED GENET, V48, P761, DOI 10.1136/jmedgenet-2011-100225; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	38	391	402	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1321	1331		10.1056/NEJMoa1200395	http://dx.doi.org/10.1056/NEJMoa1200395			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	22970919	Green Accepted			2022-12-01	WOS:000309406100008
J	Rand, DG; Greene, JD; Nowak, MA				Rand, David G.; Greene, Joshua D.; Nowak, Martin A.			Spontaneous giving and calculated greed	NATURE			English	Article							EVOLUTION; COOPERATION; SYSTEMS	Cooperation is central to human social behaviour(1-9). However, choosing to cooperate requires individuals to incur a personal cost to benefit others. Here we explore the cognitive basis of cooperative decision-making in humans using a dual-process framework(10-18). We ask whether people are predisposed towards selfishness, behaving cooperatively only through active self-control; or whether they are intuitively cooperative, with reflection and prospective reasoning favouring 'rational' self-interest. To investigate this issue, we perform ten studies using economic games. We find that across a range of experimental designs, subjects who reach their decisions more quickly are more cooperative. Furthermore, forcing subjects to decide quickly increases contributions, whereas instructing them to reflect and forcing them to decide slowly decreases contributions. Finally, an induction that primes subjects to trust their intuitions increases contributions compared with an induction that promotes greater reflection. To explain these results, we propose that cooperation is intuitive because cooperative heuristics are developed in daily life where cooperation is typically advantageous. We then validate predictions generated by this proposed mechanism. Our results provide convergent evidence that intuition supports cooperation in social dilemmas, and that reflection can undermine these cooperative impulses.	[Rand, David G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.; Greene, Joshua D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Yale University; Harvard University; Harvard University	Rand, DG (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	drand@fas.harvard.edu	Nowak, Martin A/A-6977-2008; Rand, David G./B-3716-2009	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	National Science Foundation [SES-0821978]; John Templeton Foundation; Direct For Social, Behav & Economic Scie [0821978] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank H. Ahlblad, O. Amir, F. Fu, O. Hauser, J. Horton and R. Kane for assistance with carrying out the experiments, and P. Blake, S. Bowles, N. Christakis, F. Cushman, A. Dreber, T. Ellingsen, F. Fu, D. Fudenberg, O. Hauser, J. Jordan, M. Johannesson, M. Manapat, J. Paxton, A. Peysakhovich, A. Shenhav, J. Sirlin-Rand, M. van Veelen and O. Wurzbacher for discussion and comments. This work was supported in part by a National Science Foundation grant (SES-0821978 to J. D. G.). D. G. R. and M. A. N. are supported by grants from the John Templeton Foundation.	Benhabib J, 2005, GAME ECON BEHAV, V52, P460, DOI 10.1016/j.geb.2004.10.004; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, INTERPRETATION; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Pfeiffer T., 2012, J R SOC INTERFACE; Plessner H, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P1; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Richerson P.J., 2005, NOT GENES ALONE CULT; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448	30	713	735	30	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					427	430		10.1038/nature11467	http://dx.doi.org/10.1038/nature11467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996558				2022-12-01	WOS:000308860900044
J	Takahashi, S; Brunel, LC; Edwards, DT; van Tol, J; Ramian, G; Han, S; Sherwin, MS				Takahashi, S.; Brunel, L. -C.; Edwards, D. T.; van Tol, J.; Ramian, G.; Han, S.; Sherwin, M. S.			Pulsed electron paramagnetic resonance spectroscopy powered by a free-electron laser	NATURE			English	Article							SPIN-RESONANCE; DISTANCE MEASUREMENTS; GENERATION; SPECTROMETER; COMPOSITES; SWITCHES; FIELD; ESR	Electron paramagnetic resonance (EPR) spectroscopy interrogates unpaired electron spins in solids and liquids to reveal local structure and dynamics; for example, EPR has elucidated parts of the structure of protein complexes that other techniques in structural biology have not been able to reveal(1-4). EPR can also probe the interplay of light and electricity in organic solar cells(5-7) and light-emitting diodes(8), and the origin of decoherence in condensed matter, which is of fundamental importance to the development of quantum information processors(9-13). Like nuclear magnetic resonance, EPR spectroscopy becomes more powerful at high magnetic fields and frequencies, and with excitation by coherent pulses rather than continuous waves. However, the difficulty of generating sequences of powerful pulses at frequencies above 100 gigahertz has, until now, confined high-power pulsed EPR to magnetic fields of 3.5 teslas and below. Here we demonstrate that one-kilowatt pulses from a free-electron laser can power a pulsed EPR spectrometer at 240 gigahertz (8.5 teslas), providing transformative enhancements over the alternative, a state-of-the-art similar to 30-milliwatt solid-state source. Our spectrometer can rotate spin-1/2 electrons through pi/2 in only 6 nanoseconds (compared to 300 nanoseconds with the solid-state source). Fourier-transform EPR on nitrogen impurities in diamond demonstrates excitation and detection of EPR lines separated by about 200 megahertz. We measured decoherence times as short as 63 nanoseconds, in a frozen solution of nitroxide free-radicals at temperatures as high as 190 kelvin. Both free-electron lasers and the quasi-optical technology developed for the spectrometer are scalable to frequencies well in excess of one terahertz, opening the way to high-power pulsed EPR spectroscopy up to the highest static magnetic fields currently available.	[Takahashi, S.; Brunel, L. -C.; Han, S.; Sherwin, M. S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Takahashi, S.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Edwards, D. T.; Sherwin, M. S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [van Tol, J.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Han, S.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Southern California; University of California System; University of California Santa Barbara; State University System of Florida; Florida State University; University of California System; University of California Santa Barbara	Sherwin, MS (corresponding author), Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA.	sherwin@physics.ucsb.edu	Sherwin, Mark S/Q-4762-2017; Takahashi, Susumu/ABI-2675-2020; van Tol, Johan/G-4190-2011; Takahashi, Susumu/K-2616-2014; Han, Songi/E-4723-2012	Sherwin, Mark S/0000-0002-3869-1893; Takahashi, Susumu/0000-0002-1302-2845; van Tol, Johan/0000-0001-6972-2149; Takahashi, Susumu/0000-0002-1302-2845; Han, Songi/0000-0001-6489-6246; EDWARDS, DEVIN/0000-0002-2612-9561	NSF [CHE-0821589, DMR-0520481, DMR-0703925]; W. M. Keck Foundation; Division Of Chemistry [0821589] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF (CHE-0821589, DMR-0520481 and DMR-0703925) and the W. M. Keck Foundation. We thank D. Enyeart, S. El Abbadi, N. Krauss, K. Akabori, M. Anholm, T. Visher, J. Bricker and G. Kontsevich for support of the development and operation of the FEL.	Borbat PP, 1999, CHEM PHYS LETT, V313, P145, DOI 10.1016/S0009-2614(99)00972-0; Cruickshank PAS, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3239402; Doty MF, 2004, REV SCI INSTRUM, V75, P2921, DOI 10.1063/1.1783594; Dyakonov V, 1999, PHYS REV B, V59, P8019, DOI 10.1103/PhysRevB.59.8019; Earle KA, 2005, MAGN RESON CHEM, V43, pS256, DOI 10.1002/mrc.1684; Freed JH, 2000, ANNU REV PHYS CHEM, V51, P655, DOI 10.1146/annurev.physchem.51.1.655; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hegmann FA, 1996, P SOC PHOTO-OPT INS, V2842, P90; Hofbauer W, 2004, REV SCI INSTRUM, V75, P1194, DOI 10.1063/1.1710700; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Lyon SA, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052338; McCamey DR, 2008, NAT MATER, V7, P723, DOI 10.1038/nmat2252; Mitsudo S., 2010, P IRMMW THZ 2010; Nanni E. A., 2010, 2010 IEEE INT VAC EL; Ogiwara T, 2005, CHEM PHYS LETT, V411, P378, DOI 10.1016/j.cplett.2005.06.066; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; RAMIAN G, 1992, NUCL INSTRUM METH A, V318, P225, DOI 10.1016/0168-9002(92)91056-F; ROLLAND C, 1986, J OPT SOC AM B, V3, P1625, DOI 10.1364/JOSAB.3.001625; Saxena S, 1996, CHEM PHYS LETT, V251, P102, DOI 10.1016/0009-2614(96)00075-9; SMILOWITZ L, 1993, PHYS REV B, V47, P13835, DOI 10.1103/PhysRevB.47.13835; Smith GM, 1998, REV SCI INSTRUM, V69, P3924, DOI 10.1063/1.1149200; Takahashi S, 2011, NATURE, V476, P76, DOI 10.1038/nature10314; Takahashi S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801700; Takahashi S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3270041; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; van Tol J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942533; van Tol J, 2009, APPL MAGN RESON, V36, P259, DOI 10.1007/s00723-009-0014-6	29	55	56	5	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					409	413		10.1038/nature11437	http://dx.doi.org/10.1038/nature11437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996555				2022-12-01	WOS:000308860900040
J	Andersson, C; Lyngbaek, S; Nguyen, CD; Nielsen, M; Gislason, GH; Kober, L; Torp-Pedersen, C				Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Kober, Lars; Torp-Pedersen, Christian			Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTIPLATELET THERAPY; ARTERY-DISEASE; PRACTICE GUIDELINES; FOCUSED UPDATE; HEART-FAILURE; TASK-FORCE; ASPIRIN; PRASUGREL; INHIBITION	Context Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes. Objectives To estimate the clinical effectiveness associated with clopidogrel treatment after myocardial infarction (MI) in patients with diabetes. Design, Setting, and Patients By individual-level linkage of the Danish nationwide administrative registries between 2002-2009, patients who were hospitalized with incident MI and who had survived and not undergone coronary artery bypass surgery 30 days after discharge were followed up for as long as 1 year (maximally until December 31, 2009). Adjusted for age, sex, comorbidity, calendar year, concomitant pharmacotherapy, and invasive interventions, hazard ratios that were associated with clopidogrel in patients with and without diabetes were analyzed by Cox proportional-hazard models and propensity score-matched models. Main Outcome Measures All-cause mortality, cardiovascular mortality, and a composite end point of recurrent MI and all-cause mortality. Results Of the 58 851 patients included in the study, 7247 (12%) had diabetes and 35 380 (60%) received clopidogrel. In total, 1790 patients (25%) with diabetes and 7931 patients (15%) without diabetes met the composite end point. Of these, 1225 (17%) with and 5377 (10%) without diabetes died. In total, 978 patients (80%) with and 4100 patients (76%) without diabetes died of events of cardiovascular origin. For patients with diabetes who were treated with clopidogrel, the unadjusted mortality rates (events/100 person-years) were 13.4 (95% CI, 12.8-14.0) vs 29.3 (95% CI, 28.3-30.4) for those not treated. For patients without diabetes who were treated with clopidogrel, the unadjusted mortality rates were 6.4 (95% CI, 6.3-6.6) vs 21.3 (95% CI, 21.0-21.7) for those not treated. However, among patients with diabetes vs those without diabetes, clopidogrel was associated with less effectiveness for all-cause mortality (HR, 0.89 [95% CI, 0.79-1.00] vs 0.75 [95% CI, 0.70-0.80]; P for interaction, .001) and for cardiovascular mortality (HR, 0.93 [95% CI, 0.81-1.06] vs 0.77 [95% CI, 0.72-0.83]; P for interaction, .01) but not for the composite end point (HR, 1.00 [95% CI, 0.91-1.10] vs 0.91 [95% CI, 0.87-0.96]; P for interaction, .08). Propensity score-matched models gave similar results. Conclusion Among patients with diabetes compared with patients without diabetes, the use of conventional clopidogrel treatment after MI was associated with lower reduction in the risk of all-cause death and cardiovascular death. JAMA. 2012;308(9):882-889	[Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, Ctr Heart, DK-1168 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Andersson, C (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	ca@heart.dk	Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Bristol-Myers Squibb; Sanofi; internal research foundation at Department of Cardiology, Gentofte Hospital	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi(Sanofi-Aventis); internal research foundation at Department of Cardiology, Gentofte Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported that he has received honorarium as speaker for Servier. Dr Torp-Pedersen reported that he has served on advisory boards and served on study steering committees for Cardiome, Sanofi, and Merck; and has obtained research grants from Bristol-Myers Squibb, and Sanofi. Dr Andersson reported receiving a month's salary for work on the study.; The study was founded by an internal research foundation at Department of Cardiology, Gentofte Hospital.	Andersson C, 2011, DIABETES CARE, V34, P1788, DOI 10.2337/dc11-0154; Andersson C, 2010, ESSENTIAL DURER, P12; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Gaist D, 1997, DAN MED BULL, V44, P445; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V307, P2495, DOI 10.1001/jama.2012.5930; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Ferreiro JL, 2011, CIRCULATION, V123, P798, DOI 10.1161/CIRCULATIONAHA.109.913376; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Norgaard ML, 2010, DIABETOLOGIA, V53, P1612, DOI 10.1007/s00125-010-1783-z; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Sorensen R, 2011, J AM COLL CARDIOL, V57, P1202, DOI 10.1016/j.jacc.2010.09.069; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Yusuf S, 2001, NEW ENGL J MED, V345, P494	29	41	42	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					882	889		10.1001/2012.jama.10779	http://dx.doi.org/10.1001/2012.jama.10779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948698	Bronze			2022-12-01	WOS:000308292900018
J	Kaess, BM; Rong, J; Larson, MG; Hamburg, NM; Vita, JA; Levy, D; Benjamin, EJ; Vasan, RS; Mitchell, GF				Kaess, Bernhard M.; Rong, Jian; Larson, Martin G.; Hamburg, Naomi M.; Vita, Joseph A.; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Mitchell, Gary F.			Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULSE-WAVE VELOCITY; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; INDEPENDENT PREDICTOR; COMMUNITY; INCREASE; ADULTS	Context Vascular stiffness increases with advancing age and is a major risk factor for age-related morbidity and mortality. Vascular stiffness and blood pressure pulsatility are related; however, temporal relationships between vascular stiffening and blood pressure elevation have not been fully delineated. Objective To examine temporal relationships among vascular stiffness, central hemodynamics, microvascular function, and blood pressure progression. Design, Setting, and Participants Longitudinal community-based cohort study conducted in Framingham, Massachusetts. The present investigation is based on the 2 latest examination cycles (cycle 7: 1998-2001; cycle 8: 2005-2008 [last visit: January 25, 2008]) of the Framingham Offspring study (recruited: 1971-1975). Temporal relationships among blood pressure and 3 measures of vascular stiffness and pressure pulsatility derived from arterial tonometry (carotid-femoral pulse wave velocity [CFPWV], forward wave amplitude [FWA], and augmentation index) were examined over a 7-year period in 1759 participants (mean [SD] age: 60 [9] years; 974 women). Main Outcome Measures The primary outcomes were blood pressure and incident hypertension during examination cycle 8. The secondary outcomes were CFPWV, FWA, and augmentation index during examination cycle 8. Results In a multivariable-adjusted regression model, higher FWA (beta, 1.3 [95% CI, 0.5-2.1] mm Hg per 1 SD; P = .002) and higher CFPWV (beta, 1.5 [95% CI, 0.5-2.6] mm Hg per 1 SD; P = .006) during examination cycle 7 were jointly associated with systolic blood pressure during examination cycle 8. Similarly, in a model that included systolic and diastolic blood pressure and additional risk factors during examination cycle 7, higher FWA (odds ratio [OR], 1.6 [95% CI, 1.3-2.0] per 1 SD; P < .001), augmentation index (OR, 1.7 [95% CI, 1.4-2.0] per 1 SD; P < .001), and CFPWV (OR, 1.3 [95% CI, 1.0-1.6] per 1 SD; P = .04) were associated with incident hypertension during examination cycle 8 (338 cases [32%] in 1048 participants without hypertension during examination cycle 7). Conversely, blood pressure during examination cycle 7 was not associated with CFPWV during examination cycle 8. Higher resting brachial artery flow (OR, 1.23 [95% CI, 1.04-1.46]) and lower flow-mediated dilation (OR, 0.80 [95% CI, 0.67-0.96]) during examination cycle 7 were associated with incident hypertension (in models that included blood pressure and tonometry measures collected during examination cycle 7). Conclusion In this cohort, higher aortic stiffness, FWA, and augmentation index were associated with higher risk of incident hypertension; however, initial blood pressure was not independently associated with risk of progressive aortic stiffening. JAMA. 2012;308(9):875-881	[Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA 02062 USA; [Kaess, Bernhard M.; Rong, Jian; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Kaess, Bernhard M.] Univ Hosp Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Prevent Med & Epidemiol Sect, Boston, MA 02215 USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Cardiol Sect, Boston, MA 02215 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Regensburg; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 1 Edgewater Dr,Ste 201A, Norwood, MA 02062 USA.	garyfmitchell@mindspring.com	Hamburg, Naomi/AAY-6685-2020; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011; Stefanadis, Christodoulos/ABH-2232-2020	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Hamburg, Naomi/0000-0001-5504-5589; Vita, Joseph/0000-0001-5607-1797; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health, National Heart, Lung, and Blood Institute [NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385]; Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, R01HL077447, R01HL060040, R01HL076784, R01HL071039, R01HL070100, R01HL107385, R01HL080124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported through contracts NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, and HL107385 with the National Institutes of Health, National Heart, Lung, and Blood Institute, and a grant from the Donald W. Reynolds Foundation.	Aatola H, 2010, HYPERTENSION, V55, P806, DOI 10.1161/HYPERTENSIONAHA.109.145102; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2009, ARTERY RES, V3, P56, DOI 10.1016/j.artres.2009.02.002; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2005, CIRCULATION, V112, P3722, DOI 10.1161/CIRCULATIONAHA.105.551168; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Takase H, 2011, AM J HYPERTENS, V24, P667, DOI 10.1038/ajh.2011.19; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	672	692	1	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					875	881		10.1001/2012.jama.10503	http://dx.doi.org/10.1001/2012.jama.10503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948697	Green Accepted, Bronze			2022-12-01	WOS:000308292900017
J	Huang, J; Roberts, AJ; Leschziner, AE; Reck-Peterson, SL				Huang, Julie; Roberts, Anthony J.; Leschziner, Andres E.; Reck-Peterson, Samara L.			Lis1 Acts as a "Clutch" between the ATPase and Microtubule-Binding Domains of the Dynein Motor	CELL			English	Article							CYTOPLASMIC DYNEIN; HEAVY-CHAIN; ASPERGILLUS-NIDULANS; INTRACELLULAR-TRANSPORT; ORGANELLE TRANSPORT; NEURONAL MIGRATION; LISSENCEPHALY GENE; CRYSTAL-STRUCTURE; PLUS-ENDS; NDEL1	The lissencephaly protein Lis1 has been reported to regulate the mechanical behavior of cytoplasmic dynein, the primary minus-end-directed microtubule motor. However, the regulatory mechanism remains poorly understood. Here, we address this issue using purified proteins from Saccharomyces cerevisiae and a combination of techniques, including single-molecule imaging and single-particle electron microscopy. We show that rather than binding to the main ATPase site within dynein's AAA+ ring or its microtubule-binding stalk directly, Lis1 engages the interface between these elements. Lis1 causes individual dynein motors to remain attached to microtubules for extended periods, even during cycles of ATP hydrolysis that would canonically induce detachment. Thus, Lis1 operates like a "clutch" that prevents dynein's ATPase domain from transmitting a detachment signal to its track-binding domain. We discuss how these findings provide a conserved mechanism for dynein functions in living cells that require prolonged microtubule attachments.	[Huang, Julie; Roberts, Anthony J.; Reck-Peterson, Samara L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Roberts, Anthony J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Huang, Julie; Roberts, Anthony J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of Leeds; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu		Leschziner, Andres/0000-0002-7732-7023; Reck-Peterson, Samara/0000-0002-1553-465X	Reck-Peterson lab; University of Leeds [092436/Z/10/Z]; Alfred P. Sloan Foundation; Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health [1 DP2 OD004268-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	Reck-Peterson lab; University of Leeds; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andrew P. Carter, Peter J. Knight, Tom A. Rapoport, James R. Sellers, Katerina Toropova, and Xin Xiang for critical comments on the manuscript; the Nikon Imaging Center at Harvard Medical School for technical assistance; Priscilla Yang's lab for sharing equipment; Stephen Hinshaw for initial experiments and suggesting the clutch analogy; Weihong Qiu for initial experiments; Brian Goodman for kinesin; and the Reck-Peterson lab for support. A. J. R. is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092436/Z/10/Z) sponsored by Peter J. Knight and Stan A. Burgess (University of Leeds). A.E.L. is funded in part by a research fellowship from the Alfred P. Sloan Foundation. S.R.-P. is funded by the Rita Allen Foundation, the Giovanni Armenise-Harvard Foundation, and a National Institutes of Health New Innovator award (1 DP2 OD004268-01).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Ding C, 2009, J CELL SCI, V122, P2820, DOI 10.1242/jcs.048777; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Neuwald AF, 1999, GENOME RES, V9, P27; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roberts A.J., 2012, STRUCTURE IN PRESS; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Woodruff JB, 2009, MOL BIOL CELL, V20, P3003, DOI 10.1091/mbc.E09-03-0186; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	54	147	148	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					975	986		10.1016/j.cell.2012.07.022	http://dx.doi.org/10.1016/j.cell.2012.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939623	hybrid, Green Published			2022-12-01	WOS:000308500200012
J	Nam, H; Lewis, NE; Lerman, JA; Lee, DH; Chang, RL; Kim, D; Palsson, BO				Nam, Hojung; Lewis, Nathan E.; Lerman, Joshua A.; Lee, Dae-Hee; Chang, Roger L.; Kim, Donghyuk; Palsson, Bernhard O.			Network Context and Selection in the Evolution to Enzyme Specificity	SCIENCE			English	Article							ESCHERICHIA-COLI; METABOLIC NETWORK; GENE-EXPRESSION; FLUXES; YEAST; RECONSTRUCTION; PROMISCUITY; PERSPECTIVE; MODELS	Enzymes are thought to have evolved highly specific catalytic activities from promiscuous ancestral proteins. By analyzing a genome-scale model of Escherichia coli metabolism, we found that 37% of its enzymes act on a variety of substrates and catalyze 65% of the known metabolic reactions. However, it is not apparent why these generalist enzymes remain. Here, we show that there are marked differences between generalist enzymes and specialist enzymes, known to catalyze a single chemical reaction on one particular substrate in vivo. Specialist enzymes (i) are frequently essential, (ii) maintain higher metabolic flux, and (iii) require more regulation of enzyme activity to control metabolic flux in dynamic environments than do generalist enzymes. Furthermore, these properties are conserved in Archaea and Eukarya. Thus, the metabolic network context and environmental conditions influence enzyme evolution toward high specificity.	[Nam, Hojung; Lewis, Nathan E.; Lee, Dae-Hee; Kim, Donghyuk; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lerman, Joshua A.; Chang, Roger L.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Med, Boston, MA 02115 USA; [Lewis, Nathan E.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lewis, NE (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	nlewis@genetics.med.harvard.edu; palsson@ucsd.edu	Lewis, Nathan/ABE-7290-2020; Nam, Hojung/AAR-4065-2020; LEE, DAE-HEE/O-5243-2018; Kim, Donghyuk/AAS-9141-2020	Lewis, Nathan/0000-0001-7700-3654; Nam, Hojung/0000-0002-5109-9114; LEE, DAE-HEE/0000-0002-0423-9057; Chang, Roger/0000-0003-1630-6584; Lerman, Joshua/0000-0003-0377-2674; Palsson, Bernhard/0000-0003-2357-6785	NIH; NSF; U.S. Department of Energy [2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, DE-FG02-09ER25917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Zielinski for insightful discussion on this work. This work was supported by NIH, NSF, and U.S. Department of Energy grants 2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, and DE-FG02-09ER25917. Data are available at the NCBI Gene Expression Omnibus (GEO) database (GSE34631).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2011, BIOCHEMISTRY-US, V50, P2683, DOI 10.1021/bi101763c; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Nam H, 2011, CURR OPIN BIOTECH, V22, P595, DOI 10.1016/j.copbio.2011.03.006; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Wagner A, 2007, J EXP ZOOL PART B, V308B, P322, DOI 10.1002/jez.b.21152; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495	28	198	201	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1101	1104		10.1126/science.1216861	http://dx.doi.org/10.1126/science.1216861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936779	Green Accepted			2022-12-01	WOS:000308125800049
J	Vamos, EP; Harris, M; Millett, C; Pape, UJ; Khunti, K; Curcin, V; Molokhia, M; Majeed, A				Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Khunti, Kamlesh; Curcin, Vasa; Molokhia, Mariam; Majeed, Azeem			Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSIVE PATIENTS; CARDIOVASCULAR OUTCOMES; DISEASE; METAANALYSIS; MANAGEMENT; HOT	Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom General Practice Research Database, between 1990 and 2005. Participants 126 092 adult patients (age >= 18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months. Main outcome measure All cause mortality. Results Before diagnosis, 12 379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25 495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings. Conclusion Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes.	[Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Curcin, Vasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London W6 8RP, England; [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Imperial College London; University of Leicester; Imperial College London; University of London; King's College London	Harris, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	m.harris@imperial.ac.uk	/ABC-9527-2021	Curcin, Vasa/0000-0002-8308-2886; Millett, Christopher/0000-0002-0793-9884; Khunti, Kamlesh/0000-0003-2343-7099; Harris, Matthew/0000-0002-0005-9710; Majeed, Azeem/0000-0002-2357-9858	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme [277047]; Higher Education Funding Council for England; NIHR; National Institute for Health Research [CL-2010-21-014] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme(European Commission); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Department of Primary Care and Public Health at Imperial College thank the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme, NIHR Biomedical Research Centre scheme, and Imperial Centre for Patient Safety and Service Quality for their support. The Department of Health Sciences at Leicester University thank the NIHR CLAHRC scheme for their support. This study uses data from the Full Feature General Practice Research Database, obtained under license from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The interpretation and conclusions contained in this study are those of the authors alone. Access to the General Practice Research Database was funded through the Medical Research Council's licence agreement with the MHRA.; This study received funding from the European Community Seventh Framework Programme under grant agreement 277047. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the European Community Seventh Framework Programme for the submitted work; CM is funded by the Higher Education Funding Council for England and the NIHR; EV and MH are partly funded by the NIHR; no other relationships or activities that could appear to have influenced the submitted work.	American Diabetes Association, 2010, DIABETES CARE S1, V33, P692, DOI [10.2337/dc10-S011, DOI 10.2337/DC10-S011]; [Anonymous], 2007, INDEX MULTIPLE DEPRI; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021404; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Estacio RO, 2000, DIABETES CARE, V23, pB54; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hollowell J, 1997, Popul Trends, P36; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Rutter MK, 2011, EUR HEART J, V32, P2247, DOI 10.1093/eurheartj/ehr154; STAESSEN J, 1989, BMJ-BRIT MED J, V298, P1552, DOI 10.1136/bmj.298.6687.1552; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; TURNER RC, 1993, J HYPERTENS, V11, P319; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	25	70	72	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5567	10.1136/bmj.e5567	http://dx.doi.org/10.1136/bmj.e5567			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936794	Green Published, hybrid			2022-12-01	WOS:000311050800004
J	Carrieri, C; Cimatti, L; Biagioli, M; Beugnet, A; Zucchelli, S; Fedele, S; Pesce, E; Ferrer, I; Collavin, L; Santoro, C; Forrest, ARR; Carninci, P; Biffo, S; Stupka, E; Gustincich, S				Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Beugnet, Anne; Zucchelli, Silvia; Fedele, Stefania; Pesce, Elisa; Ferrer, Isidre; Collavin, Licio; Santoro, Claudio; Forrest, Alistair R. R.; Carninci, Piero; Biffo, Stefano; Stupka, Elia; Gustincich, Stefano			Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat	NATURE			English	Article							PARKINSONS-DISEASE; MAMMALIAN GENOME; GENE-EXPRESSION; LEWY BODIES; TRANSCRIPTION; SEQUENCES; DEMENTIA; UCH-L1	Most of the mammalian genome is transcribed(1-3). This generates a vast repertoire of transcripts that includes protein-coding messenger RNAs, long non-coding RNAs (lncRNAs) and repetitive sequences, such as SINEs (short interspersed nuclear elements). A large percentage of ncRNAs are nuclear-enriched with unknown function(4). Antisense lncRNAs may form sense-antisense pairs by pairing with a protein-coding gene on the opposite strand to regulate epigenetic silencing, transcription and mRNA stability(5-10). Here we identify a nuclear-enriched lncRNA antisense to mouse ubiquitin carboxyterminal hydrolase L1 (Uchl1), a gene involved in brain function and neurodegenerative diseases(11). Antisense Uchl1 increases UCHL1 protein synthesis at a post-transcriptional level, hereby identifying a new functional class of lncRNAs. Antisense Uchl1 activity depends on the presence of a 59 overlapping sequence and an embedded inverted SINEB2 element. These features are shared by other natural antisense transcripts and can confer regulatory activity to an artificial antisense to green fluorescent protein. Antisense Uchl1 function is under the control of stress signalling pathways, as mTORC1 inhibition by rapamycin causes an increase in UCHL1 protein that is associated to the shuttling of antisense Uchl1 RNA from the nucleus to the cytoplasm. Antisense Uchl1 RNA is then required for the association of the overlapping sense protein-coding mRNA to active polysomes for translation. These data reveal another layer of gene expression control at the post-transcriptional level.	[Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Zucchelli, Silvia; Fedele, Stefania; Gustincich, Stefano] Int Sch Adv Studies SISSA, Area Neurosci, I-34136 Trieste, Italy; [Biagioli, Marta; Zucchelli, Silvia; Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy; [Beugnet, Anne; Pesce, Elisa; Biffo, Stefano] Ist Sci San Raffaele, DIBIT, Lab Mol Histol & Cell Growth, I-20132 Milan, Italy; [Ferrer, Isidre] Univ Hosp Bellvitge, IDIBELL, Inst Neuropathol, Lhospitalet De Llobregat 08907, Spain; [Collavin, Licio] LNCIB, I-34149 Trieste, Italy; [Collavin, Licio] Univ Trieste, Dept Life Sci DSV, I-34129 Trieste, Italy; [Santoro, Claudio] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy; [Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Biffo, Stefano] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15121 Alessandria, Italy; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; RIKEN; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Gustincich, S (corresponding author), Int Sch Adv Studies SISSA, Area Neurosci, Via Bonomea 265, I-34136 Trieste, Italy.	gustinci@sissa.it	Carninci, Piero/K-1568-2014; Pesce, Elisa/GXH-1752-2022; Collavin, Licio/A-5312-2010	Carninci, Piero/0000-0001-7202-7243; Collavin, Licio/0000-0001-6815-5381; Pesce, Elisa/0000-0003-4214-1904; Biagioli, Marta/0000-0001-8295-8025; biffo, stefano/0000-0002-3780-1050; Carrieri, Claudia/0000-0002-9454-1021; Stupka, Elia/0000-0003-3154-4011; Zucchelli, Silvia/0000-0003-4556-2990; Forrest, Alistair/0000-0003-4543-1675; Gustincich, Stefano/0000-0002-2749-2514	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo(Compagnia di San Paolo)	We thank S. G. laboratory members for thought-provoking discussions and C. Leonesi for technical help. We thank F. Persichetti, A. Mallamaci, E. Calautti, S. Saoncella, A. Lunardi, D. De Pietri Tonelli, R. Sanges, M. E. MacDonald and T. Perlmann for support and discussions; and M. J. Zigmond and B. Joseph for sharing the MN9D cell line. This work was supported by the FP7 Dopaminet to S.G., E.S. and P.C., by The Giovanni Armenise-Harvard Foundation to S.G. and by the Compagnia di San Paolo to S.B.	Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Barrachina M, 2006, NEUROBIOL DIS, V22, P265, DOI 10.1016/j.nbd.2005.11.005; Barrachina M, 2005, NEUROCHEM INT, V46, P253, DOI 10.1016/j.neuint.2004.08.006; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Spigoni G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008658; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	32	672	704	6	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					454	+		10.1038/nature11508	http://dx.doi.org/10.1038/nature11508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064229	Green Published			2022-12-01	WOS:000311031600048
J	Colman, E; Golden, J; Roberts, M; Egan, A; Weaver, J; Rosebraugh, C				Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis			The FDA's Assessment of Two Drugs for Chronic Weight Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Colman, E (corresponding author), US FDA, Silver Spring, MD USA.							[Anonymous], 2012, M END MET DRUGS ADV; Center for Drug Evaluation and Research Food and Drug Administration US Department of Health and Human Services, 2007, GUID IND DEV PROD WE; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524	4	121	128	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1577	1579		10.1056/NEJMp1211277	http://dx.doi.org/10.1056/NEJMp1211277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23050510				2022-12-01	WOS:000310131700001
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE CHARTING THE BRAIN'S NETWORKS	NATURE			English	Editorial Material							NERVOUS-SYSTEM											Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	8	13	13	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					293	298		10.1038/490293a	http://dx.doi.org/10.1038/490293a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060196	Bronze			2022-12-01	WOS:000309733300059
J	Holmqvist, ME; Neovius, M; Eriksson, J; Mantel, A; Wallberg-Jonsson, S; Jacobsson, LTH; Askling, J				Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Wallberg-Jonsson, Solveig; Jacobsson, Lennart T. H.; Askling, Johan			Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION	Context Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous thromboembolism (VTE), particularly in conjunction with hospitalization. Using hospitalization data to identify RA and VTE may identify patients when they are at elevated risk for other reasons, obscuring the incompletely understood underlying association between RA and VTE and leading to inappropriate institution or timing of interventions. Objective To estimate risks for VTE in patients with RA, including the relation of these risks to disease duration and hospitalization. Design, Setting, and Patients Prospective, population-based cohort study of 1 prevalent RA cohort (n = 37 856), 1 incident RA cohort (n = 7904), and matched general population comparison cohorts, all from Sweden, with follow-up from 1997 through 2010. Main Outcome Measure First-time VTE. Results Patients with prevalent RA were at greater risk of VTE than the general population (rate, 5.9 [95% CI, 5.1-6.6] vs 2.8 [95% CI, 2.6-3.1] per 1000 person-years (adjusted hazard ratio [HR], 2.0 [95% CI, 1.9-2.2]; P < .001). By the time of RA symptom onset, there was no statistically significant association between a history of VTE and RA (odds ratio, 1.2 [95% CI, 1.0-1.4]; P = .08; 150 events in the RA cohort vs 587 in the comparison cohort). Counting from RA diagnosis, an increased rate in the RA cohort vs the comparison cohort (3.8 [95% CI, 2.5-5.2] vs 2.4 [95% CI, 1.9-2.9] per 1000 person-years; HR, 1.6 [95% CI, 1.1-2.5]; P = .02) was detected within the first year and did not increase further during the first decade. Although rates for VTE following hospitalization were higher, the 1-year rate of VTE per 1000 person-years was not higher in the RA cohort than in the comparison cohort after hospital discharge (11.8 [95% CI, 8.6-15.1] vs 13.1 [11.3-14.8]; HR, 1.0 [95% CI, 0.7-1.4]; P = .90). The rates of VTE increased with age but were largely similar across sex and rheumatoid factor status, as were the HRs for VTE across age, sex, and rheumatoid factor status. Conclusions Compared with the general population, Swedish patients with RA had an elevated risk for VTE that was stable over the first 10 years after diagnosis. Although hospitalization was a risk factor for VTE the first year after discharge, the excess risk was not greater in patients with RA than in the general population. JAMA. 2012;308(13):1350-1356	[Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden; [Wallberg-Jonsson, Solveig] Univ Hosp, Inst Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Jacobsson, Lennart T. H.] Malmo Univ Hosp, Rheumatol Unit, Dept Med, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University; Lund University; Skane University Hospital	Holmqvist, ME (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, T2 01, SE-17176 Stockholm, Sweden.	marie.holmqvist@ki.se		Holmqvist, Marie/0000-0001-8996-5260; Neovius, Martin/0000-0003-2300-3055	Schering-Plough; AstraZeneca; Novo Nordisk; Pfizer; Roche; Swedish Research Council; Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research	Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Neovius reported participating in advisory boards for Pfizer (rheumatology) and Abbott (nonrheumatology) (unrelated to the current work); participating in research projects fully or partly funded by Schering-Plough, AstraZeneca, Novo Nordisk, Pfizer, and Roche (unrelated to the current work); and serving as a consultant (unrelated to rheumatology since 2008) to Pfizer, sanofi-aventis, and Abbott. Dr Wallberg-Jonsson reported serving as an invited speaker at a seminar organized by Roche (unrelated to the current work); contributing to patient information days organized by the Swedish Rheumatism Association (unrelated to the current work); receiving royalties for writing book chapters meant for education in rheumatology and cardiology; and receiving funding from Roche to travel to a conference in 2012. Dr Askling reported receiving grants within a public-private research consortium partly financed by Pfizer and AstraZeneca (unrelated to the current work); serving as an invited speaker at meeting organized by Merck on an unrelated topic; and serving as a member of a safety advisory committee at AstraZeneca.; This research was funded by the Swedish Research Council, Swedish program on Chronic inflammation (Combine), and Swedish Foundation for Strategic Research.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322; Bremell T, 2009, SRF REUMA B J SWEDIS, V732, P19; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mameli A, 2009, CLIN EXP RHEUMATOL, V27, P846; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; McEntegart A, 2001, RHEUMATOLOGY, V40, P640, DOI 10.1093/rheumatology/40.6.640; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Sanjeevi CB, 2012, LANCET, V379, P200, DOI 10.1016/S0140-6736(11)61510-9; Seriolo B, 1999, RHEUMATOLOGY, V38, P675, DOI 10.1093/rheumatology/38.7.675; Swedish National Board of Health and Wellfare (Social Styrelsen), NAT PAT REG SOC STYR; WALLBERGJONSSON S, 1993, CLIN RHEUMATOL, V12, P318, DOI 10.1007/BF02231572; World Health Organization (WHO), INT CLASS DIS IDC; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	16	96	97	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1350	1356		10.1001/2012.jama.11741	http://dx.doi.org/10.1001/2012.jama.11741			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032551				2022-12-01	WOS:000309369300029
J	Dolgin, E				Dolgin, Elie			DEVICES Artificial inspiration	NATURE			English	Editorial Material							LUNG TRANSPLANTATION											Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Potkay JA, 2011, LAB CHIP, V11, P2901, DOI 10.1039/c1lc20020h	6	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S12	S14		10.1038/489S12a	http://dx.doi.org/10.1038/489S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013709	Bronze			2022-12-01	WOS:000309167100007
J	Kirwan, ML; Mudd, SM				Kirwan, Matthew L.; Mudd, Simon M.			Response of salt-marsh carbon accumulation to climate change	NATURE			English	Article							COASTAL WETLANDS; SPARTINA-ALTERNIFLORA; DECOMPOSITION; PRODUCTIVITY; FEEDBACK; DIOXIDE; DRAG	About half of annual marine carbon burial takes place in shallow water ecosystems where geomorphic and ecological stability is driven by interactions between the flow of water, vegetation growth and sediment transport(1). Although the sensitivity of terrestrial and deep marine carbon pools to climate change has been studied for decades, there is little understanding of how coastal carbon accumulation rates will change and potentially feed back on climate(2,3). Here we develop a numerical model of salt marsh evolution, informed by recent measurements of productivity and decomposition, and demonstrate that competition between mineral sediment deposition and organic-matter accumulation determines the net impact of climate change on carbon accumulation in intertidal wetlands. We find that the direct impact of warming on soil carbon accumulation rates is more subtle than the impact of warming-driven sea level rise, although the impact of warming increases with increasing rates of sea level rise. Our simulations suggest that the net impact of climate change will be to increase carbon burial rates in the first half of the twenty-first century, but that carbon-climate feedbacks are likely to diminish over time.	[Kirwan, Matthew L.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 24151 USA; [Mudd, Simon M.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mudd, Simon M.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA	University of Virginia; University of Edinburgh; University of California System; University of California Santa Barbara	Kirwan, ML (corresponding author), Univ Virginia, Dept Environm Sci, POB 400123, Charlottesville, VA 24151 USA.	mlk4n@virginia.edu	Mudd, Simon M/F-8521-2010	Mudd, Simon M/0000-0002-1357-8501	USGS Global Change Research Program	USGS Global Change Research Program(United States Geological Survey)	We appreciate reviews by S. Bridgham and L. Larsen. This work was supported by the USGS Global Change Research Program.	BAES CF, 1977, AM SCI, V65, P310; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001823; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Charles H, 2009, ECOL APPL, V19, P1758, DOI 10.1890/08-0172.1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Chmura GL, 2013, OCEAN COAST MANAGE, V83, P25, DOI 10.1016/j.ocecoaman.2011.09.006; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Elsey-Quirk T, 2011, WETLANDS, V31, P87, DOI 10.1007/s13157-010-0139-2; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Idaszkin YL, 2011, PLANT ECOL, V212, P553, DOI 10.1007/s11258-010-9844-4; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Powlson D. S., 1996, EVALUATION SOIL ORGA; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Shugart H.H., 2011, GLOBAL CHANGE TERRES; Tanino Y, 2008, J HYDRAUL ENG-ASCE, V134, P34, DOI 10.1061/(ASCE)0733-9429(2008)134:1(34); Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wolf AA, 2007, GLOBAL CHANGE BIOL, V13, P2036, DOI 10.1111/j.1365-2486.2007.01407.x	32	195	207	22	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					550	+		10.1038/nature11440	http://dx.doi.org/10.1038/nature11440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018965				2022-12-01	WOS:000309167100047
J	Ringe, D; Petsko, GA				Ringe, Dagmar; Petsko, Gregory A.			Behind the Movement	CELL			English	Editorial Material							SQUID GIANT-AXON; MOTOR DOMAIN; CRYSTAL-STRUCTURE; MYOSIN; FILAMENTS; ACTIN; MICROTUBULES; ORGANELLES; MECHANISM; AXOPLASM		[Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Brandeis University; Brandeis University; Brandeis University; Cornell University	Ringe, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	ringe@brandeis.edu; petsko@brandeis.edu						Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Huxley HE, 2004, PHILOS T ROY SOC B, V359, P1879, DOI 10.1098/rstb.2004.1556; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; SPUDICH JA, 1985, NATURE, V315, P584, DOI 10.1038/315584a0; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; VALE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6775, DOI 10.1073/pnas.81.21.6775	16	1	1	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1093	1095		10.1016/j.cell.2012.08.031	http://dx.doi.org/10.1016/j.cell.2012.08.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980970	Bronze			2022-12-01	WOS:000308928100001
J	Bakker, K				Bakker, Karen			Water Security: Research Challenges and Opportunities	SCIENCE			English	Editorial Material							RESOURCES MANAGEMENT		[Bakker, Karen] Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada; [Bakker, Karen] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada	University of British Columbia; University of British Columbia	Bakker, K (corresponding author), Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada.	karen.bakker@ubc.ca	Quinn, Patrick/B-5489-2010					Alcamo Joseph M., 2008, Environmental Research Letters, V3, P010202, DOI 10.1088/1748-9326/3/1/010202; Allan JA, 2003, WATER INT, V28, P106, DOI 10.1080/02508060.2003.9724812; Bogardi JJ, 2012, CURR OPIN ENV SUST, V4, P35, DOI 10.1016/j.cosust.2011.12.002; Braden JB, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008216; Briscoe J., 2009, Innovations: Technology / Governance / Globalisation, V4, P3, DOI 10.1162/itgg.2009.4.3.3; Cook C, 2012, GLOBAL ENVIRON CHANG, V22, P94, DOI 10.1016/j.gloenvcha.2011.10.011; Dominic W, 2011, CHOICE REV ONLINE; Falkenmark M., 2004, EARTHSCAN; Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804; Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021; GWP (Global Water Partnership), 2000, WAT SEC FRAM ACT; Hering JG, 2012, SCIENCE, V336, P1234, DOI 10.1126/science.1218230; Hope R., 2012, SYNTHESIS REPORT SUB; Mehta L., 2012, Water Alternatives, V5, P193; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Nuzzo JB, 2006, BIOSECUR BIOTERROR, V4, P147, DOI 10.1089/bsp.2006.4.147; Office of the Director of National Intelligence, 2012, GLOB WAT SEC; Pahl-Wostl C, 2008, ECOL SOC, V13; Palmer MA, 2010, NATURE, V467, P534, DOI 10.1038/467534a; Priscoli J.D., 2009, MANAGING TRANSFORMIN; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sivapalan M, 2012, HYDROL PROCESS, V26, P1270, DOI 10.1002/hyp.8426; Sophocleous M, 2002, HYDROGEOL J, V10, P52, DOI 10.1007/s10040-001-0170-8; Swyngedouw E, 2009, J CONTEMP WAT RES ED, V142, P56, DOI 10.1111/j.1936-704X.2009.00054.x; United Nations Environment Program, 2009, WAT SEC EC SERV CRIT; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty C., 2004, EOS, V85, P509, DOI DOI 10.1029/2004EO480001; Warner J, 2008, WATER POLICY, V10, P121, DOI 10.2166/wp.2008.210; WHO, 2005, EC HUM WELL BEING HL; World Water Assessment Programme (WWAP), 2003, WAT PEOPL WAT LIF UN; Zeitoun M, 2011, GLOB POLICY, V2, P286, DOI 10.1111/j.1758-5899.2011.00097.x; [No title captured]; [No title captured]; [No title captured]	35	300	312	27	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					914	915		10.1126/science.1226337	http://dx.doi.org/10.1126/science.1226337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992VI	22923564				2022-12-01	WOS:000307807600027
J	Frost, PJ; Wise, MP				Frost, Paul J.; Wise, Matt P.			Early management of acutely ill ward patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EARLY WARNING SCORE; CARE		[Frost, Paul J.] Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Frost, Paul J.; Wise, Matt P.] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, S Glam, Wales	Cardiff University; Cardiff University	Frost, PJ (corresponding author), Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	frostp2@cf.ac.uk		Wise, Matt/0000-0002-2763-4316				Cecconi M, 2011, CURR OPIN CRIT CARE, V17, P290, DOI 10.1097/MCC.0b013e32834699cd; Gordon CF, 2011, SCOT MED J, V56, P15, DOI 10.1258/smj.2010.010009; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; *NAT CONF ENQ PAT, 2005, AC PROBL; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP; NHS Institute for Innovation and Improvement, SBAR SIT BACKGR ASS; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Royal College of Physicians, NAT EARL WARN SCOR N; Royal College of Physicians, 2011, AC CAR TOOLK 2 HIGH; Smith CM, 2007, INTENS CARE MED, V33, P901, DOI 10.1007/s00134-007-0564-8; Smith T, 2012, BRIT J SURG, V99, P192, DOI 10.1002/bjs.7777; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; The General Medical Council, 2010, TREATM CAR END LIF; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27	15	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2012	345								e5677	10.1136/bmj.e5677	http://dx.doi.org/10.1136/bmj.e5677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923534				2022-12-01	WOS:000308074500005
J	de Ligt, J; Willemsen, MH; van Bon, BWM; Kleefstra, T; Yntema, HG; Kroes, T; Vulto-van Silfhout, AT; Koolen, DA; de Vries, P; Gilissen, C; del Rosario, M; Hoischen, A; Scheffer, H; de Vries, BBA; Brunner, HG; Veltman, JA; Vissers, LELM				de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.			Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DE-NOVO MUTATIONS; MENTAL-RETARDATION; GENETICS	Background The causes of intellectual disability remain largely unknown because of extensive clinical and genetic heterogeneity. Methods We evaluated patients with intellectual disability to exclude known causes of the disorder. We then sequenced the coding regions of more than 21,000 genes obtained from 100 patients with an IQ below 50 and their unaffected parents. A data-analysis procedure was developed to identify and classify de novo, autosomal recessive, and X-linked mutations. In addition, we used high-throughput resequencing to confirm new candidate genes in 765 persons with intellectual disability (a confirmation series). All mutations were evaluated by molecular geneticists and clinicians in the context of the patients' clinical presentation. Results We identified 79 de novo mutations in 53 of 100 patients. A total of 10 de novo mutations and 3 X-linked (maternally inherited) mutations that had been previously predicted to compromise the function of known intellectual-disability genes were found in 13 patients. Potentially causative de novo mutations in novel candidate genes were detected in 22 patients. Additional de novo mutations in 3 of these candidate genes were identified in patients with similar phenotypes in the confirmation series, providing support for mutations in these genes as the cause of intellectual disability. We detected no causative autosomal recessive inherited mutations in the discovery series. Thus, the total diagnostic yield was 16%, mostly involving de novo mutations. Conclusions De novo mutations represent an important cause of intellectual disability; exome sequencing was used as an effective diagnostic strategy for their detection. (Funded by the European Union and others.)	[de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@gen.umcn.nl	Hoischen, Alexander/D-1282-2013; Koolen, D.A./L-4448-2015; AT, Vulto-van Silfhout/H-4199-2015; van Bon, Bregje/Q-2445-2015; Kleefstra, Tjitske/G-2619-2012; Willemsen, Marjolein/R-5958-2019; Yntema, H.G./L-4771-2015; Scheffer, Hans/E-4644-2012; Veltman, Joris A/F-5128-2010; Willemsen, Marjolein/G-9491-2013; Gilissen, Christian/E-5246-2012; van Bon, Bregje/D-3720-2013; Vissers, Lisenka ELM/A-2598-2015; Brunner, Han/C-9928-2013; Hoischen, Alexander/AGF-7293-2022	Hoischen, Alexander/0000-0002-8072-4476; van Bon, Bregje/0000-0003-2234-0105; Scheffer, Hans/0000-0002-2986-0915; Veltman, Joris A/0000-0002-3218-8250; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; de Ligt, Joep/0000-0002-0348-419X; Kroes, Thessa/0000-0003-1416-5407	European Union; consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development [ZonMW 907-00-365, 917-86-319, 916-12-095, 917-66-363, 916-86-016]; European Union-funded TECHGENE project [Health-F5-2009-223143]; GEUVADIS project [Health-F7-2010-261123]; European Research Council [DENOVO 281964];  [EU-7th-2010-241995]	European Union(European Commission); consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union-funded TECHGENE project; GEUVADIS project; European Research Council(European Research Council (ERC)European Commission); 	Funded by the European Union and others.; Supported by grants from the consortium Stronger on Your Own Feet (to Drs. Willemsen and Kleefstra), the Netherlands Organization for Health Research and Development (ZonMW 907-00-365, to Dr. Kleefstra; 917-86-319, to Ms. de Vries; 916-12-095, to Dr. Hoischen; 917-66-363, to Dr. Veltman; and 916-86-016, to Dr. Vissers), the GENCODYS project (EU-7th-2010-241995, to Drs. Vulto-van Silfout and Kleefstra), the European Union-funded TECHGENE project (Health-F5-2009-223143, to Mr. de Ligt and Drs. Brunner, Scheffer, and Veltman), the GEUVADIS project (Health-F7-2010-261123, to Dr. Veltman), and the European Research Council (DENOVO 281964, to Dr. Veltman).	Battaglia A, 2003, AM J MED GENET C, V117C, P3, DOI 10.1002/ajmg.c.10015; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Catarino CB, 2011, BRAIN, V134, P2982, DOI 10.1093/brain/awr129; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Hamdan FF, 2011, AM J HUM GENET, V88, P516, DOI 10.1016/j.ajhg.2011.03.011; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MATSUNAGA E, 1981, AM J MED GENET, V8, P375, DOI 10.1002/ajmg.1320080403; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moeschler JB, 2006, PEDIATRICS, V117, P2304, DOI 10.1542/peds.2006-1006; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Romano C, 2010, MONOGR HUM GENET, V18, P57; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shea Sarah E, 2006, Semin Pediatr Neurol, V13, P262, DOI 10.1016/j.spen.2006.09.010; Topper S, 2011, CLIN GENET, V80, P117, DOI 10.1111/j.1399-0004.2011.01720.x; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542	30	1067	1144	4	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1921	1929		10.1056/NEJMoa1206524	http://dx.doi.org/10.1056/NEJMoa1206524			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23033978	Bronze			2022-12-01	WOS:000311029300008
J	McFarland, E				McFarland, Eric			Unconventional Chemistry for Unconventional Natural Gas	SCIENCE			English	Editorial Material							CATALYSTS; METHANE; CHLOROMETHANE; OXIDATION		Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA	University of California System; University of California Santa Barbara	McFarland, E (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA.	ewmcfar@engineering.ucsb.edu	McFarland, Eric/G-1763-2014					Chesnokov VV, 2003, J CATAL, V218, P438, DOI 10.1016/S0021-9517(03)00085-X; Ding KL, 2012, ACS CATAL, V2, P479, DOI 10.1021/cs2006058; I.A.U. Energy, 2012, ANN ENERGY OUTLOOK 2; Lange JP, 1996, CHEM ENG SCI, V51, P2379, DOI 10.1016/0009-2509(96)00094-2; LERSCH P, 1991, APPL CATAL, V75, P133, DOI 10.1016/S0166-9834(00)83129-2; Lorkovic IM, 2004, CATAL TODAY, V98, P317, DOI 10.1016/j.cattod.2004.07.058; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Podkolzin SG, 2007, J AM CHEM SOC, V129, P2569, DOI 10.1021/ja066913w; Sousa-Aguiar EF, 2011, CATAL SCI TECHNOL, V1, P698, DOI 10.1039/c1cy00116g; Statistical B. P., 2012, REV WORLD EN 2012; Tullo AH, 2008, CHEM ENG NEWS, V86, P15, DOI 10.1021/cen-v086n011.p015; Ueda W, 2000, APPL CATAL A-GEN, V200, P135, DOI 10.1016/S0926-860X(00)00627-X; WHITE CM, 1992, ENERG FUEL, V6, P76, DOI 10.1021/ef00031a012; Zhang AH, 2011, PHYS CHEM CHEM PHYS, V13, P2550, DOI 10.1039/c0cp01985b	14	307	311	11	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					340	342		10.1126/science.1226840	http://dx.doi.org/10.1126/science.1226840			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087239				2022-12-01	WOS:000309955800030
J	Talbert, J; Blumenschein, K; Burke, A; Stromberg, A; Freeman, P				Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia			Pseudoephedrine Sales and Seizures of Clandestine Methamphetamine Laboratories in Kentucky	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia] Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA	University of Kentucky	Talbert, J (corresponding author), Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA.	jtalb1@uky.edu	Talbert, Jeffery C/F-3929-2011; Freeman, Patricia/W-2473-2019; Freeman, Patricia R./L-3752-2019	Talbert, Jeffery C/0000-0002-4304-5167; Freeman, Patricia/0000-0002-4749-6563	NCATS NIH HHS [UL1 TR000117, UL1TR000117, UL1 TR001998] Funding Source: Medline; NCRR NIH HHS [UL1RR033173, UL1 RR033173] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Kentucky State Police, 2010, METH MAN KENT; McKetin R, 2011, ADDICTION, V106, P1911, DOI 10.1111/j.1360-0443.2011.03582.x; Nonnemaker J, 2011, HEALTH ECON, V20, P519, DOI 10.1002/hec.1610; Prah PM, 2005, CQ RES, P589; US Department of Justice National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS	5	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1524	1526		10.1001/jama.2012.12992	http://dx.doi.org/10.1001/jama.2012.12992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073945	Bronze, Green Accepted			2022-12-01	WOS:000309858100014
J	Dandekar, AA; Chugani, S; Greenberg, EP				Dandekar, Ajai A.; Chugani, Sudha; Greenberg, E. Peter			Bacterial Quorum Sensing and Metabolic Incentives to Cooperate	SCIENCE			English	Article							LUXR-LUXI FAMILY; PSEUDOMONAS-AERUGINOSA; POPULATIONS; CONFLICT; REGULATORS; MECHANISM	The opportunistic pathogen Pseudomonas aeruginosa uses a cell-cell communication system termed "quorum sensing" to control production of public goods, extracellular products that can be used by any community member. Not all individuals respond to quorum-sensing signals and synthesize public goods. Such social cheaters enjoy the benefits of the products secreted by cooperators. There are some P. aeruginosa cellular enzymes controlled by quorum sensing, and we show that quorum sensing-controlled expression of such private goods can put a metabolic constraint on social cheating and prevent a tragedy of the commons. Metabolic constraint of social cheating provides an explanation for private-goods regulation by a cooperative system and has general implications for population biology, infection control, and stabilization of quorum-sensing circuits in synthetic biology.	[Chugani, Sudha; Greenberg, E. Peter] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Dandekar, Ajai A.] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Greenberg, EP (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	epgreen@u.washington.edu		Greenberg, Everett/0000-0001-9474-8041; Dandekar, Ajai/0000-0002-2992-6523	U.S. Public Health Service [GM-59026, P30 DK 89507]; Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059026] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service grants GM-59026 and P30 DK 89507 to E. P. G. A. A. D. is supported by a Cystic Fibrosis Foundation Leroy Matthews Fellowship. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/DRYAD.122SV.	BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Kurachi M., 1958, B I CHEM RES, V36, P163; Kuzdzal-Fick JJ, 2011, SCIENCE, V334, P1548, DOI 10.1126/science.1213272; Mellbye B, 2011, MBIO, V2, DOI 10.1128/mBio.00131-11; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x	19	208	220	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					264	266		10.1126/science.1227289	http://dx.doi.org/10.1126/science.1227289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066081	Green Accepted			2022-12-01	WOS:000309712300048
J	Fedorenko, A; Lishko, PV; Kirichok, Y				Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy			Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria	CELL			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; PHYSIOLOGICAL REGULATION; TRANSPORT ACTIVITY; INNER MEMBRANE; PROTEIN; SEQUENCE; BINDING; PHOSPHOLIPIDS; NUCLEOTIDE; VALUES	Mitochondrial uncoupling protein 1 (UCP1) is responsible for nonshivering thermogenesis in brown adipose tissue (BAT). Upon activation by long-chain fatty acids (LCFAs), UCP1 increases the conductance of the inner mitochondrial membrane (IMM) to make BAT mitochondria generate heat rather than ATP. Despite being a member of the family of mitochondrial anion carriers (SLC25), UCP1 is believed to transport H+ by an unusual mechanism that has long remained unresolved. Here, we achieved direct patch-clamp measurements of UCP1 currents from the IMM of BAT mitochondria. We show that UCP1 is an LCFA anion/H+ symporter. However, the LCFA anions cannot dissociate from UCP1 due to hydrophobic interactions established by their hydrophobic tails, and UCP1 effectively operates as an H+ carrier activated by LCFA. A similar LCFA-dependent mechanism of transmembrane H+ transport may be employed by other SLC25 members and be responsible for mitochondrial uncoupling and regulation of metabolic efficiency in various tissues.	[Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall,Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017		NIH [DP2OD004656]; UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Drs. David Nicholls, Eduardo Rial, Robert Farese, Frederick Sachs, and Francesca Fieni for advice and to Dr. Leslie Kozak for the UCP1<SUP>-/-</SUP> mice. This work was funded by the NIH Director's New Innovator Award DP2OD004656, the UCSF Program for Breakthrough Biomedical Research, and a Larry L. Hillblom Foundation Start-up Award. A. F. and Y.K. conceived the project and designed the experiments. A. F. performed most of the experiments. Y. K. and P. V. L. helped with pilot experiments for the project. All authors discussed the results and commented on the manuscript.	ANEL A, 1993, BIOCHEMISTRY-US, V32, P530, DOI 10.1021/bi00053a018; Annunziata O, 1999, J COLLOID INTERF SCI, V216, P16, DOI 10.1006/jcis.1999.6269; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BHAMIDIPATI SP, 1995, BIOCHEMISTRY-US, V34, P5666, DOI 10.1021/bi00016a043; Borecky J, 1997, J BIOL CHEM, V272, P19282; BOUILLAUD F, 1986, J BIOL CHEM, V261, P1487; Bruce P.Y, 2001, ORGANIC CHEM; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1977, FEBS LETT, V74, P43, DOI 10.1016/0014-5793(77)80748-5; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Goss KU, 2008, ENVIRON SCI TECHNOL, V42, P456, DOI 10.1021/es702192c; GUTHRIE JP, 1978, CAN J CHEM, V56, P2342, DOI 10.1139/v78-385; Hamilton JA, 1998, J LIPID RES, V39, P467; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Huang SG, 2003, ARCH BIOCHEM BIOPHYS, V412, P142, DOI 10.1016/S0003-9861(03)00031-6; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; JEZEK P, 1990, J BIOL CHEM, V265, P19303; JEZEK P, 1989, AM J PHYSIOL, V257, pC1142, DOI 10.1152/ajpcell.1989.257.6.C1142; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Lide D.R., 1998, HDB CHEM PHYS; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; Rial E, 2004, BBA-BIOENERGETICS, V1608, P122, DOI 10.1016/j.bbabio.2003.11.001; Rial E, 2001, BBA-BIOENERGETICS, V1504, P70, DOI 10.1016/S0005-2728(00)00240-1; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; RIDLEY RG, 1986, NUCLEIC ACIDS RES, V14, P4025, DOI 10.1093/nar/14.10.4025; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; ZURINI M, 1981, EUR J BIOCHEM, V119, P517, DOI 10.1111/j.1432-1033.1981.tb05638.x	48	538	558	11	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					400	413		10.1016/j.cell.2012.09.010	http://dx.doi.org/10.1016/j.cell.2012.09.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063128	Green Accepted, Bronze			2022-12-01	WOS:000309981000017
J	Melander, O; Maisel, AS; Almgren, P; Manjer, J; Belting, M; Hedblad, B; Engstrom, G; Kilger, U; Nilsson, P; Bergmann, A; Orho-Melander, M				Melander, Olle; Maisel, Alan S.; Almgren, Peter; Manjer, Jonas; Belting, Mattias; Hedblad, Bo; Engstrom, Gunnar; Kilger, Ute; Nilsson, Peter; Bergmann, Andreas; Orho-Melander, Marju			Plasma Proneurotensin and Incidence of Diabetes, Cardiovascular Disease, Breast Cancer, and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; BARIATRIC SURGERY; REGULATORY PEPTIDES; GASTRIC BYPASS; NEUROMEDIN-N; NEUROTENSIN; PROGRESSION; EVENTS; INTERVENTION; EXPRESSION	Context Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans. Objective To test if fasting plasma concentration of a stable 117-amino acid fragment from the neurotensin precursor hormone proneurotensin is associated with development of diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Design, Setting, and Participants Proneurotensin was measured in plasma from 4632 fasting participants of the population-based Malmo Diet and Cancer Study baseline examination 1991-1994. Multivariate Cox proportional hazards models were used to relate baseline proneurotensin to first events and death during long-term follow-up until January 2009, with median follow-up ranging from 13.2 to 15.7 years depending on the disease. Main Outcome Measures Incident diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Results Overall, proneurotensin (hazard ratio [HR] per SD increment of log-transformed proneurotensin) was related to risk of incident diabetes (142 events; HR, 1.28; 95% CI, 1.09-1.50; P=.003), cardiovascular disease (519 events; HR, 1.17; 95% CI, 1.07-1.27; P<.001), and cardiovascular mortality (174 events; HR, 1.29; 95% CI, 1.12-1.49; P=.001) with a significant interaction between proneurotensin and sex (P<.001) on risk of cardiovascular disease. Exclusively in women, proneurotensin was related to incident diabetes (74 events; HR, 1.41; 95% CI, 1.12-1.77; P=.003), cardiovascular disease (224 events; HR, 1.33; 95% CI, 1.17-1.51; P<.001), breast cancer (123 events; HR, 1.44; 95% CI, 1.21-1.71; P<.001), total mortality (285 events; HR, 1.13; 95% CI, 1.01-1.27; P=.03), and cardiovascular mortality (75 events; HR, 1.50; 95% CI, 1.20-1.87; P<.001). Conclusion Fasting proneurotensin was significantly associated with the development of diabetes, cardiovascular disease, breast cancer, and with total and cardiovascular mortality. JAMA. 2012;308(14):1469-1475 www.jama.com	[Belting, Mattias] Sect Oncol, Lund, Sweden; [Melander, Olle; Hedblad, Bo; Nilsson, Peter] Skane Univ Hosp, Ctr Emergency Med, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, SE-20502 Malmo, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, SE-20502 Malmo, Sweden; [Maisel, Alan S.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Kilger, Ute; Bergmann, Andreas] SphingoTec GmbH, Hohen Neuendorf, Germany; [Bergmann, Andreas] Waltraut Bergmann Fdn, Hohen Neuendorf, Germany; [Melander, Olle] Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, SE-20502 Malmo, Sweden; [Melander, Olle; Almgren, Peter; Manjer, Jonas; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Lund University; Skane University Hospital; Lund University	Melander, O (corresponding author), Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, Ent 72,Bldg 91,Level 12, SE-20502 Malmo, Sweden.	olle.melander@med.lu.se		Melander, Olle/0000-0002-2581-484X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engstrom, Gunnar/0000-0002-8618-9152; Belting, Mattias/0000-0003-1585-5434	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	Funding was obtained from the European Research Council (StG-282255) (Dr Melander); the Swedish Heart and Lung Foundation, and the Swedish Research Council (Drs Melander and Orho-Melander); the Skane University Hospital donation funds; the Medical Faculty, Lund University (Dr Melander); the governmental funding of clinical research within the national health services (Drs Melander and Orho-Melander); and the Albert Pahlsson Research Foundation, Region Skane, the King Gustaf V and Queen Victoria Foundation, and the Marianne and Marcus Wallenberg Foundation (Dr Melander).	ALEXANDER MJ, 1993, ENDOCRINOLOGY, V133, P1809, DOI 10.1210/en.133.4.1809; [Anonymous], 1993, J INTERN MED, V233, P39; Belting M, 2012, CANCER EPIDEM BIOMAR, V21, P513, DOI 10.1158/1055-9965.EPI-11-0840; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Christ-Crain M, 2006, J CLIN ENDOCR METAB, V91, P3544, DOI 10.1210/jc.2006-0256; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Friry C, 2002, BIOCHEM BIOPH RES CO, V290, P1161, DOI 10.1006/bbrc.2001.6308; Holdstock C, 2008, INT J OBESITY, V32, P1640, DOI 10.1038/ijo.2008.157; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim ER, 2010, NEUROSCI LETT, V468, P64, DOI 10.1016/j.neulet.2009.10.064; KITABGI P, 1976, J BIOL CHEM, V251, P7053; Kitabgi P, 2006, J MOL MED, V84, P628, DOI 10.1007/s00109-006-0044-6; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Watters JJ, 1998, J NEUROSCI, V18, P6672; WISEN O, 1992, REGUL PEPTIDES, V39, P43, DOI 10.1016/0167-0115(92)90007-H	33	99	108	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1469	1475		10.1001/jama.2012.12998	http://dx.doi.org/10.1001/jama.2012.12998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047361	Bronze			2022-12-01	WOS:000309579300026
J	Petersen, LR; Fischer, M				Petersen, Lyle R.; Fischer, Marc			Unpredictable and Difficult to Control - The Adolescence of West Nile Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Petersen, Lyle R.; Fischer, Marc] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.							[Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P529; Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347; Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1; Petersen LR, 2012, EPIDEMIOL I IN PRESS; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419	5	38	38	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1281	1284		10.1056/NEJMp1210537	http://dx.doi.org/10.1056/NEJMp1210537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23013055				2022-12-01	WOS:000309406100003
J	Maher, J				Maher, Julie			Lack of Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Maher, J (corresponding author), Tufts Med Ctr, Boston, MA USA.							Cohen JG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.019	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1331	1332		10.1001/2012.jama.12096	http://dx.doi.org/10.1001/2012.jama.12096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032548				2022-12-01	WOS:000309369300026
J	Williams, SN				Williams, Simon Nicholas			A tax on indoor tanning would reduce demand in Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MALIGNANT-MELANOMA		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Williams, SN (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	simonwilliams@northwestern.edu		Williams, Simon/0000-0003-2854-9946				Autier P, 2011, LANCET, V377, P1299, DOI 10.1016/S0140-6736(10)61966-6; Committee on medical aspects of radiation in the environment (COMARE), 2009, THIRTEENTH REPORT; European Cancer Observatory, 2008, CANCER MELANOMA OF S; Gallus S, 2006, TOB CONTROL, V15, P114, DOI 10.1136/tc.2005.012468; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Health Wellbeing and Local Government Committee National Assembly for Wales, INQUIRY INTO THE USE; Jain N, 2012, ARCH DERMATOL, V148, P122, DOI 10.1001/archderm.148.1.122; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Robinson JK, 2008, ARCH DERMATOL, V144, P484, DOI 10.1001/archderm.144.4.484; The Sunbed Association UK, 1996, CONSUMER RESEARCH ON	11	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6550	10.1136/bmj.e6550	http://dx.doi.org/10.1136/bmj.e6550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033417				2022-12-01	WOS:000309659300005
J	Guillette, LJ; Iguchi, T				Guillette, Louis J., Jr.; Iguchi, Taisen			Life in a Contaminated World	SCIENCE			English	Editorial Material							ENDOCRINE-DISRUPTING CHEMICALS; ATRAZINE		[Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29412 USA; [Guillette, Louis J., Jr.] Hollings Marine Lab, Charleston, SC 29412 USA; [Iguchi, Taisen] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Medical University of South Carolina; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Guillette, LJ (corresponding author), Med Univ S Carolina, Dept Obstet & Gynecol, 221 Ft Johnson Rd, Charleston, SC 29412 USA.	guillett@musc.edu	Iguchi, Taisen/AAL-4225-2021					Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Carson R., 1962, SILENT SPRING; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Crews D, 2011, ENVIRON HEALTH PERSP, V119, P1208, DOI 10.1289/ehp.1103451; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gore AC, 2010, FRONT NEUROENDOCRIN, V31, P395, DOI 10.1016/j.yfrne.2010.07.003; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Hamlin HJ, 2011, BIRTH DEFECTS RES C, V93, P19, DOI 10.1002/bdrc.20202; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2004, BIOSCIENCE, V54, P1138, DOI 10.1641/0006-3568(2004)054[1138:TINDTD]2.0.CO;2; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kloas W, 2009, ANN NY ACAD SCI, V1163, P437, DOI 10.1111/j.1749-6632.2009.04456.x; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Rahman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040825; Sharpe RM, 2011, NAT REV ENDOCRINOL, V7, P633, DOI 10.1038/nrendo.2011.165; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Spearow JL, 1999, SCIENCE, V285, P1259, DOI 10.1126/science.285.5431.1259; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	22	51	52	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1614	1615		10.1126/science.1226985	http://dx.doi.org/10.1126/science.1226985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019638				2022-12-01	WOS:000309215400031
J	Spann, NJ; Garmire, LX; McDonald, JG; Myers, DS; Milne, SB; Shibata, N; Reichart, D; Fox, JN; Shaked, I; Heudobler, D; Raetz, CRH; Wang, EW; Kelly, SL; Sullards, MC; Murphy, RC; Merrill, AH; Brown, HA; Dennis, EA; Li, AC; Ley, K; Tsimikas, S; Fahy, E; Subramaniam, S; Quehenberger, O; Russell, DW; Glass, CK				Spann, Nathanael J.; Garmire, Lana X.; McDonald, Jeffrey G.; Myers, David S.; Milne, Stephen B.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Shaked, Iftach; Heudobler, Daniel; Raetz, Christian R. H.; Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Murphy, Robert C.; Merrill, Alfred H., Jr.; Brown, H. Alex; Dennis, Edward A.; Li, Andrew C.; Ley, Klaus; Tsimikas, Sotirios; Fahy, Eoin; Subramaniam, Shankar; Quehenberger, Oswald; Russell, David W.; Glass, Christopher K.			Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; ATHEROSCLEROTIC PLAQUES; LDL RECEPTOR; CHOLESTEROL; PROTEIN; GENE; MICE; IDENTIFICATION; PATHOGENESIS	Inflammation and macrophage foam cells are characteristic features of atherosclerotic lesions, but the mechanisms linking cholesterol accumulation to inflammation and LXR-dependent response pathways are poorly understood. To investigate this relationship, we utilized lipidomic and transcriptomic methods to evaluate the effect of diet and LDL receptor genotype on macrophage foam cell formation within the peritoneal cavities of mice. Foam cell formation was associated with significant changes in hundreds of lipid species and unexpected suppression, rather than activation, of inflammatory gene expression. We provide evidence that regulated accumulation of desmosterol underlies many of the homeostatic responses, including activation of LXR target genes, inhibition of SREBP target genes, selective reprogramming of fatty acid metabolism, and suppression of inflammatory-response genes, observed in macrophage foam cells. These observations suggest that macrophage activation in atherosclerotic lesions results from extrinsic, proinflammatory signals generated within the artery wall that suppress homeostatic and anti-inflammatory functions of desmosterol.	[Spann, Nathanael J.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Heudobler, Daniel; Subramaniam, Shankar; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Garmire, Lana X.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dennis, Edward A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Li, Andrew C.; Tsimikas, Sotirios; Quehenberger, Oswald; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McDonald, Jeffrey G.; Russell, David W.] UT SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; [Myers, David S.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37232 USA; [Raetz, Christian R. H.] Duke Univ, Dept Biochem, Sch Med, DUMC, Durham, NC 27710 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Shaked, Iftach; Ley, Klaus] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; La Jolla Institute for Immunology	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Dennis, Edward A./M-5554-2019; Murphy, Robert/AAO-5349-2020; Glass, Christopher/AAI-3933-2021; Shaked, Iftach/AAS-9961-2020; Shaked, Iftach/GNM-9959-2022	Dennis, Edward A./0000-0003-3738-3140; Murphy, Robert/0000-0002-9430-6515; Glass, Christopher/0000-0003-4344-3592; SHIBATA, NORIHITO/0000-0001-5792-8510; Merrill, Alfred/0000-0002-6673-968X; Russell, David/0000-0002-0277-403X	NIH [GM U54 069338, PO1 HC088093, P01 DK074868]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115232, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were primarily supported by NIH grant GM U54 069338 to the LIPID MAPS Consortium. Additional support was provided by NIH grants PO1 HC088093 and P01 DK074868. N.J.S. was supported by an NIH training grant. We thank Hanna Lesch for critical comments, L. Bautista for assistance with preparation of the manuscript, and Dr. Peter Tontonoz for providing LXR DKO mice for macrophage isolation.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; AVIGAN J, 1960, BIOCHEM BIOPH RES CO, V2, P63, DOI 10.1016/0006-291X(60)90266-7; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	41	372	388	1	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					138	152		10.1016/j.cell.2012.06.054	http://dx.doi.org/10.1016/j.cell.2012.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021221	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000309544200016
J	Marteau, TM; Hollands, GJ; Fletcher, PC				Marteau, Theresa M.; Hollands, Gareth J.; Fletcher, Paul C.			Changing Human Behavior to Prevent Disease: The Importance of Targeting Automatic Processes	SCIENCE			English	Editorial Material							CHILDRENS TASTE; SOCIAL-BEHAVIOR; HABITS; METAANALYSIS; PREFERENCES; INTENTIONS; ALCOHOL	Much of the global burden of disease is associated with behaviors-overeating, smoking, excessive alcohol consumption, and physical inactivity-that people recognize as health-harming and yet continue to engage in, even when undesired consequences emerge. To date, interventions aimed at changing such behaviors have largely encouraged people to reflect on their behaviors. These approaches are often ineffectual, which is in keeping with the observation that much human behavior is automatic, cued by environmental stimuli, resulting in actions that are largely unaccompanied by conscious reflection. We propose that interventions targeting these automatic bases of behaviors may be more effective. We discuss specific interventions and suggest ways to determine whether and how interventions that target automatic processes can enhance global efforts to prevent disease.	[Marteau, Theresa M.; Hollands, Gareth J.] Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Fletcher, Paul C.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SR, England	University of Cambridge; University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England.	theresa.marteau@medschl.cam.ac.uk	Fletcher, Paul/F-5380-2011	Fletcher, Paul/0000-0001-8257-1517; Marteau, Theresa/0000-0003-3025-1129; Hollands, Gareth/0000-0002-0492-3924	Wellcome Trust [095692] Funding Source: Medline; Department of Health [107/0001] Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Benden ME, 2011, AM J PUBLIC HEALTH, V101, P1433, DOI 10.2105/AJPH.2010.300072; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; de Wit S, 2009, PSYCHOL RES-PSYCH FO, V73, P463, DOI 10.1007/s00426-009-0230-6; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Engels RCME, 2009, ALCOHOL ALCOHOLISM, V44, P244, DOI 10.1093/alcalc/agp003; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hollands G. J., 2012, ALTERING CHOICE ARCH; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Kahneman D., 2011, INTERPRETATION; Kutner M, 2006, HLTH LITERACY AM ADU; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; Moodie C., 2012, PLAIN TOBACCO PACKAG; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Papies EK, 2012, CURR OBES REP, V1, P99, DOI 10.1007/s13679-012-0009-8; Reitzel LR, 2011, AM J PUBLIC HEALTH, V101, P315, DOI 10.2105/AJPH.2010.191676; Roberto CA, 2010, PEDIATRICS, V126, P88, DOI 10.1542/peds.2009-3433; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Rossen, 2003, SCAND J NUTR, V47, P26, DOI DOI 10.1080/11026480310004262; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Spears D., 2010, EC DECISION MAKING P; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; VANHOUTEN R, 1981, J APPL BEHAV ANAL, V14, P377, DOI 10.1901/jaba.1981.14-377; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; WILLIAMS J, 2003, SKILLS LIFE SURVEY N; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	36	476	482	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1492	1495		10.1126/science.1226918	http://dx.doi.org/10.1126/science.1226918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997327	Green Published			2022-12-01	WOS:000308912900039
J	Running, SW				Running, Steven W.			A Measurable Planetary Boundary for the Biosphere	SCIENCE			English	Editorial Material							NET PRIMARY PRODUCTION; HUMAN APPROPRIATION; ECOSYSTEMS		Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Meadows D. H., 2013, LIMITS GROWTH 1972; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith WK, 2012, BIOSCIENCE, V62, P911, DOI 10.1525/bio.2012.62.10.11; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	12	191	214	5	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1458	1459		10.1126/science.1227620	http://dx.doi.org/10.1126/science.1227620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997311				2022-12-01	WOS:000308912900025
J	Taylor, CM; de Jeu, RAM; Guichard, F; Harris, PP; Dorigo, WA				Taylor, Christopher M.; de Jeu, Richard A. M.; Guichard, Francoise; Harris, Phil P.; Dorigo, Wouter A.			Afternoon rain more likely over drier soils	NATURE			English	Article							BOUNDARY LAYER INTERACTIONS; PART II; ATMOSPHERIC CONTROLS; DIURNAL CYCLE; UNITED-STATES; MOISTURE; PRECIPITATION; LAND; CONVECTION; FEEDBACK	Land surface properties, such as vegetation cover and soil moisture, influence the partitioning of radiative energy between latent and sensible heat fluxes in daytime hours. During dry periods, soil-water deficit can limit evapotranspiration, leading to warmer and drier conditions in the lower atmosphere(1,2). Soil moisture can influence the development of convective storms through such modifications of low-level atmospheric temperature and humidity(1,3), which in turn feeds back on soil moisture. Yet there is considerable uncertainty in how soil moisture affects convective storms across the world, owing to a lack of observational evidence and uncertainty in large-scale models(4). Here we present a global-scale observational analysis of the coupling between soil moisture and precipitation. We show that across all six continents studied, afternoon rain falls preferentially over soils that are relatively dry compared to the surrounding area. The signal emerges most clearly in the observations over semi-arid regions, where surface fluxes are sensitive to soil moisture, and convective events are frequent. Mechanistically, our results are consistent with enhanced afternoon moist convection driven by increased sensible heat flux over drier soils, and/or mesoscale variability in soil moisture. We find no evidence in our analysis of a positive feedback-that is, a preference for rain over wetter soils-at the spatial scale (50-100 kilometres) studied. In contrast, we find that a positive feedback of soil moisture on simulated precipitation does dominate in six state-of-the-art global weather and climate models-a difference that may contribute to excessive simulated droughts in large-scale models.	[Taylor, Christopher M.; Harris, Phil P.] NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [de Jeu, Richard A. M.] Vrije Univ Amsterdam, Dept Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Guichard, Francoise] CNRM GAME CNRS, F-31057 Toulouse, France; [Guichard, Francoise] Meteo France, F-31057 Toulouse, France; [Dorigo, Wouter A.] Vienna Univ Technol, Inst Photogrammetry & Remote Sensing IPF, A-1040 Vienna, Austria	UK Centre for Ecology & Hydrology (UKCEH); Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Technische Universitat Wien	Taylor, CM (corresponding author), NERC Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	cmt@ceh.ac.uk	de Jeu, Richard/AAE-6922-2019; Taylor, Christopher/Y-7529-2019; Taylor, Chris/K-2319-2012; Dorigo, Wouter A/C-7794-2014; Harris, Phil P/A-1933-2010	Taylor, Chris/0000-0002-0120-3198; Dorigo, Wouter A/0000-0001-8054-7572; Harris, Phil P/0000-0002-4834-7746	European Union (FP6) WATCH Integrated Project [036946]; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN) [22086/08/I-EC]; Natural Environment Research Council [earth010002, ceh010023, NE/B505538/1, NE/G018499/1] Funding Source: researchfish; NERC [earth010002, NE/G018499/1] Funding Source: UKRI	European Union (FP6) WATCH Integrated Project; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was partly funded by the European Union (FP6) WATCH Integrated Project (contract 036946), the UK National Centre for Earth Observation and the European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN/contract number 22086/08/I-EC. We thank A. Beljaars, S. Seneviratne and D. Parker for discussions on this topic. We also thank the CMORPH, TRMM, PERSIANN and GPROF teams for the provision of their precipitation data, the World Climate Research Programme's Working Group on Coupled Modelling, and the centres who provided modelling data in Figure 3.	ANTHES RA, 1984, J CLIM APPL METEOROL, V23, P541, DOI 10.1175/1520-0450(1984)023<0541:EOCPBM>2.0.CO;2; Bartalis Z, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031088; Betts AK, 1998, J ATMOS SCI, V55, P1091, DOI 10.1175/1520-0469(1998)055<1091:FSCASA>2.0.CO;2; Carleton AM, 2008, J CLIMATE, V21, P3617, DOI 10.1175/2007JCLI1584.1; Cheng WYY, 2004, J HYDROMETEOROL, V5, P934, DOI 10.1175/1525-7541(2004)005<0934:SOACSO>2.0.CO;2; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; Ek MB, 2004, J HYDROMETEOROL, V5, P86, DOI 10.1175/1525-7541(2004)005<0086:IOSMOB>2.0.CO;2; Eltahir EAB, 1998, WATER RESOUR RES, V34, P765, DOI 10.1029/97WR03499; Ferguson CR, 2011, J HYDROMETEOROL, V12, P1221, DOI 10.1175/2011JHM1380.1; Findell KL, 2011, NAT GEOSCI, V4, P434, DOI [10.1038/NGEO1174, 10.1038/ngeo1174]; Findell KL, 1997, WATER RESOUR RES, V33, P725, DOI 10.1029/96WR03756; Findell KL, 2003, J HYDROMETEOROL, V4, P570, DOI 10.1175/1525-7541(2003)004<0570:ACOSML>2.0.CO;2; Findell KL, 2003, J HYDROMETEOROL, V4, P552, DOI 10.1175/1525-7541(2003)004<0552:ACOSML>2.0.CO;2; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Goessling HF, 2011, HYDROL EARTH SYST SC, V15, P3217, DOI 10.5194/hess-15-3217-2011; Guichard F, 2004, Q J ROY METEOR SOC, V130, P3139, DOI 10.1256/qj.03.145; Guo ZC, 2006, J HYDROMETEOROL, V7, P611, DOI 10.1175/JHM511.1; Hohenegger C, 2009, J CLIMATE, V22, P5003, DOI 10.1175/2009JCLI2604.1; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; McCrary RR, 2010, J CLIMATE, V23, P2178, DOI 10.1175/2009JCLI3061.1; OOKOUCHI Y, 1984, MON WEATHER REV, V112, P2281, DOI 10.1175/1520-0493(1984)112<2281:EOSMEO>2.0.CO;2; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Santanello JA, 2011, J HYDROMETEOROL, V12, P766, DOI 10.1175/JHM-D-10-05014.1; Taylor CM, 2011, NAT GEOSCI, V4, P430, DOI 10.1038/ngeo1173; Taylor CM, 1998, MON WEATHER REV, V126, P1597, DOI 10.1175/1520-0493(1998)126<1597:OEOPCS>2.0.CO;2; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2009, P NATL ACAD SCI USA, V106, P3670, DOI 10.1073/pnas.0810156106; WEBSTER PJ, 1983, J ATMOS SCI, V40, P2110, DOI 10.1175/1520-0469(1983)040<2110:MOMLFV>2.0.CO;2; Zhang YY, 2010, J ATMOS SCI, V67, P2943, DOI 10.1175/2010JAS3366.1	30	392	404	19	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					423	426		10.1038/nature11377	http://dx.doi.org/10.1038/nature11377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972193	Green Accepted			2022-12-01	WOS:000308860900043
J	McClelland, L				McClelland, Laura			Terminally ill people shouldn't have to travel abroad for assisted dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales		McClelland, L (corresponding author), Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales.	doctormac@doctors.org.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6201	10.1136/bmj.e6201	http://dx.doi.org/10.1136/bmj.e6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983534				2022-12-01	WOS:000308865100006
J	King, MA; Bingham, RJ; Moore, P; Whitehouse, PL; Bentley, MJ; Milne, GA				King, Matt A.; Bingham, Rory J.; Moore, Phil; Whitehouse, Pippa L.; Bentley, Michael J.; Milne, Glenn A.			Lower satellite-gravimetry estimates of Antarctic sea-level contribution	NATURE			English	Article							GLACIAL ISOSTATIC-ADJUSTMENT; ICE-SHEET; GRACE; RETREAT; DRIVEN; SIGNAL; MODEL	Recent estimates of Antarctica's present-day rate of ice-mass contribution to changes in sea level range from 31 gigatonnes a year (Gt yr(-1); ref. 1) to 246 Gt yr(-1) (ref. 2), a range that cannot be reconciled within formal errors(3). Time-varying rates of mass loss(2,4-6) contribute to this, but substantial technique-specific systematic errors also exist(3). In particular, estimates of secular ice-mass change derived from Gravity Recovery and Climate Experiment (GRACE) satellite data are dominated by significant uncertainty in the accuracy of models of mass change due to glacial isostatic adjustment(7,8) (GIA). Here we adopt a new model of GIA, developed from geological constraints, which produces GIA rates systematically lower than those of previous models, and an improved fit to independent uplift data(9). After applying the model to 99 months (from August 2002 to December 2010) of GRACE data, we estimate a continent-wide ice-mass change of -69 +/- 18 Gt yr(-1) (+0.19 +/- 0.05 mm yr(-1) sea-level equivalent). This is about a third to a half of the most recently published GRACE estimates(2,5), which cover a similar time period but are based on older GIA models. Plausible GIA model uncertainties, and errors relating to removing longitudinal GRACE artefacts ('destriping'), confine our estimate to the range -126 Gt yr(-1) to -29 Gt yr(-1) (0.08-0.35 mm yr(-1) sea-level equivalent). We resolve 26 independent drainage basins and find that Antarctic mass loss, and its acceleration, is concentrated in basins along the Amundsen Sea coast. Outside this region, we find that West Antarctica is nearly in balance and that East Antarctica is gaining substantial mass.	[King, Matt A.; Bingham, Rory J.; Moore, Phil] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Whitehouse, Pippa L.; Bentley, Michael J.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Milne, Glenn A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada	Newcastle University - UK; University of Tasmania; Durham University; University of Ottawa	King, MA (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.a.king@newcastle.ac.uk	King, Matt/B-4622-2008; Bentley, Michael J/F-7386-2011	King, Matt/0000-0001-5611-9498; Bentley, Michael J/0000-0002-2048-0019; Whitehouse, Pippa/0000-0002-9092-3444	NERC; RCUK Academic Fellowship; COST Action [ES0701]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs programme; Natural Environment Research Council [NE/F01452X/1, NE/E004806/1, NE/F01466X/1, NE/E007023/1, NE/F014260/1] Funding Source: researchfish; NERC [NE/F01452X/1, NE/F014260/1, NE/F01466X/1, NE/E007023/1, NE/E004806/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); RCUK Academic Fellowship(UK Research & Innovation (UKRI)); COST Action(European Cooperation in Science and Technology (COST)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs programme(Canada Research Chairs); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC, and an RCUK Academic Fellowship to M. A. K., and partially supported by COST Action ES0701. G.A.M. acknowledges support from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chairs programme. We thank E. Ivins for discussions.	Barletta VR, 2008, GEOPHYS J INT, V172, P18, DOI 10.1111/j.1365-246X.2007.03630.x; Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Gladstone RM, 2012, EARTH PLANET SC LETT, V333, P191, DOI 10.1016/j.epsl.2012.04.022; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Horwath M, 2009, GEOPHYS J INT, V177, P849, DOI 10.1111/j.1365-246X.2009.04139.x; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI [10.1038/ngeo1061, 10.1038/NGEO1061]; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Purcell A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048624; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stammer D, 2011, SURV GEOPHYS, V32, P621, DOI 10.1007/s10712-011-9142-2; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Swenson S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005338; Tamisiea ME, 2011, GEOPHYS J INT, V186, P1036, DOI 10.1111/j.1365-246X.2011.05116.x; Tamisiea ME, 2001, J GEOPHYS RES-SOL EA, V106, P30849, DOI 10.1029/2000JB000011; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Tregoning P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006161; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5	37	138	147	1	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					586	+		10.1038/nature11621	http://dx.doi.org/10.1038/nature11621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086145				2022-12-01	WOS:000311339800050
J	McCarthy, DP; Donald, PF; Scharlemann, JPW; Buchanan, GM; Balmford, A; Green, JMH; Bennun, LA; Burgess, ND; Fishpool, LDC; Garnett, ST; Leonard, DL; Maloney, RF; Morling, P; Schaefer, HM; Symes, A; Wiedenfeld, DA; Butchart, SHM				McCarthy, Donal P.; Donald, Paul F.; Scharlemann, Joern P. W.; Buchanan, Graeme M.; Balmford, Andrew; Green, Jonathan M. H.; Bennun, Leon A.; Burgess, Neil D.; Fishpool, Lincoln D. C.; Garnett, Stephen T.; Leonard, David L.; Maloney, Richard F.; Morling, Paul; Schaefer, H. Martin; Symes, Andy; Wiedenfeld, David A.; Butchart, Stuart H. M.			Financial Costs of Meeting Global Biodiversity Conservation Targets: Current Spending and Unmet Needs	SCIENCE			English	Article							PROTECTED-AREA; ALLOCATION; RESOURCES; BENEFITS; PROGRESS	World governments have committed to halting human-induced extinctions and safeguarding important sites for biodiversity by 2020, but the financial costs of meeting these targets are largely unknown. We estimate the cost of reducing the extinction risk of all globally threatened bird species (by >= 1 International Union for Conservation of Nature Red List category) to be U. S. $0.875 to $1.23 billion annually over the next decade, of which 12% is currently funded. Incorporating threatened nonavian species increases this total to U. S. $3.41 to $4.76 billion annually. We estimate that protecting and effectively managing all terrestrial sites of global avian conservation significance (11,731 Important Bird Areas) would cost U. S. $65.1 billion annually. Adding sites for other taxa increases this to U. S. $76.1 billion annually. Meeting these targets will require conservation funding to increase by at least an order of magnitude.	[McCarthy, Donal P.; Bennun, Leon A.; Fishpool, Lincoln D. C.; Symes, Andy; Butchart, Stuart H. M.] BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England; [McCarthy, Donal P.; Donald, Paul F.; Buchanan, Graeme M.; Morling, Paul] RSPB, Sandy SG19 2DL, Beds, England; [Scharlemann, Joern P. W.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Balmford, Andrew; Green, Jonathan M. H.; Burgess, Neil D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Green, Jonathan M. H.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Burgess, Neil D.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-1165 Copenhagen, Denmark; [Burgess, Neil D.] World Wildlife Fund, Conservat Sci Program, Washington, DC 20090 USA; [Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Leonard, David L.] Univ Hawaii Manoa, Hawaii Div Forestry & Wildlife, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Maloney, Richard F.] Dept Conservat, Sci & Tech Grp, Christchurch, New Zealand; [Schaefer, H. Martin] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Wiedenfeld, David A.] 12 Fishback Court, Warrenton, VA 20186 USA	BirdLife International; Royal Society for Protection of Birds; University of Sussex; University of Cambridge; Princeton University; University of Copenhagen; World Wildlife Fund; Charles Darwin University; University of Hawaii System; University of Hawaii Manoa; University of Freiburg	Butchart, SHM (corresponding author), BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England.	stuart.butchart@birdlife.org	Green, Jonathan M H/D-7081-2017; Butchart, Stuart/AAJ-1852-2021; Garnett, Stephen/M-3877-2013; Butchart, Stuart HM/Y-2711-2018; Scharlemann, Jorn/A-4737-2008	Butchart, Stuart/0000-0002-1140-4049; Garnett, Stephen/0000-0002-0724-7060; Scharlemann, Jorn/0000-0002-2834-6367; Balmford, Andrew/0000-0002-0144-3589; Donald, Paul F./0000-0003-0023-6200; Green, Jonathan/0000-0002-5003-0203	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	This work was supported by the Cambridge Conservation Initiative Collaborative Fund for Conservation and by Arcadia. For helpful comments and assistance, we thank A. Bruner, R. Naidoo, M. Ausden, L. Donaldson, and many other individuals who kindly provided estimates of costs of species conservation or site management; a full list is given in the supplementary materials. All data sources are listed in the supplementary materials.	[Anonymous], 2009, EC ECOSYSTEMS BIODIV; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BirdLife International, 2004, STAT WORLDS BIRDS 20; BirdLife International, 2011, IUCN RED LIST BIRDS; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Convention on Biological Diversity (CBD), 2011, C PART DEC 10 2 STRA; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Donald P. F., 2010, FACING EXTINCTION WO; Drechsler M, 2011, BIODIVERS CONSERV, V20, P1045, DOI 10.1007/s10531-011-0013-4; Dudley N., 2008, GUIDELINES APPPL PRO; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Foster Matthew N., 2012, Journal of Threatened Taxa, V4, P2733; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; IUCN, 2022, IUCN RED LIST THREAT; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Laycock HF, 2011, ECOL ECON, V70, P1789, DOI 10.1016/j.ecolecon.2011.05.002; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; McKinney ML, 2002, CONSERV BIOL, V16, P539, DOI 10.1046/j.1523-1739.2002.00442.x; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; RTS Resource Ltd, 2012, SOFT DRINKS FACT SHE; UN Environment Programme-Financial Initiative and Principles for Responsible Investment, 2010, UN OWN WHY ENV EXT M; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x	33	393	401	8	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					946	949		10.1126/science.1229803	http://dx.doi.org/10.1126/science.1229803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23065904				2022-12-01	WOS:000311083600043
J	Park, HY; Man, SFP; Sin, DD				Park, Hye Yun; Man, S. F. Paul; Sin, Don D.			Inhaled corticosteroids for chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; METERED-DOSE INHALER; SHORT-TERM RESPONSE; OF-THE-LITERATURE; SALMETEROL/FLUTICASONE PROPIONATE; SPUTUM-EOSINOPHILIA; FLUTICASONE PROPIONATE; TIOTROPIUM BROMIDE; CLINICAL-TRIAL; DOUBLE-BLIND		[Sin, Don D.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of British Columbia	Sin, DD (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	don.sin@hli.ubc.ca	park, hy/O-5934-2014; Sin, Don/AAC-2219-2021					Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barnes PJ, 2010, PHARMACEUTICALS, V3, P514, DOI 10.3390/ph3030514; Briggs AH, 2010, EUR RESPIR J, V35, P532, DOI 10.1183/09031936.00153108; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dal Negro Roberto, 2007, Int J Chron Obstruct Pulmon Dis, V2, P169; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Johnell O, 2002, EUR RESPIR J, V19, P1058, DOI 10.1183/09031936.02.00276602; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; Pizzichini E, 1998, AM J RESP CRIT CARE, V158, P1511, DOI 10.1164/ajrccm.158.5.9804028; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Roland NJ, 2004, CHEST, V126, P213, DOI 10.1378/chest.126.1.213; Sharafkhaneh A, 2012, RESP MED, V106, P257, DOI 10.1016/j.rmed.2011.07.020; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Singh D, 2008, THORAX, V63, P592, DOI 10.1136/thx.2007.087213; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Sobieraj DM, 2008, CLIN THER, V30, P1416, DOI 10.1016/j.clinthera.2008.08.004; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	31	9	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2012	345								e6843	10.1136/bmj.e6843	http://dx.doi.org/10.1136/bmj.e6843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MZ	23100329				2022-12-01	WOS:000310427800008
J	Ramsey, CB; Staff, RA; Bryant, CL; Brock, F; Kitagawa, H; van der Plicht, J; Schlolaut, G; Marshall, MH; Brauer, A; Lamb, HF; Payne, RL; Tarasov, PE; Haraguchi, T; Gotanda, K; Yonenobu, H; Yokoyama, Y; Tada, R; Nakagawa, T				Ramsey, Christopher Bronk; Staff, Richard A.; Bryant, Charlotte L.; Brock, Fiona; Kitagawa, Hiroyuki; van der Plicht, Johannes; Schlolaut, Gordon; Marshall, Michael H.; Brauer, Achim; Lamb, Henry F.; Payne, Rebecca L.; Tarasov, Pavel E.; Haraguchi, Tsuyoshi; Gotanda, Katsuya; Yonenobu, Hitoshi; Yokoyama, Yusuke; Tada, Ryuji; Nakagawa, Takeshi			A Complete Terrestrial Radiocarbon Record for 11.2 to 52.8 kyr BP	SCIENCE			English	Article							C-14 CALIBRATION; ICE CORES; CAL BP; YR BP; CHRONOLOGY	Radiocarbon (C-14) provides a way to date material that contains carbon with an age up to similar to 50,000 years and is also an important tracer of the global carbon cycle. However, the lack of a comprehensive record reflecting atmospheric C-14 prior to 12.5 thousand years before the present (kyr B. P.) has limited the application of radiocarbon dating of samples from the Last Glacial period. Here, we report C-14 results from Lake Suigetsu, Japan (35 degrees 35'N, 135 degrees 53'E), which provide a comprehensive record of terrestrial radiocarbon to the present limit of the C-14 method. The time scale we present in this work allows direct comparison of Lake Suigetsu paleoclimatic data with other terrestrial climatic records and gives information on the connection between global atmospheric and regional marine radiocarbon levels.	[Ramsey, Christopher Bronk; Staff, Richard A.; Brock, Fiona] Univ Oxford, Oxford, England; [Bryant, Charlotte L.] Scottish Univ Environm Res Ctr, Nat Environm Res Council, Radiocarbon Facil, E Kilbride, Lanark, Scotland; [Kitagawa, Hiroyuki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [van der Plicht, Johannes] Univ Groningen, Groningen, Netherlands; [van der Plicht, Johannes] Leiden Univ, Leiden, Netherlands; [Schlolaut, Gordon; Brauer, Achim] German Res Ctr Geosci, GeoForschungsZentrum, Potsdam, Germany; [Payne, Rebecca L.; Nakagawa, Takeshi] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Marshall, Michael H.; Lamb, Henry F.] Aberystwyth Univ, Aberystwyth, Dyfed, Wales; [Tarasov, Pavel E.] Free Univ Berlin, Berlin, Germany; [Haraguchi, Tsuyoshi] Osaka City Univ, Osaka 558, Japan; [Gotanda, Katsuya] Chiba Univ Commerce, Chiba, Japan; [Yonenobu, Hitoshi] Naruto Univ Educ, Naruto 772, Japan; [Yokoyama, Yusuke; Tada, Ryuji] Univ Tokyo, Tokyo, Japan	University of Oxford; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Nagoya University; University of Groningen; Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Newcastle University - UK; Aberystwyth University; Free University of Berlin; Osaka Metropolitan University; Naruto University of Education; University of Tokyo	Ramsey, CB (corresponding author), Univ Oxford, Oxford, England.	christopher.ramsey@rlaha.ox.ac.uk	van der Plicht, Johannes/B-9994-2013; Ramsey, Christopher Bronk/AAQ-2227-2021; Yokoyama, Yusuke/N-9623-2013; Tarasov, Pavel/ABG-3993-2020; Brock, Fiona/I-4970-2016; Yonenobu, Hitoshi/AAB-1500-2021; Ramsey, Christopher Bronk/A-3277-2012	Ramsey, Christopher Bronk/0000-0002-8641-9309; Tarasov, Pavel/0000-0002-7219-5009; Brock, Fiona/0000-0003-0728-6091; Yonenobu, Hitoshi/0000-0002-1596-7543; Ramsey, Christopher Bronk/0000-0002-8641-9309; Brauer, Achim/0000-0002-6655-9451; Lamb, Henry Francis/0000-0003-0025-0766; Staff, Richard/0000-0002-8634-014X; Marshall, Dr Michael/0000-0001-8279-7532; Nakagawa, Takeshi/0000-0003-0831-6803	UK Natural Environment Research Council [NE/D000289/1, NE/F003048/1]; Deutsche Forschungsgemeinschaft [BR 2208/7-1, TA 540/3-1]; Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI [21101002]; John Fell Oxford University Press Research Fund; Natural Environment Research Council [NE/G011001/1, NE/F004400/1, NE/F003048/1, NRCF010001, NRCF010002, NE/F003056/1] Funding Source: researchfish; NERC [NE/F003056/1, NRCF010002, NE/G011001/1, NE/F003048/1, NE/F004400/1, NRCF010001] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23221002, 22500974, 23240116] Funding Source: KAKEN	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); John Fell Oxford University Press Research Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was funded by the UK Natural Environment Research Council (NE/D000289/1 and NE/F003048/1, as well as Radiocarbon Facility support); the Deutsche Forschungsgemeinschaft (BR 2208/7-1 and TA 540/3-1); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI (21101002); and the John Fell Oxford University Press Research Fund.	Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; Brauer A, 1999, QUATERN INT, V61, P17, DOI 10.1016/S1040-6182(99)00014-2; HAJDAS I, 1993, CLIM DYNAM, V9, P107, DOI 10.1007/BF00209748; Hoffmann DL, 2010, EARTH PLANET SC LETT, V289, P1, DOI 10.1016/j.epsl.2009.10.004; Hua Q, 2009, QUATERNARY SCI REV, V28, P2982, DOI 10.1016/j.quascirev.2009.08.013; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; Marshall M., 2012, QUAT GEOCHRONOL; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Muscheler R., COMMUNICATION; Nakagawa T, 2012, QUATERNARY SCI REV, V36, P164, DOI 10.1016/j.quascirev.2010.12.013; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schlolaut G., 2012, QUAT GEOCHRONOL; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Staff RA, 2010, NUCL INSTRUM METH B, V268, P960, DOI 10.1016/j.nimb.2009.10.074; Staff RA, 2011, RADIOCARBON, V53, P511, DOI 10.1017/S0033822200034627; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; van der Plicht J, 2004, RADIOCARBON, V46, P1225, DOI 10.1017/S0033822200033117	21	178	184	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					370	374		10.1126/science.1226660	http://dx.doi.org/10.1126/science.1226660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087245	Green Published			2022-12-01	WOS:000309955800038
J	Paik, JM; Curhan, GC; Taylor, EN				Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.			Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARATHYROID CELL-PROLIFERATION; CHRONIC-RENAL-FAILURE; SEX-RELATED INCIDENCE; SERUM-CALCIUM; HORMONE; REPRODUCIBILITY; ROCHESTER; VALIDITY; AGE; QUESTIONNAIRE	Objective To examine the association between calcium intake and risk of primary hyperparathyroidism in women. Design Prospective cohort study. Setting Nurses' Health Study I, which originally recruited participants from the 11 most populous states in the United States. Participants 58 354 female registered nurses enrolled in the Nurses' Health Study I aged 39-66 years in 1986 and with no history of primary hyperparathyroidism. Calcium intake was assessed every four years using semiquantitative questionnaires on food frequency. Main outcome measure Incident primary hyperparathyroidism, confirmed by medical record review. Results During 22 years of follow-up, we recorded 277 incident cases of primary hyperparathyroidism. Women were divided into five equal groups, according to intake of dietary calcium. After adjusting for age, body mass index, race, and other factors, the relative risk of primary hyperparathyroidism for women in the group with the highest intake of dietary calcium was 0.56 (95% confidence interval 0.37 to 0.86, P=0.009 for trend), compared with the group with the lowest intake. The multivariable relative risk of primary hyperparathyroidism for women taking more than 500 mg/day of calcium supplements compared with no calcium supplements was 0.41 (95% confidence interval 0.29 to 0.60, P<0.001 for trend). Analyses restricted to participants with regular physical exams did not significantly change the association between calcium intake and risk of primary hyperparathyroidism. Conclusion Increased calcium intake is independently associated with a reduced risk of primary hyperparathyroidism in women.	[Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Paik, Julie M.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Taylor, Eric N.] Maine Med Ctr, Div Nephrol & Transplantat, Portland, ME 04102 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Maine Medical Center	Paik, JM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA.	jmpaik@partners.org			US National Institutes of Health [DK084707, HL092947, DK91417, CA087969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084707, K24DK091417] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the US National Institutes of Health grants DK084707, HL092947, DK91417, and CA087969.	ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ARNOLD A, 1995, J CLIN INVEST, V95, P2047, DOI 10.1172/JCI117890; BEARD CM, 1989, ARCH INTERN MED, V149, P1887, DOI 10.1001/archinte.149.8.1887; Bilezikian J P, 2000, Rev Endocr Metab Disord, V1, P237, DOI 10.1023/A:1026508829397; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DENT CE, 1961, LANCET, V2, P336; INSOGNA KL, 1985, NEW ENGL J MED, V313, P1126, DOI 10.1056/NEJM198510313131805; Jorde R, 2000, J CLIN EPIDEMIOL, V53, P1164, DOI 10.1016/S0895-4356(00)00239-0; Jorde R, 2002, EUR J NUTR, V41, P258, DOI 10.1007/s00394-002-0383-1; Kanesaka Y, 2001, ENDOCRINOLOGY, V142, P407, DOI 10.1210/en.142.1.407; KAO PC, 1992, MAYO CLIN PROC, V67, P637, DOI 10.1016/S0025-6196(12)60717-4; Karp HJ, 2009, BRIT J NUTR, V102, P1341, DOI 10.1017/S0007114509990195; LJUNGHALL S, 1991, SURGERY, V110, P47; Locker FG, 1997, AM J MED, V102, P543, DOI 10.1016/S0002-9343(97)00053-3; Lundgren E, 1997, SURGERY, V121, P287, DOI 10.1016/S0039-6060(97)90357-3; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; McKane WR, 1996, J CLIN ENDOCR METAB, V81, P1699, DOI 10.1210/jc.81.5.1699; Melton LJ, 2002, J BONE MINER RES, V17, pN12; Miedlich S, 2003, CLIN ENDOCRINOL, V59, P539, DOI 10.1046/j.1365-2265.2003.t01-1-01755.x; Miedlich S, 2000, EUR J ENDOCRINOL, V143, P47, DOI 10.1530/eje.0.1430047; Miller BS, 2008, WORLD J SURG, V32, P795, DOI 10.1007/s00268-007-9427-2; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; Norman J, 2011, ENDOCR PRACT, V17, P384, DOI 10.4158/EP09346.OR; POTTS JT, 1991, ANN INTERN MED, V114, P593, DOI 10.7326/0003-4819-114-7-593; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Ruda JM, 2005, OTOLARYNG HEAD NECK, V132, P359, DOI 10.1016/j.otohns.2004.10.005; RUTLEDGE R, 1985, SURGERY, V98, P1107; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Shan L, 1997, VIRCHOWS ARCH, V430, P247, DOI 10.1007/BF01324809; Shelby H, 2008, WORLD J SURG, V32, P800, DOI 10.1007/s00268-007-9422-7; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Tordoff MG, 1998, AM J PHYSIOL-REG I, V274, pR214, DOI 10.1152/ajpregu.1998.274.1.R214; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	42	23	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2012	345								e6390	10.1136/bmj.e6390	http://dx.doi.org/10.1136/bmj.e6390			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WU	23080543	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000310142300001
J	Coste, B				Coste, Bertrand			The Cellular Feeling of Pressure	SCIENCE			English	Editorial Material							CHANNELS; CURRENTS; PIEZO		Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France		Coste, B (corresponding author), Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France.							Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	9	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229853	http://dx.doi.org/10.1126/science.1229853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042881				2022-12-01	WOS:000309457400050
J	Miyoshi, H; Ajima, R; Luo, CT; Yamaguchi, TP; Stappenbeck, TS				Miyoshi, Hiroyuki; Ajima, Rieko; Luo, Christine T.; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.			Wnt5a Potentiates TGF-beta Signaling to Promote Colonic Crypt Regeneration After Tissue Injury	SCIENCE			English	Article							STEM-CELLS; IN-VITRO; WNT/BETA-CATENIN; SMALL-INTESTINE; PATHWAY; MOUSE; CRE; RECOMBINATION; ELONGATION; EXPRESSION	Reestablishing homeostasis after tissue damage depends on the proper organization of stem cells and their progeny, though the repair mechanisms are unclear. The mammalian intestinal epithelium is well suited to approach this problem, as it is composed of well-delineated units called crypts of Lieberkuhn. We found that Wnt5a, a noncanonical Wnt ligand, was required for crypt regeneration after injury in mice. Unlike controls, Wnt5a-deficient mice maintained an expanded population of proliferative epithelial cells in the wound. We used an in vitro system to enrich for intestinal epithelial stem cells to discover that Wnt5a inhibited proliferation of these cells. Surprisingly, the effects of Wnt5a were mediated by activation of transforming growth factor-beta (TGF-beta) signaling. These findings suggest a Wnt5a-dependent mechanism for forming new crypt units to reestablish homeostasis.	[Ajima, Rieko; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Miyoshi, Hiroyuki; Luo, Christine T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Yamaguchi, TP (corresponding author), NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	stappenb@pathology.wustl.edu; yamagute@mail.nih.gov		Miyoshi, Hiroyuki/0000-0001-7400-0714	NIH [DK90251]; Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students [5T35DK074375]; Washington Univ. Digestive Disease Research Core (NIH) [P30-DK52574]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK071619, T35DK074375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students; Washington Univ. Digestive Disease Research Core (NIH); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Kopan for comments on the manuscript, W. Pu for reagents, and R. Head and C. Storer for the microarray analysis. This work was funded by the NIH (grant DK90251); the Pew Scholars Program in the Biomedical Sciences; grant 5T35DK074375 (Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students); the Washington Univ. Digestive Disease Research Core (NIH grant P30-DK52574); and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Microarray data are available on Array Express (accession no. E-MTAB-1175). Materials transfer agreements will be required for the acquisition of the Wnt5a<SUP>f/f</SUP> mice from the National Cancer Institute and the L-WRN cell line from the Washington Univ. Medical School. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gough Nancy R, 2008, Sci Signal, V1, peg8, DOI 10.1126/scisignal.146eg8; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iavarone A, 1997, NATURE, V387, P417; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PARK HS, 1995, AM J PATHOL, V147, P1416; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	37	296	299	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					108	113		10.1126/science.1223821	http://dx.doi.org/10.1126/science.1223821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22956684	Green Accepted			2022-12-01	WOS:000309457400064
J	Klein, M; Gogenur, I; Rosenberg, J				Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob			Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIVARIATE-ANALYSIS; RISK; INHIBITORS; CYCLOOXYGENASE; SURGERY; DEATH; COMPLICATIONS; SELECTIVITY; DICLOFENAC; KETOROLAC	Objectives To evaluate the effect of postoperative use of non-steroidal anti-inflammatory drugs (NSAIDs) on anastomotic leakage requiring reoperation after colorectal resection. Design Cohort study based on data from a prospective clinical database and electronically registered medical records. Setting Six major colorectal centres in eastern Denmark. Participants 2766 patients (1441 (52%) men) undergoing elective operation for colorectal cancer with colonic or rectal resection and primary anastomosis between 1 January 2006 and 31 December 2009. Median age was 70 years (interquartile range 62-77). Intervention Postoperative use of NSAID (defined as at least two days of NSAID treatment in the first seven days after surgery). Main outcome measures Frequency of clinical anastomotic leakage verified at reoperation; mortality at 30 days. Results Of 2756 patients with available data and included in the final analysis, 1871 (68%) did not receive postoperative NSAID treatment (controls) and 885 (32%) did. In the NSAID group, 655 (74%) patients received ibuprofen and 226 (26%) received diclofenac. Anastomotic leakage verified at reoperation was significantly increased among patients receiving diclofenac and ibuprofen treatment, compared with controls (12.8% and 8.2% v 5.1%; P<0.001). After unadjusted analyses and when compared with controls, more patients had anastomotic leakage after treatment with diclofenac (7.8% (95% confidence interval 3.9% to 12.8%)) and ibuprofen (3.2% (1.0% to 5.7%)). But after multivariate logistic regression analysis, only diclofenac treatment was a risk factor for leakage (odds ratio 7.2 (95% confidence interval 3.8 to 13.4), P<0.001; ibuprofen 1.5 (0.8 to 2.9), P=0.18). Other risk factors for anastomotic leakage were male sex, rectal (v colonic) anastomosis, and blood transfusion. 30 day mortality was comparable in the three groups (diclofenac 1.8% v ibuprofen 4.1% v controls 3.2%; P=0.20). Conclusions Diclofenac treatment could result in an increased proportion of patients with anastomotic leakage after colorectal surgery. Cyclo-oxygenase-2 selective NSAIDs should be used with caution after colorectal resections with primary anastomosis. Large scale, randomised controlled trials are urgently needed.	[Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Klein, M (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark.	madsklein1@gmail.com		Gogenur, Ismail/0000-0002-3753-268X; Rosenberg, Jacob/0000-0002-0063-1086				Alves A, 2002, WORLD J SURG, V26, P499, DOI 10.1007/s00268-001-0256-4; [Anonymous], 2009, YEARL REP 2009; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Cahill RA, 2004, BRIT J SURG, V91, P1613, DOI 10.1002/bjs.4722; Choi HK, 2006, DIS COLON RECTUM, V49, P1719, DOI 10.1007/s10350-006-0703-2; Christensen HK, 2011, EUR SURG RES, V46, P156, DOI 10.1159/000324406; Fosbol EL, 2010, EXPERT OPIN DRUG SAF, V9, P893, DOI 10.1517/14740338.2010.501331; Gillis JC, 1997, DRUGS, V53, P139, DOI 10.2165/00003495-199753010-00012; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Golub R, 1997, J AM COLL SURGEONS, V184, P364; Gorissen KJ, 2012, BRIT J SURG, V99, P721, DOI 10.1002/bjs.8691; Guenaga KK, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001544.pub3, DOI 10.1002/14651858.CD001544.PUB3]]; Haag MDM, 2008, ARCH INTERN MED, V168, P1219, DOI 10.1001/archinte.168.11.1219; Holte K, 2007, BRIT J ANAESTH, V99, P500, DOI 10.1093/bja/aem211; Holte K, 2009, BRIT J SURG, V96, P650, DOI 10.1002/bjs.6598; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Inan Aydin, 2006, Int J Surg, V4, P222, DOI 10.1016/j.ijsu.2006.01.002; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kendall SJH, 2000, CLIN ORTHOP RELAT R, P145; Kingham TP, 2009, J AM COLL SURGEONS, V208, P269, DOI 10.1016/j.jamcollsurg.2008.10.015; Klein M, 2012, EUR SURG RES, V48, P73, DOI 10.1159/000336208; Klein M, 2009, DIGEST SURG, V26, P27, DOI 10.1159/000193329; Lipska MA, 2006, ANZ J SURG, V76, P579, DOI 10.1111/j.1445-2197.2006.03780.x; Makela JT, 2003, DIS COLON RECTUM, V46, P653, DOI 10.1097/01.DCR.0000059328.10563.8C; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nickelsen Thomas N, 2004, Ugeskr Laeger, V166, P3092; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI200113418; PEEL ALG, 1991, ANN ROY COLL SURG, V73, P385; Schlachta CM, 2007, SURG ENDOSC, V21, P2212, DOI 10.1007/s00464-007-9335-4; Stottmeier S, 2011, COLORECTAL DIS, V13, P500, DOI 10.1111/j.1463-1318.2010.02274.x; Winkelmayer WC, 2004, NEPHROL DIAL TRANSPL, V19, P1671, DOI 10.1093/ndt/gfh104	36	103	105	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	2012	345								e6166	10.1136/bmj.e6166	http://dx.doi.org/10.1136/bmj.e6166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014OV	23015299	hybrid, Green Published			2022-12-01	WOS:000309386300004
J	Puig, P; Canals, M; Company, JB; Martin, J; Amblas, D; Lastras, G; Palanques, A; Calafat, AM				Puig, Pere; Canals, Miquel; Company, Joan B.; Martin, Jacobo; Amblas, David; Lastras, Galderic; Palanques, Albert; Calafat, Antoni M.			Ploughing the deep sea floor	NATURE			English	Article							MOBILE-FISHING-GEAR; CONTINENTAL SHELVES; SUBMARINE CANYONS; TRANSPORT; CURRENTS; GEOLOGY; IMPACT; RESUSPENSION; ECOSYSTEMS; SLOPES	Bottom trawling is a non-selective commercial fishing technique whereby heavy nets and gear are pulled along the sea floor. The direct impact of this technique on fish populations(1,2) and benthic communities(3,4) has received much attention, but trawling can also modify the physical properties of seafloor sediments, water-sediment chemical exchanges and sediment fluxes(5,6). Most of the studies addressing the physical disturbances of trawl gear on the seabed have been undertaken in coastal and shelf environments(7,8), however, where the capacity of trawling to modify the seafloor morphology coexists with high-energy natural processes driving sediment erosion, transport and deposition(9). Here we show that on upper continental slopes, the reworking of the deep sea floor by trawling gradually modifies the shape of the submarine landscape over large spatial scales. We found that trawling-induced sediment displacement and removal from fishing grounds causes the morphology of the deep sea floor to become smoother over time, reducing its original complexity as shown by high-resolution seafloor relief maps. Our results suggest that in recent decades, following the industrialization of fishing fleets, bottom trawling has become an important driver of deep seascape evolution. Given the global dimension of this type of fishery, we anticipate that the morphology of the upper continental slope in many parts of the world's oceans could be altered by intensive bottom trawling, producing comparable effects on the deep sea floor to those generated by agricultural ploughing on land.	[Puig, Pere; Company, Joan B.; Martin, Jacobo; Palanques, Albert] CSIC, Inst Marine Sci, E-08003 Barcelona, Spain; [Canals, Miquel; Amblas, David; Lastras, Galderic; Calafat, Antoni M.] Univ Barcelona, CRG Marine Geosci, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona	Puig, P (corresponding author), CSIC, Inst Marine Sci, E-08003 Barcelona, Spain.	ppuig@icm.csic.es	Company, Joan B./K-7274-2014; Calafat, Antoni/J-5848-2017; Palanques, Albert/C-2661-2013; Puig, Pere/E-5422-2013; Martin, Jacobo/F-1388-2011; Lastras, Galderic/A-6487-2013; Amblas, David/A-5482-2015; Canals, Miquel/F-4922-2013	Company, Joan B./0000-0002-5878-7155; Calafat, Antoni/0000-0001-7927-3105; Puig, Pere/0000-0001-6189-5504; Martin, Jacobo/0000-0001-8933-7731; Lastras, Galderic/0000-0002-8756-3855; Amblas, David/0000-0002-6248-5512; Canals, Miquel/0000-0001-5267-7601; Palanques, Albert/0000-0003-2544-2342	HERMIONE [226354, CTM2010-11084-E]; DOS MARES [CTM2010-21810-C03]; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER [CSD2007-00067]; REDECO [CTM2008-04973-E]; Catalan Government Grups de Recerca Consolidats grants [SGR 899, 1305]; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund	HERMIONE; DOS MARES; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER; REDECO; Catalan Government Grups de Recerca Consolidats grants; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF))	This work was supported by various research projects: HERMIONE (226354 and CTM2010-11084-E), DOS MARES (CTM2010-21810-C03), OASIS DEL MAR-Obra Social "la Caixa", GRACCIE-CONSOLIDER (CSD2007-00067) and REDECO (CTM2008-04973-E). We also received support from Catalan Government Grups de Recerca Consolidats grants (2009 SGR 899 and 1305). VMS data and support were provided by the Spanish General Secretariat of Maritime Fishing (SEGEMAR). Assistance at sea by the crews of RV Hesperides, RV Sarmiento de Gamboa and RV Garcia del Cid is also acknowledged. J.M. was funded through a JAE-DOC contract granted by Consejo Superior de Investigaciones Cientificas and co-financed by the European Social Fund. F. Sarda and T. Milligan provided comments on the manuscript. The final document benefited from a review by P. Talling.	[Anonymous], 2003, OFFICIAL J EUR UNI L, VL333, P17; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Brown EJ, 2005, CONT SHELF RES, V25, P1281, DOI 10.1016/j.csr.2004.12.005; Cacchione DA, 2002, SCIENCE, V296, P724, DOI 10.1126/science.1069803; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Csorba P, 2010, ANTHROPOGENIC GEOMORPHOLOGY: A GUIDE TO MAN-MADE LANDFORMS, P39, DOI 10.1007/978-90-481-3058-0_4; Ferre B, 2008, CONT SHELF RES, V28, P2071, DOI 10.1016/j.csr.2008.02.002; Gordon J. D. M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P137; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HEEZEN BC, 1966, SCIENCE, V152, P502, DOI 10.1126/science.152.3721.502; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NITTROUER CA, 1994, REV GEOPHYS, V32, P85, DOI 10.1029/93RG02603; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; Palanques A, 2006, MAR GEOL, V234, P43, DOI 10.1016/j.margeo.2006.09.002; Piper DJW, 2009, J SEDIMENT RES, V79, P347, DOI 10.2110/jsr.2009.046; Pratson LF, 2007, SPEC PUBL INT ASS SE, V37, P339, DOI 10.1002/9781444304398.ch7; Price SJ, 2011, PHILOS T R SOC A, V369, P1056, DOI 10.1098/rsta.2010.0296; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Tobar R., 1987, INF T CN INV PESQ, V142, P3; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Watling L, 1998, CONSERV BIOL, V12, P1178, DOI 10.1046/j.1523-1739.1998.0120061178.x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x	32	263	266	3	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					286	+		10.1038/nature11410	http://dx.doi.org/10.1038/nature11410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951970	Green Accepted, Green Submitted			2022-12-01	WOS:000308635900040
J	Basaria, S; Bhasin, S				Basaria, Shehzad; Bhasin, Shalender			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Targeting the Skeletal Muscle-Metabolism Axis in Prostate-Cancer Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; MICE; MASS; MEN; FAT		[Basaria, Shehzad; Bhasin, Shalender] Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA	Boston University	Basaria, S (corresponding author), Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA.			Basaria, Shehzad/0000-0002-8533-2383; Basaria, Shehzad/0000-0003-1749-8549				Basaria S, 2006, CANCER-AM CANCER SOC, V106, P581, DOI 10.1002/cncr.21642; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4	11	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					965	967		10.1056/NEJMcibr1203160	http://dx.doi.org/10.1056/NEJMcibr1203160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931265				2022-12-01	WOS:000308343300018
J	Killian, NJ; Jutras, MJ; Buffalo, EA				Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.			A map of visual space in the primate entorhinal cortex	NATURE			English	Article							SPATIAL REPRESENTATION SYSTEM; MONKEY HIPPOCAMPAL-NEURONS; GRID CELLS; THETA OSCILLATIONS; MACAQUE HIPPOCAMPUS; MEMORY; PLACE; ORGANIZATION; PERIODICITY; NAVIGATION	Place-modulated activity among neurons in the hippocampal formation presents a means to organize contextual information in the service of memory formation and recall(1,2). One particular spatial representation, that of grid cells, has been observed in the entorhinal cortex (EC) of rats and bats(3-5), but has yet to be described in single units in primates. Here we examined spatial representations in the EC of head-fixed monkeys performing a free-viewing visual memory task(6,7). Individual neurons were identified in the primate EC that emitted action potentials when the monkey fixated multiple discrete locations in the visual field in each of many sequentially presented complex images. These firing fields possessed spatial periodicity similar to a triangular tiling with a corresponding well-defined hexagonal structure in the spatial auto-correlation. Further, these neurons showed theta-band oscillatory activity and changing spatial scale as a function of distance from the rhinal sulcus, which is consistent with previous findings in rodents(4,8-10). These spatial representations may provide a framework to anchor the encoding of stimulus content in a complex visual scene. Together, our results provide a direct demonstration of grid cells in the primate and suggest that EC neurons encode space during visual exploration, even without locomotion.	[Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Killian, Nathaniel J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Buffalo, Elizabeth A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Buffalo, EA (corresponding author), Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	elizabeth.buffalo@emory.edu	Killian, Nathaniel/B-1914-2013	Killian, Nathaniel/0000-0002-4546-0516	National Institute of Mental Health [R01MH093807, R01MH080007, MH082559]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NSF IGERT program [DGE-0333411]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080007, F31MH082559, R01MH093807] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NSF IGERT program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Potter, C. Erickson, J. Manns, M. Meister and K. Dunne for comments on the manuscript, and M. Tompkins and D. Solyst for assistance with experiments. This project was funded by the National Institute of Mental Health, R01MH093807 (E.A.B.), R01MH080007 (E.A.B.), MH082559 (M.J.J.), the National Center for Research Resources P51RR165, and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. N.J.K. was supported by the NSF IGERT program (DGE-0333411).	Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.3.CO;2-8; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; TAMURA R, 1992, HIPPOCAMPUS, V2, P307, DOI 10.1002/hipo.450020309; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	30	239	245	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					761	764		10.1038/nature11587	http://dx.doi.org/10.1038/nature11587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103863	Green Accepted			2022-12-01	WOS:000311606000046
J	Sneddon, JB; Borowiak, M; Melton, DA				Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.			Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme	NATURE			English	Article							DIFFERENTIATION; MOUSE; EXPRESSION; DERIVATION; ENDODERM	One goal of regenerative medicine, to use stem cells to replace cells lost by injury or disease, depends on producing an excess of the relevant cell for study or transplantation. To this end, the stepwise differentiation of stem cells into specialized derivatives has been successful for some cell types(1-3), but a major problem remains the inefficient conversion of cells from one stage of differentiation to the next. If specialized cells are to be produced in large numbers it will be necessary to expand progenitor cells, without differentiation, at some steps of the process. Using the pancreatic lineage as a model for embryonic-stem-cell differentiation, we demonstrate that this is a solvable problem. Co-culture with organ-matched mesenchyme permits proliferation and self-renewal of progenitors, without differentiation, and enables an expansion of more than a million-fold for human endodermal cells with full retention of their developmental potential. This effect is specific both to the mesenchymal cell and to the progenitor being amplified. Progenitors that have been serially expanded on mesenchyme give rise to glucose-sensing, insulin-secreting cells when transplanted in vivo. Theoretically, the identification of stage-specific renewal signals can be incorporated into any scheme for the efficient production of large numbers of differentiated cells from stem cells and may therefore have wide application in regenerative biology.	[Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Borowiak, Malgorzata/0000-0002-5829-1213	National Institutes of Health [5 U42 RR006042-20, K08 DK084206]; Howard Hughes Medical Institute; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Morrison for providing the Sox17-GFP reporter mouse ESC line and K. Kaestner for the Ngn3-GFP knock-in mouse ESCs. We also thank J. LaVecchio, G. Buruzula and B. Tilton for support for cell sorting, A. Kweudjeu for help with gene-expression experiments and human ESC culture, and C. Xie, C. Balatbat and K. Koszka for technical assistance. We are grateful to A. Tward and D. Cohen for critical reading of the manuscript. We thank J. Annes for assistance in obtaining human tissue samples and acknowledge the use of human tissues provided by the National Disease Research Interchange (NDRI), with support from National Institutes of Health grants 5 U42 RR006042-20 and K08 DK084206. J.B.S. is supported by the Howard Hughes Medical Institute. M.B. was supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust. D.A.M. is an investigator of the Howard Hughes Medical Institute.	Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; JAMES R, 1991, J BIOL CHEM, V266, P3246; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Thompson DW., 1917, GROWTH FORM, DOI [10.5962/bhl.title.11332, DOI 10.5962/BHL.TITLE.11332]; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Yamashita YM, 2005, INT J HEMATOL, V82, P377, DOI 10.1532/IJH97.05097	25	100	143	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					765	+		10.1038/nature11463	http://dx.doi.org/10.1038/nature11463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041930	Green Accepted			2022-12-01	WOS:000311606000047
J	Connerth, M; Tatsuta, T; Haag, M; Klecker, T; Westermann, B; Langer, T				Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Klecker, Till; Westermann, Benedikt; Langer, Thomas			Intramitochondrial Transport of Phosphatidic Acid in Yeast by a Lipid Transfer Protein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN BIOSYNTHESIS; MITOCHONDRIA; PHOSPHOLIPIDS; TRAFFICKING; UPS1P; SYNTHASE; BIOLOGY; TAM41	Mitochondria are dynamic organelles whose function depends on intramitochondrial phospholipid synthesis and the supply of membrane lipids from the endoplasmic reticulum. How phospholipids are transported to and in-between mitochondrial membranes remained unclear. We identified Ups1, a yeast member of a conserved family of intermembrane space proteins, as a lipid transfer protein that can shuttle phosphatidic acid between mitochondrial membranes. Lipid transfer required the dynamic assembly of Ups1 with Mdm35 and allowed conversion of phosphatidic acid to cardiolipin in the inner membrane. High cardiolipin concentrations prevented membrane dissociation of Ups1, leading to its proteolysis and inhibiting transport of phosphatidic acid and cardiolipin synthesis. Thus, intramitochondrial lipid trafficking may involve a regulatory feedback mechanism that limits the accumulation of cardiolipin in mitochondria.	[Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Langer, Thomas] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Inst Cell Biol, D-95440 Bayreuth, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Electron Microscopy Lab, D-95440 Bayreuth, Germany; [Langer, Thomas] Max Planck Inst Biol Aging, D-50931 Cologne, Germany	University of Cologne; University of Bayreuth; University of Bayreuth; Max Planck Society	Langer, T (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Klecker, Till/L-6637-2017; Westermann, Benedikt/H-7766-2013	Klecker, Till/0000-0003-0149-042X; Westermann, Benedikt/0000-0002-2991-1604; Langer, Thomas/0000-0003-1250-1462	Deutsche Forschungsgemeinschaft [SFB635, FOR885]; European Research Council [233078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank G. Zimmer for technical assistance, S. Geimer for advice on electron microscopy, T. Endo for sharing unpublished results, and J. Nunnari for yeast strains. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB635, FOR885) and the European Research Council (AdG No. 233078) to T.L.	Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; KASPER AM, 1981, BIOCHIM BIOPHYS ACTA, V664, P22, DOI 10.1016/0005-2760(81)90025-4; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	21	168	172	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					815	818		10.1126/science.1225625	http://dx.doi.org/10.1126/science.1225625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042293				2022-12-01	WOS:000310839500049
J	Grivennikov, SI; Wang, KP; Mucida, D; Stewart, CA; Schnabl, B; Jauch, D; Taniguchi, K; Yu, GY; Osterreicher, CH; Hung, KE; Datz, C; Feng, Y; Fearon, ER; Oukka, M; Tessarollo, L; Coppola, V; Yarovinsky, F; Cheroutre, H; Eckmann, L; Trinchieri, G; Karin, M				Grivennikov, Sergei I.; Wang, Kepeng; Mucida, Daniel; Stewart, C. Andrew; Schnabl, Bernd; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Oesterreicher, Christoph H.; Hung, Kenneth E.; Datz, Christian; Feng, Ying; Fearon, Eric R.; Oukka, Mohamed; Tessarollo, Lino; Coppola, Vincenzo; Yarovinsky, Felix; Cheroutre, Hilde; Eckmann, Lars; Trinchieri, Giorgio; Karin, Michael			Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth	NATURE			English	Article							PROMOTES COLON TUMORIGENESIS; COLORECTAL-CANCER; HELPER-CELLS; CUTTING EDGE; MOUSE MODEL; MICE; INFLAMMATION; COLITIS; DIFFERENTIATION; CARCINOGENESIS	Approximately 2% of colorectal cancer is linked to pre-existing inflammation known as colitis-associated cancer, but most develops in patients without underlying inflammatory bowel disease. Colorectal cancer often follows a genetic pathway whereby loss of the adenomatous polyposis coli (APC) tumour suppressor and activation of beta-catenin are followed by mutations in K-Ras, PIK3CA and TP53, as the tumour emerges and progresses(1,2). Curiously, however, 'inflammatory signature' genes characteristic of colitis-associated cancer are also upregulated in colorectal cancer(3,4). Further, like most solid tumours, colorectal cancer exhibits immune/inflammatory infiltrates(5), referred to as 'tumour-elicited inflammation'(6). Although infiltrating CD4(+) T(H)1 cells and CD8(+) cytotoxic T cells constitute a positive prognostic sign in colorectal cancer(7,8), myeloid cells and T-helper interleukin (IL)-17-producing (T(H)17) cells promote tumorigenesis(5,6), and a 'T(H)17 expression signature' in stage I/II colorectal cancer is associated with a drastic decrease in disease-free survival(9). Despite its pathogenic importance, the mechanisms responsible for the appearance of tumour-elicited inflammation are poorly understood. Many epithelial cancers develop proximally to microbial communities, which are physically separated from immune cells by an epithelial barrier(10). We investigated mechanisms responsible for tumour-elicited inflammation in a mouse model of colorectal tumorigenesis, which, like human colorectal cancer, exhibits upregulation of IL-23 and IL-17. Here we show that IL-23 signalling promotes tumour growth and progression, and development of a tumoural IL-17 response. IL-23 is mainly produced by tumour-associated myeloid cells that are likely to be activated by microbial products, which penetrate the tumours but not adjacent tissue. Both early and late colorectal neoplasms exhibit defective expression of several barrier proteins. We propose that barrier deterioration induced by colorectal-cancer-initiating genetic lesions results in adenoma invasion by microbial products that trigger tumour-elicited inflammation, which in turn drives tumour growth.	[Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Wang, Kepeng] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Mucida, Daniel; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92093 USA; [Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stewart, C. Andrew; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Expt Immunol Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Schnabl, Bernd; Oesterreicher, Christoph H.; Eckmann, Lars] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Taniguchi, Koji] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Oesterreicher, Christoph H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Hung, Kenneth E.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Datz, Christian] Paracelsus Med Univ, Oberndorf Hosp, Dept Internal Med, Salzburg, Austria; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Oukka, Mohamed] Seattle Childrens Res Inst, Seattle, WA 98105 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Coppola, Vincenzo] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; La Jolla Institute for Immunology; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; Keio University; Medical University of Vienna; Tufts Medical Center; Paracelsus Private Medical University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Stewart, Charles/G-2470-2012; Coppola, Vincenzo/E-2917-2011; Yu, Guann-Yi/O-5139-2019; Coppola, Vincenzo/D-5352-2014; Trinchieri, Giorgio/F-9369-2015; Grivennikov, Sergei/AAE-7365-2019; Wang, Kepeng/F-8363-2014	Coppola, Vincenzo/0000-0001-6163-1779; Yu, Guann-Yi/0000-0002-0580-8282; Coppola, Vincenzo/0000-0001-6163-1779; Trinchieri, Giorgio/0000-0001-5892-7464; Grivennikov, Sergei/0000-0003-2987-0555; Wang, Kepeng/0000-0001-6428-4709; Mucida, Daniel/0000-0002-0000-0452; Yarovinsky, Felix/0000-0001-5825-8002	Crohn's and Colitis Foundation of America [2693]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [K99-DK088589]; University of California, San Diego, Digestive Disease Research Development Center Pilot Grant [DK080506]; Croucher Foundation; China Postdoctoral Science Foundation [20110490919]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH [R01CA082223, AI043477, DK035108]; American Association for Cancer Research [07-60-21-KARI]; NATIONAL CANCER INSTITUTE [ZIABC010793, ZICBC011265, R01CA082223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265, R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, K08DK081830, R24DK080506, K99DK088589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020703] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Diego, Digestive Disease Research Development Center Pilot Grant; Croucher Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank eBioscience, GeneTex, Santa Cruz, BioLegend and Cell Signaling for antibodies; Genentech and Amgen for Il23<SUP>-/-</SUP> and Il17ra<SUP>-/-</SUP> mice, respectively, and S. Reid and E. Southon for the help in generating Il23r<SUP>F/F</SUP> mice. This work was supported by Crohn's and Colitis Foundation of America (Career Development Award number 2693), NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K99-DK088589) and a University of California, San Diego, Digestive Disease Research Development Center Pilot Grant (DK080506) to S. I. G.; Croucher Foundation and China Postdoctoral Science Foundation (20110490919) to K. W.; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation to K. T.; SPAR Austria to C. D.; NIH (R01CA082223) to E. R. F.; and NIH (AI043477; DK035108) and American Association for Cancer Research (07-60-21-KARI) grants to M. K., who is an American Cancer Society Research Professor. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Dove WF, 1997, CANCER RES, V57, P812; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Reichling T, 2005, CANCER RES, V65, P166; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XX, 2011, THESCIENTIFICWORLDJO, V11, P826, DOI 10.1100/tsw.2011.86; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	851	882	7	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					254	+		10.1038/nature11465	http://dx.doi.org/10.1038/nature11465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23034650	Green Accepted			2022-12-01	WOS:000310774300044
J	Huber, S; Gagliani, N; Zenewicz, LA; Huber, FJ; Bosurgi, L; Hu, B; Hedl, M; Zhang, W; O'Connor, W; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Booth, CJ; Cho, JH; Ouyang, WJ; Abraham, C; Flavell, RA				Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Huber, Francis J.; Bosurgi, Lidia; Hu, Bo; Hedl, Matija; Zhang, Wei; O'Connor, William, Jr.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Booth, Carmen J.; Cho, Judy H.; Ouyang, Wenjun; Abraham, Clara; Flavell, Richard A.			IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine	NATURE			English	Article							SODIUM-INDUCED COLITIS; BINDING-PROTEIN; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTERLEUKIN 22; T-CELLS; IMMUNITY; SULFATE; CLONING; INNATE	Chronic mucosal inflammation and tissue damage predisposes patients to the development of colorectal cancer(1). This association could be explained by the hypothesis that the same factors and pathways important for wound healing also promote tumorigenesis. A sensor of tissue damage should induce these factors to promote tissue repair and regulate their action to prevent development of cancer. Interleukin 22 (IL-22), a cytokine of the IL-10 superfamily, has an important role in colonic epithelial cell repair, and its levels are increased in the blood and intestine of inflammatory bowel disease patients(2,3). This cytokine can be neutralized by the soluble IL-22 receptor, known as the IL-22 binding protein (IL-22BP, also known as IL22RA2); however, the significance of endogenous IL-22BP in vivo and the pathways that regulate this receptor are unknown(4,5). Here we describe that IL-22BP has a crucial role in controlling tumorigenesis and epithelial cell proliferation in the colon. IL-22BP is highly expressed by dendritic cells in the colon in steady-state conditions. Sensing of intestinal tissue damage via the NLRP3 or NLRP6 inflammasomes led to an IL-18-dependent downregulation of IL-22BP, thereby increasing the ratio of IL-22/IL-22BP. IL-22, which is induced during intestinal tissue damage, exerted protective properties during the peak of damage, but promoted tumour development if uncontrolled during the recovery phase. Thus, the IL-22-IL-22BP axis critically regulates intestinal tissue repair and tumorigenesis in the colon.	[Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Bosurgi, Lidia; Hu, Bo; O'Connor, William, Jr.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Huber, Samuel; Huber, Francis J.] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Hedl, Matija; Abraham, Clara] Yale Univ, Sect Digest Dis, Dept Internal Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, Sect Digest Dis, New Haven, CT 06520 USA; [Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; Yale University; Yale University; Regeneron; Yale University; Roche Holding; Genentech; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	shuber@uke.de; richard.flavell@yale.edu	Ouyang, Wenjun/ABA-8763-2020	Huber, Samuel/0000-0001-9325-8227; Bosurgi, Lidia/0000-0002-8775-4950; Murphy, Andrew/0000-0003-4152-4081; Gagliani, Nicola/0000-0001-8514-1395; Ouyang, Wenjun/0000-0002-1811-5864; Zenewicz, Lauren/0000-0002-8787-5955	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO; American Cancer Society; DFG [SFB841];  [R01DK077905];  [DK-P30-34989];  [U19-AI082713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK077905] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO(European Molecular Biology Organization (EMBO)); American Cancer Society(American Cancer Society); DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert administrative assistance, E. Eynon and J. Alderman for managing the mouse program. We also thank T. Taylor and G. Tokmoulina for expert help with the FACS sorting. R. A. F. is an Investigator of the Howard Hughes Medical Institute. S. H. was supported by a post-doctoral fellowship from the Crohn's and Colitis Foundation of America, the 'Stiftung experimentelle Biomedizin' and the Ernst Jung Foundation. N.G. was supported by an EMBO post-doctoral fellowship. L.A.Z. was supported by a post-doctoral fellowship from the American Cancer Society. A. J. M., D. M. V. and G.D.Y. were employees of Regeneron Pharmaceuticals at the time this work was performed. W.O. is an employee of Genentech Inc. This work was supported by R01DK077905, DK-P30-34989 and U19-AI082713 (to C. A. and R. A. F.) and by the DFG, SFB841 (to S.H.).	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wei CC, 2003, GENES IMMUN, V4, P204, DOI 10.1038/sj.gene.6363947; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	35	506	532	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					259	+		10.1038/nature11535	http://dx.doi.org/10.1038/nature11535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23075849	Green Accepted			2022-12-01	WOS:000310774300045
J	Tan-Wong, SM; Zaugg, JB; Camblong, J; Xu, ZY; Zhang, DW; Mischo, HE; Ansari, AZ; Luscombe, NM; Steinmetz, LM; Proudfoot, NJ				Tan-Wong, Sue Mei; Zaugg, Judith B.; Camblong, Jurgi; Xu, Zhenyu; Zhang, David W.; Mischo, Hannah E.; Ansari, Aseem Z.; Luscombe, Nicholas M.; Steinmetz, Lars M.; Proudfoot, Nick J.			Gene Loops Enhance Transcriptional Directionality	SCIENCE			English	Article							RNA-POLYMERASE-II; COMPLEX; METHYLATION; TERMINATION; PROMOTERS; SSU72; CEREVISIAE; INITIATION; UPSTREAM; RECRUITS	Eukaryotic genomes are extensively transcribed, forming both messenger RNAs (mRNAs) and noncoding RNAs (ncRNAs). ncRNAs made by RNA polymerase II often initiate from bidirectional promoters (nucleosome-depleted chromatin) that synthesize mRNA and ncRNA in opposite directions. We demonstrate that, by adopting a gene-loop conformation, actively transcribed mRNA encoding genes restrict divergent transcription of ncRNAs. Because gene-loop formation depends on a protein factor (Ssu72) that coassociates with both the promoter and the terminator, the inactivation of Ssu72 leads to increased synthesis of promoter-associated divergent ncRNAs, referred to as Ssu72-restricted transcripts (SRTs). Similarly, inactivation of individual gene loops by gene mutation enhances SRT synthesis. We demonstrate that gene-loop conformation enforces transcriptional directionality on otherwise bidirectional promoters.	[Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Tan-Wong, Sue Mei; Camblong, Jurgi; Mischo, Hannah E.; Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Zaugg, Judith B.; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Zhang, David W.; Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Luscombe, Nicholas M.] UCL, Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England	European Molecular Biology Laboratory (EMBL); University of Oxford; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; Cancer Research UK	Steinmetz, LM (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de; nicholas.proudfoot@path.ox.ac.uk	Ansari, Aseem/AAF-4945-2019	Steinmetz, Lars/0000-0002-3962-2865; Proudfoot, Nicholas/0000-0001-8646-3222; Zaugg, Judith B./0000-0001-8324-4040	Wellcome Trust; NIH; Deutsche Forschungsgemeinschaft; European Molecular Biology Laboratory; Swiss National Fonds; European Molecular Biology Organization; Direct For Biological Sciences [0747197] Funding Source: National Science Foundation; Cancer Research UK [16358] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Laboratory; Swiss National Fonds(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Cancer Research UK(Cancer Research UK)	We thank B. Dichtl and J. Kufel for strains and H. Wijayatilake for FMP27 and beta-globin 3C reagents. This work was supported by the Wellcome Trust (N.J.P.), the NIH and Deutsche Forschungsgemeinschaft (L. M. S.), European Molecular Biology Laboratory (J.B.Z., N.M.L., L. M. S.), and the Swiss National Fonds and European Molecular Biology Organization (J. C.). Genomic data are deposited at http://steinmetzlab.embl.de/proudfoot_lab/index.html (E-TABM-936).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Carninci P, 2009, NATURE, V457, P974, DOI 10.1038/457974b; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687	25	164	168	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					671	675		10.1126/science.1224350	http://dx.doi.org/10.1126/science.1224350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23019609	Green Accepted, Green Submitted			2022-12-01	WOS:000310516000054
J	Li, P; Spolski, R; Liao, W; Wang, L; Murphy, TL; Murphy, KM; Leonard, WJ				Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Murphy, Theresa L.; Murphy, Kenneth M.; Leonard, Warren J.			BATF-JUN is critical for IRF4-mediated transcription in T cells	NATURE			English	Article							B-ATF; IL-21; GENE; DIFFERENTIATION; MODULATION; ACTIVATION; EXPRESSION; RESPONSES; IRF-4; STAT3	Interferon regulatory factor 4 (IRF4) is an IRF family transcription factor with critical roles in lymphoid development and in regulating the immune response(1,2). IRF4 binds DNA weakly owing to a carboxy-terminal auto-inhibitory domain, but cooperative binding with factors such as PU.1 or SPIB in B cells increases binding affinity(3), allowing IRF4 to regulate genes containing ETS-IRF composite elements (EICEs; 5'-GGAAnnGAAA-3')(1). Here we show that in mouse CD4(+) T cells, where PU.1/SPIB expression is low, and in B cells, where PU.1 is well expressed, IRF4 unexpectedly can cooperate with activator protein-1 (AP1) complexes to bind to AP1-IRF4 composite (5'-TGAnTCA/GAAA-3') motifs that we denote as AP1-IRF composite elements (AICEs). Moreover, BATF-JUN family protein complexes cooperate with IRF4 in binding to AICEs in pre-activated CD4(+) T cells stimulated with IL-21 and in T(H)17 differentiated cells. Importantly, BATF binding was diminished in Irf4(-/-) T cells and IRF4 binding was diminished in Batf(-/-) T cells, consistent with functional cooperation between these factors. Moreover, we show that AP1 and IRF complexes cooperatively promote transcription of the Il10 gene, which is expressed in T(H)17 cells and potently regulated by IL-21. These findings reveal that IRF4 can signal via complexes containing ETS or AP1 motifs depending on the cellular context, thus indicating new approaches for modulating IRF4-dependent transcription.	[Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Li, P (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	lip3@nhlbi.nih.gov; wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022		Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZICHL006058, ZIAHL005408, ZIAHL005402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH (P.L., R.S., W.L., L.W. and W.J.L.) and the Howard Hughes Medical Institute (T.L.M. and K.M.M.). We thank J.-X. Lin for valuable suggestions, critical comments and RNA-Seq data for pro-B/pre-B-enriched populations. We thank J. Zhu and Y. Wakabayashi, NHLBI DNA Sequencing Core, for excellent services, K. Ozato and Y. Hiroaki, NICHD, for Irf4<SUP>-/-</SUP> mice, and J. Thierry-Mieg and D. Thierry-Mieg, NCBI, for early analysis of ChIP-Seq data from ref. 14.	Altin JA, 2012, J IMMUNOL, V188, P5478, DOI 10.4049/jimmunol.1102994; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Tussiwand R., 2012, NATURE; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	33	277	285	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					543	+		10.1038/nature11530	http://dx.doi.org/10.1038/nature11530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992523	Green Accepted			2022-12-01	WOS:000310196200043
J	Kratz, JR; Van den Eeden, SK; He, JX; Jablons, DM; Mann, MJ				Kratz, Johannes R.; Van den Eeden, Stephen K.; He, Jianxing; Jablons, David M.; Mann, Michael J.			A Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CANCER		[Kratz, Johannes R.; Jablons, David M.; Mann, Michael J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Van den Eeden, Stephen K.] No Calif Kaiser Permanente, Dept Res, Oakland, CA USA; [He, Jianxing] Guangzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Francisco; Kaiser Permanente; Guangzhou Medical University	Kratz, JR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	michael.mann@ucsfmedctr.org		Kratz, Johannes R/0000-0003-0696-4073; He, Jianxing/0000-0003-1737-8192				Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID, pPA2019; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	6	23	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1629	1631		10.1001/jama.2012.13551	http://dx.doi.org/10.1001/jama.2012.13551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093159	Bronze			2022-12-01	WOS:000310434100013
J	Chakkalakal, JV; Jones, KM; Basson, MA; Brack, AS				Chakkalakal, Joe V.; Jones, Kieran M.; Basson, M. Albert; Brack, Andrew S.			The aged niche disrupts muscle stem cell quiescence	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; SATELLITE CELLS; SELF-RENEWAL; PROGENITOR CELLS; PROGRESSION; MYOGENESIS; SPROUTY; DIFFERENTIATION; HETEROGENEITY; CONTRIBUTES	The niche is a conserved regulator of stem cell quiescence and function. During ageing, stem cell function declines. To what extent and by what means age-related changes within the niche contribute to this phenomenon are unknown. Here we demonstrate that the aged muscle stem cell niche, the muscle fibre, expresses Fgf2 under homeostatic conditions, driving a subset of satellite cells to break quiescence and lose their self-renewing capacity. We show in mice that relatively dormant aged satellite cells robustly express sprouty 1 (Spry1), an inhibitor of fibroblast growth factor (FGF) signalling. Increasing FGF signalling in aged satellite cells under homeostatic conditions by removing Spry1 results in the loss of quiescence, satellite cell depletion and diminished regenerative capacity. Conversely, reducing niche-derived FGF activity through inhibition of Fgfr1 signalling or overexpression of Spry1 in satellite cells prevents their depletion. These experiments identify an age-dependent change in the stem cell niche that directly influences stem cell quiescence and function.	[Chakkalakal, Joe V.; Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Jones, Kieran M.; Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England; [Brack, Andrew S.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of London; King's College London; Harvard University; Harvard University; Harvard Medical School	Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	Brack.Andrew@mgh.harvard.edu	Chakkalakal, Joe/ABD-2865-2020	Chakkalakal, Joe/0000-0002-8440-7312; Basson, M. Albert/0000-0001-9834-7528	MGH; Harvard Stem Cell Institute; NIH [R01 AR060868, R01 AR061002]; Wellcome Trust [WT091475]; MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award [BB/F017626/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061002, R01AR060868] Funding Source: NIH RePORTER	MGH; Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Hock, K. Hochedlinger and R. Friesel for the generous provision of reagents, and G. Estrada for technical assistance. We are also grateful to L. Prickett-Rice, K. Folz-Donahue and M. Weglarz for cell sorting. This work was supported by MGH start-up funds, Harvard Stem Cell Institute grants and NIH grants (R01 AR060868, R01 AR061002) (A. S. B.); a Wellcome Trust grant (WT091475) (M. A. B.); and an MGH ECOR Postdoctoral Fellow Award (J.V.C.) and a BBSRC Doctoral Training Award (BB/F017626/1) (K.M.J.).	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Flanagan-Steet H, 2000, DEV BIOL, V218, P21, DOI 10.1006/dbio.1999.9535; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	55	504	525	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					355	+		10.1038/nature11438	http://dx.doi.org/10.1038/nature11438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023126	Green Accepted, Green Submitted			2022-12-01	WOS:000309918500036
J	Carroll, MD; Kit, BK; Lacher, DA; Shero, ST; Mussolino, ME				Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.; Shero, Susan T.; Mussolino, Michael E.			Trends in Lipids and Lipoproteins in US Adults, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES ADULTS; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; NATIONAL-HEALTH; PREVALENCE; PLASMA; RISK; OBESITY	Context Serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) contribute to atherosclerosis and its clinical consequences. Between the periods 1988-1994 and 1999-2002, mean TC and mean LDL-C declined in adults. During this time, there was an increase in the percentage of adults receiving lipid-lowering medications. Geometric mean triglyceride levels increased but mean high-density lipoprotein cholesterol (HDL-C) remained unchanged. Objective To examine trends in serum lipids in adults between 1988 and 2010. Design, Setting, and Participants Three distinct US cross-sectional National Health and Nutrition Examination Surveys, 1988-1994 (n=16 573), 1999-2002 (n=9471), and 2007-2010 (n=11 766). Main Outcome Measures Mean TC, LDL-C, HDL-C, non-HDL-C, and geometric mean triglyceride levels and the prevalence of lipid-lowering medication use. Results Mean TC declined from 206 (95% CI, 205-207) mg/dL in 1988-1994 to 196 (95% CI, 195-198) mg/dL in 2007-2010 (P<.001 for linear trend); mean LDL-C declined from 129 (95% CI, 127-130) mg/dL to 116 (95% CI, 114-117) mg/dL (P<.001 for linear trend). Mean non-HDL-C declined from 155 (95% CI, 153-157) mg/dL in 1988-1994 to 144 (95% CI, 143-145) mg/dL in 2007-2010 (P<.001 for linear trend). Mean HDL-C increased from 50.7 (95% CI, 50.0-51.0) mg/dL during 1988-1994 to 52.5 (95% CI, 51.8-53.2) mg/dL in 2007-2010 (P=.001 for linear trend). Geometric mean serum triglyceride levels increased from 118 (95% CI, 114-121) mg/dL in 1988-1994 to 123 (95% CI, 119-127) mg/dL in 1999-2002 and decreased to 110 (95% CI, 107-113) mg/dL in 2007-2010 (P<.001 for quadratic trend). The prevalence of lipid-lowering medication use increased from 3.4% (95% CI, 2.9%-3.9%) in 1988-1994 to 15.5% (95% CI, 14.7%-16.3%) in 2007-2010 (P<.001 for linear trend). Among adults not receiving lipid-lowering medications, trends in lipids were similar to those reported for adults overall. Among obese adults, mean TC, non-HDL-C, LDL-C, and geometric mean triglycerides declined between 1988 and 2010. Conclusion Between 1988 and 2010, favorable trends in lipid levels have occurred among adults in the United States. JAMA. 2012;308(15):1545-1554 www.jama.com	[Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, Hyattsville, MD 20782 USA; [Shero, Susan T.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD USA; [Mussolino, Michael E.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Carroll, MD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	mdc3@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of lipids was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (intra-agency agreement Y1-HC-8039).	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], EARL REL SEL EST BAS; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 1998, EUR HEART J, V19, pA2; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BACHORIK PS, 1984, CLIN CHEM, V30, P839; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention/Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; Centers for Disease Control and Prevention/National Center for Health Statistic, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TOT CHO; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Ferrieres J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleiss J.L., 2013, STAT METHODS RATES P; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULWOOD R, 1987, JAMA-J AM MED ASSOC, V257, P937; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Klein RJ, 2010, AGE ADJUSTMENT USING; National Center for Health Statistics, NAT HLTH NUTR EX SUR; National Heart Lung and Blood Institute. National Institute of Health, 2002, NIH PUBL; Physical Activity Guidelines Advisory Committee, 2008, 12009 PHYS ACT GUID; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Skinner C, 1989, ANAL COMPLEX SURVEYS; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wiefeld A, 1974, METHODS ENZYMATIC AN; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winer B.J., 1962, STAT PRINCIPLES EXPT; Wolters KM, 1985, INTRO VARIANCE ESTIM; Wright Jacqueline D, 2010, NCHS Data Brief, P1	38	180	190	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1545	1554		10.1001/jama.2012.13260	http://dx.doi.org/10.1001/jama.2012.13260			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073951				2022-12-01	WOS:000309858100021
J	Iyer, G; Hanrahan, AJ; Milowsky, MI; Al-Ahmadie, H; Scott, SN; Janakiraman, M; Pirun, M; Sander, C; Socci, ND; Ostrovnaya, I; Viale, A; Heguy, A; Peng, LK; Chan, TA; Bochner, B; Bajorin, DF; Berger, MF; Taylor, BS; Solit, DB				Iyer, Gopa; Hanrahan, Aphrothiti J.; Milowsky, Matthew I.; Al-Ahmadie, Hikmat; Scott, Sasinya N.; Janakiraman, Manickam; Pirun, Mono; Sander, Chris; Socci, Nicholas D.; Ostrovnaya, Irina; Viale, Agnes; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Bochner, Bernard; Bajorin, Dean F.; Berger, Michael F.; Taylor, Barry S.; Solit, David B.			Genome Sequencing Identifies a Basis for Everolimus Sensitivity	SCIENCE			English	Article									[Iyer, Gopa; Hanrahan, Aphrothiti J.; Scott, Sasinya N.; Janakiraman, Manickam; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Solit, David B.] Human Oncol & Pathogenesis Program, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Weill Med Coll Cornell Univ, Dept Med, New York, NY 10065 USA; [Al-Ahmadie, Hikmat; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pirun, Mono; Sander, Chris; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Lab, New York, NY 10065 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10065 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Bochner, Bernard] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Taylor, BS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostatist, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	barry.taylor@ucsf.edu; solitd@mskcc.org	Chan, Timothy A/ABD-5850-2021; Heguy, Adriana/GPP-3907-2022; Solit, David B./AAC-5309-2019	Janakiraman, Manickam/0000-0003-4423-6237	NCI NIH HHS [R25 CA020449, T32 CA009207, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009207] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898	3	531	540	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					221	221		10.1126/science.1226344	http://dx.doi.org/10.1126/science.1226344			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923433	Green Accepted			2022-12-01	WOS:000309712300036
J	Greenwood, B; Owusu-Agyei, S				Greenwood, Brian; Owusu-Agyei, Seth			Malaria in the Post-Genome Era	SCIENCE			English	Editorial Material							RESISTANCE; SEQUENCE		[Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London NW3 5AB, England; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo 200, Ghana	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London NW3 5AB, England.	brian.greenwood@lshtm.ac.uk; seth.owusu-agyei@kintamp-hrc.org		Owusu-Agyei, Seth/0000-0002-0807-1781				Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; D'Souza BJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-28; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; WHO, 2011, WORLD MALARIA REPORT 2011, P1	13	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					49	50		10.1126/science.1229177	http://dx.doi.org/10.1126/science.1229177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042872				2022-12-01	WOS:000309457400041
J	Schaeffner, ES; Ebert, N; Delanaye, P; Frei, U; Gaedeke, J; Jakob, O; Kuhlmann, MK; Schuchardt, M; Tolle, M; Ziebig, R; van der Giet, M; Martus, P				Schaeffner, Elke S.; Ebert, Natalie; Delanaye, Pierre; Frei, Ulrich; Gaedeke, Jens; Jakob, Olga; Kuhlmann, Martin K.; Schuchardt, Mirjam; Toelle, Markus; Ziebig, Reinhard; van der Giet, Markus; Martus, Peter			Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; CREATININE-BASED FORMULAS; CKD-EPI; IOHEXOL CLEARANCE; PLASMA-CLEARANCE; ESTIMATING GFR; RENAL-DISEASE; POPULATION; PREVALENCE	Background: In older adults, current equations to estimate glomerular filtration rate (GFR) are not validated and may misclassify elderly persons in terms of their stage of chronic kidney disease. Objective: To derive the Berlin Initiative Study (BIS) equation, a novel estimator of GFR in elderly participants. Design: Cross-sectional. Data were split for analysis into 2 sets for equation development and internal validation. Setting: Random community-based population of a large insurance company. Participants: 610 participants aged 70 years or older (mean age, 78.5 years). Intervention: Iohexol plasma clearance measurement as gold standard. Measurements: GFR, measured as the plasma clearance of the endogenous marker iohexol, to compare performance of existing equations of estimated GFR with measured GFR of the gold standard; estimation of measured GFR from standardized creatinine and cystatin C levels, sex, and age in the learning sample; and comparison of the BIS equations (BIS1: creatinine-based; BIS2: creatinine- and cystatin C-based) with other estimating equations and determination of bias, precision, and accuracy in the validation sample. Results: The new BIS2 equation yielded the smallest bias followed by the creatinine- based BIS1 and Cockcroft-Gault equations. All other equations considerably overestimated GFR. The BIS equations confirmed a high prevalence of persons older than 70 years with a GFR less than 60 mL/min per 1.73 m(2) (BIS1, 50.4%; BIS2, 47.4%; measured GFR, 47.9%). The total misclassification rate for this criterion was smallest for the BIS2 equation (11.6%), followed by the cystatin C equation 2 (15.1%) proposed by the Chronic Kidney Disease Epidemiology Collaboration. Among the creatinine- based equations, BIS1 had the smallest misclassification rate (17.2%), followed by the Chronic Kidney Disease Epidemiology Collaboration equation (20.4%). Limitation: There was no validation by an external data set. Conclusion: The BIS2 equation should be used to estimate GFR in persons aged 70 years or older with normal or mild to moderately reduced kidney function. If cystatin C is not available, the BIS1 equation is an acceptable alternative.	Charite, Vivantes Klinikum Friedrichshain, Inst Biostat & Clin Epidemiol,Lab Berlin, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; Univ Liege, CHU Sart Tilman, Liege, Belgium; Univ Tubingen, UKT Tubingen, Inst Med Biostat, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Liege; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schaeffner, ES (corresponding author), Charite Hosp, Campus Virchow Klinikum, Div Nephrol & Intens Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	elke.schaeffner@charite.de	Tölle, Markus/GPP-7157-2022; Delanaye, Pierre/T-4225-2019; Schuchardt, Mirjam/AAS-3704-2021	Delanaye, Pierre/0000-0002-1480-5761; Ebert, Natalie/0000-0002-4463-3315; Schaeffner, Elke/0000-0002-7925-4577; van der Giet, Markus/0000-0003-3590-5451; Schuchardt, Mirjam/0000-0001-7388-9611	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine.; By the Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine and the Dr. Werner Jackstadt Foundation.	Agarwal R, 2003, AM J KIDNEY DIS, V41, P752, DOI 10.1016/S0272-6386(03)00022-2; ARVIDSSON A, 1990, SCAND J CLIN LAB INV, V50, P757, DOI 10.3109/00365519009091069; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Campbell KH, 2008, CURR OPIN NEPHROL HY, V17, P298, DOI 10.1097/MNH.0b013e3282f5dd90; Cavalier E, 2008, CLIN CHIM ACTA, V396, P80, DOI 10.1016/j.cca.2008.07.011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delanaye P, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-8; Delanaye P, 2008, CLIN CHIM ACTA, V398, P118, DOI 10.1016/j.cca.2008.09.001; Finney H, 1999, ARCH GERONTOL GERIAT, V29, P75, DOI 10.1016/S0167-4943(99)00025-4; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; FRENNBY B, 1994, INVEST RADIOL, V29, pS234, DOI 10.1097/00004424-199406001-00079; Garg AX, 2004, KIDNEY INT, V65, P649, DOI 10.1111/j.1523-1755.2004.00412.x; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Inker LA, 2011, AM J KIDNEY DIS, V58, P682, DOI 10.1053/j.ajkd.2011.05.019; Johnson D, 2005, NEPHROLOGY CARLTO S4, V10, pS157; KRUTZEN E, 1984, J LAB CLIN MED, V104, P955; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Newman DJ, 2002, ANN CLIN BIOCHEM, V39, P89, DOI 10.1258/0004563021901847; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; OLSSON B, 1983, INVEST RADIOL, V18, P177, DOI 10.1097/00004424-198303000-00015; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2010, CLIN J AM SOC NEPHRO, V5, P951, DOI 10.2215/CJN.03110410; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Schaeffner ES, 2010, EUR J EPIDEMIOL, V25, P203, DOI 10.1007/s10654-010-9424-x; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Segarra A, 2011, CLIN J AM SOC NEPHRO, V6, P2411, DOI 10.2215/CJN.01150211; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Smith HW., 1951, KIDNEY STRUCTURE FUN, P552; Spinler SA, 1998, ANN PHARMACOTHER, V32, P1275, DOI 10.1345/aph.18122; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stolz A, 2010, TRANSPLANTATION, V89, P440, DOI 10.1097/TP.0b013e3181ca7d1b; van den Brand JAJG, 2011, NEPHROL DIAL TRANSPL, V26, P3176, DOI 10.1093/ndt/gfr003; Van Pottelbergh C, 2011, Adv Gerontol, V24, P108; Van Pottelbergh G, 2011, AGE AGEING, V40, P401, DOI 10.1093/ageing/afr033; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	55	381	399	2	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					471	U54		10.7326/0003-4819-157-7-201210020-00003	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	23027318	Green Submitted			2022-12-01	WOS:000309523200002
J	Rajan, A; Perrimon, N				Rajan, Akhila; Perrimon, Norbert			Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion	CELL			English	Article							JAK/STAT PATHWAY; IMAGINAL DISKS; LIFE-SPAN; IN-VIVO; CELLS; GROWTH; MELANOGASTER; METABOLISM; PEPTIDES; NEURONS	In Drosophila, the fat body (FB), a functional analog of the vertebrate adipose tissue, is the nutrient sensor that conveys the nutrient status to the insulin-producing cells (IPCs) in the fly brain to release Drosophila insulin-like peptides (Dilps). Dilp secretion in turn regulates energy balance and promotes systemic growth. We identify Unpaired 2 (Upd2), a protein with similarities to type I cytokines, as a secreted factor produced by the FB in the fed state. When upd2 function is perturbed specifically in the FB, it results in a systemic reduction in growth and alters energy metabolism. Upd2 activates JAK/STAT signaling in a population of GABAergic neurons that project onto the IPCs. This activation relieves the inhibitory tone of the GABAergic neurons on the IPCs, resulting in the secretion of Dilps. Strikingly, we find that human Leptin can rescue the upd2 mutant phenotypes, suggesting that Upd2 is the functional homolog of Leptin.	[Rajan, Akhila; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rajan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	akhila@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X	National Institutes of Health [5P01CA120964, 5R01DK088718]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Zeidler, E. Bach, B. Hassan, B. White, B. Al-Anzi, M. Pankratz, P. Shen, J. Wang, D. Krantz, J. Simpson, A. Gould, E. Hafen, H. Stocker, P. Leopold, G. Technau, and E. Olson for reagents. We thank the Transgenic RNAi Resource Project, NIG-Fly Stock Center (Japan), and the Bloomington Stock Center for flies, the Developmental Studies Hybridoma Bank for monoclonal antibodies, and the Drosophila RNAi Screening Center (Harvard Medical School) for dsRNA reagents and plate-reader equipment. We also thank C. Villalta for performing embryonic microinjections to create the human Leptin transgenic flies, F. Demontis and C. Pitsouli for critical comments on the manuscript, Y. Kwon for advice on the STAT luciferase assay, I. Droujinine for discussions and help with the diet experiments, and P. Raghavan and F. Wirtz-Peitz for insightful comments and discussions during the course of this work. This work was supported by the National Institutes of Health (5P01CA120964 and 5R01DK088718). N.P. is a Howard Hughes Medical Institute investigator.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; DasGupta R., 2005, SCI STKE, pcm5; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; de Haas Y, 2011, J DAIRY SCI, V94, P6122, DOI 10.3168/jds.2011-4439; DINARELLO CA, 1986, ANNU REV MED, V37, P173; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kahn CR, 2005, JOSLINS DIABETES MEL; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RODGERS ME, 1977, CELL, V12, P915, DOI 10.1016/0092-8674(77)90155-6; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou XB, 2005, LECT NOTES COMPUT SC, V3749, P885	47	311	319	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					123	137		10.1016/j.cell.2012.08.019	http://dx.doi.org/10.1016/j.cell.2012.08.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021220	Bronze, Green Accepted			2022-12-01	WOS:000309544200015
J	Angell, SY; Danel, I; DeCock, KM				Angell, S. Y.; Danel, I.; DeCock, K. M.			Global Indicators and Targets for Noncommunicable Diseases	SCIENCE			English	Editorial Material									[Angell, S. Y.; Danel, I.; DeCock, K. M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Angell, SY (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA.	sangell@cdc.gov						Bloom D., 2011, GLOBAL EC BURDEN NON; Carin B., 2012, POST 2015 GOALS TARG; Edvardsson K, 2005, SOC CHOICE WELFARE, V24, P343, DOI 10.1007/s00355-003-0309-8; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; WHO, 2012, COMPR GLOB MON FRAM; WHO, 2011, PROP NONC DIS TARG W; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 1998, HLTH PROM GLOSS; You D., 2011, LEVELS TRENDS CHILD, P33	9	13	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1456	1457		10.1126/science.1228293	http://dx.doi.org/10.1126/science.1228293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997310				2022-12-01	WOS:000308912900024
J	Lu, P; Wang, YZ; Graham, L; McHale, K; Gao, MY; Wu, D; Brock, J; Blesch, A; Rosenzweig, ES; Havton, LA; Zheng, BH; Conner, JM; Marsala, M; Tuszynski, MH				Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Havton, Leif A.; Zheng, Binhai; Conner, James M.; Marsala, Martin; Tuszynski, Mark H.			Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTE AXONAL REGENERATION; ADULT-RAT; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; WHITE-MATTER; NEURONS; FETAL; NOGO; DIFFERENTIATION	Neural stem cells (NSCs) expressing GFP were embedded into fibrin matrices containing growth factor cocktails and grafted to sites of severe spinal cord injury. Grafted cells differentiated into multiple cellular phenotypes, including neurons, which extended large numbers of axons over remarkable distances. Extending axons formed abundant synapses with host cells. Axonal growth was partially dependent on mammalian target of rapamycin (mTOR), but not Nogo signaling. Grafted neurons supported formation of electrophysiological relays across sites of complete spinal transection, resulting in functional recovery. Two human stem cell lines (566RSC and HUES7) embedded in growth-factor-containing fibrin exhibited similar growth, and 566RSC cells supported functional recovery. Thus, properties intrinsic to early-stage neurons can overcome the inhibitory milieu of the injured adult spinal cord to mount remarkable axonal growth, resulting in formation of new relay circuits that significantly improve function. These therapeutic properties extend across stem cell sources and species.	[Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Zheng, Binhai; Conner, James M.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Lu, Paul; Tuszynski, Mark H.] Vet Adm Med Ctr, San Diego, CA 92161 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Blesch, Armin] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, D-69120 Heidelberg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Irvine; University of California System; University of California Irvine; Ruprecht Karls University Heidelberg	Lu, P (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	plu@ucsd.edu; mtuszynski@ucsd.edu	Rosenzweig, Ephron/AAI-7541-2020	Gao, Mingyong/0000-0002-8824-7600; Rosenzweig, Ephron/0000-0002-0370-9643; Blesch, Armin/0000-0003-1133-1174	Veterans Administration; NIH [NS09881]; Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS009881, R01NS049881, R01NS054734] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Ramsey Samara for electrophysiological assistance; Janet Weber, Andrea Chan, and Jeffrey Kwan for technical assistance; the Rat Resource and Research Center, University of Missouri, Columbia, MO, for providing GFP rats; and Dr. Farquhar for use of the electron microscopy core facility. Human neural stem cells were a gift from NeuralStem, Inc. This work was supported by the Veterans Administration, NIH (NS09881), Canadian Spinal Research Organization, The Craig H. Neilsen Foundation, and the Bernard and Anne Spitzer Charitable Trust. The authors declare that they have no competing financial interests.	Bamber NI, 1999, NEURAL PLAST, V6, P103, DOI 10.1155/NP.1999.103; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Boulis NM, 2012, NAT REV NEUROL, V8, P172, DOI 10.1038/nrneurol.2011.191; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Grumbles RM, 2009, J NEUROPATH EXP NEUR, V68, P736, DOI 10.1097/NEN.0b013e3181a9360f; Harris Joseph, 2007, J Vis Exp, P305, DOI 10.3791/305; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Miller KE, 1998, BRAIN RES BULL, V47, P43, DOI 10.1016/S0361-9230(98)00065-3; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Theele DP, 1996, EXP NEUROL, V142, P128, DOI 10.1006/exnr.1996.0184; Tuszynski MH, 2008, CNS REGENERATION: BASIC SCIENCE AND CLINICAL ADVANCES, 2ND EDITION, P319, DOI 10.1016/B978-012373994-0.50015-4; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	42	580	603	20	222	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1264	1273		10.1016/j.cell.2012.08.020	http://dx.doi.org/10.1016/j.cell.2012.08.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980985	Green Accepted, Bronze			2022-12-01	WOS:000308928100018
J	Vilchez, D; Morantte, I; Liu, Z; Douglas, PM; Merkwirth, C; Rodrigues, APC; Manning, G; Dillin, A				Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Rodrigues, Ana P. C.; Manning, Gerard; Dillin, Andrew			RPN-6 determines C. elegans longevity under proteotoxic stress conditions	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STEM-CELLS; DAF-16; RESTRICTION; METABOLISM; AUTOPHAGY; GENE	Organisms that protect their germ-cell lineages from damage often do so at considerable cost: limited metabolic resources become partitioned away from maintenance of the soma, leaving the ageing somatic tissues to navigate survival amid an environment containing damaged and poorly functioning proteins. Historically, experimental paradigms that limit reproductive investment result in lifespan extension. We proposed that germline-deficient animals might exhibit heightened protection from proteotoxic stressors in somatic tissues. We find that the forced re-investment of resources from the germ line to the soma in Caenorhabditis elegans results in elevated somatic proteasome activity, clearance of damaged proteins and increased longevity. This activity is associated with increased expression of rpn-6, a subunit of the 19S proteasome, by the FOXO transcription factor DAF-16. Ectopic expression of rpn-6 is sufficient to confer proteotoxic stress resistance and extend lifespan, indicating that rpn-6 is a candidate to correct deficiencies in age-related protein homeostasis disorders.	[Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Manning, Gerard/C-8308-2009; Vilchez, David/A-8446-2008; Liu, Zheng/E-6302-2012	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Grant, Ana/0000-0002-5439-9331; Manning, Gerard/0000-0002-5087-9151; Douglas, Peter/0000-0002-0734-1049; Liu, Zheng/0000-0002-7968-3849	HHMI; NIA; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Panowski for help with the generation of transgenic strains. We thank D. Joyce for proteasome activity assays and S. Wolff for comments on the manuscript. This work was supported by HHMI and the NIA. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/NMETH.1460, 10.1038/nmeth.1460]; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapierre LR, 2012, AUTOPHAGY, V8, P144, DOI 10.4161/auto.8.1.18722; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Zabel C, 2010, J PROTEOMICS, V73, P2230, DOI 10.1016/j.jprot.2010.08.008	47	286	294	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					263	+		10.1038/nature11315	http://dx.doi.org/10.1038/nature11315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922647				2022-12-01	WOS:000308635900035
J	Lesser, LI; Cohen, DA; Brook, RH				Lesser, Lenard I.; Cohen, Deborah A.; Brook, Robert H.			Changing Eating Habits for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Lesser, Lenard I.] Palo Alto Med Fdn Res Inst, Palo Alto, CA 94306 USA; [Cohen, Deborah A.; Brook, Robert H.] RAND Corp, Santa Monica, CA USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Palo Alto Medical Foundation Research Institute; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lesser, LI (corresponding author), Palo Alto Med Fdn Res Inst, 795 El Camion Real Ames Bldg, Palo Alto, CA 94306 USA.	LesserL@pamfri.org		Lesser, Lenard/0000-0002-0713-6707				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; [Anonymous], 2011, ACCME ANN REP DAT 20; Arora R, 2004, MIL MED, V169, P522, DOI 10.7205/MILMED.169.7.522; Institute of Medicine, 2012, ACC PROGR OB PREV, P478; La Puma John, 2003, Dis Manag, V6, P191; Lesser LI, 2012, ACAD PEDIATR, V12, P62, DOI 10.1016/j.acap.2011.09.004; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846	7	16	16	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					983	984		10.1001/2012.jama.10427	http://dx.doi.org/10.1001/2012.jama.10427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968886				2022-12-01	WOS:000308579300020
J	Vonk, JE; Sanchez-Garcia, L; van Dongen, BE; Alling, V; Kosmach, D; Charkin, A; Semiletov, IP; Dudarev, OV; Shakhova, N; Roos, P; Eglinton, TI; Andersson, A; Gustafsson, O				Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.; Roos, P.; Eglinton, T. I.; Andersson, A.; Gustafsson, O.			Activation of old carbon by erosion of coastal and subsea permafrost in Arctic Siberia	NATURE			English	Article							OFFSHORE PERMAFROST; SHELF; DEGRADATION; RELEASE; MATTER; LAPTEV; CYCLE	The future trajectory of greenhouse gas concentrations depends on interactions between climate and the biogeosphere(1,2). Thawing of Arctic permafrost could release significant amounts of carbon into the atmosphere in this century(3). Ancient Ice Complex deposits outcropping along the similar to 7,000-kilometre-long coastline of the East Siberian Arctic Shelf (ESAS)(4,5), and associated shallow subsea permafrost(6,7), are two large pools of permafrost carbon(8), yet their vulnerabilities towards thawing and decomposition are largely unknown(9-11). Recent Arctic warming is stronger than has been predicted by several degrees, and is particularly pronounced over the coastal ESAS region(12,13). There is thus a pressing need to improve our understanding of the links between permafrost carbon and climate in this relatively inaccessible region. Here we show that extensive release of carbon from these Ice Complex deposits dominates (57 +/- 2 per cent) the sedimentary carbon budget of the ESAS, the world's largest continental shelf, overwhelming the marine and topsoil terrestrial components. Inverse modelling of the dual-carbon isotope composition of organic carbon accumulating in ESAS surface sediments, using Monte Carlo simulations to account for uncertainties, suggests that 44 +/- 10 teragrams of old carbon is activated annually from Ice Complex permafrost, an order of magnitude more than has been suggested by previous studies(14). We estimate that about two-thirds (66 +/- 16 per cent) of this old carbon escapes to the atmosphere as carbon dioxide, with the remainder being re-buried in shelf sediments. Thermal collapse and erosion of these carbon-rich Pleistocene coastline and seafloor deposits may accelerate with Arctic amplification of climate warming(2,13).	[Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Dept Appl Environm Sci ITM, SE-11418 Stockholm, Sweden; [Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Bert Bolin Ctr Climate Res, SE-11418 Stockholm, Sweden; [Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.] Russian Acad Sci, Pacific Oceanol Inst, Vladivostok 690041, Russia; [Semiletov, I. P.; Shakhova, N.] Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99775 USA; [Roos, P.] Riso Natl Lab Sustainable Energy, DK-4000 Roskilde, Denmark; [Eglinton, T. I.] Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland	Stockholm University; Stockholm University; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gustafsson, O (corresponding author), Stockholm Univ, Dept Appl Environm Sci ITM, Svante Arrhenius Vag 8, SE-11418 Stockholm, Sweden.	orjan.gustafsson@itm.su.se	Charkin, Alexander/G-8883-2019; Kosmach, Denis Alekseevich/AAT-5710-2020; Oleg, Dudarev Victorovich/A-8269-2019; Semiletov, Igor P/B-3616-2013; Vonk, Jorien E/H-5422-2011; Semiletov, Igor/CAJ-4412-2022; Shakhova, Natalia Evgenievna/H-6691-2016; Sanchez-Garcia, Laura/N-1172-2013	Kosmach, Denis Alekseevich/0000-0002-2276-324X; Vonk, Jorien E/0000-0002-1206-5878; Sanchez-Garcia, Laura/0000-0002-7444-1242; van Dongen, Bart/0000-0003-1189-142X; Charkin, Alexander/0000-0001-9273-9950; Eglinton, Timothy/0000-0001-5060-2155	Knut and Alice Wallenberg Foundation; Far Eastern Branch of the Russian Academy of Sciences; Swedish Research Council; US National Oceanic and Atmospheric Administration; Russian Foundation of Basic Research; Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation; NOAA OAR Climate Program Office; NERC [NE/I024798/1] Funding Source: UKRI; Natural Environment Research Council [NE/I024798/1] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation(National Science Foundation (NSF)); NOAA OAR Climate Program Office; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all ISSS-08 colleagues and crew, in particular M. Krusa, P. Andersson and V. Mordukhovich, who helped with sampling. The ISSS program is supported by the Knut and Alice Wallenberg Foundation, the Far Eastern Branch of the Russian Academy of Sciences, the Swedish Research Council, the US National Oceanic and Atmospheric Administration, the Russian Foundation of Basic Research, the Swedish Polar Research Secretariat and the Nordic Council of Ministers (Arctic Co-Op and TRI-DEFROST programs). O.G. and L.S.-G. acknowledge an Academy Research Fellow grant from the Swedish Royal Academy of Sciences and an EU Marie Curie grant, respectively. N.S. and I. P. S. acknowledge grants from the US National Science Foundation and the NOAA OAR Climate Program Office.	Dmitrenko IA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007218; Dudarev OV, 2006, DOKL EARTH SCI, V409, P1000, DOI 10.1134/S1028334X06060389; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Grigoriev M. N, 2008, THESIS YAKUTSK MELNI; Gruber N, 2004, SCOPE SER, V62, P45; Keil RG, 2004, MAR CHEM, V92, P157, DOI 10.1016/j.marchem.2004.06.024; Lantuit H, 2009, MAR GEOL, V257, P1, DOI 10.1016/j.margeo.2008.10.004; Mastepanov M, 2008, NATURE, V456, P628, DOI 10.1038/nature07464; Nicolsky D, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015006; Overduin PP, 2007, GEOL SOC AM SPEC PAP, V426, P97, DOI 10.1130/2007.2426(07); Rachold V, 2000, INT J EARTH SCI, V89, P450, DOI 10.1007/s005310000113; Razumov S.O., 2000, GEOMORPHOLOGY, V3, P88; Richter-Menge J., 2010, ARCTIC REPORT CARD 2; Rivkina E, 1998, GEOMICROBIOL J, V15, P187, DOI 10.1080/01490459809378075; Romanovskii N. N., 1993, FUNDAMENTALS CRYOGEN; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Sanchez-Garcia L, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003862; Schirrmeister L, 2011, QUATERN INT, V241, P3, DOI 10.1016/j.quaint.2010.04.004; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Semiletov I. P, 1999, DOKL EARTH SCI, V369, P1140; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Solomon S., 2007, ADV CLIM CHANG RES; Soloviev V.A., 1987, CRYOTHERMIA GAS HYDR; Stein R., 2004, ORGANIC CARBON CYCLE, P24; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Vonk JE, 2010, BIOGEOSCIENCES, V7, P3153, DOI 10.5194/bg-7-3153-2010; Vonk JE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042909; Wegner C, 2003, ESTUAR COAST SHELF S, V57, P55, DOI 10.1016/S0272-7714(02)00328-1; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	30	227	246	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					137	140		10.1038/nature11392	http://dx.doi.org/10.1038/nature11392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22932271				2022-12-01	WOS:000308347000050
J	Formenti, SC; DeWyngaert, JK; Jozsef, G; Goldberg, JD				Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor; Goldberg, Judith D.			Prone vs Supine Positioning for Breast Cancer Radiotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA; [Goldberg, Judith D.] NYU, Sch Med, Dept Environm Med, New York, NY USA	New York University; New York University	Formenti, SC (corresponding author), NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA.	silvia.formenti@nyumc.org		Goldberg, Judith D./0000-0003-3758-6976				DARBY S, 2011, LANCET, V12, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Formenti SC, 2007, J CLIN ONCOL, V25, P2236, DOI 10.1200/JCO.2006.09.1041; Lymberis SC, 2012, INT J RADIAT ONCOL, V84, P902, DOI 10.1016/j.ijrobp.2012.01.040; Stegman LD, 2007, INT J RADIAT ONCOL, V68, P73, DOI 10.1016/j.ijrobp.2006.11.054	5	112	119	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					861	863		10.1001/2012.jama.10759	http://dx.doi.org/10.1001/2012.jama.10759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948692	Bronze			2022-12-01	WOS:000308292900010
J	Metcalf, WW; Griffin, BM; Cicchillo, RM; Gao, JT; Janga, SC; Cooke, HA; Circello, BT; Evans, BS; Martens-Habbena, W; Stahl, DA; van der Donk, WA				Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; Martens-Habbena, Willm; Stahl, David A.; van der Donk, Wilfred A.			Synthesis of Methylphosphonic Acid by Marine Microbes: A Source for Methane in the Aerobic Ocean	SCIENCE			English	Article							HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; BIOSYNTHESIS; PHOSPHORUS	Relative to the atmosphere, much of the aerobic ocean is supersaturated with methane; however, the source of this important greenhouse gas remains enigmatic. Catabolism of methylphosphonic acid by phosphorus-starved marine microbes, with concomitant release of methane, has been suggested to explain this phenomenon, yet methylphosphonate is not a known natural product, nor has it been detected in natural systems. Further, its synthesis from known natural products would require unknown biochemistry. Here we show that the marine archaeon Nitrosopumilus maritimus encodes a pathway for methylphosphonate biosynthesis and that it produces cell-associated methylphosphonate esters. The abundance of a key gene in this pathway in metagenomic data sets suggests that methylphosphonate biosynthesis is relatively common in marine microbes, providing a plausible explanation for the methane paradox.	[Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; van der Donk, Wilfred A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Metcalf, William W.; Circello, Benjamin T.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Martens-Habbena, Willm; Stahl, David A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Metcalf, WW (corresponding author), Univ Illinois, Inst Genom Biol, 1206 West Gregory, Urbana, IL 61801 USA.	metcalf@uiuc.edu; vddonk@illinois.edu	Martens-Habbena, Willm/I-7656-2013; Evans, Bradley S/M-2842-2013; Martens-Habbena, Willm/AAK-1372-2021; van der Donk, Wilfred/K-2961-2015	Martens-Habbena, Willm/0000-0002-8495-9125; Evans, Bradley S/0000-0002-1207-9006; Martens-Habbena, Willm/0000-0002-8495-9125; van der Donk, Wilfred/0000-0002-5467-7071; Gao, Jiangtao/0000-0002-9669-4718; Janga, Sarath Chandra/0000-0001-7351-6268; Cooke, Heather/0000-0001-9742-5993	NIH [GM PO1 GM077596, F32 GM095024]; Howard Hughes Medical Institute (HHMI); NSF [MCB-0604448, OCE-1046017, MCB-0920741]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095024, P01GM077596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grants GM PO1 GM077596 and F32 GM095024), the Howard Hughes Medical Institute (HHMI), and NSF (grants MCB-0604448, OCE-1046017, and MCB-0920741). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences, NIH, NSF, or HHMI. The authors thank L. Zhu (University of Illinois at Urbana-Champaign) for valuable help with NMR experiments.	Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Borisova SA, 2010, CHEM BIOL, V17, P28, DOI 10.1016/j.chembiol.2009.11.017; Circello BT, 2010, CHEM BIOL, V17, P402, DOI 10.1016/j.chembiol.2010.03.007; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; DAUGHTON CG, 1979, FEMS MICROBIOL LETT, V5, P91, DOI 10.1016/0378-1097(79)90191-5; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Hilderbrand R. L., 1983, ROLE PHOSPHONATES LI; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rogers J.E., 1991, MICROBIAL PRODUCTION; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Shao ZY, 2008, J BIOL CHEM, V283, P23161, DOI 10.1074/jbc.M801788200; Tebby J. C., 1991, CRC HDB PHOSPHORUS 3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	23	182	193	7	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1104	1107		10.1126/science.1219875	http://dx.doi.org/10.1126/science.1219875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936780	Green Accepted, Green Submitted			2022-12-01	WOS:000308125800050
J	Klein, F; Halper-Stromberg, A; Horwitz, JA; Gruell, H; Scheid, JF; Bournazos, S; Mouquet, H; Spatz, LA; Diskin, R; Abadir, A; Zang, T; Dorner, M; Billerbeck, E; Labitt, RN; Gaebler, C; Marcovecchio, PM; Incesu, RB; Eisenreich, TR; Bieniasz, PD; Seaman, MS; Bjorkman, PJ; Ravetch, JV; Ploss, A; Nussenzweig, MC				Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Bournazos, Stylianos; Mouquet, Hugo; Spatz, Linda A.; Diskin, Ron; Abadir, Alexander; Zang, Trinity; Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Gaebler, Christian; Marcovecchio, Paola M.; Incesu, Reha-Baris; Eisenreich, Thomas R.; Bieniasz, Paul D.; Seaman, Michael S.; Bjorkman, Pamela J.; Ravetch, Jeffrey V.; Ploss, Alexander; Nussenzweig, Michel C.			HIV therapy by a combination of broadly neutralizing antibodies in humanized mice	NATURE			English	Article							MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; B-CELLS; INFECTION; PROTECTION; GENERATION; VIREMIA; GENE; PCR	Human antibodies to human immunodeficiency virus-1 (HIV-1) can neutralize a broad range of viral isolates in vitro and protect non-human primates against infection(1,2). Previous work showed that antibodies exert selective pressure on the virus but escape variants emerge within a short period of time(3,4). However, these experiments were performed before the recent discovery of more potent anti-HIV-1 antibodies and their improvement by structure-based design(5-9). Here we re-examine passive antibody transfer as a therapeutic modality in HIV-1-infected humanized mice. Although HIV-1 can escape from antibody monotherapy, combinations of broadly neutralizing antibodies can effectively control HIV-1 infection and suppress viral load to levels below detection. Moreover, in contrast to antiretroviral therapy(10-12), the longer half-life of antibodies led to control of viraemia for an average of 60 days after cessation of therapy. Thus, combinations of potent monoclonal antibodies can effectively control HIV-1 replication in humanized mice, and should be re-examined as a therapeutic modality in HIV-1-infected individuals.	[Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Mouquet, Hugo; Spatz, Linda A.; Abadir, Alexander; Gaebler, Christian; Incesu, Reha-Baris; Eisenreich, Thomas R.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gruell, Henning] Univ Munster, Fak Med, D-48149 Munster, Germany; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Spatz, Linda A.] CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Microbiol & Immunol, New York, NY 10031 USA; [Diskin, Ron; Marcovecchio, Paola M.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Ploss, Alexander] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Gaebler, Christian] Tech Univ Dresden, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Bieniasz, Paul D.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Rockefeller University; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; California Institute of Technology; Rockefeller University; Rockefeller University; Technische Universitat Dresden; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; California Institute of Technology; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Mouquet, Hugo/M-2750-2014; Ravetch, Jeffrey/Z-1596-2019; Gaebler, Christian/GWZ-2628-2022; Ploss, Alexander/ABG-2330-2020; Bournazos, Stylianos/ABH-1578-2021; Nussenzweig, Michel/AAE-7292-2019	Mouquet, Hugo/0000-0002-4230-610X; Ravetch, Jeffrey/0000-0003-2024-9041; Gaebler, Christian/0000-0001-7295-8128; Ploss, Alexander/0000-0001-9322-7252; Grull, Henning/0000-0002-0725-7138; Dorner, Marcus/0000-0003-0321-4226; Dorner, Marcus/0000-0001-7936-1527	German Research Foundation (DFG) [KL 2389/1-1, DO 1450/1-1, BI 1422/1-1]; German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation [OPP1033115]; NIAID [1UM1AI100663]; NIH [AI081677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI081677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kaiser for analysing viral loads of reference HIV-1 samples and N. N. Freund for producing YU2 gp120. We thank B. Flatley, T. Friling, H. Gao, S. Sell and S. Hinklein for assistance and technical support, M. Suarez-Farinas for advice on statistical analysis, and M. Babayeva for helping with antibody t<INF>1/2</INF> estimation. M. C. N. and F. K. have a pending patent application for the antibody 3BC176 and M. C. N., P.J.B. and H. M. for the antibody 10-1074 with the United States Patent and Trademark Office. These reagents are available with a Material Transfer Agreement. F. K. (KL 2389/1-1), M. D. (DO 1450/1-1) and E. B. (BI 1422/1-1) were supported by the German Research Foundation (DFG). H. G., C. G. and R.-B.I. were supported by The German National Academic Foundation. M. S. S. was supported by the Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium, grant number 1032144. A. P. is a recipient of a Liver Scholar Award from the American Liver Foundation. This work was supported in part by CAVD grant OPP1033115 from the Bill and Melinda Gates Foundation to M. C. N., in part by NIAID 1UM1AI100663 to M. C. N. and NIH grant AI081677 to M. C. N. M. C. N., P.J.B. and P. D. B. are HHMI investigators.	Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ince WL, 2010, J VIROL, V84, P2740, DOI 10.1128/JVI.02180-09; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori D.C., 2005, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Mouquet H., P NATL ACAD IN PRESS; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	36	393	406	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					118	+		10.1038/nature11604	http://dx.doi.org/10.1038/nature11604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23103874	Green Accepted			2022-12-01	WOS:000311893400057
J	Chaneton, B; Hillmann, P; Zheng, L; Martin, ACL; Maddocks, ODK; Chokkathukalam, A; Coyle, JE; Jankevics, A; Holding, FP; Vousden, KH; Frezza, C; O'Reilly, M; Gottlieb, E				Chaneton, Barbara; Hillmann, Petra; Zheng, Liang; Martin, Agnes C. L.; Maddocks, Oliver D. K.; Chokkathukalam, Achuthanunni; Coyle, Joseph E.; Jankevics, Andris; Holding, Finn P.; Vousden, Karen H.; Frezza, Christian; O'Reilly, Marc; Gottlieb, Eyal			Serine is a natural ligand and allosteric activator of pyruvate kinase M2	NATURE			English	Article							MASS-SPECTROMETRY DATA; X-RAY DATA; TUMOR-GROWTH; CANCER; CRYSTALLOGRAPHY; CONTRIBUTES; GLYCOLYSIS; METABOLISM; PATHWAY; QUALITY	Cancer cells exhibit several unique metabolic phenotypes that are critical for cell growth and proliferation(1). Specifically, they overexpress the M2 isoform of the tightly regulated enzyme pyruvate kinase (PKM2), which controls glycolytic flux, and are highly dependent on de novo biosynthesis of serine and glycine(2). Here we describe a new rheostat-like mechanistic relationship between PKM2 activity and serine biosynthesis. We show that serine can bind to and activate human PKM2, and that PKM2 activity in cells is reduced in response to serine deprivation. This reduction in PKM2 activity shifts cells to a fuel-efficient mode in which more pyruvate is diverted to the mitochondria and more glucose-derived carbon is channelled into serine biosynthesis to support cell proliferation.	[Chaneton, Barbara; Zheng, Liang; Maddocks, Oliver D. K.; Vousden, Karen H.; Frezza, Christian; Gottlieb, Eyal] Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hillmann, Petra; Martin, Agnes C. L.; Coyle, Joseph E.; Holding, Finn P.; O'Reilly, Marc] Astex Pharmaceut, Cambridge CB4 0QA, England; [Chokkathukalam, Achuthanunni; Jankevics, Andris] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Jankevics, Andris] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, NL-9747 AG Groningen, Netherlands	Beatson Institute; Cancer Research UK; Astex Pharmaceuticals; University of Glasgow; University of Groningen	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	marc.oreilly@astx.com; e.gottlieb@beatson.gla.ac.uk	Frezza, Christian/G-2174-2010; Gottlieb, Eyal/G-6450-2010; Maddocks, Oliver/K-5410-2012	Frezza, Christian/0000-0002-3293-7397; Gottlieb, Eyal/0000-0002-9770-0956; Maddocks, Oliver/0000-0002-5551-9091; Jankevics, Andris/0000-0003-2095-6846; Zheng, Liang/0000-0002-5346-4111; Hillmann, Petra/0000-0001-8642-7109	Cancer Research UK	Cancer Research UK(Cancer Research UK)	The work performed at the Beatson Institute for Cancer Research was supported by Cancer Research UK. We thank D. Sumpton for technical support with two-dimensional gel electrophoresis and N. Thompson, N. Wallis and M. Jones for comments provided during manuscript preparation. We would also like to thank D. M. Sabatini for the Scramble shRNA plasmid used as a control (shCntrla) and the Structural Genomics Consortium for providing us with the PKM2 expression plasmid from their collection. We thank A. King for editorial work and S. Tardito for graphical help.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; EIGENBRODT E, 1983, BIOMED BIOCHIM ACTA, V42, pS278; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARQUEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P667, DOI 10.1016/0003-9861(89)90335-4; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MEDINA MA, 1992, BIOCHEM MED METAB B, V48, P1, DOI 10.1016/0885-4505(92)90041-V; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Salituro F. G., 2010, Preparation of Pyridinyl or Pyrimidinyl Imidazoles, Pyrroles and Pyrazoles as PKM2 Modulators Useful in Treating Cancer, Patent No. [2010118063 A2, 2010118063]; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SPELLMAN CM, 1973, FEBS LETT, V37, P281, DOI 10.1016/0014-5793(73)80478-8; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	39	393	412	9	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					458	+		10.1038/nature11540	http://dx.doi.org/10.1038/nature11540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064226	Green Accepted			2022-12-01	WOS:000311031600049
J	Li, MQ; Kao, E; Gao, X; Sandig, H; Limmer, K; Pavon-Eternod, M; Jones, TE; Landry, S; Pan, T; Weitzman, MD; David, M				Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; Pavon-Eternod, Mariana; Jones, Thomas E.; Landry, Sebastien; Pan, Tao; Weitzman, Matthew D.; David, Michael			Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11	NATURE			English	Article							INFLUENZA-A VIRUS; EXPORT PATHWAY; NUCLEAR EXPORT; MESSENGER-RNA; GENE; BIAS; IMMUNODEFICIENCY; ACTIVATION; EXPRESSION; SELECTION	In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway(1). However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination.	[Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; David, Michael] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Pavon-Eternod, Mariana; Jones, Thomas E.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Landry, Sebastien; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [David, Michael] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Chicago; Salk Institute; University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	midavid@ucsd.edu		Li, Manqing/0000-0002-7593-7979	NIH [AI81019, AI074967, P01AI090935, R01GM101982, R21AI088490, P30AI36214]; HINT Program [NIH P01AI090935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074967, R21AI081019, P01AI090935, P30AI036214, R21AI088490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HINT Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Smith for help with the HIV replication studies; M. Wood for performing the electron microscope analysis; D. Xu and D.-Y. Song for technical assistance; and J. Young, J. Guatelli, D. Smith, M. Kaul and S. Chanda for discussion. This work was supported in part by NIH AI81019 and AI074967 to M. D. W., NIH P01AI090935, R01GM101982 and R21AI088490 to M. D., and by resources from the UCSD Center for AIDS Research, NIH P30AI36214, and the HINT Program, NIH P01AI090935. The authors declare no competing financial interests.	Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Forsberg R, 2003, MOL BIOL EVOL, V20, P1252, DOI 10.1093/molbev/msg149; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; Fritz CC, 1996, CURR BIOL, V6, P848, DOI 10.1016/S0960-9822(02)00608-5; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; GRANTHAM R, 1986, NATURE, V319, P727, DOI 10.1038/319727b0; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Kofman Alexander, 2003, Tsitologiia, V45, P86; KYPR J, 1987, NATURE, V327, P20, DOI 10.1038/327020a0; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Meintjes Peter L., 2005, Journal of Bioinformatics and Computational Biology, V3, P157, DOI 10.1142/S0219720005000953; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	28	212	221	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					125	U145		10.1038/nature11433	http://dx.doi.org/10.1038/nature11433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000900	Green Accepted			2022-12-01	WOS:000310434500043
J	Jia, JL; Zheng, XB; Hu, GQ; Cui, KR; Zhang, JQ; Zhang, AY; Jiang, H; Lu, BW; Yates, J; Liu, CY; Zhao, KJ; Zheng, YX				Jia, Junling; Zheng, Xiaobin; Hu, Gangqing; Cui, Kairong; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Lu, Bingwen; Yates, John, III; Liu, Chengyu; Zhao, Keji; Zheng, Yixian			Regulation of Pluripotency and Self-Renewal of ESCs through Epigenetic-Threshold Modulation and mRNA Pruning	CELL			English	Article							EMBRYONIC STEM-CELLS; CORE TRANSCRIPTIONAL NETWORK; DEVELOPMENTAL REGULATORS; TROPHECTODERM DIFFERENTIATION; GENE-EXPRESSION; POLYMERASE-II; TARGET GENES; CHROMATIN; POLYCOMB; PROTEIN	Embryonic stem cell (ESC) pluripotency requires bivalent epigenetic modifications of key developmental genes regulated by various transcription factors and chromatin-modifying enzymes. How these factors coordinate with one another to maintain the bivalent chromatin state so that ESCs can undergo rapid self-renewal while retaining pluripotency is poorly understood. We report that Utf1, a target of Oct4 and Sox2, is a bivalent chromatin component that buffers poised states of bivalent genes. By limiting PRC2 loading and histone 3 lysine-27 trimethylation, Utf1 sets proper activation thresholds for bivalent genes. It also promotes nuclear tagging of messenger RNAs (mRNAs) transcribed from insufficiently silenced bivalent genes for cytoplasmic degradation through mRNA decapping. These opposing functions of Utf1 promote coordinated differentiation. The mRNA degradation function also ensures rapid cell proliferation by blocking the Myc-Arf feedback control. Thus, Utf1 couples the core pluripotency factors with Myc and PRC2 networks to promote the pluripotency and proliferation of ESCs.	[Jia, Junling; Zheng, Xiaobin; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Jia, Junling; Zheng, Yixian] NHLBI, Howard Hughes Med Inst, NIH, Bethesda, MD 20892 USA; [Hu, Gangqing; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, NIH, Bethesda, MD 20892 USA; [Lu, Bingwen; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Zhang, An/GRS-5852-2022; Hu, Gangqing/ABA-3507-2020; HU, GANGQING/K-5849-2012; Zheng, Xiaobin/AAD-7564-2019	HU, GANGQING/0000-0001-5453-6888; 	NIH [GM56312, MH067880, P41 RR011823]; NHLBI; HHMI [P41 RR011823, R01 HL079442-08]; Cystic Fibrosis Foundation Therapeutics, Inc. [BALCH05X5];  [R01 GM056312]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZICHL006058, ZIAHL005801, R01HL079442, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); HHMI(Howard Hughes Medical Institute); Cystic Fibrosis Foundation Therapeutics, Inc.; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Allison Pinder for deep-seq; Nick Ingolia for advice on data analyses; and Chen-ming Fan, Nick Ingolia, Xin Chen, Haiqing Zhao, Dong Yang, Ma Wan, Max Guo, and members of the Zheng lab for comments. This work was supported by NIH (GM56312 to Y. Z.; MH067880 and P41 RR011823 to J. R. Y.) and by NHLBI intramural research (G. H., K. C., C. L., and K. Z.). This work was also supported by R01 GM056312 (Y. Z., J. Z., A. Z.), HHMI (J. J., Y. Z.), P41 RR011823 and R01 HL079442-08 (J. Y.), and Cystic Fibrosis Foundation Therapeutics, Inc. BALCH05X5 (B.L.).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fukushima A, 1998, J BIOL CHEM, V273, P25840, DOI 10.1074/jbc.273.40.25840; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Vong QP, 2010, STEM CELLS, V28, P1030, DOI 10.1002/stem.428; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	57	57	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					576	589		10.1016/j.cell.2012.09.023	http://dx.doi.org/10.1016/j.cell.2012.09.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101626	Green Accepted, Bronze			2022-12-01	WOS:000310529300014
J	Sugihara, G; May, R; Ye, H; Hsieh, CH; Deyle, E; Fogarty, M; Munch, S				Sugihara, George; May, Robert; Ye, Hao; Hsieh, Chih-hao; Deyle, Ethan; Fogarty, Michael; Munch, Stephan			Detecting Causality in Complex Ecosystems	SCIENCE			English	Article							SARDINE SARDINOPS-SAGAX; PACIFIC SARDINE; ANCHOVY POPULATIONS; TIME-SERIES; FLUCTUATIONS; DYNAMICS; CHAOS; SYSTEMS	Identifying causal networks is important for effective policy and management recommendations on climate, epidemiology, financial regulation, and much else. We introduce a method, based on nonlinear state space reconstruction, that can distinguish causality from correlation. It extends to nonseparable weakly connected dynamic systems (cases not covered by the current Granger causality paradigm). The approach is illustrated both by simple models (where, in contrast to the real world, we know the underlying equations/relations and so can check the validity of our method) and by application to real ecological systems, including the controversial sardine-anchovy-temperature problem.	[Sugihara, George; Ye, Hao; Deyle, Ethan] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [May, Robert] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 106, Taiwan; [Fogarty, Michael] NOAA, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Munch, Stephan] NOAA, SW Fisheries Sci Ctr, Santa Cruz, CA 95060 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford; National Taiwan University; National Taiwan University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu; chsieh@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008; Deyle, Ethan R/AAR-8749-2021	Hsieh, Chih-hao/0000-0001-5935-7272; Ye, Hao/0000-0002-8630-1458	NSF [DEB-1020372]; NSF/NOAA CAMEO Award [NA08OAR4320894]; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University; National Science Council of Taiwan; NSF graduate research fellowships; EPA STAR graduate fellowship	NSF(National Science Foundation (NSF)); NSF/NOAA CAMEO Award; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NSF graduate research fellowships(National Science Foundation (NSF)); EPA STAR graduate fellowship(United States Environmental Protection Agency)	We thank S. Sandin, L. Kaufman, A. MacCall, J. Melack, J. Schnute, L. Richards, A. Rosenberg, M. Kumagai, H. Liu, I. Altman, B. Fissel, S. Glaser, B. Carr, E. Klein, L. Storch, S. Kealhofer, M. Kogler, and C. Perretti for their comments and assistance with this work, and P. Sugihara for developing and producing the initial animations for movies S1 and S2. Supported by NSF grant DEB-1020372, NSF/NOAA CAMEO Award NA08OAR4320894, the McQuown Chair in Natural Science, the Sugihara Family Trust, and Quantitative Advisors (http://qadvisors.com) (G. S.); National Taiwan University and the National Science Council of Taiwan (C. H.); NSF graduate research fellowships (H.Y. and E. D.); and an EPA STAR graduate fellowship (E.D.).	ASCIOTI FA, 1993, J PLANKTON RES, V15, P603, DOI 10.1093/plankt/15.6.603; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Berkeley G, 1710, TREATISE PRINCIPLES; Bischi G. I., 2010, NONLINEAR DYNAMICS E; BROCK WA, 1988, J MONETARY ECON, V22, P71, DOI 10.1016/0304-3932(88)90170-5; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Committee on Major U. S. Oceanographic Research Programs, 1999, GLOB OC SCI INT APPR; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Josic K, 2000, NONLINEARITY, V13, P1321, DOI 10.1088/0951-7715/13/4/318; Lasker R., 1983, P JOINT OC ASS 1982, P110; LLOYD AL, 1995, J THEOR BIOL, V173, P217, DOI 10.1006/jtbi.1995.0058; Lo TT, 2010, ATMOS SCI LETT, V11, P210, DOI 10.1002/asl.275; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McClatchie S, 2010, CAN J FISH AQUAT SCI, V67, P1782, DOI 10.1139/F10-101; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Murphy G. I., 1964, MIN M MAR RES COMM, V7, P1; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Patil DAS, 2001, MON WEATHER REV, V129, P2116, DOI 10.1175/1520-0493(2001)129<2116:ILDNBI>2.0.CO;2; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F., 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Veilleux B. G., 1976, THESIS U ALBERTA; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387	30	1013	1042	56	671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					496	500		10.1126/science.1227079	http://dx.doi.org/10.1126/science.1227079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	22997134				2022-12-01	WOS:000310195800049
J	Jin, MS; Oldham, ML; Zhang, QJ; Chen, J				Jin, Mi Sun; Oldham, Michael L.; Zhang, Qiuju; Chen, Jue			Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans	NATURE			English	Article							DRUG-BINDING POCKET; ATPASE ACTIVITY; ALTERNATING ACCESS; NUCLEOTIDE-BINDING; MEMBRANE; RESISTANCE; MUTATIONS; MUTANTS; CELLS; PURIFICATION	P-glycoprotein (P-gp) is an ATP-binding cassette transporter that confers multidrug resistance in cancer cells(1,2). It also affects the absorption, distribution and clearance of cancer-unrelated drugs and xenobiotics. For these reasons, the structure and function of P-gp have been studied extensively for decades(3). Here we present biochemical characterization of P-gp from Caenorhabditis elegans and its crystal structure at a resolution of 3.4 angstroms. We find that the apparent affinities of P-gp for anticancer drugs actinomycin D and paclitaxel are approximately 4,000 and 100 times higher, respectively, in the membrane bilayer than in detergent. This affinity enhancement highlights the importance of membrane partitioning when a drug accesses the transporter in the membrane(4). Furthermore, the transporter in the crystal structure opens its drug pathway at the level of the membrane's inner leaflet. In the helices flanking the opening to the membrane, we observe extended loops that may mediate drug binding, function as hinges to gate the pathway or both. We also find that the interface between the transmembrane and nucleotide-binding domains, which couples ATP hydrolysis to transport, contains a ball-and-socket joint and salt bridges similar to the ATP-binding cassette importers(5), suggesting that ATP-binding cassette exporters and importers may use similar mechanisms to achieve alternating access for transport. Finally, a model of human P-gp derived from the structure of C. elegans P-gp not only is compatible with decades of biochemical analysis(6-12), but also helps to explain perplexing functional data regarding the Phe335Ala mutant(13,14). These results increase our understanding of the structure and function of this important molecule.	[Jin, Mi Sun; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Oldham, Michael L.; Zhang, Qiuju; Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	zhang, qiu/GXG-5600-2022		Howard Hughes Medical Institute; Purdue Center for Cancer Research [NCI CCSG CA23168]; National Research Foundation of Korea; International Human Frontier Science Program; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Purdue Center for Cancer Research; National Research Foundation of Korea(National Research Foundation of Korea); International Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the beamline staff of the GM/CA CAT at the Advanced Photon System for assistance with data collection, Y.-K. Cho for assistance with protein purification and A. Davidson for comments on the manuscript. We also thank the MacKinnon laboratory for reagents and advice on the P. pastoris expression system. This work was supported by Howard Hughes Medical Institute (J.C.), Purdue Center for Cancer Research (NCI CCSG CA23168), and postdoctoral fellowships from the National Research Foundation of Korea and the International Human Frontier Science Program (M.S.J.).	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARRIGOS M, 1993, BIOCHEM BIOPH RES CO, V196, P1034, DOI 10.1006/bbrc.1993.2355; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kim IW, 2008, MINI-REV MED CHEM, V8, P193; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1993, J BIOL CHEM, V268, P19965; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	35	365	372	5	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					566	+		10.1038/nature11448	http://dx.doi.org/10.1038/nature11448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23000902	Green Accepted			2022-12-01	WOS:000310196200048
J	Weeks, JC; Catalano, PJ; Cronin, A; Finkelman, MD; Mack, JW; Keating, NL; Schrag, D				Weeks, Jane C.; Catalano, Paul J.; Cronin, Angel; Finkelman, Matthew D.; Mack, Jennifer W.; Keating, Nancy L.; Schrag, Deborah			Patients' Expectations about Effects of Chemotherapy for Advanced Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; ADVANCED COLORECTAL-CANCER; CARE OUTCOMES RESEARCH; QUALITY-OF-LIFE; SURVEILLANCE CONSORTIUM; MULTIPLE IMPUTATION; RANDOMIZED-TRIAL; PALLIATIVE CARE; SUPPORTIVE CARE; TREATMENT GOALS	Background Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. Methods We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. Results Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. Conclusions Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.)	[Weeks, Jane C.; Cronin, Angel; Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Catalano, Paul J.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Finkelman, Matthew D.] Tufts Univ, Sch Dent Med, Dept Publ Hlth & Community Serv, Boston, MA 02111 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Keating, Nancy L.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Tufts University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Weeks, JC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	jane_weeks@dfci.harvard.edu	Maslov, Victor Pavlovich/M-9068-2015; Keating, Nancy L/I-9968-2019	Maslov, Victor Pavlovich/0000-0003-2599-5086; Keating, Nancy L/0000-0002-8274-4681	National Cancer Institute (NCI) [U01 CA093344]; NCI; Dana-Farber Cancer Institute/Cancer Research Network [U01 CA093332]; Harvard Medical School/Northern California Cancer Center [U01 CA093324, RAND/UCLA U01 CA093348]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA093339]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [CRS 02-164]; NATIONAL CANCER INSTITUTE [U01CA093332, U01CA093344, U01CA093324, U01CA093329, U01CA093326, U01CA093339, U01CA093348] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana-Farber Cancer Institute/Cancer Research Network; Harvard Medical School/Northern California Cancer Center; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (NCI) to the Statistical Coordinating Center (U01 CA093344) and the NCI-supported Primary Data Collection and Research Centers, Dana-Farber Cancer Institute/Cancer Research Network (U01 CA093332), Harvard Medical School/Northern California Cancer Center (U01 CA093324, RAND/UCLA U01 CA093348), University of Alabama at Birmingham (U01 CA093329), University of Iowa (U01 CA093339), and University of North Carolina (U01 CA093326); and by a Department of Veterans Affairs grant to the Durham Veterans Affairs Medical Center (CRS 02-164).	[Anonymous], 2004, J PALLIAT MED, V7, P637; Ayanian JZ, 2010, J CLIN ONCOL, V28, P4154, DOI 10.1200/JCO.2009.27.3268; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Catalano P, 2012, MED CARE APPL M 0307; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen JY, 2008, MED CARE, V46, P1157, DOI 10.1097/MLR.0b013e31817924bc; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1007/s001740170077; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Gabrijel S, 2008, J CLIN ONCOL, V26, P297, DOI 10.1200/JCO.2007.13.0609; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; GLIMELIUS B, 1994, CANCER, V73, P556, DOI 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO;2-8; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003; He Y, 2010, STAT METHODS MED RES, V19, P653, DOI 10.1177/0962280208101273; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; Keating NL, 2010, J CLIN ONCOL, V28, P4364, DOI 10.1200/JCO.2009.26.8870; Leighl NB, 2011, J CLIN ONCOL, V29, P2077, DOI 10.1200/JCO.2010.32.0754; LIDZ CW, 1988, ARCH INTERN MED, V148, P1385, DOI 10.1001/archinte.148.6.1385; Mack JW, 2007, J CLIN ONCOL, V25, P1357, DOI 10.1200/JCO.2006.08.3170; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; MCQUELLON RP, 1995, J CLIN ONCOL, V13, P858, DOI 10.1200/JCO.1995.13.4.858; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Smith Thomas J, 2011, J Support Oncol, V9, P79; Smith TJ, 2010, CLIN CANCER RES, V16, P5981, DOI 10.1158/1078-0432.CCR-10-1278; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Tourangeau R, 2000, PSYCHOL SURVEY RESPO, DOI 10.1017/CBO9780511819322; von Gunten Charles F, 2004, J Palliat Med, V7, P209, DOI 10.1089/109662104773709332; von Roenn JH, 2003, J CLIN ONCOL, V21, P570, DOI 10.1200/JCO.2003.10.161; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	39	767	773	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1616	1625		10.1056/NEJMoa1204410	http://dx.doi.org/10.1056/NEJMoa1204410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094723	Green Accepted			2022-12-01	WOS:000310131700008
J	Freeman, MF; Gurgui, C; Helf, MJ; Morinaka, BI; Uria, AR; Oldham, NJ; Sahl, HG; Matsunaga, S; Piel, J				Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Oldham, Neil J.; Sahl, Hans-Georg; Matsunaga, Shigeki; Piel, Joern			Metagenome Mining Reveals Polytheonamides as Posttranslationally Modified Ribosomal Peptides	SCIENCE			English	Article							MARINE SPONGE; ANTIMICROBIAL PEPTIDE; BACTERIAL SYMBIONT; GENE-CLUSTER; RADICAL SAM; BIOSYNTHESIS; SUPERFAMILY; FAMILY; ACIDS	It is held as a paradigm that ribosomally synthesized peptides and proteins contain only L-amino acids. We demonstrate a ribosomal origin of the marine sponge-derived polytheonamides, exceptionally potent, giant natural-product toxins. Isolation of the biosynthetic genes from the sponge metagenome revealed a bacterial gene architecture. Only six candidate enzymes were identified for 48 posttranslational modifications, including 18 epimerizations and 17 methylations of nonactivated carbon centers. Three enzymes were functionally validated, which showed that a radical S-adenosylmethionine enzyme is responsible for the unidirectional epimerization of multiple and different amino acids. Collectively, these complex alterations create toxins that function as unimolecular minimalistic ion channels with near-femtomolar activity. This study broadens the biosynthetic scope of ribosomal systems and creates new opportunities for peptide and protein bioengineering.	[Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Oldham, Neil J.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany; [Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Piel, Joern] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Bonn; University of Nottingham; University of Bonn; University of Tokyo; Swiss Federal Institutes of Technology Domain; ETH Zurich	Piel, J (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	joern.piel@uni-bonn.de	Freeman, Michael/AIA-1555-2022	Freeman, Michael/0000-0002-0491-9618; Morinaka, Brandon/0000-0001-8239-619X; Helf, Maximilian/0000-0002-1393-3999; Oldham, Neil/0000-0001-8024-4563; Uria, Agustinus R./0000-0002-9223-7464	German Federal Ministry of Education and Research (BMBF) [GenBioCom: 0315581I]; Deutsche Forschungsgemeinschaft [PI 430/8-1, PI 430/9-1, FOR 854, SFB 813]; Japan Society for the Promotion of Science; German Academic Exchange Service (DAAD); Humboldt Foundation; Human Frontier Science Program	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Humboldt Foundation(Alexander von Humboldt Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank M. Josten for antibiotic activity testing, M. Engeser and C. Sondag for MALDI measurements, A. Schneider for high-performance liquid chromatography measurements, U. Deppenmeier and P. Schweiger for Western blot analysis, and T. Gulder for comments on the manuscript. This work was supported by grants from the German Federal Ministry of Education and Research (BMBF) (GenBioCom: 0315581I) to J.P., the Deutsche Forschungsgemeinschaft to J.P. (PI 430/8-1, PI 430/9-1, FOR 854, SFB 813) and H.-G. S. (FOR 854), the Japan Society for the Promotion of Science to J.P. and S. M., and fellowships by the German Academic Exchange Service (DAAD) to A. R. U., the Humboldt Foundation to B. I. M., and the Human Frontier Science Program to M. F. F. The data reported in this paper are reported in the supplementary materials and archived in GenBank under accession no. JX456532. J.P., C. G., M. F. F., A. R. U., and M.J.H. are inventors on European Patent Application no. 11 180 107.2. filed by Rheinische Friedrich-Wilhelms-Universitat Bonn through PROvendis GmbH titled "Biosynthetic gene cluster for the production of peptide-protein analogs."	Claesen J, 2010, P NATL ACAD SCI USA, V107, P16297, DOI 10.1073/pnas.1008608107; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamada T, 2005, J AM CHEM SOC, V127, P110, DOI 10.1021/ja045749e; Hamada T, 2010, J AM CHEM SOC, V132, P12941, DOI 10.1021/ja104616z; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Inoue M, 2010, NAT CHEM, V2, P280, DOI [10.1038/nchem.554, 10.1038/NCHEM.554]; Iwamoto M, 2010, FEBS LETT, V584, P3995, DOI 10.1016/j.febslet.2010.08.007; Jilek A, 2008, MONATSH CHEM, V139, P1, DOI 10.1007/s00706-007-0780-5; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Long PF, 2005, CHEMBIOCHEM, V6, P1760, DOI 10.1002/cbic.200500210; MATSUNAGA S, 1984, TETRAHEDRON LETT, V25, P5165, DOI 10.1016/S0040-4039(01)81553-7; Matsuoka S, 2011, ANGEW CHEM, V123, P4981; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Shen GZ, 2008, J BACTERIOL, V190, P4808, DOI 10.1128/JB.00436-08; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Ueoka R, 2010, J AM CHEM SOC, V132, P17692, DOI 10.1021/ja109275z; Velasquez JE, 2011, CHEM BIOL, V18, P857, DOI 10.1016/j.chembiol.2011.05.007; You YO, 2007, BIOCHEMISTRY-US, V46, P5991, DOI 10.1021/bi602663x; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	30	219	221	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					387	390		10.1126/science.1226121	http://dx.doi.org/10.1126/science.1226121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22983711				2022-12-01	WOS:000309955800042
J	Ackman, JB; Burbridge, TJ; Crair, MC				Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.			Retinal waves coordinate patterned activity throughout the developing visual system	NATURE			English	Article							RETINOTOPIC MAP REFINEMENT; LATERAL GENICULATE-NUCLEUS; MOUSE SUPERIOR COLLICULUS; EYE-SPECIFIC SEGREGATION; IMAGING IN-VIVO; GANGLION-CELLS; ACTIVITY TRANSIENTS; RETINOGENICULATE PROJECTIONS; DIRECTION SELECTIVITY; ACTION-POTENTIALS	The morphological and functional development of the vertebrate nervous system is initially governed by genetic factors and subsequently refined by neuronal activity. However, fundamental features of the nervous system emerge before sensory experience is possible. Thus, activity-dependent development occurring before the onset of experience must be driven by spontaneous activity, but the origin and nature of activity in vivo remains largely untested. Here we use optical methods to show in live neonatal mice that waves of spontaneous retinal activity are present and propagate throughout the entire visual system before eye opening. This patterned activity encompassed the visual field, relied on cholinergic neurotransmission, preferentially initiated in the binocular retina and exhibited spatiotemporal correlations between the two hemispheres. Retinal waves were the primary source of activity in the midbrain and primary visual cortex, but only modulated ongoing activity in secondary visual areas. Thus, spontaneous retinal activity is transmitted through the entire visual system and carries patterned information capable of guiding the activity-dependent development of complex intra-and inter-hemispheric circuits before the onset of vision.	[Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Crair, MC (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	michael.crair@yale.edu		Ackman, James/0000-0003-0802-6080	US National Institutes of Health (NIH) [P30 EY000785, R01 EY015788, T32 NS007224, T15 LM070506, T32 EY017353]; family of William Ziegler III; NATIONAL EYE INSTITUTE [R01EY017353, T32EY022312, P30EY000785, R01EY023105, R01EY015788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of William Ziegler III; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Sachdev and D. McCormick for Emx1-Cre:Ai38 mice, C. Chen for helpful advice on ganglion cell loading with calcium indicators and Y. Zhang for technical support. We would like to thank M. Colonnese and members of the Crair laboratory for valuable comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grants P30 EY000785 and R01 EY015788 (to M. C. C.), T32 NS007224 (to J.A.), and T15 LM070506 and T32 EY017353 (to T. B.). This work was also supported by the family of William Ziegler III.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dhande OS, 2011, JOVE-J VIS EXP, DOI 10.3791/2678; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gastinger MJ, 2006, CURR EYE RES, V31, P655, DOI 10.1080/02713680600776119; Gonzalez R. C., 2009, DIGITAL IMAGE PROCES; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; MULLER M, 1988, EXP BRAIN RES, V71, P611, DOI 10.1007/BF00248754; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Tolonen M, 2007, NEUROSCIENCE, V145, P997, DOI 10.1016/j.neuroscience.2006.12.070; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007	59	272	273	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					219	+		10.1038/nature11529	http://dx.doi.org/10.1038/nature11529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060192	Green Accepted			2022-12-01	WOS:000309733300041
J	Nestler, EJ				Nestler, Eric J.			Stress makes its molecular mark	NATURE			English	Editorial Material							MOUSE NUCLEUS-ACCUMBENS; HISTONE METHYLATION; DEPRESSION		[Nestler, Eric J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH051399, P50 MH096890] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Caldji C, 2011, FEBS LETT, V585, P2049, DOI 10.1016/j.febslet.2011.03.032; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Sun H, 2012, NEUROPSYCHOPHARMACOL; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	10	53	53	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					171	172		10.1038/490171a	http://dx.doi.org/10.1038/490171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060173	Green Accepted			2022-12-01	WOS:000309733300024
J	de Vanssay, A; Bouge, AL; Boivin, A; Hermant, C; Teysset, L; Delmarre, V; Antoniewski, C; Ronsseray, S				de Vanssay, Augustin; Bouge, Anne-Laure; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Antoniewski, Christophe; Ronsseray, Stephane			Paramutation in Drosophila linked to emergence of a piRNA-producing locus	NATURE			English	Article							P-ELEMENT REPRESSION; HETEROCHROMATIN FORMATION; B1 LOCUS; MAIZE; MELANOGASTER; TRANS; GENE; ESTABLISHMENT; SEQUENCES; CYTOTYPE	A paramutation is an epigenetic interaction between two alleles of a locus, through which one allele induces a heritable modification in the other allele without modifying the DNA sequence(1,2). The paramutated allele itself becomes paramutagenic, that is, capable of epigenetically converting a new paramutable allele. Here we describe a case of paramutation in animals showing long-term transmission over generations. We previously characterized a homology-dependent silencing mechanism referred to as the trans-silencing effect (TSE), involved in P-transposable-element repression in the germ line(3-5). We now show that clusters of P-element-derived transgenes that induce strong TSE6,7 can convert other homologous transgene clusters incapable of TSE into strong silencers, which transmit the acquired silencing capacity through 50 generations. The paramutation occurs without any need for chromosome pairing between the paramutagenic and the paramutated loci, and is mediated by maternal inheritance of cytoplasm carrying Piwi-interacting RNAs (piRNAs) homologous to the transgenes. The repression capacity of the paramutated locus is abolished by a loss-of-function mutation of the aubergine gene involved in piRNA biogenesis, but not by a loss-of-function mutation of the Dicer-2 gene involved in siRNA production. The paramutated cluster, previously producing barely detectable levels of piRNAs, is converted into a stable, strong piRNA-producing locus by the paramutation and becomes fully paramutagenic itself. Our work provides a genetic model for the emergence of piRNA loci, as well as for RNA-mediated trans-generational repression of transposable elements.	[de Vanssay, Augustin; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; [Bouge, Anne-Laure; Antoniewski, Christophe] Inst Pasteur, CNRS, URA2578, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ronsseray, S (corresponding author), Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, 9 Quai St Bernard, F-75005 Paris, France.	christophe.antoniewski@upmc.fr; stephane.ronsseray@upmc.fr	Antoniewski, Christophe/G-4519-2011; Ronsseray, Stephane/AAD-6378-2021	Antoniewski, Christophe/0000-0001-7709-2116; Hermant, catherine/0000-0002-3906-2546; Teysset, Laure/0000-0002-7413-1850; Boivin, Antoine/0000-0001-8671-1599	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; Association Nationale de la Recherche (ANR); Association pour la Recherche contre le Cancer; ANR (project "Nuclear endosiRNAs")	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR (project "Nuclear endosiRNAs")(French National Research Agency (ANR))	We thank O. Sismeiro, J.-Y. Copee, E. Mouchel-Vielh, V. Ribeiro, C. Pappatico and P. Graca for technical assistance, D. Dorer, S. Henikoff and the Bloomington Stock Center for providing stocks, and flybase.org for providing databases. We thank T. Josse for preliminary experiments. We thank J.-R. Huynh, V. Colot, N. Randsholt, A.-M. Pret, C. Carre and F. Peronnet for critical reading of the manuscript. S.R. thanks D. Anxolabehere and M. Lehmann for previous help. This work was supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche to A.d.V. and C.H., from the Fondation pour la Recherche Medicale to A.d.V., from the Association Nationale de la Recherche (ANR) to A.-L.B., and by grants from the Association pour la Recherche contre le Cancer to S.R. and from the ANR (project "Nuclear endosiRNAs") to C.A.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; COE EH, 1959, P NATL ACAD SCI USA, V45, P828, DOI 10.1073/pnas.45.6.828; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Engels W. R., 1989, P ELEMENTS DROSOPHIL; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOLLICK JB, 1995, GENETICS, V141, P709; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Josse T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003249; KIDWELL MG, 1977, GENETICS, V86, P813; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEMAITRE B, 1993, GENETICS, V135, P149; Marin L, 2000, GENETICS, V155, P1841; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pilu R, 2009, HEREDITY, V102, P236, DOI 10.1038/hdy.2008.96; Poyhonen M, 2012, G3-GENES GENOM GENET, V2, P331, DOI 10.1534/g3.111.001925; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; Ronsseray S, 2001, GENETICS, V159, P1631; SCHUPBACH T, 1991, GENETICS, V129, P1119; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Stuart JR, 2002, GENETICS, V162, P1641; Todeschini AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011032; Wilson JE, 1996, DEV GENET, V19, P199, DOI 10.1002/(SICI)1520-6408(1996)19:3<199::AID-DVG3>3.0.CO;2-4	37	149	154	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					112	U132		10.1038/nature11416	http://dx.doi.org/10.1038/nature11416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22922650	Green Published			2022-12-01	WOS:000309446800043
J	Perez, C; Koshy, C; Yildiz, O; Ziegler, C				Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine			Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP	NATURE			English	Article							NA+/BETAINE SYMPORTER BETP; CORYNEBACTERIUM-GLUTAMICUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CARRIER BETP; OPEN STATES; K+; HOMOLOG; BINDING; SODIUM	Betaine and Na+ symport has been extensively studied in the osmotically regulated transporter BetP from Corynebacterium glutamicum, a member of the betaine/choline/carnitine transporter family, which shares the conserved LeuT-like fold of two inverted structural repeats(1). BetP adjusts its transport activity by sensing the cytoplasmic K+ concentration as a measure for hyperosmotic stress via the osmosensing carboxy-terminal domain(2,3). BetP needs to be in a trimeric state for communication between individual protomers through several intratrimeric interaction sites(4). Recently, crystal structures of inward-facing BetP trimers have contributed to our understanding of activity regulation on a molecular level(5,6). Here we report new crystal structures, which reveal two conformationally asymmetric BetP trimers(7), capturing among them three distinct transport states. We observe a total of four new conformations at once: an outward-open apo and an outward-occluded apo state, and two closed transition states-one in complex with betaine and one substrate-free. On the basis of these new structures, we identified local and global conformational changes in BetP that underlie the molecular transport mechanism, which partially resemble structural changes observed in other sodium-coupled LeuT-like fold transporters, but show differences we attribute to the osmolytic nature of betaine, the exclusive substrate specificity and the regulatory properties of BetP.	[Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Ziegler, Christine] Univ Regensburg, Inst Biophys & Biophys Chem, D-93053 Regensburg, Germany	Max Planck Society; University of Regensburg	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@biophys.mpg.de	Perez, Camilo/AAA-8733-2021; Yildiz, Ozkan/P-9207-2016	Perez, Camilo/0000-0002-5800-0084; Yildiz, Ozkan/0000-0003-3659-2805; Ziegler, Christine Maria/0000-0003-3439-7213	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	We thank L. Forrest and R. Kramer for careful reading of the manuscript and suggestions and discussions. This work was supported by the International Max-Planck Research School (C.K. and C.P.), and by the DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (C.Z.).	Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gartner RM, 2011, J MOL BIOL, V414, P327, DOI 10.1016/j.jmb.2011.10.013; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wetzel KJ, 2011, FEMS IMMUNOL MED MIC, V61, P346, DOI 10.1111/j.1574-695X.2011.00781.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	21	106	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					126	130		10.1038/nature11403	http://dx.doi.org/10.1038/nature11403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940865				2022-12-01	WOS:000309446800046
J	Rowe, JH; Ertelt, JM; Xin, LJ; Way, SS				Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing			Pregnancy imprints regulatory memory that sustains anergy to fetal antigen	NATURE			English	Article							T-CELLS; FOXP3(+); PREECLAMPSIA; EXPRESSION; TOLERANCE; EXPANSION; SELECTION; SYSTEM	Pregnancy is an intricately orchestrated process where immune effector cells with fetal specificity are selectively silenced. This requires the sustained expansion of immune-suppressive maternal FOXP3(+) regulatory T cells (T-reg cells), because even transient partial ablation triggers fetal-specific effector T-cell activation and pregnancy loss(1,2). In turn, many idiopathic pregnancy complications proposed to originate from disrupted fetal tolerance are associated with blunted maternal T-reg expansion(3-5). Importantly, however, the antigen specificity and cellular origin of maternal Treg cells that accumulate during gestation remain incompletely defined. Here we show that pregnancy selectively stimulates the accumulation of maternal FOXP3(+) CD4 cells with fetal specificity using tetramer-based enrichment that allows the identification of rare endogenous T cells(6). Interestingly, after delivery, fetal-specific T-reg cells persist at elevated levels, maintain tolerance to pre-existing fetal antigen, and rapidly re-accumulate during subsequent pregnancy. The accelerated expansion of T-reg cells during secondary pregnancy was driven almost exclusively by proliferation of fetal-specific FOXP3(+) cells retained from prior pregnancy, whereas induced FOXP3 expression and proliferation of pre-existing FOXP3(+) cells each contribute to T-reg expansion during primary pregnancy. Furthermore, fetal resorption in secondary compared with primary pregnancy becomes more resilient to partial maternal FOXP3(+) cell ablation. Thus, pregnancy imprints FOXP3(+) CD4 cells that sustain protective regulatory memory to fetal antigen. We anticipate that these findings will spark further investigation on maternal regulatory T-cell specificity that unlocks new strategies for improving pregnancy outcomes and novel approaches for therapeutically exploiting T-reg cell memory.	[Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Pediat, Minneapolis, MN 55455 USA; [Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Way, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952	NIH-NIAID [R01AI087830, R01AI100934]; NIH-NIDDK [F30DK084674]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087830, R01AI100934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084674] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Jenkins for providing 2W1S-expressing mice, and A. Rudensky for providing Foxp3<SUP>DTR</SUP> mice. This research was supported by NIH-NIAID awards R01AI087830 and R01AI100934 (S.S.W.), and NIH-NIDDK award F30DK084674 (J.H.R.). S.S.W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Prins JR, 2009, HYPERTENS PREGNANCY, V28, P300, DOI 10.1080/10641950802601237; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986	34	336	345	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					102	U119		10.1038/nature11462	http://dx.doi.org/10.1038/nature11462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023128	Green Accepted			2022-12-01	WOS:000309446800041
J	Zhang, GF; Fang, XD; Guo, XM; Li, L; Luo, RB; Xu, F; Yang, PC; Zhang, LL; Wang, XT; Qi, HG; Xiong, ZQ; Que, HY; Xie, YL; Holland, PWH; Paps, J; Zhu, YB; Wu, FC; Chen, YX; Wang, JF; Peng, CF; Meng, J; Yang, L; Liu, J; Wen, B; Zhang, N; Huang, ZY; Zhu, QH; Feng, Y; Mount, A; Hedgecock, D; Xu, Z; Liu, YJ; Domazet-Loso, T; Du, YS; Sun, XQ; Zhang, SD; Liu, BH; Cheng, PZ; Jiang, XT; Li, J; Fan, DD; Wang, W; Fu, WJ; Wang, T; Wang, B; Zhang, JB; Peng, ZY; Li, YX; Li, N; Wang, JP; Chen, MS; He, Y; Tan, FJ; Song, XR; Zheng, QM; Huang, RL; Yang, HL; Du, XD; Chen, L; Yang, M; Gaffney, PM; Wang, S; Luo, LH; She, ZC; Ming, Y; Huang, W; Zhang, S; Huang, BY; Zhang, Y; Qu, T; Ni, PX; Miao, GY; Wang, JY; Wang, Q; Steinberg, CEW; Wang, HY; Li, N; Qian, LM; Zhang, GJ; Li, YR; Yang, HM; Liu, X; Wang, J; Yin, Y; Wang, J				Zhang, Guofan; Fang, Xiaodong; Guo, Ximing; Li, Li; Luo, Ruibang; Xu, Fei; Yang, Pengcheng; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Xiong, Zhiqiang; Que, Huayong; Xie, Yinlong; Holland, Peter W. H.; Paps, Jordi; Zhu, Yabing; Wu, Fucun; Chen, Yuanxin; Wang, Jiafeng; Peng, Chunfang; Meng, Jie; Yang, Lan; Liu, Jun; Wen, Bo; Zhang, Na; Huang, Zhiyong; Zhu, Qihui; Feng, Yue; Mount, Andrew; Hedgecock, Dennis; Xu, Zhe; Liu, Yunjie; Domazet-Loso, Tomislav; Du, Yishuai; Sun, Xiaoqing; Zhang, Shoudu; Liu, Binghang; Cheng, Peizhou; Jiang, Xuanting; Li, Juan; Fan, Dingding; Wang, Wei; Fu, Wenjing; Wang, Tong; Wang, Bo; Zhang, Jibiao; Peng, Zhiyu; Li, Yingxiang; Li, Na; Wang, Jinpeng; Chen, Maoshan; He, Yan; Tan, Fengji; Song, Xiaorui; Zheng, Qiumei; Huang, Ronglian; Yang, Hailong; Du, Xuedi; Chen, Li; Yang, Mei; Gaffney, Patrick M.; Wang, Shan; Luo, Longhai; She, Zhicai; Ming, Yao; Huang, Wen; Zhang, Shu; Huang, Baoyu; Zhang, Yong; Qu, Tao; Ni, Peixiang; Miao, Guoying; Wang, Junyi; Wang, Qiang; Steinberg, Christian E. W.; Wang, Haiyan; Li, Ning; Qian, Lumin; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Liu, Xiao; Wang, Jian; Yin, Ye; Wang, Jun			The oyster genome reveals stress adaptation and complexity of shell formation	NATURE			English	Article							TRANSPOSABLE ELEMENTS; CRASSOSTREA-GIGAS; BIVALVE MOLLUSKS; PARAHOX GENES; PROTEINS; SEQUENCE; EVOLUTION; DISCOVERY; APOPTOSIS; PATHWAY	The Pacific oyster Crassostrea gigas belongs to one of the most species-rich but genomically poorly explored phyla, the Mollusca. Here we report the sequencing and assembly of the oyster genome using short reads and a fosmid-pooling strategy, along with transcriptomes of development and stress response and the proteome of the shell. The oyster genome is highly polymorphic and rich in repetitive sequences, with some transposable elements still actively shaping variation. Transcriptome studies reveal an extensive set of genes responding to environmental stress. The expansion of genes coding for heat shock protein 70 and inhibitors of apoptosis is probably central to the oyster's adaptation to sessile life in the highly stressful intertidal zone. Our analyses also show that shell formation in molluscs is more complex than currently understood and involves extensive participation of cells and their exosomes. The oyster genome sequence fills a void in our understanding of the Lophotrochozoa.	[Fang, Xiaodong; Luo, Ruibang; Yang, Pengcheng; Xiong, Zhiqiang; Xie, Yinlong; Zhu, Yabing; Chen, Yuanxin; Peng, Chunfang; Yang, Lan; Wen, Bo; Huang, Zhiyong; Feng, Yue; Liu, Yunjie; Sun, Xiaoqing; Liu, Binghang; Jiang, Xuanting; Fan, Dingding; Fu, Wenjing; Wang, Bo; Peng, Zhiyu; Li, Na; Chen, Maoshan; Tan, Fengji; Zheng, Qiumei; Yang, Hailong; Chen, Li; Luo, Longhai; Ming, Yao; Zhang, Shu; Zhang, Yong; Ni, Peixiang; Wang, Junyi; Li, Ning; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Wang, Jian; Yin, Ye; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Guofan; Li, Li; Xu, Fei; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Que, Huayong; Wu, Fucun; Wang, Jiafeng; Meng, Jie; Liu, Jun; Zhang, Na; Zhu, Qihui; Du, Yishuai; Zhang, Shoudu; Cheng, Peizhou; Li, Juan; Wang, Wei; Wang, Tong; Zhang, Jibiao; Li, Yingxiang; Wang, Jinpeng; Song, Xiaorui; Huang, Ronglian; Du, Xuedi; Yang, Mei; She, Zhicai; Huang, Wen; Huang, Baoyu; Qu, Tao; Miao, Guoying; Wang, Qiang; Wang, Haiyan; Liu, Xiao] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; [Guo, Ximing; He, Yan; Wang, Shan; Qian, Lumin] Rutgers State Univ, Inst Marine & Coastal Sci, Haskin Shellfish Res Lab, Port Norris, NJ 08349 USA; [Luo, Ruibang; Xie, Yinlong; Liu, Binghang] HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Holland, Peter W. H.; Paps, Jordi] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Mount, Andrew] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Hedgecock, Dennis] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Xu, Zhe] Atlantic Cape Community Coll, Mays Landing, NJ 08330 USA; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Lab Evolutionary Genet, HR-10002 Zagreb, Croatia; [Gaffney, Patrick M.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Steinberg, Christian E. W.] Humboldt Univ Berlin Arboretum, Inst Biol, D-12437 Berlin, Germany; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Oceanology, CAS; Rutgers State University New Brunswick; University of Hong Kong; University of Oxford; Clemson University; University of Southern California; Rudjer Boskovic Institute; University of Delaware; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	gzhang@qdio.ac.cn; xguo@hsrl.rutgers.edu; yinye@genomics.org.cn; wangj@genomics.org.cn	LI, LI/GVS-5344-2022; Zhang, Guojie/J-7273-2019; Xu, Fei/A-1736-2012; Wu, Fucun/AAY-6115-2021; Paps, Jordi/B-2098-2012; Fang, Xiaodong/K-6743-2018; Hedgecock, Dennis/I-8655-2012; wang, junyi/GYA-3213-2022; Yang, Pengcheng/N-1037-2014; Wang, Jun/A-7261-2013; Zhang, Guojie/B-6188-2014; Li, Li/AEM-3636-2022; Peng, Zhiyu/GXV-5301-2022; Li, Yingrui/K-1064-2015; huang, wen/GXW-0661-2022; li, li/GPX-3938-2022; Zhang, Linlin/I-4970-2014; yang, hailong/GXH-9625-2022; Guo, Ximing/K-3804-2012; Wen, Bo/I-1259-2019; Steinberg, Christian/O-8572-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Guojie/0000-0001-6860-1521; Xu, Fei/0000-0002-0981-8429; Paps, Jordi/0000-0003-2636-6636; Fang, Xiaodong/0000-0001-7061-3337; Hedgecock, Dennis/0000-0002-3995-646X; Yang, Pengcheng/0000-0001-5496-8357; Zhang, Guojie/0000-0001-6860-1521; Zhang, Linlin/0000-0003-0247-7710; Guo, Ximing/0000-0002-6758-2709; Wen, Bo/0000-0003-2261-3150; CHEN, MAOSHAN/0000-0002-3827-4969; Luo, Ruibang/0000-0001-9711-6533; Holland, Peter/0000-0003-1533-9376; Li, Yingxiang/0000-0001-6671-2965; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Mount, Andrew/0000-0002-3376-1135; Wang, Jinpeng/0000-0003-1892-0246; liu, bh/0000-0002-4948-2835; Steinberg, Christian E.W./0000-0002-3132-8901	National High-Technology Research and Development Program of China (863 program) [2010AA10A110]; National Basic Research Program of China (973 Program) [2010CB126401, 2010CB126402]; 863 program [2012AA10A405]; Basic Research Program by Shenzhen City [JC2010526019]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture [2009-35205-05052, NJ32108]; Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC) [[268513]11]; Beatriu de Pinos of the Generalitat de Catalunya [2009 BP-DGR]; Dalian Zhangzidao Fishery Group Co. Ltd	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Basic Research Program by Shenzhen City; Shenzhen Key Laboratory of Transomics Biotechnologies; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture(United States Department of Agriculture (USDA)); Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC)(European Research Council (ERC)); Beatriu de Pinos of the Generalitat de Catalunya; Dalian Zhangzidao Fishery Group Co. Ltd	We acknowledge H. Wu, F. Zhang, Q. Tang, Z. Zhu, X. Xu, H. Lin, J. Lei, Z. Xiang, N. Li, J. Xiang and J. Jia for their support of the oyster genome project. We thank F. Han, X. Liu, R. Wu, L. Wang, Y. Wu, L. Yan, H. Niu, H. Li, Y. Wang, J. Liang, Z. Jia, J. Davis and Taylor Shellfish Farms for assistance with DNA, RNA and protein extraction, data analysis and oyster culture, and Y. Lu, C. Lin, H. Peng, Y. Ren, X. Xu, R. Chen and D. Zhang for library construction and sequencing. We thank L. Song, B. Z. Liu, Q. Li, Z. Yu, C. Ke, J. Yu, B. Liu, X. Sun, R. W. Chapman, Y. Han, S. R. Wessler, D. Arendt, E. H. Davidson, J. S. Evans, B. Brown, P. Boudry and B. Lieb for discussions. We thank other faculty and staff at the Institute of Oceanology, Chinese Academy of Science, BGI-Shenzhen and Rutgers who contributed to the oyster genome project. We acknowledge grant support from the National High-Technology Research and Development Program of China (863 program; 2010AA10A110), National Basic Research Program of China (973 Program; 2010CB126401 and 2010CB126402), 863 program (2012AA10A405), Basic Research Program Supported by Shenzhen City (JC2010526019), Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A), National Natural Science Foundation of China(40730845), Mollusc Research and Development Center, CARS, Shenzhen Key Laboratory of Gene Bank for National Life Science, Taishan Scholar and Scholar Climbing Programs of Shandong. X.G. acknowledges funding from the US Department of Agriculture (2009-35205-05052 and NJ32108) and the Chinese Academy of Science Marine Functional Genomics Oversea Team and Taishan Scholar Fund; P.W.H.H. acknowledges funding from the European Research Council (EU FP7 ERC grant [268513]11); and J.P. acknowledges funding from Beatriu de Pinos of the Generalitat de Catalunya (2009 BP-DGR). We are grateful to Dalian Zhangzidao Fishery Group Co. Ltd for providing support.	Barucca M, 2003, GENE, V317, P97, DOI 10.1016/S0378-1119(03)00657-7; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P219, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Harris R. S., 2007, THESIS PENNSYLVANIA; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kitzman J. O., 2010, NAT BIOTECHNOL, V29, P59; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Li B., 2012, GENOME DARWINS FINCH, DOI [10.5524/100040, DOI 10.5524/100040]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI RQ, 2010, GENOME RES, V20, P265, DOI DOI 10.1101/GR.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; McGoldrick DJ, 1997, GENETICS, V146, P321; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Mount AS, 2010, US patent, Patent No. [2010/0150982 A1, 20100150982]; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Ponder Winston F., 2008, P1; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; WAITE JH, 1983, MOLLUSCA, V1, P467; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	47	1472	1577	50	672	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					49	54		10.1038/nature11413	http://dx.doi.org/10.1038/nature11413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22992520	hybrid, Green Accepted, Green Published			2022-12-01	WOS:000309446800030
J	Shukla, S				Shukla, Shubhlakshmi			Africa's changing mosquito dynamics	LANCET			English	Editorial Material							HIGHLANDS		The Lancet, London NW1 7BY, England		Shukla, S (corresponding author), The Lancet, London NW1 7BY, England.	shubhs82@gmail.com						Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; *KEN MED RES I, KEN MAL FACT SHEET; London School of Hygiene and Tropical Medicine, NEW MAL TRANSM MOSQ; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, MAL FACT SHEET	8	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1130	1131		10.1016/S0140-6736(12)61617-1	http://dx.doi.org/10.1016/S0140-6736(12)61617-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021271				2022-12-01	WOS:000309255900008
J	Lin, CY; Loven, J; Rahl, PB; Paranal, RM; Burge, CB; Bradner, JE; Lee, TI; Young, RA				Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Paranal, Ronald M.; Burge, Christopher B.; Bradner, James E.; Lee, Tong Ihn; Young, Richard A.			Transcriptional Amplification in Tumor Cells with Elevated c-Myc	CELL			English	Article							RECRUITS P-TEFB; GENE-EXPRESSION; NEOPLASTIC PHENOTYPE; RIBOSOMAL DNA; COPY-NUMBER; CANCER; MAX; BINDING; ACTIVATION; PROTEIN	Elevated expression of the c-Myc transcription factor occurs frequently in human cancers and is associated with tumor aggression and poor clinical outcome. The effect of high levels of c-Myc on global gene regulation is poorly understood but is widely thought to involve newly activated or repressed "Myc target genes." We report here that in tumor cells expressing high levels of c-Myc the transcription factor accumulates in the promoter regions of active genes and causes transcriptional amplification, producing increased levels of transcripts within the cell's gene expression program. Thus, rather than binding and regulating a new set of genes, c-Myc amplifies the output of the existing gene expression program. These results provide an explanation for the diverse effects of oncogenic c-Myc on gene expression in different tumor cells and suggest that transcriptional amplification reduces rate-limiting constraints for tumor cell growth and proliferation.	[Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Burge, Christopher B.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Paranal, Ronald M.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bradner, James E.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Burge, Christopher B./AAH-2177-2020	Young, Richard A/0000-0001-8855-8647; 	National Institutes of Health [HG002668, CA146445]; Swedish Research Council [VR-B0086301]; American Cancer Society [PF-11-042- 01-DMC]; Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank John Minna and Chi Dang for cell lines; Ernest Martinez for constructs; David Orlando for bioinformatics support; Tom Volkert, Jennifer Love, Sumeet Gupta, and Vidya Dhanapal at the Whitehead Genome Technologies Core for Solexa sequencing; Nancy Hannett for cloning support; Jessica Reddy for assistance with FACS; Darin Fogg, Amins Corporation, and Nathan Elliott, NanoString, for excellent technical support; and Michael Cole and members of the Young, Burge and Bradner labs for helpful discussion. This work was supported by National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y., T.I.L.), Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.), American Cancer Society Postdoctoral Fellowship PF-11-042- 01-DMC (P.B.R.) and Damon-Runyon Cancer Research Foundation (J.E.B). J.E.B. and R.A.Y. are founders of Syros Pharmaceuticals.	Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowling Victoria H, 2010, Genes Cancer, V1, P576; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; HIRVONEN HE, 1994, BRIT J CANCER, V69, P16, DOI 10.1038/bjc.1994.3; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; JOHNSON BE, 1987, J CLIN INVEST, V79, P1629, DOI 10.1172/JCI112999; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	78	988	1011	7	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					56	67		10.1016/j.cell.2012.08.026	http://dx.doi.org/10.1016/j.cell.2012.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021215	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000309544200010
J	Willyard, C				Willyard, Cassandra			DIAGNOSIS To catch a killer	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S8	S9		10.1038/489S8a	http://dx.doi.org/10.1038/489S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013716	Bronze			2022-12-01	WOS:000309167100005
J	Lian, CG; Xu, YF; Ceol, C; Wu, FZ; Larson, A; Dresser, K; Xu, WQ; Tan, L; Hu, YG; Zhan, Q; Lee, CW; Hu, D; Lian, BQ; Kleffel, S; Yang, YJ; Neiswender, J; Khorasani, AJ; Fang, R; Lezcano, C; Duncan, LM; Scolyer, RA; Thompson, JF; Kakavand, H; Houvras, Y; Zon, LI; Mihm, MC; Kaiser, UB; Schatton, T; Woda, BA; Murphy, GF; Shi, YJG				Lian, Christine Guo; Xu, Yufei; Ceol, Craig; Wu, Feizhen; Larson, Allison; Dresser, Karen; Xu, Wenqi; Tan, Li; Hu, Yeguang; Zhan, Qian; Lee, Chung-wei; Hu, Di; Lian, Bill Q.; Kleffel, Sonja; Yang, Yijun; Neiswender, James; Khorasani, Abraham J.; Fang, Rui; Lezcano, Cecilia; Duncan, Lyn M.; Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr; Houvras, Yariv; Zon, Leonard I.; Mihm, Martin C., Jr.; Kaiser, Ursula B.; Schatton, Tobias; Woda, Bruce A.; Murphy, George F.; Shi, Yujiang G.			Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma	CELL			English	Article							GENE-EXPRESSION; DNA-METHYLATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; CELL-LINES; 5-METHYLCYTOSINE; MUTATIONS; TET1; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is critical for various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family of DNA hydroxylases. Here, we report that "loss of 5-hmC'' is an epigenetic hallmark of melanoma, with diagnostic and prognostic implications. Genome-wide mapping of 5-hmC reveals loss of the 5-hmC landscape in the melanoma epigenome. We show that downregulation of isocitrate dehydrogenase 2 (IDH2) and TET family enzymes is likely one of the mechanisms underlying 5-hmC loss in melanoma. Rebuilding the 5-hmC landscape in melanoma cells by reintroducing active TET2 or IDH2 suppresses melanoma growth and increases tumor-free survival in animal models. Thus, our study reveals a critical function of 5-hmC in melanoma development and directly links the IDH and TET activity-dependent epigenetic pathway to 5-hmC-mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy.	[Lian, Christine Guo; Zhan, Qian; Lee, Chung-wei; Lezcano, Cecilia; Murphy, George F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Lian, Christine Guo; Xu, Yufei; Hu, Yeguang; Hu, Di; Lian, Bill Q.; Khorasani, Abraham J.; Fang, Rui; Kaiser, Ursula B.; Shi, Yujiang G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Ceol, Craig; Houvras, Yariv; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Harvard Stem Cell Inst, Stem Cell Program & Hematol Oncol,Childrens Hosp, Boston, MA 02115 USA; [Duncan, Lyn M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Larson, Allison; Kleffel, Sonja; Mihm, Martin C., Jr.; Schatton, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Ceol, Craig; Neiswender, James] Univ Massachusetts, Dept Canc Biol, Worcester, MA 01605 USA; [Dresser, Karen; Woda, Bruce A.] Univ Massachusetts, Dept Pathol, Worcester, MA 01605 USA; [Lian, Bill Q.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Wu, Feizhen; Xu, Wenqi; Tan, Li; Shi, Yujiang G.] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [Yang, Yijun] ZIOPHARM Oncol Inc, Charlestown, MA 02129 USA; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Houvras, Yariv] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Houvras, Yariv] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Houvras, Yariv] New York Presbyterian Hosp, New York, NY 10065 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Fudan University; Melanoma Institute Australia; University of Sydney; University of Sydney; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Murphy, GF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA.	gmurphy@rics.bwh.harvard.edu; yujiang_shi@hms.harvard.edu	Wu, Feizhen/AGR-5215-2022; Scolyer, Richard/AAE-8511-2019; Thompson, John/F-9075-2013; Wu, Feizhen/R-6415-2019; Woda, Bruce/AAS-5898-2020; Larson, Allison/N-4263-2015; Schatton, Tobias/N-9898-2018	Scolyer, Richard/0000-0002-8991-0013; Thompson, John/0000-0002-2816-2496; Wu, Feizhen/0000-0002-1265-9887; Larson, Allison/0000-0001-8534-7078; Schatton, Tobias/0000-0003-1386-680X; Lian, Christine/0000-0003-4626-1612; Neiswender, James/0000-0003-4135-6479; Kakavand, Hojabr/0000-0002-3458-7853; Houvras, Yariv/0000-0003-0751-3215	National Institutes of Health (NIH) [GM078458]; NIH-NCI [5P50CA093683-09]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education [985]; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070690, R01GM078458] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David E. Fisher for his critical reading of the manuscript. This project was supported by grant number GM078458 from National Institutes of Health (NIH) to Y.G.S., grant number 5P50CA093683-09 from NIH-NCI to SPORE Core, and Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence, and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. Y.G.S. is a PEW scholar. The authors acknowledge Dr. David E. Elder, Dr. Victor G. Prieto, and Dr. Jeffrey E. Gershenwald in the the development of the SPORE TMA.	Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Haffner MC, 2011, ONCOTARGET, V2, P627; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Marks R, 2000, CLIN EXP DERMATOL, V25, P459, DOI 10.1046/j.1365-2230.2000.00693.x; Paz MF, 2003, CANCER RES, V63, P1114; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2012, ONCOGENE; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	36	562	588	4	117	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1135	1146		10.1016/j.cell.2012.07.033	http://dx.doi.org/10.1016/j.cell.2012.07.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980977	Green Accepted, Bronze			2022-12-01	WOS:000308928100008
J	Oda, Y; Fukuda, H				Oda, Yoshihisa; Fukuda, Hiroo			Initiation of Cell Wall Pattern by a Rho- and Microtubule-Driven Symmetry Breaking	SCIENCE			English	Article							ARABIDOPSIS; PLANTS; POLARITY; GTPASE; ROP; GROWTH; EXPRESSION; PROTEINS; FAMILY; DOMAIN	A specifically patterned cell wall is a determinant of plant cell shape. Yet, the precise mechanisms that underlie initiation of cell wall patterning remain elusive. By using a reconstitution assay, we revealed that ROPGEF4 (Rho of plant guanine nucleotide exchange factor 4) and ROPGAP3 [ROP guanosine triphosphatase (GTPase)-activating protein 3] mediate local activation of the plant Rho GTPase ROP11 to initiate distinct pattern of secondary cell walls in xylem cells. The activated ROP11 recruits MIDD1 to induce local disassembly of cortical microtubules. Conversely, cortical microtubules eliminate active ROP11 from the plasma membrane through MIDD1. Such a mutual inhibitory interaction between active ROP domains and cortical microtubules establishes the distinct pattern of secondary cell walls. This Rho-based regulatory mechanism shows how plant cells initiate and control cell wall patterns to form various cell shapes.	[Oda, Yoshihisa; Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Oda, Yoshihisa] Japan Sci & Technol Corp JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Oda, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	oda@biol.s.u-tokyo.ac.jp; fukuda@biol.s.u-tokyo.ac.jp		Oda, Yoshihisa/0000-0001-6934-4424	Ministry of Education, Science, Sports and Culture of Japan [19060009]; Japan Society for the Promotion of Science [23227001, 22870005]; NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO) [20103]; Grants-in-Aid for Scientific Research [19060016] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Chua of the Rockefeller University for providing the pER8 vector; U. Grossniklaus of the University of Zurich for providing the pMDC7 vector; T. Nakagawa of Shimane University for providing the pGWB vectors; Y. Ohya of the University of Tokyo for critical reading of this manuscript; A. Nakano, T. Ueda, and S. Betsuyaku of the University of Tokyo for technical advice; and Y. Nakashima for technical assistance. This work was supported partly by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (19060009) to H. F.; from the Japan Society for the Promotion of Science to H. F. (23227001) and Y.O. (22870005) and the NC-CARP project; and from JST, Precursory Research for Embryonic Science and Technology (PRESTO) to Y.O. (20103).	Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Dettmer J, 2011, CURR OPIN CELL BIOL, V23, P686, DOI 10.1016/j.ceb.2011.09.006; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Gu Y, 2006, PLANT CELL, V18, P366, DOI 10.1105/tpc.105.036434; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lavy M, 2007, CURR BIOL, V17, P947, DOI 10.1016/j.cub.2007.04.038; Lavy M, 2006, PLANT J, V46, P934, DOI 10.1111/j.1365-313X.2006.02749.x; Li SD, 2008, MOL PLANT, V1, P1021, DOI 10.1093/mp/ssn051; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mucha E, 2010, EUR J CELL BIOL, V89, P906, DOI 10.1016/j.ejcb.2010.08.003; Oda Y, 2010, CURR BIOL, V20, P1197, DOI 10.1016/j.cub.2010.05.038; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Yamaguchi M, 2011, PLANT J, V66, P579, DOI 10.1111/j.1365-313x.2011.04514.x; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	23	171	183	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1333	1336		10.1126/science.1222597	http://dx.doi.org/10.1126/science.1222597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984069				2022-12-01	WOS:000308705000040
J	Pijpe, A; Andrieu, N; Easton, DF; Kesminiene, A; Cardis, E; Nogues, C; Gauthier-Villars, M; Lasset, C; Fricker, JP; Peock, S; Frost, D; Evans, DG; Eeles, RA; Paterson, J; Manders, P; van Asperen, CJ; Ausems, MGEM; Meijers-Heijboer, H; Thierry-Chef, I; Hauptmann, M; Goldgar, D; Rookus, MA; van Leeuwen, FE				Pijpe, Anouk; Andrieu, Nadine; Easton, Douglas F.; Kesminiene, Ausrele; Cardis, Elisabeth; Nogues, Catherine; Gauthier-Villars, Marion; Lasset, Christine; Fricker, Jean-Pierre; Peock, Susan; Frost, Debra; Evans, D. Gareth; Eeles, Rosalind A.; Paterson, Joan; Manders, Peggy; van Asperen, Christi J.; Ausems, Margreet G. E. M.; Meijers-Heijboer, Hanne; Thierry-Chef, Isabelle; Hauptmann, Michael; Goldgar, David; Rookus, Matti A.; van Leeuwen, Flora E.		GENEPSO; EMBRACE; HEBON	Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; SCREENING MAMMOGRAPHY; IONIZING-RADIATION; VALIDATION; WOMEN; SUSCEPTIBILITY; PROGRAM; HISTORY; REPAIR	Objective To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations. Design Retrospective cohort study (GENE-RAD-RISK). Setting Three nationwide studies (GENEPSO, EMBRACE, HEBON) in France, United Kingdom, and the Netherlands, Participants 1993 female carriers of BRCA1/2 mutations recruited in 2006-09. Main outcome measure Risk of breast cancer estimated with a weighted Cox proportional hazards model with a time dependent individually estimated cumulative breast dose, based on nominal estimates of organ dose and frequency of self reported diagnostic procedures. To correct for potential survival bias, the analysis excluded carriers who were diagnosed more than five years before completion of the study questionnaire. Results In carriers of BRCA1/2 mutations any exposure to diagnostic radiation before the age of 30 was associated with an increased risk of breast cancer (hazard ratio 1.90, 95% confidence interval 1.20 to 3.00), with a dose-response pattern. The risks by quarter of estimated cumulative dose <0.0020 Gy, >= 0.0020-0.0065 Gy, >= 0.0066-0.0173 Gy, and >= 0.0174 Gy were 1.63 (0.96 to 2.77), 1.78 (0.88 to 3.58), 1.75 (0.72 to 4.25), and 3.84 (1.67 to 8.79), respectively. Analyses on the different types of diagnostic procedures showed a pattern of increasing risk with increasing number of radiographs before age 20 and before age 30 compared with no exposure. A history of mammography before age 30 was also associated with an increased risk of breast cancer (hazard ratio 1.43, 0.85 to 2.40). Sensitivity analysis showed that this finding was not caused by confounding by indication of family history. Conclusion In this large European study among carriers of BRCA1/2 mutations, exposure to diagnostic radiation before age 30 was associated with an increased risk of breast cancer at dose levels considerably lower than those at which increases have been found in other cohorts exposed to radiation. The results of this study support the use of non-ionising radiation imaging techniques (such as magnetic resonance imaging) as the main tool for surveillance in young women with BRCA1/2 mutations.	[Pijpe, Anouk; Rookus, Matti A.; van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol & Biostat, NL-1066 CX Amsterdam, Netherlands; [Andrieu, Nadine] Inst Natl Sante & Rech Med, Unite U900, F-75248 Paris, France; [Andrieu, Nadine] Res Ctr & Serv Biostat, Inst Curie, F-75248 Paris, France; [Andrieu, Nadine] Paris Tech, Ecole Mines Paris, F-77300 Fontainebleau, France; [Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Kesminiene, Ausrele] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon 08, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, F-92210 Paris, France; [Gauthier-Villars, Marion] Inst Curie, Serv Oncogenet, F-75005 Paris, France; [Fricker, Jean-Pierre] Ctr Paul Strauss, F-67065 Strasbourg, France; [Lasset, Christine] Ctr Leon Berard, F-69008 Lyon, France; [Evans, D. Gareth] St Marys Hosp, Dept Genet Med, Manchester M13 9WL, Lancs, England; [Eeles, Rosalind A.] Inst Canc Res, Oncogenet Team, Surrey SM2 5PT, England; [Paterson, Joan] Addenbrookes Hosp, Dept Clin Genet, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Manders, Peggy] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [van Asperen, Christi J.] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Dept Clin Genet & Human Genet, Med Ctr, Amsterdam, Netherlands; [Goldgar, David] Univ Utah, Dept Dermatol, Sch Med, Salt Lake City, UT 84132 USA	Netherlands Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Paul Strauss; UNICANCER; Centre Leon Berard; University of Manchester; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Utah System of Higher Education; University of Utah	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol & Biostat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.v.leeuwen@nki.nl	THIERRY-CHEF, Isabelle/P-8324-2018; Evans, D Gareth/AAB-4308-2022; ANDRIEU, Nadine/H-4255-2014; GLADIEFF, Laurence/O-5129-2014; Oosterwijk, Jan C./G-5770-2011; Cardis, Elisabeth/C-3904-2017; van Asperen, Christi J/D-3970-2012; Hauptmann, Michael/AAQ-8420-2021; Ligtenberg, Marjolijn/N-9666-2013	THIERRY-CHEF, Isabelle/0000-0001-6304-2783; Evans, D Gareth/0000-0002-8482-5784; GLADIEFF, Laurence/0000-0002-6980-9719; Cardis, Elisabeth/0000-0003-0999-6839; van Asperen, Christi J/0000-0002-1436-7650; Hauptmann, Michael/0000-0001-8539-0148; Ligtenberg, Marjolijn/0000-0003-1290-1474; van der Luijt, Rob/0000-0002-0018-1089; Gomez-Garcia, Encarna/0000-0003-4999-8847; Pijpe, Anouk/0000-0002-3594-4621; Bancroft, Elizabeth/0000-0002-5482-5660; Devilee, Peter/0000-0002-8023-2009; Eeles, Rosalind/0000-0002-3698-6241; Vasen, Hans/0000-0003-2682-2603	NIHR; Cancer Research UK [C5047/A8385]; Euratom Programme [012926 (FI6R)]; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK [C1287/A10118, C1287/A8874]; HEBON: Dutch Cancer Society [NKI1998-1854, NKI2004-3088, NKI 2007-3756]; Tepnel; Illumina; Vista Diagnostics; Cancer Research UK [11022, 15007, 10118] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER	NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Euratom Programme; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK; HEBON: Dutch Cancer Society; Tepnel; Illumina; Vista Diagnostics; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Coordinating Centre, Cambridge: Susan Peock, Margaret Cook, Debra Frost, Clare Oliver; North of Scotland Regional Genetics Service, Aberdeen: Helen Gregory; West Midlands Regional Clinical Genetics Service, Birmingham: Trevor Cole, Lucy Burgess; East Anglian Regional Genetics Service, Cambridge: Joan Paterson; Medical Genetics Services for Wales, Cardiff: Mark Rogers, Lisa Hughes; Peninsula Clinical Genetics Service, Exeter: Carole Brewer; West of Scotland Regional Genetics Service, Glasgow: Rosemarie Davidson, Nicola Bradshaw; South East Thames Regional Genetics Service, London: Louise Izatt, Gabriella Pichert, Caroline Langman; Yorkshire Regional Genetics Service, Leeds: Carol Chu, Julie Miller; Manchester Regional Genetics Service, Manchester: Gareth Evans, Fiona Lalloo, Andrew Shenton; Oxford Regional Genetics Service, Oxford: Lucy Side; Department of Cancer Genetics, Royal Marsden NHS Foundation Trust: Ros Eeles, Elizabeth Bancroft, Elizabeth Page, Elena Castro, Audray Ardern-Jones, Richard Houlston, Nazneen Rahman, Susan Shanley; North Trent Clinical Genetics Service, Sheffield: Jackie Cook, Lauren Baxter; South West Thames Regional Genetics Service, London: Shirley Hodgson, Sheila Goff; and Wessex Clinical Genetics Service, Southampton: Diana Eccles. Gareth Evans and Fiona Lalloo are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. Ros Eeles and Elizabeth Bancroft are also supported by Cancer Research UK Grant C5047/A8385.; The GENE-RAD-RISK study was supported by grant No 012926 (FI6R) under Euratom Programme; GENEPSO: Fondation de France and Ligue National Contre le Cancer; EMBRACE: Cancer Research UK (grant C1287/A10118 and C1287/A8874); HEBON: Dutch Cancer Society (grants NKI1998-1854, NKI2004-3088, NKI 2007-3756). DFE is a principal research fellow of Cancer Research UK. The sponsors had no role in the design of the study; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: DFE is board member of Genome Canada. RAE receives royalties for the book Genetic Predisposition to Cancer, has received educational grants from Tepnel, Illumina, and Vista Diagnostics and has received honoraria for BRCA-related lectures from MD Anderson and University of Southampton. DG receives royalties from BRCA1 testing.	Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Berrington de Gonzalez A, 2003, AM J EPIDEMIOL, V157, P652, DOI 10.1093/aje/kwg026; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; DRION R, 1961, Ned Tijdschr Geneeskd, V105, P1920; Eleveld H, 2003, 861020002 RIVM; Goldfrank D, 2006, CANCER EPIDEM BIOMAR, V15, P2311, DOI 10.1158/1055-9965.EPI-06-0176; Gronwald J, 2008, BREAST CANCER RES TR, V112, P581, DOI 10.1007/s10549-008-9892-9; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; ICRP, 2007, ICRP PUBL, V103, DOI [DOI 10.1016/J.ICRP.2007.10.003, 10.1016/j.icrp.2007.10.003]; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; LAND CE, 1995, JAMA-J AM MED ASSOC, V274, P402, DOI 10.1001/jama.274.5.402; LAND CE, 1980, CANCER, V46, P868, DOI 10.1002/1097-0142(19800815)46:4+<868::AID-CNCR2820461304>3.0.CO;2-S; Langholz B, 2010, AM J EPIDEMIOL, V171, P377, DOI 10.1093/aje/kwp403; Meeuwsen EJ, 2007, 300081001 RIVM; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; National Research Council, 1999, HLTH RISKS EXP LOW L; Nieuwenhuis B, 2002, INT J RADIAT BIOL, V78, P285, DOI 10.1080/09553000110097974; Norman SA, 2003, AM J EPIDEMIOL, V158, P264, DOI 10.1093/aje/kwg136; Pijpe A, 2011, J CLIN EPIDEMIOL, V64, P1434, DOI 10.1016/j.jclinepi.2011.04.005; Pijpe A, 2010, EUR J EPIDEMIOL, V25, P103, DOI 10.1007/s10654-009-9416-x; Pijpe A, 2010, BREAST CANCER RES TR, V120, P235, DOI 10.1007/s10549-009-0476-0; Pogoda JM, 2002, HEALTH PHYS, V83, P907, DOI 10.1097/00004032-200212000-00019; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTONMARTIN S, 1985, AM J EPIDEMIOL, V121, P430, DOI 10.1093/oxfordjournals.aje.a114015; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; SICKENGA F N, 1959, Ned Tijdschr Geneeskd, V103, P1998; Sickenga FN, 1961, NED TIJDSCHR GENEES, V105, P2417; SICKENGA FN, 1980, SHORT HIST TUBERCULO; Sigurdson AJ, 2007, CANCER EPIDEM BIOMAR, V16, P2000, DOI 10.1158/1055-9965.EPI-07-0282; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Young KC, 2005, BRIT J RADIOL, V78, P207, DOI 10.1259/bjr/41095952; Young KC, 2000, BRIT J RADIOL, V73, P278, DOI 10.1259/bjr.73.867.10817044	39	142	146	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5660	10.1136/bmj.e5660	http://dx.doi.org/10.1136/bmj.e5660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956590	Green Published, hybrid			2022-12-01	WOS:000308634100002
J	Spence, D				Spence, Des			Why do we overtreat hypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Willis EA, 2012, RE NHS HLTH CHECKS Q	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2012	345								e5923	10.1136/bmj.e5923	http://dx.doi.org/10.1136/bmj.e5923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TI	22951565				2022-12-01	WOS:000308633800020
J	Forsberg, KJ; Reyes, A; Bin, W; Selleck, EM; Sommer, MOA; Dantas, G				Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Selleck, Elizabeth M.; Sommer, Morten O. A.; Dantas, Gautam			The Shared Antibiotic Resistome of Soil Bacteria and Human Pathogens	SCIENCE			English	Article							RESISTANCE GENES; KLUYVERA; ECOLOGY; SPREAD; BUGS	Soil microbiota represent one of the ancient evolutionary origins of antibiotic resistance and have been proposed as a reservoir of resistance genes available for exchange with clinical pathogens. Using a high-throughput functional metagenomic approach in conjunction with a pipeline for the de novo assembly of short-read sequence data from functional selections (termed PARFuMS), we provide evidence for recent exchange of antibiotic resistance genes between environmental bacteria and clinical pathogens. We describe multidrug-resistant soil bacteria containing resistance cassettes against five classes of antibiotics (beta-lactams, aminoglycosides, amphenicols, sulfonamides, and tetracyclines) that have perfect nucleotide identity to genes from diverse human pathogens. This identity encompasses noncoding regions as well as multiple mobilization sequences, offering not only evidence of lateral exchange but also a mechanism by which antibiotic resistance disseminates.	[Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Selleck, Elizabeth M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sommer, Morten O. A.] Novo Nordisk Fdn Ctr Biosustainabil, DK-2900 Horsholm, Denmark	Technical University of Denmark; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk; dantas@wustl.edu	Reyes, Alejandro/AAD-8445-2022	Reyes, Alejandro/0000-0003-2907-3265; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Selleck Fiore, Elizabeth/0000-0003-0213-1250; Forsberg, Kevin/0000-0002-1545-8925; Dantas, Gautam/0000-0003-0455-8370	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation; European Union [282004]; NSF [DGE-1143954]; International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation(Lundbeckfonden); European Union(European Commission); NSF(National Science Foundation (NSF)); International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank R. Mitra for initial discussions regarding simulations of metagenomic assembly; T. Druley for discussions surrounding the use of the six beta-lactamase control fragments; J. Fay for discussions on dating horizontal gene transfer; J. Gordon for support, thoughtful discussion, and as the advisor to A. R.; A. Moore for naming PARFuMS; and the Genome Technology Access Center at Washington University in St. Louis for generating Illumina sequence data. This work was supported by awards to G. D. through the Children's Discovery Institute (award MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, and the National Academies Keck Futures Initiatives, Synthetic Biology-SB2. M.O.A.S. received funding from the Lundbeck foundation and the European Union FP7-HEALTH-2011-single-stage grant agreement 282004, EvoTAR. K. J. F. is a NSF graduate research fellow (award DGE-1143954). A. R. is the recipient of an International Fulbright Science and Technology Award. The data reported in this paper are described in the supplementary materials. Raw sequencing reads have been deposited to MG-RAST with accession nos. 4489630-39, 4489641-43, 4489645-46, 4489648-49, 4489650-51, 4489653-57, 4489659, 4489661-63, 4489665, and 4489667-68. Assembled sequences have been deposited to GenBank with accession nos. JX009202 to JX009380. The authors declare no competing financial interests.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11; CLARK VL, 1977, ANTIMICROB AGENTS CH, V11, P871, DOI 10.1128/AAC.11.5.871; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; FARMER JJ, 1981, J CLIN MICROBIOL, V13, P919, DOI 10.1128/JCM.13.5.919-933.1981; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Kieser T, 2000, PRACTICAL STREPTOMYC; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poirel L, 2002, ANTIMICROB AGENTS CH, V46, P4038, DOI 10.1128/AAC.46.12.4038-4040.2002; Rezzonico F, 2004, APPL ENVIRON MICROB, V70, P5119, DOI 10.1128/AEM.70.9.5119-5131.2004; Romano S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-267; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	28	927	986	42	855	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1107	1111		10.1126/science.1220761	http://dx.doi.org/10.1126/science.1220761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936781	Green Accepted			2022-12-01	WOS:000308125800051
J	Glowacki, DR; Lockhart, J; Blitz, MA; Klippenstein, SJ; Pilling, MJ; Robertson, SH; Seakins, PW				Glowacki, David R.; Lockhart, James; Blitz, Mark A.; Klippenstein, Stephen J.; Pilling, Michael J.; Robertson, Struan H.; Seakins, Paul W.			Interception of Excited Vibrational Quantum States by O-2 in Atmospheric Association Reactions	SCIENCE			English	Article							PHASE BIMOLECULAR REACTIONS; REACTION DYNAMICS; MASTER EQUATION; CHEMICAL-DYNAMICS; CHLORINE ATOM; KINETICS; RADICALS; GASES; OH; CHEMISTRY	Bimolecular reactions in Earth's atmosphere are generally assumed to proceed between reactants whose internal quantum states are fully thermally relaxed. Here, we highlight a dramatic role for vibrationally excited bimolecular reactants in the oxidation of acetylene. The reaction proceeds by preliminary adduct formation between the alkyne and OH radical, with subsequent O-2 addition. Using a detailed theoretical model, we show that the product-branching ratio is determined by the excited vibrational quantum-state distribution of the adduct at the moment it reacts with O-2. Experimentally, we found that under the simulated atmospheric conditions O-2 intercepts similar to 25% of the excited adducts before their vibrational quantum states have fully relaxed. Analogous interception of excited-state radicals by O-2 is likely common to a range of atmospheric reactions that proceed through peroxy complexes.	[Glowacki, David R.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Lockhart, James; Blitz, Mark A.; Pilling, Michael J.; Seakins, Paul W.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Klippenstein, Stephen J.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Robertson, Struan H.] Accelrys, Cambridge CB4 0WN, England	University of Bristol; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; BIOVIA	Glowacki, DR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	drglowacki@gmail.com; p.w.seakins@leeds.ac.uk	blitz, mark/A-1195-2009; Klippenstein, Stephen/AAF-1741-2021	blitz, mark/0000-0001-6710-4021; Klippenstein, Stephen/0000-0001-6297-9187	Engineering and Physical Sciences Research Council [EP/G00224X]; Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-06CH11357];  [NE/F018754/1]; Engineering and Physical Sciences Research Council [EP/J010871/1] Funding Source: researchfish; Natural Environment Research Council [NE/F018754/1, ncas10006] Funding Source: researchfish; EPSRC [EP/J010871/1] Funding Source: UKRI; NERC [NE/F018754/1, ncas10006] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.R.G. is supported by Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. M. A. B., P. W. S., and J.L. received support from the Natural Environment Research Council via the National Centre for Atmospheric Science and grant NE/F018754/1. S.J.K. was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, under contract DE-AC02-06CH11357.	Blake NJ, 1996, J GEOPHYS RES-ATMOS, V101, P24151, DOI 10.1029/96JD00561; Bohn B, 1998, J CHEM SOC FARADAY T, V94, P1203, DOI 10.1039/a708536b; Bohn B, 1996, J CHEM SOC FARADAY T, V92, P1459, DOI 10.1039/ft9969201459; Carr SA, 2011, J PHYS CHEM A, V115, P1069, DOI 10.1021/jp1099199; Clary DC, 2008, P NATL ACAD SCI USA, V105, P12649, DOI 10.1073/pnas.0800088105; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Czako G, 2011, SCIENCE, V334, P343, DOI 10.1126/science.1208514; Dibble TS, 2002, J PHYS CHEM A, V106, P6643, DOI 10.1021/jp025682m; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Fernandez-Ramos A, 2006, CHEM REV, V106, P4518, DOI 10.1021/cr050205w; Fleming DG, 2011, SCIENCE, V331, P448, DOI 10.1126/science.1199421; Frankcombe TJ, 2003, J THEOR COMPUT CHEM, V2, P179, DOI 10.1142/S0219633603000483; Georgievskii Y, 2003, J CHEM PHYS, V118, P5442, DOI 10.1063/1.1539035; Glowacki DR, 2011, NAT CHEM, V3, P850, DOI [10.1038/NCHEM.1154, 10.1038/nchem.1154]; Glowacki DR, 2010, CHEMPHYSCHEM, V11, P3836, DOI 10.1002/cphc.201000469; Glowacki DR, 2010, J AM CHEM SOC, V132, P13621, DOI 10.1021/ja105100f; Goldman LM, 2011, J AM CHEM SOC, V133, P5312, DOI 10.1021/ja1095717; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Maranzana A, 2008, J PHYS CHEM A, V112, P3666, DOI 10.1021/jp077180k; Maranzana A, 2008, J PHYS CHEM A, V112, P3656, DOI 10.1021/jp077174o; Mckee KW, 2007, J PHYS CHEM A, V111, P4043, DOI 10.1021/jp067594y; Miller JA, 2006, J PHYS CHEM A, V110, P10528, DOI 10.1021/jp062693x; Mollner AK, 2010, SCIENCE, V330, P646, DOI 10.1126/science.1193030; Olzmann M, 2002, PHYS CHEM CHEM PHYS, V4, P3614, DOI 10.1039/b203244a; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; SCHMIDT V, 1985, BER BUNSEN PHYS CHEM, V89, P321, DOI 10.1002/bbpc.19850890337; Senosiain JP, 2005, J PHYS CHEM A, V109, P6045, DOI 10.1021/jp050737g; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	35	77	77	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1066	1069		10.1126/science.1224106	http://dx.doi.org/10.1126/science.1224106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936771				2022-12-01	WOS:000308125800038
J	Fukunaga, R; Han, BW; Hung, JH; Xu, J; Weng, ZP; Zamore, PD				Fukunaga, Ryuya; Han, Bo W.; Hung, Jui-Hung; Xu, Jia; Weng, Zhiping; Zamore, Phillip D.			Dicer Partner Proteins Tune the Length of Mature miRNAs in Flies and Mammals	CELL			English	Article							DOUBLE-STRANDED-RNA; SMALL-INTERFERING RNA; SMALL SILENCING RNAS; ENDOGENOUS SIRNAS; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MICRORNA MATURATION; SOMATIC-CELLS; MOUSE OOCYTES; DROSOPHILA	Drosophila Dicer-1 produces microRNAs (miRNAs) from pre-miRNA, whereas Dicer-2 generates small interfering RNAs (siRNAs) from long dsRNA. Alternative splicing of the loquacious (loqs) mRNA generates three distinct Dicer partner proteins. To understand the function of each, we constructed flies expressing Loqs-PA, Loqs-PB, or Loqs-PD. Loqs-PD promotes both endo-and exo-siRNA production by Dicer-2. Loqs-PA or Loqs-PB is required for viability, but the proteins are not fully redundant: a specific subset of miRNAs requires Loqs-PB. Surprisingly, Loqs-PB tunes where Dicer-1 cleaves pre-miR-307a, generating a longer miRNA isoform with a distinct seed sequence and target specificity. The longer form of miR-307a represses glycerol kinase and taranis mRNA expression. The mammalian Dicer-partner TRBP, a Loqs-PB homolog, similarly tunes where Dicer cleaves pre-miR-132. Thus, Dicer-binding partner proteins change the choice of cleavage site by Dicer, producing miRNAs with target specificities different from those made by Dicer alone or Dicer bound to alternative protein partners.	[Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA; [Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Fukunaga, Ryuya/AAK-8609-2020; Hung, Jui-Hung/G-2673-2012; Xu, Jia/F-7750-2012	Fukunaga, Ryuya/0000-0002-5814-8206; Hung, Jui-Hung/0000-0003-2208-9213; Zamore, Phillip/0000-0002-4505-9618; Han, Bo/0000-0001-9501-8702; Xu, Jia/0000-0003-3921-018X	National Institutes of Health [GM62862, GM65236]; JSPS; Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R01GM062862, R37GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Haruhiko and Mikiko Siomi for strains and antibodies; Richard Carthew, Qinghua Liu, and the Bloomington Stock Center for strains; Ganes Sen and Robert Braun for MEF cells; Ian MacRae for human Dicer plasmid; Lin Wang and Lauren Dedow for RNA-Seq library protocols; Chengjian Li for help with small RNA libraries; Wei Wang for bioinformatics help; Alicia Boucher, Cindy Tipping, and Shengmei Ma for fly husbandry; and Traci Hall, Gang Lu, and members of the Zamore laboratory for discussion, advice, and comments on the manuscript. This work was supported in part by the National Institutes of Health (GM62862 and GM65236) and a JSPS Research Fellowship for Research Abroad and a Charles A. King Trust Postdoctoral Fellowship to R. F. P. D. Z. is a member of the scientific advisory board of Regulus Therapeutics.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	62	139	141	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					533	546		10.1016/j.cell.2012.09.027	http://dx.doi.org/10.1016/j.cell.2012.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063653	Green Accepted, Bronze			2022-12-01	WOS:000310529300011
J	Ginsberg, M; James, D; Ding, BS; Nolan, D; Geng, FQ; Butler, JM; Schachterle, W; Pulijaal, VR; Mathew, S; Chasen, ST; Xiang, J; Rosenwaks, Z; Shido, K; Elemento, O; Rabbany, SY; Rafii, S				Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Pulijaal, Venkat R.; Mathew, Susan; Chasen, Stephen T.; Xiang, Jenny; Rosenwaks, Zev; Shido, Koji; Elemento, Olivier; Rabbany, Sina Y.; Rafii, Shahin			Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGF beta Suppression	CELL			English	Article							TRANSCRIPTION FACTOR ERG; HEMATOPOIETIC STEM-CELLS; ANGIOCRINE SIGNALS; DIFFERENTIATION; ANGIOGENESIS; FAMILY; GROWTH; GENE; FLI1; ERYTHROLEUKEMIA	ETS transcription factors ETV2, FLI1, and ERG1 specify pluripotent stem cells into induced vascular endothelial cells (iVECs). However, iVECs are unstable and drift toward nonvascular cells. We show that human midgestation c-Kit(-) lineage-committed amniotic cells (ACs) can be reprogrammed into vascular endothelial cells (rAC-VECs) without transitioning through a pluripotent state. Transient ETV2 expression in ACs generates immature rAC-VECs, whereas coexpression with FLI1/ERG1 endows rAC-VECs with a vascular repertoire and morphology matching mature endothelial cells (ECs). Brief TGF beta-inhibition functionalizes VEGFR2 signaling, augmenting specification of ACs into rAC-VECs. Genome-wide transcriptional analyses showed that rAC-VECs are similar to adult ECs in which vascular-specific genes are expressed and nonvascular genes are silenced. Functionally, rAC-VECs form stable vasculature in Matrigel plugs and regenerating livers. Therefore, short-term ETV2 expression and TGF beta inhibition with constitutive ERG1/FLI1 coexpression reprogram mature ACs into durable rAC-VECs with clinical-scale expansion potential. Banking of HLA-typed rAC-VECs establishes a vascular inventory for treatment of diverse disorders.	[Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Chasen, Stephen T.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Xiang, Jenny] Weill Cornell Med Coll, Genom Resources Core Facil, New York, NY 10065 USA; [Pulijaal, Venkat R.; Mathew, Susan] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [James, Daylon; Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Cornell University; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu			Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI [R01s HL097797, DK095039]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar foundation BioMedical Research Program (BMRP); New York State Department of Health (NYSTEM) [C024180, C026438, C026878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities Research Foundation; Qatar foundation BioMedical Research Program (BMRP)(Qatar National Research Fund (QNRF)); New York State Department of Health (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S.R. is supported by Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board and New York State Department of Health grants (NYSTEM, C024180, C026438, C026878); NHLBI R01s HL097797 and DK095039; Qatar National Priorities Research Foundation NPRP08-663-3-140; and Qatar foundation BioMedical Research Program (BMRP). The authors acknowledge Agnes Stachnik and Pooja Rana for their technical contribution to this work.	Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Benavides OM, 2012, TISSUE ENG PT A, V18, P1123, DOI [10.1089/ten.tea.2011.0392, 10.1089/ten.TEA.2011.0392]; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cui JW, 2009, LEUKEMIA, V23, P1311, DOI 10.1038/leu.2009.20; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; McLaughlin F, 2001, BLOOD, V98, P3332, DOI 10.1182/blood.V98.12.3332; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; ZHANG LQ, 1993, ONCOGENE, V8, P1621; Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331	39	151	156	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					559	575		10.1016/j.cell.2012.09.032	http://dx.doi.org/10.1016/j.cell.2012.09.032			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23084400	Green Accepted, Bronze			2022-12-01	WOS:000310529300013
J	Kannan, K; Vazquez-Laslop, N; Mankin, AS				Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.			Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; NASCENT PEPTIDE; TRANSFER-RNA; TRANSLATION ELONGATION; MOLECULAR-MECHANISM; STRUCTURAL INSIGHT; HMR 3647; ANTIBIOTICS	The polypeptide exit tunnel is an important functional compartment of the ribosome where the newly synthesized proteins are surveyed. The tunnel is the target of clinically important macrolide antibiotics. Macrolides plug the tunnel and are believed to stop production of all proteins. Contrary to this view, we show that drug-bound ribosomes can synthesize a distinct subset of cellular polypeptides. The structure of a protein defines its ability to thread through the antibiotic-obstructed tunnel. Synthesis of certain polypeptides that initially bypass translational arrest can be stopped at later stages of elongation while translation of some proteins goes to completion. Our findings reveal that small-molecule effectors can accentuate the discriminatory properties of the ribosomal exit tunnel and that macrolide antibiotics reshape the cellular proteome rather than block global protein synthesis.	[Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave, Chicago, IL 60607 USA.	shura@uic.edu		Kannan, Krishna/0000-0002-2301-7900	National Science Foundation [MCB-0824739]; Div Of Molecular and Cellular Bioscience [0824739] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Anusha Rethi Paul Raj, Dorota Klepacki, Anna Ochabowicz, and Jacqueline M. LaMarre for help with experiments, Teymur Kazakov for advice, Prabha Fernandez for providing solithromycin and CEM-112, and Kirk Hevener for advice on using Chimera software. We are grateful to Peter Moore, Harry Noller, and Ada Yonath for their comments on the manuscript. This work was supported by grant MCB-0824739 from the National Science Foundation.	Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; ANDERSSON S, 1987, BIOCHIMIE, V69, P901, DOI 10.1016/0300-9084(87)90218-5; APIRION D, 1967, J MOL BIOL, V30, P255; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BROCK TD, 1959, BIOCHIM BIOPHYS ACTA, V33, P274, DOI 10.1016/0006-3002(59)90535-9; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; ENNIS HL, 1972, ANTIMICROB AGENTS CH, V1, P197, DOI 10.1128/AAC.1.3.197; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; GRAHAM MY, 1979, J BACTERIOL, V137, P1464, DOI 10.1128/JB.137.3.1464-1467.1979; Hamilton-Miller JMT, 1998, J ANTIMICROB CHEMOTH, V41, P649, DOI 10.1093/jac/41.6.649; HARDESTY B, 1990, BIOCHIM BIOPHYS ACTA, V1050, P197, DOI 10.1016/0167-4781(90)90166-Y; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HORINOUCHI S, 1980, P NATL ACAD SCI-BIOL, V77, P7079, DOI 10.1073/pnas.77.12.7079; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lovmar M, 2006, J BIOL CHEM, V281, P6742, DOI 10.1074/jbc.M511918200; Lovmar M, 2009, EMBO J, V28, P736, DOI 10.1038/emboj.2009.17; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; MAYFORD M, 1989, J MOL BIOL, V206, P69, DOI 10.1016/0022-2836(89)90524-X; MENNINGER JR, 1994, MOL GEN GENET, V243, P225, DOI 10.1007/BF00280320; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Moore SD, 2008, P NATL ACAD SCI USA, V105, P18261, DOI 10.1073/pnas.0810357105; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; ODOM OW, 1991, EUR J BIOCHEM, V198, P713, DOI 10.1111/j.1432-1033.1991.tb16071.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oleinick N.L., 1975, ANTIBIOTICS, P397; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; OTAKA T, 1975, P NATL ACAD SCI USA, V72, P2649, DOI 10.1073/pnas.72.7.2649; Peltz SW, 2009, RNA BIOL, V6, P329, DOI 10.4161/rna.6.3.8953; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Starosta AL, 2010, CHEM BIOL, V17, P504, DOI 10.1016/j.chembiol.2010.04.008; TAI PC, 1974, BIOCHEMISTRY-US, V13, P4653, DOI 10.1021/bi00719a029; TAUBMAN S B, 1963, Antimicrob Agents Chemother (Bethesda), V161, P395; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Tenson T, 1997, J BIOL CHEM, V272, P17425, DOI 10.1074/jbc.272.28.17425; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Tenson T, 2001, PEPTIDES, V22, P1661, DOI 10.1016/S0196-9781(01)00501-0; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; VAZQUEZ D, 1966, BIOCHIM BIOPHYS ACTA, V114, P289, DOI 10.1016/0005-2787(66)90310-8; Vazquez D., 1979, INHIBITORS PROTEIN B; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P377; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P10496, DOI 10.1073/pnas.1103474108; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Yao S, 2008, MOL MICROBIOL, V69, P1439, DOI 10.1111/j.1365-2958.2008.06370.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Zaporojets D, 2003, J BACTERIOL, V185, P6921, DOI 10.1128/JB.185.23.6921-6927.2003; Zhanel George G, 2002, Expert Opin Pharmacother, V3, P277	70	105	106	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					508	520		10.1016/j.cell.2012.09.018	http://dx.doi.org/10.1016/j.cell.2012.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101624	Bronze			2022-12-01	WOS:000310529300009
J	Morlot, S; Galli, V; Klein, M; Chiaruttini, N; Manzi, J; Humbert, F; Dinis, L; Lenz, M; Cappello, G; Roux, A				Morlot, Sandrine; Galli, Valentina; Klein, Marius; Chiaruttini, Nicolas; Manzi, John; Humbert, Frederic; Dinis, Luis; Lenz, Martin; Cappello, Giovanni; Roux, Aurelien			Membrane Shape at the Edge of the Dynamin Helix Sets Location and Duration of the Fission Reaction	CELL			English	Article							MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; LIPID-BILAYERS; CURVATURE; MODEL; CONSTRICTION; TENSION; AMPHIPHYSIN; RINGS	The GTPase dynamin polymerizes into a helical coat that constricts membrane necks of endocytic pits to promote their fission. However, the dynamin mechanism is still debated because constriction is necessary but not sufficient for fission. Here, we show that fission occurs at the interface between the dynamin coat and the uncoated membrane. At this location, the considerable change in membrane curvature increases the local membrane elastic energy, reducing the energy barrier for fission. Fission kinetics depends on tension, bending rigidity, and the dynamin constriction torque. Indeed, we experimentally find that the fission rate depends on membrane tension in vitro and during endocytosis in vivo. By estimating the energy barrier from the increased elastic energy at the edge of dynamin and measuring the dynamin torque, we show that the mechanical energy spent on dynamin constriction can reduce the energy barrier for fission sufficiently to promote spontaneous fission.	[Morlot, Sandrine; Galli, Valentina; Chiaruttini, Nicolas; Humbert, Frederic; Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Morlot, Sandrine; Klein, Marius; Manzi, John; Cappello, Giovanni] Univ Paris 06, Inst Curie, Ctr Rech, CNRS,UMR Physicochim Curie 168, F-75248 Paris, France; [Dinis, Luis] Univ Complutense Madrid, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain; [Dinis, Luis] GISC, Madrid 28040, Spain; [Lenz, Martin] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Lenz, Martin] Univ Paris 11, CNRS, UMR LPTMS 8626, F-91405 Orsay, France; [Roux, Aurelien] Swiss Natl Ctr Competence Res, Programme Chem Biol, CH-1211 Geneva, Switzerland	University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; Complutense University of Madrid; University of Chicago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roux, A (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	Aurelien.roux@unige.ch	Lenz, Martin/B-3329-2013; Dinis, Luis/AAN-6969-2021; Cappello, Giovanni/D-4876-2013; Dinis, Luis/B-8820-2011; Manzi, John/AAI-8253-2021; Roux, Aurelien/AAU-1262-2021; Roux, Aurelien R/G-9541-2013	Lenz, Martin/0000-0002-2307-1106; Dinis, Luis/0000-0003-2064-2396; Dinis, Luis/0000-0003-2064-2396; Manzi, John/0000-0003-2574-4260; Roux, Aurelien/0000-0002-6088-0711; Roux, Aurelien R/0000-0002-6088-0711; Morlot, Sandrine/0000-0002-0326-6694	Agence Nationale de la Recherche [JC08-317536, 0061/2008, RGY0076/2009-C, 31003A-130520/1]; Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government [FIS2011-22644]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government(Spanish GovernmentEuropean Commission)	We thank David Drubin for sharing with us the SKML-2 cells. We thank Marcos Gonzalez-Gaitan, for inspiring discussions and critical reading of the manuscript. We thank Pietro De Camilli, Jacques Prost, and Jean-Francois Joanny for thoughtful comments on this study. This work was supported by the Agence Nationale de la Recherche (Young Investigator Program Award No. JC08-317536 to A. R. and G. C.), Human Frontier Science Program Career Development Award No. 0061/2008 (to A. R.), Young Investigator Research Grant No. RGY0076/2009-C (to A. R.), Swiss National Fund for Research Grant No. 31003A-130520/1 (to A. R.), the Societe Academique de Geneve, and the Swiss National Centre for Competence in Research Programme Chemical Biology. L. D. acknowledges financial support from Grant ENFASIS (FIS2011-22644, from the Spanish Government).	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Happel J., 2012, LOW REYNOLDS NUMBER; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lenz M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011911; Lipfert J, 2010, NAT METHODS, V7, P977, DOI 10.1038/NMETH.1520; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Morlot S, 2010, BIOPHYS J, V99, P3580, DOI 10.1016/j.bpj.2010.10.015; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	41	118	119	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					619	629		10.1016/j.cell.2012.09.017	http://dx.doi.org/10.1016/j.cell.2012.09.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101629	Bronze, Green Accepted			2022-12-01	WOS:000310529300017
J	Zhang, QC; Petrey, D; Deng, L; Qiang, L; Shi, Y; Thu, CA; Bisikirska, B; Lefebvre, C; Accili, D; Hunter, T; Maniatis, T; Califano, A; Honig, B				Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Qiang, Li; Shi, Yu; Thu, Chan Aye; Bisikirska, Brygida; Lefebvre, Celine; Accili, Domenico; Hunter, Tony; Maniatis, Tom; Califano, Andrea; Honig, Barry			Structure-based prediction of protein-protein interactions on a genome-wide scale	NATURE			English	Article							NETWORKS; DATABASE; SEQUENCES; CONTEXT	The genome-wide identification of pairs of interacting proteins is an important step in the elucidation of cell regulatory mechanisms(1,2). Much of our present knowledge derives from high-throughput techniques such as the yeast two-hybrid assay and affinity purification(3), as well as from manual curation of experiments on individual systems(4). A variety of computational approaches based, for example, on sequence homology, gene co-expression and phylogenetic profiles, have also been developed for the genome-wide inference of protein-protein interactions (PPIs)(5,6). Yet comparative studies suggest that the development of accurate and complete repertoires of PPIs is still in its early stages(7-9). Here we show that three-dimensional structural information can be used to predict PPIs with an accuracy and coverage that are superior to predictions based on non-structural evidence. Moreover, an algorithm, termed PrePPI, which combines structural information with other functional clues, is comparable in accuracy to high-throughput experiments, yielding over 30,000 high-confidence interactions for yeast and over 300,000 for human. Experimental tests of a number of predictions demonstrate the ability of the PrePPI algorithm to identify unexpected PPIs of considerable biological interest. The surprising effectiveness of three-dimensional structural information can be attributed to the use of homology models combined with the exploitation of both close and remote geometric relationships between proteins.	[Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Thu, Chan Aye; Maniatis, Tom; Califano, Andrea; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Bisikirska, Brygida; Lefebvre, Celine; Califano, Andrea; Honig, Barry] Columbia Univ, Columbia Initiat Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Deng, Lei] Tongji Univ, Dept Comp Sci & Technol, Shanghai 201804, Peoples R China; [Qiang, Li; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Shi, Yu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lefebvre, Celine; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Tongji University; Columbia University; Salk Institute; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	califano@c2b2.columbia.edu; bh6@columbia.edu	Zhang, Qiangfeng/C-2902-2011; Lefebvre, Celine/E-6290-2013; Shi, Yu/N-4319-2019; dong, minghui/D-1806-2015; Califano, Andrea/F-7239-2012	Shi, Yu/0000-0001-6742-9598; Qiang, Li/0000-0001-8322-1797; Califano, Andrea/0000-0003-4742-3679	National Institutes of Health [GM030518, GM094597, CA121852, DK057539, CA082683, R01NS043915]; China Scholarship Council [2010626059]; NATIONAL CANCER INSTITUTE [R01CA082683, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518, U54GM094597, R37GM030518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health grants GM030518 and GM094597 (B.H.), CA121852 (A.C. and B.H.), DK057539 (D.A.), CA082683 (T.H.), R01NS043915 (T.M.). L.D. thanks the China Scholarship Council scholarship 2010626059. We thank U. Pieper from A. Sali's laboratory for help with ModBase, and H. Lee for help with SkyBase.	Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468852a, 10.1038/468854a]; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Davis FP, 2006, NUCLEIC ACIDS RES, V34, P2943, DOI 10.1093/nar/gkl353; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Mirkovic N, 2007, PROTEINS, V66, P766, DOI 10.1002/prot.21191; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Salwinski L, 2003, CURR OPIN STRUC BIOL, V13, P377, DOI 10.1016/S0959-440X(03)00070-8; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107	44	464	487	9	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					556	+		10.1038/nature11503	http://dx.doi.org/10.1038/nature11503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023127	Green Accepted			2022-12-01	WOS:000310196200046
J	Ferriman, A				Ferriman, Annabel			Finding the smoking gun: a speech by Richard Peto	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7119	10.1136/bmj.e7119	http://dx.doi.org/10.1136/bmj.e7119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097544				2022-12-01	WOS:000310427600016
J	Vo, TT; Ryan, J; Carrasco, R; Neuberg, D; Rossi, DJ; Stone, RM; DeAngelo, DJ; Frattini, MG; Letai, A				Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Rossi, Derrick J.; Stone, Richard M.; DeAngelo, Daniel J.; Frattini, Mark G.; Letai, Anthony			Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; BCL-2 FAMILY; BH3-ONLY PROTEINS; CYTOCHROME-C; APOPTOSIS; DEATH; MCL-1; BAX; INHIBITOR	Despite decades of successful use of cytotoxic chemotherapy in acute myelogenous leukemia (AML), the biological basis for its differential success among individuals and for the existence of a therapeutic index has remained obscure. Rather than taking a genetic approach favored by many, we took a functional approach to ask how differential mitochondrial readiness for apoptosis ("priming") might explain individual variation in clinical behavior. We found that mitochondrial priming measured by BH3 profiling was a determinant of initial response to induction chemotherapy, relapse after remission, and requirement for allogeneic bone marrow transplantation. Differential priming between malignant myeloblasts and normal hematopoietic stem cells supports a mitochondrial basis to the therapeutic index for chemotherapy. BH3 profiling identified BCL-2 inhibition as a targeted strategy likely to have a useful therapeutic index. BH3 profiling refines predictive information provided by conventional biomarkers currently in use and thus may itself have utility as a clinical predictive biomarker.	[Thanh-Trang Vo; Letai, Anthony] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Stone, Richard M.; DeAngelo, Daniel J.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Letai, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	anthony_letai@dfci.harvard.edu		Ryan, Jeremy/0000-0002-3327-1283	NIH [F31 CA150562, P01 CA139980, R01CA129974]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [F31CA150562, R01CA129974, P01CA139980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the following sources: NIH grants F31 CA150562, P01 CA139980, and R01CA129974, Gabrielle's Angel Foundation for Cancer Research. A. L. is a Leukemia and Lymphoma Society Scholar. We thank Abbott Laboratories for providing ABT-737. We thank Martha Wadleigh, MD, and Ilene Galinsky, RN, and the Pasquarello Tissue Bank for help with clinical data and samples. A. L. was a cofounder and formerly served on the scientific advisory board of Eutropics Pharmaceuticals, which has a license for BH3 profiling.	Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Sekeres Mikkael A, 2002, Curr Oncol Rep, V4, P403, DOI 10.1007/s11912-002-0034-y; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	250	271	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					344	355		10.1016/j.cell.2012.08.038	http://dx.doi.org/10.1016/j.cell.2012.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063124	Bronze, Green Accepted			2022-12-01	WOS:000309981000013
J	Joynt, KE; Blumenthal, DM; Orav, EJ; Resnic, FS; Jha, AK				Joynt, Karen E.; Blumenthal, Daniel M.; Orav, E. John; Resnic, Frederic S.; Jha, Ashish K.			Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR DATA REGISTRY; MORTALITY RISK PREDICTION; UNINTENDED CONSEQUENCES; HEART-ASSOCIATION; BYPASS-SURGERY; MANAGEMENT; UPDATE	Context Public reporting of patient outcomes is an important tool to improve quality of care, but some observers worry that such efforts will lead clinicians to avoid high-risk patients. Objective To determine whether public reporting for percutaneous coronary intervention (PCI) is associated with lower rates of PCI for patients with acute myocardial infarction (MI) or with higher mortality rates in this population. Design, Setting, and Patients Retrospective observational study conducted using data from fee-for-service Medicare patients (49 660 from reporting states and 48 142 from nonreporting states) admitted with acute MI to US acute care hospitals between 2002 and 2010. Logistic regression was used to compare PCI and mortality rates between reporting states (New York, Massachusetts, and Pennsylvania) and regional nonreporting states (Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware). Changes in PCI rates over time in Massachusetts compared with nonreporting states were also examined. Main Outcome Measures Risk-adjusted PCI and mortality rates. Results In 2010, patients with acute MI were less likely to receive PCI in public reporting states than in nonreporting states (unadjusted rates, 37.7% vs 42.7%, respectively; risk-adjusted odds ratio [OR], 0.82 [95% CI, 0.71-0.93]; P=.003). Differences were greatest among the 6708 patients with ST-segment elevation MI (61.8% vs 68.0%; OR, 0.73 [95% CI, 0.59-0.89]; P=.002) and the 2194 patients with cardiogenic shock or cardiac arrest (41.5% vs 46.7%; OR, 0.79 [95% CI, 0.64-0.98]; P=.03). There were no differences in overall mortality among patients with acute MI in reporting vs nonreporting states. In Massachusetts, odds of PCI for acute MI were comparable with odds in nonreporting states prior to public reporting (40.6% vs 41.8%; OR, 1.00 [95% CI, 0.71-1.41]). However, after implementation of public reporting, odds of undergoing PCI in Massachusetts decreased compared with nonreporting states (41.1% vs 45.6%; OR, 0.81 [95% CI, 0.47-1.38]; P=.03 for difference in differences). Differences were most pronounced for the 6081 patients with cardiogenic shock or cardiac arrest (prereporting: 44.2% vs 36.6%; OR, 1.40 [95% CI, 0.85-2.32]; postreporting: 43.9% vs 44.8%; OR, 0.92 [95% CI, 0.38-2.22]; P=.03 for difference in differences). Conclusions Among Medicare beneficiaries with acute MI, the use of PCI was lower for patients treated in 3 states with public reporting of PCI outcomes compared with patients treated in 7 regional control states without public reporting. However, there was no difference in overall acute MI mortality between states with and without public reporting. JAMA. 2012;308(14):1460-1468 www.jama.com	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.; Resnic, Frederic S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital	Joynt, KE (corresponding author), 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute.	Apolito RA, 2008, AM HEART J, V155, P267, DOI 10.1016/j.ahj.2007.10.013; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Resnic FS, 2011, J AM COLL CARDIOL, V57, P904, DOI 10.1016/j.jacc.2010.09.057; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034; Ritley D, 2011, STATE CARDIAC REVASC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e	16	153	155	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1460	1468		10.1001/jama.2012.12922	http://dx.doi.org/10.1001/jama.2012.12922			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047360	Green Accepted			2022-12-01	WOS:000309579300025
J	Walden, AP; Bonten, MJ; Wise, MP				Walden, Andrew P.; Bonten, Marc J.; Wise, Matt P.			Should selective digestive decontamination be used in critically ill patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; TRACT; OROPHARYNX		[Walden, Andrew P.] Royal Berkshire Hosp, Wantage OX12 8HG, England; [Bonten, Marc J.] Univ Med Ctr, Utrecht, Netherlands; [Wise, Matt P.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Royal Berkshire Hospital; Utrecht University; Utrecht University Medical Center; Cardiff University	Walden, AP (corresponding author), Royal Berkshire Hosp, Wantage OX12 8HG, England.	apwalden@hotmail.com		Wise, Matt/0000-0002-2763-4316				Bastin AJ, 2009, ANAESTHESIA, V64, P46, DOI 10.1111/j.1365-2044.2008.05676.x; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; de Smet AMGA, 2009, INTENS CARE MED, V35, P1609, DOI 10.1007/s00134-009-1554-9; GASTINNE H, 1992, NEW ENGL J MED, V326, P594, DOI 10.1056/NEJM199202273260903; Health Protection Agency, 2012, ENGL NAT POINT PREV; Julius Center, UMC UTR R GNOSIS; Liberati A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000022.pub3; Lingnau W, 1998, J HOSP INFECT, V39, P195, DOI 10.1016/S0195-6701(98)90258-4; Melsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Oostdijk EAN, 2010, AM J RESP CRIT CARE, V181, P452, DOI 10.1164/rccm.200908-1210OC; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5	15	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6697	10.1136/bmj.e6697	http://dx.doi.org/10.1136/bmj.e6697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23047967				2022-12-01	WOS:000309907100011
J	Chang, JC; Lockner, DA; Reches, Z				Chang, J. C.; Lockner, D. A.; Reches, Z.			Rapid Acceleration Leads to Rapid Weakening in Earthquake-Like Laboratory Experiments	SCIENCE			English	Article							RUPTURE; SLIP; GOUGE; LUBRICATION; FRACTURE; POWDER; ZONE	After nucleation, a large earthquake propagates as an expanding rupture front along a fault. This front activates countless fault patches that slip by consuming energy stored in Earth's crust. We simulated the slip of a fault patch by rapidly loading an experimental fault with energy stored in a spinning flywheel. The spontaneous evolution of strength, acceleration, and velocity indicates that our experiments are proxies of fault-patch behavior during earthquakes of moment magnitude (M-w) = 4 to 8. We show that seismically determined earthquake parameters (e.g., displacement, velocity, magnitude, or fracture energy) can be used to estimate the intensity of the energy release during an earthquake. Our experiments further indicate that high acceleration imposed by the earthquake's rupture front quickens dynamic weakening by intense wear of the fault zone.	[Chang, J. C.; Reches, Z.] Univ Oklahoma, Norman, OK 73019 USA; [Lockner, D. A.] US Geol Survey, Menlo Pk, CA 94022 USA	University of Oklahoma System; University of Oklahoma - Norman; United States Department of the Interior; United States Geological Survey	Reches, Z (corresponding author), Univ Oklahoma, 100 E Boyd St, Norman, OK 73019 USA.	reches@ou.edu		Chang, Jefferson/0000-0002-1258-589X	NSF [0732715, 1045414, NEHRP2011, G11AP20008]	NSF(National Science Foundation (NSF))	We thank J. Young, J. Fineberg, and E. Aharonov, and T. Shimamoto and two anonymous reviewers for their thoughtful reviews. This work was supported by NSF Geosciences awards 0732715 and 1045414 and NEHRP2011 award G11AP20008.	Andrews DJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003191; Fukuyama E, 2010, INT J FRACTURE, V163, P15, DOI 10.1007/s10704-009-9417-5; Goldsby DL, 2011, SCIENCE, V334, P216, DOI 10.1126/science.1207902; GRADY DE, 1985, J APPL PHYS, V58, P1210, DOI 10.1063/1.336139; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; LOCKNER DA, 1983, J GEOPHYS RES, V88, P4313, DOI 10.1029/JB088iB05p04313; Niemeijer A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008181; Ohnaka M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000123; OHNAKA M, 1989, J GEOPHYS RES-SOLID, V94, P4089, DOI 10.1029/JB094iB04p04089; OKUBO PG, 1981, GEOPHYS RES LETT, V8, P887, DOI 10.1029/GL008i008p00887; OLGAARD DL, 1983, INT J ROCK MECH MIN, V20, P11, DOI 10.1016/0148-9062(83)91610-8; Reches Z, 2005, EARTH PLANET SC LETT, V235, P361, DOI 10.1016/j.epsl.2005.04.009; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Sone H, 2009, NAT GEOSCI, V2, P705, DOI 10.1038/NGEO637; Tinti E, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003644; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Wornyoh EYA, 2007, J TRIBOL-T ASME, V129, P438, DOI 10.1115/1.2647859	20	47	49	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					101	105		10.1126/science.1221195	http://dx.doi.org/10.1126/science.1221195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042892				2022-12-01	WOS:000309457400062
J	Heckel, DG				Heckel, David G.			Insecticide Resistance After Silent Spring	SCIENCE			English	Editorial Material							BT COTTON; EVOLUTION; MUTATIONS; APHID		Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society	Heckel, DG (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Hans Knoll Str 8, D-07745 Jena, Germany.	heckel@ice.mpg.de	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Beckie HJ, 2011, PEST MANAG SCI, V67, P1037, DOI 10.1002/ps.2195; Carson R., 1962, SILENT SPRING; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Devonshire AL, 1998, PHILOS T R SOC B, V353, P1677, DOI 10.1098/rstb.1998.0318; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985; James C., 2004, GLOBAL STATUS COMMER; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Perry T, 2012, PESTIC BIOCHEM PHYS, V102, P56, DOI 10.1016/j.pestbp.2011.10.010; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	22	132	139	6	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1613	1614		10.1126/science.1226994	http://dx.doi.org/10.1126/science.1226994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019637	Green Submitted			2022-12-01	WOS:000309215400030
J	Hyatt, LA				Hyatt, Laura A.			Personal Plants: Making Botany Meaningful by Experimentation	SCIENCE			English	Editorial Material									Rider Univ, Coll Liberal Arts Educ & Sci, Lawrenceville, NJ 08648 USA	Rider University	Hyatt, LA (corresponding author), Rider Univ, Coll Liberal Arts Educ & Sci, 2083 Lawrenceville Rd, Lawrenceville, NJ 08648 USA.	lhyatt@rider.edu						Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Senchina D. S., 2008, PLANT SCI B, V54, P50; UNO GE, 1994, AM BIOL TEACH, V56, P263, DOI 10.2307/4449818; World Health Organization/UN Food and Agriculture Organization, 2003, WHO TECH REP SER	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1620	1621		10.1126/science.1215226	http://dx.doi.org/10.1126/science.1215226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019642				2022-12-01	WOS:000309215400035
J	Babu, M; Vlasblom, J; Pu, SY; Guo, XH; Graham, C; Bean, BDM; Burston, HE; Vizeacoumar, FJ; Snider, J; Phanse, S; Fong, V; Tam, YYC; Davey, M; Hnatshak, O; Bajaj, N; Chandran, S; Punna, T; Christopolous, C; Wong, V; Yu, A; Zhong, GQ; Li, J; Stagljar, I; Conibear, E; Wodak, SJ; Emili, A; Greenblatt, JF				Babu, Mohan; Vlasblom, James; Pu, Shuye; Guo, Xinghua; Graham, Chris; Bean, Bjoern D. M.; Burston, Helen E.; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Tam, Yuen Yi C.; Davey, Michael; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Conibear, Elizabeth; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.			Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae	NATURE			English	Article							PHYSICAL INTERACTOME; ER EXIT; YEAST; MAP; EXPLORATION; SELECTION	Macromolecular assemblies involving membrane proteins (MPs) serve vital biological roles and are prime drug targets in a variety of diseases(1). Large-scale affinity purification studies of soluble-protein complexes have been accomplished for diverse model organisms, but no global characterization of MP-complex membership has been described so far. Here we report a complete survey of 1,590 putative integral, peripheral and lipid-anchored MPs from Saccharomyces cerevisiae, which were affinity purified in the presence of non-denaturing detergents. The identities of the co-purifying proteins were determined by tandem mass spectrometry and subsequently used to derive a high-confidence physical interaction map encompassing 1,726 membrane protein-protein interactions and 501 putative heteromeric complexes associated with the various cellular membrane systems. Our analysis reveals unexpected physical associations underlying the membrane biology of eukaryotes and delineates the global topological landscape of the membrane interactome.	[Bean, Bjoern D. M.; Burston, Helen E.; Tam, Yuen Yi C.; Davey, Michael; Conibear, Elizabeth] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Babu, Mohan; Guo, Xinghua; Graham, Chris; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Vlasblom, James; Pu, Shuye; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Vlasblom, James; Stagljar, Igor; Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Stagljar, Igor; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Child & Family Research Institute; University of British Columbia; University of Toronto; University of Regina; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Conibear, E (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	conibear@cmmt.ubc.ca; shoshana@sickkids.ca; andrew.emili@utoronto.ca; jack.greenblatt@utoronto.ca	Vizeacoumar, Franco/GLS-7161-2022; Mohan, Babu P./I-7362-2019	Davey, Michael/0000-0002-1172-5934; Phanse, Sadhna/0000-0001-6306-0551; wodak, shoshana/0000-0002-0701-6545; Conibear, Elizabeth/0000-0001-5129-0499	Canadian Foundation for Innovation; Canadian Institutes of Health Research (CIHR MOP) [81156, 64394, 82940]; Canadian Cancer Society Research Institute; Heart and Stroke Foundation; Cystic Fibrosis Foundation; Novartis; Ontario Genomics Institute; Genome Canada; SickKids Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Novartis(Novartis); Ontario Genomics Institute; Genome Canada(Genome Canada); SickKids Foundation	We thank H. Riezman, K. Sato and A. Nakano for providing strains and reagents, C. Ungermann for Sec18 antisera, A. Pierleoni for assistance with MemPype and R. Zheng for technical assistance. This research was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR MOP no. 81156, MOP no. 64394 and MOP no. 82940), the Canadian Cancer Society Research Institute, the Heart and Stroke Foundation, the Cystic Fibrosis Foundation, Novartis, the Ontario Genomics Institute and Genome Canada. E. C. is a CIHR New Investigator. S.J.W. is a Canada Research Chair Tier-I and acknowledges support from the SickKids Foundation.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Babu M, 2009, METHODS MOL BIOL, V548, P187, DOI 10.1007/978-1-59745-540-4_11; Bao LY, 2009, MOL MEMBR BIOL, V26, P127, DOI 10.1080/09687680802637652; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Flinn RJ, 2010, CELL CYCLE, V9, P1869, DOI 10.4161/cc.9.10.11679; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; James P, 1996, GENETICS, V144, P1425; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; ROSE MD, 1990, METHODS YEAST GENETI; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SIDHU RS, 1991, GENE, V107, P111, DOI 10.1016/0378-1119(91)90303-S; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x	37	168	170	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					585	+		10.1038/nature11354	http://dx.doi.org/10.1038/nature11354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22940862				2022-12-01	WOS:000311781500008
J	Fradkin, JE; Roberts, BT; Rodgers, GP				Fradkin, Judith E.; Roberts, B. Tibor; Rodgers, Griffin P.			What's Preventing Us from Preventing Type 2 Diabetes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fradkin, Judith E.] NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA; [Roberts, B. Tibor] NIDDKD, Off Sci Program & Policy Anal, NIH, Bethesda, MD 20892 USA; [Rodgers, Griffin P.] NIDDKD, Off Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fradkin, JE (corresponding author), NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA.							Centers for Disease Control and Prevention, NAT DIAB PREV PROGR; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Huang ES, 2009, HEALTH AFFAIR, V28, pW978, DOI 10.1377/hlthaff.28.5.w978; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512	5	29	29	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1177	1179		10.1056/NEJMp1208169	http://dx.doi.org/10.1056/NEJMp1208169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013070				2022-12-01	WOS:000309161100001
J	Redwine, WB; Hernandez-Lopez, R; Zou, SR; Huang, JL; Reck-Peterson, SL; Leschziner, AE				Redwine, William B.; Hernandez-Lopez, Rogelio; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.; Leschziner, Andres E.			Structural Basis for Microtubule Binding and Release by Dynein	SCIENCE			English	Article							MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; COILED-COIL; ACTIVATION; MICROSCOPY; MECHANISM; TRANSPORT; FAMILY; DOMAIN	Cytoplasmic dynein is a microtubule-based motor required for intracellular transport and cell division. Its movement involves coupling cycles of track binding and release with cycles of force-generating nucleotide hydrolysis. How this is accomplished given the similar to 25 nanometers separating dynein's track- and nucleotide-binding sites is not understood. Here, we present a subnanometer-resolution structure of dynein's microtubule-binding domain bound to microtubules by cryo-electron microscopy that was used to generate a pseudo-atomic model of the complex with molecular dynamics. We identified large rearrangements triggered by track binding and specific interactions, confirmed by mutagenesis and single-molecule motility assays, which tune dynein's affinity for microtubules. Our results provide a molecular model for how dynein's binding to microtubules is communicated to the rest of the motor.	[Redwine, William B.; Hernandez-Lopez, Rogelio; Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Redwine, William B.; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Leschziner, AE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	aleschziner@mcb.harvard.edu	Zou, Sirui/R-1437-2017	Zou, Sirui/0000-0002-3282-6064; Hernandez-Lopez, Rogelio/0000-0003-3968-4908; Leschziner, Andres/0000-0002-7732-7023; Reck-Peterson, Samara/0000-0002-1553-465X	National Science Foundation [ECS-0335765]; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1]; Alfred P. Sloan Foundation; Consejo Nacional de Ciencia y Tecnologia; Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Carter (Laboratory of Molecular Biology-Medical Research Council) for reagents and advice, C. Sindelar (Yale), V. Ramey [University of California (UC)-Berkeley], E. Egelman (University of Virginia), and R. Sinkovits (UC-San Diego) for sharing processing scripts and helpful advice; M. Sotomayor (Harvard) and R. Gaudet (Harvard) for advice concerning MD; J. Hogle (Harvard), M. Strauss (Harvard), and M. Wolf (Harvard) for help with film and the use of a film scanner; and E. Nogales (UC-Berkeley), N. Francis (Harvard), and D. Pellman (Harvard) for critically reading the manuscript, as well as all the members of the Leschziner and Reck-Peterson Labs for advice and helpful discussions. EM data were collected at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of Harvard University. MD simulations were run on the Odyssey cluster supported by the Faculty of Arts and Sciences Science Division Research Computing Group, Harvard University. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and an NIH New Innovator award (1 DP2 OD004268-1). A.E.L. was funded in part by a Research Fellowship from the Alfred P. Sloan Foundation. R.H.-L. was supported in part by Consejo Nacional de Ciencia y Tecnologia and Fundacion Mexico en Harvard. The cryo-EM map was deposited at the EM Data Bank (EMDB-5439) and pseudo-atomic models at the Protein Data Bank (PDB-3J1T and -3J1U).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; WANG Z., 2000, BIOPHYS J, V78, P1955; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	36	113	113	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1532	1536		10.1126/science.1224151	http://dx.doi.org/10.1126/science.1224151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997337	Green Accepted, Green Published			2022-12-01	WOS:000308912900050
J	Yang, JY; Zhao, XB; Cheng, K; Du, HY; Ouyang, YD; Chen, JJ; Qiu, SQ; Huang, JY; Jiang, YH; Jiang, LW; Ding, JH; Wang, J; Xu, CG; Li, XH; Zhang, QF				Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Jiang, Liwen; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa			A Killer-Protector System Regulates Both Hybrid Sterility and Segregation Distortion in Rice	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; INDICA-JAPONICA HYBRIDS; ORYZA-SATIVA L.; WIDE-COMPATIBILITY; REPRODUCTIVE BARRIER; S-5 LOCUS; GENE; INCOMPATIBILITY; ARABIDOPSIS; STRESS	Hybrid sterility is a major form of postzygotic reproductive isolation that restricts gene flow between populations. Cultivated rice (Oryza sativa L.) consists of two subspecies, indica and japonica; inter-subspecific hybrids are usually sterile. We show that a killer-protector system at the S5 locus encoded by three tightly linked genes [Open Reading Frame 3 (ORF3) to ORF5] regulates fertility in indica-japonica hybrids. During female sporogenesis, the action of ORF5+ (killer) and ORF4+ (partner) causes endoplasmic reticulum (ER) stress. ORF3+ (protector) prevents ER stress and produces normal gametes, but ORF3- cannot prevent ER stress, resulting in premature programmed cell death and leads to embryo-sac abortion. Preferential transmission of ORF3+ gametes results in segregation distortion in the progeny. These results add to our understanding of differences between indica and japonica rice and may aid in rice genetic improvement.	[Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Shatin 999077, Hong Kong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Chinese University of Hong Kong	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	Zhao, Xiaobo/K-4182-2012; Zhao, Xiaobo/AAZ-5503-2021; JIANG, Liwen/S-6046-2018; Zhao, Xiaobo/AAR-3217-2021; Yang, Jiangyi/J-5383-2013	JIANG, Liwen/0000-0002-7829-1472; Zhao, Xiaobo/0000-0002-6012-0261; Jiang, Yunhe/0000-0002-7599-1422; Yang, Jiangyi/0000-0002-5626-1037	National Natural Science Foundation [31130032, 30921091]; 863 Project [2012AA100103]; 111 Project of China [B07041]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	We thank D. S. Brar of the International Rice Research Institute for providing the rice seeds, and S. Luan of University of California, Berkeley, USA for discussion. This research was supported by grants from the National Natural Science Foundation (31130032 and 30921091), the 863 Project (2012AA100103), and the 111 Project (B07041) of China. All of the DNA sequences obtained in this study have been deposited in the GenBank from accession codes JX138498 to JX138505. A patent for the ORF5 sequence has been approved by the State Intellectual Property Office of China (ZL200710053552.9).	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Blanvillain R, 2011, EMBO J, V30, P1173, DOI 10.1038/emboj.2011.14; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Burt A., 2006, GENES CONFLICT; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Coyne J.A., 2004, SPECIATION; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Ikehashi H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P119, DOI 10.1142/9789812814265_0011; Koide Y, 2008, GENETICS, V180, P409, DOI 10.1534/genetics.108.090126; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Liu KD, 1996, EUPHYTICA, V90, P275, DOI 10.1007/BF00027476; Liu KD, 1997, THEOR APPL GENET, V95, P809, DOI 10.1007/s001220050629; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Oono Y, 2010, PLANT BIOTECHNOL J, V8, P691, DOI 10.1111/j.1467-7652.2010.00502.x; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Ouyang YD, 2009, CHINESE SCI BULL, V54, P2332, DOI 10.1007/s11434-009-0371-4; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Qiu SQ, 2005, THEOR APPL GENET, V111, P1080, DOI 10.1007/s00122-005-0033-0; Wakasa Y, 2011, PLANT J, V65, P675, DOI 10.1111/j.1365-313X.2010.04453.x; Wang CM, 2005, GENET RES, V86, P97, DOI 10.1017/S0016672305007779; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; YANAGIHARA S, 1995, THEOR APPL GENET, V90, P182, DOI 10.1007/BF00222200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	32	170	209	10	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1336	1340		10.1126/science.1223702	http://dx.doi.org/10.1126/science.1223702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984070				2022-12-01	WOS:000308705000041
J	Ciraci, C; Hill, RT; Mock, JJ; Urzhumov, Y; Fernandez-Dominguez, AI; Maier, SA; Pendry, JB; Chilkoti, A; Smith, DR				Ciraci, C.; Hill, R. T.; Mock, J. J.; Urzhumov, Y.; Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.; Chilkoti, A.; Smith, D. R.			Probing the Ultimate Limits of Plasmonic Enhancement	SCIENCE			English	Article							FIELD ENHANCEMENT; NANOPARTICLES; QUANTUM	Metals support surface plasmons at optical wavelengths and have the ability to localize light to subwavelength regions. The field enhancements that occur in these regions set the ultimate limitations on a wide range of nonlinear and quantum optical phenomena. We found that the dominant limiting factor is not the resistive loss of the metal, but rather the intrinsic nonlocality of its dielectric response. A semiclassical model of the electronic response of a metal places strict bounds on the ultimate field enhancement. To demonstrate the accuracy of this model, we studied optical scattering from gold nanoparticles spaced a few angstroms from a gold film. The bounds derived from the models and experiments impose limitations on all nanophotonic systems.	[Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Hill, R. T.; Chilkoti, A.] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England; [Chilkoti, A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Imperial College London; Duke University	Ciraci, C (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA.	cristian.ciraci@duke.edu	Maier, Stefan/V-2883-2019; Urzhumov, Yaroslav A/E-8360-2010; Ciracì, Cristian/K-3602-2017; Fernandez-Dominguez, Antonio I./AGR-3767-2022; Smith, David R/E-4710-2012; Fernandez-Dominguez, Antonio I. I/C-4448-2013	Maier, Stefan/0000-0001-9704-7902; Ciracì, Cristian/0000-0003-3349-8389; Fernandez-Dominguez, Antonio I./0000-0002-8082-395X; Fernandez-Dominguez, Antonio I. I/0000-0002-8082-395X; Pendry, John/0000-0001-5145-5441	Air Force Office of Scientific Research [FA9550-09-1-0562]; Army Research Office through Multidisciplinary University Research Initiative [W911NF-09-1-0539]; Leverhulme Trust; Marie Curie Actions; NIH [R21EB009862, F32EB009299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB009299, R21EB009862] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H000917/2, EP/D063329/1] Funding Source: researchfish; EPSRC [EP/H000917/2, EP/D063329/1] Funding Source: UKRI	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office through Multidisciplinary University Research Initiative; Leverhulme Trust(Leverhulme Trust); Marie Curie Actions(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Scalora, S. Wolter, and A. Moreau for helpful input and discussion. Supported by Air Force Office of Scientific Research grant FA9550-09-1-0562 and by the Army Research Office through Multidisciplinary University Research Initiative grant W911NF-09-1-0539. Also supported by the Leverhulme Trust and the Marie Curie Actions (J.B.P., S. A. M., and A.I.F.-D.), NIH grant R21EB009862 (A. C.), and NIH F32 award F32EB009299 (R.T.H.).	BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Boardman AD, 1982, ELECTROMAGNETIC SURF; David C, 2011, J PHYS CHEM C, V115, P19470, DOI 10.1021/jp204261u; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Esteban R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1806; Fernandez-Dominguez AI, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106802; Fernandez-Dominguez AI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266807; FUCHS R, 1987, PHYS REV B, V35, P3722, DOI 10.1103/PhysRevB.35.3722; Gu Y, 2012, NANO LETT, V12, P2488, DOI 10.1021/nl300655n; Hill RT, 2010, NANO LETT, V10, P4150, DOI 10.1021/nl102443p; Marinica DC, 2012, NANO LETT, V12, P1333, DOI 10.1021/nl300269c; Mock JJ, 2012, NANO LETT, V12, P1757, DOI 10.1021/nl204596h; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Renger J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046803; Scalora M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043828; Toscano G, 2012, OPT EXPRESS, V20, P4176, DOI 10.1364/OE.20.004176; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	18	855	862	24	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1072	1074		10.1126/science.1224823	http://dx.doi.org/10.1126/science.1224823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936772	Green Accepted, Green Submitted			2022-12-01	WOS:000308125800040
J	Gerbode, SJ; Puzey, JR; McCormick, AG; Mahadevan, L				Gerbode, Sharon J.; Puzey, Joshua R.; McCormick, Andrew G.; Mahadevan, L.			How the Cucumber Tendril Coils and Overwinds	SCIENCE			English	Article							GELATINOUS FIBERS; CLIMBING PLANTS; CURVATURE; GENERATION; PERVERSION; MECHANISM; HELIX; FORCE; WOOD	The helical coiling of plant tendrils has fascinated scientists for centuries, yet the underlying mechanism remains elusive. Moreover, despite Darwin's widely accepted interpretation of coiled tendrils as soft springs, their mechanical behavior remains unknown. Our experiments on cucumber tendrils demonstrate that tendril coiling occurs via asymmetric contraction of an internal fiber ribbon of specialized cells. Under tension, both extracted fiber ribbons and old tendrils exhibit twistless overwinding rather than unwinding, with an initially soft response followed by strong strain-stiffening at large extensions. We explain this behavior using physical models of prestrained rubber strips, geometric arguments, and mathematical models of elastic filaments. Collectively, our study illuminates the origin of tendril coiling, quantifies Darwin's original proposal, and suggests designs for biomimetic twistless springs with tunable mechanical responses.	[Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Gerbode, Sharon J.] Harvey Mudd Coll, Dept Phys, Claremont, CA 91711 USA; [Puzey, Joshua R.; Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [McCormick, Andrew G.; Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Claremont Colleges; Harvey Mudd College; Harvard University; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu		Puzey, Joshua/0000-0001-8019-9993	MacArthur Foundation; Wyss Institute; Kavli Institute	MacArthur Foundation; Wyss Institute; Kavli Institute	This research was supported by funding from the MacArthur Foundation, the Wyss Institute, and the Kavli Institute. S.J.G., J.R.P., and L. M. designed the study. S.J.G., J.R.P., A. G. M., and L. M. conducted the research. S.J.G. and J.R.P. performed the biological and biophysical experiments. S.J.G., A. G. M., and L. M. handled biophysical theory. S.J.G., J.R.P., A. G. M., and L. M. contributed analytical tools and reagents and analyzed data. S.J.G., J.R.P., and L. M. wrote the paper. Harvard University has filed a patent application relating to a tunable, twistless overwinding spring based on the results of this study.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Bowling AJ, 2009, AM J BOT, V96, P719, DOI 10.3732/ajb.0800373; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; Darwin C., 1865, MOVEMENTS HABITS CLI; Dastur RH, 1931, ANN BOT-LONDON, V45, P279; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x; Gray A., 1880, STRUCTURAL BOT ORGAN; Isnard S, 2009, AM J BOT, V96, P1205, DOI 10.3732/ajb.0900045; Isnard S, 2009, P R SOC B, V276, P2643, DOI 10.1098/rspb.2009.0380; JAFFE MJ, 1968, ANN REV PLANT PHYSIO, V19, P417, DOI 10.1146/annurev.pp.19.060168.002221; Keller J.B., 1980, LECT MATH LIFE SCI, V13, P257; Lisk H, 1924, BOT GAZ, V78, P85, DOI 10.1086/333357; Love A.E.H., 2013, TREATISE MATH THEORY; MacDougal DT., 1896, ANN BOT-LONDON, V10, P373; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Meloche CG, 2007, PLANTA, V225, P485, DOI 10.1007/s00425-006-0363-4; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Scher JL, 2001, PLANTA, V213, P192, DOI 10.1007/s004250000503; SILK WK, 1978, AM J BOT, V65, P310, DOI 10.2307/2442271; Von Mohl H, 1852, PRINCIPLES ANATOMY P; WILSON BF, 1977, ANNU REV PLANT PHYS, V28, P23, DOI 10.1146/annurev.pp.28.060177.000323	23	258	262	21	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1087	1091		10.1126/science.1223304	http://dx.doi.org/10.1126/science.1223304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936777	Green Published			2022-12-01	WOS:000308125800045
J	Biankin, AV; Waddell, N; Kassahn, KS; Gingras, MC; Muthuswamy, LB; Johns, AL; Miller, DK; Wilson, PJ; Patch, AM; Wu, JM; Chang, DK; Cowley, MJ; Gardiner, BB; Song, S; Harliwong, I; Idrisoglu, S; Nourse, C; Nourbakhsh, E; Manning, S; Wani, S; Gongora, M; Pajic, M; Scarlett, CJ; Gill, AJ; Pinho, AV; Rooman, I; Anderson, M; Holmes, O; Leonard, C; Taylor, D; Wood, S; Xu, QY; Nones, K; Fink, JL; Christ, A; Bruxner, T; Cloonan, N; Kolle, G; Newell, F; Pinese, M; Mead, RS; Humphris, JL; Kaplan, W; Jones, MD; Colvin, EK; Nagrial, AM; Humphrey, ES; Chou, A; Chin, VT; Chantrill, LA; Mawson, A; Samra, JS; Kench, JG; Lovell, JA; Daly, RJ; Merrett, ND; Toon, C; Epari, K; Nguyen, NQ; Barbour, A; Zeps, N; Kakkar, N; Zhao, FM; Wu, YQ; Wang, M; Muzny, DM; Fisher, WE; Brunicardi, FC; Hodges, SE; Reid, JG; Drummond, J; Chang, K; Han, Y; Lewis, LR; Dinh, H; Buhay, CJ; Beck, T; Timms, L; Sam, M; Begley, K; Brown, A; Pai, D; Panchal, A; Buchner, N; De Borja, R; Denroche, RE; Yung, CK; Serra, S; Onetto, N; Mukhopadhyay, D; Tsao, MS; Shaw, PA; Petersen, GM; Gallinger, S; Hruban, RH; Maitra, A; Iacobuzio-Donahue, CA; Schulick, RD; Wolfgang, CL; Morgan, RA; Lawlor, RT; Capelli, P; Corbo, V; Scardoni, M; Tortora, G; Tempero, MA; Mann, KM; Jenkins, NA; Perez-Mancera, PA; Adams, DJ; Largaespada, DA; Wessels, LFA; Rust, AG; Stein, LD; Tuveson, DA; Copeland, NG; Musgrove, EA; Scarpa, A; Eshleman, JR; Hudson, TJ; Sutherland, RL; Wheeler, DA; Pearson, JV; McPherson, JD; Gibbs, RA; Grimmond, SM				Biankin, Andrew V.; Waddell, Nicola; Kassahn, Karin S.; Gingras, Marie-Claude; Muthuswamy, Lakshmi B.; Johns, Amber L.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Kolle, Gabriel; Newell, Felicity; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Fisher, William E.; Brunicardi, F. Charles; Hodges, Sally E.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Serra, Stefano; Onetto, Nicole; Mukhopadhyay, Debabrata; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Gallinger, Steven; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Schulick, Richard D.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Capelli, Paola; Corbo, Vincenzo; Scardoni, Maria; Tortora, Giampaolo; Tempero, Margaret A.; Mann, Karen M.; Jenkins, Nancy A.; Perez-Mancera, Pedro A.; Adams, David J.; Largaespada, David A.; Wessels, Lodewyk F. A.; Rust, Alistair G.; Stein, Lincoln D.; Tuveson, David A.; Copeland, Neal G.; Musgrove, Elizabeth A.; Scarpa, Aldo; Eshleman, James R.; Hudson, Thomas J.; Sutherland, Robert L.; Wheeler, David A.; Pearson, John V.; McPherson, John D.; Gibbs, Richard A.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes	NATURE			English	Article							SOMATIC MUTATIONS; TUMOR; INSTABILITY; EXPRESSION; RESECTION; ROLES	Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n=142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.	[Waddell, Nicola; Kassahn, Karin S.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Newell, Felicity; Pearson, John V.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Biankin, Andrew V.; Chang, David K.; Merrett, Neil D.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.; Chang, David K.] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Liverpool, NSW 2170, Australia; [Gingras, Marie-Claude; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gingras, Marie-Claude; Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Muthuswamy, Lakshmi B.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Onetto, Nicole; Stein, Lincoln D.; Hudson, Thomas J.; McPherson, John D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Gill, Anthony J.; Samra, Jaswinder S.] Royal N Shore Hosp, Dept Anat Pathol, Sydney, NSW 2065, Australia; [Gill, Anthony J.; Kench, James G.] Univ Sydney, Sydney, NSW 2006, Australia; [Kolle, Gabriel] Life Technol, Brisbane, Qld 4000, Australia; [Mead, R. Scott; Chou, Angela] St Vincents Hosp, Dept Anat Pathol, Sydney, NSW 2010, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, Sydney, NSW 2065, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fremantle Hosp, Dept Surg, Fremantle, WA 6160, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia; [Barbour, Andrew] Univ Queensland, Princess Alexandra Hosp, Dept Surg, Woollongabba, Qld 4102, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg M507, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, Subiaco, WA 6008, Australia; [Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Serra, Stefano; Tsao, Ming-Sound; Shaw, Patricia A.; Gallinger, Steven] Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Mukhopadhyay, Debabrata; Petersen, Gloria M.] Mayo Clin, Rochester, MN 55905 USA; [Gallinger, Steven] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Morgan, Richard A.; Eshleman, James R.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Schulick, Richard D.; Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Lawlor, Rita T.; Corbo, Vincenzo; Scarpa, Aldo] Univ & Hosp Trust Verona, ARC NET Ctr Appl Res Canc, I-37134 Verona, Italy; [Capelli, Paola; Scardoni, Maria; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Dept Surg & Oncol, I-37134 Verona, Italy; [Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94115 USA; [Mann, Karen M.; Jenkins, Nancy A.; Copeland, Neal G.] Methodist Hosp, Res Inst, Canc Res Program, Houston, TX 77030 USA; [Perez-Mancera, Pedro A.; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Perez-Mancera, Pedro A.; Tuveson, David A.] Dept Oncol, Cambridge CB2 0RE, England; [Adams, David J.; Rust, Alistair G.] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Musgrove, Elizabeth A.; Sutherland, Robert L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia	University of Queensland; Garvan Institute of Medical Research; University of New South Wales Sydney; Baylor College of Medicine; Baylor College of Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; Thermo Fisher Scientific; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Western Sydney University; University of Western Australia; Royal Adelaide Hospital; University of Queensland; University of Western Australia; St John of God Health Care; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Johns Hopkins University; Johns Hopkins University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of California System; University of California San Francisco; The Methodist Hospital System; The Methodist Hospital - Houston; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; University of New South Wales Sydney	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia.	s.grimmond@imb.uq.edu.au	Merrett, Neil/ABB-4342-2021; Wheeler, David A/M-9740-2018; Cowley, Mark/K-8731-2019; Largaespada, David/C-9832-2014; Gill, Anthony J./M-5015-2019; Iacobuzio-Donahue, Christine/ABF-1295-2020; Grimmond, Sean/K-3246-2019; Newell, Felicity/AAN-1253-2020; Pearson, John V/F-2249-2011; Chantrill, Lorraine/GXF-5117-2022; Tsao, Ming-Sound/M-3503-2017; Drummond, Jennifer/AAG-1654-2020; Zeps, Nikolajs/C-4180-2013; Barbour, Andrew/F-4717-2010; Corbo, Vincenzo/J-7754-2016; Mann, Karen/AAW-8323-2020; Zeps, Nikolajs/AAF-3186-2021; Gill, Anthony/D-4215-2015; Merrett, Neil/H-8033-2019; Pearson, John/AAT-4211-2020; Leonard, Conrad/AAD-2587-2020; Waddell, Nicola/H-4929-2015; Fink, Lynn/C-2031-2008; Grimmond, Sean M/J-5304-2016; Tortora, Giampaolo/AAA-1252-2019; scarpa, aldo/K-6832-2016; Cloonan, Nicole/B-5272-2008; Gardiner, Brooke B/C-7773-2011; McPherson, John D/D-2633-2017; Tsao, Ming Sound/AFQ-7332-2022; Gallinger, Steven/E-4575-2013; Patch, Ann-Marie/C-4201-2018; Nones, Katia/AAX-6453-2021; Wu, Jianmin/G-3629-2010	Merrett, Neil/0000-0002-8370-0293; Wheeler, David A/0000-0002-9056-6299; Cowley, Mark/0000-0002-9519-5714; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Grimmond, Sean/0000-0002-8102-7998; Pearson, John V/0000-0003-0904-4598; Drummond, Jennifer/0000-0002-2612-5958; Zeps, Nikolajs/0000-0002-6404-6839; Corbo, Vincenzo/0000-0002-6340-8009; Zeps, Nikolajs/0000-0002-6404-6839; Gill, Anthony/0000-0002-9447-1967; Merrett, Neil/0000-0002-8370-0293; Leonard, Conrad/0000-0002-4131-2065; Waddell, Nicola/0000-0002-3950-2476; Fink, Lynn/0000-0003-2912-6048; Grimmond, Sean M/0000-0002-8102-7998; scarpa, aldo/0000-0003-1678-739X; Cloonan, Nicole/0000-0001-7802-6647; Gardiner, Brooke B/0000-0003-3740-3244; McPherson, John D/0000-0001-8049-9347; Tsao, Ming Sound/0000-0002-9160-5405; Patch, Ann-Marie/0000-0001-6121-4019; Nones, Katia/0000-0003-1925-5196; Rooman, Ilse/0000-0001-7264-2246; Spry, Nigel/0000-0001-8659-5065; Chin, Venessa/0000-0002-4630-4451; Kench, James Geoffrey/0000-0001-8687-4988; Tortora, Giampaolo/0000-0002-1378-4962; Pajic, Marina/0000-0002-3871-3829; Brancato, Mary-Anne/0000-0002-5439-4549; Wong, Rachel/0000-0001-6760-0463; Wu, Jianmin/0000-0002-8876-128X; Chantrill, Lorraine/0000-0002-5790-0208; lawlor, Rita/0000-0003-3160-0634; Kassahn, Karin/0000-0002-1662-3355; Christophi, Christopher/0000-0002-1349-0884; Pinho, Andreia V./0000-0003-0647-4015; Chou, Angela/0000-0001-9212-6927; Chang, Kyle/0000-0001-5295-9676; Biankin, Andrew/0000-0002-0362-5597; Barbour, Andrew/0000-0002-0991-7662; Daly, Roger/0000-0002-5739-8027; Colvin, Emily/0000-0002-5435-5902; Rust, Alistair/0000-0001-7287-192X; Bruxner, Timothy/0000-0002-8088-316X; Nikfarjam, Mehrdad/0000-0003-4866-276X; Chang, David/0000-0002-4821-3078; Beck, Timothy/0000-0003-0145-3557; Scarlett, Christopher/0000-0002-4140-7785; Jones, Marc/0000-0002-3078-8359; Christ, Angelika/0000-0002-8680-2367; Yung, Christina/0000-0003-2958-150X; Adams, David/0000-0001-9490-0306; Pinese, Mark/0000-0001-5078-6687; serra, stefano/0000-0002-3258-2637	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601, 535914]; Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW [SRP06-01, ICGC09-01, SRP11-01]; Cancer Institute NSW [06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI [U54 HG003273]; CPRIT [RP101353-P7]; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH [R01 CA97075]; Agency for Science, Technology, and Research (Singapore); University of Verona; Italian Ministry of University, Rome, Italy [FIRB RBAP10AHJB]; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH [P50CA062924, P01CA134292]; Sol Goldman Pancreatic Cancer Research Center; NCI [R01 CA97075, P50 CA102701]; NIH SPORE grant [2P50CA101955]; AIRC (Associazione Italiana Ricerca sul Cancro), Italy [12182]; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA134292, P50CA102701, R01CA113636, P50CA062924, R01CA097075, P50CA101955] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland(University of Queensland); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI; CPRIT; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Pancreatic Cancer Genetic Epidemiology Consortium, NIH; Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); University of Verona; Italian Ministry of University, Rome, Italy; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); CPRIT (Cancer Prevention Research Institute of Texas); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sol Goldman Pancreatic Cancer Research Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH SPORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC (Associazione Italiana Ricerca sul Cancro), Italy(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This paper is dedicated to Robert L. Sutherland who died on 10 October 2012 of pancreatic cancer. We would like to thank C. Axford, D. Gwynne, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; and W. Waterson, J. Shepperd, E. Campbell and E. Glasov for their efforts at the Queensland Centre for Medical Genomics. We also thank M. B. Hodgin, M. Debeljak and D. Trusty for technical assistance at Johns Hopkins University, and J. Lau, M. Karaus, K. Rabe, L. Zhang and T. Smyrk at the Mayo Clinic. We acknowledge the following funding support: National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601, 535914); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW (SRP06-01; ICGC09-01; SRP11-01); Cancer Institute NSW (06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI U54 HG003273; CPRIT grant RP101353-P7 (Tumor Banking for Genomic Research and Clinical Translation Site 1); The Ontario Institute for Cancer Research; The Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH grant R01 CA97075; The Agency for Science, Technology, and Research (Singapore); University of Verona and Italian Ministry of University (FIRB RBAP10AHJB), Rome, Italy; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH P50CA062924 (SPORE) and P01CA134292 (PPG); The Sol Goldman Pancreatic Cancer Research Center; NCI grant P50 CA102701 (Mayo Clinic SPORE in Pancreatic Cancer) and NCI grant R01 CA97075 (Pancreatic Cancer Genetic Epidemiology Consortium); NIH SPORE grant 2P50CA101955 (UMN/UAB), and AIRC (Associazione Italiana Ricerca sul Cancro) 5xmille grant 12182, Italy.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Butturini G, 2008, ARCH SURG-CHICAGO, V143, P75, DOI 10.1001/archsurg.2007.17; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao Y, 2011, NAT REV CANCER, V11, P749, DOI 10.1038/nrc3138; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Chang DK, 2009, J CLIN ONCOL, V27, P2855, DOI 10.1200/JCO.2008.20.5104; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI15392; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jamieson NB, 2011, ANN SURG ONCOL, V18, P2318, DOI 10.1245/s10434-011-1560-3; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kikuchi K, 2003, J BIOL CHEM, V278, P42985, DOI 10.1074/jbc.M302395200; Kris M. G., 2011, ACCELERATING PROGR C; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Samuel N, 2012, NAT REV GASTRO HEPAT, V9, P77, DOI 10.1038/nrgastro.2011.215; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111	38	1402	1444	6	268	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					399	405		10.1038/nature11547	http://dx.doi.org/10.1038/nature11547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23103869	Green Accepted			2022-12-01	WOS:000311031600037
J	Lammel, S; Lim, BK; Ran, C; Huang, KW; Betley, MJ; Tye, KM; Deisseroth, K; Malenka, RC				Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Tye, Kay M.; Deisseroth, Karl; Malenka, Robert C.			Input-specific control of reward and aversion in the ventral tegmental area	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; LATERAL HABENULA; GABA NEURONS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; RABIES VIRUS; RAT; ACTIVATION; STIMULATION	Ventral tegmental area (VTA) dopamine neurons have important roles in adaptive and pathological brain functions related to reward and motivation. However, it is unknown whether subpopulations of VTA dopamine neurons participate in distinct circuits that encode different motivational signatures, and whether inputs to the VTA differentially modulate such circuits. Here we show that, because of differences in synaptic connectivity, activation of inputs to the VTA from the laterodorsal tegmentum and the lateral habenula elicit reward and aversion in mice, respectively. Laterodorsal tegmentum neurons preferentially synapse on dopamine neurons projecting to the nucleus accumbens lateral shell, whereas lateral habenula neurons synapse primarily on dopamine neurons projecting to the medial prefrontal cortex as well as on GABAergic (gamma-aminobutyric-acid-containing) neurons in the rostromedial tegmental nucleus. These results establish that distinct VTA circuits generate reward and aversion, and thereby provide a new framework for understanding the circuit basis of adaptive and pathological motivated behaviours.	[Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; Stanford University; Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Tye, Kay/J-6158-2013; Ran, Chen/N-3007-2017; Lammel, Stephan/O-8295-2018	Tye, Kay/0000-0002-2435-0182; Lammel, Stephan/0000-0002-3350-3208; Ran, Chen/0000-0002-6632-2366; Lim, Byungkook/0000-0002-3766-5415	National Institutes of Health [NIH NS069375]; Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Stanford Neuroscience Imaging Core, the Stanford Neuroscience Behavior Phenotyping and Pharmacology Core and the Stanford Neuroscience Gene Vector and Virus Core (all supported by National Institutes of Health grant NIH NS069375). This work was supported by grants from the Simons Foundation and NIH (to R. C. M.). K. D. is supported by the NIH, the DARPA REPAIR program, and the Wiegers Family Fund. S. L. is supported by a fellowship from the German Academy of Sciences Leopoldina. B. K. L. is supported by a Davis Foundation Postdoctoral Fellowship in Eating Disorders Research. K. M. T. is supported by the JPB Foundation and NIMH.	ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vertes RP, 1999, J COMP NEUROL, V407, P555; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	42	850	900	5	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					212	+		10.1038/nature11527	http://dx.doi.org/10.1038/nature11527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064228	Green Submitted, Green Accepted			2022-12-01	WOS:000310774300035
J	Ell, B; Kang, YB				Ell, Brian; Kang, Yibin			SnapShot: Bone Metastasis	CELL			English	Editorial Material							BREAST-CANCER		[Ell, Brian; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Ell, B (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Kang, Yibin/0000-0002-1626-6730				Bidwell B. N., 2012, NAT MED; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	10	81	83	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3							690.e1	10.1016/j.cell.2012.10.005	http://dx.doi.org/10.1016/j.cell.2012.10.005			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101634	Bronze			2022-12-01	WOS:000310529300024
J	Brennan, MD; Cheong, R; Levchenko, A				Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre			How Information Theory Handles Cell Signaling and Uncertainty	SCIENCE			English	Editorial Material							DYNAMICS; BIOLOGY; NOISE; FLOW		[Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Brennan, MD (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	alev@jhu.edu		Brennan, Matthew/0000-0003-3992-713X	NATIONAL CANCER INSTITUTE [R01CA065145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, R01GM072024] Funding Source: NIH RePORTER; NCI NIH HHS [CA65145, R01 CA065145] Funding Source: Medline; NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [GM084322, R01 GM072024, U54 GM103520, GM072024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alberts B., 2008, MOL BIOL CELL; Andrews BW, 2007, PLOS COMPUT BIOL, V3, P1489, DOI 10.1371/journal.pcbi.0030153; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BERGER T, 2003, IEEE INF THEORY SOC, V53, P1; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bowsher CG, 2012, P NATL ACAD SCI USA, V109, pE1320, DOI 10.1073/pnas.1119407109; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Cover T., 1990, ELEMENTS INFORM THEO, V2nd; de Ronde W, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048101; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mian IS, 2011, INTEGR BIOL-UK, V3, P350, DOI 10.1039/c0ib00117a; Milenkovic O, 2010, IEEE T INFORM THEORY, V56, P649, DOI 10.1109/TIT.2009.2036971; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Polani D, 2009, HFSP J, V3, P307, DOI 10.2976/1.3171566; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	25	50	51	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					334	335		10.1126/science.1227946	http://dx.doi.org/10.1126/science.1227946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022JS	23087235	Green Accepted			2022-12-01	WOS:000309955800026
J	Sun, LF; Zeng, X; Yan, CY; Sun, XY; Gong, XQ; Rao, Y; Yan, NE				Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng			Crystal structure of a bacterial homologue of glucose transporters GLUT1-4	NATURE			English	Article							DEFICIENCY SYNDROME GLUT1DS; MOLECULAR-BASIS; CLASSIFICATION DATABASE; SUBSTRATE RECOGNITION; LACTOSE PERMEASE; BINDING-SITE; MECHANISM; PROTEINS; GENE; SEQUENCE	Glucose transporters are essential for metabolism of glucose in cells of diverse organisms from microbes to humans, exemplified by the disease-related human proteins GLUT1, 2, 3 and 4. Despite rigorous efforts, the structural information for GLUT1-4 or their homologues remains largely unknown. Here we report three related crystal structures of XylE, an Escherichia coli homologue of GLUT1-4, in complex with D-xylose, D-glucose and 6-bromo-6-deoxy-D-glucose, at resolutions of 2.8, 2.9 and 2.6 angstrom, respectively. The structure consists of a typical major facilitator superfamily fold of 12 transmembrane segments and a unique intracellular four-helix domain. XylE was captured in an outward-facing, partly occluded conformation. Most of the important amino acids responsible for recognition of D-xylose or D-glucose are invariant in GLUT1-4, suggesting functional and mechanistic conservations. Structure-based modelling of GLUT1-4 allows mapping and interpretation of disease-related mutations. The structural and biochemical information reported here constitutes an important framework for mechanistic understanding of glucose transporters and sugar porters in general.	[Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Zeng, Xin/0000-0003-4207-2902	Ministry of Science and Technology [2009CB918802, 2011CB910501]; National Natural Science Foundation of China [31125009, 91017011]; Tsinghua University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	We thank J. He, L. Tang, F. Yu and S. Huang at Shanghai Synchrotron Radiation Facility, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), projects 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DAVIS EO, 1984, J BIOL CHEM, V259, P1520; DAVIS EO, 1987, J BIOL CHEM, V262, P13928; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Ho YY, 2001, PEDIATR RES, V50, P254, DOI 10.1203/00006450-200108000-00015; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; LAM VMS, 1980, J BACTERIOL, V143, P396, DOI 10.1128/JB.143.1.396-402.1980; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Mueckler Mike, 1993, Journal of Diabetes and its Complications, V7, P130, DOI 10.1016/1056-8727(93)90038-Z; Nelson D. L., 2008, LEHNINGER PRINCIPLES, P1158; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pascual JM, 2004, EUR J ENDOCRINOL, V150, P627, DOI 10.1530/eje.0.1500627; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Scheffer IE, 2012, NEUROLOGY, V78, P524, DOI 10.1212/WNL.0b013e318248a245; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Snider C., 2011, MEMBRANE PROTEINS KN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Xiang ZX, 2007, PROTEINS, V66, P814, DOI 10.1002/prot.21099; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	62	326	349	25	401	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					361	+		10.1038/nature11524	http://dx.doi.org/10.1038/nature11524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075985				2022-12-01	WOS:000309918500037
J	Maitre, JL; Berthoumieux, H; Krens, SFG; Salbreux, G; Julicher, F; Paluch, E; Heisenberg, CP				Maitre, Jean-Leon; Berthoumieux, Helene; Krens, Simon Frederik Gabriel; Salbreux, Guillaume; Juelicher, Frank; Paluch, Ewa; Heisenberg, Carl-Philipp			Adhesion Functions in Cell Sorting by Mechanically Coupling the Cortices of Adhering Cells	SCIENCE			English	Article							E-CADHERIN; TENSION; HYPOTHESIS; CONTACTS; CATENIN; FORCES; RETINA	Differential cell adhesion and cortex tension are thought to drive cell sorting by controlling cell-cell contact formation. Here, we show that cell adhesion and cortex tension have different mechanical functions in controlling progenitor cell-cell contact formation and sorting during zebrafish gastrulation. Cortex tension controls cell-cell contact expansion by modulating interfacial tension at the contact. By contrast, adhesion has little direct function in contact expansion, but instead is needed to mechanically couple the cortices of adhering cells at their contacts, allowing cortex tension to control contact expansion. The coupling function of adhesion is mediated by E-cadherin and limited by the mechanical anchoring of E-cadherin to the cortex. Thus, cell adhesion provides the mechanical scaffold for cell cortex tension to drive cell sorting during gastrulation.	[Paluch, Ewa] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Paluch, Ewa] Int Inst Mol & Cell Biol, Warsaw, Poland; [Maitre, Jean-Leon; Krens, Simon Frederik Gabriel; Heisenberg, Carl-Philipp] IST Austria, Klosterneuburg, Austria; [Berthoumieux, Helene; Salbreux, Guillaume; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Berthoumieux, Helene] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, UMR 7600, Paris, France	Max Planck Society; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Institute of Science & Technology - Austria; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Paluch, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	paluch@mpi-cbg.de; heisenberg@ist.ac.at	Krens, Gabriel/U-6760-2017; Julicher, Frank/B-1828-2009; Maître, Jean-Léon/C-4372-2017	Krens, Gabriel/0000-0003-4761-5996; Julicher, Frank/0000-0003-4731-9185; Maître, Jean-Léon/0000-0002-3688-1474; Paluch, Ewa/0000-0003-4691-2323; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Salbreux, Guillaume/0000-0001-7041-1292	Max-Planck-Society; Polish Ministry of Science and Higher Education [454/N-MPG/2009/0]; Human Frontier Science Program [RGY0067/2008]; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [HE3231/6, I812-B12]; Austrian Science Fund (FWF) [I 812] Funding Source: researchfish	Max-Planck-Society(Max Planck Society); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Human Frontier Science Program(Human Frontier Science Program); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Biro, J.-Y. Tinevez, and J. Ronsch for technical assistance, V. Barone for critical reading of earlier versions of this manuscript, and the facilities of the MPI-CBG and IST Austria for their continuous support. This work was supported by the Max-Planck-Society and grants from the Polish Ministry of Science and Higher Education to E. P. (454/N-MPG/2009/0), the Human Frontier Science Program to E. P. (RGY0067/2008), and the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) to C.-P. H. (HE3231/6; I812-B12).	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maitre JL, 2011, CURR OPIN CELL BIOL, V23, P508, DOI 10.1016/j.ceb.2011.07.004; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	15	351	353	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					253	256		10.1126/science.1225399	http://dx.doi.org/10.1126/science.1225399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923438				2022-12-01	WOS:000309712300045
J	Mueller, ND; Gerber, JS; Johnston, M; Ray, DK; Ramankutty, N; Foley, JA				Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Ramankutty, Navin; Foley, Jonathan A.			Closing yield gaps through nutrient and water management	NATURE			English	Article							INTENSIFICATION; CLIMATE; IMBALANCES; CHALLENGE; DEMAND	In the coming decades, a crucial challenge for humanity will be meeting future food demands without undermining further the integrity of the Earth's environmental systems(1-6). Agricultural systems are already major forces of global environmental degradation(4,7), but population growth and increasing consumption of calorie- and meat-intensive diets are expected to roughly double human food demand by 2050 (ref. 3). Responding to these pressures, there is increasing focus on 'sustainable intensification' as a means to increase yields on underperforming landscapes while simultaneously decreasing the environmental impacts of agricultural systems(2-4,8-11). However, it is unclear what such efforts might entail for the future of global agricultural landscapes. Here we present a global-scale assessment of intensification prospects from closing 'yield gaps' (differences between observed yields and those attainable in a given region), the spatial patterns of agricultural management practices and yield limitation, and the management changes that may be necessary to achieve increased yields. We find that global yield variability is heavily controlled by fertilizer use, irrigation and climate. Large production increases (45% to 70% for most crops) are possible from closing yield gaps to 100% of attainable yields, and the changes to management practices that are needed to close yield gaps vary considerably by region and current intensity. Furthermore, we find that there are large opportunities to reduce the environmental impact of agriculture by eliminating nutrient overuse, while still allowing an approximately 30% increase in production of major cereals (maize, wheat and rice). Meeting the food security and sustainability challenges of the coming decades is possible, but will require considerable changes in nutrient and water management.	[Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 2K6, Canada; [Ramankutty, Navin] McGill Univ, Global Environm & Climate Change Ctr, Montreal, PQ H3A 2K6, Canada	University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University	Mueller, ND (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	muell512@umn.edu	Foley, Jonathan A/GRS-5522-2022; Mueller, Nathan D/E-5864-2010; Ramankutty, Navin/AAM-6074-2020; Ray, Deepak K/F-7720-2012	Mueller, Nathan D/0000-0003-1857-5104; Ramankutty, Navin/0000-0002-3737-5717; Ray, Deepak/0000-0002-2856-9608; Gerber, James/0000-0002-6890-0481	National Science Foundation Graduate Research Fellowship; University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant; Gordon and Betty Moore Foundation; University of Minnesota Institute on the Environment	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Minnesota Institute on the Environment	We thank G. Allez and K. Milligan for assistance with data collection. We are grateful to R. Licker, G. MacDonald, M. Mueller, S. Polasky, P. Potter, P. Reich, L. Schulte-Moore, D. Tilman, J. Van Wart and the Foley Laboratory for helpful conversations. We thank P. Robertson and P. Smith for helpful comments on the manuscript. Funding was provided by a National Science Foundation Graduate Research Fellowship and a University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship to N.D.M., a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant to N.R., Gordon and Betty Moore Foundation funding to J. A. F., and support from the University of Minnesota Institute on the Environment.	[Anonymous], 2009, REAP BEN SCI SUST IN, p[1, 47]; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Johnston M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034028; Jordan N, 2007, SCIENCE, V316, P1570, DOI 10.1126/science.1141700; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Oenema O, 2002, AMBIO, V31, P159, DOI 10.1639/0044-7447(2002)031[0159:NMIFPA]2.0.CO;2; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.1890/1540-9295(2005)003[0038:RAPAEI]2.0.CO;2; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261	29	1519	1596	96	2022	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					254	257		10.1038/nature11420	http://dx.doi.org/10.1038/nature11420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22932270				2022-12-01	WOS:000309733300048
J	Dodwell, E; Snyder, B; Wright, J				Dodwell, Emily; Snyder, Brian; Wright, James			Off-Label Use of Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Dodwell, Emily] Hosp Special Surg, New York, NY 10021 USA; [Snyder, Brian] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wright, James] Childrens Hosp, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital	Dodwell, E (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	dodwelle@hss.edu		Dodwell, Emily/0000-0001-8424-4341				Agency for Healthcare Research and Quality, 2009, HEALTHC COST UT PROJ; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Dewald R, 2003, SPINAL DEFORMITIES C, P644; HCUP central distributor SID California file composition, 2006, HEALTHC COST UT PROJ; Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2; US Food and Drug Administration, OP 1 H010002; US Food and Drug Administration, F INFUSE BON GRAFT L	7	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1429	1432		10.1001/jama.2012.12929	http://dx.doi.org/10.1001/jama.2012.12929			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047351	Bronze			2022-12-01	WOS:000309579300015
J	Agrawal, AA; Hastings, AP; Johnson, MTJ; Maron, JL; Salminen, JP				Agrawal, Anurag A.; Hastings, Amy P.; Johnson, Marc T. J.; Maron, John L.; Salminen, Juha-Pekka			Insect Herbivores Drive Real-Time Ecological and Evolutionary Change in Plant Populations	SCIENCE			English	Article							RESISTANCE; ELLAGITANNINS; COMMUNITIES; DEFENSE	Insect herbivores are hypothesized to be major factors affecting the ecology and evolution of plants. We tested this prediction by suppressing insects in replicated field populations of a native plant, Oenothera biennis, which reduced seed predation, altered interspecific competitive dynamics, and resulted in rapid evolutionary divergence. Comparative genotyping and phenotyping of nearly 12,000 O. biennis individuals revealed that in plots protected from insects, resistance to herbivores declined through time owing to changes in flowering time and lower defensive ellagitannins in fruits, whereas plant competitive ability increased. This independent real-time evolution of plant resistance and competitive ability in the field resulted from the relaxation of direct selective effects of insects on plant defense and through indirect effects due to reduced herbivory on plant competitors.	[Agrawal, Anurag A.; Hastings, Amy P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Agrawal, Anurag A.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Johnson, Marc T. J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Maron, John L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Lab Organ Chem & Chem Biol, FI-20014 Turku, Finland	Cornell University; Cornell University; University of Toronto; University Toronto Mississauga; University of Montana System; University of Montana; University of Turku	Agrawal, AA (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	agrawal@cornell.edu	Agrawal, Anurag A/Y-2497-2019; Salminen, Juha-Pekka/N-3313-2017	Agrawal, Anurag A/0000-0003-0095-1220; Salminen, Juha-Pekka/0000-0002-2912-7094	University of Turku; U.S. NSF [EAGER DEB-0950231]; Natural Sciences and Engineering Research Council of Canada; Government of Ontario; Connaught Early Researcher Award; NSF [DEB 0614406, DEB-0915409]; Academy of Finland [258992]; Direct For Biological Sciences [1118783] Funding Source: National Science Foundation	University of Turku; U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Ontario; Connaught Early Researcher Award; NSF(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Alfano, F. Chen, S. Cook-Patton, P. Cooper, T. Dodge, N. Durfee, A. Erwin, M. Falise, J. Goldstein, E. Kearney, A. Knight, S. McArt, J. Peters, S. Rasmann, A. Smith, T. Ramsey, E. Reyes, M. Weber, and E. Woods for help with field work and discussion; T. Zhao, J. Yi, and A. Koivuniemi for assistance with chemical analyses; and J. Good, N. Hairston, S. McArt, T. Zust, and the Plant Interactions Group at Cornell University for comments. Molecular work for this study was conducted in the Evolutionary Genetics Core Facility at Cornell University with support from V. Askinazi, S. Bogdanowicz, R. Harrison, E. Larson, and E. Reyes. Chemical analyses on an ultraperformance liquid chromatography-mass spectrometry system were made possible by a Strategic Research Grant of University of Turku. This study was primarily supported by a U.S. NSF grant (EAGER DEB-0950231), and for this we thank L. Gough. M.T.J.J. was supported by the Natural Sciences and Engineering Research Council of Canada, the Government of Ontario, and a Connaught Early Researcher Award; J.L.M. was supported by NSF grants DEB 0614406 and DEB-0915409; J.-P.S was supported by the Academy of Finland (grant 258992). Data sets for genotype frequencies described in this paper are available in the DRYAD data repository under http://dx.doi.org/10.5061/dryad.6331s. This paper is dedicated to Paul Feeny and Dick Root.	Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Barbehenn RV, 2006, J CHEM ECOL, V32, P2253, DOI 10.1007/s10886-006-9143-7; Bode RF, 2012, J ECOL, V100, P795, DOI 10.1111/j.1365-2745.2012.01958.x; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Desurmont GA, 2011, P NATL ACAD SCI USA, V108, P7070, DOI 10.1073/pnas.1102891108; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.1111/j.1558-5646.1964.tb01674.x; Fornoni J, 2004, EVOLUTION, V58, P1696, DOI 10.1111/j.0014-3820.2004.tb00455.x; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Karonen M, 2010, RAPID COMMUN MASS SP, V24, P3151, DOI 10.1002/rcm.4756; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Uriarte M, 2002, ECOLOGY, V83, P2649, DOI 10.1890/0012-9658(2002)083[2649:AMOSEO]2.0.CO;2; Zangerl AR, 2005, P NATL ACAD SCI USA, V102, P15529, DOI 10.1073/pnas.0507805102	24	293	298	11	519	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					113	116		10.1126/science.1225977	http://dx.doi.org/10.1126/science.1225977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042894				2022-12-01	WOS:000309457400065
J	Bangalore, S; Steg, PG; Deedwania, P; Crowley, K; Eagle, KA; Goto, S; Ohman, EM; Cannon, CP; Smith, SC; Zeymer, U; Hoffman, EB; Messerli, FH; Bhatt, DL				Bangalore, Sripal; Steg, Ph Gabriel; Deedwania, Prakash; Crowley, Kevin; Eagle, Kim A.; Goto, Shinya; Ohman, E. Magnus; Cannon, Christopher P.; Smith, Sidney C., Jr.; Zeymer, Uwe; Hoffman, Elaine B.; Messerli, Franz H.; Bhatt, Deepak L.		REACH Registry Investigators	beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENT RATES; BLOOD-PRESSURE; PROPENSITY SCORE; HEART-FAILURE; HYPERTENSION; RISK; THERAPY; ASSOCIATION; CARVEDILOL	Context beta-Blockers remain the standard of care after a myocardial infarction (MI). However, the benefit of beta-blocker use in patients with coronary artery disease (CAD) but no history of MI, those with a remote history of MI, and those with only risk factors for CAD is unclear. Objective To assess the association of beta-blocker use with cardiovascular events in stable patients with a prior history of MI, in those with CAD but no history of MI, and in those with only risk factors for CAD. Design, Setting, and Patients Longitudinal, observational study of patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry who were divided into 3 cohorts: known prior MI (n = 14 043), known CAD without MI (n = 12 012), or those with CAD risk factors only (n = 18 653). Propensity score matching was used for the primary analyses. The last follow-up data collection was April 2009. Main Outcome Measures The primary outcome was a composite of cardiovascular death, nonfatal MI, or nonfatal stroke. The secondary outcome was the primary outcome plus hospitalization for atherothrombotic events or a revascularization procedure. Results Among the 44 708 patients, 21 860 were included in the propensity score-matched analysis. With a median follow-up of 44 months (interquartile range, 35-45 months), event rates were not significantly different in patients with beta-blocker use compared with those without beta-blocker use for any of the outcomes tested, even in the prior MI cohort (489 [16.93%] vs 532 [18.60%], respectively; hazard ratio [HR], 0.90 [95% CI, 0.79-1.03]; P = .14). In the CAD without MI cohort, the associated event rates were not significantly different in those with beta-blocker use for the primary outcome (391 [12.94%]) vs without beta-blocker use (405 [13.55%]) (HR, 0.92[95% CI, 0.79-1.08]; P = .31), with higher rates for the secondary outcome (1101 [30.59%] vs 1002 [27.84%]; odds ratio [OR], 1.14 [95% CI, 1.03-1.27]; P = .01) and for the tertiary outcome of hospitalization (870 [24.17%] vs 773 [21.48%]; OR, 1.17 [95% CI, 1.04-1.30]; P = .01). In the cohort with CAD risk factors only, the event rates were higher for the primary outcome with beta-blocker use (467 [14.22%]) vs without beta-blocker use (403 [12.11%]) (HR, 1.18 [95% CI, 1.02-1.36]; P = .02), for the secondary outcome (870 [22.01%] vs 797 [20.17%]; OR, 1.12 [95% CI, 1.00-1.24]; P = .04) but not for the tertiary outcomes of MI (89 [2.82%] vs 68 [2.00%]; HR, 1.36 [95% CI, 0.97-1.90]; P = .08) and stroke (210 [6.55%] vs 168 [5.12%]; HR, 1.22 [95% CI, 0.99-1.52]; P = .06). However, in those with recent MI (<= 1 year), beta-blocker use was associated with a lower incidence of the secondary outcome (OR, 0.77 [95% CI, 0.64-0.92]). Conclusion In this observational study of patients with either CAD risk factors only, known prior MI, or known CAD without MI, the use of beta-blockers was not associated with a lower risk of composite cardiovascular events. JAMA. 2012;308(13):1340-1349	[Bangalore, Sripal] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; [Steg, Ph Gabriel] Univ Paris Diderot, Hosp Bichat, AP HP, INSERM,U698, Paris, France; [Deedwania, Prakash] Univ Calif San Francisco, Dept Internal Med Cardiol, Sch Med, Fresno, CA USA; [Crowley, Kevin; Cannon, Christopher P.; Hoffman, Elaine B.; Bhatt, Deepak L.] TIMI Study Grp, Boston, MA USA; [Eagle, Kim A.] Univ Michigan Hlth Syst, Cardiovasc Ctr, Ann Arbor, MI USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA; [Zeymer, Uwe] Herzzentrum Ludwigshafen, Ludwigshafen, Germany; [Zeymer, Uwe] Inst Herzinfarktforsch Ludwigshafen, Ludwigshafen, Germany; [Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Tokai University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Institute Heart Attack Research; Mount Sinai St. Luke's; Mount Sinai West; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bangalore, S (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 550 1st Ave, New York, NY 10016 USA.	sripalbangalore@gmail.com	Statsenko, Mikhail E./N-7573-2015; Goto, Shinya/AAU-6045-2020; Bangalore, Sripal/B-6246-2013; Cannon, Christopher P/AAY-7644-2020; Messerli, Franz/AAR-4783-2021; STEG, Philippe Gabriel/Z-1567-2019	Statsenko, Mikhail E./0000-0002-3306-0312; Goto, Shinya/0000-0002-6821-1504; Cannon, Christopher P/0000-0003-4596-2791; Bangalore, Sripal/0000-0001-9485-0652; STEG, Philippe Gabriel/0000-0001-6896-2941	sanofi-aventis; Servier [U-698]; New York University School of Medicine; Ablynx; Amarin; Amgen; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Meyers Squibb; Daiichi Sankyo; Eisai; GlaxoSmithKline; Lilly; Medtronic; Merck Sharp Dohme; Novartis; Otsuka; Pfizer; Roche; Medicines Company; Forest Pharmaceuticals; Daichii Sankyo; Asteras; Medtronics Japan; Mitsubishi Tanabe; Takeda; Mochida; Eli Lilly Company; Maquet; Accumetrics; Essentials; Merck; Regeneron; Ethicon; Waksman Foundation (Tokyo, Japan)	sanofi-aventis(Sanofi-Aventis); Servier(Servier); New York University School of Medicine; Ablynx(Ablynx); Amarin; Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Meyers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Medtronic(Medtronic); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Roche(Roche Holding); Medicines Company; Forest Pharmaceuticals; Daichii Sankyo(Daiichi Sankyo Company Limited); Asteras; Medtronics Japan; Mitsubishi Tanabe(Mitsubishi Tanabe Pharma Corporation); Takeda(Takeda Pharmaceutical Company Ltd); Mochida; Eli Lilly Company(Eli Lilly); Maquet; Accumetrics; Essentials; Merck(Merck & Company); Regeneron(Regeneron); Ethicon; Waksman Foundation (Tokyo, Japan)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Steg reported receiving a research grant from sanofi-aventis and Servier awarded to INSERM U-698 and the New York University School of Medicine; serving as a consultant or receiving speakers fees from Ablynx, Amarin, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Daiichi Sankyo, Eisai, GlaxoSmithKline, Lilly, Medtronic, Merck Sharp & Dohme, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, the Medicines Company; and holding stock in Aterovax. Dr Deedwania reported serving as a consultant or receiving speakers fees from Forest Pharmaceuticals, Novartis, Daichii Sankyo, Servier, and Pfizer. Dr Goto reported receiving consulting fees and honoraria from Eisai, sanofi-aventis, Otsuka, Bayer, Novartis, AstraZeneca, Asteras, Pfizer, Medtronics Japan, Mitsubishi Tanabe, Takeda, Daiichi Sankyo, Mochida, Merck Sharp & Dohme; and receiving research grants from sanofi-aventis, Eisai, Boehringer Ingelheim, Otsuka, and Daiichi Sankyo. Dr Ohman reported receiving research grants from Daiichi Sankyo, Eli Lilly & Company, Maquet; serving as a consultant to AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, LipoScience, Merck, Pozen, Roche, sanofi-aventis, the Medicines Company, and WebMD; and serving on the speakers bureau for Boehringer Ingelheim, Gilead Sciences, and the Medicines Company. Dr Cannon reported receiving research grants or support from Accumetrics, AstraZeneca, Essentials, GlaxoSmithKline, Merck, Regeneron, sanofi-aventis, and Takeda; serving on advisory boards (but funds donated to charity) for Bristol-Myers Squibb, Alnylam, Pfizer, and CSL; receiving honoraria for the development of independent educational symposia for Pfizer and AstraZeneca; and serving as a clinical advisor for and owning equity in Automedics Medical Systems. Dr Bhatt reported serving on an advisory board for Medscape Cardiology; serving on the boards of directors for Boston VA Research Institute and the Society of Chest Pain Centers; serving as chair for the American Heart Association Get With The Guidelines Science Subcommittee; receiving honoraria from the American College of Cardiology for serving as editor of Clinical Trials, Cardiosource, Duke Clinical Research Institute for serving on clinical trial steering committees, Slack Publications for serving as chief medical editor of Cardiology Today Intervention, and WebMD for serving on continuing medical education steering committees; serving as senior associate editor for the Journal of Invasive Cardiology; receiving research grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, sanofi-aventis, and the Medicines Company; and unfunded research from FlowCo, PLx Pharma, and Takeda. Drs Bangalore, Eagle, Smith Jr, Zeymer, Hoffman, and Messerli and Mr Crowley did not report any disclosures.; The REACH Registry is sponsored by sanofi-aventis, Bristol-Myers Squibb, and the Waksman Foundation (Tokyo, Japan) and is endorsed by the World Heart Federation. Statistical analyses of the REACH database by TIMI Study Group statisticians were funded by sanofi-aventis.	Ahmed A, 2006, EUR HEART J, V27, P1431, DOI 10.1093/eurheartj/ehi890; Bangalore S, 2008, INT J CLIN PRACT, V62, P1643, DOI 10.1111/j.1742-1241.2008.01916.x; Bangalore S, 2007, J HUM HYPERTENS, V21, P259, DOI 10.1038/sj.jhh.1002144; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1482, DOI 10.1016/j.jacc.2008.06.048; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Bangalore S, 2008, AM HEART J, V156, P241, DOI 10.1016/j.ahj.2008.02.023; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Bangalore S, 2006, J AM COLL CARDIOL, V48, P1284, DOI 10.1016/j.jacc.2006.06.038; Bangalore Sripal, 2007, Curr Cardiol Rep, V9, P441, DOI 10.1007/BF02938387; Bangalore Sripal, 2006, Anadolu Kardiyol Derg, V6, P358; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947; Chen ZM, 2005, LANCET, V366, P1622; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hirata K, 2005, J HYPERTENS, V23, P551, DOI 10.1097/01.hjh.0000160211.56103.48; Jonsson G, 2005, CARDIOLOGY, V103, P148, DOI 10.1158/000084584; Kramer JM, 2006, AM HEART J, V152, P454, DOI 10.1016/j.ahj.2006.02.030; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; Messerli FH, 2002, JAMA-J AM MED ASSOC, V288, P1845; Messerli FH, 2008, J AM COLL CARDIOL, V51, P330, DOI 10.1016/j.jacc.2007.09.040; Morgan T, 2004, AM J HYPERTENS, V17, P118, DOI 10.1016/j.amjhyper.2003.09.012; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Rubin DB, 2001, HLTH SERV OUTCOMES R, V2, P169, DOI [DOI 10.1023/A:1020363010465, 10.1023/A:1020363010465]; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; SNOW PJD, 1965, LANCET, V2, P551; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Weir MR, 2000, AM HEART J, V139, P174, DOI 10.1016/S0002-8703(00)90325-9; Wiysonge CS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub2; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; [No title captured]	46	318	332	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1340	1349		10.1001/jama.2012.12559	http://dx.doi.org/10.1001/jama.2012.12559			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032550	Bronze			2022-12-01	WOS:000309369300028
J	Hughes, V				Hughes, Virginia			PUBLIC HEALTH Where there's smoke	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; COPD; EXPOSURE; CHINA; RISK											Han Jing-Xiu, 2006, Wei Sheng Yan Jiu, V35, P609; He Y, 2012, CHEST; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Jiang Y, 2007, AM J PREV MED, V33, P15, DOI 10.1016/j.amepre.2007.02.037; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2006, RESPIROLOGY, V11, P603, DOI 10.1111/j.1440-1843.2006.00897.x	8	14	14	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S18	S20		10.1038/489S18a	http://dx.doi.org/10.1038/489S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011LT	23013712	Bronze			2022-12-01	WOS:000309167100010
J	Adams, TD; Davidson, LE; Litwin, SE; Kolotkin, RL; LaMonte, MJ; Pendleton, RC; Strong, MB; Vinik, R; Wanner, NA; Hopkins, PN; Gress, RE; Walker, JM; Cloward, TV; Nuttall, RT; Hammoud, A; Greenwood, JLJ; Crosby, RD; McKinlay, R; Simper, SC; Smith, SC; Hunt, SC				Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Kolotkin, Ronette L.; LaMonte, Michael J.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom; Hammoud, Ahmad; Greenwood, Jessica L. J.; Crosby, Ross D.; McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.; Hunt, Steven C.			Health Benefits of Gastric Bypass Surgery After 6 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUX-EN-Y; CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; MEDICAL THERAPY; UNITED-STATES; OBESITY; WEIGHT; MORBIDITY	Context Extreme obesity is associated with health and cardiovascular disease risks. Although gastric bypass surgery induces rapid weight loss and ameliorates many of these risks in the short term, long-term outcomes are uncertain. Objective To examine the association of Roux-en-Y gastric bypass (RYGB) surgery with weight loss, diabetes mellitus, and other health risks 6 years after surgery. Design, Setting, and Participants A prospective Utah-based study conducted between July 2000 and June 2011 of 1156 severely obese (body mass index [BMI] >= 35) participants aged 18 to 72 years (82% women; mean BMI, 45.9; 95% CI, 31.2-60.6) who sought and received RYGB surgery (n = 418), sought but did not have surgery (n = 417; control group 1), or who were randomly selected from a population-based sample not seeking weight loss surgery (n = 321; control group 2). Main Outcome Measures Weight loss, diabetes, hypertension, dyslipidemia, and health-related quality of life were compared between participants having RYGB surgery and control participants using propensity score adjustment. Results Six years after surgery, patients who received RYGB surgery (with 92.6% follow-up) lost 27.7% (95% CI, 26.6%-28.9%) of their initial body weight compared with 0.2% (95% CI, -1.1% to 1.4%) gain in control group 1 and 0% (95% CI, -1.2% to 1.2%) in control group 2. Weight loss maintenance was superior in patients who received RYGB surgery, with 94% (95% CI, 92%-96%) and 76% (95% CI, 72%-81%) of patients receiving RYGB surgery maintaining at least 20% weight loss 2 and 6 years after surgery, respectively. Diabetes remission rates 6 years after surgery were 62% (95% CI, 49%-75%) in the RYGB surgery group, 8% (95% CI, 0%-16%) in control group 1, and 6% (95% CI, 0%-13%) in control group 2, with remission odds ratios (ORs) of 16.5 (95% CI, 4.7-57.6; P < .001) vs control group 1 and 21.5 (95% CI, 5.4-85.6; P < .001) vs control group 2. The incidence of diabetes throughout the course of the study was reduced after RYGB surgery (2%; 95% CI, 0%-4%; vs 17%; 95% CI, 10%-24%; OR, 0.11; 95% CI, 0.04-0.34 compared with control group 1 and 15%; 95% CI, 9%-21%; OR, 0.21; 95% CI, 0.060.67 compared with control group 2; both P < .001). The numbers of participants with bariatric surgery-related hospitalizations were 33 (7.9%), 13 (3.9%), and 6 (2.0%) for the RYGB surgery group and 2 control groups, respectively. Conclusion Among severely obese patients, compared with nonsurgical control patients, the use of RYGB surgery was associated with higher rates of diabetes remission and lower risk of cardiovascular and other health outcomes over 6 years. JAMA. 2012;308(11):1122-1131 www.jama.com	[Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Hunt, Steven C.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84108 USA; [Hammoud, Ahmad] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84108 USA; [Greenwood, Jessica L. J.] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84108 USA; [Adams, Ted D.] Intermt Healthcare, Intermt Hlth & Fitness Inst, LDS Hosp, Salt Lake City, UT USA; [Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom] Intermt Healthcare, Intermt Sleep Disorders Ctr, Salt Lake City, UT USA; [McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.] Rocky Mt Associated Phy Inc, Salt Lake City, UT USA; [Litwin, Sheldon E.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Obes & Qual Life Consulting, Durham, NC USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Dept Community & Family Med, Durham, NC USA; [LaMonte, Michael J.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Crosby, Ross D.] Univ N Dakota, Sch Med, Neuropsychiat Res Inst, Fargo, ND USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; University System of Georgia; Augusta University; Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Neuropsychiatric Research Institute; University of North Dakota Grand Forks	Adams, TD (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 420 Chipeta Way,Room 1160, Salt Lake City, UT 84108 USA.	ted.adams@utah.edu	Davidson, Lance E./AAA-9689-2019; LaMonte, Mike/AAC-9953-2021	Davidson, Lance E./0000-0002-1383-0666; Crosby, Ross/0000-0001-9131-1629; Kolotkin, Ronette/0000-0002-1300-2131	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases [DK-55006]; Public Health Service from the National Center for Research Resources [M01-RR00064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067, KL2TR001065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055006, R01DK055006] Funding Source: NIH RePORTER	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Public Health Service from the National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK-55006 from the National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases and Public Health Service research grant M01-RR00064 from the National Center for Research Resources.	Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2010, OBESITY, V18, P121, DOI 10.1038/oby.2009.178; Benraouane F, 2011, CURR OPIN CARDIOL, V26, P555, DOI 10.1097/HCO.0b013e32834b7fc4; Bocchieri LE, 2002, OBES SURG, V12, P781, DOI 10.1381/096089202320995556; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dixon JB, 2012, OBES REV, V13, P57, DOI 10.1111/j.1467-789X.2011.00928.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Espeland M, 2007, DIABETES CARE, V30, P1374; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Horm J., 1996, NATL DEATH INDEX PLU, pA5; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kushner RF, 2006, MAYO CLIN PROC, V81, pS46; Madala MC, 2008, J AM COLL CARDIOL, V52, P979, DOI 10.1016/j.jacc.2008.04.067; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SC, 2004, OBES SURG, V14, P73, DOI 10.1381/096089204772787329; SMITH SC, 1995, OBES SURG, V5, P314, DOI 10.1381/096089295765557700; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Wee CC, 2008, J AM COLL CARDIOL, V52, P620, DOI 10.1016/j.jacc.2008.05.021; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wittgrove AC, 2000, OBES SURG, V10, P233, DOI 10.1381/096089200321643511; Zimmet P, 2012, NEW ENGL J MED, V366, P1635, DOI 10.1056/NEJMe1202443	40	447	454	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1122	1131		10.1001/2012.jama.11164	http://dx.doi.org/10.1001/2012.jama.11164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990271	Green Accepted			2022-12-01	WOS:000308861000028
J	Farley, TA				Farley, Thomas A.			The Role of Government in Preventing Excess Calorie Consumption The Example of New York City	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Farley, TA (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8th Floor, Queens, NY 11101 USA.	tfarley@health.nyc.gov						Alcorn T, 2012, LANCET, V379, P2037, DOI 10.1016/S0140-6736(12)60879-4; [Anonymous], 2010, REP DIET GUID ADV D; Esterl Mike, 2011, WALL STREET J; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182	8	14	14	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1093	1094		10.1001/2012.jama.11623	http://dx.doi.org/10.1001/2012.jama.11623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990264				2022-12-01	WOS:000308861000021
J	Hiatt, WR; Goldfine, AB; Kaul, S				Hiatt, William R.; Goldfine, Allison B.; Kaul, Sanjay			Cardiovascular Risk Assessment in the Development of New Drugs for Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hiatt, William R.] Univ Colorado, Sch Med, CPC Clin Res, Aurora, CO 80045 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Kaul, Sanjay] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, CPC Clin Res, 13199 E Montview Blvd,Ste 200, Aurora, CO 80045 USA.	will.hiatt@ucdenver.edu		Goldfine, Allison/0000-0002-0345-1048				[Anonymous], GUID IND DIAB MELL E; Hiatt WR, 2012, CIRCULATION, V125, P1171, DOI 10.1161/CIRCULATIONAHA.111.023499; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; US Food and Drug Administration, CLIN BRIEF DOC NEW D; US Food and Drug Administration, GUID IND DEV PROD WE	5	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1099	1100		10.1001/jama.2012.9931	http://dx.doi.org/10.1001/jama.2012.9931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990267				2022-12-01	WOS:000308861000024
J	Buganim, Y; Faddah, DA; Cheng, AW; Itskovich, E; Markoulaki, S; Ganz, K; Klemm, SL; van Oudenaarden, A; Jaenisch, R				Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Klemm, Sandy L.; van Oudenaarden, Alexander; Jaenisch, Rudolf			Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase	CELL			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; MOUSE; GENERATION; NETWORKS; STATE	During cellular reprogramming, only a small fraction of cells become induced pluripotent stem cells (iPSCs). Previous analyses of gene expression during reprogramming were based on populations of cells, impeding single-cell level identification of reprogramming events. We utilized two gene expression technologies to profile 48 genes in single cells at various stages during the reprogramming process. Analysis of early stages revealed considerable variation in gene expression between cells in contrast to late stages. Expression of Esrrb, Utf1, Lin28, and Dppa2 is a better predictor for cells to progress into iPSCs than expression of the previously suggested reprogramming markers Fbxo15, Fgf4, and Oct4. Stochastic gene expression early in reprogramming is followed by a late hierarchical phase with Sox2 being the upstream factor in a gene expression hierarchy. Finally, downstream factors derived from the late phase, which do not include Oct4, Sox2, Klf4, c-Myc, and Nanog, can activate the pluripotency circuitry.	[Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; van Oudenaarden, Alexander; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Klemm, Sandy L.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Cheng, Albert/0000-0003-2653-5743	NIH Kirschstein NRSA [1 F32 GM099153-01A1]; NSF; Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH [HD 045022, R37CA084198, 1DP1OD003936]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198, U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NIH Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Yarden Katz, Sovan Sarkar, Malkiel Cohen, Bryce Carey, and Jonathan Friedman for fruitful discussions, Patti Wisniewski and Chad Araneo for their help with cell sorting, and Stuart Levine for help with pilot Fluidigm experiments. Y.B. was supported by an NIH Kirschstein NRSA (1 F32 GM099153-01A1). D.A.F. is a Vertex Scholar and was supported by an NSF Graduate Research Fellowship and Jerome and Florence Brill Graduate Student Fellowship. A.W.C. was supported by a Croucher and Ludwig Research Fellowship. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics. This work was supported by NIH grants HD 045022 and R37CA084198 to R.J. and the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) and a NIH Pioneer award (1DP1OD003936) to A.v.O.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	43	606	630	7	163	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1209	1222		10.1016/j.cell.2012.08.023	http://dx.doi.org/10.1016/j.cell.2012.08.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980981	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000308928100014
J	Kastenmuller, W; Torabi-Parizi, P; Subramanian, N; Lammermann, T; Germain, RN				Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.			A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread	CELL			English	Article							CD8(+) T-CELLS; VACCINIA VIRUS; MACROPHAGE POLARIZATION; SUBCAPSULAR SINUS; MIGRATION; INFECTION; RECOGNITION; LYMPHOCYTES; ACTIVATION; MECHANISM	The lymphatic network that transports interstitial fluid and antigens to lymph nodes constitutes a conduit system that can be hijacked by invading pathogens to achieve systemic spread unless dissemination is blocked in the lymph node itself. Here, we show that a network of diverse lymphoid cells (natural killer cells, gamma delta T cells, natural killer T cells, and innate-like CD8+ T cells) are spatially prepositioned close to lymphatic sinus-lining sentinel macrophages where they can rapidly and efficiently receive inflammasome-generated IL-18 and additional cytokine signals from the pathogen-sensing phagocytes. This leads to rapid IFN gamma secretion by the strategically positioned innate lymphocytes, fostering antimicrobial resistance in the macrophage population. Interference with this innate immune response loop allows systemic spread of lymph-borne bacteria. These findings extend our understanding of the functional significance of cellular positioning and local intercellular communication within lymph nodes while emphasizing the role of these organs as highly active locations of innate host defense.	[Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastenmuller, W (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	kastenmullerw@mail.nih.gov; rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Lämmermann, Tim/AAD-7453-2022; Germain, Ronald N./Z-1945-2019	Subramanian, Naeha/0000-0003-3754-0521	NIAID; NIH; DFG; International Human Frontier Science Program;  [KA 3091/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); International Human Frontier Science Program(Human Frontier Science Program); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program, NIAID, NIH, DFG, KA 3091/1-1 to W.K. and by a fellowship grant from the International Human Frontier Science Program to T.L. We thank A. Sher, Y. Belkaid, and K. Abdi for kindly providing mouse strains, B. Moss for generously providing pLW-73, E. Miao and B. Borlee for generously providing PA strains and E. Long for critically reading this manuscript. The authors would also like to thank Austin Rinker for technical support.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BODEY GP, 1983, REV INFECT DIS, V5, P279; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dayer JM, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00000403b; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2010, EUR J IMMUNOL, V40, P2103, DOI 10.1002/eji.201040482; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; SENKEVICH TG, 1995, J VIROL, V69, P4103, DOI 10.1128/JVI.69.7.4103-4111.1995; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	55	261	263	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1235	1248		10.1016/j.cell.2012.07.021	http://dx.doi.org/10.1016/j.cell.2012.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980983	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000308928100016
J	Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Bar, NS; Batut, P; Bell, K; Bell, I; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Falconnet, E; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, H; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Luo, OJ; Park, E; Persaud, K; Preall, JB; Ribeca, P; Risk, B; Robyr, D; Sammeth, M; Schaffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, H; Wrobel, J; Yu, YB; Ruan, XA; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, T; Reymond, A; Antonarakis, SE; Hannon, G; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR				Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Bar, Nadav S.; Batut, Philippe; Bell, Kimberly; Bell, Ian; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Falconnet, Emilie; Fastuca, Meagan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Luo, Oscar J.; Park, Eddie; Persaud, Kimberly; Preall, Jonathan B.; Ribeca, Paolo; Risk, Brian; Robyr, Daniel; Sammeth, Michael; Schaffer, Lorian; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Ruan, Xiaoan; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Tim; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.			Landscape of transcription in human cells	NATURE			English	Article							RNA; GENOME; IDENTIFICATION; ENHANCERS; MAPS	Eukaryotic cells make many types of primary and processed RNAs that are found either in specific subcellular compartments or throughout the cells. A complete catalogue of these RNAs is not yet available and their characteristic subcellular localizations are also poorly understood. Because RNA represents the direct output of the genetic information encoded by genomes and a significant proportion of a cell's regulatory capabilities are focused on its synthesis, processing, transport, modification and translation, the generation of such a catalogue is crucial for understanding genome function. Here we report evidence that three-quarters of the human genome is capable of being transcribed, as well as observations about the range and levels of expression, localization, processing fates, regulatory regions and modifications of almost all currently annotated and thousands of previously unannotated RNAs. These observations, taken together, prompt a redefinition of the concept of a gene.	[Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] Ctr Gen Regulat, Barcelona 08003, Catalonia, Spain; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] UPF, Barcelona 08003, Catalonia, Spain; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Meagan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Persaud, Kimberly; Preall, Jonathan B.; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11742 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Omics Sci Ctr, RIKEN Yokohama Inst, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Mortazavi, Ali; Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaffer, Lorian; Trout, Diane; Wold, Barbara] CALTECH, Beckman Inst 2, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Khatun, Jainab; Risk, Brian; Wrobel, John] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kokocinski, Felix; Harrow, Jennifer; Hubbard, Tim] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Alioto, Tyler; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bar, Nadav S.; Skancke, Jorgen] Norwegian Univ Sci & Technol, Dept Chem Engn, NO-7491 Trondheim, Norway; [Bell, Ian; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Chen, Xian; Gunawardena, Harsha; Yu, Yanbao; Giddings, Morgan C.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] IGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Shahab, Atif; Ruan, Xiaoan; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Kapranov, Philipp] St Laurent Inst, Cambridge, MA 02141 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Cold Spring Harbor Laboratory; RIKEN; California Institute of Technology; University of California System; University of California Irvine; Idaho; Boise State University; Yale University; Yale University; Wellcome Trust Sanger Institute; Norwegian University of Science & Technology (NTNU); Affymetrix; University of North Carolina; University of North Carolina Chapel Hill; University of Lausanne; University of Geneva; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Yale University; Pompeu Fabra University	Guigo, R (corresponding author), Ctr Gen Regulat, Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.	roderic.guigo@crg.eu; gingeras@cshl.edu	Sammeth, Michael/C-1157-2014; Takahashi, Hazuki/F-9007-2017; Gao, Hui/AAF-9770-2019; Johnson, Rory/H-2961-2015; Hannon, Gregory/AAB-3568-2019; Yu, Yanbao/G-3035-2010; Tanzer, Andrea/L-3147-2015; Johnson, Rory/ABE-2503-2021; Lin, Wei/AAH-9924-2019; Alioto, Tyler/K-7267-2015; Djebali, Sarah/O-9817-2014; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Lagarde, Julien/AAI-1686-2020; Ferreira, Pedro/HDO-1346-2022; Fullwood, Melissa/G-5713-2011; Derrien, Thomas/ABD-6197-2020; Alioto, Tyler/AAF-6342-2020; Carninci, Piero/K-1568-2014; Lassmann, Timo/HCH-4313-2022; Luo, Oscar Junhong/G-3293-2018; Lassmann, Timo/A-8271-2008; Tanzer, Andrea/AAY-5431-2021; Guigo, Roderic/D-1303-2010; Antonarakis, Stylianos E/N-8866-2014; Ferreira, Pedro G/J-6379-2013; Luo, Junhong/N-8583-2019	Sammeth, Michael/0000-0002-6528-9883; Takahashi, Hazuki/0000-0001-7315-7349; Johnson, Rory/0000-0003-4607-2782; Yu, Yanbao/0000-0003-2994-1974; Tanzer, Andrea/0000-0003-2873-4236; Johnson, Rory/0000-0003-4607-2782; Lin, Wei/0000-0002-7506-3466; Alioto, Tyler/0000-0002-2960-5420; Djebali, Sarah/0000-0002-0599-1267; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Lagarde, Julien/0000-0002-0290-7445; Fullwood, Melissa/0000-0003-0321-7865; Alioto, Tyler/0000-0002-2960-5420; Carninci, Piero/0000-0001-7202-7243; Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Tanzer, Andrea/0000-0003-2873-4236; Guigo, Roderic/0000-0002-5738-4477; Antonarakis, Stylianos E/0000-0001-8907-5823; Ferreira, Pedro G/0000-0003-3838-8664; Gingeras, Thomas/0000-0001-9106-3573; Curado, Joao/0000-0003-3916-0936; Dobin, Alexander/0000-0002-4115-9128; Bell, Kimberly/0000-0003-2204-8569; Merkel, Angelika/0000-0001-5164-6803; Harrow, Jennifer/0000-0003-0338-3070; Reymond, Alexandre/0000-0003-1030-8327; Batut, Philippe/0000-0003-4250-0663; Luo, Oscar Junhong/0000-0002-1266-3069; Kokocinski, Felix/0000-0002-8472-9207; park, eddie/0000-0001-5651-1481; Derrien, Thomas/0000-0002-8211-5789; Rozowsky, Joel/0000-0002-3565-0762; Marinov, Georgi/0000-0003-1822-7273; Foissac, Sylvain/0000-0002-2631-5356; Kapranov, Philipp/0000-0003-2647-4856	National Human Genome Research Institute (NHGRI) [U54HG004557, U54HG004555, U54HG004576, U54HG004558]; NHGRI pilot grant [R01HG003700]; NHGRI ARRA stimulus grant [1RC2HG005591]; National Science Foundation (SNF) [127375]; European Research Council (ERC) [249968]; Japanese Ministry of Education, Culture, Sports, Science and Technology; INB GNV-1 from the Spanish Ministry of Science;  [BIO2011-26205];  [CSD2007-00050]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555, U54HG004557, U54HG004558, U01HG003147, U54HG004576, U54HG007004, RC2HG005591, R01HG003700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI pilot grant; NHGRI ARRA stimulus grant; National Science Foundation (SNF); European Research Council (ERC)(European Research Council (ERC)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); INB GNV-1 from the Spanish Ministry of Science; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute (NHGRI) production grants U54HG004557, U54HG004555, U54HG004576 and U54HG004558, and by the NHGRI pilot grant R01HG003700. It was also supported by the NHGRI ARRA stimulus grant 1RC2HG005591, the National Science Foundation (SNF) grant 127375, the European Research Council (ERC) grant 249968, a research grant for the RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and grants BIO2011-26205, CSD2007-00050 and INB GNV-1 from the Spanish Ministry of Science. We would also like to thank C. Gunter and W. Spitzer for editorial assistance with the manuscript.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Arvey A., GENOME RES IN PRESS; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Harrow J., GENOME RES IN PRESS; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hoffman M., GENOME RES IN PRESS; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kundaje A., GENOME RES IN PRESS; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mattick JS, 2011, SEMIN CELL DEV BIOL, V22, P327, DOI 10.1016/j.semcdb.2011.05.002; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Miller B., GENOME RES IN PRESS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Park E., 1943, GENOME RES IN PRESS; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Tilgner H., GENOME RES IN PRESS; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang J., GENOME RES IN PRESS; Yip K. Y., GENOME BIOL IN PRESS	36	3406	3542	12	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					101	108		10.1038/nature11233	http://dx.doi.org/10.1038/nature11233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955620	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000308347000043
J	Cruz-Ramirez, A; Diaz-Trivino, S; Blilou, I; Grieneisen, VA; Sozzani, R; Zamioudis, C; Miskolczi, P; Nieuwland, J; Benjamins, R; Dhonukshe, P; Caballero-Perez, J; Horvath, B; Long, YC; Mahonen, AP; Zhang, HT; Xu, J; Murray, JAH; Benfey, PN; Bako, L; Maree, AFM; Scheres, B				Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Grieneisen, Veronica A.; Sozzani, Rosangela; Zamioudis, Christos; Miskolczi, Pal; Nieuwland, Jeroen; Benjamins, Rene; Dhonukshe, Pankaj; Caballero-Perez, Juan; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Murray, James A. H.; Benfey, Philip N.; Bako, Laszlo; Maree, Athanasius F. M.; Scheres, Ben			A Bistable Circuit Involving SCARECROW-RETINOBLASTOMA Integrates Cues to Inform Asymmetric Stem Cell Division	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; ARABIDOPSIS ROOT-MERISTEM; TUMOR-SUPPRESSOR; SPLIT LUCIFERASE; AUXIN TRANSPORT; CYCLE; GENE; DIFFERENTIATION; PLANTS; GROWTH	In plants, where cells cannot migrate, asymmetric cell divisions (ACDs) must be confined to the appropriate spatial context. We investigate tissue-generating asymmetric divisions in a stem cell daughter within the Arabidopsis root. Spatial restriction of these divisions requires physical binding of the stem cell regulator SCARECROW (SCR) by the RETINOBLASTOM-RELATED (RBR) protein. In the stem cell niche, SCR activity is counteracted by phosphorylation of RBR through a cyclinD6;1-CDK complex. This cyclin is itself under transcriptional control of SCR and its partner SHORT ROOT (SHR), creating a robust bistable circuit with either high or low SHR-SCR complex activity. Auxin biases this circuit by promoting CYCD6;1 transcription. Mathematical modeling shows that ACDs are only switched on after integration of radial and longitudinal information, determined by SHR and auxin distribution, respectively. Coupling of cell-cycle progression to protein degradation resets the circuit, resulting in a "flip flop" that constrains asymmetric cell division to the stem cell region.	[Grieneisen, Veronica A.; Maree, Athanasius F. M.] John Innes Ctr, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England; [Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Zamioudis, Christos; Benjamins, Rene; Dhonukshe, Pankaj; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Grieneisen, Veronica A.] Univ E Anglia, Sch Biol Sci, Dept Cell & Dev Biol, Norwich NR4 7TJ, Norfolk, England; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [Miskolczi, Pal; Bako, Laszlo] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Miskolczi, Pal; Bako, Laszlo] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Nieuwland, Jeroen; Murray, James A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Caballero-Perez, Juan] Inst Syst Biol, Seattle, WA 98109 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Utrecht University; University of East Anglia; Duke University; Duke University; Umea University; Swedish University of Agricultural Sciences; Umea University; Cardiff University; Institute for Systems Biology (ISB)	Maree, AFM (corresponding author), John Innes Ctr, Dept Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stan.maree@jic.ac.uk; b.scheres@uu.nl	Xu, Jian/I-2921-2012; Murray, James AH/D-3399-2009; Cruz-Ramirez, Luis Alfredo/B-7588-2009; Long, Yuchen/GZA-6989-2022; Ramírez, Luis Alfredo Cruz/K-2548-2019; Zamioudis, Christos/AAO-2325-2021; Mähönen, Ari Pekka/B-9764-2015	Xu, Jian/0000-0001-6194-6316; Murray, James AH/0000-0002-2282-3839; Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Long, Yuchen/0000-0001-5071-4632; Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Mähönen, Ari Pekka/0000-0001-6051-866X; Miskolczi, Pal/0000-0003-1036-5831; Zhang, Hongtao/0000-0002-4903-571X; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578; Sozzani, Rosangela/0000-0003-3316-2367; Maree, Athanasius F. M./0000-0003-2689-2484; Grieneisen, Veronica/0000-0001-6780-8301; Caballero Perez, Juan/0000-0002-6160-3644	ERC; ALW-ERAPG [855.50.017]; EMBO-ALTF [1114-2006]; CONACYT [000000000092916]; Ministerio de Educacion y Ciencia, Spain; Marie Curie IEF [IEF-2008-237643]; Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC) [BB/J004553/1]; NWO VIDI grant; NIH [R01-GM043778]; Swedish Research Council; Carl Tryggers Stiftelse grants; BBSRC [BB/G00482X]; ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; BBSRC [BBS/E/J/000C0646, BB/G00482X/1, BB/E022383/1, BB/E022383/2, BBS/E/J/000C0645, BB/J009199/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0645, BB/J009199/1, BB/E022383/2, BB/E022383/1, BB/G00482X/1, BBS/E/J/000C0646] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883, R01GM043778] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); ALW-ERAPG; EMBO-ALTF; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Marie Curie IEF(European Commission); Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dominique Bergmann for critically reviewing this manuscript; Fred Sack, Lieven de Veylder, Naohiro Kato, Dorus Gadella, Joachim Goedhart, Tom Beeckman, and Tom Bennett for materials; and Anahi Perez-Torres, Luis Herrera-Estrella, and Juan Carlos del Pozo for technical advice. B. S. was supported by an ERC Advanced Investigator Fellowship and by ALW-ERAPG grant 855.50.017. A.C.-R. was supported by EMBO-ALTF 1114-2006 and CONACYT 000000000092916 grants. S.D.-T. was funded by Ministerio de Educacion y Ciencia, Spain, and by Marie Curie IEF (IEF-2008-237643). V. A. G. was supported by the Dorothy Hodgkin Fellowship. V. A. G. and A. F. M. M. were supported by the UK Biological and Biotechnology Research Council (BBSRC) via grant BB/J004553/1 to the John Innes Centre. I. B. was sponsored by an NWO VIDI grant. P.N.B. was funded by NIH grant R01-GM043778. L. B. was supported by Swedish Research Council and by Carl Tryggers Stiftelse grants. Work in James A. H. Murray laboratory was supported by the BBSRC grant BB/G00482X and by the ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cools T, 2010, PLANT J, V64, P705, DOI 10.1111/j.1365-313X.2010.04361.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fulop K, 2005, CELL CYCLE, V4, P1084; Genschik P, 1998, PLANT CELL, V10, P2063; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Kosugi S, 2002, PLANT J, V29, P45, DOI 10.1046/j.1365-313x.2002.01196.x; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lendvai A, 2007, J EXP BOT, V58, P1663, DOI 10.1093/jxb/erm022; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nieuwland J, 2009, P NATL ACAD SCI USA, V106, P22528, DOI 10.1073/pnas.0906354106; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; PEACEMAN DW, 1955, J SOC IND APPL MATH, V3, P28, DOI 10.1137/0103003; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Planchais S, 2004, PLANT J, V38, P616, DOI 10.1111/j.0960-7412.2004.02071.x; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sanz L, 2011, PLANT CELL, V23, P641, DOI 10.1105/tpc.110.080002; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Segers G, 1996, PLANT J, V10, P601, DOI 10.1046/j.1365-313X.1996.10040601.x; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Takahashi I, 2010, PLANT CELL REP, V29, P307, DOI 10.1007/s00299-010-0817-9; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	52	202	219	2	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1002	1015		10.1016/j.cell.2012.07.017	http://dx.doi.org/10.1016/j.cell.2012.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921914	Bronze, Green Accepted			2022-12-01	WOS:000308500200014
J	van Luenen, HGAM; Farris, C; Jan, S; Genest, PA; Tripathi, P; Velds, A; Kerkhoven, RM; Nieuwland, M; Haydock, A; Ramasamy, G; Vainio, S; Heidebrecht, T; Perrakis, A; Pagie, L; van Steensel, B; Myler, PJ; Borst, P				van Luenen, Henri G. A. M.; Farris, Carol; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja; Haydock, Andrew; Ramasamy, Gowthaman; Vainio, Saara; Heidebrecht, Tatjana; Perrakis, Anastassis; Pagie, Ludo; van Steensel, Bas; Myler, Peter J.; Borst, Piet			Glucosylated Hydroxymethyluracil, DNA Base J, Prevents Transcriptional Readthrough in Leishmania	CELL			English	Article							PROTOZOAN PARASITE LEISHMANIA; MAJOR FRIEDLIN CHROMOSOME-1; SURFACE GLYCOPROTEIN GENES; J-BINDING PROTEIN; TRYPANOSOMA-BRUCEI; POLYCISTRONIC TRANSCRIPTION; KINETOPLASTID PROTOZOANS; GENOMIC ORGANIZATION; MESSENGER-RNAS; SEQUENCE	Some Ts in nuclear DNA of trypanosomes and Leishmania are hydroxylated and glucosylated to yield base J (beta-D-glucosyl-hydroxymethyluracil). In Leishmania, about 99% of J is located in telomeric repeats. We show here that most of the remaining J is located at chromosome-internal RNA polymerase II termination sites. This internal J and telomeric J can be reduced by a knockout of J-binding protein 2 (JBP2), an enzyme involved in the first step of J biosynthesis. J levels are further reduced by growing Leishmania JBP2 knockout cells in BrdU-containing medium, resulting in cell death. The loss of internal J in JBP2 knockout cells is accompanied by massive readthrough at RNA polymerase II termination sites. The readthrough varies between transcription units but may extend over 100 kb. We conclude that J is required for proper transcription termination and infer that the absence of internal J kills Leishmania by massive readthrough of transcriptional stops.	[van Luenen, Henri G. A. M.; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Vainio, Saara; Borst, Piet] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja] Netherlands Canc Inst, Microarray & Deep Sequencing Facil, NL-1066 CX Amsterdam, Netherlands; [Heidebrecht, Tatjana; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Pagie, Ludo; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Farris, Carol; Haydock, Andrew; Ramasamy, Gowthaman; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Farris, Carol; Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Borst, P (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.borst@nki.nl	Myler, Peter John/AAR-9535-2021; Perrakis, Anastassis/E-8704-2013	Perrakis, Anastassis/0000-0002-1151-6227; van Luenen, Henri/0000-0002-5584-7968; Myler, Peter/0000-0002-0056-0513; Velds, Arno/0000-0003-4333-8872; Genest, Paul-Andre/0000-0001-6341-900X	PHS from the National Institute of Allergy and Infectious Diseases [R01 AI053667]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053667] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Raymond, B. Papadopoulou, M. Olivier, M.J. Tremblay, M. Ouellette, and J. Corbeil at CIHR in Quebec, Canada, for sharing the genomic sequence of L. tarentolae before publication. We thank U. Desselberger, University of Cambridge, UK, for providing purified rotavirus RNA preparations. We thank E. Christodoulou for help with JBP1 production. We are grateful to K. de Visser and F. van Leeuwen for critical reading of the manuscript and discussions. This work was supported by PHS grant R01 AI053667 from the National Institute of Allergy and Infectious Diseases to P.J.M.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Belli SI, 2003, INT J PARASITOL, V33, P965, DOI 10.1016/S0020-7519(03)00126-7; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; BORST P, 1965, P NATL ACAD SCI USA, V54, P982, DOI 10.1073/pnas.54.3.982; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; Cross M, 2002, MOL MICROBIOL, V46, P37, DOI 10.1046/j.1365-2958.2002.03144.x; DELANGE T, 1984, NUCLEIC ACIDS RES, V12, P4431, DOI 10.1093/nar/12.11.4431; DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9; DiPaolo C, 2005, MOL CELL, V17, P441, DOI 10.1016/j.molcel.2004.12.022; Dossin FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002313; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake DK, 2011, MOL CELL BIOL, V31, P1690, DOI 10.1128/MCB.01277-10; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fujii M, 2010, MOL GENET GENOMICS, V283, P461, DOI 10.1007/s00438-010-0535-6; Genest PA, 2005, NUCLEIC ACIDS RES, V33, P1699, DOI 10.1093/nar/gki304; Genest PA, 2007, NUCLEIC ACIDS RES, V35, P2116, DOI 10.1093/nar/gkm050; GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H; Grover RK, 2007, ANGEW CHEM INT EDIT, V46, P2839, DOI 10.1002/anie.200604635; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Miki K, 2010, FEBS J, V277, P4539, DOI 10.1111/j.1742-4658.2010.07868.x; Monnerat S, 2004, MOL BIOCHEM PARASIT, V134, P233, DOI 10.1016/j.molbiopara.2003.12.004; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Myler PJ, 2000, BIOCHEM SOC T, V28, P527, DOI 10.1042/bst0280527; NELSON RG, 1983, CELL, V34, P901, DOI 10.1016/0092-8674(83)90547-0; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sabatini R, 2002, J BIOL CHEM, V277, P958, DOI 10.1074/jbc.M109000200; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Stevens JR, 2008, PARASITE, V15, P226, DOI 10.1051/parasite/2008153226; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Toaldo CB, 2005, MOL BIOCHEM PARASIT, V143, P111, DOI 10.1016/j.molbiopara.2005.05.001; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; Vainio S, 2009, MOL BIOCHEM PARASIT, V164, P157, DOI 10.1016/j.molbiopara.2008.12.001; van Leeuwen F, 1998, MOL CELL BIOL, V18, P5643, DOI 10.1128/MCB.18.10.5643; van Leeuwen F, 1998, P NATL ACAD SCI USA, V95, P2366, DOI 10.1073/pnas.95.5.2366; van Leeuwen F, 2000, MOL BIOCHEM PARASIT, V109, P133, DOI 10.1016/S0166-6851(00)00247-4; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P3591, DOI 10.1093/nar/10.12.3591; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	63	102	103	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					909	921		10.1016/j.cell.2012.07.030	http://dx.doi.org/10.1016/j.cell.2012.07.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939620	Green Accepted, Bronze			2022-12-01	WOS:000308500200007
J	Weng, JK; Li, Y; Mo, HP; Chapple, C				Weng, Jing-Ke; Li, Yi; Mo, Huaping; Chapple, Clint			Assembly of an Evolutionarily New Pathway for alpha-Pyrone Biosynthesis in Arabidopsis	SCIENCE			English	Article							LIGNIN BIOSYNTHESIS; SYRINGYL LIGNIN; PLANTS	Plants possess arrays of functionally diverse specialized metabolites, many of which are distributed taxonomically. Here, we describe the evolution of a class of substituted alpha-pyrone metabolites in Arabidopsis, which we have named arabidopyrones. The biosynthesis of arabidopyrones requires a cytochrome P450 enzyme (CYP84A4) to generate the catechol-substituted substrate for an extradiol ring-cleavage dioxygenase (AtLigB). Unlike other ring-cleavage-derived plant metabolites made from tyrosine, arabidopyrones are instead derived from phenylalanine through the early steps of phenylpropanoid metabolism. Whereas CYP84A4, an Arabidopsis-specific paralog of the lignin-biosynthetic enzyme CYP84A1, has neofunctionalized relative to its ancestor, AtLigB homologs are widespread among land plants and many bacteria. This study exemplifies the rapid evolution of a biochemical pathway formed by the addition of a new biological activity into an existing metabolic infrastructure.	[Weng, Jing-Ke; Li, Yi; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Mo, Huaping] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Weng, Jing-Ke/E-7343-2013; Chapple, Clint CS/Q-5456-2017; Weng, Jing-Ke/V-5934-2019; Weng, Jing-Ke/A-6900-2015	Weng, Jing-Ke/0000-0003-1079-3668; Chapple, Clint CS/0000-0002-5195-562X; Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-3059-0075	NSF [MCB-1121925]; Global Climate and Energy Project	NSF(National Science Foundation (NSF)); Global Climate and Energy Project	This work is supported by NSF grant MCB-1121925 and the Global Climate and Energy Project (to C. C.). We thank D. A. Colby for helpful discussions about the chemical synthesis of APs and J. Ralph and H. Kim for providing authentic standards. Supporting data and figures relevant to this paper are presented online in the supplementary materials.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; SAITO K, 1976, EUR J BIOCHEM, V68, P237, DOI 10.1111/j.1432-1033.1976.tb10783.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528; Wink M., 2010, BIOCH PLANT SECONDAR, V2nd; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	16	64	67	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					960	964		10.1126/science.1221614	http://dx.doi.org/10.1126/science.1221614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923580				2022-12-01	WOS:000307807600044
J	Stringhini, S; Tabak, AG; Akbaraly, TN; Sabia, S; Shipley, MJ; Marmot, MG; Brunner, EJ; Batty, GD; Bovet, P; Kivimaki, M				Stringhini, Silvia; Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Bovet, Pascal; Kivimaeki, Mika			Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC POSITION; PHYSICAL-ACTIVITY; LIFE-STYLE; FOLLOW-UP; HEALTH BEHAVIORS; AFRICAN-AMERICAN; NATIONAL-HEALTH; MORTALITY; MELLITUS	Objective To assess the contribution of modifiable risk factors to social inequalities in the incidence of type 2 diabetes when these factors are measured at study baseline or repeatedly over follow-up and when long term exposure is accounted for. Design Prospective cohort study with risk factors (health behaviours (smoking, alcohol consumption, diet, and physical activity), body mass index, and biological risk markers (systolic blood pressure, triglycerides and high density lipoprotein cholesterol)) measured four times and diabetes status assessed seven times between 1991-93 and 2007-09. Setting Civil service departments in London (Whitehall II study). Participants 7237 adults without diabetes (mean age 49.4 years; 2196 women). Main outcome measures Incidence of type 2 diabetes and contribution of risk factors to its association with socioeconomic status. Results Over a mean follow-up of 14.2 years, 818 incident cases of diabetes were identified. Participants in the lowest occupational category had a 1.86-fold (hazard ratio 1.86, 95% confidence interval 1.48 to 2.32) greater risk of developing diabetes relative to those in the highest occupational category. Health behaviours and body mass index explained 33% (-1% to 78%) of this socioeconomic differential when risk factors were assessed at study baseline (attenuation of hazard ratio from 1.86 to 1.51), 36% (22% to 66%) when they were assessed repeatedly over the follow-up (attenuated hazard ratio 1.48), and 45% (28% to 75%) when long term exposure over the follow-up was accounted for (attenuated hazard ratio 1.41). With additional adjustment for biological risk markers, a total of 53% (29% to 88%) of the socioeconomic differential was explained (attenuated hazard ratio 1.35, 1.05 to 1.72). Conclusions Modifiable risk factors such as health behaviours and obesity, when measured repeatedly over time, explain almost half of the social inequalities in incidence of type 2 diabetes. This is more than was seen in previous studies based on single measurement of risk factors.	[Stringhini, Silvia; Bovet, Pascal] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Akbaraly, Tasnime N.] INSERM, U1061, Montpellier, France; [Akbaraly, Tasnime N.] Univ Montpellier I, Montpellier, France; [Batty, G. David] Univ Edinburgh, MRC Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Semmelweis University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Edinburgh	Stringhini, S (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland.	silvia.stringhini@chuv.ch	Brunner, Eric/H-2114-2011; Sabia, Séverine/G-2966-2017; Kivimaki, Mika/B-3607-2012; Stringhini, Silvia/B-4899-2013; Batty, GD/Y-4401-2018; AKBARALY, Tasnime/H-1389-2018; Marmot, M G/Y-3920-2019; Bovet, Pascal/F-4477-2011; Tabak, Adam/A-5007-2012	Brunner, Eric/0000-0002-0595-4474; Sabia, Séverine/0000-0003-3109-9720; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; AKBARALY, Tasnime/0000-0002-2150-4190; Marmot, M G/0000-0002-2431-6419; Bovet, Pascal/0000-0002-0242-4259; Tabak, Adam/0000-0002-6234-3936	Swiss School of Public Health; UK Medical Research Council (MRC); US National Institutes of Health (NIH) [R01HL036310, R01AG034454]; EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC); National Heart, Lung, and Blood Institute [R01HL036310]; National Institute of Aging, NIH [R01AG034454]; British Heart Foundation; MRC; British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G0100222, G19/35] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Swiss School of Public Health; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SStringhini is supported by a postdoctoral fellowship awarded by the Swiss School of Public Health. MK is supported by the UK Medical Research Council (MRC), the US National Institutes of Health (NIH) (R01HL036310; R01AG034454), the EU New OSH ERA Research Programme, and an Economic and Social Research Council (ESRC) professorship. DB is a Wellcome Trust fellow. TA is supported by the National Heart, Lung, and Blood Institute (R01HL036310). SSabia is supported by a grant from the National Institute of Aging, NIH (R01AG034454). MS is supported by the British Heart Foundation. The Whitehall II study has been supported by grants from the MRC; the British Heart Foundation; the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (R01HL036310); and the National Institute on Aging, NIH. The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology is funded as part of the joint UK research council call for lifelong health and wellbeing. The funding organisations or sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Agardh EE, 2004, DIABETES CARE, V27, P716, DOI 10.2337/diacare.27.3.716; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132; [Anonymous], 2007, CHALL OB WHO EUR REG; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Athyros VG, 2010, EXPERT OPIN PHARMACO, V11, P1965, DOI 10.1517/14656566.2010.489553; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; EVERHART JE, 1992, DIABETES, V41, P235, DOI 10.2337/diabetes.41.2.235; Hardoon SL, 2012, EUR HEART J, V33, P478, DOI 10.1093/eurheartj/ehr142; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; International Diabetes Federation, 2006, DIAB ALL; Investigators TA-H, 2011, NEW ENGL J MED, V365, P2255, DOI DOI 10.1056/NEJM0A1107579; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Matsushima M, 1996, DIABETOLOGIA, V39, P710; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; OSLER M, 1993, PUBLIC HEALTH, V107, P251, DOI 10.1016/S0033-3506(05)80504-9; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Samuel-Hodge CD, 2004, DIABETES CARE, V27, P663, DOI 10.2337/diacare.27.3.663; Shah S, 2001, J HYPERTENS, V19, P1333, DOI 10.1097/00004872-200107000-00020; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; WHO, 2011, DIAB; Wikstrom K, 2011, EUR J PUBLIC HEALTH, V21, P768, DOI 10.1093/eurpub/ckq164; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Wooldridge JM, 2007, J ECONOMETRICS, V141, P1281, DOI 10.1016/j.jeconom.2007.02.002; Zhang P, 2004, ANN INTERN MED, V140, P972, DOI 10.7326/0003-4819-140-11-200406010-00039; Zhang Wei-Zheng, HYPERTENSION, V48, P278, DOI [DOI 10.1161/01.HYP.0000107251.49515.C2, 10.1161/01.HYP.0000231509.27406.42, DOI 10.1161/01.HYP.9.2_PT_2.II36]; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531	58	104	105	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5452	10.1136/bmj.e5452	http://dx.doi.org/10.1136/bmj.e5452			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915665	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000308073200002
J	Piel, FB; Patil, AP; Howes, RE; Nyangiri, OA; Gething, PW; Dewi, M; Temperley, WH; Williams, TN; Weatherall, DJ; Hay, SI				Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Nyangiri, Oscar A.; Gething, Peter W.; Dewi, Mewahyu; Temperley, William H.; Williams, Thomas N.; Weatherall, David J.; Hay, Simon I.			Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates	LANCET			English	Article							CELL-DISEASE; MALARIA; DISORDERS; GENE; COUNTRIES; BURDEN	Background Reliable estimates of populations affected by diseases are necessary to guide efficient allocation of public health resources. Sickle haemoglobin (HbS) is the most common and clinically significant haemoglobin structural variant, but no contemporary estimates exist of the global populations affected. Moreover, the precision of available national estimates of heterozygous (AS) and homozygous (SS) neonates is unknown. We aimed to provide evidence-based estimates at various scales, with uncertainty measures. Methods Using a database of sickle haemoglobin surveys, we created a contemporary global map of HbS allele frequency distribution within a Bayesian geostatistical model. The pairing of this map with demographic data enabled calculation of global, regional, and national estimates of the annual number of AS and SS neonates. Subnational estimates were also calculated in data-rich areas. Findings Our map shows subnational spatial heterogeneities and high allele frequencies across most of sub-Saharan Africa, the Middle East, and India, as well as gene flow following migrations to western Europe and the eastern coast of the Americas. Accounting for local heterogeneities and demographic factors, we estimated that the global number of neonates affected by HbS in 2010 included 5 476 000 (IQR 5 291 000-5 679 000) AS neonates and 312 000 (294 000-330 000) SS neonates. These global estimates are higher than previous conservative estimates. Important differences predicted at the national level are discussed. Interpretation HbS will have an increasing effect on public health systems. Our estimates can help countries and the international community gauge the need for appropriate diagnoses and genetic counselling to reduce the number of neonates affected. Similar mapping and modelling methods could be used for other inherited disorders.	[Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Gething, Peter W.; Temperley, William H.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Nyangiri, Oscar A.; Williams, Thomas N.] Kilifi Dist Hosp, Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Programme, Kilifi, Kenya; [Dewi, Mewahyu] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Williams, Thomas N.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PS, England; [Weatherall, David J.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; Eijkman Institute; University of Oxford; University of Oxford	Piel, FB (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	fred.piel@zoo.ox.ac.uk	Gething, Peter/GQR-1884-2022; Hay, Simon I/F-8967-2015; Gething, Peter/ABD-2110-2020	Gething, Peter/0000-0001-6759-5449; Hay, Simon I/0000-0002-0611-7272; Piel, Frederic B./0000-0001-8131-7728	Kenyan Medical Research Institute (KEMRI); Wellcome Trust [085406, 079091, 091758]; Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC); MRC [MC_UU_12009/13] Funding Source: UKRI; Medical Research Council [MC_UU_12009/13] Funding Source: researchfish	Kenyan Medical Research Institute (KEMRI); Wellcome Trust(Wellcome TrustEuropean Commission); Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kevin Baird and Sunetra Gupta for providing comments on the report. We also thank the following people for sharing unpublished data: Anabel Arends and Gilberto Gomez for Venezuela data; Marcelo Urbano Ferreira for Brazil data; Rick Fairhurst, Carole Long, and Mahamadou Diakite for Mali data; Rick Fairhurst and Duong Socheat for Cambodia data. Data from the MalariaGEN Consortium have been shared for inclusion in the database. We acknowledge all its contributing collaborators and members for collecting, preparing, and genotyping the samples. We thank Andy Tatem for providing modified Global Rural Urban Mapping Project data and members of the Malaria Atlas Project (MAP) including Katherine Battle, Catherine Moyes, and Marianne Sinka who have contributed their expertise and to Janey Messina and David Pigott for proofreading. We acknowledge the support of the Kenyan Medical Research Institute (KEMRI). FBP, REH, and OAN were funded by a Biomedical Resources Grant (#085406) from the Wellcome Trust (to SIH) and acknowledge contributions from their Technical Advisory Group: Kevin Baird, Suthat Fucharoen, Dominic Kwiatkowski, Kevin Marsh, Kirk Rockett, Graham Serjeant, David J Weatherall, Tom N Williams, and Bill Wood. SIH is supported by a Senior Research Fellowship from the Wellcome Trust (#079091), which also supported APP and PWG. TNW is supported by a Senior Fellowship from the Wellcome Trust (#091758). MD acknowledges the support of the Li Ka Shing Foundation. We are also grateful for support from the Philippe Wiener-Maurice Anspach Foundation and the European Research Council (ERC Advanced Grant-Diversity).	Akinyanju O, 2010, NATL BURDEN SICKLE C; Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Balgir RS, 2000, CURR SCI INDIA, V79, P1536; Bittles AH, 2005, COMMUNITY GENET, V8, P17, DOI 10.1159/000083332; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Dyson S. M., 2012, GENETICS GLOBAL PUBL; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; LIVINGSTONE FB, 1964, AM J HUM GENET, V16, P435; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Panepinto JA, 2000, J PEDIATR-US, V136, P201, DOI 10.1016/S0022-3476(00)70102-8; Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003; Penman BS, 2009, P NATL ACAD SCI USA, V106, P21242, DOI 10.1073/pnas.0910840106; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Streetly A, 2000, BRIT MED J, V320, P1353, DOI 10.1136/bmj.320.7246.1353; *UN, 2003, DEM YB; WEATHERALL D, 2006, INHERITED DISORDERS, P663; Weatherall DJ, 2011, BRIT J HAEMATOL, V154, P736, DOI 10.1111/j.1365-2141.2011.08742.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2010, BRIT J HAEMATOL, V149, P635, DOI 10.1111/j.1365-2141.2010.08118.x; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; Williams TN, 2011, TRENDS PARASITOL, V27, P315, DOI 10.1016/j.pt.2011.02.004; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; World Health Organization Regional Office for Africa, 2010, SICKL CELL DIS STRAT	35	565	570	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					142	151		10.1016/S0140-6736(12)61229-X	http://dx.doi.org/10.1016/S0140-6736(12)61229-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23103089	Green Published			2022-12-01	WOS:000313420900030
J	Mudd, PA; Martins, MA; Ericsen, AJ; Tully, DC; Power, KA; Bean, AT; Piaskowski, SM; Duan, LJ; Seese, A; Gladden, AD; Weisgrau, KL; Furlott, JR; Kim, YI; de Santana, MGV; Rakasz, E; Capuano, S; Wilson, NA; Bonaldo, MC; Galler, R; Allison, DB; Piatak, M; Haase, AT; Lifson, JD; Allen, TM; Watkins, DI				Mudd, Philip A.; Martins, Mauricio A.; Ericsen, Adam J.; Tully, Damien C.; Power, Karen A.; Bean, Alex T.; Piaskowski, Shari M.; Duan, Lijie; Seese, Aaron; Gladden, Adrianne D.; Weisgrau, Kim L.; Furlott, Jessica R.; Kim, Young-il; Veloso de Santana, Marlon G.; Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.; Bonaldo, Myrna C.; Galler, Ricardo; Allison, David B.; Piatak, Michael, Jr.; Haase, Ashley T.; Lifson, Jeffrey D.; Allen, Todd M.; Watkins, David I.			Vaccine-induced CD8(+) T cells control AIDS virus replication	NATURE			English	Article							MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNODEFICIENCY; SIV; RESPONSES; HIV; INFECTION; DISEASE; ESCAPE; HOST	Developing a vaccine for human immunodeficiency virus(HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus(1-3). Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus(4,5), yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control(6), with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.	[Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Mudd, Philip A.; Ericsen, Adam J.; Bean, Alex T.; Piaskowski, Shari M.; Weisgrau, Kim L.; Furlott, Jessica R.; Wilson, Nancy A.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Mudd, Philip A.] Univ Wisconsin Madison, Med Scientist Training Program, Madison, WI 53705 USA; [Tully, Damien C.; Power, Karen A.; Seese, Aaron; Gladden, Adrianne D.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Kim, Young-il] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Veloso de Santana, Marlon G.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil; [Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Fundacao Oswaldo Cruz; University of Wisconsin System; University of Wisconsin Madison; Fundacao Oswaldo Cruz; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	dwatkins@med.miami.edu	Bonaldo, Myrna C/D-9494-2013; Ericsen, Adam/AAW-1187-2020; Martins, Mauricio/AAU-9226-2020; Bonaldo, Myrna/AAE-2799-2021; Allen, Todd/F-5473-2011; Galler, Ricardo/B-3280-2014; Rakasz, Eva G/H-9197-2019; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Ericsen, Adam/0000-0003-4176-8270; Martins, Mauricio/0000-0001-8336-216X; Allen, Todd/0000-0002-6609-1318; Tully, Damien/0000-0002-7620-9340; Mudd, Philip/0000-0002-3860-5473; Wilson, Nancy/0000-0002-9472-6026; Allison, David/0000-0003-3566-9399; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X	National Institutes of Health (NIH) [R37 AI052056, RO1 AI076114, RR015371, HHSN261200800001E]; FAPERJ; INCTV; CNPq; MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, R37AI052056, R01AI076114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCTV; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank M. Stevenson, M. Reynolds, N. Maness and J. Sacha for discussions and suggestions. We also thank D. Evans, L. Heyer and Z. R. Bergman for facilitating the experiments. This work was funded in part by National Institutes of Health (NIH) grants R37 AI052056, RO1 AI076114, RR015371, contract number HHSN261200800001E and FAPERJ, INCTV, CNPq, MCT and FIOCRUZ.	Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09	24	143	149	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					129	U152		10.1038/nature11443	http://dx.doi.org/10.1038/nature11443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23023123	Green Accepted			2022-12-01	WOS:000310434500044
J	Sun, YD; Joachimski, MM; Wignall, PB; Yan, CB; Chen, YL; Jiang, HS; Wang, LN; Lai, XL				Sun, Yadong; Joachimski, Michael M.; Wignall, Paul B.; Yan, Chunbo; Chen, Yanlong; Jiang, Haishui; Wang, Lina; Lai, Xulong			Lethally Hot Temperatures During the Early Triassic Greenhouse	SCIENCE			English	Article							END-PERMIAN EXTINCTION; THERMAL TOLERANCE; DEPENDENT BIOGEOGRAPHY; OXYGEN LIMITATION; NANPANJIANG BASIN; CLIMATE-CHANGE; SOUTH CHINA; BOUNDARY; RECOVERY; PALEOENVIRONMENTS	Global warming is widely regarded to have played a contributing role in numerous past biotic crises. Here, we show that the end-Permian mass extinction coincided with a rapid temperature rise to exceptionally high values in the Early Triassic that were inimical to life in equatorial latitudes and suppressed ecosystem recovery. This was manifested in the loss of calcareous algae, the near-absence of fish in equatorial Tethys, and the dominance of small taxa of invertebrates during the thermal maxima. High temperatures drove most Early Triassic plants and animals out of equatorial terrestrial ecosystems and probably were a major cause of the end-Smithian crisis.	[Sun, Yadong; Yan, Chunbo; Jiang, Haishui; Wang, Lina; Lai, Xulong] China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China; [Sun, Yadong; Wignall, Paul B.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Joachimski, Michael M.] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Chen, Yanlong] Graz Univ, Inst Earth Sci Geol & Paleontol, A-8010 Graz, Austria	China University of Geosciences; University of Leeds; University of Erlangen Nuremberg; University of Graz	Sun, YD (corresponding author), China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China.	eeys@leeds.ac.uk	Joachimski, Michael M./B-9477-2011; Sun, Yadong/AAG-8781-2019; Sun, Yadong/N-6907-2013	Sun, Yadong/0000-0003-4032-2082; Sun, Yadong/0000-0003-4032-2082; Chen, Yanlong/0000-0003-1110-9020; Joachimski, Michael/0000-0001-6088-3261; Lai, Xulong/0000-0002-2837-0885	Chinese 973 Program [2011CB808800]; Natural Science Foundation of China [41172024, 40830212]	Chinese 973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	D. Lutz, F. Nenning, B. Yang, and X. Liu are acknowledged for lab and field assistance. This study was supported by Chinese 973 Program (2011CB808800) and the Natural Science Foundation of China (41172024 and 40830212). Y.S. acknowledges China University of Geosciences and China Scholarship Council for split-site Ph.D. at Wuhan, Leeds, and Erlangen.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Borsuk-Bialynicka M, 1999, ACTA PALAEONTOL POL, V44, P167; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; CALLAWAY JM, 1989, CAN J EARTH SCI, V26, P1491, DOI 10.1139/e89-126; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chen J., 2004, MASS EXTINCTION RECO, VII, P647; CLARK DL, 1986, SCIENCE, V233, P984, DOI 10.1126/science.233.4767.984; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; Ellis RJ, 2010, NATURE, V463, P164, DOI 10.1038/463164a; Frank T. D., 2000, P ODP SCI RESULTS, V166, P137; Galfetti T, 2008, SEDIMENT GEOL, V204, P36, DOI 10.1016/j.sedgeo.2007.12.008; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; HALLAM A, 1997, MASS EXTINCTIONS THE; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Lehrmann DJ, 2003, PALAIOS, V18, P138, DOI 10.1669/0883-1351(2003)18<138:PBSFSC>2.0.CO;2; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Looy CV, 1999, P NATL ACAD SCI USA, V96, P13857, DOI 10.1073/pnas.96.24.13857; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Muttoni G, 2009, GEOARABIA, V14, P17; O'Dogherty L, 2009, GEODIVERSITAS, V31, P213, DOI 10.5252/g2009n2a3; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Pan H., 1994, PALAEOWORLD, V4, P249; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reichow MK, 2009, EARTH PLANET SC LETT, V277, P9, DOI 10.1016/j.epsl.2008.09.030; Retallack GJ, 1999, AUST J EARTH SCI, V46, P785, DOI 10.1046/j.1440-0952.1999.00745.x; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Schneebeli-Hermann E, 2012, PALAEOGEOGR PALAEOCL, V339, P12, DOI 10.1016/j.palaeo.2012.04.010; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Song HJ, 2011, GEOLOGY, V39, P739, DOI 10.1130/G32191.1; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; Stanley SM, 2009, P NATL ACAD SCI USA, V106, P15264, DOI 10.1073/pnas.0907992106; Sues H.-D., 2010, TRIASSIC LIFE LAND; Sun D., 2004, MASS EXTINCTION RECO, VII, P543; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Ziegler A. M., 1997, LATE GLACIAL POSTGLA, P111	51	693	760	38	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					366	370		10.1126/science.1224126	http://dx.doi.org/10.1126/science.1224126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087244				2022-12-01	WOS:000309955800037
J	Venditti, R; Scanu, T; Santoro, M; Di Tullio, G; Spaar, A; Gaibisso, R; Beznoussenko, GV; Mironov, AA; Mironov, A; Zelante, L; Piemontese, MR; Notarangelo, A; Malhotra, V; Vertel, BM; Wilson, C; De Matteis, MA				Venditti, Rossella; Scanu, Tiziana; Santoro, Michele; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.; Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo; Malhotra, Vivek; Vertel, Barbara M.; Wilson, Cathal; De Matteis, Maria Antonietta			Sedlin Controls the ER Export of Procollagen by Regulating the Sar1 Cycle	SCIENCE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA-TARDA; COPII; PROTEIN; MUTATION; COL2A1; SEC23; COAT	Newly synthesized proteins exit the endoplasmic reticulum (ER) via coat protein complex II (COPII) vesicles. Procollagen (PC), however, forms prefibrils that are too large to fit into typical COPII vesicles; PC thus needs large transport carriers, which we term megacarriers. TANGO1 assists PC packing, but its role in promoting the growth of megacarriers is not known. We found that TANGO1 recruited Sedlin, a TRAPP component that is defective in spondyloepiphyseal dysplasia tarda (SEDT), and that Sedlin was required for the ER export of PC. Sedlin bound and promoted efficient cycling of Sar1, a guanosine triphosphatase that can constrict membranes, and thus allowed nascent carriers to grow and incorporate PC prefibrils. This joint action of TANGO1 and Sedlin sustained the ER export of PC, and its derangement may explain the defective chondrogenesis underlying SEDT.	[Venditti, Rossella; Santoro, Michele; Wilson, Cathal; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Scanu, Tiziana; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.] Consorzio Mario Negri Sud, I-66030 Chieti, Italy; [Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, I-71013 Foggia, Italy; [Malhotra, Vivek] Ctr Regulacio Genom, Dept Cell & Dev Biol, Barcelona 08010, Spain; [Malhotra, Vivek] Pg Lluis Co 23, Inst Catalana Recerca Estudis Avancats, Barcelona 08010, Spain; [Vertel, Barbara M.] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consorzio Mario Negri Sud; IRCCS Casa Sollievo Della Sofferenza; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Rosalind Franklin University Medical & Science	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	De Matteis, Maria Antonietta/AHE-5161-2022; Malhotra, Vivek/O-9811-2014; Venditti, Rossella/AAT-4281-2020	De Matteis, Maria Antonietta/0000-0003-0053-3061; Malhotra, Vivek/0000-0001-6198-7943; Venditti, Rossella/0000-0002-1884-6501; Mironov, Aleksandr/0000-0002-1497-328X; Wilson, Cathal/0000-0002-0637-8608; Notarangelo, Angelantonio/0000-0002-1540-8530	Telethon EM Core Facility [GTF08001]; Telethon [GSP08002, GGP06166]; AIRC [IG 8623]; Programma Operativo Nazionale [01_00862]; Telethon grant [GGP07075]; NIH [NIH/AR053696]; Plan Nacional [BFU2008-00414]; Consolider [CSD2009-00016]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government [SGR2009-1488]; European Research Council [268692]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053696] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Telethon EM Core Facility(Fondazione Telethon); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); Programma Operativo Nazionale; Telethon grant(Fondazione Telethon); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional; Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ICREA(ICREA)	We thank A. Luini, G. D'Angelo, B. Franco, and G. Manco for insightful discussions; the Telethon EM Core Facility (project no. GTF08001) for the EM analysis; J. Gecz for the Sedlin cDNAs; R. Schekman for the Sar1A cDNA; W. Balch for the Sar1B and Sec23 cDNAs; and J. Kimura for the use of Rx chondrocytes. Supported by Telethon grants GSP08002 and GGP06166, AIRC grant IG 8623, and Programma Operativo Nazionale grant 01_00862 (M. A. D. M.), Telethon grant GGP07075 (C. W.), NIH grant NIH/AR053696 (B. M. V.), and grants from Plan Nacional (BFU2008-00414), Consolider (CSD2009-00016), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents (SGR2009-1488; AGAUR-Catalan Government), the European Research Council (268692). (V. M.), and an AIRC fellowship (R.V.).	Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BLEASEL JF, 1995, J RHEUMATOL, V22, P255; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Pepperkok R, 1998, J CELL SCI, V111, P1877; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zankl A, 2004, AM J MED GENET A, V129A, P144, DOI 10.1002/ajmg.a.30222	19	120	125	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1668	1672		10.1126/science.1224947	http://dx.doi.org/10.1126/science.1224947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019651	Green Accepted			2022-12-01	WOS:000309215400049
J	Wamstad, JA; Alexander, JM; Truty, RM; Shrikumar, A; Li, FG; Eilertson, KE; Ding, HM; Wylie, JN; Pico, AR; Capra, JA; Erwin, G; Kattman, SJ; Keller, GM; Srivastava, D; Levine, SS; Pollard, KS; Holloway, AK; Boyer, LA; Bruneau, BG				Wamstad, Joseph A.; Alexander, Jeffrey M.; Truty, Rebecca M.; Shrikumar, Avanti; Li, Fugen; Eilertson, Kirsten E.; Ding, Huiming; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Kattman, Steven J.; Keller, Gordon M.; Srivastava, Deepak; Levine, Stuart S.; Pollard, Katherine S.; Holloway, Alisha K.; Boyer, Laurie A.; Bruneau, Benoit G.			Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; NONCODING RNAS; CHROMATIN SIGNATURES; HEART; TRANSCRIPTION; ENHANCERS; DIFFERENTIATION; MOUSE; GATA4	Heart development is exquisitely sensitive to the precise temporal regulation of thousands of genes that govern developmental decisions during differentiation. However, we currently lack a detailed understanding of how chromatin and gene expression patterns are coordinated during developmental transitions in the cardiac lineage. Here, we interrogated the transcriptome and several histone modifications across the genome during defined stages of cardiac differentiation. We find distinct chromatin patterns that are coordinated with stage-specific expression of functionally related genes, including many human disease-associated genes. Moreover, we discover a novel preactivation chromatin pattern at the promoters of genes associated with heart development and cardiac function. We further identify stage-specific distal enhancer elements and find enriched DNA binding motifs within these regions that predict sets of transcription factors that orchestrate cardiac differentiation. Together, these findings form a basis for understanding developmentally regulated chromatin transitions during lineage commitment and the molecular etiology of congenital heart disease.	[Wamstad, Joseph A.; Shrikumar, Avanti; Li, Fugen; Ding, Huiming; Levine, Stuart S.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Alexander, Jeffrey M.; Truty, Rebecca M.; Eilertson, Kirsten E.; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Srivastava, Deepak; Pollard, Katherine S.; Holloway, Alisha K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Alexander, Jeffrey M.; Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Erwin, Genevieve] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94158 USA; [Kattman, Steven J.; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu; bbruneau@gladstone.ucsf.edu	Alexander, Jeffrey/D-8809-2015; Holloway, Alisha/H-9574-2013; Capra, Tony/C-7784-2013; Pico, Alexander/HCH-4305-2022	Alexander, Jeffrey/0000-0002-2258-5738; Holloway, Alisha/0000-0001-9810-389X; Eilertson, Kirsten/0000-0003-4850-1210; Levine, Stuart/0000-0001-7363-562X; Bruneau, Benoit/0000-0002-0804-7597; Keller, Gordon/0000-0001-9309-9297; Pico, Alexander/0000-0001-5706-2163	NHLBI Bench to Bassinet Program [U01HL098179]; NIH [F32-HL104913]; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association; Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL104913, U01HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	NHLBI Bench to Bassinet Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association(American Heart Association); Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sukonnik for cloning enhancer fragments; S. Thomas (Gladstone Bioinformatics Core) for help with Figure 3; J. Wythe and P. Devine for the modified pGL3 constructs; M. Cleary, E.N. Olson, and D. Wotton for constructs; and Bruneau, Boyer, and Pollard lab members for helpful discussions. This work was supported by the NHLBI Bench to Bassinet Program (U01HL098179, to B.G.B., L.A.B., K.S.P., and D.S.), NIH F32-HL104913 (J.A.W.), the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award (B.G.B.), by William H. Younger, Jr. (B.G.B.) and Massachusetts Life Sciences Center (L.A.B.). L.A.B. is a Pew Scholar in the Biomedical Sciences. D. S. is a scientific founder of iPierian, and member of the Scientific Advisory Boards of iPieirian and RegeneRx Biopharmaceuticals.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pollard KS., 2005, BIOINFORMATICS COMPU, P251; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou PZ, 2012, CURR TOP DEV BIOL, V100, P143, DOI 10.1016/B978-0-12-387786-4.00005-1; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	52	437	446	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					206	220		10.1016/j.cell.2012.07.035	http://dx.doi.org/10.1016/j.cell.2012.07.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981692	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000309544200021
J	Wrighton, KC; Thomas, BC; Sharon, I; Miller, CS; Castelle, CJ; VerBerkmoes, NC; Wilkins, MJ; Hettich, RL; Lipton, MS; Williams, KH; Long, PE; Banfield, JF				Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Castelle, Cindy J.; VerBerkmoes, Nathan C.; Wilkins, Michael J.; Hettich, Robert L.; Lipton, Mary S.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.			Fermentation, Hydrogen, and Sulfur Metabolism in Multiple Uncultivated Bacterial Phyla	SCIENCE			English	Article							PYROCOCCUS-FURIOSUS; MICROBIAL COMMUNITY; DIVISION OP11; GENOMES; RECONSTRUCTION; ARCHAEAL; OKLAHOMA; GENES	BD1-5, OP11, and OD1 bacteria have been widely detected in anaerobic environments, but their metabolisms remain unclear owing to lack of cultivated representatives and minimal genomic sampling. We uncovered metabolic characteristics for members of these phyla, and a new lineage, PER, via cultivation-independent recovery of 49 partial to near-complete genomes from an acetate-amended aquifer. All organisms were nonrespiring anaerobes predicted to ferment. Three augment fermentation with archaeal-like hybrid type II/III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) that couples adenosine monophosphate salvage with CO2 fixation, a pathway not previously described in Bacteria. Members of OD1 reduce sulfur and may pump protons using archaeal-type hydrogenases. For six organisms, the UGA stop codon is translated as tryptophan. All bacteria studied here may play previously unrecognized roles in hydrogen production, sulfur cycling, and fermentation of refractory sedimentary carbon.	[Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Castelle, Cindy J.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [VerBerkmoes, Nathan C.; Hettich, Robert L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Wilkins, Michael J.; Lipton, Mary S.] Pacific NW Natl Lab, Richland, WA 99352 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Williams, Kenneth Hurst/O-5181-2014; Wilkins, Michael/A-9358-2013; Hettich, Robert L/N-1458-2016; Wrighton, Kelly C/ABD-6621-2021; Long, Philip E/F-5728-2013; Lipton, Mary S/H-3913-2012	Williams, Kenneth Hurst/0000-0002-3568-1155; Hettich, Robert L/0000-0001-7708-786X; Wrighton, Kelly C/0000-0003-0434-4217; Long, Philip E/0000-0003-4152-5682; Wilkins, Michael/0000-0002-3595-0853; Miller, Christopher/0000-0002-9448-8144; Banfield, Jill/0000-0001-8203-8771	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO; U.S. DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO(European Molecular Biology Organization (EMBO)); U.S. DOE(United States Department of Energy (DOE))	We thank F. Larimer for RuBisCO analyses input; M. Shah for proteomic support; C. Thrash, P. Hugenholtz, and J. Eisen for manuscript suggestions; and the U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program for funding, the DOE Knowledgebase Program for funding GGkbase, and EMBO for a fellowship to I. S. The Rifle, Colorado, Integrated Field Research Center Project is managed by Lawrence Berkeley National Laboratory for the U.S. DOE (contract no. DE-AC02-05CH11231). Portions of this work were performed in the Environmental Molecular Science Laboratory, a DOE national scientific user facility at Pacific Northwest National Laboratory. The sequences were deposited in the National Center for Biotechnology Information Sequence Read Archive (accession no. SRA050978.1). This Whole-Genome Shotgun project has been deposited at GenBank under the accession no. AMFJ00000000. The version described in this paper is the first version, AMFJ01000000. Genomic and proteomic data can be accessed via http://geomicrobiology.berkeley.edu/rifle/acd_ggkbase.html.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Elshahed MS, 2005, APPL ENVIRON MICROB, V71, P7598, DOI 10.1128/AEM.71.11.7598-7602.2005; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kanai T, 2011, J BACTERIOL, V193, P3109, DOI 10.1128/JB.01072-10; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; Mai XH, 1996, J BACTERIOL, V178, P5897, DOI 10.1128/jb.178.20.5897-5903.1996; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schocke L, 1998, EUR J BIOCHEM, V256, P589, DOI 10.1046/j.1432-1327.1998.2560589.x; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Haaster DJ, 2008, J BACTERIOL, V190, P1584, DOI 10.1128/JB.01562-07; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11	28	428	434	10	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1661	1665		10.1126/science.1224041	http://dx.doi.org/10.1126/science.1224041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019650				2022-12-01	WOS:000309215400047
J	Lingwood, D; McTamney, PM; Yassine, HM; Whittle, JRR; Guo, XT; Boyington, JC; Wei, CJ; Nabel, GJ				Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.			Structural and genetic basis for development of broadly neutralizing influenza antibodies	NATURE			English	Article							CELL ANTIGEN RECEPTOR; VIRUS; SPECIFICITY; VACCINATION; ACTIVATION; INDUCTION; LYMPHOMAS; IMMUNITY; DENSITY; HIV-1	Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors(1,2), but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G(IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural 'patterns' that provide a substrate for further affinity maturation.	[Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	YASSINE, HADI M./AAW-6475-2020; Wei, Chih/GVT-5734-2022	YASSINE, HADI M./0000-0001-7592-2788; 	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Longo for help with JOINSOLVER analysis, Z.-Y. Yang for the design of membrane-bound IgM antibody, and X. Chen for technical support. We also thank A. Tislerics for manuscript preparation, B. Hartman and J. Farrar for preparation of figures, members of the G. J. N. laboratory and P. Kwong for advice and discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(01)00096-6; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; METZGER H, 1992, J IMMUNOL, V149, P1477; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	31	182	186	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					566	+		10.1038/nature11371	http://dx.doi.org/10.1038/nature11371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22932267	Green Published			2022-12-01	WOS:000311781500004
J	Randall, DW; Fickling, WE				Randall, David W.; Fickling, William E.			PICTURE QUIZ A swollen leg in the middle of the night	BRITISH MEDICAL JOURNAL			English	Editorial Material							GAS-GANGRENE; INFECTIONS		[Randall, David W.; Fickling, William E.] Queens Univ Hosp, Romford RM7 0AG, Essex, England		Randall, DW (corresponding author), Queens Univ Hosp, Romford RM7 0AG, Essex, England.	drandall@uclh.nhs.uk						Gibson Michael A, 2008, Cases J, V1, P300, DOI 10.1186/1757-1626-1-300; Jackisch T, 2006, ZBL CHIR, V131, P84, DOI 10.1055/s-2006-921399; Jamieson NF, 2001, POSTGRAD MED J, V77, P47, DOI 10.1136/pmj.77.903.47; MEYER RD, 1976, SOUTHERN MED J, V69, P1178, DOI 10.1097/00007611-197609000-00025; Schneeweiss S, 2009, ALIMENT PHARM THER, V30, P253, DOI 10.1111/j.1365-2036.2009.04037.x	5	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6189	10.1136/bmj.e6189	http://dx.doi.org/10.1136/bmj.e6189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014902				2022-12-01	WOS:000309385500005
J	Rasmussen, TA; Jorgensen, MRS; Bjerrum, S; Jensen-Fangel, S; Stovring, H; Ostergaard, L; Sogaard, OS				Rasmussen, Thomas A.; Jorgensen, Martin R. S.; Bjerrum, Stephanie; Jensen-Fangel, Soren; Stovring, Henrik; Ostergaard, Lars; Sogaard, Ole S.			Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; RUBELLA VACCINATION; TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; FEBRILE SEIZURES; MMR VACCINATION; ADVERSE EVENTS; AUTISM; MEASLES	Objectives To predict the number of selected outcomes temporally associated but not caused by vaccination, to aid causality assessment of adverse events arising after mass immunisation in a paediatric population. Design Nationwide population based cohort study. Setting Denmark. Participants All liveborn infants delivered after 1 January 1980. Study population was followed from date of birth until hospital admission for selected outcome diagnoses, death, first emigration, age 18 years, or 31 December 2009. The study population was subject to vaccines used in standard childhood immunisation in Denmark, with 82-93% vaccine coverage. Main outcome measures Incidence of acute infectious and post-infectious polyneuritis (Guillain-Barre syndrome), acute transverse myelitis, optic polyneuritis, facial nerve palsy, anaphylactic shock, seizure, multiple sclerosis, autoimmune thrombocytopenia, type 1 diabetes mellitus, juvenile and rheumatoid arthritis, narcolepsy, and death of unknown cause stratified by sex, age, and season. We predicted the number of events for a hypothetical vaccine cohort of 1 000 000 people for follow-up periods of up to 182 days. Results The study included 2 300 227 liveborn infants, yielding 37 262 404 person years of follow-up; median follow-up was 16.8 person years. Incidence of outcome diagnoses spanned from 0.32 per 100 000 patient years for autoimmune thrombocytopenia to 189.82 per 100 000 patient years for seizure. Seasonal differences were most pronounced for anaphylactic shock, seizure, and multiple sclerosis. Even for rare outcomes, numerous events were predicted in the hypothetical vaccine cohort. We predicted that 20 cases of type 1 diabetes mellitus, 19 of juvenile or rheumatoid arthritis, eight of facial nerve palsy, and five of multiple sclerosis per 1 000 000 children would occur within 42 days after vaccination. Conclusions Incorporating exact background rates of disease based on age, sex, and seasonal distribution could strengthen vaccine safety assessment, and provides an evidence based focus for discussing the incremental risk of newly introduced vaccines.	[Rasmussen, Thomas A.; Jensen-Fangel, Soren; Ostergaard, Lars; Sogaard, Ole S.] Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark; [Jorgensen, Martin R. S.] Aarhus Univ Hosp, Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark; [Bjerrum, Stephanie] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Stovring, Henrik] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; Aarhus University	Rasmussen, TA (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark.	thomrasm@rm.dk	Søgaard, Ole S/P-6058-2016; Ostergaard, Lars/AAA-3020-2020; Støvring, Henrik/I-4683-2012; Søgaard, Ole Schmeltz/AEP-7968-2022; Støvring, Henrik/H-5754-2019	Ostergaard, Lars/0000-0003-2459-0511; Støvring, Henrik/0000-0002-5821-2351; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Støvring, Henrik/0000-0002-5821-2351; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Ostergaard, Lars/0000-0002-7619-605X; Bjerrum, Stephanie/0000-0002-9046-6255	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	The study was funded by the Department of Infectious Diseases, Aarhus University Hospital, Denmark.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from Aarhus University Hospital for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2011, PRESCRIRE INT, V20, P154; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Berlin JA, 2008, AM J PUBLIC HEALTH, V98, P1366, DOI 10.2105/AJPH.2007.124537; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Choe YJ, 2011, VACCINE, V29, P2066, DOI 10.1016/j.vaccine.2011.01.007; Christiansen CF, 2010, NEUROEPIDEMIOLOGY, V35, P267, DOI 10.1159/000320245; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; DeStefano F, 2010, LANCET, V375, P1146, DOI 10.1016/S0140-6736(09)61917-6; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Arcond MF, 2011, MEDICINA-BUENOS AIRE, V71, P161; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Haba-Rubio J, 2011, REV NEUROL-FRANCE, V167, P563, DOI 10.1016/j.neurol.2011.04.003; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; Hviid A, 2008, AM J EPIDEMIOL, V168, P1277, DOI 10.1093/aje/kwn253; Institute of Medicine, 2010, ADV EFF VACC EV CAUS; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jiang GX, 1997, J NEUROL NEUROSUR PS, V62, P447, DOI 10.1136/jnnp.62.5.447; Klein NP, 2010, VACCINE, V28, P1062, DOI 10.1016/j.vaccine.2009.10.115; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lieu TA, 2007, MED CARE, V45, pS89, DOI 10.1097/MLR.0b013e3180616c0a; Lower Johannes, 2008, MMW Fortschr Med, V150, P6; Madsen KM, 2004, DRUG SAFETY, V27, P831, DOI 10.2165/00002018-200427120-00001; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Norgaard M, 2007, PHARMACOEPIDEM DR S, V16, pS220; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; Sato N, 2011, INTERNAL MED, V50, P503, DOI 10.2169/internalmedicine.50.4340; Siegrist CA, 2007, PEDIATR INFECT DIS J, V26, P979, DOI 10.1097/INF.0b013e318149dfea; Statens Serum Institut, 2011, HPV VACC COV 2010; Statens Serum Institut, 2011, PCV COV INV PNEUM DI; Statens Serum Institut, VACC SURV; Statens Serum Institut, 2011, DTAP IPV HIB VACC CO; Statens Serum Institut, 2011, MMR VACC COV 2010; Sun YL, 2012, JAMA-J AM MED ASSOC, V307, P823, DOI 10.1001/jama.2012.165; Svanstrom H, 2010, DRUG SAFETY, V33, P1015, DOI 10.2165/11537630-000000000-00000; Thomsen RW, 2004, DIABETES CARE, V27, P70, DOI 10.2337/diacare.27.1.70; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016; Williams SE, 2011, VACCINE; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	45	16	16	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 17	2012	345								e5823	10.1136/bmj.e5823	http://dx.doi.org/10.1136/bmj.e5823			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JG	22988304	hybrid, Green Published			2022-12-01	WOS:000309160300001
J	Mattiroli, F; Vissers, JHA; van Dijk, WJ; Ikpa, P; Citterio, E; Vermeulen, W; Marteijn, JA; Sixma, TK				Mattiroli, Francesca; Vissers, Joseph H. A.; van Dijk, Willem J.; Ikpa, Pauline; Citterio, Elisabetta; Vermeulen, Wim; Marteijn, Jurgen A.; Sixma, Titia K.			RNF168 Ubiquitinates K13-15 on H2A/H2AX to Drive DNA Damage Signaling	CELL			English	Article							X-RAY SOLUTION; DEPENDENT MONOUBIQUITYLATION; HOMOLOGOUS RECOMBINATION; HISTONE UBIQUITYLATION; H2A UBIQUITINATION; CONTAINING PROTEIN; 53BP1 RECRUITMENT; RING FINGER; LIGASE; REPAIR	Ubiquitin-dependent signaling during the DNA damage response (DDR) to double-strand breaks (DSBs) is initiated by two E3 ligases, RNF8 and RNF168, targeting histone H2A and H2AX. RNF8 is the first ligase recruited to the damage site, and RNF168 follows RNF8-dependent ubiquitination. This suggests that RNF8 initiates H2A/H2AX ubiquitination with K63-linked ubiquitin chains and RNF168 extends them. Here, we show that RNF8 is inactive toward nucleosomal H2A, whereas RNF168 catalyzes the monoubiquitination of the histones specifically on K13-15. Structure-based mutagenesis of RNF8 and RNF168 RING domains shows that a charged residue determines whether nucleosomal proteins are recognized. We find that K63 ubiquitin chains are conjugated to RNF168-dependent H2A/H2AX monoubiquitination at K13-15 and not on K118-119. Using a mutant of RNF168 unable to target histones but still catalyzing ubiquitin chains at DSBs, we show that ubiquitin chains per se are insufficient for signaling, but RNF168 target ubiquitination is required for DDR.	[Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Vissers, Joseph H. A.; Citterio, Elisabetta] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl	Vissers, Joseph/AAB-7160-2019; Vermeulen, Wim/W-8708-2019; Marteijn, Jurgen A/B-5696-2014; Mattiroli, Francesca/AAT-1489-2020	Vissers, Joseph/0000-0003-0435-6824; Vermeulen, Wim/0000-0003-3616-734X; Marteijn, Jurgen A/0000-0001-9321-518X; Mattiroli, Francesca/0000-0002-1574-7217; Citterio, Elisabetta/0000-0003-2347-3495; Ikpa, Pauline/0000-0002-3523-6318; Sixma, Titia K/0000-0001-6180-0632	ERC; EU project Ubiregulators [KWF 2006-3476]; Dutch Organization for Scientific Research ZonMW Veni [917-96-120]; NWO Vidi [864.08.011]; KWF [2007-3877]	ERC(European Research Council (ERC)European Commission); EU project Ubiregulators; Dutch Organization for Scientific Research ZonMW Veni; NWO Vidi(Netherlands Organization for Scientific Research (NWO)); KWF	We thank A. Perrakis, P. Rucktooa, and R. Joosten for crystallography support, J. Smit for contribution to E1 and E2 purifications, M. Uckelmann for contribution to in vitro specificity, D. Svergun and F. Groothuizen for assistance in SAXS measurements and analysis, J. Lukas, R. Klevit, L. Penengo, K. Luger, M. Peuscher, and J. Jacobs for plasmids, J. van der Knaap for providing Drosophila oligonucleosomes enriched in ubiquitinated H2B, G. Smeenk for help with gH2AX IPs, R. Hibbert for PCNA and Rad6 samples, J. Chen for anti-RAP80 antibodies, A. Nussenzweig for H2ax<SUP>-/-</SUP> MEFs, Genentech for K63-specific antibodies, W.A. van Cappellen of the Optical Imaging Centre, ErasmusMC, for help with the quantification of foci, and T. Brummelkamp, F. van Leeuwen, colleagues and members of the Sixma laboratory for critical reading of the manuscript. These studies were funded by the ERC Advanced grant, EU project Ubiregulators, KWF 2006-3476 to T.K.S., Dutch Organization for Scientific Research ZonMW Veni 917-96-120 to J.A.M., NWO Vidi 864.08.011 to E.C., and KWF 2007-3877. F.M. designed and performed all experiments and wrote the manuscript. J.H.A.V. contributed to cell-based experiments and discussions. J.A.M., W.V., and E.C. supervised immunofluorescence experiments and imaging. J.A.M. performed quantifications of immunofluorescence data. W.J.vD. assisted in purification and western blots. P.I. cloned and purified the RNF8 RING domain. T.K.S. designed and supervised experiments and wrote the manuscript. All authors critically read the paper.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hibbert RG, 2009, DNA REPAIR, V8, P525, DOI 10.1016/j.dnarep.2009.01.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUNT LT, 1977, BIOCHEM BIOPH RES CO, V74, P650, DOI 10.1016/0006-291X(77)90352-7; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ramadan K, 2012, CELL CYCLE, V11, P1062, DOI 10.4161/cc.11.6.19446; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2011, FEBS LETT, V585, P2795, DOI 10.1016/j.febslet.2011.07.034; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	62	418	452	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1182	1195		10.1016/j.cell.2012.08.005	http://dx.doi.org/10.1016/j.cell.2012.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980979	Bronze, Green Accepted			2022-12-01	WOS:000308928100012
J	Klein, NP; Bartlett, J; Rowhani-Rahbar, A; Fireman, B; Baxter, R				Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger			Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-CELL; UNITED-STATES; INFANTS; ADOLESCENTS; RATES; RISK	Background In the United States, children receive five doses of diphtheria, tetanus, and acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five doses of DTaP is unknown. Methods We assessed the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011. This period included a large outbreak in 2010. We conducted a case-control study involving members of Kaiser Permanente Northern California who were vaccinated with DTaP at 47 to 84 months of age. We compared children with pertussis confirmed by a positive polymerase-chain-reaction (PCR) assay with two sets of controls: those who were PCR-negative for pertussis and closely matched controls from the general population of health-plan members. We used logistic regression to examine the risk of pertussis in relation to the duration of time since the fifth DTaP dose. Children who received whole- cell pertussis vaccine during infancy or who received any pertussis-containing vaccine after their fifth dose of DTaP were excluded. Results We compared 277 children, 4 to 12 years of age, who were PCR-positive for pertussis with 3318 PCR-negative controls and 6086 matched controls. PCR-positive children were more likely to have received the fifth DTaP dose earlier than PCR-negative controls (P<0.001) or matched controls (P = 0.005). Comparison with PCR-negative controls yielded an odds ratio of 1.42 (95% confidence interval, 1.21 to 1.66), indicating that after the fifth dose of DTaP, the odds of acquiring pertussis increased by an average of 42% per year. Conclusions Protection against pertussis waned during the 5 years after the fifth dose of DTaP. (Funded by Kaiser Permanente).	[Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger] Kaiser Permanente, Vaccine Study Ctr, Oakland, CA 94612 USA	Kaiser Permanente	Klein, NP (corresponding author), Kaiser Permanente, Vaccine Study Ctr, 1 Kaiser Plaza,16th Fl, Oakland, CA 94612 USA.	nicola.klein@kp.org		Rowhani-Rahbar, Ali/0000-0002-2705-4485	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline; Novartis; Merck; Pfizer	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Merck(Merck & Company); Pfizer(Pfizer)	Funded by Kaiser Permanente.; Drs. Klein and Baxter report receiving grant support to their institution from Sanofi Pasteur, GlaxoSmithKline, Novartis, Merck, and Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P817; [Anonymous], 2007, MMWR MORB MORTAL WKL, V54, P1; [Anonymous], 2006, PEDIATRICS, V117, P965; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Cherry JD, 1988, PEDIATRICS S, V81, pS933; CODY CL, 1981, PEDIATRICS, V68, P650; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Gustafsson L, 2006, PEDIATRICS, V118, P978, DOI 10.1542/peds.2005-2746; Khan FN, 2006, PEDIATR INFECT DIS J, V25, P1132, DOI 10.1097/01.inf.0000245099.01427.93; Lacombe K, 2004, VACCINE, V23, P623, DOI 10.1016/j.vaccine.2004.07.007; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Matheson A J, 2000, Paediatr Drugs, V2, P139, DOI 10.2165/00128072-200002020-00007; Moore David M, 2002, Can J Infect Dis, V13, P305; MORTIMER EA, 1979, REV INFECT DIS, V1, P927; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X; Vickers D, 2006, CAN MED ASSOC J, V175, P1213, DOI 10.1503/cmaj.051637; 2011, MMWR MORB MORTAL WKL, V60, P13	24	387	395	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1012	1019		10.1056/NEJMoa1200850	http://dx.doi.org/10.1056/NEJMoa1200850			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970945				2022-12-01	WOS:000308649100007
J	Petreanu, L; Gutnisky, DA; Huber, D; Xu, NL; O'Connor, DH; Tian, L; Looger, L; Svoboda, K				Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel			Activity in motor-sensory projections reveals distributed coding in somatosensation	NATURE			English	Article							OBJECT LOCALIZATION; ACTION-POTENTIALS; NEURAL ACTIVITY; LAYER-I; CORTEX; RAT; ORGANIZATION; PLASTICITY; CIRCUITS; DYNAMICS	Cortical-feedback projections to primary sensory areas terminate most heavily in layer 1 (L1) of the neocortex(1,2), where they make synapses with tuft dendrites of pyramidal neurons. L1 input is thought to provide 'contextual' information(3), but the signals transmitted by L1 feedback remain uncharacterized. In the rodent somatosensory system, the spatially diffuse(4) feedback projection from vibrissal motor cortex (vM1) to vibrissal somatosensory cortex (vS1, also known as the barrel cortex) may allow whisker touch to be interpreted in the context of whisker position to compute object location(5,6). When mice palpate objects with their whiskers to localize object features(7,8), whisker touch excites vS1(9) and later vM1 in a somatotopic manner(10-13). Here we use axonal calcium imaging to track activity in vM1 -> vS1 afferents in L1 of the barrel cortex while mice performed whisker-dependent object localization. Spatially intermingled individual axons represent whisker movements, touch and other behavioural features. In a subpopulation of axons, activity depends on object location and persists for seconds after touch. Neurons in the barrel cortex thus have information to integrate movements and touches of multiple whiskers over time, key components of object identification and navigation by active touch.	[Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Gutnisky, Diego/E-3846-2012; Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Gutnisky, Diego/0000-0002-8578-0039; Xu, Ning-long/0000-0002-1651-401X; Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679; Tian, Lin/0000-0001-7012-6926				Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DAVIDSON PW, 1972, J EXP PSYCHOL, V93, P43, DOI 10.1037/h0032632; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Duda RO., 2001, PATTERN CLASSIFICATI; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hastie T., 2004, ELEMENTS STAT LEARNI, V27, P83, DOI [10.1007/BF02985802, 10.1007/978-0-387-21606-5, DOI 10.1007/978-0-387-21606-5, DOI 10.1007/978-0-387-84858-7]; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Suter Benjamin A, 2010, Front Neural Circuits, V4, P100, DOI 10.3389/fncir.2010.00100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008	41	215	215	1	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					299	+		10.1038/nature11321	http://dx.doi.org/10.1038/nature11321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922646	Green Accepted, Green Published			2022-12-01	WOS:000308635900043
J	Cappa, CD; Onasch, TB; Massoli, P; Worsnop, DR; Bates, TS; Cross, ES; Davidovits, P; Hakala, J; Hayden, KL; Jobson, BT; Kolesar, KR; Lack, DA; Lerner, BM; Li, SM; Mellon, D; Nuaaman, I; Olfert, JS; Petaja, T; Quinn, PK; Song, C; Subramanian, R; Williams, EJ; Zaveri, RA				Cappa, Christopher D.; Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.; Bates, Timothy S.; Cross, Eben S.; Davidovits, Paul; Hakala, Jani; Hayden, Katherine L.; Jobson, B. Tom; Kolesar, Katheryn R.; Lack, Daniel A.; Lerner, Brian M.; Li, Shao-Meng; Mellon, Daniel; Nuaaman, Ibraheem; Olfert, Jason S.; Petaja, Tuukka; Quinn, Patricia K.; Song, Chen; Subramanian, R.; Williams, Eric J.; Zaveri, Rahul A.			Radiative Absorption Enhancements Due to the Mixing State of Atmospheric Black Carbon	SCIENCE			English	Article							CITY METROPOLITAN-AREA; LIGHT-ABSORPTION; CROSS-SECTION; AEROSOL; SOOT; MODELS; IMPACT; BROWN	Atmospheric black carbon (BC) warms Earth's climate, and its reduction has been targeted for near-term climate change mitigation. Models that include forcing by BC assume internal mixing with non-BC aerosol components that enhance BC absorption, often by a factor of similar to 2; such model estimates have yet to be clearly validated through atmospheric observations. Here, direct in situ measurements of BC absorption enhancements (E-abs) and mixing state are reported for two California regions. The observed E-abs is small-6% on average at 532 nm-and increases weakly with photochemical aging. The E-abs is less than predicted from observationally constrained theoretical calculations, suggesting that many climate models may overestimate warming by BC. These ambient observations stand in contrast to laboratory measurements that show substantial E-abs for BC are possible.	[Cappa, Christopher D.; Kolesar, Katheryn R.; Mellon, Daniel] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.] Aerodyne Res, Billerica, MA 01821 USA; [Onasch, Timothy B.; Cross, Eben S.; Davidovits, Paul] Boston Coll, Dept Chem, Boston, MA 02467 USA; [Worsnop, Douglas R.; Hakala, Jani; Petaja, Tuukka] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Bates, Timothy S.; Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Hayden, Katherine L.; Li, Shao-Meng; Nuaaman, Ibraheem] Environm Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada; [Jobson, B. Tom] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA; [Lack, Daniel A.; Lerner, Brian M.; Williams, Eric J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Lack, Daniel A.; Lerner, Brian M.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Nuaaman, Ibraheem] York Univ, Ctr Atmospher Chem, Toronto, ON M3J 1P3, Canada; [Olfert, Jason S.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 2R3, Canada; [Song, Chen; Zaveri, Rahul A.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Subramanian, R.] RTI Int, Res Triangle Pk, NC 27709 USA	University of California System; University of California Davis; Aerodyne Research; Boston College; University of Helsinki; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; York University - Canada; University of Alberta; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Research Triangle Institute	Cappa, CD (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	cdcappa@ucdavis.edu; onasch@aerodyne.com	Bates, Timothy S/L-6080-2016; Worsnop, Douglas R/D-2817-2009; Petäjä, Tuukka/A-8009-2008; Lerner, Brian M/H-6556-2013; Lack, Daniel/I-9053-2012; Onasch, Tim/AAY-4998-2020; Subramanian, R/A-4913-2013; Quinn, Patricia/R-1493-2016; Zaveri, Rahul/G-4076-2014	Worsnop, Douglas R/0000-0002-8928-8017; Petäjä, Tuukka/0000-0002-1881-9044; Lerner, Brian M/0000-0001-8721-8165; Onasch, Tim/0000-0001-7796-7840; Subramanian, R/0000-0002-5553-5913; Quinn, Patricia/0000-0003-0337-4895; Olfert, Jason/0000-0002-9681-5428; Jobson, Bertram/0000-0003-1812-9745; Zaveri, Rahul/0000-0001-9874-8807; Li, Shao-Meng/0000-0002-7628-6581; Cappa, Christopher/0000-0002-3528-3368	American River College; NOAA Climate Program Office [NA09OAR4310124, NA09OAR4310125]; U.S. Environmental Protection Agency [RD834558]; NSF Atmospheric Chemistry; California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program; DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD) [C12.007]; Natural Sciences and Engineering Research Council of Canada; Div Atmospheric & Geospace Sciences [0904292] Funding Source: National Science Foundation	American River College; NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NSF Atmospheric Chemistry(National Science Foundation (NSF)); California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program(United States Department of Energy (DOE)); DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the crew of the R/V Atlantis, the support at American River College and Cambustion for loan of the centrifugal particle mass analyzer (CPMA). This work was supported by the NOAA Climate Program Office (NA09OAR4310124 and NA09OAR4310125), U.S. Environmental Protection Agency (RD834558), NSF Atmospheric Chemistry, California Air Resources Board, U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program and DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility, the Canadian Federal Government (PERD Project C12.007), and the Natural Sciences and Engineering Research Council of Canada.	Adachi K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012868; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Barnard JC, 2008, ATMOS CHEM PHYS, V8, P6665, DOI 10.5194/acp-8-6665-2008; Bond TC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007315; Chung SH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005441; Cross ES, 2010, AEROSOL SCI TECH, V44, P592, DOI 10.1080/02786826.2010.482113; Dickerson RR, 1997, SCIENCE, V278, P827, DOI 10.1126/science.278.5339.827; Doran C, 2007, ATMOS CHEM PHYS, V7, P2197, DOI 10.5194/acp-7-2197-2007; Ghan SJ, 2007, B AM METEOROL SOC, V88, P1059, DOI 10.1175/BAMS-88-7-1059; Grieshop AP, 2009, NAT GEOSCI, V2, P533, DOI 10.1038/ngeo595; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Jacobson MZ, 1999, J GEOPHYS RES-ATMOS, V104, P3527, DOI 10.1029/1998JD100054; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Johnson KS, 2005, ATMOS CHEM PHYS, V5, P3033, DOI 10.5194/acp-5-3033-2005; Knox A, 2009, AEROSOL SCI TECH, V43, P522, DOI 10.1080/02786820902777207; Koch D, 2009, ATMOS CHEM PHYS, V9, P9001, DOI 10.5194/acp-9-9001-2009; Lack DA, 2010, ATMOS CHEM PHYS, V10, P4207, DOI 10.5194/acp-10-4207-2010; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002106; Myhre G, 2009, SCIENCE, V325, P187, DOI 10.1126/science.1174461; Onasch TB, 2012, AEROSOL SCI TECH, V46, P804, DOI 10.1080/02786826.2012.663948; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Schnaiter M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006046; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Zaveri RA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013616	25	453	470	28	483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1078	1081		10.1126/science.1223447	http://dx.doi.org/10.1126/science.1223447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936774				2022-12-01	WOS:000308125800042
J	Liu, XP; Betzenhauser, MJ; Reiken, S; Meli, AC; Xie, WJ; Chen, BX; Arancio, O; Marks, AR				Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Arancio, Ottavio; Marks, Andrew R.			Role of Leaky Neuronal Ryanodine Receptors in Stress-Induced Cognitive Dysfunction	CELL			English	Article							INTRACELLULAR CALCIUM LEAK; SKELETAL-MUSCLE; HEART-FAILURE; PKA PHOSPHORYLATION; REPEATED IMMOBILIZATION; NUCLEAR TRANSLOCATION; TYROSINE-HYDROXYLASE; DEFECTIVE REGULATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE	The type 2 ryanodine receptor/calcium release channel (RyR2), required for excitation-contraction coupling in the heart, is abundant in the brain. Chronic stress induces catecholamine biosynthesis and release, stimulating beta-adrenergic receptors and activating cAMP signaling pathways in neurons. In a murine chronic restraint stress model, neuronal RyR2 were phosphorylated by protein kinase A (PKA), oxidized, and nitrosylated, resulting in depletion of the stabilizing subunit calstabin2 (FKBP12.6) from the channel complex and intracellular calcium leak. Stress-induced cognitive dysfunction, including deficits in learning and memory, and reduced long-term potentiation (LTP) at the hippocampal CA3-CA1 connection were rescued by oral administration of S107, a compound developed in our laboratory that stabilizes RyR2-calstabin2 interaction, or by genetic ablation of the RyR2 PKA phosphorylation site at serine 2808. Thus, neuronal RyR2 remodeling contributes to stress-induced cognitive dysfunction. Leaky RyR2 could be a therapeutic target for treatment of stress-induced cognitive dysfunction.	[Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Arancio, Ottavio] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	arancio, ottavio/AAB-7959-2019; Xie, Wenjun/O-4637-2019; Xie, Wenjun/AAD-6881-2021; Meli, Albano C./O-7647-2018; Xie, Wenjun/G-3869-2015	Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Meli, Albano C./0000-0002-1727-3027; Xie, Wenjun/0000-0003-0493-062X; arancio, ottavio/0000-0001-6335-164X	 [RO1-HL56180];  [RO1-NS049442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056180, R01HL061503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Steven Siegelbaum and Michael Shelanski for helpful comments and Shi-Xian Deng for synthesis of S107. This work was supported by RO1-HL56180 and RO1-NS049442. A.R.M. is a consultant for a startup company, ARMGO Pharma, Inc., which is targeting RyR channels for therapeutic purposes.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Brennan AR, 2008, LEARN MEMORY, V15, P93, DOI 10.1101/lm.767408; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Copeland BJ, 2005, SYNAPSE, V57, P167, DOI 10.1002/syn.20169; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Etgen T, 2009, FORTSCHR NEUROL PSYC, V77, P72, DOI 10.1055/s-0028-1109116; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Fukui Y, 1997, J NEUROIMMUNOL, V79, P211, DOI 10.1016/S0165-5728(97)00126-4; Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KEEFE KA, 1989, ARCH NEUROL-CHICAGO, V46, P1070, DOI 10.1001/archneur.1989.00520460046012; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lehnart SE, 2004, ANN NY ACAD SCI, V1015, P144, DOI 10.1196/annals.1302.012; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Liu XP, 2008, ANN NY ACAD SCI, V1148, P1, DOI 10.1196/annals.1410.082; Liu XP, 2005, MOL BRAIN RES, V141, P19, DOI 10.1016/j.molbrainres.2005.07.019; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MCMAHON A, 1992, J NEUROCHEM, V58, P2124, DOI 10.1111/j.1471-4159.1992.tb10954.x; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Sabban EL, 2004, ANN NY ACAD SCI, V1032, P130, DOI 10.1196/annals.1314.010; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Son H, 1998, LEARN MEMORY, V5, P231; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSUDA A, 1985, BEHAV NEUROSCI, V99, P802; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yehuda R, 1998, AM J PSYCHIAT, V155, P841; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	71	102	106	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1055	1067		10.1016/j.cell.2012.06.052	http://dx.doi.org/10.1016/j.cell.2012.06.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939628	Bronze, Green Accepted			2022-12-01	WOS:000308500200018
J	Marquez, PV; Farrington, JL				Marquez, Patricio V.; Farrington, Jill L.			No more disease silos for sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOUTH EAST-ASIA; NONCOMMUNICABLE DISEASES; SCALE-UP; CARE; PARTNERSHIP; PREGNANCY; LESSONS; RECORDS		[Marquez, Patricio V.] World Bank, Washington, DC 20433 USA; [Farrington, Jill L.] Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	The World Bank; University of Leeds	Marquez, PV (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	pmarquez@worldbank.org						Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Alamo ST, 2012, AIDS BEHAV, V16, P368, DOI 10.1007/s10461-011-9996-9; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Baingana FK, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P1; Bischoff A, 2009, INT J ENV RES PUB HE, V6, P2258, DOI 10.3390/ijerph6082258; Braitstein P, 2009, JAIDS-J ACQ IMM DEF, V52, pS54, DOI 10.1097/QAI.0b013e3181bbcb67; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Delisle H, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S10; Dybul M, 2012, POLICY REV, V174; Gangopadhyay R, 2011, INT J GYNECOL OBSTET, V115, pS11, DOI 10.1016/S0020-7292(11)60005-2; GAVI Alliance, 2012, HUM PAP VACC SUPP; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grepin KA, 2011, JAIDS-J ACQ IMM DEF, V57, pS77, DOI 10.1097/QAI.0b013e31821f6afa; Haazen D, 2012, MAKING HEALTH FINANCING WORK FOR POOR PEOPLE IN TANZANIA, P1, DOI 10.1596/978-0-8213-9473-1; Harding R, 2005, LANCET, V365, P1971, DOI 10.1016/S0140-6736(05)66666-4; Isenhower W, 2011, CHRON CAR DES M TRAN; KOBER K, 2006, EXPERT PATIENTS AIDS; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Mbewu A, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P305; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nolte E, 2008, CARING PEOPLE CHRONI; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schneider M, 2009, SCAND J PUBLIC HEALT, V37, P176, DOI 10.1177/1403494808100272; Starfield B, 1988, PRIMARY CARE BALANCI; Steyn K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P247; Sunley EM, 2009, TAXATION CIGARETTES; Swartz L, 2002, BMJ-BRIT MED J, V325, P914, DOI 10.1136/bmj.325.7370.914; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Wagner E H, 1998, Eff Clin Pract, V1, P2; WHO, 2011, GLOB STAT REP NONC D; WHO Global Forum for Government Chief Nursing and Midwifery Officers, 2012, FOR STAT STRENGTH RO; World Bank, 2011, AFR FUT WORLD BANKS; World Health Organization, 2020, GLOBAL REPORT EPIDEM; World Health Organization, 2008, WORLD HLTH REP 2008	39	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2012	345								e5812	10.1136/bmj.e5812	http://dx.doi.org/10.1136/bmj.e5812			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SN	22942189				2022-12-01	WOS:000311050900004
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope II	CELL			English	Editorial Material							PORE COMPLEX		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037	6	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1084	+		10.1016/j.cell.2012.08.003	http://dx.doi.org/10.1016/j.cell.2012.08.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939630	Bronze			2022-12-01	WOS:000308500200021
J	Barone-Adesi, F; Chapman, RS; Silverman, DT; He, XZ; Hu, W; Vermeulen, R; Ning, BF; Fraumeni, JF; Rothman, N; Lan, Q				Barone-Adesi, Francesco; Chapman, Robert S.; Silverman, Debra T.; He, Xinghzhou; Hu, Wei; Vermeulen, Roel; Ning, Bofu; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing			Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOUSEHOLD STOVE IMPROVEMENT; INDOOR AIR-POLLUTION; MORTALITY; MUTATIONS; SMOKING	Objective To estimate the risk of lung cancer associated with the use of different types of coal for household cooking and heating. Setting Xuanwei County, Yunnan Province, China. Design Retrospective cohort study (follow-up 1976-96) comparing mortality from lung cancer between lifelong users of "smoky coal" (bituminous) and "smokeless coal" (anthracite). Participants 27 310 individuals using smoky coal and 9962 individuals using smokeless coal during their entire life. Main outcome measures Primary outcomes were absolute and relative risk of death from lung cancer among users of different types of coal. Unadjusted survival analysis was used to estimate the absolute risk of lung cancer, while Cox regression models compared mortality hazards for lung cancer between smoky and smokeless coal users. Results Lung cancer mortality was substantially higher among users of smoky coal than users of smokeless coal. The absolute risks of lung cancer death before 70 years of age for men and women using smoky coal were 18% and 20%, respectively, compared with less than 0.5% among smokeless coal users of both sexes. Lung cancer alone accounted for about 40% of all deaths before age 60 among individuals using smoky coal. Compared with smokeless coal, use of smoky coal was associated with an increased risk of lung cancer death (for men, hazard ratio 36 (95% confidence interval 20 to 65); for women, 99 (37 to 266)). Conclusions In Xuanwei, the domestic use of smoky coal is associated with a substantial increase in the absolute lifetime risk of developing lung cancer and is likely to represent one of the strongest effects of environmental pollution reported for cancer risk. Use of less carcinogenic types of coal could translate to a substantial reduction of lung cancer risk.	[Barone-Adesi, Francesco; Silverman, Debra T.; Hu, Wei; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Chapman, Robert S.] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok 10330, Thailand; [He, Xinghzhou] Chinese Acad Prevent Med, Inst Environm Hlth & Engn, Beijing 100050, Peoples R China; [Vermeulen, Roel] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, NL-3584 CK Utrecht, Netherlands; [Ning, Bofu] Xuanwei Ctr Dis Control, Qujing 655400, Yunnan, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chulalongkorn University; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Utrecht University	Barone-Adesi, F (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, 6120 Executive Blv,EPS 8015, Bethesda, MD 20892 USA.	baroneadesif@mail.nih.gov	Barone-Adesi, Francesco/ABG-1580-2020; wei, hu/GXW-2391-2022; Vermeulen, Roel/F-8037-2011	Vermeulen, Roel/0000-0003-4082-8163; Barone-Adesi, Francesco/0000-0003-1550-436X	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency [5D2290NFFX]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010121] Funding Source: NIH RePORTER	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency(United States Environmental Protection Agency); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Chinese Academy of Preventive Medicine, Beijing, China, by the Yunnan Province Antiepidemic Station, Kunming, China, and by contract 5D2290NFFX from the US Environmental Protection Agency. This study was also supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Xuanwei cohort study has been reviewed by the US Environmental Protection Agency and the National Cancer Institute. The contents do not necessarily reflect the views or policies of these institutions, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chen J., 2006, MORTALITY BIOCH DIET; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Crispo A, 2004, BRIT J CANCER, V91, P1280, DOI 10.1038/sj.bjc.6602078; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Granville CA, 2003, MUTAT RES-FUND MOL M, V525, P77, DOI 10.1016/S0027-5107(02)00314-7; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Hosgood HD, 2011, INT J EPIDEMIOL, V40, P719, DOI 10.1093/ije/dyq259; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Keohavong P, 2003, LUNG CANCER-J IASLC, V41, P21, DOI 10.1016/S0169-5002(03)00125-9; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2008, INT J CANCER, V123, P2164, DOI 10.1002/ijc.23748; Lee KM, 2010, BRIT J CANCER, V103, P727, DOI 10.1038/sj.bjc.6605791; LUBIN JH, 1990, CANCER RES, V50, P174; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; TAYLOR PR, 1989, BRIT J IND MED, V46, P881; World Health Organization, 1977, INT CLASS DIS; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	24	96	103	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5414	10.1136/bmj.e5414	http://dx.doi.org/10.1136/bmj.e5414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936785	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-01	WOS:000311050800002
J	Treon, SP; Xu, L; Yang, G; Zhou, YS; Liu, X; Cao, Y; Sheehy, P; Manning, RJ; Patterson, CJ; Tripsas, C; Arcaini, L; Pinkus, GS; Rodig, SJ; Sohani, AR; Harris, NL; Laramie, JM; Skifter, DA; Lincoln, SE; Hunter, ZR				Treon, Steven P.; Xu, Lian; Yang, Guang; Zhou, Yangsheng; Liu, Xia; Cao, Yang; Sheehy, Patricia; Manning, Robert J.; Patterson, Christopher J.; Tripsas, Christina; Arcaini, Luca; Pinkus, Geraldine S.; Rodig, Scott J.; Sohani, Aliyah R.; Harris, Nancy Lee; Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.; Hunter, Zachary R.			MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL GAMMOPATHIES; FREQUENT MUTATION; KAPPA-B; GENOME; ARID1A; BORTEZOMIB; DISORDERS; EVOLUTION; DISCOVERY; COMPLEX	BACKGROUND Waldenstrom's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated. METHODS We performed whole-genome sequencing of bone marrow LPL cells in 30 patients with Waldenstrom's macroglobulinemia, with paired normal-tissue and tumor-tissue sequencing in 10 patients. Sanger sequencing was used to validate the findings in samples from an expanded cohort of patients with LPL, those with other B-cell disorders that have some of the same features as LPL, and healthy donors. RESULTS Among the patients with Waldenstrom's macroglobulinemia, a somatic variant (T -> C) in LPL cells was identified at position 38182641 at 3p22.2 in the samples from all 10 patients with paired tissue samples and in 17 of 20 samples from patients with unpaired samples. This variant predicted an amino acid change (L265P) in MYD88, a mutation that triggers IRAK-mediated NF-kappa B signaling. Sanger sequencing identified MYD88 L265P in tumor samples from 49 of 54 patients with Waldenstrom's macroglobulinemia and in 3 of 3 patients with non-IgM-secreting LPL (91% of all patients with LPL). MYD88 L265P was absent in paired normal tissue samples from patients with Waldenstrom's macroglobulinemia or non-IgM LPL and in B cells from healthy donors and was absent or rarely expressed in samples from patients with multiple myeloma, marginal-zone lymphoma, or IgM monoclonal gammopathy of unknown significance. Inhibition of MYD88 signaling reduced I kappa B alpha and NF-kappa B p65 phosphorylation, as well as NF-kappa B nuclear staining, in Waldenstrom's macroglobulinemia cells expressing MYD88 L265P. Somatic variants in ARID1A in 5 of 30 patients (17%), leading to a premature stop or frameshift, were also identified and were associated with an increased disease burden. In addition, 2 of 3 patients with Waldenstrom's macroglobulinemia who had wild-type MYD88 had somatic variants in MLL2. CONCLUSIONS MYD88 L265P is a commonly recurring mutation in patients with Waldenstrom's macroglobulinemia that can be useful in differentiating Waldenstrom's macroglobulinemia and non-IgM LPL from B-cell disorders that have some of the same features. (Funded by the Peter and Helen Bing Foundation and others.)	[Treon, Steven P.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, Boston, MA 02115 USA; [Pinkus, Geraldine S.; Rodig, Scott J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Sohani, Aliyah R.; Harris, Nancy Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA USA; [Hunter, Zachary R.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Arcaini, Luca] Univ Pavia, Sch Med, Dept Hematol Oncol, I-27100 Pavia, Italy; [Arcaini, Luca] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, I-27100 Pavia, Italy; [Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.] Complete Genom, Mountain View, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Pavia; IRCCS Fondazione San Matteo	Treon, SP (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, M547,450 Brookline Ave, Boston, MA 02115 USA.	steven_treon@dfci.harvard.edu	Rodig, Scott/Y-3889-2019; Arcaini, Luca/P-8913-2015; Hunter, Zachary Richard/H-3018-2013	Arcaini, Luca/0000-0002-9504-991X; Hunter, Zachary Richard/0000-0002-1689-1691; Yang, Guang/0000-0003-3049-4200	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Funded by the Peter and Helen Bing Foundation and others.; Supported by the Peter and Helen Bing Foundation, the International Waldenstrom's Macroglobulinemia Foundation, the Coyote Fund for Waldenstrom's Macroglobulinemia, the Waldenstrom's Cancer Fund, the Bailey Family Fund for Waldenstrom's Macroglobulinemia, the D'Amato Family Fund for Genomic Discovery, the Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research, the Bauman Family Trust, and the Tannenhauser Family Foundation.	Arcaini L, 2011, CL LYMPH MYELOM LEUK, V11, P103, DOI 10.3816/CLML.2011.n.020; Baldini L, 2005, J CLIN ONCOL, V23, P4662, DOI 10.1200/JCO.2005.06.147; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Dimopoulos MA, 2010, CL LYMPH MYELOM LEUK, V10, P110, DOI 10.3816/CLML.2010.n.015; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kristinsson SY, 2008, BLOOD, V112, P3052, DOI 10.1182/blood-2008-06-162768; Kyle RA, 2003, BLOOD, V102, P3759, DOI 10.1182/blood-2003-03-0801; Kyrtsonis MC, 2011, CL LYMPH MYELOM LEUK, V11, P99, DOI 10.3816/CLML.2011.n.019; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leleu X, 2008, BLOOD, V111, P5068, DOI 10.1182/blood-2007-09-115170; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; McMaster ML, 2007, CLIN CANCER RES, V13, P5063, DOI 10.1158/1078-0432.CCR-07-0299; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morra E, 2004, LEUKEMIA, V18, P1512, DOI 10.1038/sj.leu.2403442; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Swerdlow SH, 2008, WHO CLASSIFICATION T, P194; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; Treon SP, 2007, CLIN CANCER RES, V13, P3320, DOI 10.1158/1078-0432.CCR-06-2511; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095	35	813	878	3	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					826	833		10.1056/NEJMoa1200710	http://dx.doi.org/10.1056/NEJMoa1200710			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931316	Bronze			2022-12-01	WOS:000308067400004
J	Glasmacher, E; Agrawal, S; Chang, AB; Murphy, TL; Zeng, WW; Vander Lugt, B; Khan, AA; Ciofani, M; Spooner, CJ; Rutz, S; Hackney, J; Nurieva, R; Escalante, CR; Ouyang, WJ; Littman, DR; Murphy, KM; Singh, H				Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Murphy, Theresa L.; Zeng, Wenwen; Vander Lugt, Bryan; Khan, Aly A.; Ciofani, Maria; Spooner, Chauncey J.; Rutz, Sascha; Hackney, Jason; Nurieva, Roza; Escalante, Carlos R.; Ouyang, Wenjun; Littman, Dan R.; Murphy, Kenneth M.; Singh, Harinder			A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1-IRF Complexes	SCIENCE			English	Article							TRANSCRIPTION FACTOR IRF4; FACTOR BATF CONTROLS; CELL-DIFFERENTIATION; FAMILY; ACTIVATION; EXPRESSION; PROGRAM; ABSENCE; MEMBER; ROLES	Interferon regulatory factor 4 (IRF4) and IRF8 regulate B, T, macrophage, and dendritic cell differentiation. They are recruited to cis-regulatory Ets-IRF composite elements by PU.1 or Spi-B. How these IRFs target genes in most T cells is enigmatic given the absence of specific Ets partners. Chromatin immunoprecipitation sequencing in T helper 17 (T(H)17) cells reveals that IRF4 targets sequences enriched for activating protein 1 (AP-1)-IRF composite elements (AICEs) that are co-bound by BATF, an AP-1 factor required for T(H)17, B, and dendritic cell differentiation. IRF4 and BATF bind cooperatively to structurally divergent AICEs to promote gene activation and T(H)17 differentiation. The AICE motif directs assembly of IRF4 or IRF8 with BATF heterodimers and is also used in T(H)2, B, and dendritic cells. This genomic regulatory element and cognate factors appear to have evolved to integrate diverse immunomodulatory signals.	[Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Zeng, Wenwen; Vander Lugt, Bryan; Spooner, Chauncey J.; Rutz, Sascha; Ouyang, Wenjun; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Inst Syst & Genom Biol, Chicago, IL 60637 USA; [Ciofani, Maria] NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Nurieva, Roza] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23219 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Roche Holding; Genentech; University of Chicago; University of Chicago; Howard Hughes Medical Institute; New York University; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu; harindsi@gene.com	Glasmacher, Elke/B-8939-2015; Zeng, Wenwen/D-7276-2017; Ouyang, Wenjun/ABA-8763-2020	Glasmacher, Elke/0000-0003-1265-2543; Zeng, Wenwen/0000-0001-8544-3318; Ouyang, Wenjun/0000-0002-1811-5864; Ciofani, Maria/0000-0001-6472-5260; Hackney, Jason/0000-0002-5922-563X	NIH [RC1 AI087266, RC4 AI092765]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI087266, RC4AI092765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Dong for insightful discussions and suggestions and the fluorescence-activated cell sorting (FACS), antibody engineering, DNA sequencing, microarray, and oligonucleotide synthesis facilities at Genentech for providing valuable reagents and technical assistance. The data presented in the manuscript are tabulated in the main paper and the supplementary materials. Reagents will be provided upon request. D.R.L. and K.M.M. are Howard Hughes Medical Institute investigators. D.R.L. also acknowledges funding from NIH grants RC1 AI087266 and RC4 AI092765, and M. C. was supported by a fellowship from the Crohn's and Colitis Foundation of America. Genentech, Incorporated, has filed a provisional patent application that is focused on targeting of IRF4-BATF complexes in the context of T<INF>H</INF>17-mediated inflammatory or autoimmune diseases. The complete gene expression and ChIPseq data sets can be accessed at www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE40483.	Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	27	231	239	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					975	980		10.1126/science.1228309	http://dx.doi.org/10.1126/science.1228309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	22983707	Green Accepted			2022-12-01	WOS:000311083600051
J	Upton, JP; Wang, LK; Han, D; Wang, ES; Huskey, NE; Lim, L; Truitt, M; McManus, MT; Ruggero, D; Goga, A; Papa, FR; Oakes, SA				Upton, John-Paul; Wang, Likun; Han, Dan; Wang, Eric S.; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; McManus, Michael T.; Ruggero, Davide; Goga, Andrei; Papa, Feroz R.; Oakes, Scott A.			IRE1 alpha Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; PROTEIN; APOPTOSIS; REQUIRES; PATHWAY	The endoplasmic reticulum (ER) is the primary organelle for folding and maturation of secretory and transmembrane proteins. Inability tomeet protein-folding demand leads to "ER stress," and activates IRE1 alpha, an ER transmembrane kinase-endoribonuclease (RNase). IRE1 alpha promotes adaptation through splicing Xbp1 mRNA or apoptosis through incompletely understood mechanisms. Here, we found that sustained IRE1 alpha RNase activation caused rapid decay of select microRNAs (miRs -17, -34a, -96, and -125b) that normally repress translation of Caspase-2 mRNA, and thus sharply elevates protein levels of this initiator protease of the mitochondrial apoptotic pathway. In cell-free systems, recombinant IRE1 alpha endonucleolytically cleaved microRNA precursors at sites distinct from DICER. Thus, IRE1 alpha regulates translation of a proapoptotic protein through terminating microRNA biogenesis, and noncoding RNAs are part of the ER stress response.	[Wang, Likun; Han, Dan; Huskey, Noelle E.; Lim, Lionel; Goga, Andrei; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Upton, John-Paul; Wang, Eric S.; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [McManus, Michael T.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; McManus, Michael T.] Univ Calif San Francisco, Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Upton, John-Paul; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; Ruggero, Davide; Goga, Andrei; Oakes, Scott A.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu; scott.oakes@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Papa, Feroz/0000-0002-3684-9108	NIH [DP2OD001925, R01CA136577, R01CA136717, R01DK080955, R01CA154916, GM080783, DK063720, R01CA140456]; Leukemia & Lymphoma Society Scholar Award; Howard Hughes Medical Institute Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Hillblom Foundation; Juvenile Diabetes Research Foundation; Partnership for Cures; National Science Foundation; Susan G. Komen Foundation; A*STAR Fellowship; NATIONAL CANCER INSTITUTE [R01CA136577, R01CA154916, R01CA140456, R01CA136717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Partnership for Cures; National Science Foundation(National Science Foundation (NSF)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); A*STAR Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Kaufman for Atf6a<SUP>-/-</SUP> MEFs and D. Ron for Perk<SUP>-/-</SUP> and Ire1 alpha<SUP>-/-</SUP> MEFs. The work was supported by NIH: DP2OD001925 (F.R.P), R01CA136577 (S.A.O.), R01CA136717 (A.G.), R01DK080955 (F.R.P), R01CA154916 (D.R.), GM080783 (M.T.M.), DK063720 (M.T.M.), and R01CA140456 (D.R.); Leukemia & Lymphoma Society Scholar Award (D.R.); Howard Hughes Medical Institute Physician-Scientist Early Career Award (S.A.O.); American Cancer Society Research Scholar Award (S.A.O.); Burroughs Wellcome Foundation (F.R.P.); Hillblom Foundation (F.R.P.); Juvenile Diabetes Research Foundation (F.R.P); Partnership for Cures (F.R.P); National Science Foundation (E.S.W.); Susan G. Komen Foundation (A.G.); and an A*STAR Fellowship (L.L.). J-P.U., L.W., D.H., E.S.W., N.H., and M.T. designed and performed experiments and contributed to the manuscript. L.L., M.T.M., D.R., and A.G. contributed key ideas, reagents, and data interpretation. F.R.P. and S.A.O. designed the study and wrote the manuscript. There are no conflicts of interest.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reyes NA, 2010, J CLIN INVEST, V120, P3673, DOI 10.1172/JCI42986; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	24	440	455	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					818	822		10.1126/science.1226191	http://dx.doi.org/10.1126/science.1226191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042294	Green Accepted			2022-12-01	WOS:000310839500050
J	Nishimasu, H; Ishizu, H; Saito, K; Fukuhara, S; Kamatani, MK; Bonnefond, L; Matsumoto, N; Nishizawa, T; Nakanaga, K; Aoki, J; Ishitani, R; Siomi, H; Siomi, MC; Nureki, O				Nishimasu, Hiroshi; Ishizu, Hirotsugu; Saito, Kuniaki; Fukuhara, Satoshi; Kamatani, Miharu K.; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Nakanaga, Keita; Aoki, Junken; Ishitani, Ryuichiro; Siomi, Haruhiko; Siomi, Mikiko C.; Nureki, Osamu			Structure and function of Zucchini endoribonuclease in piRNA biogenesis	NATURE			English	Article							PHOSPHOLIPASE-D FAMILY; CRYSTAL-STRUCTURE; NUAGE FORMATION; SMALL RNAS; DROSOPHILA; GERMLINE; GENOME; PIWI; REPLACEMENT; MECHANISM	PIWI-interacting RNAs (piRNAs) silence transposons to maintain genome integrity in animal germ lines(1-4). piRNAs are classified as primary and secondary piRNAs, depending on their biogenesis machinery(5-10). Primary piRNAs are processed from long non-coding RNA precursors transcribed from piRNA clusters in the genome through the primary processing pathway(5,8-10). Although the existence of a ribonuclease participating in this pathway has been predicted, its molecular identity remained unknown. Here we show that Zucchini (Zuc), a mitochondrial phospholipase D (PLD) superfamily member(11), is an endoribonuclease essential for primary piRNA biogenesis. We solved the crystal structure of Drosophila melanogaster Zuc (DmZuc) at 1.75 angstrom resolution. The structure revealed that DmZuc has a positively charged, narrow catalytic groove at the dimer interface, which could accommodate a single-stranded, but not a double-stranded, RNA. DmZuc and the mouse homologue MmZuc (also known as Pld6 and MitoPLD)(12-14) showed endoribonuclease activity for single-stranded RNAs in vitro. The RNA cleavage products bear a 5'-monophosphate group, a hallmark of mature piRNAs. Mutational analyses revealed that the conserved active-site residues of DmZuc are critical for the ribonuclease activity in vitro, and for piRNA maturation and transposon silencing in vivo. We propose a model for piRNA biogenesis in animal germ lines, in which the Zuc endoribonuclease has a key role in primary piRNA maturation.	[Nishimasu, Hiroshi; Ishizu, Hirotsugu; Fukuhara, Satoshi; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Siomi, Mikiko C.; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Ishizu, Hirotsugu; Saito, Kuniaki; Kamatani, Miharu K.; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Nakanaga, Keita; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Siomi, Mikiko C.; Nureki, Osamu] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan	University of Tokyo; Keio University; Tohoku University; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	siomim@biochem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	Siomi, Haruhiko/A-7020-2015; ISHIZU, HIROTSUGU/G-4991-2014; Saito, Kuniaki/A-6967-2015; Bonnefond, Luc/P-3926-2016; NUREKI, OSAMU/G-4960-2014	Siomi, Haruhiko/0000-0001-8690-3822; Saito, Kuniaki/0000-0001-8233-9283; Bonnefond, Luc/0000-0002-1164-742X; Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [11J05211] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Kurabayashi, H. Kotani and Y. Tamaki for technical assistance; other members of the Siomi laboratory for discussions and comments on the manuscript; the beamline staff at BL32XU of SPring-8 for assistance in data collection; and T. Suzuki and H. Suga for technical suggestions and comments. This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program' to O.N., by the Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST) to O.N. and M. C. S., and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H.N., H. I., H. S., M. C. S. and O.N.. K.S. is supported by the JSPS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuhara S, ACTA CRYS F IN PRESS; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAAE AJ, 1975, EUR J BIOCHEM, V60, P437, DOI 10.1111/j.1432-1033.1975.tb21021.x; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Zhao Y, 1997, PROTEIN SCI, V6, P2655	33	229	243	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					284	U157		10.1038/nature11509	http://dx.doi.org/10.1038/nature11509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064230				2022-12-01	WOS:000310774300050
J	Vaidya, N; Manapat, ML; Chen, IA; Xulvi-Brunet, R; Hayden, EJ; Lehman, N				Vaidya, Nilesh; Manapat, Michael L.; Chen, Irene A.; Xulvi-Brunet, Ramon; Hayden, Eric J.; Lehman, Niles			Spontaneous network formation among cooperative RNA replicators	NATURE			English	Article							NATURAL SELF-ORGANIZATION; EVOLUTION; RIBOZYME; ORIGIN; HYPERCYCLE; PRINCIPLE; LIFE; EMERGENCE; SELECTION; SYSTEMS	The origins of life on Earth required the establishment of self-replicating chemical systems capable of maintaining and evolving biological information. In an RNA world, single self-replicating RNAs would have faced the extreme challenge of possessing a mutation rate low enough both to sustain their own information and to compete successfully against molecular parasites with limited evolvability. Thus theoretical analyses suggest that networks of interacting molecules were more likely to develop and sustain life-like behaviour. Here we show that mixtures of RNA fragments that self-assemble into self-replicating ribozymes spontaneously form cooperative catalytic cycles and networks. We find that a specific three-membered network has highly cooperative growth dynamics. When such cooperative networks are competed directly against selfish autocatalytic cycles, the former grow faster, indicating an intrinsic ability of RNA populations to evolve greater complexity through cooperation. We can observe the evolvability of networks through in vitro selection. Our experiments highlight the advantages of cooperative behaviour even at the molecular stages of nascent life.	[Vaidya, Nilesh; Lehman, Niles] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Manapat, Michael L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Chen, Irene A.; Xulvi-Brunet, Ramon] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hayden, Eric J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Portland State University; Harvard University; Harvard University; Harvard University; Stanford University	Lehman, N (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	niles@pdx.edu	Lehman, Niles/ABF-7609-2021	Lehman, Niles/0000-0002-9056-6600; Chen, Irene/0000-0001-6040-7927; Xulvi-Brunet, Ramon/0000-0002-6013-4831	NASA [NNX10AR15G]; Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization; Direct For Biological Sciences [0963548] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization(Human Frontier Science Program); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank A. Burton, R. Ghadiri, P. Higgs, B. Larson, K. Chacon and A. Lopez Garcia de Lomana for help during preparation of this manuscript. This work was supported by NASA grant NNX10AR15G to N.L., the Center for Life in Extreme Environments at Portland State University, and a fellowship from the Human Frontier Science Program Organization to R.X.-B.	[Anonymous], 1993, ORIGINS ORDER; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; Draper WE, 2008, NUCLEIC ACIDS RES, V36, P520, DOI 10.1093/nar/gkm1055; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Hayden EJ, 2008, ANGEW CHEM INT EDIT, V47, P8424, DOI 10.1002/anie.200802177; Hayden EJ, 2006, CHEM BIOL, V13, P909, DOI 10.1016/j.chembiol.2006.06.014; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; Lee DH, 1997, CURR OPIN CHEM BIOL, V1, P491, DOI 10.1016/S1367-5931(97)80043-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Levy M, 2001, NAT STRUCT BIOL, V8, P580, DOI 10.1038/89601; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Nowak M., 2007, Q REV BIOL, V82; Nowak MA, 2008, P NATL ACAD SCI USA, V105, P14924, DOI 10.1073/pnas.0806714105; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	32	231	234	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					72	77		10.1038/nature11549	http://dx.doi.org/10.1038/nature11549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23075853				2022-12-01	WOS:000310434500032
J	Orozco, LD; Bennett, BJ; Farber, CR; Ghazalpour, A; Pan, C; Che, N; Wen, PZ; Qi, HX; Mutukulu, A; Siemers, N; Neuhaus, I; Yordanova, R; Gargalovic, P; Pellegrini, M; Kirchgessner, T; Lusis, AJ				Orozco, Luz D.; Bennett, Brian J.; Farber, Charles R.; Ghazalpour, Anatole; Pan, Calvin; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Mutukulu, Adonisa; Siemers, Nathan; Neuhaus, Isaac; Yordanova, Roumyana; Gargalovic, Peter; Pellegrini, Matteo; Kirchgessner, Todd; Lusis, Aldons J.			Unraveling Inflammatory Responses using Systems Genetics and Gene-Environment Interactions in Macrophages	CELL			English	Article							PPAR-GAMMA; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS; CHOLESTEROL; EXPRESSION; RECEPTORS; IMMUNITY; ABCA1; ALPHA	Many common diseases have an important inflammatory component mediated in part by macrophages. Here we used a systems genetics strategy to examine the role of common genetic variation in macrophage responses to inflammatory stimuli. We examined genome-wide transcript levels in macrophages from 92 strains of the Hybrid Mouse Diversity Panel. We exposed macrophages to control media, bacterial lipopolysaccharide (LPS), or oxidized phospholipids. We performed association mapping under each condition and identified several thousand expression quantitative trait loci (eQTL), gene-by-environment interactions, and eQTL "hot spots" that specifically control LPS responses. We used siRNA knockdown of candidate genes to validate an eQTL hot spot in chromosome 8 and identified the gene 2310061C15Rik as a regulator of inflammatory responses in macrophages. We have created a public database where the data presented here can be used as a resource for understanding many common inflammatory traits that are modeled in the mouse and for the dissection of regulatory relationships between genes.	[Orozco, Luz D.; Pan, Calvin; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bennett, Brian J.; Ghazalpour, Anatole; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mutukulu, Adonisa] Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Farber, Charles R.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Siemers, Nathan; Neuhaus, Isaac] Bristol Myers Squibb Co, Dept Bioinformat & Proteom, Pennington, NJ 08534 USA; [Yordanova, Roumyana] Bristol Myers Squibb Co, Dept Appl Genom, Pennington, NJ 08534 USA; [Gargalovic, Peter; Kirchgessner, Todd] Bristol Myers Squibb Co, Dept Atherosclerosis Drug Discovery, Pennington, NJ 08534 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Virginia; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Orozco, LD (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	ldorozco@mednet.ucla.edu	Yordanova, Roumyana/AAR-2275-2021	Pellegrini, Matteo/0000-0001-9355-9564; Farber, Charles/0000-0002-6748-4711; bennett, brian/0000-0002-0766-3195	NIH [HL30568, HL28481, D094311, K99 HL102223]; Ruth L. Kirschstein NIH F32 Fellowship [5F32DK074317]; USPHS National Research Service Award [GM07104, T32-HG002536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL030568, R00HL102223, K99HL102223] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK074317, DP3DK094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104, R01GM095656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NIH F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.L. and this work were supported by the NIH grants HL30568, HL28481, and D094311. B. J. B. was supported by the NIH grant K99 HL102223. C. R. F. was supported by the Ruth L. Kirschstein NIH F32 Fellowship 5F32DK074317. L. D. O. was supported by USPHS National Research Service Award GM07104 and USPHS National Research Service Award T32-HG002536. N. S., I. N., R. Y., P. G., and T. K. are employees of Bristol-Myers Squibb.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Edgel KA, 2010, ATHEROSCLEROSIS, V209, P387, DOI 10.1016/j.atherosclerosis.2009.10.019; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Rojo L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73976; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	21	92	95	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					658	670		10.1016/j.cell.2012.08.043	http://dx.doi.org/10.1016/j.cell.2012.08.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101632	Green Accepted, Bronze			2022-12-01	WOS:000310529300020
J	Breen, MS; Kemena, C; Vlasov, PK; Notredame, C; Kondrashov, FA				Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.			Epistasis as the primary factor in molecular evolution	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPENSATORY EVOLUTION; ADAPTIVE EVOLUTION; PROTEIN EVOLUTION; NATURAL-SELECTION; GENETIC-VARIATION; PERSPECTIVE; DROSOPHILA; MUTATIONS; LANDSCAPE	The main forces directing long-term molecular evolution remain obscure. A sizable fraction of amino-acid substitutions seem to be fixed by positive selection(1-4), but it is unclear to what degree long-term protein evolution is constrained by epistasis, that is, instances when substitutions that are accepted in one genotype are deleterious in another. Here we obtain a quantitative estimate of the prevalence of epistasis in long-term protein evolution by relating data on amino-acid usage in 14 organelle proteins and 2 nuclear-encoded proteins to their rates of short-term evolution. We studied multiple alignments of at least 1,000 orthologues for each of these 16 proteins from species from a diverse phylogenetic background and found that an average site contained approximately eight different amino acids. Thus, without epistasis an average site should accept two-fifths of all possible amino acids, and the average rate of amino-acid substitutions should therefore be about three-fifths lower than the rate of neutral evolution. However, we found that the measured rate of amino-acid substitution in recent evolution is 20 times lower than the rate of neutral evolution and an order of magnitude lower than that expected in the absence of epistasis. These data indicate that epistasis is pervasive throughout protein evolution: about 90 per cent of all amino-acid substitutions have a neutral or beneficial impact only in the genetic backgrounds in which they occur, and must therefore be deleterious in a different background of other species. Our findings show that most amino-acid substitutions have different fitness effects in different species and that epistasis provides the primary conceptual framework to describe the tempo and mode of long-term protein evolution.	[Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Kondrashov, Fyodor A.] 23 Passeig Lluis Co, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, 88 Dr Aiguader, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Vlasov, Peter/O-6392-2015; Kondrashov, Fyodor Alexeevich/H-6331-2015; notredame, cedric/G-3868-2010	Vlasov, Peter/0000-0003-0489-4200; Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Kemena, Carsten/0000-0002-2416-9842; notredame, cedric/0000-0003-1461-0988	Spanish Ministry of Science and Innovation; European Union [KBBE2A222664]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); ICREA(ICREA)	The work was supported by Plan Nacional grants from the Spanish Ministry of Science and Innovation, to F.A.K. and C.N. C.K. was supported by the European Union FP7 project Quantomics (KBBE2A222664). F.A.K. is a European Molecular Biology Organization Young Investigator and Howard Hughes Medical Institute International Early Career Scientist. We thank B. Lehner and T. Warnecke for input and a critical reading of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; GILLESPIE JH, 1986, MOL BIOL EVOL, V3, P138; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li W. H., 1997, MOL EVOLUTION, P419; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Poon AFY, 2006, EVOLUTION, V60, P2032, DOI 10.1111/j.0014-3820.2006.tb01841.x; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gks1189, 10.1093/nar/gkr1184, 10.1093/nar/gky1069]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	237	244	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					535	+		10.1038/nature11510	http://dx.doi.org/10.1038/nature11510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23064225				2022-12-01	WOS:000310196200041
J	Novarino, G; El-Fishawy, P; Kayserili, H; Meguid, NA; Scott, EM; Schroth, J; Silhavy, JL; Kara, M; Khalil, RO; Ben-Omran, T; Ercan-Sencicek, AG; Hashish, AF; Sanders, SJ; Gupta, AR; Hashem, HS; Matern, D; Gabriel, S; Sweetman, L; Rahimi, Y; Harris, RA; State, MW; Gleeson, JG				Novarino, Gaia; El-Fishawy, Paul; Kayserili, Hulya; Meguid, Nagwa A.; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Kara, Majdi; Khalil, Rehab O.; Ben-Omran, Tawfeg; Ercan-Sencicek, A. Gulhan; Hashish, Adel F.; Sanders, Stephan J.; Gupta, Abha R.; Hashem, Hebatalla S.; Matern, Dietrich; Gabriel, Stacey; Sweetman, Larry; Rahimi, Yasmeen; Harris, Robert A.; State, Matthew W.; Gleeson, Joseph G.			Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy	SCIENCE			English	Article							SYRUP-URINE-DISEASE; DEHYDROGENASE KINASE; AMINO-ACIDS; METABOLISM; EXPRESSION; TRANSPORT; MICE	Autism spectrum disorders are a genetically heterogeneous constellation of syndromes characterized by impairments in reciprocal social interaction. Available somatic treatments have limited efficacy. We have identified inactivating mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous families with autism, epilepsy, and intellectual disability. The encoded protein is responsible for phosphorylation-mediated inactivation of the E1 alpha subunit of branched-chain ketoacid dehydrogenase (BCKDH). Patients with homozygous BCKDK mutations display reductions in BCKDK messenger RNA and protein, E1 alpha phosphorylation, and plasma branched-chain amino acids. Bckdk knockout mice show abnormal brain amino acid profiles and neurobehavioral deficits that respond to dietary supplementation. Thus, autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome.	[Novarino, Gaia; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, Program Neurogenet,Dept Psychiat, New Haven, CT 06520 USA; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Faith Istanbul, Turkey; [Meguid, Nagwa A.; Khalil, Rehab O.; Hashish, Adel F.; Hashem, Hebatalla S.] Natl Res Ctr, Dept Res Children Special Needs, Cairo, Egypt; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha, Qatar; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, Ctr Child Study, New Haven, CT 06520 USA; [Matern, Dietrich] Mayo Clin, Dept Lab Med & Pathol, Biochem Genet Lab, Rochester, MN 55905 USA; [Gabriel, Stacey] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Sweetman, Larry] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Yale University; Istanbul University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; Yale University; Yale University; Mayo Clinic; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor Scott & White Health; Baylor University Medical Center; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington	Novarino, G (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	gnovarino@ucsd.edu; jogleeson@ucsd.edu	Sanders, Stephan/S-8645-2019; Kayserili, Hülya/AAA-5593-2021; State, Matthew/W-2256-2019; meguid, nagwa/S-7099-2016	Kayserili, Hülya/0000-0003-0376-499X; State, Matthew/0000-0003-1624-8302; Sanders, Stephan/0000-0001-9112-5148; Meguid, Nagwa/0000-0002-7962-2501; HASHISH, ADEL/0000-0001-9549-2973	NIH [P01HD070494, R01NS048453, P30NS047101, RC2MH089956, K08MH087639, T32MH018268]; Broad Institute [U54HG003067]; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation; American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH087639, T32MH018268, RC2MH089956, R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, P30NS047101, R01NS041537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation(German Research Foundation (DFG)); American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation; R. Weavers and E. Morava (Nijmegen Medical Center, Netherlands) and B. Barshop for providing patients; M. Kara's colleague for arranging shipment during the Libyan revolution; C. Lynch for the pSer293 antibody; the S. Taylor lab (UCSD) for help in protein modeling; M. Seashore, W. MacLean Jr., T. Cowan, and A. El-Gharabawy for suggestions; N. Wright-Davis, M. Murtha, M. Raubeson, N. DiLullo, M. Walker, Y. Song, N. Lifton, K. Bilguvar, A. Caglayan, Z. Omay, M. Choi, N. Carriero, R. D. Bjornson, P. Ventola, K. Koenig, and A. Bozik for technical assistance; the Yale Center for Genome Analysis (S. Mane); and the Sanford Burnham Institute. Supported by NIH grants P01HD070494, R01NS048453, and P30NS047101 (J.G.G.), RC2MH089956 (M. W. S.), K08MH087639 (A. R. G.), T32MH018268 and (P.E.-F.); Broad Institute grant U54HG003067 (E. L.); the Center for Inherited Disease Research for genotyping; the Simons Foundation Autism Research Initiative (J.G.G. and M. W. S.); a Veterans Administration Merit Award (R. A. H.); the German Research Foundation (G. N.); the American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund (P.E.-F.); and the American Psychiatric Association/Lilly Research Fellowship (P.E.-F.). J.G.G. is an investigator of the Howard Hughes Medical Institute. Data have been deposited into dbGap (phs000288) and the NCBI Sequence Read Archive (SRS351252) (whole exome sequencing) and into GEO (GSE39447) (microarrays). J.G.G. is a consultant for Halozyme Therapeutics, a biopharmaceutical company that develops products targeting the extracellular matrix. M. W. S. is a consultant to Synapdx, that is developing diagnostic tests for autism, and to Pfizer Pharmaceuticals that is working to develop autism therapeutics. Bckdk gene trap mice are available for noncommercial research from R. A. H. under MTA agreement with Lexicon. J.G.G. and M. W. S. are inventors on a patent application filed 17 July 2012 by UCSD covering diagnostic and therapeutic strategies for patients with autism and epilepsy.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Doering CB, 1998, GENE, V212, P213, DOI 10.1016/S0378-1119(98)00182-6; Duelli R, 2000, J CEREBR BLOOD F MET, V20, P1557, DOI 10.1097/00004647-200011000-00005; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Lepage N, 1997, CLIN CHEM, V43, P2397; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; MENKES JH, 1954, PEDIATRICS, V14, P462; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; SNYDERMAN SE, 1964, PEDIATRICS, V34, P454; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	21	200	209	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					394	397		10.1126/science.1224631	http://dx.doi.org/10.1126/science.1224631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22956686	Green Accepted			2022-12-01	WOS:000309955800044
J	Qiao, H; Shen, ZX; Huang, SSC; Schmitz, RJ; Urich, MA; Briggs, SP; Ecker, JR				Qiao, Hong; Shen, Zhouxin; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Briggs, Steven P.; Ecker, Joseph R.			Processing and Subcellular Trafficking of ER-Tethered EIN2 Control Response to Ethylene Gas	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SEEDLINGS; PATHWAY; ACTIVATION; PROTEOMICS; REGULATOR; PROTEINS; RECEPTOR; FAMILY; CTR1	Ethylene gas is essential for many developmental processes and stress responses in plants. ETHYLENE INSENSITIVE2 (EIN2), an NRAMP-like integral membrane protein, plays an essential role in ethylene signaling, but its function remains enigmatic. Here we report that phosphorylation-regulated proteolytic processing of EIN2 triggers its endoplasmic reticulum (ER)-to-nucleus translocation. ER-tethered EIN2 shows CONSTITUTIVE TRIPLE RESPONSE1 (CTR1) kinase-dependent phosphorylation. Ethylene triggers dephosphorylation at several sites and proteolytic cleavage at one of these sites, resulting in nuclear translocation of a carboxyl-terminal EIN2 fragment (EIN2-C'). Mutations that mimic EIN2 dephosphorylation, or inactivate CTR1, show constitutive cleavage and nuclear localization of EIN2-C' and EIN3 and EIN3-LIKE1-dependent activation of ethylene responses. These findings uncover a mechanism of subcellular communication whereby ethylene stimulates phosphorylation-dependent cleavage and nuclear movement of the EIN2-C' peptide, linking hormone perception and signaling components in the ER with nuclear-localized transcriptional regulators.	[Qiao, Hong; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; qiao, hong/J-7796-2012; Schmitz, Robert/AAY-7659-2020	Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663	NIH National Research Service Award postdoctoral fellowship [F32-HG004830]; NSF [MCB-0924871, MCB-1024999, DBI-0924023]; Direct For Biological Sciences [1024999] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER	NIH National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Song, N. Benson, and R. O'Malley for comments; J. Lin for plant maintenance; J. Chory for access to, and N. Geldner for assistance with, confocal microscopy; and J. Harper for the antibody to ACA2. We thank J. Nery for assistance with next-generation sequencing. R. J. S. was supported by an NIH National Research Service Award postdoctoral fellowship (F32-HG004830). This work was supported by grants from NSF (MCB-0924871 and MCB-1024999 to J. R. E. and DBI-0924023 to S. P. B.). J. R. E is an Investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation. Sequence data can be downloaded from the National Center for Biotechnology Information's Sequence Read Archive (accession no. SRA052247).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen RQ, 2011, MOL BIOSYST, V7, P2637, DOI 10.1039/c1mb05159h; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li H, 2009, PROTEOMICS, V9, P1646, DOI 10.1002/pmic.200800420; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812	22	313	339	12	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					390	393		10.1126/science.1225974	http://dx.doi.org/10.1126/science.1225974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936567	Green Accepted			2022-12-01	WOS:000309955800043
J	Li, W; Shuai, L; Wan, HF; Dong, MZ; Wang, M; Sang, LS; Feng, CJ; Luo, GZ; Li, TD; Li, X; Wang, LB; Zheng, QY; Sheng, C; Wu, HJ; Liu, ZH; Liu, L; Wang, L; Wang, XJ; Zhao, XY; Zhou, Q				Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Wang, Meng; Sang, Lisi; Feng, Chunjing; Luo, Guan-Zheng; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Wu, Hua-Jun; Liu, Zhonghua; Liu, Lei; Wang, Liu; Wang, Xiu-Jie; Zhao, Xiao-Yang; Zhou, Qi			Androgenetic haploid embryonic stem cells produce live transgenic mice	NATURE			English	Article							MOUSE EMBRYOS; GENERATION; EMBRYOGENESIS; PLURIPOTENT; DERIVATION; OOCYTES; GENOME; EXPRESSION; INJECTION; DEVELOP	Haploids and double haploids are important resources for studying recessive traits and have large impacts on crop breeding(1), but natural haploids are rare in animals. Mammalian haploids are restricted to germline cells and are occasionally found in tumours with massive chromosome loss(2,3). Recent success in establishing haploid embryonic stem (ES) cells in medaka fish(4) and mice(5,6) raised the possibility of using engineered mammalian haploid cells in genetic studies. However, the availability and functional characterization of mammalian haploid ES cells are still limited. Here we show that mouse androgenetic haploid ES (ahES) cell lines can be established by transferring sperm into an enucleated oocyte. The ahES cells maintain haploidy and stable growth over 30 passages, express pluripotent markers, possess the ability to differentiate into all three germ layers in vitro and in vivo, and contribute to germlines of chimaeras when injected into blastocysts. Although epigenetically distinct from sperm cells, the ahES cells can produce viable and fertile progenies after intracytoplasmic injection into mature oocytes. The oocyte-injection procedure can also produce viable transgenic mice from genetically engineered ahES cells. Our findings show the developmental pluripotency of androgenentic haploids and provide a new tool to quickly produce genetic models for recessive traits. They may also shed new light on assisted reproduction.	[Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Liu, Lei; Wang, Liu; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Li, Wei; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Wang, Libin; Zheng, Qin-Yuan; Wu, Hua-Jun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Shuai, Ling; Li, Tianda; Li, Xin; Sheng, Chao; Liu, Zhonghua] NE Agr Univ China, Coll Life Sci, Harbin 150030, Peoples R China; [Wang, Meng; Luo, Guan-Zheng; Wu, Hua-Jun; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	xyzhao@ioz.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019; Liu, Zhunghua/F-2485-2010	Liu, Zhunghua/0000-0002-9199-6493; ZHAO, Xiao-Yang/0000-0003-2544-8293; Shuai, Ling/0000-0003-0671-7478	National Science Foundation of China [90919060]; China National Basic Research Program [2012CBA01300]; Chinese Academy of Sciences [XDA01020100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank all members of the Group of Reproductive Engineering for discussion and help. This study was supported by a grant from the National Science Foundation of China 90919060 (to Q.Z.) and the China National Basic Research Program 2012CBA01300 (to Q.Z.), and a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences XDA01020100 (to Q.Z.). We thank Fluidigm Corporation for their support in the utilization of BioMark HD system. We thank Eppendorf and Leica for supporting the facility.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Germana MA, 2011, PLANT CELL REP, V30, P839, DOI 10.1007/s00299-011-1061-7; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Loren J, 2006, REPRODUCTION, V131, P259, DOI 10.1530/rep.1.00894; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1977, J EMBRYOL EXP MORPH, V38, P187; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhao XY, 2010, STEM CELL REV REP, V6, P390, DOI 10.1007/s12015-010-9160-3; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	31	127	157	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					407	+		10.1038/nature11435	http://dx.doi.org/10.1038/nature11435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023130				2022-12-01	WOS:000309918500047
J	Ou, HD; Kwiatkowski, W; Deerinck, TJ; Noske, A; Blain, KY; Land, HS; Soria, C; Powers, CJ; May, AP; Shu, XK; Tsien, RY; Fitzpatrick, JAJ; Long, JA; Ellisman, MH; Choe, S; O'Shea, CC				Ou, Horng D.; Kwiatkowski, Witek; Deerinck, Thomas J.; Noske, Andrew; Blain, Katie Y.; Land, Hannah S.; Soria, Conrado; Powers, Colin J.; May, Andrew P.; Shu, Xiaokun; Tsien, Roger Y.; Fitzpatrick, James A. J.; Long, Jeff A.; Ellisman, Mark H.; Choe, Senyon; O'Shea, Clodagh C.			A Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor Suppressors	CELL			English	Article							E4 ORF3 PROTEIN; DNA-BINDING DOMAIN; ADENOVIRUS INFECTION; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; MRE11 COMPLEX; REPLICATION; E1A; 3D; MICROSCOPY	Evolution of minimal DNA tumor virus' genomes has selected for small viral oncoproteins that hijack critical cellular protein interaction networks. The structural basis for the multiple and dominant functions of adenovirus oncoproteins has remained elusive. E4-ORF3 forms a nuclear polymer and simultaneously inactivates p53, PML, TRIM24, and MRE11/RAD50/NBS1 (MRN) tumor suppressors. We identify oligomerization mutants and solve the crystal structure of E4-ORF3. E4-ORF3 forms a dimer with a central beta core, and its structure is unrelated to known polymers or oncogenes. E4-ORF3 dimer units coassemble through reciprocal and nonreciprocal exchanges of their C-terminal tails. This results in linear and branched oligomer chains that further assemble in variable arrangements to form a polymer network that partitions the nuclear volume. E4-ORF3 assembly creates avidity-driven interactions with PML and an emergent MRN binding interface. This reveals an elegant structural solution whereby a small protein forms a multivalent matrix that traps disparate tumor suppressors.	[Ou, Horng D.; Soria, Conrado; Powers, Colin J.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Kwiatkowski, Witek; Blain, Katie Y.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Land, Hannah S.; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Fitzpatrick, James A. J.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Deerinck, Thomas J.; Noske, Andrew; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Shu, Xiaokun] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Shu, Xiaokun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu	Fitzpatrick, James/C-2268-2009	Fitzpatrick, James/0000-0002-7907-3602; shu, Xiaokun/0000-0001-9248-7095; Lipton, Stuart/0000-0002-3490-1259	NIH [CA137094, CA009370, P30CA014195, P30NS057096, 5P41RR004050, P41GM103412-24, RO1GM086197]; William Scandling Developmental Chair; American Cancer Society; Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE [T32CA009370, P30CA014195, R01CA137094] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Scandling Developmental Chair; American Cancer Society(American Cancer Society); Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. McCormick, T. Hunter, J. Chory, V. Lundblad, J. Young, I. Verma, and members of the C.C.O. laboratory for all of their support, insights, and helpful comments. We thank S. Phan and M. Terada for help with EM tomography. This work was supported by the following NIH grants awarded to the Salk Institute: CA137094 to C.C.O., a T32 fellowship (CA009370) to H.D.O., P30CA014195 provides support for the Salk Cancer Center, P30NS057096 supports in part the Salk X-ray equipment. The National Center for Microscopy contributions were supported by NIH awards 5P41RR004050 and P41GM103412-24 to M. H. E. The MiniSOG probe development was supported under RO1GM086197 (to R.Y.T. and M. H. E.). C.C.O. is also supported by the William Scandling Developmental Chair and young investigator awards from the American Cancer Society, the Sontag Foundation, the Arnold and Mabel Beckman Foundation, and the Anna Fuller Fund.	AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Berk A.J, 2007, FIELDS VIROLOGY, P2355; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Evans JD, 2003, J VIROL, V77, P5295, DOI 10.1128/JVI.77.9.5295-5304.2003; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martos V, 2008, CURR OPIN CHEM BIOL, V12, P698, DOI 10.1016/j.cbpa.2008.08.024; MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; Ou HD, 2011, WIRES SYST BIOL MED, V3, P48, DOI 10.1002/wsbm.88; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Ponstingl H, 2000, PROTEINS, V41, P47; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seeliger MA, 2005, J BIOL CHEM, V280, P30448, DOI 10.1074/jbc.M501450200; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	55	61	64	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					304	319		10.1016/j.cell.2012.08.035	http://dx.doi.org/10.1016/j.cell.2012.08.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063122	Green Accepted, Bronze			2022-12-01	WOS:000309981000010
J	Cohen, MR				Cohen, Marlene R.			When Attention Wanders	SCIENCE			English	Editorial Material							VISUAL-CORTEX; NEURONAL RESPONSES; AREA V4; PERFORMANCE; MECHANISMS; MOTION; SPACE; MIND		Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cohen, MR (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	cohenm@pitt.edu			NATIONAL EYE INSTITUTE [R01EY005911, R00EY020844, K99EY020844] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01EY005911, 5R00EY020844-04, K99EY020844-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2009, VISION RES, V49, P1182, DOI 10.1016/j.visres.2008.06.011; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	22	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					58	59		10.1126/science.1229552	http://dx.doi.org/10.1126/science.1229552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042879				2022-12-01	WOS:000309457400048
J	Reed, M; Huang, J; Graetz, I; Brand, R; Hsu, J; Fireman, B; Jaffe, M				Reed, Mary; Huang, Jie; Graetz, Ilana; Brand, Richard; Hsu, John; Fireman, Bruce; Jaffe, Marc			Outpatient Electronic Health Records and the Clinical Care and Outcomes of Patients With Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; INFORMATION-TECHNOLOGY; AMBULATORY-CARE; IMPACT	Background: Physicians can receive federal payments for meaningful use of complete certified electronic health records (EHRs). Evidence is limited on how EHR use affects clinical care and outcomes. Objective: To examine the association between use of a commercially available certified EHR and clinical care processes and disease control in patients with diabetes. Design: Quasi-experimental design with outpatient EHR implementation sequentially across 17 medical centers. Multivariate analyses adjusted for patient characteristics, medical center, time trends, and facility-level clustering. Setting: Kaiser Permanente Northern California, an integrated delivery system. Patients: 169 711 patients with diabetes mellitus. Intervention: Use of a commercially available certified EHR. Measurements: Drug treatment intensification and hemoglobin A(1c) (HbA(1c)) and low-density lipoprotein cholesterol (LDL-C) testing and values. Results: Use of an EHR was associated with statistically significant improvements in treatment intensification after HbA(1c) values of 9% or greater (odds ratio, 1.10 [95% CI, 1.05 to 1.15]) or LDL-C values of 2.6 to 3.3 mmol/L (100 to 129 mg/dL) (odds ratio, 1.06 [CI, 1.00 to 1.12]); increases in 1-year retesting for HbA(1c) and LDL-C levels among all patients, with the most dramatic change among patients with the worst disease control (HbA(1c) levels >= 9% or LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]); and decreased 90-day retesting among patients with HbA(1c) levels less than 7% or LDL-C levels less than 2.6 mmol/ L (<100 mg/dL). The EHR was also associated with statistically significant reductions in HbA(1c) and LDL-C levels, with the largest reductions among patients with the worst control (0.06-mmol/ L [2.19-mg/dL] reduction among patients with baseline LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]; P < 0.001). Limitation: The EHR was implemented in a setting with strong baseline performance on cardiovascular care quality measures. Conclusion: Use of a commercially available certified EHR was associated with improved drug treatment intensification, monitoring, and physiologic control among patients with diabetes, with greater improvements among patients with worse control and less testing in patients already meeting guideline-recommended glycemic and lipid targets.	[Reed, Mary] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Permanente Med Grp Inc, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Permanente Medical Groups	Reed, M (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	mary.e.reed@kp.org	Graetz, Ilana/N-1189-2016	Graetz, Ilana/0000-0003-3664-5815; Jaffe, Marc/0000-0002-5049-7815	National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK R01DK085070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases.; By the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK R01DK085070).	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Brailer DJ, 2010, HEALTH AFFAIR, V29, P586, DOI 10.1377/hlthaff.2010.0274; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cameron A., 2010, HDB EMPIRICAL EC FIN, V3666, P1, DOI [10.1201/b10440-2, DOI 10.1201/B10440-2]; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Costa BM, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-72; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Herrin J, 2012, HEALTH SERV RES, V47, P1522, DOI 10.1111/j.1475-6773.2011.01370.x; Jha AK, 2010, JAMA-J AM MED ASSOC, V304, P1709, DOI 10.1001/jama.2010.1497; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sequist TD, 2005, J AM MED INFORM ASSN, V12, P431, DOI 10.1197/jamia.M1788; Sharma M, 2009, ANN INTERN MED, V151, P622, DOI 10.7326/0003-4819-151-9-200911030-00144; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; StataCorp, 2007, STAT BAS REF MAN REL; Wooldridge J.M., 2002, DATA; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128	21	79	79	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					482	U66		10.7326/0003-4819-157-7-201210020-00004	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	016MQ	23027319	Green Accepted			2022-12-01	WOS:000309523200003
J	Du, JM; Zhong, XH; Bernatavichute, YV; Stroud, H; Feng, SH; Caro, E; Vashisht, AA; Terragni, J; Chin, HG; Tu, A; Hetzel, J; Wohlschlegel, JA; Pradhan, S; Patel, DJ; Jacobsen, SE				Du, Jiamu; Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Vashisht, Ajay A.; Terragni, Jolyon; Chin, Hang Gyeong; Tu, Andy; Hetzel, Jonathan; Wohlschlegel, James A.; Pradhan, Sriharsa; Patel, Dinshaw J.; Jacobsen, Steven E.			Dual Binding of Chromomethylase Domains to H3K9me2-Containing Nucleosomes Directs DNA Methylation in Plants	CELL			English	Article							HISTONE H3; STRUCTURAL BASIS; BAH DOMAIN; ARABIDOPSIS; RECOGNITION; MAINTENANCE; UHRF1; DIMETHYLATION; SPECIFICITY; MECHANISM	DNA methylation and histone modification exert epigenetic control over gene expression. CHG methylation by CHROMOMETHYLASE3 (CMT3) depends on histone H3K9 dimethylation (H3K9me2), but the mechanism underlying this relationship is poorly understood. Here, we report multiple lines of evidence that CMT3 interacts with H3K9me2-containing nucleosomes. CMT3 genome locations nearly perfectly correlated with H3K9me2, and CMT3 stably associated with H3K9me2-containing nucleosomes. Crystal structures of maize CMT3 homolog ZMET2, in complex with H3K9me2 peptides, showed that ZMET2 binds H3K9me2 via both bromo adjacent homology (BAH) and chromo domains. The structures reveal an aromatic cage within both BAH and chromo domains as interaction interfaces that capture H3K9me2. Mutations that abolish either interaction disrupt CMT3 binding to nucleosomes and show a complete loss of CMT3 activity in vivo. Our study establishes dual recognition of H3K9me2 marks by BAH and chromo domains and reveals a distinct mechanism of interplay between DNA methylation and histone modification.	[Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Tu, Andy; Hetzel, Jonathan; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Terragni, Jolyon; Chin, Hang Gyeong; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New England Biolabs	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Caro, Elena/G-6352-2012; Du, Jiamu/I-1334-2013; Caro, Elena/D-2611-2014; Du, Jiamu/G-3308-2010; Stroud, Hume/ABF-1325-2021	Du, Jiamu/0000-0002-1337-0786; Caro, Elena/0000-0002-1034-1621; 	Ruth L. Kirschstein National Research Service Award [F32GM096483-01]; Leukemia & Lymphoma Society; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM089778, GM60398]; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778, F32GM096483, R37GM060398, R01GM060398] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anders Lindroth and Debasis Patnak for initiating CMT3 in vitro activity assays, staff members at APS for support in diffraction data collection and at UCLA BSCRC BioSequencing core for high-throughput sequencing, and Nathan Springer and Shawn Kaeppler for providing ZMET2 gene. We are also grateful to Lianna Johnson for help with histone peptide array experiments, Greg Horwitz for help with baculoviral protein expression, and their critical reading of this manuscript. X.Z. is supported by Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S.F. is supported by Leukemia & Lymphoma Society. This work was supported by the Abby Rockefeller Mauze Trust and the Maloris and STARR foundations to D.J.P., NIH grant GM089778 and the UCLA Jonsson Cancer Center to J.A.W., and NIH grant GM60398 to S.E.J. S.E.J. is an Investigator at the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bartee L, 2001, NUCLEIC ACIDS RES, V29, P2127, DOI 10.1093/nar/29.10.2127; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chang YQ, 2011, J MOL BIOL, V408, P807, DOI 10.1016/j.jmb.2011.03.018; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	41	309	317	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					167	180		10.1016/j.cell.2012.07.034	http://dx.doi.org/10.1016/j.cell.2012.07.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021223	Green Accepted, Bronze			2022-12-01	WOS:000309544200018
J	Gornall, J				Gornall, Jonathan			SMOKING CESSATION Electronic cigarettes: medical device or consumer product?	BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						MHRA, 2010, PUBL CONS MLX 364 RE; MHRA, 2010, DRUG SAFETY UPDATE, V3, P6; MHRA (Medicines Healthcare products Regulatory Agency), 2010, CONS LETT MLX 364 RE	3	5	5	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6417	10.1136/bmj.e6417	http://dx.doi.org/10.1136/bmj.e6417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014904				2022-12-01	WOS:000309385500010
J	Andersen, CBF; Torvund-Jensen, M; Nielsen, MJ; de Oliveira, CLP; Hersleth, HP; Andersen, NH; Pedersen, JS; Andersen, GR; Moestrup, SK				Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Pinto de Oliveira, Cristiano Luis; Hersleth, Hans-Petter; Andersen, Niels Hojmark; Pedersen, Jan Skov; Andersen, Gregers Rom; Moestrup, Soren Kragh			Structure of the haptoglobin-haemoglobin complex	NATURE			English	Article							SERINE-PROTEASE; BIOLOGICAL MACROMOLECULES; SUBUNIT DISSOCIATION; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; BINDING; RESOLUTION; CD163; EQUILIBRIUM	Red cell haemoglobin is the fundamental oxygen-transporting molecule in blood, but also a potentially tissue-damaging compound owing to its highly reactive haem groups. During intravascular haemolysis, such as in malaria and haemoglobinopathies(1), haemoglobin is released into the plasma, where it is captured by the protective acute-phase protein haptoglobin. This leads to formation of the haptoglobin-haemoglobin complex, which represents a virtually irreversible non-covalent protein-protein interaction(2). Here we present the crystal structure of the dimeric porcine haptoglobin-haemoglobin complex determined at 2.9 angstrom resolution. This structure reveals that haptoglobin molecules dimerize through an unexpected beta-strand swap between two complement control protein (CCP) domains, defining a new fusion CCP domain structure. The haptoglobin serine protease domain forms extensive interactions with both the alpha- and beta-subunits of haemoglobin, explaining the tight binding between haptoglobin and haemoglobin. The haemoglobin-interacting region in the alpha beta dimer is highly overlapping with the interface between the two alpha beta dimers that constitute the native haemoglobin tetramer. Several haemoglobin residues prone to oxidative modification after exposure to haem-induced reactive oxygen species are buried in the haptoglobin-haemoglobin interface, thus showing a direct protective role of haptoglobin. The haptoglobin loop previously shown to be essential for binding of haptoglobin-haemoglobin to the macrophage scavenger receptor CD163 (ref. 3) protrudes from the surface of the distal end of the complex, adjacent to the associated haemoglobin alpha-subunit. Small-angle X-ray scattering measurements of human haptoglobin-haemoglobin bound to the ligand-binding fragment of CD163 confirm receptor binding in this area, and show that the rigid dimeric complex can bind two receptors. Such receptor cross-linkage may facilitate scavenging and explain the increased functional affinity of multimeric haptoglobin-haemoglobin for CD163 (ref. 4).	[Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis] Univ Sao Paulo, Inst Phys, BR-0531497 Sao Paulo, Brazil; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Hersleth, Hans-Petter] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway; [Andersen, Niels Hojmark] Univ Oslo, Dept Chem, NO-0315 Oslo, Norway; [Andersen, Gregers Rom] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Universidade de Sao Paulo; Aarhus University; Aarhus University; University of Oslo; University of Oslo; Aarhus University	Andersen, CBF (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.	cbfa@biokemi.au.dk; skm@biokemi.au.dk	Complexos, INCT Fluidos/H-9172-2013; Moestrup, Søren Kragh/A-1403-2014; Nielsen, Marina/F-5625-2012; Moestrup, Søren Kragh/AAD-1735-2019; Pedersen, Jan Skov/A-8346-2008; Oliveira, Cristiano L P/B-4403-2008	Moestrup, Søren Kragh/0000-0003-3862-2107; Pedersen, Jan Skov/0000-0002-7768-0206; Oliveira, Cristiano L P/0000-0002-3426-6507; Andersen, Gregers Rom/0000-0001-6292-3319; Hersleth, Hans-Petter/0000-0002-1142-9983; Andersen, Niels Hojmark/0000-0003-3668-2800	Lundbeck Foundation; Novo Nordisk Foundation; Research Council of Norway; European Research Council; Danish Council for Independent Research; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to G. Ratz for technical assistance, R. Kidmose, N. S. Laursen and the staff at the Swiss Light Source beamlines for help with data collection. We thank G. V. Jensen for performing SAXS measurements and R. E. Weber for scientific discussion. The research was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, The Research Council of Norway, The European Research Council and The Danish Council for Independent Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bunn H. F., 1977, HEMOGLOBINOPATHIES, V308; Dickerson RE, 1983, HEMOGLOBIN STRUCTURE; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; IP SHC, 1976, BIOCHEMISTRY-US, V15, P654, DOI 10.1021/bi00648a032; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; NAGEL RL, 1971, J BIOL CHEM, V246, P69; NAGEL RL, 1965, BIOCHIM BIOPHYS ACTA, V100, P286, DOI 10.1016/0304-4165(65)90454-X; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SHIM BS, 1965, NATURE, V207, P1264, DOI 10.1038/2071264a0; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; Smulevich G, 1998, J RAMAN SPECTROSC, V29, P57, DOI 10.1002/(SICI)1097-4555(199801)29:1<57::AID-JRS209>3.0.CO;2-P; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Venkatesh B, 2004, J BIOCHEM, V136, P595, DOI 10.1093/jb/mvh166; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEJMAN JC, 1984, J MOL BIOL, V174, P319, DOI 10.1016/0022-2836(84)90341-3	47	172	180	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					456	U150		10.1038/nature11369	http://dx.doi.org/10.1038/nature11369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22922649				2022-12-01	WOS:000308860900051
J	Taipale, M; Krykbaeva, I; Koeva, M; Kayatekin, C; Westover, KD; Karras, GI; Lindquist, S				Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Westover, Kenneth D.; Karras, Georgios I.; Lindquist, Susan			Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition	CELL			English	Article							HSP90; KINASE; PROTEIN; BINDING; INHIBITORS; CAPACITOR; RECEPTOR; SURFACE; KINOME; SRC	HSP90 is a molecular chaperone that associates with numerous substrate proteins called clients. It plays many important roles in human biology and medicine, but determinants of client recognition by HSP90 have remained frustratingly elusive. We systematically and quantitatively surveyed most human kinases, transcription factors, and E3 ligases for interaction with HSP90 and its cochaperone CDC37. Unexpectedly, many more kinases than transcription factors bound HSP90. CDC37 interacted with kinases, but not with transcription factors or E3 ligases. HSP90::kinase interactions varied continuously over a 100-fold range and provided a platform to study client protein recognition. In wild-type clients, HSP90 did not bind particular sequence motifs, but rather associated with intrinsically unstable kinases. Stabilization of the kinase in either its active or inactive conformation with diverse small molecules decreased HSP90 association. Our results establish HSP90 client recognition as a combinatorial process: CDC37 provides recognition of the kinase family, whereas thermodynamic parameters determine client binding within the family.	[Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Karras, Georgios I.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Westover, Kenneth D.] UT SW, Dept Biochem, Dallas, TX 75390 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Westover, Ken/AAZ-1795-2020; Kayatekin, Can/B-6618-2009	Westover, Ken/0000-0003-3653-5923; Karras, Georgios/0000-0002-6169-5569; Krykbaeva, Irina/0000-0003-1380-7607; Kayatekin, Can/0000-0002-4367-9645; Taipale, Mikko/0000-0003-3811-1761; Karras, Georgios/0000-0003-2933-1535	Academy of Finland; Sigrid Juselius Foundation; Human Frontier Science Program; EMBO; NIH Genomics Based Drug Discovery-Driving Medical Projects [UL1-DE019585]; NIH [RL1-GM084437, RL1-CA133834, RL1-HG004671]; NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); NIH Genomics Based Drug Discovery-Driving Medical Projects(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. F. Jarosz, L. Whitesell, and M. Mendillo for valuable comments, K. Salehi-Ashtiani and M. Vidal (Dana-Farber Cancer Institute) for the human ORFeome collection, D. Proia (Synta Pharmaceuticals) for ganetespib, and N.S. Gray (Dana-Farber Cancer Institute) for DPH. M.T. was supported by the Academy of Finland, Sigrid Juselius Foundation and the Human Frontier Science Program. G. I. K. was supported by an EMBO Long-Term Fellowship and the Human Frontier Science Program. S. L. is an investigator of the Howard Hughes Medical Institute. Support for this study was also provided by the NIH Genomics Based Drug Discovery-Driving Medical Projects grant UL1-DE019585, administratively linked to NIH grants RL1-GM084437, RL1-CA133834, and RL1-HG004671. M.T. and S.L. planned the project and designed the experiments. M. T. developed and validated LUMIER with BACON assay and performed all the experiments with the help of I. K. G. I. K. assayed HSP90 interactions against E3 ligases. K. D. W. and M. T. expressed and purified recombinant ABL, and C. K. and M. T. analyzed ABL with circular dichroism. M. T. and M. K. performed computational analyses of HSP90 interactions. M. T. and S. L. wrote the paper, with comments from all the coauthors.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Buchner J, 2010, MOL MICROBIOL, V76, P540, DOI 10.1111/j.1365-2958.2010.07140.x; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	39	570	582	11	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					987	1001		10.1016/j.cell.2012.06.047	http://dx.doi.org/10.1016/j.cell.2012.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939624	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000308500200013
J	Keller, KE; Tan, IS; Lee, YS				Keller, Kirstie E.; Tan, Irene S.; Lee, Young-Sam			SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions	SCIENCE			English	Article							TUMOR; METABOLISM; INHIBITION	Pyruvate kinase isoform M2 (PKM2) plays an important role in the growth and metabolic reprogramming of cancer cells in stress conditions. Here, we report that SAICAR (succinylaminoimidazolecarboxamide ribose-5'-phosphate, an intermediate of the de novo purine nucleotide synthesis pathway) specifically stimulates PKM2. Upon glucose starvation, cellular SAICAR concentration increased in an oscillatory manner and stimulated PKM2 activity in cancer cells. Changes in SAICAR amounts in cancer cells altered cellular energy level, glucose uptake, and lactate production. The SAICAR-PKM2 interaction also promoted cancer cell survival in glucose-limited conditions. SAICAR accumulation was not observed in normal adult epithelial cells or lung fibroblasts, regardless of glucose conditions. This allosteric regulation may explain how cancer cells coordinate different metabolic pathways to optimize their growth in the nutrient-limited conditions commonly observed in the tumor microenvironment.	[Keller, Kirstie E.; Lee, Young-Sam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Tan, Irene S.] Natl Inst Hlth Johns Hopkins Univ Grad Partnershi, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA	Lee, YS (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	ylee99@jhu.edu	Lee, Young-Sam/A-2499-2013		Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Coupet, D. Meyer, and E. Pryce for technical assistance; R. Coleman, Y. Wang, C. Arrowsmith, and members of our department for sharing their equipment and materials; and A. Le, E. O'Shea, and members of our department for comments on the manuscript. Supported by Johns Hopkins University Krieger School of Arts and Sciences startup fund to Y.-S.L. The authors declare no conflict of interest.	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee P, 2007, PROTEIN EXPRES PURIF, V51, P227, DOI 10.1016/j.pep.2006.07.023; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; SANT ME, 1992, J BIOL CHEM, V267, P11038; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470	17	145	155	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1069	1072		10.1126/science.1224409	http://dx.doi.org/10.1126/science.1224409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086999	Green Accepted			2022-12-01	WOS:000311390600041
J	Kim, B; Eggel, A; Tarchevskaya, SS; Vogel, M; Prinz, H; Jardetzky, TS				Kim, Beomkyu; Eggel, Alexander; Tarchevskaya, Svetlana S.; Vogel, Monique; Prinz, Heino; Jardetzky, Theodore S.			Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor	NATURE			English	Article							CONFORMATIONAL FLEXIBILITY; DISSOCIATION RATE; CRYSTAL-STRUCTURE; FC; REVEALS; LIGANDS; BINDING; SITE	IgE antibodies bind the high-affinity IgE Fc receptor (Fc epsilon RI), found primarily on mast cells and basophils, and trigger inflammatory cascades of the allergic response(1,2). Inhibitors of IgE-Fc epsilon RI binding have been identified and an anti-IgE therapeutic antibody (omalizumab) is used to treat severe allergic asthma(3,4). However, preformed IgE-Fc epsilon RI complexes that prime cells before allergen exposure dissociate extremely slowly(5) and cannot be disrupted by strictly competitive inhibitors. IgE-Fc conformational flexibility indicated that inhibition could be mediated by allosteric or other non-classical mechanisms(6-8). Here we demonstrate that an engineered protein inhibitor, DARPin E2_79 (refs 9-11), acts through a non-classical inhibition mechanism, not only blocking IgE-Fc epsilon RI interactions, but actively stimulating the dissociation of preformed ligand-receptor complexes. The structure of the E2_79-IgE-Fc(3-4) complex predicts the presence of two non-equivalent E2_79 sites in the asymmetric IgE-Fc epsilon RI complex, with site 1 distant from the receptor and site 2 exhibiting partial steric overlap. Although the structure is indicative of an allosteric inhibition mechanism, mutational studies and quantitative kinetic modelling indicate that E2_79 acts through a facilitated dissociation mechanism at site 2 alone. These results demonstrate that high-affinity IgE-Fc epsilon RI complexes can be actively dissociated to block the allergic response and suggest that protein-protein complexes may be more generally amenable to active disruption by macromolecular inhibitors.	[Kim, Beomkyu; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Eggel, Alexander; Vogel, Monique] Univ Bern, Inst Immunol, CH-3010 Bern, Switzerland; [Prinz, Heino] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Stanford University; University of Bern; Max Planck Society	Jardetzky, TS (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Eggel, Alexander/J-8177-2019; Kim, Beomkyu/AAM-7220-2020	Eggel, Alexander/0000-0001-8746-3339; 	NIH [AI-18939]; American Asthma Foundation; Swiss National Science Foundation [310030_127350]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038972, R01AI018939, R37AI018939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Wurzburg and other past and present members of the Jardetzky Laboratory. This research was supported in part by an NIH research grant (AI-18939) and an American Asthma Foundation Senior Investigator Award as well as the Swiss National Science Foundation grant number 310030_127350 to T.S.J. We also thank C. A. Dahinden and B. M. Stadler and members of their groups for valuable discussions. Furthermore, we thank M. J. Baumann for technical support and Molecular Partners AG, especially P. Amstutz, M. T. Stumpp, P. Forrer and D. Steiner, for placing DARPin libraries at our disposal and providing scientific support.	BASU M, 1993, J BIOL CHEM, V268, P13118; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; BOULAIN JC, 1982, SCIENCE, V217, P732, DOI 10.1126/science.7100919; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Amato Gennaro, 2006, Treat Respir Med, V5, P393, DOI 10.2165/00151829-200605060-00004; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; GUTFREUND H, 1995, KINETICS LIFE SCI RE; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRINZ H, 1993, J BIOL CHEM, V268, P18580; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WANG CC, 1988, P NATL ACAD SCI USA, V85, P8400, DOI 10.1073/pnas.85.22.8400; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiegand TW, 1996, J IMMUNOL, V157, P221; Wright JD, 1998, PROTEIN ENG, V11, P421, DOI 10.1093/protein/11.6.421; Wuezburg B.A., J BIOL CHEM; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	34	75	77	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					613	+		10.1038/nature11546	http://dx.doi.org/10.1038/nature11546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103871	Green Accepted			2022-12-01	WOS:000311339800056
J	Derr, ND; Goodman, BS; Jungmann, R; Leschziner, AE; Shih, WM; Reck-Peterson, SL				Derr, N. D.; Goodman, B. S.; Jungmann, R.; Leschziner, A. E.; Shih, W. M.; Reck-Peterson, S. L.			Tug-of-War in Motor Protein Ensembles Revealed with a Programmable DNA Origami Scaffold	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; ORGANELLE TRANSPORT; TRANSIENT BINDING; STEPPING BEHAVIOR; MOLECULAR MOTORS; CARGO TRANSPORT; KINESIN; MICROTUBULES	Cytoplasmic dynein and kinesin-1 are microtubule-based motors with opposite polarity that transport a wide variety of cargo in eukaryotic cells. Many cellular cargos demonstrate bidirectional movement due to the presence of ensembles of dynein and kinesin, but are ultimately sorted with spatial and temporal precision. To investigate the mechanisms that coordinate motor ensemble behavior, we built a programmable synthetic cargo using three-dimensional DNA origami to which varying numbers of DNA oligonucleotide-linked motors could be attached, allowing for control of motor type, number, spacing, and orientation in vitro. In ensembles of one to seven identical-polarity motors, motor number had minimal affect on directional velocity, whereas ensembles of opposite-polarity motors engaged in a tug-of-war resolvable by disengaging one motor species.	[Derr, N. D.; Goodman, B. S.; Reck-Peterson, S. L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jungmann, R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Jungmann, R.; Shih, W. M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Leschziner, A. E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu	Jungmann, Ralf/A-6357-2015	Jungmann, Ralf/0000-0003-4607-3312; Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023	Alexander von Humboldt Foundation; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1, 1U54GM094608, 1DP2OD004641]; ONR [N000014091118, N000141010241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641, DP2OD004268] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Lin for assistance with electron microscopy; F. Aguet for assistance with data analysis; J. Huang, W. Qiu, W. B. Redwine, and A. Roberts for helpful advice and critical reading of the manuscript; members of the Reck-Peterson and Shih labs for advice and helpful discussions; and J. Iwasa for illustrations. EM data were collected at the Center for Nanoscale Systems, Harvard University. DNA-PAINT data were collected at the Nikon Imaging Center, Harvard Medical School. R. J. is supported from the Alexander von Humboldt Foundation through a Feodor Lynen fellowship. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and a NIH New Innovator award (1 DP2 OD004268-1). W. M. S. is funded by NIH awards (1U54GM094608 and 1DP2OD004641) and ONR awards (N000014091118 and N000141010241).	Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Bryantseva SA, 2012, CELL BIOL INT, V36, P1, DOI 10.1042/CBI20110413; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Constantinou PE, 2010, J BIOMECH, V43, P31, DOI 10.1016/j.jbiomech.2009.09.006; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Ko SH, 2012, ADV FUNCT MATER, V22, P1015, DOI 10.1002/adfm.201102077; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leduc C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128103; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Lu HL, 2012, J BIOL CHEM, V287, P27753, DOI 10.1074/jbc.M112.371393; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xu J, 2012, TRAFFIC, V13, P1198, DOI 10.1111/j.1600-0854.2012.01385.x; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	38	279	291	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					662	665		10.1126/science.1226734	http://dx.doi.org/10.1126/science.1226734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23065903	Green Accepted, Green Submitted			2022-12-01	WOS:000310516000052
J	Liao, XY; Lochhead, P; Nishihara, R; Morikawa, T; Kuchiba, A; Yamauchi, M; Imamura, Y; Qian, ZR; Baba, Y; Shima, K; Sun, RF; Nosho, K; Meyerhardt, JA; Giovannucci, E; Fuchs, CS; Chan, AT; Ogino, S				Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Baba, Yoshifumi; Shima, Kaori; Sun, Ruifang; Nosho, Katsuhiko; Meyerhardt, Jeffrey A.; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji			Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; MICROSATELLITE INSTABILITY; COLON-CANCER; PERSONALIZED MEDICINE; RANDOMIZED-TRIALS; BRAF MUTATION; RISK; METASTASIS; INHIBITION	BACKGROUND Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers. METHODS We obtained data on 964 patients with rectal or colon cancer from the Nurses' Health Study and the Health Professionals Follow-up Study, including data on aspirin use after diagnosis and the presence or absence of PIK3CA mutation. We used a Cox proportional-hazards model to compute the multivariate hazard ratio for death. We examined tumor markers, including PTGS2, phosphorylated AKT, KRAS, BRAF, microsatellite instability, CpG island methylator phenotype, and methylation of long interspersed nucleotide element 1. RESULTS Among patients with mutated-PIK3CA colorectal cancers, regular use of aspirin after diagnosis was associated with superior colorectal cancer-specific survival (multivariate hazard ratio for cancer-related death, 0.18; 95% confidence interval [CI], 0.06 to 0.61; P<0.001 by the log-rank test) and overall survival (multivariate hazard ratio for death from any cause, 0.54; 95% CI, 0.31 to 0.94; P = 0.01 by the log-rank test). In contrast, among patients with wild-type PIK3CA, regular use of aspirin after diagnosis was not associated with colorectal cancer-specific survival (multivariate hazard ratio, 0.96; 95% CI, 0.69 to 1.32; P = 0.76 by the log-rank test; P = 0.009 for interaction between aspirin and PIK3CA variables) or overall survival (multivariate hazard ratio, 0.94; 95% CI, 0.75 to 1.17; P = 0.96 by the log-rank test; P = 0.07 for interaction). CONCLUSIONS Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. The findings from this molecular pathological epidemiology study suggest that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy. (Funded by The National Institutes of Health and others.)	[Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Baba, Yoshifumi] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan; [Shima, Kaori] Kagoshima Univ, Dept Oral Pathol, Kagoshima 890, Japan; [Nosho, Katsuhiko] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Tokyo; Kumamoto University; Kagoshima University; Sapporo Medical University	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02115 USA.	achan@partners.org; shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323; Qian, Zhi rong/0000-0003-1633-4120	National Institutes of Health [P01 CA87969, P01 CA55075, P50 CA127003, R01 CA149222, R01 CA137178, R01 CA151993]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE [R01CA137178, P50CA127003, P01CA087969, R01CA149222, P01CA055075, R01CA151993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; Chief Scientist Office [CAF/10/15] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chief Scientist Office	Supported by grants from the National Institutes of Health (P01 CA87969 and P01 CA55075; P50 CA127003, to Dr. Fuchs; R01 CA149222, to Dr. Meyerhardt; R01 CA137178, to Dr. Chan; and R01 CA151993, to Dr. Ogino), the Bennett Family Fund for Targeted Therapies Research, and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; by the Frank Knox Memorial Fellowship at Harvard University and a fellowship from the Chief Scientist Office, Scotland (to Dr. Lochhead); and by a Damon Runyon Clinical Investigator Award (to Dr. Chan).	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; He YJ, 2009, CLIN CANCER RES, V15, P6956, DOI 10.1158/1078-0432.CCR-09-1165; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kaur J, 2010, TUMOR BIOL, V31, P623, DOI 10.1007/s13277-010-0078-9; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/erm.12.46, 10.1586/ERM.12.46]; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	40	618	643	8	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1596	1606		10.1056/NEJMoa1207756	http://dx.doi.org/10.1056/NEJMoa1207756			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094721	Green Accepted, Bronze			2022-12-01	WOS:000310131700006
J	Hammerman, PS; Lawrence, MS; Voet, D; Jing, R; Cibulskis, K; Sivachenko, A; Stojanov, P; McKenna, A; Lander, ES; Gabriel, S; Getz, G; Sougnez, C; Imielinski, M; Helman, E; Hernandez, B; Pho, NH; Meyerson, M; Chu, A; Chun, HJE; Mungall, AJ; Pleasance, E; Robertson, AG; Sipahimalani, P; Stoll, D; Balasundaram, M; Birol, I; Butterfield, YSN; Chuah, E; Coope, RJN; Corbett, R; Dhalla, N; Guin, R; Hirst, AC; Hirst, M; Holt, RA; Lee, D; Li, HI; Mayo, M; Moore, RA; Mungall, K; Nip, KM; Olshen, A; Schein, JE; Slobodan, JR; Tam, A; Thiessen, N; Varhol, R; Zeng, T; Zhao, Y; Jones, SJM; Marra, MA; Saksena, G; Cherniack, AD; Schumacher, SE; Tabak, B; Carter, SL; Pho, NH; Nguyen, H; Onofrio, RC; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Hammerman, PS; Getz, G; Meyerson, M; Protopopov, A; Zhang, JH; Hadjipanayis, A; Lee, S; Xi, RB; Yang, LX; Ren, XJ; Zhang, HL; Shukla, S; Chen, PC; Haseley, P; Lee, E; Chin, L; Park, PJ; Kucherlapati, R; Socci, ND; Liang, YP; Schultz, N; Borsu, L; Lash, AE; Viale, A; Sander, C; Ladanyi, M; Auman, JT; Hoadley, KA; Wilkerson, MD; Shi, Y; Liquori, C; Meng, SW; Li, L; Turman, YJ; Topal, MD; Tan, DH; Waring, S; Buda, E; Walsh, J; Jones, CD; Mieczkowski, PA; Singh, D; Wu, J; Gulabani, A; Dolina, P; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; O'Connor, BD; Prins, JF; Liu, J; Chiang, DY; Hayes, DN; Perou, CM; Cope, L; Danilova, L; Weisenberger, DJ; Maglinte, DT; Pan, F; den Berg, DJ; Triche, T; Herman, JG; Baylin, SB; Laird, PW; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Schultz, N; Sinha, R; Ciriello, G; Cerami, E; Gross, B; Jacobsen, A; Gao, J; Aksoy, BA; Weinhold, N; Ramirez, R; Taylor, BS; Antipin, Y; Reva, B; Shen, RL; Mo, Q; Seshan, V; Paik, PK; Ladanyi, M; Sander, C; Akbani, R; Zhang, NX; Broom, BM; Casasent, T; Unruh, A; Wakefield, C; Cason, RC; Baggerly, KA; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Zhu, JC; Szeto, C; Scott, GK; Yau, C; Ng, S; Goldstein, T; Waltman, P; Sokolov, A; Ellrott, K; Collisson, EA; Zerbino, D; Wilks, C; Ma, S; Craft, B; Wilkerson, MD; Auman, JT; Hoadley, KA; Du, Y; Cabanski, C; Walter, V; Singh, D; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Marron, JS; Liu, Y; Wang, K; Liu, J; Prins, JF; Hayes, DN; Perou, CM; Creighton, CJ; Zhang, YQ; Travis, WD; Rekhtman, N; Yi, J; Aubry, MC; Cheney, R; Dacic, S; Flieder, D; Funkhouser, W; Illei, P; Myers, J; Tsao, MS; Penny, R; Mallery, D; Shelton, T; Hatfield, M; Morris, S; Yena, P; Shelton, C; Sherman, M; Paulauskis, J; Meyerson, M; Baylin, SB; Govindan, R; Akbani, R; Azodo, I; Beer, D; Bose, R; Byers, LA; Carbone, D; Chang, LW; Chiang, D; Chu, A; Chun, E; Collisson, E; Cope, L; Creighton, CJ; Danilova, L; Ding, L; Getz, G; Hammerman, PS; Hayes, DN; Hernandez, B; Herman, JG; Heymach, J; Ida, C; Imielinski, M; Johnson, B; Jurisica, I; Kaufman, J; Kosari, F; Kucherlapati, R; Kwiatkowski, D; Ladanyi, M; Lawrence, MS; Maher, CA; Mungall, A; Ng, S; Pao, W; Peifer, M; Penny, R; Robertson, G; Rusch, V; Sander, C; Schultz, N; Shen, RL; Siegfried, J; Sinha, R; Sivachenko, A; Sougnez, C; Stoll, D; Stuart, J; Thomas, RK; Tomaszek, S; Tsao, MS; Travis, WD; Vaske, C; Weinstein, JN; Weisenberger, D; Wheeler, D; Wigle, DA; Wilkerson, MD; Wilks, C; Yang, P; Zhang, JJ; Jensen, MA; Sfeir, R; Kahn, AB; Chu, AL; Kothiyal, P; Wang, Z; Snyder, EE; Pontius, J; Pihl, TD; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, DL; Nicholls, MC; Srinivasan, D; Raman, R; Girshik, S; Kigonya, PA; Alonso, S; Sanbhadti, RN; Barletta, SP; Greene, JM; Pot, DA; Tsao, MS; Bandarchi-Chamkhaleh, B; Boyd, J; Weaver, J; Wigle, DA; Azodo, IA; Tomaszek, SC; Aubry, MC; Ida, CM; Yang, P; Kosari, F; Brock, MV; Rogers, K; Rutledge, M; Brown, T; Lee, B; Shin, J; Trusty, D; Dhir, R; Siegfried, JM; Potapova, O; Fedosenko, KV; Nemirovich-Danchenko, E; Rusch, V; Zakowski, M; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Fan, Z; Todaro, N; Eckman, J; Myers, J; Rathmell, WK; Thorne, LB; Huang, M; Boice, L; Hill, A; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Morrison, C; Gaudioso, C; Bartlett, JS; Kodeeswaran, S; Zanke, B; Sekhon, H; David, K; Juhl, H; Van Le, X; Kohl, B; Thorp, R; Tien, NV; Van Bang, N; Sussman, H; Phu, BD; Hajek, R; PhiHung, N; Khan, KZ; Muley, T; Shaw, KRM; Sheth, M; Yang, L; Buetow, K; Davidsen, T; Demchok, JA; Eley, G; Ferguson, M; Dillon, LAL; Schaefer, C; Guyer, MS; Ozenberger, BA; Palchik, JD; Peterson, J; Sofia, HJ; Thomson, E; Meyerson, M				Hammerman, Peter S.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Imielinski, Marcin; Helman, Elena; Hernandez, Bryan; Pho, Nam H.; Meyerson, Matthew; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Nip, Ka Ming; Olshen, Adam; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Hammerman, Peter S.; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Jianhua; Hadjipanayis, Angela; Lee, Semin; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Ladanyi, Marc; Auman, J. Todd; Hoadley, Katherine A.; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Liu, Jinze; Chiang, Derek Y.; Hayes, D. Neil; Perou, Charles M.; Cope, Leslie; Danilova, Ludmila; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Herman, James G.; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Jinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Schultz, Nikolaus; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Mo, Qianxing; Seshan, Venkatraman; Paik, Paul K.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Collisson, Eric A.; Zerbino, Daniel; Wilks, Christopher; Ma, Singer; Craft, Brian; Wilkerson, Matthew D.; Auman, J. Todd; Hoadley, Katherine A.; Du, Ying; Cabanski, Christopher; Walter, Vonn; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Marron, J. S.; Liu, Yufeng; Wang, Kai; Liu, Jinze; Prins, Jan F.; Hayes, D. Neil; Perou, Charles M.; Creighton, Chad J.; Zhang, Yiqun; Travis, William D.; Rekhtman, Natasha; Yi, Joanne; Aubry, Marie C.; Cheney, Richard; Dacic, Sanja; Flieder, Douglas; Funkhouser, William; Illei, Peter; Myers, Jerome; Tsao, Ming-Sound; Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Meyerson, Matthew; Baylin, Stephen B.; Govindan, Ramaswamy; Akbani, Rehan; Azodo, Ijeoma; Beer, David; Bose, Ron; Byers, Lauren A.; Carbone, David; Chang, Li-Wei; Chiang, Derek; Chu, Andy; Chun, Elizabeth; Collisson, Eric; Cope, Leslie; Creighton, Chad J.; Danilova, Ludmila; Ding, Li; Getz, Gad; Hammerman, Peter S.; Hayes, D. Neil; Hernandez, Bryan; Herman, James G.; Heymach, John; Ida, Cristiane; Imielinski, Marcin; Johnson, Bruce; Jurisica, Igor; Kaufman, Jacob; Kosari, Farhad; Kucherlapati, Raju; Kwiatkowski, David; Ladanyi, Marc; Lawrence, Michael S.; Maher, Christopher A.; Mungall, Andy; Ng, Sam; Pao, William; Peifer, Martin; Penny, Robert; Robertson, Gordon; Rusch, Valerie; Sander, Chris; Schultz, Nikolaus; Shen, Ronglai; Siegfried, Jill; Sinha, Rileen; Sivachenko, Andrey; Sougnez, Carrie; Stoll, Dominik; Stuart, Joshua; Thomas, Roman K.; Tomaszek, Sandra; Tsao, Ming-Sound; Travis, William D.; Vaske, Charles; Weinstein, John N.; Weisenberger, Daniel; Wheeler, David; Wigle, Dennis A.; Wilkerson, Matthew D.; Wilks, Christopher; Yang, Ping; Zhang, Jianjua John; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique L.; Nicholls, Matthew C.; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter A.; Alonso, Shelley; Sanbhadti, Rashmi N.; Barletta, Sean P.; Greene, John M.; Pot, David A.; Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan; Boyd, Jeff; Weaver, JoEllen; Wigle, Dennis A.; Azodo, Ijeoma A.; Tomaszek, Sandra C.; Aubry, Marie Christine; Ida, Christiane M.; Yang, Ping; Kosari, Farhad; Brock, Malcolm V.; Rogers, Kristen; Rutledge, Marian; Brown, Travis; Lee, Beverly; Shin, James; Trusty, Dante; Dhir, Rajiv; Siegfried, Jill M.; Potapova, Olga; Fedosenko, Konstantin V.; Nemirovich-Danchenko, Elena; Rusch, Valerie; Zakowski, Maureen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Fan, Zhen; Todaro, Nicole; Eckman, John; Myers, Jerome; Rathmell, W. Kimryn; Thorne, Leigh B.; Huang, Mei; Boice, Lori; Hill, Ashley; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo; Bartlett, Johnm. S.; Kodeeswaran, Sugy; Zanke, Brent; Sekhon, Harman; David, Kerstin; Juhl, Hartmut; Van Le, Xuan; Kohl, Bernard; Thorp, Richard; Tien, Nguyen Viet; Van Bang, Nguyen; Sussman, Howard; Phu, Bui Duc; Hajek, Richard; PhiHung, Nguyen; Khan, Khurram Z.; Muley, Thomas; Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Buetow, Ken; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin; Dillon, Laura A. L.; Schaefer, Carl; Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth; Meyerson, Matthew		Canc Genome Atlas Res Network	Comprehensive genomic characterization of squamous cell lung cancers	NATURE			English	Article							COPY-NUMBER ALTERATION; THERAPEUTIC TARGET; MUTATIONS; GENE; AMPLIFICATION; CARCINOMA; SENSITIVITY; LANDSCAPE; GEFITINIB; ONCOGENE	Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths per year worldwide. Genomic alterations in squamous cell lung cancers have not been comprehensively characterized, and no molecularly targeted agents have been specifically developed for its treatment. As part of The Cancer Genome Atlas, here we profile 178 lung squamous cell carcinomas to provide a comprehensive landscape of genomic and epigenomic alterations. We show that the tumour type is characterized by complex genomic alterations, with a mean of 360 exonic mutations, 165 genomic rearrangements, and 323 segments of copy number alteration per tumour. We find statistically recurrent mutations in 11 genes, including mutation of TP53 in nearly all specimens. Previously unreported loss-of-function mutations are seen in the HLA-A class I major histocompatibility gene. Significantly altered pathways included NFE2L2 and KEAP1 in 34%, squamous differentiation genes in 44%, phosphatidylinositol-3-OH kinase pathway genes in 47%, and CDKN2A and RB1 in 72% of tumours. We identified a potential therapeutic target in most tumours, offering new avenues of investigation for the treatment of squamous cell lung cancers.	[Sivachenko, Andrey; McKenna, Aaron; Cherniack, Andrew D.; Crenshaw, Andrew; Hadjipanayis, Angela; Chen, Peng-Chieh; Kucherlapati, Raju] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hammerman, Peter S.; Meyerson, Matthew; Beroukhim, Rameen; Hammerman, Peter S.; Meyerson, Matthew; Johnson, Bruce] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.; Sougnez, Carrie] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Onofrio, Robert C.; Ardlie, Kristin] Harvard Univ, Genet Anal Platform, Cambridge, MA 02142 USA; [Imielinski, Marcin; Meyerson, Matthew; Meyerson, Matthew; Imielinski, Marcin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Chuah, Eric; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Mungall, Karen; Nip, Ka Ming; Schein, Jacqueline E.; Slobodan, Jared R.; Thiessen, Nina; Marra, Marco A.; Chun, Elizabeth; Mungall, Andy; Robertson, Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Olshen, Adam] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam] Dana Farber Canc Inst, Boston, MA 02115 USA; [Protopopov, Alexei; Zhang, Jianhua; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Zhang, Jinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77030 USA; [Hadjipanayis, Angela; Ren, Xiaojia; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lee, Semin; Xi, Ruibin; Yang, Lixing; Haseley, Psalm; Lee, Eunjung; Gehlenborg, Nils] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Mol Oncol, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, New York, NY 10065 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd; Zerbino, Daniel; Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mose, Lisle E.; Jefferys, Stuart R.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Wilkerson, Matthew D.; Liquori, Christina; Li, Ling; Buda, Elizabeth; Walsh, Jesse; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Collisson, Eric A.; Craft, Brian; Cabanski, Christopher; Prins, Jan F.; Chiang, Derek; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tan, Donghui; Liu, Yufeng] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Hayes, D. Neil] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Balu, Saianand; Prins, Jan F.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Cope, Leslie; Danilova, Ludmila; Herman, James G.; Baylin, Stephen B.] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Laird, Peter W.; Weisenberger, Daniel; Wilks, Christopher] Univ So Calif, Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Unruh, Anna; Wakefield, Chris; Baggerly, Keith A.; Weinstein, John N.; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Cason, R. Craig] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Ng, Sam; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Collisson, Eric] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Marron, J. S.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Creighton, Chad J.; Zhang, Yiqun] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Yiqun] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Travis, William D.; Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Yi, Joanne; Aubry, Marie C.; Ida, Cristiane] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Cheney, Richard; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Dacic, Sanja] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Flieder, Douglas; Boyd, Jeff; Weaver, JoEllen] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Funkhouser, William] Univ N Carolina, Dept Pathol, Med Ctr, Chapel Hill, NC 27599 USA; [Illei, Peter] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21287 USA; [Myers, Jerome] Penrose St Francis Hlth Syst, Dept Pathol, Colorado Springs, CO 80907 USA; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Ontario Canc Inst, Dept Pathol & Med Biophys, Toronto, ON M5G 2MY, Canada; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Princess Margaret Hosp, Toronto, ON M5G 2MY, Canada; [Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Hill, Ashley; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Govindan, Ramaswamy; Bose, Ron; Chang, Li-Wei; Ding, Li; Maher, Christopher A.] Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO 63110 USA; [Beer, David] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Carbone, David; Kaufman, Jacob; Pao, William] Vanderbilt Univ, Dept Hematol, Nashville, TN 37232 USA; [Jurisica, Igor; Brock, Malcolm V.] IBM Life Sci Discovery Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Peifer, Martin; Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Rusch, Valerie] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Siegfried, Jill; Siegfried, Jill M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Med Ctr, Pittsburgh, PA 15232 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Canc Genom, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Wheeler, David] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ida, Christiane M.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Rogers, Kristen; Brown, Travis] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Rutledge, Marian; Lee, Beverly] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Shin, James; Trusty, Dante] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Dhir, Rajiv] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Potapova, Olga; Nemirovich-Danchenko, Elena] Cureline, San Francisco, CA 94080 USA; [Fedosenko, Konstantin V.] City Clin Oncol Dispensary, St Petersburg 197022, Russia; [Zakowski, Maureen] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Fan, Zhen; Todaro, Nicole; Huang, Mei] St Joseph Med Ctr, Towson, MD 21204 USA; [Thorne, Leigh B.] UNC Lineberger Canc Ctr, UNC Tissue Procurement Facil, Dept Pathol, Chapel Hill, NC 27599 USA; [Kodeeswaran, Sugy; Zanke, Brent] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [David, Kerstin] Indivumed GmbH, D-20251 Hamburg, Germany; [Juhl, Hartmut] Indivumed Inc, Kensington, MD 20895 USA; [Van Le, Xuan; Kohl, Bernard; Thorp, Richard] ILSBio LLC, Chestertown, MD 21620 USA; [Tien, Nguyen Viet] Minist Hlth, Hanoi, Vietnam; [Van Bang, Nguyen] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Phu, Bui Duc; PhiHung, Nguyen] Natl Canc Inst, Hanoi, Vietnam; [Khan, Khurram Z.] ILSBio LLC, Chestertown, MD 21620 USA; [Muley, Thomas] Univ Heidelberg Hosp, ThoraxKlin, D-69126 Heidelberg, Germany; [Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Demchok, John A.; Dillon, Laura A. L.] NCI, Canc Genome Atlas Program Off, Bethesda, MD 20892 USA; [Buetow, Ken; Davidsen, Tanja; Eley, Greg; Schaefer, Carl] NCI, CBIIT, NIH, Rockville, MD 20852 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; International Genomics Consortium; Washington University (WUSTL); University of Michigan System; University of Michigan; Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cologne; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; Baylor College of Medicine; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Helen F. Graham Cancer Center & Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Ruprecht Karls University Heidelberg; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyerson, M (corresponding author), MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	Laird, Peter W/G-8683-2012; Perou, Charles M/H-9934-2014; Schultz, Nikolaus/ABE-6347-2020; Heymach, John/AAG-2361-2019; Auman, James/AAY-7748-2020; Cherniack, Andrew/AAC-5310-2019; Weisenberger, Daniel/AAA-8314-2020; Hirst, Martin/B-7684-2016; Schein, Jacquie E/G-3674-2015; Reva, Boris/AAB-8932-2022; Schumacher, Steven/E-9821-2013; Skanderup, Anders Jacobsen/K-1081-2013; Zhang, YiQun/HCI-2427-2022; Van Den Berg, David J/G-8598-2017; Yang, Lixing/A-7073-2013; Reva, Boris A./B-6436-2014; Mesirov, Jill/AGF-7626-2022; Tsao, Ming-Sound/M-3503-2017; Stojanov, Petar/GQI-4462-2022; Ladanyi, Marc/AAG-8585-2019; Cibulskis, Kristian/AAC-7380-2019; Birol, Inanc/G-5440-2011; Gao, JianJiong/B-5673-2016; Cherniack, Andrew D./AAY-8132-2020; Muley, Thomas/AAY-9200-2020; Jones, Steven J/C-3621-2009; Akbani, Rehan/AAG-1490-2019; Wheeler, David A/M-9740-2018; Vaske, Charles/D-6018-2013; Tsao, Ming Sound/AFQ-7332-2022; Kucherlapati, Raju/ABC-8807-2021; Chiang, Derek/L-6452-2019; Noble, Michelle M/C-4653-2011; Lee, Semin/S-2629-2016; Holt, Robert A/C-3303-2009; Marra, Marco A/B-5987-2008; , Pathology Services Core/CEZ-2246-2022; Mungall, Andrew J./U-7067-2018; Lawrence, Michael/AAC-8202-2020; Walter, Vonn/AAI-3450-2021	Laird, Peter W/0000-0001-9117-3641; Perou, Charles M/0000-0001-9827-2247; Heymach, John/0000-0001-9068-8942; Weisenberger, Daniel/0000-0001-8303-2603; Schumacher, Steven/0000-0002-6819-5647; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Van Den Berg, David J/0000-0002-5404-5218; Reva, Boris A./0000-0002-8805-389X; Stojanov, Petar/0000-0001-7815-776X; Birol, Inanc/0000-0003-0950-7839; Gao, JianJiong/0000-0002-5739-1781; Cherniack, Andrew D./0000-0003-0470-0111; Jones, Steven J/0000-0003-3394-2208; Wheeler, David A/0000-0002-9056-6299; Vaske, Charles/0000-0001-8151-6612; Tsao, Ming Sound/0000-0002-9160-5405; Noble, Michelle M/0000-0001-6820-1034; Lee, Semin/0000-0002-9015-6046; Holt, Robert A/0000-0002-7259-1247; Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Walter, Vonn/0000-0001-6114-6714; Jensen, Mark/0000-0001-5215-101X; Auman, James/0000-0002-9328-8829; Lash, Alex/0000-0003-3787-1590; Sinha, Rileen/0000-0001-5497-5055; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765; Rusch, Valerie/0000-0003-2345-6900; O'Connor, Brian/0000-0002-7681-6415; Stuart, Joshua/0000-0002-2171-565X; Casasent, Anna/0000-0002-7857-179X; Pot, David/0000-0002-1480-9826; Zerbino, Daniel/0000-0001-5350-3056; Mieczkowski, Piotr/0000-0003-2418-0096; Weinstein, John/0000-0001-9401-6908; Schultz, Nikolaus/0000-0002-0131-4904; Park, Peter/0000-0001-9378-960X; Peifer, Martin/0000-0002-5243-5503; Gehlenborg, Nils/0000-0003-0327-8297; Hoadley, Katherine/0000-0002-1216-477X; Xi, Ruibin/0000-0001-7545-7361; Ciriello, Giovanni/0000-0003-2021-8683; Stoll, Dominik/0000-0003-0701-4301; Cibulskis, Kristian/0000-0003-1343-1582; Triche, Tim/0000-0001-5665-946X; Meyerson, Matthew/0000-0002-9133-8108; Hayes, D. Neil/0000-0001-6203-7771	NIH [U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079, U54 HG003273]; Emerging Frontiers [0850237] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U24CA143840, U24CA143867, U24CA143883, U24CA126546, P30CA016086, U24CA143858, P30CA016672, U24CA126551, R01CA149569, U24CA126544, U24CA143845, U24CA126554, U24CA143882, U24CA126561, U24CA143799, R01CA094143, U24CA143866, U24CA144025, T32CA009172, U24CA126543, U24CA143848, R00CA149182, U24CA143843, U24CA126563, U24CA143835, K08CA137153] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, R01HG006272, U54HG003273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by NIH grants U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079 and U54 HG003273.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bishop JA, 2011, MODERN PATHOL, V24, p405A; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Felip E, 2011, VET REC, V169, P1507, DOI 10.1093/annonc/mdr150; Govindan R, 2010, J THORAC ONCOL, V5, pS433, DOI 10.1097/JTO.0b013e3181fd6fe1; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kancha RK, 2011, J THORAC ONCOL, V6, P387, DOI 10.1097/JTO.0b013e3182021f3e; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massion PP, 2003, CANCER RES, V63, P7113; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morris PG, 2010, J CLIN ONCOL, V28, P3154, DOI 10.1200/JCO.2009.27.5743; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wikman H, 2006, EXPERT REV ANTICANC, V6, P515, DOI 10.1586/14737140.6.4.515; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; World Health Organization (WHO), CANCER	46	2586	2630	16	333	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					519	525		10.1038/nature11404	http://dx.doi.org/10.1038/nature11404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22960745	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-01	WOS:000309167100041
J	Hawrylycz, MJ; Lein, ES; Guillozet-Bongaarts, AL; Shen, EH; Ng, L; Miller, JA; van de Lagemaat, LN; Smith, KA; Ebbert, A; Riley, ZL; Abajian, C; Beckmann, CF; Bernard, A; Bertagnolli, D; Boe, AF; Cartagena, PM; Chakravarty, MM; Chapin, M; Chong, J; Dalley, RA; Daly, BD; Dang, C; Datta, S; Dee, N; Dolbeare, TA; Faber, V; Feng, D; Fowler, DR; Goldy, J; Gregor, BW; Haradon, Z; Haynor, DR; Hohmann, JG; Horvath, S; Howard, RE; Jeromin, A; Jochim, JM; Kinnunen, M; Lau, C; Lazarz, ET; Lee, C; Lemon, TA; Li, L; Li, Y; Morris, JA; Overly, CC; Parker, PD; Parry, SE; Reding, M; Royall, JJ; Schulkin, J; Sequeira, PA; Slaughterbeck, CR; Smith, SC; Sodt, AJ; Sunkin, SM; Swanson, BE; Vawter, MP; Williams, D; Wohnoutka, P; Zielke, HR; Geschwind, DH; Hof, PR; Smith, SM; Koch, C; Grant, SGN; Jones, AR				Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; van de lagemaat, Louie N.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Beckmann, Christian F.; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Cartagena, Preston M.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Daly, Barry David; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Fowler, David R.; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Haynor, David R.; Hohmann, John G.; Horvath, Steve; Howard, Robert E.; Jeromin, Andreas; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Ling; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Schulkin, Jay; Sequeira, Pedro Adolfo; Slaughterbeck, Clifford R.; Smith, Simon C.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Vawter, Marquis P.; Williams, Derric; Wohnoutka, Paul; Zielke, H. Ronald; Geschwind, Daniel H.; Hof, Patrick R.; Smith, Stephen M.; Koch, Christof; Grant, Seth G. N.; Jones, Allan R.			An anatomically comprehensive atlas of the adult human brain transcriptome	NATURE			English	Article							LISTS	Neuroanatomically precise, genome-wide maps of transcript distributions are critical resources to complement genomic sequence data and to correlate functional and genetic brain architecture. Here we describe the generation and analysis of a transcriptional atlas of the adult human brain, comprising extensive histological analysis and comprehensive microarray profiling of similar to 900 neuroanatomically precise subdivisions in two individuals. Transcriptional regulation varies enormously by anatomical location, with different regions and their constituent cell types displaying robust molecular signatures that are highly conserved between individuals. Analysis of differential gene expression and gene co-expression relationships demonstrates that brain-wide variation strongly reflects the distributions of major cell classes such as neurons, oligodendrocytes, astrocytes and microglia. Local neighbourhood relationships between fine anatomical subdivisions are associated with discrete neuronal subtypes and genes involved with synaptic transmission. The neocortex displays a relatively homogeneous transcriptional pattern, but with distinct features associated selectively with primary sensorimotor cortices and with enriched frontal lobe expression. Notably, the spatial topography of the neocortex is strongly reflected in its molecular topography-the closer two cortical regions, the more similar their transcriptomes. This freely accessible online data resource forms a high-resolution transcriptional baseline for neurogenetic studies of normal and abnormal human brain function.	[Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Hohmann, John G.; Howard, Robert E.; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Slaughterbeck, Clifford R.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Williams, Derric; Wohnoutka, Paul; Koch, Christof; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [van de lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland; [Beckmann, Christian F.] Univ Twente, MIRA Inst, Nijmegen, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst, NL-6525 ED Nijmegen, Netherlands; [Cartagena, Preston M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Chakravarty, M. Mallar] Ctr Addict & Mental Hlth Toronto, Kimel Family Translat Imaging Genet Lab, Toronto, ON M5S 2S1, Canada; [Daly, Barry David] Univ Maryland, Sch Med, Dept Diagnost Radiol, Med Ctr, Baltimore, MD 21201 USA; [Fowler, David R.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Haynor, David R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Res Ctr, Los Angeles, CA 90095 USA; [Jeromin, Andreas] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Li, Ling] Off Chief Med Examiner, Baltimore, MD USA; [Li, Ling] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Schulkin, Jay] Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; [Sequeira, Pedro Adolfo; Vawter, Marquis P.] Univ Calif Irvine, Funct Genom Lab, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92697 USA; [Smith, Simon C.] Histion LLC, Everett, WA 98204 USA; [Zielke, H. Ronald] Univ Maryland, Eunice Kennedy Shriver NICHD Brain & Tissue Bank, Baltimore, MD 21201 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Smith, Stephen M.] Univ Oxford, FMRIB, Oxford OX3 9DU, England; [Koch, Christof] CALTECH, Pasadena, CA 91125 USA	Allen Institute for Brain Science; University of Edinburgh; Radboud University Nijmegen; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Banyan Biomarkers Inc.; University System of Maryland; University of Maryland Baltimore; Georgetown University; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; California Institute of Technology	Hawrylycz, MJ (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	mikeh@alleninstitute.org	Beckmann, Christian F./E-6374-2012; Sequeira, Adolfo/K-7278-2015	Beckmann, Christian F./0000-0002-3373-3193; Sequeira, Adolfo/0000-0003-3040-1190; Feng, David/0000-0002-4920-8123; Dee, Nick/0000-0002-2831-9254; Koch, Christof/0000-0001-6482-8067; Grant, Seth/0000-0001-8732-8735; Parker, Patrick/0000-0001-5217-107X; Smith, Stephen/0000-0001-8166-069X; Arnold, James/0000-0001-7011-591X; Bernard, Amy/0000-0003-2540-1153	Department of Health and Human Services Health Resources and Services Administration Awards [1C76HF15069-01-00, 1 1C76HF19619-01-00]; MRCD; Wellcome Trust; European Union Seventh Framework Programme [241498 EUROSPIN, 242167 SynSys, 241995 GENCODYS]; MRC [G0700399, G0802238] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801, R37MH060233] Funding Source: NIH RePORTER; Medical Research Council [G0802238, G0700399] Funding Source: researchfish	Department of Health and Human Services Health Resources and Services Administration Awards; MRCD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Seventh Framework Programme(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement, and support. We express our gratitude to past and present Allen Institute staff members R. Adams, K. Aiona, A. Alpisa, J. Arnold, C. Bennet, K. Brouner, S. Butler, E. Byrnes, S. Caldejon, J. Campiche, A. Carey, J. Chen, C. Copeland, C. Cuhaciyan, T. Desta, N. Dotson, S. Faber, T. Fliss, E. Fulfs, G. Gee, T. Gilbert, L. Gourley, G. Gu, J. Heilman, N. Ivanov, K. Keyser, A. Kriedberg, J. Laoenkue, F. Lee, S. Levine, L. Luong, N. Mastan, N. Mosqueda, E. Mott, N. Motz, D. Muzia, K. Ngo, A. Oldre, E. Olson, J. Parente, J. Phillips, L. Potekhina, T. Roberts, K. Roll, D. Rosen, M. Sarreal, S. Shapouri, N. Shapovalova, C. Simpson, D. Simpson, M. Smith, N. Stewart, K. Sweeney, A. Szafer, L. Velasquez, U. Wagley, W. Wakeman, C. White and B. Youngstrom for their technical assistance. We thank C. Long for mechanical engineering contract work. We thank R. Gullapalli, A. McMillan and R. Morales for post-mortem magnetic resonance imaging and radiology interpretation of MR data; J. Cottrell, M. Davis, R. Johnson, K. Moraniec, R. Vigorito, A. Weldon and the NICHD Brain and Tissue Bank for Developmental Disorders for tissue acquisition and processing; J. Davis for donor coordination; F. Mamdani, M. Martin, E. Moon, L. Morgan, B. Rollins and D. Walsh for tissue processing and psychological autopsy (DW); D. Patel for magnetic resonance imaging; and J. Sonnen for consultation on tissue microneuropathology. We also thank the External RNA Controls Consortium (ERCC), the US National Institute of Standards (NIST) and Technology, and M. Salit for access to ERCC transcripts during Phase V testing. We are grateful to Beckman Coulter Genomics (formerly Cogenics) and their staff P. Hurban, E. Lobenhofer, K. Phillips, A. Rouse and S. Beaver for microarray data generation and design of the custom Agilent array. We also wish to thank the Allen Human Brain Atlas Advisory Council members D. Geschwind, R. Gibbs, P. Hof, E. Jones, C. Koch, C. Saper, L. Swanson, A. Toga and D. Van Essen for their scientific guidance and dedication to the successful execution of this project. The project described was supported in part by Grant Numbers 1C76HF15069-01-00 and 1 1C76HF19619-01-00 from the Department of Health and Human Services Health Resources and Services Administration Awards and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services Health Resources and Services Administration Awards. S. G. N. G and L. V. L. were supported by the MRCD, Wellcome Trust and European Union Seventh Framework Programme under grants 241498 EUROSPIN, 242167 SynSys, and 241995 GENCODYS Projects.	Amaral D. G., 1990, HUMAN NERVOUS SYSTEM, P771; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd Y. L., 2005, HDB CHEM NEUROANATOM, P525; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zilles K, 2002, EUR NEUROPSYCHOPHARM, V12, P587, DOI 10.1016/S0924-977X(02)00108-6	35	1383	1401	10	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					391	399		10.1038/nature11405	http://dx.doi.org/10.1038/nature11405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996553	Green Accepted			2022-12-01	WOS:000308860900037
J	Phillips, R; Hancock, B; Graham, J; Bromham, N; Jin, HJ; Berendse, S				Phillips, Robert; Hancock, Barry; Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine			Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Phillips, Robert] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Hancock, Barry] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England; [Graham, John] Taunton & Somerset NHS Fdn Trust, Taunton TA1 5DA, Somerset, England	Leeds General Infirmary; University of Leeds; University of Sheffield; Weston Park Hospital	Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net	; Jin, Huajie/J-1332-2014	Graham, John/0000-0003-3381-9787; Jin, Huajie/0000-0002-3872-3998; Bromham, Nathan/0000-0003-2165-4188	MRC [G0800472] Funding Source: UKRI; Medical Research Council [G0800472] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dommett R, 2009, EUR J CANCER, V45, P2843, DOI 10.1016/j.ejca.2009.06.003; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; National Cancer Action Team, 2011, MAN CANC SERV AC ONC; National Chemotherapy Advisory Group, 2010, CHEM SERV ENGL ENS Q; National Confidential Enquiry into Patient Outcome and Death, 2008, SYST ANT THER BETT W; National Institute of Health and Clinical Excellence, 2012, NEUTR SEPS PREV MAN	7	36	37	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 19	2012	345								e5368	10.1136/bmj.e5368	http://dx.doi.org/10.1136/bmj.e5368			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JI	22993392	Green Submitted			2022-12-01	WOS:000309160500001
J	Franchi, L; Nunez, G				Franchi, Luigi; Nunez, Gabriel			Orchestrating Inflammasomes	SCIENCE			English	Editorial Material							III SECRETION APPARATUS; INNATE IMMUNE RECEPTOR; NLRC4 INFLAMMASOME; HOST TARGET; ACTIVATION; FLAGELLIN; INTERLEUKIN-1-BETA; RECOGNITION; CASPASE-1; IPAF		[Franchi, Luigi] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Comprehens Canc Ctr, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Franchi, L (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK091191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	13	51	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1299	1300		10.1126/science.1229010	http://dx.doi.org/10.1126/science.1229010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984056	Green Accepted			2022-12-01	WOS:000308705000026
J	Yu, DB; Pendergraff, H; Liu, J; Kordasiewicz, HB; Cleveland, DW; Swayze, EE; Lima, WF; Crooke, ST; Prakash, TP; Corey, DR				Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Kordasiewicz, Holly B.; Cleveland, Don W.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.; Corey, David R.			Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression	CELL			English	Article							EXPANDED CAG REPEATS; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; GENE-EXPRESSION; MESSENGER-RNAS; DISEASE GENES; MOUSE MODEL; INTERFERENCE; ANTISENSE; SIRNAS	Mutant huntingtin (HTT) protein causes Huntington disease (HD), an incurable neurological disorder. Silencing mutant HTT using nucleic acids would eliminate the root cause of HD. Developing nucleic acid drugs is challenging, and an ideal clinical approach to gene silencing would combine the simplicity of single-stranded antisense oligonucleotides with the efficiency of RNAi. Here, we describe RNAi by single-stranded siRNAs (ss-siRNAs). ss-siRNAs are potent (>100-fold more than unmodified RNA) and allele-selective (>30-fold) inhibitors of mutant HTT expression in cells derived from HD patients. Strategic placement of mismatched bases mimics micro-RNA recognition and optimizes discrimination between mutant and wild-type alleles. ss-siRNAs require Argonaute protein and function through the RNAi pathway. Intraventricular infusion of ss-siRNA produced selective silencing of the mutant HTT allele throughout the brain in a mouse HD model. These data demonstrate that chemically modified ss-siRNAs function through the RNAi pathway and provide allele-selective compounds for clinical development.	[Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kordasiewicz, Holly B.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kordasiewicz, Holly B.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.] ISIS Pharmaceut, Carlsbad, CA 92010 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Isis Pharmaceuticals Inc	Corey, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	david.corey@utsouthwestern.edu	Cleveland, Don/AAN-9783-2021	Swayze, Eric/0000-0001-6430-6576; Cleveland, Don/0000-0002-1934-3682	US National Institutes of Health [NIGMS 73042]; McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation [I-1244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073042] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Corey Laboratory was supported by the US National Institutes of Health (NIGMS 73042), an award from the McKnight Foundation for Neuroscience, CHDI Foundation Inc., and the Robert A. Welch Foundation (I-1244). We thank Dr. Hui Tian and Haoming Liu of Qinghua Liu's Lab for generously providing us with recombinant hAgo2 proteins and the training on Ago2 activity assay and Dr. Keith Gagnon for helpful comments and for assistance setting up the in vitro AGO2 and RNAse H assays. The authors have filed a patent application related to this research.	Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gagnon KT, 2011, J AM CHEM SOC, V133, P8404, DOI 10.1021/ja200312y; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Hall AHS, 2006, NUCLEIC ACIDS RES, V34, P2773, DOI 10.1093/nar/gkl339; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Hu JX, 2011, BIOL CHEM, V392, P315, DOI 10.1515/BC.2011.045; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matsui M, 2012, DRUG DISCOV TODAY, V17, P443, DOI 10.1016/j.drudis.2012.01.006; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	52	201	240	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					895	908		10.1016/j.cell.2012.08.002	http://dx.doi.org/10.1016/j.cell.2012.08.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939619	Green Accepted, Bronze			2022-12-01	WOS:000308500200006
J	Humphries, C				Humphries, Courtney			SCREENING Testing times	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S8	S9		10.1038/488S8a	http://dx.doi.org/10.1038/488S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932440	Bronze			2022-12-01	WOS:000308095100007
J	Imai, KS; Daido, Y; Kusakabe, TG; Satou, Y				Imai, Kaoru S.; Daido, Yutaka; Kusakabe, Takehiro G.; Satou, Yutaka			Cis-Acting Transcriptional Repression Establishes a Sharp Boundary in Chordate Embryos	SCIENCE			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; ORGANIZER; ADMP; GENE; EXPRESSION	The function of bone morphogenetic protein (BMP) signaling in dorsoventral (DV) patterning of animal embryos is conserved among Bilateria. In vertebrates, the BMP ligand antidorsalizing morphogenetic protein (Admp) is expressed dorsally and moves to the opposite side to specify the ventral fate. Here, we show that Pinhead is an antagonist specific for Admp with a role in establishing the DV axis of the trunk epidermis in embryos of the ascidian Ciona intestinalis. Pinhead and Admp exist in tandem in the genomes of various animals from arthropods to vertebrates. This genomic configuration is important for mutually exclusive expression of these genes, because Pinhead transcription directly disturbs the action of the Admp enhancer. Our data suggest that this dual negative regulatory mechanism is widely conserved in animals.	[Imai, Kaoru S.; Satou, Yutaka] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Kaoru S.] Kyoto Univ, Grad Sch Sci, Dept Biodivers, Sakyo Ku, Kyoto 6068502, Japan; [Daido, Yutaka; Kusakabe, Takehiro G.] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan	Kyoto University; Kyoto University; Konan University	Satou, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yutaka@ascidian.zool.kyoto-u.ac.jp	Kusakabe, Takehiro/H-7178-2012; Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012	Kusakabe, Takehiro/0000-0002-8325-3665; Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Imai, Kaoru/0000-0001-9113-6074	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS) [22870018, 22310120, 21671004]; Global Center of Excellence program [A06]; Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research [21671004, 22310120] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JSPS) to K. S. I. (22870018), T. G. K. (22310120), and Y.S. (21671004) and also in part by the Global Center of Excellence program (A06) to Kyoto University. K. S. I. was supported by a Restart Postdoctoral Fellowship (RPD) from JSPS. The cDNA sequences for Admp and Pinhead are available under accession nos. AB210298 and AK113761 in the DDBJ/EMBL/GenBank database. We are grateful to K. Hirayama for her assistance with this research.	Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dickmeis T, 2001, DEV GENES EVOL, V211, P568, DOI 10.1007/s00427-001-0190-3; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Gavino MA, 2011, CURR BIOL, V21, P294, DOI 10.1016/j.cub.2011.01.017; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Satou Y, 2008, DEV GENES EVOL, V218, P715, DOI 10.1007/s00427-008-0219-y; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494	14	20	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					964	967		10.1126/science.1222488	http://dx.doi.org/10.1126/science.1222488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923581				2022-12-01	WOS:000307807600045
J	Doronin, K; Flatt, JW; Di Paolo, NC; Khare, R; Kalyuzhniy, O; Acchione, M; Sumida, JP; Ohto, U; Shimizu, T; Akashi-Takamura, S; Miyake, K; MacDonald, JW; Bammler, TK; Beyer, RP; Farin, FM; Stewart, PL; Shayakhmetov, DM				Doronin, Konstantin; Flatt, Justin W.; Di Paolo, Nelson C.; Khare, Reeti; Kalyuzhniy, Oleksandr; Acchione, Mauro; Sumida, John P.; Ohto, Umeharu; Shimizu, Toshiyuki; Akashi-Takamura, Sachiko; Miyake, Kensuke; MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.; Stewart, Phoebe L.; Shayakhmetov, Dmitry M.			Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus	SCIENCE			English	Article							GENE-TRANSFER; IMMUNOCOMPROMISED PATIENTS; VIRUS-INFECTION; IN-VIVO; BINDING; HEXON; TRIGGERS; VECTORS; PATIENT; CELL	Although coagulation factors play a role in host defense for "living fossils" such as horseshoe crabs, the role of the coagulation system in immunity in higher organisms remains unclear. We modeled the interface of human species C adenovirus (HAdv) interaction with coagulation factor X (FX) and introduced a mutation that abrogated formation of the HAdv-FX complex. In vivo genome-wide transcriptional profiling revealed that FX-binding-ablated virus failed to activate a distinct network of nuclear factor kappa B-dependent early-response genes that are activated by HAdv-FX complex downstream of TLR4/MyD88/TRIF/TRAF6 signaling. Our study implicates host factor "decoration" of the virus as a mechanism to trigger an innate immune sensor that responds to a misplacement of coagulation FX from the blood into intracellular macrophage compartments upon virus entry into the cell.	[Doronin, Konstantin; Di Paolo, Nelson C.; Khare, Reeti; Shayakhmetov, Dmitry M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Kalyuzhniy, Oleksandr] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Acchione, Mauro; Sumida, John P.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Div Innate Immun, Minato Ku, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Lab Innate Immun, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.] Univ Washington, Funct Genom & Prote Core Facil, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; University of Washington; University of Washington Seattle	Shayakhmetov, DM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	dshax@uw.edu		Flatt, Justin/0000-0003-2985-0386; Flatt, Justin/0000-0001-5406-8156; Flatt, Justin/0000-0003-3227-8763; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	U.S. NIH [AI065429, CA141439]; University of Washington National Institute of Environmental Health Sciences [P30ES07033]; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE [R01CA141439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington National Institute of Environmental Health Sciences; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Akira (Osaka University, Japan) for providing mice deficient in MyD88, MD2, TLR4, TLR7/8, and TLR9; J.-I. Inoue (University of Tokyo, Japan) for TRAF6-deficient mice; R.A. Flavell (Yale University, CT) for Caspase-1-deficient mice; and V. Dixit (Roche, CA) for ASC-deficient mice. We acknowledge the assistance of D. R. Williams during cryo-EM data acquisition. The cryo-EM data was collected while J.W.F. and P.L.S. were at Vanderbilt University. We thank M. D. Hollenberg (University of Calgary, Canada), A. Aderem, and D. Zak (SeattleBioMed, USA) for helpful discussion and L. K. Baldwin for manuscript editing. This study was supported by U.S. NIH grants AI065429 and CA141439 to D.M.S., the University of Washington National Institute of Environmental Health Sciences-sponsored Center for Ecogenetics & Environmental Health (P30ES07033), and Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility, which is funded by the Washington State Life Sciences Discovery Fund. D.M.S. and P.L.S. designed the research; K.D., J.W.F., N.C.D.P., R.K., M.A., J.P.S., and O.K. conducted experiments and collected and analyzed the data; U.O, T.S., S.A.-T., and K.M. expressed, purified, and provided critical reagents; J.W.M., T.K.B., R.P.B., and F.M.F. collected and processed all the microarray data; and P.S. and D.S. wrote the paper. The data are tabulated in the main paper and supplementary materials. The cryo-EM structure has been deposited in the Electron Microscopy Data Bank with accession no. EMD-5494. The microarray data have been submitted in Minimum Information About a Microarray Experiment (MIAME)-compliant format to the Gene Expression Omnibus database (accession no. GSE36078).	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Ardehali H, 2001, TRANSPLANTATION, V71, P998, DOI 10.1097/00007890-200104150-00029; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Leen AM, 2005, BRIT J HAEMATOL, V128, P135, DOI 10.1111/j.1365-2141.2004.05218.x; Livingston JR, 2006, BIOCHEM J, V393, P529, DOI 10.1042/BJ20051313; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	21	109	112	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					795	798		10.1126/science.1226625	http://dx.doi.org/10.1126/science.1226625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23019612	Green Accepted			2022-12-01	WOS:000310839500043
J	Allotey, P; Amazigo, U; Adjei, S; Seddoh, A; Lusamba-Dikassa, PS				Allotey, Pascale; Amazigo, Uche; Adjei, Sam; Seddoh, Anthony; Lusamba-Dikassa, Paul-Samson			15 years of APOC-a lifetime of public health evidence	LANCET			English	Editorial Material							ONCHOCERCIASIS CONTROL; ELIMINATION; AFRICA; DISEASES; LOIASIS; REALITY; IMPACT; CARE		[Allotey, Pascale] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway 46150, Selangor DE, Malaysia; [Amazigo, Uche; Lusamba-Dikassa, Paul-Samson] APOC, Ouagadougou, Burkina Faso; [Adjei, Sam; Seddoh, Anthony] Ctr Hlth & Social Serv, Accra, Ghana	Monash University; Monash University Sunway	Allotey, P (corresponding author), Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Bandar Sunway 46150, Selangor DE, Malaysia.	pascale.allotey@monash.edu		Allotey, Pascale/0000-0002-6942-5774				Adjei S, 2010, REPORT EXTERNAL MIDT; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Boatin B, 1997, J HELMINTHOL, V71, P91, DOI 10.1017/S0022149X00015741; DFID, BRIT PROT MOR 140 MI; Heymann DL, NEGLECTED INFECT DIS; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Molyneux DH, 2005, TRENDS PARASITOL, V21, P525, DOI 10.1016/j.pt.2005.08.027; RIFKIN SB, 1986, SOC SCI MED, V23, P559, DOI 10.1016/0277-9536(86)90149-8; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Tekle AH, 2011, ACTA TROP, V120, pS81, DOI 10.1016/j.actatropica.2010.05.008; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Waters HR, 2004, TROP MED INT HEALTH, V9, pA16, DOI 10.1111/j.1365-3156.2004.01210.x; WHO APOC, 2011, WHO YEAR 2011 PROGR; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	15	2	2	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1361	1363		10.1016/S0140-6736(12)60723-5	http://dx.doi.org/10.1016/S0140-6736(12)60723-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084441				2022-12-01	WOS:000310196500005
J	Henne, WM; Buchkovich, NJ; Zhao, YY; Emr, SD				Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.			The Endosomal Sorting Complex ESCRT-II Mediates the Assembly and Architecture of ESCRT-III Helices	CELL			English	Article							STRUCTURAL BASIS; FTSZ; AUTOINHIBITION; ENDOCYTOSIS; CARGO	The endosomal sorting complexes required for transport (ESCRTs) constitute hetero-oligomeric machines that mediate topologically similar membrane-sculpting processes, including cytokinesis, retroviral egress, and multivesicular body (MVB) biogenesis. Although ESCRT-III drives membrane remodeling that creates MVBs, its structure and the mechanism of vesicle formation are unclear. Using electron microscopy, we visualize an ESCRT-II: ESCRT-III supercomplex and propose how it mediates vesicle formation. We define conformational changes that activate ESCRT-III subunit Snf7 and show that it assembles into spiraling similar to 9 nm protofilaments on lipid monolayers. A high-content flow cytometry assay further demonstrates that mutations halting ESCRT-III assembly block ESCRT function. Strikingly, the addition of Vps24 and Vps2 transforms flat Snf7 spirals into membrane-sculpting helices. Finally, we show that ESCRT-II and ESCRT-III coassemble into similar to 65 nm diameter rings indicative of a cargo-sequestering supercomplex. We propose that ESCRT-III has distinct architectural stages that are modulated by ESCRT-II to mediate cargo capture and vesicle formation by ordered assembly.	[Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu			Sam and Nancy Fleming Research Fellowship; American Cancer Society [PF-12-062-01-DMC]	Sam and Nancy Fleming Research Fellowship; American Cancer Society(American Cancer Society)	W. M. H. is supported by a Sam and Nancy Fleming Research Fellowship. N.J.B. is supported by an American Cancer Society Postdoctoral Fellowship (PF-12-062-01-DMC). We thank Beverly Wendland for the Mup1-pHluorin integration plasmid and Roger Williams for the ESCRT-II expression construct. The authors also thank Neil Adige and Bret Judson for all technical expertise. We also thank Chris Stefan, Jason MacGurn, Jeremy Thorner, Tony Bretscher, Chris Fromme, Gerald Feigenson, David Teis, Suraj Saksena, Jeanne Quirit, and Abbie Davies for helpful discussions.	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	27	144	146	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					356	371		10.1016/j.cell.2012.08.039	http://dx.doi.org/10.1016/j.cell.2012.08.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063125	Bronze			2022-12-01	WOS:000309981000014
J	Meyer, M; Kircher, M; Gansauge, MT; Li, H; Racimo, F; Mallick, S; Schraiber, JG; Jay, F; Prufer, K; de Filippo, C; Sudmant, PH; Alkan, C; Fu, QM; Do, R; Rohland, N; Tandon, A; Siebauer, M; Green, RE; Bryc, K; Briggs, AW; Stenzel, U; Dabney, J; Shendure, J; Kitzman, J; Hammer, MF; Shunkov, MV; Derevianko, AP; Patterson, N; Andres, AM; Eichler, EE; Slatkin, M; Reich, D; Kelso, J; Paabo, S				Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Li, Heng; Racimo, Fernando; Mallick, Swapan; Schraiber, Joshua G.; Jay, Flora; Pruefer, Kay; de Filippo, Cesare; Sudmant, Peter H.; Alkan, Can; Fu, Qiaomei; Do, Ron; Rohland, Nadin; Tandon, Arti; Siebauer, Michael; Green, Richard E.; Bryc, Katarzyna; Briggs, Adrian W.; Stenzel, Udo; Dabney, Jesse; Shendure, Jay; Kitzman, Jacob; Hammer, Michael F.; Shunkov, Michael V.; Derevianko, Anatoli P.; Patterson, Nick; Andres, Aida M.; Eichler, Evan E.; Slatkin, Montgomery; Reich, David; Kelso, Janet; Paeaebo, Svante			A High-Coverage Genome Sequence from an Archaic Denisovan Individual	SCIENCE			English	Article							NEANDERTHAL GENOME; PATTERNS; HISTORY; HOMININ; SIBERIA; ORIGIN; ASIA	We present a DNA library preparation method that has allowed us to reconstruct a high-coverage (30x) genome sequence of a Denisovan, an extinct relative of Neandertals. The quality of this genome allows a direct estimation of Denisovan heterozygosity indicating that genetic diversity in these archaic hominins was extremely low. It also allows tentative dating of the specimen on the basis of "missing evolution" in its genome, detailed measurements of Denisovan and Neandertal admixture into present-day human populations, and the generation of a near-complete catalog of genetic changes that swept to high frequency in modern humans since their divergence from Denisovans.	[Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Racimo, Fernando; Pruefer, Kay; de Filippo, Cesare; Fu, Qiaomei; Siebauer, Michael; Stenzel, Udo; Dabney, Jesse; Andres, Aida M.; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Li, Heng; Mallick, Swapan; Do, Ron; Rohland, Nadin; Tandon, Arti; Patterson, Nick; Reich, David] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Rohland, Nadin; Tandon, Arti; Bryc, Katarzyna; Briggs, Adrian W.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schraiber, Joshua G.; Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Alkan, Can] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Sudmant, Peter H.; Alkan, Can; Shendure, Jay; Kitzman, Jacob; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut, Beijing 100044, Peoples R China; [Green, Richard E.] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Hammer, Michael F.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Palaeolith Dept, Novosibirsk 630090, Russia; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Ihsan Dogramaci Bilkent University; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of California System; University of California Santa Cruz; University of Arizona; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de; reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Kircher, Martin/HDL-9392-2022; Li, Heng/D-9344-2011; Andres, Aida/B-4088-2014; Kelso, Janet/N-1812-2019; Alkan, Can/D-2982-2009; Kircher, Martin/H-6909-2019; Dabney, Jesse/Y-8889-2019; Shunkov, Mikhail V./Q-6576-2016; Derevianko, Anatoly P./Q-5975-2016; Shendure, Jay/AAU-3684-2021	Li, Heng/0000-0003-4874-2874; Andres, Aida/0000-0002-8590-9672; Kelso, Janet/0000-0002-3618-322X; Alkan, Can/0000-0002-5443-0706; Kircher, Martin/0000-0001-9278-5471; Dabney, Jesse/0000-0001-8893-1245; Shunkov, Mikhail V./0000-0003-1388-2308; Derevianko, Anatoly P./0000-0003-1156-8331; jay, flora/0000-0001-5884-4730; Green, Richard/0000-0003-0516-5827; Kitzman, Jacob/0000-0002-6145-882X; Shendure, Jay/0000-0002-1516-1865; Racimo, Fernando/0000-0002-5025-2607; Sudmant, Peter/0000-0002-9573-8248	Max Planck Society; NSF HOMINID [1032255]; NIH [GM100233, R01-GM40282]; HHMI International Student Fellowship; German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, R01GM040282] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); NSF HOMINID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI International Student Fellowship; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Denisovan sequence reads are available from the European Nucleotide Archive (ENA) under study accession ERP001519. The present-day human sequence reads are available from the Short Read Archive (SRA) under accession SRA047577. Alignments and genotype calls for each of the sequenced individuals are available at www.eva.mpg.de/denisova/. In addition, the Denisovan sequence reads and alignments are available as a public data set via Amazon Web Services (AWS) at http://aws.amazon.com/datasets/2357/ and as a track in the University of California, Santa Cruz genome browser. We thank D. Falush, P. Johnson, J. Krause, M. Lachmann, S. Sawyer, L. Vigilant and B. Viola for comments, help, and suggestions; A. Aximu, B. Hober, B. Hoffner, A. Weihmann, T. Kratzer, and R. Roesch for expert technical assistance; R. Schultz for help with data management; and M. Schreiber for improvement of graphics. The Presidential Innovation Fund of the Max Planck Society made this project possible. D. R. and N.P. are grateful for support from NSF HOMINID grant no. 1032255 and NIH grant GM100233. J. G. S., F. J., and M. S. were supported by NIH grant R01-GM40282 to M. S. P. H. S. is supported by an HHMI International Student Fellowship. F. R. is supported by a German Academic Exchange Service (DAAD) study scholarship. E. E. E. is on the scientific advisory boards for Pacific Biosciences, Inc., SynapDx Corp, and DNAnexus, Inc.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cerqueira CCS, 2012, AM J HUM BIOL, V24, P705, DOI 10.1002/ajhb.22263; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coyne J.A., 1989, P180; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Gibbons A, 2011, SCIENCE, V333, P1084, DOI 10.1126/science.333.6046.1084; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; KIDD JR, 1991, HUM BIOL, V63, P775; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pickrell J., 2012, NATURE PRECEDINGS; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828	27	1067	1097	36	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					222	226		10.1126/science.1224344	http://dx.doi.org/10.1126/science.1224344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22936568	Green Accepted, Green Submitted			2022-12-01	WOS:000309712300037
J	Wimmer, GE; Shohamy, D				Wimmer, G. Elliott; Shohamy, Daphna			Preference by Association: How Memory Mechanisms in the Hippocampus Bias Decisions	SCIENCE			English	Article							REACTIVATION; COMPETITION; CHOICE; MIND	Every day people make new choices between alternatives that they have never directly experienced. Yet, such decisions are often made rapidly and confidently. Here, we show that the hippocampus, traditionally known for its role in building long-term declarative memories, enables the spread of value across memories, thereby guiding decisions between new choice options. Using functional brain imaging in humans, we discovered that giving people monetary rewards led to activation of a preestablished network of memories, spreading the positive value of reward to nonrewarded items stored in memory. Later, people were biased to choose these nonrewarded items. This decision bias was predicted by activity in the hippocampus, reactivation of associated memories, and connectivity between memory and reward regions in the brain. These findings explain how choices among new alternatives emerge automatically from the associative mechanisms by which the brain builds memories. Further, our findings demonstrate a previously unknown role for the hippocampus in value-based decisions.	[Wimmer, G. Elliott; Shohamy, Daphna] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Shohamy, D (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	shohamy@psych.columbia.edu	Wimmer, G. Elliott/AAJ-8537-2020	Wimmer, G. Elliott/0000-0002-2227-119X; Shohamy, Daphna/0000-0003-4239-4960	NSF Career Development Award; National Institutes of Drug Abuse [R03-DA026957]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026957] Funding Source: NIH RePORTER	NSF Career Development Award; National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by a NSF Career Development Award and National Institutes of Drug Abuse grant R03-DA026957 to D. S. We thank E. K. Braun, L. Davachi, R. Hassin, and E. Weber for helpful comments on an earlier draft of the manuscript; L. Atlas and T. Wager for guidance with the mediation analyses; and N. Daw and R. Hassin for insightful conversations.	Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Houwer J., 2007, IMPLICIT MEASURES AT, P179; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 2004, CONDITIONING CONSCIO; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gilovich T., 2002, HEURISTICS BIASES PS, V16th edn, DOI DOI 10.1017/CBO9780511808098; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, INTERPRETATION; KIMMEL HD, 1977, AM J PSYCHOL, V90, P319, DOI 10.2307/1422055; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Wimmer GE, 2011, DECISION MAKING AFFE, P281, DOI 10.1093/acprof:oso/9780199600434.003.0013	33	290	291	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					270	273		10.1126/science.1223252	http://dx.doi.org/10.1126/science.1223252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019BQ	23066083				2022-12-01	WOS:000309712300050
J	Baudouin, SJ; Gaudias, J; Gerharz, S; Hatstatt, L; Zhou, KK; Punnakkal, P; Tanaka, KF; Spooren, W; Hen, R; De Zeeuw, CI; Vogt, K; Scheiffele, P				Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Zhou, Kuikui; Punnakkal, Pradeep; Tanaka, Kenji F.; Spooren, Will; Hen, Rene; De Zeeuw, Chris I.; Vogt, Kaspar; Scheiffele, Peter			Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism	SCIENCE			English	Article							LONG-TERM DEPRESSION; RARE DE-NOVO; NEUROLIGIN-3; MUTATIONS; RECEPTOR; PROTEIN	The genetic heterogeneity of autism poses a major challenge for identifying mechanism-based treatments. A number of rare mutations are associated with autism, and it is unclear whether these result in common neuronal alterations. Monogenic syndromes, such as fragile X, include autism as one of their multifaceted symptoms and have revealed specific defects in synaptic plasticity. We discovered an unexpected convergence of synaptic pathophysiology in a nonsyndromic form of autism with those in fragile X syndrome. Neuroligin-3 knockout mice (a model for nonsyndromic autism) exhibited disrupted heterosynaptic competition and perturbed metabotropic glutamate receptor-dependent synaptic plasticity, a hallmark of fragile X. These phenotypes could be rescued by reexpression of neuroligin-3 in juvenile mice, highlighting the possibility of reverting neuronal circuit alterations in autism after the completion of development.	[Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Punnakkal, Pradeep; Vogt, Kaspar; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland; [Zhou, Kuikui; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Spooren, Will] Hoffmann La Roche AG, Basel, Switzerland; [De Zeeuw, Chris I.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Basel; Erasmus University Rotterdam; Erasmus MC; Columbia University; Keio University; Roche Holding; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	peter.scheiffele@unibas.ch	baudouin, stephane/I-4372-2012	Scheiffele, Peter/0000-0002-9516-9399; Vogt, Kaspar/0000-0002-0859-876X; baudouin, stephane/0000-0001-6902-6071; Tanaka, Kenji/0000-0003-2511-0057	Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative [115300]; European Union; European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation; Kanton Basel-Stadt	Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community)(European CommissionEuropean Research Council (ERC)); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt	We are grateful to our colleagues Arber, Barde, Gosh, Sylwestrak, Witte, and Xiao for comments on the manuscript; to Ponti, Genoud, Sauder, Ahrne, Ehrenfeuchter, and Stiefvater for technical help; and Zeilhofer, Fritschy, Brose, and Sans for sharing reagents. C.D.Z. was supported by the Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; and the European Research Council-advanced, CEREBNET, and C7 programs (European Community). This work was supported by a SystemsX grant (P.S. and W.S.); by EU-AIMS (European Autism Interventions), which receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, the resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (grant FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies' in-kind contributions, and from Autism Speaks, resulting in a total of (sic)29.6 million; by NCCR Synapsy; the Swiss National Science Foundation; and Kanton Basel-Stadt.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	30	206	210	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					128	132		10.1126/science.1224159	http://dx.doi.org/10.1126/science.1224159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983708				2022-12-01	WOS:000309457400069
J	Hwang, SW; Tao, H; Kim, DH; Cheng, HY; Song, JK; Rill, E; Brenckle, MA; Panilaitis, B; Won, SM; Kim, YS; Song, YM; Yu, KJ; Ameen, A; Li, R; Su, YW; Yang, MM; Kaplan, DL; Zakin, MR; Slepian, MJ; Huang, YG; Omenetto, FG; Rogers, JA				Hwang, Suk-Won; Tao, Hu; Kim, Dae-Hyeong; Cheng, Huanyu; Song, Jun-Kyul; Rill, Elliott; Brenckle, Mark A.; Panilaitis, Bruce; Won, Sang Min; Kim, Yun-Soung; Song, Young Min; Yu, Ki Jun; Ameen, Abid; Li, Rui; Su, Yewang; Yang, Miaomiao; Kaplan, David L.; Zakin, Mitchell R.; Slepian, Marvin J.; Huang, Yonggang; Omenetto, Fiorenzo G.; Rogers, John A.			A Physically Transient Form of Silicon Electronics	SCIENCE			English	Article							CRYSTALLINE SILICON; SILK FIBROIN; OXIDE	A remarkable feature of modern silicon electronics is its ability to remain physically invariant, almost indefinitely for practical purposes. Although this characteristic is a hallmark of applications of integrated circuits that exist today, there might be opportunities for systems that offer the opposite behavior, such as implantable devices that function for medically useful time frames but then completely disappear via resorption by the body. We report a set of materials, manufacturing schemes, device components, and theoretical design tools for a silicon-based complementary metal oxide semiconductor (CMOS) technology that has this type of transient behavior, together with integrated sensors, actuators, power supply systems, and wireless control strategies. An implantable transient device that acts as a programmable nonantibiotic bacteriocide provides a system-level example.	[Tao, Hu; Brenckle, Mark A.; Panilaitis, Bruce; Yang, Miaomiao; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Ctr Nanoparticle Res,Inst Basic Sci, WCU Program Chem Convergence Energy & Environm, Seoul 151741, South Korea; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Song, Jun-Kyul; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Won, Sang Min; Yu, Ki Jun; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Li, Rui] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dept Engn Mech, Dalian 116024, Peoples R China; [Zakin, Mitchell R.] Nano Terra, Brighton, MA 02135 USA; [Slepian, Marvin J.] Univ Arizona, Dept Med, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Slepian, Marvin J.] Univ Arizona, Dept Biomed Engn, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02155 USA	Tufts University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Northwestern University; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Dalian University of Technology; University of Arizona; University of Arizona; Tufts University	Omenetto, FG (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	fiorenzo.omenetto@tufts.edu; jrogers@uiuc.edu	Su, Yewang/GXF-2357-2022; Rogers, John/L-2798-2016; Tao, Hu/C-1528-2013; Song, Young Min/B-2215-2010; Sunny, QI/M-5188-2019; Brenckle, Mark/I-5931-2014; Li, Rui/C-2155-2009; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Cheng, Huanyu/J-7379-2015; Slepian, Marvin/ABG-8305-2020; HWANG, SUKWON/Q-8329-2018	Song, Young Min/0000-0002-4473-6883; Sunny, QI/0000-0002-5817-1609; Brenckle, Mark/0000-0002-5535-1110; Cheng, Huanyu/0000-0001-6075-4208; Slepian, Marvin/0000-0002-7864-6691; Kim, Dae-Hyeong/0000-0002-4722-1893; HWANG, SUKWON/0000-0002-6883-201X; Li, Rui/0000-0001-6051-4204	Defense Advanced Research Projects Agency; NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health [EB002520]; U.S. Department of Energy; Division Of Materials Research [1242240] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work on materials, integration schemes, manufacturing approaches, and design strategies was supported by the Defense Advanced Research Projects Agency. The theoretical analysis and associated experiments were supported by an NSF INSPIRE grant. The techniques for creating and manipulating Si nanomembranes were developed in work supported by an Air Force Office of Scientific Research Multi University Research Initiative program. The animal studies were funded by the National Institutes of Health (grant EB002520). The facilities for characterization and analysis were provided by the Material Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign, both of which are supported by the U.S. Department of Energy.	Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; [Anonymous], 1996, Am J Infect Control, V24, P380; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Chung HJ, 2011, ADV FUNCT MATER, V21, P3029, DOI 10.1002/adfm.201100124; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; ILER RK, 1973, J COLLOID INTERF SCI, V43, P399, DOI 10.1016/0021-9797(73)90386-X; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011; Levine R. D., 2005, MOL REACTION DYNAMIC, DOI [10.1017/CBO9780511614125, DOI 10.1017/CBO9780511614125]; MORITA M, 1990, J APPL PHYS, V68, P1272, DOI 10.1063/1.347181; RIMSTIDT JD, 1980, GEOCHIM COSMOCHIM AC, V44, P1683, DOI 10.1016/0016-7037(80)90220-3; Santra S, 2010, IEEE SENS J, V10, P997, DOI 10.1109/JSEN.2009.2037822; SEIDEL H, 1990, J ELECTROCHEM SOC, V137, P3612, DOI 10.1149/1.2086277; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Won SM, 2011, IEEE T ELECTRON DEV, V58, P4074, DOI 10.1109/TED.2011.2164923	17	852	889	41	849	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1640	1644		10.1126/science.1226325	http://dx.doi.org/10.1126/science.1226325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019646	Green Accepted			2022-12-01	WOS:000309215400041
J	Voigt, P; LeRoy, G; Drury, WJ; Zee, BM; Son, J; Beck, DB; Young, NL; Garcia, BA; Reinberg, D				Voigt, Philipp; LeRoy, Gary; Drury, William J., III; Zee, Barry M.; Son, Jinsook; Beck, David B.; Young, Nicolas L.; Garcia, Benjamin A.; Reinberg, Danny			Asymmetrically Modified Nucleosomes	CELL			English	Article							HISTONE MODIFICATIONS; DNA-REPLICATION; CHROMATIN-STRUCTURE; BINDING MODULES; CELL-CYCLE; METHYLATION; GENOME; GENES; MARKS; INFORMATION	Mononucleosomes, the basic building blocks of chromatin, contain two copies of each core histone. The associated posttranslational modifications regulate essential chromatin-dependent processes, yet whether each histone copy is identically modified in vivo is unclear. We demonstrate that nucleosomes in embryonic stem cells, fibroblasts, and cancer cells exist in both symmetrically and asymmetrically modified populations for histone H3 lysine 27 di/trimethylation (H3K27me2/3) and H4K20me1. Further, we obtained direct physical evidence for bivalent nucleosomes carrying H3K4me3 or H3K36me3 along with H3K27me3, albeit on opposite H3 tails. Bivalency at target genes was resolved upon differentiation of ES cells. Polycomb repressive complex 2-mediated methylation of H3K27 was inhibited when nucleosomes contain symmetrically, but not asymmetrically, placed H3K4me3 or H3K36me3. These findings uncover a potential mechanism for the incorporation of bivalent features into nucleosomes and demonstrate how asymmetry might set the stage to diversify functional nucleosome states.	[Voigt, Philipp; Drury, William J., III; Son, Jinsook; Beck, David B.; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [LeRoy, Gary; Zee, Barry M.; Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Schultz Lab 415, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; New York University; Princeton University	Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, 522 1st Ave, New York, NY 10016 USA.	danny.reinberg@nyumc.org		Young, Nicolas/0000-0002-3323-2815; Reinberg, Danny/0000-0003-4288-2016; Zee, Barry/0000-0002-3123-8375; Voigt, Philipp/0000-0003-4366-0490	Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; Empire State Training Program in Stem Cell Research (NYSTEM) [C026880]; Howard Hughes Medical Institute; National Institute of Health [GM064844, R37GM037120]; NSF [CBET-0941143]; American Society for Mass Spectrometry; NIH Office of the Director [DP2OD007447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM064844] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; Empire State Training Program in Stem Cell Research (NYSTEM); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Society for Mass Spectrometry; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Till Bartke and Tony Kouzarides for the H4 Delta(1-27)I28C construct. We are grateful to Dr. Inti De La Rosa Velazquez for advice on sequential ChIP experiments. We thank Drs. W.W. Tee and R. Bonasio for helpful discussions and Dr. L. Vales for critical reading of the manuscript. P.V. is supported by fellowships from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) and the Empire State Training Program in Stem Cell Research (NYSTEM, contract # C026880). Work in the Reinberg laboratory is funded by the Howard Hughes Medical Institute and the National Institute of Health (grants GM064844 and R37GM037120). The Garcia laboratory is supported by grants from the NSF (Early Faculty Career award and CBET-0941143), the American Society for Mass Spectrometry, and the NIH Office of the Director (DP2OD007447).	Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen XZ, 2011, EMBO REP, V12, P244, DOI 10.1038/embor.2011.6; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Voigt P, 2011, CHEMBIOCHEM, V12, P236, DOI 10.1002/cbic.201000493; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	36	281	285	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					181	193		10.1016/j.cell.2012.09.002	http://dx.doi.org/10.1016/j.cell.2012.09.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021224	Green Accepted, Bronze			2022-12-01	WOS:000309544200019
J	Gross, L; Mohn, F; Moll, N; Schuler, B; Criado, A; Guitian, E; Pena, D; Gourdon, A; Meyer, G				Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Criado, Alejandro; Guitian, Enrique; Pena, Diego; Gourdon, Andre; Meyer, Gerhard			Bond-Order Discrimination by Atomic Force Microscopy	SCIENCE			English	Article							CHEMICAL-STRUCTURE; CRYSTAL-STRUCTURE; SINGLE; RESOLUTION; C60; BUCKMINSTERFULLERENE; MOLECULES; LENGTHS	We show that the different bond orders of individual carbon-carbon bonds in polycyclic aromatic hydrocarbons and fullerenes can be distinguished by noncontact atomic force microscopy (AFM) with a carbon monoxide (CO)-functionalized tip. We found two different contrast mechanisms, which were corroborated by density functional theory calculations: The greater electron density in bonds of higher bond order led to a stronger Pauli repulsion, which enhanced the brightness of these bonds in high-resolution AFM images. The apparent bond length in the AFM images decreased with increasing bond order because of tilting of the CO molecule at the tip apex.	[Criado, Alejandro; Guitian, Enrique; Pena, Diego] Univ Santiago de Compostela, CIQUS, E-15782 Santiago De Compostela, Spain; [Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Meyer, Gerhard] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland; [Gourdon, Andre] CEMES CNRS, F-31055 Toulouse, France	Universidade de Santiago de Compostela; CiQUS; International Business Machines (IBM); Centre National de la Recherche Scientifique (CNRS)	Gross, L (corresponding author), IBM Res Zurich, CH-8803 Ruschlikon, Switzerland.	lgr@zurich.ibm.com	Moll, Nikolaj/C-5674-2013; Guitián, Enrique/H-9018-2015; Gross, Leo/M-8564-2019; Peña, Diego/D-2051-2009; Gross, Leo/E-1789-2011; Gourdon, André/C-9799-2009; Criado, Alejandro/I-9826-2017; Criado, Alejandro/HDO-0316-2022	Moll, Nikolaj/0000-0001-5645-4667; Guitián, Enrique/0000-0003-4785-3812; Gross, Leo/0000-0002-5337-4159; Peña, Diego/0000-0003-3814-589X; Gross, Leo/0000-0002-5337-4159; Gourdon, André/0000-0002-0370-1019; Criado, Alejandro/0000-0002-9732-513X; Schuler, Bruno/0000-0002-9641-0340	European Union [243421, 214954]; European Research Council; Spanish Ministry of Economy and Competitiveness (MINECO) [CTQ2010-18208]; Xunta de Galicia [10PXIB2200222PR]; Fondo Europeo de Desarrollo Regional (FEDER)	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	We thank R. Allenspach, J. Repp, and A. Curioni for comments and European Union projects ARTIST (contract no. 243421) and HERODOT (contract no. 214954), the European Research Council advanced grant CEMAS, the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2010-18208), Xunta de Galicia (10PXIB2200222PR), and Fondo Europeo de Desarrollo Regional (FEDER) for financial support.	Alemani M, 2006, J AM CHEM SOC, V128, P14446, DOI 10.1021/ja065449s; Ashino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.136101; Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q; Comstock MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038301; Criado A, 2010, CHEM-EUR J, V16, P9736, DOI 10.1002/chem.201001057; DAVID WIF, 1991, NATURE, V353, P147, DOI 10.1038/353147a0; FAGAN PJ, 1991, SCIENCE, V252, P1160, DOI 10.1126/science.252.5009.1160; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; GODDARD R, 1995, J AM CHEM SOC, V117, P30, DOI 10.1021/ja00106a004; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Guo CS, 2010, LANGMUIR, V26, P16271, DOI 10.1021/la101317s; HEDBERG K, 1991, SCIENCE, V254, P410, DOI 10.1126/science.254.5030.410; Larsson JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115434; LIU SZ, 1991, SCIENCE, V254, P408, DOI 10.1126/science.254.5030.408; Mohn F, 2012, NAT NANOTECHNOL, V7, P227, DOI [10.1038/nnano.2012.20, 10.1038/NNANO.2012.20]; Mohn F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619829; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Narita S, 2000, J MOL STRUC-THEOCHEM, V532, P37, DOI 10.1016/S0166-1280(00)00563-7; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pauling L, 1935, J AM CHEM SOC, V57, P2705, DOI 10.1021/ja01315a105; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Pawlak R, 2011, ACS NANO, V5, P6349, DOI 10.1021/nn201462g; Schleyer PV, 2001, CHEM REV, V101, P1115, DOI 10.1021/cr0103221; Schull G, 2011, NANO LETT, V11, P3142, DOI 10.1021/nl201185y; Sedlar J, 2006, CHEM PHYS LETT, V427, P418, DOI 10.1016/j.cplett.2006.06.026; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sun ZX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046104; Ugeda MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.116803; Wang HT, 2012, NANO LETT, V12, P141, DOI 10.1021/nl2031629; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850	31	356	363	6	469	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1326	1329		10.1126/science.1225621	http://dx.doi.org/10.1126/science.1225621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984067				2022-12-01	WOS:000308705000038
J	Neph, S; Stergachis, AB; Reynolds, A; Sandstrom, R; Borenstein, E; Stamatoyannopoulos, JA				Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.			Circuitry and Dynamics of Human Transcription Factor Regulatory Networks	CELL			English	Article							PROTEIN-DNA; IN-VIVO; GLUCOCORTICOID-RECEPTOR; ERYTHROID LINEAGE; STEM-CELLS; CHROMATIN; GENE; DATABASE; EXPRESSION; DIFFERENTIATION	The combinatorial cross-regulation of hundreds of sequence-specific transcription factors (TFs) defines a regulatory network that underlies cellular identity and function. Here we use genome-wide maps of in vivo DNaseI footprints to assemble an extensive core human regulatory network comprising connections among 475 sequence-specific TFs and to analyze the dynamics of these connections across 41 diverse cell and tissue types. We find that human TF networks are highly cell selective and are driven by cohorts of factors that include regulators with previously unrecognized roles in control of cellular identity. Moreover, we identify many widely expressed factors that impact transcriptional regulatory networks in a cell-selective manner. Strikingly, in spite of their inherent diversity, all cell-type regulatory networks independently converge on a common architecture that closely resembles the topology of living neuronal networks. Together, our results provide an extensive description of the circuitry, dynamics, and organizing principles of the human TF regulatory network.	[Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Borenstein, E (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	elbo@uw.edu; jstam@uw.edu		Sandstrom, Richard/0000-0002-3356-1547	NIH [HG004592]; NIDDK F30 fellowship [FDK095678A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK F30 fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Sam John for critical reading of the manuscript and our colleagues for many helpful and insightful observations and discussions. This work was supported by NIH grant HG004592 to J.A.S. All data are available through the ENCODE data repository at the UCSC genome browser (http://genome.ucsc.edu). E.B. is an Alfred P. Sloan Research Fellow. A.B.S. was supported by an NIDDK F30 fellowship (FDK095678A).	Alon U, 2006, INTRO SYSTEMS BIOL D; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KUO MT, 1979, NUCLEIC ACIDS RES, V7, P2105, DOI 10.1093/nar/7.8.2105; MacNeill C, 2000, DEV BIOL, V217, P62, DOI 10.1006/dbio.1999.9539; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Neph S.J., 2012, NATURE; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Serov VN, 1998, BIOINFORMATICS, V14, P546, DOI 10.1093/bioinformatics/14.6.546; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Sucov HM, 1996, BIOCHEM SOC SYMP, P143; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; The ENCODE Project Consortium, 2012, NATURE; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Waddington C.H., 1940, ORG GENES; Waddington C. H., 1939, INTRO MODERN GENETIC; Waddington CH, 1957, STRATEGY GENES DISCU; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Xing YM, 2010, DEVELOPMENT, V137, P825, DOI 10.1242/dev.040535; YUH CH, 1994, MECH DEVELOP, V47, P165, DOI 10.1016/0925-4773(94)90088-4; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	62	295	304	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1274	1286		10.1016/j.cell.2012.04.040	http://dx.doi.org/10.1016/j.cell.2012.04.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959076	Green Accepted, Bronze			2022-12-01	WOS:000308928100019
J	Mattison, JA; Roth, GS; Beasley, TM; Tilmont, EM; Handy, AM; Herbert, RL; Longo, DL; Allison, DB; Young, JE; Bryant, M; Barnard, D; Ward, WF; Qi, WB; Ingram, DK; de Cabo, R				Mattison, Julie A.; Roth, George S.; Beasley, T. Mark; Tilmont, Edward M.; Handy, April M.; Herbert, Richard L.; Longo, Dan L.; Allison, David B.; Young, Jennifer E.; Bryant, Mark; Barnard, Dennis; Ward, Walter F.; Qi, Wenbo; Ingram, Donald K.; de Cabo, Rafael			Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study	NATURE			English	Article							T-CELL SENESCENCE; DIETARY RESTRICTION; LIFE-SPAN; AGE; MORTALITY; DISEASE; MODEL; RATS; MICE; INFLAMMATION	Calorie restriction (CR), a reduction of 10-40% in intake of a nutritious diet, is often reported as the most robust non-genetic mechanism to extend lifespan and healthspan. CR is frequently used as a tool to understand mechanisms behind ageing and age-associated diseases. In addition to and independently of increasing lifespan, CR has been reported to delay or prevent the occurrence of many chronic diseases in a variety of animals. Beneficial effects of CR on outcomes such as immune function(1,2), motor coordination(3) and resistance to sarcopenia(4) in rhesus monkeys have recently been reported. We report here that a CR regimen implemented in young and older age rhesus monkeys at the National Institute on Aging (NIA) has not improved survival outcomes. Our findings contrast with an ongoing study at the Wisconsin National Primate Research Center (WNPRC), which reported improved survival associated with 30% CR initiated in adult rhesus monkeys (7-14 years)(5) and a preliminary report with a small number of CR monkeys(6). Over the years, both NIA and WNPRC have extensively documented beneficial health effects of CR in these two apparently parallel studies. The implications of the WNPRC findings were important as they extended CR findings beyond the laboratory rodent and to a long-lived primate. Our study suggests a separation between health effects, morbidity andmortality, and similar to what has been shown in rodents(7-9), study design, husbandry and diet composition may strongly affect the life-prolonging effect of CR in a long-lived nonhuman primate.	[Mattison, Julie A.; Tilmont, Edward M.; Handy, April M.; Young, Jennifer E.] NIA, Lab Expt Gerontol, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Roth, George S.] GeroScience, Pylesville, MD 21132 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Handy, April M.] SoBran Inc, Burtonsville, MD 20866 USA; [Herbert, Richard L.] NIAID, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Longo, Dan L.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Birmingham, AL 35294 USA; [Bryant, Mark; Barnard, Dennis] NIH, Off Director, Diagnost & Res Serv Branch, Bethesda, MD 20814 USA; [Ward, Walter F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Qi, Wenbo] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Ingram, Donald K.] Louisiana State Univ, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA 70808 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattison, JA (corresponding author), NIA, Lab Expt Gerontol, NIH, Anim Ctr, 16701 Elmer Sch Rd,Bldg 103, Dickerson, MD 20842 USA.	mattisonj@mail.nih.gov; Donald.Ingram@pbrc.edu; deCaboRa@grc.nia.nih.gov	de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/E-7996-2010; Longo, Dan L./F-6022-2011; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Allison, David/0000-0003-3566-9399	NIH, National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000371, ZIAAG000368] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the animal care staff and technicians, both past and present, especially J. Travis and M. Szarowicz; K. Vaughan for her editorial help; and the many collaborators that have contributed to this project. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Allison P.D., 2010, SURVIVAL ANAL USING; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Branch-Mays GL, 2008, J PERIODONTOL, V79, P1184, DOI [10.1902/jop.2008.070629, 10.1902/jop.2008.070629 ]; Colman R. J., 1998, METHODS AGING RES, P249; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; Kastman EK, 2010, J NEUROSCI, V30, P7940, DOI 10.1523/JNEUROSCI.0835-10.2010; LANE MA, 1995, J NUTR, V125, P1600; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Littell R.C., 2006, SAS SYSTEM MIXED MOD; Lomba A, 2009, J NUTRIGENET NUTRIGE, V2, P267, DOI 10.1159/000308465; Mattison JA, 2005, NEUROBIOL AGING, V26, P1117, DOI 10.1016/j.neurobiolaging.2004.09.013; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Messaoudi I, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P55, DOI 10.1007/978-90-481-8556-6_4; Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x; MURTAGHMARK CM, 1995, J GERONTOL A-BIOL, V50, pB148, DOI 10.1093/gerona/50A.3.B148; Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Raman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE101, DOI 10.1152/ajpendo.00127.2006; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; [No title captured]	30	722	741	10	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					318	+		10.1038/nature11432	http://dx.doi.org/10.1038/nature11432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22932268	Green Accepted			2022-12-01	WOS:000308635900047
J	Feld, ED				Feld, Ellen D.			Worries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA	Drexel University	Feld, ED (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA.	edf26@drexel.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					873	874		10.1001/2012.jama.10452	http://dx.doi.org/10.1001/2012.jama.10452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948696				2022-12-01	WOS:000308292900016
J	Pinheiro, I; Margueron, R; Shukeir, N; Eisold, M; Fritzsch, C; Richter, FM; Mittler, G; Genoud, C; Goyama, S; Kurokawa, M; Son, J; Reinberg, D; Lachner, M; Jenuwein, T				Pinheiro, Ines; Margueron, Raphael; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Genoud, Christel; Goyama, Susumu; Kurokawa, Mineo; Son, Jinsook; Reinberg, Danny; Lachner, Monika; Jenuwein, Thomas			Prdm3 and Prdm16 are H3K9me1 Methyltransferases Required for Mammalian Heterochromatin Integrity	CELL			English	Article							GERM-CELL LINEAGE; HISTONE H3; LYSINE 9; PERICENTRIC HETEROCHROMATIN; NONHISTONE PROTEINS; CHROMATIN-STRUCTURE; METHYLATION STATES; GENES; MOUSE; MONOMETHYLATION	Heterochromatin serves important functions, protecting genome integrity and stabilizing gene expression programs. Although the Suv39h methyltransferases (KMTs) are known to ensure pericentric H3K9me3 methylation, the mechanisms that initiate and maintain mammalian heterochromatin organization remain elusive. We developed a biochemical assay and used in vivo analyses in mouse embryonic fibroblasts to identify Prdm3 and Prdm16 as redundant H3K9me1-specific KMTs that direct cytoplasmic H3K9me1 methylation. The H3K9me1 is converted in the nucleus to H3K9me3 by the Suv39h enzymes to reinforce heterochromatin. Simultaneous depletion of Prdm3 and Prdm16 abrogates H3K9me1 methylation, prevents Suv39h-dependent H3K9me3 trimethylation, and derepresses major satellite transcription. Most strikingly, DNA-FISH and electron microscopy reveal that combined impairment of Prdm3 and Prdm16 results in disintegration of heterochromatic foci and disruption of the nuclear lamina. Our data identify Prdm3 and Prdm16 as H3K9me1 methyltransferases and expose a functional framework in which anchoring to the nuclear periphery helps maintain the integrity of mammalian heterochromatin.	[Pinheiro, Ines; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Lachner, Monika; Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, D-79108 Freiburg, Germany; [Pinheiro, Ines; Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Margueron, Raphael; Son, Jinsook; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Smilow Res Ctr, New York, NY 10016 USA; [Genoud, Christel] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Goyama, Susumu; Kurokawa, Mineo] Tokyo Univ Hosp, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; Friedrich Miescher Institute for Biomedical Research; University of Tokyo	Jenuwein, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	jenuwein@ie-freiburg.mpg.de	Margueron, Raphael F/B-9996-2015	Margueron, Raphael F/0000-0002-9093-7977; genoud, christel/0000-0002-0933-9911; Reinberg, Danny/0000-0003-4288-2016	IMP through Boehringer Ingelheim; European Union NoE network "The Epigenome" [LSHG-CT-2004-503433]; Austrian GEN-AU initiative; Max-Planck Society; Boehringer Ingelheim	IMP through Boehringer Ingelheim(Boehringer Ingelheim); European Union NoE network "The Epigenome"; Austrian GEN-AU initiative; Max-Planck Society(Max Planck Society); Boehringer Ingelheim(Boehringer Ingelheim)	We thank the MS facility at Rutgers University, New Jersey, USA, for analyzing fractions enriched for H3K9me1 activity. We are also grateful to Masato Yonezawa (University of Tokyo) for providing the Eset Baculovirus expression construct, to Gunter Reuter (Martin Luther University Halle-Wittenberg) for sharing information on Prdm orthologues in Drosophila and to Antoine Peters (FMI Basel) for insightful discussions and help with IF analysis. We further acknowledge interactions and discussions with Susan Gasser (FMI Basel) on the general relevance of H3K9 methylation for anchoring heterochromatin to the nuclear lamina in C. elegans. We would also like to thank Rudi Grosschedl (MPI of Immunobiology and Epigenetics) for insightful comments. Research in the laboratory of T.J. was sponsored by the IMP through Boehringer Ingelheim, the European Union NoE network "The Epigenome" (LSHG-CT-2004-503433), the Austrian GEN-AU initiative, and is now provided by the Max-Planck Society. During part of this work, I.P. was supported by a Boehringer Ingelheim doctoral Fellowship (2007-2009).	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Karslioglu A.B., 2012, NAT STRUCT IN PRESS; Kim KC, 2003, CANCER RES, V63, P7619; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2009, SCI CHINA SER C, V52, P311, DOI 10.1007/s11427-009-0054-z; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	53	206	213	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					948	960		10.1016/j.cell.2012.06.048	http://dx.doi.org/10.1016/j.cell.2012.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939622	Bronze			2022-12-01	WOS:000308500200010
J	Gamuyao, R; Chin, JH; Pariasca-Tanaka, J; Pesaresi, P; Catausan, S; Dalid, C; Slamet-Loedin, I; Tecson-Mendoza, EM; Wissuwa, M; Heuer, S				Gamuyao, Rico; Chin, Joong Hyoun; Pariasca-Tanaka, Juan; Pesaresi, Paolo; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Tecson-Mendoza, Evelyn Mae; Wissuwa, Matthias; Heuer, Sigrid			The protein kinase Pstol1 from traditional rice confers tolerance of phosphorus deficiency	NATURE			English	Article							REPRODUCTIVE-STAGE; RESPONSE-FACTOR; DROUGHT STRESS; GENE; PUP1; EXPRESSION; INFERENCE; SEQUENCE; FAMILY; YIELD	As an essential macroelement for all living cells, phosphorus is indispensable in agricultural production systems. Natural phosphorus reserves are limited(1), and it is therefore important to develop phosphorus-efficient crops. A major quantitative trait locus for phosphorus-deficiency tolerance, Pup1, was identified in the traditional aus-type rice variety Kasalath about a decade ago(2,3). However, its functional mechanism remained elusive(4,5) until the locus was sequenced, showing the presence of a Pup1-specific protein kinase gene(6), which we have named phosphorus-starvation tolerance 1 (PSTOL1). This gene is absent from the rice reference genome and other phosphorus-starvation-intolerant modern varieties(7,8). Here we show that overexpression of PSTOL1 in such varieties significantly enhances grain yield in phosphorus-deficient soil. Further analyses show that PSTOL1 acts as an enhancer of early root growth, thereby enabling plants to acquire more phosphorus and other nutrients. The absence of PSTOL1 and other genes-for example, the submergence-tolerance gene SUB1A-from modern rice varieties underlines the importance of conserving and exploring traditional germplasm. Introgression of this quantitative trait locus into locally adapted rice varieties in Asia and Africa is expected to considerably enhance productivity under low phosphorus conditions.	[Gamuyao, Rico; Chin, Joong Hyoun; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Heuer, Sigrid] Int Rice Res Inst, Manila 1301, Philippines; [Pariasca-Tanaka, Juan; Wissuwa, Matthias] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Pesaresi, Paolo] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Tecson-Mendoza, Evelyn Mae] Univ Philippines, Los Banos 4031, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); Japan International Research Center for Agricultural Sciences; University of Milan; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Heuer, S (corresponding author), Int Rice Res Inst, DAPO Box 7777, Manila 1301, Philippines.	s.heuer@cgiar.org	Dalid, Cheryl/AAI-8043-2021; Chin, Joong Hyoun/L-1307-2015; Pesaresi, Paolo/F-9476-2014	Dalid, Cheryl/0000-0001-6327-404X; Chin, Joong Hyoun/0000-0003-3932-8639; Pesaresi, Paolo/0000-0002-3236-7005; Slamet-Loedin, Inez/0000-0001-9145-3571; Gamuyao, Rico/0000-0002-0112-6428; Wissuwa, Matthias/0000-0003-3505-9398	Generation Challenge Program (GCP)	Generation Challenge Program (GCP)	We would like to thank A. Cruz, E. Ramos and L. Olivo for technical and secretarial support, the staff at the transformation laboratory, F. Rossi for help with the Pstol1 kinase assay, M. Akutsu for help with the analysis of transgenic plants, and S. Haefele and his team for their support. We thank J. Prasetiyono, M. Bustamam and S. Moeljopawiro for their long-term collaboration. This project has been primarily funded by the Generation Challenge Program (GCP) since 2005.	[Anonymous], 2010, WORLD PHOSPHATE ROCK; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Bimpong I.K., 2011, J PLANT BREED CROP S, V3, P60; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Chin JH, 2010, THEOR APPL GENET, V120, P1073, DOI 10.1007/s00122-009-1235-7; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Dawe D., 2010, RICE GLOBAL EC STRAT, P5; Falush D, 2003, GENETICS, V164, P1567; Gomez MS, 2006, AM J BIOCH BIOTECHNO, V2, P161, DOI DOI 10.3844/ajbbsp.2006.161.169; Gowda VRP, 2012, FUNCT PLANT BIOL, V39, P402, DOI 10.1071/FP12015; Gregory PD, 2000, FOOD TECHNOL BIOTECH, V38, P295; Haefele S. M., 2009, RICE TODAY, V8, P30; HAEFELE SM, 2007, SCI TECHNOLOGY TRADE, P297; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Hiei Y, 2006, PLANT CELL TISS ORG, V87, P233, DOI 10.1007/s11240-006-9157-4; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Manzanilla DO, 2011, AGR SYST, V104, P335, DOI 10.1016/j.agsy.2010.12.005; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Pritchard JK, 2000, GENETICS, V155, P945; Scarpella E, 2005, PLANT CELL PHYSIOL, V46, P1400, DOI 10.1093/pcp/pci153; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Wissuwa M, 2005, PLANT SOIL, V269, P57, DOI 10.1007/s11104-004-2026-1; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wissuwa M, 2001, PLANT BREEDING, V120, P43, DOI 10.1046/j.1439-0523.2001.00561.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yoshida S., 1972, LAB MANUAL PHYSL STU, V2nd edn, P1; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655	47	463	493	20	347	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					535	+		10.1038/nature11346	http://dx.doi.org/10.1038/nature11346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914168				2022-12-01	WOS:000307761600042
J	Lembke, A				Lembke, Anna			Why Doctors Prescribe Opioids to Known Opioid Abusers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University	Lembke, A (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.							[Anonymous], 2011, PUBL SMA; Fassin Didier, 2009, EMPIRE TRAUMA INQUIR; Meldrum ML, 2003, JAMA-J AM MED ASSOC, V290, P2470, DOI 10.1001/jama.290.18.2470; Pizzo PA, 2012, NEW ENGL J MED, V366, P197, DOI 10.1056/NEJMp1109084	4	81	81	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1580	1581		10.1056/NEJMp1208498	http://dx.doi.org/10.1056/NEJMp1208498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094719				2022-12-01	WOS:000310131700002
J	Astrow, AB				Astrow, Alan B.			Cancer Survivorship and Beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Astrow, AB (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.	aastrow@maimonidesmed.org						[Anonymous], 2006, PION SURV 20 YEARS A, P7; Hoffman B, 2006, J CLIN ONCOL, V24, P5154, DOI 10.1200/JCO.2006.06.5300; Institute of Medicine, 2005, CANC PAT CANC SURV L; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; Mullan F, 1982, VITAL SIGNS YOUNG DO	5	9	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1639	1640		10.1001/jama.2012.13258	http://dx.doi.org/10.1001/jama.2012.13258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093162				2022-12-01	WOS:000310434100017
J	Hagberg, CE; Mehlem, A; Falkevall, A; Muhl, L; Fam, BC; Ortsater, H; Scotney, P; Nyqvist, D; Samen, E; Lu, L; Stone-Elander, S; Proietto, J; Andrikopoulos, S; Sjoholm, A; Nash, A; Eriksson, U				Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Fam, Barbara C.; Ortsater, Henrik; Scotney, Pierre; Nyqvist, Daniel; Samen, Erik; Lu, Li; Stone-Elander, Sharon; Proietto, Joseph; Andrikopoulos, Sofianos; Sjoholm, Ake; Nash, Andrew; Eriksson, Ulf			Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes	NATURE			English	Article							GROWTH-FACTOR-B; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-PRODUCTION; SKELETAL-MUSCLE; METABOLISM; TOLERANCE; ISOFORMS	The prevalence of type 2 diabetes is rapidly increasing, with severe socioeconomic impacts(1,2). Excess lipid deposition in peripheral tissues impairs insulin sensitivity and glucose uptake, and has been proposed to contribute to the pathology of type 2 diabetes(3-5). However, few treatment options exist that directly target ectopic lipid accumulation(6). Recently it was found that vascular endothelial growth factor B (VEGF-B) controls endothelial uptake and transport of fatty acids in heart and skeletal muscle(7). Here we show that decreased VEGF-B signalling in rodent models of type 2 diabetes restores insulin sensitivity and improves glucose tolerance. Genetic deletion of Vegfb in diabetic db/db mice prevented ectopic lipid deposition, increased-muscle glucose uptake and maintained normoglycaemia. Pharmacological inhibition of VEGF-B signalling by antibody administration to db/db mice enhanced glucose tolerance, preserved pancreatic islet architecture, improved beta-cell function and ameliorated dyslipidaemia, key elements of type 2 diabetes and the metabolic syndrome. The potential use of VEGF-B neutralization in type 2 diabetes was further elucidated in rats fed a high-fat diet, in which it normalized insulin sensitivity and increased glucose uptake in skeletal muscle and heart. Our results demonstrate that the vascular endothelium can function as an efficient barrier to excess muscle lipid uptake even under conditions of severe obesity and type 2 diabetes, and that this barrier can be maintained by inhibition of VEGF-B signalling. We propose VEGF-B antagonism as a novel pharmacological approach for type 2 diabetes, targeting the lipid-transport properties of the endothelium to improve muscle insulin sensitivity and glucose disposal.	[Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Nyqvist, Daniel; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Muhl, Lars] Karolinska Inst, Stockholm Branch, Ludwig Inst Canc Res Ltd, SE-17177 Stockholm, Sweden; [Fam, Barbara C.; Proietto, Joseph; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med AH, Heidelberg, Vic 3091, Australia; [Ortsater, Henrik; Sjoholm, Ake] Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, SE-11883 Stockholm, Sweden; [Scotney, Pierre; Nash, Andrew] CSL Ltd, Parkville, Vic 3052, Australia; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Dept Neuroradiol, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Karolinska Expt Res & Imaging Ctr, SE-17176 Stockholm, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Melbourne; Karolinska Institutet; CSL; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Mehlem, Annika/AAB-4883-2022	Nyqvist, Daniel/0000-0002-6527-6716; Hagberg, Carolina/0000-0002-5497-2855	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation; Diabetes Foundation; Karolinska Institutet	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Foundation; Karolinska Institutet(Karolinska Institutet)	We thank S. Wittgren and A. Gustafsson for technical assistance, and G. Christofori for the RIP VEGF-B mice. C.E.H. was supported by the Frans Wilhelm och Waldemar von Frenckells Fond and Wilhelm och Else Stockmanns Stiftelse. D.N. was supported by the Swedish Society for Medical Research. This study was supported by the Ludwig Institute for Cancer Research, the Novo Nordisk Foundation, the Swedish Cancer Foundation, the Swedish Research Council, Torsten och Ragnar Soderbergs Stiftelser, Dr Peter Wallenbergs Foundation for Economics and Technology, the Swedish Heart and Lung Foundation, the Diabetes Foundation and Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Albrecht I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014109; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Chaggar PS, 2009, DIABETES VASC DIS RE, V6, P146, DOI 10.1177/1479164109338772; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fujimoto WY., 2000, AM J MED S6A, V108, p9S, DOI DOI 10.1016/S0002-9343(00)00337-5; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lamont BJ, 2003, DIABETOLOGIA, V46, P1338, DOI 10.1007/s00125-003-1180-y; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2010, NEW ENGL J MED, V363, P291, DOI 10.1056/NEJMcibr1005397; NOLAN CJ, 1994, DIABETOLOGIA, V37, P976, DOI 10.1007/s001250050207; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 2010, DIABETES, V59, P2351, DOI 10.2337/db10-0912; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Visinoni S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1132, DOI 10.1152/ajpendo.90552.2008; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	38	200	217	4	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					426	+		10.1038/nature11464	http://dx.doi.org/10.1038/nature11464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023133				2022-12-01	WOS:000309918500051
J	Korkhov, VM; Mireku, SA; Locher, KP				Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.			Structure of AMP-PNP-bound vitamin B-12 transporter BtuCD-F	NATURE			English	Article							ABC TRANSPORTER; ATP-BINDING; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; MECHANISM; DOMAIN; INTERMEDIATE; SUGGEST; SYSTEM	The ATP-binding cassette (ABC) transporter BtuCD mediates the uptake of vitamin B-12 across the inner membrane of Escherichia coli. Previous structures have shown the conformations of apo states, but the transport mechanism has remained unclear. Here we report the 3.5 angstrom crystal structure of the transporter-binding protein complex BtuCD-BtuF (BtuCD-F) trapped in an beta-gamma-imidoadenosine 5'-phosphate (AMP-PNP)-bound intermediate state. Although the ABC domains (BtuD subunits) form the expected closed sandwich dimer, the membrane-spanning BtuC subunits adopt a new conformation, with the central translocation pathway sealed by a previously unrecognized cytoplasmic gate. A fully enclosed cavity is thus formed approximately halfway across the membrane. It is large enough to accommodate a vitamin B-12 molecule, and radioligand trapping showed that liposome-reconstituted BtuCD-F indeed contains bound B-12 in the presence of AMP-PNP. In combination with engineered disulphide crosslinking and functional assays, our data suggest an unexpected peristaltic transport mechanism that is distinct from those observed in other ABC transporters.	[Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Korkhov, Volodymyr/0000-0002-0962-9433	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection. We are grateful to R. Schibli and M. Badertscher for access to the gamma counter. This research was supported by the NCCR Structural Biology Zurich and Swiss National Science Foundation (grant SNF 31003A-131075/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	44	122	125	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					367	+		10.1038/nature11442	http://dx.doi.org/10.1038/nature11442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23000901				2022-12-01	WOS:000309918500038
J	Lotti, F; Imlach, WL; Saieva, L; Beck, ES; Hao, LT; Li, DK; Jiao, W; Mentis, GZ; Beattie, CE; McCabe, BD; Pellizzoni, L				Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Hao, Le T.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; Beattie, Christine E.; McCabe, Brian D.; Pellizzoni, Livio			An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL; NEURON; DEFECTS; PROTEIN; GENE; ZEBRAFISH; MODEL; BIOGENESIS; DEFICIENCY	Spinal muscular atrophy (SMA) is a motor neuron disease caused by deficiency of the ubiquitous survival motor neuron (SMN) protein. To define the mechanisms of selective neuronal dysfunction in SMA, we investigated the role of SMN-dependent U12 splicing events in the regulation of motor circuit activity. We show that SMN deficiency perturbs splicing and decreases the expression of a subset of U12 intron-containing genes in mammalian cells and Drosophila larvae. Analysis of these SMN target genes identifies Stasimon as a protein required for motor circuit function. Restoration of Stasimon expression in the motor circuit corrects defects in neuromuscular junction transmission and muscle growth in Drosophila SMN mutants and aberrant motor neuron development in SMN-deficient zebrafish. These findings directly link defective splicing of critical neuronal genes induced by SMN deficiency to motor circuit dysfunction, establishing a molecular framework for the selective pathology of SMA.	[Lotti, Francesco; Saieva, Luciano; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Imlach, Wendy L.; Beck, Erin S.; Jiao, Wei; McCabe, Brian D.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Hao, Le T.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University	McCabe, BD (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	brian@mccabelab.org; lp2284@columbia.edu	Imlach, Wendy/G-7609-2011; Lotti, Francesco/AAC-3186-2019; Beck, Erin/AAA-8399-2022	Imlach, Wendy/0000-0002-7521-9969; McCabe, Brian/0000-0003-1620-0501; Pellizzoni, Livio/0000-0002-9168-5628	NIH-NINDS [R01NS069601, R21NS077038, R01NS078375, R01NS050414]; DoD [W81XWH-08-1-0009, W81XWH-11-1-0753, W81XWH-11-1-0689]; SMA Foundation; MDA USA; FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069601, R01NS050414, R21NS077038, R01NS078375] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DoD(United States Department of Defense); SMA Foundation; MDA USA(Muscular Dystrophy Association); FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank Chris Henderson for invaluable comments. We are grateful to Spyros Artavanis-Tsakonas and Greg Matera for Drosophila stocks and reagents. This work was supported by grants from NIH-NINDS R01NS069601 and R21NS077038 (L. P.), R01NS078375 (G.Z.M.), and R01NS050414 (C. E. B.); DoD W81XWH-08-1-0009 and W81XWH-11-1-0753 (B. D. M.) and W81XWH-11-1-0689 (G.Z.M.); SMA Foundation (L. P. and C. E. B.); MDA USA (L. P.); FSMA A. Lewis Young Investigator Award (G.Z.M.); and Columbia University Motor Neuron Center (L. P. and B. D. M.).	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	225	234	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					440	454		10.1016/j.cell.2012.09.012	http://dx.doi.org/10.1016/j.cell.2012.09.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063131	Green Accepted, Bronze			2022-12-01	WOS:000309981000020
J	Sharpley, MS; Marciniak, C; Eckel-Mahan, K; McManus, M; Crimi, M; Waymire, K; Lin, CS; Masubuchi, S; Friend, N; Koike, M; Chalkia, D; MacGregor, G; Sassone-Corsi, P; Wallace, DC				Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; McManus, Meagan; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Masubuchi, Satoru; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; MacGregor, Grant; Sassone-Corsi, Paolo; Wallace, Douglas C.			Heteroplasmy of Mouse mtDNA Is Genetically Unstable and Results in Altered Behavior and Cognition	CELL			English	Article							MAMMALIAN MITOCHONDRIAL-DNA; EVOLUTIONARY MEDICINE; SPERM MITOCHONDRIA; RAPID SEGREGATION; SELECTION; TRANSMISSION; BOTTLENECK; MODEL; MICE; REPLICATION	Maternal inheritance of mtDNA is the rule in most animals, but the reasons for this pattern remain unclear. To investigate the consequence of overriding uniparental inheritance, we generated mice containing an admixture (heteroplasmy) of NZB and 129S6 mtDNAs in the presence of a congenic C57BL/6J nuclear background. Analysis of the segregation of the two mtDNAs across subsequent maternal generations revealed that proportion of NZB mtDNA was preferentially reduced. Ultimately, this segregation process produced NZB-129 heteroplasmic mice and their NZB or 129 mtDNA homoplasmic counterparts. Phenotypic comparison of these three mtDNA lines demonstrated that the NZB-129 heteroplasmic mice, but neither homoplasmic counterpart, had reduced activity, food intake, respiratory exchange ratio; accentuated stress response; and cognitive impairment. Therefore, admixture of two normal but different mouse mtDNAs can be genetically unstable and can produce adverse physiological effects, factors that may explain the advantage of uniparental inheritance of mtDNA.	[Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; Marciniak, Christine; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; MacGregor, Grant; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; Sassone-Corsi, Paolo; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Eckel-Mahan, Kristin; Masubuchi, Satoru; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Waymire, Katrina; MacGregor, Grant] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Colket Translat Res Bldg, Philadelphia, PA 19104 USA.	wallaced1@email.chop.edu	McManus, Meagan J/F-7932-2018; Chalkia, Dimitra/J-3793-2016; Crimi, Marco/A-4032-2008	McManus, Meagan J/0000-0001-6064-0665; Chalkia, Dimitra/0000-0003-4780-544X; Crimi, Marco/0000-0001-6903-9163; Eckel-Mahan, Kristin/0000-0001-8201-1675	NIH [HD36437, HD45913, NS21328, NS070298, AG24373, DK73691]; California Institute of Regenerative Medicine [RC1-00353]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045913, R01HD036437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS070298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We express our special appreciation for the technical contributions of Prasanth Potluri, PhD, Marie Lott, Christopher deSolis, Kierstin Keller, Stefanie Navarro, and Paulette Allard. This work was supported by NIH grants HD36437 and HD45913 to G. R. M. and NS21328, NS070298, AG24373, and DK73691, and California Institute of Regenerative Medicine grant RC1-00353 awarded to D. C. W.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; ALONSO SJ, 1991, PHYSIOL BEHAV, V49, P69, DOI 10.1016/0031-9384(91)90232-D; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Flaisher-Grinberg S, 2010, J PSYCHOPHARMACOL, V24, P437, DOI 10.1177/0269881108097905; Gindre C, 2010, ENCEPHALE, V36, pD92, DOI 10.1016/j.encep.2008.09.006; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Hogan B., 2014, MANIPULATING MOUSE E; Isobe Y, 2011, J NEUROSCI RES, V89, P929, DOI 10.1002/jnr.22609; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012; Minassian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024185; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011; Poole JC, 2010, BIOL CHEM, V391, P1115, DOI 10.1515/BC.2010.125; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sartori SB, 2012, NEUROPHARMACOLOGY, V62, P304, DOI 10.1016/j.neuropharm.2011.07.027; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; SOLIGNAC M, 1987, GENETICS, V117, P687; Sportiche N, 2010, NEUROSCIENCE, V170, P247, DOI 10.1016/j.neuroscience.2010.06.038; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808	47	243	249	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					333	343		10.1016/j.cell.2012.09.004	http://dx.doi.org/10.1016/j.cell.2012.09.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063123	Green Accepted, Bronze			2022-12-01	WOS:000309981000012
J	Ekiert, DC; Kashyap, AK; Steel, J; Rubrum, A; Bhabha, G; Khayat, R; Lee, JH; Dillon, MA; O'Neil, RE; Faynboym, AM; Horowitz, M; Horowitz, L; Ward, AB; Palese, P; Webby, R; Lerner, RA; Bhatt, RR; Wilson, IA				Ekiert, Damian C.; Kashyap, Arun K.; Steel, John; Rubrum, Adam; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Ward, Andrew B.; Palese, Peter; Webby, Richard; Lerner, Richard A.; Bhatt, Ramesh R.; Wilson, Ian A.			Cross-neutralization of influenza A viruses mediated by a single antibody loop	NATURE			English	Article							POTENT NEUTRALIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HEMAGGLUTININ; EPITOPE; SYSTEM; BROAD; RECOGNITION; INSERTIONS; DELETIONS	Immune recognition of protein antigens relies on the combined interaction of multiple antibody loops, which provide a fairly large footprint and constrain the size and shape of protein surfaces that can be targeted. Single protein loops can mediate extremely high-affinity binding, but it is unclear whether such a mechanism is available to antibodies. Here we report the isolation and characterization of an antibody called C05, which neutralizes strains from multiple subtypes of influenza A virus, including H1, H2 and H3. X-ray and electron microscopy structures show that C05 recognizes conserved elements of the receptor-binding site on the haemagglutinin surface glycoprotein. Recognition of the haemagglutinin receptor-binding site is dominated by a single heavy-chain complementarity-determining region 3 loop, with minor contacts from heavy-chain complementarity-determining region 1, and is sufficient to achieve nanomolar binding with a minimal footprint. Thus, binding predominantly with a single loop can allow antibodies to target small, conserved functional sites on otherwise hypervariable antigens.	[Ekiert, Damian C.; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kashyap, Arun K.; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Bhatt, Ramesh R.] Sea Lane Biotechnol, Mountain View, CA 94043 USA; [Steel, John; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Rubrum, Adam; Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ramesh.bhatt@sealanebio.com; wilson@scripps.edu	Ward, Andrew/ABD-7728-2021; Webby, Richard J/N-5657-2018; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Palese, Peter/0000-0002-0337-5823; Lee, Jeong Hyun/0000-0001-7371-845X; Ekiert, Damian/0000-0002-2570-0404	National Institutes of Health (NIH) [P01AI058113]; Achievement Rewards for College Scientists Foundation [GM080209]; NIH Molecular Evolution Training Program; Skaggs Institute; Northeast Biodefense Center [U54-AI057158-Lipkin]; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI070373]; Center for Research on Influenza Pathogenesis NIAID [HHSN266200700010C]; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences (NIGMS); National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NIH though the P41 program at the National Center for Research Resources [RR017573]; NIH [U54 GM094586]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070373, U54AI057158, P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209, U54GM094586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; Northeast Biodefense Center; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Research on Influenza Pathogenesis NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH though the P41 program at the National Center for Research Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien and D. Marciano for automated crystal screening, the staff of the Advanced Photon Source (APS) GM/CA-CAT and Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 for beamline support, X. Dai and R. Stanfield for assistance with data collection and processing, M. Hothorn for assistance with ITC experiments, J. Paulson and D. Burton for comments and discussion, A. Estelles and R. Briante, L. Xu, S. Wang and D. Corn for technical support and P. Foremanfor assistance with animal study design. This project was funded in part by National Institutes of Health (NIH) grant P01AI058113 (I. A. W.), a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.), grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.), the Skaggs Institute (I. A. W.), a career development fellowship from the Northeast Biodefense Center (U54-AI057158-Lipkin) (J. S.), National Institute of Allergy and Infectious Diseases (NIAID) grant U01AI070373 (R. W.), and Center for Research on Influenza Pathogenesis NIAID contract HHSN266200700010C (P. P.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences (NIGMS). The GM/CA-CAT 23-ID-B beamline has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The electron microscopy data presented here was collected at the National Resource for Automated Molecular Microscopy, which is supported by the NIH though the P41 program (RR017573) at the National Center for Research Resources. The JCSG is supported by NIH grant U54 GM094586. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. This is publication 21421 from The Scripps Research Institute.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MIYAZAKI J, 1989, GENE, V79, P269; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Smith T, 1996, BRIT MED J, V312, P383; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	50	338	367	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					526	+		10.1038/nature11414	http://dx.doi.org/10.1038/nature11414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22982990	Green Accepted			2022-12-01	WOS:000309167100042
J	Silverman, EK				Silverman, Edwin K.			PERSPECTIVE How can genetics help?	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; GENOME		[Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Silverman, Edwin K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Silverman, EK (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu						Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	8	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S7	S7		10.1038/489S7a	http://dx.doi.org/10.1038/489S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013715				2022-12-01	WOS:000309167100004
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The key to longevity	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Black D, 1982, INEQUALITIES HLTH BL; Kamerow D, 2007, BRIT MED J, V334, P126, DOI 10.1136/bmj.39097.516609.59; Link BG, 2005, POLICY CHALLENGES MO, P71; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Tavernise Sabrina, 2012, NEW YORK TIMES  0112, pA1	6	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6456	10.1136/bmj.e6456	http://dx.doi.org/10.1136/bmj.e6456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014907				2022-12-01	WOS:000309385500013
J	Wagschal, A; Rousset, E; Basavarajaiah, P; Contreras, X; Harwig, A; Laurent-Chabalier, S; Nakamura, M; Chen, X; Zhang, K; Meziane, O; Boyer, F; Parrinello, H; Berkhout, B; Terzian, C; Benkirane, M; Kiernan, R				Wagschal, Alexandre; Rousset, Emilie; Basavarajaiah, Poornima; Contreras, Xavier; Harwig, Alex; Laurent-Chabalier, Sabine; Nakamura, Mirai; Chen, Xin; Zhang, Ke; Meziane, Oussama; Boyer, Frederic; Parrinello, Hugues; Berkhout, Ben; Terzian, Christophe; Benkirane, Monsef; Kiernan, Rosemary			Microprocessor, Setx, Xrn2, and Rrp6 Co-operate to Induce Premature Termination of Transcription by RNAPII	CELL			English	Article							POLYMERASE-II; PAUSE SITES; HIV-1; GENE; COMPLEX; INTERFERENCE; RECRUITMENT; PROTEASOME; INITIATION; DOMAIN	Transcription elongation is increasingly recognized as an important mechanism of gene regulation. Here, we show that microprocessor controls gene expression in an RNAi-independent manner. Microprocessor orchestrates the recruitment of termination factors Setx and Xrn2, and the 30-50 exoribonuclease, Rrp6, to initiate RNAPII pausing and premature termination at the HIV-1 promoter through cleavage of the stem-loop RNA, TAR. Rrp6 further processes the cleavage product, which generates a small RNA that is required to mediate potent transcriptional repression and chromatin remodeling at the HIV-1 promoter. Using chromatin immunoprecipitation coupled to high-throughput sequencing (ChIP-seq), we identified cellular gene targets whose transcription is modulated by microprocessor. Our study reveals RNAPII pausing and premature termination mediated by the co-operative activity of ribonucleases, Drosha/Dgcr8, Xrn2, and Rrp6, as a regulatory mechanism of RNAPII-dependent transcription elongation.	[Wagschal, Alexandre; Laurent-Chabalier, Sabine; Zhang, Ke; Meziane, Oussama; Benkirane, Monsef; Kiernan, Rosemary] CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France; [Harwig, Alex; Berkhout, Ben] Univ Amsterdam, Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Boyer, Frederic; Terzian, Christophe] Univ Lyon 1, INRA, EPHE, ENVL,Retrovirus & Pathol Comparee, F-69366 Lyon 07, France; [Parrinello, Hugues] MGX Montpellier GenomiX, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Amsterdam; INRAE; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Claude Bernard Lyon 1; VetAgro Sup; Universite de Montpellier	Kiernan, R (corresponding author), CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France.	rosemary.kiernan@igh.cnrs.fr	Harwig, Alex/AAG-9952-2020; Boyer, Frédéric/AAR-8176-2020; Kiernan, Rosemary/GXV-8695-2022; Boyer, Frédéric/Y-2184-2018; contreras, xavier/ABA-3533-2020	Boyer, Frédéric/0000-0003-0021-9590; Boyer, Frédéric/0000-0003-0021-9590; contreras, xavier/0000-0003-0748-6923; Harwig, Alex/0000-0002-1117-9216; Kiernan, Rosemary/0000-0001-6645-0686	ERC [250333]; ANR-BLAN [0040]; Sidaction; ANRS; FRM "equipe labellisee''; ANR; ERC; CNRS; FRM; RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); ANR-BLAN(French National Research Agency (ANR)); Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); FRM "equipe labellisee''; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); FRM(Fondation pour la Recherche Medicale); RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Molecular Virology and Gene Regulation labs for critical reading of the manuscript, N. Kim for Drosha WT and mutant plasmids, and S. Emiliani for HeLa-LTR-luc. ChIP-seq experiments were performed using MGX-Montpellier facilities. This work was supported by grants from the ERC (250333), ANR-BLAN-0040, Sidaction, ANRS, and FRM "equipe labellisee'' to M.B. and ANRS and Sidaction to R.K. A.W. was supported by ANR and ERC; E.R. and M.N. by Sidaction; P.B. by ANRS; S.L.-C. by ERC; X. Chen by CNRS and FRM; K.Z. by CNRS; O.M. by RTRS grand Sud; and B.B. by The Netherlands Organization for Scientific Research (NWO-CW, Top grant).	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-13; Nechaev Sergei, 2011, Biochim Biophys Acta, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wagschal Alexandre, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4767; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	126	126	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1147	1157		10.1016/j.cell.2012.08.004	http://dx.doi.org/10.1016/j.cell.2012.08.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980978	Bronze, Green Accepted			2022-12-01	WOS:000308928100009
J	McCartney, M				McCartney, Margaret			Statins for all?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cohen JD, 2012, J CLIN LIPIDOL, V6, P208, DOI 10.1016/j.jacl.2012.03.003; Collins N, DAILY TELEGRAPH; Collins R, TOP NEWS        0829; European Society of Cardiology, CAS STAT WID POP; Gaskell S, WALES ONLINE    0830; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hope J, ADELAIDE NOW    0829; Hope J, DAILY MAIL; Lefever R, DAILY MAIL; MRC/BHF Heart Protection Study Collaborative Group, 2009, BMC Clin Pharmacol, V9, P6, DOI 10.1186/1472-6904-9-6; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	13	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2012	345								e6044	10.1136/bmj.e6044	http://dx.doi.org/10.1136/bmj.e6044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BP	22977108				2022-12-01	WOS:000308864100010
J	Petruk, S; Sedkov, Y; Johnston, DM; Hodgson, JW; Black, KL; Kovermann, SK; Beck, S; Canaani, E; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Hodgson, Jacob W.; Black, Kathryn L.; Kovermann, Sina K.; Beck, Samantha; Canaani, Eli; Brock, Hugh W.; Mazo, Alexander			TrxG and PcG Proteins but Not Methylated Histones Remain Associated with DNA through Replication	CELL			English	Article							POLYCOMB RESPONSE ELEMENT; EPIGENETIC INHERITANCE; METHYLTRANSFERASE ACTIVITY; CHROMATIN; DROSOPHILA; TRITHORAX; COMPLEX; BINDING; GENES; SITES	Propagation of gene-expression patterns through the cell cycle requires the existence of an epigenetic mark that re-establishes the chromatin architecture of the parental cell in the daughter cells. We devised assays to determine which potential epigenetic marks associate with epigenetic maintenance elements during DNA replication in Drosophila embryos. Histone H3 trimethylated at lysines 4 or 27 is present during transcription but, surprisingly, is replaced by nonmethylated H3 following DNA replication. Methylated H3 is detected on DNA only in nuclei not in S phase. In contrast, the TrxG and PcG proteins Trithorax and Enhancer-of-Zeste, which are H3K4 and H3K27 methylases, and Polycomb continuously associate with their response elements on the newly replicated DNA. We suggest that histone modification enzymes may re-establish the histone code on newly assembled unmethylated histones and thus may act as epigenetic marks.	[Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Hodgson, Jacob W.; Kovermann, Sina K.; Beck, Samantha; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Jefferson University; University of British Columbia; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	mazo@mail.jci.tju.edu			Canadian Institutes of Health Research;  [NIH R01GM075141];  [NIH P01CA129242]; NATIONAL CANCER INSTITUTE [P01CA050507, P01CA129242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Valerio Orlando, Nicole Francis, Richard Jones, and Yi Zhang for antibodies. This work was supported by the following grants: NIH R01GM075141, NIH P01CA129242 to A.M., and a grant from the Canadian Institutes of Health Research to H.W.B.	Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; BROWN DD, 1984, PHILOS T ROY SOC B, V307, P297, DOI 10.1098/rstb.1984.0130; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dellino GI, 2002, INT J DEV BIOL, V46, P133; Dietzel S, 1999, CHROMOSOMA, V108, P83, DOI 10.1007/s004120050355; Fanti L, 2008, CHROMOSOMA, V117, P25, DOI 10.1007/s00412-007-0123-7; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Fonseca JP, 2012, GENE DEV, V26, P857, DOI 10.1101/gad.184648.111; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; KASSIS JA, 1994, GENETICS, V136, P1025; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; KRIEGSTEIN HJ, 1974, P NATL ACAD SCI USA, V71, P135, DOI 10.1073/pnas.71.1.135; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tillib S, 1999, MOL CELL BIOL, V19, P5189	44	178	185	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					922	933		10.1016/j.cell.2012.06.046	http://dx.doi.org/10.1016/j.cell.2012.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921915	Green Accepted, Bronze			2022-12-01	WOS:000308500200008
J	Prasad, KVSK; Song, BH; Olson-Manning, C; Anderson, JT; Lee, CR; Schranz, ME; Windsor, AJ; Clauss, MJ; Manzaneda, AJ; Naqvi, I; Reichelt, M; Gershenzon, J; Rupasinghe, SG; Schuler, MA; Mitchell-Olds, T				Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Clauss, Maria J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Reichelt, Michael; Gershenzon, Jonathan; Rupasinghe, Sanjeewa G.; Schuler, Mary A.; Mitchell-Olds, Thomas			A Gain-of-Function Polymorphism Controlling Complex Traits and Fitness in Nature	SCIENCE			English	Article							BOECHERA-STRICTA; BIOSYNTHESIS; CYTOCHROME-P450; CYP79F1; CYP83B1	Identification of the causal genes that control complex trait variation remains challenging, limiting our appreciation of the evolutionary processes that influence polymorphisms in nature. We cloned a quantitative trait locus that controls plant defensive chemistry, damage by insect herbivores, survival, and reproduction in the natural environments where this polymorphism evolved. These ecological effects are driven by duplications in the BCMA (branched-chain methionine allocation) loci controlling this variation and by two selectively favored amino acid changes in the glucosinolate-biosynthetic cytochrome P450 proteins that they encode. These changes cause a gain of novel enzyme function, modulated by allelic differences in catalytic rate and gene copy number. Ecological interactions in diverse environments likely contribute to the widespread polymorphism of this biochemical function.	[Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Clauss, Maria J.; Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Rupasinghe, Sanjeewa G.; Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Duke University; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Mitchell-Olds, T (corresponding author), Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA.	tmo1@duke.edu	Olson-Manning, Carrie/K-2724-2012; Mitchell-Olds, Thomas/K-8121-2012; Schranz, M. Eric/AAB-7601-2022; Manzaneda, Antonio/AAG-1776-2019; Gershenzon, Jonathan/K-1331-2013; Schranz, Michael/D-7155-2017; Song, Bao-Hua/B-4867-2017	Mitchell-Olds, Thomas/0000-0003-3439-9921; Schranz, M. Eric/0000-0001-6777-6565; Gershenzon, Jonathan/0000-0002-1812-1551; Schranz, Michael/0000-0001-6777-6565; Anderson, Jill/0000-0002-3253-8142; Lee, Cheng-Ruei/0000-0002-1913-9964; Manzaneda Avila, Antonio Jose/0000-0001-9384-7910; Olson-Manning, Carrie/0000-0001-8054-3889; Song, Bao-Hua/0000-0003-3537-7783	Heald family; NIH [R01-GM086496, R01-GM079530]; NSF [EF-0723447, 1011167, 1110445]; Netherlands Organization for Scientific Research (NWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086496, R01GM079530] Funding Source: NIH RePORTER; Division Of Environmental Biology [1011167] Funding Source: National Science Foundation	Heald family; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Colautti, K. Donohue, M. Feder, T. Pendergast, M. Rausher, C. Rushworth, A. Shumate, M. Wagner, J. Willis, and two anonymous reviewers for helpful comments. K. Springer, E. Ballweg, M. Cameron, K. Chu, S. Hurst, V. Cousins, K. Dales, R. Doll, J. Lutkenhaus, M. Mitchell-Olds, S. Mitchell-Olds, E. Raskin, J. Rivera, L. Saucier, M. Wagner, and T. Weiss-Lehman helped in lab and field. N. Wicks and Bitterroot National Forest allowed us to work on their property. We thank the Heald family for support and hospitality. Supported by NIH grants R01-GM086496 (T.M.-O.) and R01-GM079530 (M. A. S.), NSF grant EF-0723447 (T.M.-O.); NSF dissertation grants 1011167 (C.O.-M.) and 1110445 (C.-R.L.); and a Netherlands Organization for Scientific Research (NWO) Ecogenomics grant (M. E. S.). Data in the supplementary materials are also available as GenBank accession nos. JX185680, JX185681, and BCMA JQ337904 to BCMA JQ337909. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.kc6m8.	Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Brunelle A, 2005, QUATERNARY SCI REV, V24, P2281, DOI 10.1016/j.quascirev.2004.11.010; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Poulos T. L., 2005, CYTOCHROME P450 STRU, P217; Poulos T. L., 2007, UBIQUITOUS ROLES CYT, P57; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Schranz ME, 2009, HEREDITY, V102, P465, DOI 10.1038/hdy.2009.12; Schranz ME, 2007, PLANT PHYSIOL, V144, P286, DOI 10.1104/pp.107.096685; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	19	123	123	1	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1081	1084		10.1126/science.1221636	http://dx.doi.org/10.1126/science.1221636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936775	Green Accepted			2022-12-01	WOS:000308125800043
J	Lum, L; Clevers, H				Lum, Lawrence; Clevers, Hans			The Unusual Case of Porcupine	SCIENCE			English	Editorial Material							INTESTINAL STEM-CELLS; LUNG ADENOCARCINOMA; WNT; MUTATIONS; METASTASIS; PATHWAYS; DISEASE; CANCER; GENES		[Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Lum, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu; h.clevers@hubrecht.eu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061303] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD061303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2012, EMBO C 30 YEARS WNT; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	18	52	52	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					922	923		10.1126/science.1228179	http://dx.doi.org/10.1126/science.1228179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923569	Green Accepted			2022-12-01	WOS:000307807600032
J	Singer, T				Singer, Thea			NUTRITION The vitamin D complex	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; D DEFICIENCY; COPD											Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Gold DR, 2012, ANN INTERN MED, V156, P156, DOI 10.7326/0003-4819-156-2-201201170-00013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Persson LJ, 2012, AM J RESP CRIT CARE, V185, pA3889; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	9	6	6	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S10	S11		10.1038/489S10a	http://dx.doi.org/10.1038/489S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013708	Bronze			2022-12-01	WOS:000309167100006
J	Dance, A				Dance, Amber			HEALTH IMPACT Breathless	NATURE			English	Editorial Material																			0	69	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S2	S2		10.1038/489S2a	http://dx.doi.org/10.1038/489S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013713	Bronze			2022-12-01	WOS:000309167100002
